PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Li, DL; Zhao, ZJ; Huang, YD; Lu, ZJ; Yao, M; Hao, YJ; Zhai, CH; Wang, YC				Li, Delong; Zhao, Zhijian; Huang, Yidan; Lu, Zhaojun; Yao, Meng; Hao, Yujuan; Zhai, Chunhua; Wang, Yuanchao			PsVPS1, a Dynamin-Related Protein, Is Involved in Cyst Germination and Soybean Infection of Phytophthora sojae	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CANDIDA-ALBICANS; FUNCTIONAL-ANALYSIS; VACUOLE BIOGENESIS; FILAMENTOUS FUNGI; USTILAGO-MAYDIS; YEAST; PATHOGEN; AVIRULENCE; SECRETION	Plant pathogens secrete effector proteins to suppress plant immunity. However, the mechanism by which oomycete pathogens deliver effector proteins during plant infection remains unknown. In this report, we characterized a Phytophthora sojae vps1 gene. This gene encodes a homolog of the Saccharomyces cerevisiae vacuolar protein sorting gene vps1 that mediates budding of clathrin-coated vesicles from the late Golgi, which are diverted from the general secretory pathway to the vacuole. PsVPS1-silenced mutants were generated using polyethylene glycol-mediated protoplast stable transformation and were viable but had reduced extracellular protein activity. The PsVPS1-silenced mutants showed impaired hyphal growth, and the shapes of the vacuoles were highly fragmented. Silencing of PsVPS1 affected cyst germination as well as the polarized growth of germinated cysts. Silenced mutants showed impaired invasion of susceptible soybean plants regardless of wounding. These results suggest that PsVPS1 is involved in vacuole morphology and cyst development. Moreover, it is essential for the virulence of P. sojae and extracellular protein secretion.	[Wang, Yuanchao] Nanjing Agr Univ, Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Jiangsu, Peoples R China; Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Nanjing Agricultural University	Wang, YC (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Jiangsu, Peoples R China.	wangyc@njau.edu.cn	wang, yuanchao/G-9667-2011	wang, yuanchao/0000-0001-5803-5343	National Natural Science Funds for Distinguished Young Scholar from the Chinese government [31225022]	National Natural Science Funds for Distinguished Young Scholar from the Chinese government	This work was supported by National Natural Science Funds for Distinguished Young Scholar (31225022) from the Chinese government to YCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Fong AMV, 2011, FUNGAL BIOL-UK, V115, P882, DOI 10.1016/j.funbio.2011.07.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barelle CJ, 2006, EUKARYOT CELL, V5, P359, DOI 10.1128/EC.5.2.359-367.2006; Bernardo SM, 2008, FUNGAL GENET BIOL, V45, P861, DOI 10.1016/j.fgb.2008.01.001; Birch PRJ, 2001, MOL PLANT PATHOL, V2, P257, DOI 10.1046/j.1464-6722.2001.00073.x; Bruckmann A, 2001, YEAST, V18, P343, DOI 10.1002/1097-0061(20010315)18:4&lt;343::AID-YEA675&gt;3.0.CO;2-Z; Conesa A, 2001, FUNGAL GENET BIOL, V33, P155, DOI 10.1006/fgbi.2001.1276; CONIBEAR E, 1995, CELL, V83, P513, DOI 10.1016/0092-8674(95)90088-8; Cornet M, 2005, INFECT IMMUN, V73, P7977, DOI 10.1128/IAI.73.12.7977-7987.2005; Doehlemann G, 2011, MOL MICROBIOL, V81, P751, DOI 10.1111/j.1365-2958.2011.07728.x; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Erwin D. C., 1996, Phytophthora diseases worldwide.; Franke K, 2006, MICROBIOL-SGM, V152, P3111, DOI 10.1099/mic.0.29115-0; Gilbert MJ, 2006, NATURE, V440, P535, DOI 10.1038/nature04567; Gow Neil A. R., 1997, Current Topics in Medical Mycology, V8, P43; Griffin D., 1996, FUNGAL PHYSL; Guerriero G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001070; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; HERTH W, 1980, PROTOPLASMA, V105, P129, DOI 10.1007/BF01279855; Howlett BJ, 2009, PLOS PATHOG, V5; Hua CL, 2008, EUKARYOT CELL, V7, P2133, DOI 10.1128/EC.00286-08; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; JUDELSON HS, 1991, MOL PLANT MICROBE IN, V4, P602, DOI 10.1094/MPMI-4-602; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; Kroon LPNM, 2012, PHYTOPATHOLOGY, V102, P348, DOI 10.1094/PHYTO-01-11-0025; Kuravi K, 2006, J CELL SCI, V119, P3994, DOI 10.1242/jcs.03166; Lee SA, 2007, FEMS YEAST RES, V7, P973, DOI 10.1111/j.1567-1364.2007.00253.x; LIN CC, 1970, ARCH MIKROBIOL, V72, P111, DOI 10.1007/BF00409517; MACKENZIE DA, 1993, J GEN MICROBIOL, V139, P2295, DOI 10.1099/00221287-139-10-2295; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; McLeod A, 2004, EUKARYOT CELL, V3, P91, DOI 10.1128/EC.3.1.91-99.2004; Mishra Ritu, 2011, Commun Integr Biol, V4, P115, DOI 10.4161/cib.4.1.14206; MOEHLE CM, 1989, J CELL BIOL, V108, P309, DOI 10.1083/jcb.108.2.309; Morris PF, 1998, PLANT PHYSIOL, V117, P1171, DOI 10.1104/pp.117.4.1171; Palmer GE, 2003, EUKARYOT CELL, V2, P411, DOI 10.1128/EC.2.3.411-421.2003; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Rafiqi M, 2010, PLANT CELL, V22, P2017, DOI 10.1105/tpc.109.072983; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Rothlisberger S, 2009, FUNGAL GENET BIOL, V46, P927, DOI 10.1016/j.fgb.2009.07.008; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Siriputthaiwan P, 2005, J CELL SCI, V118, P323, DOI 10.1242/jcs.01616; Smaczynska-de Rooij II, 2010, J CELL SCI, V123, P3496, DOI 10.1242/jcs.070508; Steinberg G, 1998, J CELL SCI, V111, P2235; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Takegawa K, 2003, CELL STRUCT FUNCT, V28, P399, DOI 10.1247/csf.28.399; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tarutani Y, 2001, GENE, V268, P23, DOI 10.1016/S0378-1119(01)00418-8; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Van Damme M, 2005, MOL PLANT MICROBE IN, V18, P583, DOI 10.1094/MPMI-18-0583; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wrather JA, 2006, J NEMATOL, V38, P173; Ye WW, 2011, MOL PLANT MICROBE IN, V24, P1530, DOI 10.1094/MPMI-05-11-0106; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988; Zhao W, 2011, FUNGAL GENET BIOL, V48, P241, DOI 10.1016/j.fgb.2010.11.006; Zuo YuHu, 2005, Acta Phytopathologica Sinica, V35, P235	58	4	4	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58623	10.1371/journal.pone.0058623	http://dx.doi.org/10.1371/journal.pone.0058623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516518	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400041
J	Barriga, M; Cal, R; Cabello, N; Llach, A; Vallmitjana, A; Benitez, R; Badimon, L; Cinca, J; Llorente-Cortes, V; Hove-Madsen, L				Barriga, Montserrat; Cal, Roi; Cabello, Nuria; Llach, Anna; Vallmitjana, Alexander; Benitez, Raul; Badimon, Lina; Cinca, Juan; Llorente-Cortes, Vicenta; Hove-Madsen, Leif			Low Density Lipoproteins Promote Unstable Calcium Handling Accompanied by Reduced SERCA2 and Connexin-40 Expression in Cardiomyocytes	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; HUMAN ATRIAL-FIBRILLATION; VENTRICULAR-FIBRILLATION; SARCOPLASMIC-RETICULUM; MYOCYTES; PROTEIN; ARRHYTHMIAS; SIMVASTATIN; RECEPTORS; JUNCTIONS	The damaging effects of high plasma levels of cholesterol in the cardiovascular system are widely known, but little attention has been paid to direct effects on cardiomyocyte function. We therefore aimed at testing the hypothesis that Low Density Lipoprotein (LDL) cholesterol affects calcium dynamics and signal propagation in cultured atrial myocytes. For this purpose, mRNA and protein expression levels were determined by real time PCR and western blot analysis, respectively, and intracellular calcium was visualized in fluo-4 loaded atrial HL-1 myocyte cultures subjected to field stimulation. At low stimulation frequencies all cultures had uniform calcium transients at all tested LDL concentrations. However, 500 mu g LDL/mL maximally reduced the calcium transient amplitude by 43% from 0.30 +/- 0.04 to 0.17 +/- 0.02 (p<0.05). Moreover, LDL-cholesterol dose-dependently increased the fraction of alternating and irregular beat-to-beat responses observed when the stimulation interval was shortened. This effect was linked to a concurrent reduction in SERCA2, RyR2, IP3RI and IP3RII mRNA levels. SERCA2 protein levels were also reduced by 43% at 200 mu g LDL/mL (p<0.05) and SR calcium loading was reduced by 38 +/- 6% (p<0.001). By contrast, HDL-cholesterol had no significant effect on SERCA expression or SR calcium loading. LDL-cholesterol also slowed the conduction velocity of the calcium signal from 3.2 +/- 0.2 mm/s without LDL to 1.7 +/- 0.1 mm/s with 500 mu g LDL/mL (p<0.05). This coincided with a reduction in Cx40 expression (by 44 +/- 3%; p<0.05 for mRNA and by 79 +/- 2%; p<0.05 for Cx40 protein at 200 mu g/ml LDL) whereas the Cx-43 expression did not significantly change. In conclusion, LDL-cholesterol destabilizes calcium handling in cultured atrial myocytes subjected to rapid pacing by reducing SERCA2 and Cx40 expression and by slowing the conduction velocity of the calcium signal.	[Barriga, Montserrat; Cal, Roi; Cabello, Nuria; Badimon, Lina; Llorente-Cortes, Vicenta; Hove-Madsen, Leif] CSIC, Inst Catala Ciencies Cardiovasc, Cardiovasc Res Ctr, Barcelona, Spain; [Barriga, Montserrat; Cal, Roi; Cabello, Nuria; Badimon, Lina; Llorente-Cortes, Vicenta; Hove-Madsen, Leif] Inst Invest Biomed St Pau, Barcelona, Spain; [Llach, Anna; Cinca, Juan] Inst Invest Biomed St Pau, Serv Cardiol, Barcelona, Spain; [Llach, Anna; Cinca, Juan] Univ Autonoma Barcelona, E-08193 Barcelona, Spain; [Badimon, Lina] Ctr Invest Biomed Red Obesidad & Nutr, Barcelona, Spain; [Vallmitjana, Alexander; Benitez, Raul] Univ Politecn Cataluna, Dept Ingn Sistemas Automat & Informat Ind, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat Politecnica de Catalunya	Llorente-Cortes, V (corresponding author), CSIC, Inst Catala Ciencies Cardiovasc, Cardiovasc Res Ctr, Barcelona, Spain.	cllorente@csic-iccc.org; lhove@csic-iccc.org	BADIMON, LINA/O-4711-2014; Benítez, Raúl/AGO-5018-2022; Vallmitjana, Alexander/B-5058-2019; BADIMON, LINA/S-2950-2019; Llach Martinez, Ana/M-6691-2016	BADIMON, LINA/0000-0002-9162-2459; Benítez, Raúl/0000-0002-8782-9406; Vallmitjana, Alexander/0000-0002-7149-9385; Llach Martinez, Ana/0000-0002-7486-1079; Hove-Madsen, Leif/0000-0001-5493-3998; Llach, Anna/0000-0002-4352-2920	Spanish Ministry of Science and Innovation [SAF2011-30312, CNIC2009-08]; Spanish Ministry of Health and Consume [FIS PI11/00747]; Redes de Investigacion Cooperativa, Instituto de Salud Carlos III, red REDINSCOR [RD06-0003-0000, RD06-0003-0015];  [DPI2009-06999]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Health and Consume; Redes de Investigacion Cooperativa, Instituto de Salud Carlos III, red REDINSCOR; 	This work was supported by grants from the Spanish Ministry of Science and Innovation: SAF2011-30312 and CNIC2009-08 to Leif Hove Madsen, DPI2009-06999 to Raul Benitez and from the Spanish Ministry of Health and Consume: FIS PI11/00747 to Vicenta Llorente. Funding from Redes de Investigacion Cooperativa, Instituto de Salud Carlos III, red REDINSCOR RD06-0003-0000 and RD06-0003-0015 is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacova B, 2010, J PHYSIOL PHARMACOL, V61, P717; Castellano J, 2011, J MOL CELL CARDIOL, V50, P894, DOI 10.1016/j.yjmcc.2011.02.002; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Clunn GF, 2010, INT J CARDIOL, V139, P2, DOI 10.1016/j.ijcard.2009.05.019; de Groot JR, 2003, CARDIOVASC RES, V60, P288, DOI 10.1016/j.cardiores.2003.07.004; Draeger A, 2010, AM J PATHOL, V177, P291, DOI 10.2353/ajpath.2010.091140; Fujita S, 2008, HEART VESSELS, V23, P440, DOI 10.1007/s00380-008-1079-0; GOURDIE RG, 1993, J CELL SCI, V105, P985; Gray DF, 2000, CARDIOVASC RES, V47, P329, DOI 10.1016/S0008-6363(00)00106-1; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; Huang Y, 2004, CIRCULATION, V109, P97, DOI 10.1161/01.CIR.0000109213.10461.F6; Ito M, 2004, CIRCULATION, V110, P412, DOI 10.1161/01.CIR.0000136088.18960.E6; Kirchhoff S, 1998, CURR BIOL, V8, P299, DOI 10.1016/S0960-9822(98)70114-9; Lin LC, 2005, LAB INVEST, V85, P1224, DOI 10.1038/labinvest.3700324; Liu YB, 2003, CIRC RES, V92, P1145, DOI 10.1161/01.RES.0000072999.51484.92; Llach A, 2011, J PHYSIOL-LONDON, V589, P3247, DOI 10.1113/jphysiol.2010.197715; Llach A, 2011, EUR HEART J, V32, P721, DOI 10.1093/eurheartj/ehq464; Llorente-Cortes V, 2006, ARTERIOSCL THROM VAS, V26, P117, DOI 10.1161/01.ATV.0000193618.32611.8b; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; Maguy A, 2009, CIRC RES, V104, P1113, DOI 10.1161/CIRCRESAHA.108.191809; Muhlhauser U, 2006, FASEB J, V20, P785, DOI 10.1096/fj.05-5067fje; Osadchii OE, 2011, AM J PHYSIOL-HEART C, V300, pH989, DOI 10.1152/ajpheart.00816.2010; Pogwizd SM, 2000, CIRC RES, V87, P641, DOI 10.1161/01.RES.87.8.641; Seto SW, 2007, BRIT J PHARMACOL, V151, P987, DOI 10.1038/sj.bjp.0707327; van der Velden HMW, 2002, CARDIOVASC RES, V54, P270, DOI 10.1016/S0008-6363(01)00557-0; van der Velden HMW, 1998, J CARDIOVASC ELECTR, V9, P596; Van Wagoner DR, 1999, CIRC RES, V85, P428, DOI 10.1161/01.RES.85.5.428; VanWagoner DR, 1997, CIRC RES, V80, P772; Wehrens XHT, 2004, SCIENCE, V304, P292, DOI 10.1126/science.1094301; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Yeh HI, 2003, ARTERIOSCL THROM VAS, V23, P1391, DOI 10.1161/01.ATV.0000083508.21989.15; Zipes DP, 1998, CIRCULATION, V98, P2334, DOI 10.1161/01.CIR.98.21.2334	32	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58128	10.1371/journal.pone.0058128	http://dx.doi.org/10.1371/journal.pone.0058128			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516438	Green Published, gold			2022-12-27	WOS:000316849200035
J	Naviaux, RK; Zolkipli, Z; Wang, L; Nakayama, T; Naviaux, JC; Le, TP; Schuchbauer, MA; Rogac, M; Tang, QB; Dugan, LL; Powell, SB				Naviaux, Robert K.; Zolkipli, Zarazuela; Wang, Lin; Nakayama, Tomohiro; Naviaux, Jane C.; Le, Thuy P.; Schuchbauer, Michael A.; Rogac, Mihael; Tang, Qingbo; Dugan, Laura L.; Powell, Susan B.			Antipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model	PLOS ONE			English	Article							RECEPTOR; ACTIVATION; CHILDREN; PROTEIN; STRESS; BRAIN; ABNORMALITIES; MITOCHONDRIA; SUPPRESSION; CEREBELLUM	Background: Autism spectrum disorders (ASDs) are caused by both genetic and environmental factors. Mitochondria act to connect genes and environment by regulating gene-encoded metabolic networks according to changes in the chemistry of the cell and its environment. Mitochondrial ATP and other metabolites are mitokines-signaling molecules made in mitochondria-that undergo regulated release from cells to communicate cellular health and danger to neighboring cells via purinergic signaling. The role of purinergic signaling has not yet been explored in autism spectrum disorders. Objectives and Methods: We used the maternal immune activation (MIA) mouse model of gestational poly(IC) exposure and treatment with the non-selective purinergic antagonist suramin to test the role of purinergic signaling in C57BL/6J mice. Results: We found that antipurinergic therapy (APT) corrected 16 multisystem abnormalities that defined the ASD-like phenotype in this model. These included correction of the core social deficits and sensorimotor coordination abnormalities, prevention of cerebellar Purkinje cell loss, correction of the ultrastructural synaptic dysmorphology, and correction of the hypothermia, metabolic, mitochondrial, P2Y2 and P2X7 purinergic receptor expression, and ERK1/2 and CAMKII signal transduction abnormalities. Conclusions: Hyperpurinergia is a fundamental and treatable feature of the multisystem abnormalities in the poly(IC) mouse model of autism spectrum disorders. Antipurinergic therapy provides a new tool for refining current concepts of pathogenesis in autism and related spectrum disorders, and represents a fresh path forward for new drug development.	[Naviaux, Robert K.; Zolkipli, Zarazuela; Wang, Lin; Nakayama, Tomohiro; Naviaux, Jane C.; Le, Thuy P.; Rogac, Mihael] Univ Calif San Diego, Sch Med, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA; [Naviaux, Robert K.; Wang, Lin; Rogac, Mihael; Tang, Qingbo; Dugan, Laura L.] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; [Naviaux, Robert K.; Le, Thuy P.] Univ Calif San Diego, Sch Med, Dept Pediat, San Diego, CA 92103 USA; [Naviaux, Robert K.] Univ Calif San Diego, Sch Med, Dept Pathol, San Diego, CA 92103 USA; [Zolkipli, Zarazuela; Nakayama, Tomohiro] Univ Calif San Diego, Sch Med, Dept Neurosci, San Diego, CA 92103 USA; [Naviaux, Jane C.; Schuchbauer, Michael A.; Powell, Susan B.] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Naviaux, RK (corresponding author), Univ Calif San Diego, Sch Med, Mitochondrial & Metab Dis Ctr, San Diego, CA 92103 USA.	Naviaux@ucsd.edu	Nakayama, Tomohiro/GYU-0303-2022		Autism Speaks Trailblazer program; Jane Botsford-Johnson Foundation; Wright Family Foundation; UCSD Christini Foundation; Lennox Foundation; Hailey's Wish Foundation; Larry L. Hillblom Foundation; Gerber Foundation;  [MH091407]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033679] Funding Source: NIH RePORTER	Autism Speaks Trailblazer program; Jane Botsford-Johnson Foundation; Wright Family Foundation; UCSD Christini Foundation; Lennox Foundation; Hailey's Wish Foundation; Larry L. Hillblom Foundation; Gerber Foundation; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the Autism Speaks Trailblazer program, the Jane Botsford-Johnson Foundation, and the Wright Family Foundation, and MH091407, with additional support from the UCSD Christini Foundation, the Lennox Foundation, the Hailey's Wish Foundation, and the Larry L. Hillblom Foundation, and the Gerber Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bitanihirwe BKY, 2010, NEUROPSYCHOPHARMACOL, V35, P2462, DOI 10.1038/npp.2010.129; Bouma HR, 2012, J CELL PHYSIOL, V227, P1285, DOI 10.1002/jcp.22850; Bouwknecht JA, 2007, NEUROSCI BIOBEHAV R, V31, P41, DOI 10.1016/j.neubiorev.2006.02.002; Buie T, 2010, PEDIATRICS, V125, pS19, DOI 10.1542/peds.2009-1878D; COURCHESNE E, 1994, AM J ROENTGENOL, V162, P123, DOI 10.2214/ajr.162.1.8273650; DUNN PM, 1988, BRIT J PHARMACOL, V93, P243, DOI 10.1111/j.1476-5381.1988.tb11427.x; Franike H, 2009, GLIA, V57, P1031, DOI 10.1002/glia.20827; Frenzel M, 2010, EXP GERONTOL, V45, P563, DOI 10.1016/j.exger.2010.02.003; Galassetti Pietro R, 2005, Diabetes Technol Ther, V7, P115, DOI 10.1089/dia.2005.7.115; Gallego D, 2008, NEUROGASTROENT MOTIL, V20, P159, DOI 10.1111/j.1365-2982.2007.01004.x; Greco CM, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-2; Harada K, 2011, J NEUROCHEM, V116, P1138, DOI 10.1111/j.1471-4159.2011.07170.x; HASHIMOTO T, 1995, J AUTISM DEV DISORD, V25, P1, DOI 10.1007/BF02178163; Hatefi Y, 1978, Methods Enzymol, V53, P48; Heuer L, 2008, AUTISM RES, V1, P275, DOI 10.1002/aur.42; Housley GD, 2002, AUDIOL NEURO-OTOL, V7, P55, DOI 10.1159/000046865; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; James SJ, 2008, J AUTISM DEV DISORD, V38, P1966, DOI [10.1007/s10803-008-0614-2, 10.1007/s10803-008-0591-5]; Jones CK, 2012, NEUROPSYCHOPHARMACOL, V37, P16, DOI 10.1038/npp.2011.199; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Khera TK, 2010, FEBS J, V277, P2754, DOI 10.1111/j.1742-4658.2010.07692.x; Kobayashi K, 1996, CANCER, V78, P2411, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2411::AID-CNCR20>3.0.CO;2-2; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Korjamo T, 2009, J PHARM SCI-US, V98, P4469, DOI 10.1002/jps.21762; Kou Y, 2012, AM J MED GENET C, V160C, P130, DOI 10.1002/ajmg.c.31330; Leng YX, 2008, NEUROSCI LETT, V445, P195, DOI 10.1016/j.neulet.2008.09.014; Leon D, 2006, EUR J NEUROSCI, V23, P2999, DOI 10.1111/j.1460-9568.2006.04832.x; Light AR, 2006, NEURON GLIA BIOL, V2, P125, DOI 10.1017/S1740925X05000323; Matos JE, 2007, PFLUG ARCH EUR J PHY, V454, P977, DOI 10.1007/s00424-007-0248-9; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Mulder EJ, 2004, J AM ACAD CHILD PSY, V43, P491, DOI 10.1097/00004583-200404000-00016; Naviaux RK, 1999, ANN NEUROL, V45, P54, DOI 10.1002/1531-8249(199901)45:1<54::AID-ART10>3.0.CO;2-B; Page T, 2000, BBA-MOL BASIS DIS, V1500, P291, DOI 10.1016/S0925-4439(99)00113-1; Pallier PN, 2009, BRAIN RES BULL, V78, P347, DOI 10.1016/j.brainresbull.2008.10.007; Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63; Patterson PH, 2011, PEDIATR RES, V69, p34R, DOI 10.1203/PDR.0b013e318212b80f; Pelegrin P, 2008, DRUG NEWS PERSPECT, V21, P424, DOI 10.1358/dnp.2008.21.8.1265800; Pesta D, 2011, AM J PHYSIOL-REG I, V301, pR1078, DOI 10.1152/ajpregu.00285.2011; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Shepherd D., 1969, METHODS ENZYMOL, V13, P11, DOI [10.1016/0076-6879(69)13006-2, DOI 10.1016/0076-6879(69)13006-2]; Shi LM, 2009, BRAIN BEHAV IMMUN, V23, P116, DOI 10.1016/j.bbi.2008.07.012; Speciale A, 2011, CURR MOL MED, V11, P770, DOI 10.2174/156652411798062395; STUMPF DA, 1981, BIOCHEM MED METAB B, V25, P234, DOI 10.1016/0006-2944(81)90080-6; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Tal MC, 2011, IMMUNOL REV, V243, P215, DOI 10.1111/j.1600-065X.2011.01038.x; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Traynor TR, 2004, LIFE SCI, V74, P2563, DOI 10.1016/j.lfs.2003.10.010; Tulapurkar ME, 2005, CELL MOL LIFE SCI, V62, P1388, DOI 10.1007/s00018-005-5052-0; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; VOOGD TE, 1993, PHARMACOL REV, V45, P177; Waring R. H., 2000, Journal of Nutritional and Environmental Medicine (Abingdon), V10, P25, DOI 10.1080/13590840050000861; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Wharton DC., 1967, METHOD ENZYMOL, P245; Yang D, 2009, ENVIRON HEALTH PERSP, V117, P426, DOI 10.1289/ehp.11771; Zerbo O, 2012, J AUTISM DEV DISORD; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	60	107	111	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57380	10.1371/journal.pone.0057380	http://dx.doi.org/10.1371/journal.pone.0057380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516405	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200011
J	Rikhtegar, F; Pacheco, F; Wyss, C; Stok, KS; Ge, H; Choo, RJ; Ferrari, A; Poulikakos, D; Muller, R; Kurtcuoglu, V				Rikhtegar, Farhad; Pacheco, Fernando; Wyss, Christophe; Stok, Kathryn S.; Ge, Heng; Choo, Ryan J.; Ferrari, Aldo; Poulikakos, Dimos; Mueller, Ralph; Kurtcuoglu, Vartan			Compound Ex Vivo and In Silico Method for Hemodynamic Analysis of Stented Arteries	PLOS ONE			English	Article							WALL SHEAR-STRESS; CORONARY-ARTERY; BLOOD-FLOW; VITRO EVALUATION; IMPLANTATION; RESTENOSIS; VELOCITY; TOMOGRAPHY; GEOMETRY; BALLOON	Hemodynamic factors such as low wall shear stress have been shown to influence endothelial healing and atherogenesis in stent-free vessels. However, in stented vessels, a reliable quantitative analysis of such relations has not been possible due to the lack of a suitable method for the accurate acquisition of blood flow. The objective of this work was to develop a method for the precise reconstruction of hemodynamics and quantification of wall shear stress in stented vessels. We have developed such a method that can be applied to vessels stented in or ex vivo and processed ex vivo. Here we stented the coronary arteries of ex vivo porcine hearts, performed vascular corrosion casting, acquired the vessel geometry using micro-computed tomography and reconstructed blood flow and shear stress using computational fluid dynamics. The method yields accurate local flow information through anatomic fidelity, capturing in detail the stent geometry, arterial tissue prolapse, radial and axial arterial deformation as well as strut malapposition. This novel compound method may serve as a unique tool for spatially resolved analysis of the relationship between hemodynamic factors and vascular biology. It can further be employed to optimize stent design and stenting strategies.	[Rikhtegar, Farhad; Ferrari, Aldo; Poulikakos, Dimos; Kurtcuoglu, Vartan] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Lab Thermodynam Emerging Technol, Zurich, Switzerland; [Pacheco, Fernando] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Wyss, Christophe; Ge, Heng] Univ Zurich Hosp, Clin Cardiol, CH-8091 Zurich, Switzerland; [Stok, Kathryn S.; Choo, Ryan J.; Mueller, Ralph] Swiss Fed Inst Technol, Inst Biomech, Dept Hlth Sci & Technol, Zurich, Switzerland; [Kurtcuoglu, Vartan] Univ Zurich, Inst Physiol, Interface Grp, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Imperial College London; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Kurtcuoglu, V (corresponding author), Swiss Fed Inst Technol, Dept Mech & Proc Engn, Lab Thermodynam Emerging Technol, Zurich, Switzerland.	vartan.kurtcuoglu@uzh.ch	Müller, Ralph/A-1198-2008; Stok, Kathryn S/A-4871-2011; Kurtcuoglu, Vartan/A-8940-2008; Stok, Kathryn/AAA-2667-2021; Ferrari, Aldo/H-5209-2012; poulikakos, dimos/O-2853-2014	Müller, Ralph/0000-0002-5811-7725; Stok, Kathryn S/0000-0002-0522-4180; Kurtcuoglu, Vartan/0000-0003-2665-0995; Stok, Kathryn/0000-0002-0522-4180; poulikakos, dimos/0000-0001-5733-6478	Swiss Federal Commission for Technology and Innovation (CTI) through the EnOp project [9921.1]	Swiss Federal Commission for Technology and Innovation (CTI) through the EnOp project	This work was partially funded by the Swiss Federal Commission for Technology and Innovation (CTI) through the EnOp project, grant 9921.1. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andermahr J, 1998, SURG RADIOL ANAT, V20, P419, DOI 10.1007/BF01653134; ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793; Benndorf G, 2009, AM J NEURORADIOL, V30, P479, DOI 10.3174/ajnr.A1396; Benndorf G, 2010, J BIOMECH, V43, P740, DOI 10.1016/j.jbiomech.2009.10.015; Berne R. M., 1986, CARDIOVASCULAR PHYSL; Castagna MT, 2001, AM HEART J, V142, P970, DOI 10.1067/mhj.2001.119613; Chiastra C, 2012, EUR J MECH B-FLUID, V35, P76, DOI 10.1016/j.euromechflu.2012.01.011; Connolley T, 2007, MED ENG PHYS, V29, P1132, DOI 10.1016/j.medengphy.2006.10.016; De Santis G, 2011, COMPUTER METHODS BIO, P1; Doriot PA, 2000, ULTRASOUND MED BIOL, V26, P221, DOI 10.1016/S0301-5629(99)00133-7; Ehara M, 2007, J AM COLL CARDIOL, V49, P951, DOI 10.1016/j.jacc.2006.10.065; Elezi S, 1998, CIRCULATION, V98, P1875, DOI 10.1161/01.CIR.98.18.1875; Fearon WF, 2003, CIRCULATION, V108, P2198, DOI 10.1161/01.CIR.0000099521.31396.9D; FINGERLE J, 1990, ARTERIOSCLEROSIS, V10, P1082, DOI 10.1161/01.ATV.10.6.1082; Foerst J, 2010, CATHETER CARDIO INTE, V76, P527, DOI 10.1002/ccd.22498; Foin N, 2011, EUROINTERVENTION, V7, P597, DOI 10.4244/EIJV7I5A96; Furber AP, 1999, AM J CARDIOL, V84, P24, DOI 10.1016/S0002-9149(99)00186-1; Garasic JM, 2000, CIRCULATION, V101, P812, DOI 10.1161/01.CIR.101.7.812; Gatehouse PD, 2005, EUR RADIOL, V15, P2172, DOI 10.1007/s00330-005-2829-3; Gimbrone MA, 2000, ANN NY ACAD SCI, V902, P230; GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018; Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6; Gundert TJ, 2011, ANN BIOMED ENG, V39, P1423, DOI 10.1007/s10439-010-0238-5; Hikichi Y, 2009, J INTERV CARDIOL, V22, P128, DOI 10.1111/j.1540-8183.2009.00442.x; Hoffmann R, 2000, EUR HEART J, V21, P1739, DOI 10.1053/euhj.2000.2153; Hollnagel DI, 2009, NMR BIOMED, V22, P795, DOI 10.1002/nbm.1389; Hong YJ, INT J CARDI IN PRESS; Jang IK, 2001, CIRCULATION, V104, P2754, DOI 10.1161/hc4701.098069; Johnson K, 2008, J BIOMECH, V41, P595, DOI 10.1016/j.jbiomech.2007.10.010; Katritsis DG, 2012, CIRC-CARDIOVASC INTE, V5, P530, DOI 10.1161/CIRCINTERVENTIONS.112.968347; Kaufmann PA, 2005, J NUCL MED, V46, P75; Kralev S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021778; Krucker T, 2006, MICROSC RES TECHNIQ, V69, P138, DOI 10.1002/jemt.20263; LaDisa JF, 2005, AM J PHYSIOL-HEART C, V288, pH2465, DOI 10.1152/ajpheart.01107.2004; LaDisa JF, 2005, J APPL PHYSIOL, V98, P947, DOI 10.1152/japplphysiol.00872.2004; LaDisa JF, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-40; LaDisa JF, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-59; Larrabide I, 2012, MED IMAGE ANAL, V16, P721, DOI 10.1016/j.media.2010.04.009; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Meyer EP, 2007, CLIN ANAT, V20, P448, DOI 10.1002/ca.20403; Morlacchi S, 2011, ANN BIOMED ENG, V39, P2615, DOI 10.1007/s10439-011-0355-9; Mortier P, 2010, ANN BIOMED ENG, V38, P88, DOI 10.1007/s10439-009-9836-5; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Murphy J, 2010, COMPUT BIOL MED, V40, P408, DOI 10.1016/j.compbiomed.2010.02.005; Murphy JB, 2010, BIORHEOLOGY, V47, P117, DOI 10.3233/BIR-2010-0568; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Myers JG, 2001, ANN BIOMED ENG, V29, P109, DOI 10.1114/1.1349703; Napoli C, 2006, SCAND J CLIN LAB INV, V66, P407, DOI 10.1080/00365510600763319; Ohta M, 2007, J INTEL MAT SYST STR, V19, P313, DOI DOI 10.1177/1045389X07083184; Olgac U, 2009, AM J PHYSIOL-HEART C, V296, pH1969, DOI 10.1152/ajpheart.01182.2008; RIEW CK, 1971, J POLYM SCI A1, V9, P2739, DOI 10.1002/pol.1971.150090927; Rikhtegar F, 2012, ATHEROSCLEROSIS, V221, P432, DOI 10.1016/j.atherosclerosis.2012.01.018; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Steinmetz M, 2010, HYPERTENSION, V55, P593, DOI 10.1161/HYPERTENSIONAHA.109.134213; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD; van der Giessen AG, 2011, J BIOMECH, V44, P1089, DOI 10.1016/j.jbiomech.2011.01.036; Venkitachalam L, 2009, CIRC-CARDIOVASC INTE, V2, P6, DOI 10.1161/CIRCINTERVENTIONS.108.825323; Verli FD, 2007, SCANNING, V29, P128, DOI 10.1002/sca.20051; Vignon-Clementel IE, 2010, COMPUT METHOD BIOMEC, V13, P625, DOI 10.1080/10255840903413565; Wang SZ, 2011, COMPUT METHOD BIOMEC, V14, P927, DOI 10.1080/10255842.2010.502531; Wentzel JJ, 2001, CIRCULATION, V103, P1740, DOI 10.1161/01.CIR.103.13.1740; Wentzel JJ, 2000, J BIOMECH, V33, P1287, DOI 10.1016/S0021-9290(00)00066-X; Williams AR, 2010, J APPL PHYSIOL, V109, P532, DOI 10.1152/japplphysiol.00086.2010; Yajima J, 2007, QUANTIFIZIERUNG INTI; Yilmaz F, 2008, KOREA-AUST RHEOL J, V20, P197	66	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58147	10.1371/journal.pone.0058147	http://dx.doi.org/10.1371/journal.pone.0058147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516442	Green Published, Green Accepted, gold			2022-12-27	WOS:000316849200037
J	Wallace, SC; Hulbert, RC				Wallace, Steven C.; Hulbert, Richard C., Jr.			A New Machairodont from the Palmetto Fauna (Early Pliocene) of Florida, with Comments on the Origin of the Smilodontini (Mammalia, Carnivora, Felidae)	PLOS ONE			English	Article							LATE MIOCENE; PREDATORY BEHAVIOR; OGYGIA FELIDAE; PLEISTOCENE; SPAIN; DISPERSAL; REVISION; FATALIS; CANINE; SITE	South-central Florida's latest Hemphillian Palmetto Fauna includes two machairodontine felids, the lion-sized Machairodus coloradensis and a smaller, jaguar-sized species, initially referred to Megantereon hesperus based on a single, relatively incomplete mandible. This made the latter the oldest record of Megantereon, suggesting a New World origin of the genus. Subsequent workers variously accepted or rejected this identification and biogeographic scenario. Fortunately, new material, which preserves previously unknown characters, is now known for the smaller taxon. The most parsimonious results of a phylogenetic analysis using 37 cranio-mandibular characters from 13 taxa place it in the Smilodontini, like the original study; however, as the sister-taxon to Megantereon and Smilodon. Accordingly, we formally describe Rhizosmilodon fiteae gen. et sp. nov. Rhizosmilodon, Megantereon, and Smilodon (= Smilodontini) share synapomorphies relative to their sister-taxon Machairodontini: serrations smaller and restricted to canines; offset of P3 with P4 and p4 with m1; complete verticalization of mandibular symphysis; m1 shortened and robust with widest point anterior to notch; and extreme posterior "lean'' to p3/p4. Rhizosmilodon has small anterior and posterior accessory cusps on p4, a relatively large lower canine, and small, non-procumbent lower incisors; all more primitive states than in Megantereon and Smilodon. The former also differs from Megantereon and Smilodon gracilis by having a very small mandibular flange. Rhizosmilodon is the oldest known member of the Smilodontini, suggesting that the tribe originated in North America. Two more derived, similar-sized species evolved in parallel during the Blancan, Megantereon hesperus and Smilodon gracilis. The former is rarer, known only from the north-central and northwestern US, and presumably dispersed into the Old World. The latter is known from the eastern and southern US, and dispersed into South America.	[Wallace, Steven C.] E Tennessee State Univ, Don Sundquist Ctr Excellence Paleontol, Dept Geosci, Johnson City, TN 37614 USA; [Hulbert, Richard C., Jr.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	East Tennessee State University; State University System of Florida; University of Florida	Wallace, SC (corresponding author), E Tennessee State Univ, Don Sundquist Ctr Excellence Paleontol, Dept Geosci, Johnson City, TN 37614 USA.	wallaces@etsu.edu	Wang, Xiaoming/I-9033-2019; Hulbert Jr, Richard C./HDM-4028-2022	Hulbert, Richard/0000-0002-2242-4256	Don Sundquist Center of Excellence in Paleontology; East Tennessee State University; National Science Foundation (NSF Award) [0958985]; Directorate For Geosciences [0958985] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1203222] Funding Source: National Science Foundation	Don Sundquist Center of Excellence in Paleontology; East Tennessee State University; National Science Foundation (NSF Award)(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded in part by the Don Sundquist Center of Excellence in Paleontology (http://www.etsu.edu/cas/paleontology/default.aspx), East Tennessee State University and the National Science Foundation (NSF Award ID (-) 0958985) (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024971; Anton M, 2004, J VERTEBR PALEONTOL, V24, P957, DOI 10.1671/0272-4634(2004)024[0957:FKCSOT]2.0.CO;2; Anton M, 1999, J VERTEBR PALEONTOL, V19, P771, DOI 10.1080/02724634.1999.10011190; BERTA A, 1987, Bulletin of the Florida State Museum Biological Sciences, V31, P1; BERTA A, 1983, J PALEONTOL, V57, P892; BERTA A, 1985, CONTRIB SCI, V370, P1; Biknevicius AR, 1996, J VERTEBR PALEONTOL, V16, P510, DOI 10.1080/02724634.1996.10011336; Christiansen P, 2005, J MORPHOL, V266, P369, DOI 10.1002/jmor.10384; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V151, P423, DOI 10.1111/j.1096-3642.2007.00321.x; Churcher CS., 1984, R ONTARIO MUS LIFE S, V140, P1; Feranec Robert S., 2005, Bulletin of the Florida Museum of Natural History, V45, P369; Feranec RS, 2004, PALAEOGEOGR PALAEOCL, V206, P303, DOI 10.1016/j.palaeo.2004.01.009; GAZIN C. LEWIS, 1933, JOUR MAMMALOGY, V14, P251, DOI 10.2307/1373825; GILL T., 1872, SMITHSONIAN MISC COL, V11, P2; GONYEA W J, 1976, Paleobiology, V2, P332; Hodnett John-Paul, 2010, Paleobios, V29, P76; Kohn MJ, 2005, GEOLOGY, V33, P649, DOI 10.1130/G21476.1; Kurten B., 1990, Journal of Vertebrate Paleontology, V10, P158; Kurten B., 1963, Eiszeitalter und Gegenwart, V14, P96; MARTINEZ-NAVARRO B, 1995, J ARCHAEOL SCI, V22, P569, DOI 10.1006/jasc.1994.0054; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; McKenna MC, 1997, CLASSIFICATION MAMMA; Meachen-Samuels JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011412; Merriam J. C., 1932, FELIDAE RANCHO LA BR; Morgan Gary S., 1994, Proceedings of the San Diego Society of Natural History, V29, P239; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Palmqvist P, 2007, J VERTEBR PALEONTOL, V27, P160, DOI 10.1671/0272-4634(2007)27[160:AROTDO]2.0.CO;2; PIRKLE EC, 1967, ECON GEOL, V62, P237, DOI 10.2113/gsecongeo.62.2.237; Rincon AD, 2011, J VERTEBR PALEONTOL, V31, P468, DOI 10.1080/02724634.2011.550366; Salesa MJ, 2010, PALAEONTOLOGY, V53, P1369, DOI 10.1111/j.1475-4983.2010.01013.x; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Salesa MJ, 2006, J ZOOL, V268, P243, DOI 10.1111/j.1469-7998.2005.00032.x; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; SARDELLA R., 1998, NEUES JB GEOLOGIE PA, V207, P1, DOI [10.1127/njgpa/207/1998/1, DOI 10.1127/njgpa/207/1998/1]; Scott T, 1988, FLORIDA GEOL SURV B, V59, P1; Shaw CA, 1985, CONTRIBUTIONS SCI, V359, P1; Tedford Richard H., 2004, P169; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; TURNER A, 1987, J PALEONTOL, V61, P1256, DOI 10.1017/S0022336000029632; Turner A., 1997, BIG CATS THEIR FOSSI; Van Valkenburgh B, 2002, J VERTEBR PALEONTOL, V22, P164, DOI 10.1671/0272-4634(2002)022[0164:SDSBAI]2.0.CO;2; Webb S. D., 1986, VERTEBRATES PHYLOGEN, V3, P237, DOI DOI 10.2113/GSR0CKY.24.SPECIAL_; Webb S David, 2000, P38; Webb S. David, 2008, Natural History Museum of Los Angeles County Science Series, P293; Werdelin L, 2001, ZOOL J LINN SOC-LOND, V132, P147, DOI 10.1006/zjls.2000.0260; Wroe S, 2008, ZOOLOGY, V111, P196, DOI 10.1016/j.zool.2007.07.008	46	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e56173	10.1371/journal.pone.0056173	http://dx.doi.org/10.1371/journal.pone.0056173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516394	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200003
J	Aronson, D; Kapeliovich, M; Hammerman, H; Dragu, R				Aronson, Doron; Kapeliovich, Michael; Hammerman, Haim; Dragu, Robert			The Relation between Serum Phosphorus Levels and Clinical Outcomes after Acute Myocardial Infarction	PLOS ONE			English	Article							DEPENDENT PHOSPHATE COTRANSPORTER; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; MATRIX GLA PROTEIN; GROWTH-FACTOR 23; CARDIOVASCULAR-DISEASE; VASCULAR CALCIFICATION; PARATHYROID-HORMONE; HEART-FAILURE; HEMODIALYSIS-PATIENTS	Background: Elevated serum phosphorus levels have been linked with cardiovascular disease and mortality with conflicting results, especially in the presence of normal renal function. Methods: We studied the association between serum phosphorus levels and clinical outcomes in 1663 patients with acute myocardial infarction (AMI). Patients were categorized into 4 groups based on serum phosphorus levels (<2.50, 2.51-3.5, 3.51-4.50 and >4.50 mg/dL). Cox proportional-hazards models were used to examine the association between serum phosphorus and clinical outcomes after adjustment for potential confounders. Results: The mean follow up was 45 months. The lowest mortality occurred in patients with serum phosphorus between 2.5-3.5 mg/dL, with a multivariable-adjusted hazard ratio of 1.24 (95% CI 0.85-1.80), 1.35 (95% CI 1.05-1.74), and 1.75 (95% CI 1.27-2.40) in patients with serum phosphorus of <2.50, 3.51-4.50 and >4.50 mg/dL, respectively. Higher phosphorus levels were also associated with increased risk of heart failure, but not the risk of myocardial infarction or stroke. The effect of elevated phosphorus was more pronounced in patients with chronic kidney disease (CKD). The hazard ratio for mortality in patients with serum phosphorus >4.5 mg/dL compared to patients with serum phosphorus 2.50-3.50 mg/dL was 2.34 (95% CI 1.55-3.54) with CKD and 1.53 (95% CI 0.87-2.69) without CKD. Conclusion: We found a graded, independent association between serum phosphorus and all-cause mortality and heart failure in patients after AMI. The risk for mortality appears to increase with serum phosphorus levels within the normal range and is more prominent in the presence of CKD.	[Aronson, Doron; Kapeliovich, Michael; Hammerman, Haim; Dragu, Robert] Rambam Med Ctr, Dept Cardiol, Haifa, Israel; [Aronson, Doron; Hammerman, Haim] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Aronson, Doron; Hammerman, Haim] Technion Israel Inst Technol, Res Inst, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Aronson, D (corresponding author), Rambam Med Ctr, Dept Cardiol, Haifa, Israel.	daronson@tx.technion.ac.il	Aronson, Doron/F-3390-2010					Aronson D, 2011, AM J CARDIOL, V107, P1738, DOI 10.1016/j.amjcard.2011.02.334; Aronson D, 2010, CIRC-HEART FAIL, V3, P125, DOI 10.1161/CIRCHEARTFAILURE.109.877340; Ayus JC, 2005, J AM SOC NEPHROL, V16, P2778, DOI 10.1681/ASN.2005040392; Bishara R, 2011, THROMB HAEMOSTASIS, V106, P877, DOI 10.1160/TH11-05-0343; Brosius FC, 2006, CIRCULATION, V114, P1083, DOI 10.1161/CIRCULATIONAHA.106.177321; Bushinsky DA, 1998, LANCET, V352, P306, DOI 10.1016/S0140-6736(97)12331-5; de Boer IH, 2009, AM J KIDNEY DIS, V53, P399, DOI 10.1053/j.ajkd.2008.07.036; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Dhingra R, 2010, EUR J HEART FAIL, V12, P812, DOI 10.1093/eurjhf/hfq106; Ellam TJ, 2012, ATHEROSCLEROSIS, V220, P310, DOI 10.1016/j.atherosclerosis.2011.09.002; Foley RN, 2008, AM HEART J, V156, P556, DOI 10.1016/j.ahj.2008.05.016; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hruska KA, 2008, KIDNEY INT, V74, P148, DOI 10.1038/ki.2008.130; Huang H, 2001, CIRCULATION, V103, P1051, DOI 10.1161/01.CIR.103.8.1051; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; Kendrick J, 2011, AM J KIDNEY DIS, V58, P826, DOI 10.1053/j.ajkd.2011.07.020; Kestenbaum B, 2007, SEMIN DIALYSIS, V20, P286, DOI 10.1111/j.1525-139X.2007.00303.x; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Lau WL, 2010, THROMB HAEMOSTASIS, V104, P464, DOI 10.1160/TH09-12-0814; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lomashvili KA, 2005, J AM SOC NEPHROL, V16, P2495, DOI 10.1681/ASN.2004080694; Marrie RA, 2009, J CLIN EPIDEMIOL, V62, P511, DOI 10.1016/j.jclinepi.2008.05.015; Mathew S, 2008, J AM SOC NEPHROL, V19, P1092, DOI 10.1681/ASN.2007070760; Murer H, 2000, PHYSIOL REV, V80, P1373, DOI 10.1152/physrev.2000.80.4.1373; OCONNOR LR, 1977, NEW ENGL J MED, V297, P901, DOI 10.1056/NEJM197710272971702; OGNIBENE A, 1994, SOUTHERN MED J, V87, P65, DOI 10.1097/00007611-199401000-00014; Oh J, 2002, CIRCULATION, V106, P100, DOI 10.1161/01.CIR.0000020222.63035.C0; Parker BD, 2010, ANN INTERN MED, V152, P640, DOI 10.7326/0003-4819-152-10-201005180-00004; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Ritz E, 2008, CLIN J AM SOC NEPHRO, V3, P920, DOI 10.2215/CJN.04571007; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schurgers LJ, 2010, CLIN J AM SOC NEPHRO, V5, P568, DOI 10.2215/CJN.07081009; Schurgers LJ, 2005, ARTERIOSCL THROM VAS, V25, P1629, DOI 10.1161/01.ATV.0000173313.46222.43; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Shroff RC, 2010, J AM SOC NEPHROL, V21, P103, DOI 10.1681/ASN.2009060640; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Slinin Y, 2011, INT J CARDIOL, V149, P335, DOI 10.1016/j.ijcard.2010.02.013; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Suleiman M, 2006, J AM COLL CARDIOL, V47, P962, DOI 10.1016/j.jacc.2005.10.055; Sullivan C, 2009, JAMA-J AM MED ASSOC, V301, P629, DOI 10.1001/jama.2009.96; Taddei S, 2011, HEART FAIL REV, V16, P615, DOI 10.1007/s10741-010-9197-z; Taylor EN, 2011, AM HEART J, V161, P956, DOI 10.1016/j.ahj.2011.02.012; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198	47	18	18	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58348	10.1371/journal.pone.0058348	http://dx.doi.org/10.1371/journal.pone.0058348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505492	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100047
J	Kalantari-Dehaghi, M; Anhalt, GJ; Camilleri, MJ; Chernyavsky, AI; Chun, S; Felgner, PL; Jasinskas, A; Leiferman, KM; Liang, L; Marchenko, S; Nakajima-Sasaki, R; Pittelkow, MR; Zone, JJ; Grando, SA				Kalantari-Dehaghi, Mina; Anhalt, Grant J.; Camilleri, Michael J.; Chernyavsky, Alex I.; Chun, Sookhee; Felgner, Philip L.; Jasinskas, Algis; Leiferman, Kristin M.; Liang, Li; Marchenko, Steve; Nakajima-Sasaki, Rie; Pittelkow, Mark R.; Zone, John J.; Grando, Sergei A.			Pemphigus Vulgaris Autoantibody Profiling by Proteomic Technique	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSE; INDIRECT IMMUNOFLUORESCENCE; PATHOGENIC AUTOANTIBODIES; DESMOGLEIN 3; CONFORMATIONAL EPITOPES; ANNEXIN A8; ANTIBODIES; ANTIGEN; AUTOIMMUNITY; CALCIUM	Pemphigus vulgaris (PV) is a mucocutaneous blistering disease characterized by IgG autoantibodies against the stratified squamous epithelium. Current understanding of PV pathophysiology does not explain the mechanism of acantholysis in patients lacking desmoglein antibodies, which justifies a search for novel targets of pemphigus autoimmunity. We tested 264 pemphigus and 138 normal control sera on the multiplexed protein array platform containing 701 human genes encompassing many known keratinocyte cell-surface molecules and members of protein families targeted by organ-nonspecific PV antibodies. The top 10 antigens recognized by the majority of test patients' sera were proteins encoded by the DSC1, DSC3, ATP2C1, PKP3, CHRM3, COL21A1, ANXA8L1, CD88 and CHRNE genes. The most common combinations of target antigens included at least one of the adhesion molecules DSC1, DSC3 or PKP3 and/or the acetylcholine receptor CHRM3 or CHRNE with or without the MHC class II antigen DRA. To identify the PV antibodies most specific to the disease process, we sorted the data based on the ratio of patient to control frequencies of antigen recognition. The frequency of antigen recognition by patients that exceeded that of control by 10 and more times were the molecules encoded by the CD33, GP1BA, CHRND, SLC36A4, CD1B, CD32, CDH8, CDH9, PMP22 and HLA-E genes as well as mitochondrial proteins encoded by the NDUFS1, CYB5B, SOD2, PDHA1 and FH genes. The highest specificity to PV showed combinations of autoantibodies to the calcium pump encoded by ATP2C1 with C5a receptor plus DSC1 or DSC3 or HLA-DRA. The results identified new targets of pemphigus autoimmunity. Novel autoantibody signatures may help explain individual variations in disease severity and treatment response, and serve as sensitive and specific biomarkers for new diagnostic assays in PV patients.	[Kalantari-Dehaghi, Mina; Chernyavsky, Alex I.; Marchenko, Steve; Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA; [Anhalt, Grant J.] Johns Hopkins Univ, Dept Dermatol, Baltimore, MD 21218 USA; [Camilleri, Michael J.; Pittelkow, Mark R.] Mayo Clin, Dept Dermatol, Rochester, MN USA; [Chun, Sookhee; Felgner, Philip L.; Jasinskas, Algis; Liang, Li; Nakajima-Sasaki, Rie] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Leiferman, Kristin M.; Zone, John J.] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Grando, Sergei A.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Grando, Sergei A.] Univ Calif Irvine, Inst Immunol, Irvine, CA USA	University of California System; University of California Irvine; Johns Hopkins University; Mayo Clinic; University of California System; University of California Irvine; Utah System of Higher Education; University of Utah; University of California System; University of California Irvine; University of California System; University of California Irvine	Kalantari-Dehaghi, M (corresponding author), Univ Calif Irvine, Dept Dermatol, Irvine, CA 92717 USA.	mkalanta@uci.edu; sgrando@uci.edu	Liang, Li/AGH-5380-2022; liang, li/I-3972-2013	Liang, Li/0000-0001-6185-2651				Abasq C, 2009, ARCH DERMATOL, V145, P529, DOI 10.1001/archdermatol.2009.9; AHMED AR, 1982, J AM ACAD DERMATOL, V7, P221; Akman Ayse, 2010, Skinmed, V8, P12; AMAGAI M, 1995, J INVEST DERMATOL, V105, P243, DOI 10.1111/1523-1747.ep12317587; AMAGAI M, 1995, J INVEST DERMATOL, V104, P895, DOI 10.1111/1523-1747.ep12606168; Amagai M, 2006, EXP DERMATOL, V15, P815, DOI 10.1111/j.1600-0625.2006.00499.x; AMAGAI M, 1992, J CLIN INVEST, V90, P919, DOI 10.1172/JCI115968; AMAGAI M, 1994, J CLIN INVEST, V94, P59, DOI 10.1172/JCI117349; Amagai M, 1998, J CLIN INVEST, V102, P775, DOI 10.1172/JCI3647; Amagai M, 1996, J INVEST DERMATOL, V107, P539, DOI 10.1111/1523-1747.ep12582796; Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; ANDERSON HJ, 1970, ARCH DERMATOL, V101, P538, DOI 10.1001/archderm.101.5.538; Arin MJ, 2005, BRIT J DERMATOL, V153, P620, DOI 10.1111/j.1365-2133.2005.06651.x; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Bastian Boris C., 1994, Journal of Dermatological Science, V8, P194, DOI 10.1016/0923-1811(94)90054-X; Behne MJ, 2003, J INVEST DERMATOL, V121, P688, DOI 10.1046/j.1523-1747.2003.12528.x; Belloni-Fortina A, 2009, CLIN DEV IMMUNOL, P1, DOI 10.1155/2009/187864; BEUTNER EH, 1965, J AMER MED ASSOC, V192, P682, DOI 10.1001/jama.1965.03080210026006; Botelho-Nogueira L, 2011, REV BRAS PSIQUIATR, V33, P412, DOI 10.1590/S1516-44462011000400017; Brandsen R, 1997, J AM ACAD DERMATOL, V36, P44, DOI 10.1016/S0190-9622(97)70324-4; Carson PJ, 1996, J AM ACAD DERMATOL, V34, P645, DOI 10.1016/S0190-9622(96)80066-1; Chams-Davatchi C, 2005, INT J DERMATOL, V44, P470, DOI 10.1111/j.1365-4632.2004.02501.x; Chen JL, 2008, J CELL SCI, V121, P2844, DOI 10.1242/jcs.031518; Chernyavsky AI, 2008, J BIOL CHEM, V283, P3401, DOI 10.1074/jbc.M704956200; Cozzani E, 2010, ARCH DERMATOLOGICAL; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Davies L, 2009, J CELL MOL MED, V13, P1995, DOI 10.1111/j.1582-4934.2008.00590.x; Desai BV, 2009, J CELL SCI, V122, P4401, DOI 10.1242/jcs.037457; Di Zenzo G, 2012, J CLIN INVEST, DOI 10.1172/JCI64413; DMOCHOWSKI M, 1995, BRIT J DERMATOL, V133, P519, DOI 10.1111/j.1365-2133.1995.tb02698.x; DMOCHOWSKI M, 1993, J INVEST DERMATOL, V100, P380, DOI 10.1111/1523-1747.ep12471934; Evangelista F, 2008, J INVEST DERMATOL, V128, P1710, DOI 10.1038/sj.jid.5701260; Fathman CG, 2005, NATURE, V435, P605, DOI 10.1038/nature03726; Flores G, 2012, J INVEST DERMATOL; Gallo R, 2002, CONTACT DERMATITIS, V46, P364, DOI 10.1034/j.1600-0536.2002.460614.x; GEOGHEGAN W, 1992, J INVEST DERMATOL, V98, P589; GERARD C, 1994, ANNU REV IMMUNOL, V12, P775, DOI 10.1146/annurev.iy.12.040194.004015; Gil MP, 2012, EXP DERMATOL, V21, P254, DOI 10.1111/j.1600-0625.2012.01441.x; Goebeler V, 2008, MOL BIOL CELL, V19, P5267, DOI 10.1091/mbc.E08-04-0383; Grando SA, 2000, DERMATOLOGY, V201, P290, DOI 10.1159/000051540; Grando Sergei A, 2006, Autoimmunity, V39, P521, DOI 10.1080/08916930600971414; Grando SA, 2012, AUTOIMMUNITY, V45, P7, DOI 10.3109/08916934.2011.606444; Hilario-Vargas J, 2006, J INVEST DERMATOL, V126, P2044, DOI 10.1038/sj.jid.5700388; Horvath B, 2012, BRIT J DERMATOL, V166, P405, DOI 10.1111/j.1365-2133.2011.10663.x; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Hueber W, 2002, ARTHRITIS RES, V4, P290, DOI 10.1186/ar426; Hueber W, 2006, PROTEOMICS, V6, P4100, DOI 10.1002/pmic.200600017; Ihrie RA, 2005, CELL, V120, P843, DOI 10.1016/j.cell.2005.01.008; Jiao D, 1997, J AM ACAD DERMATOL, V37, P211, DOI 10.1016/S0190-9622(97)80127-2; JORDON RE, 1985, J INVEST DERMATOL, V85, pS72, DOI 10.1111/1523-1747.ep12275497; JUDD KP, 1979, J INVEST DERMATOL, V72, P314, DOI 10.1111/1523-1747.ep12531752; Kalantari-Dehaghi M, 2011, EXP DERMATOL, V20, P154, DOI 10.1111/j.1600-0625.2010.01193.x; Kamiya K, 2012, BRIT J DERMATOL, V167, P252, DOI 10.1111/j.1365-2133.2012.10929.x; KAWANA S, 1989, J INVEST DERMATOL, V92, P588, DOI 10.1111/1523-1747.ep12709624; Khandpur S, 2010, INDIAN J DERMATOL VE, V76, P27, DOI 10.4103/0378-6323.58675; Kitajima Y, 2002, CLIN EXP DERMATOL, V27, P684, DOI 10.1046/j.1365-2230.2002.01116.x; Kricheli D, 2000, BRIT J DERMATOL, V143, P337, DOI 10.1046/j.1365-2133.2000.03659.x; Kwon EJ, 2008, J EUR ACAD DERMATOL, V22, P1070, DOI 10.1111/j.1468-3083.2008.02715.x; Lambert JL, 2006, J INVEST DERMATOL, V126, P11; Lessey E, 2008, IMMUNOL RES, V41, P223, DOI 10.1007/s12026-008-8028-y; Liang L, 2011, J PROTEOME RES, V10, P4813, DOI 10.1021/pr200619r; Lim PL, 2006, IMMUNOL LETT, V103, P17, DOI 10.1016/j.imlet.2005.10.023; Luevano M, 2010, VIROLOGY; Mao XM, 2010, AM J PATHOL, V177, P2724, DOI 10.2353/ajpath.2010.100483; Marchenko S, 2010, J BIOL CHEM, V285, P3695, DOI 10.1074/jbc.M109.081570; Naziroglu Mustafa, 2003, Journal of Basic and Clinical Physiology and Pharmacology, V14, P31; Nguyen VT, 2000, J BIOL CHEM, V275, P29466, DOI 10.1074/jbc.M003174200; Nguyen VT, 2000, AM J PATHOL, V157, P1377, DOI 10.1016/S0002-9440(10)64651-2; Nguyen VT, 1998, ARCH DERMATOL, V134, P971, DOI 10.1001/archderm.134.8.971; Nguyen VT, 2004, ARCH DERMATOL, V140, P327, DOI 10.1001/archderm.140.3.327; Payne AS, 2005, J CLIN INVEST, V115, P888, DOI 10.1172/JCI200524185; PISANTI S, 1974, ORAL SURG ORAL MED O, V38, P382, DOI 10.1016/0030-4220(74)90365-X; Plebani M, 2009, AUTOIMMUN REV, V8, P238, DOI 10.1016/j.autrev.2008.07.032; RAINTEAU D, 1995, FEBS LETT, V360, P80, DOI 10.1016/0014-5793(95)00087-P; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; ROSENBERG FR, 1976, ARCH DERMATOL, V112, P962, DOI 10.1001/archderm.112.7.962; Runkel F, 2006, J MOL HISTOL, V37, P353, DOI 10.1007/s10735-006-9063-4; SEISHIMA M, 1995, J INVEST DERMATOL, V104, P33, DOI 10.1111/1523-1747.ep12613469; Sharma VK, 2006, INT J DERMATOL, V45, P518, DOI 10.1111/j.1365-4632.2006.02593.x; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Sinha AA, 2012, AUTOIMMUNITY, V45, P36, DOI 10.3109/08916934.2011.606445; Spindler V, 2009, J BIOL CHEM, V284, P30556, DOI 10.1074/jbc.M109.024810; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Taylor VC, 1999, J BIOL CHEM, V274, P11505, DOI 10.1074/jbc.274.17.11505; Thwaites DT, 2011, BRIT J PHARMACOL, V164, P1802, DOI 10.1111/j.1476-5381.2011.01438.x; TIGALONOWA M, 1990, ACTA DERM-VENEREOL, V70, P385; Tirado-Sanchez Andres, 2012, Dermatol Online J, V18, P14; Torzecka Jolanta D, 2003, Med Sci Monit, V9, pCR528; Torzecka JD, 2007, ARCH DERMATOL RES, V299, P239, DOI 10.1007/s00403-007-0760-y; Tozzoli R, 2008, CLIN CHEM LAB MED, V46, P577, DOI 10.1515/CCLM.2008.138; VERMEER BJ, 1985, BRIT J DERMATOL, V113, P118, DOI 10.1111/j.1365-2133.1985.tb15639.x; Vigil A, 2010, FUTURE MICROBIOL, V5, P241, DOI 10.2217/FMB.09.127; Ware J, 1997, BLOOD CELL MOL DIS, V23, P292, DOI 10.1006/bcmd.1997.0146; Yamagami J, 2008, J DERMATOL SCI, V52, P98, DOI 10.1016/j.jdermsci.2008.05.002; Yazdanpanah MJ, 2011, INT J DERMATOL, V50, P1343, DOI 10.1111/j.1365-4632.2011.04968.x; Yesilova Y, 2012, J EUR ACAD DERMATOL; Yoshimura T, 2001, CLIN EXP DERMATOL, V26, P441, DOI 10.1046/j.1365-2230.2001.00854.x; Zagorodniuk I, 2005, INT J DERMATOL, V44, P541, DOI 10.1111/j.1365-4632.2004.02541.x; ZIMMERMAN UJP, 1995, BIOCHEM MOL BIOL INT, V35, P307	99	72	73	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57587	10.1371/journal.pone.0057587	http://dx.doi.org/10.1371/journal.pone.0057587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505434	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500026
J	Kendjo, E; Agbenyega, T; Bojang, K; Newton, CRJC; Bouyou-Akotet, M; Pedross, F; Kombila, M; Helbok, R; Kremsner, PG				Kendjo, Eric; Agbenyega, Tsiri; Bojang, Kalifa; Newton, Charles R. J. C.; Bouyou-Akotet, Marielle; Pedross, Florian; Kombila, Maryvonne; Helbok, Raimund; Kremsner, Peter Gottfried			Mortality Patterns and Site Heterogeneity of Severe Malaria in African Children	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TRANSMISSION INTENSITY; MALAWIAN CHILDREN; PROGNOSTIC INDICATORS; FALCIPARUM-MALARIA; CLINICAL-FEATURES; AGE-PATTERNS; SEASONALITY; MANAGEMENT; INFECTION	Background: In this study we aimed to assess site heterogeneity of early, intermediate, and late mortality prediction in children with severe Plasmodium falciparum malaria in sub-Saharan Africa. Methods: Medical records of 26,036 children admitted with severe Plasmodium falciparum malaria in six hospital research centers between December 2000 to May 2005 were analyzed. Demographic, clinical and laboratory data of children who died within 24 hours (early), between 24 and 47 hours (intermediate) and thereafter (48 hours or later, late mortality) were compared between groups and survivors. Results: Overall mortality was 4.3% (N = 1,129). Median time to death varied across sites (P<0.001), ranging from 8h (3h-2h) in Lambarene to 40h (10h-100h) in Kilifi. Fifty-eight percent of deaths occurred within 24 hours and intermediate and late mortality rate were 19% and 23%, respectively. Combining all sites, deep breathing, prostration and hypoglycemia were independent predictors for early, intermediate and late mortality (P<0.01). Site specific independent predictors for early death included prostration, coma and deep breathing at all sites (P<0.001). Site specific independent predictors for intermediate and late death largely varied between sites (P<0.001) and included between 1 and 7 different clinical and laboratory variables. Conclusion: Site heterogeneity for mortality prediction is evident in African children with severe malaria. Prediction for early mortality has the highest consistency between sites.	[Kendjo, Eric; Helbok, Raimund; Kremsner, Peter Gottfried] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Kendjo, Eric; Kremsner, Peter Gottfried] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Kendjo, Eric; Bouyou-Akotet, Marielle; Kombila, Maryvonne] Univ Hlth Sci, Fac Med, Dept Parasitol Mycol & Trop Med, Libreville, Gabon; [Kendjo, Eric] Univ Paris 06, CNR Paludisme, Paris, France; [Agbenyega, Tsiri] Univ Sci & Technol Kumasi, Sch Med Sci, Kumasi, Ghana; [Bojang, Kalifa] MRC Labs, Banjul, Gambia; [Newton, Charles R. J. C.] KEMRI Ctr Geog Med Res Coast, Kilifi, Kenya; [Newton, Charles R. J. C.] UCL, Inst Child Hlth, London, England; [Pedross, Florian] Med Univ Innsbruck, Dept Med Stat Informat & Hlth Econ, A-6020 Innsbruck, Austria; [Helbok, Raimund] Med Univ Innsbruck, Dept Clin Neurol, A-6020 Innsbruck, Austria	Eberhard Karls University of Tubingen; UDICE-French Research Universities; Sorbonne Universite; Kwame Nkrumah University Science & Technology; MRC Laboratory Molecular Biology; University of London; University College London; Medical University of Innsbruck; Medical University of Innsbruck	Helbok, R (corresponding author), Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon.	raimund.helbok@uki.at	Newton, Charles/V-7872-2019; Newton, Charles RJC/B-7578-2014; Helbok, Raimund/AAA-8361-2021; KENDJO, Eric/AAI-7830-2021	Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; KENDJO, Eric/0000-0002-2632-0964; Bojang, Kalifa/0000-0001-7506-0938	US National Institutes of Health, Institute of Allergy and Infectious Diseases [AI45955]; MRC [MC_UP_A900_1118] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI045955, U01AI045955] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A900_1118] Funding Source: researchfish	US National Institutes of Health, Institute of Allergy and Infectious Diseases; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by a grant from the US National Institutes of Health, Institute of Allergy and Infectious Diseases, AI45955. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbenyega T, 2000, J CLIN ENDOCR METAB, V85, P1569, DOI 10.1210/jc.85.4.1569; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; Berkley JA, 2009, CLIN INFECT DIS, V49, P336, DOI 10.1086/600299; Biai S, 2007, BRIT MED J, V335, P862, DOI 10.1136/bmj.39345.467813.80; Branca F, 2002, ANN NUTR METAB, V46, P8, DOI 10.1159/000066397; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Carneiro I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008988; ENGLISH M, 1995, ARCH DIS CHILD, V72, P334, DOI 10.1136/adc.72.4.334; Fernando D, 2003, T ROY SOC TROP MED H, V97, P161, DOI 10.1016/S0035-9203(03)90107-6; Helbok R, 2009, J INFECT DIS, V200, P1834, DOI 10.1086/648409; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Kazembe LN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-93; Kremsner PG, 2009, J INFECT DIS, V199, P142, DOI 10.1086/595295; KRISHNA S, 1994, T ROY SOC TROP MED H, V88, P67, DOI 10.1016/0035-9203(94)90504-5; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; MOLYNEUX ME, 1989, Q J MED, V71, P441; Muller O, 2003, TROP MED INT HEALTH, V8, P290, DOI 10.1046/j.1365-3156.2003.01030.x; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; Nyakeriga AM, 2004, AM J CLIN NUTR, V80, P1604, DOI 10.1093/ajcn/80.6.1604; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Reyburn H, 2008, B WORLD HEALTH ORGAN, V86, P132, DOI 10.2471/BLT.07.041723; Roca-Feltrer A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-282; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; WALLER D, 1995, CLIN INFECT DIS, V21, P577, DOI 10.1093/clinids/21.3.577; WHO, 2011, WORLD MALARIA REPORT 2011, P1	28	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58686	10.1371/journal.pone.0058686	http://dx.doi.org/10.1371/journal.pone.0058686			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505549	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500113
J	Oxlade, O; Pinto, M; Trajman, A; Menzies, D				Oxlade, Olivia; Pinto, Marcia; Trajman, Anete; Menzies, Dick			How Methodologic Differences Affect Results of Economic Analyses: A Systematic Review of Interferon Gamma Release Assays for the Diagnosis of LTBI	PLOS ONE			English	Review							LATENT TUBERCULOSIS INFECTION; COST-EFFECTIVENESS ANALYSIS; QUANTIFERON(R)-TB GOLD; RECOMMENDATIONS; TESTS	Introduction: Cost effectiveness analyses (CEA) can provide useful information on how to invest limited funds, however they are less useful if different analysis of the same intervention provide unclear or contradictory results. The objective of our study was to conduct a systematic review of methodologic aspects of CEA that evaluate Interferon Gamma Release Assays (IGRA) for the detection of Latent Tuberculosis Infection (LTBI), in order to understand how differences affect study results. Methods: A systematic review of studies was conducted with particular focus on study quality and the variability in inputs used in models used to assess cost-effectiveness. A common decision analysis model of the IGRA versus Tuberculin Skin Test (TST) screening strategy was developed and used to quantify the impact on predicted results of observed differences of model inputs taken from the studies identified. Results: Thirteen studies were ultimately included in the review. Several specific methodologic issues were identified across studies, including how study inputs were selected, inconsistencies in the costing approach, the utility of the QALY (Quality Adjusted Life Year) as the effectiveness outcome, and how authors choose to present and interpret study results. When the IGRA versus TST test strategies were compared using our common decision analysis model predicted effectiveness largely overlapped. Implications: Many methodologic issues that contribute to inconsistent results and reduced study quality were identified in studies that assessed the cost-effectiveness of the IGRA test. More specific and relevant guidelines are needed in order help authors standardize modelling approaches, inputs, assumptions and how results are presented and interpreted.	[Oxlade, Olivia] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Pinto, Marcia] Fiocruz MS, Fernandes Figueira Inst, Dept Res, BR-21045900 Rio De Janeiro, Brazil; [Trajman, Anete] Univ Gama Filho, Rio De Janeiro, Brazil; [Trajman, Anete] McGill Univ, Montreal, PQ, Canada; [Menzies, Dick] McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada	Harvard University; Harvard T.H. Chan School of Public Health; Fundacao Oswaldo Cruz; Universidade Gama Filho; McGill University; McGill University	Menzies, D (corresponding author), McGill Univ, Montreal Chest Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada.	dick.menzies@mcgill.ca	Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984	Canadian Institute for Health Research (CIHR) [FRN 106987]	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was made possible, in part, by the generous support of the American people through the United States Agency for International Development (USAID) via the USAID-funded TREAT TB Initiative. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. OO is funded through a Canadian Institute for Health Research (CIHR) Post Doctoral fellowship [FRN 106987 to OO]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Burgos JL, 2009, INT J TUBERC LUNG D, V13, P962; de Perio MA, 2009, ARCH INTERN MED, V169, P179, DOI 10.1001/archinternmed.2008.524; Deuffic-Burban S, 2010, INT J TUBERC LUNG D, V14, P471; Diel R, 2007, EUR RESPIR J, V30, P321, DOI 10.1183/09031936.00145906; Diel R, 2007, CHEST, V131, P1424, DOI 10.1378/chest.06-2728; Dowdy DW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001063; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Kowada A, 2008, MOL DIAGN THER, V12, P235, DOI 10.1007/BF03256289; Kowada A, 2010, MOL DIAGN THER, V14, P367, DOI 10.2165/11586190-000000000-00000; Kowada A, 2010, MOL DIAGN THER, V14, P229, DOI 10.2165/11538610-000000000-00000; Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC; Marra F, 2008, INT J TUBERC LUNG D, V12, P1414; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Nienhaus A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-247; Oxlade O, 2007, INT J TUBERC LUNG D, V11, P16; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pareek M, 2011, LANCET INFECT DIS, V11, P435, DOI 10.1016/S1473-3099(11)70069-X; Pooran A, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-7; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; WHO, 2010, POL FRAM IMPL NEW TU; WHO, 2011, WHO GLOBAL TUBERCULO	24	20	20	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e56044	10.1371/journal.pone.0056044	http://dx.doi.org/10.1371/journal.pone.0056044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505412	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500005
J	Rice, WL; Van Hoek, AN; Paunescu, TG; Huynh, C; Goetze, B; Singh, B; Scipioni, L; Stern, LA; Brown, D				Rice, William L.; Van Hoek, Alfred N.; Paunescu, Teodor G.; Huynh, Chuong; Goetze, Bernhard; Singh, Bipin; Scipioni, Larry; Stern, Lewis A.; Brown, Dennis			High Resolution Helium Ion Scanning Microscopy of the Rat Kidney	PLOS ONE			English	Article							ACUTE RESPIRATORY-ACIDOSIS; ELECTRON-MICROSCOPY; INTERCALATED CELLS; COATED PITS; ULTRASTRUCTURE; IDENTIFICATION; LOCALIZATION; MICROVILLI; NEURONS; SURFACE	Helium ion scanning microscopy is a novel imaging technology with the potential to provide sub-nanometer resolution images of uncoated biological tissues. So far, however, it has been used mainly in materials science applications. Here, we took advantage of helium ion microscopy to explore the epithelium of the rat kidney with unsurpassed image quality and detail. In addition, we evaluated different tissue preparation methods for their ability to preserve tissue architecture. We found that high contrast, high resolution imaging of the renal tubule surface is possible with a relatively simple processing procedure that consists of transcardial perfusion with aldehyde fixatives, vibratome tissue sectioning, tissue dehydration with graded methanol solutions and careful critical point drying. Coupled with the helium ion system, fine details such as membrane texture and membranous nanoprojections on the glomerular podocytes were visualized, and pores within the filtration slit diaphragm could be seen in much greater detail than in previous scanning EM studies. In the collecting duct, the extensive and striking apical microplicae of the intercalated cells were imaged without the shrunken or distorted appearance that is typical with conventional sample processing and scanning electron microscopy. Membrane depressions visible on principal cells suggest possible endo- or exocytotic events, and central cilia on these cells were imaged with remarkable preservation and clarity. We also demonstrate the use of colloidal gold probes for highlighting specific cell-surface proteins and find that 15 nm gold labels are practical and easily distinguishable, indicating that external labels of various sizes can be used to detect multiple targets in the same tissue. We conclude that this technology represents a technical breakthrough in imaging the topographical ultrastructure of animal tissues. Its use in future studies should allow the study of fine cellular details and provide significant advances in our understanding of cell surface structures and membrane organization.	[Rice, William L.; Van Hoek, Alfred N.; Paunescu, Teodor G.; Brown, Dennis] Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Boston, MA 02114 USA; [Rice, William L.; Van Hoek, Alfred N.; Paunescu, Teodor G.; Brown, Dennis] Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA; [Rice, William L.; Van Hoek, Alfred N.; Paunescu, Teodor G.; Brown, Dennis] Harvard Univ, Sch Med, Boston, MA USA; [Huynh, Chuong; Goetze, Bernhard; Singh, Bipin; Scipioni, Larry; Stern, Lewis A.] Carl Zeiss Microscopy, Peabody, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Carl Zeiss AG	Brown, D (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Program Membrane Biol, Boston, MA 02114 USA.	brown.dennis@mgh.harvard.edu	Paunescu, Teodor/AAX-7533-2020	Van Hoek, Alfred/0000-0003-2724-6855; Paunescu, Teodor/0000-0003-0227-9028	NIH [DK42956]; Zeiss Corporation; Massachusetts General Hospital; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, R37DK042956, R01DK042956, R01DK096586, P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zeiss Corporation; Massachusetts General Hospital(General Electric); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was in part from an NIH grant to D. Brown to examine the role of renal intercalated cell cells in kidney function (DK42956). Additional funding was provided by a sponsored research agreement to Dr. Brown from the Zeiss Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts. The work was performed partially with a sponsored research agreement between the Massachusetts General Hospital and the Zeiss Corporation. Four of the authors are employed by the Zeiss Corporation in the Helium Ion Microscopy Facility in Peabody, MA. The corresponding author D. Brown is the PI of the sponsored research agreement from the Zeiss Corporation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	ANDREWS P M, 1980, Scanning Electron Microscopy, P179; ANDREWS PM, 1974, AM J ANAT, V140, P81, DOI 10.1002/aja.1001400107; BACHINSKY DR, 1993, AM J PATHOL, V143, P598; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437, DOI 10.1152/ajprenal.2001.280.3.F437; Bazou D, 2011, J MICROSC-OXFORD, V242, P290, DOI 10.1111/j.1365-2818.2010.03467.x; Bazou D, 2011, BRIT J PHARMACOL, V162, P1577, DOI 10.1111/j.1476-5381.2010.01182.x; BEARER EL, 1985, J CELL BIOL, V100, P418, DOI 10.1083/jcb.100.2.418; Bell DC, 2009, MICROSC MICROANAL, V15, P147, DOI 10.1017/S1431927609090138; BHAN AK, 1985, LAB INVEST, V53, P421; BRETTON R, 1976, J HISTOCHEM CYTOCHEM, V24, P1093, DOI 10.1177/24.10.977938; Brown D, 2012, AM J PHYSIOL-CELL PH, V302, pC1421, DOI 10.1152/ajpcell.00085.2012; Chen X, 2011, BIOPHYS J, V101, P1788, DOI 10.1016/j.bpj.2011.08.028; CONNOLLY JL, 1981, J CELL BIOL, V90, P176, DOI 10.1083/jcb.90.1.176; DEHARVEN E, 1984, J CELL BIOL, V99, P53, DOI 10.1083/jcb.99.1.53; ESKELINEN S, 1988, SCANNING MICROSCOPY, V2, P1765; EVERHART TE, 1960, J SCI INSTRUM, V37, P246, DOI 10.1088/0950-7671/37/7/307; FAN JY, 1982, P NATL ACAD SCI-BIOL, V79, P7788, DOI 10.1073/pnas.79.24.7788; Gagliardini E, 2010, J AM SOC NEPHROL, V21, P2081, DOI 10.1681/ASN.2010020199; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; GILULA NB, 1972, J CELL BIOL, V53, P494, DOI 10.1083/jcb.53.2.494; GROSS DK, 1990, J HISTOCHEM CYTOCHEM, V38, P775, DOI 10.1177/38.6.2139886; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; KERJASCHKI D, 1984, J CELL BIOL, V98, P1505, DOI 10.1083/jcb.98.4.1505; Kiernan J.A., 2000, MICROSC TODAY, V1, P8, DOI [10.1017/S1551929500057060, DOI 10.1017/S1551929500057060]; MADSEN KM, 1983, AM J PHYSIOL, V245, pF670, DOI 10.1152/ajprenal.1983.245.6.F670; MADSEN KM, 1986, AM J PHYSIOL, V250, pF1, DOI 10.1152/ajprenal.1986.250.1.F1; ORCI L, 1981, INT REV CYTOL, V73, P183, DOI 10.1016/S0074-7696(08)61289-9; Paunescu TG, 2010, AM J PHYSIOL-RENAL, V298, pF643, DOI 10.1152/ajprenal.00584.2009; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; RODMAN JS, 1986, J CELL BIOL, V102, P77, DOI 10.1083/jcb.102.1.77; Schatten H, 2011, MICRON, V42, P175, DOI 10.1016/j.micron.2010.08.008; STUMP RF, 1988, J HISTOCHEM CYTOCHEM, V36, P493, DOI 10.1177/36.5.2965720; Vanden Berg-Foels W, 2011, MICROSC MICROANAL, V17, P282; VERLANDER JW, 1987, AM J PHYSIOL, V253, pF1142, DOI 10.1152/ajprenal.1987.253.6.F1142; Ward B, 2007, PHOTONIC SPECTRA, V41, P68; Winter C, 2011, AM J PHYSIOL-CELL PH, V301, pC1251, DOI 10.1152/ajpcell.00076.2011; Yabuki A, 2012, RES VET SCI, V93, P560, DOI 10.1016/j.rvsc.2011.12.001	37	56	56	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57051	10.1371/journal.pone.0057051	http://dx.doi.org/10.1371/journal.pone.0057051			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505418	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500010
J	Bar-Oz, G; Nahshoni, P; Motro, H; Oren, ED				Bar-Oz, Guy; Nahshoni, Pirhiya; Motro, Hadas; Oren, Eliezer D.			Symbolic Metal Bit and Saddlebag Fastenings in a Middle Bronze Age Donkey Burial	PLOS ONE			English	Article								Here we report the unprecedented discovery of the skeleton of a ritually interred donkey with a metal horse bit in association with its teeth and saddlebag fastenings on its back. This discovery in the Middle Bronze Age III sacred precinct (1700/1650-1550 BCE) at Tel Haror, Israel, presents a unique combination of evidence for the early employment of equid harnessing equipment, both for chariot bridling (horse bit) and pack animals (saddlebags). The ritually deposited donkey with its unique accoutrements advances our understanding of the broad social and religious significance of equids in the Levantine Bronze Age, previously known mainly from textual and iconographical sources.	[Bar-Oz, Guy] Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel; [Nahshoni, Pirhiya; Oren, Eliezer D.] Ben Gurion Univ Negev, Dept Bible Archaeol & Ancient Near Eastern Studie, IL-84105 Beer Sheva, Israel; [Motro, Hadas] Hebrew Univ Jerusalem, Koret Sch Vet Med, IL-76100 Rehovot, Israel	University of Haifa; Ben Gurion University; Hebrew University of Jerusalem	Bar-Oz, G (corresponding author), Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Israel.	guybar@research.haifa.ac.il	BarOz, Guy/ABF-6518-2020	BarOz, Guy/0000-0002-1009-5619	Israel Science Foundation [52/10]	Israel Science Foundation(Israel Science Foundation)	This study was partially supported by the Israel Science Foundation (http://www.isf.org.il/) (grant 52/10 for G. Bar-Oz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 1982, BAR BRIT SERIES; Baines J, 1982, ATLAS ANCIENT EGYPT, P240; Bietak M, 1996, AVARIS CAPITAL HYKSO, P98; Binford L.R, 1981, BONES ANCIENT MEN MO, P312; Brownrigg G., 2006, HORSES HUMANS EVOLUT, P165; Charpin D., 1990, CONTRIBUTION HIST IR, P109; Clutton-Brock J., 1992, Horse power: a history of the horse and the donkey in human societies.; Clutton-Brock J., 1986, Beihefte zum Tuebinger Atlas des Vorderen Orients Reihe A Naturwissenschaften, P207; Clutton-Brock J., 2003, PREHISTORIC STEPPE A, P126; CLUTTON-BROCK J., 1989, IRAQ, V51, P217; Clutton-Brock J., 2001, EXCAVATIONS TELL BRA, P327; Clutton-Brock J., 1993, IRAQ, V55, P209, DOI [10.2307/4200377, DOI 10.2307/4200377]; Crouwel JH, 1981, CHARIOTS OTHER MEANS, P215; Dercksen JG, 2004, OLD ASSYRIAN I, P305; Dietz Ute Luise, 2003, PREHISTORIC STEPPE A, P189; Eisenmann V., 1988, P1; Gardiner AH, 1952, INSCRIPTIONS SINAI, P22; Gardiner AH, 1955, INSCRIPTIONS SINAI, P242; HOLLADAY Jr. J.S., 1997, HYKSOS NEW HIST ARCH, V96, P183; Johnstone CJ, 2004, BIOMETRIC STUDY EQUI, P499; Klenck JD, 2002, BAR INT SERIES, V1029, P263; Krecher Joachim, 1995, TOPOI S, P141; Kutschera W, 2012, RADIOCARBON, V54, P407, DOI 10.1017/S0033822200047172; Lafont B., 2001, AMURRU, V2, P213; LITTAUER MA, 1969, ANTIQUITY, V43, P289, DOI 10.1017/S0003598X00040734; Littauer MA, 2001, OXFORD J ARCHAEOL, V20, P329, DOI DOI 10.1111/1468-0092.00140; Littauer MA, 1979, WHEELED VEHICLES RID, P185; Littauer MA, 1988, IRAQ, V50, P169; Lyman R.L., 1994, VERTEBRATE TAPHONOMY, P524, DOI DOI 10.1017/CBO9781139878302; Michel C., 2002, PECUS MAN ANIMAL ANT, P190; MOOREY PRS, 1986, WORLD ARCHAEOL, V18, P196, DOI 10.1080/00438243.1986.9979998; Muller V, 2008, OPFERDEPONIERUNGEN H, VXVII, P488; Muller Vera, 2002, MIDDL BRONZ AG LEV P, P269; Newberry PE, 1893, BENI HASAN, VI, P85; Oates D, 2001, EXCAVATIONS TELL BRA, V2, P642; Oates Joa, 2003, PREHISTORIC STEPPE A, P115; Oren E.D., 1997, HYKSOS NEW HIST ARCH, P253; Oren ED, 1993, NEW ENCY ARCHAEOLOGI, P580; Petrie WMF, 1931, EGYPTIAN RES ACCOUNT, V53, P88; Postgate JN, 1992, EARLY MESOPOTAMIA SO, P367; Potratz JAH, 1966, ANALECTA ORIENTALIA, V41, P260; Raulwing P, 2009, J EGYPT HIST, V2, P1, DOI 10.1163/187416509X12492786609122; Rossel S, 2008, P NATL ACAD SCI USA, V105, P3715, DOI 10.1073/pnas.0709692105; Schwartz GM, 2012, AM J ARCHAEOL, V116, P157, DOI 10.3764/aja.116.1.0157; Shaw I., 1998, SOCIAL APPROACHES IN, P242; Silver I.A, 1969, SCI ARCHAEOLOGY SURV, V2nd, P283; Staubli T, 2001, Z DEUT PALASTINA-VER, V117, P97; Van den Brink ECM, 1982, TOMBS BURIAL CUSTOMS, P140; Wapnish P, 1997, HYKSOS NEW HIST ARCH, P335; Way KC, 2011, DONKEYS BIBLICAL WOR, P272; Way KC, 2010, LEVANT, V42, P210, DOI 10.1179/175638010X12797246583852; Weber JA, 2008, ARCHAEOZOOLOGY NEAR, V8, P499, DOI [DOI 10.1038/S41598-021-86832-9, 10.1038/s41598-021-86832-9]; Zarins J, 1986, EQUIDS ANCIENT WORLD, P164; Ziffer I, 1990, TIME CANAANITES WERE, P132	54	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58648	10.1371/journal.pone.0058648	http://dx.doi.org/10.1371/journal.pone.0058648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	117EP	23484046	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100133
J	Druzhkova, AS; Thalmann, O; Trifonov, VA; Leonard, JA; Vorobieva, NV; Ovodov, ND; Graphodatsky, AS; Wayne, RK				Druzhkova, Anna S.; Thalmann, Olaf; Trifonov, Vladimir A.; Leonard, Jennifer A.; Vorobieva, Nadezhda V.; Ovodov, Nikolai D.; Graphodatsky, Alexander S.; Wayne, Robert K.			Ancient DNA Analysis Affirms the Canid from Altai as a Primitive Dog	PLOS ONE			English	Article							EVOLUTIONARY HISTORY; WOLF; DOMESTICATION; PATTERNS; ORIGIN	The origin of domestic dogs remains controversial, with genetic data indicating a separation between modern dogs and wolves in the Late Pleistocene. However, only a few dog-like fossils are found prior to the Last Glacial Maximum, and it is widely accepted that the dog domestication predates the beginning of agriculture about 10,000 years ago. In order to evaluate the genetic relationship of one of the oldest dogs, we have isolated ancient DNA from the recently described putative 33,000-year old Pleistocene dog from Altai and analysed 413 nucleotides of the mitochondrial control region. Our analyses reveal that the unique haplotype of the Altai dog is more closely related to modern dogs and prehistoric New World canids than it is to contemporary wolves. Further genetic analyses of ancient canids may reveal a more exact date and centre of domestication.	[Druzhkova, Anna S.; Trifonov, Vladimir A.; Vorobieva, Nadezhda V.; Graphodatsky, Alexander S.] Russian Acad Sci, Dept Genom Div & Evolut, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia; [Thalmann, Olaf] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland; [Leonard, Jennifer A.] CSIC, Conservat & Evolutionary Genet Grp, Estn Biol Donana, Seville, Spain; [Ovodov, Nikolai D.] Russian Acad Sci, Inst Archaeol & Ethnog, Siberian Branch, Novosibirsk, Russia; [Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	Russian Academy of Sciences; University of Turku; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Russian Academy of Sciences; Institute of Archaeology & Ethnography, Siberian Branch of Russian Academy of Sciences; University of California System; University of California Los Angeles	Trifonov, VA (corresponding author), Russian Acad Sci, Dept Genom Div & Evolut, Inst Mol & Cellular Biol, Siberian Branch, Novosibirsk, Russia.	vlad@mcb.nsc.ru	Druzhkova, Anna/N-2011-2015; Trifonov, Vladimir/E-4907-2012; Graphodatsky, Alexander/B-4922-2010; Vorobieva, Nadezhda/N-6461-2015; Leonard, Jennifer/A-7894-2010	Trifonov, Vladimir/0000-0003-0454-8359; Graphodatsky, Alexander/0000-0002-8282-1085; Leonard, Jennifer/0000-0003-0291-7819; Thalmann, Olaf/0000-0003-1700-0130	Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Russian Foundation for Basic Research; Emil Aaltonen grant; Division Of Environmental Biology [1021397] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0910272] Funding Source: National Science Foundation	Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Emil Aaltonen grant; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Institute of Molecular and Cellular Biology, Siberian Branch of the Russian Academy of Sciences and Russian Foundation for Basic Research grants to ASD, VAT, NVV, NO, ASG; Emil Aaltonen grant to OT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Crockford SJ, 2012, J ARCHAEOL SCI, V39, P2797, DOI 10.1016/j.jas.2012.04.033; Germonpre M, 2013, J ARCHAEOL SCI, V40, P786, DOI 10.1016/j.jas.2012.06.016; Germonpre M, 2012, J ARCHAEOL SCI, V39, P184, DOI 10.1016/j.jas.2011.09.022; Germonpre M, 2009, J ARCHAEOL SCI, V36, P473, DOI 10.1016/j.jas.2008.09.033; Ginolhac A, 2011, BIOINFORMATICS, V27, P2153, DOI 10.1093/bioinformatics/btr347; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Larson G, 2012, P NATL ACAD SCI USA, V109, P8878, DOI 10.1073/pnas.1203005109; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Leonard JA, 2007, CURR BIOL, V17, P1146, DOI 10.1016/j.cub.2007.05.072; Ovodov ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022821; Pang JF, 2009, MOL BIOL EVOL, V26, P2849, DOI 10.1093/molbev/msp195; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Poulakakis N, 2006, BIOL LETTERS, V2, P451, DOI 10.1098/rsbl.2006.0467; Sablin MV, 2002, CURR ANTHROPOL, V43, P795, DOI 10.1086/344372; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tchernov E, 1997, J ARCHAEOL SCI, V24, P65, DOI 10.1006/jasc.1995.0096; Verginelli F, 2005, MOL BIOL EVOL, V22, P2541, DOI 10.1093/molbev/msi248; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Yang DY, 1998, AM J PHYS ANTHROPOL, V105, P539, DOI 10.1002/(SICI)1096-8644(199804)105:4<539::AID-AJPA10>3.3.CO;2-2; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	30	69	73	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57754	10.1371/journal.pone.0057754	http://dx.doi.org/10.1371/journal.pone.0057754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483925	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100041
J	Maeda, Y; Fukushima, K; Omichi, R; Kariya, S; Nishizaki, K				Maeda, Yukihide; Fukushima, Kunihiro; Omichi, Ryotaro; Kariya, Shin; Nishizaki, Kazunori			Time Courses of Changes in Phospho- and Total- MAP Kinases in the Cochlea after Intense Noise Exposure	PLOS ONE			English	Article							PROTEIN-KINASES; ACOUSTIC INJURY; HEARING-LOSS; PATHWAY; ACTIVATION; OTOTOXICITY; MECHANISMS; PROTECTION; TRAUMA; AM-111	Mitogen-activated protein kinases (MAP kinases) are intracellular signaling kinases activated by phosphorylation in response to a variety of extracellular stimuli. Mammalian MAP kinase pathways are composed of three major pathways: MEK1 (mitogen-activated protein kinase kinase 1)/ERK 1/2 (extracellular signal-regulated kinases 1/2)/p90 RSK (p90 ribosomal S6 kinase), JNK (c-Jun amino (N)-terminal kinase)/c-Jun, and p38 MAPK pathways. These pathways coordinately mediate physiological processes such as cell survival, protein synthesis, cell proliferation, growth, migration, and apoptosis. The involvement of MAP kinase in noise-induced hearing loss (NIHL) has been implicated in the cochlea; however, it is unknown how expression levels of MAP kinase change after the onset of NIHL and whether they are regulated by transient phosphorylation or protein synthesis. CBA/J mice were exposed to 120-dB octave band noise for 2 h. Auditory brainstem response confirmed a component of temporary threshold shift within 0-24 h and significant permanent threshold shift at 14 days after noise exposure. Levels and localizations of phospho-and total-MEK1/ERK1/2/p90 RSK, JNK/c-Jun, and p38 MAPK were comprehensively analyzed by the Bio-Plex (R) Suspension Array System and immunohistochemistry at 0, 3, 6, 12, 24 and 48 h after noise exposure. The phospho-MEK1/ERK1/2/p90 RSK signaling pathway was activated in the spiral ligament and the sensory and supporting cells of the organ of Corti, with peaks at 3-6 h and independently of regulations of total-MEK1/ERK1/2/p90 RSK. The expression of phospho-JNK and p38 MAPK showed late upregulation in spiral neurons at 48 h, in addition to early upregulations with peaks at 3 h after noise trauma. Phospho-p38 MAPK activation was dependent on upregulation of total-p38 MAPK. At present, comprehensive data on MAP kinase expression provide significant insight into understanding the molecular mechanism of NIHL, and for developing therapeutic models for acute sensorineural hearing loss.	[Maeda, Yukihide; Fukushima, Kunihiro; Omichi, Ryotaro; Kariya, Shin; Nishizaki, Kazunori] Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharm, Okayama 7008530, Japan	Okayama University	Maeda, Y (corresponding author), Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharm, Okayama 7008530, Japan.	maedayj@yahoo.co.jp	Omichi, Ryotaro/AAN-9037-2021	Omichi, Ryotaro/0000-0001-5441-9796	Japanese Ministry of Health, Labour and Welfare [H23-NANCHI-IPPAN-021]; Japanese Ministry of Education, Culture, Sports, Science and Technology [KAKEN 22591880]	Japanese Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from Japanese Ministry of Health, Labour and Welfare (H23-NANCHI-IPPAN-021; http://www.mhlw.go.jp/) and Japanese Ministry of Education, Culture, Sports, Science and Technology (KAKEN 22591880; http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Coleman JKM, 2007, HEARING RES, V226, P70, DOI 10.1016/j.heares.2006.05.006; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Cui Y, 2011, EUR ARCH OTO-RHINO-L, V268, P973, DOI 10.1007/s00405-011-1484-3; DRAGUNOW M, 1993, MOL BRAIN RES, V18, P347, DOI 10.1016/0169-328X(93)90101-T; Eshraghi AA, 2007, HEARING RES, V226, P168, DOI 10.1016/j.heares.2006.09.008; Jamesdaniel S, 2011, J PROTEOMICS, V75, P410, DOI 10.1016/j.jprot.2011.08.007; Meltser I, 2010, NEUROSCIENCE, V165, P1439, DOI 10.1016/j.neuroscience.2009.11.025; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Nagashima R, 2010, J PHARMACOL SCI, V114, P50, DOI 10.1254/jphs.10113FP; Omotehara Y, 2011, OTOL NEUROTOL, V32, P1422, DOI 10.1097/MAO.0b013e3182355658; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Tabuchi K, 2010, NEUROSCIENCE, V166, P665, DOI 10.1016/j.neuroscience.2009.12.038; Wang J, 2007, MOL PHARMACOL, V71, P654, DOI 10.1124/mol.106.028936; Wei X, 2005, NEUROSCIENCE, V131, P513, DOI 10.1016/j.neuroscience.2004.11.014; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zarich N, 2006, MOL BIOL CELL, V17, P3591, DOI 10.1091/mbc.E05-12-1104	21	37	38	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58775	10.1371/journal.pone.0058775	http://dx.doi.org/10.1371/journal.pone.0058775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484051	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100137
J	Mendes, B; Silva, P; Aveiro, F; Pereira, J; Camara, JS				Mendes, Berta; Silva, Pedro; Aveiro, Fernando; Pereira, Jorge; Camara, Jose S.			A Micro-Extraction Technique Using a New Digitally Controlled Syringe Combined with UHPLC for Assessment of Urinary Biomarkers of Oxidatively Damaged DNA	PLOS ONE			English	Article							PACKED SORBENT MEPS; LIQUID-CHROMATOGRAPHY; 8-HYDROXY-2'-DEOXYGUANOSINE 8-OHDG; CAPILLARY-ELECTROPHORESIS; BREAST-CANCER; MICROEXTRACTION; PERFORMANCE; STRESS; 5-HYDROXYMETHYLURACIL; EXCRETION	The formation of reactive oxygen species (ROS) within cells causes damage to biomolecules, including membrane lipids, DNA, proteins and sugars. An important type of oxidative damage is DNA base hydroxylation which leads to the formation of 8-oxo-7,8-dihydro-2 '-deoxyguanosine (8-oxodG) and 5-hydroxymethyluracil (5-HMUra). Measurement of these biomarkers in urine is challenging, due to the low levels of the analytes and the matrix complexity. In order to simultaneously quantify 8-oxodG and 5-HMUra in human urine, a new, reliable and powerful strategy was optimised and validated. It is based on a semi-automatic microextraction by packed sorbent (MEPS) technique, using a new digitally controlled syringe (eVol((R)) ), to enhance the extraction efficiency of the target metabolites, followed by a fast and sensitive ultrahigh pressure liquid chromatography (UHPLC). The optimal methodological conditions involve loading of 250 mu L urine sample (1: 10 dilution) through a C8 sorbent in a MEPS syringe placed in the semi-automatic eVol H syringe followed by elution using 90 mL of 20% methanol in 0.01% formic acid solution. The obtained extract is directly analysed in the UHPLC system using a binary mobile phase composed of aqueous 0.1% formic acid and methanol in the isocratic elution mode (3.5 min total analysis time). The method was validated in terms of selectivity, linearity, limit of detection (LOD), limit of quantification (LOQ), extraction yield, accuracy, precision and matrix effect. Satisfactory results were obtained in terms of linearity (r(2). 0.991) within the established concentration range. The LOD varied from 0.00005 to 0.04 mu g mL 21 and the LOQ from 0.00023 to 0.13 mu g mL 21. The extraction yields were between 80.1 and 82.2 %, while inter-day precision (n= 3 days) varied between 4.9 and 7.7 % and intra-day precision between 1.0 and 8.3 %. This approach presents as main advantages the ability to easily collect and store urine samples for further processing and the high sensitivity, reproducibility, and robustness of eVol H MEPS combined with UHPLC analysis, thus retrieving a fast and reliable assessment of oxidatively damaged DNA.	[Mendes, Berta; Silva, Pedro; Pereira, Jorge; Camara, Jose S.] Univ Madeira, Ctr Ciencias Exatas & Engn, CQM, Funchal, Portugal; [Mendes, Berta; Silva, Pedro; Camara, Jose S.] Univ Madeira, Ctr Ciencias Exatas & Engn, Funchal, Portugal; [Aveiro, Fernando] Hosp Dr Nelio Mendonca, SESARAM, Funchal, Portugal	Universidade da Madeira; Universidade da Madeira	Camara, JS (corresponding author), Univ Madeira, Ctr Ciencias Exatas & Engn, CQM, Funchal, Portugal.	jsc@uma.pt	Pereira, Jorge A. M./J-4186-2013; Câmara, José/G-3003-2013	Pereira, Jorge A. M./0000-0003-0316-5348; Câmara, José/0000-0003-1965-3151; Capelo da Silva, Pedro Miguel/0000-0003-1487-9346	FEDER (Transnational Cooperation MAC 2007-2013 Program) [MAC/1/M105]; Fundacao, para a Ciencia e a Tecnologia (FCT) [PEst-OE/QUI/UI0674/2011]; Portuguese Mass Spectrometry Network - RNEM [REDE/1508/RNEM/2005]	FEDER (Transnational Cooperation MAC 2007-2013 Program); Fundacao, para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and Technology); Portuguese Mass Spectrometry Network - RNEM	The authors thank the financial support of FEDER (Transnational Cooperation MAC 2007-2013 Program) through VinSaudeMAC project (MAC/1/M105) and Fundacao, para a Ciencia e a Tecnologia (FCT) through the Strategic Plan PEst-OE/QUI/UI0674/2011, and the Portuguese Mass Spectrometry Network - RNEM 2013 (REDE/1508/RNEM/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rehim M, 2011, ANAL CHIM ACTA, V701, P119, DOI 10.1016/j.aca.2011.05.037; Abdel-Rehim M, 2010, J CHROMATOGR A, V1217, P2569, DOI 10.1016/j.chroma.2009.09.053; Altun Z, 2008, ANAL CHIM ACTA, V630, P116, DOI 10.1016/j.aca.2008.09.067; Baker D, 2002, CHEM RES TOXICOL, V15, P33, DOI 10.1021/tx010113b; Bianchini F, 1996, BIOMARKERS, V1, P178, DOI 10.3109/13547509609079354; Botello I, 2012, ANAL BIOANAL CHEM, V403, P777, DOI 10.1007/s00216-012-5872-3; Brody Jerome S, 2006, Proc Am Thorac Soc, V3, P535, DOI 10.1513/pats.200603-089MS; Cadet J, 2012, FREE RADICAL RES, V46, P367, DOI 10.3109/10715762.2012.659248; Chang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027218; Chen HJC, 2005, TOXICOL LETT, V155, P403, DOI 10.1016/j.toxlet.2004.11.009; Cooke MS, 2008, CANCER EPIDEM BIOMAR, V17, P3, DOI 10.1158/1055-9965.EPI-07-0751; Davis JD, 2011, WORLD J CLIN ONCOL, V2, P329, DOI 10.5306/wjco.v2.i9.329; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Djuric Z, 1998, J AM DIET ASSOC, V98, P524, DOI 10.1016/S0002-8223(98)00119-9; Goncalves J, 2012, J CHROMATOGR A, V1229, P13, DOI 10.1016/j.chroma.2012.01.023; Harri M, 2007, J CHROMATOGR B, V853, P242, DOI 10.1016/j.jchromb.2007.03.016; Himmetoglu S, 2009, J INVEST MED, V57, P720, DOI 10.2310/JIM.0b013e3181adfb5b; Hu JJ, 2010, J CHROMATOGR B, V878, P2765, DOI 10.1016/j.jchromb.2010.08.017; Inaba Y, 2011, J CHROMATOGR SCI, V49, P303, DOI 10.1093/chrsci/49.4.303; Kang Duck-Hee, 2002, AACN Clin Issues, V13, P540, DOI 10.1097/00044067-200211000-00007; Klaunig JE, 2004, ANNU REV PHARMACOL, V44, P239, DOI 10.1146/annurev.pharmtox.44.101802.121851; Kuo HW, 2007, MUTAT RES-GEN TOX EN, V631, P62, DOI 10.1016/j.mrgentox.2007.04.009; Lam PMW, 2012, FREE RADICAL BIO MED, V52, P2057, DOI 10.1016/j.freeradbiomed.2012.03.004; Matsumura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008819; Mei SR, 2005, J CHROMATOGR B, V827, P83, DOI 10.1016/j.jchromb.2005.04.001; Poulsen HE, 2005, EXP TOXICOL PATHOL, V57, P161, DOI 10.1016/j.etp.2005.05.015; Rani S, 2012, J SEP SCI, V35, P359, DOI 10.1002/jssc.201100789; Ravanat JL, 1999, CHEM RES TOXICOL, V12, P802, DOI 10.1021/tx980194k; Silva CL, 2012, J CHROMATOGRAPHY A; Sova H, 2010, BRIT J CANCER, V102, P1018, DOI 10.1038/sj.bjc.6605565; Uppuluri P, 2009, J CLIN MICROBIOL, V47, P4078, DOI 10.1128/JCM.01377-09; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Vlckova H, 2012, TALANTA, V90, P22, DOI 10.1016/j.talanta.2011.12.043; Yano T, 2009, LUNG CANCER, V63, P111, DOI 10.1016/j.lungcan.2008.04.014; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030181	37	12	13	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58366	10.1371/journal.pone.0058366	http://dx.doi.org/10.1371/journal.pone.0058366			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484022	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100112
J	Scherer, KR; Meuleman, B				Scherer, Klaus R.; Meuleman, Ben			Human Emotion Experiences Can Be Predicted on Theoretical Grounds: Evidence from Verbal Labeling	PLOS ONE			English	Article							ANTECEDENT APPRAISAL; SPECIFICITY; PATTERNS	In an effort to demonstrate that the verbal labeling of emotional experiences obeys lawful principles, we tested the feasibility of using an expert system called the Geneva Emotion Analyst (GEA), which generates predictions based on an appraisal theory of emotion. Several thousand respondents participated in an Internet survey that applied GEA to self-reported emotion experiences. Users recalled appraisals of emotion-eliciting events and labeled the experienced emotion with one or two words, generating a massive data set on realistic, intense emotions in everyday life. For a final sample of 5969 respondents we show that GEA achieves a high degree of predictive accuracy by matching a user's appraisal input to one of 13 theoretically predefined emotion prototypes. The first prediction was correct in 51% of the cases and the overall diagnosis was considered as at least partially correct or appropriate in more than 90% of all cases. These results support a component process model that encourages focused, hypothesis-guided research on elicitation and differentiation, memory storage and retrieval, and categorization and labeling of emotion episodes. We discuss the implications of these results for the study of emotion terms in natural language semantics.	[Scherer, Klaus R.; Meuleman, Ben] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland	University of Geneva	Scherer, KR (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.	Klaus.scherer@unige.ch			National Center of Competence in Research (NCCR) Affective Sciences; Swiss National Science Foundation [51NF40-104897]; European Research Council (ERC) [230331-PROPEREMO]	National Center of Competence in Research (NCCR) Affective Sciences; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission)	This research was funded by the National Center of Competence in Research (NCCR) Affective Sciences financed by the Swiss National Science Foundation (no 51NF40-104897) (http://www.snf.ch/E/Pages/default.aspx) and a European Research Council (ERC) Advanced Grant (no 230331-PROPEREMO) to KRS (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Barrett LF, 2006, PERSPECT PSYCHOL SCI, V1, P28, DOI 10.1111/j.1745-6916.2006.00003.x; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; DAVIDSON RJ, 2003, HDB AFFECTIVE SCI; de Sousa R., 1987, RATIONALITY EMOTION; Dixon Thomas, 2003, PASSIONS EMOTIONS CR; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Fischer A.H., 2001, APPRAISAL PROCESSES, P221; Fontaine J. R. J., COMPONENTS IN PRESS; Frijda N. H., 2007, LAWS EMOTION; Frijda NH, 2009, SERIES AFFECTIVE SCI, P142; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Kuppens P, 2003, EMOTION, V3, P254, DOI 10.1037/1528-3542.3.3.254; LANG PJ, 1979, PSYCHOPHYSIOLOGY, V16, P495, DOI 10.1111/j.1469-8986.1979.tb01511.x; Leventhal H., 1987, COGNITION EMOTION, V1, P3, DOI [DOI 10.1080/02699938708408361, 10.1080/02699938708408361]; Moors A., HDB COGNITI IN PRESS; Romney AK, 2000, P NATL ACAD SCI USA, V97, P518, DOI 10.1073/pnas.97.1.518; Roseman IJ, 2004, COGNITION EMOTION, V18, P1, DOI 10.1080/02699930244000390; Russell JA, 2009, COGNITION EMOTION, V23, P1259, DOI 10.1080/02699930902809375; Sander D.E., 2009, OXFORD COMPANION EMO; Scherer K.R., 2001, APPRAISAL PROCESSES, DOI DOI 10.1016/S0166-4115(08)62387-0; Scherer KR, 2011, INT J PSYCHOL, V46, P401, DOI 10.1080/00207594.2011.626049; Scherer KR, 2009, COGNITION EMOTION, V23, P1307, DOI 10.1080/02699930902928969; Scherer KR, 2004, SOC SCI INFORM, V43, P499, DOI 10.1177/0539018404047701; Scherer KR, 1997, MOTIV EMOTION, V21, P211, DOI 10.1023/A:1024498629430; SCHERER KR, 1993, COGNITION EMOTION, V7, P325, DOI 10.1080/02699939308409192; Scherer KR, 2013, COMPONENTS IN PRESS; SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061; Siemer M, 2007, EMOTION, V7, P592, DOI 10.1037/1528-3542.7.3.592; SMITH CA, 1987, J PERS SOC PSYCHOL, V52, P475, DOI 10.1037/0022-3514.52.3.475	31	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58166	10.1371/journal.pone.0058166	http://dx.doi.org/10.1371/journal.pone.0058166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483988	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100083
J	Cheng, CH; Lee, YS; Chang, CJ; Lin, TY				Cheng, Chi-Hui; Lee, Yun-Shien; Chang, Chee-Jen; Lin, Tzou-Yien			Genetic Polymorphisms in Toll-Like Receptors among Pediatric Patients with Renal Parenchymal Infections of Different Clinical Severities	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; ACUTE PYELONEPHRITIS; TLR2 POLYMORPHISMS; SUSCEPTIBILITY; ASSOCIATION; GENOTYPES; IMMUNITY; HOST	Background: Although several studies have suggested single gene defects or variations in the genes associated with host immune response could confer differences in susceptibility to urinary pathogen invasion, no studies have examined the genetic polymorphisms in various toll-like receptors (TLRs) that activate innate immune responses in pediatric renal parenchymal infections of different clinical severities, namely acute pyelonephritis and the clinically more severe disease, acute lobar nephronia. Methodology: Patients who fulfilled the diagnostic criteria for acute pyelonephritis (APN) and acute lobar nephronia (ALN) without underlying diseases or structural anomalies, except for vesicoureteral reflux (VUR), were enrolled. Genotyping of the single nucleotide polymorphisms (SNPs) in the genes encoding TLR-1, TLR-2, TLR-4, TLR-5, and TLR-6 was performed by matrix-assisted laser desorption/ionization time-of-flight-based mini-sequencing analysis. Principal Findings: A total of 16 SNPs were selected for genotyping. Analysis of 96 normal and 48 patients' samples revealed that only four SNPs had heterozygosity rates >0.01. These SNPs were selected for further investigation. Hardy-Weinberg equilibrium was satisfied for the observed genotype frequencies. Statistically significant differences in the genotype frequency of TLR-2 (rs3804100, T1350C) between controls and ALN or (APN+ALN) combined group were identified using the recessive model with the correction for multiple-SNP testing. Further genotype pattern frequency analysis in TLR-2 SNPs (rs3804099 and rs3804100) showed significantly reduced occurrence of the rare allele homozygote (CC+CC) in the no-VUR subgroup of APN and ALN cases. Conclusions: As the inflammatory responses in ALN patients are more severe than those in APN patients (higher CRP levels, longer duration of fever after antibiotic treatment), these findings suggest that the genetic variant in TLR-2 (rs3804100, T1350C) may protect the host from severe urinary tract infections as ALN.	[Cheng, Chi-Hui] Chang Gung Mem Hosp, Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Nephrol, Tao Yuan, Taiwan; [Cheng, Chi-Hui; Lin, Tzou-Yien] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Lee, Yun-Shien] Chang Gung Mem Hosp, GMRCL, Tao Yuan, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Tao Yuan, Taiwan; [Chang, Chee-Jen] Chang Gung Mem Hosp, Stat Ctr Clin Res, Tao Yuan, Taiwan; [Lin, Tzou-Yien] Chang Gung Mem Hosp, Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Ming Chuan University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Cheng, CH (corresponding author), Chang Gung Mem Hosp, Chang Gung Childrens Hosp, Dept Pediat, Div Pediat Nephrol, Tao Yuan, Taiwan.	pedneph.cheng@msa.hinet.net	Cheng, Chi-Hui/C-8048-2012	Cheng, Chi-Hui/0000-0002-0070-0571	National Science Council of Taiwan [98-2314-B-182A-007-MY3]; Chang Gung Memorial Hospital [CMRPG 470033, 4A0111]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	Financial support was provided by the National Science Council of Taiwan (98-2314-B-182A-007-MY3) and Chang Gung Memorial Hospital (CMRPG 470033, 4A0111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Maziad A, 2010, PEDIATR RES, V68, P323, DOI 10.1203/00006450-201011001-00632; Ahmad-Nejad P, 2004, J ALLERGY CLIN IMMUN, V113, P565, DOI 10.1016/j.jaci.2003.12.583; Artifoni L, 2007, J UROLOGY, V177, P1102, DOI 10.1016/j.juro.2006.10.037; Bergman DA, 1999, PEDIATRICS, V103, P843; Beutler B, 2001, J ENDOTOXIN RES, V7, P277, DOI 10.1177/09680519010070040901; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bochud PY, 2008, J INFECT DIS, V197, P253, DOI 10.1086/524688; Chen YL, 2010, BMC MED GENET, V11, DOI [10.1186/1471-2350-11-46, 10.1186/1471-2350-11-17]; Cheng CH, 2006, PEDIATRICS, V117, pE84, DOI 10.1542/peds.2005-0917; Cheng CH, 2007, PEDIATR INFECT DIS J, V26, P228, DOI 10.1097/01.inf.0000254388.66367.13; Cheng CH, 2011, PEDIATR INFECT DIS J, V30, P309, DOI 10.1097/INF.0b013e3181ff84ff; Cheng CH, 2010, PEDIATR INFECT DIS J, V29, P736, DOI 10.1097/INF.0b013e3181dab249; Cheng CH, 2010, J PEDIATR-US, V156, P82, DOI 10.1016/j.jpeds.2009.07.010; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008300; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Junpee A, 2010, PARASITOL RES, V107, P807, DOI 10.1007/s00436-010-1932-9; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Ma JF, 2004, UROL CLIN N AM, V31, P517, DOI 10.1016/j.ucl.2004.04.016; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Orellana P, 2004, PEDIATR NEPHROL, V19, P1122, DOI 10.1007/s00467-004-1501-5; Ragnarsdottir B, 2011, NAT REV UROL, V8, P449, DOI 10.1038/nrurol.2011.100; Ragnarsdottir B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010734; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Tabel Y, 2007, INT J IMMUNOGENET, V34, P399, DOI 10.1111/j.1744-313X.2007.00709.x; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Tseng CC, 2002, AM J KIDNEY DIS, V39, P744, DOI 10.1053/ajkd.2002.32992; Yin XL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014223	32	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58687	10.1371/journal.pone.0058687	http://dx.doi.org/10.1371/journal.pone.0058687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484049	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900098
J	Ewers, RM; Banks-Leite, C				Ewers, Robert M.; Banks-Leite, Cristina			Fragmentation Impairs the Microclimate Buffering Effect of Tropical Forests	PLOS ONE			English	Article							ATLANTIC FOREST; SOIL-MOISTURE; EDGE; GRADIENTS; IMPACTS; VARIABILITY; RESPONSES; ECOSYSTEM; DYNAMICS; HABITAT	Background: Tropical forest species are among the most sensitive to changing climatic conditions, and the forest they inhabit helps to buffer their microclimate from the variable climatic conditions outside the forest. However, habitat fragmentation and edge effects exposes vegetation to outside microclimatic conditions, thereby reducing the ability of the forest to buffer climatic variation. In this paper, we ask what proportion of forest in a fragmented ecosystem is impacted by altered microclimate conditions driven by edge effects, and extrapolate these results to the whole Atlantic Forest biome, one of the most disturbed biodiversity hotspots. To address these questions, we collected above and below ground temperature for a full year using temperature sensors placed in forest fragments of different sizes, and at different distances from the forest edge. Principal Findings: In the Atlantic forests of Brazil, we found that the buffering effect of forests reduced maximum outside temperatures by one third or more at ground level within a forest, with the buffering effect being stronger below-ground than one metre above-ground. The temperature buffering effect of forests was, however, reduced near forest edges with the edge effect extending up to 20 m inside the forest. The heavily fragmented nature of the Brazilian Atlantic forest means that 12% of the remaining biome experiences altered microclimate conditions. Conclusions: Our results add further information about the extent of edge effects in the Atlantic Forest, and we suggest that maintaining a low perimeter-to-area ratio may be a judicious method for minimizing the amount of forest area that experiences altered microclimatic conditions in this ecosystem.	[Ewers, Robert M.; Banks-Leite, Cristina] Imperial Coll London, Ascot, Berks, England	Imperial College London	Ewers, RM (corresponding author), Imperial Coll London, Silwood Pk Campus, Ascot, Berks, England.	r.ewers@imperial.ac.uk	Banks-Leite, Cristina/D-3075-2011	Banks-Leite, Cristina/0000-0002-0091-2857	Royal Society of London [RG080214]; Natural Environment Research Council [NE/H016228/1]; NERC [NE/H016228/1] Funding Source: UKRI	Royal Society of London(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Fieldwork was funded by the Royal Society of London (Research Grant RG080214, http://royalsociety.org/), and CBL was funded by the Natural Environment Research Council (Grant Number NE/H016228/1, http://www.nerc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Banks-Leite C, ECOLOGICAL IN PRESS; Banks-Leite C, 2012, ECOLOGY, V93, P2560, DOI 10.1890/11-2054.1; Banks-Leite C, 2010, OIKOS, V119, P918, DOI 10.1111/j.1600-0706.2009.18061.x; Bennie JJ, 2010, AGR FOREST METEOROL, V150, P12, DOI 10.1016/j.agrformet.2009.07.014; Billings SA, 2008, LANDSCAPE ECOL, V23, P581, DOI 10.1007/s10980-008-9218-7; Cadenasso ML, 1997, CAN J FOREST RES, V27, P774, DOI 10.1139/cjfr-27-5-774; CAMARGO JLC, 1995, J TROP ECOL, V11, P205, DOI 10.1017/S026646740000866X; Chen JQ, 1999, BIOSCIENCE, V49, P288, DOI 10.2307/1313612; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Davies-Colley RJ, 2000, NEW ZEAL J ECOL, V24, P111; Didham RK, 2012, BIOL CONSERV, V155, P104, DOI 10.1016/j.biocon.2012.06.019; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Didham RK, 1999, BIOTROPICA, V31, P17, DOI 10.1111/j.1744-7429.1999.tb00113.x; Ewers RM, 2008, P NATL ACAD SCI USA, V105, P5426, DOI 10.1073/pnas.0800460105; Ewers RM, 2007, CONSERV BIOL, V21, P926, DOI 10.1111/j.1523-1739.2007.00720.x; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Ewers RM, 2010, TRENDS ECOL EVOL, V25, P699, DOI 10.1016/j.tree.2010.09.008; Fletcher RJ, 2005, J ANIM ECOL, V74, P342, DOI 10.1111/j.1365-2656.2005.00930.x; Guan XD, 2009, ADV ATMOS SCI, V26, P692, DOI 10.1007/s00376-009-8198-0; Harper KA, 2001, ECOLOGY, V82, P649, DOI 10.1890/0012-9658(2001)082[0649:SACORB]2.0.CO;2; Hennenberg KJ, 2008, BASIC APPL ECOL, V9, P275, DOI 10.1016/j.baae.2007.02.004; Honnay O, 2002, FOREST ECOL MANAG, V161, P109, DOI 10.1016/S0378-1127(01)00490-X; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kitoh A, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014920; Lafortezza R, 2010, GLOBAL ECOL BIOGEOGR, V19, P741, DOI 10.1111/j.1466-8238.2010.00542.x; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Lira PK, 2012, FOREST ECOL MANAG, V278, P80, DOI 10.1016/j.foreco.2012.05.008; Malcolm JR, 1998, CLIMATIC CHANGE, V39, P487, DOI 10.1023/A:1005376603186; MALCOLM JR, 1994, ECOLOGY, V75, P2438, DOI 10.2307/1940897; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Pardini R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013666; Pincebourde S, 2007, J ANIM ECOL, V76, P424, DOI 10.1111/j.1365-2656.2007.01231.x; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Smith DL, 2004, ECOLOGY, V85, P3348, DOI 10.1890/03-0576; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stewart KJ, 2006, ECOL APPL, V16, P1474, DOI 10.1890/1051-0761(2006)016[1474:BRTMEE]2.0.CO;2; Tabarelli M, 2008, BIOTROPICA, V40, P657, DOI 10.1111/j.1744-7429.2008.00454.x; Temple S.A., 1986, P301; Williams-Linera G, 1998, CONSERV BIOL, V12, P1091, DOI 10.1046/j.1523-1739.1998.97262.x	46	136	139	10	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58093	10.1371/journal.pone.0058093	http://dx.doi.org/10.1371/journal.pone.0058093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483976	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900069
J	Nofiele, JT; Cheng, HLM				Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret			Ultrashort Echo Time for Improved Positive-Contrast Manganese-Enhanced MRI of Cancer	PLOS ONE			English	Article							LABELED CELLS; QUANTIFICATION; NANOPARTICLES	Objective: Manganese (Mn) is a positive magnetic resonance imaging (MRI) contrast agent that has been used to obtain physiological, biochemical, and molecular biological information. There is great interest to broaden its applications, but a major challenge is to increase detection sensitivity. Another challenge is distinguishing regions of Mn-related signal enhancement from background tissue with inherently similar contrast. To overcome these limitations, this study investigates the use of ultrashort echo time (UTE) and subtraction UTE (SubUTE) imaging for more sensitive and specific determination of Mn accumulation. Materials and Methods: Simulations were performed to investigate the feasibility of UTE and SubUTE for Mn-enhanced MRI and to optimize imaging parameters. Phantoms containing aqueous Mn solutions were imaged on a MRI scanner to validate simulations predictions. Breast cancer cells that are very aggressive (MDA-MB-231 and a more aggressive variant LM2) and a less aggressive cell line (MCF7) were labeled with Mn and imaged on MRI. All imaging was performed on a 3 Tesla scanner and compared UTE and SubUTE against conventional T-1-weighted spoiled gradient echo (SPGR) imaging. Results: Simulations and phantom imaging demonstrated that UTE and SubUTE provided sustained and linearly increasing positive contrast over a wide range of Mn concentrations, whereas conventional SPGR displayed signal plateau and eventual decrease. Higher flip angles are optimal for imaging higher Mn concentrations. Breast cancer cell imaging demonstrated that UTE and SubUTE provided high sensitivity, with SubUTE providing background suppression for improved specificity and eliminating the need for a pre-contrast baseline image. The SubUTE sequence allowed the best distinction of aggressive breast cancer cells. Conclusions: UTE and SubUTE allow more sensitive and specific positive-contrast detection of Mn enhancement. This imaging capability can potentially open many new doors for Mn-enhanced MRI in vascular, cellular, and molecular imaging.	[Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Nofiele, Joris Tchouala; Cheng, Hai-Ling Margaret] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Cheng, HLM (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	Hai-Ling.Cheng@sickkids.ca	Cheng, Hai-Ling Margaret/E-5551-2011	Cheng, Hai-Ling Margaret/0000-0002-0733-9512	The SickKids Foundation; The Garron Family Cancer Centre Small Grant Competition	The SickKids Foundation; The Garron Family Cancer Centre Small Grant Competition	This study was supported by funding from The SickKids Foundation and The Garron Family Cancer Centre Small Grant Competition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baio G, 2012, EUR RADIOL, V22, P551, DOI 10.1007/s00330-011-2285-1; BERGIN CJ, 1991, RADIOLOGY, V179, P777, DOI 10.1148/radiology.179.3.2027991; Bowen CV, 2002, MAGNET RESON MED, V48, P52, DOI 10.1002/mrm.10192; Braga HJV, 2002, RADIOLOGY, V223, P525, DOI 10.1148/radiol.2232010908; Brismar TB, 2012, EUR RADIOL, V22, P633, DOI 10.1007/s00330-011-2288-y; Brurok H, 1999, NMR BIOMED, V12, P364, DOI 10.1002/(SICI)1099-1492(199910)12:6<364::AID-NBM585>3.3.CO;2-Q; Bulte JWM, 1999, MAGN RESON MED, V42, P379, DOI 10.1002/(SICI)1522-2594(199908)42:2<379::AID-MRM20>3.0.CO;2-L; Crowe LA, 2011, AM J TRANSPLANT, V11, P1158, DOI 10.1111/j.1600-6143.2011.03559.x; Girard OM, 2012, CONTRAST MEDIA MOL I, V7, P411, DOI 10.1002/cmmi.1467; Girard OM, 2011, MAGN RESON MED, V65, P1649, DOI 10.1002/mrm.22755; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; Kotek G, 2012, CONTRAST MEDIA MOL I, V7, P195, DOI 10.1002/cmmi.481; Lauterbur PC., 1978, FRONTIERS BIOL ENERG, V1978, P752; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; MENDONCADIAS MH, 1983, SEMIN NUCL MED, V13, P364, DOI 10.1016/S0001-2998(83)80048-8; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Weissleder R, 1997, J MAGN RESON IMAGING, V7, P258, DOI 10.1002/jmri.1880070140; Zhang LJ, 2011, J MAGN RESON IMAGING, V33, P194, DOI 10.1002/jmri.22412	18	16	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58617	10.1371/journal.pone.0058617	http://dx.doi.org/10.1371/journal.pone.0058617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484042	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900094
J	Dane, B; Harris, R; Reed, JM				Dane, Benjamin; Harris, Rebecca; Reed, J. Michael			Female Goldeneye Ducks (Bucephala clangula) Do Not Discriminate among Male Precopulatory Display Patterns	PLOS ONE			English	Article							SEXUAL SELECTION; REPERTOIRE SIZE; EVOLUTION; SONG; COURTSHIP; PREFERENCES; PEACOCKS	Female goldeneyes remain motionless on the surface of the water while single males circle them performing a series of highly stereotyped displays. After performing between eight and 90 of these displays the male either copulates or attempts to copulate with the female. However, females allow only 58% of males to mount them, while rejecting 42%. We have examined 804 of these precopulatory sequences containing 11,841 actions in an effort to determine why females find some display sequences of males unsuitable, while others are accepted. Males have an extraordinarily varied sequence of actions, and sequence variation leading to successful and unsuccessful copulation attempts was similar. Most surprising was the tendency of males to eliminate one of the five actions, whether in successful or unsuccessful attempts. As unlikely as we think it might be as the result of natural selection, the only statistically significant difference we found between successful and unsuccessful attempts was the reduction in the frequency of expression of one or more of the behaviors in successful attempts. These observations, coupled with the large variation seen in most sequences, suggest that there is not a correct sequence, or even a correct set of actions leading to copulation. The male must, however, perform goldeneye species-specific precopulatory behavior as performed by adult males, although it apparently can be performed in a wide variety of patterns.	[Dane, Benjamin; Harris, Rebecca; Reed, J. Michael] Tufts Univ, Dept Biol, Medford, MA 02155 USA	Tufts University	Reed, JM (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	michael.reed@tufts.edu						AFTON AD, 1982, CAN FIELD NAT, V96, P295; BATESON P, 1982, NATURE, V295, P236, DOI 10.1038/295236a0; Buchanan KL, 1997, P ROY SOC B-BIOL SCI, V264, P521, DOI 10.1098/rspb.1997.0074; BURGHARDT GM, 1985, FDN COMP ETHOLOGY; CATCHPOLE CK, 1980, BEHAVIOUR, V74, P149, DOI 10.1163/156853980X00366; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Dane B., 1964, Behaviour, V22, P282, DOI 10.1163/156853964X00058; DANE BENJAMIN, 1959, BEHAVIOUR, V14, P265, DOI 10.1163/156853959X00108; Davis ES, 1997, ANIM BEHAV, V53, P1025, DOI 10.1006/anbe.1996.0355; FINLEY J, 1983, ANIM BEHAV, V31, P348, DOI 10.1016/S0003-3472(83)80053-0; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Heinroth O., 1911, BEITRAGE BIOL NAMENT, P589; Johnson KP, 2000, J EVOLUTION BIOL, V13, P634; Johnson KP, 2000, ANIM BEHAV, V59, P953, DOI 10.1006/anbe.1999.1399; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; LIND HANS, 1959, DANSK ORNITHOL FOR TIDSSKR, V53, P177; LORENZ K., 1935, Journal fur Ornithologie, V83, P137, DOI 10.1007/BF01905355; Lorenz K., 1941, Journal fuer Ornithologie Berlin Festschrift Oskar Heinroth, P194; Lorenz KZ, 1935, J ORNITHOL, V83, P289, DOI DOI 10.1007/BF01905572; MacDougall AK, 2003, NATURWISSENSCHAFTEN, V90, P464, DOI 10.1007/s00114-003-0459-7; MCKINNEY F, 1990, AUK, V107, P188; MCKINNEY F, 1983, BEHAVIOUR, V86, P250, DOI 10.1163/156853983X00390; McKinney Frank, 1992, P214; PAYNE RB, 1977, Z TIERPSYCHOL, V45, P113; Payne RJH, 1997, ANIM BEHAV, V54, P109, DOI 10.1006/anbe.1996.0391; PETRIE M, 1994, BEHAV ECOL SOCIOBIOL, V35, P213, DOI 10.1007/s002650050090; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; Rowe C, 1999, ANIM BEHAV, V58, P921, DOI 10.1006/anbe.1999.1242; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; SEARCY WA, 1984, Z TIERPSYCHOL, V66, P128; SEARCY WA, 1984, BEHAV ECOL SOCIOBIOL, V14, P281, DOI 10.1007/BF00299499; SEARCY WA, 1981, SCIENCE, V213, P926, DOI 10.1126/science.213.4510.926; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WISHART RA, 1983, CAN J ZOOL, V61, P1733, DOI 10.1139/z83-224; [No title captured]	36	0	0	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57589	10.1371/journal.pone.0057589	http://dx.doi.org/10.1371/journal.pone.0057589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516410	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400011
J	Shah, MA; Wainberg, ZA; Catenacci, DVT; Hochster, HS; Ford, J; Kunz, P; Lee, FC; Kallender, H; Cecchi, F; Rabe, DC; Keer, H; Martin, AM; Liu, Y; Gagnon, R; Bonate, P; Liu, L; Gilmer, T; Bottaro, DP				Shah, Manish A.; Wainberg, Zev A.; Catenacci, Daniel V. T.; Hochster, Howard S.; Ford, James; Kunz, Pamela; Lee, Fa-Chyi; Kallender, Howard; Cecchi, Fabiola; Rabe, Daniel C.; Keer, Harold; Martin, Anne-Marie; Liu, Yuan; Gagnon, Robert; Bonate, Peter; Liu, Li; Gilmer, Tona; Bottaro, Donald P.			Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL GROWTH; C-MET; ACQUIRED-RESISTANCE; PROGNOSTIC MARKER; AMPLIFICATION; CARCINOMA; GENE; ACTIVATION; EXPRESSION; SUNITINIB	Purpose: The receptors for hepatocyte and vascular endothelial cell growth factors (MET and VEGFR2, respectively) are critical oncogenic mediators in gastric adenocarcinoma. The purpose is to examine the safety and efficacy of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR2 receptors, for the treatment of metastatic gastric adenocarcinoma. Patients and Methods: Foretinib safety and tolerability, and objective response rate (ORR) were evaluated in patients using intermittent (240 mg/day, for 5 days every 2 weeks) or daily (80 mg/day) dosing schedules. Thirty evaluable patients were required to achieve alpha = 0.10 and beta = 0.2 to test the alternative hypothesis that single-agent foretinib would result in an ORR of >= 25%. Up to 10 additional patients could be enrolled to ensure at least eight with MET amplification. Correlative studies included tumor MET amplification, MET signaling, pharmacokinetics and plasma biomarkers of foretinib activity. Results: From March 2007 until October 2009, 74 patients were enrolled; 74% male; median age, 61 years (range, 25-88); 93% had received prior therapy. Best response was stable disease (SD) in 10 (23%) patients receiving intermittent dosing and five (20%) receiving daily dosing; SD duration was 1.9-7.2 months (median 3.2 months). Of 67 patients with tumor samples, 3 had MET amplification, one of whom had SD. Treatment-related adverse events occurred in 91% of patients. Rates of hypertension (35% vs. 15%) and elevated aspartate aminotransferase (23% vs. 8%) were higher with intermittent dosing. In both patients with high baseline tumor phospho-MET (pMET), the pMET: total MET protein ratio decreased with foretinib treatment. Conclusion: These results indicate that few gastric carcinomas are driven solely by MET and VEGFR2, and underscore the diverse molecular oncogenesis of this disease. Despite evidence of MET inhibition by foretinib, single-agent foretinib lacked efficacy in unselected patients with metastatic gastric cancer.	[Shah, Manish A.] New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA; [Wainberg, Zev A.] Univ Calif Los Angeles, Los Angeles, CA USA; [Catenacci, Daniel V. T.] Univ Chicago, Chicago, IL 60637 USA; [Hochster, Howard S.] Yale Univ, New Haven, CT USA; [Ford, James; Kunz, Pamela] Stanford Univ, Stanford, CA 94305 USA; [Lee, Fa-Chyi] Univ New Mexico, Albuquerque, NM 87131 USA; [Kallender, Howard; Martin, Anne-Marie; Liu, Yuan; Gagnon, Robert; Liu, Li] GlaxoSmithKline, Collegeville, PA USA; [Cecchi, Fabiola; Rabe, Daniel C.; Bottaro, Donald P.] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Keer, Harold] Exelixis, San Francisco, CA USA; [Bonate, Peter; Gilmer, Tona] GlaxoSmithKline, Res Triangle Pk, NC USA	Cornell University; NewYork-Presbyterian Hospital; University of California System; University of California Los Angeles; University of Chicago; Yale University; Stanford University; University of New Mexico; GlaxoSmithKline; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Exelixis, Inc.; GlaxoSmithKline	Shah, MA (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA.	mas9313@med.cornell.edu	Shah, Manish A/AHI-4322-2022; Bottaro, Donald P/AAF-3853-2020; Rabe, Daniel/F-2420-2018; Catenacci, Daniel/K-4177-2019; Bottaro, Donald P/F-8550-2010	Bottaro, Donald P/0000-0002-5057-5334; Rabe, Daniel/0000-0001-6126-2280; Bottaro, Donald P/0000-0002-5057-5334; Ford, James/0000-0002-2513-7025	GlaxoSmithKline; NATIONAL CANCER INSTITUTE [K12CA139160, ZIABC011124] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was provided by GlaxoSmithKline. The funders were intimately involved in study design, data collection, and analysis. They had no role in the decision to publish, but they were involved in manuscript preparation.	Amemiya H, 2002, ONCOLOGY-BASEL, V63, P286, DOI 10.1159/000065477; Bachleitner-Hofmann T, 2008, MOL CANCER THER, V7, P3499, DOI 10.1158/1535-7163.MCT-08-0374; Bang YJ, 2010, LANCET, V376, P1302; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Catenacci DVT, 2011, CANCER BIOL THER, V12, P9, DOI 10.4161/cbt.12.1.15747; Cepero V, 2010, CANCER RES, V70, P7580, DOI 10.1158/0008-5472.CAN-10-0436; Choueiri TK, 2012, J CLIN ONCOL S5, V30; DePrimo SE, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-32; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; Ebos JML, 2007, P NATL ACAD SCI USA, V104, P17069, DOI 10.1073/pnas.0708148104; Eder JP, 2010, CLIN CANCER RES, V16, P3507, DOI 10.1158/1078-0432.CCR-10-0574; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Hall PS, 2012, J CLIN ONCOL, V30; Huang TJ, 2001, ACTA ONCOL, V40, P638; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Janjigian YY, 2011, CANCER EPIDEM BIOMAR, V20, P1021, DOI 10.1158/1055-9965.EPI-10-1080; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lee J, 2011, ONCOL REP, V25, P1517, DOI 10.3892/or.2011.1219; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Liu L, 2010, J THORAC ONCOL, V5, pS20; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; LoRusso P, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-A8; Nessling M, 1998, GENE CHROMOSOME CANC, V23, P307, DOI 10.1002/(SICI)1098-2264(199812)23:4<307::AID-GCC5>3.0.CO;2-#; Power DG, 2010, CANCER TREAT REV, V36, P384, DOI 10.1016/j.ctrv.2010.01.005; Qian F, 2009, CANCER RES, V69, P8009, DOI 10.1158/0008-5472.CAN-08-4889; Sakakura C, 1999, GENE CHROMOSOME CANC, V24, P299, DOI 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U; Sastre J, 2006, WORLD J GASTROENTERO, V12, P204, DOI 10.3748/wjg.v12.i2.204; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Srinivasan R, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.5103; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tsugawa K, 1998, ONCOLOGY-BASEL, V55, P475, DOI 10.1159/000011898; Tsujimoto H, 1997, VIRCHOWS ARCH, V431, P383, DOI 10.1007/s004280050115; WHO, GLOB CANC RAT COULD; Yau T, 2011, J HEPATOL, V54, pS268, DOI 10.1016/S0168-8278(11)60667-3	36	166	173	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e54014	10.1371/journal.pone.0054014	http://dx.doi.org/10.1371/journal.pone.0054014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516391	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400003
J	Vostatek, P; Novak, D; Rychnovsky, T; Rychnovska, S				Vostatek, Pavel; Novak, Daniel; Rychnovsky, Tomas; Rychnovska, Sarka			Diaphragm Postural Function Analysis Using Magnetic Resonance Imaging	PLOS ONE			English	Article							LOW-BACK-PAIN; OBSTRUCTIVE PULMONARY-DISEASE; DYNAMIC BREATHING MRI; MUSCLE RECRUITMENT; HEALTHY-ADULTS; LUMBAR SPINE; MOVEMENT; MOTION; MANEUVERS; PEOPLE	We present a postural analysis of diaphragm function using magnetic resonance imaging (MRI). The main aim of the study was to identify changes in diaphragm motion and shape when postural demands on the body were increased (loading applied to a distal part of the extended lower extremities against the flexion of the hips was used). Sixteen healthy subjects were compared with 17 subjects suffering from chronic low back pain and in whom structural spine disorders had been identified. Two sets of features were calculated from MRI recordings: dynamic parameters reflecting diaphragm action, and static parameters reflecting diaphragm anatomic characteristics. A statistical analysis showed that the diaphragm respiratory and postural changes were significantly slower, bigger in size and better balanced in the control group. When a load was applied to the lower limbs, the pathological subjects were mostly not able to maintain the respiratory diaphragm function, which was lowered significantly. Subjects from the control group showed more stable parameters of both respiratory and postural function. Our findings consistently affirmed worse muscle cooperation in the low back pain population subgroup. A clear relation with spinal findings and with low back pain remains undecided, but various findings in the literature were confirmed. The most important finding is the need to further address various mechanisms used by patients to compensate deep muscle insufficiency.	[Vostatek, Pavel; Novak, Daniel] Czech Tech Univ, Dept Cybernet, CR-16635 Prague, Czech Republic; [Rychnovsky, Tomas; Rychnovska, Sarka] AVETE OMNE Physiotherapy Ctr, Prague, Czech Republic	Czech Technical University Prague	Vostatek, P (corresponding author), Czech Tech Univ, Dept Cybernet, CR-16635 Prague, Czech Republic.	vostapav@fel.cvut.cz	Novak, Daniel/G-9231-2014	Novak, Daniel/0000-0001-6996-9344	CVUT [SGS.SGS10/279/OHK3/3T/13]; Ministry of Education, Youth and Sport of the Czech Republic [MSM6840770012]	CVUT; Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work has been supported by the research program CVUT SGS.SGS10/279/OHK3/3T/13 and by Ministry of Education, Youth and Sport of the Czech Republic with the grant number MSM6840770012 entitled "Transdisciplinary Research in Biomedical Engineering II''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr KP, 2005, AM J PHYS MED REHAB, V84, P473, DOI 10.1097/01.phm.0000163709.70471.42; Butler JE, 2001, J APPL PHYSIOL, V90, P147, DOI 10.1152/jappl.2001.90.1.147; Carragee E, 2006, SPINE J, P624; Cholewicki J, 2002, EUR J APPL PHYSIOL, V87, P127, DOI 10.1007/s00421-002-0598-0; Cholewicki J, 1996, CLIN BIOMECH, P1; Chu WCW, 2006, SPINE, V31, P2243, DOI 10.1097/01.brs.0000232822.74349.32; COHEN E, 1994, THORAX, V49, P885, DOI 10.1136/thx.49.9.885; Courtney R, 2009, INT J OSTEOPATH MED, V12, P78, DOI 10.1016/j.ijosm.2009.04.002; Daggfeldt K, 2003, J BIOMECH, V36, P815, DOI 10.1016/S0021-9290(03)00015-0; Etlik O, 2004, EUR J RADIOL, V51, P150, DOI 10.1016/S0720-048X(03)00210-9; Gierada DS, 1997, J THORAC IMAG, V12, P70, DOI 10.1097/00005382-199701000-00011; GIERADA DS, 1995, RADIOLOGY, V194, P879, DOI 10.1148/radiology.194.3.7862995; Grimstone SK, 2003, EXP BRAIN RES, V151, P218, DOI 10.1007/s00221-003-1433-5; HARRIS RI, 1954, J BONE JOINT SURG BR, V36, P304, DOI 10.1302/0301-620X.36B2.304; Hodges PW, 2000, J PHYSIOL-LONDON, V522, P165, DOI 10.1111/j.1469-7793.2000.t01-1-00165.xm; Hodges PW, 1997, J PHYSIOL-LONDON, V505, P539, DOI 10.1111/j.1469-7793.1997.539bb.x; Hodges PW, 1999, ARCH PHYS MED REHAB, V80, P1005, DOI 10.1016/S0003-9993(99)90052-7; Hodges PW, 1997, J APPL PHYSIOL, V83, P753, DOI 10.1152/jappl.1997.83.3.753; Hodges PW, 2002, EXP BRAIN RES, V144, P293, DOI 10.1007/s00221-002-1040-x; Hodges PW, 2001, EXP BRAIN RES, V141, P261, DOI 10.1007/s002210100873; Hodges PW, 1997, ERGONOMICS, P539; Hungerford B, 2003, SPINE, V28, P1593, DOI 10.1097/00007632-200307150-00022; Iwasawa T, 2002, EUR RESPIR J, V19, P225, DOI 10.1183/09031936.02.00044602; Janda V, 1996, FUNKCNI SVALOVY TEST; Janssens L, 2010, SPINE, V35, P1088, DOI 10.1097/BRS.0b013e3181bee5c3; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Kapandji I, 1998, PHYSL JOINTS, VThree; Kolar P, 2009, PHYSIOL RES, V58, P383, DOI 10.33549/physiolres.931376; Kolar P, 2012, J ORTHOP SPORT PHYS, V42, P352, DOI 10.2519/jospt.2012.3830; Kondo T, 2005, TOKAI J EXPT CLIN ME, P15; Kondo T, 2000, RESPIROLOGY, P19; Kotani T, 2004, SPINE, V29, P298, DOI 10.1097/01.BRS.0000106490.82936.89; LEWIT K, 1980, J AM OSTEOPATH ASSOC, V79, P525; McGill SM, 1995, ERGONIMICS, P1772; Miyamoto K, 2002, SPINE, V27, P1749, DOI 10.1097/00007632-200208150-00012; Plathow C, 2005, J MAGN RESON IMAGING, V21, P212, DOI 10.1002/jmri.20255; Plathow C, 2005, INVEST RADIOL, V40, P173, DOI 10.1097/00004424-200503000-00007; Plathow C, 2006, EUR RADIOL, V16, P173, DOI 10.1007/s00330-005-2795-9; Plathow C, 2005, INT J RADIAT ONCOL, V62, P238, DOI 10.1016/j.ijrobp.2005.01.042; Plathow C, 2004, EUR RADIOL, V14, P1392, DOI 10.1007/s00330-004-2336-y; Roussel N, 2009, EUR SPINE J, V18, P1066, DOI 10.1007/s00586-009-1020-y; SHARP JT, 1977, AM REV RESPIR DIS, V115, P47; SKLADAL J, 1978, AGRESSOLOGIE, V19, P45; Smith MD, 2005, AUSTR J PHYSIOTHERAP, P11; Smolkov L, 2006, FYZIOTERAPIE POHYBOV; Suga K, 1999, JMRI-J MAGN RESON IM, V10, P510, DOI 10.1002/(SICI)1522-2586(199910)10:4<510::AID-JMRI3>3.0.CO;2-G; Suwatanapongched T, 2003, CHEST, V123, P2019, DOI 10.1378/chest.123.6.2019; Takazakura R, 2004, J MAGN RESON IMAGING, V19, P605, DOI 10.1002/jmri.20051; Troyer AD, 1981, THORAX, P169; Troyer AD, 1997, EUROPEAN RESP J OFFI, P708; Unal O, 2000, CLIN IMAG, V24, P347, DOI 10.1016/S0899-7071(00)00245-X	51	38	39	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e56724	10.1371/journal.pone.0056724	http://dx.doi.org/10.1371/journal.pone.0056724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516397	Green Published, gold			2022-12-27	WOS:000316407400005
J	Balko, SM; Kreer, T; Costanzo, PJ; Patten, TE; Johner, A; Kuhl, TL; Marques, CM				Balko, Suzanne M.; Kreer, Torsten; Costanzo, Philip J.; Patten, Tim E.; Johner, Albert; Kuhl, Tonya L.; Marques, Carlos M.			Polymer Brushes under High Load	PLOS ONE			English	Article							POLYELECTROLYTE BRUSHES; FORCES; SURFACES; LUBRICATION; CHAINS; SHEAR; COMPRESSION; ADSORPTION; FRICTION; LAYERS	Polymer coatings are frequently used to provide repulsive forces between surfaces in solution. After 25 years of design and study, a quantitative model to explain and predict repulsion under strong compression is still lacking. Here, we combine experiments, simulations, and theory to study polymer coatings under high loads and demonstrate a validated model for the repulsive forces, proposing that this universal behavior can be predicted from the polymer solution properties.	[Balko, Suzanne M.; Kuhl, Tonya L.] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; [Balko, Suzanne M.; Kreer, Torsten] Leibniz Inst Polymerforsch Dresden EV, Dresden, Germany; [Costanzo, Philip J.; Patten, Tim E.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Johner, Albert; Marques, Carlos M.] Univ Strasbourg, CNRS, Inst Charles Sadron, Strasbourg, France	University of California System; University of California Davis; Leibniz Institut fur Polymerforschung Dresden; University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kuhl, TL (corresponding author), Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.	tlkuhl@ucdavis.edu; marques@unistra.fr	Marques, Carlos M/B-2322-2010; Balko, Suzanne M/K-2669-2014; Costanzo, Philip/E-8879-2011	Marques, Carlos M/0000-0002-3952-0498; Balko, Suzanne M/0000-0002-9713-3349; Costanzo, Philip/0000-0001-6220-463X	United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG02-06ER46340]; Chateaubriand Fellowship (Paris, France); Deutsche Forschungsgemeinshaft (DFG) [DFG-KR 2854/3-1]	United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Chateaubriand Fellowship (Paris, France); Deutsche Forschungsgemeinshaft (DFG)(German Research Foundation (DFG))	The authors are grateful to O. Felix for QCM-D measurements. This research was supported primarily by the United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award DE-FG02-06ER46340 (TLK, SMB & PJC). SMB thanks the Chateaubriand Fellowship (Paris, France) for partial financial support. TK thanks the Deutsche Forschungsgemeinshaft (DFG) for financial support (DFG-KR 2854/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER S, 1977, J PHYS-PARIS, V38, P977, DOI 10.1051/jphys:01977003808097700; [Anonymous], 1992, INTERMOLECULAR SURFA; [Anonymous], SIMULATION DATA LEAD; AUROY P, 1991, PHYS REV LETT, V66, P719, DOI 10.1103/PhysRevLett.66.719; CARIGNANO MA, 1993, J CHEM PHYS, V98, P5006, DOI 10.1063/1.464954; Chen M, 2009, SCIENCE, V323, P1698, DOI 10.1126/science.1169399; Costanzo PJ, 2005, ASSEMBLY MECH APPL N; DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009; ESPANOL P, 1995, EUROPHYS LETT, V30, P191, DOI 10.1209/0295-5075/30/4/001; ESPANOL P, 1995, PHYS REV E, V52, P1734, DOI 10.1103/PhysRevE.52.1734; Frenkel D., 2000, UNDERSTANDING MOL SI; Galuschko A, 2010, LANGMUIR, V26, P6418, DOI 10.1021/la904119c; Grest GS, 1999, ADV POLYM SCI, V138, P149; GREST GS, 1986, PHYS REV A, V33, P3628, DOI 10.1103/PhysRevA.33.3628; HADZIIOANNOU G, 1986, J AM CHEM SOC, V108, P2869, DOI 10.1021/ja00271a014; Hamley I. W., 2007, INTRO SOFT MATTER SY; HOOGERBRUGGE PJ, 1992, EUROPHYS LETT, V19, P155, DOI 10.1209/0295-5075/19/3/001; ISRAELAC.JN, 1973, J COLLOID INTERF SCI, V44, P259, DOI 10.1016/0021-9797(73)90218-X; ISRAELACHVILI JN, 1978, J CHEM SOC FARAD T 1, V74, P975, DOI 10.1039/f19787400975; Kim JU, 2007, EUR PHYS J E, V23, P135, DOI 10.1140/epje/i2007-10188-1; Kim JU, 2009, MACROMOLECULES, V42, P3430, DOI 10.1021/ma900033p; Klein J, 1996, ANNU REV MATER SCI, V26, P581, DOI 10.1146/annurev.ms.26.080196.003053; Kreer T, 2003, LANGMUIR, V19, P7551, DOI 10.1021/la030008x; Liao WP, 2012, MACROMOLECULES, V45, P5766, DOI 10.1021/ma3009146; Malham IB, 2010, LANGMUIR, V26, P4762, DOI 10.1021/la9035387; MILNER ST, 1988, EUROPHYS LETT, V7, P695, DOI 10.1209/0295-5075/7/8/005; MILNER ST, 1988, MACROMOLECULES, V21, P2610, DOI 10.1021/ma00186a051; MILNER ST, 1994, J POLYM SCI POL PHYS, V32, P2743, DOI 10.1002/polb.1994.090321620; MILNER ST, 1989, MACROMOLECULES, V22, P853, DOI 10.1021/ma00192a057; Moore NW, 2008, LANGMUIR, V24, P1212, DOI 10.1021/la702202x; Mulder DJ, 2010, SOFT MATTER, V6, P5401, DOI 10.1039/c0sm00444h; MURAT M, 1989, PHYS REV LETT, V63, P1074, DOI 10.1103/PhysRevLett.63.1074; Odian G., 1991, PRINCIPLES POLYM, V3; Ruths M, 2000, MACROMOLECULES, V33, P3860, DOI 10.1021/ma9920994; Spirin L, 2013, ACS MACRO LETT, V2, P63, DOI 10.1021/mz300504k; Spirin L, 2011, MACROMOLECULES, V44, P9399, DOI 10.1021/ma2014029; Spirin L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.168301; Spirin L, 2010, EUR PHYS J E, V33, P307, DOI 10.1140/epje/i2010-10674-3; SWANN DA, 1984, ARTHRITIS RHEUM, V27, P552, DOI 10.1002/art.1780270511; Szleifer I, 1996, ADV CHEM PHYS, V94, P165, DOI 10.1002/9780470141533.ch3; TAUNTON HJ, 1990, MACROMOLECULES, V23, P571, DOI 10.1021/ma00204a033; TAUNTON HJ, 1988, NATURE, V332, P712, DOI 10.1038/332712a0; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750; WATANABE H, 1993, MACROMOLECULES, V26, P6455, DOI 10.1021/ma00076a023; Zappone B, 2007, BIOPHYS J, V92, P1693, DOI 10.1529/biophysj.106.088799; Zhulina EB, 1997, J CHEM PHYS, V107, P5952, DOI 10.1063/1.474320	46	20	20	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58392	10.1371/journal.pone.0058392	http://dx.doi.org/10.1371/journal.pone.0058392			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516470	gold, Green Published			2022-12-27	WOS:000316849200062
J	Green, JL; Bauer, M; Yum, KW; Li, YC; Cox, ML; Willert, K; Wahl, GM				Green, Jennifer L.; Bauer, Matthieu; Yum, Kyu Won; Li, Yao-Cheng; Cox, Miranda L.; Willert, Karl; Wahl, Geoffrey M.			Use of a Molecular Genetic Platform Technology to Produce Human Wnt Proteins Reveals Distinct Local and Distal Signaling Abilities	PLOS ONE			English	Article							ACUTE LYMPHOBLASTOID LEUKEMIA; HEMATOPOIETIC STEM-CELLS; WNT/BETA-CATENIN; PATHWAY; RECEPTORS; LGR5; TRANSFORMATION; ENDOCYTOSIS; ACTIVATION; INHIBITION	Functional and mechanistic studies of Wnt signaling have been severely hindered by the inaccessibility of bioactive proteins. To overcome this long-standing barrier, we engineered and characterized a panel of Chinese hamster ovary (CHO) cell lines with inducible transgenes encoding tagged and un-tagged human WNT1, WNT3A, WNT5A, WNT7A, WNT11, WNT16 or the soluble Wnt antagonist Fzd8CRD, all integrated into an identical genomic locus. Using a quantitative real-time bioluminescence assay, we show that cells expressing WNT1, 3A and 7A stimulate Wnt/beta-catenin reporter activity, while the other WNT expressing cell lines interfere with this activation. Additionally, in contrast to WNT3A, WNT1 only exhibits activity when cell-associated, and thus only signals to neighboring cells. The reporter assay also revealed a rapid decline of Wnt activity at 37 degrees C, indicating that Wnt activity is highly labile. These engineered cell lines will reduce the cost of making and purifying Wnt proteins and serve as a continuous, reliable and regulatable source of Wnts to research laboratories around the world.	[Green, Jennifer L.; Yum, Kyu Won; Li, Yao-Cheng; Cox, Miranda L.; Wahl, Geoffrey M.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Bauer, Matthieu; Willert, Karl] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Wahl, GM (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wahl@salk.edu			Department of Defense (DoD) Breast Cancer Research Program (BCRP) [W81XWH-09-1-0326]; DOD [WH1210106]; National Cancer Institute [5P30CA014195]; Susan G. Komen Foundation; California Institute for Regenerative Medicine [RB1-01406]; CIRM training grant [TG2-01154]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Department of Defense (DoD) Breast Cancer Research Program (BCRP)(United States Department of Defense); DOD(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); CIRM training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Department of Defense (DoD) Breast Cancer Research Program (BCRP) (Award W81XWH-09-1-0326 to J. Green), DOD WH1210106 (to G. Wahl), National Cancer Institute 5P30CA014195 (to G. Wahl), the Susan G. Komen Foundation (to G. Wahl), and the California Institute for Regenerative Medicine (to KW RB1-01406). MB is supported by a CIRM training grant awarded to University of California San Diego (UCSD) (TG2-01154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; BRADLEY RS, 1990, EMBO J, V9, P1569, DOI 10.1002/j.1460-2075.1990.tb08276.x; Brafman DA, 2009, STEM CELLS DEV, V18, P1141, DOI 10.1089/scd.2008.0410; Cajanek L, 2010, J CELL BIOCHEM, V111, P1077, DOI 10.1002/jcb.22771; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Ettenberg SA, 2010, P NATL ACAD SCI USA, V107, P15473, DOI 10.1073/pnas.1007428107; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012682; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; JUE SF, 1992, MOL CELL BIOL, V12, P321, DOI 10.1128/MCB.12.1.321; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; MASON JO, 1992, MOL BIOL CELL, V3, P521, DOI 10.1091/mbc.3.5.521; Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/sj.onc.1208568; McWhirter JR, 1999, P NATL ACAD SCI USA, V96, P11464, DOI 10.1073/pnas.96.20.11464; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Najdi R, 2012, DIFFERENTIATION; PAPKOFF J, 1989, MOL CELL BIOL, V9, P3377, DOI 10.1128/MCB.9.8.3377; PAPKOFF J, 1987, MOL CELL BIOL, V7, P3978, DOI 10.1128/MCB.7.11.3978; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; Uysal-Onganer P, 2011, ACTA PHYSL OXF; van Amerongen R, 2012, DEV BIOL; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert Karl H., 2008, V468, P17, DOI 10.1007/978-1-59745-249-6_2; Wong ET, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni145; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	44	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58395	10.1371/journal.pone.0058395	http://dx.doi.org/10.1371/journal.pone.0058395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516471	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200063
J	Kandouz, M; Zhao, J; Bier, A; Di Marco, S; Oviedo-Landaverde, I; Gallouzi, IE; Batist, G				Kandouz, Mustapha; Zhao, Jing; Bier, Andrew; Di Marco, Sergio; Oviedo-Landaverde, Irene; Gallouzi, Imed-Eddine; Batist, Gerald			Post-Transcriptional Regulation of Connexin43 in H-Ras-Transformed Cells	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; ACTIVATED PROTEIN-KINASE; MESSENGER-RNA DECAY; HUMAN BREAST-CANCER; GAP-JUNCTIONS; GROWTH-FACTOR; GLIOMA-CELLS; POLY(C)-BINDING PROTEINS; ADENOCARCINOMA CELLS; SIGNALING PATHWAY	Connexin43 (Cx43) expression is lost in cancer cells and many studies have reported that Cx43 is a tumor suppressor gene. Paradoxically, in a cellular NIH3T3 model, we have previously shown that Ha-Ras-mediated oncogenic transformation results in increased Cx43 expression. Although the examination of transcriptional regulation revealed essential regulatory elements, it could not solve this paradox. Here we studied post-transcriptional regulation of Cx43 expression in cancer using the same model in search of novel gene regulatory elements. Upon Ras transformation, both Cx43 mRNA stability and translation efficiency were increased. We investigated the role of Cx43 mRNA 3' and 5'Untranslated regions (UTRs) and found an opposing effect; a 5'UTR-driven positive regulation is observed in Ras-transformed cells (NIH-3T3(Ras)), while the 3'UTR is active only in normal NIH-3T3(Neo) cells and completely silenced in NIH-3T3(Ras) cells. Most importantly, we identified a previously unknown regulatory element within the 3'UTR, named S1516, which accounts for this 3'UTR-mediated regulation. We also examined the effect of other oncogenes and found that Ras- and Src-transformed cells show a different Cx43 UTRs post-transcriptional regulation than ErbB2-transformed cells, suggesting distinct regulatory pathways. Next, we detected different patterns of S1516 RNA-protein complexes in NIH-3T3(Neo) compared to NIH-3T3(Ras) cells. A proteomic approach identified most of the S1516-binding proteins as factors involved in post-transcriptional regulation. Building on our new findings, we propose a model to explain the discrepancy between the Cx43 expression in Ras-transformed NIH3T3 cells and the data in clinical specimens.	[Kandouz, Mustapha] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Kandouz, Mustapha] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Zhao, Jing; Bier, Andrew; Oviedo-Landaverde, Irene; Batist, Gerald] McGill Univ, Montreal Ctr Expt Therapeut Canc, Segal Canc Ctr, Lady Davis Inst Med Res,Dept Oncol, Montreal, PQ, Canada; [Di Marco, Sergio; Gallouzi, Imed-Eddine] McGill Univ, Dept Biochem, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Lady Davis Institute; McGill University; McGill University	Kandouz, M (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA.	ag1764@wayne.edu; gerald.batist@mcgill.ca		Di Marco, Sergio/0000-0002-4039-0600	Canadian Breast Cancer Research Alliance/National Cancer Institute; Wayne State University School of Medicine, Department of Pathology	Canadian Breast Cancer Research Alliance/National Cancer Institute; Wayne State University School of Medicine, Department of Pathology	This work was supported by a Canadian Breast Cancer Research Alliance/National Cancer Institute grant to G. B. and a start-up fund from Wayne State University School of Medicine, Department of Pathology, to M. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT CD, 1990, TOXICOL PATHOL, V18, P324, DOI 10.1177/019262339001800211; Alldredge B, 2008, J CLIN PATHOL, V61, P885, DOI 10.1136/jcp.2008.055699; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Auboeuf D, 2005, MOL CELL BIOL, V25, P5307, DOI 10.1128/MCB.25.13.5307-5316.2005; Bao XP, 2000, AM J PHYSIOL-HEART C, V278, pH1598, DOI 10.1152/ajpheart.2000.278.5.H1598; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bier A, 2009, MOL CANCER THER, V8, P786, DOI 10.1158/1535-7163.MCT-08-0930; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; BOS JL, 1989, CANCER RES, V49, P4682; BRISSETTE JL, 1991, MOL CELL BIOL, V11, P5364, DOI 10.1128/MCB.11.10.5364; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; Carystinos GD, 2003, MOL PHARMACOL, V63, P821, DOI 10.1124/mol.63.4.821; Challa AA, 2011, MOL CELL BIOL, V31, P3773, DOI 10.1128/MCB.05263-11; Choi HS, 2009, BIOCHEM BIOPH RES CO, V380, P431, DOI 10.1016/j.bbrc.2009.01.136; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Fox AH, 2002, CURR BIOL, V12, P13, DOI 10.1016/S0960-9822(01)00632-7; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Fuller-Pace FV, 2012, METHOD ENZYMOL, V511, P347, DOI 10.1016/B978-0-12-396546-2.00016-4; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Greco SJ, 2012, REPORTER ASSAY DETEC; Gregory LA, 2011, CURR CANCER THER REV, V7, P176, DOI 10.2174/157339411796234915; Hofer A, 1996, J NEUROSCI, V16, P4311; Holden PR, 1997, CARCINOGENESIS, V18, P15, DOI 10.1093/carcin/18.1.15; Hossain MZ, 1999, J BIOL CHEM, V274, P10489, DOI 10.1074/jbc.274.15.10489; Hossain MZ, 1998, J CELL PHYSIOL, V176, P332, DOI 10.1002/(SICI)1097-4652(199808)176:2<332::AID-JCP11>3.3.CO;2-O; Hossain MZ, 1999, J CELL PHYSIOL, V179, P87, DOI 10.1002/(SICI)1097-4652(199904)179:1<87::AID-JCP11>3.0.CO;2-K; Huang RP, 1999, J SURG ONCOL, V70, P21, DOI 10.1002/(SICI)1096-9098(199901)70:1<21::AID-JSO4>3.3.CO;2-S; Inose H, 2009, MICRORNA REGULATORY; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Jagatheesan G, 1999, J CELL SCI, V112, P4651; Ji XJ, 2007, MOL CELL BIOL, V27, P3290, DOI 10.1128/MCB.02289-05; Kandouz M, 2004, ONCOGENE, V23, P4763, DOI 10.1038/sj.onc.1207506; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Klotz LO, 2012, ARCH BIOCHEM BIOPHYS, V524, P23, DOI 10.1016/j.abb.2012.03.012; Krysko DV, 2005, APOPTOSIS, V10, P459, DOI 10.1007/s10495-005-1875-2; Kumaran RI, 2002, J CELL BIOL, V159, P783, DOI 10.1083/jcb.200204149; Lahlou H, 2005, MOL CELL BIOL, V25, P4034, DOI 10.1128/MCB.25.10.4034-4045.2005; Laird DW, 1999, CANCER RES, V59, P4104; Laroia G, 1999, SCIENCE, V284, P499, DOI 10.1126/science.284.5413.499; Lee CG, 2002, J BIOL CHEM, V277, P39679, DOI 10.1074/jbc.C200337200; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lewis JD, 2000, SCIENCE, V288, P1385, DOI 10.1126/science.288.5470.1385; Lim PK, 2011, GAP JUNCTION MEDIATE; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Macaluso M, 2002, J CELL PHYSIOL, V192, P125, DOI 10.1002/jcp.10109; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; NICOLSON GL, 1988, P NATL ACAD SCI USA, V85, P473, DOI 10.1073/pnas.85.2.473; Pesole G, 2002, NUCLEIC ACIDS RES, V30, P335, DOI 10.1093/nar/30.1.335; Pfeifer I, 2004, NUCLEIC ACIDS RES, V32, P4550, DOI 10.1093/nar/gkh792; Prendergast GC, 1996, CANCER RES, V56, P2626; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Raponi M, 2008, CURR OPIN PHARMACOL, V8, P413, DOI 10.1016/j.coph.2008.06.006; RAYTER SI, 1989, ONCOGENES, P113; RINKERSCHAEFFER CW, 1993, INT J CANCER, V55, P841, DOI 10.1002/ijc.2910550525; SATOH T, 1990, P NATL ACAD SCI USA, V87, P7926, DOI 10.1073/pnas.87.20.7926; Schiavi A, 1999, FEBS LETT, V464, P118, DOI 10.1016/S0014-5793(99)01699-3; Tomakidi P, 2000, CELL TISSUE RES, V301, P323, DOI 10.1007/s004410000231; Tsai H, 1996, BIOCHEM BIOPH RES CO, V227, P64, DOI 10.1006/bbrc.1996.1468; Umhauer S, 2000, AM J OBSTET GYNECOL, V182, P999, DOI 10.1016/S0002-9378(00)70135-9; Vinken M, 2006, CELL SIGNAL, V18, P592, DOI 10.1016/j.cellsig.2005.08.012; von Lintig FC, 2000, BREAST CANCER RES TR, V62, P51, DOI 10.1023/A:1006491619920; Warn-Cramer BJ, 1998, J BIOL CHEM, V273, P9188, DOI 10.1074/jbc.273.15.9188; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wong RCB, 2008, STEM CELL REV, V4, P283, DOI 10.1007/s12015-008-9038-9; YAMASAKI H, 1990, CARCINOGENESIS, V11, P1051, DOI 10.1093/carcin/11.7.1051; Yamasaki H, 1995, MUTAT RES-FUND MOL M, V333, P181, DOI 10.1016/0027-5107(95)00144-1; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; ZHU D, 1991, P NATL ACAD SCI USA, V88, P1883, DOI 10.1073/pnas.88.5.1883; ZHU DG, 1992, P NATL ACAD SCI USA, V89, P10218, DOI 10.1073/pnas.89.21.10218	77	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58500	10.1371/journal.pone.0058500	http://dx.doi.org/10.1371/journal.pone.0058500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505521	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100056
J	Kang, AD; Cosenza, SC; Bonagura, M; Manair, M; Reddy, MVR; Reddy, EP				Kang, Anthony D.; Cosenza, Stephen C.; Bonagura, Marie; Manair, Manoj; Reddy, M. V. Ramana; Reddy, E. Premkumar			ON01210.Na (Ex-RAD (R)) Mitigates Radiation Damage through Activation of the AKT Pathway	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; ENDOTHELIAL APOPTOSIS; IN-VIVO; AGENTS; AMIFOSTINE; PROGENITORS; RESISTANCE; STABILITY; SURVIVAL	Development of radio-protective agents that are non-toxic is critical in light of ever increasing threats associated with proliferation of nuclear materials, terrorism and occupational risks associated with medical and space exploration. In this communication, we describe the discovery, characterization and mechanism of action of ON01210.Na, which effectively protects mouse and human bone marrow cells from radiation-induced damage both in vitro and in vivo. Our results show that treatment of normal fibroblasts with ON01210.Na before and after exposure to ionizing radiation provides dose dependent protection against radiation-induced damage. Treatment of mice with ON01210.Na prior to radiation exposure was found to result in a more rapid recovery of their hematopoietic system. The mechanistic studies described here show that ON01210.Na manifests its protective effects through the up-regulation of PI3-Kinase/AKT pathways in cells exposed to radiation. These results suggest that ON01210.Na is a safe and effective radioprotectant and could be a novel agent for use in radiobiological disasters.	[Kang, Anthony D.; Cosenza, Stephen C.; Bonagura, Marie; Reddy, M. V. Ramana; Reddy, E. Premkumar] Fels Inst Canc Res & Mol Biol, Philadelphia, PA USA; [Manair, Manoj] Onconova Therapeut Inc, Newtown, PA USA		Reddy, EP (corresponding author), Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA.	ep.reddy@mssm.edu	Reddy, E. Premkumar/F-6233-2011		Onconova Therapeutics Inc.	Onconova Therapeutics Inc.	This work was supported by Onconova Therapeutics Inc. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bonnaud S, 2010, CANCER RES, V70, P9905, DOI 10.1158/0008-5472.CAN-10-2043; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Dainiak Nicholas, 2003, Hematology Am Soc Hematol Educ Program, P473; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DENEKAMP J, 1986, INT J RADIAT BIOL, V49, P357, DOI 10.1080/09553008514552591; Dumont F, 2010, EXPERT OPIN THER PAT, V20, P73, DOI 10.1517/13543770903490429; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313; Ghosh SP, 2009, RADIAT RES, V171, P173, DOI 10.1667/RR1367.1; Gumireddy K, 2005, P NATL ACAD SCI USA, V102, P1992, DOI 10.1073/pnas.0408283102; Gupta AK, 2003, INT J RADIAT ONCOL, V56, P846, DOI 10.1016/S0360-3016(03)00214-1; Gupta AK, 2001, METHOD ENZYMOL, V333, P284; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hosseinimehr SJ, 2007, DRUG DISCOV TODAY, V12, P794, DOI 10.1016/j.drudis.2007.07.017; Jia JH, 2003, GENE DEV, V17, P2709, DOI 10.1101/gad.1136603; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Lancell J, 2008, AVIAT SPACE ENVIR MD, V79, P651, DOI 10.3357/ASEM.2113.2008; List AF, 1998, LEUKEMIA, V12, P1596, DOI 10.1038/sj.leu.2401151; Moulder JE, 2007, SEMIN RADIAT ONCOL, V17, P141, DOI 10.1016/j.semradonc.2006.11.010; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Paris F, 2001, J BIOL CHEM, V276, P8297, DOI 10.1074/jbc.M008732200; Porta C, 2000, HAEMATOLOGICA, V85, P820; Ramdas J, 2003, J PEDIAT HEMATOL ONC, V25, P19, DOI 10.1097/00043426-200301000-00006; Reddy EP, 2004, E STYRYL SULFONE ANT; Reddy EP, 2002, METHOD PROTECTING CE; Reddy MVR, 2008, J MED CHEM, V51, P86, DOI 10.1021/jm701077b; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stone HB, 2004, RADIAT RES, V162, P711, DOI 10.1667/RR3276; Suman S, 2012, J RADIAT RES, V53, P368, DOI 10.1269/jrr.11191; Thotala DK, 2008, CANCER RES, V68, P5859, DOI 10.1158/0008-5472.CAN-07-6327; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Yazlovitskaya EM, 2006, LITHIUM TREATMENT PR; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	35	24	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58355	10.1371/journal.pone.0058355	http://dx.doi.org/10.1371/journal.pone.0058355			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505494	Green Submitted, gold, Green Published			2022-12-27	WOS:000318334500073
J	Dharmani, P; De Simone, C; Chadee, K				Dharmani, Poonam; De Simone, Claudio; Chadee, Kris			The Probiotic Mixture VSL#3 Accelerates Gastric Ulcer Healing by Stimulating Vascular Endothelial Growth Factor	PLOS ONE			English	Article							LACTOBACILLUS-PLANTARUM; HELICOBACTER-PYLORI; GENE-EXPRESSION; FACTOR-ALPHA; INDOMETHACIN; MULTISTRAIN; MECHANISMS; PREVENTION	Studies assessing the effect and mechanism of probiotics on diseases of the upper gastrointestinal tract (GI) including gastric ulcers are limited despite extensive work and promising results of this therapeutic option for other GI diseases. In this study, we investigated the mechanisms by which the probiotic mixture VSL#3 (a mixture of eight probiotic bacteria including Lactobacilli, Bifidobacteria and Streptococcus species) heals acetic acid induced gastric ulcer in rats. VSL#3 was administered orally at low (6x10(9) bacteria) or high (1.2x10(10) bacteria) dosages from day 3 after ulcer induction for 14 consecutive days. VSL#3 treatments significantly enhanced gastric ulcer healing in a dose-dependent manner. To assess the mechanism(s) whereby VSL#3 exerted its protective effects, we quantified the gene expression of several pro-inflammatory cytokines, protein and expression of stomach mucin-Muc5ac, regulatory cytokine-IL-10, COX-2 and various growth factors. Of all the components examined, only expression and protein production of VEGF was increased 332-fold on day 7 in the ulcerated tissues of animals treated with VSL#3. Predictably, animals treated with VEGF neutralizing antibody significantly delayed gastric ulcer healing in VSL#3 treated animals. This is the first report to demonstrate high efficacy of the probiotic mixture VSL#3 in enhancing gastric ulcer healing. Probiotic efficacy was effective at higher concentrations of VSL#3 by specifically increasing the expression and production of angiogenesis promoting growth factors, primarily VEGF.	[Dharmani, Poonam; Chadee, Kris] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [De Simone, Claudio] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy	University of Calgary; University of L'Aquila	Chadee, K (corresponding author), Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada.	kchadee@ucalgary.ca			Canadian Institute for Health Research (CIHR); Canadian Association of Gastroenterology-Axcan Pharma-CIHR	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Association of Gastroenterology-Axcan Pharma-CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institute for Health Research (CIHR, KC). PD was funded by a Canadian Association of Gastroenterology-Axcan Pharma-CIHR Research and Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caballero-Franco C, 2007, AM J PHYSIOL-GASTR L, V292, pG315, DOI 10.1152/ajpgi.00265.2006; Chenoll E, 2011, APPL ENVIRON MICROB, V77, P1335, DOI 10.1128/AEM.01820-10; Medeiros JAD, 2011, EUR J CLIN MICROBIOL, V30, P555, DOI 10.1007/s10096-010-1119-4; Dharmani P, 2004, J ETHNOPHARMACOL, V93, P197, DOI 10.1016/j.jep.2004.02.029; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Dudar GK, 2008, AM J PHYSIOL-GASTR L, V295, pG374, DOI 10.1152/ajpgi.90325.2008; Elliott SN, 1998, AM J PHYSIOL-GASTR L, V275, pG425, DOI 10.1152/ajpgi.1998.275.3.G425; Girard P, 2010, PHARMACOLOGY, V85, P188, DOI 10.1159/000275146; Gotteland M, 2001, ALIMENT PHARM THER, V15, P11, DOI 10.1046/j.1365-2036.2001.00898.x; Halper J, 2003, EXP BIOL MED, V228, P1329, DOI 10.1177/153537020322801111; Jackson LM, 2000, GUT, V47, P762, DOI 10.1136/gut.47.6.762; Konturek PC, 2003, EUR J PHARMACOL, V472, P213, DOI 10.1016/S0014-2999(03)01932-0; KONTUREK PC, 1995, EUR J GASTROEN HEPAT, V7, P933, DOI 10.1097/00042737-199510000-00005; Lam EKY, 2007, EUR J PHARMACOL, V565, P171, DOI 10.1016/j.ejphar.2007.02.050; Lam EKY, 2007, LIFE SCI, V80, P2128, DOI 10.1016/j.lfs.2007.03.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YL, 1996, GASTROENTEROLOGY, V111, P334, DOI 10.1053/gast.1996.v111.pm8690198; Mimura T, 2004, GUT, V53, P108, DOI 10.1136/gut.53.1.108; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nikitenko V I, 2004, J Wound Care, V13, P363; Ogihara Y, 1993, J Physiol Pharmacol, V44, P109; Perini RF, 2003, CURR PHARM DESIGN, V9, P2207, DOI 10.2174/1381612033454027; Poonam D, 2005, EUR J PHARMACOL, V519, P277, DOI 10.1016/j.ejphar.2005.06.055; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Rosania Rosa, 2012, Inflammation & Allergy Drug Targets, V11, P244; Sakurai T, 2004, J ENDOCRINOL, V183, P527, DOI 10.1677/joe.1.05629; SANTUCCI L, 1995, GASTROENTEROLOGY, V108, P393, DOI 10.1016/0016-5085(95)90065-9; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Schultz M, 2002, INFLAMM BOWEL DIS, V8, P71, DOI 10.1097/00054725-200203000-00001; Senol A, 2011, TURK J GASTROENTEROL, V22, P18, DOI 10.4318/tjg.2011.0151; Singh PK, 2012, J PHARM PHARMACOL, V64, P207, DOI 10.1111/j.2042-7158.2011.01397.x; SZABO S, 1994, GASTROENTEROLOGY, V106, P1106, DOI 10.1016/0016-5085(94)90773-0; Tarnawski A, 2001, J PHYSIOL-PARIS, V95, P337, DOI 10.1016/S0928-4257(01)00046-8; Timmerman HM, 2004, INT J FOOD MICROBIOL, V96, P219, DOI 10.1016/j.ijfoodmicro.2004.05.012; Uchida M, 2010, BIOSCI BIOTECH BIOCH, V74, P1891, DOI 10.1271/bbb.100287; Valdez JC, 2005, CLIN MICROBIOL INFEC, V11, P472, DOI 10.1111/j.1469-0691.2005.01142.x	36	40	56	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58671	10.1371/journal.pone.0058671	http://dx.doi.org/10.1371/journal.pone.0058671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484048	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100135
J	Liu, TA; Jan, YJ; Ko, BS; Liang, SM; Chen, SC; Wang, J; Hsu, C; Wu, YM; Liou, JY				Liu, Tzu-An; Jan, Yee-Jee; Ko, Bor-Sheng; Liang, Shu-Man; Chen, Shyh-Chang; Wang, John; Hsu, Chiun; Wu, Yao-Ming; Liou, Jun-Yang			14-3-3 epsilon Overexpression Contributes to Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma	PLOS ONE			English	Article							ISOFORM-SPECIFIC EXPRESSION; TUMOR PROGRESSION; BREAST-CANCER; 14-3-3 PROTEINS; LUNG-CANCER; E-CADHERIN; EXTRAHEPATIC METASTASIS; DOWN-REGULATION; KAPPA-B; SNAIL	Background: 14-3-3 epsilon is implicated in regulating tumor progression, including hepatocellular carcinoma (HCC). Our earlier study indicated that elevated 14-3-3 epsilon expression is significantly associated with higher risk of metastasis and lower survival rates of HCC patients. However, the molecular mechanisms of how 14-3-3 epsilon regulates HCC tumor metastasis are still unclear. Methodology and Principal Findings: In this study, we show that increased 14-3-3 epsilon expression induces HCC cell migration and promotes epithelial-mesenchymal transition (EMT), which is determined by the reduction of E-cadherin expression and induction of N-cadherin and vimentin expression. Knockdown with specific siRNA abolished 14-3-3 epsilon-induced cell migration and EMT. Furthermore, 14-3-3 epsilon selectively induced Zeb-1 and Snail expression, and 14-3-3 epsilon-induced cell migration was abrogated by Zeb-1 or Snail siRNA. In addition, the effect of 14-3-3 epsilon-reduced E-cadherin was specifically restored by Zeb-1 siRNA. Positive 14-3-3 epsilon expression was significantly correlated with negative E-cadherin expression, as determined by immunohistochemistry analysis in HCC tumors. Analysis of 14-3-3 epsilon/E-cadherin expression associated with clinicopathological characteristics revealed that the combination of positive 14-3-3 epsilon and negative E-cadherin expression is significantly correlated with higher incidence of HCC metastasis and poor 5-year overall survival. In contrast, patients with positive 14-3-3 epsilon and positive E-cadherin expression had better prognostic outcomes than did those with negative E-cadherin expression. Significance: Our findings show for the first time that E-cadherin is one of the downstream targets of 14-3-3 epsilon in modulating HCC tumor progression. Thus, 14-3-3 epsilon may act as an important regulator in modulating tumor metastasis by promoting EMT as well as cell migration, and it may serve as a novel prognostic biomarker or therapeutic target for HCC.	[Liu, Tzu-An; Ko, Bor-Sheng; Liang, Shu-Man; Liou, Jun-Yang] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Jan, Yee-Jee; Chen, Shyh-Chang; Wang, John] Taichung Vet Gen Hosp, Dept Pathol & Lab Med, Taichung, Taiwan; [Ko, Bor-Sheng] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Hsu, Chiun] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Wu, Yao-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Liou, Jun-Yang] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan	Liou, JY (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.	jliou@nhri.org.tw	Liou, Jun-Yang/B-1065-2010	KO, BOR-SHENG/0000-0002-7965-7579; Hsu, Chiun/0000-0002-1122-0055; WU, YAO-MING/0000-0002-1720-7863	National Health Research Institutes [01A1-CSPP07-014]; National Science Council [98-2320-B-400-008-MY3]; Taichung Veterans General Hospital [TCVGH-1005801B]; Department of Health of Taiwan [DOH-100-TD-C-111-001]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital; Department of Health of Taiwan	This work was supported by the National Health Research Institutes (01A1-CSPP07-014), the National Science Council (98-2320-B-400-008-MY3), the Taichung Veterans General Hospital (TCVGH-1005801B) and the Department of Health (DOH-100-TD-C-111-001) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 2011, SEMIN CELL DEV BIOL, V22, P673, DOI 10.1016/j.semcdb.2011.08.003; Barnes DM, 1996, BRIT J CANCER, V74, P1445, DOI 10.1038/bjc.1996.563; Chang GC, 2006, CLIN CANCER RES, V12, P5746, DOI 10.1158/1078-0432.CCR-06-0324; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Hou ZY, 2010, CANCER RES, V70, P4385, DOI 10.1158/0008-5472.CAN-10-0070; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Jan YJ, 2009, HUM PATHOL, V40, P1384, DOI 10.1016/j.humpath.2009.03.006; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kanai Y, 1997, INT J CANCER, V71, P355; Ko BS, 2011, HISTOPATHOLOGY, V58, P705, DOI 10.1111/j.1365-2559.2011.03789.x; Ko BS, 2011, HUM PATHOL, V42, P129, DOI 10.1016/j.humpath.2010.01.028; Ko BS, 2010, LIFE SCI, V86, P199, DOI 10.1016/j.lfs.2009.12.003; Ko BS, 2013, UPREGULATIO IN PRESS; Leal MF, 2012, WORLD J GASTROENTERO, V18, P1531, DOI 10.3748/wjg.v18.i13.1531; Lee TK, 2006, CLIN CANCER RES, V12, P5369, DOI 10.1158/1078-0432.CCR-05-2722; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Li ZG, 2008, P NATL ACAD SCI USA, V105, P162, DOI 10.1073/pnas.0710905105; Liang SF, 2009, PROTEOM CLIN APPL, V3, P743, DOI 10.1002/prca.200800198; Liou JY, 2008, MOL PHARMACOL, V74, P1399, DOI 10.1124/mol.108.049569; Liou JY, 2007, CANCER RES, V67, P3185, DOI 10.1158/0008-5472.CAN-06-3431; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; Liu TA, 2011, AM J PATHOL, V179, P2698, DOI 10.1016/j.ajpath.2011.08.010; Liu Y, 2010, BRAIN RES, V1336, P98, DOI 10.1016/j.brainres.2010.04.009; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Matsumura T, 2001, CLIN CANCER RES, V7, P594; Miyoshi A, 2004, BRIT J CANCER, V90, P1265, DOI 10.1038/sj.bjc.6601685; Moreno-Bueno G, 2008, ONCOGENE, V27, P6958, DOI 10.1038/onc.2008.346; Neal CL, 2012, ONCOGENE, V31, P897, DOI 10.1038/onc.2011.284; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Sofiadis A, 2012, EUR J ENDOCRINOL, V166, P657, DOI 10.1530/EJE-11-0856; Sugimachi K, 2003, CLIN CANCER RES, V9, P2657; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wang ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024843; Yang B, 2003, AM J PATHOL, V163, P1101, DOI 10.1016/S0002-9440(10)63469-4; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Yang XL, 2009, J NEUROL SCI, V276, P54, DOI 10.1016/j.jns.2008.08.040; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhou YM, 2012, ANN SURG ONCOL, V19, P1700, DOI 10.1245/s10434-011-1772-6	44	46	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57968	10.1371/journal.pone.0057968	http://dx.doi.org/10.1371/journal.pone.0057968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483955	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100061
J	Walsh, CO; Ebbeling, CB; Swain, JF; Markowitz, RL; Feldman, HA; Ludwig, DS				Walsh, Carolyn O.; Ebbeling, Cara B.; Swain, Janis F.; Markowitz, Robert L.; Feldman, Henry A.; Ludwig, David S.			Effects of Diet Composition on Postprandial Energy Availability during Weight Loss Maintenance	PLOS ONE			English	Article							GLYCEMIC INDEX; HUNGER RATINGS; KETONE-BODIES; FOOD-INTAKE; KETOSIS; TRIAL; FAT	Background: The major circulating metabolic fuels regulate hunger, and each is affected by dietary composition. An integrated measure of postprandial energy availability from circulating metabolic fuels may help inform dietary recommendations for weight maintenance after weight loss. Aim: We examined the effect of low-fat (LF, 60% of energy from carbohydrate, 20% fat, 20% protein), low-glycemic index (LGI, 40%-40%-20%), and very low-carbohydrate (VLC, 10%-60%-30%) diets on total postprandial metabolic fuel energy availability (EA) during weight loss maintenance. Methods: Eight obese young adults were fed a standard hypocaloric diet to produce 10-15% weight loss. They were then provided isocaloric LF, LGI, and VLC diets in a randomized crossover design, each for a 4-week period of weight loss maintenance. At the end of each dietary period, a test meal representing the respective diet was provided, and blood samples were obtained every 30 minutes for 5 hours. The primary outcome was EA, defined as the combined energy density (circulating levelxrelative energy content) of glucose, free fatty acids, and beta-hydroxybutyrate. Secondary outcomes were individual metabolic fuels, metabolic rate, insulin, glucagon, cortisol, epinephrine, and hunger ratings. Respiratory quotient was a process measure. Data were analyzed by repeated-measures analysis of variance, with outcomes compared in the early (30 to 150 min) and late (180 to 300 min) postprandial periods. Results: EA did not differ between the test meals during the early postprandial period (p = 0.99). However, EA in the late postprandial period was significantly lower after the LF test meal than the LGI (p < 0.0001) and VLC (p < 0.0001) test meals. Metabolic rate also differed in the late postprandial period (p = 0.0074), with higher values on the VLC than LF (p = 0.0064) and LGI (p = 0.0066) diets. Conclusion: These findings suggest that an LF diet may adversely affect postprandial EA and risk for weight regain during weight loss maintenance. Trial Registration: ClinicalTrials.gov NCT00315354	[Walsh, Carolyn O.; Ebbeling, Cara B.; Markowitz, Robert L.; Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn, Obes Prevent Ctr, Boston, MA USA; [Swain, Janis F.] Brigham & Womens Hosp, Ctr Clin Investigat, Boston, MA 02115 USA; [Feldman, Henry A.] Boston Childrens Hosp, Clin Res Ctr, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Ludwig, DS (corresponding author), Boston Childrens Hosp, New Balance Fdn, Obes Prevent Ctr, Boston, MA USA.	david.ludwig@childrens.harvard.edu	Feldman, Henry/M-2302-2013	Ludwig, David/0000-0003-3307-8544	National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, Maryland) [R01 DK072428, K24DK082730]; National Center for Research Resources, National Institutes of Health [M01-02635, UL1 RR025758-01]; New Balance Foundation; Harvard Clinical and Translational Science Center (Catalyst) [NIH UL1 RR-025758]; Harvard Medical School branch of the Doris Duke Clinical Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730, R01DK072428] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, Maryland)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); New Balance Foundation; Harvard Clinical and Translational Science Center (Catalyst); Harvard Medical School branch of the Doris Duke Clinical Research Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants R01 DK072428 and K24DK082730 from the National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, Maryland); grant M01-02635 from the National Center for Research Resources, National Institutes of Health, to the Brigham and Women's Hospital General Clinical Research Center; grant UL1 RR025758-01 from the National Center for Research Resources, National Institutes of Health, to the Harvard Catalyst Clinical and Translational Science Center, and a grant from the New Balance Foundation. HAF was supported by the Harvard Clinical and Translational Science Center (Catalyst) under NIH UL1 RR-025758. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the study staff Hope Forbes, Sarah Kalil, and Erica Garcia-Lago for assistance with data collection and management; Karen Yee, Rachel Froelich, and Lisa Bielak for implementation of the dietary interventions; and Meredith Beard for administrative support. Additionally, we are grateful to the Harvard Medical School branch of the Doris Duke Clinical Research Fellowship for its support of the primary author for this project.	Agatston A, 2005, S BEACH DIET; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; ATKINS RC, 2001, ATKINS NEW DIET REVO; Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; Carmant L, 2008, EPILEPSIA, V49, P20, DOI 10.1111/j.1528-1167.2008.01826.x; Chearskul S, 2008, AM J CLIN NUTR, V87, P1238; Ebbeling CB, 2012, JAMA-J AM MED ASSOC, V307, P2627, DOI 10.1001/jama.2012.6607; Fischer K, 2004, APPETITE, V42, P49, DOI 10.1016/S0195-6663(03)00116-8; Frankenfield D, 2005, J AM DIET ASSOC, V105, P775, DOI 10.1016/j.jada.2005.02.005; Franz Marion J, 2003, Diabetes Care, V26 Suppl 1, pS51; Freeman JM, 2009, EPILEPSIA, V50, P322, DOI 10.1111/j.1528-1167.2008.01740.x; FREINKEL N, 1969, NEW ENGL J MED, V280, P820, DOI 10.1056/NEJM196904102801508; FRIEDMAN MI, 1983, AM J PHYSIOL, V244, pR374, DOI 10.1152/ajpregu.1983.244.3.R374; Fuehrlein BS, 2004, J CLIN ENDOCR METAB, V89, P1641, DOI 10.1210/jc.2003-031796; Herman CP, 2003, APPETITE, V41, P15, DOI 10.1016/S0195-6663(03)00027-8; Johansson UB, 2007, DIABETES METAB, V33, P469, DOI 10.1016/j.diabet.2007.06.005; Koutsari C, 2000, METABOLISM, V49, P1150, DOI 10.1053/meta.2000.8612; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lowe MR, 2007, PHYSIOL BEHAV, V91, P432, DOI 10.1016/j.physbeh.2007.04.006; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Ludwig DS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e26; MATTES R, 1990, APPETITE, V15, P103, DOI 10.1016/0195-6663(90)90043-8; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; National Institutes of Health, 2000, PRACT GUID ID EV TRE; OWENS DR, 1979, DIABETES CARE, V2, P409, DOI 10.2337/diacare.2.5.409; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; RICH AJ, 1990, P NUTR SOC, V49, P361, DOI 10.1079/PNS19900042; SCHARRER E, 1986, AM J PHYSIOL, V250, P1003, DOI 10.1152/ajpregu.1986.250.6.R1003; US Department of Health and Human Services & US Department of Agriculture, 2010, DIET GUID AM 2010; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363	32	28	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58172	10.1371/journal.pone.0058172	http://dx.doi.org/10.1371/journal.pone.0058172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483989	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100084
J	Wang, YR; Zhu, J; Li, Q; Li, W; Wu, N; Zheng, Y; Chang, HF; Chen, JJ; Wang, W				Wang, Yarong; Zhu, Jia; Li, Qiang; Li, Wei; Wu, Ning; Zheng, Ying; Chang, Haifeng; Chen, Jiajie; Wang, Wei			Altered Fronto-Striatal and Fronto-Cerebellar Circuits in Heroin-Dependent Individuals: A Resting-State fMRI Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; ABSTINENT COCAINE ABUSERS; ANTERIOR CINGULATE CORTEX; LOW-FREQUENCY FLUCTUATION; WORKING-MEMORY TASK; DORSAL STRIATUM; BRAIN ACTIVITY; DECISION-MAKING; FUNCTIONAL MRI	Background: The formation of compulsive pattern of drug use is related to abnormal regional neural activity and functional reorganization in the heroin addicts' brain, but the relationship between heroin-use-induced disrupted local neural activity and its functional organization pattern in resting-state is unknown. Methodology/Principal Findings: With fMRI data acquired during resting state from 17 male heroin dependent individuals (HD) and 15 matched normal controls (NC), we analyzed the changes of amplitude of low frequency fluctuation (ALFF) in brain areas, and its relationship with history of heroin use. Then we investigated the addiction related alteration in functional connectivity of the brain regions with changed ALFF using seed-based correlation analysis. Compared with NC, the ALFF of HD was obviously decreased in the right caudate, right dorsal anterior cingulate cortex (dACC), right superior medial frontal cortex and increased in the bilateral cerebellum, left superior temporal gyrus and left superior occipital gyrus. Of the six regions, only the ALFF value of right caudate had a negative correlation with heroin use. Setting the six regions as "seeds'', we found the functional connectivity between the right caudate and dorsolateral prefrontal cortex (dlPFC) was reduced but that between the right caudate and cerebellum was enhanced. Besides, an abnormal lateral PFC-dACC connection was also observed in HD. Conclusions: The observations of dysfunction of fronto-striatal and fronto-cerebellar circuit in HD implicate an altered balance between local neuronal assemblies activity and their integrated network organization pattern which may be involved in the process from voluntary to habitual and compulsive drug use.	[Wang, Yarong; Zhu, Jia; Li, Qiang; Li, Wei; Wu, Ning; Zheng, Ying; Chang, Haifeng; Chen, Jiajie; Wang, Wei] Fourth Mil Med Univ, Tangdu Hosp, Dept Radiol, Xian 710032, Peoples R China	Air Force Military Medical University	Wang, W (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Radiol, Xian 710032, Peoples R China.	m_d_wang@hotmail.com			National Natural Science Foundation of China [30870685, 81071143, 81071142]; Shaanxi Province Science and Technology Development Projection [2008k12-02, 2009K01-65, 2010k16-03-01, 2010K16-03-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shaanxi Province Science and Technology Development Projection	This work was supported by the grants from National Natural Science Foundation of China (NO: 30870685, 81071143 and 81071142; http://www.nsfc.gov.cn) and Shaanxi Province Science and Technology Development Projection (NO: 2008k12-02, 2009K01-65, 2010k16-03-01 and 2010K16-03-02; http://www.sninfo.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2000, ALCOHOL CLIN EXP RES, V24, P1850, DOI 10.1097/00000374-200012000-00014; Amiaz R, 2009, ADDICTION, V104, P653, DOI 10.1111/j.1360-0443.2008.02448.x; Anderson CM, 2006, NEUROPSYCHOPHARMACOL, V31, P1318, DOI 10.1038/sj.npp.1300937; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Banich MT, 2009, NEUROPSYCHOLOGIA, V47, P3095, DOI 10.1016/j.neuropsychologia.2009.07.005; Banich MT, 2000, COGNITIVE BRAIN RES, V10, P1, DOI 10.1016/S0926-6410(00)00015-X; BECK CHM, 1995, J PSYCHIATR NEUROSCI, V20, P25; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Bora E, 2010, ADDICT BIOL; Botta P, 2007, ALCOHOL, V41, P187, DOI 10.1016/j.alcohol.2007.04.004; BROTHERS L, 1990, BEHAV BRAIN RES, V41, P199, DOI 10.1016/0166-4328(90)90108-Q; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cox WM, 2006, PSYCHOL BULL, V132, P443, DOI 10.1037/0033-2909.132.3.443; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; Daglish MRC, 2003, NEUROIMAGE, V20, P1964, DOI 10.1016/j.neuroimage.2003.07.025; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fingelkurts AA, 2004, INT J NEUROSCI, V114, P843, DOI 10.1080/00207450490450046; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Garavan H, 2000, MICROSC RES TECHNIQ, V51, P54, DOI 10.1002/1097-0029(20001001)51:1<54::AID-JEMT6>3.0.CO;2-J; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Gruol DL, 1997, BRAIN RES, V773, P82, DOI 10.1016/S0006-8993(97)00912-8; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jiang GH, 2011, NEUROIMAGE, V57, P149, DOI 10.1016/j.neuroimage.2011.04.004; Jimenez-Rivera CA, 2000, EUR J PHARMACOL, V407, P91, DOI 10.1016/S0014-2999(00)00711-1; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Lee TMC, 2005, NEUROSCI LETT, V382, P211, DOI 10.1016/j.neulet.2005.03.053; Liu HH, 2008, AM J DRUG ALCOHOL AB, V34, P562, DOI 10.1080/00952990802295238; Liu HH, 2009, PSYCHIAT CLIN NEUROS, V63, P563, DOI 10.1111/j.1440-1819.2009.01989.x; Liu JX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023098; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Lu L, 2008, CELL MOL NEUROBIOL, V28, P479, DOI 10.1007/s10571-007-9225-2; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; Martin-Solch C, 2001, EXP BRAIN RES, V139, P278, DOI 10.1007/s002210100751; Miquel Marta, 2009, Curr Drug Abuse Rev, V2, P26; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Oscar-Berman M, 1987, Recent Dev Alcohol, V5, P59; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rubino T, 2003, EUR J NEUROSCI, V17, P325, DOI 10.1046/j.1460-9568.2003.02452.x; Schneider F, 2001, AM J PSYCHIAT, V158, P1075, DOI 10.1176/appi.ajp.158.7.1075; Shi J, 2008, EUR J PHARMACOL, V579, P160, DOI 10.1016/j.ejphar.2007.09.042; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Sinha R, 2005, PSYCHOPHARMACOLOGY, V183, P171, DOI 10.1007/s00213-005-0147-8; Skidmore FM, 2011, NEUROIMAGE; Tavares P, 2008, CEREB CORTEX, V18, P1876, DOI 10.1093/cercor/bhm212; Thanos PK, 2005, BEHAV BRAIN RES, V164, P206, DOI 10.1016/j.bbr.2005.06.021; Van den Eynde F, 2010, BIOL PSYCHIAT, V67, P793, DOI 10.1016/j.biopsych.2009.11.023; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Volkow ND, 2003, J NEUROSCI, V23, P11461; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2011, P NATL ACAD SCI USA, V108, P15037, DOI 10.1073/pnas.1010654108; Vollstadt-Klein S, 2010, ADDICTION, V105, P1741, DOI 10.1111/j.1360-0443.2010.03022.x; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; Wang Xuyi, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P728, DOI 10.3969/j.issn.1672-7347.2011.08.005; Weissman DH, 2002, NEUROIMAGE, V17, P1266, DOI 10.1006/nimg.2002.1284; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004; Xiao ZW, 2006, DRUG ALCOHOL DEPEN, V83, P157, DOI 10.1016/j.drugalcdep.2005.11.012; Xu JS, 2005, BIOL PSYCHIAT, V58, P143, DOI 10.1016/j.biopsych.2005.03.028; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919; Yuan K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020708; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang Zhi-Qiang, 2008, Zhonghua Yi Xue Za Zhi, V88, P1594; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982	74	41	45	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58098	10.1371/journal.pone.0058098	http://dx.doi.org/10.1371/journal.pone.0058098			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483978	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100076
J	Wilkinson, M; Sherratt, E; Starace, F; Gower, DJ				Wilkinson, Mark; Sherratt, Emma; Starace, Fausto; Gower, David J.			A New Species of Skin-Feeding Caecilian and the First Report of Reproductive Mode in Microcaecilia (Amphibia: Gymnophiona: Siphonopidae)	PLOS ONE			English	Article							ICHTHYOPHIS	A new species of siphonopid caecilian, Microcaecilia dermatophaga sp. nov., is described based on nine specimens from French Guiana. The new species is the first new caecilian to be described from French Guiana for more than 150 years. It differs from all other Microcaecilia in having fewer secondary annular grooves and/or in lacking a transverse groove on the dorsum of the first collar. Observations of oviparity and of extended parental care in M. dermatophaga are the first reproductive mode data for any species of the genus. Microcaecilia dermatophaga is the third species, and represents the third genus, for which there has been direct observation of young animals feeding on the skin of their attending mother. The species is named for this maternal dermatophagy, which is hypothesised to be characteristic of the Siphonopidae.	[Wilkinson, Mark; Sherratt, Emma; Gower, David J.] Nat Hist Museum, Dept Zool, London SW7 5BD, England; [Sherratt, Emma] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Sherratt, Emma] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Natural History Museum London; Harvard University; Harvard University	Sherratt, E (corresponding author), Nat Hist Museum, Dept Zool, Cromwell Rd, London SW7 5BD, England.	emma.sherratt@gmail.com	Wilkinson, Mark/J-2026-2014; Sherratt, Emma/A-9931-2011	Wilkinson, Mark/0000-0002-9459-8976; Sherratt, Emma/0000-0003-2164-7877	Centre national de la recherche scientifique; Biotechnology and Biological Sciences Research Council Syntax scheme; Natural Environment Research Council CASE Studentship [NE/F009011/1]	Centre national de la recherche scientifique(Centre National de la Recherche Scientifique (CNRS)); Biotechnology and Biological Sciences Research Council Syntax scheme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council CASE Studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported in part by funding from Centre national de la recherche scientifique, from the Biotechnology and Biological Sciences Research Council Syntax scheme, and from a Natural Environment Research Council CASE Studentship NE/F009011/1 to ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila-Pires Teresa Cristina Sauer, 2010, Boletim do Museu Paraense Emilio Goeldi Ciencias Naturais, V5, P13; Dubbin W, 2001, SOILS; Dumeril A, 1864, MEMOIRES SOC IMPERIA, V1, P307; Kamei RG, 2009, ZOOTAXA, P26, DOI 10.11646/zootaxa.2267.1.2; Kouete TM, 2012, ISRN ZOOL, V2012, P7; Kupfer A, 2006, NATURE, V440, P926, DOI 10.1038/nature04403; Kupfer A, 2005, ACTA OECOL, V28, P95, DOI 10.1016/j.actao.2005.03.002; Lescure J., 2000, COLLECTION PATRIMOIN, V45; Maciel AO, 2011, ZOOTAXA, P1; Maciel Adriano Oliveira, 2011, Boletim do Museu Paraense Emilio Goeldi Ciencias Naturais, V6, P67; NUSSBAUM R A, 1979, Zoologische Mededelingen (Leiden), V54, P217; Renous S., 1990, Gegenbaurs Morphologisches Jahrbuch, V136, P781; Taylor E.H., 1968, CAECILIANS WORLD TAX; Teodecki EE, 1998, HERPETOLOGICA, V54, P154; Wilkinson M, 2008, BIOL LETTERS, V4, P358, DOI 10.1098/rsbl.2008.0217; Wilkinson M, 2010, ZOOTAXA, P35; Wilkinson M, 2011, ZOOTAXA, P41; Wilkinson M, 2009, HERPETOLOGICA, V65, P413, DOI 10.1655/08-030.1	18	32	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57756	10.1371/journal.pone.0057756	http://dx.doi.org/10.1371/journal.pone.0057756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483926	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100042
J	Yamaguchi, R; Imoto, S; Kami, M; Watanabe, K; Miyano, S; Yuji, K				Yamaguchi, Rui; Imoto, Seiya; Kami, Masahiro; Watanabe, Kenji; Miyano, Satoru; Yuji, Koichiro			Does Twitter Trigger Bursts in Signature Collections?	PLOS ONE			English	Article								Introduction: The quantification of social media impacts on societal and political events is a difficult undertaking. The Japanese Society of Oriental Medicine started a signature-collecting campaign to oppose a medical policy of the Government Revitalization Unit to exclude a traditional Japanese medicine, "Kampo,'' from the public insurance system. The signature count showed a series of aberrant bursts from November 26 to 29, 2009. In the same interval, the number of messages on Twitter including the keywords "Signature'' and "Kampo,'' increased abruptly. Moreover, the number of messages on an Internet forum that discussed the policy and called for signatures showed a train of spikes. Methods and Findings: In order to estimate the contributions of social media, we developed a statistical model with state-space modeling framework that distinguishes the contributions of multiple social media in time-series of collected public opinions. We applied the model to the time-series of signature counts of the campaign and quantified contributions of two social media, i.e., Twitter and an Internet forum, by the estimation. We found that a considerable portion (78%) of the signatures was affected from either of the social media throughout the campaign and the Twitter effect (26%) was smaller than the Forum effect (52%) in total, although Twitter probably triggered the initial two bursts of signatures. Comparisons of the estimated profiles of the both effects suggested distinctions between the social media in terms of sustainable impact of messages or tweets. Twitter shows messages on various topics on a time-line; newer messages push out older ones. Twitter may diminish the impact of messages that are tweeted intermittently. Conclusions: The quantification of social media impacts is beneficial to better understand people's tendency and may promote developing strategies to engage public opinions effectively. Our proposed method is a promising tool to explore information hidden in social phenomena.	[Yamaguchi, Rui; Imoto, Seiya; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Kami, Masahiro] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Tokyo, Japan; [Watanabe, Kenji] Keio Univ, Sch Med, Ctr Kampo Med, Tokyo, Japan; [Yuji, Koichiro] Univ Tokyo, Inst Med Sci, Res Hosp, Dept Internal Med, Tokyo, Japan	University of Tokyo; University of Tokyo; Keio University; University of Tokyo	Yuji, K (corresponding author), Univ Tokyo, Inst Med Sci, Res Hosp, Dept Internal Med, Tokyo, Japan.	yuji-tky@umin.ac.jp		Miyano, Satoru/0000-0002-1753-6616	Yoshida Hideo Memorial Foundation	Yoshida Hideo Memorial Foundation	This study was supported by a grant from Yoshida Hideo Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abroms LC, 2009, J HEALTH COMMUN, V14, P415, DOI 10.1080/10810730903033000; [Anonymous], 2009, NATURE, V462, P389, DOI 10.1038/462389a; [Anonymous], CRISIS KAMPO MED; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Bakshy E., 2011, P 4 ACM INT C WEB SE, P65, DOI DOI 10.1145/1935826.1935845; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Burns A., 2009, RECORD COMMUNICATION, P298; Cha M, 2012, IEEE T SYST MAN CY A, V42, P991, DOI 10.1109/TSMCA.2012.2183359; Christakis N.A., 2009, CONNECTED SURPRISING; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Daniel D, 2010, AUST FAM PHYSICIAN, V39, P615; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Japanese Society of Oriental Medicine, SIGN COLL CAMP; Kitagawa G., 1996, SMOOTHNESS PRIORS AN; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Mashup (Web application hybrid), MASH WEG APPL HYBR; Nickerson DW, 2007, Q J POLIT SCI, V2, P369, DOI 10.1561/100.00007032; Red V, 2011, SIAM REV, V53, P526, DOI 10.1137/080734315; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Suarez-Almazor ME, 2011, OSTEOPOROSIS INT, V22, pS461, DOI 10.1007/s00198-011-1699-6; Thomson A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004264; Twitter Corporation, TWITT; Vergeer M., 2011, PARTY POLITICS	26	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58252	10.1371/journal.pone.0058252	http://dx.doi.org/10.1371/journal.pone.0058252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484004	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100096
J	Costello, MJ; Bouchet, P; Boxshall, G; Fauchald, K; Gordon, D; Hoeksema, BW; Poore, GCB; van Soest, RWM; Stohr, S; Walter, TC; Vanhoorne, B; Decock, W; Appeltans, W				Costello, Mark J.; Bouchet, Philippe; Boxshall, Geoff; Fauchald, Kristian; Gordon, Dennis; Hoeksema, Bert W.; Poore, Gary C. B.; van Soest, Rob W. M.; Stohr, Sabine; Walter, T. Chad; Vanhoorne, Bart; Decock, Wim; Appeltans, Ward			Global Coordination and Standardisation in Marine Biodiversity through the World Register of Marine Species (WoRMS) and Related Databases	PLOS ONE			English	Article							CLIMATE-CHANGE; TAXONOMY; COLLECTIONS; INFORMATION; CONSERVATION; PUBLICATION; RICHNESS; IMPACT; OCEAN; RATES	The World Register of Marine Species is an over 90% complete open-access inventory of all marine species names. Here we illustrate the scale of the problems with species names, synonyms, and their classification, and describe how WoRMS publishes online quality assured information on marine species. Within WoRMS, over 100 global, 12 regional and 4 thematic species databases are integrated with a common taxonomy. Over 240 editors from 133 institutions and 31 countries manage the content. To avoid duplication of effort, content is exchanged with 10 external databases. At present WoRMS contains 460,000 taxonomic names (from Kingdom to subspecies), 368,000 species level combinations of which 215,000 are currently accepted marine species names, and 26,000 related but non-marine species. Associated information includes 150,000 literature sources, 20,000 images, and locations of 44,000 specimens. Usage has grown linearly since its launch in 2007, with about 600,000 unique visitors to the website in 2011, and at least 90 organisations from 12 countries using WoRMS for their data management. By providing easy access to expert-validated content, WoRMS improves quality control in the use of species names, with consequent benefits to taxonomy, ecology, conservation and marine biodiversity research and management. The service manages information on species names that would otherwise be overly costly for individuals, and thus minimises errors in the application of nomenclature standards. WoRMS' content is expanding to include host-parasite relationships, additional literature sources, locations of specimens, images, distribution range, ecological, and biological data. Species are being categorised as introduced (alien, invasive), of conservation importance, and on other attributes. These developments have a multiplier effect on its potential as a resource for biodiversity research and management. As a consequence of WoRMS, we are witnessing improved communication within the scientific community, and anticipate increased taxonomic efficiency and quality control in marine biodiversity research and management.	[Costello, Mark J.] Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand; [Bouchet, Philippe] Museum Natl Hist Nat, F-75231 Paris, France; [Boxshall, Geoff] Nat Hist Museum, London SW7 5BD, England; [Fauchald, Kristian; Walter, T. Chad] Smithsonian Inst, Washington, DC 20560 USA; [Gordon, Dennis] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Hoeksema, Bert W.; van Soest, Rob W. M.] Nat Biodivers Ctr, Leiden, Netherlands; [Poore, Gary C. B.] Museum Victoria, Melbourne, Vic, Australia; [Stohr, Sabine] Swedish Museum Nat Hist, Dept Invertebrate Zool, S-10405 Stockholm, Sweden; [Vanhoorne, Bart; Decock, Wim; Appeltans, Ward] Flanders Marine Inst, Oostende, Belgium; [Appeltans, Ward] Intergovt Oceanog Commiss UNESCO, IOC Project Off IODE, Oostende, Belgium	University of Auckland; Museum National d'Histoire Naturelle (MNHN); Natural History Museum London; Smithsonian Institution; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Naturalis Biodiversity Center; Museum Victoria; Swedish Museum of Natural History	Costello, MJ (corresponding author), Univ Auckland, Leigh Marine Lab, Auckland 1, New Zealand.	m.costello@auckland.ac.nz	Hoeksema, Bert W./U-8530-2019; Stöhr, Sabine/B-8629-2011; Costello, Mark/C-9267-2013; Hoeksema, Bert W/B-2973-2010	Hoeksema, Bert W./0000-0001-8259-3783; Stöhr, Sabine/0000-0002-2586-7239; Costello, Mark/0000-0003-2362-0328; Hoeksema, Bert W/0000-0001-8259-3783; Boxshall, Geoffrey/0000-0001-8170-7734	European commission research programme: FP4 Marine Science and Technology programme for ERMS [MAS3-CT97-0146]; Species 2000 europa; FP6 Marine biodiversity and Ecosystem Function (MarBEF) network of excellence; FP6 PESI; FP7 4D4 life; National Science Foundation CORONA project; Ocean Biogeographic Information system; Census of Marine Life Synthesis project; Global Biodiversity Information Facility; Musee Cantonal de Zoologie (Switzerland); Universite Pierre AMP; Marie Curie(France); School of computer Science AMP; Statitics, Lloyds Institute; Trinity College, Dublin(Ireland); Academia Sinica; Biodiversity Research Centre (Taiwan); Future of Marine Animal Program, Department of Biological Sciences, Dalhousie University (Canada); University of Aucklan's Leigh Marine Laboratory (New Zealand)	European commission research programme: FP4 Marine Science and Technology programme for ERMS; Species 2000 europa; FP6 Marine biodiversity and Ecosystem Function (MarBEF) network of excellence; FP6 PESI; FP7 4D4 life; National Science Foundation CORONA project; Ocean Biogeographic Information system; Census of Marine Life Synthesis project; Global Biodiversity Information Facility; Musee Cantonal de Zoologie (Switzerland); Universite Pierre AMP; Marie Curie(France); School of computer Science AMP; Statitics, Lloyds Institute; Trinity College, Dublin(Ireland); Academia Sinica(Academia Sinica - Taiwan); Biodiversity Research Centre (Taiwan); Future of Marine Animal Program, Department of Biological Sciences, Dalhousie University (Canada); University of Aucklan's Leigh Marine Laboratory (New Zealand)	The development of WoRMS has benefited from major funding from the European commission research programme: FP4 Marine Science and Technology programme for ERMS(MAS3-CT97-0146), Species 2000 europa, FP6 Marine biodiversity and Ecosystem Function (MarBEF) network of excellence, FP6 PESI and FP7 4D4 life. Funding has also been provided by the National Science Foundation CORONA project, Ocean Biogeographic Information system, Census of Marine Life Synthesis project and Global Biodiversity Information Facility. SMEBD acknowledges financial contributions from Musee Cantonal de Zoologie (Switzerland); Universite Pierre & Marie Curie(France); School of computer Science & Statitics, Lloyds Institute; Trinity College, Dublin(Ireland), Academia Sinica, Biodiversity Research Centre (Taiwan); Future of Marine Animal Program, Department of Biological Sciences, Dalhousie University (Canada); and the University of Aucklan's Leigh Marine Laboratory (New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRS, 2009, AUSTR FAUN DIR; Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Agatha S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022466; Alroy J, 2002, P NATL ACAD SCI USA, V99, P3706, DOI 10.1073/pnas.062691099; Appeltans W, 2012, WORLD REGISTER MARIN; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Arizona State University International Institute for Species Exploration, 2012, TOP 10 NEW SPEC 2012; Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; Bisby FA, 2010, SPECIES 2000 ITIS CA; Blazewicz-Paszkowycz Magdalena, 2012, PLoS One, V7, pe33068, DOI 10.1371/journal.pone.0033068; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Bouchet P, 1997, VELIGER, V40, P1; Bouchet Philippe, 2006, P31; Bowman DD, 2005, TRENDS PARASITOL, V21, P267, DOI 10.1016/j.pt.2005.04.008; Cairns SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021670; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Cavalier-Smith T, 2001, MYCOTA, V7, P3; Costello M, 2001, EUROPEAN REGISTER MA; Costello M.J, 2001, OCEANIS, V24, P25; Costello MJ, 2006, MAR ECOL PROG SER, V316, P203, DOI 10.3354/meps316203; Costello MJ, 2006, MAR ECOL PROG SER, V316, P257, DOI 10.3354/meps316257; Costello Mark J., 2000, Oceanography, V13, P48; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Costello MJ, 2011, GLOBAL ECOL BIOGEOGR, V20, P319, DOI 10.1111/j.1466-8238.2010.00603.x; Costello MJ, 2009, BIOSCIENCE, V59, P418, DOI 10.1525/bio.2009.59.5.9; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Costello MJ, 2005, MARBEF NEWSLETTER, V2, P20; Costello MJ, 2004, MARBEF NEWSLETTER, V1, P22; Costello MJ, 2010, GLOSSARY TERMINOLOGY; Cuvelier D, 2006, MARBEF NEWSL, V4, P14; Drew J, 2011, CONSERV BIOL, V25, P1250, DOI 10.1111/j.1523-1739.2011.01725.x; Edwards JL, 2000, SCIENCE, V289, P2312, DOI 10.1126/science.289.5488.2312; Eitel M, PLOS ONE UNPUB; Eschmeyer WN, 2010, ZOOTAXA, P19; Essl F, 2012, GLOBAL ECOL IN PRESS; Euzeby JP, 2012, LPSN LIST PROKARYOTI; Felder DL, 2009, BIODIVERSITY, V1; Fisher R, 2012, ENVIRON MODELL SOFTW, V30, P1, DOI 10.1016/j.envsoft.2011.11.011; Fisher R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026556; Fontaine B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036881; GASTON KJ, 1993, P ROY SOC B-BIOL SCI, V251, P139, DOI 10.1098/rspb.1993.0020; Godfray HCJ, 2007, NATURE, V446, P259, DOI 10.1038/446259a; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Gollner S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009801; Gordon D., 2009, NZ INVENTORY BIODIVE, V1; Gordon DP, 2010, NZ INVENTORY BIODIVE, V2; Gordon DP, 2009, SPEC 2000 ITIS CAT L; Gordon DP, 2012, NZ INVENTORY BIODIVE; Gordon DP, 2012, NZ INVENTORY BIODIVE, V3, P17; Govaerts R, 2003, TAXON, V52, P583, DOI 10.2307/3647457; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Hawksworth DL, 2011, IMA FUNGUS, V2, P55; Hoeksema BW, 2011, MAR ECOL-EVOL PERSP, V32, P135, DOI 10.1111/j.1439-0485.2011.00434.x; Hoeksema BW, 2009, RAFFLES B ZOOL, P91; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; ICZN, 1999, INT CODE ZOOLOGICAL; Iglesias SP, 2010, AQUAT CONSERV, V20, P319, DOI 10.1002/aqc.1083; International Commission on Zoological Nomenclature, 2012, ZOOTAXA, V3450, P1, DOI DOI 10.11646/zootaxa.3450.1.1; Johnson GD, 2009, BIOL LETTERS, V5, P235, DOI 10.1098/rsbl.2008.0722; Johnson KG, 2011, BIOSCIENCE, V61, P147, DOI 10.1525/bio.2011.61.2.10; Kennedy MK, 2011, CANADIAN TECHNICAL R, V2933, P1; Kirk P., 2008, Ainsworth and Bisby�s Dictionary of the Fungi, DOI 10.1079/9780851998268.0000; Knapp S, 2007, NATURE, V446, P261, DOI 10.1038/446261a; Knapp Sandra, 2011, PhytoKeys, V6, P5, DOI [10.3897/phytokeys.6.1960, 10.1111/j.1096-0031.2011.00378.x, 10.1111/j.1469-8137.2011.03914.x]; Kottelat M, 1997, BIOLOGIA, V52, P1; Lapage SP, 1992, INT CODE NOMENCLATUR; Linnaeus G, 1758, ANIMALIA, V1; Lleonart J, 2006, MAR ECOL PROG SER, V316, P231, DOI 10.3354/meps316231; Ludwig A, 2002, NATURE, V419, P447, DOI 10.1038/419447a; Mah CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035644; Mallet J, 2003, TRENDS ECOL EVOL, V18, P57, DOI 10.1016/S0169-5347(02)00061-7; McNeill J., 2006, V146, P1; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Moretzsohn F, 2002, SPEC 2000 AS OC P 2, V171, P142; Mozzherin D, 2012, SCI NAMES PARSER; Munilla T, 2009, ANTARCT SCI, V21, P99, DOI 10.1017/S095410200800151X; Neiber MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019627; Nic Donnacha E, 2002, BIOL ENVIRON, V102, P185; Patterson DJ, 2010, TRENDS ECOL EVOL, V1297, P1; Pennisi E, 2000, SCIENCE, V289, P2306, DOI 10.1126/science.289.5488.2306; Perrin WF, 2012, WORLD CETACEA DATABA; Polaszek A, 2005, NATURE, V437, P477, DOI 10.1038/437477a; Poore GCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043529; Pyle RL, 2008, ZOOTAXA, P39, DOI 10.11646/zootaxa.1950.1.6; Rainbow PS, 2009, ZOOL SCR, V38, P33, DOI 10.1111/j.1463-6409.2007.00313.x; Rasmussen AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027373; Rees T, 2012, IRMNG HOMONYMS LIST; Rees T, 2011, TAXAMATCH FUZZY MATC; Ruggiero M, 2012, SPEC 2000 ITIS CAT L; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Scotland RW, 2003, TAXON, V52, P101, DOI 10.2307/3647306; Segers Hendrik, 2012, Zootaxa, V3179, P61; Shenkar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020657; Stohr S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031940; Stork Nigel E., 1997, P41; Stork NE, 2010, BIODIVERS CONSERV, V19, P357, DOI 10.1007/s10531-009-9761-9; Suarez-Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022915; Thomas James D., 1997, P357; van Bruggen A.C., 2001, Zoologische Verhandelingen (Leiden), V334, P7; van der Land J, 1994, UNESCO IOC REGISTER; van der Meij SET, 2009, MAR POLLUT BULL, V59, P101, DOI 10.1016/j.marpolbul.2009.02.021; van der Meij SET, 2010, MAR POLLUT BULL, V60, P1442, DOI 10.1016/j.marpolbul.2010.05.011; Van Soest RWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035105; van Soest RWM, 2012, WORLD PORIFERA DATAB; Vandepitte L, 2011, HYDROBIOLOGIA, V667, P1, DOI 10.1007/s10750-011-0656-x; Wheeler QD, 2010, STATE OBSERVED SPECI; Wheeler QD, 2007, NATURE, V447, P142, DOI 10.1038/447142c; Williams GC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022747; Williams JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035350; Wilson EO, 2000, SCIENCE, V289, P2279; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Wilson SP, 2005, J R STAT SOC C-APPL, V54, P897, DOI 10.1111/j.1467-9876.2005.00513.x	113	126	131	0	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e51629	10.1371/journal.pone.0051629	http://dx.doi.org/10.1371/journal.pone.0051629			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23505408	gold, Green Submitted, Green Published			2022-12-27	WOS:000313551500006
J	Relan, V; Morrison, L; Parsonson, K; Clarke, BE; Duhig, EE; Windsor, MN; Matar, KS; Naidoo, R; Passmore, L; McCaul, E; Courtney, D; Yang, IA; Fong, KM; Bowman, RV				Relan, Vandana; Morrison, Leanne; Parsonson, Kylie; Clarke, Belinda E.; Duhig, Edwina E.; Windsor, Morgan N.; Matar, Kevin S.; Naidoo, Rishendran; Passmore, Linda; McCaul, Elizabeth; Courtney, Deborah; Yang, Ian A.; Fong, Kwun M.; Bowman, Rayleen V.			Phenotypes and Karyotypes of Human Malignant Mesothelioma Cell Lines	PLOS ONE			English	Article							COPY-NUMBER CHANGES; CHROMOSOMAL-ABNORMALITIES; ESTABLISHMENT; ASBESTOS; TISSUE; TUMORIGENICITY; EXPRESSION; DIAGNOSIS; CULTURE; MARKER	Background: Malignant mesothelioma is an aggressive tumour of serosal surfaces most commonly pleura. Characterised cell lines represent a valuable tool to study the biology of mesothelioma. The aim of this study was to develop and biologically characterise six malignant mesothelioma cell lines to evaluate their potential as models of human malignant mesothelioma. Methods: Five lines were initiated from pleural biopsies, and one from pleural effusion of patients with histologically proven malignant mesothelioma. Mesothelial origin was assessed by standard morphology, Transmission Electron Microscopy (TEM) and immunocytochemistry. Growth characteristics were assayed using population doubling times. Spectral karyotyping was performed to assess chromosomal abnormalities. Authentication of donor specific derivation was undertaken by DNA fingerprinting using a panel of SNPs. Results: Most of cell lines exhibited spindle cell shape, with some retaining stellate shapes. At passage 2 to 6 all lines stained positively for calretinin and cytokeratin 19, and demonstrated capacity for anchorage-independent growth. At passage 4 to 16, doubling times ranged from 30-72 hours, and on spectral karyotyping all lines exhibited numerical chromosomal abnormalities ranging from 41 to 113. Monosomy of chromosomes 8, 14, 22 or 17 was observed in three lines. One line displayed four different karyotypes at passage 8, but only one karyotype at passage 42, and another displayed polyploidy at passage 40 which was not present at early passages. At passages 5-17, TEM showed characteristic features of mesothelioma ultrastructure in all lines including microvilli and tight intercellular junctions. Conclusion: These six cell lines exhibit varying cell morphology, a range of doubling times, and show diverse passage-dependent structural chromosomal changes observed in malignant tumours. However they retain characteristic immunocytochemical protein expression profiles of mesothelioma during maintenance in artificial culture systems. These characteristics support their potential as in vitro model systems for studying cellular, molecular and genetic aspects of mesothelioma.	[Relan, Vandana; Parsonson, Kylie; Passmore, Linda; McCaul, Elizabeth; Courtney, Deborah; Yang, Ian A.; Fong, Kwun M.; Bowman, Rayleen V.] Univ Queensland, Sch Med, UQ Thorac Res Ctr, Brisbane, Qld, Australia; [Relan, Vandana; Morrison, Leanne; Parsonson, Kylie; Passmore, Linda; McCaul, Elizabeth; Courtney, Deborah; Yang, Ian A.; Fong, Kwun M.; Bowman, Rayleen V.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Clarke, Belinda E.; Duhig, Edwina E.] Prince Charles Hosp, Dept Anat Pathol, Brisbane, Qld 4032, Australia; [Windsor, Morgan N.; Matar, Kevin S.; Naidoo, Rishendran] Prince Charles Hosp, Dept Thorac Surg, Brisbane, Qld 4032, Australia	University of Queensland; Prince Charles Hospital; Prince Charles Hospital; Prince Charles Hospital	Relan, V (corresponding author), Univ Queensland, Sch Med, UQ Thorac Res Ctr, Brisbane, Qld, Australia.	v.relan@uq.edu.au	Parsonson, Kylie R/J-9466-2014; Yang, Ian A/B-9609-2008; Bowman, Rayleen V/G-4144-2013; Fong, Kwun M/G-6369-2010	Yang, Ian A/0000-0001-8338-1993; Fong, Kwun/0000-0002-6507-1403	Prince Charles Hospital Foundation; Dust Diseases Board (New South Wales, Australia); Cancer Australia; NHMRC Practitioner Fellowship; NHMRC Career Development Fellowship; UQ Early Career Researcher	Prince Charles Hospital Foundation; Dust Diseases Board (New South Wales, Australia); Cancer Australia; NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); UQ Early Career Researcher	The study was supported by the following funding bodies: The Prince Charles Hospital Foundation, The Dust Diseases Board (New South Wales, Australia), Cancer Australia, NHMRC Practitioner Fellowship (KF), NHMRC Career Development Fellowship (IY) and UQ Early Career Researcher (VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi C, 2007, IND HEALTH, V45, P379, DOI 10.2486/indhealth.45.379; Bjorkqvist AM, 1997, BRIT J CANCER, V75, P523, DOI 10.1038/bjc.1997.91; Bowman R, 2011, AUST PRESCR, V34, P144; Carbone M, 1997, NAT MED, V3, P908, DOI 10.1038/nm0897-908; Dong Woo Kang S-HL, 2010, CANCER RES, V70, P4233; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gazdar AF, 1981, SMALL CELL LUNG CANC, P145; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Hiyama J, 1998, INTERN MED, P37; Ivanov SV, 2009, BIOCHEM BIOPH RES CO, V382, P514, DOI 10.1016/j.bbrc.2009.03.042; KNUDSON A, 1995, P NATL ACAD SCI USA, V92, P10819, DOI 10.1073/pnas.92.24.10819; Krismann M, 2004, LUNG CANCER, V45, pS29, DOI 10.1016/j.lungcan.2004.04.005; Lindholm PM, 2007, CYTOGENET GENOME RES, V119, P46, DOI 10.1159/000109618; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; Marchevsky AM, 2008, ARCH PATHOL LAB MED, V132, P397, DOI 10.1043/1543-2165(2008)132[397:AOITTD]2.0.CO;2; Masters JRW, 2000, BRIT J CANCER, V82, P1495; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Neragi-Miandoab Siyamek, 2009, Interact Cardiovasc Thorac Surg, V9, P42, DOI 10.1510/icvts.2008.201509; Orengo AM, 1999, EUR RESPIR J, V13, P527, DOI 10.1183/09031936.99.13352799; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; PELINENLUND K, 1990, CARCINOGENESIS, V11, P673, DOI 10.1093/carcin/11.4.673; Philippeaux MM, 2004, HISTOCHEM CELL BIOL, V122, P249, DOI 10.1007/s00418-004-0701-1; Pylkkanen L, 2002, ONCOL REP, V9, P955; Safe work Australia, 2009, MES AUSTR INCIDENCE; SANDBERG AA, 1983, CANCER GENET CYTOGEN, V8, P277, DOI 10.1016/0165-4608(83)90070-5; Sato G, 2008, CYTOTECHNOLOGY, V57, P111, DOI 10.1007/s10616-007-9109-9; Sato GH, 2010, IN VITRO CELL DEV-AN, V46, P590, DOI 10.1007/s11626-010-9315-1; SCHAEFFER WI, 1990, IN VITRO CELL DEV B, V26, P97; Suster S, 2005, EXPERT REV MOL DIAGN, V5, P715, DOI 10.1586/14737159.5.5.715; Suzuki H, 2010, ANTICANCER RES, V30, P4343; TIAINEN M, 1989, BRIT J CANCER, V60, P618, DOI 10.1038/bjc.1989.326; TIAINEN M, 1988, CANCER GENET CYTOGEN, V33, P251, DOI 10.1016/0165-4608(88)90035-0; Usami N, 2006, CANCER SCI, V97, P387, DOI 10.1111/j.1349-7006.2006.00184.x; Veldwijk MR, 2008, ONKOLOGIE, V31, P91, DOI 10.1159/000113504; Wenger SL, 2004, BIOSCIENCE REP, V24, P631, DOI 10.1007/s10540-005-2797-5; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Zanazzi C, 2007, GENE CHROMOSOME CANC, V46, P895, DOI 10.1002/gcc.20475	38	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58132	10.1371/journal.pone.0058132	http://dx.doi.org/10.1371/journal.pone.0058132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516439	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400018
J	Guo, L; Wu, CJ; Zhou, HL; Wu, C; Paranhos-Baccala, G; Vernet, G; Jin, Q; Wang, JW; Hung, T				Guo, Li; Wu, Chengjun; Zhou, Hongli; Wu, Chao; Paranhos-Baccala, Glaucia; Vernet, Guy; Jin, Qi; Wang, Jianwei; Hung, Tao			Identification of a Nonstructural DNA-Binding Protein (DBP) as an Antigen with Diagnostic Potential for Human Adenovirus	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMORAL IMMUNE-RESPONSES; OUTER-MEMBRANE PROTEINS; ANTIBODY DETECTION; GENE; SENSITIVITY; VECTORS; SPECIFICITY; INFECTIONS; ASSAYS	Background: Human adenoviruses (HAdVs) have been implicated as important agents in a wide range of human illnesses. To date, 58 distinct HAdV serotypes have been identified and can be grouped into six species. For the immunological diagnosis of adenoviruses, the hexon protein, a structural protein, has been used. The potential of other HAdV proteins has not been fully addressed. Methodology/Principal Findings: In this study, a nonstructural antigenic protein, the DNA binding protein (DBP) of human adenovirus 5 and 35 (Ad5, Ad35) - was identified using immunoproteomic technology. The expression of Ad5 and Ad35 DBP in insect cells could be detected by rhesus monkey serum antibodies and healthy adult human serum positive for Ad5 and Ad35. Recombinant DBPs elicited high titer antibodies in mice. Their conserved domain displayed immunological cross-reactions with heterologous DBP antibodies in Western blot assays. DBP-IgM ELISA showed higher sensitivity adenovirus IgM detection than the commercial Adenovirus IgM Human ELISA Kit. A Western blot method developed based on Ad5 DBP was highly consistent with (chi(2) = 44.9, P<0.01) the Western blot assay for the hexon protein in the detection of IgG, but proved even more sensitive. Conclusions/Significance: The HAdV nonstructural protein DBP is an antigenic protein that could serve as an alternative common antigen for adenovirus diagnosis.	[Guo, Li; Wu, Chengjun; Zhou, Hongli; Wu, Chao; Jin, Qi; Wang, Jianwei; Hung, Tao] Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, IPB,MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China; [Guo, Li; Wu, Chengjun; Zhou, Hongli; Wu, Chao; Jin, Qi; Wang, Jianwei; Hung, Tao] Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, IPB,Christophe Merieux Lab, Beijing 100730, Peoples R China; [Guo, Li; Wu, Chengjun; Zhou, Hongli; Wu, Chao; Jin, Qi; Wang, Jianwei; Hung, Tao] Peking Union Med Coll, Beijing 100021, Peoples R China; [Paranhos-Baccala, Glaucia; Vernet, Guy] Fdn Merieux, Lyon, France; [Hung, Tao] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Jin, Q (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, CAMS Fdn Merieux, IPB,MOH Key Lab Syst Biol Pathogens, Beijing 100730, Peoples R China.	zdsys@vip.sina.com; wangjw28@163.com	Wang, Jianwei/W-5916-2019; Wang, Jianwei/AAW-9499-2020	Wang, Jianwei/0000-0002-1116-4559	International Science and Technology Cooperation Program of China [2010DFB33270]; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China [2012ZX10004-206]	International Science and Technology Cooperation Program of China; National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China	This study was supported in part by the International Science and Technology Cooperation Program of China (2010DFB33270) (http://www.cistc.gov.cn) and National Major Science & Technology Project for Control and Prevention of Major Infectious Diseases of China (2012ZX10004-206) (http://www.nmp.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; ALTER HJ, 1992, HEPATOLOGY, V15, P350, DOI 10.1002/hep.1840150228; Ayalew S, 2010, PROTEOMICS, V10, P2151, DOI 10.1002/pmic.200900557; BAHRAOUI E, 1990, AIDS RES HUM RETROV, V6, P1087, DOI 10.1089/aid.1990.6.1087; BARRERA JM, 1991, ANN INTERN MED, V115, P596, DOI 10.7326/0003-4819-115-8-596; Bauer U, 2005, J CLIN MICROBIOL, V43, P4426, DOI 10.1128/JCM.43.9.4426-4433.2005; Bell C, 2012, J PROTEOME RES, V11, P119, DOI 10.1021/pr2007939; Caravokyri C, 1996, VIRUS GENES, V12, P65, DOI 10.1007/BF00370002; CLEGHON V, 1989, J VIROL, V63, P2289, DOI 10.1128/JVI.63.5.2289-2299.1989; Colin C, 2001, J VIRAL HEPATITIS, V8, P87, DOI 10.1046/j.1365-2893.2001.00280.x; Curreem SOT, 2012, PROTEIN CELL, V3, P346, DOI 10.1007/s13238-012-2034-5; DAI YF, 1995, P NATL ACAD SCI USA, V92, P1401, DOI 10.1073/pnas.92.5.1401; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; El-Gogo S, 2008, J GENE MED, V10, P177, DOI 10.1002/jgm.1144; Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06; Harfst E, 1999, VIRUS GENES, V18, P97, DOI 10.1023/A:1008009630695; Harvey BG, 1999, J VIROL, V73, P6729, DOI 10.1128/JVI.73.8.6729-6742.1999; Jian-Umpunkul P, 2012, J VIROL METHODS, V185, P24, DOI 10.1016/j.jviromet.2012.05.021; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Kamili S., 2012, Clinical Infectious Diseases, V55, P43, DOI 10.1093/cid/cis368; Liao YH, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-172; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Lu GL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-62; NICOLAS JC, 1983, VIROLOGY, V126, P228, DOI 10.1016/0042-6822(83)90474-9; Sankar SG, 2012, CLIN MICROBIOL INFEC, V18, pE8, DOI 10.1111/j.1469-0691.2011.03694.x; Shenk T. E., 2001, Fundamental virology, P1053; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TSERNOGLOU D, 1985, FEBS LETT, V188, P248, DOI 10.1016/0014-5793(85)80381-1; Williams JN, 2009, INFECT IMMUN, V77, P5080, DOI 10.1128/IAI.00701-09; Wold WSM, 2007, FIELDS VIROLOGY, V1, P2396; Wu CJ, 2011, J VIROL METHODS, V177, P55, DOI 10.1016/j.jviromet.2011.06.016; Zheng Q, 2011, VACCINE, V29, P763, DOI 10.1016/j.vaccine.2010.11.014; Zhu YZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013915; ZIJDERVELD DC, 1994, J VIROL, V68, P8288, DOI 10.1128/JVI.68.12.8288-8295.1994	36	1	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e56708	10.1371/journal.pone.0056708	http://dx.doi.org/10.1371/journal.pone.0056708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516396	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200005
J	Musetti, C; Krapcho, AP; Palumbo, M; Sissi, C				Musetti, Caterina; Krapcho, A. Paul; Palumbo, Manlio; Sissi, Claudia			Effect of G-Quadruplex Polymorphism on the Recognition of Telomeric DNA by a Metal Complex	PLOS ONE			English	Article							CONFORMATIONAL SWITCH; BINDING; CALORIMETRY; ENERGETICS; LIGANDS; TARGETS; DESIGN; CANCER	The physiological role(s) played by G-quadruplexes renders these 'non-canonical' DNA secondary structures interesting new targets for therapeutic intervention. In particular, the search for ligands for selective recognition and stabilization of G-quadruplex arrangements has led to a number of novel targeted agents. An interesting approach is represented by the use of metal-complexes, their binding to DNA being modulated by ligand and metal ion nature, and by complex stoichiometry. In this work we characterized thermodynamically and stereochemically the interactions of a Ni(II) bis-phenanthroline derivative with telomeric G-quadruplex sequences using calorimetric, chiroptical and NMR techniques. We employed three strictly related sequences based on the human telomeric repeat, namely Tel22, Tel26 and wtTel26, which assume distinct conformations in potassium containing solutions. We were able to monitor specific enthalpy/entropy changes according to the structural features of the target telomeric sequence and to dissect the binding process into distinct events. Interestingly, temperature effects turned out to be prominent both in terms of binding stoichiometry and Delta H/Delta S contributions, while the final G-quadruplex-metal complex architecture tended to merge for the examined sequences. These results underline the critical choice of experimental conditions and DNA sequence for practical use of thermodynamic data in the rational development of effective G-quadruplex binders.	[Musetti, Caterina; Palumbo, Manlio; Sissi, Claudia] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Krapcho, A. Paul] Univ Vermont, Dept Chem, Burlington, VT 05405 USA	University of Padua; University of Vermont	Sissi, C (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	claudia.sissi@unipd.it		SISSI, CLAUDIA/0000-0002-9713-1415; Palumbo, Manlio/0000-0002-3163-1564	University of Padova [CPDA114388]; MIUR (Ministero dell'Istruzione, dell'Universita' e della Ricerca) (PRIN) [2009MFRKZ8_004]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	University of Padova; MIUR (Ministero dell'Istruzione, dell'Universita' e della Ricerca) (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The authors thank Dr. Giuseppe Marson for helpful discussion and Dr. Ileana Menegazzo for NMR assistance. This work was funded by University of Padova (grant # CPDA114388) and MIUR (Ministero dell'Istruzione, dell'Universita' e della Ricerca) (PRIN # 2009MFRKZ8_004) is gratefully acknowledged. The authors also thank AIRC for the Postdoctoral Fellowship "Gabriele Santoro" to C.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacolla A, 2006, DNA REPAIR, V5, P1161, DOI 10.1016/j.dnarep.2006.05.032; Bertrand H, 2007, ORG BIOMOL CHEM, V5, P2555, DOI 10.1039/b708635k; Bhattacharjee AJ, 2011, BIOCHIMIE, V93, P1297, DOI 10.1016/j.biochi.2011.05.038; Bianco S, 2010, DALTON T, V39, P5833, DOI 10.1039/c0dt00038h; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; Choi J, 2011, CHEM SOC REV, V40, P5893, DOI 10.1039/c1cs15153c; Cooper A, 2001, BIOPHYS CHEM, V93, P215, DOI 10.1016/S0301-4622(01)00222-8; Cuesta J, 2003, MINI-REV MED CHEM, V3, P11, DOI 10.2174/1389557033405502; Dai JX, 2008, BIOCHIMIE, V90, P1172, DOI 10.1016/j.biochi.2008.02.026; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P4927, DOI 10.1093/nar/gkm522; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P2440, DOI 10.1093/nar/gkm009; Davis JT, 2007, CHEM SOC REV, V36, P296, DOI 10.1039/b600282j; Donate LE, 2011, PHILOS T R SOC B, V366, P76, DOI 10.1098/rstb.2010.0291; Fernando H, 2009, NUCLEIC ACIDS RES, V37, P6716, DOI 10.1093/nar/gkp740; Folini M, 2011, EXPERT OPIN THER TAR, V15, P579, DOI 10.1517/14728222.2011.556621; Garbett NC, 2012, EXPERT OPIN DRUG DIS, V7, P299, DOI 10.1517/17460441.2012.666235; Georgiades SN, 2010, ANGEW CHEM INT EDIT, V49, P4020, DOI 10.1002/anie.200906363; Grandin N, 2008, BIOCHIMIE, V90, P41, DOI 10.1016/j.biochi.2007.07.008; Gray RD, 2009, J PHYS CHEM B, V113, P2676, DOI 10.1021/jp809578f; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x; Jiang YL, 2010, MINI-REV MED CHEM, V10, P726, DOI 10.2174/138955710791572433; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Mazur S, 2000, J MOL BIOL, V300, P321, DOI 10.1006/jmbi.2000.3869; Monchaud D, 2008, ANGEW CHEM INT EDIT, V47, P4858, DOI 10.1002/anie.200800468; Monchaud D, 2008, ORG BIOMOL CHEM, V6, P627, DOI 10.1039/b714772b; Musetti C, 2009, DALTON T, P3657, DOI 10.1039/b904630p; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; Orlotti NI, 2012, AUTOPHAGY, V8, P1185, DOI 10.4161/auto.20519; Pagano B, 2007, CURR CANCER DRUG TAR, V7, P520, DOI 10.2174/156800907781662257; Pagano B, 2009, INT J MOL SCI, V10, P2935, DOI 10.3390/ijms10072935; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Pilch DS, 2008, BIOCHIMIE, V90, P1233, DOI 10.1016/j.biochi.2008.03.011; Privalov PL, 2007, BIOPHYS CHEM, V126, P16, DOI 10.1016/j.bpc.2006.05.004; Rajput C, 2006, CHEM-EUR J, V12, P4611, DOI 10.1002/chem.200501349; Ralph SF, 2011, CURR TOP MED CHEM, V11, P572; Rao L, 2011, J PHYS CHEM B, V115, P13701, DOI 10.1021/jp207265s; Reed JE, 2009, DALTON T, P2558, DOI 10.1039/b820086f; Riou Jean-Francois, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P439, DOI 10.2174/1568011043352740; Sissi C, 2011, BIOCHIMIE, V93, P1219, DOI 10.1016/j.biochi.2011.04.018; Velazquez-Campoy Adrian, 2004, Curr Protoc Cell Biol, VChapter 17, DOI 10.1002/0471143030.cb1708s23; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zeglis BM, 2007, CHEM COMMUN, P4565, DOI 10.1039/b710949k; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	48	17	17	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58529	10.1371/journal.pone.0058529	http://dx.doi.org/10.1371/journal.pone.0058529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516498	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200079
J	Sheet, T; Supakar, S; Banerjee, R				Sheet, Tridip; Supakar, Subhrangshu; Banerjee, Raja			Conformational Preference of '(CNN)-N-alpha' Short Peptide Motif towards Recognition of Anions	PLOS ONE			English	Article							PHOSPHATE-BINDING; INORGANIC-PHOSPHATE; CRYSTAL-STRUCTURE; STRUCTURAL MOTIF; DOMINANT ROLE; ALPHA-HELIX; PROTEIN; SITES; NMR; SIMULATION	Among several 'anion binding motifs', the recently described '(CNN)-N-alpha' motif occurring in the loop regions preceding a helix, is conserved through evolution both in sequence and its conformation. To establish the significance of the conserved sequence and their intrinsic affinity for anions, a series of peptides containing the naturally occurring '(CNN)-N-alpha' motif at the N-terminus of a designed helix, have been modeled and studied in a context free system using computational techniques. Appearance of a single interacting site with negative binding free-energy for both the sulfate and phosphate ions, as evidenced in docking experiments, establishes that the '(CNN)-N-alpha' segment has an intrinsic affinity for anions. Molecular Dynamics (MD) simulation studies reveal that interaction with anion triggers a conformational switch from non-helical to helical state at the '(CNN)-N-alpha' segment, which extends the length of the anchoring-helix by one turn at the N-terminus. Computational experiments substantiate the significance of sequence/structural context and justify the conserved nature of the '(CNN)-N-alpha' sequence for anion recognition through "local'' interaction.	[Sheet, Tridip; Supakar, Subhrangshu; Banerjee, Raja] West Bengal Univ Technol, Dept Bioinformat, Kolkata, India	Maulana Abul Kalam Azad University of Technology	Banerjee, R (corresponding author), West Bengal Univ Technol, Dept Bioinformat, Kolkata, India.	ban_raja@yahoo.com		Sheet, Tridip/0000-0002-7269-5353	DBT,GOI (Department of Biotechnology, Govt. of India) [BT/PR10277/GBD/27/90/2007]; BIF-DBT,GOI (Bioinformatics Infra structural facility-Department of Biotechnology, Govt. of India) [BT/BI/25/001/2006-Vol. II]	DBT,GOI (Department of Biotechnology, Govt. of India); BIF-DBT,GOI (Bioinformatics Infra structural facility-Department of Biotechnology, Govt. of India)	Funding was provided by (a) DBT,GOI (Department of Biotechnology, Govt. of India) Sanction No. BT/PR10277/GBD/27/90/2007 dt. 25-03-2008; and (b) BIF-DBT,GOI (Bioinformatics Infra structural facility-Department of Biotechnology, Govt. of India) Sanction No. BT/BI/25/001/2006-Vol. II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev ZK, 2002, BIOCHEM J, V362, P749, DOI 10.1042/0264-6021:3620749; Aburi M., 2004, J PHYS CHEM B, V108, P7382, DOI DOI 10.1021/JP036582Z; Accelrys Software Inc, 2010, DISC STUD MOD ENV RE; Allen TW, 2004, P NATL ACAD SCI USA, V101, P117, DOI 10.1073/pnas.2635314100; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Aquist J, 1991, P NATL ACAD SCI USA, V88, P2026; Banerjee R, 2002, CHEMBIOCHEM, V3, P1263, DOI 10.1002/1439-7633(20021202)3:12<1263::AID-CBIC1263>3.0.CO;2-O; Banerjee R, 2009, PROTEINS, V76, P184, DOI 10.1002/prot.22337; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bianchi A, 2012, PROTEINS, V80, P1418, DOI 10.1002/prot.24038; Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473; CHAKRABARTI P, 1993, J MOL BIOL, V234, P463, DOI 10.1006/jmbi.1993.1599; Cobessi D, 1999, J MOL BIOL, V290, P161, DOI 10.1006/jmbi.1999.2853; Crisma M, 2007, J PEPT SCI, V13, P190, DOI 10.1002/psc.833; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Demuth C, 2001, BIOSENS BIOELECTRON, V16, P783, DOI 10.1016/S0956-5663(01)00221-4; Denessiouk KA, 2005, J MOL BIOL, V345, P611, DOI 10.1016/j.jmb.2004.10.058; Denessiouk KA, 2003, J MOL BIOL, V333, P1025, DOI 10.1016/j.jmb.2003.09.017; Denessiouk KA, 2001, PROTEINS, V44, P282, DOI 10.1002/prot.1093; Denesyuk AI, 2003, BBA-PROTEINS PROTEOM, V1647, P234, DOI 10.1016/S1570-9639(03)00057-8; Dennington R., 2016, GAUSSVIEW VERSION 6; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HE JJ, 1993, PROTEIN SCI, V2, P1643, DOI 10.1002/pro.5560021010; He QY, 2000, BIOCHEM J, V350, P909, DOI 10.1042/0264-6021:3500909; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Holt PA, 2008, J MED CHEM, V51, P3878; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARLE IL, 1994, PROTEIN SCI, V3, P1547, DOI 10.1002/pro.5560030920; Kinoshita K, 1999, PROTEIN ENG, V12, P11, DOI 10.1093/protein/12.1.11; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Ledvina PS, 1996, P NATL ACAD SCI USA, V93, P6786, DOI 10.1073/pnas.93.13.6786; Ledvina PS, 1998, PROTEIN SCI, V7, P2550, DOI 10.1002/pro.5560071208; Liu MTW, 2000, J BIOL CHEM, V275, P1814, DOI 10.1074/jbc.275.3.1814; LOUIE GV, 1990, J MOL BIOL, V214, P527, DOI 10.1016/0022-2836(90)90197-T; Markovich D, 2001, PHYSIOL REV, V81, P1499, DOI 10.1152/physrev.2001.81.4.1499; MARTINEZLIARTE JH, 1992, BIOCHEMISTRY-US, V31, P2712, DOI 10.1021/bi00125a011; MEIERING EM, 1991, BIOCHEMISTRY-US, V30, P11348, DOI 10.1021/bi00111a022; Milner-White EJ, 2005, ORIGINS LIFE EVOL B, V35, P19, DOI 10.1007/s11084-005-4582-7; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramakrishnan C, 2002, PROTEIN ENG, V15, P783, DOI 10.1093/protein/15.10.783; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Sansom MSP, 1998, J STRUCT BIOL, V121, P246, DOI 10.1006/jsbi.1997.3950; Sheet T, 2010, J STRUCT BIOL, V171, P345, DOI 10.1016/j.jsb.2010.06.003; SMITH SO, 1989, SCIENCE, V244, P961, DOI 10.1126/science.2499045; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Watson JD, 2002, J MOL BIOL, V315, P171, DOI 10.1006/jmbi.2001.5227; WIERENGA RK, 1984, J MOL BIOL, V178, P487, DOI 10.1016/0022-2836(84)90155-4; Wuthrich K, 1986, NMR PROTEINS NUCL AC	61	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57366	10.1371/journal.pone.0057366	http://dx.doi.org/10.1371/journal.pone.0057366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516403	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200009
J	Kawasaki, H; Doi, R; Ito, K; Shimoda, M; Ishida, N				Kawasaki, Haruhisa; Doi, Ryosuke; Ito, Kumpei; Shimoda, Masami; Ishida, Norio			The Circadian Binding of CLOCK Protein to the Promoter of C/ebp alpha Gene in Mouse Cells	PLOS ONE			English	Article							MUTANT MICE; MOLECULAR ANALYSIS; MYELOID-LEUKEMIA; EXPRESSION; TRANSCRIPTION; LIVER; DIFFERENTIATION; HOMEOSTASIS; RHYTHMS; ELEMENT	C/ebp alpha plays important roles in metabolism as well as in the maintenance of energy homeostasis. Here we describe loss of the circadian oscillation of C/ebp alpha expression in liver of Clock mutant mice. Reporter assays indicate Clock and Bmal significantly induced C/ebp alpha gene expression whereas Cry suppressed. Real time reporter assays showed that two mutated E-boxes disrupted C/ebp alpha promoter dependent-oscillation. Chromatin immunoprecipitation suggests Clock can bind to two E-boxes in the C/ebp alpha promoter with a circadian manner in vivo. Thus, C/ebp alpha gene transcription is under circadian control of a core clock component, Clock. The data suggests that circadian disturbances may affect metabolic abnormalities through the C/ebp alpha pathway in liver.	[Kawasaki, Haruhisa; Doi, Ryosuke; Ito, Kumpei; Ishida, Norio] Natl Inst Adv Sci & Technol AIST, Biomed Res Inst, Ishida Grp Clock Gene, Tsukuba, Ibaraki, Japan; [Doi, Ryosuke; Ito, Kumpei; Ishida, Norio] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Doi, Ryosuke] Kobe Univ, Div Cell Physiol, Dept Physiol & Cell Biol, Grad Sch Med, Kobe, Hyogo 657, Japan; [Shimoda, Masami] Natl Inst Agrobiol Sci, Div Insect Sci, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Kobe University; National Institute of Agrobiological Sciences - Japan	Ishida, N (corresponding author), Natl Inst Adv Sci & Technol AIST, Biomed Res Inst, Ishida Grp Clock Gene, 6-5 Cent, Tsukuba, Ibaraki, Japan.	n.ishida@aist.go.jp		DOI, RYOSUKE/0000-0002-1725-2082				Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Ando H, 2009, CLIN EXP HYPERTENS, V31, P201, DOI 10.1080/10641960902822450; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Delgado-Lista J, 2012, NUTR METAB CARDIOVAS; Doi R, 2010, J BIOL CHEM, V285, P22114, DOI 10.1074/jbc.M110.110361; Friedman AD, 2003, BLOOD CELL MOL DIS, V31, P338, DOI 10.1016/S1079-9796(03)00135-9; Gery S, 2005, BLOOD, V106, P2827, DOI 10.1182/blood-2005-01-0358; Gery S, 2009, INTEGR CANCER THER, V8, P317, DOI 10.1177/1534735409352084; Ishida N, 2007, NEUROSCI RES, V57, P483, DOI 10.1016/j.neures.2006.12.012; Kobayashi Y, 2000, GENES CELLS, V5, P725, DOI 10.1046/j.1365-2443.2000.00364.x; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; Lu Y, 2010, AM J HEMATOL, V85, P426, DOI 10.1002/ajh.21706; Mongrain V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026622; Nakahata Y, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-1; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Ohno T, 2007, NUCLEIC ACIDS RES, V35, P648, DOI 10.1093/nar/gkl868; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oishi K, 2003, J BIOL CHEM, V278, P41519, DOI 10.1074/jbc.M304564200; Oishi K, 2002, BIOCHEM BIOPH RES CO, V298, P198, DOI 10.1016/S0006-291X(02)02427-0; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pando MP, 2001, NATURE, V410, P311, DOI 10.1038/35066655; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JA, 2000, GENE DEV, V14, P679; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Westmacott A, 2006, INT J DEV BIOL, V50, P653, DOI 10.1387/ijdb.062146aw	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58221	10.1371/journal.pone.0058221	http://dx.doi.org/10.1371/journal.pone.0058221			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505471	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100036
J	Cravo, RM; Frazao, R; Perello, M; Osborne-Lawrence, S; Williams, KW; Zigman, JM; Vianna, C; Elias, CF				Cravo, Roberta M.; Frazao, Renata; Perello, Mario; Osborne-Lawrence, Sherri; Williams, Kevin W.; Zigman, Jeffery M.; Vianna, Claudia; Elias, Carol F.			Leptin Signaling in Kiss1 Neurons Arises after Pubertal Development	PLOS ONE			English	Article							PROOPIOMELANOCORTIN NEURONS; BODY-WEIGHT; ONSET; MICE; HYPOGONADISM; PEPTIDE; TARGETS	The adipocyte-derived hormone leptin is required for normal pubertal maturation in mice and humans and, therefore, leptin has been recognized as a crucial metabolic cue linking energy stores and the onset of puberty. Several lines of evidence have suggested that leptin acts via kisspeptin expressing neurons of the arcuate nucleus to exert its effects. Using conditional knockout mice, we have previously demonstrated that deletion of leptin receptors (LepR) from kisspeptin cells cause no puberty or fertility deficits. However, developmental adaptations and system redundancies may have obscured the physiologic relevance of direct leptin signaling in kisspeptin neurons. To overcome these putative effects, we re-expressed endogenous LepR selectively in kisspeptin cells of mice otherwise null for LepR, using the Cre-loxP system. Kiss1-Cre LepR null mice showed no pubertal development and no improvement of the metabolic phenotype, remaining obese, diabetic and infertile. These mice displayed decreased numbers of neurons expressing Kiss1 gene, similar to prepubertal control mice, and an unexpected lack of re-expression of functional LepR. To further assess the temporal coexpression of Kiss1 and Lepr genes, we generated mice with the human renilla green fluorescent protein (hrGFP) driven by Kiss1 regulatory elements and crossed them with mice that express Cre recombinase from the Lepr locus and the R26-tdTomato reporter gene. No coexpression of Kiss1 and LepR was observed in prepubertal mice. Our findings unequivocally demonstrate that kisspeptin neurons are not the direct target of leptin in the onset of puberty. Leptin signaling in kisspeptin neurons arises only after completion of sexual maturation.	[Cravo, Roberta M.; Frazao, Renata; Perello, Mario; Osborne-Lawrence, Sherri; Williams, Kevin W.; Zigman, Jeffery M.; Vianna, Claudia; Elias, Carol F.] Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA; [Frazao, Renata] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Perello, Mario] CONICET CICPBA, Multidisciplinary Inst Cell Biol, Neurophysiol Lab, La Plata, Buenos Aires, Argentina; [Elias, Carol F.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidade de Sao Paulo; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Michigan System; University of Michigan	Elias, CF (corresponding author), Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA.	cfelias@umich.edu	Frazao, Renata/D-1374-2012; Williams, Kevin W/ABD-5818-2021; Williams, Kevin W/AAA-4243-2020	Williams, Kevin W/0000-0002-8434-8658; Williams, Kevin W/0000-0002-8434-8658; Frazao, Renata/0000-0002-0877-8453; Elias, Carol F/0000-0001-9878-9203; Zigman, Jeffrey/0000-0003-3477-1295; Perello, Mario/0000-0003-2114-6765	National Institutes of Health [R01HD061539, R01HD69702, R01DA024680, R01MH085298, K01DK087780];  [c DK081182-01];  [UL1RR024923]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061539, R01HD069702] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK087780, PL1DK081182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (grants R01HD061539 and R01HD69702 to C. F. E.; R01DA024680 and R01MH085298 to J.M.Z.; K01DK087780 to K.W.W.), and by c DK081182-01 and UL1RR024923, for the metabolic core at UTSW Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barash IA, 1996, ENDOCRINOLOGY, V137, P3144, DOI 10.1210/en.137.7.3144; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Bentsen AH, 2010, PEPTIDES, V31, P275, DOI 10.1016/j.peptides.2009.11.017; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Bluher Susann, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P458, DOI 10.1097/MED.0b013e3282f1cfdc; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x; Colledge WH, 2009, TRENDS ENDOCRIN MET, V20, P115, DOI 10.1016/j.tem.2008.10.005; Cravo RM, 2011, NEUROSCIENCE, V173, P37, DOI 10.1016/j.neuroscience.2010.11.022; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Desroziers E, 2012, J NEUROENDOCRINOL, V24, P1154, DOI 10.1111/j.1365-2826.2012.02317.x; Donato J, 2011, J CLIN INVEST, V121, P355, DOI 10.1172/JCI45106; Elias CF, 2012, TRENDS ENDOCRIN MET, V23, P9, DOI 10.1016/j.tem.2011.09.002; Elias CF, 2000, J COMP NEUROL, V423, P261; Elias CF, 2012, CELL MOL LIFE SCI; FRISCH RE, 1985, PERSPECT BIOL MED, V28, P611; Fu LY, 2010, J NEUROSCI, V30, P10205, DOI 10.1523/JNEUROSCI.2098-10.2010; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; KENNEDY GC, 1963, J PHYSIOL-LONDON, V166, P408, DOI 10.1113/jphysiol.1963.sp007112; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Myers MG, 2004, RECENT PROG HORM RES, V59, P287, DOI 10.1210/rp.59.1.287; Navarro VM, 2004, J PHYSIOL-LONDON, V561, P379, DOI 10.1113/jphysiol.2004.072298; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; Pinilla L, 2012, PHYSIOL REV, V92, P1235, DOI 10.1152/physrev.00037.2010; Qiu JA, 2011, ENDOCRINOLOGY, V152, P1503, DOI 10.1210/en.2010-1285; Quennell JH, 2011, ENDOCRINOLOGY, V152, P1541, DOI 10.1210/en.2010-1100; Roa J, 2010, MOL CELL ENDOCRINOL, V324, P87, DOI 10.1016/j.mce.2009.12.018; Scott MM, 2009, J COMP NEUROL, V514, P518, DOI 10.1002/cne.22025; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Smith JT, 2006, J NEUROENDOCRINOL, V18, P298, DOI 10.1111/j.1365-2826.2006.01417.x; Terasawa E, 2012, ENDOCRINOLOGY, V153, P1696, DOI 10.1210/en.2011-1970; Topaloglu AK, 2012, NEW ENGL J MED, V366, P629, DOI 10.1056/NEJMoa1111184; VANDENBERGH JG, 1989, J ANIM SCI, V67, P1841; Williams KW, 2011, J NEUROSCI, V31, P13147, DOI 10.1523/JNEUROSCI.2602-11.2011; ZHANG YY, 1995, NATURE, V374, P479, DOI 10.1038/374479a0; Zhao AZ, 2002, NAT NEUROSCI, V5, P727, DOI 10.1038/nn885	40	100	103	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58698	10.1371/journal.pone.0058698	http://dx.doi.org/10.1371/journal.pone.0058698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505551	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500116
J	Farmer, JR; Altschaefl, KM; O'Shea, KS; Miller, DJ				Farmer, Jocelyn R.; Altschaefl, Kate M.; O'Shea, K. Sue; Miller, David J.			Activation of the Type I Interferon Pathway Is Enhanced in Response to Human Neuronal Differentiation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; NEURAL PROGENITOR CELLS; SINDBIS VIRUS-INFECTION; CENTRAL-NERVOUS-SYSTEM; HUMAN CYTOMEGALOVIRUS-INFECTION; EQUINE ENCEPHALITIS VIRUSES; AGE-DEPENDENT RESISTANCE; TOLL-LIKE RECEPTORS; ALPHA/BETA-INTERFERON; EXPRESSION LEVELS	Despite the crucial role of innate immunity in preventing or controlling pathogen-induced damage in most, if not all, cell types, very little is known about the activity of this essential defense system in central nervous system neurons, especially in humans. In this report we use both an established neuronal cell line model and an embryonic stem cell-based system to examine human neuronal innate immunity and responses to neurotropic alphavirus infection in cultured cells. We demonstrate that neuronal differentiation is associated with increased expression of crucial type I interferon signaling pathway components, including interferon regulatory factor-9 and an interferon receptor heterodimer subunit, which results in enhanced interferon stimulation and subsequent heightened antiviral activity and cytoprotective responses against neurotropic alphaviruses such as western equine encephalitis virus. These results identify important differentiation-dependent changes in innate immune system function that control cell-autonomous neuronal responses. Furthermore, this work demonstrates the utility of human embryonic stem cell-derived cultures as a platform to study the interactions between innate immunity, virus infection, and pathogenesis in central nervous system neurons.	[Farmer, Jocelyn R.; Miller, David J.] Univ Michigan, Sch Med, Dept Microbiol, Ann Arbor, MI 48109 USA; [Farmer, Jocelyn R.; Miller, David J.] Univ Michigan, Sch Med, Dept Immunol, Ann Arbor, MI 48109 USA; [Altschaefl, Kate M.] Univ Michigan, Sch Med, Dept Epidemiol, Ann Arbor, MI 48109 USA; [O'Shea, K. Sue] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Miller, David J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Miller, DJ (corresponding author), Univ Michigan, Sch Med, Dept Microbiol, Ann Arbor, MI 48109 USA.	milldavi@umich.edu		Farmer, Jocelyn/0000-0003-4901-9848	National Institute of Allergy and Infectious Diseases [U54 AI057153, R21 A1076975]; National Institute of General Medical Sciences [T32 GM007863, GM069985]; National Institute of Neurological Disorders and Stroke [F30 NS065566]; A. Alfred Taubman Consortium for Stem Cell Therapies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069985, T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS065566] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); A. Alfred Taubman Consortium for Stem Cell Therapies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institute of Allergy and Infectious Diseases grants U54 AI057153 (Region V "Great Lakes" Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research Career Development Award to D.J.M), R21 A1076975 (to D.J.M.), National Institute of General Medical Sciences grant T32 GM007863 (to J.R.F.) and GM069985 (to K.S.O.), National Institute of Neurological Disorders and Stroke grant F30 NS065566 (to J.R.F.), and the A. Alfred Taubman Consortium for Stem Cell Therapies. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Akwa Y, 1998, J IMMUNOL, V161, P5016; Bianchi TI, 1997, ACTA VIROL, V41, P13; Brnic D, 2012, J VIROL, V86, P2512, DOI 10.1128/JVI.05663-11; Burdeinick-Kerr R, 2005, J VIROL, V79, P5374, DOI 10.1128/JVI.79.9.5374-5385.2005; Castorena KM, 2008, VIROLOGY, V372, P208, DOI 10.1016/j.virol.2007.10.025; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; COHEN B, 1995, MOL CELL BIOL, V15, P4208; Cohen M. A., 2007, CURR PROTOC CELL BIO; Daffis S, 2008, J VIROL, V82, P10349, DOI 10.1128/JVI.00935-08; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Delhaye S, 2006, P NATL ACAD SCI USA, V103, P7835, DOI 10.1073/pnas.0602460103; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; DICKERSON RB, 1952, AM J MED, V12, P277, DOI 10.1016/0002-9343(52)90356-2; Du ZY, 2007, J CELL BIOCHEM, V102, P1087, DOI 10.1002/jcb.21535; Dukhovny A, 2012, J VIROL, V86, P3211, DOI 10.1128/JVI.06810-11; Fantuzzi L, 1997, EUR J IMMUNOL, V27, P1075, DOI 10.1002/eji.1830270506; FAZAKERLEY JK, 1993, VIROLOGY, V195, P627, DOI 10.1006/viro.1993.1414; Feuer R, 2005, J NEUROSCI, V25, P2434, DOI 10.1523/JNEUROSCI.4517-04.2005; Gaspard N, 2011, DEV MED CHILD NEUROL, V53, P13, DOI 10.1111/j.1469-8749.2010.03827.x; Gazziola C, 2005, INT J ONCOL, V26, P129; GRIFFIN DE, 1976, J INFECT DIS, V133, P456, DOI 10.1093/infdis/133.4.456; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Hardy MP, 2001, BLOOD, V97, P473, DOI 10.1182/blood.V97.2.473; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Jakel RJ, 2004, NAT REV GENET, V5, P136, DOI 10.1038/nrg1268; Kattman SJ, 2011, J CARDIOVASC TRANSL, V4, P66, DOI 10.1007/s12265-010-9235-1; Kosugi I, 2000, LAB INVEST, V80, P1373, DOI 10.1038/labinvest.3780145; Krathwohl MD, 2004, J INFECT DIS, V190, P216, DOI 10.1086/422008; Lawrence DMP, 2004, J VIROL, V78, P7319, DOI 10.1128/JVI.78.14.7319-7328.2004; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lowry PW, 1997, J LAB CLIN MED, V129, P405, DOI 10.1016/S0022-2143(97)90073-1; Luo MH, 2008, J VIROL, V82, P9994, DOI 10.1128/JVI.00943-08; Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09; LUTFALLA G, 1995, EMBO J, V14, P5100, DOI 10.1002/j.1460-2075.1995.tb00192.x; Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90; Markus A, 2011, J VIROL, V85, P6220, DOI 10.1128/JVI.02396-10; Menager P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000315; Moisse K, 2006, BBA-MOL BASIS DIS, V1762, P1083, DOI 10.1016/j.bbadis.2006.03.001; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; Odeberg J, 2006, J VIROL, V80, P8929, DOI 10.1128/JVI.00676-06; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; PATTYN SR, 1975, ARCH VIROL, V49, P33, DOI 10.1007/BF02175593; Pekosz A, 1996, J VIROL, V70, P5329, DOI 10.1128/JVI.70.8.5329-5335.1996; Peltier DC, 2010, J IMMUNOL, V184, P7010, DOI 10.4049/jimmunol.0904133; Peng WP, 2009, J INFECT DIS, V199, P950, DOI 10.1086/597275; Pestka S, 2007, J BIOL CHEM, V282, P20047, DOI 10.1074/jbc.R700004200; Porret Andree, 2006, V337, P185; Reed DS, 2005, J INFECT DIS, V192, P1173, DOI 10.1086/444397; REHBERG E, 1982, J BIOL CHEM, V257, P1497; REINARZ ABG, 1971, INFECT IMMUN, V3, P268, DOI 10.1128/IAI.3.2.268-273.1971; Ryman KD, 2000, J VIROL, V74, P3366, DOI 10.1128/JVI.74.7.3366-3378.2000; SABIN AB, 1947, JAMA-J AM MED ASSOC, V133, P281, DOI 10.1001/jama.1947.02880050001001; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Sarnat HB, 1998, BRAIN DEV-JPN, V20, P88, DOI 10.1016/S0387-7604(97)00111-3; Schoepp RJ, 2002, VIROLOGY, V302, P299, DOI 10.1006/viro.2002.1677; SHAW G, 1982, NATURE, V298, P277, DOI 10.1038/298277a0; Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508; Tsueng G, 2011, J VIROL, V85, P5718, DOI 10.1128/JVI.02261-10; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Vernon PS, 2005, J VIROL, V79, P3438, DOI 10.1128/JVI.79.6.3438-3447.2005; Wang TW, 2006, J COMP NEUROL, V497, P88, DOI 10.1002/cne.20984; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wellen J, 2009, NEUROPHARMACOLOGY, V56, P386, DOI 10.1016/j.neuropharm.2008.09.011; Wen YJ, 2011, EXPERT OPIN BIOL TH, V11, P41, DOI 10.1517/14712598.2011.540235; White LJ, 2001, J VIROL, V75, P3706, DOI 10.1128/JVI.75.8.3706-3718.2001; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhou Y, 2009, J NEUROSCI RES, V87, P2916, DOI 10.1002/jnr.22110; Zurney J, 2007, J VIROL, V81, P13668, DOI 10.1128/JVI.01172-07	73	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58813	10.1371/journal.pone.0058813	http://dx.doi.org/10.1371/journal.pone.0058813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505563	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500128
J	Nguyen, EV; Gharib, SA; Palazzo, SJ; Chow, YH; Goodlett, DR; Schnapp, LM				Nguyen, Elizabeth V.; Gharib, Sina A.; Palazzo, Steven J.; Chow, Yu-hua; Goodlett, David R.; Schnapp, Lynn M.			Proteomic Profiling of Bronchoalveolar Lavage Fluid in Critically Ill Patients with Ventilator-Associated Pneumonia	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; C-REACTIVE PROTEIN; MASS-SPECTROMETRY; ANTIMICROBIAL PROTEINS; MICROARRAY DATA; INFLAMMATION; DIAGNOSIS; RECEPTOR; FIBRONECTIN; EXPRESSION	Rationale: Ventilator-associated pneumonia (VAP) is a common complication in patients with acute lung injury (ALI) and can lead to increased morbidity and mortality. Identifying protein profiles specific to VAP in bronchoalveolar lavage fluid (BALF) may aid in earlier diagnosis, elucidate mechanisms of disease, and identify putative targets for therapeutic intervention. Methods: BALF was obtained from 5 normal subjects and 30 ALI patients: 14 with VAP (VAP(+)) and 16 without VAP (VAP(-)). Each sample underwent shotgun proteomic analysis based on tandem mass spectrometry. Differentially expressed proteins between the groups were identified using statistical methods based on spectral counting. Mechanisms of disease were explored using functional annotation and protein interaction network analysis. Supervised classification algorithms were implemented to discover a proteomic classifier for identifying critically ill patients with VAP. Results: ALI patients had distinct BALF proteomic profiles compared to normal controls. Within the ALI group, we identified 76 differentially expressed proteins between VAP(+) and VAP(-). Functional analysis of these proteins suggested activation of pro-inflammatory pathways during VAP. We identified and validated a limited proteomic signature that discriminated VAP(+) from VAP(-) patients comprised of three proteins: S100A8, lactotransferrin (LTF), and actinin 1 (ACTN1). Conclusions: Combining proteomic with computational analyses is a powerful approach to study the BALF proteome during lung injury and development of VAP. This integrative methodology is a promising strategy to differentiate clinically relevant subsets of ALI patients, including those suffering from VAP.	[Nguyen, Elizabeth V.; Goodlett, David R.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Gharib, Sina A.; Chow, Yu-hua; Schnapp, Lynn M.] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Ctr Lung Biol, Seattle, WA 98195 USA; [Palazzo, Steven J.] Seattle Univ, Coll Nursing, Seattle, WA 98122 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle University	Gharib, SA (corresponding author), Univ Washington, Dept Med, Div Pulm & Crit Care Med, Ctr Lung Biol, Seattle, WA 98195 USA.	sagharib@u.washington.edu; goodlett@u.washington.edu	Palazzo, Steven/V-4571-2019	Nguyen, Elizabeth/0000-0002-6495-7827; GHARIB, SINA A./0000-0002-2480-4367	National Institutes of Health (NIH) Institute of Translational Health Sciences award [UL1RR025014]; American Heart Association; NIH [HL083481, K24HL068796, 1U54 447 AI57141]; National Center for Research Resources [1S10RR-449017262]; Washington State Life Sciences Discovery Fund [2496490]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Institute of Translational Health Sciences award; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Washington State Life Sciences Discovery Fund; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health (NIH) UL1RR025014 Institute of Translational Health Sciences award (SAG), American Heart Association grant-in-aid (LMS), NIH HL083481 (LMS), K24HL068796 (LMS), NIH 1U54 447 AI57141 (DRG), National Center for Research Resources Grant 1S10RR-449017262 (DRG), and Grant #2496490 from the Washington State Life Sciences Discovery Fund to the Center for Intracellular Drug Delivery (LMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chen JZ, 2008, PROTEOM CLIN APPL, V2, P585, DOI 10.1002/prca.200780006; Determann RM, 2005, INTENS CARE MED, V31, P1495, DOI 10.1007/s00134-005-2818-7; El Kebir D, 2008, CIRC RES, V103, P352, DOI 10.1161/01.RES.0000326772.76822.7a; Fagon JY, 2011, CRIT CARE, V15, DOI 10.1186/cc10050; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Fu X, 2008, J PROTEOME RES, V7, P845, DOI 10.1021/pr070271+; Ghio AJ, 2003, CRIT CARE MED, V31, P395, DOI 10.1097/01.CCM.0000050284.35609.97; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Herard AL, 1996, AM J PHYSIOL-LUNG C, V271, pL726, DOI 10.1152/ajplung.1996.271.5.L726; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lu YT, 2008, PROTEOM CLIN APPL, V2, P1208, DOI 10.1002/prca.200800069; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oppert M, 2002, RESUSCITATION, V53, P167, DOI 10.1016/S0300-9572(02)00008-4; Oudhuis GJ, 2009, INTENS CARE MED, V35, P1265, DOI 10.1007/s00134-009-1463-y; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Povoa P, 2005, EUR RESPIR J, V25, P804, DOI 10.1183/09031936.05.00071704; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Rasband W.S., 1997, IMAGE J; Rea-Neto A, 2008, CRIT CARE, V12, DOI 10.1186/cc6877; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sagel SD, 2009, PEDIATR PULM, V44, P402, DOI 10.1002/ppul.21028; Scherl A, 2008, ANAL CHEM, V80, P1182, DOI 10.1021/ac701680f; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; THOMPSON AB, 1990, J LAB CLIN MED, V115, P148; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016	34	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58782	10.1371/journal.pone.0058782	http://dx.doi.org/10.1371/journal.pone.0058782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505561	Green Submitted, gold, Green Published			2022-12-27	WOS:000318334500126
J	Saussereau, EL; Roussel, D; Diallo, S; Debarbieux, L; Edelman, A; Sermet-Gaudelus, I				Saussereau, Emilie Lyne; Roussel, Delphine; Diallo, Siradiou; Debarbieux, Laurent; Edelman, Aleksander; Sermet-Gaudelus, Isabelle			Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; ION-TRANSPORT; CHLORIDE TRANSPORT; TRAFFICKING; COEFFICIENT; VALIDATION; EPITHELIUM; CHILDREN; CHANNELS	Background: Treatments designed to correct cystic fibrosis transmembrane conductance regulator (CFTR) defects must first be evaluated in preclinical experiments in the mouse model of cystic fibrosis (CF). Mice nasal mucosa mimics the bioelectric defect seen in humans. The use of nasal potential difference (V-TE) to assess ionic transport is a powerful test evaluating the restoration of CFTR function. Nasal V-TE in CF mice must be well characterized for correct interpretation. Methods: We performed V-TE measurements in large-scale studies of two mouse models of CF-B6; 129 cftr knockout and FVB F508del-CFTR-and their respective wild-type (WT) littermates. We assessed the repeatability of the test for cftr knockout mice and defined cutoff points distinguishing between WT and F508del-CFTR mice. Results: We determined the typical V-TE values for CF and WT mice and demonstrated the existence of residual CFTR activity in F508del-CFTR mice. We characterized intra-animal variability in B6;129 mice and defined the cutoff points for F508del-CFTR chloride secretion rescue. Hyperpolarization of more than -2.15 mV after perfusion with a low-concentration Cl solution was considered to indicate a normal response. Conclusions: These data will make it possible to interpret changes in nasal V-TE in mouse models of CF, in future preclinical studies.	[Saussereau, Emilie Lyne; Debarbieux, Laurent] Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France; [Saussereau, Emilie Lyne; Roussel, Delphine; Diallo, Siradiou; Edelman, Aleksander; Sermet-Gaudelus, Isabelle] Univ Paris 05, Fac Med Necker Enfants Malad, INSERM, U845, Paris, France; [Saussereau, Emilie Lyne] Univ Paris 06, Cellule Pasteur UPMC, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite	Saussereau, EL (corresponding author), Inst Pasteur, Dept Microbiol, Mol Biol Gene Extremophiles Unit, Paris, France.	sauss72@hotmail.fr		Roussel, Delphine/0000-0003-4644-7679; Debarbieux, Laurent/0000-0001-6875-5758	Vaincre la Mucoviscidose [IC0704]	Vaincre la Mucoviscidose	E. Saussereau received a PhD grant from Vaincre la Mucoviscidose (IC0704). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Amaral MD, 2004, J MOL NEUROSCI, V23, P41, DOI 10.1385/JMN:23:1-2:041; Barker PM, 2005, AM J RESP CRIT CARE, V171, P868, DOI 10.1164/rccm.200311-1508OC; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brady KG, 2001, AM J PHYSIOL-LUNG C, V281, pL1173, DOI 10.1152/ajplung.2001.281.5.L1173; Bruscia EM, 2006, P NATL ACAD SCI USA, V103, P2965, DOI 10.1073/pnas.0510758103; Cartiera MS, 2010, MOL PHARMACEUT, V7, P86, DOI 10.1021/mp900138a; Colas J, 2011, HUMAN MOL GENETICS; Egli M, 2004, J PHYSIOL-LONDON, V560, P857, DOI 10.1113/jphysiol.2004.066704; Goubau C, 2009, THORAX, V64, P683, DOI 10.1136/thx.2008.104752; Griesenbach U, 2008, AM J RESP CELL MOL, V39, P490, DOI 10.1165/rcmb.2007-0385OC; Grubb BR, 2009, AM J PHYSIOL-CELL PH, V296, pC1301, DOI 10.1152/ajpcell.00578.2008; Grubb BR, 2006, AM J RESP CELL MOL, V34, P355, DOI 10.1165/rcmb.2005-0286OC; Grubb BR, 1999, PHYSIOL REV, V79, P193; Lubamba B, 2008, AM J RESP CRIT CARE, V177, P506, DOI 10.1164/rccm.200703-344OC; Lubamba B, 2009, AM J RESP CRIT CARE, V179, P1022, DOI 10.1164/rccm.200901-0049OC; Middleton PG, 2010, PEDIATR PULM, V45, P789, DOI 10.1002/ppul.21253; Parsons DW, 2000, GENE THER, V7, P1810, DOI 10.1038/sj.gt.3301317; Ratjen F, 2003, LANCET, V361, P681, DOI 10.1016/S0140-6736(03)12567-6; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Salinas DB, 2004, AM J PHYSIOL-LUNG C, V287, pL936, DOI 10.1152/ajplung.00354.2003; Schwiebert EM, 1998, P NATL ACAD SCI USA, V95, P2674, DOI 10.1073/pnas.95.5.2674; SCHWIEBERT EM, 1994, AM J PHYSIOL, V266, pC1464, DOI 10.1152/ajpcell.1994.266.5.C1464; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Sermet-Gaudelus I, 2010, THORAX, V65, P539, DOI 10.1136/thx.2009.123422; Sorensen JB, 2002, SOCIOL METHOD RES, V30, P475, DOI 10.1177/0049124102030004001; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; Tamanini A, 2011, AM J PHYSIOL-LUNG C, V300, pL380, DOI 10.1152/ajplung.00129.2010; Taylor SL, 1999, COMMUN SOIL SCI PLAN, V30, P1439, DOI 10.1080/00103629909370298; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Zhang ZR, 2000, J MEMBRANE BIOL, V175, P35, DOI 10.1007/s002320001053	31	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57317	10.1371/journal.pone.0057317	http://dx.doi.org/10.1371/journal.pone.0057317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505426	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500018
J	Sproull, M; Avondoglio, D; Kramp, T; Shankavaram, U; Camphausen, K				Sproull, Mary; Avondoglio, Dane; Kramp, Tamalee; Shankavaram, Uma; Camphausen, Kevin			Correlation of Plasma FL Expression with Bone Marrow Irradiation Dose	PLOS ONE			English	Article							TOTAL-BODY IRRADIATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE-RADIATION-SYNDROME; LIGAND CONCENTRATION; URINE BIOSPECIMENS; HEMATOPOIESIS; MICE; TRANSPLANTATION; CHEMOTHERAPY; BIODOSIMETRY	Purpose: Ablative bone marrow irradiation is an integral part of hematopoietic stem cell transplantation. These treatment regimens are based on classically held models of radiation dose and the bone marrow response. Flt-3 ligand (FL) has been suggested as a marker of hematopoiesis and bone marrow status but the kinetics of its response to bone marrow irradiation has yet to be fully characterized. In the current study, we examine plasma FL response to total body and partial body irradiation in mice and its relationship with irradiation dose, time of collection and pattern of bone marrow exposure. Materials/Methods: C57BL6 mice received a single whole body or partial body irradiation dose of 1-8 Gy. Plasma was collected by mandibular or cardiac puncture at 24, 48 and 72 hr post-irradiation as well as 1-3 weeks post-irradiation. FL levels were determined via ELISA assay and used to generate two models: a linear regression model and a gated values model correlating plasma FL levels with radiation dose. Results: At all doses between 1-8 Gy, plasma FL levels were greater than control and the level of FL increased proportionally to the total body irradiation dose. Differences in FL levels were statistically significant at each dose and at all time points. Partial body irradiation of the trunk areas, encompassing the bulk of the hematopoietically active bone marrow, resulted in significantly increased FL levels over control but irradiation of only the head or extremities did not. FL levels were used to generate a dose prediction model for total body irradiation. In a blinded study, the model differentiated mice into dose received cohorts of 1, 4 or 8 Gy based on plasma FL levels at 24 or 72 hrs post-irradiation. Conclusion: Our findings indicate that plasma FL levels might be used as a marker of hematopoietically active bone marrow and radiation exposure in mice.	[Sproull, Mary; Avondoglio, Dane; Kramp, Tamalee; Shankavaram, Uma; Camphausen, Kevin] NCI, Radiat Oncol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Camphausen, K (corresponding author), NCI, Radiat Oncol Branch, Bldg 10, Bethesda, MD 20892 USA.	camphauk@mail.nih.gov						Adkins DR, 2008, CURR OPIN HEMATOL, V15, P555, DOI 10.1097/MOH.0b013e32831188f5; Bertho JM, 2008, RADIAT RES, V169, P543, DOI 10.1667/RR1259.1; Bertho JM, 2009, BRIT J RADIOL, V82, P764, DOI 10.1259/bjr/49063618; Bertho JM, 2009, BIOMARKERS, V14, P94, DOI 10.1080/13547500902773904; Bertho JM, 2001, INT J RADIAT BIOL, V77, P703, DOI 10.1080/09553000110043711; Bieri S, 2001, INT J RADIAT ONCOL, V49, P1071, DOI 10.1016/S0360-3016(00)01491-7; Blakely WF, 2011, RADIAT MEAS, V46, P898, DOI 10.1016/j.radmeas.2011.05.006; Blumenthal RD, 2000, CANCER, V88, P333, DOI 10.1002/(SICI)1097-0142(20000115)88:2<333::AID-CNCR13>3.0.CO;2-D; Bourland J, 2007, CLIN RAD ONCOLOGY, P111; Chklovskaia E, 1999, BLOOD, V93, P2595, DOI 10.1182/blood.V93.8.2595.408k16_2595_2604; Corvo R, 1999, INT J RADIAT ONCOL, V43, P497, DOI 10.1016/S0360-3016(98)00441-6; Dainiak N, 2007, EXP HEMATOL, V35, P17, DOI 10.1016/j.exphem.2007.01.007; Davies SM, 2000, J CLIN ONCOL, V18, P340, DOI 10.1200/JCO.2000.18.2.340; DOWN JD, 1991, BLOOD, V77, P661; Fichelson S, 1998, EUR CYTOKINE NETW, V9, P7; Fish J, 2012, LONG TERM EFFECTS BO; Fliedner TM, 2002, CANCER BIOTHER RADIO, V17, P405, DOI 10.1089/108497802760363204; Forman S, 2008, CANC MANAGEMENT MULT, P877; Gourmelon P, 2010, HEALTH PHYS, V98, P825, DOI 10.1097/HP.0b013e3181ce64d4; Gratwohl A, 1998, BLOOD, V92, P765; Harden SV, 2001, BRIT J RADIOL, V74, P1041, DOI 10.1259/bjr.74.887.741041; Hayward RM, 2008, J CELL MOL MED, V12, P343, DOI 10.1111/j.1582-4934.2007.00135.x; Huchet A, 2003, INT J RADIAT ONCOL, V57, P508, DOI 10.1016/S0360-3016(03)00584-4; Iversen PO, 2002, AM J PHYSIOL-REG I, V282, pR166, DOI 10.1152/ajpregu.2002.282.1.R166; Ivey RG, 2009, RADIAT RES, V171, P549, DOI 10.1667/RR1638.1; Iwashita T, 2003, J NEURO-ONCOL, V64, P265, DOI 10.1023/A:1025684903137; Kirk MJ, 2008, J CELL MOL MED, V12, P1250, DOI 10.1111/j.1582-4934.2008.00182.x; Koenig KL, 2005, ANN EMERG MED, V45, P643, DOI 10.1016/j.annemergmed.2005.01.020; KRICUN ME, 1985, SKELETAL RADIOL, V14, P10, DOI 10.1007/BF00361188; Kun L, 2005, PEDIAT RAD ONCOLOGY, P15; Ljungman P, 2006, BONE MARROW TRANSPL, V37, P439, DOI 10.1038/sj.bmt.1705265; LYMAN SD, 1995, ONCOGENE, V11, P1165; LYMAN SD, 1994, STEM CELLS, V12, P99; Lyman SD, 1994, STEM CELLS S1, V12, P108; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; McClanahan T, 1996, BLOOD, V88, P3371, DOI 10.1182/blood.V88.9.3371.bloodjournal8893371; Meineke V., 2005, BR J RADIOL S, P196, DOI DOI 10.1259/BJR/25654769; Partridge MA, 2010, INT J RADIAT BIOL, V86, P321, DOI 10.3109/09553000903564034; Poujol C, 1998, BLOOD, V92, P2012, DOI 10.1182/blood.V92.6.2012.418k28_2012_2023; Prat M, 2006, LEUKEMIA LYMPHOMA, V47, P77, DOI 10.1080/10428190500175122; Prat M, 2005, RADIAT RES, V163, P408, DOI 10.1667/RR3340; Prat M, 2006, RADIAT RES, V166, P504, DOI 10.1667/RR0568.1; Shank B, 2007, CLIN RAD ONCOLOGY, P343; Shaposhnikov V, 1979, B EXP BIOL MED, P510; Siegel JA, 2003, J NUCL MED, V44, P67; Snyder WS, 1975, REPORT TASK GROUP RE; Waller E, 2009, HEALTH PHYS, V97, P145, DOI 10.1097/01.HP.0000348464.78396.23; Williams W, 1995, HEMATOLOGY, P15; Wodnar-Filipowicz A, 2003, NEWS PHYSIOL SCI, V18, P247, DOI 10.1152/nips.01452.2003; WodnarFilipowicz A, 1996, BLOOD, V88, P4493, DOI 10.1182/blood.V88.12.4493.bloodjournal88124493	50	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58558	10.1371/journal.pone.0058558	http://dx.doi.org/10.1371/journal.pone.0058558			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505536	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500101
J	Fu, JJ; Ye, XH; Chen, C; Chen, SD				Fu, Jinjian; Ye, Xiaohua; Chen, Cha; Chen, Sidong			The Efficacy and Safety of Linezolid and Glycopeptides in the Treatment of Staphylococcus aureus Infections	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; GRAM-POSITIVE INFECTIONS; SKIN-STRUCTURE INFECTIONS; ANTIMICROBIAL SURVEILLANCE PROGRAM; VANCOMYCIN-RESISTANT ENTEROCOCCI; BLOOD-STREAM INFECTIONS; METHICILLIN-RESISTANT; NOSOCOMIAL PNEUMONIA; COMPLICATED SKIN; DOUBLE-BLIND	To assess the effectiveness and safety of linezolid in comparison with glycopeptides (vancomycin and teicoplanin) for the treatment of Staphylococcus aureus infections, we conducted a meta-analysis of relevant randomized controlled trials. A thorough search of Pubmed and other databases was performed. Thirteen trials on 3863 clinically assessed patients were included. Linezolid was slightly more effective than glycopeptides in the intent-to-treat population (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.01-1.10), was more effective in clinically assessed patients (OR 95% CI: 1.38, 1.17-1.64) and in all microbiologically assessed patients (OR 95% CI: 1.38, 1.15-1.65). Linezolid was associated with better treatment in skin and soft-tissue infections (SSTIs) patients (OR 95% CI: 1.61, 1.22-2.12), but not in bacteraemia (OR 95% CI: 1.24, 0.78-1.97) or pneumonia (OR 95% CI: 1.25, 0.97-1.60) patients. No difference of mortality between linezolid and glycopeptides was seen in the pooled trials (OR 95% CI: 0.98, 0.83-1.15). While linezolid was associated with more haematological (OR 95% CI: 2.23, 1.07-4.65) and gastrointestinal events (OR 95% CI: 2.34, 1.53-3.59), a significantly fewer events of skin adverse effects (OR 95% CI: 0.27, 0.16-0.46) and nephrotoxicity (OR 95% CI: 0.45, 0.28-0.72) were recorded in linezolid. Based on the analysis of the pooled data of randomized control trials, linezolid should be a better choice for treatment of patients with S. aureus infections, especially in SSTIs patients than glycopeptides. However, when physicians choose to use linezolid, risk of haematological and gastrointestinal events should be taken into account according to the characteristics of the specific patient populations.	[Fu, Jinjian; Ye, Xiaohua] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China; [Fu, Jinjian; Ye, Xiaohua; Chen, Sidong] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Fu, Jinjian] Liuzhou Municipal Matern & Child Healthcare Hosp, Dept Lab Med, Liuzhou, Guangxi, Peoples R China; [Chen, Cha] Guangzhou High Educ Mega Ctr Hosp, Branch Guangdong Prov Hosp Tradit Chinese Med, Dept Lab Med, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Guangdong Pharmaceutical University; Guangzhou University of Chinese Medicine	Chen, SD (corresponding author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China.	chensidong1@126.com			Guangdong Natural Science Foundation [S2011010002481]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This research was supported by grants from Guangdong Natural Science Foundation (No. S2011010002481). The funding organization had no role in the design and conduct of the study and the collection, analysis, and interpretation of the data.	Alaniz C, 2012, ANN PHARMACOTHER, V46, P1432, DOI 10.1345/aph.1R221; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Appelbaum PC, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01402.x; Bell JM, 2002, ANTIMICROB AGENTS CH, V46, P879, DOI 10.1128/AAC.46.3.880-882.2002; Beringer P, 2005, ANTIMICROB AGENTS CH, V49, P3676, DOI 10.1128/AAC.49.9.3676-3681.2005; Burkhardt O, 2002, J ANTIMICROB CHEMOTH, V50, P707, DOI 10.1093/jac/dkf163; Butterfield JM, 2012, J ANTIMICROB CHEMOTH, V67, P494, DOI 10.1093/jac/dkr467; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P565; Cepeda JA, 2004, J ANTIMICROB CHEMOTH, V53, P345, DOI 10.1093/jac/dkh048; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deville JG, 2003, PEDIATR INFECT DIS J, V22, pS158, DOI 10.1097/01.inf.0000086955.93702.c7; Dodds TJ, 2009, ANZ J SURG, V79, P629, DOI 10.1111/j.1445-2197.2009.05018.x; Duane TM, 2012, SURG INFECT, V13, P147, DOI 10.1089/sur.2011.062; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; European Antimicrobial Resistance Surveillance System, 2002, EARSS ANN REP 2001; Falagas ME, 2008, LANCET INFECT DIS, V8, P53, DOI 10.1016/S1473-3099(07)70312-2; Florescu I, 2008, J ANTIMICROB CHEMOTH, V62, pI17, DOI 10.1093/jac/dkn250; French G, 2001, INT J CLIN PRACT, V55, P59; Gee T, 2001, ANTIMICROB AGENTS CH, V45, P1843, DOI 10.1128/AAC.45.6.1843-1846.2001; Grudinina S. A., 2002, Antibiotiki i Khimioterapiya, V47, P12; Hague NZ, 2010, CHEST, V138, P1356, DOI 10.1378/chest.09-2453; Hendershot PE, 2001, J CLIN PHARMACOL, V41, P563, DOI 10.1177/00912700122010302; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Itani KMF, 2010, AM J SURG, V199, P804, DOI 10.1016/j.amjsurg.2009.08.045; Itani KMF, 2005, INT J ANTIMICROB AG, V26, P442, DOI 10.1016/j.ijantimicag.2005.09.003; Jaksic B, 2006, CLIN INFECT DIS, V42, P597, DOI 10.1086/500139; Jantausch BA, 2003, PEDIATR INFECT DIS J, V22, pS164, DOI 10.1097/01.inf.0000086956.45566.55; Jones ME, 2003, INT J ANTIMICROB AG, V22, P406, DOI 10.1016/S0924-8579(03)00154-7; Kalil AC, 2010, CRIT CARE MED, V38, P1802, DOI 10.1097/CCM.0b013e3181eb3b96; Kaplan SL, 2003, PEDIATR INFECT DIS J, V22, P677, DOI 10.1097/01.inf.0000078160.29072.42; Khare M, 2003, EXPERT OPIN PHARMACO, V4, P165, DOI 10.1517/14656566.4.2.165; Kiem S, 2008, ANTIMICROB AGENTS CH, V52, P24, DOI 10.1128/AAC.00133-06; Kim HB, 2003, J CLIN MICROBIOL, V41, P2279, DOI [10.1128/JCM.41.6.2279-2281.2003, 10.1128/JCM.41.6.2779-2281.2003]; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kohno S, 2007, J ANTIMICROB CHEMOTH, V60, P1361, DOI 10.1093/jac/dkm369; Kuti JL, 2008, CLIN MICROBIOL INFEC, V14, P116, DOI 10.1111/j.1469-0691.2007.01885.x; Li Jim Zhiming, 2003, Surg Infect (Larchmt), V4, P57, DOI 10.1089/109629603764655290; Li JZM, 2002, PHARMACOTHERAPY, V22, p45S, DOI 10.1592/phco.22.4.45S.33654; Li ZM, 2001, PHARMACOTHERAPY, V21, P263, DOI 10.1592/phco.21.3.263.34198; Liang BB, 2010, INT J ANTIMICROB AG, V35, P3, DOI 10.1016/j.ijantimicag.2009.09.013; Lin DF, 2008, INT J ANTIMICROB AG, V32, P241, DOI 10.1016/j.ijantimicag.2008.04.004; Lipsky BA, 2011, INT J INFECT DIS, V15, pE140, DOI 10.1016/j.ijid.2010.10.003; Lodise TP, 2008, ANTIMICROB AGENTS CH, V52, P3315, DOI 10.1128/AAC.00113-08; Lodise TP, 2007, PHARMACOTHERAPY, V27, P1001, DOI 10.1592/phco.27.7.1001; MANTEL N, 1959, J NATL CANCER I, V22, P719; McKinnon PS, 2006, ANN PHARMACOTHER, V40, P1017, DOI 10.1345/aph.1G728; Mendes RE, 2012, J CLIN MICROBIOL, V50, P3694, DOI 10.1128/JCM.02024-12; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Patanwala AE, 2007, CURR MED RES OPIN, V23, P185, DOI 10.1185/030079906X162700; Rubinstein E, 2001, CLIN INFECT DIS, V32, P402, DOI 10.1086/318486; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; San Pedro GS, 2002, SCAND J INFECT DIS, V34, P720, DOI 10.1080/0036554021000026933; Sharpe JN, 2005, AM J SURG, V189, P425, DOI 10.1016/j.amjsurg.2005.01.011; Sisson TL, 1999, J CLIN PHARMACOL, V39, P1277, DOI 10.1177/00912709922011962; Slatter JG, 2001, DRUG METAB DISPOS, V29, P1136; Sofroniadou S, 2012, SEMIN DIALYSIS, V25, P344, DOI 10.1111/j.1525-139X.2011.00965.x; Stalker DJ, 2003, J ANTIMICROB CHEMOTH, V51, P1239, DOI 10.1093/jac/dkg180; Stevens DL, 2006, CLIN INFECT DIS, V42, pS51, DOI 10.1086/491714; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Stevens DL, 2002, CLIN INFECT DIS, V34, P1481, DOI 10.1086/340353; Swaney SM, 1998, ANTIMICROB AGENTS CH, V42, P3251, DOI 10.1128/AAC.42.12.3251; Vardakas KZ, 2009, EUR RESPIR J, V34, P1148, DOI 10.1183/09031936.00041009; Vardakas KZ, 2012, MAYO CLIN PROC, V87, P349, DOI 10.1016/j.mayocp.2011.12.011; Walkey AJ, 2011, CHEST, V139, P1148, DOI 10.1378/chest.10-1556; Wang F, 2001, J Infect Chemother, V7, P117, DOI 10.1007/s101560100019; Warren DK, 2004, INFECT CONT HOSP EP, V25, P99, DOI 10.1086/502357; Weigelt J, 2004, AM J SURG, V188, P760, DOI 10.1016/j.amjsurg.2004.08.045; Weigelt J, 2005, ANTIMICROB AGENTS CH, V49, P2260, DOI 10.1128/AAC.49.6.2260-2266.2005; Welshman IR, 2001, BIOPHARM DRUG DISPOS, V22, P91, DOI 10.1002/bdd.255; Whitehouse T, 2005, J ANTIMICROB CHEMOTH, V55, P333, DOI 10.1093/jac/dki014; Wilcox M, 2004, J ANTIMICROB CHEMOTH, V53, P335, DOI 10.1093/jac/dkh088; Wilcox MH, 2009, CLIN INFECT DIS, V48, P203, DOI 10.1086/595686; Willke RJ, 2002, INT J TECHNOL ASSESS, V18, P540; Wunderink RG, 2003, CHEST, V124, P1789, DOI 10.1378/chest.124.5.1789; Wunderink RG, 2003, CLIN THER, V25, P980, DOI 10.1016/S0149-2918(03)80118-2; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895; Wunderink RG, 2008, CHEST, V134, P1200, DOI 10.1378/chest.08-0011; Yogev R, 2003, PEDIATR INFECT DIS J, V22, pS172, DOI 10.1097/01.inf.0000088671.35064.7c; Zurenko Gary E., 2001, Current Opinion in Pharmacology, V1, P470, DOI 10.1016/S1471-4892(01)00082-0	82	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58240	10.1371/journal.pone.0058240	http://dx.doi.org/10.1371/journal.pone.0058240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484002	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100093
J	Jablonsky, J; Hagemann, M; Schwarz, D; Wolkenhauer, O				Jablonsky, Jiri; Hagemann, Martin; Schwarz, Doreen; Wolkenhauer, Olaf			Phosphoglycerate Mutases Function as Reverse Regulated Isoenzymes in Synechococcus elongatus PCC 7942	PLOS ONE			English	Article							SYNECHOCYSTIS SP PCC-6803; CARBON ACCLIMATION; METABOLISM; MUTANTS; SERINE	Phosphoglycerate-mutase (PGM) is an ubiquitous glycolytic enzyme, which in eukaryotic cells can be found in different compartments. In prokaryotic cells, several PGMs are annotated/localized in one compartment. The identification and functional characterization of PGMs in prokaryotes is therefore important for better understanding of metabolic regulation. Here we introduce a method, based on a multi-level kinetic model of the primary carbon metabolism in cyanobacterium Synechococcus elongatus PCC 7942, that allows the identification of a specific function for a particular PGM. The strategy employs multiple parameter estimation runs in high CO2, combined with simulations testing a broad range of kinetic parameters against the changes in transcript levels of annotated PGMs. Simulations are evaluated for a match in metabolic level in low CO2, to reveal trends that can be linked to the function of a particular PGM. A one-isoenzyme scenario shows that PGM2 is a major regulator of glycolysis, while PGM1 and PGM4 make the system robust against environmental changes. Strikingly, combining two PGMs with reverse transcriptional regulation allows both features. A conclusion arising from our analysis is that a two-enzyme PGM system is required to regulate the flux between glycolysis and the Calvin-Benson cycle, while an additional PGM increases the robustness of the system.	[Jablonsky, Jiri; Wolkenhauer, Olaf] Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany; [Hagemann, Martin; Schwarz, Doreen] Univ Rostock, Dept Plant Physiol, D-18055 Rostock, Germany	University of Rostock; University of Rostock	Jablonsky, J (corresponding author), Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany.	jiri.jablonsky@gmail.com	Jablonsky, Jiri/F-7958-2015	Wolkenhauer, Olaf/0000-0001-6105-2937; Schwarz, Doreen/0000-0002-1071-5865	German Research Foundation (DFG) as part of PROMICS research group 1186	German Research Foundation (DFG) as part of PROMICS research group 1186(German Research Foundation (DFG))	The work presented here has been supported by the German Research Foundation (DFG) as part of PROMICS research group 1186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi S, 2012, BIOINFORMATICS, V28, P3203, DOI 10.1093/bioinformatics/bts608; BORKENHAGEN LF, 1959, J BIOL CHEM, V234, P849; CARRERAS J, 1982, COMP BIOCHEM PHYS B, V71, P591, DOI 10.1016/0305-0491(82)90467-9; Chiba Y, 2012, J BIOL CHEM, V287, P11934, DOI 10.1074/jbc.M111.330621; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; Foster JM, 2010, PLOS ONE, V5; Fraser HI, 1999, FEBS LETT, V455, P344, DOI 10.1016/S0014-5793(99)00910-2; Hackenberg C, 2012, MICROBIOL-SGM, V158, P398, DOI 10.1099/mic.0.054544-0; Heinrich R., 1996, REGULATION CELLULAR; Huege J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016278; Jablonsky J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-185; KALLAS T, 1982, J BACTERIOL, V149, P229, DOI 10.1128/JB.149.1.229-236.1982; Knoop H, 2010, PLANT PHYSIOL, V154, P410, DOI 10.1104/pp.110.157198; PONCEDELEON MM, 1972, J BACTERIOL, V110, P895, DOI 10.1128/JB.110.3.895-904.1972; Schwarz D, 2011, PLANT PHYSIOL, V155, P1640, DOI 10.1104/pp.110.170225; Steuer R, 2012, J EXP BOT, V63, P2259, DOI 10.1093/jxb/ers018; Tabei Y, 2007, BIOCHEM BIOPH RES CO, V355, P1045, DOI 10.1016/j.bbrc.2007.02.065; Takahashi H, 2008, J EXP BOT, V59, P3009, DOI 10.1093/jxb/ern157; Young JD, 2011, METAB ENG, V13, P656, DOI 10.1016/j.ymben.2011.08.002; Zaretsky Joseph Z, 2008, Transl Oncogenomics, V3, P99; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986; Zhu XG, 2007, PLANT PHYSIOL, V145, P513, DOI 10.1104/pp.107.103713	22	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58281	10.1371/journal.pone.0058281	http://dx.doi.org/10.1371/journal.pone.0058281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484009	Green Published, gold			2022-12-27	WOS:000316936100099
J	Jiang, Y; Tang, JJ; Wu, BQ; Yuan, B; Qu, Z				Jiang, Yong; Tang, Jian Jun; Wu, Bao Qiang; Yuan, Bo; Qu, Zhen			The Protective Effects of Different-Time-Ischemic Preconditioning on the Reperfusion Injury in Fatty Livers in Rats	PLOS ONE			English	Article								Background: The present study was aimed to investigate the protective effects of different-time-ischemic preconditioning on the reperfusion injury in fatty livers in rats, and to elucidate the mechanisms underlying the protective effects and the optimal safe ischemic preconditioning time on the hepatic IR injury in steatotic livers. Methodology/Principal Findings: A rat fatty liver model was established by high-fat diet feeding. We investigated the changes in the concentration of AST, ALT, LDH and NO in the serum, and of MDA, SOD, and MPO in the liver samples in response to different ischemic preconditioning times and ischemia-reperfusion injury. Histological analysis was performed to evaluate the results of the hepatic fatty infiltration. 1) At 24 h after 15 min ischemic preconditioning with 10 min reperfusion (15 min +10 min IP), the extent and area of the necrosis was markedly higher in the fatty liver samples with respect to IR, compared to the normal liver samples. 2) In response to the treatment of 5/8 min + 10 min IP, the fatty liver group showed lower levels of serological indicators and liver MDA and MPO compared to the other groups, while the SOD activity of the fatty liver group was significantly higher than the other groups (p<.05). Compared to the corresponding IR group, all IP groups showed a significantly higher serum NO concentration (p<.05). Among the fatty liver groups, the 5/8 min+10 min IP group showed the highest NO concentration (p<.05). Conclusions/Significance: Fat infiltration could aggravate the ischemia-reperfusion injury in the rat liver. Furthermore, ischemic preconditioning could increase the tolerance of the fatty liver, which was induced by the high-fat diet, to hepatic ischemia-reperfusion injury in rats. The protocol of 5/8 min +10 min IP was the optimal regimen for the treatment of moderate and severe fatty livers.	[Jiang, Yong; Wu, Bao Qiang; Yuan, Bo; Qu, Zhen] 1st Peoples Hosp Changzhou, Dept Hepatobiliary Surg, Changzhou, Jiangsu, Peoples R China; [Tang, Jian Jun] Peoples Hosp Wujin, Dept Hepatobiliary Surg, Changzhou, Jiangsu, Peoples R China		Jiang, Y (corresponding author), 1st Peoples Hosp Changzhou, Dept Hepatobiliary Surg, Changzhou, Jiangsu, Peoples R China.	yjiang8888@hotmail.com			General Project of Jiangsu Province Department of Health [H200870]; Bidding Project of Changzhou Bureau of Health [ZD200811]; Social Development Project of Changzhou [CS2008912]	General Project of Jiangsu Province Department of Health; Bidding Project of Changzhou Bureau of Health; Social Development Project of Changzhou	The General Project of Jiangsu Province Department of Health (H200870), the Bidding Project of Changzhou Bureau of Health (ZD200811), the Social Development Project of Changzhou (CS2008912). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Federico A, 2006, DIGEST LIVER DIS, V38, P789, DOI 10.1016/j.dld.2006.04.009; Iniguez Maria, 2008, Recent Pat Cardiovasc Drug Discov, V3, P9; Lehmann TG, 2003, TRANSPLANTATION, V76, P28, DOI 10.1097/01.TP.0000065299.29900.17; Nakano H, 1997, HEPATOLOGY, V26, P670, DOI 10.1002/hep.510260320; Rensen SS, 2009, AM J PATHOL, V175, P1473, DOI 10.2353/ajpath.2009.080999; Camara-Lemarroy CR, 2009, EUR J PHARMACOL, V621, P78, DOI 10.1016/j.ejphar.2009.08.038; Romanque P, 2010, TRANSPL P, V42, P1569, DOI 10.1016/j.transproceed.2009.11.052; Rutherford A, 2006, CLIN GASTROENTEROL H, V4, P1544, DOI 10.1016/j.cgh.2006.07.014	8	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58086	10.1371/journal.pone.0058086	http://dx.doi.org/10.1371/journal.pone.0058086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483973	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100074
J	Shimizu, C; Kim, J; Stepanowsky, P; Trinh, C; Lau, HD; Akers, JC; Chen, C; Kanegaye, JT; Tremoulet, A; Ohno-Machado, L; Burns, JC				Shimizu, Chisato; Kim, Jihoon; Stepanowsky, Petra; Trinh, Christine; Lau, Hubert D.; Akers, Johnny C.; Chen, Clark; Kanegaye, John T.; Tremoulet, Adriana; Ohno-Machado, Lucila; Burns, Jane C.			Differential Expression of miR-145 in Children with Kawasaki Disease	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CONVERTING-ENZYME GENE; GENOME-WIDE ASSOCIATION; CIRCULATING MICRORNAS; INSERTION/DELETION POLYMORPHISM; CARDIOVASCULAR-DISEASE; VASCULAR HOMEOSTASIS; SUSCEPTIBILITY; ACTIVATION; POPULATION	Background: Kawasaki disease is an acute, self-limited vasculitis of childhood that can result in structural damage to the coronary arteries. Previous studies have implicated the TGF-beta pathway in disease pathogenesis and generation of myofibroblasts in the arterial wall. microRNAs are small non-coding RNAs that modulate gene expression at the post-transcriptional level and can be transported between cells in extracellular vesicles. To understand the role that microRNAs play in modifying gene expression in Kawasaki disease, we studied microRNAs from whole blood during the acute and convalescent stages of the illness. Methodology/Principal Findings: RNA isolated from the matched whole blood of 12 patients with acute and convalescent Kawasaki disease were analyzed by sequencing of small RNA. This analysis revealed six microRNAs (miRs-143, -199b-5p, -618, -223, -145 and -145* (complementary strand)) whose levels were significantly elevated during the acute phase of Kawasaki disease. The result was validated using targeted qRT-PCR using an independent cohort (n = 16). miR-145, which plays a critical role in the differentiation of neutrophils and vascular smooth muscle cells, was expressed at high levels in blood samples from acute Kawasaki disease but not adenovirus-infected control patients (p = 0.005). miR-145 was also detected in small extracellular vesicles isolated from acute Kawasaki disease plasma samples. Pathway analysis of the predicted targets of the 6 differentially expressed microRNAs identified the TGF-beta pathway as the top pathway regulated by microRNAs in Kawasaki disease. Conclusion: Sequencing of small RNA species allowed discovery of microRNAs that may participate in Kawasaki disease pathogenesis. miR-145 may participate, along with other differentially expressed microRNAs, in regulating expression of genes in the TGF-beta pathway during the acute illness. If the predicted target genes are confirmed, our findings suggest a model of Kawasaki disease pathogenesis whereby miR-145 modulates TGF-beta signaling in the arterial wall.	[Shimizu, Chisato; Trinh, Christine; Lau, Hubert D.; Kanegaye, John T.; Tremoulet, Adriana; Burns, Jane C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Kim, Jihoon; Stepanowsky, Petra; Ohno-Machado, Lucila] Univ Calif San Diego, Dept Med, Div Biomed Informat, La Jolla, CA 92093 USA; [Akers, Johnny C.; Chen, Clark] Univ Calif San Diego, Dept Neurosurg, La Jolla, CA 92093 USA; [Kanegaye, John T.; Tremoulet, Adriana; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Shimizu, C (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	c1shimizu@ucsd.edu	Shimizu, Chisato/J-6516-2015; Burns, Jane C/J-6167-2015; Chen, Clark C/C-8714-2013	Chen, Clark C/0000-0001-6258-9277; Ohno-Machado, Lucila/0000-0002-8005-7327; Shimizu, Chisato/0000-0002-3149-2699	 [NIH U54 HL108460];  [NIH NHLBI 69413]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL108460, T35HL007491] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH U54 HL108460, NIH NHLBI 69413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allantaz F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029979; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Batliner J, 2012, LEUKEMIA RES, V36, P237, DOI 10.1016/j.leukres.2011.10.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fukazawa R, 2004, PEDIATR RES, V56, P597, DOI 10.1203/01.PDR.0000139426.16381.C8; Gatsiou A, 2012, CURR VASC PHARMACOL, V10, P524, DOI 10.2174/157016112801784611; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kin T, 2007, NUCLEIC ACIDS RES, V35, pD145, DOI 10.1093/nar/gkl837; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Lindsay ME, 2011, NATURE, V473, P308, DOI 10.1038/nature10145; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Lu LF, 2009, IMMUNOLOGY, V127, P291, DOI 10.1111/j.1365-2567.2009.03092.x; Martins PAD, 2010, NAT CELL BIOL, V12, P1220, DOI 10.1038/ncb2126; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Orenstein JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038998; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Reczko M, 2012, BIOINFORMATICS, V28, P771, DOI 10.1093/bioinformatics/bts043; Rowley AH, 2011, ANNU REV MED, V62, P69, DOI 10.1146/annurev-med-042409-151944; Shim YH, 2006, J KOREAN MED SCI, V21, P208, DOI 10.3346/jkms.2006.21.2.208; Shimizu C, 2012, HUM PATHOL; Shimizu C, 2011, CIRC-CARDIOVASC GENE, V4, P16, DOI 10.1161/CIRCGENETICS.110.940858; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; SUZUKI A, 1986, PEDIATR CARDIOL, V7, P3, DOI 10.1007/BF02315475; Takahashi K, 2005, PEDIATR INT, V47, P305, DOI 10.1111/j.1442-200x.2005.02049.x; Takeuchi K, 1997, EUR J PEDIATR, V156, P266, DOI 10.1007/s004310050597; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tremoulet AH, 2011, PEDIATR INFECT DIS J, V30, P1022, DOI 10.1097/INF.0b013e31822d4f56; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wu SF, 2004, PEDIATR CARDIOL, V25, P529, DOI 10.1007/s00246-003-0662-5; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; YONESAKA S, 1989, Acta Paediatrica Japonica, V31, P706; Zhang M, 2012, EUR J CANCER CARE, V21, P274, DOI 10.1111/j.1365-2354.2011.01308.x; Zhu HL, 2012, J CLIN IMMUNOL, V32, P514, DOI 10.1007/s10875-011-9647-y	55	51	54	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58159	10.1371/journal.pone.0058159	http://dx.doi.org/10.1371/journal.pone.0058159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483985	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100081
J	van Meegen, MA; Terheggen-Lagro, SWJ; Koymans, KJ; van der Ent, CK; Beekman, JM				van Meegen, Marit Arianne; Terheggen-Lagro, Suzanne Willemina Julia; Koymans, Kirsten Judith; van der Ent, Cornelis Korstiaan; Beekman, Jeffrey Matthijn			Apical CFTR Expression in Human Nasal Epithelium Correlates with Lung Disease in Cystic Fibrosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-KINASE-A; PSEUDOMONAS-AERUGINOSA; RESPIRATORY EPITHELIA; POTENTIAL DIFFERENCE; DELTA-F508 MUTATION; AIRWAY CELLS; WILD-TYPE; PHENOTYPE; SEVERITY	Introduction: Although most individuals with cystic fibrosis (CF) develop progressive obstructive lung disease, disease severity is highly variable, even for individuals with similar CFTR mutations. Measurements of chloride transport as expression of CFTR function in nasal epithelial cells correlate with pulmonary function and suggest that F508del-CFTR is expressed at the apical membrane. However, an association between quantitative apical CFTR expression in nasal epithelium and CF disease severity is still missing. Methods and Materials: Nasal epithelial cells from healthy individuals and individuals with CF between 12-18 years were obtained by nasal brushing. Apical CFTR expression was measured by confocal microscopy using CFTR mAb 596. Expression was compared between both groups and expression in CF nasal epithelial cells was associated with standardized pulmonary function (FEV1%). Results: The proportion of cells expressing apical CFTR in columnar epithelium is lower in CF compared to non-CF. The apical CFTR expression level was significantly correlated with FEV1% in F508del homozygous subjects (r = 0.63, p = 0.012). Conclusion: CFTR expression in nasal epithelial cells is lower in subjects with CF compared to healthy subjects. The proportion of cells expressing F508del-CFTR at the apical membrane is variable between subjects and is positively correlated with FEV1% in F508del-CFTR homozygous subjects.	[van Meegen, Marit Arianne; Terheggen-Lagro, Suzanne Willemina Julia; Koymans, Kirsten Judith; van der Ent, Cornelis Korstiaan; Beekman, Jeffrey Matthijn] Univ Med Ctr Utrecht, Dept Pediat Pulmonol, Utrecht, Netherlands; [van Meegen, Marit Arianne; Koymans, Kirsten Judith; Beekman, Jeffrey Matthijn] Univ Med Ctr Utrecht, Ctr Mol & Cellular Intervent, Utrecht, Netherlands; [van Meegen, Marit Arianne; Koymans, Kirsten Judith; Beekman, Jeffrey Matthijn] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Beekman, JM (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Pulmonol, Utrecht, Netherlands.	J.Beekman@umcutrecht.nl	Beekman, Jeffrey M/I-7781-2014	Beekman, Jeffrey M/0000-0003-4886-3756; Van der Ent, Cornelis/0000-0002-2501-4121	Grunenthal; Glaxo Smith Kline; Wilhelmina Children's Hospital (WKZ) Foundation, The Netherlands	Grunenthal(HAL Allergy Group); Glaxo Smith Kline(GlaxoSmithKline); Wilhelmina Children's Hospital (WKZ) Foundation, The Netherlands	C.K. van der Ent has received unrestricted research grants from Grunenthal and Glaxo Smith Kline. This work was supported by the Wilhelmina Children's Hospital (WKZ) Foundation, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; BERRYMAN M, 1993, J CELL SCI, V105, P1025; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borthwick LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023226; BREZILLON S, 1995, LAB INVEST, V72, P191; Bronsveld I, 2001, J CLIN INVEST, V108, P1705; Carvalho-Oliveira I, 2004, J HISTOCHEM CYTOCHEM, V52, P193, DOI 10.1177/002215540405200207; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; DUPUIT F, 1995, J CLIN INVEST, V96, P1601, DOI 10.1172/JCI118199; Fanellli T, 2008, BIOL CELL, V100, P399, DOI 10.1042/BC20070095; Flume PA, 2012, CHEST; Hegedus T, 2009, BBA-BIOMEMBRANES, V1788, P1341, DOI 10.1016/j.bbamem.2009.03.015; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; Koopman M, 2011, RESP MED, V105, P15, DOI 10.1016/j.rmed.2010.07.020; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Kunzelmann K, 1999, J MEMBRANE BIOL, V168, P1, DOI 10.1007/s002329900492; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Li CY, 2010, INTEGR BIOL-UK, V2, P161, DOI [10.1039/B924455G, 10.1039/b924455g]; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastro.2003.10.049; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Penque D, 2000, LAB INVEST, V80, P857, DOI 10.1038/labinvest.3780090; Quanjer PH, 2012, EUR RESP J; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schroeder TH, 2002, P NATL ACAD SCI USA, V99, P6907, DOI 10.1073/pnas.092160899; Schwiebert Erik M., 1999, Physiological Reviews, V79, pS145; Sermet-Gaudelus I, 2002, PEDIATR RES, V52, P628, DOI 10.1203/01.PDR.0000032981.64413.AD; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sun F, 2000, J BIOL CHEM, V275, P14360, DOI 10.1074/jbc.275.19.14360; Sweezey NB, 2007, PEDIATR PULM, V42, P519, DOI 10.1002/ppul.20624; Taouil K, 2003, J BIOL CHEM, V278, P17320, DOI 10.1074/jbc.M212227200; Thomas SR, 1999, LANCET, V353, P984, DOI 10.1016/S0140-6736(98)05447-6; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; van Meegen MA, 2013, J CYST FIBR IN PRESS; van Meegen MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027658; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	42	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57617	10.1371/journal.pone.0057617	http://dx.doi.org/10.1371/journal.pone.0057617			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483918	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100034
J	Alkerwi, A; Pagny, S; Lair, ML; Delagardelle, C; Beissel, J				Alkerwi, Ala'a; Pagny, Sybil; Lair, Marie-Lise; Delagardelle, Charles; Beissel, Jean			Level of Unawareness and Management of Diabetes, Hypertension, and Dyslipidemia among Adults in Luxembourg: Findings from ORISCAV-LUX Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; GENERAL-POPULATION; TASK-FORCE; PREVALENCE; AWARENESS; GUIDELINES	Background: In the absence of evidence-based information, assessment of population awareness and management of diabetes, hypertension and dyslipidemia (treatable and preventable cardiovascular risk factors) are important to halt coronary and cerebrovascular diseases and to improve public health. Methods: The analysis was based on a nationally representative sample of 1432 adult subjects, recruited for the ORISCAV-LUX survey (2007-2008). Descriptive and multivariable logistic regression analyses were performed. The 10-year Framingham risk score was calculated for each participant who classified at low, intermediate and high risk. Results: Among the diagnosed cases, 32%, 60%, and 85% were respectively unaware of their diabetes, hypertension and dyslipidemia. Increasing age and BMI were the strongest protective factors against unawareness of hypertension and dyslipidemia. Having a family history decreased the risk of unawareness of hypertension (OR = 0.57; 95% CI 0.36, 0.92; P = 0.021), whereas, not having a family doctor increased double-fold the odd of being unaware of hypertension (P = 0.048). Poor health perception reduced significantly the risk of unawareness of dyslipidemia (OR = 0.27; 95% CI 0.11, 0.68). Concerning the management, diabetes was markedly better treated than hypertension and dyslipidemia. Among diabetic subjects (constituting 4% of the population), 3% were treated vs. 1% not treated. In contrast, 22% of the hypertensive participants (35% of the population) were not treated vs. 13% treated. Concerning dyslipidemia, only 9% of those with lipid disorder (70% of the population) were under medication vs. 61% not treated. For the treated cases of these pathologies, almost only one-third was under control. Framingham risk of developing CHD within 10 years was moderate to high among 62%, 27%, and 17% of the unaware/untreated diabetic, hypertensive, and dyslipidemic participants, respectively. Conclusion: The considerable lack of awareness and insufficient management underscore the urgent need for intensive efforts to reduce the gap in prevention strategies, and control of cases according to explicit clinical guidelines.	[Alkerwi, Ala'a; Pagny, Sybil; Lair, Marie-Lise] Ctr Rech Publ Sante CRP Sante, Dept Publ Hlth, Strassen, Grand Duchy Of, Luxembourg; [Delagardelle, Charles; Beissel, Jean] Ctr Hosp Luxembourg, Serv Cardiol, Luxembourg, Grand Duchy Of, Luxembourg	Luxembourg Institute of Health; Luxembourg Hospital Center	Alkerwi, A (corresponding author), Ctr Rech Publ Sante CRP Sante, Dept Publ Hlth, Strassen, Grand Duchy Of, Luxembourg.	alaa.alkerwi@crp-sante.lu	Alkerwi, Ala'a/M-3435-2014	Alkerwi, Ala'a/0000-0002-7448-3936	National Fund of Research (Fond National de Recherche; project MSF) [784844]; Ministry of Health and Ministry of Research	National Fund of Research (Fond National de Recherche; project MSF); Ministry of Health and Ministry of Research	The present study was supported by a research grant from the National Fund of Research (Fond National de Recherche; project MSF, 784844, BM). The authors acknowledge the financial support of the Ministry of Health and Ministry of Research for the financial support of the ORISCAV-LUX study. The funders had no role in data analysis, decision to publish, or preparation of the manuscript.	Alkerwi A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-80; Alkerwi A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-468; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], 2009, BMC GERIATR, V9, P16, DOI DOI 10.1186/1471-2318-9-16; Braun M, 2012, EUR J PREV CARDIOL; Cai L, 2012, J ATHEROSCLER THROMB, V19, P159, DOI 10.5551/jat.10116; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Costanzo S, 2008, J HYPERTENS, V26, P2303, DOI 10.1097/HJH.0b013e328311ce04; Danon-Hersch N, 2009, EUR J CARDIOV PREV R, V16, P66, DOI 10.1097/HJR.0b013e32831e9511; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; El Assaad MA, 2002, BLOOD PRESS MONIT, V7, P237, DOI 10.1097/00126097-200208000-00006; Goff DC, 2006, CIRCULATION, V113, P647, DOI 10.1161/CIRCULATIONAHA.105.552737; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Macedo ME, 2005, J HYPERTENS, V23, P1661, DOI 10.1097/01.hjh.0000179908.51187.de; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; McDonald M, 2009, J GERONTOL A-BIOL, V64, P256, DOI 10.1093/gerona/gln016; Ministry of Health, 2010, NAT STAT ALL CAUS DE; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Psaltopoulou T, 2004, INT J EPIDEMIOL, V33, P1345, DOI 10.1093/ije/dyh249; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; Thoenes M, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/925046; Verberk WJ, 2006, J HYPERTENS, V24, P1541, DOI 10.1097/01.hjh.0000239289.87141.b6; Volpe M, 2007, J HYPERTENS, V25, P1491, DOI 10.1097/HJH.0b013e3280fa83a6; Wang SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017326; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10	26	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57920	10.1371/journal.pone.0057920	http://dx.doi.org/10.1371/journal.pone.0057920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483942	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900054
J	Bolton, CC; Gatica, G; Parada, V				Contreras Bolton, Carlos; Gatica, Gustavo; Parada, Victor			Automatically Generated Algorithms for the Vertex Coloring Problem	PLOS ONE			English	Article							GENETIC ALGORITHMS; SEARCH HEURISTICS; GRAPH; OPTIMIZATION	The vertex coloring problem is a classical problem in combinatorial optimization that consists of assigning a color to each vertex of a graph such that no adjacent vertices share the same color, minimizing the number of colors used. Despite the various practical applications that exist for this problem, its NP-hardness still represents a computational challenge. Some of the best computational results obtained for this problem are consequences of hybridizing the various known heuristics. Automatically revising the space constituted by combining these techniques to find the most adequate combination has received less attention. In this paper, we propose exploring the heuristics space for the vertex coloring problem using evolutionary algorithms. We automatically generate three new algorithms by combining elementary heuristics. To evaluate the new algorithms, a computational experiment was performed that allowed comparing them numerically with existing heuristics. The obtained algorithms present an average 29.97% relative error, while four other heuristics selected from the literature present a 59.73% error, considering 29 of the more difficult instances in the DIMACS benchmark.	[Contreras Bolton, Carlos; Parada, Victor] Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile; [Gatica, Gustavo] Univ Andres Bello, Escuela Informat, Santiago, Chile	Universidad de Santiago de Chile; Universidad Andres Bello	Parada, V (corresponding author), Univ Santiago Chile, Dept Ingn Informat, Santiago, Chile.	victor.parada@usach.cl	Contreras-Bolton, Carlos/D-9624-2016; Parada, Victor/AHD-6455-2022; Parada, Victor/M-5840-2014	Contreras-Bolton, Carlos/0000-0001-9549-4143; Parada, Victor/0000-0002-8649-5694; Gustavo, Gatica/0000-0002-1816-6856	Complex Engineering Systems Institute [ICM: P-05-004-F, CONICYT: FBO16]; DICYT-USACH	Complex Engineering Systems Institute; DICYT-USACH	Funding was provided by the Complex Engineering Systems Institute (ICM: P-05-004-F, CONICYT: FBO16) and DICYT-USACH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affenzeller M, 2009, NUMER INSIGHT, P1, DOI 10.1201/9781420011326; Al-Omari H, 2006, J MATH STAT, V2, P739; [Anonymous], 1998, GENETIC ALGORITHMS G; [Anonymous], 2001, BOOST GRAPH LIB USER; [Anonymous], 1983, DATA STRUCTURES ALGO; Bain S, 2005, LECT NOTES COMPUT SC, V3709, P732, DOI 10.1007/11564751_54; BRELAZ D, 1979, COMMUN ACM, V22, P251, DOI 10.1145/359094.359101; Burke E, 2010, J SCHED, V13, P1, DOI 10.1007/s10951-010-0161-5; Burke EK, 2007, EUR J OPER RES, V176, P177, DOI 10.1016/j.ejor.2005.08.012; Burke EK, 2010, IEEE T EVOLUT COMPUT, V14, P942, DOI 10.1109/TEVC.2010.2041061; Culberson J.C., 1996, DIMACS SERIES DISCRE, P245; Epstein S.L., 2002, LNCS, V2470, P525; Fukunaga A, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P641; Fukunaga AS, 2008, EVOL COMPUT, V16, P31, DOI 10.1162/evco.2008.16.1.31; Garey M.R., 1979, COMPUTERS INTRACTABI; GEORGE A, 1989, SIAM REV, V31, P1, DOI 10.1137/1031001; GREFENSTETTE JJ, 1986, IEEE T SYST MAN CYB, V16, P122, DOI 10.1109/TSMC.1986.289288; HERTZ A, 1987, COMPUTING, V39, P345, DOI 10.1007/BF02239976; Johnson DS, 1996, DIMACS SERIES DISCRE, V26, P1; Koza J.R., 2003, GENETIC PROGRAMMING; Koza JR, 1992, GENETIC PROGRAMMING; LEIGHTON FT, 1979, J RES NAT BUR STAND, V84, P489, DOI 10.6028/jres.084.024; Malaguti E, 2008, INFORMS J COMPUT, V20, P302, DOI 10.1287/ijoc.1070.0245; Malaguti E, 2011, DISCRETE OPTIM, V8, P174, DOI 10.1016/j.disopt.2010.07.005; Malaguti E, 2010, INT T OPER RES, V17, P1, DOI 10.1111/j.1475-3995.2009.00696.x; Matula David W, 1972, GRAPH THEORY COMPUT, P109, DOI DOI 10.1016/B978-1-4832-3187-7.50015-5; Mendez-Diaz I, 2006, DISCRETE APPL MATH, V154, P826, DOI 10.1016/j.dam.2005.05.022; Mendez-Diaz I, 2008, DISCRETE APPL MATH, V156, P159, DOI 10.1016/j.dam.2006.07.010; Minton S, 1993, P 13 INT JOINT C ART, P922; Nareyek A, 2004, APPL OPTIM, V86, P523; Poli R., 2008, FIELD GUIDE GENETIC; Porumbel DC, 2010, COMPUT OPER RES, V37, P1822, DOI 10.1016/j.cor.2010.01.015; Rothlauf F., 2006, REPRESENTATIONS GENE; Titiloye O, 2011, LECT NOTES ARTIF INT, V6682, P553, DOI 10.1007/978-3-642-22000-5_57; Titiloye O, 2011, DISCRETE OPTIM, V8, P376, DOI 10.1016/j.disopt.2010.12.001	35	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58551	10.1371/journal.pone.0058551	http://dx.doi.org/10.1371/journal.pone.0058551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516506	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200085
J	Fidler, V; Nagelkerke, N				Fidler, Vaclav; Nagelkerke, Nico			The Mantel-Haenszel Procedure Revisited: Models and Generalizations	PLOS ONE			English	Article							BINARY DATA	Several statistical methods have been developed for adjusting the Odds Ratio of the relation between two dichotomous variables X and Y for some confounders Z. With the exception of the Mantel-Haenszel method, commonly used methods, notably binary logistic regression, are not symmetrical in X and Y. The classical Mantel-Haenszel method however only works for confounders with a limited number of discrete strata, which limits its utility, and appears to have no basis in statistical models. Here we revisit the Mantel-Haenszel method and propose an extension to continuous and vector valued Z. The idea is to replace the observed cell entries in strata of the Mantel-Haenszel procedure by subject specific classification probabilities for the four possible values of (X,Y) predicted by a suitable statistical model. For situations where X and Y can be treated symmetrically we propose and explore the multinomial logistic model. Under the homogeneity hypothesis, which states that the odds ratio does not depend on Z, the logarithm of the odds ratio estimator can be expressed as a simple linear combination of three parameters of this model. Methods for testing the homogeneity hypothesis are proposed. The relationship between this method and binary logistic regression is explored. A numerical example using survey data is presented.	[Fidler, Vaclav] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 AB Groningen, Netherlands; [Nagelkerke, Nico] United Arab Emirates Univ, Inst Publ Hlth, Al Ain, U Arab Emirates; [Nagelkerke, Nico] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Nagelkerke, Nico] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	University of Groningen; United Arab Emirates University; University of Manitoba; Erasmus University Rotterdam; Erasmus MC	Fidler, V (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 AB Groningen, Netherlands.	v.fidler@umcg.nl						Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; Fidler V, 2013, PARTIALOR R PACKAGE; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Lash T. L, 2008, MODERN EPIDEMIOLOGY, V3rd; LECESSIE S, 1994, J R STAT SOC C-APPL, V43, P95; MANTEL N, 1959, J NATL CANCER I, V22, P719; MIETTINEN OS, 1976, AM J EPIDEMIOL, V104, P609, DOI 10.1093/oxfordjournals.aje.a112339; Pike MC, 1979, EPIDEMIOL COMMUNITY, V33, P104; R Core Team, 2012, R LANG ENV STAT COMP; Robins JM, 2001, EPIDEMIOLOGY, V12, P313, DOI 10.1097/00001648-200105000-00011	11	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58327	10.1371/journal.pone.0058327	http://dx.doi.org/10.1371/journal.pone.0058327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516463	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200056
J	Georgi, JA; Sipla, JS; Forster, CA				Georgi, Justin A.; Sipla, Justin S.; Forster, Catherine A.			Turning Semicircular Canal Function on Its Head: Dinosaurs and a Novel Vestibular Analysis	PLOS ONE			English	Article							EARLY EVOLUTION; BONY LABYRINTH; BODY-SIZE; BIOMECHANICS; ALLOMETRY; SYSTEM; LENGTH; MOLE; MASS	Previous investigations have correlated vestibular function to locomotion in vertebrates by scaling semicircular duct radius of curvature to body mass. However, this method fails to discriminate bipedal from quadrupedal non-avian dinosaurs. Because they exhibit a broad range of relative head sizes, we use dinosaurs to test the hypothesis that semicircular ducts scale more closely with head size. Comparing the area enclosed by each semicircular canal to estimated body mass and to two different measures of head size, skull length and estimated head mass, reveals significant patterns that corroborate a connection between physical parameters of the head and semicircular canal morphology. Head mass more strongly correlates with anterior semicircular canal size than does body mass and statistically separates bipedal from quadrupedal taxa, with bipeds exhibiting relatively larger canals. This morphologic dichotomy likely reflects adaptations of the vestibular system to stability demands associated with terrestrial locomotion on two, versus four, feet. This new method has implications for reinterpreting previous studies and informing future studies on the connection between locomotion type and vestibular function.	[Georgi, Justin A.] Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ 85308 USA; [Sipla, Justin S.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA USA; [Forster, Catherine A.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA	Midwestern University; University of Iowa; George Washington University	Georgi, JA (corresponding author), Midwestern Univ, Arizona Coll Osteopath Med, Dept Anat, Glendale, AZ 85308 USA.	jgeorgi@midwestern.edu		Sipla, Justin/0000-0001-8171-8126	Jurassic Foundation	Jurassic Foundation	This study was funded by Jurassic Foundation (jurasicfoundation.org) grants to the first and second authors. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J. A., 1913, MEM AM MUS NAT HIST, V1, P101; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Butler RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2041, DOI 10.1098/rspb.2007.0367; Choiniere J, 2010, THESIS G WASHINGTON; Christian A, 2010, BIOL LETTERS, V6, P823, DOI 10.1098/rsbl.2010.0359; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Christiansen Per, 1999, Historical Biology, V13, P269; Clarke AH, 2005, J VESTIBUL RES-EQUIL, V15, P65; Dashzeveg D, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)498[0001:NSSDEA]2.0.CO;2; David R, 2010, CR PALEVOL, V9, P397, DOI 10.1016/j.crpv.2010.07.012; Eberth DA, 1993, GEOLOGICAL ASS CANAD, P84; Falster D., 2006, STANDARDISED MAJOR A; Fish FE, 2003, J EXP BIOL, V206, P667, DOI 10.1242/jeb.00144; Fish FE, 2000, PHYSIOL BIOCHEM ZOOL, V73, P683, DOI 10.1086/318108; Fitzpatrick RC, 2006, CURR BIOL, V16, P1509, DOI 10.1016/j.cub.2006.05.063; foundation R, 2009, R STAT COMP SOFTW; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; GRAND TI, 1990, ANAT EMBRYOL, V182, P85; Gray AA, 1906, P R SOC LOND B-CONTA, V78, P284, DOI 10.1098/rspb.1906.0063; GRAY AA, 1907, LABYRINTH ANIMALS, V1; GRAY AA, 1908, LABYRINTH ANIMALS, V2; Green AM, 2010, EXP BRAIN RES, V200, P197, DOI 10.1007/s00221-009-2054-4; Gunz P, 2012, J ANAT, V220, P529, DOI 10.1111/j.1469-7580.2012.01493.x; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hicks JF, 2002, GEOL S AM S, P35; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; HOWLAND HC, 1973, Z MORPHOL TIERE, V75, P283, DOI 10.1007/BF00288475; Huterer M, 2002, J NEUROPHYSIOL, V88, P13, DOI 10.1152/jn.2002.88.1.13; JONES GM, 1963, PROC R SOC SER B-BIO, V157, P403, DOI 10.1098/rspb.1963.0019; LINDENLAUB T, 1994, ANAT RECORD, V240, P286, DOI 10.1002/ar.1092400217; Maddison W., 2018, MESQUITE MODULAR SYS; Martin John, 1998, Oryctos, V1, P113; MathWorks, 2010, MATLAB; Mayne R, 1965, NASA SP77, P57; McVean A, 1999, COMP BIOCHEM PHYS A, V123, P173, DOI 10.1016/S1095-6433(99)00047-1; Midford P. E., 2010, PDAP PDTREE PACKAGE; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Oikawa S, 2003, FISHERIES SCI, V69, P687, DOI 10.1046/j.1444-2906.2003.00675.x; Rabbitt RD, 2004, SPR HDB AUD, P153; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Savelle JM, 1996, J ARCHAEOL SCI, V23, P705, DOI 10.1006/jasc.1996.0066; Schoonaert K, 2007, J ANAT, V210, P518, DOI 10.1111/j.1469-7580.2007.00720.x; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sereno PC, 2007, ACTA PALAEONTOL POL, V52, P275; Simmons RE, 1996, AM NAT, V148, P771, DOI 10.1086/285955; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; SPOOR F, 1994, NATURE, V369, P645, DOI 10.1038/369645a0; Spoor F, 2003, J HUM EVOL, V44, P141, DOI 10.1016/S0047-2484(02)00166-5; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; Spoor F, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P257; Spoor F, 2007, P NATL ACAD SCI USA, V104, P10808, DOI 10.1073/pnas.0704250104; Taylor MP, 2010, GEOL SOC SPEC PUBL, V343, P361, DOI 10.1144/SP343.22; TENKATE JH, 1970, J EXP BIOL, V53, P495; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Trujillo K.C., 2006, GEOLOGICAL SOC AM AB, V38, P7; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Visage Imaging, 2009, VIS IM; Wagner JR, 2009, J VERTEBR PALEONTOL, V29, P605, DOI 10.1671/039.029.0208; Weishampel DB., 2004, DINOSAURIA; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048	60	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58517	10.1371/journal.pone.0058517	http://dx.doi.org/10.1371/journal.pone.0058517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516495	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849200076
J	Wong, CKH; Lam, CLK; Poon, JTC; Kwong, DLW				Wong, Carlos K. H.; Lam, Cindy L. K.; Poon, Jensen T. C.; Kwong, Dora L. W.			Clinical Correlates of Health Preference and Generic Health-Related Quality of Life in Patients with Colorectal Neoplasms	PLOS ONE			English	Article							CANCER PATIENTS; SURVIVORS; PREDICTORS; EQUIVALENT; RESECTION; COLON; SF-6D	Background: The aims of the study were to assess the health preference and health-related quality of life (HRQOL) in patients with colorectal neoplasms (CRN), and to determine the clinical correlates that significantly influence the HRQOL of patients. Methods: Five hundred and fifty-four CRN patients, inclusive of colorectal polyp or cancer, who attended the colorectal specialist outpatient clinic at Queen Mary Hospital in Hong Kong between October 2009 and July 2010, were included. Patients were interviewed with questionnaires on socio-demographic characteristics, and generic and health preference measures of HRQOL using the SF-12 and SF-6D Health Surveys, respectively. Clinical information on stage of disease at diagnosis, time since diagnosis, primary tumour site was extracted from electronic case record. Mean HRQOL and health preference scores of CRN patients were compared with age-sex matched controls from the Chinese general population using independent t-test. Multiple linear regression analyses were conducted to explore the associations of clinical characteristics with HRQOL measures with the adjustment of socio-demographic characteristics. Results: Cross-sectional data of 515 eligible patients responded to the whole questionnaires were included in outcome analysis. In comparison with age-sex matched normative values, CRN patients reported comparable physical-related HRQOL but better mental-related HRQOL. Amongst CRN patients, time since diagnosis was positively associated with health preference score whilst patients with rectal neoplasms had lower health preference and physical-related HRQOL scores than those with sigmoid neoplasms. Health preference and HRQOL scores were significantly lower in patients with stage IV colorectal cancer than those with other less severe stages, indicating that progressive decline from low-risk polyp to stage IV colorectal cancer was observed in HRQOL scores. Conclusion: In CRN patients, a more advanced stage of disease was associated with worse HRQOL scores. Despite potentially adverse effect of disease on physical-related HRQOL, the mental-related HRQOL of CRN patients were better than that of Chinese general population.	[Wong, Carlos K. H.; Lam, Cindy L. K.] Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Poon, Jensen T. C.] Univ Hong Kong, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Kwong, Dora L. W.] Univ Hong Kong, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Wong, CKH (corresponding author), Univ Hong Kong, Dept Family Med & Primary Care, Hong Kong, Hong Kong, Peoples R China.	carlosho@hku.hk	Wong, Carlos King Ho/B-4322-2011	Wong, Carlos King Ho/0000-0002-6895-6071	Committee of Research and Conference Grants of the University of Hong Kong [200907176135]; Health and Health Service Research Fund (HHSRF) of Food and Health Bureau, Hong Kong Special Administrative Region [08090851]	Committee of Research and Conference Grants of the University of Hong Kong; Health and Health Service Research Fund (HHSRF) of Food and Health Bureau, Hong Kong Special Administrative Region	This study was financially supported by the Committee of Research and Conference Grants (Project code 200907176135) of the University of Hong Kong, and Health and Health Service Research Fund (HHSRF #08090851) of Food and Health Bureau, Hong Kong Special Administrative Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin WS, 2002, GUT, V51, pV6, DOI 10.1136/gut.51.suppl_5.v6; Bernhard J, 1999, ANN ONCOL, V10, P775, DOI 10.1023/A:1008311918967; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Byrne C, 2007, EJSO-EUR J SURG ONC, V33, pS95, DOI 10.1016/j.ejso.2007.10.003; CELLA DF, 1993, CANCER INVEST, V11, P327, DOI 10.3109/07357909309024860; Santos VLCD, 2006, J WOUND OSTOMY CONT, V33, P503, DOI 10.1097/00152192-200609000-00008; Fong DYT, 2010, J CLIN EPIDEMIOL, V63, P1020, DOI 10.1016/j.jclinepi.2009.11.011; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Hays RD, 2001, ANN MED, V33, P350, DOI 10.3109/07853890109002089; Hornbrook MC, 2011, MED CARE, V49, P321, DOI 10.1097/MLR.0b013e31820194c8; Krouse RS, 2009, J CLIN ONCOL, V27, P4664, DOI 10.1200/JCO.2008.20.9502; Lam CLK, 2008, VALUE HEALTH, V11, P295, DOI 10.1111/j.1524-4733.2007.00233.x; Lam CLK, 2005, QUAL LIFE RES, V14, P539, DOI 10.1007/s11136-004-0704-3; Lam CLK, 2010, HONG KONG PRACTITION, V32, P77; Lam ETP, 2013, J EVAL CLIN PRACT, V19, P200, DOI 10.1111/j.1365-2753.2011.01800.x; Liu LY, 2010, DIS COLON RECTUM, V53, P200, DOI 10.1007/DCR.0b013e3181bdc408; McGhee S M, 2011, Hong Kong Med J, V17 Suppl 6, P17; National Institute for Clinical Excellence, 2008, N1618 NICE; Paika V, 2010, PSYCHO-ONCOLOGY, V19, P273, DOI 10.1002/pon.1563; Ramsey SD, 2002, AM J GASTROENTEROL, V97, P1228, DOI 10.1111/j.1572-0241.2002.05694.x; Ramsey SD, 2000, CANCER-AM CANCER SOC, V88, P1294, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1294::AID-CNCR4>3.3.CO;2-D; Rauch P, 2004, J CLIN ONCOL, V22, P354, DOI 10.1200/JCO.2004.03.137; Rinaldis M, 2010, BRIT J PSYCHOL, V101, P259, DOI 10.1348/000712609X448676; Ristvedt SL, 2009, BRIT J HEALTH PSYCH, V14, P701, DOI 10.1348/135910708X400462; Ross L, 2007, SUPPORT CARE CANCER, V15, P505, DOI 10.1007/s00520-006-0177-8; Sharma A, 2007, ANN SURG ONCOL, V14, P3435, DOI 10.1245/s10434-007-9554-x; Shiroiwa T, 2009, QUAL LIFE RES, V18, P1095, DOI 10.1007/s11136-009-9513-z; Simon AE, 2009, COLORECTAL DIS, V11, P19, DOI 10.1111/j.1463-1318.2008.01501.x; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Sultan S, 2004, CANCER-AM CANCER SOC, V101, P2737, DOI 10.1002/cncr.20699; Trentham-Dietz A, 2003, ONCOLOGIST, V8, P342, DOI 10.1634/theoncologist.8-4-342; Wilson TR, 2006, DIS COLON RECTUM, V49, P1692, DOI 10.1007/s10350-006-0709-9; Wong CK, 2013, J CLIN EPIDEMIOL, V66, P557, DOI 10.1016/j.jclinepi.2012.11.010; Wong CKH, 2013, QUAL LIFE RES, V22, P1415, DOI 10.1007/s11136-012-0272-x; Wong CKH, 2012, J EVAL CLIN PRACT, V18, P1186, DOI 10.1111/j.1365-2753.2011.01753.x; Wong CKH, 2012, J EVAL CLIN PRACT, V18, P1203, DOI 10.1111/j.1365-2753.2011.01776.x; Wong CKH, 2012, VALUE HEALTH, V15, P495, DOI 10.1016/j.jval.2011.12.009; Wong CKH, 2013, VALUE HEALTH, V16, P373, DOI 10.1016/j.jval.2012.12.004; Yost KJ, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-66	40	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58341	10.1371/journal.pone.0058341	http://dx.doi.org/10.1371/journal.pone.0058341			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516465	Green Published, gold			2022-12-27	WOS:000316849200057
J	Mundkur, L; Mukhopadhyay, R; Samson, S; Varma, M; Kale, D; Chen, DX; Shivaprasad, S; Sivanandan, H; Soman, V; Lu, XJ; Kakkar, VV				Mundkur, Lakshmi; Mukhopadhyay, Rupak; Samson, Sonia; Varma, Meenakshi; Kale, Dnyaneswar; Chen, Daxin; Shivaprasad, Sneha; Sivanandan, Hemapriya; Soman, Vinod; Lu, Xinjie; Kakkar, Vijay V.			Mucosal Tolerance to a Combination of ApoB and HSP60 Peptides Controls Plaque Progression and Stabilizes Vulnerable Plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; GROWTH-FACTOR-BETA; ATHEROSCLEROTIC LESIONS; MACROPHAGE APOPTOSIS; ORAL TOLERANCE; MECHANISMS; SUPPRESSION; INFLAMMATION; AUTOIMMUNITY; INDUCTION	Oral tolerance to auto antigens reduces the development of atherosclerosis in mouse models. However, the effect of immune tolerance to multiple self antigenic peptides in plaque progression and stabilization is not known. We studied the protective effect of mucosal tolerance to peptides from apolipoprotein B (ApoB; 661-680) and heat shock protein 60 (HSP60; 153-163), in combination with diet, in the prevention of atherosclerotic lesion progression and plaque stabilization in ApoB(tm25gy)LDLr(tm1Her) mice. We found that oral administration of five doses of a combination of ApoB and HSP60 peptides (20 mu g/mice/dose) induced tolerance to both the peptides and reduced early plaque development by 39.9% better than the individual peptides (ApoB = 28.7%; HSP60 = 26.8%)(P<0.001). Oral tolerance to combination of peptides along with diet modification arrested plaque progression by 37.6% which was associated with increases in T-regulatory cell and transforming growth factor-beta expression in the plaque and peripheral circulation. Reduced macrophage infiltration and tumor necrosis factor-alpha expression in the plaque was also observed. Tolerance with continued hypercholesterolemia resulted in 60.8% reduction in necrotic core area suggesting plaque stabilization, which was supported by reduction in apoptosis and increased efferocytosis demonstrated by greater expression of receptor tyrosine kinase Mer (MerTK) in the plaque. Tolerance to the two peptides also reduced the expression of matrix metalloproteinase 9, tissue factor, calprotectin, and increased its collagen content. Our study suggests that oral tolerance to ApoB and HSP60 peptide combination induces CD4(+) CTLA4(+) Tregs and CD4(+) CD25(+) Foxp3(+) Tregs secreting TGF-beta, which inhibit pathogenic T cell response to both peptides thus reducing the development and progression of atherosclerosis and provides evidence for plaque stabilization in ApoB(tm25gy)LDLr(tm1Her) mice.	[Mundkur, Lakshmi; Mukhopadhyay, Rupak; Samson, Sonia; Varma, Meenakshi; Kale, Dnyaneswar; Shivaprasad, Sneha; Sivanandan, Hemapriya; Soman, Vinod; Kakkar, Vijay V.] Thrombosis Res Inst, Mary & Gary Western & Tata Mol Immunol Unit, Bangalore, Karnataka, India; [Chen, Daxin; Lu, Xinjie; Kakkar, Vijay V.] Thrombosis Res Inst, Mol Immunol Unit, London SW3 6LR, England	Thrombosis Research Institute; University of London; University College London	Kakkar, VV (corresponding author), Thrombosis Res Inst, Mary & Gary Western & Tata Mol Immunol Unit, Bangalore, Karnataka, India.	vijay@tri-london.ac.uk	Mukhopadhyay, Rupak/Q-9168-2017; Mundkur, Lakshmi/ABI-8141-2020	Mukhopadhyay, Rupak/0000-0001-5211-1413; Mundkur, Lakshmi/0000-0003-2928-1726	Thrombosis Research Institute, London; Thrombosis Research Institute, Bangalore,; Tata Social Welfare Trust, India (TSWT/IG/SNB/JP/Sdm); Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/01/CDE/08/07]	Thrombosis Research Institute, London; Thrombosis Research Institute, Bangalore,; Tata Social Welfare Trust, India (TSWT/IG/SNB/JP/Sdm); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by grants from the trustees of Thrombosis Research Institute, London and Bangalore, Tata Social Welfare Trust, India (TSWT/IG/SNB/JP/Sdm) and Department of Biotechnology, Ministry of Science and Technology, Government of India (BT/01/CDE/08/07). The sponsors did not participate in the design, conduct, analysis and interpretation of the data or in the preparation, review or approval of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Almanzar G, 2012, J AUTOIMMUN; Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; Binder CJ, 2007, J AM COLL CARDIOL, V50, P547, DOI 10.1016/j.jacc.2007.04.054; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Bjorkerud S, 1996, AM J PATHOL, V149, P367; Boks MA, 2010, SCAND J IMMUNOL, V72, P158, DOI 10.1111/j.1365-3083.2010.02414.x; Carrier Y, 2007, J IMMUNOL, V178, P179, DOI 10.4049/jimmunol.178.1.179; Dickhout JG, 2011, FASEB J, V25, P576, DOI 10.1096/fj.10-159319; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; Farese RV, 1996, P NATL ACAD SCI USA, V93, P6393, DOI 10.1073/pnas.93.13.6393; Feng B, 2003, P NATL ACAD SCI USA, V100, P10423, DOI 10.1073/pnas.1732494100; Fredrikson GN, 2007, ATHEROSCLEROSIS, V194, pE188, DOI 10.1016/j.atherosclerosis.2006.12.014; George J, 2004, CARDIOVASC RES, V62, P603, DOI 10.1016/j.cardiores.2004.01.028; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Grundtman C, 2011, CURR OPIN LIPIDOL, V22, P327, DOI 10.1097/MOL.0b013e32834aa0c2; Grundtman C, 2011, ARTERIOSCL THROM VAS, V31, P960, DOI 10.1161/ATVBAHA.110.217877; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hansson GK, 2009, ATHEROSCLEROSIS, V202, P2, DOI 10.1016/j.atherosclerosis.2008.08.039; Herbin O, 2012, ARTERIOSCL THROM VAS, V32, P605, DOI 10.1161/ATVBAHA.111.242800; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; Lu XJ, 2010, ATHEROSCLEROSIS, V212, P472, DOI 10.1016/j.atherosclerosis.2010.06.007; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Maganto-Garcia E, 2011, CIRCULATION, V124, P185, DOI 10.1161/CIRCULATIONAHA.110.006411; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Mallat Z, 2004, EXPERT OPIN BIOL TH, V4, P1387, DOI 10.1517/14712598.4.9.1387; Mallat Z, 2007, TRENDS CARDIOVAS MED, V17, P113, DOI 10.1016/j.tcm.2007.03.001; Maron R, 2002, CIRCULATION, V106, P1708, DOI 10.1161/01.CIR.0000029750.99462.30; Milovanova TN, 2007, CYTOM PART B-CLIN CY, V72B, P265, DOI 10.1002/cyto.b.20166; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Mundkur L, 2013, J VACCIN, V2013, P13; Nilsson J, 2008, J INTERN MED, V263, P464, DOI 10.1111/j.1365-2796.2008.01945.x; Nilsson J, 2009, J INTERN MED, V266, P221, DOI 10.1111/j.1365-2796.2009.02150.x; Nilsson J, 2012, CURR OPIN LIPIDOL, V23, P422, DOI 10.1097/MOL.0b013e328356ec7c; Qi GF, 2005, LIFE SCI, V77, P2690, DOI 10.1016/j.lfs.2005.05.037; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Schrijvers DM, 2007, CARDIOVASC RES, V73, P470, DOI 10.1016/j.cardiores.2006.09.005; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Stoneman V, 2007, CIRC RES, V100, P884, DOI 10.1161/01.RES.0000260802.75766.00; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Tabas I, 2009, ANN NY ACAD SCI, V1173, pE40, DOI 10.1111/j.1749-6632.2009.04957.x; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; van Puijvelde GHM, 2006, CIRCULATION, V114, P1968, DOI 10.1161/CIRCULATIONAHA.106.615609; van Puijvelde HM, 2007, ARTERIOSCL THROM VAS, V27, P2677, DOI 10.1161/ATVBAHA.107.151274; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Wick G, 2004, ANNU REV IMMUNOL, V22, P361, DOI 10.1146/annurev.immunol.22.012703.104644	55	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58364	10.1371/journal.pone.0058364	http://dx.doi.org/10.1371/journal.pone.0058364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505495	gold, Green Submitted, Green Published			2022-12-27	WOS:000316251100048
J	Zerbato, M; Holic, N; Moniot-Frin, S; Ingrao, D; Galy, A; Perea, J				Zerbato, Madeleine; Holic, Nathalie; Moniot-Frin, Sophie; Ingrao, Dina; Galy, Anne; Perea, Javier			The Brown Algae Pl.LSU/2 Group II Intron-Encoded Protein Has Functional Reverse Transcriptase and Maturase Activities	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; SELF-SPLICING INTRON; SEVERE COMBINED IMMUNODEFICIENCY; SECONDARY STRUCTURE PREDICTION; CHRONIC GRANULOMATOUS-DISEASE; MITOCHONDRIAL GROUP-I; GENE-THERAPY; DNA ENDONUCLEASE; PYLAIELLA-LITTORALIS; YEAST MITOCHONDRIA	Group II introns are self-splicing mobile elements found in prokaryotes and eukaryotic organelles. These introns propagate by homing into precise genomic locations, following assembly of a ribonucleoprotein complex containing the intron-encoded protein (IEP) and the spliced intron RNA. Engineered group II introns are now commonly used tools for targeted genomic modifications in prokaryotes but not in eukaryotes. We speculate that the catalytic activation of currently known group II introns is limited in eukaryotic cells. The brown algae Pylaiella littoralis Pl.LSU/2 group II intron is uniquely capable of in vitro ribozyme activity at physiological level of magnesium but this intron remains poorly characterized. We purified and characterized recombinant Pl.LSU/2 IEP. Unlike most IEPs, Pl.LSU/2 IEP displayed a reverse transcriptase activity without intronic RNA. The Pl.LSU/2 intron could be engineered to splice accurately in Saccharomyces cerevisiae and splicing efficiency was increased by the maturase activity of the IEP. However, spliced transcripts were not expressed. Furthermore, intron splicing was not detected in human cells. While further tool development is needed, these data provide the first functional characterization of the Pl.LSU/2 IEP and the first evidence that the Pl.LSU/2 group II intron splicing occurs in vivo in eukaryotes in an IEP-dependent manner.	[Zerbato, Madeleine; Holic, Nathalie; Moniot-Frin, Sophie; Ingrao, Dina; Galy, Anne; Perea, Javier] INSERM, U951, Evry, France; [Zerbato, Madeleine; Holic, Nathalie; Moniot-Frin, Sophie; Ingrao, Dina; Galy, Anne; Perea, Javier] Univ Evry Val dEssonne, UMR S 951, Evry, France; [Zerbato, Madeleine; Holic, Nathalie; Moniot-Frin, Sophie; Ingrao, Dina; Galy, Anne; Perea, Javier] Genethon, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Perea, J (corresponding author), INSERM, U951, Evry, France.	perea@genethon.fr	Holic, Nathalie/U-8979-2018; Galy, Anne HM/J-4439-2013; Holic, Nathalie/J-6886-2013	Holic, Nathalie/0000-0001-9869-1388; Galy, Anne HM/0000-0002-0153-4392; Holic, Nathalie/0000-0001-9869-1388	Association Francaise contre les myopathies (AFM); Institut national de la sante et de la recherche medicale (INSERM); University of Evry Val d'Essonne; 7th European Commission Framework Program (FP7) "PERSIST" [222878]	Association Francaise contre les myopathies (AFM)(Association Francaise contre les Myopathies); Institut national de la sante et de la recherche medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Evry Val d'Essonne; 7th European Commission Framework Program (FP7) "PERSIST"	This work was supported by the Association Francaise contre les myopathies (AFM, http://www.afm-telethon.fr/); the Institut national de la sante et de la recherche medicale (INSERM http://www.inserm.fr); the University of Evry Val d'Essonne (www.univ-evry.fr); and by the 7th European Commission Framework Program (FP7) "PERSIST" (agreement 222878). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; Arnould S, 2007, J MOL BIOL, V371, P49, DOI 10.1016/j.jmb.2007.04.079; Barzel A, 2011, NUCLEIC ACIDS RES, V39, P6646, DOI 10.1093/nar/gkr242; Belfort M, 2003, GENE DEV, V17, P2860, DOI 10.1101/gad.1162503; Bibikova M, 2002, GENETICS, V161, P1169; Brachmann CB, 1998, YEAST, V14, P115; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chalamcharla VR, 2010, GENE DEV, V24, P827, DOI 10.1101/gad.1905010; Charrier S, 2007, GENE THER, V14, P415, DOI 10.1038/sj.gt.3302863; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Costa M, 1999, EMBO J, V18, P1025, DOI 10.1093/emboj/18.4.1025; Costa M, 2000, EMBO J, V19, P5007, DOI 10.1093/emboj/19.18.5007; Costa M, 1998, RNA, V4, P1055, DOI 10.1017/S1355838298980670; Costa M, 1997, J MOL BIOL, V274, P353, DOI 10.1006/jmbi.1997.1416; Cui XX, 2004, J MOL BIOL, V340, P211, DOI 10.1016/j.jmb.2004.05.004; DELAHODDE A, 1989, CELL, V56, P431, DOI 10.1016/0092-8674(89)90246-8; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Ding Y, 2003, NUCLEIC ACIDS RES, V31, P7280, DOI 10.1093/nar/gkg938; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; FONTAINE JM, 1995, J MOL BIOL, V251, P378, DOI 10.1006/jmbi.1995.0441; Fontaine JM, 1997, J MOL EVOL, V44, P33, DOI 10.1007/PL00006119; Frazier CL, 2003, APPL ENVIRON MICROB, V69, P1121, DOI 10.1128/AEM.69.2.1121-1128.2003; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Garcia-Rodriguez FM, 2011, APPL ENVIRON MICROB, V77, P854, DOI 10.1128/AEM.02319-10; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452; Guo HT, 1997, EMBO J, V16, P6835, DOI 10.1093/emboj/16.22.6835; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Ho Y, 1997, P NATL ACAD SCI USA, V94, P8994, DOI 10.1073/pnas.94.17.8994; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Huang HR, 2003, MOL CELL BIOL, V23, P8809, DOI 10.1128/MCB.23.23.8809-8819.2003; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Karberg M, 2001, NAT BIOTECHNOL, V19, P1162, DOI 10.1038/nbt1201-1162; KENNELL JC, 1993, CELL, V73, P133, DOI 10.1016/0092-8674(93)90166-N; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Mastroianni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003121; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; Matsuura M, 2001, EMBO J, V20, P7259, DOI 10.1093/emboj/20.24.7259; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; MOHR G, 1993, NUCLEIC ACIDS RES, V21, P4991, DOI 10.1093/nar/21.22.4991; Mohr G, 2000, GENE DEV, V14, P559; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Olszewska M, 2012, CELL BIOCHEM FUNCT, V30, P177, DOI 10.1002/cbf.2804; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Porteus MH, 2009, NATURE, V459, P337, DOI 10.1038/459337a; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; Rambo RP, 2004, BIOCHEMISTRY-US, V43, P6486, DOI 10.1021/bi049912u; Romani AMP, 2002, BIOMETALS, V15, P271, DOI 10.1023/A:1016082900838; Saldanha R, 1999, BIOCHEMISTRY-US, V38, P9069, DOI 10.1021/bi982799l; SALDANHA R, 1993, FASEB J, V7, P15, DOI 10.1096/fasebj.7.1.8422962; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; SCHAFER B, 1994, CURR GENET, V25, P336, DOI 10.1007/BF00351487; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Singh NN, 2001, J MOL BIOL, V309, P361, DOI 10.1006/jmbi.2001.4658; Smith J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl720; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Szczepanek T, 2000, MOL GEN GENET, V264, P137, DOI 10.1007/s004380000297; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Toor N, 2009, CURR OPIN STRUC BIOL, V19, P260, DOI 10.1016/j.sbi.2009.04.002; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Vellore J, 2004, APPL ENVIRON MICROB, V70, P7140, DOI 10.1128/AEM.70.12.7140-7147.2004; Wank H, 1999, MOL CELL, V4, P239, DOI 10.1016/S1097-2765(00)80371-8; WENZLAU JM, 1989, CELL, V56, P421, DOI 10.1016/0092-8674(89)90245-6; White TB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002534; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706; Zarschler K, 2009, APPL ENVIRON MICROB, V75, P3077, DOI 10.1128/AEM.00087-09; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248; Zhuang FL, 2009, RNA, V15, P432, DOI 10.1261/rna.1378909	80	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58263	10.1371/journal.pone.0058263	http://dx.doi.org/10.1371/journal.pone.0058263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505475	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100039
J	Katragadda, U; Fan, W; Wang, YZ; Teng, Q; Tan, C				Katragadda, Usha; Fan, Wei; Wang, Yingzhe; Teng, Quincy; Tan, Chalet			Combined Delivery of Paclitaxel and Tanespimycin via Micellar Nanocarriers: Pharmacokinetics, Efficacy and Metabolomic Analysis	PLOS ONE			English	Article							IN-VIVO; INDOCYANINE GREEN; CELL METABOLISM; PHASE-I; CANCER; DRUG; TUMORS; THERAPEUTICS; CHEMOTHERAPY; MALIGNANCIES	Background: Despite the promising anticancer efficacy observed in preclinical studies, paclitaxel and tanespimycin (17-AAG) combination therapy has yielded meager responses in a phase I clinical trial. One serious problem associated with paclitaxel/17-AAG combination therapy is the employment of large quantities of toxic organic surfactants and solvents for drug solubilization. The goal of this study was to evaluate a micellar formulation for the concurrent delivery of paclitaxel and 17-AAG in vivo. Methodology/Principal Findings: Paclitaxel/17-AAG-loaded micelles were assessed in mice bearing human ovarian tumor xenografts. Compared with the free drugs at equivalent doses, intravenous administration of paclitaxel/17-AAG-loaded micelles led to 3.5- and 1.7-fold increase in the tumor concentrations of paclitaxel and 17-AAG, respectively, without significant altering drug levels in normal organs. The enhanced tumor accumulation of the micellar drugs was further confirmed by the whole-body near infrared imaging using indocyanine green-labeled micelles. Subsequently, the anticancer efficacy of paclitaxel/17-AAG-loaded micelles was examined in comparison with the free drugs (weekly 20 mg/kg paclitaxel, twice-weekly 37.5 mg/kg 17-AAG). We found that paclitaxel/17-AAG-loaded micelles caused near-complete arrest of tumor growth, whereas the free drug-treated tumors experienced rapid growth shortly after the 3-week treatment period ended. Furthermore, comparative metabolomic profiling by proton nuclear magnetic resonance revealed significant decrease in glucose, lactate and alanine with simultaneous increase in glutamine, glutamate, aspartate, choline, creatine and acetate levels in the tumors of mice treated with paclitaxel/17-AAG-loaded micelles. Conclusions/Significance: We have demonstrated in the current wok a safe and efficacious nano-sized formulation for the combined delivery of paclitaxel and 17-AAG, and uncovered unique metabolomic signatures in the tumor that correlate with the favorable therapeutic response to paclitaxel/17-AAG combination therapy.	[Katragadda, Usha; Fan, Wei; Wang, Yingzhe; Tan, Chalet] Mercer Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Canc Nanomed Lab, Atlanta, GA USA; [Teng, Quincy] Univ Georgia, Coll Pharm, Dept Pharmaceut & Biomed Sci, Athens, GA 30602 USA	Mercer University; University System of Georgia; University of Georgia	Tan, C (corresponding author), Mercer Univ, Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Canc Nanomed Lab, Atlanta, GA USA.	tan_c@mercer.edu	Wang, Yingzhe/AAA-4340-2020	Wang, Yingzhe/0000-0002-7382-9683; Fan, Wei/0000-0001-5893-6045	National Institutes of Health [R15CA152860]; Georgia Cancer Coalition Cancer Research Award; NATIONAL CANCER INSTITUTE [R15CA152860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Cancer Coalition Cancer Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R15CA152860 (CT) and the Georgia Cancer Coalition Cancer Research Award (CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aryal S, 2010, SMALL, V6, P1442, DOI 10.1002/smll.201000631; Chen H, 2008, LANGMUIR, V24, P5213, DOI 10.1021/la703570m; Collette TW, 2010, ENVIRON SCI TECHNOL, V44, P6881, DOI 10.1021/es1011884; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dicko A, 2010, EXPERT OPIN DRUG DEL, V7, P1329, DOI 10.1517/17425247.2010.538678; Egorin MJ, 2001, CANCER CHEMOTH PHARM, V47, P291, DOI 10.1007/s002800000242; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Katragadda U, 2011, INT J PHARMACEUT, V419, P281, DOI 10.1016/j.ijpharm.2011.07.033; Kim SC, 2001, J CONTROL RELEASE, V72, P191, DOI 10.1016/S0168-3659(01)00275-9; Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655; Kolishetti N, 2010, P NATL ACAD SCI USA, V107, P17939, DOI 10.1073/pnas.1011368107; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Mordon S, 1998, MICROVASC RES, V55, P146, DOI 10.1006/mvre.1998.2068; Munster PN, 2001, CLIN CANCER RES, V7, P2228; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006; Ramalingam SS, 2008, CLIN CANCER RES, V14, P3456, DOI 10.1158/1078-0432.CCR-07-5088; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Shin HC, 2009, J CONTROL RELEASE, V140, P294, DOI 10.1016/j.jconrel.2009.04.024; Solit DB, 2003, CANCER RES, V63, P2139; Spaareboom A, 1996, CANCER RES, V56, P2112; Tang N, 2007, JNCI-J NATL CANCER I, V99, P1004, DOI 10.1093/jnci/djm027; Teng Q, 2012, ANALYST, V137, P2226, DOI 10.1039/c2an16251b; Teng Q, 2009, METABOLOMICS, V5, P199, DOI 10.1007/s11306-008-0137-z; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; WHEELER HO, 1958, P SOC EXP BIOL MED, V99, P11	30	36	38	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58619	10.1371/journal.pone.0058619	http://dx.doi.org/10.1371/journal.pone.0058619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505544	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500108
J	Blok, DC; van der Sluijs, KF; Florquin, S; de Boer, OJ; van 't Veer, C; de Vos, AF; van der Poll, T				Blok, Dana C.; van der Sluijs, Koenraad F.; Florquin, Sandrine; de Boer, Onno J.; van 't Veer, Cornelis; de Vos, Alex F.; van der Poll, Tom			Limited Anti-Inflammatory Role for Interleukin-1 Receptor Like 1 (ST2) in the Host Response to Murine Postinfluenza Pneumococcal Pneumonia	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; INNATE LYMPHOID-CELLS; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL PNEUMONIA; KINASE-M; INFLAMMATORY RESPONSE; MICE DEMONSTRATE; INFLUENZA-VIRUS; DEFENSE; INFECTION	Interleukin-1 receptor like 1 (ST2) is a negative regulator of Toll-like receptor (TLR) signaling. TLRs are important for host defense during respiratory tract infections by both influenza and Streptococcus (S.) pneumoniae. Enhanced susceptibility to pneumococcal pneumonia is an important complication following influenza virus infection. We here sought to determine the role of ST2 in primary influenza A infection and secondary pneumococcal pneumonia. ST2 knockout (st2(-/-)) and wildtype (WT) mice were intranasally infected with influenza A virus; in some experiments mice were infected 2 weeks later with S. pneumoniae. Both mouse strains cleared the virus similarly during the first 14 days of influenza infection and had recovered their weights equally at day 14. Overall st2(-/-) mice tended to have a stronger pulmonary inflammatory response upon infection with influenza; especially 14 days after infection modest but statistically significant elevations were seen in lung IL-6, IL-1 beta, KC, IL-10, and IL-33 concentrations and myeloperoxidase levels, indicative of enhanced neutrophil activity. Interestingly, bacterial lung loads were higher in st2(-/-) mice during the later stages of secondary pneumococcal pneumonia, which was associated with relatively increased lung IFN-gamma levels. ST2 deficiency did not impact on gross lung pathology in either influenza or secondary S. pneumoniae pneumonia. These data show that ST2 plays a limited anti-inflammatory role during both primary influenza and postinfluenza pneumococcal pneumonia.	[Blok, Dana C.; van 't Veer, Cornelis; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [van der Sluijs, Koenraad F.] Univ Amsterdam, Acad Med Ctr, Lab Expt Intens Care & Anesthesiol, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine; de Boer, Onno J.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Blok, DC (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.c.blok@amc.uva.nl		Florquin, Sandrine/0000-0002-9676-1722; de Boer, Onno/0000-0001-8844-1326				Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Albiger B, 2005, CELL MICROBIOL, V7, P1603, DOI 10.1111/j.1462-5822.2005.00578.x; Albiger B, 2007, CELL MICROBIOL, V9, P633, DOI 10.1111/j.1462-5822.2006.00814.x; Alicino C, 2011, J Prev Med Hyg, V52, P102; Ballinger MN, 2010, J INTERF CYTOK RES, V30, P643, DOI 10.1089/jir.2010.0049; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Clark NM, 2011, SEMIN RESP CRIT CARE, V32, P373, DOI 10.1055/s-0031-1283278; Deng JC, 2006, J CLIN INVEST, V116, P2532, DOI 10.1172/JCI28054; Dessing MC, 2007, AM J RESP CELL MOL, V36, P609, DOI 10.1165/rcmb.2006-0166OC; Dessing MC, 2009, J INNATE IMMUN, V1, P366, DOI 10.1159/000167961; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Giamarellos-Bourboulis EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008393; Grabowska K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-58; Hoogerwerf JJ, 2012, MOL MED, V18, P1067, DOI 10.2119/molmed.2011.00450; Hoogerwerf JJ, 2011, AM J RESP CRIT CARE, V183, P932, DOI 10.1164/rccm.201006-0934OC; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Irizarry-Acosta M, 2010, MED HLTH R I, V93, P211; Irizarry-Acosta Melina, 2010, Med Health R I, V93, P204; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Kager LM, 2011, J THROMB HAEMOST, V9, P2020, DOI 10.1111/j.1538-7836.2011.04473.x; Karlstrom A, 2011, J INFECT DIS, V204, P1358, DOI 10.1093/infdis/jir522; Klugman KP, 2009, VACCINE, V27, pC9, DOI 10.1016/j.vaccine.2009.06.007; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kozak W, 1997, AM J PHYSIOL-REG I, V272, pR621, DOI 10.1152/ajpregu.1997.272.2.R621; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; LeVine AM, 2001, J VIROL METHODS, V94, P173, DOI 10.1016/S0166-0934(01)00287-7; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Milovanovic M, 2012, IMMUNOL RES, V52, P89, DOI 10.1007/s12026-012-8283-9; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Mogensen TH, 2006, J LEUKOCYTE BIOL, V80, P267, DOI 10.1189/jlb.1105626; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Paterson GK, 2010, RESPIROLOGY, V15, P1057, DOI 10.1111/j.1440-1843.2010.01814.x; Rijneveld AW, 2002, J IMMUNOL, V168, P3507, DOI 10.4049/jimmunol.168.7.3507; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Seki M, 2010, J IMMUNOL, V184, P1410, DOI 10.4049/jimmunol.0901709; Seo SU, 2010, J VIROL, V84, P12713, DOI 10.1128/JVI.01675-10; Shinya K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-97; Smith MW, 2007, COMPARATIVE MED, V57, P82; Srivastava A, 2005, INFECT IMMUN, V73, P6479, DOI 10.1128/IAI.73.10.6479-6487.2005; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Townsend MJ, 2000, J EXP MED, V191, P1069, DOI 10.1084/jem.191.6.1069; Tuvim MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030596; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; van der Sluijs KF, 2006, J INFECT DIS, V193, P214, DOI 10.1086/498911; van der Sluijs KF, 2006, AM J PHYSIOL-LUNG C, V290, pL194, DOI 10.1152/ajplung.00050.2005; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; van der Sluijs KF, 2003, IMMUNOL LETT, V89, P201, DOI 10.1016/S0165-2478(03)00138-X; van der Sluijs KF, 2010, CRIT CARE, V14, DOI 10.1186/cc8893; van der Windt GJW, 2012, J INFECT DIS, V205, P1849, DOI 10.1093/infdis/jis290; Wong JP, 2009, VACCINE, V27, P3481, DOI 10.1016/j.vaccine.2009.01.048	62	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58191	10.1371/journal.pone.0058191	http://dx.doi.org/10.1371/journal.pone.0058191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483993	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100086
J	Eremenko, E; Ben-Zvi, A; Morozova-Roche, LA; Raveh, D				Eremenko, Ekaterina; Ben-Zvi, Anat; Morozova-Roche, Ludmilla A.; Raveh, Dina			Aggregation of Human S100A8 and S100A9 Amyloidogenic Proteins Perturbs Proteostasis in a Yeast Model	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; URE3 PRION PROPAGATION; EF-HAND PROTEINS; SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; NEURODEGENERATIVE DISEASE; MOLECULAR CHAPERONES; HUNTINGTIN TOXICITY; MUTANT HUNTINGTIN; GENE-EXPRESSION	Amyloid aggregates of the calcium-binding EF-hand proteins, S100A8 and S100A9, have been found in the corpora amylacea of patients with prostate cancer and may play a role in carcinogenesis. Here we present a novel model system using the yeast Saccharomyces cerevisiae to study human S100A8 and S100A9 aggregation and toxicity. We found that S100A8, S100A9 and S100A8/9 cotransfomants form SDS-resistant non-toxic aggregates in yeast cells. Using fluorescently tagged proteins, we showed that S100A8 and S100A9 accumulate in foci. After prolonged induction, S100A8 foci localized to the cell vacuole, whereas the S100A9 foci remained in the cytoplasm when present alone, but entered the vacuole in cotransformants. Biochemical analysis of the proteins indicated that S100A8 and S100A9 alone or coexpressed together form amyloid-like aggregates in yeast. Expression of S100A8 and S100A9 in wild type yeast did not affect cell viability, but these proteins were toxic when expressed on a background of unrelated metastable temperature-sensitive mutant proteins, Cdc53-1p, Cdc34-2p, Srp1-31p and Sec27-1p. This finding suggests that the expression and aggregation of S100A8 and S100A9 may limit the capacity of the cellular proteostasis machinery. To test this hypothesis, we screened a set of chaperone deletion mutants and found that reducing the levels of the heat-shock proteins Hsp104p and Hsp70p was sufficient to induce S100A8 and S100A9 toxicity. This result indicates that the chaperone activity of the Hsp104/Hsp70 bi-chaperone system in wild type cells is sufficient to reduce S100A8 and S100A9 amyloid toxicity and preserve cellular proteostasis. Expression of human S100A8 and S100A9 in yeast thus provides a novel model system for the study of the interaction of amyloid deposits with the proteostasis machinery.	[Eremenko, Ekaterina; Ben-Zvi, Anat; Raveh, Dina] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Ben-Zvi, Anat] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Morozova-Roche, Ludmilla A.] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden	Ben Gurion University; Ben Gurion University; Umea University	Ben-Zvi, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	anatbz@bgu.ac.il; raveh@bgu.ac.il	BEN-ZVI, ANAT/F-1674-2012; Morozova-Roche, Ludmilla A./AAU-9044-2021; Morozova-Roche, Ludmilla/AAV-9983-2021	BEN-ZVI, ANAT/0000-0003-2477-6519; Morozova-Roche, Ludmilla/0000-0001-5886-2023; Eremenko, Ekaterina/0000-0001-5520-9416	EU [PITN-GA-2008-215148]	EU(European Commission)	This work was supported by FP7 EU contract PITN-GA-2008-215148, http://cordis.europa.eu/fp7/home_en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bagriantsev S, 2004, J BIOL CHEM, V279, P51042, DOI 10.1074/jbc.M410611200; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Bates GP, 2006, SCIENCE, V311, P1385, DOI 10.1126/science.1125246; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cashikar AG, 2005, J BIOL CHEM, V280, P23869, DOI 10.1074/jbc.M502854200; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Derkatch IL, 1997, GENETICS, V147, P507; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; DUDEN R, 1994, J BIOL CHEM, V269, P24486; Duennwald Martin L, 2012, PLoS Biol, V10, pe1001346, DOI 10.1371/journal.pbio.1001346; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gabriely G, 2007, MOL CELL BIOL, V27, P526, DOI 10.1128/MCB.00577-06; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Gidalevitz T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000399; Giorgini F, 2009, METHODS MOL BIOL, V548, P161, DOI 10.1007/978-1-59745-540-4_9; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Halfmann Randal, 2008, J Vis Exp, DOI 10.3791/838; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hood JK, 2000, J CELL SCI, V113, P1471; Hoyaux D, 2000, BRAIN RES, V867, P280, DOI 10.1016/S0006-8993(00)02393-3; Hunter MJ, 1998, J BIOL CHEM, V273, P12427, DOI 10.1074/jbc.273.20.12427; Ivantsiv Y, 2006, MOL CELL BIOL, V26, P1579, DOI 10.1128/MCB.26.5.1579-1588.2006; Kaplun L, 2003, J BIOL CHEM, V278, P48727, DOI 10.1074/jbc.M308671200; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kryndushkin DS, 2011, GENETICS, V188, P339, DOI 10.1534/genetics.111.127779; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Miller-Fleming Leonor, 2008, Biotechnol J, V3, P325, DOI 10.1002/biot.200700217; Mitra S, 2009, J BIOL CHEM, V284, P4398, DOI 10.1074/jbc.M806269200; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; Petroi D, 2012, J BIOL CHEM, V287, P27567, DOI 10.1074/jbc.M112.361865; Prendergast JA, 1996, MOL CELL BIOL, V16, P677; Rikhvanov EG, 2007, PRION, V1, P217, DOI 10.4161/pri.1.4.5058; Roberts BT, 2004, YEAST, V21, P107, DOI 10.1002/yea.1062; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schirmer EC, 2004, MOL BIOL CELL, V15, P2061, DOI 10.1091/mbc.E02-08-0502; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Su HB, 2010, CARDIOVASC RES, V85, P253, DOI 10.1093/cvr/cvp287; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Tauber E, 2011, J BIOL CHEM, V286, P410, DOI 10.1074/jbc.M110.101527; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893; Winkler J, 2012, J STRUCT BIOL, V179, P152, DOI 10.1016/j.jsb.2012.05.002; Wolfe KJ, 2011, SEMIN CELL DEV BIOL, V22, P476, DOI 10.1016/j.semcdb.2011.03.011; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562	75	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58218	10.1371/journal.pone.0058218	http://dx.doi.org/10.1371/journal.pone.0058218			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483999	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100091
J	Fawsitt, CG; Bourke, J; Greene, RA; Everard, CM; Murphy, A; Lutomski, JE				Fawsitt, Christopher G.; Bourke, Jane; Greene, Richard A.; Everard, Claire M.; Murphy, Aileen; Lutomski, Jennifer E.			At What Price? A Cost-Effectiveness Analysis Comparing Trial of Labour after Previous Caesarean versus Elective Repeat Caesarean Delivery	PLOS ONE			English	Article							VAGINAL BIRTH; SECTION; WOMEN; MORBIDITY; PREGNANCY; OUTCOMES; ACCRETA; PERIOD; VBAC; RISK	Background: Elective repeat caesarean delivery (ERCD) rates have been increasing worldwide, thus prompting obstetric discourse on the risks and benefits for the mother and infant. Yet, these increasing rates also have major economic implications for the health care system. Given the dearth of information on the cost-effectiveness related to mode of delivery, the aim of this paper was to perform an economic evaluation on the costs and short-term maternal health consequences associated with a trial of labour after one previous caesarean delivery compared with ERCD for low risk women in Ireland. Methods: Using a decision analytic model, a cost-effectiveness analysis (CEA) was performed where the measure of health gain was quality-adjusted life years (QALYs) over a six-week time horizon. A review of international literature was conducted to derive representative estimates of adverse maternal health outcomes following a trial of labour after caesarean (TOLAC) and ERCD. Delivery/procedure costs derived from primary data collection and combined both "bottom-up" and "top-down" costing estimations. Results: Maternal morbidities emerged in twice as many cases in the TOLAC group than the ERCD group. However, a TOLAC was found to be the most-effective method of delivery because it was substantially less expensive than ERCD ((sic)1,835.06 versus (sic)4,039.87 per women, respectively), and QALYs were modestly higher (0.84 versus 0.70). Our findings were supported by probabilistic sensitivity analysis. Conclusions: Clinicians need to be well informed of the benefits and risks of TOLAC among low risk women. Ideally, clinician-patient discourse would address differences in length of hospital stay and postpartum recovery time. While it is premature advocate a policy of TOLAC across maternity units, the results of the study prompt further analysis and repeat iterations, encouraging future studies to synthesis previous research and new and relevant evidence under a single comprehensive decision model.	[Fawsitt, Christopher G.; Greene, Richard A.; Lutomski, Jennifer E.] Natl Perinatal Epidemiol Ctr, Cork, Ireland; [Fawsitt, Christopher G.; Bourke, Jane; Murphy, Aileen] Natl Univ Ireland Univ Coll Cork, Sch Econ, Cork, Ireland; [Everard, Claire M.] Cork Univ Matern Hosp, Cork, Ireland	University College Cork	Fawsitt, CG (corresponding author), Natl Perinatal Epidemiol Ctr, Cork, Ireland.	c.fawsitt@ucc.ie	Bourke, Jane/GQH-8687-2022; Greene, Richard A/J-7051-2014; Lutomski, Jennifer E./U-2466-2019	Greene, Richard A/0000-0003-0247-523X; Bourke, Jane/0000-0002-3994-3239; Fawsitt, Christopher/0000-0003-4526-3659	National Perinatal Epidemiology Centre of Ireland	National Perinatal Epidemiology Centre of Ireland	This research was supported by the National Perinatal Epidemiology Centre of Ireland. The funders had no role in study design, data collection and analysis, but contributed to the critical revision of the manuscript for publication.	[Anonymous], 2007, EC ANAL HLTH CARE; Blanchette H, 2001, AM J OBSTET GYNECOL, V184, P1478, DOI 10.1067/mob.2001.114852; Bonanno C, 2011, CLIN PERINATOL, V38, P217, DOI 10.1016/j.clp.2011.03.005; Bortolini MAT, 2010, INT UROGYNECOL J, V21, P1025, DOI 10.1007/s00192-010-1146-9; Bost BW, 2003, AM J OBSTET GYNECOL, V188, P1418, DOI 10.1067/mob.2003.455; Briggs A, 2006, DECISION MODELLING H; CHATTOPADHYAY SK, 1993, EUR J OBSTET GYN R B, V52, P151, DOI 10.1016/0028-2243(93)90064-J; Chung A, 2001, OBSTET GYNECOL, V97, P932, DOI 10.1016/S0029-7844(01)01355-2; Crowther CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001192; d'Orsi E, 2001, EUR J OBSTET GYN R B, V97, P152, DOI 10.1016/S0301-2115(00)00523-6; Dekker GA, 2010, BJOG-INT J OBSTET GY, V117, P1358, DOI 10.1111/j.1471-0528.2010.02688.x; DiMaio H, 2002, AM J OBSTET GYNECOL, V186, P890, DOI 10.1067/mob.2002.123073; DOHC, 2010, CONS SAL SCAL; EISENBERG JM, 1988, AM J CLIN NUTR, V47, P382, DOI 10.1093/ajcn/47.2.382; Fitzpatrick KE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001184; Fu JC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-548; Fuglenes D, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.043; Grobman WA, 2000, OBSTET GYNECOL, V95, P745, DOI 10.1016/S0029-7844(00)00783-3; HAGE ML, 1992, AM J OBSTET GYNECOL, V166, P1853, DOI 10.1016/0002-9378(92)91577-W; Harrington J., 2008, SLAN 2007 SURVEY LIF; Hemminki E, 1996, AM J OBSTET GYNECOL, V174, P1569, DOI 10.1016/S0002-9378(96)70608-7; Hibbard JU, 2001, AM J OBSTET GYNECOL, V184, P1365, DOI 10.1067/mob.2001.115044; Hibbard JU, 2006, OBSTET GYNECOL, V108, P125, DOI 10.1097/01.AOG.0000223871.69852.31; HIQA, 2009, HLTH TECHN ASS HTA P; *HIQA, 2010, GUID EC EV HLTH TECH; Homer CSE, 2011, MIDWIFERY, V27, P165, DOI 10.1016/j.midw.2009.04.009; Jackson S, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.023; Jauniaux E, 2012, PLACENTA, V33, P244, DOI 10.1016/j.placenta.2011.11.010; Kazandjian VA, 2006, J EVAL CLIN PRACT, V13, P16; Kwee A, 2007, EUR J OBSTET GYN R B, V132, P171, DOI 10.1016/j.ejogrb.2006.07.017; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Lydon-Rochelle MT, 2010, SEMIN PERINATOL, V34, P249, DOI 10.1053/j.semperi.2010.03.004; MacDorman M, 2011, CLIN PERINATOL, V38, P179, DOI 10.1016/j.clp.2011.03.007; McMahon MJ, 1996, NEW ENGL J MED, V335, P689, DOI 10.1056/NEJM199609053351001; MidU, 2009, EV MIDW LED CAR HLTH; NHS, 1997, 1 CLASS DEL IMPR MAT; NICE, 2007, INTR CAR; NPRS, 2011, PER STAT REP 2009; O'Connor DJ, 2011, ANN VASC SURG, V25, P9, DOI 10.1016/j.avsg.2010.04.003; QWB, 2008, QUAL WELL BEING SELF; RIA, 2009, COND REG IMP AN; Rossi AC, 2008, AM J OBSTET GYNECOL, V199, P224, DOI 10.1016/j.ajog.2008.04.025; Sinnott P, 2007, PREFERENCE MEASUREME; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Tahseen S, 2010, BJOG-INT J OBSTET GY, V117, P5, DOI 10.1111/j.1471-0528.2009.02351.x; Tower C L, 2000, J Obstet Gynaecol, V20, P365; Wen SW, 2004, AM J OBSTET GYNECOL, V191, P1263, DOI 10.1016/j.ajog.2004.03.022; Zwecker P, 2011, AM J PERINAT, V28, P277, DOI 10.1055/s-0030-1271213	48	29	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58577	10.1371/journal.pone.0058577	http://dx.doi.org/10.1371/journal.pone.0058577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484038	Green Published, gold			2022-12-27	WOS:000316936100126
J	Kang, FX; Wang, H; Gao, YZ; Long, J; Wang, Q				Kang, Fuxing; Wang, Hong; Gao, Yanzheng; Long, Jian; Wang, Qian			Ca2+ Promoted the Low Transformation Efficiency of Plasmid DNA Exposed to PAH Contaminants	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; STRUCTURAL-ANALYSIS; ESCHERICHIA-COLI; ORGANIC-MATTER; GENE-TRANSFER; DEGRADATION; WATER; FTIR; CD	The effects of interactions between genetic materials and polycyclic aromatic hydrocarbons (PAHs) on gene expression in the extracellular environment remain to be elucidated and little information is currently available on the effect of ionic strength on the transformation of plasmid DNA exposed to PAHs. Phenanthrene and pyrene were used as representative PAHs to evaluate the transformation of plasmid DNA after PAH exposure and to determine the role of Ca2+ during the transformation. Plasmid DNA exposed to the test PAHs demonstrated low transformation efficiency. In the absence of PAHs, the transformation efficiency was 4.7 log units; however, the efficiency decreased to 3.72-3.14 log units with phenanthrene/pyrene exposures of 50 mu g.L-1. The addition of Ca2+ enhanced the low transformation efficiency of DNA exposed to PAHs. Based on the co-sorption of Ca2+ and phenanthrene/pyrene by DNA, we employed Fourier-transform infrared spectroscopy (FTIR), X-ray photoelectron spectroscopy (XPS), and mass spectrometry (MS) to determine the mechanisms involved in PAH-induced DNA transformation. The observed low transformation efficiency of DNA exposed to either phenanthrene or pyrene can be attributed to a broken hydrogen bond in the double helix caused by planar PAHs. Added Ca2+ formed strong electrovalent bonds with "-POO-'' groups in the DNA, weakening the interaction between PAHs and DNA based on weak molecular forces. This decreased the damage of PAHs to hydrogen bonds in double-stranded DNA by isolating DNA molecules from PAHs and consequently enhanced the transformation efficiency of DNA exposed to PAH contaminants. The findings provide insight into the effects of anthropogenic trace PAHs on DNA transfer in natural environments.	[Kang, Fuxing; Wang, Hong; Gao, Yanzheng] Nanjing Agr Univ, Coll Resource & Environm Sci, Inst Organ Contaminant Control & Soil Remediat, Nanjing, Jiangsu, Peoples R China; [Kang, Fuxing; Long, Jian] Guizhou Normal Univ, Key Lab Informat Syst Mountainous Areas & Protect, Guiyang, Peoples R China; [Wang, Qian] Nanjing Univ, Sch Earth Sci & Engn, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Agricultural University; Guizhou Normal University; Nanjing University	Gao, YZ (corresponding author), Nanjing Agr Univ, Coll Resource & Environm Sci, Inst Organ Contaminant Control & Soil Remediat, Nanjing, Jiangsu, Peoples R China.	gaoyanzheng@njau.edu.cn	Gao, Yanzheng/G-6391-2010	Gao, Yanzheng/0000-0002-3814-3555	National Natural Science Foundation of China [41171193, 51278252, 21077056]; Key Technology R&D Program of Jiangsu Province [BE2011780]; Fundamental Research Funds for the Central Universities of China [KYZ201109]; Foundation of State Key Laboratory of Pollution Control and Resources Reuse, China [PCRRF11034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technology R&D Program of Jiangsu Province; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Foundation of State Key Laboratory of Pollution Control and Resources Reuse, China	The work was supported by the National Natural Science Foundation of China (41171193, 51278252, 21077056), the Key Technology R&D Program of Jiangsu Province (BE2011780), the Fundamental Research Funds for the Central Universities of China (KYZ201109), and the Foundation of State Key Laboratory of Pollution Control and Resources Reuse, China (PCRRF11034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MP, 2005, WORLD J MICROB BIOT, V21, P1157, DOI 10.1007/s11274-005-0381-6; ALEX S, 1989, INORG CHIM ACTA, V157, P271, DOI 10.1016/S0020-1693(00)80552-6; Banyay E, 1990, SPECTROCHIM ACTA A, V46A, P107; Banyay M, 2002, J MOL BIOL, V324, P667, DOI 10.1016/S0022-2836(02)01104-X; Baur B, 1996, APPL ENVIRON MICROB, V62, P3673, DOI 10.1128/AEM.62.10.3673-3678.1996; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; Cai P, 2006, ENVIRON SCI TECHNOL, V40, P2971, DOI 10.1021/es0522985; Cai P, 2007, THESIS HUAZHONG AGR, P1; Cajthaml T, 2002, J CHROMATOGR A, V974, P213, DOI 10.1016/S0021-9673(02)00904-4; Chauhan A, 2008, INDIAN J MICROBIOL, V48, P95, DOI 10.1007/s12088-008-0010-9; FERGUSON LR, 1991, MUTAT RES, V258, P123, DOI 10.1016/0165-1110(91)90006-H; Gao YZ, 2008, PLANT SOIL, V311, P201, DOI 10.1007/s11104-008-9671-8; Gao YZ, 2008, CHEMOSPHERE, V72, P636, DOI 10.1016/j.chemosphere.2008.02.032; Gao YZ, 2007, J HAZARD MATER, V140, P138, DOI 10.1016/j.jhazmat.2006.06.053; Gao YZ, 2009, ENVIRON SCI TECHNOL, V43, P6190, DOI 10.1021/es900662d; Hamdi H, 2007, CHEMOSPHERE, V70, P135, DOI 10.1016/j.chemosphere.2007.06.043; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Inbaraj BS, 2008, BIORESOURCE TECHNOL, V99, P1026, DOI 10.1016/j.biortech.2007.03.008; JEFFREY AM, 1985, PHARMACOL THERAPEUT, V28, P237, DOI 10.1016/0163-7258(85)90013-0; Kang FX, 2010, ENVIRON SCI TECHNOL, V44, P8891, DOI 10.1021/es103215b; Kang FX, 2010, FUND APPL LIMNOL, V176, P173, DOI 10.1127/1863-9135/2010/0176-0173; KASTNER M, 1994, APPL MICROBIOL BIOT, V41, P267, DOI 10.1007/BF00186971; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Ledford HA, 2010, NATURE, DOI [10.1038/news.2010.169, DOI 10.1038/NEWS.2010.169]; Lindqvist M, 2001, J MOL BIOL, V314, P423, DOI 10.1006/jmbi.2001.5164; Liquier J, 1996, INFRARED SPECTROSCOP; LOPRETE DM, 1993, BIOCHEMISTRY-US, V32, P4077, DOI 10.1021/bi00066a032; Lou SL, 2002, GENE INTRO CELL ACCE; MAO Y, 1994, ENVIRON HEALTH PERSP, V102, P165, DOI 10.2307/3432234; Mott HV, 2002, ADV ENVIRON RES, V6, P577, DOI 10.1016/S1093-0191(01)00104-6; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ouameur AA, 2004, J BIOL CHEM, V279, P42041, DOI 10.1074/jbc.M406053200; Raber B, 1997, EUR J SOIL SCI, V48, P443, DOI 10.1046/j.1365-2389.1997.00101.x; Rensing C, 2002, SOIL BIOL BIOCHEM, V34, P285, DOI 10.1016/S0038-0717(01)00183-3; Seiichi Kondo, 2005, ADSORPTION SCI; Shimanouchi T, 1964, ADV CHEM PHYS; Stephens TD, 2000, BIOCHEM PHARMACOL, V59, P1489, DOI 10.1016/S0006-2952(99)00388-3; TAILLANDIER E, 1992, METHOD ENZYMOL, V211, P307; Tajmir-Riahi HA, 2009, SPECTROSC-INT J, V23, P81, DOI 10.1155/2009/587956; TAJMIRRIAHI HA, 1995, FEBS LETT, V370, P105, DOI 10.1016/0014-5793(95)00802-G; TSUBOI M, 1969, APPL SPECTROSC REV, V3, P45; Veronico P, 2001, FEBS LETT, V508, P470, DOI 10.1016/S0014-5793(01)03132-5; Wang X.R., 1993, ENVIRON CHEM, V2nd; Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454	45	8	10	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58238	10.1371/journal.pone.0058238	http://dx.doi.org/10.1371/journal.pone.0058238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484001	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100092
J	Santoni, D; Castiglione, F; Paci, P				Santoni, Daniele; Castiglione, Filippo; Paci, Paola			Identifying Correlations between Chromosomal Proximity of Genes and Distance of Their Products in Protein-Protein Interaction Networks of Yeast	PLOS ONE			English	Article							ORGANIZATION; NUCLEOSOME	In this article we present evidence for a relationship between chromosome gene loci and the topological properties of the protein-protein interaction network corresponding to the set of genes under consideration. Specifically, for each chromosome of the Saccharomyces cerevisiae genome, the distribution of the intra-chromosome inter-gene distances was analyzed and a positive correlation with the distance among the corresponding proteins of the protein-protein interaction network was found. In order to study this relationship we used concepts based on non-parametric statistics and information theory. We provide statistical evidence that if two genes are closely located, then it is likely that their protein products are closely located in the protein-protein interaction network, or in other words, that they are involved in the same biological process.	[Santoni, Daniele; Paci, Paola] Natl Res Council Italy, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy; [Castiglione, Filippo] Natl Res Council Italy, Inst Comp Applicat Mauro Picone, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR)	Santoni, D (corresponding author), Natl Res Council Italy, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy.	daniele.santoni@iasi.cnr.it	santoni, daniele/E-8853-2010; Castiglione, Filippo/B-1366-2010	Castiglione, Filippo/0000-0002-1442-3552; SANTONI, DANIELE/0000-0003-1898-5285	"Consorzio interuniversitario per le Applicazioni di Supercalcolo Per Universita e Ricerca" (CASPUR)	"Consorzio interuniversitario per le Applicazioni di Supercalcolo Per Universita e Ricerca" (CASPUR)	We thank the "Consorzio interuniversitario per le Applicazioni di Supercalcolo Per Universita e Ricerca" (CASPUR) for computing resources and support. We thank Professor G. Cesareni for illuminating discussion and for providing MINT data network.	Batada NN, 2007, TRENDS GENET, V23, P480, DOI 10.1016/j.tig.2007.08.003; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Duan Z, 2010, NATURE; FINCH JT, 1977, NATURE, V269, P29, DOI 10.1038/269029a0; Goetze S, 2007, SEMIN CELL DEV BIOL, V18, P707, DOI 10.1016/j.semcdb.2007.08.007; Hill T., 2006, STAT METHODS APPL; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; Lee J, 2003, GENOME RES; Lehmann E. L., 2006, NONPARAMETRICS STAT; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; MacKay D. J. C., 2003, INFORM THEORY INFERE; Numata Jorge, 2008, Genome Inform, V20, P112; Park K, 2009, PROTEOMICS, V9, P5143, DOI 10.1002/pmic.200900357; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Woodcock CL, 2001, CURR OPIN GENET DEV, V11, P130, DOI 10.1016/S0959-437X(00)00169-6; Wuchty S, 2004, GENOME RES, V14, P1310, DOI 10.1101/gr.2300204; Yanai I, 2002, TRENDS GENET, V18, P176, DOI 10.1016/S0168-9525(01)02621-X	20	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57707	10.1371/journal.pone.0057707	http://dx.doi.org/10.1371/journal.pone.0057707			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483922	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100038
J	Le Saux, CJ; Davy, P; Brampton, C; Ahuja, SS; Fauce, S; Shivshankar, P; Nguyen, H; Ramaseshan, M; Tressler, R; Pirot, Z; Harley, CB; Allsopp, R				Le Saux, Claude Jourdan; Davy, Philip; Brampton, Christopher; Ahuja, Seema S.; Fauce, Steven; Shivshankar, Pooja; Hieu Nguyen; Ramaseshan, Mahesh; Tressler, Robert; Pirot, Zhu; Harley, Calvin B.; Allsopp, Richard			A Novel Telomerase Activator Suppresses Lung Damage in a Murine Model of Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							DYSKERATOSIS-CONGENITA; REVERSE-TRANSCRIPTASE; CELLULAR SENESCENCE; IN-VIVO; CELLS; MUTATIONS; ASSOCIATION; EXPRESSION; GENE; MICE	The emergence of diseases associated with telomere dysfunction, including AIDS, aplastic anemia and pulmonary fibrosis, has bolstered interest in telomerase activators. We report identification of a new small molecule activator, GRN510, with activity ex vivo and in vivo. Using a novel mouse model, we tested the potential of GRN510 to limit fibrosis induced by bleomycin in mTERT heterozygous mice. Treatment with GRN510 at 10 mg/kg/day activated telomerase 2-4 fold both in hematopoietic progenitors ex vivo and in bone marrow and lung tissue in vivo, respectively. Telomerase activation was countered by co-treatment with Imetelstat (GRN163L), a potent telomerase inhibitor. In this model of bleomycin-induced fibrosis, treatment with GRN510 suppressed the development of fibrosis and accumulation of senescent cells in the lung via a mechanism dependent upon telomerase activation. Treatment of small airway epithelial cells (SAEC) or lung fibroblasts ex vivo with GRN510 revealed telomerase activating and replicative lifespan promoting effects only in the SAEC, suggesting that the mechanism accounting for the protective effects of GRN510 against induced lung fibrosis involves specific types of lung cells. Together, these results support the use of small molecule activators of telomerase in therapies to treat idiopathic pulmonary fibrosis.	[Le Saux, Claude Jourdan; Ahuja, Seema S.; Shivshankar, Pooja] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Davy, Philip; Brampton, Christopher; Hieu Nguyen; Allsopp, Richard] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Fauce, Steven; Ramaseshan, Mahesh; Tressler, Robert; Pirot, Zhu; Harley, Calvin B.] Geron Corp, Menlo Pk, CA USA; [Tressler, Robert] Cellerant, Redwood City, CA USA; [Fauce, Steven] Beckman Coulter Inc, Brea, CA USA	University of Texas System; University of Texas Health San Antonio; University of Hawaii System; Geron Corporation; Beckman Coulter Inc.	Allsopp, R (corresponding author), Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA.	allsopp@hawaii.edu	Le Saux, Claude/AGF-7659-2022	Le Saux, Claude/0000-0002-6041-2870	Geron Corporation	Geron Corporation	This study was funded by a small grant from Geron Corporation. Those individuals at Geron Corporation specifically responsible for funding this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239; Dasari A, 2006, CANCER RES, V66, P10805, DOI 10.1158/0008-5472.CAN-06-1236; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Diaz de Leon A, PLOS ONE, V5; Drakopanagiotakis F, 2008, EUR RESPIR J, V32, P1631, DOI 10.1183/09031936.00176807; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Fauce SR, 2008, J IMMUNOL, V181, P7400, DOI 10.4049/jimmunol.181.10.7400; Fridlender ZG, 2007, EUR RESPIR J, V30, P205, DOI 10.1183/09031936.00009407; Fust A, 2005, AM J PHYSIOL-LUNG C, V288, pL159, DOI 10.1152/ajplung.00089.2004; HARLEY CB, 1991, MUTAT RES, V256, P271, DOI 10.1016/0921-8734(91)90018-7; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Keane MP, 1999, J IMMUNOL, V162, P5511; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kottmann RM, 2009, RESPIROLOGY, V14, P917, DOI 10.1111/j.1440-1843.2009.01624.x; Lee J, 2009, AM J PHYSIOL-LUNG C, V296, pL57, DOI 10.1152/ajplung.90411.2008; Liu T, 2006, AM J RESP CELL MOL, V34, P625, DOI 10.1165/rcmb.2005-0252OC; Liu TJ, 2007, J CLIN INVEST, V117, P3800, DOI 10.1172/JCI32369; Liu TJ, 2002, AM J RESP CELL MOL, V26, P534, DOI 10.1165/ajrcmb.26.5.4668; Liu Y, 2000, CURR BIOL, V10, P1459, DOI 10.1016/S0960-9822(00)00805-8; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; Mallick S, 2008, RESP MED, V102, P1355, DOI 10.1016/j.rmed.2008.06.003; Marshall RP, 2000, THORAX, V55, P143, DOI 10.1136/thorax.55.2.143; Mazzucchelli GD, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-12; Mehrad B, 2009, INT J BIOCHEM CELL B, V41, P1708, DOI 10.1016/j.biocel.2009.02.020; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Park JI, 2009, NATURE, V460, P66, DOI 10.1038/nature08137; Roth A, 2010, RECENT RESULTS CANC, V184, P221, DOI 10.1007/978-3-642-01222-8_16; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shivshankar P, 2011, AGING CELL, V10, P798, DOI 10.1111/j.1474-9726.2011.00720.x; STACK BHR, 1972, THORAX, V27, P535, DOI 10.1136/thx.27.5.535; STELLATO C, 1995, J IMMUNOL, V155, P410; Thannickal VJ, 2008, AM J RESP CRIT CARE, V178, P663, DOI 10.1164/rccm.200807-1127ED; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Verma S, 2007, NEW ENGL J MED, V356, P1370, DOI 10.1056/NEJMcibr070490; Volonte D, 2009, AGING-US, V1, P831, DOI 10.18632/aging.100079; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Wang Y, 2009, AM J HUM GENET, V84, P52, DOI 10.1016/j.ajhg.2008.11.010; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980	46	44	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58423	10.1371/journal.pone.0058423	http://dx.doi.org/10.1371/journal.pone.0058423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516479	Green Submitted, gold, Green Published			2022-12-27	WOS:000316407400028
J	Brunnschweiler, JM; Barnett, A				Brunnschweiler, Juerg M.; Barnett, Adam			Opportunistic Visitors: Long-Term Behavioural Response of Bull Sharks to Food Provisioning in Fiji	PLOS ONE			English	Article							REEF-MARINE-RESERVE; SITE FIDELITY; CARCHARHINUS-LEUCAS; MOVEMENT PATTERNS; ECOTOURISM; WILDLIFE; TOURISM; CONSERVATION; FREQUENCY; TRACKING	Shark-based tourism that uses bait to reliably attract certain species to specific sites so that divers can view them is a growing industry globally, but remains a controversial issue. We evaluate multi-year (2004-2011) underwater visual (n = 48 individuals) and acoustic tracking data (n = 82 transmitters; array of up to 16 receivers) of bull sharks Carcharhinus leucas from a long-term shark feeding site at the Shark Reef Marine Reserve and reefs along the Beqa Channel on the southern coast of Viti Levu, Fiji. Individual C. leucas showed varying degrees of site fidelity. Determined from acoustic tagging, the majority of C. leucas had site fidelity indexes >0.5 for the marine reserve (including the feeding site) and neighbouring reefs. However, during the time of the day (09:00-12:00) when feeding takes place, sharks mainly had site fidelity indexes <0.5 for the feeding site, regardless of feeding or non-feeding days. Site fidelity indexes determined by direct diver observation of sharks at the feeding site were lower compared to such values determined by acoustic tagging. The overall pattern for C. leucas is that, if present in the area, they are attracted to the feeding site regardless of whether feeding or non-feeding days, but they remain for longer periods of time (consecutive hours) on feeding days. The overall diel patterns in movement are for C. leucas to use the area around the feeding site in the morning before spreading out over Shark Reef throughout the day and dispersing over the entire array at night. Both focal observation and acoustic monitoring show that C. leucas intermittently leave the area for a few consecutive days throughout the year, and for longer time periods (weeks to months) at the end of the calendar year before returning to the feeding site.	[Barnett, Adam] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Barnett, Adam] Inst Marine & Antarctic Studies, Fisheries Aquaculture & Coasts Ctr, Hobart, Tas, Australia	Deakin University; University of Tasmania		juerg@gluecklich.net	Brunnschweiler, Juerg/A-2110-2008	Brunnschweiler, Juerg/0000-0002-9901-3279; , Adam/0000-0001-7430-8428	Save Our Seas Foundation; Shark Foundation Switzerland	Save Our Seas Foundation; Shark Foundation Switzerland	This work was funded through grants to JMB from the Save Our Seas Foundation (http://saveourseas.com/) and the Shark Foundation Switzerland (http://www.shark.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, INFECT DIS POVERTY, DOI DOI 10.1186/s40249-020-00640-3; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2011, ANIM BEHAV, V81, P1039, DOI 10.1016/j.anbehav.2011.02.011; Bessudo S, 2011, ENVIRON BIOL FISH, V91, P165, DOI 10.1007/s10641-011-9769-3; BLACKMAN R, 1958, MEASUREMENT POWER SP; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Brunnschweiler JM, 2010, J FISH BIOL, V77, P1343, DOI 10.1111/j.1095-8649.2010.02757.x; Brunnschweiler JM, 2009, MAR FRESHW BEHAV PHY, V42, P201, DOI 10.1080/10236240903033519; Brunnschweiler JM, 2006, CYBIUM, V30, P133; Brunnschweiler JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016597; Brunnschweiler JM, 2010, J SUSTAIN TOUR, V18, P29, DOI 10.1080/09669580903071987; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Clarke C, 2011, MAR FRESHWATER RES, V62, P668, DOI 10.1071/MF10171; Clua E, 2010, MAR ECOL PROG SER, V414, P257, DOI 10.3354/meps08746; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Dobson J, 2008, MARINE WILDLIFE AND TOURISM MANAGEMENT: INSIGHTS FROM THE NATURAL AND SOCIAL SCIENCES, P49, DOI 10.1079/9781845933456.0049; Driggers WB, 2012, MAR ECOL PROG SER, V465, P185, DOI 10.3354/meps09901; Fitzpatrick R, 2011, CORAL REEFS, V30, P569, DOI 10.1007/s00338-011-0769-8; Gallagher AJ, 2011, CURR ISSUES TOUR, V14, P797, DOI 10.1080/13683500.2011.585227; Gaspar C, 2008, CYBIUM, V32, P153; Goetze JS, 2013, CORAL REEFS IN PRESS; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hearn A, 2010, MAR BIOL, V157, P1899, DOI 10.1007/s00227-010-1460-2; Knight J, 2009, SOC ANIM, V17, P167, DOI 10.1163/156853009X418091; Knip DM, 2012, MAR BIOL, V159, P1647, DOI 10.1007/s00227-012-1950-5; Laroche RK, 2007, MAR ECOL PROG SER, V338, P199, DOI 10.3354/meps338199; Maljkovic A, 2011, BIOL CONSERV, V144, P859, DOI 10.1016/j.biocon.2010.11.019; McCord ME, 2009, AFR J MAR SCI, V31, P107, DOI 10.2989/AJMS.2009.31.1.11.782; Meyer CG, 2010, MAR BIOL, V157, P1499, DOI 10.1007/s00227-010-1424-6; Meyer CG, 2009, ENVIRON CONSERV, V36, P104, DOI 10.1017/S0376892909990038; Milazzo M, 2006, MAR ECOL PROG SER, V310, P165, DOI 10.3354/meps310165; Milazzo M, 2011, ENVIRON BIOL FISH, V91, P127, DOI 10.1007/s10641-011-9784-4; Newsome David., 2005, WILDLIFE TOURISM; Orams MB, 2002, TOURISM MANAGE, V23, P281, DOI 10.1016/S0261-5177(01)00080-2; Papastamatiou YP, 2010, MAR FRESHWATER RES, V61, P1366, DOI 10.1071/MF10056; Rasalato E, 2010, ENVIRON CONSERV, V37, P90, DOI 10.1017/S0376892910000317; Semeniuk CAD, 2008, MAR ECOL PROG SER, V357, P271, DOI 10.3354/meps07299; Semeniuk CAD, 2007, ENVIRON MANAGE, V40, P665, DOI 10.1007/s00267-006-0321-8; Semeniuk CAD, 2009, BIOL CONSERV, V142, P1818, DOI 10.1016/j.biocon.2009.03.022; Shackley M., 1998, Journal of Sustainable Tourism, V6, P328, DOI 10.1080/09669589808667320; Speed CW, 2012, CORAL REEFS, V31, P357, DOI 10.1007/s00338-011-0850-3; Speed CW, 2011, MAR ECOL PROG SER, V429, P261, DOI 10.3354/meps09080; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Taylor S, 2011, MAR FRESHWATER RES, V62, P638, DOI 10.1071/MF10154; Welsh JQ, 2012, CORAL REEFS, V31, P693, DOI 10.1007/s00338-012-0892-1	47	66	67	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58522	10.1371/journal.pone.0058522	http://dx.doi.org/10.1371/journal.pone.0058522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516496	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000316849200077
J	Kesisova, IA; Nakos, KC; Tsolou, A; Angelis, D; Lewis, J; Chatzaki, A; Agianian, B; Giannis, A; Koffa, MD				Kesisova, Iliana A.; Nakos, Konstantinos C.; Tsolou, Avgi; Angelis, Dimitrios; Lewis, Joe; Chatzaki, Aikaterini; Agianian, Bogos; Giannis, Athanassios; Koffa, Maria D.			Tripolin A, a Novel Small-Molecule Inhibitor of Aurora A Kinase, Reveals New Regulation of HURP's Distribution on Microtubules	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; A KINASE; MITOTIC SPINDLE; CENTROSOME AMPLIFICATION; CHROMOSOME CONGRESSION; HUMAN-CELLS; MLN8054; TPX2; OVEREXPRESSION; DYNAMICS	Mitotic regulators exhibiting gain of function in tumor cells are considered useful cancer therapeutic targets for the development of small-molecule inhibitors. The human Aurora kinases are a family of such targets. In this study, from a panel of 105 potential small-molecule inhibitors, two compounds Tripolin A and Tripolin B, inhibited Aurora A kinase activity in vitro. In human cells however, only Tripolin A acted as an Aurora A inhibitor. We combined in vitro, in vivo single cell and in silico studies to demonstrate the biological action of Tripolin A, a non-ATP competitive inhibitor. Tripolin A reduced the localization of pAurora A on spindle microtubules (MTs), affected centrosome integrity, spindle formation and length, as well as MT dynamics in interphase, consistent with Aurora A inhibition by RNAi or other specific inhibitors, such as MLN8054 or MLN8237. Interestingly, Tripolin A affected the gradient distribution towards the chromosomes, but not the MT binding of HURP (Hepatoma Up-Regulated Protein), a MT-associated protein (MAP) and substrate of the Aurora A kinase. Therefore Tripolin A reveals a new way of regulating mitotic MT stabilizers through Aurora A phosphorylation. Tripolin A is predicted to bind Aurora A similarly but not identical to MLN8054, therefore it could be used to dissect pathways orchestrated by Aurora kinases as well as a scaffold for further inhibitor development.	[Kesisova, Iliana A.; Nakos, Konstantinos C.; Tsolou, Avgi; Angelis, Dimitrios; Agianian, Bogos; Koffa, Maria D.] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Lewis, Joe] European Mol Biol Lab, Chem Biol Core Facil, D-69012 Heidelberg, Germany; [Chatzaki, Aikaterini] Democritus Univ Thrace, Dept Med, Alexandroupolis, Greece; [Giannis, Athanassios] Univ Leipzig, Inst Organ Chem, D-04109 Leipzig, Germany	Democritus University of Thrace; European Molecular Biology Laboratory (EMBL); Democritus University of Thrace; Leipzig University	Koffa, MD (corresponding author), Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece.	mkoffa@mbg.duth.gr	Tsolou, Avgi/L-7776-2017; Koffa, Maria/AAP-3999-2020; Agianian, Bogos/O-8019-2016	Agianian, Bogos/0000-0003-1295-6846; Lewis, Joe/0000-0002-9926-1328; Koffa, Maria (Margy)/0000-0003-2255-3426	Bodossaki Foundation; European Community's Seventh Framework Programme (FP7) [227764]; FP7-REGPOT-2008 [229971]	Bodossaki Foundation; European Community's Seventh Framework Programme (FP7); FP7-REGPOT-2008	IAK was supported by a Bodossaki Foundation postgraduate fellowship (http://www.bodossaki.gr/Default.aspx?lang=2) and by a p-cube short-term fellowship. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 227764 (P-CUBE). The CIBIT facility was supported by a FP7-REGPOT-2008 grant (no 229971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Asteriti IA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-131; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; De Luca M, 2006, CELL CYCLE, V5, P296; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dodson CA, 2010, BIOCHEM J, V427, P19, DOI 10.1042/BJ20091530; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Giet R, 2002, J CELL BIOL, V156, P437, DOI 10.1083/jcb.200108135; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Goepfert TM, 2002, CANCER RES, V62, P4115; Gorgun G, 2010, BLOOD, V115, P5202, DOI 10.1182/blood-2009-12-259523; Gruss OJ, 2002, NAT CELL BIOL, V4, P871, DOI 10.1038/ncb870; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Hu W, 2005, ONCOL RES, V15, P49, DOI 10.3727/096504005775082101; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kirkin V, 2001, EUR J BIOCHEM, V268, P5530, DOI 10.1046/j.1432-1033.2001.02476.x; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155; Lorenzo C, 2009, CELL CYCLE, V8, P1733, DOI 10.4161/cc.8.11.8617; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Plotnikova OV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1061; Santarella RA, 2007, J MOL BIOL, V365, P1587, DOI 10.1016/j.jmb.2006.10.064; Sardon T, 2009, CHEMBIOCHEM, V10, P464, DOI 10.1002/cbic.200800600; Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070; Sloane DA, 2010, ACS CHEM BIOL, V5, P563, DOI 10.1021/cb100053q; Soncini C, 2006, CLIN CANCER RES, V12, P4080, DOI 10.1158/1078-0432.CCR-05-1964; Song DS, 2010, ANAL QUANT CYTOL, V32, P280; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Yang Y, 2012, MOL BIOSYST, V8, P3049, DOI 10.1039/c2mb25217a; Ye F, 2011, CURR BIOL, V21, P1584, DOI 10.1016/j.cub.2011.08.024; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005	41	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58485	10.1371/journal.pone.0058485	http://dx.doi.org/10.1371/journal.pone.0058485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516487	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200072
J	Ng, YH; Rome, S; Jalabert, A; Forterre, A; Singh, H; Hincks, CL; Salamonsen, LA				Ng, York Hunt; Rome, Sophie; Jalabert, Audrey; Forterre, Alexis; Singh, Harmeet; Hincks, Cassandra L.; Salamonsen, Lois A.			Endometrial Exosomes/Microvesicles in the Uterine Microenvironment: A New Paradigm for Embryo-Endometrial Cross Talk at Implantation	PLOS ONE			English	Article							CHORIONIC-GONADOTROPIN; DENDRITIC CELLS; EXOSOMES; MECHANISM; EXPRESSION; MICRORNAS; MICROVESICLES; PROGESTERONE; RECEPTIVITY; PROTEINS	Exosomes are nanoparticles (similar to 100 nm diameter) released from cells, which can transfer small RNAs and mRNA via the extracellular environment to cells at distant sites. We hypothesised that exosomes or the slightly larger microvesicles (100-300 nm) are released from the endometrial epithelium into the uterine cavity, and that these contain specific micro (mi)RNA that could be transferred to either the trophectodermal cells of the blastocyst or to endometrial epithelial cells, to promote implantation. The aim of this study was to specifically identify and characterise exosomes/microvesicles (mv) released from endometrial epithelial cells and to determine whether exosomes/mv are present in uterine fluid. Immunostaining demonstrated that the tetraspanins, CD9 and CD63 used as cell surface markers of exosomes are present on the apical surfaces of endometrial epithelial cells in tissue sections taken across the menstrual cycle: CD63 showed cyclical regulation. Exosome/mv pellets were prepared from culture medium of endometrial epithelial cell (ECC1 cells) and from uterine fluid and its associated mucus by sequential ultracentifugation. Exosomes/mv were positively identified in all preparations by FACS and immunofluorescence staining following exosome binding to beads. Size particle analysis confirmed the predominance of particles of 50-150 nm in each of these fluids. MiRNA analysis of the ECC1 cells and their exosomes/mv demonstrated sorting of miRNA into exosomes/mv: 13 of the 227 miRNA were specific to exosomes/mv, while a further 5 were not present in these. The most abundant miRNA in exosomes/mv were hsa-miR-200c, hsa-miR-17 and hsa-miR-106a. Bioinformatic analysis showed that the exosome/mv-specific miRNAs have potential targets in biological pathways highly relevant for embryo implantation. Thus exosomes/mv containing specific miRNA are present in the microenvironment in which embryo implantation occurs and may contribute to the endometrial-embryo cross talk essential for this process.	[Ng, York Hunt; Singh, Harmeet; Hincks, Cassandra L.; Salamonsen, Lois A.] Prince Henrys Inst Med Res, Melbourne, Vic, Australia; [Rome, Sophie; Jalabert, Audrey; Forterre, Alexis] Univ Lyon, Fac Med Lyon Sud, INSA, Lab CarMeN,Inserm 1060,INRA 1235, Oullins, France	Prince Henry's Institute of Medical Research; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm)	Salamonsen, LA (corresponding author), Prince Henrys Inst Med Res, Melbourne, Vic, Australia.	lois.salamonsen@princehenrys.org	Salamonsen, Lois/J-9822-2019	Forterre, Alexis/0000-0002-5000-9009; Salamonsen, Lois/0000-0003-0558-7325; ROME, SOPHIE/0000-0003-3986-5936	National Health and Medical Research Council of Australia [494802, 1002028]; Victorian Government's Operational Infrastructure Support Program; Australian Government; Fondation pour la Recherche Medicale; Association Francaise de recherche sur les Myopathies; Association Francaise de Diabetologie; INRA specific grant - ANSSD	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Australian Government(Australian GovernmentCGIAR); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association Francaise de recherche sur les Myopathies; Association Francaise de Diabetologie; INRA specific grant - ANSSD	Work in the Salamonsen Laboratory was supported by the National Health and Medical Research Council of Australia, Program grant #494802 and Fellowship #1002028 to LAS (www.nhmrc.gov.au). The Victorian Government's Operational Infrastructure Support Program (www.business.vic.gov.au/industries/science-technology-and-innovation/programs/medical-research-operational-infrastructure-program). YHN was the recipient of an Endeavour Fellowship from the Australian Government (http://www.innovation.gov.au/INTERNATIONALEDUCATION/ENDEAVOURAWARDS). The Rome laboratory is supported by Fondation pour la Recherche Medicale (www.frm.org), Association Francaise de recherche sur les Myopathies (www.afm-telethon.com), Association Francaise de Diabetologie (www.sfdiabete.org) and an INRA specific grant - ANSSD (www.international.inra.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PHI Data Audit 12-28.	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Aliotta JM, 2010, EXP HEMATOL, V38, P233, DOI 10.1016/j.exphem.2010.01.002; Altmae S, 2012, REPROD SCI IN PRESS; Aplin JD, 2006, REPROD BIOMED ONLINE, V13, P833, DOI 10.1016/S1472-6483(10)61032-2; Apparao KBC, 2001, J CLIN ENDOCR METAB, V86, P4991, DOI 10.1210/jc.86.10.4991; Bang C, 2012, INT J BIOCHEM CELL B, V44, P2060, DOI 10.1016/j.biocel.2012.08.007; Burnett LA, 2012, J CLIN ENDOCR METAB, V97, P4613, DOI 10.1210/jc.2012-2098; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Deo A, 2011, J BIOINF COMPUT BIOL, V9, P795, DOI 10.1142/S0219720011005793; Dominguez F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013380; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Forterre A, 2013, MYOTUBES SO IN PRESS; Germeyer A, 2007, FERTIL STERIL, V87, P657, DOI 10.1016/j.fertnstert.2006.07.1526; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Hannan NJ, 2011, ENDOCRINOLOGY, V152, P4948, DOI 10.1210/en.2011-1248; Hannan NJ, 2010, BIOL REPROD, V82, P235, DOI 10.1095/biolreprod.109.077800; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; Hessvik NP, 2012, BBA-GENE REGUL MECH, V1819, P1154, DOI 10.1016/j.bbagrm.2012.08.016; Jones CJP, 2009, GLYCOCONJUGATE J, V26, P359, DOI 10.1007/s10719-008-9152-6; Kaneko Y, 2013, J MORPHOL, V274, P63, DOI 10.1002/jmor.20076; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lee Y, 2012, HUM MOL GENET, V21, pR125, DOI 10.1093/hmg/dds317; LESSEY BA, 1995, FERTIL STERIL, V63, P535, DOI 10.1016/S0015-0282(16)57422-6; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li R, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-29; Licht P, 2007, MOL CELL ENDOCRINOL, V269, P85, DOI 10.1016/j.mce.2006.09.016; Liu WM, 2006, J MOL ENDOCRINOL, V36, P121, DOI 10.1677/jme.1.01910; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; McCallie B, 2010, FERTIL STERIL, V93, P2374, DOI 10.1016/j.fertnstert.2009.01.069; Meseguer M, 2001, BIOL REPROD, V64, P590, DOI 10.1095/biolreprod64.2.590; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Murphy CR, 2000, HUM REPROD, V15, P182, DOI 10.1093/humrep/15.suppl_3.182; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Okada H, 1999, MOL HUM REPROD, V5, P554, DOI 10.1093/molehr/5.6.554; Paiva P, 2011, HUM REPROD, V26, P1153, DOI 10.1093/humrep/der027; Paiva P, 2009, CYTOKINE GROWTH F R, V20, P319, DOI 10.1016/j.cytogfr.2009.07.001; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Rana S, 2011, INT J BIOCHEM CELL B, V43, P106, DOI 10.1016/j.biocel.2010.10.002; Salamonsen LA, 2012, FERTIL STER IN PRESS; Salamonsen LA, 2009, REPROD FERT DEVELOP, V21, P923, DOI 10.1071/RD09145; Segura E, 2007, J IMMUNOL, V179, P1489, DOI 10.4049/jimmunol.179.3.1489; Sha AG, 2011, FERTIL STERIL, V96, P150, DOI 10.1016/j.fertnstert.2011.04.072; Sherwin JRA, 2007, ENDOCRINOLOGY, V148, P618, DOI 10.1210/en.2006-0832; Shimomura Y, 2006, MOL HUM REPROD, V12, P491, DOI 10.1093/molehr/gal019; Silveira CGT, 2012, HUM REPROD, V27, P3187, DOI 10.1093/humrep/des282; Simpson RJ, 2008, PROTEOMICS, V8, P4083, DOI 10.1002/pmic.200800109; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vogel R, 2011, ANAL CHEM, V83, P3499, DOI 10.1021/ac200195n; Wang J, 2002, CELLS TISSUES ORGANS, V172, P190, DOI 10.1159/000066970	59	238	247	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58502	10.1371/journal.pone.0058502	http://dx.doi.org/10.1371/journal.pone.0058502			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516492	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200074
J	Robinson, DP; Jaidah, MY; Jabado, RW; Lee-Brooks, K; El-Din, NMN; Al Malki, AA; Elmeer, K; McCormick, PA; Henderson, AC; Pierce, SJ; Ormond, RFG				Robinson, David P.; Jaidah, Mohammed Y.; Jabado, Rima W.; Lee-Brooks, Katie; El-Din, Nehad M. Nour; Al Malki, Ameena A.; Elmeer, Khaled; McCormick, Paul A.; Henderson, Aaron C.; Pierce, Simon J.; Ormond, Rupert F. G.			Whale Sharks, Rhincodon typus, Aggregate around Offshore Platforms in Qatari Waters of the Arabian Gulf to Feed on Fish Spawn	PLOS ONE			English	Article							SATELLITE TRACKING; DIVING BEHAVIOR; POPULATION; MOVEMENTS; BIOLOGY; SEA; IDENTIFICATION; ABUNDANCE; ECOLOGY; ISLAND	Whale sharks, Rhincodon typus, are known to aggregate to feed in a small number of locations in tropical and subtropical waters. Here we document a newly discovered major aggregation site for whale sharks within the Al Shaheen oil field, 90 km off the coast of Qatar in the Arabian Gulf. Whale sharks were observed between April and September, with peak numbers observed between May and August. Density estimates of up to 100 sharks within an area of 1 km(2) were recorded. Sharks ranged between four and eight metres' estimated total length (mean 6.92 +/- 1.53 m). Most animals observed were actively feeding on surface zooplankton, consisting primarily of mackerel tuna, Euthynnus affinis, eggs.	[Robinson, David P.; Ormond, Rupert F. G.] Herriot Watt Univ, Edinburgh, Midlothian, Scotland; [Jaidah, Mohammed Y.; El-Din, Nehad M. Nour; Al Malki, Ameena A.; Elmeer, Khaled; McCormick, Paul A.] Qatar Minist Environm, Doha, Qatar; [Jabado, Rima W.] UAE Univ, Abu Dhabi, U Arab Emirates; [Lee-Brooks, Katie] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Pierce, Simon J.] Marine Megafauna Fdn, ECOCEAN USA, Tofo Beach, Mozambique; [Ormond, Rupert F. G.] Marine Conservat Int, Edinburgh, Midlothian, Scotland	Heriot Watt University; United Arab Emirates University; University of York - UK	Robinson, DP (corresponding author), Herriot Watt Univ, Edinburgh, Midlothian, Scotland.	sharkwatcharabia@gmail.com	Elmeer, Khaled/GWQ-5808-2022	Jabado, Rima/0000-0001-6239-6723; Henderson, Aaron/0000-0001-8873-0785; Elmeer, Khaled/0000-0002-7855-5319	Qatar Ministry of Environment. Direct collaborators within the Qatar Ministry of Environment; Save Our Seas Foundation; Shark Foundation	Qatar Ministry of Environment. Direct collaborators within the Qatar Ministry of Environment; Save Our Seas Foundation; Shark Foundation	The research project was funded through the Qatar Ministry of Environment. Direct collaborators within the Qatar Ministry of Environment also provided advice, support in study design, data collection and analysis. DPR's work on this manuscript was supported by funding from the Save Our Seas Foundation. SJP's work on this manuscript was supported by the Shark Foundation and private donors. The journal publication fees for this manuscript were provided by Maersk Oil. All other funders, apart from collaborators from the Qatar Ministry of Environment, had no role in the preparation or decision to publish the manuscript.	Alava M, 1997, FISHERY TRADE WHALE; Alava MNR, 2002, ELASMOBRANCH BIODIVE, P132; Anderson R.C., 1993, SHARK FISHERIES MALD; [Anonymous], [No title captured]; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Beech MJ, 2005, EMIRATES NATURAL HIS; BISHOP JM, 1993, J FISH BIOL, V43, P939, DOI 10.1006/jfbi.1993.1197; Blegvad H, 1944, DANISH SCI INVESTI 3; Brooks Katie, 2010, Western Indian Ocean Journal of Marine Science, V9, P185; Brown J, 1992, TRIBULUS, V2.1, P22; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Che-Tsimg C, 1997, PRELIMINARY REPORT T; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; Compagno LJ, 1984, FAO FISH SYNOP, V125, P209; Compango LJV, 2001, SHARKS WORLD ANNOTAT; Venegas RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018994; Eckert SA, 2002, J ZOOL, V257, P111, DOI 10.1017/S0952836902000705; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Gifford A, 2007, FISH RES, V84, P17, DOI 10.1016/j.fishres.2006.11.011; Girard C, 2004, ANIM BEHAV, V67, P319, DOI 10.1016/j.anbehav.2003.07.007; Graham RT, 2007, FISH RES, V84, P71, DOI 10.1016/j.fishres.2006.11.026; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Hanfee F, 2001, GENTLE GIANTS SEA IN; Heyman WD, 2001, MAR ECOL PROG SER, V215, P275, DOI 10.3354/meps215275; Hoffmayer Eric R., 2007, Gulf and Caribbean Research, V19, P69; Hsu HH, 2007, FISH RES, V84, P25, DOI 10.1016/j.fishres.2006.11.030; Itano D, 2004, DEV DESIGN RECENT ST; Joung SJ, 1996, ENVIRON BIOL FISH, V46, P219, DOI 10.1007/BF00004997; Mahdi, 1971, ADDITIONS MARINE FIS; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; Meekan MG, 2009, MAR FRESHWATER RES, V60, P607, DOI 10.1071/MF08254; Meekan MG, 2006, MAR ECOL PROG SER, V319, P275, DOI 10.3354/meps319275; Motlagh SAT, 2010, IRAN J FISH SCI, V9, P315; Motta PJ, 2010, ZOOLOGY, V113, P199, DOI 10.1016/j.zool.2009.12.001; Nelson JD, 2007, FISH RES, V84, P47, DOI 10.1016/j.fishres.2006.11.013; Newell G. E., 1979, MARINE PLANKTON PRAC; Newman H.E., 2002, Occasional Papers of the IUCN Species Survival Commission, V25, P230; Norman B, 2005, IUCN 2012 IUCN RED L; Norman B. M., 1999, ASPECTS BIOL ECOTOUR; Pierce SJ, 2010, AQUAT CONSERV, V20, P782, DOI 10.1002/aqc.1149; RAMACHANDRAN A, 1990, Fishery Technology, V27, P138; Ramirez-Macias D, 2012, J FISH BIOL, V80, P1401, DOI 10.1111/j.1095-8649.2012.03258.x; Riley MJ, 2010, AQUAT BIOL, V8, P145, DOI 10.3354/ab00215; Rose M., 1933, FAUNE FRANCE, V26; Rowat D, 2007, FISH RES, V84, P32, DOI 10.1016/j.fishres.2006.11.009; Rowat D, 2007, ENVIRON BIOL FISH, V80, P465, DOI 10.1007/s10641-006-9148-7; Rowat D, 2012, J FISH BIOL, V80, P1019, DOI 10.1111/j.1095-8649.2012.03252.x; ROWAT D, 1997, PHELSUMA NATURE PROT, V5, P77; Rowat D, 2011, MAR FRESHWATER RES, V62, P621, DOI 10.1071/MF10135; Rowat D, 2009, J EXP MAR BIOL ECOL, V368, P1, DOI 10.1016/j.jembe.2008.09.001; Sequeira A, 2011, DIVERSITY DISTRIBUTI; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; Sivasubramaniam K, 1981, DEMERSAL RESOURCES G; Sivasubramaniam K., 1983, QATAR SCI B, V3, P297; Speed CW, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-2; Struthers I, 2009, PLANKTON GUIDE THEIR; Todd CD, 1991, COASTAL MARINE ZOOPL; Trono R., 1996, IUCN NEWSLETTER SHAR, V7, P13; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; White A.W., 1971, COMMON SEA FISHES AR; White AE, 1971, SURVEY TRUCIAL STATE, V1; Wilson SG, 2007, FISH OCEANOGR, V16, P547, DOI 10.1111/j.1365-2419.2007.00450.x; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8; Yamaji I, 1986, ILLUSTRATIONS MARINE	64	75	77	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58255	10.1371/journal.pone.0058255	http://dx.doi.org/10.1371/journal.pone.0058255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516456	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200050
J	Kurt, K; Rasigade, JP; Laurent, F; Goering, RV; Zemlickova, H; Machova, I; Struelens, MJ; Zautner, AE; Holtfreter, S; Broker, B; Ritchie, S; Reaksmey, S; Limmathurotsakul, D; Peacock, SJ; Cuny, C; Layer, F; Witte, W; Nubel, U				Kurt, Kevin; Rasigade, Jean-Philippe; Laurent, Frederic; Goering, Richard V.; Zemlickova, Helena; Machova, Ivana; Struelens, Marc J.; Zautner, Andreas E.; Holtfreter, Silva; Broeker, Barbara; Ritchie, Stephen; Reaksmey, Sin; Limmathurotsakul, Direk; Peacock, Sharon J.; Cuny, Christiane; Layer, Franziska; Witte, Wolfgang; Nuebel, Ulrich			Subpopulations of Staphylococcus aureus Clonal Complex 121 Are Associated with Distinct Clinical Entities	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; RESISTANT IMPETIGO CLONE; CHROMOSOME MEC SCCMEC; METHICILLIN-RESISTANT; FUSIDIC ACID; EXFOLIATIVE TOXIN; EDIN-B; COMMUNITY; INFECTIONS; EMERGENCE	We investigated the population structure of Staphylococcus aureus clonal complex CC121 by mutation discovery at 115 genetic housekeeping loci from each of 154 isolates, sampled on five continents between 1953 and 2009. In addition, we pyro-sequenced the genomes from ten representative isolates. The genome-wide SNPs that were ascertained revealed the evolutionary history of CC121, indicating at least six major clades (A to F) within the clonal complex and dating its most recent common ancestor to the pre-antibiotic era. The toxin gene complement of CC121 isolates was correlated with their SNP-based phylogeny. Moreover, we found a highly significant association of clinical phenotypes with phylogenetic affiliations, which is unusual for S. aureus. All isolates evidently sampled from superficial infections (including staphylococcal scalded skin syndrome, bullous impetigo, exfoliative dermatitis, conjunctivitis) clustered in clade F, which included the European epidemic fusidic-acid resistant impetigo clone (EEFIC). In comparison, isolates from deep-seated infections (abscess, furuncle, pyomyositis, necrotizing pneumonia) were disseminated in several clades, but not in clade F. Our results demonstrate that phylogenetic lineages with distinct clinical properties exist within an S. aureus clonal complex, and that SNPs serve as powerful discriminatory markers, able to identify these lineages. All CC121 genomes harboured a 41-kilobase prophage that was dissimilar to S. aureus phages sequenced previously. Community-associated MRSA and MSSA from Cambodia were extremely closely related, suggesting this MRSA arose in the region.	[Kurt, Kevin; Cuny, Christiane; Layer, Franziska; Witte, Wolfgang; Nuebel, Ulrich] Robert Koch Inst, Wernigerode, Germany; [Rasigade, Jean-Philippe; Laurent, Frederic] Univ Lyon, Fac Med, Natl Reference Ctr Staphylococci, Lyon, France; [Goering, Richard V.] Creighton Univ, Sch Med, Omaha, NE USA; [Zemlickova, Helena; Machova, Ivana] Natl Inst Publ Hlth, Prague, Czech Republic; [Struelens, Marc J.] European Ctr Dis Prevent & Control, Stockholm, Sweden; [Zautner, Andreas E.] Univ Med Gottingen, Inst Med Mikrobiol, Gottingen, Germany; [Holtfreter, Silva; Broeker, Barbara] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [Ritchie, Stephen] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Reaksmey, Sin] Angkor Hosp Children, Siem Reap, Cambodia; [Limmathurotsakul, Direk; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Peacock, Sharon J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	Robert Koch Institute; Creighton University; National Institute of Public Health (SZU) - Czech Republic; European Centre for Disease Prevention & Control; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ernst Moritz Arndt Universitat Greifswald; University of Auckland; Mahidol University; University of Cambridge	Nubel, U (corresponding author), Robert Koch Inst, Wernigerode, Germany.	nuebelu@rki.de	Zemlickova, Helena/G-6105-2017; Rasigade, Jean-Philippe/AAE-1667-2021; Rasigade, Jean-Philippe/L-9320-2014; Zautner, Andreas Erich/ABA-9655-2020; Laurent, Frederic/M-4719-2014; Zautner, Andreas Erich/AAE-7425-2019; Peacock, Sharon J/ABE-6331-2020; Bröker, Barbara M/O-4850-2015; LAURENT, Frederic/AGM-0706-2022	Zemlickova, Helena/0000-0002-3868-0545; Rasigade, Jean-Philippe/0000-0002-8264-0452; Zautner, Andreas Erich/0000-0003-0984-013X; Zautner, Andreas Erich/0000-0003-0984-013X; Bröker, Barbara M/0000-0002-5020-8542; Peacock, Sharon/0000-0002-1718-2782; Limmathurotsakul, Direk/0000-0001-7240-5320; Struelens, Marc/0000-0001-5150-4944; Layer, Franziska/0000-0002-4613-6478; Ritchie, Stephen/0000-0001-5001-8899; laurent, frederic/0000-0003-0609-9091; Goering, Richard/0000-0001-7502-7185; Holtfreter, Silva/0000-0002-2672-8230	European Commission, Framework Programme 7 (project TROCAR)	European Commission, Framework Programme 7 (project TROCAR)	This work was partially funded by the European Commission, Framework Programme 7 (project TROCAR). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P3790, DOI 10.1128/JCM.01192-06; Amagai M, 2002, J INVEST DERMATOL, V118, P845, DOI 10.1046/j.1523-1747.2002.01751.x; Basset P, 2012, J CLIN MICROBIOL, V50, P1475, DOI 10.1128/JCM.00664-11; Bukowski M, 2010, TOXINS, V2, P1148, DOI 10.3390/toxins2051148; Chheng K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006630; Chlebowicz MA, 2010, ANTIMICROB AGENTS CH, V54, P783, DOI 10.1128/AAC.00696-09; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Durupt F, 2007, BRIT J DERMATOL, V157, P1161, DOI 10.1111/j.1365-2133.2007.08197.x; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Franke GC, 2010, MICROBIOL-SGM, V156, P860, DOI 10.1099/mic.0.030304-0; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Gravet A, 2001, J CLIN MICROBIOL, V39, P4349, DOI 10.1128/JCM.39.12.4349-4356.2001; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; HOOD AM, 1953, J HYG-CAMBRIDGE, V51, P1, DOI 10.1017/S0022172400015448; Iwatsuki K, 2006, J DERMATOL SCI, V42, P203, DOI 10.1016/j.jdermsci.2006.03.011; Kaneko J, 2004, BIOSCI BIOTECH BIOCH, V68, P981, DOI 10.1271/bbb.68.981; Larsen AR, 2008, J ANTIMICROB CHEMOTH, V61, P589, DOI 10.1093/jac/dkm532; Laurent F, 2009, J ANTIMICROB CHEMOTH, V63, P420, DOI 10.1093/jac/dkn456; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Masiuk H, 2010, J CLIN MICROBIOL, V48, P1527, DOI 10.1128/JCM.02094-09; McAdam PR, 2012, P NATL ACAD SCI USA, V109, P9107, DOI 10.1073/pnas.1202869109; Melles DC, 2006, EMERG INFECT DIS, V12, P1174, DOI 10.3201/eid1207.050865; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Nickerson EK, 2011, AM J TROP MED HYG, V84, P313, DOI 10.4269/ajtmh.2011.10-0300; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; Noto MJ, 2006, ANTIMICROB AGENTS CH, V50, P2782, DOI 10.1128/AAC.00032-06; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; O'Hara FP, 2008, J INFECT DIS, V197, P187, DOI 10.1086/524684; O'Neill AJ, 2007, J CLIN MICROBIOL, V45, P1505, DOI 10.1128/JCM.01984-06; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Rasigade JP, 2010, J INFECT DIS, V201, P1589, DOI 10.1086/652008; Rijnders MIA, 2012, J ANTIMICROB CHEMOTH, V67, P1176, DOI 10.1093/jac/dkr590; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruzickova V, 2012, INT J MED MICROBIOL, V302, P237, DOI 10.1016/j.ijmm.2012.04.001; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; Turner KME, 2007, INT J ANTIMICROB AG, V29, P129, DOI 10.1016/j.ijantimicag.2006.11.002; Wirtz C, 2010, VIROLOGY, V406, P322, DOI 10.1016/j.virol.2010.07.017; Yamaguchi T, 2002, INFECT IMMUN, V70, P5835, DOI 10.1128/IAI.70.10.5835-5845.2002; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	45	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58155	10.1371/journal.pone.0058155	http://dx.doi.org/10.1371/journal.pone.0058155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505464	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500056
J	Novozhilova, E; Olivius, P; Siratirakun, P; Lundberg, C; Englund-Johansson, U				Novozhilova, Ekaterina; Olivius, Petri; Siratirakun, Piyaporn; Lundberg, Cecilia; Englund-Johansson, Ulrica			Neuronal Differentiation and Extensive Migration of Human Neural Precursor Cells following Co-Culture with Rat Auditory Brainstem Slices	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; DORSAL-ROOT GANGLION; PROGENITOR CELLS; INNER-EAR; IN-VITRO; HAIR-CELLS; SPIRAL GANGLION; COCHLEAR IMPLANTATION; SENSORY NEURONS; MAMMALIAN BRAIN	Congenital or acquired hearing loss is often associated with a progressive degeneration of the auditory nerve (AN) in the inner ear. The AN is composed of processes and axons of the bipolar spiral ganglion neurons (SGN), forming the connection between the hair cells in the inner ear cochlea and the cochlear nuclei (CN) in the brainstem (BS). Therefore, replacement of SGNs for restoring the AN to improve hearing function in patients who receive a cochlear implantation or have severe AN malfunctions is an attractive idea. A human neural precursor cell (HNPC) is an appropriate donor cell to investigate, as it can be isolated and expanded in vitro with maintained potential to form neurons and glia. We recently developed a post-natal rodent in vitro auditory BS slice culture model including the CN and the central part of the AN for initial studies of candidate cells. Here we characterized the survival, distribution, phenotypic differentiation, and integration capacity of HNPCs into the auditory circuitry in vitro. HNPC aggregates (spheres) were deposited adjacent to or on top of the BS slices or as a monoculture (control). The results demonstrate that co-cultured HNPCs compared to monocultures (1) survive better, (2) distribute over a larger area, (3) to a larger extent and in a shorter time-frame form mature neuronal and glial phenotypes. HNPC showed the ability to extend neurites into host tissue. Our findings suggest that the HNPC-BS slice co-culture is appropriate for further investigations on the integration capacity of HNPCs into the auditory circuitry.	[Olivius, Petri] Cty Council Ostergotland, UHL, Dept ENT Head & Neck Surg, Linkoping, Sweden; [Novozhilova, Ekaterina; Olivius, Petri] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Otorhinolaryngol & Head & Neck Surg, Linkoping, Sweden; [Novozhilova, Ekaterina; Olivius, Petri; Siratirakun, Piyaporn] Karolinska Univ Hosp, Ctr Hearing & Commun Res, Stockholm, Sweden; [Novozhilova, Ekaterina; Olivius, Petri; Siratirakun, Piyaporn] Karolinska Univ Hosp, Karolinska Inst, Sect Otorhinolaryngol, Dept Clin Neurosci, Stockholm, Sweden; [Lundberg, Cecilia] Lund Univ, Dept Expt Med Sci, CNS Gene Therapy Unit, Lund, Sweden; [Englund-Johansson, Ulrica] Lund Univ, Dept Ophthalmol, Inst Clin Sci Lund, Lund, Sweden	City Council Ostergotland; Linkoping University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University; Lund University	Olivius, P (corresponding author), Cty Council Ostergotland, UHL, Dept ENT Head & Neck Surg, Linkoping, Sweden.	petri.olivius@lio.se		Olivius, Petri/0000-0002-7401-9826; Lundberg, Cecilia/0000-0002-6959-2564	Swedish Research Council [2008-2822]; Marianne and Marcus Wallenbergs Foundation; Petrus and Augusta Hedlunds Foundation; Swedish Association of Hard of Hearing People; Acta Otolaryngologica's Foundation; Foundation Tysta Skolan; Ollie and Elof Ericssons Foundation for Medical Research; Karolinska Institutet Foundations; Medical faculty; Lund University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne and Marcus Wallenbergs Foundation; Petrus and Augusta Hedlunds Foundation; Swedish Association of Hard of Hearing People; Acta Otolaryngologica's Foundation; Foundation Tysta Skolan; Ollie and Elof Ericssons Foundation for Medical Research; Karolinska Institutet Foundations(Karolinska Institutet); Medical faculty; Lund University	P. Olivius: This work was supported by The Swedish Research Council n:o 2008-2822, Marianne and Marcus Wallenbergs Foundation, Petrus and Augusta Hedlunds Foundation, The Swedish Association of Hard of Hearing People, Acta Otolaryngologica's Foundation, The Foundation Tysta Skolan, Ollie and Elof Ericssons Foundation for Medical Research and Karolinska Institutet Foundations. U. Englund-Johansson: This work was supported by the Medical faculty and Lund University. The funders hade no role in the study design, data collection and analysis, descision to publish, or preparation of the manuscript.	Altschuler RA, 2008, HEARING RES, V242, P110, DOI 10.1016/j.heares.2008.06.004; Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; BAJJALIEH SM, 1992, SCIENCE, V257, P1271, DOI 10.1126/science.1519064; Baker PS, 2009, CURR OPIN OPHTHALMOL, V20, P175, DOI 10.1097/ICU.0b013e328329b5f2; Benninger F, 2003, J NEUROSCI, V23, P7075, DOI 10.1523/JNEUROSCI.23-18-07075.2003; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Bjorklund A, 2000, NATURE, V405, P892, DOI 10.1038/35016175; Burnstein RM, 2004, INT J BIOCHEM CELL B, V36, P702, DOI 10.1016/j.biocel.2003.11.011; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Carricondo F, 2010, CELL TISSUE RES, V342, P13, DOI 10.1007/s00441-010-1039-8; Chen W, 2012, NATURE, V490, P278, DOI 10.1038/nature11415; Christophersen NS, 2006, BRAIN RES BULL, V70, P457, DOI 10.1016/j.brainresbull.2006.07.001; Coco A, 2007, HEARING RES, V225, P60, DOI 10.1016/j.heares.2006.12.004; Coleman B, 2007, EXP CELL RES, V313, P232, DOI 10.1016/j.yexcr.2006.10.010; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Corrales CE, 2006, J NEUROBIOL, V66, P1489, DOI 10.1002/neu.20310; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Englund U, 2002, EXP NEUROL, V173, P1, DOI 10.1006/exnr.2001.7750; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Englund U, 2000, NEUROREPORT, V11, P3973, DOI 10.1097/00001756-200012180-00014; Englund-Johansson U, 2010, EXP EYE RES, V90, P292, DOI 10.1016/j.exer.2009.11.005; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Fricker RA, 1999, J NEUROSCI, V19, P5990, DOI 10.1523/JNEUROSCI.19-14-05990.1999; Glavaski-Joksimovic A, 2009, NEUROSCIENCE, V162, P472, DOI 10.1016/j.neuroscience.2009.04.070; Glavaski-Joksimovic A, 2008, CLONING STEM CELLS, V10, P75, DOI 10.1089/clo.2007.0065; Groves AK, 2010, EXP BIOL MED, V235, P434, DOI 10.1258/ebm.2009.009281; Gunewardene N, 2012, STEM CELL REV REP, V8, P741, DOI 10.1007/s12015-011-9320-0; Han Z, 2010, NEUROREPORT, V21, P490, DOI 10.1097/WNR.0b013e3283383410; Hu ZQ, 2005, NEUROBIOL DIS, V18, P184, DOI 10.1016/j.nbd.2004.09.010; Hu ZQ, 2004, BRAIN RES, V1026, P68, DOI 10.1016/j.brainres.2004.08.013; Hu ZQ, 2004, EXP NEUROL, V185, P7, DOI 10.1016/j.expneurol.2003.09.013; Ibekwe TS, 2012, J LARYNGOL OTOL, V126, P653, DOI 10.1017/S0022215112000850; Jongkamonwiwat N, 2010, CURR DRUG TARGETS, V11, P888, DOI 10.2174/138945010791320836; Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72; Kamei N, 2004, NEUROREPORT, V15, P2579, DOI 10.1097/00001756-200412030-00004; Kim Hyuk Min, 2010, Exp Neurobiol, V19, P106, DOI 10.5607/en.2010.19.2.106; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li HW, 2003, P NATL ACAD SCI USA, V100, P13495, DOI 10.1073/pnas.2334503100; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Lundberg C, 2002, EXP NEUROL, V175, P370, DOI 10.1006/exnr.2002.7888; Martinez-Moneder R, 2007, INT J DEV BIOL, V51, P655, DOI 10.1387/ijdb.072372rm; Martinez-Monedero R, 2008, DEV NEUROBIOL, V68, P669, DOI 10.1002/dneu.20616; Matsumoto M, 2008, J NEUROSCI RES, V86, P3075, DOI 10.1002/jnr.21754; McBride JL, 2004, J COMP NEUROL, V475, P211, DOI 10.1002/cne.20176; Nishimura K, 2009, NEUROREPORT, V20, P1250, DOI 10.1097/WNR.0b013e32832ff287; Olivius P, 2004, BRAIN RES PROTOC, V12, P152, DOI 10.1016/j.brainresprot.2003.11.002; Olivius P, 2003, BRAIN RES, V979, P1, DOI 10.1016/S0006-8993(03)02802-6; Ostenfeld T, 2000, EXP NEUROL, V164, P215, DOI 10.1006/exnr.2000.7427; Palmgren B, 2011, BRAIN RES, V1377, P41, DOI 10.1016/j.brainres.2010.12.078; Pandit SR, 2011, STEM CELLS, V29, P670, DOI 10.1002/stem.609; Park DH, 2010, THESCIENTIFICWORLDJO, V10, P470, DOI 10.1100/tsw.2010.39; Pfingst BE, 2011, HEARING RES, V281, P65, DOI 10.1016/j.heares.2011.05.002; Radojevic V, 2004, EXP NEUROL, V188, P11, DOI 10.1016/j.expneurol.2004.03.015; Rask-Andersen H, 2005, HEARING RES, V203, P180, DOI 10.1016/j.heares.2004.12.005; Regala C, 2005, EXP NEUROL, V193, P326, DOI 10.1016/j.expneurol.2004.12.027; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rivolta Marcelo N., 2006, V330, P71; Rivolta MN, 2010, DRUG DISCOV TODAY, V15, P283, DOI 10.1016/j.drudis.2010.02.006; Roth TN, 2011, EUR ARCH OTO-RHINO-L, V268, P1101, DOI 10.1007/s00405-011-1597-8; Salazar DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012272; Scheffler B, 2003, DEVELOPMENT, V130, P5533, DOI 10.1242/dev.00714; Skogh C, 2001, MOL CELL NEUROSCI, V17, P811, DOI 10.1006/mcne.2001.0973; Sullivan JM, 2011, NEUROBIOL DIS, V41, P552, DOI 10.1016/j.nbd.2010.11.001; Takuma H, 2002, NEUROSCIENCE, V109, P359, DOI 10.1016/S0306-4522(01)00472-9; Thonabulsombat C, 2007, BRAIN RES, V1170, P48, DOI 10.1016/j.brainres.2007.06.085; Ulfendahl M, 2007, PHYSIOL BEHAV, V92, P75, DOI 10.1016/j.physbeh.2007.05.054; Visigalli I, 2010, BLOOD, V116, P5130, DOI 10.1182/blood-2010-04-278234; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7	72	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57301	10.1371/journal.pone.0057301	http://dx.doi.org/10.1371/journal.pone.0057301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505423	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500015
J	Verhoef, SPM; Camps, SGJA; Bouwman, FG; Mariman, ECM; Westerterp, KR				Verhoef, Sanne P. M.; Camps, Stefan G. J. A.; Bouwman, Freek G.; Mariman, Edwin C. M.; Westerterp, Klaas R.			Physiological Response of Adipocytes to Weight Loss and Maintenance	PLOS ONE			English	Article							TISSUE GENE-EXPRESSION; ADIPOSE-TISSUE; FAT OXIDATION; RESTRICTION; AUTOPHAGY; OBESITY	Background: Metabolic processes in adipose tissue are dysregulated in obese subjects and, in response to weight loss, either normalize or change in favor of weight regain. Objective: To determine changes in adipocyte glucose and fatty acid metabolism in relation to changes in adipocyte size during weight loss and maintenance. Methods: Twenty-eight healthy subjects (12 males), age 20-50 y, and BMI 28-35 kg/m(2), followed a very low energy diet for 2 months, followed by a 10-month period of weight maintenance. Body weight, body composition (deuterium dilution and BodPod), protein levels (Western blot) and adipocyte size were assessed prior to and after weight loss and after the 10-month follow-up. Results: A 10% weight loss resulted in a 16% decrease in adipocyte size. A marker for glycolysis decreased (AldoC) during weight loss in association with adipocyte shrinking, and remained decreased during follow-up in association with weight maintenance. A marker for fatty acid transport increased (FABP4) during weight loss and remained increased during follow-up. Markers for mitochondrial beta-oxidation (HADHsc) and lipolysis (ATGL) were only increased after the 10-month follow-up. During weight loss HADHsc and ATGL were coordinately regulated, which became weaker during follow-up due to adipocyte size-related changes in HADHsc expression. AldoC was the major denominator of adipocyte size and body weight, whereas changes in ATGL during weight loss contributed to body weight during follow-up. Upregulation of ATGL and HADHsc occured in the absence of a negative energy balance and was triggered by adipocyte shrinkage or indicated preadipocyte differentiation. Conclusion: Markers for adipocyte glucose and fatty acid metabolism are changed in response to weight loss in line with normalization from a dysregulated obese status to an improved metabolic status.	[Verhoef, Sanne P. M.; Camps, Stefan G. J. A.; Bouwman, Freek G.; Mariman, Edwin C. M.; Westerterp, Klaas R.] Maastricht Univ, Nutr & Toxicol Res Inst Maastricht, Dept Human Biol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Verhoef, SPM (corresponding author), Maastricht Univ, Nutr & Toxicol Res Inst Maastricht, Dept Human Biol, Maastricht, Netherlands.	s.verhoef@maastrichtuniversity.nl	Biguzzi, Felipe A/E-4724-2015; Camps, Stefan/AAM-8648-2020	Camps, Stefan/0000-0003-2053-1135	NUTRIM	NUTRIM	This work was supported by NUTRIM (http://www.nutrim.unimaas.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin D, 2004, OBES RES, V12, P1231, DOI 10.1038/oby.2004.156; Bennetzen MF, 2005, INT J OBES LOND, V35, P1377; Blaak EE, 2006, J CLIN ENDOCR METAB, V91, P1462, DOI 10.1210/jc.2005-1598; Bouwman FG, 2009, J PROTEOME RES, V8, P5532, DOI 10.1021/pr900606m; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capel F, 2008, J CLIN ENDOCR METAB, V93, P4315, DOI 10.1210/jc.2008-0814; Chen HC, 2002, J LIPID RES, V43, P986; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; Frisancho AR, 2003, AM J HUM BIOL, V15, P522, DOI 10.1002/ajhb.10191; GOLDRICK RB, 1967, AM J PHYSIOL, V212, P777, DOI 10.1152/ajplegacy.1967.212.4.777; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; Kovsan J, 2011, J CLIN ENDOCR METAB, V96, pE268, DOI 10.1210/jc.2010-1681; Kovsan J, 2010, AM J PHYSIOL-ENDOC M, V298, pE1, DOI 10.1152/ajpendo.00562.2009; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; MacLean PS, 2011, AM J PHYSIOL-REG I, V301, pR581, DOI 10.1152/ajpregu.00755.2010; Mariman ECM, 2012, J NUTRIGENET NUTRIGE, V5, P13, DOI 10.1159/000337081; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Marquez-Quinones A, 2010, AM J CLIN NUTR, V92, P975, DOI 10.3945/ajcn.2010.29808; Mutch DM, 2011, AM J CLIN NUTR, V94, P1399, DOI 10.3945/ajcn.110.006858; Siri W., 1961, TECHNIQUES MEASURING, P223; Walewski JL, 2010, OBES SURG, V20, P93, DOI 10.1007/s11695-009-0002-9; Wang P, 2009, PROTEOMICS, V9, P2955, DOI 10.1002/pmic.200800826; Westerterp KR, 2008, AM J CLIN NUTR, V87, P132, DOI 10.1093/ajcn/87.1.132; WESTERTERP KR, 1995, OBES RES, V3, P49, DOI 10.1002/j.1550-8528.1995.tb00007.x; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323	26	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58011	10.1371/journal.pone.0058011	http://dx.doi.org/10.1371/journal.pone.0058011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505452	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500044
J	Wang, JS; Lei, YM; Xiong, K; Marek, K				Wang, Jinsung; Lei, Yuming; Xiong, Khongchee; Marek, Katie			Substantial Generalization of Sensorimotor Learning from Bilateral to Unilateral Movement Conditions	PLOS ONE			English	Article							SINGLE LIMB PERFORMANCE; INTERLIMB TRANSFER; VISUOMOTOR ROTATIONS; ADAPTATION; REHABILITATION; DYNAMICS; SKILL	Controversy exists regarding whether bimanual skill learning can generalize to unimanual performance. For example, some investigators showed that dynamic adaptation could only partially generalize between bilateral and unilateral movement conditions, while others demonstrated complete generalization of visuomotor adaptation. Here, we identified three potential factors that might have contributed to the discrepancy between the two sets of findings. In our first experiment, subjects performed reaching movements toward eight targets bilaterally with a novel force field applied to both arms, then unilaterally with the force field applied to one arm. Results showed that the dynamic adaptation generalized completely from bilateral to unilateral movements. In our second experiment, the same force field was only applied to one arm during both bilateral and unilateral movements. Results indicated complete transfer again. Finally, our subjects performed reaching movements toward a single target with the force field or a novel visuomotor rotation applied only to one arm during both bilateral and unilateral movements. The reduced breadth of experience obtained during bilateral movements resulted in incomplete transfer, which explains previous findings of limited generalization. These findings collectively suggest a substantial overlap between the neural processes underlying bilateral and unilateral movements, supporting the idea that bilateral training, often employed in stroke rehabilitation, is a valid method for improving unilateral performance. However, our findings also suggest that while the neural representations developed during bilateral training can generalize to facilitate unilateral performance, the extent of generalization may depend on the breadth of experience obtained during bilateral training.	[Wang, Jinsung; Lei, Yuming; Xiong, Khongchee; Marek, Katie] Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Wang, JS (corresponding author), Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA.	wang34@uwm.edu			National Institutes of Health [K01HD050245]; University of Wisconsin - Milwaukee SURF Awards; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K01HD050245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin - Milwaukee SURF Awards; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the National Institutes of Health grant K01HD050245 (JW) and University of Wisconsin - Milwaukee SURF Awards (KX, KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraduc P, 2002, J NEUROPHYSIOL, V88, P973, DOI 10.1152/jn.2002.88.2.973; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Burgess JK, 2007, IEEE T NEUR SYS REH, V15, P347, DOI 10.1109/TNSRE.2007.903908; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Cauraugh JH, 2010, HUM MOVEMENT SCI, V29, P853, DOI 10.1016/j.humov.2009.09.004; FRANZ EA, 1992, J MOTOR BEHAV, V24, P281, DOI 10.1080/00222895.1992.9941623; Galea JM, 2007, EXP BRAIN RES, V182, P267, DOI 10.1007/s00221-007-1069-y; Heuer H., 1996, HDB PERCEPTION ACTIO, V2, P121; Howard IS, 2010, J NEUROPHYSIOL, V104, P2082, DOI 10.1152/jn.00299.2010; Jancke L, 2000, NEUROPSYCHOLOGIA, V38, P164, DOI 10.1016/S0028-3932(99)00062-7; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Sainburg RL, 2002, EXP BRAIN RES, V145, P437, DOI 10.1007/s00221-002-1140-7; SCHMIDT RA, 1992, PSYCHOL SCI, V3, P207, DOI 10.1111/j.1467-9280.1992.tb00029.x; Seidler RD, 2004, J COGNITIVE NEUROSCI, V16, P65, DOI 10.1162/089892904322755566; Shadmehr R, 2000, J NEUROSCI, V20, P7807; SHEA CH, 1990, RES Q EXERCISE SPORT, V61, P169, DOI 10.1080/02701367.1990.10608671; Stewart KC, 2006, J NEUROL SCI, V244, P89, DOI 10.1016/j.jns.2006.01.005; Stinear JW, 2004, J CLIN NEUROPHYSIOL, V21, P124, DOI 10.1097/00004691-200403000-00008; Stoykov ME, 2009, OCCUP THER INT, V16, P190, DOI 10.1002/oti.277; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Swinnen SP, 2004, TRENDS COGN SCI, V8, P18, DOI 10.1016/j.tics.2003.10.017; Tcheang L, 2007, EXP BRAIN RES, V127, P182; Trlep M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-43; Waller SM, 2004, ARCH PHYS MED REHAB, V85, P1076, DOI 10.1016/j.apmr.2003.10.020; Wang JS, 2010, J NEUROPHYSIOL, V104, P2913, DOI 10.1152/jn.00225.2010; Wang JS, 2009, J NEUROPHYSIOL, V102, P2790, DOI 10.1152/jn.00444.2009; Wang JS, 2005, J NEUROSCI, V25, P4024, DOI 10.1523/JNEUROSCI.5000-04.2005; Wang JS, 2004, J NEUROPHYSIOL, V92, P349, DOI 10.1152/jn.00960.2003	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58495	10.1371/journal.pone.0058495	http://dx.doi.org/10.1371/journal.pone.0058495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23505519	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500092
J	Xu, HZ; Wang, ZQ; Wang, Y; Hu, SD; Liu, NF				Xu, Hongzeng; Wang, Zhongqun; Wang, Yan; Hu, Shengda; Liu, Naifeng			Biodistribution and Elimination Study of Fluorine-18 Labeled N-epsilon-Carboxymethyl-Lysine following Intragastric and Intravenous Administration	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; POSITRON-EMISSION-TOMOGRAPHY; CACO-2 CELL MONOLAYERS; TRANSEPITHELIAL FLUX; DIABETIC-NEPHROPATHY; MAILLARD REACTION; HUMAN HEALTH; AMINO-ACID; ENDPRODUCTS; N-EPSILON-(CARBOXYMETHYL)LYSINE	Background: N-epsilon-carboxymethyl-lysine (CML) is a major advanced glycation end-product (AGEs) widely found in foods. The aim of our study was to evaluate how exogenous CML-peptide is dynamically absorbed from the gastrointestinal tract and eliminated by renal tubular secretion using microPET imaging. Methods: The present study consisted of three investigations. In study I, we synthesized the imaging tracer F-18-CML by reacting N-succinimidyl 4-F-18-fluorobenzoate (F-18-SFB) with CML. In study II, the biological activity of F-18-CML was evaluated in RAW264.7 cells and HepG2 cells. In study III, the biodistribution and elimination of AGEs in ICR mice were studied in vivo following tail vein injection and intragastric administration of F-18-CML. Result: The formation of F-18-CML was confirmed by comparing its retention time with the corresponding reference compound F-19-CML. The radiochemical purity (RCP) of F-18-CML was >95%, and it showed a stable character in vitro and in vivo. Uptake of F-18-CML by RAW264.7 cells and HepG2 cells could be inhibited by unmodified CML. F-18-CML was quickly distributed via the blood, and it was rapidly excreted through the kidneys 20 min after tail vein injection. However, F-18-CML was only slightly absorbed following intragastric administration. After administration of F-18-CML via a stomach tube, the radioactivity was completely localized in the stomach for the first 15 min. At 150 min post intragastric administration, intense accumulation of radioactivity in the intestines was still observed. Conclusions: PET technology is a powerful tool for the in vivo analysis of the gastrointestinal absorption of orally administered drugs. F-18-CML is hardly absorbed by the gastrointestinal tract. It is rapidly distributed and eliminated from blood following intravenous administration. Thus, it may not be harmful to healthy bodies. Our study showed the feasibility of noninvasively imaging F-18-labeled AGEs and was the first to describe CML-peptide gastrointestinal absorption by means of PET.	[Xu, Hongzeng; Wang, Zhongqun; Hu, Shengda; Liu, Naifeng] Southeast Univ, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Wang, Yan] Jiangsu Inst Nucl Med, Wuxi, Peoples R China	Southeast University - China	Liu, NF (corresponding author), Southeast Univ, Zhongda Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	liunf@seu.edu.cn	Liu, Nai-feng/AAM-7836-2020		National Natural Science Foundation of China [81170254]; Research and Innovation Project for College Graduates of Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and Innovation Project for College Graduates of Jiangsu Province	This work was partly supported by the National Natural Science Foundation of China (No. 81170254) to Prof. Naifeng Liu (http://www.nsfc.gov.cn/Portal0/default124.htm) and sponsored by the Research and Innovation Project for College Graduates of Jiangsu Province (http://www.ec.js.edu.cn/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2009, J CLIN BIOCHEM NUTR, V44, P14, DOI 10.3164/jcbn.08-190; Ames JM, 2008, ANN NY ACAD SCI, V1126, P20, DOI 10.1196/annals.1433.030; Ames JM, 2007, MOL NUTR FOOD RES, V51, P1085, DOI 10.1002/mnfr.200600304; Bergmann R, 2001, NAHRUNG, V45, P182, DOI 10.1002/1521-3803(20010601)45:3&lt;182::AID-FOOD182&gt;3.0.CO;2-Q; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Drusch S, 1999, FOOD CHEM, V65, P547, DOI 10.1016/S0308-8146(98)00244-1; Forster A, 2005, ANN NY ACAD SCI, V1043, P474, DOI 10.1196/annals.1333.054; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Grunwald S, 2006, BRIT J NUTR, V95, P1221, DOI 10.1079/BJN20061793; Gugliucci A, 1996, DIABETOLOGIA, V39, P149, DOI 10.1007/BF00403957; Hellwig M, 2011, CHEMBIOCHEM, V12, P1270, DOI 10.1002/cbic.201000759; Hellwig M, 2009, J AGR FOOD CHEM, V57, P6474, DOI 10.1021/jf901224p; Henle T, 2005, AMINO ACIDS, V29, P313, DOI 10.1007/s00726-005-0200-2; Henle T, 2003, KIDNEY INT, V63, pS145, DOI 10.1046/j.1523-1755.63.s84.16.x; Henle T, 2007, MOL NUTR FOOD RES, V51, P1075, DOI 10.1002/mnfr.200700067; Horiuchi S, 2002, J HEPATOL, V36, P123, DOI 10.1016/S0168-8278(01)00293-8; Hull GLJ, 2012, FOOD CHEM, V131, P170, DOI 10.1016/j.foodchem.2011.08.055; Hultsch C, 2006, NUCL MED BIOL, V33, P865, DOI 10.1016/j.nucmedbio.2006.07.007; Ikeda K, 1996, BIOCHEMISTRY-US, V35, P8075, DOI 10.1021/bi9530550; Ilchmann A, 2010, J ALLERGY CLIN IMMUN, V125, P175, DOI 10.1016/j.jaci.2009.08.013; Koschinsky T, 1997, P NATL ACAD SCI USA, V94, P6474, DOI 10.1073/pnas.94.12.6474; Kuchar M, 2012, AMINO ACIDS; Kuniyasu A, 2003, FEBS LETT, V537, P85, DOI 10.1016/S0014-5793(03)00096-6; Lasne MC, 2002, TOP CURR CHEM, V222, P201; Li ZB, 2010, ADV DRUG DELIVER REV, V62, P1031, DOI 10.1016/j.addr.2010.09.007; Lin RY, 2003, ATHEROSCLEROSIS, V168, P213, DOI 10.1016/S0021-9150(03)00050-9; Miyazaki A, 2002, TRENDS CARDIOVAS MED, V12, P258, DOI 10.1016/S1050-1738(02)00171-8; Ohgami N, 2001, J BIOL CHEM, V276, P13348, DOI 10.1074/jbc.M011613200; Ohgami Nobutaka, 2003, J Atheroscler Thromb, V10, P1; Park H, 2010, J BIOL CHEM, V285, P40762, DOI 10.1074/jbc.M110.169276; Pawelke B, 2005, AMINO ACIDS, V29, P377, DOI 10.1007/s00726-005-0202-0; Perkins BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035655; Piroddi M, 2011, J RENAL NUTR, V21, P329, DOI 10.1053/j.jrn.2010.06.024; Rapin JR, 2010, CLINICS, V65, P635, DOI 10.1590/S1807-59322010000600012; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; Saito A, 2005, ANN NY ACAD SCI, V1043, P637, DOI 10.1196/annals.1333.072; Sano H, 1999, MECH AGEING DEV, V107, P333, DOI 10.1016/S0047-6374(99)00011-1; Semba RD, 2012, EUR J CLIN NUTR, V66, P3, DOI 10.1038/ejcn.2011.139; Semba RD, 2010, J RENAL NUTR, V20, P74, DOI 10.1053/j.jrn.2009.08.001; Serdons K, 2009, METHODS, V48, P104, DOI 10.1016/j.ymeth.2009.03.010; Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567; Svistounov D, 2004, J HEPATOL, V41, P1038, DOI 10.1016/j.jhep.2004.10.004; Tessier FJ, 2012, AMINO ACIDS, V42, P1119, DOI 10.1007/s00726-010-0776-z; Uribarri J, 2005, ANN NY ACAD SCI, V1043, P461, DOI 10.1196/annals.1333.052; Uribarri J, 2007, J GERONTOL A-BIOL, V62, P427, DOI 10.1093/gerona/62.4.427; Vaidyanathan G, 2006, NAT PROTOC, V1, P1655, DOI 10.1038/nprot.2006.264; Wang ZQ, 2012, ATHEROSCLEROSIS, V221, P387, DOI 10.1016/j.atherosclerosis.2012.01.019; Wuest F, 2005, AMINO ACIDS, V29, P323, DOI 10.1007/s00726-005-0201-1; Zheng F, 2002, DIABETES-METAB RES, V18, P224, DOI 10.1002/dmrr.283	50	15	15	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57897	10.1371/journal.pone.0057897	http://dx.doi.org/10.1371/journal.pone.0057897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505446	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500038
J	Bermingham, D; Hill, RD; Woltz, D; Gardner, MK				Bermingham, Douglas; Hill, Robert D.; Woltz, Dan; Gardner, Michael K.			Cognitive Strategy Use and Measured Numeric Ability in Immediate- and Long-Term Recall of Everyday Numeric Information	PLOS ONE			English	Article							SELF-GENERATED MNEMONICS; AGE-DIFFERENCES; OLDER-ADULTS; MEMORY; PERFORMANCE; LIMITS; PLASTICITY; YOUNGER; SKILL; LEVEL	The goals of this study were to assess the primary effects of the use of cognitive strategy and a combined measure of numeric ability on recall of every-day numeric information (i.e. prices). Additionally, numeric ability was assessed as a moderator in the relationship between strategy use and memory for prices. One hundred participants memorized twelve prices that varied from 1 to 6 digits; they recalled these immediately and after 7 days. The use of strategies, assessed through self-report, was associated with better overall recall, but not forgetting. Numeric ability was not associated with either better overall recall or forgetting. A small moderating interaction was found, in which higher levels of numeric ability enhanced the beneficial effects of strategy use on overall recall. Exploratory analyses found two further small moderating interactions: simple strategy use enhanced overall recall at higher levels of numeric ability, compared to complex strategy use; and complex strategy use was associated with lower levels of forgetting, but only at higher levels of numeric ability, compared to the simple strategy use. These results provide support for an objective measure of numeric ability, as well as adding to the literature on memory and the benefits of cognitive strategy use.	[Bermingham, Douglas; Hill, Robert D.; Woltz, Dan; Gardner, Michael K.] Univ Utah, Dept Educ Psychol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Bermingham, D (corresponding author), Univ Utah, Dept Educ Psychol, Salt Lake City, UT 84112 USA.	doug.bermingham@utah.edu						BALTES PB, 1992, DEV PSYCHOL, V28, P121, DOI 10.1037/0012-1649.28.1.121; BALTES PB, 1993, GERONTOLOGIST, V33, P580, DOI 10.1093/geront/33.5.580; Bjork E.L., 1996, HDB PERCEPTION COGNI, V10, P411; Blanchet S, 2006, AGING NEUROPSYCHOL C, V13, P490, DOI 10.1080/13825580500428492; Carr M, 2011, CONTEMP EDUC PSYCHOL, V36, P323, DOI 10.1016/j.cedpsych.2011.04.002; Castel AD, 2005, PSYCHOL AGING, V20, P718, DOI 10.1037/0882-7974.20.4.718; Castel AD, 2007, J GERONTOL B-PSYCHOL, V62, pP194, DOI 10.1093/geronb/62.3.P194; Castel AD, 2007, MEM COGNITION, V35, P689, DOI 10.3758/BF03193307; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Craik F. I., 1982, AGING COGNITIVE PROC, P191, DOI DOI 10.1007/978-1-4684-4178-9_11; Craik F. I. M., 1986, HUMAN MEMORY COGNITI; Craik F. I. M., 1977, HDB PSYCHOL AGING; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; CRAIK FIM, 1987, J EXP PSYCHOL LEARN, V13, P474, DOI 10.1037/0278-7393.13.3.474; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Derwinger A, 2005, NEUROPSYCHOL REHABIL, V15, P37, DOI 10.1080/09602010343000336; Derwinger A, 2003, AGING NEUROPSYCHOL C, V10, P202, DOI 10.1076/anec.10.3.202.16452; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Ekstrom R., 1976, MANUAL KIT FACTOR RE; Gaskill PJ, 2004, CONTEMP EDUC PSYCHOL, V29, P27, DOI 10.1016/S0361-476X(03)00008-0; Gobet F, 1996, COGNITIVE PSYCHOL, V31, P1, DOI 10.1006/cogp.1996.0011; Hagen E. P., 2001, COGNITIVE ABILITIES; Hambrick DZ, 2005, J MEM LANG, V52, P377, DOI 10.1016/j.jml.2005.01.004; Hambrick DZ, 2002, COGNITIVE PSYCHOL, V44, P339, DOI 10.1006/cogp.2001.0769; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; HILL RD, 1990, EXP AGING RES, V16, P141, DOI 10.1080/07340669008251541; Hill RD, 1997, EXP AGING RES, V23, P275, DOI 10.1080/03610739708254284; HILL RD, 1993, PERCEPT MOTOR SKILL, V76, P467, DOI 10.2466/pms.1993.76.2.467; Kalakoski V, 2007, SCAND J PSYCHOL, V48, P87, DOI 10.1111/j.1467-9450.2007.00535.x; KLIEGL R, 1989, DEV PSYCHOL, V25, P247, DOI 10.1037/0012-1649.25.2.247; Kliegl R, 1987, COGNITION INSTRUCT; MacDonald SWS, 2006, J EXP PSYCHOL GEN, V135, P368, DOI 10.1037/0096-3445.135.3.368; Mayer RE, 2003, J EDUC PSYCHOL, V95, P833, DOI 10.1037/0022-0663.95.4.833; Morrow DG, 2001, PSYCHOL AGING, V16, P31, DOI 10.1037//0882-7974.16.1.31; PRESSLEY M, 1988, CONTEMP EDUC PSYCHOL, V13, P157, DOI 10.1016/0361-476X(88)90016-1; REBOK GW, 1989, DEV PSYCHOL, V25, P714, DOI 10.1037/0012-1649.25.5.714; Weber N, 2003, APPL COGNITIVE PSYCH, V17, P295, DOI 10.1002/acp.865	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57999	10.1371/journal.pone.0057999	http://dx.doi.org/10.1371/journal.pone.0057999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483964	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100068
J	De Cecco, L; Berardi, M; Sommariva, M; Cataldo, A; Canevari, S; Mezzanzanica, D; Iorio, MV; Tagliabue, E; Balsari, A				De Cecco, Loris; Berardi, Martina; Sommariva, Michele; Cataldo, Alessandra; Canevari, Silvana; Mezzanzanica, Delia; Iorio, Marilena V.; Tagliabue, Elda; Balsari, Andrea			Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; DNA-DAMAGE RESPONSE; OVARIAN-CANCER; IMMUNE-SYSTEM; TLR9 AGONISTS; REPAIR GENES; CELLS; EXPRESSION; TUMOR; RESISTANCE	We recently reported that peritumoral CpG-ODN treatment, activating TLR-9 expressing cells in tumor microenvironment, induces modulation of genes involved in DNA repair and sensitizes cancer cells to DNA-damaging cisplatin treatment. Here, we investigated whether this treatment induces modulation of miRNAs in tumor cells and their relevance to chemotherapy response. Array analysis identified 20 differentially expressed miRNAs in human IGROV-1 ovarian tumor cells from CpG-ODN-treated mice versus controls (16 down-and 4 up-regulated). Evaluation of the role of the 3 most differentially expressed miRNAs on sensitivity to cisplatin of IGROV-1 cells revealed significantly increased cisplatin cytotoxicity upon ectopic expression of hsa-miR-302b (up-modulated in our array), but no increased effect upon reduced expression of hsa-miR-424 or hsa-miR-340 (down-modulated in our array). Accordingly, hsa-miR-302b expression was significantly associated with time to relapse or overall survival in two data sets of platinum-treated ovarian cancer patients. Use of bio-informatics tools identified 19 mRNAs potentially targeted by hsa-miR-302b, including HDAC4 gene, which has been reported to mediate cisplatin sensitivity in ovarian cancer. Both HDAC4 mRNA and protein levels were significantly reduced in IGROV-1 cells overexpressing hsa-miR-302b. Altogether, these findings indicate that hsa-miR-302b acts as a "chemosensitizer" in human ovarian carcinoma cells and may represent a biomarker able to predict response to cisplatin treatment. Moreover, the identification of miRNAs that improve sensitivity to chemotherapy provides the experimental underpinning for their possible future clinical use.	[De Cecco, Loris] Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Tumori, Funct Genom Core Facil, Milan, Italy; [Berardi, Martina; Sommariva, Michele; Tagliabue, Elda; Balsari, Andrea] Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Tumori, Mol Targeting Unit, Milan, Italy; [Sommariva, Michele; Cataldo, Alessandra; Balsari, Andrea] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Canevari, Silvana; Mezzanzanica, Delia] Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Tumori, Mol Therapies Unit, Milan, Italy; [Iorio, Marilena V.] Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Tumori, Start Unit, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Balsari, A (corresponding author), Fdn Ist Ricovero & Cura Carattere Sci, Ist Nazl Tumori, Mol Targeting Unit, Milan, Italy.	andrea.balsari@unimi.it	Mezzanzanica, Delia/C-2607-2017; Cataldo, Alessandra/C-6204-2017; Iorio, Marilena V/K-5446-2016; Sommariva, Michele/C-1174-2017; balsari, andrea/M-5657-2016; De Cecco, Loris/K-7036-2016; Tagliabue, Elda/B-9377-2017	Mezzanzanica, Delia/0000-0002-9664-6871; Cataldo, Alessandra/0000-0002-1882-9410; Iorio, Marilena V/0000-0002-6058-1527; Sommariva, Michele/0000-0002-7622-0996; balsari, andrea/0000-0002-3250-2668; De Cecco, Loris/0000-0002-7066-473X; Tagliabue, Elda/0000-0001-9877-2903	Associazione Italiana per la Ricerca sul Cancro (AIRC); "Dote ricerca": FSE, Regione Lombardia; Start Up AIRC Grant	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); "Dote ricerca": FSE, Regione Lombardia(Regione Lombardia); Start Up AIRC Grant(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (AIRC). MS was supported by "Dote ricerca": FSE, Regione Lombardia. MVI is supported by Start Up AIRC Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2005, J IMMUNOL, V174, P4453, DOI 10.4049/jimmunol.174.8.4453; Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Bagnoli M, 2011, ONCOTARGET, V2, P1265, DOI 10.18632/oncotarget.401; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BENARD J, 1985, CANCER RES, V45, P4970; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; De Cesare M, 2008, CLIN CANCER RES, V14, P5512, DOI 10.1158/1078-0432.CCR-08-0445; Dolezalova D, 2012, STEM CELLS, V30, P1362, DOI 10.1002/stem.1108; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gryder BE, 2012, FUTURE MED CHEM, V4, P505, DOI [10.4155/FMC.12.3, 10.4155/fmc.12.3]; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Hu HL, 2011, J MOL CELL BIOL, V3, P151, DOI 10.1093/jmcb/mjq042; Jackson AL, 2012, NUCLEIC ACID THER, V22, P213, DOI 10.1089/nat.2012.0356; Jin KL, 2010, J GYNECOL ONCOL, V21, P262, DOI 10.3802/jgo.2010.21.4.262; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim TH, 2010, HISTOPATHOLOGY, V57, P734, DOI 10.1111/j.1365-2559.2010.03686.x; Krieg Arthur M, 2007, Proc Am Thorac Soc, V4, P289, DOI 10.1513/pats.200701-021AW; Landau DA, 2011, SEMIN ONCOL, V38, P743, DOI 10.1053/j.seminoncol.2011.08.003; Lodish HF, 2008, NAT REV IMMUNOL, V8, P120, DOI 10.1038/nri2252; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Ozaki K, 2008, CANCER SCI, V99, P376, DOI 10.1111/j.1349-7006.2007.00669.x; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shih KK, 2011, GYNECOL ONCOL, V121, P444, DOI 10.1016/j.ygyno.2011.01.025; Sommariva M, 2012, ONCOIMMUNOLOGY, V1, P258, DOI 10.4161/onci.1.2.18343; Sommariva M, 2011, CANCER RES, V71, P6382, DOI 10.1158/0008-5472.CAN-11-1285; Stiborova M, 2012, CURR MED CHEM; Stronach EA, 2011, CANCER RES, V71, P4412, DOI 10.1158/0008-5472.CAN-10-4111; Thurn KT, 2011, FUTURE ONCOL, V7, P263, DOI 10.2217/FON.11.2; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34	39	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58849	10.1371/journal.pone.0058849	http://dx.doi.org/10.1371/journal.pone.0058849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484053	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100139
J	de Graaf, M; Herfst, S; Aarbiou, J; Burgers, PC; Zaaraoui-Boutahar, F; Bijl, M; van IJcken, W; Schrauwen, EJA; Osterhaus, ADME; Luider, TM; Scholte, BJ; Fouchier, RAM; Andeweg, AC				de Graaf, Miranda; Herfst, Sander; Aarbiou, Jamil; Burgers, Peter C.; Zaaraoui-Boutahar, Fatiha; Bijl, Maarten; van IJcken, Wilfred; Schrauwen, Eefje J. A.; Osterhaus, Albert D. M. E.; Luider, Theo M.; Scholte, Bob J.; Fouchier, Ron A. M.; Andeweg, Arno C.			Small Hydrophobic Protein of Human Metapneumovirus Does Not Affect Virus Replication and Host Gene Expression In Vitro	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; AIRWAY EPITHELIAL-CELLS; SH GENE; G-GLYCOPROTEIN; INFECTION; TRANSCRIPTION; DELETION; LACKING; TRACT; NS2	Human metapneumovirus (HMPV) encodes a small hydrophobic (SH) protein of unknown function. HMPV from which the SH open reading frame was deleted (HMPV Delta SH) was viable and displayed similar replication kinetics, cytopathic effect and plaque size compared with wild type HMPV in several cell-lines. In addition, no differences were observed in infection efficiency or cell-to-cell spreading in human primary bronchial epithelial cells (HPBEC) cultured at an air-liquid interphase. Host gene expression was analyzed in A549 cells infected with HMPV or HMPV Delta SH using microarrays and mass spectrometry (MS) based techniques at multiple time points post infection. Only minor differences were observed in mRNA or protein expression levels. A possible function of HMPV SH as apoptosis blocker, as proposed for several members of the family Paramyxoviridae, was rejected based on this analysis. So far, a clear phenotype of HMPV SH deletion mutants in vitro at the virus and host levels is absent.	[de Graaf, Miranda; Herfst, Sander; Zaaraoui-Boutahar, Fatiha; Bijl, Maarten; Schrauwen, Eefje J. A.; Osterhaus, Albert D. M. E.; Fouchier, Ron A. M.; Andeweg, Arno C.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands; [Aarbiou, Jamil; Scholte, Bob J.] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands; [Burgers, Peter C.; Luider, Theo M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [van IJcken, Wilfred] Erasmus MC, Ctr Biom, Rotterdam, Netherlands; [de Graaf, Miranda] Univ Cambridge, Dept Zool, Cambridge, England	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Cambridge	Andeweg, AC (corresponding author), Erasmus MC, Dept Virosci, Rotterdam, Netherlands.	a.andeweg@erasmusmc.nl	van ijcken, willem/N-9805-2018; de Graaf, Miranda/K-1262-2018; de Graaf, Miranda/AFM-6878-2022; Fouchier, Ron A/A-1911-2014	van ijcken, willem/0000-0002-0421-8301; de Graaf, Miranda/0000-0002-7831-0098; de Graaf, Miranda/0000-0002-7831-0098; Fouchier, Ron A/0000-0001-8095-2869; Osterhaus, Albert/0000-0002-6074-1172; Herfst, Sander/0000-0001-9866-8903	MedImmune Vaccines, Inc.; European Union; Virgo consortium	MedImmune Vaccines, Inc.(AstraZenecaMedimmune); European Union(European Commission); Virgo consortium	This work was sponsored by MedImmune Vaccines, Inc., framework five grant "Hammocsa" ''from the European Union, the Virgo consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative (BSIK 03012), Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao X, 2008, VIROLOGY, V374, P114, DOI 10.1016/j.virol.2007.12.024; Bao XY, 2008, J VIROL, V82, P8224, DOI 10.1128/JVI.02584-07; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biacchesi S, 2005, J VIROL, V79, P12608, DOI 10.1128/JVI.79.19.12608-12613.2005; Biacchesi S, 2004, VIROLOGY, V321, P247, DOI 10.1016/j.virol.2003.12.020; Biacchesi S, 2004, J VIROL, V78, P12877, DOI 10.1128/JVI.78.23.12877-12887.2004; Biacchesi S, 2007, J VIROL, V81, P6057, DOI 10.1128/JVI.00128-07; Brasier AR, 1998, J BIOL CHEM, V273, P3551, DOI 10.1074/jbc.273.6.3551; Buchholz UJ, 2005, J VIROL, V79, P6588, DOI 10.1128/JVI.79.11.6588-6597.2005; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Bukreyev A, 1997, J VIROL, V71, P8973, DOI 10.1128/JVI.71.12.8973-8982.1997; de Graaf M, 2007, J VIROL METHODS, V143, P169, DOI 10.1016/j.jviromet.2007.03.005; Dekker LJ, 2007, J CHROMATOGR B, V847, P62, DOI 10.1016/j.jchromb.2006.08.031; Fearns R, 1999, J VIROL, V73, P5852, DOI 10.1128/JVI.73.7.5852-5864.1999; Fuentes S, 2007, J VIROL, V81, P8361, DOI 10.1128/JVI.02717-06; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; He B, 2001, J VIROL, V75, P4068, DOI 10.1128/JVI.75.9.4068-4079.2001; Herfst S, 2004, J VIROL, V78, P8264, DOI 10.1128/JVI.78.15.8264-8270.2004; Herfst S, 2008, J GEN VIROL, V89, P1553, DOI 10.1099/vir.0.2008/002022-0; Jin H, 2000, VIROLOGY, V273, P210, DOI 10.1006/viro.2000.0393; Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06; Kuiken T, 2004, AM J PATHOL, V164, P1893, DOI 10.1016/S0002-9440(10)63750-9; Lin YA, 2003, J VIROL, V77, P3371, DOI 10.1128/JVI.77.6.3371-3383.2003; Mustafa DAN, 2007, MOL CELL PROTEOMICS, V6, P1147, DOI 10.1074/mcp.M600295-MCP200; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perez M, 1997, VIROLOGY, V235, P342, DOI 10.1006/viro.1997.8696; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schildgen V, 2011, CLIN MICROBIOL REV, V24, P734, DOI 10.1128/CMR.00015-11; Skiba M, 2008, J VIROL, V82, P9689, DOI 10.1128/JVI.00995-08; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Teng MN, 2001, VIROLOGY, V289, P283, DOI 10.1006/viro.2001.1138; Titulaer MK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-403; van den Hoogen BG, 2002, VIROLOGY, V295, P119, DOI 10.1006/viro.2001.1355; van den Hoogen BG, 2004, EMERG INFECT DIS, V10, P658, DOI 10.3201/eid1004.030393; van den Hoogen BG, 2003, J INFECT DIS, V188, P1571, DOI 10.1086/379200; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van Wetering S, 2007, MOL IMMUNOL, V44, P803, DOI 10.1016/j.molimm.2006.04.008; Wang J, 2012, J BIOL CHEM; Whitehead SS, 1999, J VIROL, V73, P3438, DOI 10.1128/JVI.73.4.3438-3442.1999; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wilson RL, 2006, J VIROL, V80, P1700, DOI 10.1128/JVI.80.4.1700-1709.2006; Yunus AS, 2003, VIRUS RES, V93, P91, DOI 10.1016/S0168-1702(03)00074-1; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002	45	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58572	10.1371/journal.pone.0058572	http://dx.doi.org/10.1371/journal.pone.0058572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484037	gold, Green Submitted, Green Published			2022-12-27	WOS:000316936100125
J	Wu, ZL; MacNeil, AJ; Berman, JN; Lin, TJ				Wu, Zhengli; MacNeil, Adam J.; Berman, Jason N.; Lin, Tong-Jun			Syntaxin Binding Protein 1 Is Not Required for Allergic Inflammation via IgE-Mediated Mast Cell Activation	PLOS ONE			English	Article							STXBP1 MUTATIONS; MUNC18-1 BINDING; VESICLE DOCKING; MEMBRANE-FUSION; IL-4 PRODUCTION; RAT-BRAIN; KINASE-C; EXOCYTOSIS; DEGRANULATION; PHOSPHORYLATION	Mast cells play a central role in both innate and acquired immunity. When activated by IgE-dependent Fc epsilon RI cross-linking, mast cells rapidly initiate a signaling cascade and undergo an extensive release of their granule contents, including inflammatory mediators. Some SNARE ( soluble N-ethylmaleimide-sensitive fusion factor attachment protein receptor) proteins and SM (Sec1/Munc18) family proteins are involved in mast cell degranulation. However, the function of syntaxin binding protein 1 (STXBP1), a member of SM family, in mast cell degranulation is currently unknown. In this study, we examined the role of STXBP1 in IgE-dependent mast cell activation. Liver-derived mast cells (LMCs) from wild-type and STXBP1-deficient mice were cultured in vitro for the study of mast cell maturation, degranulation, cytokine and chemokine production, as well as MAPK, I kappa B-NF kappa B, and NFAT signaling pathways. In addition, in vivo models of passive cutaneous anaphylaxis and late-phase IgE-dependent inflammation were conducted in mast cell deficient W (sh) mice that had been reconstituted with wild-type or STXBP1-deficient mast cells. Our findings indicate that STXBP1 is not required for any of these important functional mechanisms in mast cells both in vitro and in vivo. Our results demonstrate that STXBP1 is dispensable during IgE-mediated mast cell activation and in IgE-dependent allergic inflammatory reactions.	[Lin, Tong-Jun] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; IWK Hlth Ctr, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Lin, TJ (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	tong-jun.lin@dal.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from Canadian Institutes of Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin K, 2012, RESP MED, V106, P9, DOI 10.1016/j.rmed.2011.09.007; Bax HJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00229; Broeke JHP, 2010, BIOL CELL, V102, P479, DOI 10.1042/BC20100036; Ciufo LF, 2005, MOL BIOL CELL, V16, P470, DOI 10.1091/mbc.E04-08-0685; Craig TJ, 2003, J NEUROCHEM, V86, P1450, DOI 10.1046/j.1471-4159.2003.01955.x; de Vries KJ, 2000, EUR J NEUROSCI, V12, P385, DOI 10.1046/j.1460-9568.2000.00931.x; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Deprez L, 2010, NEUROLOGY, V75, P1159, DOI 10.1212/WNL.0b013e3181f4d7bf; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; Diao JJ, 2010, ACS CHEM NEUROSCI, V1, P168, DOI 10.1021/cn900034p; Dong YM, 2007, BIOCHEM BIOPH RES CO, V360, P609, DOI 10.1016/j.bbrc.2007.06.107; Endo S, 2011, CELL IMMUNOL, V271, P488, DOI 10.1016/j.cellimm.2011.08.019; Fu J, 2005, J BIOL CHEM, V280, P3178, DOI 10.1074/jbc.M410044200; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hamdan FF, 2009, ANN NEUROL, V65, P748, DOI 10.1002/ana.21625; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hepp G, 2005, J BIOL CHEM, V280, P6610, DOI 10.1074/jbc.M412126200; Hibi T, 2000, BIOCHEM BIOPH RES CO, V271, P36, DOI 10.1006/bbrc.2000.2591; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Houng A, 2003, J BIOL CHEM, V278, P19627, DOI 10.1074/jbc.M212465200; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; Li B, 2006, BLOOD, V107, P2814, DOI 10.1182/blood-2005-09-3610; Logan MR, 2003, J ALLERGY CLIN IMMUN, V111, P923, DOI 10.1067/mai.2003.1573; MacNeil AJ, 2011, J IMMUNOL, V187, P3374, DOI 10.4049/jimmunol.1003126; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nanamori M, 2007, J IMMUNOL, V178, P416, DOI 10.4049/jimmunol.178.1.416; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Nigam R, 2005, BBA-GENE STRUCT EXPR, V1728, P77, DOI 10.1016/j.bbaexp.2005.01.018; Otsuka M, 2010, EPILEPSIA, V51, P2449, DOI 10.1111/j.1528-1167.2010.02767.x; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Quackenbush EJ, 1998, BLOOD, V92, P1887, DOI 10.1182/blood.V92.6.1887.418k17_1887_1897; Saitsu H, 2011, CLIN GENET, V80, P484, DOI 10.1111/j.1399-0004.2010.01575.x; Saitsu H, 2012, JASPERS BASIC MECH E, P1; Saitsu H, 2010, EPILEPSIA, V51, P2397, DOI 10.1111/j.1528-1167.2010.02728.x; Schraw TD, 2003, BIOCHEM J, V374, P207, DOI 10.1042/BJ20030610; Sharma VM, 2005, NEUROCHEM INT, V47, P225, DOI 10.1016/j.neuint.2005.01.005; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Suzuki Y, 2009, MOL IMMUNOL, V46, P2200, DOI 10.1016/j.molimm.2009.04.013; Tkaczyk C, 2002, MOL IMMUNOL, V38, P1289, DOI 10.1016/S0161-5890(02)00077-9; Vercelli D, 2005, J ALLERGY CLIN IMMUN, V116, P60, DOI 10.1016/j.jaci.2005.04.031; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Yang YJ, 2008, J BIOL CHEM, V283, P32110, DOI 10.1074/jbc.M802610200; Yang YJ, 2009, J EXP MED, V206, P195, DOI 10.1084/jem.20081140	50	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58560	10.1371/journal.pone.0058560	http://dx.doi.org/10.1371/journal.pone.0058560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484036	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100124
J	Bignone, PA; Krupa, RA; Sternberg, H; Funk, WD; Snyder, EY; West, MD; Larocca, D				Bignone, Paola A.; Krupa, Rachel A.; Sternberg, Hal; Funk, Walter D.; Snyder, Evan Y.; West, Michael D.; Larocca, David			Identification of Human Embryonic Progenitor Cell Targeting Peptides Using Phage Display	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS	Human pluripotent stem (hPS) cells are capable of differentiation into derivatives of all three primary embryonic germ layers and can self-renew indefinitely. They therefore offer a potentially scalable source of replacement cells to treat a variety of degenerative diseases. The ability to reprogram adult cells to induced pluripotent stem (iPS) cells has now enabled the possibility of patient-specific hPS cells as a source of cells for disease modeling, drug discovery, and potentially, cell replacement therapies. While reprogramming technology has dramatically increased the availability of normal and diseased hPS cell lines for basic research, a major bottleneck is the critical unmet need for more efficient methods of deriving well-defined cell populations from hPS cells. Phage display is a powerful method for selecting affinity ligands that could be used for identifying and potentially purifying a variety of cell types derived from hPS cells. However, identification of specific progenitor cell-binding peptides using phage display may be hindered by the large cellular heterogeneity present in differentiating hPS cell populations. We therefore tested the hypothesis that peptides selected for their ability to bind a clonal cell line derived from hPS cells would bind early progenitor cell types emerging from differentiating hPS cells. The human embryonic stem (hES) cell-derived embryonic progenitor cell line, W10, was used and cell-targeting peptides were identified. Competition studies demonstrated specificity of peptide binding to the target cell surface. Efficient peptide targeted cell labeling was accomplished using multivalent peptide-quantum dot complexes as detected by fluorescence microscopy and flow cytometry. The cell-binding peptides were selective for differentiated hPS cells, had little or no binding on pluripotent cells, but preferential binding to certain embryonic progenitor cell lines and early endodermal hPS cell derivatives. Taken together these data suggest that selection of phage display libraries against a clonal progenitor stem cell population can be used to identify progenitor stem cell targeting peptides. The peptides may be useful for monitoring hPS cell differentiation and for the development of cell enrichment procedures to improve the efficiency of directed differentiation toward clinically relevant human cell types.	[Bignone, Paola A.; Krupa, Rachel A.; Larocca, David] Mandala Biosci LLC, San Diego, CA USA; [Sternberg, Hal; Funk, Walter D.; West, Michael D.] BioTime Inc, Alameda, CA USA; [Snyder, Evan Y.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Larocca, D (corresponding author), Mandala Biosci LLC, San Diego, CA USA.	dlarocca@mandalabio.com		Larocca, Dana/0000-0001-5863-9833; West, Michael/0000-0002-4842-5468; Bignone, Paola/0000-0003-2296-7039	California Institute for Regenerative Medicine (CIRM) [TR1-1276]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	The research was made possible by a grant from the California Institute for Regenerative Medicine (CIRM Grant Number TR1-1276). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of CIRM or any other agency of the State of California. CIRM had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanpain C, 2012, NAT REV MOL CELL BIO, V13, P471, DOI 10.1038/nrm3371; Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Grutzkau A, 2010, CYTOM PART A, V77A, P643, DOI 10.1002/cyto.a.20918; Holig P, 2004, PROTEIN ENG DES SEL, V17, P433, DOI 10.1093/protein/gzh055; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Laposa RR, 2011, J CARDIOVASC PHARM, V58, P240, DOI 10.1097/FJC.0b013e31821823f5; Leonardo TR, 2012, HUMAN STEM CELL MANU, P3; Lin S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-67; Lu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012075; Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857; Nakagawa M, 2010, ADV EXP MED BIOL, V695, P215, DOI 10.1007/978-1-4419-7037-4_14; Nelson TJ, 2010, STEM CELLS CLONING, V3, P29; Rasmussen UB, 2002, CANCER GENE THER, V9, P606, DOI 10.1038/sj.cgt.7700476; Slotkin JR, 2007, DEV DYNAM, V236, P3393, DOI 10.1002/dvdy.21235; Spear MA, 2001, CANCER GENE THER, V8, P506, DOI 10.1038/sj.cgt.7700334; Sternberg H, 2012, REGEN MED, V7, P481, DOI [10.2217/RME.12.29, 10.2217/rme.12.29]; Teesalu T, 2012, METHOD ENZYMOL, V503, P35, DOI 10.1016/B978-0-12-396962-0.00002-1; Tiscornia G, 2011, NAT MED, V17, P1570, DOI 10.1038/nm.2504; West MD, 2008, REGEN MED, V3, P287, DOI 10.2217/17460751.3.3.287; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhao SJ, 2010, PEPTIDES, V31, P2027, DOI 10.1016/j.peptides.2010.08.004; Zhao WX, 2010, J BIOMOL SCREEN, V15, P687, DOI 10.1177/1087057110370997	24	8	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58200	10.1371/journal.pone.0058200	http://dx.doi.org/10.1371/journal.pone.0058200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483995	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900076
J	Ma, GL; Li, YF; Zhang, J; Liu, H; Hou, DY; Zhu, L; Zhang, ZY; Zhang, L				Ma, Guiling; Li, Yanfang; Zhang, Juan; Liu, Hao; Hou, Dongyan; Zhu, Lei; Zhang, Zhenyu; Zhang, Lin			Association between the Presence of Autoantibodies against Adrenoreceptors and Severe Pre-Eclampsia: A Pilot Study	PLOS ONE			English	Article							RECEPTOR AGONISTIC ANTIBODIES; PROTEIN; CELLS; CDNA; CLONING; GENE	Background: Pre-eclampsia is the leading cause of maternal and neonatal morbidity and mortality with incompletely understood etiopathogenesis. The purpose of the current study is to determine whether there is a relationship between the presence of autoantibodies against beta(1), beta(2) and alpha(1) adrenoreceptors and severe pre-eclampsia. Methodology/Principal Findings: Synthetic peptides corresponding to amino acid sequences of the second extracellular loops of beta(1), beta(2) and alpha(1) adrenoreceptors were synthesized as antigens to test 34 patients with severe pre-eclampsia, 36 normal pregnancy women and 40 non-pregnant controls for the presence of autoantibodies using enzyme-linked immunosorbent assay. The respective frequencies of autoantibodies against beta(1), beta(2) and alpha(1) adrenoreceptors were 50.0% (17/34), 52.9% (18/34) and 55.9% (19/34) in patients with severe pre-eclampsia, 19.4% (7/36) (p = 0.011), 19.4% (7/36) (p = 0.006) and 17.6% (6/36) (p = 0.001) in normal pregnancy women and 10% (4/40), 7.5% (3/40) and 10% (4/40) (p, 0.001) in non-pregnant controls. Titers of these autoantibodies were also significantly increased in patients with severe pre-eclampsia. By logistic regression analysis, the presence of these three autoantibodies significantly increased the risk of neonatal death (odds ratio, 13.5; 95% confidence interval, 1.3-141.3; p = 0.030) and long-term neonatal hospitalization (odds ratio, 5.0; 95% confidence interval, 1.3-19.1; p = 0.018). The risk of hypertension and fetal distress were also associated with the presence of these three autoantibodies. Conclusions/Significance: This novel pilot study demonstrated for the first time that the presence of autoantibodies against beta(1), beta(2) and alpha(1) adrenoreceptors are increased in patients with severe pre-eclampsia. Pregnant women who are positive for the three autoantibodies are at increased risks of neonatal mortality and morbidity. We posit that these autoantibodies may be involved in the pathogenesis of severe pre-eclampsia.	[Ma, Guiling; Zhang, Juan; Hou, Dongyan; Zhang, Lin] Capital Med Univ, Ctr Heart, Chao Yang Hosp, Beijing, Peoples R China; [Li, Yanfang; Liu, Hao; Zhu, Lei; Zhang, Zhenyu] Capital Med Univ, Dept Obstet & Gynaecol, Chao Yang Hosp, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Zhang, ZY (corresponding author), Capital Med Univ, Dept Obstet & Gynaecol, Chao Yang Hosp, Beijing, Peoples R China.	cyzhangzhenyu@sina.com; linzhangpeking@hotmail.com	Zhang, Juan/GRX-2638-2022; li, yan/GTI-4638-2022		Natural Science Foundation of China [30971236, 81250011]; Beijing Natural Science Foundation project [7102058]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation project(Beijing Natural Science Foundation)	This study was funded by the Natural Science Foundation of China (30971236, 81250011) and Beijing Natural Science Foundation project (7102058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APGAR V, 1953, Curr Res Anesth Analg, V32, P260; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bobst SM, 2005, AM J HYPERTENS, V18, P330, DOI 10.1016/j.amjhyper.2004.10.002; Dechend R, 2000, CIRCULATION, V101, P2382, DOI 10.1161/01.CIR.101.20.2382; Dechend R, 2003, CIRCULATION, V107, P1632, DOI 10.1161/01.CIR.0000058200.90059.B1; Dekker GA, 1999, SEMIN PERINATOL, V23, P24, DOI 10.1016/S0146-0005(99)80057-3; Dietl J, 2000, J PERINAT MED, V28, P464, DOI 10.1515/JPM.2000.063; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; FU MLX, 1994, LANCET, V344, P1660, DOI 10.1016/S0140-6736(94)90456-1; FU MLX, 1994, CLIN IMMUNOL IMMUNOP, V72, P15, DOI 10.1006/clin.1994.1101; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Graham RM, 1996, CIRC RES, V78, P737, DOI 10.1161/01.RES.78.5.737; Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006; KOBILKA BK, 1987, P NATL ACAD SCI USA, V84, P46, DOI 10.1073/pnas.84.1.46; Lee RM, 2003, OBSTET GYNECOL, V102, P294, DOI 10.1016/S0029-7844(03)00477-0; Lei Z, 2003, CHIN J CLIN REHAB, V7, P2160; Lin Z, 1998, CHIN J HYPERTENS, V6, P5; LOMASNEY JW, 1991, J BIOL CHEM, V266, P6365; Luther HP, 1997, HYPERTENSION, V29, P678, DOI 10.1161/01.HYP.29.2.678; McDonald SD, 2008, AM HEART J, V156, P918, DOI 10.1016/j.ahj.2008.06.042; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Roberts JM, 1998, LANCET, V352, P22; Wallukat G, 1999, J CLIN INVEST, V103, P945, DOI 10.1172/JCI4106; WALSH DA, 1994, FASEB J, V8, P1227, DOI 10.1096/fasebj.8.15.8001734; Zhou CCY, 2008, HYPERTENSION, V51, P1010, DOI 10.1161/HYPERTENSIONAHA.107.097790	27	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57983	10.1371/journal.pone.0057983	http://dx.doi.org/10.1371/journal.pone.0057983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483958	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900062
J	van Houwelingen, AH; den Elzen, WPJ; Mooijaart, SP; Heijmans, M; Blom, JW; de Craen, AJM; Gussekloo, J				van Houwelingen, Anne H.; den Elzen, Wendy P. J.; Mooijaart, Simon P.; Heijmans, Margot; Blom, Jeanet W.; de Craen, Anton J. M.; Gussekloo, Jacobijn			Predictive Value of a Profile of Routine Blood Measurements on Mortality in Older Persons in the General Population: The Leiden 85-Plus Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MINI-MENTAL-STATE; ALLOSTATIC LOAD; ELDERLY SUBJECTS; RISK; AGE; DISABILITY; FRAILTY; ASSOCIATION; CHOLESTEROL	Background: Various questionnaires and performance tests predict mortality in older people. However, most are heterogeneous, laborious and a validated consensus index is not available yet. Since most older people are regularly monitored by laboratory tests, we compared the predictive value of a profile of seven routine laboratory measurements on mortality in older persons in the general population with other predictors of mortality; gait speed and disability in instrumental activities of daily living (IADL). Methodology/Principal Findings: Within the Leiden 85-plus Study, a prospective population-based study, we followed 562 participants aged 85 years for mortality over five years. At baseline (age 85 years) high-density lipoprotein cholesterol, albumin, alanine transaminase, hemoglobin, creatinin clearance, C-reactive protein and homocysteine were measured. Participants were stratified based on their number of laboratory abnormalities (0, 1, 2-4 and 5-7). The predictive capacity was compared with gait speed (6-meter walking test) and disability in IADL (Groningen Activity Restriction Scale) by C-statistics. At baseline, 418 (74%) 85-year old participants had at least one laboratory abnormality. All cause mortality risk increased with increasing number of laboratory abnormalities to a hazard ratio of 5.64 [95% CI 3.49-9.12] for those with 5-7 laboratory abnormalities (p<0.001) compared to those without abnormalities. The c-statistic was 0.66 [95% CI 0.59-0.69], similar to that of gait speed and disability in IADL. Conclusions/Significance: In the general population of oldest old, the number of abnormalities in seven routine laboratory measurements predicts five-year mortality as accurately as gait speed and IADL disability.	[van Houwelingen, Anne H.; den Elzen, Wendy P. J.; Heijmans, Margot; Blom, Jeanet W.; Gussekloo, Jacobijn] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [Mooijaart, Simon P.; de Craen, Anton J. M.] Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands; [Mooijaart, Simon P.] Inst Evidence Based Med Old Age IEMO, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	den Elzen, WPJ (corresponding author), Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands.	w.p.j.den_elzen@lumc.nl	Gussekloo, Jacobijn/ABE-3879-2021; Mooijaart, Simon P./A-5306-2008	Gussekloo, Jacobijn/0000-0001-7186-8278; Mooijaart, Simon P./0000-0003-3106-3568; den Elzen, Wendy/0000-0002-6774-4077	Dutch Ministry of Health, Welfare and Sports	Dutch Ministry of Health, Welfare and Sports	The Leiden 85-plus Study was funded (in part) by an unrestricted grant from the Dutch Ministry of Health, Welfare and Sports (1997-2001). No additional external funding was received. The Funders had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Balducci Lodovico, 2007, Cancer Control, V14, P7; Bates CJ, 2010, BRIT J NUTR, V104, P893, DOI 10.1017/S0007114510001236; Bloem B R, 1992, J Geriatr Psychiatry Neurol, V5, P78; Boots-van der Wiel A, 2005, EUR J PUBLIC HEALTH, V15, P494, DOI 10.1093/eurpub/cki015; Bootsma-van der Wiel A, 2002, J CLIN EPIDEMIOL, V55, P1119, DOI 10.1016/S0895-4356(02)00505-X; Bootsma-van der Wiel A, 2001, J AM GERIATR SOC, V49, P909; Christensen K, 2004, EPIDEMIOLOGY, V15, P251, DOI 10.1097/01.ede.0000112211.11416.a6; Christensen Kaare, 2009, BMJ, V339, pb5262; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Culleton BF, 2006, BLOOD, V107, P3841, DOI 10.1182/blood-2005-10-4308; de Craen AJM, 2006, JAMA-J AM MED ASSOC, V296, P648, DOI 10.1001/jama.296.6.648-b; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; de Vries NM, 2011, AGEING RES REV, V10, P104, DOI 10.1016/j.arr.2010.09.001; den Elzen WPJ, 2009, CAN MED ASSOC J, V181, P151, DOI 10.1503/cmaj.090040; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford I, 2011, INT J EPIDEMIOL, V40, P1530, DOI 10.1093/ije/dyr172; Giovannini S, 2011, J AM GERIATR SOC, V59, P1679, DOI 10.1111/j.1532-5415.2011.03570.x; Gruenewald Tara L, 2009, J Am Geriatr Soc, V57, P1525, DOI 10.1111/j.1532-5415.2009.02389.x; HEEREN TJ, 1990, J AM GERIATR SOC, V38, P1093, DOI 10.1111/j.1532-5415.1990.tb01371.x; Horne BD, 2009, AM J MED, V122, P550, DOI 10.1016/j.amjmed.2008.10.043; Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2; Kempen GIJM, 1996, SOC SCI MED, V43, P1601, DOI 10.1016/S0277-9536(96)00057-3; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; May HT, 2009, AM HEART J, V157, P946, DOI 10.1016/j.ahj.2008.12.021; Novack V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012184; Pandya A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020416; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; Schalk BWM, 2006, AM J EPIDEMIOL, V164, P969, DOI 10.1093/aje/kwj312; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Taekema DG, 2012, AM J MED, V125, P1188, DOI 10.1016/j.amjmed.2012.01.034; van Bemmel T, 2006, J HYPERTENS, V24, P287, DOI 10.1097/01.hjh.0000200513.48441.8e; van Bemmel T, 2006, J AM SOC NEPHROL, V17, P2561, DOI 10.1681/ASN.2005090902; van Vliet P, 2010, J GERONTOL A-BIOL, V65, P488, DOI 10.1093/gerona/glq014; Vermeulen J, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-33; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Weverling-Rijnsburger AWE, 2003, ARCH INTERN MED, V163, P1549, DOI 10.1001/archinte.163.13.1549; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; Willems JM, 2010, J GERONTOL A-BIOL, V65, P764, DOI 10.1093/gerona/glq004; World Health Organisation, 2007, INT CLASS DIS REL DI; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	42	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58050	10.1371/journal.pone.0058050	http://dx.doi.org/10.1371/journal.pone.0058050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099PY	23483967	gold, Green Submitted, Green Published			2022-12-27	WOS:000315634900065
J	Song, N; Liang, AP				Song, Nan; Liang, Ai-Ping			A Preliminary Molecular Phylogeny of Planthoppers (Hemiptera: Fulgoroidea) Based on Nuclear and Mitochondrial DNA Sequences	PLOS ONE			English	Article							FULGOROMORPHA; SELECTION; EVOLUTION; INSECTA	The planthopper superfamily Fulgoroidea (Insecta: Hemiptera) is one of the most dominant groups of phytophagous insects. It comprises about 20 families, containing a total of 9000 species worldwide. Despite several recent studies, the phylogeny of Fulgoroidea is not yet satisfactorily resolved and the phylogenetic positions of several key families, especially Cixiidae, Delphacidae, Tettigometridae, Nogodinidae, Acanaloniidae and Issidae, are contentious. Here, we expand upon recent phylogenetic work using additional nuclear (18S and 28S) and novel mitochondrial (16S and cytb) markers. Maximum likelihood and Bayesian analyses yielded robust phylogenetic trees. In these topologies, a group containing Cixiidae and Delphacidae is recovered as the sister group to the remaining taxa. Tettigometridae is placed in a more nested position and is grouped with Caliscelidae. Sister relationships are found between Flatidae and Ricaniidae, and between Dictyopharidae and Fulgoridae. Nogodinidae and Issidae are confirmed to be non-monophyletic families. For major nodes of interest, divergence date estimates are generally older than those from the fossil record.	[Song, Nan; Liang, Ai-Ping] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Song, Nan] Henan Entry Exit Inspect & Quarantine Bur, Zhengzhou, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Liang, AP (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	liangap@ioz.ac.cn			National Basic Research Program of China (973 Program) [2007CB411601]; National Natural Science Foundation of China [30530110, 30770269, 30970400]; Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences [O529YX5105]; National Science Fund for Fostering Talents in Basic Research [NSFCJ0630964/J0109]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences; National Science Fund for Fostering Talents in Basic Research	This study was supported by grants from the National Basic Research Program of China (973 Program) grant # 2007CB411601, the National Natural Science Foundation of China grants # 30530110, 30770269 and 30970400, the Key Laboratory of the Zoological Systematics and Evolution of the Chinese Academy of Sciences grant # O529YX5105, and the National Science Fund for Fostering Talents in Basic Research, Special subjects in animal taxonomy, grant # NSFCJ0630964/J0109, all awarded to APL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Asche M., 1988, P 6 AUCH M TUR IT 7, P47; BOURGOIN T, 1993, ANN SOC ENTOMOL FR, V29, P225; Bourgoin T, 1997, CLADISTICS, V13, P207, DOI 10.1111/j.1096-0031.1997.tb00316.x; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Chen Shuo, 1995, Chinese Journal of Entomology, V15, P257; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dyck V. A., 1979, International Rice Research Institute: Brown planthopper: threat to rice production in Asia., P3; EMEL'YANOV A F, 1990, Entomologicheskoe Obozrenie, V69, P353; Emeljanov A.F., 1999, Zoosystematica Rossica, V8, P61; FENNAH R. G., 1954, TRANS ROY ENT SOC LONDON, V105, P455; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamilton K.G. Andrew, 2011, Cicadina, V12, P57; HAMILTON KGA, 1990, B AM MUS NAT HIST, P82; Kukalova-Peck J., 1991, INSECTS AUSTR, VI, P141; Liang AP, 2001, RAFFLES B ZOOL, V49, P221; Lin CP, 2004, MOL PHYLOGENET EVOL, V30, P686, DOI 10.1016/S1055-7903(03)00241-0; Metcalf ZP, 1932, GEN CATALOGUE HOMO 1; Metcalf ZP, 1958, GEN CATALOGUE HOMOPT, V4, P561; Muir F, 1930, ANN MAGAZINE NATURAL, V10, P461; Muir F.A.G., 1923, P HAWAII ENTOMOL SOC, V5, P205; Nylander JAA., 2004, BIOINFORMATICS; O'Brien L.B., 1985, P61; Rambaut A., 2007, TRACER V1 4; Rambaut A, 2010, FIGTREE V131; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Shcherbakov DE, 1996, ENTOMOL SOC AM, P31; Shcherbakov DE, 2005, 12 INT AUCH C BERK 7, pI; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Soulier-Perkins A, 2001, CLADISTICS, V17, P56, DOI 10.1006/clad.2000.0152; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; SWOFFORD DL, 1996, MOL SYSTEMATICS; Szwedo J, 2005, 12 INT AUCH C 6 INT, P30; Szwedo Jacek, 2004, P1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urban JM, 2007, MOL PHYLOGENET EVOL, V42, P556, DOI 10.1016/j.ympev.2006.08.009; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia X, 2003, FUNDAMENTAL CONCEPTS, P149; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yeh W.B., 1999, CHINESE J ENTOMOLOGY, V11, P87; Yeh WB, 1998, ZOOL STUD, V37, P45; Yeh WB, 2005, ZOOL STUD, V44, P519; Zwickl DJ., 2006, THESIS	50	53	59	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58400	10.1371/journal.pone.0058400	http://dx.doi.org/10.1371/journal.pone.0058400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516472	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400025
J	Toldo, S; Goehe, RW; Lotrionte, M; Mezzaroma, E; Sumner, ET; Biondi-Zoccai, GGL; Seropian, IM; Van Tassell, BW; Loperfido, F; Palazzoni, G; Voelkel, NF; Abbate, A; Gewirtz, DA				Toldo, Stefano; Goehe, Rachel W.; Lotrionte, Marzia; Mezzaroma, Eleonora; Sumner, Evan T.; Biondi-Zoccai, Giuseppe G. L.; Seropian, Ignacio M.; Van Tassell, Benjamin W.; Loperfido, Francesco; Palazzoni, Giovanni; Voelkel, Norbert F.; Abbate, Antonio; Gewirtz, David A.			Comparative Cardiac Toxicity of Anthracyclines In Vitro and In Vivo in the Mouse	PLOS ONE			English	Article							CELL-LINE; CANCER; CARDIOTOXICITY; STIMULATION; DOXORUBICIN; EPIRUBICIN; ADRIAMYCIN; NATION; TUMORS; HEART	Purpose: The antineoplastic efficacy of anthracyclines is limited by their cardiac toxicity. In this study, we evaluated the toxicity of doxorubicin, non-pegylated liposomal-delivered doxorubicin, and epirubicin in HL-1 adult cardiomyocytes in culture as well as in the mouse in vivo. Methods: The cardiomyocytes were incubated with the three anthracyclines (1 mu M) to assess reactive oxygen generation, DNA damage and apoptotic cell death. CF-1 mice (10/group) received doxorubicin, epirubicin or non-pegylated liposomal-doxorubicin (10 mg/kg) and cardiac function was monitored by Doppler echocardiography to measure left ventricular ejection fraction (LVEF), heart rate (HR) and cardiac output (CO) both prior to and 10 days after drug treatment. Results: In HL-1 cells, non-pegylated liposomal-doxorubicin generated significantly less reactive oxygen species (ROS), as well as less DNA damage and apoptosis activation when compared with doxorubicin and epirubicin. Cultured breast tumor cells showed similar sensitivity to the three anthracyclines. In the healthy mouse, non-pegylated liposomal doxorubicin showed a minimal and non-significant decrease in LVEF with no change in HR or CO, compared to doxorubicin and epirubicin. Conclusion: This study provides evidence for reduced cardiac toxicity of non-pegylated-liposomal doxorubicin characterized by attenuation of ROS generation, DNA damage and apoptosis in comparison to epirubicin and doxorubicin.	[Toldo, Stefano; Mezzaroma, Eleonora; Seropian, Ignacio M.; Van Tassell, Benjamin W.; Voelkel, Norbert F.; Abbate, Antonio] Virginia Commonwealth Univ, Pauley Heart Ctr, Richmond, VA 23284 USA; [Toldo, Stefano; Mezzaroma, Eleonora; Seropian, Ignacio M.; Van Tassell, Benjamin W.; Voelkel, Norbert F.; Abbate, Antonio] Virginia Commonwealth Univ, Victoria Johnson Ctr, Richmond, VA USA; [Goehe, Rachel W.; Sumner, Evan T.; Gewirtz, David A.] Virginia Commonwealth Univ, Dept Pharmacol & Massey Canc, Richmond, VA USA; [Lotrionte, Marzia; Loperfido, Francesco] Univ Cattolica Sacro Cuore, Div Cardiol, I-00168 Rome, Italy; [Biondi-Zoccai, Giuseppe G. L.] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, Rome, Italy; [Palazzoni, Giovanni] Univ Cattolica Sacro Cuore, Div Radiotherapy, I-00168 Rome, Italy	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Toldo, S (corresponding author), Virginia Commonwealth Univ, Pauley Heart Ctr, Richmond, VA 23284 USA.	stoldo2@vcu.edu	Sumner, Evan/B-3426-2014; Abbate, Antonio/E-3405-2014; Biondi-Zoccai, Giuseppe/C-9670-2012; Abbate, Antonio/G-8805-2016	Biondi-Zoccai, Giuseppe/0000-0001-6103-8510; Abbate, Antonio/0000-0002-1930-785X; Toldo, Stefano/0000-0002-1588-4019; Seropian, Ignacio Miguel/0000-0002-6823-4001	Cephalon, Rome, Italy; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER	Cephalon, Rome, Italy; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	ML and GGLBZ have received research support from Cephalon, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthiaume JM, 2007, CELL BIOL TOXICOL, V23, P15, DOI 10.1007/s10565-006-0140-y; Calderone A, 1998, J CLIN INVEST, V101, P812, DOI 10.1172/JCI119883; Chan S, 2004, ANN ONCOL, V15, P1527, DOI 10.1093/annonc/mdh393; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cortes-Funes H, 2007, CARDIOVASC TOXICOL, V7, P56, DOI 10.1007/s12012-007-0015-3; Fernandez A, 2009, TRENDS PHARMACOL SCI, V30, P403, DOI 10.1016/j.tips.2009.06.001; Gardin JM, 2002, J AM SOC ECHOCARDIOG, V15, P275, DOI 10.1067/mje.2002.121536; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Henderson IC, 2011, ONCOLOGY-NY, V25, P115; Hoyano Y, 1996, J CARDIOVASC PHARM, V27, P37, DOI 10.1097/00005344-199601000-00007; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Krischer JP, 1997, J CLIN ONCOL, V15, P1544, DOI 10.1200/JCO.1997.15.4.1544; Kuo LJ, 2008, IN VIVO, V22, P305; L'Ecuyer T, 2001, MOL GENET METAB, V74, P370, DOI 10.1006/mgme.2001.3243; Leonard RCF, 2009, BREAST, V18, P218, DOI 10.1016/j.breast.2009.05.004; Lotrionte M, 2007, Minerva Cardioangiol, V55, P711; Lotrionte M, 2012, INT J CARDI IN PRESS; Menna P, 2012, EXPERT OPIN DRUG SAF, V11, pS21, DOI 10.1517/14740338.2011.589834; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Montaigne D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/951539; Mordente A, 2012, ADV EXP MED BIOL, V942, P385, DOI 10.1007/978-94-007-2869-1_18; NERI B, 1984, BIOCHEM BIOPH RES CO, V125, P954, DOI 10.1016/0006-291X(84)91376-7; Salvatorelli E, 2007, J PHARMACOL EXP THER, V320, P790, DOI 10.1124/jpet.106.116160; Schafer M, 2001, J AM COLL CARDIOL, V37, P300, DOI 10.1016/S0735-1097(00)01065-2; Shan K, 1996, ANN INTERN MED, V125, P47, DOI 10.7326/0003-4819-125-1-199607010-00008; Smith LA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-337; SOLAINI G, 1985, DRUG EXP CLIN RES, V11, P115; Sreeramoju P, 2010, ADV GENET, V69, P135, DOI 10.1016/S0065-2660(10)69015-3; Strigun A, 2012, TOXICOL SCI, V125, P595, DOI 10.1093/toxsci/kfr298; Toldo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018102	31	34	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58421	10.1371/journal.pone.0058421	http://dx.doi.org/10.1371/journal.pone.0058421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516478	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400027
J	Boel, ME; Rijken, MJ; Leenstra, T; Phyo, AP; Pimanpanarak, M; Keereecharoen, NL; Proux, S; Laochan, N; Imwong, M; Singhasivanon, P; White, NJ; McGready, R; Nosten, FH				Boel, Machteld E.; Rijken, Marcus J.; Leenstra, Tjalling; Phyo, Aung Pyae; Pimanpanarak, Mupawjay; Keereecharoen, Naw Lily; Proux, Stephane; Laochan, Natthapon; Imwong, Mallika; Singhasivanon, Pratap; White, Nicholas J.; McGready, Rose; Nosten, Francois H.			Malaria in the Post-Partum Period; a Prospective Cohort Study	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM PARASITEMIA; AFRICAN ISOLATES SENEGAL; IN-VITRO ACTIVITY; PREGNANT-WOMEN; VIVAX MALARIA; THAILAND; EPIDEMIOLOGY; CHLOROQUINE; CLEARANCE; BORDER	Background: Several studies have shown a prolonged or increased susceptibility to malaria in the post-partum period. A matched cohort study was conducted to evaluate prospectively the susceptibility to malaria of post-partum women in an area where P.falciparum and P.vivax are prevalent. Methods: In an area of low seasonal malaria transmission on the Thai-Myanmar border pregnant women attending antenatal clinics were matched to a non-pregnant, non-post-partum control and followed up prospectively until 12 weeks after delivery. Results: Post-partum women (n = 744) experienced significantly less P.falciparum episodes than controls (hazard ratio (HR) 0.39 (95%CI 0.21-0.72) p = 0.003) but significantly more P.vivax (HR 1.34 (1.05-1.72) p = 0.018). The reduced risk of falciparum malaria was accounted for by reduced exposure, whereas a history of P.vivax infection during pregnancy was a strong risk factor for P.vivax in post-partum women (HR 13.98 (9.13-21.41), p<0.001). After controlling for effect modification by history of P.vivax, post-partum women were not more susceptible to P.vivax than controls (HR: 0.33 (0.21-0.51), p<0.001). Genotyping of pre- and post-partum infections (n circle plus = circle plus 10) showed that each post-partum P.falciparum was a newly acquired infection. Conclusions: In this area of low seasonal malaria transmission post-partum women were less likely to develop falciparum malaria but more likely to develop vivax malaria than controls. This was explained by reduced risk of exposure and increased risk of relapse, respectively. There was no evidence for altered susceptibility to malaria in the post-partum period. The treatment of vivax malaria during and immediately after pregnancy needs to be improved.	[Boel, Machteld E.; Rijken, Marcus J.; Phyo, Aung Pyae; Pimanpanarak, Mupawjay; Keereecharoen, Naw Lily; Proux, Stephane; Laochan, Natthapon; McGready, Rose; Nosten, Francois H.] Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand; [Boel, Machteld E.; Leenstra, Tjalling] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, NL-1105 AZ Amsterdam, Netherlands; [Imwong, Mallika; Singhasivanon, Pratap; White, Nicholas J.; McGready, Rose; Nosten, Francois H.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [White, Nicholas J.; McGready, Rose; Nosten, Francois H.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	Mahidol University; University of Amsterdam; Academic Medical Center Amsterdam; Mahidol University; University of Oxford	Boel, ME (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand.	machteld@shoklo-unit.com	Imwong, Mallika/ABE-6493-2020; Phyo, Aung Pyae/K-2413-2019; McGready, Rose/A-3290-2014; Nosten, Francois/AAC-5509-2019; Phyo, Aung Pyae/GYU-6181-2022; White, Nick/AAC-6527-2019	Phyo, Aung Pyae/0000-0002-0383-9624; McGready, Rose/0000-0003-1621-3257; Nosten, Francois/0000-0002-7951-0745; Phyo, Aung Pyae/0000-0002-0383-9624; White, Nick/0000-0002-1897-1978; Rijken, Marcus/0000-0003-0914-5508; Singhasivanon, Pratap/0000-0002-9759-1702	Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Christophe and Rodolphe Merieux Foundation	Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Christophe and Rodolphe Merieux Foundation	SMRU is supported by The Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. The Christophe and Rodolphe Merieux Foundation supported the study through a prize (2008) to FN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boel ME, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-114; Bottero J, 2011, AM J TROP MED HYG, V84, P267, DOI 10.4269/ajtmh.2011.10-0139; Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Carrara VI, 2006, PLOS MED, V3, P856, DOI 10.1371/journal.pmed.0030183; Diagne N, 2000, NEW ENGL J MED, V343, P598, DOI 10.1056/NEJM200008313430901; DOLAN G, 1993, T ROY SOC TROP MED H, V87, P620, DOI 10.1016/0035-9203(93)90262-O; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Imwong M, 2012, J INFECT DIS, V205, P680, DOI 10.1093/infdis/jir806; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; NGUYENDINH P, 1988, LANCET, V2, P751; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; NOSTEN F, 1991, T ROY SOC TROP MED H, V85, P424, DOI 10.1016/0035-9203(91)90205-D; Phyo AP, 2011, CLIN INFECT DIS, V53, P977, DOI 10.1093/cid/cir631; Plewes K, 2008, INT J STD AIDS, V19, P833, DOI 10.1258/ijsa.2008.008034; Pradines B, 1998, AM J TROP MED HYG, V58, P354, DOI 10.4269/ajtmh.1998.58.354; Pradines B, 1998, J ANTIMICROB CHEMOTH, V42, P333, DOI 10.1093/jac/42.3.333; Ramharter M, 2005, J INFECT DIS, V191, P1005, DOI 10.1086/427781; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Serra-Casas E, 2011, INFECT IMMUN, V79, P298, DOI 10.1128/IAI.00814-10; SMRU, 2011, TREATM GUID; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; Snounou Georges, 2002, Methods Mol Med, V72, P103, DOI 10.1385/1-59259-271-6:103; Therneau TM, 2003, J COMPUT GRAPH STAT, V12, P156, DOI 10.1198/1061860031365; Villegas L, 2007, TROP MED INT HEALTH, V12, P209, DOI [10.1111/j.1365-3165.2006.01778.x, 10.1111/j.1365-3156.2006.01778.x]; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2010, GUID TREATM MAL, V2nd; WICKRAMASURIYA GAW, 1936, MALARIA ANKYLOSTOMIA	28	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57890	10.1371/journal.pone.0057890	http://dx.doi.org/10.1371/journal.pone.0057890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516418	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200020
J	Kloepper, JW; McInroy, JA; Liu, K; Hu, CH				Kloepper, Joseph W.; McInroy, John A.; Liu, Ke; Hu, Chia-Hui			Symptoms of Fern Distortion Syndrome Resulting from Inoculation with Opportunistic Endophytic Fluorescent Pseudomonas spp.	PLOS ONE			English	Article							LEATHERLEAF FERN; BACTERIA; RHIZOSPHERE; GROWTH	Background: Fern Distortion Syndrome (FDS) is a serious disease of Leatherleaf fern (Rumohra adiantiformis). The main symptom of FDS is distortion of fronds, making them unmarketable. Additional symptoms include stunting, irregular sporulation, decreased rhizome diameter, and internal discoloration of rhizomes. We previously reported an association of symptoms with increased endophytic rhizome populations of fluorescent pseudomonads (FPs). The aim of the current study was to determine if FPs from ferns in Costa Rica with typical FDS symptoms would recreate symptoms of FDS. Methodology and Findings: Greenhouse tests were conducted over a 29-month period. Micro-propagated ferns derived from tissue culture were first grown one year to produce rhizomes. Then, using an 8x9 randomized complete block experimental design, 8 replicate rhizomes were inoculated by dipping into 9 different treatments before planting. Treatments included water without bacteria (control), and four different groups of FPs, each at a two concentrations. The four groups of FPs included one group from healthy ferns without symptoms (another control treatment), two groups isolated from inside rhizomes of symptomatic ferns, and one group isolated from inside roots of symptomatic ferns. Symptoms were assessed 12 and 17 months later, and populations of FPs inside newly formed rhizomes were determined after 17 months. Results showed that inoculation with mixtures of FPs from ferns with FDS symptoms, but not from healthy ferns, recreated the primary symptom of frond deformities and also the secondary symptoms of irregular sporulation, decreased rhizome diameter, and internal discoloration of rhizomes. Conclusions: These results suggest a model of causation of FDS in which symptoms result from latent infections by multiple species of opportunistic endophytic bacteria containing virulence genes that are expressed when populations inside the plant reach a minimum level.	[Kloepper, Joseph W.; McInroy, John A.; Liu, Ke; Hu, Chia-Hui] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA	Auburn University System; Auburn University	Kloepper, JW (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	kloepjw@auburn.edu			Alabama Agricultural Experiment Station (AAES)	Alabama Agricultural Experiment Station (AAES)	Funding was provided by the Alabama Agricultural Experiment Station (AAES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barazani O, 2001, CRIT REV MICROBIOL, V27, P41, DOI 10.1080/20014091096693; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; CAMPBELL JN, 1986, CAN J MICROBIOL, V32, P201, DOI 10.1139/m86-041; FRANKENBERGER WT, 1988, SOIL BIOL BIOCHEM, V20, P299, DOI 10.1016/0038-0717(88)90007-7; GARDNER JM, 1982, APPL ENVIRON MICROB, V43, P1335, DOI 10.1128/AEM.43.6.1335-1342.1982; Gonzalez AJ, 2003, APPL ENVIRON MICROB, V69, P2936, DOI 10.1128/AEM.69.5.2936-2941.2003; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; KLEMENT Z, 1964, PHYTOPATHOLOGY, V54, P474; Kloepper JW, 2010, PLANT DIS, V94, P940, DOI 10.1094/PDIS-94-8-0940; Kloepper JW, 2012, APPL SOIL ECOL, V61, P236, DOI 10.1016/j.apsoil.2011.09.009; Kremer RJ, 1996, J PLANT NUTR, V19, P939, DOI 10.1080/01904169609365171; Laasik E, 2006, FEMS MICROBIOL LETT, V258, P227, DOI 10.1111/j.1574-6968.2006.00222.x; Lindow SE, 1998, PHYTOPATHOLOGY, V88, P1149, DOI 10.1094/PHYTO.1998.88.11.1149; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; Mills HA, 1996, J PLANT NUTR, V19, P917, DOI 10.1080/01904169609365170; Okon Y, 1997, ASM NEWS, V63, P366; Preston GM, 2004, PHILOS T R SOC B, V359, P907, DOI 10.1098/rstb.2003.1384; Strandberg JO, 1999, EFFECTS LIGHT INTENS; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121	20	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58531	10.1371/journal.pone.0058531	http://dx.doi.org/10.1371/journal.pone.0058531			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516499	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200080
J	Lewis, NS; Javakhishvili, Z; Russell, CA; Machablishvili, A; Lexmond, P; Verhagen, JH; Vuong, O; Onashvili, T; Donduashvili, M; Smith, DJ; Fouchier, RAM				Lewis, Nicola S.; Javakhishvili, Zurab; Russell, Colin A.; Machablishvili, Ann; Lexmond, Pascal; Verhagen, Josanne H.; Oanh Vuong; Onashvili, Tinatin; Donduashvili, Marina; Smith, Derek J.; Fouchier, Ron A. M.			Avian Influenza Virus Surveillance in Wild Birds in Georgia: 2009-2011	PLOS ONE			English	Article							A VIRUS; HEMAGGLUTININ	The Caucasus, at the border of Europe and Asia, is important for migration and over-wintering of wild waterbirds. Three flyways, the Central Asian, East Africa-West Asia, and Mediterranean/Black Sea flyways, converge in the Caucasus region. Thus, the Caucasus region might act as a migratory bridge for influenza virus transmission when birds aggregate in high concentrations in the post-breeding, migrating and overwintering periods. Since August 2009, we have established a surveillance network for influenza viruses in wild birds, using five sample areas geographically spread throughout suitable habitats in both eastern and western Georgia. We took paired tracheal and cloacal swabs and fresh feces samples. We collected 8343 swabs from 76 species belonging to 17 families in 11 orders of birds, of which 84 were real-time RT-PCR positive for avian influenza virus (AIV). No highly pathogenic AIV (HPAIV) H5 or H7 viruses were detected. The overall AIV prevalence was 1.6%. We observed peak prevalence in large gulls during the autumn migration (5.3-9.8%), but peak prevalence in Black-headed Gulls in spring (4.2-13%). In ducks, we observed increased AIV prevalence during the autumn post-moult aggregations and migration stop-over period (6.3%) but at lower levels to those observed in other more northerly post-moult areas in Eurasia. We observed another prevalence peak in the overwintering period (0.14-5.9%). Serological and virological monitoring of a breeding colony of Armenian Gulls showed that adult birds were seropositive on arrival at the breeding colony, but juveniles remained serologically and virologically negative for AIV throughout their time on the breeding grounds, in contrast to gull AIV data from other geographic regions. We show that close phylogenetic relatives of viruses isolated in Georgia are sourced from a wide geographic area throughout Western and Central Eurasia, and from areas that are represented by multiple different flyways, likely linking different host sub-populations.	[Lewis, Nicola S.; Russell, Colin A.; Smith, Derek J.] Univ Cambridge, Dept Zool, Cambridge, England; [Lexmond, Pascal; Verhagen, Josanne H.; Oanh Vuong; Smith, Derek J.; Fouchier, Ron A. M.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Lexmond, Pascal; Verhagen, Josanne H.; Oanh Vuong; Smith, Derek J.; Fouchier, Ron A. M.] Erasmus MC, Natl Influenza Ctr, Rotterdam, Netherlands; [Russell, Colin A.; Smith, Derek J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Javakhishvili, Zurab] Ilia State Univ, Inst Ecol, Tbilisi, Georgia; [Machablishvili, Ann] Ivane Javakhishvili Tbilisi State Univ, Tbilisi, Georgia; [Machablishvili, Ann] Natl Ctr Dis Control, Influenza Sect, Tbilisi, Georgia; [Onashvili, Tinatin; Donduashvili, Marina] Lab Minist Agr, Tbilisi, Georgia	University of Cambridge; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Ilia State University; Ivane Javakhishvili Tbilisi State University; National Center for Disease Control & Public Health - Georgia	Lewis, NS (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	nsl25@cam.ac.uk	Smith, Derek/Z-3075-2019; Russell, Colin/ABE-7106-2020; Javakhishvili, Zura/ACR-6041-2022; Fouchier, Ron A/A-1911-2014	Smith, Derek/0000-0002-2393-1890; Fouchier, Ron A/0000-0001-8095-2869; Tripp, Ralph/0000-0002-2924-9956; Russell, Colin/0000-0002-2113-162X; Verhagen, Josanne/0000-0003-3133-5228	Wellcome Trust Fellowship [WT089235MF]; NIAID-NIH "NIAID Centres of Excellence for Influenza Research and Surveillance'' [HHSN266200700010C]	Wellcome Trust Fellowship(Wellcome Trust); NIAID-NIH "NIAID Centres of Excellence for Influenza Research and Surveillance''	This work was supported by a Wellcome Trust Fellowship WT089235MF http://www.wellcome.ac.uk/index.htm and by NIAID-NIH contract No. HHSN266200700010C "NIAID Centres of Excellence for Influenza Research and Surveillance'' http://www.niaid.nih.gov/LabsAndResources/resources/ceirs/Pages/crip.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Beruchashvili N, 2000, P 1 NAT C BIOL LANDS, P221; CHAMBERS TM, 1989, VIROLOGY, V172, P180, DOI 10.1016/0042-6822(89)90119-0; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Hanson BA, 2008, J WILDLIFE DIS, V44, P351, DOI 10.7589/0090-3558-44.2.351; Jackwood MW, 2007, AVIAN DIS, V51, P448, DOI 10.1637/7536-032706R.1; Jourdain E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024155; Karamendin K, 2011, VIRUS GENES, V43, P46, DOI 10.1007/s11262-011-0603-y; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; PODCHERNYAEVA RY, 1979, VOP VIRUSOL+, P227; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramsar, 2013, RAMS LIST WETL INT I; ROSLAYA IG, 1984, VOP VIRUSOL+, P155; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Velarde R, 2010, AVIAN DIS, V54, P411, DOI 10.1637/8808-040109-Reg.1; Yamnikova S. S., 2009, Voprosy Virusologii, V54, P10	22	35	35	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58534	10.1371/journal.pone.0058534	http://dx.doi.org/10.1371/journal.pone.0058534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516501	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200081
J	Liu, XK; Wang, DS; Ren, JX; Tong, C; Feng, EL; Wang, XF; Zhu, L; Wang, HL				Liu, Xiankai; Wang, Dongshu; Ren, Jingxiao; Tong, Chao; Feng, Erling; Wang, Xuefang; Zhu, Li; Wang, Hengliang			Identification of the Immunogenic Spore and Vegetative Proteins of Bacillus anthracis Vaccine Strain A16R	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; CELL-SURFACE; PROTEOMICS; CEREUS; COMPONENT; ANTIGENS; EXOSPORIUM; CANDIDATES; INFECTION; EFFICACY	Immunoproteomics was used to screen the immunogenic spore and vegetative proteins of Bacillus anthracis vaccine strain A16R. The spore and vegetative proteins were separated by 2D gel electrophoresis and transferred to polyvinylidene difluoride membranes, and then western blotting was performed with rabbit immune serum against B. anthracis live spores. Immunogenic spots were cut and digested by trypsin. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry was performed to identify the proteins. As a result, 11 and 45 immunogenic proteins were identified in the spores and vegetative cells, respectively; 26 of which have not been reported previously. To verify their immunogenicity, 12 of the identified proteins were selected to be expressed, and the immune sera from the mice vaccinated by the 12 expressed proteins, except BA0887, had a specific western blot band with the A16R whole cellular lytic proteins. Some of these immunogenic proteins might be used as novel vaccine candidates themselves or for enhancing the protective efficacy of a protective-antigen-based vaccine.	[Liu, Xiankai; Wang, Dongshu; Ren, Jingxiao; Tong, Chao; Feng, Erling; Wang, Xuefang; Zhu, Li; Wang, Hengliang] Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China		Zhu, L (corresponding author), Beijing Inst Biotechnol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	jewly54@126.com; wanghl@nic.bmi.ac.cn	Wang, Hengliang/AAL-5340-2021; wang, hengliang/AAA-8300-2020; Wang, Hengliang/AAT-4586-2021; Zhu, Li/Q-7499-2017; zhang, xiaoyan/F-4789-2013	Wang, Hengliang/0000-0001-8476-4320; Zhu, Li/0000-0001-9975-8978; 	State Major Science and Technology Special Projects of China [2012ZX10004215]; National Natural Science Foundation of China [81125012, 81271785]	State Major Science and Technology Special Projects of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the State Major Science and Technology Special Projects of China (number 2012ZX10004215) and the National Natural Science Foundation of China (numbers 81125012 and 81271785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariel N, 2003, INFECT IMMUN, V71, P4563, DOI 10.1128/IAI.71.8.4563-4579.2003; Ariel N, 2002, INFECT IMMUN, V70, P6817, DOI 10.1128/IAI.70.12.6817-6827.2002; Blendon Robert J, 2002, MedGenMed, V4, P1; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brossier F, 2002, INFECT IMMUN, V70, P661; BUCHMEIER NA, 1990, SCIENCE, V248, P730, DOI 10.1126/science.1970672; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Cohen S, 2000, INFECT IMMUN, V68, P4549, DOI 10.1128/IAI.68.8.4549-4558.2000; Cordwell SJ, 2002, METHOD ENZYMOL, V358, P207; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Dong S, 1999, Zhonghua Liu Xing Bing Xue Za Zhi, V20, P135; Drake RR, 2005, EXPERT REV PROTEOMIC, V2, P203, DOI 10.1586/14789450.2.2.203; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Fouet A, 2002, CURR TOP MICROBIOL, V271, P87; Friedlander AM, 2002, CURR TOP MICROBIOL, V271, P33; Gat O, 2006, INFECT IMMUN, V74, P3987, DOI 10.1128/IAI.00174-06; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; HAMBLETON P, 1984, Vaccine, V2, P125, DOI 10.1016/0264-410X(84)90003-3; Hanna P, 1998, CURR TOP MICROBIOL, V225, P13; Klade CS, 2002, CURR OPIN MOL THER, V4, P216; Lei BF, 2000, INFECT IMMUN, V68, P6807, DOI 10.1128/IAI.68.12.6807-6818.2000; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; March JB, 2006, INFECT IMMUN, V74, P167, DOI 10.1128/IAI.74.1.167-174.2006; Mesnage S, 1999, INFECT IMMUN, V67, P4847, DOI 10.1128/IAI.67.9.4847-4850.1999; Mesnage S, 1997, MOL MICROBIOL, V23, P1147, DOI 10.1046/j.1365-2958.1997.2941659.x; Mesnage S, 1999, J APPL MICROBIOL, V87, P256, DOI 10.1046/j.1365-2672.1999.00880.x; Mesnage S, 2000, EMBO J, V19, P4473, DOI 10.1093/emboj/19.17.4473; Montigiani S, 2002, INFECT IMMUN, V70, P368, DOI 10.1128/IAI.70.1.368-379.2002; Mukhopadhyay S, 2009, MOL CELL PROTEOMICS, V8, P1174, DOI 10.1074/mcp.M800403-MCP200; Nakamura T, 2004, ARCH MICROBIOL, V181, P74, DOI 10.1007/s00203-003-0632-6; Okinaka R, 1999, J APPL MICROBIOL, V87, P261, DOI 10.1046/j.1365-2672.1999.00883.x; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Schoeni JL, 2005, J FOOD PROTECT, V68, P636, DOI 10.4315/0362-028X-68.3.636; Shin GW, 2007, J CHROMATOGR B, V849, P315, DOI 10.1016/j.jchromb.2006.11.009; Shin GW, 2006, DIS AQUAT ORGAN, V70, P71, DOI 10.3354/dao070071; SHLYAKHOV EN, 1994, VACCINE, V12, P727, DOI 10.1016/0264-410X(94)90223-2; Sylvestre P, 2002, MOL MICROBIOL, V45, P169, DOI 10.1046/j.1365-2958.2000.03000.x; TURNBULL PCB, 1991, VACCINE, V9, P533, DOI 10.1016/0264-410X(91)90237-Z; Wang JJ, 2005, PROTEOMICS, V5, P4488, DOI 10.1002/pmic.200401322; WELKOS SL, 1988, MICROB PATHOGENESIS, V5, P127, DOI 10.1016/0882-4010(88)90015-0; Whiting GC, 2004, VACCINE, V22, P4245, DOI 10.1016/j.vaccine.2004.04.036; Wu M, 2002, ELECTROPHORESIS, V23, P2373, DOI 10.1002/1522-2683(200208)23:15<2373::AID-ELPS2373>3.0.CO;2-W; Yan Q, 2009, BIOTECHNOLOGY B, P15	45	21	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57959	10.1371/journal.pone.0057959	http://dx.doi.org/10.1371/journal.pone.0057959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516421	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200021
J	Nagayasu, E; Ishikawa, SA; Taketani, S; Chakraborty, G; Yoshida, A; Inagaki, Y; Maruyama, H				Nagayasu, Eiji; Ishikawa, Sohta A.; Taketani, Shigeru; Chakraborty, Gunimala; Yoshida, Ayako; Inagaki, Yuji; Maruyama, Haruhiko			Identification of a Bacteria-Like Ferrochelatase in Strongyloides venezuelensis, an Animal Parasitic Nematode	PLOS ONE			English	Article							HEME-BIOSYNTHESIS; DRAFT GENOME; HAEMOPHILUS-INFLUENZAE; BRUGIA-MALAYI; CLASSIC RACE; LIFE-STYLE; SEQUENCE; PATHWAY; INFECTIONS; HEMOGLOBIN	Heme is an essential molecule for vast majority of organisms serving as a prosthetic group for various hemoproteins. Although most organisms synthesize heme from 5-aminolevulinic acid through a conserved heme biosynthetic pathway composed of seven consecutive enzymatic reactions, nematodes are known to be natural heme auxotrophs. The completely sequenced Caenorhabditis elegans genome, for example, lacks all seven genes for heme biosynthesis. However, genome/transcriptome sequencing of Strongyloides venezuelensis, an important model nematode species for studying human strongyloidiasis, indicated the presence of a gene for ferrochelatase (FeCH), which catalyzes the terminal step of heme biosynthesis, whereas the other six heme biosynthesis genes are apparently missing. Phylogenetic analyses indicated that nematode FeCH genes, including that of S. venezuelensis (SvFeCH) have a fundamentally different evolutionally origin from the FeCH genes of non-nematode metazoa. Although all non-nematode metazoan FeCH genes appear to be inherited vertically from an ancestral opisthokont, nematode FeCH may have been acquired from an alpha-proteobacterium, horizontally. The identified SvFeCH sequence was found to function as FeCH as expected based on both in vitro chelatase assays using recombinant SvFeCH and in vivo complementation experiments using an FeCH-deficient strain of Escherichia coli. Messenger RNA expression levels during the S. venezuelensis lifecycle were examined by real-time RT-PCR. SvFeCH mRNA was expressed at all the stages examined with a marked reduction at the infective third-stage larvae. Our study demonstrates the presence of a bacteria-like FeCH gene in the S. venezuelensis genome. It appeared that S. venezuelensis and some other animal parasitic nematodes reacquired the once-lost FeCH gene. Although the underlying evolutionary pressures that necessitated this reacquisition remain to be investigated, it is interesting that the presence of FeCH genes in the absence of other heme biosynthesis genes has been reported only for animal pathogens, and this finding may be related to nutritional availability in animal hosts.	[Nagayasu, Eiji; Chakraborty, Gunimala; Yoshida, Ayako; Maruyama, Haruhiko] Miyazaki Univ, Fac Med, Div Parasitol, Dept Infect Dis, Miyazaki, Japan; [Ishikawa, Sohta A.; Inagaki, Yuji] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Taketani, Shigeru] Kyoto Inst Technol, Dept Biotechnol, Kyoto 606, Japan	University of Miyazaki; University of Tsukuba; Kyoto Institute of Technology	Maruyama, H (corresponding author), Miyazaki Univ, Fac Med, Div Parasitol, Dept Infect Dis, Miyazaki, Japan.	hikomaru@med.miyazaki-u.ac.jp	Chakraborty, Gunimala/AAP-1273-2021	Chakraborty, Gunimala/0000-0001-5904-492X; Inagaki, Yuji/0000-0003-0101-8483	Japan Society for the Promotion of Science (JSPS) [23790461]; MEXT [21590466, 21022041, H23-Shinko-Ippan-014, H21-kokui-shitei-004]; Japan Society for Promotion of Sciences for Young Scientists [00007]; Grants-in-Aid for Scientific Research [21247010] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Sciences for Young Scientists; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Young Scientists (B) (23790461) from Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research C (21590466), Grant-in-aid for Scientific Research on Priority Areas 'Matrix of Infection Phenomena' (21022041), Health Labor Sciences Research Grant (H23-Shinko-Ippan-014, H21-kokui-shitei-004), and Grant-in-Aid for Scientific Research on Innovative Areas "Genome Science" from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SI is a research fellow supported by the Japan Society for Promotion of Sciences for Young Scientists (No. 00007). We thank Dr. Tadasuke Ooka (University of Miyazaki, Japan) for helpful discussions and Amy Hombu (University of Miyazaki) for critical reading of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves JMP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023518; Amino H, 2003, MOL BIOCHEM PARASIT, V128, P175, DOI 10.1016/S0166-6851(03)00074-4; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; BLAXTER ML, 1993, PARASITOL TODAY, V9, P353, DOI 10.1016/0169-4758(93)90082-Q; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHANG KP, 1974, SCIENCE, V183, P531, DOI 10.1126/science.183.4124.531; CHANG KP, 1975, P NATL ACAD SCI USA, V72, P2979, DOI 10.1073/pnas.72.8.2979; Dailey HA, 1997, J BIOL INORG CHEM, V2, P411, DOI 10.1007/s007750050151; Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Elsworth B, 2011, INT J PARASITOL, V41, P881, DOI 10.1016/j.ijpara.2011.03.009; Ferreira GC, 1999, INT J BIOCHEM CELL B, V31, P995, DOI 10.1016/S1357-2725(99)00066-7; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Jex AR, 2011, NATURE, V479, P529, DOI 10.1038/nature10553; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; KOHNO H, 1994, BBA-PROTEIN STRUCT M, V1209, P95, DOI 10.1016/0167-4838(94)90142-2; Koreny L, 2012, P NATL ACAD SCI USA, V109, P3808, DOI 10.1073/pnas.1201089109; Koreny L, 2011, PLANT CELL, V23, P3454, DOI 10.1105/tpc.111.089102; Koreny L, 2011, GENOME BIOL EVOL, V3, P359, DOI 10.1093/gbe/evr029; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LOEB MR, 1995, J BACTERIOL, V177, P3613, DOI 10.1128/jb.177.12.3613-3615.1995; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maruyama H, 2003, PARASITOLOGY, V126, P165, DOI 10.1017/S0031182002002718; Medlock AE, 2007, J MOL BIOL, V373, P1006, DOI 10.1016/j.jmb.2007.08.040; Minning DM, 1999, NATURE, V401, P497, DOI 10.1038/46822; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Montes M, 2010, CURR OPIN INFECT DIS, V23, P500, DOI 10.1097/QCO.0b013e32833df718; Nagayasu E, 2013, PARASITOL INT, V62, P57, DOI 10.1016/j.parint.2012.09.006; NAKAHIGASHI K, 1991, P NATL ACAD SCI USA, V88, P10520, DOI 10.1073/pnas.88.23.10520; Nakayama T, 2009, CURR BIOL, V19, pR284, DOI 10.1016/j.cub.2009.02.043; Obornik M, 2005, MOL BIOL EVOL, V22, P2343, DOI 10.1093/molbev/msi230; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sato S, 2003, CURR GENET, V42, P292, DOI 10.1007/s00294-002-0360-5; SATO Y, 1990, INT J PARASITOL, V20, P57, DOI 10.1016/0020-7519(90)90173-K; Schlor S, 2000, INFECT IMMUN, V68, P3007, DOI 10.1128/IAI.68.5.3007-3009.2000; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2742, DOI 10.1038/nprot.2006.481; Scotto-Lavino E, 2006, NAT PROTOC, V1, P2555, DOI 10.1038/nprot.2006.480; Sommer RJ, 2011, ANNU REV GENET, V45, P1, DOI 10.1146/annurev-genet-110410-132417; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Takamiya S, 2009, PARASITOL INT, V58, P278, DOI 10.1016/j.parint.2009.03.003; Taketani S, 2007, BIOCHEMISTRY-US, V46, P15054, DOI 10.1021/bi701460x; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Viney Mark E, 2007, WormBook, P1; WAINRIGHT PO, 1993, SCIENCE, V260, P340, DOI 10.1126/science.8469985; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475	56	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58458	10.1371/journal.pone.0058458	http://dx.doi.org/10.1371/journal.pone.0058458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516484	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200070
J	Shi, GX; Cui, WJ; Benchimol, M; Liu, YT; Mattrey, RF; Mukthavaram, R; Kesari, S; Esener, SC; Simberg, D				Shi, Guixin; Cui, Wenjin; Benchimol, Michael; Liu, Yu-Tsueng; Mattrey, Robert F.; Mukthavaram, Rajesh; Kesari, Santosh; Esener, Sadik C.; Simberg, Dmitri			Isolation of Rare Tumor Cells from Blood Cells with Buoyant Immuno-Microbubbles	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; PERIPHERAL-BLOOD; CONTRAST AGENTS; GENE-EXPRESSION; BONE-MARROW; ULTRASOUND; CARCINOMA; NANOPARTICLES; TECHNOLOGY; DELIVERY	Circulating tumor cells (CTCs) are exfoliated at various stages of cancer, and could provide invaluable information for the diagnosis and prognosis of cancers. There is an urgent need for the development of cost-efficient and scalable technologies for rare CTC enrichment from blood. Here we report a novel method for isolation of rare tumor cells from excess of blood cells using gas-filled buoyant immuno-microbubbles (MBs). MBs were prepared by emulsification of perfluorocarbon gas in phospholipids and decorated with anti-epithelial cell adhesion molecule (EpCAM) antibody. EpCAM-targeted MBs efficiently (85%) and rapidly (within 15 minutes) bound to various epithelial tumor cells suspended in cell medium. EpCAM-targeted MBs efficiently (88%) isolated frequent tumor cells that were spiked at 100,000 cells/ml into plasma-depleted blood. Anti-EpCAM MBs efficiently (>77%) isolated rare mouse breast 4T1, human prostate PC-3 and pancreatic cancer BxPC-3 cells spiked into 1, 3 and 7 ml (respectively) of plasma-depleted blood. Using EpCAM targeted MBs CTCs from metastatic cancer patients were isolated, suggesting that this technique could be developed into a valuable clinical tool for isolation, enumeration and analysis of rare cells.	[Shi, Guixin; Liu, Yu-Tsueng; Mattrey, Robert F.; Esener, Sadik C.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Cui, Wenjin; Mattrey, Robert F.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Benchimol, Michael] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Mukthavaram, Rajesh; Kesari, Santosh] Univ Calif San Diego, Neurooncol Program, Moores Canc Ctr, La Jolla, CA 92093 USA; [Kesari, Santosh] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Esener, Sadik C.] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Simberg, Dmitri] Univ Calif San Diego, Solid Tumor Therapeut Program, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Simberg, D (corresponding author), Univ Calif San Diego, Solid Tumor Therapeut Program, Moores Canc Ctr, La Jolla, CA 92093 USA.	dsimberg@ucsd.edu	Kesari, Santosh/E-8461-2013		United States National Institutes of Health (NIH) [1R21CA137721-01]; UCSD Cancer Center Specialized Support Grant [P30 CA23100]; NIH [P50CA128346]; NCI [5U54CA119335]; NATIONAL CANCER INSTITUTE [U54CA119335, P50CA128346, R21CA137721, P30CA023100] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Cancer Center Specialized Support Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the United States National Institutes of Health (NIH) 1R21CA137721-01 IMAT grant awarded to D. S. and by the UCSD Cancer Center Specialized Support Grant P30 CA23100. W.C. was partially supported by the NIH P50CA128346 (ICMIC) grant. M.B. was partially supported by the NCI 5U54CA119335 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AA, 2008, J AM CHEM SOC, V130, P8633, DOI 10.1021/ja8015022; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Bauer KD, 2000, CLIN CANCER RES, V6, P3552; Bouvet M, 2000, CLIN EXP METASTAS, V18, P213, DOI 10.1023/A:1006767405609; Cevc G., 1987, PHOSPHOLIPID BILAYER; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Fehm T, 2002, CLIN CANCER RES, V8, P2073; Ferrara K, 2007, ANNU REV BIOMED ENG, V9, P415, DOI 10.1146/annurev.bioeng.8.061505.095852; Grover WH, 2011, P NATL ACAD SCI USA, V108, P10992, DOI 10.1073/pnas.1104651108; Hager G, 2005, GYNECOL ONCOL, V98, P211, DOI 10.1016/j.ygyno.2005.04.042; Hettiarachchi K, 2007, LAB CHIP, V7, P463, DOI 10.1039/b701481n; Huang J, 2001, J SURG RES, V99, P222, DOI 10.1006/jsre.2001.6195; Karmali PP, 2012, MOL PHARMACEUT, V9, P539, DOI 10.1021/mp200375x; Khoja L, 2011, BR J CANC; Kraeft SK, 2004, CLIN CANCER RES, V10, P3020, DOI 10.1158/1078-0432.CCR-03-0361; Krag D. N., 1999, Breast J, V5, P354, DOI 10.1046/j.1524-4741.1999.99016.x; Krivacic RT, 2004, P NATL ACAD SCI USA, V101, P10501, DOI 10.1073/pnas.0404036101; Marth C, 2002, CANCER-AM CANCER SOC, V94, P707, DOI 10.1002/cncr.10250; Molnar B, 2001, CLIN CANCER RES, V7, P4080; Myrset AH, 2011, ULTRASOUND MED BIOL, V37, P136, DOI 10.1016/j.ultrasmedbio.2010.10.010; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Pecot CV, 2011, CANCER DISCOV, V1, P580, DOI 10.1158/2159-8290.CD-11-0215; Podell S, 1999, BIOTECHNOL APPL BIOC, V30, P213; Rao CG, 2005, INT J ONCOL, V27, P49; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Sboros V, 2007, ULTRASONICS, V46, P349, DOI 10.1016/j.ultras.2007.06.004; Schutt EG, 2003, ANGEW CHEM INT EDIT, V42, P3218, DOI 10.1002/anie.200200550; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sieuwerts AM, 2009, BREAST CANCER RES TR, V118, P455, DOI 10.1007/s10549-008-0290-0; Simberg D, 2009, J DRUG TARGET, V17, P392, DOI 10.1080/10611860902902797; Smirnov DA, 2005, CANCER RES, V65, P4993, DOI 10.1158/0008-5472.CAN-04-4330; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sugahara KN, 2009, CANCER CELL, V16, P510, DOI 10.1016/j.ccr.2009.10.013; Tveito S, 2007, CLIN EXP METASTAS, V24, P317, DOI 10.1007/s10585-006-9052-8; von Bibra H, 1999, ECHOCARDIOGR-J CARD, V16, P733, DOI 10.1111/j.1540-8175.1999.tb00143.x; Wong JY, 1997, SCIENCE, V275, P820, DOI 10.1126/science.275.5301.820; Xu T, 2010, CANCER RES, V70, P6420, DOI 10.1158/0008-5472.CAN-10-0686; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021	39	28	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58017	10.1371/journal.pone.0058017	http://dx.doi.org/10.1371/journal.pone.0058017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516425	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200025
J	Guo, YY; Yuan, HS; Cho, HS; Kuruppu, D; Jokivarsi, K; Agarwal, A; Shah, K; Josephson, L				Guo, Yanyan; Yuan, Hushan; Cho, Hoonsung; Kuruppu, Darshini; Jokivarsi, Kimmo; Agarwal, Aayush; Shah, Khalid; Josephson, Lee			High Efficiency Diffusion Molecular Retention Tumor Targeting	PLOS ONE			English	Article							RGD PEPTIDES; THERAPY; DESIGN; PROTEINS; DRUG	Here we introduce diffusion molecular retention (DMR) tumor targeting, a technique that employs PEG-fluorochrome shielded probes that, after a peritumoral (PT) injection, undergo slow vascular uptake and extensive interstitial diffusion, with tumor retention only through integrin molecular recognition. To demonstrate DMR, RGD (integrin binding) and RAD (control) probes were synthesized bearing DOTA (for (111) In3+), a NIR fluorochrome, and 5 kDa PEG that endows probes with a protein-like volume of 25 kDa and decreases non-specific interactions. With a GFP-BT-20 breast carcinoma model, tumor targeting by the DMR or IV methods was assessed by surface fluorescence, biodistribution of [In-111] RGD and [In-111] RAD probes, and whole animal SPECT. After a PT injection, both probes rapidly diffused through the normal and tumor interstitium, with retention of the RGD probe due to integrin interactions. With PT injection and the [In-111] RGD probe, SPECT indicated a highly tumor specific uptake at 24 h post injection, with 352% ID/g tumor obtained by DMR (vs 4.14% ID/g by IV). The high efficiency molecular targeting of DMR employed low probe doses (e. g. 25 ng as RGD peptide), which minimizes toxicity risks and facilitates clinical translation. DMR applications include the delivery of fluorochromes for intraoperative tumor margin delineation, the delivery of radioisotopes (e. g. toxic, short range alpha emitters) for radiotherapy, or the delivery of photosensitizers to tumors accessible to light.	[Guo, Yanyan; Yuan, Hushan; Cho, Hoonsung; Kuruppu, Darshini; Josephson, Lee] Massachusetts Gen Hosp, Dept Radiol, Ctr Translat Nucl Med & Mol Imaging, Charlestown, MA 02129 USA; [Jokivarsi, Kimmo; Josephson, Lee] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Jokivarsi, Kimmo] Univ Eastern Finland, AI Virtanen Inst, Dept Neurobiol, Kuopio, Finland; [Agarwal, Aayush; Shah, Khalid] Massachusetts Gen Hosp, Mol Neurotherapy & Imaging Lab, Dept Radiol, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Eastern Finland; Harvard University; Massachusetts General Hospital	Josephson, L (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Ctr Translat Nucl Med & Mol Imaging, Charlestown, MA 02129 USA.	ljosephson@mgh.harvard.edu		Cho, Hoonsung/0000-0003-0778-5640	National Institutes of Health [R01 EB 011996, R01 EB 009691]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009691, R01EB011996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	National Institutes of Health Grants to Josephson # R01 EB 011996 and # R01 EB 009691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antczak C, 2006, BIOCONJUGATE CHEM, V17, P1551, DOI 10.1021/bc060156+; BAGSHAWE KD, 1990, BIOCHEM SOC T, V18, P750, DOI 10.1042/bst0180750; Beer AJ, 2011, METHODS MOL BIOL, V680, P183, DOI 10.1007/978-1-60761-901-7_13; Benshushan A, 1998, Obstet Gynecol Surv, V53, P383, DOI 10.1097/00006254-199806000-00024; Butlin NG, 2006, ACCOUNTS CHEM RES, V39, P780, DOI 10.1021/ar020275e; Carlsson J, 2003, RADIOTHER ONCOL, V66, P107, DOI 10.1016/S0167-8140(02)00374-2; Cordier D, 2010, EUR J NUCL MED MOL I, V37, P1335, DOI 10.1007/s00259-010-1385-5; Cremonesi M, 2006, J NUCL MED, V47, P1467; Dapp S, 2011, NUCL MED BIOL, V38, P997, DOI 10.1016/j.nucmedbio.2011.02.014; Dmochowski Roger, 2003, Curr Urol Rep, V4, P350, DOI 10.1007/s11934-003-0005-3; Dubey PK, 2004, J DRUG TARGET, V12, P257, DOI 10.1080/10611860410001728040; Fani M, 2012, THERANOSTICS, V2, P481, DOI 10.7150/thno.4024; Fani M, 2012, EUR J NUCL MED MOL I, V39, P11, DOI 10.1007/s00259-011-2001-z; Fee Conan J, 2011, Methods Biochem Anal, V54, P339; Forrer F, 2005, J NUCL MED, V46, P1310; Garanger E, 2005, MOL THER, V12, P1168, DOI 10.1016/j.ymthe.2005.06.095; Garanger E, 2008, CHEM COMMUN, P4792, DOI 10.1039/b809537j; Garanger E, 2010, J COMB CHEM, V12, P57, DOI 10.1021/cc900141b; Goldenberg David M, 2007, Update Cancer Ther, V2, P19, DOI 10.1016/j.uct.2007.04.003; Goldenberg DM, 2012, THERANOSTICS, V2, P523, DOI 10.7150/thno.3582; Guo YY, 2012, J AM CHEM SOC, V134, P19338, DOI 10.1021/ja309085b; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; JAIN RK, 1990, CANCER METAST REV, V9, P253, DOI 10.1007/BF00046364; Kam BLR, 2012, EUR J NUCL MED MOL I, V39, P103, DOI 10.1007/s00259-011-2039-y; Kok RJ, 2002, BIOCONJUGATE CHEM, V13, P128, DOI 10.1021/bc015561+; Kuil J, 2011, BIOCONJUGATE CHEM, V22, P859, DOI 10.1021/bc2000947; Liu ZF, 2009, EUR J NUCL MED MOL I, V36, P947, DOI 10.1007/s00259-008-1045-1; Lohof E, 2000, ANGEW CHEM INT EDIT, V39, P2761, DOI 10.1002/1521-3773(20000804)39:15<2761::AID-ANIE2761>3.0.CO;2-9; McDevitt MR, 2002, APPL RADIAT ISOTOPES, V57, P841, DOI 10.1016/S0969-8043(02)00167-7; Meares CF, 2008, ADV DRUG DELIVER REV, V60, P1383, DOI 10.1016/j.addr.2008.04.010; Milenic DE, 2004, NAT REV DRUG DISCOV, V3, P488, DOI 10.1038/nrd1413; Mittra ES, 2011, RADIOLOGY, V260, P182, DOI 10.1148/radiol.11101139; Montet X, 2006, LAB INVEST, V86, P517, DOI 10.1038/labinvest.3700404; Montet X, 2006, J MED CHEM, V49, P6087, DOI 10.1021/jm060515m; Montet X, 2006, NEOPLASIA, V8, P214, DOI 10.1593/neo.05769; Mulder WJM, 2005, FASEB J, V19, P2008, DOI 10.1096/fj.05-4145fje; Naspro R, 2005, CURR OPIN UROL, V15, P49, DOI 10.1097/00042307-200501000-00012; Olafsen T, 2010, SEMIN NUCL MED, V40, P167, DOI 10.1053/j.semnuclmed.2009.12.005; Porter CJH, 2001, ADV DRUG DELIVER REV, V50, P157, DOI 10.1016/S0169-409X(01)00153-3; Reubi JC, 2008, J NUCL MED, V49, P1735, DOI 10.2967/jnumed.108.053041; Ricart AD, 2011, CLIN PHARMACOL THER, V89, P513, DOI 10.1038/clpt.2011.8; Shao FW, 2011, DYES PIGMENTS, V90, P119, DOI 10.1016/j.dyepig.2010.12.008; Sherman Warren, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS57, DOI 10.1038/ncpcardio0446; Shore N, 2010, EXPERT OPIN INV DRUG, V19, P305, DOI 10.1517/13543780903555196; Teicher BA, 2011, CLIN CANCER RES, V17, P6389, DOI 10.1158/1078-0432.CCR-11-1417; Thurber GM, 2008, TRENDS PHARMACOL SCI, V29, P57, DOI 10.1016/j.tips.2007.11.004; Velikyan I, 2012, NUCL MED BIOL, V39, P628, DOI 10.1016/j.nucmedbio.2011.12.010; Villard L, 2012, J CLIN ONCOL, V30, P1100, DOI 10.1200/JCO.2011.37.2151; Virgolini I, 2002, CURR PHARM DESIGN, V8, P1781, DOI 10.2174/1381612023393756; Wild D, 2011, CANCER RES, V71, P1009, DOI 10.1158/0008-5472.CAN-10-1186; Wu Anna M, 2004, Methods Mol Biol, V248, P209; Ye YP, 2006, J MED CHEM, V49, P2268, DOI 10.1021/jm050947h	52	10	10	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58290	10.1371/journal.pone.0058290	http://dx.doi.org/10.1371/journal.pone.0058290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505478	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100041
J	Dowling, MR; Josefsson, EC; Henley, KJ; Kile, BT; Hodgkin, PD				Dowling, Mark R.; Josefsson, Emma C.; Henley, Katya J.; Kile, Benjamin T.; Hodgkin, Philip D.			A Model for Studying the Hemostatic Consumption or Destruction of Platelets	PLOS ONE			English	Article							LIFE-SPAN; CELL SURVIVAL; SIALIC-ACID; SIZE; AGE; KINETICS	A fundamental issue in understanding homeostasis of the hematopoietic system is to what extent intrinsic and extrinsic factors regulate cell fate. We recently revisited this issue for the case of blood platelets and concluded that platelet life span is largely regulated by internal factors, in contrast to the long-held view that accumulated damage from the environment triggers clearance. However, it is known that in humans there is an ongoing fixed requirement for platelets to maintain hemostasis and prevent bleeding; hence a proportion of platelets may be consumed in such processes before the end of their natural life span. Whether it is possible to detect this random loss of platelets in normal individuals at steady-state is unknown. To address this question, we have developed a mathematical model that independently incorporates age-independent random loss and age-dependent natural senescent clearance. By fitting to population survival curves, we illustrate the application of the model in quantifying the fixed requirement for platelets to maintain hemostasis in mice, and discuss the relationship with previous work in humans. Our results suggest a higher requirement for platelets in mice than in humans, however experimental uncertainty in the data limits our ability to constrain this quantity. We then explored the relationship between experimental uncertainty and parameter constraint using simulated data. We conclude that in order to provide useful constraint on the random loss fraction the standard error in the mean of the data must be reduced substantially, either through improving experimental uncertainty or increasing the number of experimental replicates to impractical levels. Finally we find that parameter constraint is improved at higher values of the random loss fraction; thus the model find utility in situations where the random loss fraction is expected to be high, for example during active bleeding or some types of thrombocytopenia.	[Dowling, Mark R.; Hodgkin, Philip D.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia; [Josefsson, Emma C.; Henley, Katya J.; Kile, Benjamin T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Canc & Hematol Div, Parkville, Vic 3050, Australia; [Dowling, Mark R.; Josefsson, Emma C.; Kile, Benjamin T.; Hodgkin, Philip D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Dowling, MR (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia.	dowling@wehi.edu.au	Kile, Benjamin/GNP-3246-2022; Josefsson, Emma/CAF-4970-2022; Kile, Benjamin T/F-6593-2011	Kile, Benjamin/0000-0002-8836-8947; Kile, Benjamin T/0000-0002-8836-8947; Dowling, Mark/0000-0002-8056-5348; Josefsson, Emma/0000-0001-6478-5204; Hodgkin, Philip/0000-0002-8604-1940	Independent Research Institutes Infrastructure Support Scheme from the Australian National Health and Medical Research Council [361646]; Sylvia and Charles Viertel Charitable Foundation; Leukemia & Lymphoma Society; Australian Cancer Research Fund; Victorian State Government;  [516725];  [575535];  [1010654];  [1016647]	Independent Research Institutes Infrastructure Support Scheme from the Australian National Health and Medical Research Council; Sylvia and Charles Viertel Charitable Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Australian Cancer Research Fund; Victorian State Government; ; ; ; 	This work was supported by project grants (516725, 575535, 1010654), a program grant (1016647), Fellowships (M. R. D., B. T. K. and P. D. H.) and an Independent Research Institutes Infrastructure Support Scheme Grant (361646) from the Australian National Health and Medical Research Council, a Fellowship from the Sylvia and Charles Viertel Charitable Foundation (B. T. K.), a Fellowship from the Leukemia & Lymphoma Society (E.C.J), the Australian Cancer Research Fund, and Victorian State Government Operational Infrastructure Support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen AF, 1968, SCAND J HAEMATOL   S, V3, P7; Balduini CL, 1999, BRIT J HAEMATOL, V106, P202; DETWILER TC, 1962, AM J PHYSIOL, V203, P107, DOI 10.1152/ajplegacy.1962.203.1.107; DORNHORST AC, 1951, BLOOD, V6, P1284, DOI 10.1182/blood.V6.12.1284.1284; Dowling MR, 2010, BLOOD, V116, P1776, DOI 10.1182/blood-2009-12-259663; Dowling MR, 2005, J R SOC INTERFACE, V2, P517, DOI 10.1098/rsif.2005.0069; George J N, 1978, Prog Clin Biol Res, V28, P39; GINSBURG AD, 1972, THROMB DIATH HAEMOST, V27, P407; HANSON SR, 1985, BLOOD, V66, P1105; HARKER LA, 1977, CLIN HAEMATOL, V6, P671; HOFFMANNFEZER G, 1993, ANN HEMATOL, V67, P81, DOI 10.1007/BF01788131; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lomax, 2007, STAT CONCEPTS 2 COUR; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Motulsky H, 2003, PRACTICAL GUIDE CURV; MURPHY EA, 1969, THROMB DIATH HAEMOST, V22, P281; MURPHY EA, 1971, THROMB DIATH HAEMOST, V25, P53, DOI 10.1055/s-0038-1654280; MUSTARD JF, 1966, BRIT J HAEMATOL, V12, P1, DOI 10.1111/j.1365-2141.1966.tb00121.x; RAND ML, 1981, BLOOD, V57, P741; RITCHIE JL, 1977, AM J CARDIOL, V39, P595, DOI 10.1016/S0002-9149(77)80171-9; Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414; THOMPSON CB, 1982, BRIT J HAEMATOL, V50, P509, DOI 10.1111/j.1365-2141.1982.tb01947.x; THOMPSON CB, 1984, BLOOD, V63, P1372; THOMPSON CB, 1983, BLOOD, V62, P487	24	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57783	10.1371/journal.pone.0057783	http://dx.doi.org/10.1371/journal.pone.0057783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505441	gold, Green Published			2022-12-27	WOS:000318334500033
J	Liu, XJ; Zhou, Y; Yang, HS; Ru, SG				Liu, Xujia; Zhou, Yi; Yang, Hongsheng; Ru, Shaoguo			Eelgrass Detritus as a Food Source for the Sea Cucumber Apostichopus japonicus Selenka (Echinidermata: Holothuroidea) in Coastal Waters of North China: An Experimental Study in Flow-Through Systems	PLOS ONE			English	Article							STICHOPUS-TREMULUS; ECOSYSTEM SERVICES; SEAGRASS; GROWTH; ESTABLISHMENT; HABITAT	Eelgrass ecosystems have a wide variety of ecological functions in which living tissues and detritus may be a food source for many marine animals. In this study, we conducted a laboratory simulating experiment to understand the trophic relationship between the eelgrass Zostera marina L and the sea cucumber Apostichopus japonicus. A mixture of decaying eelgrass debris and seafloor surface muddy sediments was used as food to feed A. japonicus, and then specific growth rates (SGR) and fecal production rates (FPR) were measured. According to the proportion of eelgrass debris, we designed five treatment diets, i.e., ES0, ES10, ES20, ES40, and ES100, with eelgrass debris accounting for 0%, 10%, 20%, 40%, and 100% in dry weight, respectively. Results showed that diet composition had a great influence on the growth of A. japonicus. Sea cucumbers could use decaying eelgrass debris as their food source; and when the organic content of a mixture of eelgrass debris and sediment was 19.6% (ES40), a relatively high SGR (1.54%.d(-1)) and FPR (1.31 g.ind.(-1) d(-1)) of A. japonicus were obtained. It is suggested that eelgrass beds can not only provide habitat for the sea cucumber A. japonicus but can also provide an indirect food source for the deposit feeder. This means that the restoration and reconstruction of eelgrass beds, especially in coastal waters of China, would be a potential and effective measure for sea-cucumber fisheries, in respect to both resource restoration and aquaculture of this valuable species.	[Liu, Xujia; Zhou, Yi; Yang, Hongsheng] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Liu, Xujia] Guangxi Inst Oceanol, Beihai, Peoples R China; [Ru, Shaoguo] Ocean Univ China, Sch Marine Life Sci, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Ocean University of China	Zhou, Y (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	yizhou@qdio.ac.cn	Zhou, Yi/F-4219-2011	Zhou, Yi/0000-0001-7300-0173	National Natural Science Foundation of China [41121064/30972268]; Key Projects in the National Science & Technology Pillar Program [2011BAD13B06]; National Marine Public Welfare Research Project [201305043]; Science & Technology Development Project of Qingdao City South District [2009517HY]; Science & Technology Development Project of Tinjin Binhai New Area [2011-XJR12093]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program; National Marine Public Welfare Research Project; Science & Technology Development Project of Qingdao City South District; Science & Technology Development Project of Tinjin Binhai New Area	This research was supported by the National Natural Science Foundation of China (number 41121064/30972268), the Key Projects in the National Science & Technology Pillar Program during the 12th Five-Year Plan Period (2011BAD13B06), the National Marine Public Welfare Research Project (201305043), the Science & Technology Development Project of Qingdao City South District (2009517HY), and the Science & Technology Development Project of Tinjin Binhai New Area (2011-XJR12093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostrom C, 2000, MAR ECOL PROG SER, V205, P123, DOI 10.3354/meps205123; Chen J., 2003, BECHE INF BULL, V17, P18, DOI DOI 10.1038/S41598-019-45271-3; Chen JX., 2004, ADV SEA CUCUMBER AQU, V1, P25; CHOE S, 1963, STUDY SEA CUCUMBER M, P219; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Duarte CM, 2000, J EXP MAR BIOL ECOL, V250, P117, DOI 10.1016/S0022-0981(00)00194-5; Goshima Seiji, 1994, Suisan Zoshoku, V42, P261; Guo D, 2000, PERIODICAL OCEAN U C, V40, P51; Hamel JF, 2001, ADV MAR BIOL, V41, P129, DOI 10.1016/S0065-2881(01)41003-0; HAUKSSON E, 1979, SARSIA, V64, P155, DOI 10.1080/00364827.1979.10411376; Heck KL, 2006, J EXP MAR BIOL ECOL, V330, P420, DOI 10.1016/j.jembe.2005.12.044; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hemming MA, 2000, SEAGRASS ECOLOGY, P20; Hudson IR, 2004, J EXP MAR BIOL ECOL, V301, P75, DOI 10.1016/j.jembe.2003.09.015; Jones CG, 1997, ECOLOGY, V78, P1946, DOI 10.1890/0012-9658(1997)078[1946:PANEOO]2.0.CO;2; Kang KH, 2003, AQUACULTURE, V216, P87, DOI 10.1016/S0044-8486(02)00203-X; Li H, 2006, J FISHERY SCI CHINA, V11, P77; [李文涛 Li Wentao], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P977; Liao YL, 1984, STUDIA MARINA SINICA, V23, P221; McGlathery KJ, 2007, MAR ECOL PROG SER, V348, P1, DOI 10.3354/meps07132; Nakamura Y, 2003, ICHTHYOL RES, V50, P15, DOI 10.1007/s102280300002; NELSON WG, 1981, MAR ECOL PROG SER, V5, P141, DOI 10.3354/meps005141; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Otero-Villanueva MDM, 2004, J EXP MAR BIOL ECOL, V304, P159, DOI 10.1016/j.jembe.2003.12.002; Park JI, 2007, MAR POLLUT BULL, V54, P1238, DOI 10.1016/j.marpolbul.2007.03.020; Ramofafia C, 1997, AQUACULTURE, V152, P119, DOI 10.1016/S0044-8486(96)01525-6; ROBERTSON ML, 1982, MAR ECOL PROG SER, V7, P279, DOI 10.3354/meps007279; SLOAN NA, 1980, MAR ECOL PROG SER, V2, P257, DOI 10.3354/meps002257; Tiensongrusmee B, 1988, SEAFARMING DEV PROJE, P18; Uthicke Sven, 2004, FAO Fisheries Technical Paper, V463, P163; Vizzini S, 2009, BOT MAR, V52, P383, DOI 10.1515/BOT.2009.056; WALKER DI, 1992, MAR POLLUT BULL, V25, P191, DOI 10.1016/0025-326X(92)90224-T; Wang XZ, 2000, MOD FISH INFORM, V15, P20; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Woods CMC, 1997, J EXP MAR BIOL ECOL, V214, P49, DOI 10.1016/S0022-0981(96)02767-0; Xu Z., 1999, SHANDONG FISHERIES, V16, P30; Yang Z.D., 1979, T OCEANOL LIMNOL, V2, P41; YU DY, 1999, J FISHERY SCI CHINA, V6, P109; [于函 YU Han], 2009, [渔业科学进展, Progress in Fishery Sciences], V30, P131; Yuan XT, 2006, AQUACULTURE, V256, P457, DOI 10.1016/j.aquaculture.2006.01.029; Zhang B., 1995, MAR SCI-CHINA, V3, P11; Zhou Y, 2006, MAR ECOL PROG SER, V317, P127, DOI 10.3354/meps317127; Zhou Y, 2006, AQUACULTURE, V256, P510, DOI 10.1016/j.aquaculture.2006.02.005	43	49	53	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58293	10.1371/journal.pone.0058293	http://dx.doi.org/10.1371/journal.pone.0058293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505480	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500064
J	Takahashi, M; Obayashi, M; Ishiguro, T; Sato, N; Niimi, Y; Ozaki, K; Mogushi, K; Mahmut, Y; Tanaka, H; Tsuruta, F; Dolmetsch, R; Yamada, M; Takahashi, H; Kato, T; Mori, O; Eishi, Y; Mizusawa, H; Ishikawa, K				Takahashi, Makoto; Obayashi, Masato; Ishiguro, Taro; Sato, Nozomu; Niimi, Yusuke; Ozaki, Kokoro; Mogushi, Kaoru; Mahmut, Yasen; Tanaka, Hiroshi; Tsuruta, Fuminori; Dolmetsch, Ricardo; Yamada, Mitsunori; Takahashi, Hitoshi; Kato, Takeo; Mori, Osamu; Eishi, Yoshinobu; Mizusawa, Hidehiro; Ishikawa, Kinya			Cytoplasmic Location of alpha 1A Voltage-Gated Calcium Channel C-Terminal Fragment (Ca(v)2.1-CTF) Aggregate Is Sufficient to Cause Cell Death	PLOS ONE			English	Article							ATAXIA TYPE 6; PURE CEREBELLAR-ATAXIA; CREB-BINDING PROTEIN; EXPANDED POLYGLUTAMINE; PURKINJE-CELLS; INTRANUCLEAR INCLUSIONS; HUNTINGTONS-DISEASE; LARGE COHORT; SPINOCEREBELLAR; TYPE-6	The human alpha(1A) voltage-dependent calcium channel (Ca(v)2.1) is a pore-forming essential subunit embedded in the plasma membrane. Its cytoplasmic carboxyl(C)-tail contains a small poly-glutamine (Q) tract, whose length is normally 4 similar to 19 Q, but when expanded up to 20 similar to 33Q, the tract causes an autosomal-dominant neurodegenerative disorder, spinocerebellar ataxia type 6 (SCA6). A recent study has shown that a 75-kDa C-terminal fragment (CTF) containing the polyQ tract remains soluble in normal brains, but becomes insoluble mainly in the cytoplasm with additional localization to the nuclei of human SCA6 Purkinje cells. However, the mechanism by which the CTF aggregation leads to neurodegeneration is completely elusive, particularly whether the CTF exerts more toxicity in the nucleus or in the cytoplasm. We tagged recombinant (r)CTF with either nuclear-localization or nuclear-export signal, created doxycyclin-inducible rat pheochromocytoma (PC12) cell lines, and found that the CTF is more toxic in the cytoplasm than in the nucleus, the observations being more obvious with Q28 (disease range) than with Q13 (normal-length). Surprisingly, the CTF aggregates co-localized both with cAMP response element-binding protein (CREB) and phosphorylated-CREB (p-CREB) in the cytoplasm, and Western blot analysis showed that the quantity of CREB and p-CREB were both decreased in the nucleus when the rCTF formed aggregates in the cytoplasm. In human brains, polyQ aggregates also co-localized with CREB in the cytoplasm of SCA6 Purkinje cells, but not in other conditions. Collectively, the cytoplasmic Ca(v)2.1-CTF aggregates are sufficient to cause cell death, and one of the pathogenic mechanisms may be abnormal CREB trafficking in the cytoplasm and reduced CREB and p-CREB levels in the nuclei.	[Takahashi, Makoto; Obayashi, Masato; Ishiguro, Taro; Sato, Nozomu; Niimi, Yusuke; Ozaki, Kokoro; Mizusawa, Hidehiro; Ishikawa, Kinya] Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo, Japan; [Mogushi, Kaoru; Mahmut, Yasen; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Informat Ctr Med Sci, Bunkyo Ku, Tokyo, Japan; [Tsuruta, Fuminori; Dolmetsch, Ricardo] Stanford Univ, Sch Med, Dept Neurobiol, Palo Alto, CA 94304 USA; [Eishi, Yoshinobu] Tokyo Med & Dent Univ, Grad Sch, Dept Pathol, Bunkyo Ku, Tokyo, Japan; [Yamada, Mitsunori; Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Pathol Neurosci Branch, Niigata, Japan; [Yamada, Mitsunori] Saigata Natl Hosp, Natl Hosp Org, Dept Clin Res, Ohgata Ku, Johetsu, Niigata, Japan; [Kato, Takeo] Yamagata Univ, Fac Med, Dept Neurol Hematol Metab Endocrinol & Diabetol, Yamagata 990, Japan; [Mori, Osamu] Hatsuishi Hosp, Dept Internal Med & Neurol, Nishihara, Chiba, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Stanford University; Tokyo Medical & Dental University (TMDU); Niigata University; Yamagata University	Ishikawa, K (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Neurol & Neurol Sci, Bunkyo Ku, Tokyo, Japan.	pico.nuro@tmd.ac.jp	Eishi, Yoshinobu/N-3602-2017	Eishi, Yoshinobu/0000-0002-0521-1670; Mogushi, Kaoru/0000-0002-2618-8684; Takahashi, Makoto/0000-0002-2452-0268; Sato, Nozomu/0000-0002-8906-2798; Ozaki, Kokoro/0000-0001-9081-8348	Japanese Ministry of Education, Sports and Culture; Japan Society for Promotion of Science (JSPS); Japanese Ministry of Education, Science and Culture; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japanese Ministry of Health, Labour and Welfare, Japan	Japanese Ministry of Education, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labour and Welfare, Japan	This study was funded by the Japanese Ministry of Education, Sports and Culture (KI and HM), the Japan Society for Promotion of Science (JSPS) (KI and HM), the 21st Century COE Program on Brain Integration and its Disorders from the Japanese Ministry of Education, Science and Culture (HM), the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (HM) and from the Health and Labour Sciences Research Grants on Ataxic Diseases (HM) of the Japanese Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data cellection and analysis, decision to publish, or preparation of the manuscript.	Chalovich EM, 2006, J BIOL CHEM, V281, P17870, DOI 10.1074/jbc.M602632200; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Forwood JK, 2001, BIOCHEMISTRY-US, V40, P5208, DOI 10.1021/bi002732+; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Ishiguro T, 2010, ACTA NEUROPATHOL, V119, P447, DOI 10.1007/s00401-009-0630-0; Ishikawa K, 1999, HUM MOL GENET, V8, P1185, DOI 10.1093/hmg/8.7.1185; Ishikawa K, 2001, NEUROLOGY, V56, P1753, DOI 10.1212/WNL.56.12.1753; Ishikawa K, 1997, AM J HUM GENET, V61, P336, DOI 10.1086/514867; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Kordasiewicz HB, 2006, HUM MOL GENET, V15, P1587, DOI 10.1093/hmg/ddl080; Li L, 2009, GENES CELLS, V14, P1253, DOI 10.1111/j.1365-2443.2009.01348.x; Li XJ, 1999, MOL NEUROBIOL, V20, P111, DOI 10.1007/BF02742437; Marqueze-Pouey B, 2008, TRAFFIC, V9, P1088, DOI 10.1111/j.1600-0854.2008.00743.x; Matsuyama Z, 1999, J Neurosci, V19, pRC14; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Piedras-Renteria ES, 2001, J NEUROSCI, V21, P9185, DOI 10.1523/JNEUROSCI.21-23-09185.2001; Restituito S, 2000, J NEUROSCI, V20, P6394, DOI 10.1523/JNEUROSCI.20-17-06394.2000; Saegusa H, 2007, MOL CELL NEUROSCI, V34, P261, DOI 10.1016/j.mcn.2006.11.006; Shao J, 2007, HUM MOL GENET, V16, pR115, DOI 10.1093/hmg/ddm213; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Takahashi H, 2004, J HUM GENET, V49, P256, DOI 10.1007/s10038-004-0142-7; Takahashi M, 2012, NEUROPATHOL IN PRESS; Toru S, 2000, J BIOL CHEM, V275, P10893, DOI 10.1074/jbc.275.15.10893; Watase K, 2008, P NATL ACAD SCI USA, V105, P11987, DOI 10.1073/pnas.0804350105; Yabe I, 1998, J NEUROL SCI, V156, P89, DOI 10.1016/S0022-510X(98)00009-4; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	31	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e50121	10.1371/journal.pone.0050121	http://dx.doi.org/10.1371/journal.pone.0050121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505410	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500002
J	Adams, LV; Craig, SR; Mmbaga, EJ; Naburi, H; Lahey, T; Nutt, CT; Kisenge, R; Noel, GJ; Spielberg, SP				Adams, Lisa V.; Craig, Sienna R.; Mmbaga, Elia John; Naburi, Helga; Lahey, Timothy; Nutt, Cameron T.; Kisenge, Rodrick; Noel, Gary J.; Spielberg, Stephen P.			Children's Medicines in Tanzania: A National Survey of Administration Practices and Preferences	PLOS ONE			English	Article							DEVELOPING-WORLD; PHARMACOLOGY; INITIATIVES; FORMULATION; ADHERENCE; HEALTH	Objective: The dearth of age-appropriate formulations of many medicines for children poses a major challenge to pediatric therapeutic practice, adherence, and health care delivery worldwide. We provide information on current administration practices of pediatric medicines and describe key stakeholder preferences for new formulation characteristics. Patients and Methods: We surveyed children aged 6-12 years, parents/caregivers over age 18 with children under age 12, and healthcare workers in 10 regions of Tanzania to determine current pediatric medicine prescription and administration practices as well as preferences for new formulations. Analyses were stratified by setting, pediatric age group, parent/caregiver education, and healthcare worker cadre. Results: Complete data were available for 206 children, 202 parents/caregivers, and 202 healthcare workers. Swallowing oral solid dosage forms whole or crushing/dissolving them and mixing with water were the two most frequently reported methods of administration. Children frequently reported disliking medication taste, and many had vomited doses. Healthcare workers reported medicine availability most significantly influences prescribing practices. Most parents/caregivers and children prefer sweet-tasting medicine. Parents/caregivers and healthcare workers prefer oral liquid dosage forms for young children, and had similar thresholds for the maximum number of oral solid dosage forms children at different ages can take. Conclusions: There are many impediments to acceptable and accurate administration of medicines to children. Current practices are associated with poor tolerability and the potential for under-or over-dosing. Children, parents/caregivers, and healthcare workers in Tanzania have clear preferences for tastes and formulations, which should inform the development, manufacturing, and marketing of pediatric medications for resource-limited settings.	[Adams, Lisa V.; Lahey, Timothy] Audrey & Theodor Geisel Sch Med Dartmouth, Hanover, NH USA; [Craig, Sienna R.] Dartmouth Coll, Hanover, NH 03755 USA; [Mmbaga, Elia John; Naburi, Helga; Kisenge, Rodrick] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Nutt, Cameron T.] Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH USA; [Noel, Gary J.] Inst Pediat Innovat, Cambridge, MA USA; [Noel, Gary J.] Weill Cornell Med Coll, New York, NY USA; [Noel, Gary J.] AstraZeneca, Waltham, MA USA; [Spielberg, Stephen P.] US FDA, Washington, DC 20204 USA	Dartmouth College; Muhimbili University of Health & Allied Sciences; Dartmouth College; Cornell University; AstraZeneca; US Food & Drug Administration (FDA)	Adams, LV (corresponding author), Audrey & Theodor Geisel Sch Med Dartmouth, Hanover, NH USA.	Lisa.V.Adams@Dartmouth.edu		Naburi, Helga/0000-0003-1659-5224	World Health Organization (WHO), Better Medicines for Children project	World Health Organization (WHO), Better Medicines for Children project	This research was supported by a grant from the World Health Organization (WHO) as part of the Better Medicines for Children project. The funders had no role in the data collection, decision to publish, or preparation of the manuscript. Technical advice on the study design and data analysis was provided by appropriate experts at WHO. The named authors alone are responsible for the views expressed in this publication.	Access to Medicine Foundation, 2010, ACC MED IND 2010; [Anonymous], SOURC PRIC SEL MED C; Ansah EK, 2001, TROP MED INT HEALTH, V6, P496, DOI 10.1046/j.1365-3156.2001.00740.x; Baguley D, 2012, ARCH DIS CHILD, V97, P293, DOI 10.1136/archdischild-2011-300909; Beggs SA, 2005, ARCH DIS CHILD, V90, P1091, DOI 10.1136/adc.2005.076703; Breitkreutz J., 1999, PAEDIAT PERINAT DRUG, V3, P25; Craig SR, 2009, SOC SCI MED, V69, P1681, DOI 10.1016/j.socscimed.2009.08.024; Gazarian Madlen, 2009, Paediatr Drugs, V11, P41; Hill S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038055; Hill SR, 2012, B WORLD HEALTH ORGAN, V90, P236, DOI 10.2471/BLT.11.088658; Hoppu K, 2008, EUR J CLIN PHARMACOL, V64, P201, DOI 10.1007/s00228-007-0390-5; Hoppu K, 2012, EUR J CLIN PHARMACOL, V68, P1, DOI 10.1007/s00228-011-1089-1; Hoppu K, 2011, ARCH DIS CHILD, V96, P764, DOI 10.1136/adc.2009.180000; Knoppert David C, 2009, Paediatr Drugs, V11, P55; MacLeod Stuart, 2007, Paediatr Drugs, V9, P215, DOI 10.2165/00148581-200709040-00002; Mennella JA, 2008, CLIN THER, V30, P2120, DOI 10.1016/j.clinthera.2008.11.018; Nahirya-Ntege P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036186; NOTTERMAN DA, 1986, PEDIATRICS, V77, P850; Nunn T, 2005, BRIT J CLIN PHARMACO, V59, P674, DOI 10.1111/j.1365-2125.2005.02410.x; Peacock G, 2010, J AM PHARM ASSOC, V50, P84, DOI 10.1331/JAPhA.2010.09006; Rodriguez W, 2008, PEDIATRICS, V121, P530, DOI 10.1542/peds.2007-1529; Sachs AN, 2012, JAMA-J AM MED ASSOC, V307, P1914, DOI 10.1001/jama.2012.3435; Taylor DM, 2009, J PAEDIATR CHILD H, V45, P304, DOI 10.1111/j.1440-1754.2008.01462.x; Teng Jaja, 2002, J Am Pharm Assoc (Wash), V42, P195; United Nations, 2012, CONC NOT EST UN COMM; United Nations Children's Fund, 2012, LEV TRENDS CHILD MOR; World Health Organization, 2012, WORLD HLTH STAT 2012; Zucker H, 2007, CLIN PHARMACOL THER, V82, P503, DOI 10.1038/sj.clpt.6100395	28	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58303	10.1371/journal.pone.0058303	http://dx.doi.org/10.1371/journal.pone.0058303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484012	Green Submitted, gold, Green Published			2022-12-27	WOS:000316936100102
J	Athreya, V; Odden, M; Linnell, JDC; Krishnaswamy, J; Karanth, U				Athreya, Vidya; Odden, Morten; Linnell, John D. C.; Krishnaswamy, Jagdish; Karanth, Ullas			Big Cats in Our Backyards: Persistence of Large Carnivores in a Human Dominated Landscape in India	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; LEOPARDS PANTHERA-PARDUS; HYENA-HYENA; HUMAN DENSITIES; PREY ABUNDANCE; NATIONAL-PARK; CAMERA-TRAPS; CONSERVATION; TIGER; POPULATION	Protected areas are extremely important for the long term viability of biodiversity in a densely populated country like India where land is a scarce resource. However, protected areas cover only 5% of the land area in India and in the case of large carnivores that range widely, human use landscapes will function as important habitats required for gene flow to occur between protected areas. In this study, we used photographic capture recapture analysis to assess the density of large carnivores in a human-dominated agricultural landscape with density >300 people/km(2) in western Maharashtra, India. We found evidence of a wide suite of wild carnivores inhabiting a cropland landscape devoid of wilderness and wild herbivore prey. Furthermore, the large carnivores; leopard (Panthera pardus) and striped hyaena (Hyaena hyaena) occurred at relatively high density of 4.8 +/- 1.2 (sd) adults/100 km(2) and 5.03 +/- 1.3 (sd) adults/100 km(2) respectively. This situation has never been reported before where 10 large carnivores/100 km(2) are sharing space with dense human populations in a completely modified landscape. Human attacks by leopards were rare despite a potentially volatile situation considering that the leopard has been involved in serious conflict, including human deaths in adjoining areas. The results of our work push the frontiers of our understanding of the adaptability of both, humans and wildlife to each other's presence. The results also highlight the urgent need to shift from a PA centric to a landscape level conservation approach, where issues are more complex, and the potential for conflict is also very high. It also highlights the need for a serious rethink of conservation policy, law and practice where the current management focus is restricted to wildlife inside Protected Areas.	[Athreya, Vidya; Karanth, Ullas] Ctr Wildlife Studies, Wildlife Conservat Soc India, Bangalore, Karnataka, India; [Odden, Morten] Hedmark Univ Coll, Fac Appl Ecol & Agr Sci, Elverum, Norway; [Linnell, John D. C.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway; [Krishnaswamy, Jagdish] Ashoka Trust Res Ecol & Environm, Bangalore, Karnataka, India	Inland Norway University of Applied Sciences; Norwegian Institute Nature Research	Athreya, V (corresponding author), Ctr Wildlife Studies, Wildlife Conservat Soc India, Bangalore, Karnataka, India.	vidya.athreya@gmail.com	Linnell, John/V-4177-2019	Linnell, John/0000-0002-8370-5633; Krishnaswamy, Jagdish/0000-0001-7985-0005	Kaplan Graduate Award; Norwegian Embassy; Norwegian Research Council; Maharashtra Forest Department	Kaplan Graduate Award; Norwegian Embassy; Norwegian Research Council(Research Council of NorwayEuropean Commission); Maharashtra Forest Department	The project was funded by a Kaplan Graduate Award (http://www.panthera.org/); a Norwegian Embassy and Norwegian Research Council grant (http://www.nina.no/ninaenglish/Researchprojects/HumanWildlifeConflicts.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Maharashtra Forest Department for their support. We would also like to thank the Centre for Wildlife Studies and the Asian Nature Conservation Foundation, Bangalore for institutional support and N. Samba Kumar and D. Jathanna for providing support for the camera trapping study and for useful discussions and advice.	Athreya V, 2011, CONSERV BIOL, V25, P133, DOI 10.1111/j.1523-1739.2010.01599.x; Athreya Vidya R., 2007, Journal of the Bombay Natural History Society, V104, P45; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Banerjee K, 2010, ORYX, V44, P248, DOI 10.1017/S0030605309990949; Borchers DL, 2008, BIOMETRICS, V64, P377, DOI 10.1111/j.1541-0420.2007.00927.x; Breitenmoser U, 2005, CONSERV BIOL SER, V9, P49; BURNHAM KP, 1993, BIOMETRICS, V49, P1194, DOI 10.2307/2532261; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Carbone C, 2011, BIOL LETTERS, V7, P312, DOI 10.1098/rsbl.2010.0996; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Chauvenet ALM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028671; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Dalerum F, 2008, BIODIVERS CONSERV, V17, P2939, DOI 10.1007/s10531-008-9406-4; DeFries R, 2010, BIOL CONSERV, V143, P2870, DOI 10.1016/j.biocon.2010.02.010; Gray TNE, 2012, J WILDLIFE MANAGE, V76, P163, DOI 10.1002/jwmg.230; Gehrt SD., 2010, URBAN CARNIVORES ECO; Gopalaswamy AM, 2012, ANIM CONSERV, V15, P669, DOI 10.1111/j.1469-1795.2012.00565.x; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Gupta Shilpi, 2009, Journal of the Bombay Natural History Society, V106, P284; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; Harihar A, 2010, MAMMALIA, V74, P83, DOI 10.1515/MAMM.2009.072; Harihar A, 2009, MAMMALIA, V73, P68, DOI 10.1515/MAMM.2009.007; Hayward MW, 2007, BIOL CONSERV, V139, P219, DOI 10.1016/j.biocon.2007.06.018; Henschel P, 2003, LEOPARDS AFRICAN RAI; Janecka JE, 2011, J MAMMAL, V92, P771, DOI 10.1644/10-MAMM-A-036.1; JHALA YV, 1991, CONSERV BIOL, V5, P476, DOI 10.1111/j.1523-1739.1991.tb00354.x; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 2010, TIGERS OF THE WORLD: THE SCIENCE, POLITICS, AND CONSERVATION OF PANTHERA TIGRIS, 2ND EDITION, P241; Karanth KU, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P145, DOI 10.1007/978-4-431-99495-4_9; KARANTH KU, 1995, J ANIM ECOL, V64, P439, DOI 10.2307/5647; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2005, CONSERV BIOL SER, V9, P373; Karanth KU, 1998, ECOLOGY, V79, P2852; Khorozyan IG, 2008, INTEGR ZOOL, V3, P322, DOI 10.1111/j.1749-4877.2008.00111.x; Kruuk H, 2003, HUNTER HUNTED; Linnell JDC, 2000, BIODIVERS CONSERV, V9, P857, DOI 10.1023/A:1008969104618; Linnell JDC, 2001, ANIM CONSERV, V4, P345, DOI 10.1017/S1367943001001408; Linnell JDC, 2001, ENVIRON MANAGE, V27, P869; Loveridge Andrew J., 2010, P283; Maddox T.M., 2003, ECOLOGY CHEETAHS OTH; MAEHR DS, 1990, CONSERV BIOL, V4, P167, DOI 10.1111/j.1523-1739.1990.tb00105.x; Mazzolli M, 2010, ENVIRON MANAGE, V46, P237, DOI 10.1007/s00267-010-9528-9; Mech D., 2003, WOLVES BEHAV ECOLOGY; Negroes N, 2011, BIODIVERS CONSERV, V20, P505, DOI 10.1007/s10531-010-9961-3; Nichols JD, 2002, MONITORING TIGERS TH, P139; Odden M, 2005, WILDLIFE BIOL, V11, P145, DOI 10.2981/0909-6396(2005)11[145:SAAPOL]2.0.CO;2; OTIS DL, 1978, WILDLIFE MONOGR, P1; Otis DL., 1982, CAPTURE RECAPTURE RE; Ramesh T., 2009, J SCI T ENV TECHN, V2, P170, DOI DOI 10.20894/STET.116.002.003.010; Rexstad E., 1992, USERS GUIDE INTERACT; Rosas-Rosas OC, 2010, CONSERV BIOL, V24, P366, DOI 10.1111/j.1523-1739.2009.01441.x; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Royle JA, 2009, J APPL ECOL, V46, P118, DOI 10.1111/j.1365-2664.2008.01578.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Sanderson EW, 2002, LANDSCAPE URBAN PLAN, V58, P41, DOI 10.1016/S0169-2046(01)00231-6; Singh P, 2010, J MAMMAL, V91, P1152, DOI 10.1644/09-MAMM-A-159.1; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Stein AB, 2011, AFR J ECOL, V49, P383, DOI 10.1111/j.1365-2028.2011.01267.x; TERBORGH J, 1999, REQUIEM NATURE; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe Rosie, 2005, P154; Working Plan, 2010, WORK PLAN AHM FOR DI	67	210	228	8	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57872	10.1371/journal.pone.0057872	http://dx.doi.org/10.1371/journal.pone.0057872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483933	Green Published, gold			2022-12-27	WOS:000316936100049
J	Corbacho, J; Romojaro, F; Pech, JC; Latche, A; Gomez-Jimenez, MC				Corbacho, Jorge; Romojaro, Felix; Pech, Jean-Claude; Latche, Alain; Gomez-Jimenez, Maria C.			Transcriptomic Events Involved in Melon Mature-Fruit Abscission Comprise the Sequential Induction of Cell-Wall Degrading Genes Coupled to a Stimulation of Endo and Exocytosis	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; CUCUMIS-MELO; ETHYLENE BIOSYNTHESIS; DIFFERENTIAL EXPRESSION; SIGNALING PATHWAYS; ORGAN ABSCISSION; ARABIDOPSIS; AUXIN; ZONE; IDENTIFICATION	Background: Mature-fruit abscission (MFA) in fleshy-fruit is a genetically controlled process with mechanisms that, contrary to immature-fruit abscission, has not been fully characterized. Here, we use pyrosequencing to characterize the transcriptomes of melon abscission zone (AZ) at three stages during AZ-cell separation in order to understand MFA control at an early stage of AZ-activation. Principal Findings: The results show that by early induction of MFA, the melon AZ exhibits major gene induction, while by late induction of MFA, melon AZ shows major gene repression. Although some genes displayed similar regulation in both early and late induction of abscission, such as EXT1-EXT4, EGase1, IAA2, ERF1, AP2D15, FLC, MADS2, ERAF17, SAP5 and SCL13 genes, the majority had different expression patterns. This implies that time-specific events occur during MFA, and emphasizes the value of characterizing multiple time-specific abscission transcriptomes. Analysis of gene-expression from these AZs reveal that a sequential induction of cell-wall-degrading genes is associated with the upregulation of genes involved in endo and exocytosis, and a shift in plant-hormone metabolism and signaling genes during MFA. This is accompanied by transcriptional activity of small-GTPases and synthaxins together with tubulins, dynamins, V-type ATPases and kinesin-like proteins potentially involved in MFA signaling. Early events are potentially controlled by down-regulation of MADS-box, AP2/ERF and Aux/IAA transcription-factors, and up-regulation of homeobox, zinc finger, bZIP, and WRKY transcription-factors, while late events may be controlled by up-regulation of MYB transcription-factors. Significance: Overall, the data provide a comprehensive view on MFA in fleshy-fruit, identifying candidate genes and pathways associated with early induction of MFA. Our comprehensive gene-expression profile will be very useful for elucidating gene regulatory networks of the MFA in fleshy-fruit.	[Corbacho, Jorge; Gomez-Jimenez, Maria C.] Univ Extremadura, Dept Plant Physiol, Badajoz, Spain; [Romojaro, Felix] CEBAS CSIC, Murcia, Spain; [Pech, Jean-Claude; Latche, Alain] UMR990 INRA INP ENSA Toulouse, Castanet Tolosan, France	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); INRAE	Gomez-Jimenez, MC (corresponding author), Univ Extremadura, Dept Plant Physiol, Avda Elvas S-N, Badajoz, Spain.	mcgomez@unex.es	Gomez-Jimenez, Maria-Carmen/A-6875-2011	Gomez-Jimenez, Maria-Carmen/0000-0003-2977-5814; Corbacho Sanchez, Jorge/0000-0002-0745-3374	'Ministerio de Ciencia e Innovacion', Spain [BFU2010-18116]	'Ministerio de Ciencia e Innovacion', Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the 'Ministerio de Ciencia e Innovacion', Spain (BFU2010-18116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-127; Ayub R, 1996, NAT BIOTECHNOL, V14, P862, DOI 10.1038/nbt0796-862; Berardini TZ, 2010, NUCLEIC ACIDS RES, V38, pD331, DOI 10.1093/nar/gkp1018; Botton A, 2011, PLANT PHYSIOL, V155, P185, DOI 10.1104/pp.110.165779; Burr CA, 2011, PLANT PHYSIOL, V156, P1837, DOI 10.1104/pp.111.175224; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; Cho SK, 2008, P NATL ACAD SCI USA, V105, P15629, DOI 10.1073/pnas.0805539105; Clepet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-252; Dal Cin V, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-139; Deleu W, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-90; Deneka M, 2003, CRIT REV BIOCHEM MOL, V38, P121, DOI 10.1080/713609214; Eduardo I, 2005, THEOR APPL GENET, V112, P139, DOI 10.1007/s00122-005-0116-y; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Farrar K, 2003, PLANT J, V33, P61, DOI 10.1046/j.1365-313X.2003.01608.x; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gil-Amado JA, 2012, PLANTA, V235, P1221, DOI 10.1007/s00425-011-1570-1; Gomez-Cadenas A, 2000, PLANTA, V210, P636, DOI 10.1007/s004250050054; Gomez-Jimenez MC, 2010, J PLANT PHYSIOL, V167, P1432, DOI 10.1016/j.jplph.2010.05.020; Gonzalez-Carranza ZH, 2012, ANNU PLANT REV, V44, P243, DOI 10.1002/9781118223086.ch10; Gonzalo MJ, 2005, THEOR APPL GENET, V110, P802, DOI 10.1007/s00122-004-1814-6; Gudesblat GE, 2011, CURR OPIN PLANT BIOL, V14, P530, DOI 10.1016/j.pbi.2011.05.004; Guis M, 1997, J AM SOC HORTIC SCI, V122, P748, DOI 10.21273/JASHS.122.6.748; Haizel T, 1997, PLANT J, V11, P93, DOI 10.1046/j.1365-313X.1997.11010093.x; Harel-Beja R, 2010, THEOR APPL GENET, V121, P511, DOI 10.1007/s00122-010-1327-4; Keuskamp DH, 2011, PLANT J, V67, P208, DOI 10.1111/j.1365-313X.2011.04597.x; Kuromori T, 2010, PLANT SIGNAL BEHAV, V5, P1124, DOI 10.4161/psb.5.9.12566; Lewis MW, 2010, PLANT J, V62, P817, DOI 10.1111/j.1365-313X.2010.04194.x; Leyman B, 2000, PLANT J, V24, P369, DOI 10.1046/j.1365-313x.2000.00886.x; Li JG, 2008, J PLANT GROWTH REGUL, V27, P283, DOI 10.1007/s00344-008-9055-6; Li JG, 2010, J AM SOC HORTIC SCI, V135, P391, DOI 10.21273/JASHS.135.5.391; Li P, 2009, EUR J PLANT PATHOL, V125, P533, DOI 10.1007/s10658-009-9501-8; Liljegren SJ, 2009, DEVELOPMENT, V136, P1909, DOI 10.1242/dev.033605; Liu L, 2004, EUPHYTICA, V135, P305, DOI 10.1023/B:EUPH.0000013330.66819.6f; Lycett G, 2008, J EXP BOT, V59, P4061, DOI 10.1093/jxb/ern255; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; Meir S, 2010, PLANT PHYSIOL, V154, P1929, DOI 10.1104/pp.110.160697; Merkouropoulos G, 2003, PLANTA, V217, P356, DOI 10.1007/s00425-003-1002-y; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakano R, 2003, PLANT PHYSIOL, V131, P276, DOI 10.1104/pp.010462; Nieto C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-34; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; Ophir R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-269; Parra-Lobato MC, 2011, J EXP BOT, V62, P4447, DOI 10.1093/jxb/err124; Pattison RJ, 2012, PLANT J, V70, P585, DOI 10.1111/j.1365-313X.2011.04895.x; Pech JC, 2008, PLANT SCI, V175, P114, DOI 10.1016/j.plantsci.2008.01.003; Perin C, 2002, PLANT PHYSIOL, V129, P300, DOI 10.1104/pp.010613; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Portnoy V, 2011, PLANT GENOME-US, V4, P36, DOI 10.3835/plantgenome2010.11.0026; Rasori A, 2002, J EXP BOT, V53, P2333, DOI [10.1093/jxb/\\, 10.1093/jxb/\\|[ast ]\\|, 10.1093/jxb/erf097]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rose JKC, 1998, PLANT PHYSIOL, V117, P345, DOI 10.1104/pp.117.2.345; Ruperti B, 2002, J EXP BOT, V53, P429, DOI 10.1093/jexbot/53.368.429; Singh AP, 2011, J EXP BOT, V62, P5091, DOI 10.1093/jxb/err209; Skottke KR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001370; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tucker ML, 2007, J EXP BOT, V58, P3395, DOI 10.1093/jxb/erm188; van Leeuwen H, 2003, PLANT MOL BIOL, V51, P703, DOI 10.1023/A:1022573230486; Vandenbussche F, 2010, DEVELOPMENT, V137, P597, DOI 10.1242/dev.040790; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang X, 2006, PLANT PHYSIOL, V140, P91, DOI 10.1104/pp.105.071670; WEBSTER BD, 1975, J AM SOC HORTIC SCI, V100, P180; Yamaoka S, 2008, PLANT CELL, V20, P589, DOI 10.1105/tpc.107.055756; Zang AP, 2010, J EXP BOT, V61, P777, DOI 10.1093/jxb/erp341; Zhu H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-138	66	61	62	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58363	10.1371/journal.pone.0058363	http://dx.doi.org/10.1371/journal.pone.0058363			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484021	gold, Green Submitted, Green Published			2022-12-27	WOS:000316936100111
J	Jozefkowicz, C; Rosi, P; Sigaut, L; Soto, G; Pietrasanta, LI; Amodeo, G; Alleva, K				Jozefkowicz, Cintia; Rosi, Pablo; Sigaut, Lorena; Soto, Gabriela; Isabel Pietrasanta, Lia; Amodeo, Gabriela; Alleva, Karina			Loop A Is Critical for the Functional Interaction of Two Beta vulgaris PIP Aquaporins	PLOS ONE			English	Article							PLASMA-MEMBRANE AQUAPORINS; XENOPUS OOCYTES; WATER TRANSPORT; PROTEIN; STRESS; IDENTIFICATION; EXPRESSION; EVOLUTION; CHANNELS; RESIDUE	Research done in the last years strongly support the hypothesis that PIP aquaporin can form heterooligomeric assemblies, specially combining PIP2 monomers with PIP1 monomers. Nevertheless, the structural elements involved in the ruling of homo versus heterooligomeric organization are not completely elucidated. In this work we unveil some features of monomer-monomer interaction in Beta vulgaris PIP aquaporins. Our results show that while BvPIP2;2 is able to interact with BvPIP1;1, BvPIP2;1 shows no functional interaction. The lack of functional interaction between BvPIP2;1 and BvPIP1;1 was further corroborated by dose-response curves of water permeability due to aquaporin activity exposed to different acidic conditions. We also found that BvPIP2;1 is unable to translocate BvPIP1;1-ECFP from an intracellular position to the plasma membrane when co-expressed, as BvPIP2;2 does. Moreover we postulate that the first extracellular loop (loop A) of BvPIP2;1, could be relevant for the functional interaction with BvPIP1;1. Thus, we investigate BvPIP2;1 loop A at an atomic level by Molecular Dynamics Simulation (MDS) and by direct mutagenesis. We found that, within the tetramer, each loop A presents a dissimilar behavior. Besides, BvPIP2;1 loop A mutants restore functional interaction with BvPIP1;1. This work is a contribution to unravel how PIP2 and PIP1 interact to form functional heterooligomeric assemblies. We postulate that BvPIP2;1 loop A is relevant for the lack of functional interaction with BvPIP1;1 and that the monomer composition of PIP assemblies determines their functional properties.	[Jozefkowicz, Cintia; Amodeo, Gabriela; Alleva, Karina] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina; [Rosi, Pablo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Inst Quim Fis Mat Medio Ambiente & Energia INQUIM, Buenos Aires, DF, Argentina; [Sigaut, Lorena; Isabel Pietrasanta, Lia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Ctr Microscopi Avanzadas CMA, Buenos Aires, DF, Argentina; [Sigaut, Lorena; Isabel Pietrasanta, Lia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, Buenos Aires, DF, Argentina; [Soto, Gabriela] INTA, Inst Genet Ewald A Favret, CICVyA, Castelar, Argentina; [Jozefkowicz, Cintia; Rosi, Pablo; Sigaut, Lorena; Soto, Gabriela; Isabel Pietrasanta, Lia; Amodeo, Gabriela; Alleva, Karina] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires; Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Alleva, K (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Buenos Aires, DF, Argentina.	karina.alleva@bg.fcen.uba.ar	ALLEVA, KARINA/F-2577-2016	ALLEVA, KARINA/0000-0002-9081-2103; PIETRASANTA, LIA/0000-0002-2714-3162; Soto, Gabriela/0000-0002-3492-1268; Jozefkowicz, Cintia/0000-0001-8982-5698; Sigaut, Lorena/0000-0001-9417-9600	Prestamo BID PICT (Proyecto de Investigacion en Ciencia y Tecnologia) [2010-02042, 2007-655, 0457]; PIP (Proyecto de Investigacion Plurianual) [0190]; UBACyT (Programacion Cientifica de la Universidad de Buenos Aires) [2010-2012 659, 2010-2012 164]	Prestamo BID PICT (Proyecto de Investigacion en Ciencia y Tecnologia); PIP (Proyecto de Investigacion Plurianual); UBACyT (Programacion Cientifica de la Universidad de Buenos Aires)	Grants to KA: Prestamo BID PICT (Proyecto de Investigacion en Ciencia y Tecnologia) 2010-02042, PIP (Proyecto de Investigacion Plurianual) 0190, UBACyT (Programacion Cientifica de la Universidad de Buenos Aires)2010-2012 659. Grants to GA: Prestamo BID PICT (Proyecto de Investigacion en Ciencia y Tecnologia) 2007-655. Grants to LIP: Prestamo BID PICT (Proyecto de Investigacion en Ciencia y Tecnologia) 0457, UBACyT (Programacion Cientifica de la Universidad de Buenos Aires) 2010-2012 164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 1999, Methods Enzymol, V294, P550; Alleva K, 2006, J EXP BOT, V57, P609, DOI 10.1093/jxb/erj046; Alleva K, 2010, J EXP BOT, V61, P3935, DOI 10.1093/jxb/erq210; Alleva K, 2009, EUR BIOPHYS J BIOPHY, V38, P175, DOI 10.1007/s00249-008-0365-1; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ayadi M, 2011, PLANT PHYSIOL BIOCH, V49, P1029, DOI 10.1016/j.plaphy.2011.06.002; Barone LM, 1998, PLANT PHYSIOL, V118, P315, DOI 10.1104/pp.118.1.315; Bellati J, 2010, PLANT MOL BIOL, V74, P105, DOI 10.1007/s11103-010-9658-8; Betts MJ, 1999, PROTEIN ENG, V12, P271, DOI 10.1093/protein/12.4.271; Bienert GP, 2012, BIOCHEM J, V445, P101, DOI 10.1042/BJ20111704; Brooks JM, 2003, DEV BIOL, V261, P353, DOI 10.1016/S0012-1606(03)00301-4; Case D.A., 2022, AMBER 2020; Cavez D, 2009, PLANT SIGNAL BEHAV, V4, P890, DOI 10.4161/psb.4.9.9484; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Fujiyoshi Y, 2002, CURR OPIN STRUC BIOL, V12, P509, DOI 10.1016/S0959-440X(02)00355-X; Hayward S, 2010, BIOPHYS J, V98, P1976, DOI 10.1016/j.bpj.2010.01.017; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Khandelia H, 2009, J PHYS CHEM B, V113, P5239, DOI 10.1021/jp809152c; Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mahdieh M, 2008, PLANT CELL PHYSIOL, V49, P801, DOI 10.1093/pcp/pcn054; Mathai JC, 1999, BIOCHEMISTRY-US, V38, P923, DOI 10.1021/bi9823683; Matsumoto T, 2009, PLANT CELL PHYSIOL, V50, P216, DOI 10.1093/pcp/pcn190; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Otto B, 2010, J BIOL CHEM, V285, P31253, DOI 10.1074/jbc.M110.115881; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1993, J BIOL CHEM, V268, P17; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shi LB, 1996, BIOCHEMISTRY-US, V35, P538, DOI 10.1021/bi9520038; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Soto G, 2012, GENE, V503, P165, DOI 10.1016/j.gene.2012.04.021; Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Tournaire-Roux C, 2003, NATURE, V425, P393, DOI 10.1038/nature01853; Vandeleur RK, 2009, PLANT PHYSIOL, V149, P445, DOI 10.1104/pp.108.128645; VERBAVATZ JM, 1993, J CELL BIOL, V123, P605, DOI 10.1083/jcb.123.3.605; Zelazny E, 2007, P NATL ACAD SCI USA, V104, P12359, DOI 10.1073/pnas.0701180104; ZHANG R, 1991, AM J PHYSIOL, V260, pC26, DOI 10.1152/ajpcell.1991.260.1.C26; Zhou Y, 2007, PLANT CELL ENVIRON, V30, P1566, DOI 10.1111/j.1365-3040.2007.01732.x	43	31	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57993	10.1371/journal.pone.0057993	http://dx.doi.org/10.1371/journal.pone.0057993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483963	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900063
J	Chen, XY; Wang, SM; Li, N; Hu, Y; Zhang, Y; Xu, JF; Li, X; Ren, J; Su, B; Yuan, WZ; Teng, XR; Zhang, RX; Jiang, DH; Mulet, X; Li, HP				Chen, Xue-Yuan; Wang, Shan-Mei; Li, Nan; Hu, Yang; Zhang, Yuan; Xu, Jin-Fu; Li, Xia; Ren, Jie; Su, Bo; Yuan, Wei-Zhong; Teng, Xin-Rong; Zhang, Rong-Xuan; Jiang, Dian-hua; Mulet, Xavier; Li, Hui-Ping			Creation of Lung-Targeted Dexamethasone Immunoliposome and Its Therapeutic Effect on Bleomycin-Induced Lung Injury in Rats	PLOS ONE			English	Article							DISTRESS-SYNDROME ARDS; CORTICOSTEROIDS; LIPOSOMES; DELIVERY; DOXORUBICIN; INHIBITION; EXPRESSION; PREVENTION; STRATEGY; BRAIN	Objective: Acute lung injury (ALI), is a major cause of morbidity and mortality, which is routinely treated with the administration of systemic glucocorticoids. The current study investigated the distribution and therapeutic effect of a dexamethasone(DXM)-loaded immunoliposome (NLP) functionalized with pulmonary surfactant protein A (SP-A) antibody (SPA-DXM-NLP) in an animal model. Methods: DXM-NLP was prepared using film dispersion combined with extrusion techniques. SP-A antibody was used as the lung targeting agent. Tissue distribution of SPA-DXM-NLP was investigated in liver, spleen, kidney and lung tissue. The efficacy of SPA-DXM-NLP against lung injury was assessed in a rat model of bleomycin-induced acute lung injury. Results: The SPA-DXM-NLP complex was successfully synthesized and the particles were stable at 4 degrees C. Pulmonary dexamethasone levels were 40 times higher with SPA-DXM-NLP than conventional dexamethasone injection. Administration of SPA-DXM-NLP significantly attenuated lung injury and inflammation, decreased incidence of infection, and increased survival in animal models. Conclusions: The administration of SPA-DXM-NLP to animal models resulted in increased levels of DXM in the lungs, indicating active targeting. The efficacy against ALI of the immunoliposomes was shown to be superior to conventional dexamethasone administration. These results demonstrate the potential of actively targeted glucocorticoid therapy in the treatment of lung disease in clinical practice.	[Chen, Xue-Yuan; Wang, Shan-Mei; Li, Nan; Hu, Yang; Zhang, Yuan; Xu, Jin-Fu; Li, Xia; Li, Hui-Ping] Tongji Univ, Sch Med, Dept Resp Med, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China; [Ren, Jie; Yuan, Wei-Zhong; Teng, Xin-Rong] Tongji Univ, Inst Nano & Biopolymer Mat, Shanghai 200092, Peoples R China; [Su, Bo] Tongji Univ, Sch Med, Centrol Lab, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China; [Zhang, Rong-Xuan] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Pathol, Shanghai 200092, Peoples R China; [Jiang, Dian-hua] Duke Univ, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Durham, NC 27706 USA; [Mulet, Xavier] CSIRO Mat Sci & Engn, Clayton, Vic, Australia	Tongji University; Tongji University; Tongji University; Tongji University; Duke University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Li, HP (corresponding author), Tongji Univ, Sch Med, Dept Resp Med, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China.	liw2013@126.com	Jiang, Dianhua/B-1421-2009; Mulet, Xavier/B-1650-2009; Ren, Jie/J-2811-2012	Jiang, Dianhua/0000-0002-4508-3829; Mulet, Xavier/0000-0001-8241-0924; Ren, Jie/0000-0002-3744-1470	National Science Foundation of China [30971323, 81170011]; Science and Technology Commission of Shanghai Municipality [11430702100, 114119b2200, 09411951500]; International Science & Technology Cooperation Program of China [2011DFB30010]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); International Science & Technology Cooperation Program of China	The study was funded by grants from the National Science Foundation of China ( No: 30971323, 81170011); Science and Technology Commission of Shanghai Municipality (No: 11430702100, 114119b2200, 09411951500); and International Science & Technology Cooperation Program of China (2011DFB30010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afergan E, 2008, J CONTROL RELEASE, V132, P84, DOI 10.1016/j.jconrel.2008.08.017; ALLEN TM, 1995, BBA-BIOMEMBRANES, V1237, P99, DOI 10.1016/0005-2736(95)00085-H; Asgeirdottir SA, 2007, MOL PHARMACOL, V72, P121, DOI 10.1124/mol.107.034140; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bellingan GJ, 2002, THORAX, V57, P540, DOI 10.1136/thorax.57.6.540; Bendas G, 2001, BIODRUGS, V15, P215, DOI 10.2165/00063030-200115040-00002; Berlin M, 2010, EXPERT OPIN THER PAT, V20, P855, DOI 10.1517/13543776.2010.493876; BERNARD GR, 1987, NEW ENGL J MED, V317, P1565, DOI 10.1056/NEJM198712173172504; Bertorelli G, 2008, PULM PHARMACOL THER, V21, P214, DOI 10.1016/j.pupt.2007.03.001; BETAGERI GV, 1993, J PHARM PHARMACOL, V45, P48, DOI 10.1111/j.2042-7158.1993.tb03678.x; Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; De Bosscher K, 2010, J STEROID BIOCHEM, V120, P96, DOI 10.1016/j.jsbmb.2010.02.027; Devos S, 2003, BIOCHEM PHARMACOL, V65, P303, DOI 10.1016/S0006-2952(02)01507-1; Dik WA, 2003, THORAX, V58, P765, DOI 10.1136/thorax.58.9.765; Drescher W, 2011, NEPHROL DIAL TRANSPL, V26, P2728, DOI 10.1093/ndt/gfr212; Eachempati SR, 2007, J TRAUMA, V63, P344, DOI 10.1097/TA.0b013e3180eea5a1; ElBayoumi TA, 2010, METHODS MOL BIOL, V605, P1, DOI 10.1007/978-1-60327-360-2_1; Fernandes ABS, 2005, BRAZ J MED BIOL RES, V38, P147, DOI 10.1590/S0100-879X2005000200003; Gregoriadis G, 2008, J DRUG TARGET, V16, P520, DOI 10.1080/10611860802228350; Grutters JC, 2006, EUR RESPIR J, V28, P627, DOI 10.1183/09031936.06.00105805; Gupta N, 2006, AM J PHYSIOL-LUNG C, V291, pL436, DOI 10.1152/ajplung.00415.2005; Hao H, 2003, AM J PHYSIOL-LUNG C, V285, pL593, DOI 10.1152/ajplung.00037.2003; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Kwak H W, 1995, Korean J Ophthalmol, V9, P79; Madsen J, 2003, AM J RESP CELL MOL, V29, P591, DOI 10.1165/rcmb.2002-0274OC; Mamot C, 2004, J NEURO-ONCOL, V68, P1, DOI 10.1023/B:NEON.0000024743.56415.4b; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Metselaar JM, 2003, ARTHRITIS RHEUM-US, V48, P2059, DOI 10.1002/art.11140; Mikawa K, 2003, ANESTH ANALG, V97, P1751, DOI 10.1213/01.ANE.0000086896.90343.13; Pan Hong, 2006, Yao Xue Xue Bao, V41, P506; Peter JV, 2008, BMJ-BRIT MED J, V336, P1006, DOI 10.1136/bmj.39537.939039.BE; Sadzuka Y, 2002, INT J PHARM, V238, P171, DOI 10.1016/S0378-5173(02)00075-3; Scherphof GL, 2001, PROG LIPID RES, V40, P149, DOI 10.1016/S0163-7827(00)00020-5; SZAPIEL SV, 1979, AM REV RESPIR DIS, V120, P893; Thompson BT, 2010, MINERVA ANESTESIOL, V76, P441; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wang XQ, 2008, RESPIROLOGY, V13, P772, DOI 10.1111/j.1440-1843.2008.01344.x; Yokoe JI, 2008, INT J PHARMACEUT, V353, P28, DOI 10.1016/j.ijpharm.2007.11.008	40	21	24	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58275	10.1371/journal.pone.0058275	http://dx.doi.org/10.1371/journal.pone.0058275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516459	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400022
J	Olivan-Viguera, A; Valero, MS; Murillo, MD; Wulff, H; Garcia-Otin, AL; Arbones-Mainar, JM; Kohler, R				Olivan-Viguera, Aida; Sofia Valero, Marta; Divina Murillo, Maria; Wulff, Heike; Garcia-Otin, Angel-Luis; Arbones-Mainar, Jose-Miguel; Koehler, Ralf			Novel Phenolic Inhibitors of Small/IntermediateConductance Ca2+-Activated K+ Channels, KCa3.1 and KCa2.3	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; AORTIC SMOOTH-MUSCLE; CD4 T-CELLS; INTERMEDIATE-CONDUCTANCE; HYPERPOLARIZING FACTOR; ENDOTHELIAL-CELLS; ION CHANNELS; CA-CHANNELS; CALCIUM; BLOCK	Background: KCa3.1 channels are calcium/calmodulin-regulated voltage-independent K+ channels that produce membrane hyperpolarization and shape Ca2+-signaling and thereby physiological functions in epithelia, blood vessels, and white and red blood cells. Up-regulation of KCa3.1 is evident in fibrotic and inflamed tissues and some tumors rendering the channel a potential drug target. In the present study, we searched for novel potent small molecule inhibitors of KCa3.1 by testing a series of 20 selected natural and synthetic (poly) phenols, synthetic benzoic acids, and non-steroidal anti-inflammatory drugs (NSAIDs), with known cytoprotective, anti-inflammatory, and/or cytostatic activities. Methodology/Principal Findings: In electrophysiological experiments, we identified the natural phenols, caffeic acid (EC50 1.3 mu M) and resveratrol (EC50 10 mu M) as KCa3.1 inhibitors with moderate potency. The phenols, vanillic acid, gallic acid, and hydroxytyrosol had weak or no blocking effects. Out of the NSAIDs, flufenamic acid was moderately potent (EC50 1.6 mu M), followed by mesalamine (EC50 >= 10 mu M). The synthetic fluoro-trivanillic ester, 13b ([3,5-bis[(3-fluoro-4-hydroxy-benzoyl) oxymethyl] phenyl] methyl 3-fluoro-4-hydroxy-benzoate), was identified as a potent mixed KCa2/3 channel inhibitor with an EC50 of 19 nM for KCa3.1 and 360 pM for KCa2.3, which affected KCa1.1 and Kv channels only at micromolar concentrations. The KCa3.1/KCa2-activator SKA-31 antagonized the 13b-blockade. In proliferation assays, 13b was not cytotoxic and reduced proliferation of 3T3 fibroblasts as well as caffeic acid. In isometric vessel myography, 13b increased contractions of porcine coronary arteries to serotonin and antagonized endothelium-derived hyperpolarization-mediated vasorelaxation to pharmacological KCa3.1/KCa2.3 activation. Conclusions/Significance: We identified the natural phenols, caffeic acid and resveratrol, the NSAID, flufenamic acid, and the polyphenol 13b as novel KCa3.1 inhibitors. The high potency of 13b with pan-activity on KCa3.1/KCa2 channels makes 13b a new pharmacological tool to manipulate inflammation and cancer growth through KCa3.1/KCa2 blockade and a promising template for new drug design.	[Olivan-Viguera, Aida; Garcia-Otin, Angel-Luis; Arbones-Mainar, Jose-Miguel; Koehler, Ralf] Aragon Inst Hlth Sci I CS, Zaragoza, Spain; [Olivan-Viguera, Aida; Koehler, Ralf] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark; [Sofia Valero, Marta] Univ San Jorge, Fac Hlth Sci, GIMACES, Villanueva De Gallego, Spain; [Divina Murillo, Maria] Univ Zaragoza, Fac Vet, Dept Physiol & Pharmacol, Zaragoza, Spain; [Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Garcia-Otin, Angel-Luis] Hosp Univ Miguel Servet, Lab Invest Mol, GIPASC, Zaragoza, Spain; [Arbones-Mainar, Jose-Miguel] Hosp Univ Miguel Servet, Adipocyte & Fat Biol Lab, Zaragoza, Spain; [Koehler, Ralf] Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza, Spain	University of Southern Denmark; Universidad San Jorge; University of Zaragoza; University of California System; University of California Davis; Miguel Servet University Hospital; Miguel Servet University Hospital	Kohler, R (corresponding author), Aragon Inst Hlth Sci I CS, Zaragoza, Spain.	rkohler.iacs@aragon.es	Murillo, M Divina/K-8591-2014; wulff, Heike/Z-2056-2019; Garcia-Otin, Angel-Luis/P-9595-2016; Oliván-Viguera, Aida/I-4260-2015; Arbones-Mainar, Jose M/AGL-8624-2022; Oliván-Viguera, Aida/ABG-4048-2020; Valero, Marta Sofía/AAV-5643-2020	Murillo, M Divina/0000-0002-3917-4740; Garcia-Otin, Angel-Luis/0000-0002-5123-2480; Oliván-Viguera, Aida/0000-0001-5348-924X; Arbones-Mainar, Jose M/0000-0002-8982-3737; Oliván-Viguera, Aida/0000-0001-5348-924X; Valero, Marta Sofía/0000-0002-2231-7565; Kohler, Ralf/0000-0001-9563-2913	Deutsche Forschungsgemeinschaft [KO1899/11-1]; Lundbeckfonden; National Institutes of Health [R21 NS072585]; Miguel Servet program from the Instituto de Salud Carlos III (Spain); European Commission [303717-APOMET]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072585] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Lundbeckfonden(Lundbeckfonden); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Miguel Servet program from the Instituto de Salud Carlos III (Spain); European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the Deutsche Forschungsgemeinschaft (KO1899/11-1 to RK), Lundbeckfonden (to RK) and the National Institutes of Health (R21 NS072585 to HW). JMA-M is supported by the Miguel Servet program from the Instituto de Salud Carlos III (Spain) and by the Marie-Curie Action: 303717-APOMET from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Alda JO, 2009, J PHARM PHARMACOL, V61, P641, DOI 10.1211/jpp/61.05.0013; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Brahler S, 2009, CIRCULATION, V119, P2323, DOI 10.1161/CIRCULATIONAHA.108.846634; Cao YJ, 1999, FEBS LETT, V446, P137, DOI 10.1016/S0014-5793(99)00194-5; Choi S, 2012, PHARMACOL RES, V66, P51, DOI 10.1016/j.phrs.2012.02.009; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Grgic I, 2005, ARTERIOSCL THROM VAS, V25, P704, DOI 10.1161/01.ATV.0000156399.12787.5c; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; Grgic I, 2009, PFLUG ARCH EUR J PHY, V458, P291, DOI 10.1007/s00424-008-0619-x; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; HUANG MT, 1988, CANCER RES, V48, P5941; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jenkins DP, 2011, MOL PHARMACOL, V79, P899, DOI 10.1124/mol.110.069807; Kohler R, 2000, CIRC RES, V87, P496; Kohler R, 2003, CIRCULATION, V108, P1119, DOI 10.1161/01.CIR.0000086464.04719.DD; Kohler R, 2010, EXPERT OPIN THER TAR, V14, P143, DOI 10.1517/14728220903540257; Kroigaard C, 2012, BRIT J PHARMACOL, V167, P37, DOI 10.1111/j.1476-5381.2012.01986.x; Lambertsen KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047744; Lamoral-Theys D, 2012, J CELL MOL MED, V16, P1421, DOI 10.1111/j.1582-4934.2011.01403.x; Lamoral-Theys D, 2010, BIOORGAN MED CHEM, V18, P3823, DOI 10.1016/j.bmc.2010.04.047; Ledoux J, 2008, J GEN PHYSIOL, V131, P125, DOI 10.1085/jgp.200709875; Malykhina AP, 2002, EUR J PHARMACOL, V452, P269, DOI 10.1016/S0014-2999(02)02330-0; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; OTTOLIA M, 1994, BIOPHYS J, V67, P2272, DOI 10.1016/S0006-3495(94)80712-X; Pena TL, 1999, J MEMBRANE BIOL, V172, P249, DOI 10.1007/s002329900601; Phipps DJ, 1996, CELL SIGNAL, V8, P141, DOI 10.1016/0898-6568(95)02039-X; Raspotnig G, 1999, ANAL BIOCHEM, V275, P74, DOI 10.1006/abio.1999.4309; Rosa JC, 1998, J MED CHEM, V41, P2, DOI 10.1021/jm970571a; Sankaranarayanan A, 2009, MOL PHARMACOL, V75, P281, DOI 10.1124/mol.108.051425; Srivastava S, 2008, P NATL ACAD SCI USA, V105, P14442, DOI 10.1073/pnas.0803678105; Srivastava S, 2009, MOL BIOL CELL, V20, P3783, DOI 10.1091/mbc.E09-05-0390; Strobaek D, 2012, BR J PHARM; Tharp DL, 2008, ARTERIOSCL THROM VAS, V28, P1084, DOI 10.1161/ATVBAHA.107.155796; Toyama K, 2008, J CLIN INVEST, V118, P3025, DOI 10.1172/JCI30836; Valero MS, 2011, J PHARM PHARMACOL, V63, P222, DOI 10.1111/j.2042-7158.2010.01203.x; Vandorpe DH, 1998, J BIOL CHEM, V273, P21542, DOI 10.1074/jbc.273.34.21542; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; WERKMAN TR, 1992, NEUROSCIENCE, V50, P935, DOI 10.1016/0306-4522(92)90216-O; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151; Wulff H, 2001, J BIOL CHEM, V276, P32040, DOI 10.1074/jbc.M105231200; Wulff H, 2008, CHEM REV, V108, P1744, DOI 10.1021/cr078234p; Zhang M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2017; Zhang XH, 2012, J CELL PHYSIOL, V227, P1972, DOI 10.1002/jcp.22925	47	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58614	10.1371/journal.pone.0058614	http://dx.doi.org/10.1371/journal.pone.0058614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516517	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400040
J	Pannetier, NA; Debacker, CS; Mauconduit, F; Christen, T; Barbier, EL				Pannetier, Nicolas Adrien; Debacker, Clement Stephan; Mauconduit, Franck; Christen, Thomas; Barbier, Emmanuel Luc			A Simulation Tool for Dynamic Contrast Enhanced MRI	PLOS ONE			English	Article							MAGNETIC-FIELD STRENGTHS; VESSEL SIZE; NMR SIGNAL; IN-VIVO; WATER EXCHANGE; BOLUS-TRACKING; RAT GLIOMA; SUSCEPTIBILITY; DIFFUSION; PERFUSION	The quantification of bolus-tracking MRI techniques remains challenging. The acquisition usually relies on one contrast and the analysis on a simplified model of the various phenomena that arise within a voxel, leading to inaccurate perfusion estimates. To evaluate how simplifications in the interstitial model impact perfusion estimates, we propose a numerical tool to simulate the MR signal provided by a dynamic contrast enhanced (DCE) MRI experiment. Our model encompasses the intrinsic R-1 and R-2 relaxations, the magnetic field perturbations induced by susceptibility interfaces (vessels and cells), the diffusion of the water protons, the blood flow, the permeability of the vessel wall to the the contrast agent (CA) and the constrained diffusion of the CA within the voxel. The blood compartment is modeled as a uniform compartment. The different blocks of the simulation are validated and compared to classical models. The impact of the CA diffusivity on the permeability and blood volume estimates is evaluated. Simulations demonstrate that the CA diffusivity slightly impacts the permeability estimates (<5% for classical blood flow and CA diffusion). The effect of long echo times is investigated. Simulations show that DCE-MRI performed with an echo time T-E=5ms may already lead to significant underestimation of the blood volume (up to 30% lower for brain tumor permeability values). The potential and the versatility of the proposed implementation are evaluated by running the simulation with realistic vascular geometry obtained from two photons microscopy and with impermeable cells in the extravascular environment. In conclusion, the proposed simulation tool describes DCE-MRI experiments and may be used to evaluate and optimize acquisition and processing strategies.	[Pannetier, Nicolas Adrien; Debacker, Clement Stephan; Mauconduit, Franck; Barbier, Emmanuel Luc] INSERM, U836, Grenoble, France; [Pannetier, Nicolas Adrien; Debacker, Clement Stephan; Mauconduit, Franck; Barbier, Emmanuel Luc] Univ Grenoble 1, Grenoble Inst Neurosci, Grenoble, France; [Christen, Thomas] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Stanford University	Pannetier, NA (corresponding author), INSERM, U836, Grenoble, France.	nicolas.pannetier@gmail.com	christen, thomas/O-4482-2018; Barbier, Emmanuel/E-6302-2011; Debacker, Clement/GVS-6487-2022	christen, thomas/0000-0002-8791-9145; Barbier, Emmanuel/0000-0002-4952-1240; Debacker, Clement/0000-0003-4887-7920; Pannetier, Nicolas/0000-0002-0744-5155; Mauconduit, Franck/0000-0002-0128-061X	Institut National du Cancer; Association pour la Recherche sur le Cancer; Ministry for Higher Education and Research of France	Institut National du Cancer(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ministry for Higher Education and Research of France	This work was funded by the Institut National du Cancer, the Association pour la Recherche sur le Cancer and the Ministry for Higher Education and Research of France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDETTINI PA, 1995, INT J IMAG SYST TECH, V6, P133, DOI 10.1002/ima.1850060203; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Beaumont M, 2009, J CEREBR BLOOD F MET, V29, P1714, DOI 10.1038/jcbfm.2009.86; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Brix G, 2004, MAGNET RESON MED, V52, P420, DOI 10.1002/mrm.20161; Buckley DL, 2008, MAGN RESON MED, V60, P1011, DOI 10.1002/mrm.21748; Christen T, 2012, MAGN RESON MED, V67, P1458, DOI 10.1002/mrm.23094; Christen T, 2011, NMR BIOMED, V24, P393, DOI 10.1002/nbm.1603; Deistung A, 2008, MAGN RESON MED, V60, P1155, DOI 10.1002/mrm.21754; Dickson JD, 2010, J MAGN RESON IMAGING, V32, P953, DOI 10.1002/jmri.22151; Dobre MC, 2007, MAGN RESON IMAGING, V25, P733, DOI 10.1016/j.mri.2006.10.020; Donahue KM, 1997, JMRI-J MAGN RESON IM, V7, P102, DOI 10.1002/jmri.1880070114; Donaldson SB, 2010, MAGN RESON MED, V63, P691, DOI 10.1002/mrm.22217; Franiel T, 2011, EUR RADIOL, V21, P616, DOI 10.1007/s00330-010-2037-7; Guibert R, 2012, NEUROIMAGE, V62, P408, DOI 10.1016/j.neuroimage.2012.04.030; Hall MG, 2009, IEEE T MED IMAGING, V28, P1354, DOI 10.1109/TMI.2009.2015756; Jensen JH, 2000, MAGNET RESON MED, V43, P226, DOI 10.1002/(SICI)1522-2594(200002)43:2<226::AID-MRM9>3.0.CO;2-P; KENNAN RP, 1994, MAGNET RESON MED, V31, P9, DOI 10.1002/mrm.1910310103; Kettunen MI, 2007, RADIOLOGY, V243, P796, DOI 10.1148/radiol.2433052077; Kiselev VG, 1998, PHYS REV LETT, V81, P5696, DOI 10.1103/PhysRevLett.81.5696; Kiselev VG, 2001, MAGN RESON MED, V46, P1113, DOI 10.1002/mrm.1307; Klassen LM, 2007, BIOPHYS J, V92, P1014, DOI 10.1529/biophysj.106.087965; Le Bihan D, 1995, DIUSION PERFUSION MA; Le Bihan D, 2007, PHYS MED BIOL, V52, pR57, DOI 10.1088/0031-9155/52/7/R02; Lemasson B, 2011, NMR BIOMED, V24, P473, DOI 10.1002/nbm.1611; Marinovich ML, 2012, BREAST IN PRESS; Marques JP, 2005, CONCEPT MAGN RESON B, V25B, P65, DOI 10.1002/cmr.b.20034; Marty B, 2010, ISMRM 2010 STOCKH SW; Novikov DS, 2012, ISMRM 2012 MELB AUST; Ostergaard L, 2005, J MAGN RESON IMAGING, V22, P710, DOI 10.1002/jmri.20460; Pathak AP, 2008, NEUROIMAGE, V40, P1130, DOI 10.1016/j.neuroimage.2008.01.022; Pellerin M, 2007, MAGN RESON MED, V58, P1124, DOI 10.1002/mrm.21400; Pollack GH, 2003, ADV COLLOID INTERFAC, V103, P173, DOI 10.1016/S0001-8686(02)00095-7; Quarles CC, 2009, PHYS MED BIOL, V54, P5749, DOI 10.1088/0031-9155/54/19/006; Risser L, 2007, J CEREBR BLOOD F MET, V27, P293, DOI 10.1038/sj.jcbfm.9600332; Salomir R, 2003, CONCEPT MAGN RESON B, V19B, P26, DOI 10.1002/cmr.b.10083; Schmiedeskamp H, 2012, MAGN RESON MED, V68, P30, DOI 10.1002/mrm.23195; Sourbron S, 2009, MAGN RESON MED, V62, P672, DOI 10.1002/mrm.22042; Sourbron S, 2012, MAGNETIC RE IN PRESS; Sourbron SP, 2012, PHYS MED BIOL, V57, pR1, DOI 10.1088/0031-9155/57/2/R1; Lawrence KS, 2012, MAGN RESON MED, V67, P1275, DOI 10.1002/mrm.23104; Sukstanskii AL, 2003, J MAGN RESON, V163, P236, DOI 10.1016/S1090-7807(03)00131-9; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Tropres I, 2004, MAGN RESON MED, V51, P533, DOI 10.1002/mrm.20017; Valable S, 2008, NMR BIOMED, V21, P1043, DOI 10.1002/nbm.1278; Xu C, 2012, CEREBROVASC DIS, V33, P303, DOI 10.1159/000335302; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Yankeelov TE, 2008, MAGN RESON MED, V59, P326, DOI 10.1002/mrm.21449; Zhao JM, 2007, MAGN RESON MED, V58, P592, DOI 10.1002/mrm.21342	49	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57636	10.1371/journal.pone.0057636	http://dx.doi.org/10.1371/journal.pone.0057636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516414	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400012
J	Baixeries, J; Elvevag, B; Ferrer-i-Cancho, R				Baixeries, Jaume; Elvevag, Brita; Ferrer-i-Cancho, Ramon			The Evolution of the Exponent of Zipf's Law in Language Ontogeny	PLOS ONE			English	Article							ACQUISITION; WORD; COMMUNICATION; SYNTAX	It is well-known that word frequencies arrange themselves according to Zipf's law. However, little is known about the dependency of the parameters of the law and the complexity of a communication system. Many models of the evolution of language assume that the exponent of the law remains constant as the complexity of a communication systems increases. Using longitudinal studies of child language, we analysed the word rank distribution for the speech of children and adults participating in conversations. The adults typically included family members (e.g., parents) or the investigators conducting the research. Our analysis of the evolution of Zipf's law yields two main unexpected results. First, in children the exponent of the law tends to decrease over time while this tendency is weaker in adults, thus suggesting this is not a mere mirror effect of adult speech. Second, although the exponent of the law is more stable in adults, their exponents fall below 1 which is the typical value of the exponent assumed in both children and adults. Our analysis also shows a tendency of the mean length of utterances (MLU), a simple estimate of syntactic complexity, to increase as the exponent decreases. The parallel evolution of the exponent and a simple indicator of syntactic complexity (MLU) supports the hypothesis that the exponent of Zipf's law and linguistic complexity are inter-related. The assumption that Zipf's law for word ranks is a power-law with a constant exponent of one in both adults and children needs to be revised.	[Baixeries, Jaume] Univ Politecn Cataluna, Dept Llenguatges & Sistemes Informat, Lab Relat Algorithm Complex & Learning LARCA, Barcelona, Catalonia, Spain; [Baixeries, Jaume; Ferrer-i-Cancho, Ramon] Univ Politecn Cataluna, Ctr Language & Speech Technol & Applicat TALP Res, Dept Llenguatges & Sistemes Informat, Complex & Quantitat Linguist Lab, Barcelona, Catalonia, Spain; [Elvevag, Brita] Univ Tromso, Dept Clin Med, Psychiat Res Grp, Tromso, Norway; [Elvevag, Brita] Univ Hosp North Norway, Norwegian Ctr Integrated Care & Telemed NST, Tromso, Norway	Universitat Politecnica de Catalunya; Universitat Politecnica de Catalunya; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Ferrer-i-Cancho, R (corresponding author), Univ Politecn Cataluna, Ctr Language & Speech Technol & Applicat TALP Res, Dept Llenguatges & Sistemes Informat, Complex & Quantitat Linguist Lab, Barcelona, Catalonia, Spain.	rferrericancho@lsi.upc.edu	Elvevåg, Brita/ABC-1835-2021; Ferrer-i-Cancho, Ramon/A-5424-2011; Baixeries, Jaume/L-5804-2014	Elvevåg, Brita/0000-0003-0441-3729; Ferrer-i-Cancho, Ramon/0000-0002-7820-923X; Baixeries, Jaume/0000-0003-2896-2247	grant 'Iniciacio i reincorporacio a la recerca' from the Universitat Politecnica de Catalunya; grant 'Biological and Social Data Mining: Algorithms, Theory, and Implementations' from the Spanish Ministry of Science and Innovation [TIN2011-27479-C04-03]; Northern Norwegian Regional Health Authority, Helse Nord RHF	grant 'Iniciacio i reincorporacio a la recerca' from the Universitat Politecnica de Catalunya; grant 'Biological and Social Data Mining: Algorithms, Theory, and Implementations' from the Spanish Ministry of Science and Innovation; Northern Norwegian Regional Health Authority, Helse Nord RHF	This work was supported by grant 'Iniciacio i reincorporacio a la recerca' from the Universitat Politecnica de Catalunya (http://www.upc.cat) and the grant 'Biological and Social Data Mining: Algorithms, Theory, and Implementations' (TIN2011-27479-C04-03) from the Spanish Ministry of Science and Innovation (http://www.micinn.es/) (JB and RFC). This work was supported by the Northern Norwegian Regional Health Authority, Helse Nord RHF (BE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann G., 1999, THESAURUS UNIVARIATE; American English Corpora, CHILDES DAT MAN; [Anonymous], DAT MAN; [Anonymous], 2007, MATH STAT METASTATIS; Baayen R. Harald, 2001, WORD FREQUENCY DISTR; Bates E, 1995, HDB CHILD LANGUAGE, P86; Behrens H, 2006, LANG COGNITIVE PROC, V21, P2, DOI 10.1080/01690960400001721; Bernhardsson S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123015; BLOOM L, 1974, COGNITIVE PSYCHOL, V6, P380, DOI 10.1016/0010-0285(74)90018-8; BLOOM L, 1975, MONOGR SOC RES CHILD, V40, P1, DOI 10.2307/1165986; Bloom Lois., 1970, LANGUAGE DEV FUNCTIO; BOL GW, 1995, AMSTERDAM SERIES CHI, V3, P1; British English Corpora, DAT MAN; Brown R., 1973, 1 LANGUAGE EARLY STA; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cancho RFI, 2006, BIOSYSTEMS, V84, P242, DOI 10.1016/j.biosystems.2005.12.001; Cancho RFI, 2005, P ROY SOC B-BIOL SCI, V272, P561, DOI 10.1098/rspb.2004.2957; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Castro Sotos A, 2007, B ISI, V62, P4609; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Corominas-Murtra B, 2009, ADV COMPLEX SYST, V12, P371, DOI 10.1142/S0219525909002192; Demuth K, 2006, LANG SPEECH, V49, P137, DOI 10.1177/00238309060490020201; Ferrer i Cancho R, 2001, J QUANT LINGUIST, V8, P165; Ferrer i Cancho R, 2008, CAMBRIDGE ENCY LANGU, P555; Ferrer-i-Cancho R, 2012, GLOTTOTHEORY, V4; Germanic Corpora, CHILDES DAT MAN; Goldstein ML, 2004, EUR PHYS J B, V41, P255, DOI 10.1140/epjb/e2004-00316-5; Howes D., 1964, DISORDERS COMMUNICAT, P229; KUCZAJ SA, 1977, J VERB LEARN VERB BE, V16, P589, DOI 10.1016/S0022-5371(77)80021-2; Li WT, 2010, ENTROPY-SWITZ, V12, P1743, DOI 10.3390/e12071743; MacWhinney B., 2000, CHILDES PROJECT TOOL, V2; Mandelbrot B., 1961, STRUCTURE LANGUAGE I, P190, DOI 10.1090/psapm/012/9970; McCowan B, 2002, J COMP PSYCHOL, V116, P166, DOI 10.1037//0735-7036.116.2.166; Montemurro M.A., 2002, GLOTTOMETRICS, V87, P99; Nowak MA, 2000, NATURE, V404, P495, DOI 10.1038/35006635; Nowak MA, 2000, J THEOR BIOL, V204, P179, DOI 10.1006/jtbi.2000.1085; Piotrowski R.G., 2007, EXACT METHODS STUDY, P545; Plotkin J. B., 2001, Entropy, V3, DOI 10.3390/e3040227; Plunkett K., 1992, CROSS LINGUISTIC STU, P457; Reich P., 1986, LANGUAGE DEV; Rescorla L, 2001, J SPEECH LANG HEAR R, V44, P598, DOI 10.1044/1092-4388(2001/049); Rowland CF, 2006, J CHILD LANG, V33, P859, DOI 10.1017/S0305000906007537; Sachs J., 1983, CHILDRENS LANGUAGE, V4, P1; Saxton M., 2010, CHILD LANGUAGE ACQUI; Schaerlaekens AnneMarie., 1973, 2 WORD SENTENCE CHIL; Snow C. E., 1995, HDB CHILD LANGUAGE, P180; Stromqvist S, 1993, GOTHENBURG PAPERS TH, V66; SUPPES P, 1974, AM PSYCHOL, V29, P103, DOI 10.1037/h0036026; SZAGUN G, 2001, 1 LANGUAGE, V0021; Theakston AL, 2001, J CHILD LANG, V28, P127, DOI 10.1017/S0305000900004608; van Kampen, 1994, LINGUISTICS NETHERLA, V199, P83, DOI [10.1075/avt.11.10kam, DOI 10.1075/AVT]; Wells CG, 1981, LEARNING INTERACTION; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; [No title captured]; [No title captured]	56	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e53227	10.1371/journal.pone.0053227	http://dx.doi.org/10.1371/journal.pone.0053227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516390	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200001
J	Dong, YJ; Pan, JS; Zhang, LP				Dong, Yanjun; Pan, Jenny S.; Zhang, Liping			Myostatin Suppression of Akirin1 Mediates Glucocorticoid-Induced Satellite Cell Dysfunction	PLOS ONE			English	Article							SKELETAL-MUSCLE ATROPHY; PROMYOGENIC FACTOR; GENE; REGENERATION; EXPRESSION; DIFFERENTIATION; GROWTH; TRANSCRIPTION; LOCALIZATION; DEPLETION	Glucocorticoids production is increased in many pathological conditions that are associated with muscle loss, but their role in causing muscle wasting is not fully understood. We have demonstrated a new mechanism of glucocorticoid-induced muscle atrophy: Dexamethasone (Dex) suppresses satellite cell function contributing to the development of muscle atrophy. Specifically, we found that Dex decreases satellite cell proliferation and differentiation in vitro and in vivo. The mechanism involved Dex-induced upregulation of myostatin and suppression of Akirin1, a promyogenic gene. When myostatin was inhibited in Dex-treated mice, Akirin1 expression increased as did satellite cell activity, muscle regeneration and muscle growth. In addition, silencing myostatin in myoblasts or satellite cells prevented Dex from suppressing Akirin1 expression and cellular proliferation and differentiation. Finally, overexpression of Akirin1 in myoblasts increased their expression of MyoD and myogenin and improved cellular proliferation and differentiation, theses improvements were no longer suppressed by Dex. We conclude that glucocorticoids stimulate myostatin which inhibits Akirin1 expression and the reparative functions of satellite cells. These responses attribute to muscle atrophy. Thus, inhibition of myostatin or increasing Akirin1 expression could lead to therapeutic strategies for improving satellite cell activation and enhancing muscle growth in diseases associated with increased glucocorticoid production.	[Dong, Yanjun; Pan, Jenny S.; Zhang, Liping] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA	Baylor College of Medicine	Zhang, LP (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA.	lipingz@bcm.edu		Dong, Yanjun/0000-0001-6396-8949	Norman S. Coplon extramural research grants from Satellite Health and American Diabetic Association [1-11-BS-194]; United States National Institutes of Health (NIH) grant [R37 DK37175, NIH T32 DK062706]; Satellite Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062706, R37DK037175] Funding Source: NIH RePORTER	Norman S. Coplon extramural research grants from Satellite Health and American Diabetic Association; United States National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Satellite Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the generous support of Dr. and Mrs. Harold Selzman, the Norman S. Coplon extramural research grants from Satellite Health and American Diabetic Association (1-11-BS-194) to L.Z. and support from the United States National Institutes of Health (NIH) grant R37 DK37175 and NIH T32 DK062706. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly funded by Satellite Health. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Artaza JN, 2002, J CELL PHYSIOL, V190, P170, DOI 10.1002/JCP.10044; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Chen JCJ, 2005, GENESIS, V41, P116, DOI 10.1002/gene.20104; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Gilson H, 2007, ENDOCRINOLOGY, V148, P452, DOI 10.1210/en.2006-0539; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Hu Zhaoyong, 2009, J Clin Invest, V119, P3059, DOI 10.1172/JCI38770; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Kawada S, 2001, J MUSCLE RES CELL M, V22, P627, DOI 10.1023/A:1016366409691; Komiya Y, 2008, J BIOL CHEM, V283, P18753, DOI 10.1074/jbc.M802530200; Lalani R, 2000, J ENDOCRINOL, V167, P417, DOI 10.1677/joe.0.1670417; Lang CH, 2002, AM J PHYSIOL-REG I, V282, pR207, DOI 10.1152/ajpregu.00319.2001; Lang CH, 2001, FASEB J, V15, P1807, DOI 10.1096/fj.00-0849fje; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; Ma K, 2001, AM J PHYSIOL-ENDOC M, V281, pE1128, DOI 10.1152/ajpendo.2001.281.6.E1128; Marshall A, 2008, EXP CELL RES, V314, P1013, DOI 10.1016/j.yexcr.2008.01.004; MAY RC, 1986, J CLIN INVEST, V77, P614, DOI 10.1172/JCI112344; May RC, 1996, KIDNEY INT, V49, P679, DOI 10.1038/ki.1996.96; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McCroskery S, 2005, J CELL SCI, V118, P3531, DOI 10.1242/jcs.02482; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; Nowak SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002547; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; ROULEAU G, 1987, MUSCLE NERVE, V10, P428, DOI 10.1002/mus.880100509; ROY RR, 1983, ARCH ORAL BIOL, V28, P639, DOI 10.1016/0003-9969(83)90012-2; Salerno MS, 2009, EXP CELL RES, V315, P2012, DOI 10.1016/j.yexcr.2009.04.014; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; te Pas MFW, 2000, MOL BIOL REP, V27, P87, DOI 10.1023/A:1007120921064; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Wang XNH, 2011, J AM SOC NEPHROL, V22, P2068, DOI 10.1681/ASN.2010121278; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Zhang LP, 2010, J AM SOC NEPHROL, V21, P419, DOI 10.1681/ASN.2009060571; Zhang LP, 2009, AM J PATHOL, V175, P2518, DOI 10.2353/ajpath.2009.090275; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	41	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58554	10.1371/journal.pone.0058554	http://dx.doi.org/10.1371/journal.pone.0058554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516508	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200087
J	Huang, SG; Liu, F; Niu, Q; Li, Y; Liu, C; Zhang, LL; Ni, DN; Pu, XY				Huang, Shaoguang; Liu, Fei; Niu, Qin; Li, Yi; Liu, Chang; Zhang, Lele; Ni, Danni; Pu, Xiaoyun			GLIPR-2 Overexpression in HK-2 Cells Promotes Cell EMT and Migration through ERK1/2 Activation	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; ENRICHED MICRODOMAINS; DIABETIC-NEPHROPATHY; GOLGI-COMPLEX; FIBROSIS; KIDNEY; MYOFIBROBLASTS; IDENTIFICATION; FIBROBLASTS	The epithelial-to-mesenchymal transition (EMT) of tubular epithelial cells in the adult kidney is one of the key events in renal interstitial fibrosis. Glioma pathogenesis related-2 (GLIPR-2) has been shown to be up-regulated in proximal tubular cells (PTCs) in the fibrotic kidney. However, the biological function of GLIPR-2 remains unknown. In this study, we found that GLIPR-2 expression is elevated in the kidney tissue samples of patients with diabetic nephropathy (DN). Human proximal renal tubular epithelial cells (HK-2 cells) were transfected with pcDNA3.0-GLIPR-2 and selected with G418. To identify the biological function of GLIPR-2, an epithelial-to-mesenchymal transition (EMT) PCR array analysis was performed, and genes that had statistically significantly altered expression levels with more than a two-fold difference compared with the pcDNA3.0-transfected HK-2 cells were considered. Key elements of the EMT process, such as E-cadherin and vimentin, were transcriptionally activated in the pcDNA3.0-GLIPR-2-transfected sublines. In addition, alpha-SMA gene expression, which is a marker of myofibroblasts, increased in the pcDNA3.0-GLIPR-2-transfected HK-2 cells. The cell migration assay demonstrated that the transfection of HK-2 with GLIPR-2 promoted cell migration following an EMT. Additionally, consistent with the effects of increased EGFR expression levels, we found that the activation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) was highly elevated in the pcDNA3.0-GLIPR-2-transfected group. Our study demonstrates that GLIPR-2 overexpression in HK-2 cells can potentiate EMT-like processes in this cell type through the ERK1/2 signaling pathway. GLIPR-2 may be responsible for the development of renal fibrosis by increasing the accumulation of interstitial fibroblasts.	[Huang, Shaoguang; Liu, Fei; Li, Yi; Liu, Chang; Zhang, Lele; Ni, Danni; Pu, Xiaoyun] Third Mil Med Univ, Xin Qiao Hosp, Dept Clin Lab, Chongqing, Peoples R China; [Niu, Qin] Third Mil Med Univ, Southwest Hosp, Inst Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Pu, XY (corresponding author), Third Mil Med Univ, Xin Qiao Hosp, Dept Clin Lab, Chongqing, Peoples R China.	puxiaoyong@yahoo.com			National Natural Science Foundation of China [2009ZX10601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Contract grant sponsor is the National Natural Science Foundation of China, contract grant number No. 2009ZX10601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Xia Zhang (Institute of Pathology, Southwest Hospital, Third Military Medical University, Chongqing, China) for a critical reading of the manuscript. We further acknowledge the National Natural Science Foundation of China for financial support, and Dr. Bo Zhu and Dr. Yifang Ping (Institute of Cancer, Xinqiao Hospital, Institute of Pathology, Southwest Hospital, Third Military Medical University, Chongqing, China) for kindly giving helpful advice.	Baxter RM, 2007, MATRIX BIOL, V26, P20, DOI 10.1016/j.matbio.2006.09.005; Chiarelli F, 2003, PANMINERVA MED, V45, P23; Eberle HB, 2002, J CELL SCI, V115, P827; Eisenberg I, 2002, GENE, V293, P141, DOI 10.1016/S0378-1119(02)00703-5; Essawy M, 1997, NEPHROL DIAL TRANSPL, V12, P43, DOI 10.1093/ndt/12.1.43; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Inoue T, 2005, KIDNEY INT, V67, P2488, DOI 10.1111/j.1523-1755.2005.00358.x; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Ng YY, 1998, KIDNEY INT, V54, P864, DOI 10.1046/j.1523-1755.1998.00076.x; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Serrano RL, 2004, J MOL BIOL, V339, P173, DOI 10.1016/j.jmb.2004.03.015; Soldatos G, 2008, DIABETES RES CLIN PR, V82, pS75, DOI 10.1016/j.diabres.2008.09.042; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Van Galen J, 2010, MOL MEMBR BIOL, V27, P81, DOI 10.3109/09687680903507080; VANLOON LC, 1970, VIROLOGY, V40, P199, DOI 10.1016/0042-6822(70)90395-8; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Zeisberg M, 2002, AM J PATHOL, V160, P2001, DOI 10.1016/S0002-9440(10)61150-9; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang WJ, 2012, J BIOL CHEM, V287, P11850, DOI 10.1074/jbc.M111.258236	24	16	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58574	10.1371/journal.pone.0058574	http://dx.doi.org/10.1371/journal.pone.0058574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516513	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200093
J	Lewis, JS; Wartzok, D; Heithaus, M; Krutzen, M				Lewis, Jennifer S.; Wartzok, Douglas; Heithaus, Michael; Kruetzen, Michael			Could Relatedness Help Explain Why Individuals Lead in Bottlenose Dolphin Groups?	PLOS ONE			English	Article							PATERNAL KIN DISCRIMINATION; REPRODUCTIVE SUCCESS; INBREEDING AVOIDANCE; SOCIAL-STRUCTURE; DECISION-MAKING; SITE FIDELITY; WHALES; LEADERSHIP; DOMINANCE; MOVEMENTS	In many species, particular individuals consistently lead group travel. While benefits to followers often are relatively obvious, including access to resources, benefits to leaders are often less obvious. This is especially true for species that feed on patchy mobile resources where all group members may locate prey simultaneously and food intake likely decreases with increasing group size. Leaders in highly complex habitats, however, could provide access to foraging resources for less informed relatives, thereby gaining indirect benefits by helping kin. Recently, leadership has been documented in a population of bottlenose dolphins (Tursiops truncatus) where direct benefits to leaders appear unlikely. To test whether leaders could benefit indirectly we examined relatedness between leader-follower pairs and compared these levels to pairs who associated but did not have leader-follower relationship (neither ever led the other). We found the average relatedness value for leader-follower pairs was greater than expected based on chance. The same was not found when examining non leader-follower pairs. Additionally, relatedness for leader-follower pairs was positively correlated with association index values, but no correlation was found for this measure in non leader-follower pairs. Interestingly, haplotypes were not frequently shared between leader-follower pairs (25%). Together, these results suggest that bottlenose dolphin leaders have the opportunity to gain indirect benefits by leading relatives. These findings provide a potential mechanism for the maintenance of leadership in a highly dynamic fission-fusion population with few obvious direct benefits to leaders.	[Lewis, Jennifer S.; Wartzok, Douglas] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Heithaus, Michael] Florida Int Univ, Dept Biol Sci, North Miami, FL USA; [Kruetzen, Michael] Univ Zurich, Anthropol Inst & Museum, Evolutionary Genet Grp, Zurich, Switzerland	State University System of Florida; Florida International University; State University System of Florida; Florida International University; University of Zurich	Lewis, JS (corresponding author), Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA.	jennifer.lewis1@fiu.edu	Heithaus, Michael/AAF-9914-2020; Krutzen, Michael C/D-9550-2011	Heithaus, Michael/0000-0002-3219-1003; Krutzen, Michael/0000-0003-1055-5299	Sigma Xi; Project Aware; Harbor Branch Oceanographic Institute Protect Wild Dolphins Grant; Florida International University's Dissertation Acquisition and Dissertation Year Fellowships	Sigma Xi; Project Aware; Harbor Branch Oceanographic Institute Protect Wild Dolphins Grant; Florida International University's Dissertation Acquisition and Dissertation Year Fellowships	This research was supported through funding from Sigma Xi, Project Aware, and Harbor Branch Oceanographic Institute Protect Wild Dolphins Grant. J Lewis was supported while conducting this research and writing this manuscript by Florida International University's Dissertation Acquisition and Dissertation Year Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 1999, P ROY SOC B-BIOL SCI, V266, P1501, DOI 10.1098/rspb.1999.0807; AMOS B, 1993, SCIENCE, V260, P670, DOI 10.1126/science.8480176; Archie EA, 2007, MOL ECOL, V16, P4138, DOI 10.1111/j.1365-294X.2007.03483.x; Baird RW, 2008, MAR MAMMAL SCI, V24, P591, DOI 10.1111/j.1748-7692.2008.00200.x; Baird RW, 2000, CETACEAN SOCIETIES, P127; BAKER CS, 1993, J HERED, V84, P281, DOI 10.1093/oxfordjournals.jhered.a111340; Barelli C, 2008, BEHAVIOUR, V145, P965, DOI 10.1163/156853908784089243; Barros N.B., 1990, P309; Bates LA, 2008, BIOL LETTERS, V4, P34, DOI 10.1098/rsbl.2007.0529; BREATHNACH AS, 1960, BIOL REV, V35, P187, DOI 10.1111/j.1469-185X.1960.tb01414.x; Charpentier M, 2005, BEHAV ECOL, V16, P614, DOI 10.1093/beheco/ari034; Connor RC, 2000, CETACEAN SOCIETIES, P91; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Di Bitetti MS, 2001, ANIM BEHAV, V62, P47, DOI 10.1006/anbe.2000.1730; Dugatkin L.A., 1997, COOPERATION ANIMALS; Erhart EM, 1999, INT J PRIMATOL, V20, P927, DOI 10.1023/A:1020830703012; Frere CH, 2010, ANIM BEHAV, V80, P481, DOI 10.1016/j.anbehav.2010.06.007; Fripp D, 2005, ANIM COGN, V8, P17, DOI 10.1007/s10071-004-0225-z; Gero S, 2008, BEHAV ECOL SOCIOBIOL, V63, P143, DOI 10.1007/s00265-008-0645-x; Gero S, 2009, BEHAV ECOL, V20, P838, DOI 10.1093/beheco/arp068; Gilson A, 1998, CALIF FISH GAME, V84, P159; Hain TJA, 2006, CURR BIOL, V16, P1807, DOI 10.1016/j.cub.2006.07.021; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hoelzel AR, 1998, P ROY SOC B-BIOL SCI, V265, P1177, DOI 10.1098/rspb.1998.0416; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Krutzen M, 2001, MOL ECOL NOTES, V1, P170, DOI 10.1046/j.1471-8278.2001.00065.x; Krutzen M, 2003, P ROY SOC B-BIOL SCI, V270, P497, DOI 10.1098/rspb.2002.2229; Lewis Jennifer S., 2003, Gulf of Mexico Science, V21, P92; Lewis JS, 2011, BEHAV ECOL SOCIOBIOL, V65, P1061, DOI 10.1007/s00265-010-1113-y; Lewis JS, 2010, THESIS FLORIDA INT U; Lewis JS, 2002, THESIS U ALABAMA; Lusseau D, 2007, EVOL ECOL, V21, P357, DOI 10.1007/s10682-006-9105-0; Maher CR, 2009, ANIM BEHAV, V78, P925, DOI 10.1016/j.anbehav.2009.06.027; Markowitz TM, 2004, AQUAT CONSERV, V14, P133, DOI 10.1002/aqc.602; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; McSweeney DJ, 2009, MAR MAMMAL SCI, V25, P557, DOI 10.1111/j.1748-7692.2008.00267.x; Mehlis M, 2008, ANIM COGN, V11, P643, DOI 10.1007/s10071-008-0154-3; Milton K, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P375; Moller LM, 2001, P ROY SOC B-BIOL SCI, V268, P1941, DOI 10.1098/rspb.2001.1756; Moller Luciana M., 2008, Research Letters in Ecology, V2008, P1, DOI 10.1155/2008/498390; Moss CJ, 1983, PRIMATE SOCIAL RELAT, P315; Muniz L, 2010, AM J PRIMATOL, V72, P1118, DOI 10.1002/ajp.20876; Nater A, 2009, MOL ECOL RESOUR, V9, P531, DOI 10.1111/j.1755-0998.2008.02246.x; Payne K, 2003, ANIMAL SOCIAL COMPLEXITY, P57; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Piyapong C, 2007, ETHOLOGY, V113, P821, DOI 10.1111/j.1439-0310.2007.01382.x; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Ralls K, 2001, J MAMMAL, V82, P858, DOI 10.1644/1545-1542(2001)082<0858:KSRADS>2.0.CO;2; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ruch J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-257; Samuels A, 1997, MAR MAMMAL SCI, V13, P70, DOI 10.1111/j.1748-7692.1997.tb00613.x; Schwacke L, 2005, RERAT RELATEDNESS ES; Shinohara M, 1997, MOL ECOL, V6, P695, DOI 10.1046/j.1365-294X.1997.00231.x; Silk JB, 2002, INT J PRIMATOL, V23, P849, DOI 10.1023/A:1015581016205; Smolker R, 1999, ETHOLOGY, V105, P595, DOI 10.1046/j.1439-0310.1999.00441.x; Stueckle S, 2008, ANIM BEHAV, V75, P1995, DOI 10.1016/j.anbehav.2007.12.012; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Watwood SL, 2004, BEHAV ECOL SOCIOBIOL, V55, P531, DOI 10.1007/s00265-003-0724-y; Whitehead H, 1997, ANIM BEHAV, V53, P1053, DOI 10.1006/anbe.1996.0358; WHITEHEAD H, 1991, BEHAV ECOL SOCIOBIOL, V29, P385, DOI 10.1007/BF00165964; Whitehead H, 2008, ANIM BEHAV, V75, P1093, DOI 10.1016/j.anbehav.2007.08.022; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Whitehead Hal, 1999, Animal Behaviour Forum, V57, pF26, DOI 10.1006/anbe.1999.1099; Widdig A, 2007, BIOL REV, V82, P319, DOI 10.1111/j.1469-185X.2007.00011.x	69	9	9	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58162	10.1371/journal.pone.0058162	http://dx.doi.org/10.1371/journal.pone.0058162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516445	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000316849200040
J	Pandi, G; Nakka, VP; Dharap, A; Roopra, A; Vemuganti, R				Pandi, Gopal; Nakka, Venkata P.; Dharap, Ashutosh; Roopra, Avtar; Vemuganti, Raghu			MicroRNA miR-29c Down-Regulation Leading to De-Repression of Its Target DNA Methyltransferase 3a Promotes Ischemic Brain Damage	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; CEREBRAL-ISCHEMIA; NONCODING RNAS; IN-VITRO; EXPRESSION; NEUROPROTECTION; CONTRIBUTES; INJURY; DEATH; WELL	Recent studies showed that stroke extensively alters cerebral microRNA (miRNA) expression profiles and several miRNAs play a role in mediating ischemic pathophysiology. We currently evaluated the significance of miR-29c, a highly expressed miRNA in rodent brain that was significantly down-regulated after focal ischemia in adult rats as well as after oxygen-glucose deprivation in PC12 cells. Bioinformatics indicated that DNA methyltransferase 3a (DNMT3a) is a major target of miR-29c and co-transfection with premiR-29c prevented DNMT3a 3'UTR vector expression. In PC12 cells, treatment with premiR-29c prevented OGD-induced cell death (by 58 +/- 6%; p<0.05). Furthermore, treatment with antagomiR-29c resulted in a 46 +/- 5% cell death in PC12 cells. When rats were treated with premiR-29c and subjected to transient focal ischemia, post-ischemic miR-29c levels were restored and the infarct volume decreased significantly (by 34 +/- 6%; p<0.05) compared to control premiR treated group. DNMT3a siRNA treatment also significantly curtailed the post-OGD cell death in PC12 cells (by 54 +/- 6%; p<0.05) and decreased the post-ischemic infarct volume in rats (by 30 +/- 5%; p<0.05) compared to respective control siRNA treated groups. The miR-29c gene promoter showed specific binding sites for the transcription factor REST and the miR-29c promoter vector expression was curtailed when cotransfected with a REST expressing plasmid. Furthermore, treatment with REST siRNA prevented the post-ischemic miR-29c down-regulation and DNMT3a induction in PC12 cells and curtailed ischemic cell death (by 64 +/- 9%; p<0.05) compared to control siRNA treatment. These studies suggest that miR-29c is a pro-survival miRNA and its down-regulation is a promoter of ischemic brain damage by acting through its target DNMT3a. Furthermore, REST is an upstream transcriptional controller of miR-29c and curtailing REST induction prevents miR-29c down-regulation and ischemic neuronal death.	[Pandi, Gopal; Nakka, Venkata P.; Dharap, Ashutosh; Vemuganti, Raghu] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53715 USA; [Roopra, Avtar] Univ Wisconsin, Dept Neurosci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vemuganti, R (corresponding author), Univ Wisconsin, Dept Neurol Surg, Madison, WI 53715 USA.	vemuganti@neurosurgery.wisc.edu	Dharap, Ashutosh/H-7466-2013; Pandi, Gopal/M-2465-2019	Pandi, Gopal/0000-0002-2186-2473; Nakka, Venkata Prasuja/0000-0001-5509-6925	National Institutes of Health [NS074444, NS079585, NS065067]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079585, R21NS074444, R01NS065067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were funded by National Institutes of Health grants NS074444, NS079585 and NS065067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Buller B, 2010, FEBS J, V277, P4299, DOI 10.1111/j.1742-4658.2010.07818.x; Chedin F, 2011, PROG MOL BIOL TRANSL, V101, P255, DOI 10.1016/B978-0-12-387685-0.00007-X; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Dharap A, 2012, STROKE, V43, P2800, DOI 10.1161/STROKEAHA.112.669465; Dharap A, 2011, STROKE, V42, P1105, DOI 10.1161/STROKEAHA.110.598391; Dharap A, 2010, J NEUROCHEM, V113, P1685, DOI 10.1111/j.1471-4159.2010.06735.x; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kinney SRM, 2011, PROG MOL BIOL TRANSL, V101, P311, DOI 10.1016/B978-0-12-387685-0.00009-3; Lenart B, 2004, J NEUROSCI, V24, P9585, DOI 10.1523/JNEUROSCI.2569-04.2004; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Liu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023461; Noh KM, 2012, P NATL ACAD SCI USA, V109, pE962, DOI 10.1073/pnas.1121568109; Ouyang YB, 2012, NEUROBIOL DIS, V45, P555, DOI 10.1016/j.nbd.2011.09.012; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Sepramaniam S, 2010, J BIOL CHEM, V285, P29223, DOI 10.1074/jbc.M110.144576; Siegel C, 2011, P NATL ACAD SCI USA, V108, P11662, DOI 10.1073/pnas.1102635108; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tureyen K, 2008, J NEUROCHEM, V105, P1313, DOI 10.1111/j.1471-4159.2008.05233.x; Tureyen K, 2007, J NEUROCHEM, V101, P41, DOI 10.1111/j.1471-4159.2006.04376.x; Witwer KW, 2010, J IMMUNOL, V184, P2369, DOI 10.4049/jimmunol.0902712; Yin KJ, 2010, J NEUROSCI, V30, P6398, DOI 10.1523/JNEUROSCI.0780-10.2010; Yin KJ, 2010, NEUROBIOL DIS, V38, P17, DOI 10.1016/j.nbd.2009.12.021	27	82	86	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58039	10.1371/journal.pone.0058039	http://dx.doi.org/10.1371/journal.pone.0058039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516428	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200028
J	Pinart, M; Zhang, M; Li, F; Hussain, F; Zhu, J; Wiegman, C; Ryffel, B; Chung, KF				Pinart, Mariona; Zhang, Min; Li, Feng; Hussain, Farhana; Zhu, Jie; Wiegman, Coen; Ryffel, Bernard; Chung, Kian Fan			IL-17A Modulates Oxidant Stress-Induced Airway Hyperresponsiveness but Not Emphysema	PLOS ONE			English	Article							NEUTROPHIL RECRUITMENT; T-CELLS; MICE; INTERLEUKIN-17; EXPRESSION; OZONE; INFLAMMATION; STIMULATION; CHEMOKINE; DISEASE	IL-17A induces the release of pro-inflammatory cytokines and of reactive oxygen species which could lead to neutrophilic inflammation. We determined the role of IL-17 receptor (IL-17R) signalling in oxidant-induced lung emphysema and airway hyperresponsiveness. IL-17R(-/-) and wild-type C57/BL6 mice were exposed to ozone (3 ppm; 3 hours) for 12 times over 6 weeks. Bronchial responsiveness to acetylcholine was measured, and lungs were retrieved. Mean linear intercept (L-m) and isometric contractile responses of intrapulmonary airways to acetylcholine were determined. In wild-type mice but not in IL-17R(-/-), chronic ozone exposure caused airway hyperresponsiveness. The increase in L-m after chronic ozone exposure of wild-type mice was also observed in IL-17R(-/-) mice. The increased maximal contractile response to acetylcholine seen in airways of wild-type mice exposed to ozone was abolished in IL-17R(-/-) mice. p38-mitogen-activated protein kinase (MAPK) and dexamethasone-dependent increase in contractile response was reduced in airways from IL-17R(-/-) ozone-exposed mice. Lung inflammation scores were not altered in IL-17R(-/-) mice exposed to ozone compared to wild-type mice. The increased release of IL-17 and IL-1 beta, and the activation of p38 MAPK in the lungs of ozone-exposed mice was reduced in IL-17R(-/-) mice. IL-17R signalling underlies the increase in airway hyperresponsiveness seen after ozone exposure, mediated by the increased contractility of airway smooth muscle. The emphysema and lung inflammation induced by ozone is not dependent on IL-17.	[Pinart, Mariona; Zhang, Min; Li, Feng; Hussain, Farhana; Zhu, Jie; Wiegman, Coen; Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Ryffel, Bernard] Univ Orleans, Orleans, France; [Ryffel, Bernard] CNRS, UMR Mol Immunol & Embryol 6218, F-45071 Orleans, France	Imperial College London; Universite de Orleans; Centre National de la Recherche Scientifique (CNRS)	Chung, KF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	f.chung@imperial.ac.uk	Chung, Kian Fan/I-8456-2019; Pinart, Mariona/L-1931-2015; Pinart Gilberga, Mariona/GLS-8842-2022; Chung, Kian Fan/B-1872-2012	Chung, Kian Fan/0000-0001-7101-1426; Pinart, Mariona/0000-0002-8223-1325; Pinart Gilberga, Mariona/0000-0002-8223-1325; Chung, Kian Fan/0000-0001-7101-1426; Wiegman, Coen/0000-0001-9161-0581	Wellcome Trust [083905]; European Respiratory Society; European Respiratory Society/Marie Curie Joint Postdoctoral Research Fellowship [MC [0935]-2009]; European Community [PCOFUND-GA-2008-229571]	Wellcome Trust(Wellcome TrustEuropean Commission); European Respiratory Society; European Respiratory Society/Marie Curie Joint Postdoctoral Research Fellowship; European Community(European Commission)	This work was supported by Project Grant 083905 from the Wellcome Trust. MP and FL were supported by Long-term Fellowships from the European Respiratory Society. Dr Mariona Pinart is the recipient of a European Respiratory Society/Marie Curie Joint Postdoctoral Research Fellowship - Number MC [0935]-2009. The research leading to these results has received funding from the European Respiratory Society and the European Community's Seventh Framework Programme FP7/2007-2013 - Marie Curie Actions under grant agreement RESPIRE, PCOFUND-GA-2008-229571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Doe C, 2010, CHEST, V138, P1140, DOI 10.1378/chest.09-3058; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Li F, 2011, EUR RESPIR J, V37, P933, DOI 10.1183/09031936.00021110; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pichavant M, 2008, J EXP MED, V205, P385, DOI 10.1084/jem.20071507; Prause O, 2004, THORAX, V59, P313, DOI 10.1136/thx.2003.008854; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Shapiro SD, 2007, EUR RESPIR J, V29, P375, DOI 10.1183/09031936.00087606; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Triantaphyllopoulos K, 2011, AM J PHYSIOL-LUNG C, V300, pL691, DOI 10.1152/ajplung.00252.2010; Vanaudenaerde BM, 2011, AM J RESP CRIT CARE, V183, P977, DOI 10.1164/rccm.201007-1196PP; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	23	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58452	10.1371/journal.pone.0058452	http://dx.doi.org/10.1371/journal.pone.0058452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505509	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100052
J	Schoffelen, AF; Wensing, AMJ; Tempelman, HA; Geelen, SPM; Hoepelman, AIM; Barth, RE				Schoffelen, Annelot F.; Wensing, Annemarie M. J.; Tempelman, Hugo A.; Geelen, Sibyl P. M.; Hoepelman, Andy I. M.; Barth, Roos E.			Sustained Virological Response on Second-Line Antiretroviral Therapy following Virological Failure in HIV-Infected Patients in Rural South Africa	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RESOURCE-LIMITED SETTINGS; HIGH EARLY MORTALITY; DRUG-RESISTANCE; OUTCOMES; MONOTHERAPY; PREDICTORS; CRITERIA; PROGRAM; VIREMIA	Objective: This study aims to describe the virological, immunological and clinical efficacy of protease inhibitor (PI)-based second-line antiretroviral therapy (ART) in rural South Africa. Methods: An observational cohort study was performed on 210 patients (including 39 children) who initiated PI-based second-line therapy at least 12 months prior to data collection. Biannual clinical, immunological and virological monitoring was performed. Primary endpoints were adequate virological response (plasma HIV-1 RNA<400 copies/ml), full virological suppression (plasma HIV-1 RNA<50 copies/ml) and treatment failure (virological failure (plasma HIV-1 RNA>1000 after initial virological response) or on-going viremia (plasma HIV-1 RNA never<400 copies/ml for more than six months)). Data were analyzed by an on-treatment (OT) and intention-to-treat (ITT) approach. Analyses were primarily performed on the group of patients who switched following first-line virological failure. Results: Median duration of follow-up after switch to second-line treatment was 20 months [IQR 11-35]. 191 patients had switched to second-line ART due to first-line virological failure. 139/191 of them (72.8%, ITT) were in care and on treatment at the end of follow-up and 11/191 (5.8%, ITT) had died. After twelve months, an adequate virological response was seen in 92/128 patients (71.9%, OT), of which 78/128 (60.9%, OT) experienced full virological suppression. Virological response remained stable after 24 months. Virological efficacy was similar amongst adult and pediatric patients. As in first-line ART, we observed a lack of correlation between virological failure and WHO-defined immunological failure. Conclusions: Good virological outcomes following first-line failure can be achieved with PI-based, second-line antiretroviral therapy in both adult and pediatric patients in rural South Africa. Retention rates were high and virological outcomes were sustainable during the two-year follow-up period, although persisting low-level viremia occurred in a subset of patients. The observed viro-immunological dissociation emphasizes the need for virological monitoring.	[Schoffelen, Annelot F.; Hoepelman, Andy I. M.; Barth, Roos E.] Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Wensing, Annemarie M. J.] Univ Med Ctr Utrecht, Dept Virol, Utrecht, Netherlands; [Tempelman, Hugo A.] Ndlovu Care Grp, Elandsdoorn, Limpopo, South Africa; [Geelen, Sibyl P. M.] Univ Med Ctr Utrecht, Dept Paediat Infect Dis, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Schoffelen, AF (corresponding author), Univ Med Ctr Utrecht, Dept Internal Med & Infect Dis, Utrecht, Netherlands.	A.F.Schoffelen@umcutrecht.nl			ViiV healthcare; BMS; Gilead; Janssen; MSD; Virology Education; Pfizer; Royal Netherlands Embassy (RNE); USAID; PharmAccess Foundation; Roche	ViiV healthcare; BMS(Bristol-Myers Squibb); Gilead(Gilead Sciences); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); MSD; Virology Education; Pfizer(Pfizer); Royal Netherlands Embassy (RNE); USAID(United States Agency for International Development (USAID)); PharmAccess Foundation; Roche(Roche Holding)	None of the authors have a financial interest in or a financial conflict with the subject matter and materials discussed in this manuscript. A. F. S. has received financial support for travel, accommodation and meeting expenses from ViiV healthcare. A.M.J.W. has received financial support for research, travel, speaking engagement or consultancy from BMS, Gilead, Janssen, MSD, ViiV healthcare and Virology Education and grant support from MSD, Pfizer and ViiV healthcare. H. A. T. has received financial support for employment from Royal Netherlands Embassy (RNE) and grant support from USAID. S. P. M. G. has received financial support for employment from PharmAccess Foundation. A. I. M. H. is member of the advisory board of BMS, Gilead, ViiV healthcare, Janssen and MSD and has received financial grant support from Gilead, Janssen, MSD and Roche. R. E. B. has received no financial support. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; Barth RE, 2008, EUR J CLIN MICROBIOL, V27, P977, DOI 10.1007/s10096-008-0534-2; Barth RE, 2008, AIDS, V22, P2210, DOI 10.1097/QAD.0b013e328313bf87; Barth RE, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/434375; Barth RE, 2011, PEDIATR INFECT DIS J, V30, P52, DOI 10.1097/INF.0b013e3181ed2af3; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bartlett JA, 2012, AIDS, V26, P1345, DOI 10.1097/QAD.0b013e328353b066; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cohen C, 2009, HIV CLIN TRIALS, V10, P116, DOI 10.1310/hct1002-116; Deeks SG, 2002, AIDS, V16, P201, DOI 10.1097/00002030-200201250-00009; DHHS, 2011, GUID US ANT AG HIV 1; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; Fox MP, 2010, JAIDS-J ACQ IMM DEF, V53, P500, DOI 10.1097/QAI.0b013e3181bcdac1; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Harries AD, 2010, LANCET INFECT DIS, V10, P60, DOI 10.1016/S1473-3099(09)70321-4; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Keiser O, 2011, AIDS, V25, P1761, DOI 10.1097/QAD.0b013e328349822f; Levison JH, 2011, ANTIVIR THER, V16, P853, DOI 10.3851/IMP1819; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; National Department of Health South Africa, 2021, 2019 NAT ANT HIV SEN; Palombi L, 2009, CLIN INFECT DIS, V48, P115, DOI 10.1086/593312; Pujades-Rodriguez M, 2010, JAMA-J AM MED ASSOC, V304, P303, DOI 10.1001/jama.2010.980; Reynolds SJ, 2009, AIDS, V23, P697, DOI 10.1097/QAD.0b013e3283262a78; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; van Zyl GU, 2011, JAIDS-J ACQ IMM DEF, V56, P333, DOI 10.1097/QAI.0b013e31820dc0cc; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; WHO, 2010, ANT THER HIV INF AD; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	32	31	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58526	10.1371/journal.pone.0058526	http://dx.doi.org/10.1371/journal.pone.0058526			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505529	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100060
J	Bonnet, N; Lesclous, P; Saffar, JL; Ferrari, S				Bonnet, Nicolas; Lesclous, Philippe; Saffar, Jean Louis; Ferrari, Serge			Zoledronate Effects on Systemic and Jaw Osteopenias in Ovariectomized Periostin-Deficient Mice	PLOS ONE			English	Article							BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; ALVEOLAR BONE-RESORPTION; PLACEBO-CONTROLLED TRIAL; EXPERIMENTAL PERIODONTITIS; POSTMENOPAUSAL WOMEN; PREVENTIVE MEASURES; CANCER-PATIENTS; IN-VIVO; DISEASE; RATS	Osteoporosis and periodontal disease (PD) are frequently associated in the elderly, both concurring to the loss of jaw alveolar bone and finally of teeth. Bisphosphonates improve alveolar bone loss but have also been associated with osteonecrosis of the jaw (ONJ), particularly using oncological doses of zoledronate. The effects and therapeutic margin of zoledronate on jaw bone therefore remain uncertain. We reappraised the efficacy and safety of Zoledronate (Zol) in ovariectomized (OVX) periostin (Postn)-deficient mice, a unique genetic model of systemic and jaw osteopenia. Compared to vehicle, Zol 1M (100 mu g/kg/month) and Zol 1W (100 mu g/kg/week) for 3 months both significantly improved femur BMD, trabecular bone volume on tissue volume (BV/TV) and cortical bone volume in both OVX Postn(+/+) and Postn(-/-) (all p<0.01). Zol 1M and Zol 1W also improved jaw alveolar and basal BV/TV, although the highest dose (Zol 1W) was less efficient, particularly in Postn(-/-). Zol decreased osteoclast number and bone formation indices, i.e. MAR, MPm/BPm and BFR, independently in Postn(-/-) and Postn(+/+), both in the long bones and in deep jaw alveolar bone, without differences between Zol doses. Zol 1M and Zol 1W did not reactivate inflammation nor increase fibrous tissue in the bone marrow of the jaw, whereas the distance between the root and the enamel of the incisor (DRI) remained high in Postn(-/-) vs Postn(+/+) confirming latent inflammation and lack of crestal alveolar bone. Zol 1W and Zol 1M decreased osteocyte numbers in Postn(-/-) and Postn(+/+) mandible, and Zol 1W increased the number of empty lacunae in Postn(-/-), however no areas of necrotic bone were observed. These results demonstrate that zoledronate improves jaw osteopenia and suggest that in Postn(-/-) mice, zoledronate is not sufficient to induce bone necrosis.	[Bonnet, Nicolas; Ferrari, Serge] Univ Hosp Geneva, Dept Internal Med Specialties, Div Bone Dis, Geneva, Switzerland; [Lesclous, Philippe; Saffar, Jean Louis] Univ Paris 05, Fac Chirurg Dent, Lab Pathol Imagerie & Biotherapie Organe Dent EA, Paris, France; [Lesclous, Philippe] LUNAM Univ, STEP Skeletal Tissue Engn & Physiopathol Grp, Hotel Dieu Hosp,Univ Nantes,Sch Dent, INSERM UMRS 791,LIOAD Lab Ingn Osteoarticulaire &, Nantes, France	University of Geneva; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Bonnet, N (corresponding author), Univ Hosp Geneva, Dept Internal Med Specialties, Div Bone Dis, Geneva, Switzerland.	nicolas.bonnet@unige.ch	Ferrari, Serge/ABD-2730-2020; Lesclous, Philippe/P-6255-2014	Ferrari, Serge/0000-0002-1372-4417; lesclous, Philippe/0000-0002-9840-4542; Bonnet, Nicolas/0000-0001-9832-5767; Saffar, Jean-Louis/0000-0001-6288-9325	Swiss National Science Foundation [3100A0-116633/1, EC 201099-TALOS]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	These studies were supported by a Swiss National Science Foundation grant No. 3100A0-116633/1 and EC 201099-TALOS (to S. F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahi J, 2012, J ORAL PATH IN PRESS; Aghaloo TL, 2011, J BONE MINER RES, V26, P1871, DOI 10.1002/jbmr.379; Aguirre JI, 2012, J BONE MINE IN PRESS; Albandar JM, 1999, J PERIODONTOL, V70, P30, DOI 10.1902/jop.1999.70.1.30; Alencar VBM, 2002, J PERIODONTOL, V73, P251, DOI 10.1902/jop.2002.73.3.251; Allen MR, 2011, OSTEOPOROSIS INT, V22, P693, DOI 10.1007/s00198-010-1268-4; Allen MR, 2011, IBMS BONEKEY, V8, P141; Bauss F, 2008, J BONE MINER METAB, V26, P406, DOI 10.1007/s00774-007-0837-x; Bilezikian JP, 2006, NEW ENGL J MED, V355, P2278, DOI 10.1056/NEJMp068157; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; CHAPPARD D, 1987, ACTA HISTOCHEM, V81, P183, DOI 10.1016/S0065-1281(87)80012-0; Contie S, 2010, CALCIFIED TISSUE INT, V87, P341, DOI 10.1007/s00223-010-9391-y; Cornish J, 2011, BONE, V49, P710, DOI 10.1016/j.bone.2011.07.020; Cremers S, 2011, BONE, V49, P42, DOI 10.1016/j.bone.2011.01.014; Dimopoulos MA, 2009, ANN ONCOL, V20, P117, DOI 10.1093/annonc/mdn554; Duarte PM, 2004, J PERIODONTOL, V75, P1196, DOI 10.1902/jop.2004.75.9.1196; El-Shinnawi Una M, 2003, J Int Acad Periodontol, V5, P5; Gasser JA, 2008, J BONE MINER RES, V23, P544, DOI 10.1359/JBMR.071207; GOTCHER JE, 1981, J PERIODONTAL RES, V16, P275, DOI 10.1111/j.1600-0765.1981.tb00976.x; Hansen T, 2006, J ORAL PATHOL MED, V35, P155, DOI 10.1111/j.1600-0714.2006.00391.x; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hoff AO, 2008, J BONE MINER RES, V23, P826, DOI [10.1359/jbmr.080205, 10.1359/JBMR.080205]; Huja SS, 2009, ARCH ORAL BIOL, V54, P851, DOI 10.1016/j.archoralbio.2009.06.002; Iida-Klein A, 2003, J CLIN DENSITOM, V6, P25, DOI 10.1385/JCD:6:1:25; Jeffcoat Marjorie K, 2007, J Int Acad Periodontol, V9, P70; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Koduganti Rekha Rani, 2009, J Indian Soc Periodontol, V13, P90, DOI 10.4103/0972-124X.55841; Lane N, 2005, J PERIODONTOL, V76, P1113, DOI 10.1902/jop.2005.76.7.1113; LASFARGUES JJ, 1993, ANAT REC, V237, P458, DOI 10.1002/ar.1092370404; LEONARD EP, 1979, ARCH ORAL BIOL, V24, P707, DOI 10.1016/0003-9969(79)90122-5; Lerner UH, 2006, J DENT RES, V85, P596, DOI 10.1177/154405910608500704; Lesclous P, 2009, BONE, V45, P843, DOI 10.1016/j.bone.2009.07.011; Ma DD, 2009, IN VITRO CELL DEV-AN, V45, P467, DOI 10.1007/s11626-009-9214-5; Masarachia P, 1996, BONE, V19, P281, DOI 10.1016/8756-3282(96)00182-2; Mavropoulos A, 2007, J BONE MINER RES, V22, P403, DOI 10.1359/JBMR.061208; MCMILLAN PJ, 1989, CALCIFIED TISSUE INT, V44, P399, DOI 10.1007/BF02555968; Merle B, 2012, OSTEOPOROS IN PRESS; Mitsuta T, 2002, J PERIODONTOL, V73, P479, DOI 10.1902/jop.2002.73.5.479; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ouyang GL, 2009, CANCER LETT, V281, P213, DOI 10.1016/j.canlet.2009.02.030; Padial-Molina M, 2012, J DENT RES IN PRESS; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rani S, 2009, BONE, V44, P502, DOI 10.1016/j.bone.2008.11.012; Ravosa MJ, 2011, ARCH ORAL BIOL, V56, P491, DOI 10.1016/j.archoralbio.2010.11.003; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Ripamonti CI, 2009, ANN ONCOL, V20, P137, DOI 10.1093/annonc/mdn526; Rizzoli R, 2008, BONE, V42, P841, DOI 10.1016/j.bone.2008.01.003; Rocha M, 2001, J PERIODONTOL, V72, P204, DOI 10.1902/jop.2001.72.2.204; Rocha ML, 2004, J PERIODONTOL, V75, P1579, DOI 10.1902/jop.2004.75.12.1579; Roelofs AJ, 2010, J BONE MINER RES, V25, P606, DOI 10.1359/jbmr.091009; Russell RGG, 2008, OSTEOPOROSIS INT, V19, P733, DOI 10.1007/s00198-007-0540-8; Scheper MA, 2009, BRIT J HAEMATOL, V144, P667, DOI 10.1111/j.1365-2141.2008.07504.x; Sheng ZF, 2009, OSTEOPOROSIS INT, V20, P151, DOI 10.1007/s00198-008-0640-0; SHOJI K, 1995, J PERIODONTAL RES, V30, P277, DOI 10.1111/j.1600-0765.1995.tb02134.x; Sonis ST, 2009, ORAL ONCOL, V45, P164, DOI 10.1016/j.oraloncology.2008.04.013; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Tani-Ishii N, 2003, J PERIODONTOL, V74, P603, DOI 10.1902/jop.2003.74.5.603; Tezal M, 2005, J PERIODONTOL, V76, P1123, DOI 10.1902/jop.2005.76.7.1123; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Van Poznak CH, 2011, J ONCOL PRACT, V7, P117, DOI 10.1200/JOP.2011.000212; Wactawski-Wende J, 2001, Ann Periodontol, V6, P197, DOI 10.1902/annals.2001.6.1.197; WactawskiWende J, 1996, J PERIODONTOL, V67, P1076, DOI 10.1902/jop.1996.67.10s.1076; WEINREB M, 1994, J PERIODONTAL RES, V29, P35, DOI 10.1111/j.1600-0765.1994.tb01088.x; Weiss HM, 2008, DRUG METAB DISPOS, V36, P2043, DOI 10.1124/dmd.108.021071; Yu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031771; 2006, J AM DENT ASS, V137, P1144	71	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58726	10.1371/journal.pone.0058726	http://dx.doi.org/10.1371/journal.pone.0058726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505553	gold, Green Submitted, Green Published			2022-12-27	WOS:000318334500118
J	Gorzelak, P; Salamon, MA; Trzesiok, D; Niedzwiedzki, R				Gorzelak, Przemyslaw; Salamon, Mariusz A.; Trzesiok, Dawid; Niedzwiedzki, Robert			Drill Holes and Predation Traces versus Abrasion-Induced Artifacts Revealed by Tumbling Experiments	PLOS ONE			English	Article							BOREHOLES; SHELLS; BRACHIOPODS; COMPETITION; INTENSITY; PATTERNS; PLIOCENE; BORINGS; RECORD; SNAILS	Drill holes made by predators in prey shells are widely considered to be the most unambiguous bodies of evidence of predator-prey interactions in the fossil record. However, recognition of traces of predatory origin from those formed by abiotic factors still waits for a rigorous evaluation as a prerequisite to ascertain predation intensity through geologic time and to test macroevolutionary patterns. New experimental data from tumbling various extant shells demonstrate that abrasion may leave holes strongly resembling the traces produced by drilling predators. They typically represent singular, circular to oval penetrations perpendicular to the shell surface. These data provide an alternative explanation to the drilling predation hypothesis for the origin of holes recorded in fossil shells. Although various non-morphological criteria (evaluation of holes for non-random distribution) and morphometric studies (quantification of the drill hole shape) have been employed to separate biological from abiotic traces, these are probably insufficient to exclude abrasion artifacts, consequently leading to overestimate predation intensity. As a result, from now on, we must adopt more rigorous criteria to appropriately distinguish abrasion artifacts from drill holes, such as microstructural identification of micro-rasping traces.	[Gorzelak, Przemyslaw] Polish Acad Sci, Inst Paleobiol, Dept Biogeol, Warsaw, Poland; [Salamon, Mariusz A.; Trzesiok, Dawid] Univ Silesia, Fac Earth Sci, Dept Palaeontol & Biostratig, Sosnowiec, Poland; [Niedzwiedzki, Robert] Univ Wroclaw, Inst Geol Sci, PL-50138 Wroclaw, Poland	Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; University of Silesia in Katowice; University of Wroclaw	Gorzelak, P (corresponding author), Polish Acad Sci, Inst Paleobiol, Dept Biogeol, Warsaw, Poland.	pgorzelak@twarda.pan.pl	Gorzelak, Przemyslaw/B-6329-2015	Gorzelak, Przemyslaw/0000-0001-5706-1881; Salamon, Mariusz/0000-0001-9399-2798; Niedzwiedzki, Robert/0000-0002-6222-3977	National Science Centre [UMO-2011/01/B/ST10/02639]	National Science Centre(National Science Centre, Poland)	This work was partly supported by National Science Centre grant no. UMO-2011/01/B/ST10/02639. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baumiller TK, 1996, PALAEOGEOGR PALAEOCL, V123, P343, DOI 10.1016/0031-0182(95)00124-7; Baumiller TK, 2006, LETHAIA, V39, P313, DOI 10.1080/00241160600847546; Baumiller TK, 2010, P NATL ACAD SCI USA, V107, P5893, DOI 10.1073/pnas.0914199107; Chave K. E., 1964, P377; Cintra-Buenrostro CE, 2007, J SHELLFISH RES, V26, P221, DOI 10.2983/0730-8000(2007)26[221:TPANMA]2.0.CO;2; Cintra-Buenrostro CE, 2005, PALAIOS, V20, P296, DOI 10.2110/palo-2004.p04-21; Dietl GP, 2004, SCIENCE, V306, P2229, DOI 10.1126/science.1106182; Dietl Gregory P., 2006, Ichnos, V13, P103, DOI 10.1080/10420940600848889; DRISCOLL EG, 1967, J SEDIMENT PETROL, V37, P1117; Gorzelak P, 2012, P NATL ACAD SCI USA, V109, P7004, DOI 10.1073/pnas.1201573109; Grey M, 2005, J MOLLUS STUD, V71, P253, DOI 10.1093/mollus/eyi035; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harper EM, 2005, PALAEONTOLOGY, V48, P197, DOI 10.1111/j.1475-4983.2004.00433.x; Hoffmeister AP, 2003, LETHAIA, V36, P107, DOI 10.1080/00241160310000408; Huntley JW, 2007, P NATL ACAD SCI USA, V104, P15006, DOI 10.1073/pnas.0704960104; Kaplan P, 2001, PALAIOS, V16, P525, DOI 10.2307/3515567; KELLEY P H, 1988, Palaios, V3, P436, DOI 10.2307/3514789; Kelley PH, 2006, PALAEOGEOGR PALAEOCL, V236, P302, DOI 10.1016/j.palaeo.2005.11.012; KITCHELL JA, 1981, PALEOBIOLOGY, V7, P533, DOI 10.1017/S0094837300025574; Kowalewski M, 2005, SCIENCE, V308, P1774, DOI 10.1126/science.1113408; KOWALEWSKI M, 1993, PALAEOGEOGR PALAEOCL, V102, P69, DOI 10.1016/0031-0182(93)90006-5; Kowalewski M, 2000, J PALEONTOL, V74, P532, DOI 10.1666/0022-3360(2000)074<0532:DHISOP>2.0.CO;2; Kowalewski M, 1998, GEOLOGY, V26, P1091, DOI 10.1130/0091-7613(1998)026<1091:AFRFOH>2.3.CO;2; Kowalewski M., 2002, PALEONTOLOGICAL SOC; KUENEN PH, 1956, J GEOL, V64, P336, DOI 10.1086/626370; Leighton LR, 2003, PALAEOGEOGR PALAEOCL, V210, P221, DOI 10.1016/S0031-0182(03)00627-8; Leighton LR, 2002, PALEOBIOLOGY, V28, P328, DOI 10.1666/0094-8373(2002)028<0328:IPIITM>2.0.CO;2; Leighton LR, 2001, PALAEOGEOGR PALAEOCL, V165, P53, DOI 10.1016/S0031-0182(00)00153-X; LESCINSKY HL, 1994, PALAIOS, V9, P599, DOI 10.2307/3515130; Oji T, 2003, PALEOBIOLOGY, V29, P520, DOI 10.1666/0094-8373(2003)029<0520:IOSPRI>2.0.CO;2; RICHARDS R P, 1969, Journal of Paleontology, V43, P838; Schiffbauer JD, 2008, PALAIOS, V23, P810, DOI 10.2110/palo.2008.p08-045r; SHEEHAN PM, 1978, J PALEONTOL, V52, P812; Stanley SM, 2008, PALEOBIOLOGY, V34, P1, DOI 10.1666/07026.1; Tyler CL, 2012, PALAIOS, V27, P659, DOI 10.2110/palo.2012.p12-014r; Urrutia GX, 2001, J EXP MAR BIOL ECOL, V258, P141, DOI 10.1016/S0022-0981(00)00349-X; VERMEIJ G J, 1977, Paleobiology, V3, P245; Vermeij G.J, 1987, EVOLUTION ESCALATION; Villier L, 2008, NEUES JAHRB GEOL P-A, V247, P147, DOI 10.1127/0077-7749/2008/0247-0147; Walker Sally E., 2007, P324, DOI 10.1016/B978-044452949-7/50144-3; Wilson MA, 2001, PALAIOS, V16, P524, DOI 10.2307/3515566	41	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58528	10.1371/journal.pone.0058528	http://dx.doi.org/10.1371/journal.pone.0058528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505530	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500098
J	Hambarde, S; Singh, V; Chandna, S				Hambarde, Shashank; Singh, Vijaypal; Chandna, Sudhir			Evidence for Involvement of Cytosolic Thioredoxin Peroxidase in the Excessive Resistance of Sf9 Lepidopteran Insect Cells against Radiation-Induced Apoptosis	PLOS ONE			English	Article							ALKYL HYDROPEROXIDE REDUCTASE; PEROXIREDOXIN-I EXPRESSION; CYCLIN-DEPENDENT KINASES; 2-CYS PEROXIREDOXIN; UP-REGULATION; NITRIC-OXIDE; DROSOPHILA; PROTEIN; RADIOSENSITIVITY; PHOSPHORYLATION	Lepidopteran insect cells display 50-100 times higher radioresistance compared to human cells, and reportedly have more efficient antioxidant system that can significantly reduce radiation-induced oxidative stress and cell death. However, the antioxidant mechanisms that contribute substantially to this excessive resistance still need to be understood thoroughly. In this study, we investigated the role of thioredoxin peroxidase (TPx) in high-dose gamma-radiation response of Sf9 cell line derived from Spodoptera frugiperda, the Fall armyworm. We identified a TPx orthologue (Sf-TPx) in Spodoptera system, with primarily cytosolic localization. Gamma-irradiation at 500 Gy dose significantly up-regulated Sf-TPx, while higher doses (1000 Gy-2000 Gy) had no such effect. G2/M checkpoint induced following 500 Gy was associated with transition of Sf-TPx decamer into enzymatically active dimer. Same effect was observed during G2/M block induced by 5 nM okadaic acid or 10 mu M CDK1 (cycline dependent kinase-1) inhibitor roscovitine, thus indicating that radiation-induced Sf-TPx activity is mediated by CDKs. Accumulation of TPx dimer form during G2/M checkpoint might favour higher peroxidase activity facilitating efficient survival at this dose. Confirming this, higher lethal doses (1000 Gy-2000 Gy) caused significantly less accumulation of dimer form and induced dose-dependent apoptosis. A similar to 50% knock-down of Sf-TPx by siRNA caused remarkable increase in radiation-induced ROS as well as caspase-3 dependent radiation-induced apoptosis, clearly implying TPx role in the radioresistance of Sf9 cells. Quite importantly, our study demonstrates for the first time that thioredoxin peroxidase contributes significantly in the radioresistance of Lepidopteran Sf9 insect cells, especially in their exemplary resistance against radiation-induced apoptosis. This is an important insight into the antioxidant mechanisms existing in this highly stress-resistant model cell system.	[Hambarde, Shashank; Singh, Vijaypal; Chandna, Sudhir] Inst Nucl Med & Allied Sci, Div Radiat Biosci, Nat Radiat Response Mech Grp, Delhi, India	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS)	Chandna, S (corresponding author), Inst Nucl Med & Allied Sci, Div Radiat Biosci, Nat Radiat Response Mech Grp, Delhi, India.	sudhirchandna@yahoo.com		Chandna, Sudhir/0000-0001-8210-5786	DRDO grant [INM-311.1.5]; Ministry of Defence, Government of India	DRDO grant; Ministry of Defence, Government of India	The present study was carried out as a part of DRDO grant no. INM-311.1.5 funded by Ministry of Defence, Government of India. SH is thankful to DRDO for providing a research fellowship during the course of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Cha MK, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-93; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Chandna S, 2004, INT J RADIAT BIOL, V80, P301, DOI [10.1080/09553000440001679794, 10.1080/09553000410001679794]; Chandna S, 2009, MUTAGENESIS, V24, P259; Chandna S, 2010, MUTAGENESIS, V25, P431, DOI 10.1093/mutage/geq022; Chang JW, 2001, BIOCHEM BIOPH RES CO, V289, P507, DOI 10.1006/bbrc.2001.5989; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Chen L, 1998, MOL CELL, V1, P795, DOI 10.1016/S1097-2765(00)80079-9; Chen MF, 2006, INT J RADIAT ONCOL, V64, P581, DOI 10.1016/j.ijrobp.2005.10.012; Chung YM, 2001, ANTICANCER RES, V21, P1129; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Demasi APD, 2009, J ORAL PATHOL MED, V38, P514, DOI 10.1111/j.1600-0714.2009.00753.x; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; EVANS HJ, 1962, INT REV CYTOL, V13, P221; Hambarde S, 2010, BIOINFORMATION, V4, P399, DOI 10.6026/97320630004399; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; KIM IH, 1989, P NATL ACAD SCI USA, V86, P6018, DOI 10.1073/pnas.86.16.6018; KIM KW, 1988, J BIOL CHEM, V263, P4704; Kinnula VL, 2002, J PATHOL, V196, P316, DOI 10.1002/path.1042; KOVAL TM, 1983, RADIAT RES, V96, P118, DOI 10.2307/3576171; Kumar JS, 2012, MOL CELL BIOCH; Kumarswamy R, 2009, INT J BIOCHEM CELL B, V41, P1430, DOI 10.1016/j.biocel.2008.12.009; Lee K, 2002, BIOCHEM BIOPH RES CO, V296, P337, DOI 10.1016/S0006-291X(02)00801-X; Lu ZJ, 2008, NUCLEIC ACIDS RES, V36, pW104, DOI 10.1093/nar/gkn250; Mathews DH, 2010, METHODS MOL BIOL, V629, P107, DOI 10.1007/978-1-60761-657-3_8; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Missirlis F, 2002, J BIOL CHEM, V277, P11521, DOI 10.1074/jbc.M111692200; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Oberley TD, 2001, FREE RADICAL BIO MED, V30, P412, DOI 10.1016/S0891-5849(00)00486-X; Park JJ, 2009, INT J RADIAT ONCOL, V73, P1196, DOI 10.1016/j.ijrobp.2008.10.070; Park SH, 2000, CLIN CANCER RES, V6, P4915; Radyuk SN, 2003, BIOCHEM J, V371, P743, DOI 10.1042/BJ20021522; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; Reinartz M, 2008, J BIOL CHEM, V283, P17440, DOI 10.1074/jbc.M800126200; Suman S, 2011, INT J BIOCH CELL BIO; Suman S, 2007, FREE RADICAL BIO MED, V43, pS133; Suman S, 2009, BIOINFORMATION, V4, P19, DOI 10.6026/97320630004019; Suman S, 2008, BIOINFORMATION, V3, P8, DOI 10.6026/97320630003008; Suman S, 2009, INT J RADIAT BIOL, V85, P238, DOI 10.1080/09553000902748591; Tsuda M, 2010, FEBS LETT, V584, P3398, DOI 10.1016/j.febslet.2010.06.034; VANMAANEN JMS, 1988, J NATL CANCER I, V80, P1526, DOI 10.1093/jnci/80.19.1526; VESELY J, 1994, EUR J BIOCHEM, V224, P771, DOI 10.1111/j.1432-1033.1994.00771.x; Wang Y, 2001, FREE RADICAL BIO MED, V30, P1254, DOI 10.1016/S0891-5849(01)00520-2; Wolf G, 2010, J ENDOCRINOL, V207, P163, DOI 10.1677/JOE-09-0455; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanagawa T, 2000, CANCER LETT, V156, P27, DOI 10.1016/S0304-3835(00)00434-1; Zhang B, 2008, BIOCHEM PHARMACOL, V75, P660, DOI 10.1016/j.bcp.2007.09.016	55	12	14	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58261	10.1371/journal.pone.0058261	http://dx.doi.org/10.1371/journal.pone.0058261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505474	gold, Green Submitted, Green Published			2022-12-27	WOS:000318334500061
J	Storm, P; Klausen, TK; Trulsson, M; Ho, CSJ; Dosnon, M; Westergren, T; Chao, YX; Rydstrom, A; Yang, H; Pedersen, SF; Svanborg, C				Storm, Petter; Klausen, Thomas Kjaer; Trulsson, Maria; Ho, James C. S.; Dosnon, Marion; Westergren, Tomas; Chao, Yinxia; Rydstroem, Anna; Yang, Henry; Pedersen, Stine Falsig; Svanborg, Catharina			A Unifying Mechanism for Cancer Cell Death through Ion Channel Activation by HAMLET	PLOS ONE			English	Article							HUMAN ALPHA-LACTALBUMIN; APOPTOSIS-LIKE MECHANISM; TUMOR-CELLS; OLEIC-ACID; VOLUME REGULATION; CATION CHANNELS; TRP CHANNELS; MAP KINASE; PROTEIN; LETHAL	Ion channels and ion fluxes control many aspects of tissue homeostasis. During oncogenic transformation, critical ion channel functions may be perturbed but conserved tumor specific ion fluxes remain to be defined. Here we used the tumoricidal protein-lipid complex HAMLET as a probe to identify ion fluxes involved in tumor cell death. We show that HAMLET activates a non-selective cation current, which reached a magnitude of 2.74 +/- 0.88 nA within 1.43 +/- 0.13 min from HAMLET application. Rapid ion fluxes were essential for HAMLET-induced carcinoma cell death as inhibitors (amiloride, BaCl2), preventing the changes in free cellular Na+ and K+ concentrations also prevented essential steps accompanying carcinoma cell death, including changes in morphology, uptake, global transcription, and MAP kinase activation. Through global transcriptional analysis and phosphorylation arrays, a strong ion flux dependent p38 MAPK response was detected and inhibition of p38 signaling delayed HAMLET-induced death. Healthy, differentiated cells were resistant to HAMLET challenge, which was accompanied by innate immunity rather than p38-activation. The results suggest, for the first time, a unifying mechanism for the initiation of HAMLET's broad and rapid lethal effect on tumor cells. These findings are particularly significant in view of HAMLET's documented therapeutic efficacy in human studies and animal models. The results also suggest that HAMLET offers a two-tiered therapeutic approach, killing cancer cells while stimulating an innate immune response in surrounding healthy tissues.	[Storm, Petter; Trulsson, Maria; Ho, James C. S.; Dosnon, Marion; Westergren, Tomas; Rydstroem, Anna; Svanborg, Catharina] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden; [Klausen, Thomas Kjaer; Pedersen, Stine Falsig] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Chao, Yinxia; Yang, Henry] ASTAR, Singapore Immunol Network, Singapore, Singapore	Lund University; University of Copenhagen; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Svanborg, C (corresponding author), Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden.	catharina.svanborg@med.lu.se	Pedersen, Stine Falsig/O-1133-2019; Ho, James CS/ADQ-2735-2022; Ho, James CS/AAF-8197-2022; Pedersen, Stine Falsig/M-8347-2014	Pedersen, Stine Falsig/0000-0002-3044-7714; Ho, James CS/0000-0002-6131-1297; Ho, James CS/0000-0002-6131-1297; Pedersen, Stine Falsig/0000-0002-3044-7714; Storm, Petter/0000-0002-7655-3731; Chao, Yinxia/0000-0003-1185-3511; Rydstrom, Anna/0000-0002-3404-7195	Sharon D. Lund foundation; American Cancer Society; Swedish Cancer Society; Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation; Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; H. J. Forssman Foundation for Medical Research; Royal Physiographic Society; Danish Council for Independent Research (Medical sciences)	Sharon D. Lund foundation; American Cancer Society(American Cancer Society); Swedish Cancer Society(Swedish Cancer Society); Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; H. J. Forssman Foundation for Medical Research; Royal Physiographic Society; Danish Council for Independent Research (Medical sciences)(Det Frie Forskningsrad (DFF))	This study was supported by the Sharon D. Lund foundation grant and the American Cancer Society, the Swedish Cancer Society, the Medical Faculty (Lund University), the Soderberg Foundation, the Segerfalk Foundation, the Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research, the Knut and Alice Wallenberg Foundation, the Lund City Jubileumsfond, the John and Augusta Persson Foundation for Medical Research, the Maggie Stephens Foundation, the Gunnar Nilsson Cancer Foundation, the Inga-Britt and Arne Lundberg Foundation, the H. J. Forssman Foundation for Medical Research and the Royal Physiographic Society. Support was also obtained from the Danish Council for Independent Research (Medical sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; Ajiro K, 2008, EXP CELL RES, V314, P1237, DOI 10.1016/j.yexcr.2007.12.028; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Arcangeli A, 2011, AM J PHYSIOL-CELL PH, V301, pC762, DOI 10.1152/ajpcell.00113.2011; BARBIERO G, 1995, EXP CELL RES, V217, P410, DOI 10.1006/excr.1995.1104; Baumann A, 2012, J MOL BIOL; Beacham DW, 2010, J BIOMOL SCREEN, V15, P441, DOI 10.1177/1087057109359807; BLEASDALE JE, 1989, ADV PROSTAG THROMB L, V19, P590; Boriek AM, 2008, REGULATION INTRACELL; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Campbell J, 2004, J IMMUNOL, V173, P6928, DOI 10.4049/jimmunol.173.11.6928; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; Drosopoulos K, 2007, EXPERT OPIN THER TAR, V11, P641, DOI 10.1517/14728222.11.5.641; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hallgren O, 2006, APOPTOSIS, V11, P221, DOI 10.1007/s10495-006-3607-7; Hallgren O, 2008, ADV EXP MED BIOL, V606, P217, DOI 10.1007/978-0-387-74087-4_8; Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Karpman D, 1998, INFECT IMMUN, V66, P636, DOI 10.1128/IAI.66.2.636-644.1998; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kukkonen JP, 2011, CELL CALCIUM, V50, P9, DOI 10.1016/j.ceca.2011.04.005; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; Permyakov SE, 2011, BIOL CHEM; Poulsen KA, 2010, AM J PHYSIOL-CELL PH, V298, pC14, DOI 10.1152/ajpcell.00654.2008; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; Spolaore B, 2010, BIOCHEMISTRY-US, V49, P8658, DOI 10.1021/bi1012832; Storm P, 2011, ONCOGENE; Strober W., 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima03bs21, DOI 10.1002/0471142735.IMA03BS111]; Stuhmer W, 2010, FUTURE MED CHEM, V2, P745, DOI [10.4155/fmc.10.24, 10.4155/FMC.10.24]; Svanborg C, 2003, ADV CANCER RES, V88, P1; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Verkhratsky A, 2003, J CELL MOL MED, V7, P351, DOI 10.1111/j.1582-4934.2003.tb00238.x; Wilhelm K, 2009, FEBS J, V276, P3975, DOI 10.1111/j.1742-4658.2009.07107.x; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu W, 1999, J MEMBRANE BIOL, V171, P117, DOI 10.1007/s002329900564; Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus; Zhang H, 2001, J BIOL CHEM, V276, P6905, DOI 10.1074/jbc.C000917200	58	24	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58578	10.1371/journal.pone.0058578	http://dx.doi.org/10.1371/journal.pone.0058578			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505537	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500102
J	Walton, MB; Cowderoy, E; Lascelles, D; Innes, JF				Walton, Myles Benjamin; Cowderoy, Emily; Lascelles, Duncan; Innes, John F.			Evaluation of Construct and Criterion Validity for the 'Liverpool Osteoarthritis in Dogs' (LOAD) Clinical Metrology Instrument and Comparison to Two Other Instruments	PLOS ONE			English	Article							GROUND REACTION FORCES; CHRONIC PAIN; DETECT RESPONSE; ACCELEROMETER; QUESTIONNAIRE; COEFFICIENT; OWNERS	Objective: To test the 'Liverpool Osteoarthritis in Dogs' (LOAD) questionnaire for construct and criterion validity, and to similarly test the Helsinki Chronic Pain Index (HCPI) and the Canine Brief Pain Inventory (CBPI). Design: Prospective Study. Animals: 222 dogs with osteoarthritis. Procedure: Osteoarthritis was diagnosed in a cohort of dogs on the basis of clinical history and orthopedic examination. Force-platform analysis was performed and a "symmetry index'' for peak vertical force (PVF) was calculated. Owners completed LOAD, CBPI and HCPI instruments. As a test of construct validity, inter-instrument correlations were calculated. As a test of criterion validity, the correlations between instrument scores and PVF symmetry scores were calculated. Additionally, internal consistency of all instruments was calculated and compared to those previously reported. Factor analysis is reported for the first time for LOAD, and is compared to that previously reported for CBPI and HCPI. Results: Significant moderate correlations were found between all instruments, implying construct validity for all instruments. Significant weak correlations were found between LOAD scores and PVF symmetry index, and between CBPI scores and PVF symmetry index. Conclusion and Clinical Relevance: LOAD is an owner-completed clinical metrology instrument that can be recommended for the measurement of canine osteoarthritis. It is convenient to use, validated and, as demonstrated here for the first time, has a correlation with force-platform data.	[Walton, Myles Benjamin; Cowderoy, Emily; Innes, John F.] Univ Liverpool, Dept Musculoskeletal Biol, Wirral L64 7TE, Merseyside, England; [Walton, Myles Benjamin; Cowderoy, Emily; Innes, John F.] Univ Liverpool, Sch Vet Sci, Wirral L64 7TE, Merseyside, England; [Lascelles, Duncan] N Carolina State Univ, Comparat Pain Res Lab, Raleigh, NC 27695 USA; [Lascelles, Duncan] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Lascelles, Duncan] N Carolina State Univ, Coll Vet Med, Raleigh, NC USA	University of Liverpool; University of Liverpool; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Innes, JF (corresponding author), Univ Liverpool, Dept Musculoskeletal Biol, Wirral L64 7TE, Merseyside, England.	j.f.innes@liv.ac.uk	Innes, John/ABI-6553-2020	Innes, John/0000-0003-2758-3851; Lascelles, B. Duncan X./0000-0002-2950-9009	Pfizer Animal Health; University of Liverpool	Pfizer Animal Health; University of Liverpool	Salary for MBW and EC was funded by Pfizer Animal Health during the data collection phase of this study. Remaining funding was provided by University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Bellamy N, 1991, MUSCULOSKELETAL CLIN; Brown DC, 2008, JAVMA-J AM VET MED A, V233, P1278, DOI 10.2460/javma.233.8.1278; Brown DC, 2007, AM J VET RES, V68, P631, DOI 10.2460/ajvr.68.6.631; Brown DC, 2010, JAVMA-J AM VET MED A, V237, P66, DOI 10.2460/javma.237.1.66; Brown DC, 2010, AM J VET RES, V71, P322, DOI 10.2460/ajvr.71.3.322; Budsberg SC, 2001, AM J VET RES, V62, P1207, DOI 10.2460/ajvr.2001.62.1207; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dow C, 2009, AM J VET RES, V70, P444, DOI 10.2460/ajvr.70.4.444; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Frost MH, 2007, VALUE HEALTH, V10, pS94, DOI 10.1111/j.1524-4733.2007.00272.x; GUILFORD JP, 1948, PSYCHOL REV, V55, P79, DOI 10.1037/h0056564; Hansen BD, 2007, AM J VET RES, V68, P468, DOI 10.2460/ajvr.68.5.468; Hercock CA, 2009, J SMALL ANIM PRACT, V50, P266, DOI 10.1111/j.1748-5827.2009.00765.x; Hielm-Bjorkman AK, 2003, J AM VET MED ASSOC, V222, P1552, DOI 10.2460/javma.2003.222.1552; Hielm-Bjorkman AK, 2009, AM J VET RES, V70, P727, DOI 10.2460/ajvr.70.6.727; Hudson JT, 2004, AM J VET RES, V65, P1634, DOI 10.2460/ajvr.2004.65.1634; Innes JF, 1998, J SMALL ANIM PRACT, V39, P373, DOI 10.1111/j.1748-5827.1998.tb03735.x; Innes JF, 2003, VET REC, V152, P457, DOI 10.1136/vr.152.15.457; Johnston SA, 1997, VET CLIN N AM-SMALL, V27, P699, DOI 10.1016/S0195-5616(97)50076-3; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; McCrory JL, 2001, GAIT POSTURE, V14, P104, DOI 10.1016/S0966-6362(01)00140-0; Michel KE, 2011, AM J VET RES, V72, P866, DOI 10.2460/ajvr.72.7.866; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Preston T, 2012, RES VET SCI, V93, P412, DOI 10.1016/j.rvsc.2011.08.005; Schmidt J, 2005, US TODAY; VASSEUR PB, 1995, J AM VET MED ASSOC, V206, P807; Waxman AS, 2008, VET SURG, V37, P241, DOI 10.1111/j.1532-950X.2008.00372.x; Wernham BGJ, 2011, J VET INTERN MED, V25, P1298, DOI 10.1111/j.1939-1676.2011.00825.x; Wiseman ML, 2001, VET REC, V149, P423, DOI 10.1136/vr.149.14.423	31	129	129	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58125	10.1371/journal.pone.0058125	http://dx.doi.org/10.1371/journal.pone.0058125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505459	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500051
J	Mikolas, P; Kollarova, J; Sebkova, K; Saudek, V; Yilma, P; Kostrouchova, M; Krause, MW; Kostrouch, Z; Kostrouchova, M				Mikolas, Pavol; Kollarova, Johana; Sebkova, Katerina; Saudek, Vladimir; Yilma, Petr; Kostrouchova, Marketa; Krause, Michael W.; Kostrouch, Zdenek; Kostrouchova, Marta			GEI-8, a Homologue of Vertebrate Nuclear Receptor Corepressor NCoR/SMRT, Regulates Gonad Development and Neuronal Functions in Caenorhabditis elegans	PLOS ONE			English	Article							MEDIATED REPRESSION; NERVOUS-SYSTEM; PROTEIN; SMRT; COMPLEX; PROGRESSION; EXPRESSION; CELL; IDENTIFICATION; TRANSCRIPTION	NCoR and SMRT are two paralogous vertebrate proteins that function as corepressors with unliganded nuclear receptors. Although C. elegans has a large number of nuclear receptors, orthologues of the corepressors NCoR and SMRT have not unambiguously been identified in Drosophila or C. elegans. Here, we identify GEI-8 as the closest homologue of NCoR and SMRT in C. elegans and demonstrate that GEI-8 is expressed as at least two isoforms throughout development in multiple tissues, including neurons, muscle and intestinal cells. We demonstrate that a homozygous deletion within the gei-8 coding region, which is predicted to encode a truncated protein lacking the predicted NR domain, results in severe mutant phenotypes with developmental defects, slow movement and growth, arrested gonadogenesis and defects in cholinergic neurotransmission. Whole genome expression analysis by microarrays identified sets of de-regulated genes consistent with both the observed mutant phenotypes and a role of GEI-8 in regulating transcription. Interestingly, the upregulated transcripts included a predicted mitochondrial sulfide: quinine reductase encoded by Y9C9A.16. This locus also contains non-coding, 21-U RNAs of the piRNA class. Inhibition of the expression of the region coding for 21-U RNAs leads to irregular gonadogenesis in the homozygous gei-8 mutants, but not in an otherwise wild-type background, suggesting that GEI-8 may function in concert with the 21-U RNAs to regulate gonadogenesis. Our results confirm that GEI-8 is the orthologue of the vertebrate NCoR/SMRT corepressors and demonstrate important roles for this putative transcriptional corepressor in development and neuronal function.	[Mikolas, Pavol; Sebkova, Katerina; Kostrouchova, Marta] Charles Univ Prague, Fac Med 1, Inst Cellular Biol & Pathol, Lab Mol Biol & Genet, Prague, Czech Republic; [Kollarova, Johana; Saudek, Vladimir; Yilma, Petr; Kostrouchova, Marketa; Kostrouch, Zdenek] Charles Univ Prague, Fac Med 1, Inst Cellular Biol & Pathol, Lab Mol Pathol, Prague, Czech Republic; [Krause, Michael W.] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Charles University Prague; Charles University Prague; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kostrouchova, M (corresponding author), Charles Univ Prague, Fac Med 1, Inst Cellular Biol & Pathol, Lab Mol Biol & Genet, Prague, Czech Republic.	marta.kostrouchova@lf1.cuni.cz	Kollárová, Johana/M-9463-2017; Mikolas, Pavol/GLR-0797-2022	Kollárová, Johana/0000-0003-2686-4555; Mikolas, Pavol/0000-0002-3974-7115; Krause, Michael/0000-0001-6127-3940	Czech Science Foundation [304/08/0970]; Ministry of Education, Youth and Sports of the Czech Republic [0021620806]; Charles University in Prague [SVV 2012 264514, 579612]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health, USA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036133, ZIADK036117] Funding Source: NIH RePORTER	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following grants: grant 304/08/0970 from the Czech Science Foundation (http://www.gacr.cz/international.htm), grant 0021620806 from the Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz), Prvouk/1LF/1 and UNCE 204022 from the Charles University in Prague ( http://www.cuni.cz). PM, JK and KS were partially supported by the grant SVV 2012 264514 from the Charles University in Prague (http:// www.cuni.cz). KS was partially supported by the Grant 579612 from the Charles University in Prague. MWK is supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health, USA (http://www2.niddk.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakawa Kazuharu, 2005, In Silico Biology, V5, P419; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Barberan-Soler S, 2009, RNA, V15, P1652, DOI 10.1261/rna.1711109; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Boxem M, 2001, DEVELOPMENT, V128, P4349; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; BRENNER S, 1974, GENETICS, V77, P71; Budde MW, 2011, GENETICS, V189, P521, DOI 10.1534/genetics.111.129841; Cecere G, 2012, MOL CELL, V47, P734, DOI 10.1016/j.molcel.2012.06.021; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Choy SW, 2007, BIOCHEM BIOPH RES CO, V358, P802, DOI 10.1016/j.bbrc.2007.04.194; Codina A, 2005, P NATL ACAD SCI USA, V102, P6009, DOI 10.1073/pnas.0500299102; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; Dorak M. T., 2006, REAL TIME PCR ADV ME; Fan XM, 1997, J COMP NEUROL, V387, P53, DOI 10.1002/(SICI)1096-9861(19971013)387:1<53::AID-CNE5>3.0.CO;2-M; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; Faumont S, 2005, J NEUROBIOL, V65, P171, DOI 10.1002/neu.20196; Fay DS, 2000, DEVELOPMENT, V127, P4049; FIRE A, 1989, EMBO J, V8, P3419, DOI 10.1002/j.1460-2075.1989.tb08506.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Glenn CF, 2004, J GERONTOL A-BIOL, V59, P1251, DOI 10.1093/gerona/59.12.1251; Goodson Michael, 2005, Nucl Recept Signal, V3, pe003; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Han HF, 2009, MOL BIOL CELL, V20, P2361, DOI 10.1091/mbc.E08-06-0584; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hodgson MC, 2008, MOL CANCER THER, V7, P3187, DOI 10.1158/1535-7163.MCT-08-0461; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hu X, 2001, MOL CELL BIOL, V21, P1747, DOI 10.1128/MCB.21.5.1747-1758.2001; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2008, GENE DEV, V22, P740, DOI 10.1101/gad.1637108; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kelly WG, 1997, GENETICS, V146, P227; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Kostrouchova M, 2001, P NATL ACAD SCI USA, V98, P7360, DOI 10.1073/pnas.131171898; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; MacMorris M, 2007, RNA, V13, P511, DOI 10.1261/rna.426707; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Malartre M, 2004, NUCLEIC ACIDS RES, V32, P4676, DOI 10.1093/nar/gkh786; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; Maryon EB, 1998, J CELL SCI, V111, P2885; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Mercer KB, 2003, MOL BIOL CELL, V14, P2492, DOI 10.1091/mbc.E02-10-0676; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Park M, 1999, DEVELOPMENT, V126, P4849; Privalsky ML, 2001, CURR TOP MICROBIOL, V254, P117; RAIZEN DM, 1995, GENETICS, V141, P1365; Simeckova K, 2007, FOLIA BIOL-PRAGUE, V53, P85; Tahirov TH, 2001, ACTA CRYSTALLOGR D, V57, P1655, DOI 10.1107/S0907444901011982; Torres-Padilla ME, 2002, J BIOL CHEM, V277, P44677, DOI 10.1074/jbc.M207545200; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tsuboi D, 2002, BIOCHEM BIOPH RES CO, V292, P697, DOI 10.1006/bbrc.2002.6717; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Watanabe N, 2005, DEVELOPMENT, V132, P3175, DOI 10.1242/dev.01895; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Yu JJ, 2003, EMBO J, V22, P3403, DOI 10.1093/emboj/cdg326	68	6	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58462	10.1371/journal.pone.0058462	http://dx.doi.org/10.1371/journal.pone.0058462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484030	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100119
J	Torres-Sanchez, J; Lopez-Granados, F; De Castro, AI; Pena-Barragan, JM				Torres-Sanchez, Jorge; Lopez-Granados, Francisca; Isabel De Castro, Ana; Manuel Pena-Barragan, Jose			Configuration and Specifications of an Unmanned Aerial Vehicle (UAV) for Early Site Specific Weed Management	PLOS ONE			English	Article							MULTISPECTRAL IMAGERY; REMOTE ESTIMATION; SCALE; IDENTIFICATION; REFLECTANCE; PATCHES; UTILITY; CROP; SOIL	A new aerial platform has risen recently for image acquisition, the Unmanned Aerial Vehicle (UAV). This article describes the technical specifications and configuration of a UAV used to capture remote images for early season site-specific weed management (ESSWM). Image spatial and spectral properties required for weed seedling discrimination were also evaluated. Two different sensors, a still visible camera and a six-band multispectral camera, and three flight altitudes (30, 60 and 100 m) were tested over a naturally infested sunflower field. The main phases of the UAV workflow were the following: 1) mission planning, 2) UAV flight and image acquisition, and 3) image pre-processing. Three different aspects were needed to plan the route: flight area, camera specifications and UAV tasks. The pre-processing phase included the correct alignment of the six bands of the multispectral imagery and the orthorectification and mosaicking of the individual images captured in each flight. The image pixel size, area covered by each image and flight timing were very sensitive to flight altitude. At a lower altitude, the UAV captured images of finer spatial resolution, although the number of images needed to cover the whole field may be a limiting factor due to the energy required for a greater flight length and computational requirements for the further mosaicking process. Spectral differences between weeds, crop and bare soil were significant in the vegetation indices studied (Excess Green Index, Normalised Green-Red Difference Index and Normalised Difference Vegetation Index), mainly at a 30 m altitude. However, greater spectral separability was obtained between vegetation and bare soil with the index NDVI. These results suggest that an agreement among spectral and spatial resolutions is needed to optimise the flight mission according to every agronomical objective as affected by the size of the smaller object to be discriminated (weed plants or weed patches).	[Torres-Sanchez, Jorge; Lopez-Granados, Francisca; Isabel De Castro, Ana; Manuel Pena-Barragan, Jose] CSIC, Spanish Natl Res Council, IAS, Dept Crop Protect, Cordoba, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS)	Torres-Sanchez, J (corresponding author), CSIC, Spanish Natl Res Council, IAS, Dept Crop Protect, Cordoba, Spain.	jtorres@ias.csic.es	Lopez-Granados, Francisca/J-5617-2014; Torres-Sánchez, Jorge/H-4714-2019; De Castro Megías, Ana Isabel/K-7429-2017; Peña, Jose M/K-4201-2014	Lopez-Granados, Francisca/0000-0001-9165-7558; Torres-Sánchez, Jorge/0000-0003-1420-0145; De Castro Megías, Ana Isabel/0000-0002-6699-2204; Peña, Jose M/0000-0003-4592-3792	TOAS Project (Marie Curie Program, EU) [FP7-PEOPLE-2011-CIG-293991]; Spanish Ministry of Economy and Competition) [AGL2011-30442-CO2-01]; JAEDoc Program; JAEPre Program; FPI Program	TOAS Project (Marie Curie Program, EU); Spanish Ministry of Economy and Competition)(Spanish Government); JAEDoc Program; JAEPre Program; FPI Program	This research was partly financed by the TOAS Project (Marie Curie Program, ref.: FP7-PEOPLE-2011-CIG-293991, EU-7th Frame Program) and the AGL2011-30442-CO2-01 project (Spanish Ministry of Economy and Competition, FEDER Funds). Research of Dr. Pena-Barragan, Ms. De Castro and Mr. Torres-Sanchez was financed by JAEDoc, JAEPre and FPI Programs, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Christensen S, 2009, WEED RES, V49, P233, DOI 10.1111/j.1365-3180.2009.00696.x; Decarolis F, 2014, CENT ISS CONT ECON T, P1, DOI 10.1007/s11119-013-9304-y; Gitelson AA, 2002, REMOTE SENS ENVIRON, V80, P76, DOI 10.1016/S0034-4257(01)00289-9; Gray CJ, 2008, WEED TECHNOL, V22, P713, DOI 10.1614/WT-07-116.1; Hardin PJ, 2010, GEOGR COMPASS, V4, P1297, DOI 10.1111/j.1749-8198.2010.00381.x; Hardin PJ, 2011, GISCI REMOTE SENS, V48, P99, DOI 10.2747/1548-1603.48.1.99; Hengl T, 2006, COMPUT GEOSCI-UK, V32, P1283, DOI 10.1016/j.cageo.2005.11.008; Herwitz SR, 2004, COMPUT ELECTRON AGR, V44, P49, DOI 10.1016/j.compag.2004.02.006; Houborg R, 2009, REMOTE SENS ENVIRON, V113, P259, DOI 10.1016/j.rse.2008.09.014; Hunt E. Raymond Jr, 2005, Precision Agriculture, V6, P359, DOI 10.1007/s11119-005-2324-5; de Castro AI, 2012, PRECIS AGRIC, V13, P302, DOI 10.1007/s11119-011-9247-0; KAUFMAN YJ, 1994, IEEE T GEOSCI REMOTE, V32, P672, DOI 10.1109/36.297984; Kelcey J, 2012, REMOTE SENS-BASEL, V4, P1462, DOI 10.3390/rs4051462; Laliberte AS, 2011, REMOTE SENS-BASEL, V3, P2529, DOI 10.3390/rs3112529; Laliberte AS, 2010, PHOTOGRAMM ENG REM S, V76, P661, DOI 10.14358/PERS.76.6.661; Laliberte AS, 2009, IEEE T GEOSCI REMOTE, V47, P761, DOI 10.1109/TGRS.2008.2009355; Lee WS, 2010, COMPUT ELECTRON AGR, V74, P2, DOI 10.1016/j.compag.2010.08.005; Lelong CCD, 2008, SENSORS-BASEL, V8, P3557, DOI 10.3390/s8053557; Lopez-Granados F, 2006, WEED SCI, V54, P346; Lopez-Granados F, 2005, EUR J AGRON, V23, P279, DOI 10.1016/j.eja.2004.12.003; Lopez-Granados F, 2011, WEED RES, V51, P1, DOI 10.1111/j.1365-3180.2010.00829.x; Castillejo-Gonzalez IL, 2009, COMPUT ELECTRON AGR, V68, P207, DOI 10.1016/j.compag.2009.06.004; Meron M, 2010, PRECIS AGRIC, V11, P148, DOI 10.1007/s11119-009-9153-x; National Research Council, 1997, PREC AGR 21 CENT; Pena-Barragan JM, 2007, WEED RES, V47, P164, DOI 10.1111/j.1365-3180.2007.00553.x; Pena-Barragan JM, 2011, REMOTE SENS ENVIRON, V115, P1301, DOI 10.1016/j.rse.2011.01.009; Primicerio J, 2012, PRECIS AGRIC, V13, P517, DOI 10.1007/s11119-012-9257-6; Ribeiro A, 2005, PRECISION AGRICULTURE 05, P169; Robert P. C, 1996, P 26 INT S REM SENS; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Smith AMS, 2007, INT J REMOTE SENS, V28, P2753, DOI 10.1080/01431160600954704; Thorp K. R., 2004, Precision Agriculture, V5, P477, DOI 10.1007/s11119-004-5321-1; WOEBBECKE DM, 1995, T ASAE, V38, P259, DOI 10.13031/2013.27838; Xiang HT, 2011, BIOSYST ENG, V108, P174, DOI 10.1016/j.biosystemseng.2010.11.010; Zhang CH, 2012, PRECIS AGRIC, V13, P693, DOI 10.1007/s11119-012-9274-5	36	174	183	6	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58210	10.1371/journal.pone.0058210	http://dx.doi.org/10.1371/journal.pone.0058210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483997	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100089
J	Tyagi, E; Agrawal, R; Zhuang, YM; Abad, C; Waschek, JA; Gomez-Pinilla, F				Tyagi, Ethika; Agrawal, Rahul; Zhuang, Yumei; Abad, Catalina; Waschek, James A.; Gomez-Pinilla, Fernando			Vulnerability Imposed by Diet and Brain Trauma for Anxiety-Like Phenotype: Implications for Post-Traumatic Stress Disorders	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; BDNF FUNCTION; DEPRESSION; INJURY; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; HOMEOSTASIS; MECHANISMS; EXPRESSION; PLASTICITY	Mild traumatic brain injury (mTBI, cerebral concussion) is a risk factor for the development of psychiatric illness such as posttraumatic stress disorder (PTSD). We sought to evaluate how omega-3 fatty acids during brain maturation can influence challenges incurred during adulthood (transitioning to unhealthy diet and mTBI) and predispose the brain to a PTSD-like pathobiology. Rats exposed to diets enriched or deficient in omega-3 fatty acids (n-3) during their brain maturation period, were transitioned to a western diet (WD) when becoming adult and then subjected to mTBI. TBI resulted in an increase in anxiety-like behavior and its molecular counterpart NPY1R, a hallmark of PTSD, but these effects were more pronounced in the animals exposed to n-3 deficient diet and switched to WD. The n-3 deficiency followed by WD disrupted BDNF signaling and the activation of elements of BDNF signaling pathway (TrkB, CaMKII, Akt and CREB) in frontal cortex. TBI worsened these effects and more prominently in combination with the n-3 deficiency condition. Moreover, the n-3 deficiency primed the immune system to the challenges imposed by the WD and brain trauma as evidenced by results showing that the WD or mTBI affected brain IL1b levels and peripheral Th17 and Treg subsets only in animals previously conditioned to the n-3 deficient diet. These results provide novel evidence for the capacity of maladaptive dietary habits to lower the threshold for neurological disorders in response to challenges.	[Tyagi, Ethika; Agrawal, Rahul; Zhuang, Yumei; Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Gomez-Pinilla, Fernando] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA USA; [Abad, Catalina; Waschek, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gomez-Pinilla, F (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA.	fgomezpi@ucla.edu	Agrawal, Rahul/F-6412-2015	Agrawal, Rahul/0000-0001-8128-3724; Abad, Catalina/0000-0001-9144-9310	National Institute of Health [NS050465, NS056413]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050465, R01NS056413] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants NS050465 and NS056413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Alonso M, 2002, CELL MOL NEUROBIOL, V22, P663, DOI 10.1023/A:1021848706159; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Bannon AW, 2000, BRAIN RES, V868, P79, DOI 10.1016/S0006-8993(00)02285-X; Bazarian JJ, 2012, J HEAD TRAUMA REHABI; Bowen A, 2010, ANXIETY STRESS COPIN, V23, P449, DOI 10.1080/10615800903414315; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Chapkin RS, 2007, J NUTR, V137, p200S, DOI 10.1093/jn/137.1.200S; D R Jr BS, 2000, ENVIRON HEALTH PERSP, V108, P511; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; Dell'Osso L, 2009, PROG NEURO-PSYCHOPH, V33, P899, DOI 10.1016/j.pnpbp.2009.04.018; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521; Freeman MP, 2010, AM J PSYCHIAT, V167, P244, DOI 10.1176/appi.ajp.2009.09121746; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Gomez-Pinilla F, 2008, EUR J NEUROSCI, V28, P2278, DOI 10.1111/j.1460-9568.2008.06524.x; Greiner RS, 2003, LIPIDS, V38, P431, DOI 10.1007/s11745-003-1080-2; Issazadeh-Navikas S, 2012, MOL MED, V18, P95, DOI 10.2119/molmed.2011.00311; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Lewis MD, 2011, J CLIN PSYCHIAT, V72, P1585, DOI 10.4088/JCP.11m06879; MacConmara MP, 2006, ANN SURG, V244, P514, DOI 10.1097/01.sla.0000239031.06906.1f; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Neylan TC, 2011, BRAIN BEHAV IMMUN, V25, P524, DOI 10.1016/j.bbi.2010.12.001; Pandey SC, 2006, J NEUROSCI, V26, P8320, DOI 10.1523/JNEUROSCI.4988-05.2006; Primeaux SD, 2005, NEUROPSYCHOPHARMACOL, V30, P1589, DOI 10.1038/sj.npp.1300705; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Robidoux J, 2000, ENDOCRINOLOGY, V141, P2795, DOI 10.1210/en.141.8.2795; Sah R, 2009, BIOL PSYCHIAT, V66, P705, DOI 10.1016/j.biopsych.2009.04.037; Segman RH, 2005, MOL PSYCHIATR, V10, P500, DOI 10.1038/sj.mp.4001636; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Stahl LA, 2008, CURR OPIN INVEST DR, V9, P57; Tan YV, 2009, P NATL ACAD SCI USA, V106, P2012, DOI 10.1073/pnas.0812257106; Thorsell A, 2000, P NATL ACAD SCI USA, V97, P12852, DOI 10.1073/pnas.220232997; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872	39	19	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57945	10.1371/journal.pone.0057945	http://dx.doi.org/10.1371/journal.pone.0057945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483949	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100059
J	Alves, SP; Santos-Silva, J; Cabrita, ARJ; Fonseca, AJM; Bessa, RJB				Alves, Susana P.; Santos-Silva, Jose; Cabrita, Ana R. J.; Fonseca, Antonio J. M.; Bessa, Rui J. B.			Detailed Dimethylacetal and Fatty Acid Composition of Rumen Content from Lambs Fed Lucerne or Concentrate Supplemented with Soybean Oil	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; MILK-FAT; DICARBOXYLIC-ACIDS; OLEIC-ACID; IN-VITRO; IDENTIFICATION; BIOHYDROGENATION; BACTERIA; QUALITY; LIPIDS	Lipid metabolism in the rumen is responsible for the complex fatty acid profile of rumen outflow compared with the dietary fatty acid composition, contributing to the lipid profile of ruminant products. A method for the detailed dimethylacetal and fatty acid analysis of rumen contents was developed and applied to rumen content collected from lambs fed lucerne or concentrate based diets supplemented with soybean oil. The methodological approach developed consisted on a basic/acid direct transesterification followed by thin-layer chromatography to isolate fatty acid methyl esters from dimethylacetal, oxo- fatty acid and fatty acid dimethylesters. The dimethylacetal composition was quite similar to the fatty acid composition, presenting even-, odd- and branched-chain structures. Total and individual odd- and branched-chain dimethylacetals were mostly affected by basal diet. The presence of 18:1 dimethylacetals indicates that biohydrogenation intermediates might be incorporated in structural microbial lipids. Moreover, medium-chain fatty acid dimethylesters were identified for the first time in the rumen content despite their concentration being relatively low. The fatty acids containing 18 carbon-chain lengths comprise the majority of the fatty acids present in the rumen content, most of them being biohydrogenation intermediates of 18:2n-6 and 18:3n-3. Additionally, three oxo- fatty acids were identified in rumen samples, and 16-O-18:0 might be produced during biohydrogenation of the 18:3n-3.	[Alves, Susana P.; Santos-Silva, Jose] INRB, Unidade Prod Anim, Vale De Santarem, Portugal; [Alves, Susana P.; Bessa, Rui J. B.] Univ Tecn Lisboa, CIISA, FMV, P-1100 Lisbon, Portugal; [Cabrita, Ana R. J.] Univ Porto, REQUIMTE, Dept Geociencias Ambiente & OrdenamentoTerr, Fac Ciencias, Vairao, Portugal; [Fonseca, Antonio J. M.] Univ Porto, ICBAS, REQUIMTE, P-4100 Oporto, Portugal	Universidade de Lisboa; Universidade do Porto; Universidade do Porto	Alves, SP (corresponding author), INRB, Unidade Prod Anim, Vale De Santarem, Portugal.	susanaalves@fmv.utl.pt	Alves, Susana P/C-1447-2008; Cabrita, Ana/C-2731-2008; Santos-Silva, José M B/B-1931-2017; Bessa, Rui J. B./B-8006-2008; Alves, Susana/Q-3889-2019; Fonseca, António/A-5743-2008	Alves, Susana P/0000-0002-3171-9566; Cabrita, Ana/0000-0002-1904-0358; Santos-Silva, José M B/0000-0002-9171-0977; Bessa, Rui J. B./0000-0003-4109-3488; Alves, Susana/0000-0002-3171-9566; Fonseca, António/0000-0001-6237-417X	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/76836/2011, PEst-OE/AGR/UI0276/2011, PEst-C/EQB/LA0006/2011]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	SPA was supported by Fundacao para a Ciencia e a Tecnologia (FCT) (www.fct.pt) through the grant SFRH/BPD/76836/2011. The work was also supported by Fundacao para a Ciencia e a Tecnologia through grants PEst-OE/AGR/UI0276/2011 and PEst-C/EQB/LA0006/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldai N, 2011, ANIMAL, V5, P1643, DOI 10.1017/S1751731111000607; Aldai N, 2012, MEAT SCI, V92, P687, DOI 10.1016/j.meatsci.2012.06.024; Alves SP, 2011, J ANIM SCI, V89, P2537, DOI 10.2527/jas.2010-3128; Alves SP, 2007, EUR J LIPID SCI TECH, V109, P879, DOI 10.1002/ejlt.200700035; Alves SP, 2009, J CHROMATOGR A, V1216, P5130, DOI 10.1016/j.chroma.2009.04.079; Bas P, 2003, J DAIRY SCI, V86, P2940, DOI 10.3168/jds.S0022-0302(03)73891-0; BAUMANN NA, 1965, J BIOL CHEM, V240, P1559; Bessa RJB, 2009, ANIM FEED SCI TECH, V150, P197, DOI 10.1016/j.anifeedsci.2008.09.005; Bessa RJB, 2005, LIVEST PROD SCI, V96, P185, DOI 10.1016/j.livprodsci.2005.01.017; Bessa RJB, 2007, EUR J LIPID SCI TECH, V109, P868, DOI 10.1002/ejlt.200600311; BRECHANY EY, 1992, J DAIRY RES, V59, P57, DOI 10.1017/S0022029900030247; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; Chilliard Y, 2007, EUR J LIPID SCI TECH, V109, P828, DOI 10.1002/ejlt.200700080; Cruz-Hernandez C, 2007, J DAIRY SCI, V90, P3786, DOI 10.3168/jds.2006-698; Dembitsky VM, 2001, BIOCHEMISTRY-MOSCOW+, V66, P72, DOI 10.1023/A:1002837830653; Destaillats F, 2005, J DAIRY SCI, V88, P3231, DOI 10.3168/jds.S0022-0302(05)73006-X; FARQUHAR JW, 1962, J LIPID RES, V3, P21; Fukuda S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004893; Goldfine H, 2010, PROG LIPID RES, V49, P493, DOI 10.1016/j.plipres.2010.07.003; Gomez-Cortes P, 2009, J LIPID RES, V50, P2412, DOI 10.1194/jlr.M800662-JLR200; Green KD, 2000, ENZYME MICROB TECH, V27, P205, DOI 10.1016/S0141-0229(00)00217-9; GRIINARI J. M., 1999, BIOSYNTHESIS CONJUGA, V1, P180; Guan ZQ, 2011, BBA-MOL CELL BIOL L, V1811, P186, DOI 10.1016/j.bbalip.2010.12.010; Harfoot C, 1997, RUMEN MICROBIAL ECOS, P382; Hudson JA, 1995, APPL MICROBIOL BIOT, V44, P1, DOI 10.1007/BF00164472; Jenkins TC, 2005, J DAIRY SCI, V88, P371; Jenkins TC, 2010, J DAIRY SCI, V93, P1170, DOI 10.3168/jds.2009-2509; JENKINS TC, 1982, J ANIM SCI, V55, P957, DOI 10.2527/jas1982.554957x; Jeronimo E, 2010, ANIM FEED SCI TECH, V158, P136, DOI 10.1016/j.anifeedsci.2010.04.010; Joint FAO/WHO Expert Consultation, 2009, ANN NUTR METAB, V55; Jouany JP, 2007, LIPIDS, V42, P351, DOI 10.1007/s11745-007-3032-x; Kairenius P, 2011, LIPIDS, V46, P587, DOI 10.1007/s11745-011-3561-1; Kalscheur KF, 1997, J DAIRY SCI, V80, P2104, DOI 10.3168/jds.S0022-0302(97)76156-3; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; KATZ I, 1966, J DAIRY SCI, V49, P967, DOI 10.3168/jds.S0022-0302(66)87991-2; KATZ I, 1964, BIOCHIM BIOPHYS ACTA, V84, P128, DOI 10.1016/0926-6542(64)90068-X; KLEIN RA, 1979, BIOCHEM J, V183, P691, DOI 10.1042/bj1830691; KUSUNOSE M, 1964, J BIOL CHEM, V239, P1374; Laverroux S, 2011, LIPIDS, V46, P843, DOI 10.1007/s11745-011-3584-7; MAHADEVA.V, 1967, J LIPID RES, V8, P2; Maia MRG, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-52; MINATO H, 1988, J GEN APPL MICROBIOL, V34, P303, DOI 10.2323/jgam.34.303; MIYAGAWA E, 1982, J GEN APPL MICROBIOL, V28, P389, DOI 10.2323/jgam.28.389; MORRISON WR, 1964, J LIPID RES, V5, P600; Pariza MW, 2001, PROG LIPID RES, V40, P283, DOI 10.1016/S0163-7827(01)00008-X; PASSI S, 1993, BIOCHIM BIOPHYS ACTA, V1168, P190, DOI 10.1016/0005-2760(93)90124-R; Precht D, 2000, EUR J LIPID SCI TECH, V102, P102, DOI 10.1002/(SICI)1438-9312(200002)102:2<102::AID-EJLT102>3.3.CO;2-3; Santercole V, 2007, LIPIDS, V42, P361, DOI 10.1007/s11745-006-3003-7; Shingfield KJ, 2008, BRIT J NUTR, V99, P971, DOI 10.1017/S0007114507853323; Shingfield KJ, 2010, ANIMAL, V4, P1140, DOI 10.1017/S1751731110000510; Van Kessel JS, 2002, J ANIM SCI, V80, P3027; Viviani R, 1970, Adv Lipid Res, V8, P267; Vlaeminck B, 2008, J DAIRY SCI, V91, P1122, DOI 10.3168/jds.2007-0537; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Vlaeminck B, 2006, J DAIRY SCI, V89, P2668, DOI 10.3168/jds.S0022-0302(06)72343-8; WEIHRAUCH JL, 1974, LIPIDS, V9, P883, DOI 10.1007/BF02532614; Wolff RL, 2002, LIPIDS, V37, P811, DOI 10.1007/s11745-002-0965-4	57	55	55	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58386	10.1371/journal.pone.0058386	http://dx.doi.org/10.1371/journal.pone.0058386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484024	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900084
J	Baek, SH; Shin, WC; Ryu, HS; Lee, DW; Moon, E; Seo, CS; Hwang, E; Lee, HS; Ahn, MH; Jeon, Y; Kang, HJ; Lee, SW; Kim, SY; D'Souza, R; Kim, HJ; Hong, ST; Jeon, JS				Baek, So-Hyeon; Shin, Woon-Chul; Ryu, Hak-Seung; Lee, Dae-Woo; Moon, Eunjung; Seo, Chun-Sun; Hwang, Eunson; Lee, Hyun-Seo; Ahn, Mi-Hyun; Jeon, Youngju; Kang, Hyeon-Jung; Lee, Sang-Won; Kim, Sun Yeou; D'Souza, Roshan; Kim, Hyeon-Jin; Hong, Seong-Tshool; Jeon, Jong-Seong			Creation of Resveratrol-Enriched Rice for the Treatment of Metabolic Syndrome and Related Diseases	PLOS ONE			English	Article							STILBENE SYNTHASE GENE; EXPRESSION; SIRT1; GLUCOSYLTRANSFERASE; SIRTUINS; RATS; MICE	Resveratrol has been clinically shown to possess a number of human health benefits. As a result, many attempts have been made to engineer resveratrol production in major cereal grains but have been largely unsuccessful. In this study, we report the creation of a transgenic rice plant that accumulates 1.9 mu g resveratrol/g in its grain, surpassing the previously reported anti-metabolic syndrome activity of resveratrol through a synergistic interaction between the transgenic resveratrol and the endogenous properties of the rice. Consumption of our transgenic resveratrol-enriched rice significantly improved all aspects of metabolic syndrome and related diseases in animals fed a high-fat diet. Compared with the control animals, the resveratrol-enriched rice reduced body weight, blood glucose, triglycerides, total cholesterol, and LDL-cholesterol by 24.7%, 22%, 37.4%, 27%, and 59.6%, respectively. The resveratrol-enriched rice from our study may thus provide a safe and convenient means of preventing metabolic syndrome and related diseases without major lifestyle changes or the need for daily medications. These results also suggest that future transgenic plants could be improved if the synergistic interactions of the transgene with endogenous traits of the plant are considered in the experimental design.	[Baek, So-Hyeon; Shin, Woon-Chul; Seo, Chun-Sun; Kang, Hyeon-Jung] Rural Dev Adm, Natl Inst Crop Sci, Iksan, South Korea; [Ryu, Hak-Seung; Lee, Dae-Woo; Jeon, Jong-Seong] Kyung Hee Univ, Grad Sch Biotechnol, Yongin, Gyeonggi, South Korea; [Ryu, Hak-Seung; Lee, Dae-Woo; Lee, Sang-Won; Jeon, Jong-Seong] Kyung Hee Univ, Crop Biotech Inst, Yongin, Gyeonggi, South Korea; [Moon, Eunjung; Hwang, Eunson] Kyung Hee Univ, Grad Sch East West Med Sci, Yongin, Gyeonggi, South Korea; [Lee, Hyun-Seo; Ahn, Mi-Hyun; Jeon, Youngju; Hong, Seong-Tshool] Chonbuk Natl Univ, Genet Lab, Sch Med, Jeonju, Chonbuk, South Korea; [Lee, Hyun-Seo; Ahn, Mi-Hyun; Jeon, Youngju; Hong, Seong-Tshool] Chonbuk Natl Univ, Dept Microbiol, Sch Med, Jeonju, Chonbuk, South Korea; [Lee, Sang-Won] Kyung Hee Univ, Dept Plant Mol Syst Biotechnol, Yongin, Gyeonggi, South Korea; [Kim, Sun Yeou] Gachon Univ, Coll Pharm, Inchon, South Korea; [D'Souza, Roshan; Kim, Hyeon-Jin] JINIS Biopharmaceut Inc, BDRD Res Inst, Wonju, Chonbuk, South Korea	Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Kyung Hee University; Kyung Hee University; Kyung Hee University; Jeonbuk National University; Jeonbuk National University; Kyung Hee University; Gachon University	Hong, ST (corresponding author), Chonbuk Natl Univ, Genet Lab, Sch Med, Jeonju, Chonbuk, South Korea.	seonghong@chonbuk.ac.kr; jjeon@khu.ac.kr	Jeon, Jong-Seong/AAJ-2161-2020; Dsouza, Roshan/Q-2965-2019; Kim, Hyeonjin/M-3761-2019	Jeon, Jong-Seong/0000-0001-6221-4993; Hong, Seong-Tshool/0000-0001-8254-6581; Kim, Hyeon Jin/0000-0003-3117-353X	Next-Generation BioGreen 21 Program [PJ0079732012]; RDA program, Rural Development Administration, Korea [PJ0075392012]	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); RDA program, Rural Development Administration, Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ0079732012) and RDA program (No. PJ0075392012), Rural Development Administration, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekwilder J, 2006, APPL ENVIRON MICROB, V72, P5670, DOI 10.1128/AEM.00609-06; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Choi H, 2012, J KOREAN SOC APPL BI, V55, P19, DOI 10.1007/s13765-012-0004-5; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Delaunois B, 2009, PLANT BIOTECHNOL J, V7, P2, DOI 10.1111/j.1467-7652.2008.00377.x; Du H, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S42; Fischer R, 1997, PLANT J, V11, P489, DOI 10.1046/j.1365-313X.1997.11030489.x; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HAIN R, 1993, NATURE, V361, P153, DOI 10.1038/361153a0; Hall D, 2007, PLANT J, V49, P579, DOI 10.1111/j.1365-313X.2006.02987.x; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; KIMURA Y, 1985, BIOCHIM BIOPHYS ACTA, V834, P275; Leckband G, 1998, THEOR APPL GENET, V96, P1004, DOI 10.1007/s001220050832; Lee Sichul, 1999, Journal of Plant Biology, V42, P310; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Liu BL, 2007, CANCER BIOL THER, V6, P1833, DOI 10.4161/cbt.6.12.5161; Liu SJ, 2006, J AGR FOOD CHEM, V54, P8082, DOI 10.1021/jf061462k; Lunkenbein S, 2006, PLANT PHYSIOL, V140, P1047, DOI 10.1104/pp.105.074955; Meng XF, 2004, J AGR FOOD CHEM, V52, P935, DOI 10.1021/jf030582e; Morelli R, 2006, MOL CELL BIOCHEM, V282, P65, DOI 10.1007/s11010-006-1260-7; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NORMOLLE DP, 1993, STAT MED, V12, P2025, DOI 10.1002/sim.4780122106; Sobolev VS, 2011, J AGR FOOD CHEM, V59, P1673, DOI 10.1021/jf104742n; Souto AA, 2001, J FOOD COMPOS ANAL, V14, P441, DOI 10.1006/jfca.2000.0970; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; StarkLorenzen P, 1997, PLANT CELL REP, V16, P668, DOI 10.1007/s002990050299; Sydor T, 2010, APPL ENVIRON MICROB, V76, P3361, DOI 10.1128/AEM.02796-09; Yang W, 2001, PROTEIN EXPRES PURIF, V22, P472, DOI 10.1006/prep.2001.1453; Zhuang H, 2003, ANN NY ACAD SCI, V993, P276, DOI 10.1111/j.1749-6632.2003.tb07534.x	31	44	48	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57930	10.1371/journal.pone.0057930	http://dx.doi.org/10.1371/journal.pone.0057930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483945	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900056
J	Martin, R; Albrecht-Eckardt, D; Brunke, S; Hube, B; Hunniger, K; Kurzai, O				Martin, Ronny; Albrecht-Eckardt, Daniela; Brunke, Sascha; Hube, Bernhard; Huenniger, Kerstin; Kurzai, Oliver			A Core Filamentation Response Network in Candida albicans Is Restricted to Eight Genes	PLOS ONE			English	Article							PH-REGULATED GENE; MORPHOLOGICAL DEVELOPMENT; HYPHAL FORMATION; LARGE-SCALE; GROWTH; EXPRESSION; MORPHOGENESIS; INDUCTION; YEAST; EFG1	Although morphological plasticity is a central virulence trait of Candida albicans, the number of filament-associated genes and the interplay of mechanisms regulating their expression remain unknown. By correlation-based network modeling of the transcriptional response to different defined external stimuli for morphogenesis we identified a set of eight genes with highly correlated expression patterns, forming a core filamentation response. This group of genes included ALS3, ECE1, HGT2, HWP1, IHD1 and RBT1 which are known or supposed to encode for cell-wall associated proteins as well as the Rac1 guanine nucleotide exchange factor encoding gene DCK1 and the unknown function open reading frame orf19.2457. The validity of network modeling was confirmed using a dataset of advanced complexity that describes the transcriptional response of C. albicans during epithelial invasion as well as comparing our results with other previously published transcriptome studies. Although the set of core filamentation response genes was quite small, several transcriptional regulators are involved in the control of their expression, depending on the environmental condition.	[Martin, Ronny; Huenniger, Kerstin; Kurzai, Oliver] Univ Jena, Sept Res Ctr, Jena, Germany; [Martin, Ronny; Huenniger, Kerstin; Kurzai, Oliver] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Albrecht-Eckardt, Daniela] BioControl Jena GmbH, Jena, Germany; [Brunke, Sascha; Hube, Bernhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Brunke, Sascha; Hube, Bernhard] Univ Jena, Jena, Germany; [Brunke, Sascha; Hube, Bernhard] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany	Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Kurzai, O (corresponding author), Univ Jena, Sept Res Ctr, Jena, Germany.	oliver.kurzai@hki-jena.de	Brunke, Sascha/G-1486-2012	Brunke, Sascha/0000-0001-7740-4570; Kurzai, Oliver/0000-0002-7277-2646	German Ministry for Education and Science in the program Unternehmen Region [BMBF 03Z2JN21]	German Ministry for Education and Science in the program Unternehmen Region	This work was financed by the German Ministry for Education and Science in the program Unternehmen Region (BMBF 03Z2JN21 to OK). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almeida RS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000217; Alvarez FJ, 2007, MOL BIOL CELL, V18, P965, DOI 10.1091/mbc.E06-10-0931; Argimon S, 2007, EUKARYOT CELL, V6, P682, DOI 10.1128/EC.00340-06; Arnaud MB, 2007, NUCLEIC ACIDS RES, V35, pD452, DOI 10.1093/nar/gkl899; Banerjee M, 2008, MOL BIOL CELL, V19, P1354, DOI 10.1091/mbc.E07-11-1110; Bensen ES, 2004, MOL MICROBIOL, V54, P1335, DOI 10.1111/j.1365-2958.2004.04350.x; BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993; Braun BR, 2000, GENETICS, V155, P57; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; BUFFO J, 1984, MYCOPATHOLOGIA, V85, P21, DOI 10.1007/BF00436698; Carlisle PL, 2009, P NATL ACAD SCI USA, V106, P599, DOI 10.1073/pnas.0804061106; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; El Barkani A, 2000, MOL CELL BIOL, V20, P4635, DOI 10.1128/MCB.20.13.4635-4647.2000; Ene IV, 2009, EUKARYOT CELL, V8, P1909, DOI 10.1128/EC.00245-09; Enjalbert B, 2005, EUKARYOT CELL, V4, P1203, DOI 10.1128/EC.4.7.1203-1210.2005; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Fradin C, 2003, MOL MICROBIOL, V47, P1523, DOI 10.1046/j.1365-2958.2003.03396.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gunasekera A, 2010, EUKARYOT CELL, V9, P1476, DOI 10.1128/EC.00178-10; Hnisz D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000889; Holton NJ, 2001, NUCLEIC ACIDS RES, V29, P4014, DOI 10.1093/nar/29.19.4014; Hope H, 2008, MOL BIOL CELL, V19, P3638, DOI 10.1091/mbc.E07-12-1272; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kamthan M, 2012, FUNGAL GENET BIOL, V49, P369, DOI 10.1016/j.fgb.2012.02.006; Kumar MJ, 2000, P NATL ACAD SCI USA, V97, P14218, DOI 10.1073/pnas.250452997; Kurzai O, 2005, INT J MED MICROBIOL, V295, P121, DOI 10.1016/j.ijmm.2005.02.003; Lamarre C, 2000, MOL MICROBIOL, V35, P444, DOI 10.1046/j.1365-2958.2000.01715.x; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Lu Y, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001105; Lu YQ, 2012, PLANT METHODS, V8, DOI [10.1186/1746-4811-8-9, 10.1371/journal.ppat.1002663]; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Martin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018394; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Naseem S, 2011, J BIOL CHEM, V286, P28671, DOI 10.1074/jbc.M111.249854; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Ramon AM, 1999, J BACTERIOL, V181, P7524, DOI 10.1128/JB.181.24.7524-7530.1999; SAPORITOIRWIN SM, 1995, MOL CELL BIOL, V15, P601; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Schaub Y, 2006, J BASIC MICROB, V46, P416, DOI 10.1002/jobm.200510133; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharkey LL, 1999, J BACTERIOL, V181, P5273, DOI 10.1128/JB.181.17.5273-5279.1999; SIMS W, 1986, J MED MICROBIOL, V22, P203, DOI 10.1099/00222615-22-3-203; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Stoldt VR, 1997, EMBO J, V16, P1982, DOI 10.1093/emboj/16.8.1982; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Wozniok I, 2008, CELL MICROBIOL, V10, P807, DOI 10.1111/j.1462-5822.2007.01086.x; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0; Zheng XD, 2004, EMBO J, V23, P1845, DOI 10.1038/sj.emboj.7600195	65	61	63	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58613	10.1371/journal.pone.0058613	http://dx.doi.org/10.1371/journal.pone.0058613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516516	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400039
J	Zheng, MJ; Schaal, M; Chen, Y; Li, XK; Shentu, WH; Zhang, PY; Ashraf, M; Ge, SP; Sahn, DJ				Zheng, Minjuan; Schaal, Micheal; Chen, Yan; Li, Xiaokui; Shentu, Weihui; Zhang, Pengyuan; Ashraf, Muhammad; Ge, Shuping; Sahn, David J.			Real-Time 3-Dimensional Echocardiographic Assessment of Ventricular Volume, Mass, and Function in Human Fetuses	PLOS ONE			English	Article							FETAL CARDIAC-OUTPUT; COMPUTER-AIDED ANALYSIS; EJECTION FRACTION; 2-DIMENSIONAL ECHOCARDIOGRAPHY; 4-DIMENSIONAL ULTRASOUND; PICTORIAL ESSAY; 4D ULTRASOUND; STROKE VOLUME; HEART-VOLUME; MATRIX-ARRAY	Objectives: We sought to determine the feasibility and reproducibility of real-time 3-dimensional echocardiography (RT3DE) for evaluation of cardiac volume, mass, and function and to characterize maturational changes of these measurements in human fetuses. Methods: Eighty pregnant women in the 2nd and 3rd trimesters (59 with normal fetuses and 21 with fetuses with congenital heart disease [CHD]) were enrolled. We acquired RT3DE images using a matrix-array transducer. RT3DE measurements of volume, mass, stroke volume (SV), combined cardiac output (CCO), and ejection fraction (EF) were obtained. Images were scored and analyzed by two blinded independent observers. Inter-and intraobserver variabilities and correlations between fetal cardiac indices and gestational age were determined. Results: Fifty-two of 59 normal data sets (88%) and 9 of 21 CHD data sets (43%) were feasible for analysis. In normal fetuses, the right ventricle (RV) is larger than the left ventricle (LV) (P<0.05), but no difference exists between the LV and RV in mass, SV, CO, and CO/CCO. The EFs for the LV and RV were diminished; the RVSV/LVSV was reduced in CHD fetuses compared with normal fetuses (P<0.05). Fetal ventricular volumes, mass, SV, and CCO fit best into exponential curves with gestational age, but LVEF, RVEF, and RVSV/LVSV remain relatively constant. Conclusions: RT3DE is feasible and reproducible for assessment of LV and RV volume, mass, and function, especially in normal fetuses. Gestational growth of these measures, except for EF, is exponential in normal and CHD fetuses. CHD fetuses exhibit diminished LV and RV EFs.	[Zheng, Minjuan; Schaal, Micheal; Li, Xiaokui; Shentu, Weihui; Zhang, Pengyuan; Ashraf, Muhammad; Sahn, David J.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Zheng, Minjuan] Fourth Mil Med Univ, Xijing Hosp, Dept Ultrasound, Xian 710032, Peoples R China; [Chen, Yan] Fourth Mil Med Univ, Xijing Hosp, Dept Oncol, Xian 710032, Peoples R China; [Ge, Shuping] Drexel Univ, St Christophers Hosp Children, Coll Med, Cardiol Sect, Philadelphia, PA 19104 USA	Oregon Health & Science University; Air Force Military Medical University; Air Force Military Medical University; Drexel University	Ge, SP (corresponding author), Drexel Univ, St Christophers Hosp Children, Coll Med, Cardiol Sect, Philadelphia, PA 19104 USA.	shuping.ge@tenethealth.com; sahnd@ohsu.edu			Oregon Health and Science University	Oregon Health and Science University	This work was supported by Oregon Health and Science University (http://www.ohsu.edu/xd/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar P, 2005, PRENATAL DIAG, V25, P370, DOI 10.1002/pd.1159; Bhat AH, 2004, CIRCULATION, V110, P1054, DOI 10.1161/01.CIR.0000139848.33468.22; Chang FM, 1997, ULTRASOUND OBST GYN, V9, P42, DOI 10.1046/j.1469-0705.1997.09010042.x; Barreto EQD, 2012, J ULTRAS MED, V31, P673; DeKoninck P, 2012, FETAL DIAGN THER, V32, P72, DOI 10.1159/000336128; DESMEDT MCH, 1987, AM J CARDIOL, V60, P338, DOI 10.1016/0002-9149(87)90238-4; DEVORE GR, 1985, J ULTRAS MED, V4, P335; Goncalves LF, 2006, J ULTRAS MED, V25, P745, DOI 10.7863/jum.2006.25.6.745; Goncalves LF, 2006, J ULTRAS MED, V25, P691, DOI 10.7863/jum.2006.25.6.691; GRAHAM TP, 1973, CIRCULATION, V47, P144, DOI 10.1161/01.CIR.47.1.144; Hung J, 2007, J AM SOC ECHOCARDIOG, V20, P213, DOI 10.1016/j.echo.2007.01.010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lu XZ, 2008, AM HEART J, V155, P946, DOI 10.1016/j.ahj.2007.11.034; Lu XZ, 2008, J AM SOC ECHOCARDIOG, V21, P84, DOI 10.1016/j.echo.2007.05.009; Messing B, 2007, ULTRASOUND OBST GYN, V30, P142, DOI 10.1002/uog.4036; Messing B, 2011, ULTRASOUND OBST GYN, V38, P191, DOI 10.1002/uog.8980; Mielke G, 2001, CIRCULATION, V103, P1662, DOI 10.1161/01.CIR.103.12.1662; Molina FS, 2008, ULTRASOUND OBST GYN, V32, P181, DOI 10.1002/uog.5374; Myerson SG, 2002, HYPERTENSION, V40, P673, DOI 10.1161/01.HYP.0000036401.99908.DB; Rizzo G, 2007, PRENATAL DIAG, V27, P1147, DOI 10.1002/pd.1870; Rizzo G, 2010, J ULTRAS MED, V29, P261, DOI 10.7863/jum.2010.29.2.261; RUDOLPH AM, 1976, AM J OBSTET GYNECOL, V124, P183, DOI 10.1016/S0002-9378(16)33296-3; Sapin PM, 1996, AM J HYPERTENS, V9, P467, DOI 10.1016/0895-7061(95)00394-0; SCHMIDT KG, 1995, AM J CARDIOL, V76, P1313, DOI 10.1016/S0002-9149(99)80365-8; SCHMIDT KG, 1990, CIRCULATION, V81, P325, DOI 10.1161/01.CIR.81.1.325; SIIMES ASI, 1978, AM J OBSTET GYNECOL, V132, P42, DOI 10.1016/0002-9378(78)90796-2; Simioni C, 2012, REV BRAS CIR CARDIOV, V27, P275, DOI 10.5935/1678-9741.20120058; Simioni C, 2011, J MATERN-FETAL NEO M, V24, P1159, DOI 10.3109/14767058.2010.545921; Simpson JM, 2002, ULTRASOUND OBST GYN, V20, P332, DOI 10.1046/j.1469-0705.2002.00799.x; Sklansky MS, 2004, J ULTRAS MED, V23, P283, DOI 10.7863/jum.2004.23.2.283; Soriano BD, 2008, CIRCULATION, V117, P1842, DOI 10.1161/CIRCULATIONAHA.107.715854; Yagel S, 2007, ULTRASOUND OBST GYN, V29, P81, DOI 10.1002/uog.3912	32	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58494	10.1371/journal.pone.0058494	http://dx.doi.org/10.1371/journal.pone.0058494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516490	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400035
J	Bouchet, F; Geworski, L; Knoop, BO; Ferrer, L; Barriolo-Riedinger, A; Millardet, C; Fourcade, M; Martineau, A; Belly-Poinsignon, A; Djoumessi, F; Tendero, K; Keros, L; Montoya, F; Mesleard, C; Martin, AL; Lacoeuille, F; Couturier, O				Bouchet, Francis; Geworski, Lilli; Knoop, Bernd O.; Ferrer, Ludovic; Barriolo-Riedinger, Alina; Millardet, Corinne; Fourcade, Marjolaine; Martineau, Antoine; Belly-Poinsignon, Anne; Djoumessi, Francis; Tendero, Karine; Keros, Laurent; Montoya, Frederic; Mesleard, Christel; Martin, Anne-Laure; Lacoeuille, Franck; Couturier, Olivier			Calibration Test of PET Scanners in a Multi-Centre Clinical Trial on Breast Cancer Therapy Monitoring Using 18F-FLT	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ROI DEFINITION; UPTAKE VALUES; STANDARDIZATION; F-18-FDG; ACCURACY	A multi-centre trial using PET requires the analysis of images acquired on different systems We designed a multi-centre trial to estimate the value of 18F-FLT-PET to predict response to neoadjuvant chemotherapy in patients with newly diagnosed breast cancer. A calibration check of each PET-CT and of its peripheral devices was performed to evaluate the reliability of the results. Material and Methods: 11 centres were investigated. Dose calibrators were assessed by repeated measurements of a 68Ge certified source. The differences between the clocks associated with the dose calibrators and inherent to the PET systems were registered. The calibration of PET-CT was assessed with an homogeneous cylindrical phantom by comparing the activities per unit of volume calculated from the dose calibrator measurements with that measured on 15 Regions of Interest (ROIs) drawn on 15 consecutive slices of reconstructed filtered back-projection (FBP) images. Both repeatability of activity concentration based upon the 15 ROIs (ANOVA-test) and its accuracy were evaluated. Results: There was no significant difference for dose calibrator measurements (median of difference -0.04%; min = -4.65%; max = +5.63%). Mismatches between the clocks were less than 2 min in all sites and thus did not require any correction, regarding the half life of 18F. For all the PET systems, ANOVA revealed no significant difference between the activity concentrations estimated from the 15 ROIs (median of difference -0.69%; min = -9.97%; max = +9.60%). Conclusion: No major difference between the 11 centres with respect to calibration and cross-calibration was observed. The reliability of our 18F-FLT multi-centre clinical trial was therefore confirmed from the physical point of view. This type of procedure may be useful for any clinical trial involving different PET systems.	[Bouchet, Francis; Lacoeuille, Franck; Couturier, Olivier] Acad Hosp, Dept Nucl Med, Angers, France; [Geworski, Lilli; Knoop, Bernd O.] Hannover Med Sch, Dept Radiat Protect, Hannover, Germany; [Geworski, Lilli; Knoop, Bernd O.] Hannover Med Sch, Dept Med Phys, Hannover, Germany; [Ferrer, Ludovic] R Gauducheau Canc Ctr, Dept Nucl Med, Nantes, France; [Barriolo-Riedinger, Alina] GF Leclerc Canc Ctr, Dept Nucl Med, Dijon, France; [Millardet, Corinne] J Perrin Canc Ctr, Dept Nucl Med, Clermont Ferrand, France; [Fourcade, Marjolaine] Acad Hosp, Dept Nucl Med, Montpellier, France; [Martineau, Antoine] St Louis Acad Hosp, Dept Nucl Med, Paris, France; [Belly-Poinsignon, Anne] R Huguenin Canc Ctr, Dept Nucl Med, St Cloud, France; [Djoumessi, Francis] Acad Hosp, Dept Nucl Med, Tours, France; [Tendero, Karine] Acad Hosp, Dept Nucl Med, Bordeaux, France; [Keros, Laurent] Hosp Bayonne, Dept Nucl Med, Bayonne, France; [Montoya, Frederic] Curie Canc Ctr, Dept Nucl Med, Paris, France; [Mesleard, Christel; Martin, Anne-Laure] UNICANCER, Paris, France; [Lacoeuille, Franck; Couturier, Olivier] Univ Angers, INSERM, MINT, LUNAM Univ,UMR 1066, Angers, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Hannover Medical School; Hannover Medical School; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Rene Huguenin Hospital; CHU Bordeaux; UNICANCER; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Bouchet, F (corresponding author), Acad Hosp, Dept Nucl Med, Angers, France.	FrBouchet@chu-angers.fr	LACOEUILLE, Franck/K-4430-2015; Couturier, Olivier F/L-6635-2015; Ferrer, Ludovic/M-2945-2015	LACOEUILLE, Franck/0000-0002-7070-7664; Ferrer, Ludovic/0000-0002-5166-1998; couturier, olivier-francois/0000-0002-4900-7807	French Ministry of Health (PHRC); ABX-CRO; R&D UNICANCER of the French Federation against Cancer; French League against Cancer	French Ministry of Health (PHRC); ABX-CRO; R&D UNICANCER of the French Federation against Cancer; French League against Cancer	This study was supported by a grant from the French Ministry of Health (PHRC). The supply of the radioactive calibration source was funded by ABX-CRO (www.abx-cro.com). Transport of the radioactive source from site to site and displacements of the physicist were funded by R&D UNICANCER of the French Federation against Cancer (www.unicancer.fr) and the French League against Cancer (www.ligue-cancer.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Been LB, 2004, EUR J NUCL MED MOL I, V31, P1659, DOI 10.1007/s00259-004-1687-6; Boellaard R, 2004, J NUCL MED, V45, P1519; Boellaard R, 2011, J NUCL MED, V52, p93S, DOI 10.2967/jnumed.110.085662; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Boellaard R, 2009, J NUCL MED, V50, p11S, DOI 10.2967/jnumed.108.057182; Boellaard R, 2008, EUR J NUCL MED MOL I, V35, P2320, DOI 10.1007/s00259-008-0874-2; Couturier O, 2004, EUR J NUCL MED MOL I, V31, P1182, DOI 10.1007/s00259-004-1607-9; Geworski L, 2002, J NUCL MED, V43, P635; Geworski L, 2010, J NUCL MED, V51, P997, DOI 10.2967/jnumed.109.069989; Geworski Lilli, 2003, Z Med Phys, V13, P109; Geworski L, 2010, Z MED PHYS, V20, P46, DOI 10.1016/j.zemedi.2009.10.009; Krak NC, 2005, EUR J NUCL MED MOL I, V32, P294, DOI 10.1007/s00259-004-1566-1; Paquet N, 2004, J NUCL MED, V45, P784; Scheuermann JS, 2009, J NUCL MED, V50, P1187, DOI 10.2967/jnumed.108.057455; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Sokole EB, 2010, EUR J NUCL MED MOL I, V37, P662, DOI 10.1007/s00259-009-1347-y	17	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58152	10.1371/journal.pone.0058152	http://dx.doi.org/10.1371/journal.pone.0058152			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516443	Green Published, gold			2022-12-27	WOS:000316849200038
J	Candolin, U; Vlieger, L				Candolin, Ulrika; Vlieger, Leon			Should Attractive Males Sneak: The Trade-Off between Current and Future Offspring	PLOS ONE			English	Article							EXTRA-PAIR PATERNITY; SEXUAL SELECTION; GASTEROSTEUS-ACULEATUS; 3-SPINED STICKLEBACK; THREESPINE STICKLEBACK; REPRODUCTIVE SUCCESS; MALE COMPETITION; MALE PHENOTYPE; EVOLUTION; TACTICS	Alternative reproductive tactics are predicted to be adopted by less competitive males when competition for fertilization is intense. Yet, in some species, competitively superior males use an alternative tactic alongside the conventional tactic. This can jeopardize their success through the conventional tactic, but surprisingly little attention has been paid to this cost. We investigated 1) the degree to which competitive males sneak fertilize eggs in the polygamous threespine stickleback, Gasterosteus aculeatus, and 2) if males balance the cost of sneaking against its benefit. We found competitive males that succeeded in establishing a territory and in attracting spawning females to perform most sneak fertilizations. However, when we reduced the benefit of sneak attempts, by reducing visibility and the success rate of sneak attempts, males sneaked less. When we increased the cost of sneak attempts, by increasing the perceived value of current offspring (by mating males to preferred females rather than unpreferred females or no females), the interest of males in sneak opportunities decreased. Intriguingly, larger males, who presumably had a higher probability of future reproduction, were more willing to risk their current offspring for sneak opportunities. These findings suggest that competitive males that are attractive to females carefully balance costs against benefits in their sneaking decisions. More broadly, our results imply that changes in the environment can influence the cost-benefit ratio of sneaking and alter the distribution of fertilizations in a population. We end with discussing the implications that alterations in sneaking behavior could have for the operation of sexual selection in changing environments.	[Candolin, Ulrika; Vlieger, Leon] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Helsinki	Candolin, U (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	ulrika.candolin@helsinki.fi		Candolin, Ulrika/0000-0001-8736-7793	Academy of Finland	Academy of Finland(Academy of Finland)	The work was funded by the Academy of Finland to UC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAK A, 1988, ANIM BEHAV, V36, P416, DOI 10.1016/S0003-3472(88)80012-5; Bergman M, 2009, ANIM BEHAV, V78, P1161, DOI 10.1016/j.anbehav.2009.08.003; Birkhead TR, 1998, SPERM COMPETITION SE; Boughman JW, 2005, EVOLUTION, V59, P361; Briffa M, 2007, FUNCT ECOL, V21, P627, DOI 10.1111/j.1365-2435.2006.01188.x; Candolin U, 1999, P ROY SOC B-BIOL SCI, V266, P785, DOI 10.1098/rspb.1999.0706; Candolin U, 2003, EVOLUTION, V57, P862, DOI 10.1111/j.0014-3820.2003.tb00297.x; Candolin U, 2002, BEHAV ECOL SOCIOBIOL, V51, P146, DOI 10.1007/s00265-001-0422-6; Candolin U, 2009, J FISH BIOL, V75, P2108, DOI 10.1111/j.1095-8649.2009.02405.x; Candolin U, 2001, OIKOS, V95, P225, DOI 10.1034/j.1600-0706.2001.950204.x; Candolin U, 2000, P ROY SOC B-BIOL SCI, V267, P2425, DOI 10.1098/rspb.2000.1301; Candolin U, 1997, BEHAV ECOL SOCIOBIOL, V41, P81, DOI 10.1007/s002650050367; Candolin U, 2007, J EVOLUTION BIOL, V20, P233, DOI 10.1111/j.1420-9101.2006.01207.x; Candolin U, 2008, TRENDS ECOL EVOL, V23, P446, DOI 10.1016/j.tree.2008.04.008; Candolin U, 2008, OIKOS, V117, P459, DOI 10.1111/j.2007.0030-1299.16302.x; Candolin U, 2012, BEHAVIOURAL RESPONSES TO A CHANGING WORLD: MECHANISMS AND CONSEQUENCES, P201; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dzieweczynski TL, 2004, ANIM BEHAV, V68, P465, DOI 10.1016/j.anbehav.2003.08.024; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Forstmeier W, 2011, P NATL ACAD SCI USA, V108, P10608, DOI 10.1073/pnas.1103195108; Fu P, 2001, P ROY SOC B-BIOL SCI, V268, P1105, DOI 10.1098/rspb.2001.1625; GOLDSCHMIDT T, 1992, ANIM BEHAV, V44, P793, DOI 10.1016/S0003-3472(05)80310-0; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2001, ANIM BEHAV, V61, P987, DOI 10.1006/anbe.2000.1666; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Heuschele J, 2012, ANIM BEHAV, V83, P1505, DOI 10.1016/j.anbehav.2012.03.027; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Iossa G, 2008, J MAMMAL, V89, P1481, DOI 10.1644/07-MAMM-A-405.1; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Mori S, 1995, BEHAVIOUR, V132, P1011, DOI 10.1163/156853995X00423; Oliveira RF, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602; Pilastro A, 2002, P ROY SOC B-BIOL SCI, V269, P1325, DOI 10.1098/rspb.2002.2017; Reichard M, 2007, ANIM BEHAV, V74, P679, DOI 10.1016/j.anbehav.2007.03.005; SARGENT RC, 1985, BEHAVIOUR, V93, P217, DOI 10.1163/156853986X00892; SARGENT RC, 1980, BEHAV ECOL SOCIOBIOL, V7, P137, DOI 10.1007/BF00299519; SHELDON BC, 1994, P ROY SOC B-BIOL SCI, V257, P25, DOI 10.1098/rspb.1994.0089; SHUSTER SM, 2003, MG BEH ECOL, pR7; Shuster SM, 2011, J ANIM ECOL, V80, P905, DOI 10.1111/j.1365-2656.2011.01890.x; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2008, ADV STUD BEHAV, V38, P227, DOI 10.1016/S0065-3454(08)00005-3; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Tomkins JL, 2007, TRENDS ECOL EVOL, V22, P522, DOI 10.1016/j.tree.2007.09.002; Tomkins JL, 2011, CURR BIOL, V21, P569, DOI 10.1016/j.cub.2011.02.032; Townsend AK, 2010, AM NAT, V175, pE1, DOI 10.1086/648553; van Iersel JJA., 1953, BEHAVIOUR, V3, P1; VANDENASSEM J, 1967, BEHAVIOUR S, V16, P1; Vlieger L, 2009, J FISH BIOL, V75, P2163, DOI 10.1111/j.1095-8649.2009.02403.x; Wade MJ, 2004, AM NAT, V164, pE83, DOI 10.1086/424531; Watters JV, 2005, ANIM BEHAV, V70, P1055, DOI 10.1016/j.anbehav.2005.01.025; WEATHERHEAD PJ, 1995, BEHAV ECOL SOCIOBIOL, V37, P81, DOI 10.1007/s0026550370081; Westneat DF, 2005, MOL ECOL, V14, P2155, DOI 10.1111/j.1365-294X.2005.02562.x; WHORISKEY FG, 1985, BEHAV ECOL SOCIOBIOL, V18, P15; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Wootton R.J., 1976, BIOL STICKLEBACKS	55	12	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57992	10.1371/journal.pone.0057992	http://dx.doi.org/10.1371/journal.pone.0057992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516423	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200023
J	Ramalho-Carvalho, J; Pires, M; Lisboa, S; Graca, I; Rocha, P; Barros-Silva, JD; Savva-Bordalo, J; Mauricio, J; Resende, M; Teixeira, MR; Honavar, M; Henrique, R; Jeronimo, C				Ramalho-Carvalho, Joao; Pires, Malini; Lisboa, Susana; Graca, Ines; Rocha, Patricia; Barros-Silva, Joao Diogo; Savva-Bordalo, Joana; Mauricio, Joaquina; Resende, Mario; Teixeira, Manuel R.; Honavar, Mrinalini; Henrique, Rui; Jeronimo, Carmen			Altered Expression of MGMT in High-Grade Gliomas Results from the Combined Effect of Epigenetic and Genetic Aberrations	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; PROMOTER HYPERMETHYLATION; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; CPG METHYLATION; MS-MLPA; CANCER; DNA; GLIOBLASTOMA; TEMOZOLOMIDE	MGMT downregulation in high-grade gliomas (HGG) has been mostly attributed to aberrant promoter methylation and is associated with increased sensitivity to alkylating agent-based chemotherapy. However, HGG harboring 10q deletions also benefit from treatment with alkylating agents. Because the MGMT gene is mapped at 10q26, we hypothesized that both epigenetic and genetic alterations might affect its expression and predict response to chemotherapy. To test this hypothesis, promoter methylation and mRNA levels of MGMT were determined by quantitative methylation-specific PCR (qMSP) or methylation-specific multiplex ligation dependent probe amplification (MS-MLPA) and quantitative RT-PCR, respectively, in a retrospective series of 61 HGG. MGMT/chromosome 10 copy number variations were determined by FISH or MS-MLPA analysis. Molecular findings were correlated with clinical parameters to assess their predictive value. Overall, MGMT methylation ratios assessed by qMSP and MS-MLPA were inversely correlated with mRNA expression levels (best coefficient value obtained with MS-MLPA). By FISH analysis in 68.3% of the cases there was loss of 10q26.1 and in 15% of the cases polysomy was demonstrated; the latter displayed the highest levels of transcript. When genetic and epigenetic data were combined, cases with MGMT promoter methylation and MGMT loss depicted the lowest transcript levels, although an impact in response to alkylating agent chemotherapy was not apparent. Cooperation between epigenetic (promoter methylation) and genetic (monosomy, locus deletion) changes affecting MGMT in HGG is required for effective MGMT silencing. Hence, evaluation of copy number alterations might add relevant prognostic and predictive information concerning response to alkylating agent-based chemotherapy.	[Ramalho-Carvalho, Joao; Pires, Malini; Graca, Ines; Savva-Bordalo, Joana; Henrique, Rui; Jeronimo, Carmen] Res Ctr Portuguese Oncol Inst Porto, Canc Epigenet Grp, Oporto, Portugal; [Barros-Silva, Joao Diogo; Teixeira, Manuel R.] Res Ctr Portuguese Oncol Inst Porto, Canc Genet Grp, Oporto, Portugal; [Ramalho-Carvalho, Joao; Pires, Malini; Lisboa, Susana; Graca, Ines; Rocha, Patricia; Barros-Silva, Joao Diogo; Teixeira, Manuel R.; Jeronimo, Carmen] Portuguese Oncol Inst Porto, Dept Genet, Oporto, Portugal; [Savva-Bordalo, Joana; Mauricio, Joaquina] Portuguese Oncol Inst Porto, Dept Med Oncol, Oporto, Portugal; [Henrique, Rui] Portuguese Oncol Inst Porto, Dept Pathol, Oporto, Portugal; [Teixeira, Manuel R.; Henrique, Rui; Jeronimo, Carmen] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Dept Pathol & Mol Immunol, P-4100 Oporto, Portugal; [Resende, Mario] Hosp Pedro Hispano, Local Hlth Unit Matosinhos, Dept Neurosurg, Matosinhos, Portugal; [Honavar, Mrinalini] Hosp Pedro Hispano, Local Hlth Unit Matosinhos, Dept Pathol, Matosinhos, Portugal	Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Portuguese Institute of Oncology; Universidade do Porto	Jeronimo, C (corresponding author), Res Ctr Portuguese Oncol Inst Porto, Canc Epigenet Grp, Oporto, Portugal.	carmenjeronimo@ipoporto.min-saude.pt	Ramalho-Carvalho, João/U-2356-2017; Teixeira, Manuel AC/AAZ-7251-2020; Henrique, Rui Manuel Ferreira/I-2757-2013; Teixeira, Manuel António Rodrigues/E-4885-2011; Jerónimo, Carmen/H-3284-2013; Vilela Resende, Mário Lúcio de Resende Mário Lúcio Vilela de/AAT-6646-2021	Ramalho-Carvalho, João/0000-0001-6140-7363; Teixeira, Manuel AC/0000-0002-1959-0624; Henrique, Rui Manuel Ferreira/0000-0003-3171-4666; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Jerónimo, Carmen/0000-0003-4186-5345; Pires, Malini/0000-0002-9609-7550; Savva-Bordalo, Joana/0000-0002-9585-7474; Rocha, Patricia/0000-0001-6275-026X; Lisboa, Susana/0000-0002-9773-331X; Pinho dos Santos Graca, Maria Ines/0000-0003-1383-4242; Barros Silva, Joao Diogo/0000-0002-6648-0217	Liga Portuguesa Contra o Cancro - Nucleo Regional do Norte; FCT - Fundacao para a Ciencia e a Tecnologia [SFRH/BD/64082/2009, SFRH/BD/46574/2008]; Research Center of Portuguese Oncology Institute - Porto [CI-IPOP 4-2008]	Liga Portuguesa Contra o Cancro - Nucleo Regional do Norte; FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); Research Center of Portuguese Oncology Institute - Porto	JR-C was supported by a grant from Liga Portuguesa Contra o Cancro - Nucleo Regional do Norte. IG and JDB-S are supported by grants from FCT - Fundacao para a Ciencia e a Tecnologia (SFRH/BD/64082/2009 and SFRH/BD/46574/2008, respectively). This study was funded by a research grant from the Research Center of Portuguese Oncology Institute - Porto (CI-IPOP 4-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barros-Silva JD, 2011, GENE CHROMOSOME CANC, V50, P662, DOI 10.1002/gcc.20888; Bourne TD, 2010, NAT REV NEUROL, V6, P695, DOI 10.1038/nrneurol.2010.159; Burton EC, 2002, CANCER RES, V62, P6205; Choy KW, 2005, NEOPLASIA, V7, P200, DOI 10.1593/neo.04565; Christians A, PLOS ONE, V7; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; Dunn J, 2009, BRIT J CANCER, V101, P124, DOI 10.1038/sj.bjc.6605127; Esteller M, 1999, CANCER RES, V59, P793; Esteller M, 2002, J NATL CANCER I, V94, P26; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Hata N, 2006, CLIN CHEM, V52, P370, DOI 10.1373/clinchem.2005.060954; Havik AB, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-36; Herfarth KKF, 1999, MOL CARCINOGEN, V24, P90, DOI 10.1002/(SICI)1098-2744(199902)24:2<90::AID-MC3>3.0.CO;2-B; Jansen M, 2010, LANCET NEUROL, V9, P717, DOI 10.1016/S1474-4422(10)70105-8; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Karayan-Tapon L, 2010, J NEURO-ONCOL, V97, P311, DOI 10.1007/s11060-009-0031-1; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Malley DS, 2011, ACTA NEUROPATHOL, V121, P651, DOI 10.1007/s00401-011-0803-5; Nakagawachi T, 2003, ONCOGENE, V22, P8835, DOI 10.1038/sj.onc.1207183; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Nygren AOH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni127; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; PEGG AE, 1990, CANCER RES, V50, P6119; Preusser M, 2009, HISTOL HISTOPATHOL, V24, P511, DOI 10.14670/HH-24.511; Qian XLC, 1997, CANCER RES, V57, P3672; Robinson MD, 2010, GENOME RES, V20, P1719, DOI 10.1101/gr.110601.110; Shima K, CANC CAUSES CONTROL, V22, P301; Smith-Sorensen B, 2002, ONCOGENE, V21, P8878, DOI 10.1038/sj.onc.1205978; van den Bent MJ, 2009, J CLIN ONCOL, V27, P5881, DOI 10.1200/JCO.2009.24.1034; van Nifterik KA, BR J CANC, V103, P29; von Deimling A, 2011, BRAIN PATHOL, V21, P74, DOI 10.1111/j.1750-3639.2010.00454.x; Weller M, 2010, NAT REV NEUROL, V6, P39, DOI 10.1038/nrneurol.2009.197; Wemmert S, 2005, NEOPLASIA, V7, P883, DOI 10.1593/neo.05307; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xue Heng-Chuan, 2008, Ai Zheng, V27, P1256	37	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58206	10.1371/journal.pone.0058206	http://dx.doi.org/10.1371/journal.pone.0058206			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505468	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100034
J	Nguyen, NP; Smith-Raymond, L; Vinh-Hung, V; Vos, P; Davis, R; Desai, A; Sroka, T; Abraham, D; Krafft, SP; Stevie, M; Modarresifar, H; Jo, BH; Ceizyk, M				Nguyen, Nam P.; Smith-Raymond, Lexie; Vinh-Hung, Vincent; Vos, Paul; Davis, Rick; Desai, Anand; Sroka, Thomas; Abraham, Dave; Krafft, Shane P.; Stevie, Michelle; Modarresifar, Homayoun; Jo, Beng-Hoey; Ceizyk, Misty			Feasibility of Tomotherapy-Based Image-Guided Radiotherapy to Reduce Aspiration Risk in Patients with Non-Laryngeal and Non-Pharyngeal Head and Neck Cancer	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; LOCALLY ADVANCED HEAD; RADIATION-THERAPY; DYSPHAGIA SEVERITY; CHEMORADIOTHERAPY; CHEMORADIATION; IMPACT	Purpose: The study aims to assess the feasibility of Tomotherapy-based image-guided radiotherapy (IGRT) to reduce the aspiration risk in patients with non-laryngeal and non-hypopharyngeal cancer. A retrospective review of 48 patients undergoing radiation for non-laryngeal and non-hypopharyngeal head and neck cancers was conducted. All patients had a modified barium swallow (MBS) prior to treatment, which was repeated one month following radiotherapy. Mean middle and inferior pharyngeal dose was recorded and correlated with the MBS results to determine aspiration risk. Results: Mean pharyngeal dose was 23.2 Gy for the whole group. Two patients (4.2%) developed trace aspiration following radiotherapy which resolved with swallowing therapy. At a median follow-up of 19 months (1-48 months), all patients were able to resume normal oral feeding without aspiration. Conclusion and Clinical Relevance: IGRT may reduce the aspiration risk by decreasing the mean pharyngeal dose in the presence of large cervical lymph nodes. Further prospective studies with IGRT should be performed in patients with non-laryngeal and non-hypopharyngeal head and neck cancers to verify this hypothesis.	[Nguyen, Nam P.; Smith-Raymond, Lexie; Davis, Rick; Abraham, Dave; Stevie, Michelle; Jo, Beng-Hoey; Ceizyk, Misty] Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA; [Vinh-Hung, Vincent] Univ Hosp Geneva, Dept Radiat Oncol, Geneva, Switzerland; [Vos, Paul] E Carolina Univ, Greenville, NC USA; [Desai, Anand; Krafft, Shane P.] Univ Texas MD Anderson, Dept Radiat Oncol, Houston, TX USA; [Sroka, Thomas] Dartmouth Coll, Dept Radiat Oncol, Hanover, NH 03755 USA; [Modarresifar, Homayoun] Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA	University of Arizona; University of Geneva; University of North Carolina; East Carolina University; University of Texas System; UTMD Anderson Cancer Center; Dartmouth College; University of Arizona	Nguyen, NP (corresponding author), Univ Arizona, Dept Radiat Oncol, Tucson, AZ 85721 USA.	NamPhong.Nguyen@yahoo.com	Vinh-Hung, Vincent/A-5762-2008	Vinh-Hung, Vincent/0000-0002-6403-6120; Krafft, Shane/0000-0002-4582-8587				Amdur RJ, 2007, INT J RADIAT ONCOL, V69, pS46, DOI 10.1016/j.ijrobp.2007.04.091; Caglar HB, 2008, INT J RADIAT ONCOL, V72, P1110, DOI 10.1016/j.ijrobp.2008.02.048; Chao KSC, 2003, INT J RADIAT ONCOL, V55, P312, DOI 10.1016/S0360-3016(02)03940-8; Dirix P, 2009, INT J RADIAT ONCOL, V78, P1356; Eisbruch A, 2004, INT J RADIAT ONCOL, V60, P1425, DOI 10.1016/j.ijrobp.2004.05.050; Feng FY, 2007, INT J RADIAT ONCOL, V68, P1289, DOI 10.1016/j.ijrobp.2007.02.049; Feng FY, 2010, J CLIN ONCOL, V28, P2732, DOI 10.1200/JCO.2009.24.6199; Fua TF, 2007, INT J RADIAT ONCOL, V67, P976, DOI 10.1016/j.ijrobp.2006.10.028; Gokhale AS, 2010, ANN ONCOL, V21, P145, DOI 10.1093/annonc/mdp268; Kamprad F, 2008, STRAHLENTHER ONKOL, V184, P157, DOI 10.1007/s00066-008-1780-z; Langerman A, 2007, ARCH OTOLARYNGOL, V133, P1289, DOI 10.1001/archotol.133.12.1289; Lee N, 2007, INT J RADIAT ONCOL, V68, P1299, DOI 10.1016/j.ijrobp.2006.11.019; Levendag PC, 2007, RADIOTHER ONCOL, V85, P64, DOI 10.1016/j.radonc.2007.07.009; Logemann JA, 2006, HEAD NECK-J SCI SPEC, V28, P64, DOI 10.1002/hed.20299; Nguyen NP, 2008, BRIT J RADIOL, V81, P706, DOI 10.1259/bjr/98862877; Nguyen NP, 2009, BRIT J RADIOL, V82, P675, DOI 10.1259/bjr/72852974; Nguyen NP, 2008, ANTICANCER RES, V28, P431; Nguyen NP, 2007, ORAL ONCOL, V43, P352, DOI 10.1016/j.oraloncology.2006.04.002; Nguyen NP, 2006, RADIOTHER ONCOL, V80, P302, DOI 10.1016/j.radonc.2006.07.031; Nguyen NP, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-253; Nguyen NP, 2011, ORAL ONCOL, V47, P900, DOI 10.1016/j.oraloncology.2011.06.004; Nguyen NP, 2010, ORAL ONCOL, V46, P283, DOI 10.1016/j.oraloncology.2010.01.010; Schwartz DL, 2010, INT J RADIAT ONCOL, V78, P1356, DOI 10.1016/j.ijrobp.2009.10.002	23	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e56290	10.1371/journal.pone.0056290	http://dx.doi.org/10.1371/journal.pone.0056290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505414	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500007
J	Capra, V; Mascelli, S; Garre, ML; Nozza, P; Vaccari, C; Bricco, L; Sloan-Bena, F; Gimelli, S; Cuoco, C; Gimelli, G; Tassano, E				Capra, Valeria; Mascelli, Samantha; Garre, Maria Luisa; Nozza, Paolo; Vaccari, Carlotta; Bricco, Lara; Sloan-Bena, Frederique; Gimelli, Stefania; Cuoco, Cristina; Gimelli, Giorgio; Tassano, Elisa			Parental Imbalances Involving Chromosomes 15q and 22q May Predispose to the Formation of De Novo Pathogenic Microdeletions and Microduplications in the Offspring	PLOS ONE			English	Article							22Q11.2 DELETION SYNDROME; MENTAL-RETARDATION; GENOMIC DISORDERS; DUPLICATION	Microarray-based comparative genomic hybridization (array-CGH) led to the discovery of genetic abnormalities among patients with complex phenotype and normal karyotype. Also several apparently normal individuals have been found to be carriers of cryptic imbalances, hence the importance to perform parental investigations after the identification of a deletion/duplication in a proband. Here, we report the molecular cytogenetic characterization of two individuals in which the microdeletions/duplications present in their parents could have predisposed and facilitated the formation of de novo pathogenic different copy number variations (CNVs). In family 1, a 4-year-old girl had a de novo pathogenic 10.5 Mb duplication at 15q21.2q22.2, while her mother showed a 2.262 Mb deletion at 15q13.2q13.3; in family 2, a 9-year-old boy had a de novo 1.417 Mb deletion at 22q11.21 and a second paternal deletion of 247 Kb at 22q11.23 on the same chromosome 22. Chromosome 22 at band q11.2 and chromosome 15 at band q11q13 are considered unstable regions. We could hypothesize that 15q13.2q13.3 and 22q11.21 deletions in the two respective parents might have increased the risk of rearrangements in their children. This study highlights the difficulty to make genetic counseling and predict the phenotypic consequences in these situations.	[Capra, Valeria; Mascelli, Samantha] Ist Giannina Gaslini, Unita Operat Neurochirurg, I-16148 Genoa, Italy; [Garre, Maria Luisa] Ist Giannina Gaslini, Modulo Dipartimentale Neurooncol, I-16148 Genoa, Italy; [Nozza, Paolo] Ist Giannina Gaslini, Unita Operat Anat Patol, I-16148 Genoa, Italy; [Vaccari, Carlotta; Bricco, Lara] Ist Giannina Gaslini, Mol Genet & Cytogenet Unit, I-16148 Genoa, Italy; [Sloan-Bena, Frederique; Gimelli, Stefania] Univ Hosp Geneva, Serv Genet Med, Geneva, Switzerland; [Cuoco, Cristina; Gimelli, Giorgio; Tassano, Elisa] Ist Giannina Gaslini, Lab Citogenet, I-16148 Genoa, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Geneva; University of Genoa; IRCCS Istituto Giannina Gaslini	Tassano, E (corresponding author), Ist Giannina Gaslini, Lab Citogenet, I-16148 Genoa, Italy.	eli.tassano@gmail.com	Tassano, Elisa/AAB-1108-2020; Nozza, Paolo/AAC-5901-2022; Garrè, Maria Luisa/K-4205-2018; Valeria, Capra/AAB-1501-2019; capra, valeria/N-4367-2013	Tassano, Elisa/0000-0003-2037-0554; Garrè, Maria Luisa/0000-0002-9055-3340; Nozza, Paolo/0000-0002-7595-1420; capra, valeria/0000-0002-3097-0388	Contributi del "Cinque per mille dell'IRPEF"-Finanziamento della ricerca sanitaria; Finanziamento Ricerca Corente, Ministero Salute	Contributi del "Cinque per mille dell'IRPEF"-Finanziamento della ricerca sanitaria; Finanziamento Ricerca Corente, Ministero Salute	The work has been supported by Contributi del "Cinque per mille dell'IRPEF"-Finanziamento della ricerca sanitaria and Finanziamento Ricerca Corente, Ministero Salute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aradhya S, 2007, AM J MED GENET A, V143A, P1431, DOI 10.1002/ajmg.a.31773; Bailey JA, 2003, COLD SPRING HARB SYM, V68, P115, DOI 10.1101/sqb.2003.68.115; Carlson C, 1997, AM J HUM GENET, V61, P620, DOI 10.1086/515508; Fernandez L, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-48; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Kerstjens-Frederikse WS, 1999, J MED GENET, V36, P721; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Ou Z, 2008, GENET MED, V10, P267, DOI 10.1097/GIM.0b013e31816b64c2; Rauch A, 2005, J MED GENET, V42, P871, DOI 10.1136/jmg.2004.030619; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Tabet AC, 2012, EUR J HUM GENET, V20, P594, DOI 10.1038/ejhg.2012.32; Tan TY, 2010, CLIN GENET, V78, P201, DOI 10.1111/j.1399-0004.2010.01456.x; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Van der Aa N, 2009, EUR J MED GENET, V52, P94, DOI 10.1016/j.ejmg.2009.02.006; Zody MC, 2006, NATURE, V440, P671, DOI 10.1038/nature04601	20	6	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57910	10.1371/journal.pone.0057910	http://dx.doi.org/10.1371/journal.pone.0057910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483941	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100054
J	Klassen, JL; Currie, CR				Klassen, Jonathan L.; Currie, Cameron R.			ORFcor: Identifying and Accommodating ORF Prediction Inconsistencies for Phylogenetic Analysis	PLOS ONE			English	Article							TRANSLATION INITIATION SITE; PROKARYOTIC GENOMES; MICROBIAL GENOMES; GENE PREDICTION; ANNOTATION; PHYLOGENOMICS; INFERENCE; PIPELINE; ERRORS	The high-throughput annotation of open reading frames (ORFs) required by modern genome sequencing projects necessitates computational protocols that sometimes annotate orthologous ORFs inconsistently. Such inconsistencies hinder comparative analyses by non-uniformly extending or truncating 5 ' and/or 3 ' sequence ends, causing ORFs that are in fact identical to artificially diverge. Whereas strategies exist to correct such inconsistencies during whole-genome annotation, equivalent software designed to correct subsets of these data without genome reannotation is lacking. We therefore developed ORFcor, which corrects annotation inconsistencies using consensus start and stop positions derived from sets of closely related orthologs. ORFcor corrects inconsistent ORF annotations in diverse test datasets with specificities and sensitivities approaching 100% when sufficiently related orthologs (e.g., from the same taxonomic family) are available for comparison. The ORFcor package is implemented in Perl, multithreaded to handle large datasets, includes related scripts to facilitate high-throughput phylogenomic analyses, and is freely available at www.currielab.wisc.edu/downloads.html.	[Klassen, Jonathan L.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Currie, Cameron R.] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Klassen, JL (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	jlklassen@wisc.edu	Klassen, Jonathan/B-5060-2010	Klassen, Jonathan/0000-0003-1745-8838	Department of Energy Great Lakes Bioenery Research Center (DOE Office of Science) [BER DE-FC02-07ER64494]; National Institute of Health [GM096347]; National Science Foundation [MCB 0731822]; (Canada) National Science and Engineering Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC4GM096347] Funding Source: NIH RePORTER	Department of Energy Great Lakes Bioenery Research Center (DOE Office of Science)(United States Department of Energy (DOE)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); (Canada) National Science and Engineering Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Department of Energy Great Lakes Bioenery Research Center (DOE Office of Science BER DE-FC02-07ER64494); National Institute of Health grant GM096347; National Science Foundation grant MCB 0731822; and a postdoctoral fellowship from the (Canada) National Science and Engineering Research Council to JLK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Dunbar J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-125; Earl D, 2011, GENOME RES, V21, P2224, DOI 10.1101/gr.126599.111; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Fang G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000703; Hoff KJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-520; Hu GQ, 2009, BIOINFORMATICS, V25, P1843, DOI 10.1093/bioinformatics/btp272; Hu GQ, 2009, BIOINFORMATICS, V25, P123, DOI 10.1093/bioinformatics/btn576; Hu GQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-160; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kislyuk Andrey, 2009, Int J Bioinform Res Appl, V5, P458, DOI 10.1504/IJBRA.2009.027519; Kislyuk AO, 2010, BIOINFORMATICS, V26, P1819, DOI 10.1093/bioinformatics/btq284; Klassen JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-14; Kristensen DM, 2011, BRIEF BIOINFORM, V12, P379, DOI 10.1093/bib/bbr030; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Palleja A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-335; Pati A, 2010, NAT METHODS, V7, P455, DOI [10.1038/nmeth.1457, 10.1038/NMETH.1457]; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Starmer J, 2006, PLOS COMPUT BIOL, V2, P454, DOI 10.1371/journal.pcbi.0020057; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Wall ME, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002284; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Yu JF, 2011, DNA RES, V18, P435, DOI 10.1093/dnares/dsr030	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58387	10.1371/journal.pone.0058387	http://dx.doi.org/10.1371/journal.pone.0058387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484025	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100114
J	Mathews, P; Sear, R				Mathews, Paul; Sear, Rebecca			Family and Fertility: Kin Influence on the Progression to a Second Birth in the British Household Panel Study	PLOS ONE			English	Article							CHILD-CARE; DEMOGRAPHIC-TRANSITION; WESTERN-GERMANY; EVOLUTION; GRANDPARENTS; PERSONALITY; EUROPE; TIME; UK; REPRODUCTION	Particular features of human female life history, such as short birth intervals and the early cessation of female reproduction (menopause), are argued to be evidence that humans are 'cooperative breeders', with a reproductive strategy adapted to conditions where mothers receive substantial assistance in childraising. Evolutionary anthropologists have so far largely focussed on measuring the influence of kin on reproduction in natural fertility populations. Here we look at the effect in a present-day low-fertility population, by analysing whether kin affect parity progression in the British Household Panel Study. Two explanatory variables related to kin influence significantly increase the odds of a female having a second birth: i) having relatives who provide childcare and ii) having a larger number of frequently contacted and emotionally close relatives. Both effects were measured subject to numerous socio-economic controls and appear to be independent of one another. We therefore conclude that kin may influence the progression to a second birth. This influence is possibly due to two proximate mechanisms: kin priming through communication and kin assistance with childcare.	[Mathews, Paul] Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England; [Sear, Rebecca] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England	University of Essex; University of London; London School of Hygiene & Tropical Medicine	Mathews, P (corresponding author), Univ Essex, Inst Social & Econ Res, Colchester CO4 3SQ, Essex, England.	pmathews@essex.ac.uk	Sear, Rebecca/K-9616-2019	Sear, Rebecca/0000-0002-4315-0223	Economic and Social Research Council [EBB5800]; ESRC [ES/H00811X/1, ES/I03727X/1] Funding Source: UKRI; Economic and Social Research Council [ES/H00811X/1, ES/I03727X/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The first author was funded by the Economic and Social Research Council award EBB5800. http://www.esrc.ac.uk/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P.D., 1984, EVENT HIST ANAL REGR; Alvergne A, 2010, P NATL ACAD SCI; [Anonymous], 2007, ENDS MEANS FUTURE RO; Asendorpf JB, 1998, J PERS SOC PSYCHOL, V74, P1531, DOI 10.1037/0022-3514.74.6.1531; Attias-Donfut Claudine, 2005, Eur J Ageing, V2, P161, DOI 10.1007/s10433-005-0008-7; AXINN WG, 1994, DEMOGRAPHY, V31, P65, DOI 10.2307/2061908; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Becker Gary S., 1991, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; Bell A, 2005, USE CHILDCARE FAMILI; Box-Steffensmeier JanetM., 2004, EVENT HIST MODELING; Burgless RL, 2005, EVOLUTIONARY PERSPEC; CASPI A, 1999, HDB PERSONALITY THEO; Clarke L, 2003, GRANDPARENTHOOD ITS; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Coleman DA, 2010, POP STUD-J DEMOG, V64, P19, DOI 10.1080/00324720903391201; COSTA PT, 1992, PERS INDIV DIFFER, V13, P653, DOI 10.1016/0191-8869(92)90236-I; DAVIS K, 1956, ECON DEV CULT CHANGE, V4, P211, DOI 10.1086/449714; Del Boca D, 2002, J POPUL ECON, V15, P549, DOI 10.1007/s001480100089; Engelhardt H, 2004, EUR J POPUL, V20, P35, DOI 10.1023/B:EUJP.0000014543.95571.3b; Fergusson E, 2008, J CHILD PSYCHOL PSYC, V49, P161, DOI 10.1111/j.1469-7610.2007.01840.x; Gray A, 2005, J SOC POLICY, V34, P557, DOI 10.1017/S0047279405009153; Greene ME, 2000, POPUL DEV REV, V26, P81, DOI 10.1111/j.1728-4457.2000.00081.x; Grundy E., 2006, CAMBRIDGE SOCIOLEGAL, P195; Grundy E., 1999, POPULATION TRENDS, V97, P19; Gutman D, 1988, RECLAIMED POWERS NEW; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hank K, 2003, J MARRIAGE FAM, V65, P584, DOI 10.1111/j.1741-3737.2003.00584.x; Hank K, 2009, J FAM ISSUES, V30, P53, DOI 10.1177/0192513X08322627; Hansen K, 2009, J SOC POLICY, V38, P211, DOI 10.1017/S004727940800281X; Hawkes D, 2007, MILLENNIUM COHORT ST; Hawkes K, 1997, CURR ANTHROPOL, V38, P551, DOI 10.1086/204646; Hill K., 1996, ACHE LIFE HIST ECOLO, DOI 10.4324/9781351329248; Hrdy S. B., 2006, ATTACHMENT BONDING N; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Iacovou M, 2011, POPUL DEV REV, V37, P89, DOI 10.1111/j.1728-4457.2011.00391.x; Igel C, 2011, J EUR SOC POLICY, V21, P210, DOI 10.1177/0958928711401766; Jappens M, 2012, DEMOGR RES, V27, P85, DOI 10.4054/DemRes.2012.27.4; Jokela M, 2009, J PERS SOC PSYCHOL, V96, P218, DOI 10.1037/a0014058; Joshi H., 2008, MILLENNIUM COHORT ST, P76; Kaptijn R, 2010, HUM NATURE-INT BIOS, V21, P393, DOI 10.1007/s12110-010-9098-9; Keim S, 2009, CURR SOCIOL, V57, P888, DOI 10.1177/0011392109342226; Kramer KL, 2005, EVOL ANTHROPOL, V14, P224, DOI 10.1002/evan.20082; Lang FR, 2006, HDB PERSONALITY DEV; LEHRER EL, 1985, DEMOGRAPHY, V22, P499, DOI 10.2307/2061585; Lundberg S, 2005, OXFORD REV ECON POL, V21, P340, DOI 10.1093/oxrep/gri020; Mace R., 2005, GRANDMOTHERHOOD EVOL, P143; Mathews P, 2012, DEMOGRAPHIC IN PRESS; McQuillan K, 2004, POPUL DEV REV, V30, P25, DOI 10.1111/j.1728-4457.2004.00002.x; Mulder MB, 1998, TRENDS ECOL EVOL, V13, P266, DOI 10.1016/S0169-5347(98)01357-3; Murphy M, 1999, SOC BIOL, V46, P122; Murphy M, 2008, POPUL DEV REV, V34, P19, DOI 10.1111/j.1728-4457.2008.00204.x; Nettle D, 2006, AM PSYCHOL, V61, P622, DOI 10.1037/0003-066X.61.6.622; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; NEWMAN JL, 1983, AM ECON REV, V73, P33; Newson L, 2005, PERS SOC PSYCHOL REV, V9, P360, DOI 10.1207/s15327957pspr0904_5; Newson L, 2007, EVOL HUM BEHAV, V28, P199, DOI 10.1016/j.evolhumbehav.2007.01.003; Nolan J, 2006, KINSHIP MATTERS, P175; Owen C, 2004, MILLENNIUM COHORT ST, P51; Pahl R, 2005, BRIT J SOCIOL, V56, P433, DOI 10.1111/j.1468-4446.2005.00076.x; Rendall Michael S, 2003, Popul Trends, P18; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Sear R, 2011, POPUL DEV REV, V37, P81, DOI 10.1111/j.1728-4457.2011.00379.x; Shiner R. L., 2006, HDB PERSONALITY DEV; SMITH JM, 1978, ANNU REV ECOL SYST, V9, P31, DOI 10.1146/annurev.es.09.110178.000335; Srivastava S, 2003, J PERS SOC PSYCHOL, V84, P1041, DOI 10.1037/0022-3514.84.5.1041; Strassmann BI, 2011, P NATL ACAD SCI USA, V108, P10894, DOI 10.1073/pnas.1100306108; Tan JP, 2010, J FAM ISSUES, V31, P992, DOI 10.1177/0192513X09360499; Tavares L.P., 2010, ISER WORKING PAPER S; TURKE PW, 1989, POPUL DEV REV, V15, P61, DOI 10.2307/1973405; Vandell DL, 2003, J MARRIAGE FAM, V65, P375, DOI 10.1111/j.1741-3737.2003.00375.x; Waynforth D., 2011, P ROYAL SOC B; Wheelock J, 2002, J SOC POLICY, V31, P441, DOI 10.1017/S0047279402006657; Young Michael, 1957, FAMILY KINSHIP E LON	74	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e56941	10.1371/journal.pone.0056941	http://dx.doi.org/10.1371/journal.pone.0056941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516398	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000316849200006
J	Kim, J; Lee, D; Kahng, B				Kim, Jinhong; Lee, Deokjae; Kahng, Byungnam			Microscopic Modelling Circadian and Bursty Pattern of Human Activities	PLOS ONE			English	Article							HEAVY TAILS; DYNAMICS; MEMORY	Recent studies for a wide range of human activities such as email communication, Web browsing, and library visiting, have revealed the bursty nature of human activities. The distribution of inter-event times (IETs) between two consecutive human activities exhibits a heavy-tailed decay behavior and the oscillating pattern with a one-day period, reflective of the circadian pattern of human life. Even though a priority-based queueing model was successful as a basic model for understanding the heavy-tailed behavior, it ignored important ingredients, such as the diversity of individual activities and the circadian pattern of human life. Here, we collect a large scale of dataset which contains individuals' time stamps when articles are posted on blog posts, and based on which we construct a theoretical model which can take into account of both ignored ingredients. Once we identify active and inactive time intervals of individuals and remove the inactive time interval, thereby constructing an ad hoc continuous time domain. Therein, the priority-based queueing model is applied by adjusting the arrival and the execution rates of tasks by comparing them with the activity data of individuals. Then, the obtained results are transferred back to the real-time domain, which produces the oscillating and heavy-tailed IET distribution. This microscopic model enables us to develop theoretical understanding towards more empirical results.	[Kim, Jinhong] NHN Corp, Complex Syst Anal Team, Songnam, Gyeonggi Do, South Korea; [Lee, Deokjae; Kahng, Byungnam] Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea	Seoul National University (SNU)	Kahng, B (corresponding author), Seoul Natl Univ, Dept Phys & Astron, Seoul, South Korea.	bkahng@snu.ac.kr			National Research Foundation [2010-0015066]	National Research Foundation	National Research Foundation grant awarded through the Acceleration Research Program (Grant No. 2010-0015066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BURSTS HIDDEN PATTER; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Chessa AG, 2004, PHYSICA A, V333, P541, DOI 10.1016/j.physa.2003.10.037; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Dezso Z, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066132; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Goh KI, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/48002; Grinstein G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.130201; Harder U, 2006, PHYSICA A, V361, P329, DOI 10.1016/j.physa.2005.06.079; Hidalgo CA, 2006, PHYSICA A, V369, P877, DOI 10.1016/j.physa.2005.12.035; Holme P, 2003, EUROPHYS LETT, V64, P427, DOI 10.1209/epl/i2003-00505-4; Jo HH, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013055; Jo HH, 2012, PHYS REV E, V85; Johansen A, 2004, PHYSICA A, V338, P286, DOI 10.1016/j.physa.2004.02.054; Johansen A, 2000, PHYSICA A, V276, P338, DOI 10.1016/S0378-4371(99)00468-9; Johansen A, 2001, PHYSICA A, V296, P539, DOI 10.1016/S0378-4371(01)00202-3; Karsai M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00397; Kivela M, 2011, J STAT MECH-THEORY E; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; LEWIS PAW, 1979, NAV RES LOG, V26, P403, DOI 10.1002/nav.3800260304; Malmgren RD, 2009, SCIENCE, V325, P1696, DOI 10.1126/science.1174562; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026118; Scalas E, 2006, PHYSICA A, V366, P463, DOI 10.1016/j.physa.2005.09.047; Vajna S, 2012, ARXIV12111175; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Vazquez A, 2007, PHYSICA A, V373, P747, DOI 10.1016/j.physa.2006.04.060; Wu Y, 2010, P NATL ACAD SCI USA, V107, P18803, DOI 10.1073/pnas.1013140107; Zhou T, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/28002	32	103	105	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58292	10.1371/journal.pone.0058292	http://dx.doi.org/10.1371/journal.pone.0058292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505479	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100042
J	Molloy, EM; Field, D; O'Connor, PM; Cotter, PD; Hill, C; Ross, RP				Molloy, Evelyn M.; Field, Des; O'Connor, Paula M.; Cotter, Paul D.; Hill, Colin; Ross, R. Paul			Saturation Mutagenesis of Lysine 12 Leads to the Identification of Derivatives of Nisin A with Enhanced Antimicrobial Activity	PLOS ONE			English	Article							PRECURSOR LIPID II; LANTIBIOTIC NISIN; LISTERIA-MONOCYTOGENES; LACTOCOCCUS-LACTIS; INNATE RESISTANCE; PEPTIDES; GENE; BIOSYNTHESIS; PROTEIN; ACID	It is becoming increasingly apparent that innovations from the "golden age'' of antibiotics are becoming ineffective, resulting in a pressing need for novel therapeutics. The bacteriocin family of antimicrobial peptides has attracted much attention in recent years as a source of potential alternatives. The most intensively studied bacteriocin is nisin, a broad spectrum lantibiotic that inhibits Gram-positive bacteria including important food pathogens and clinically relevant antibiotic resistant bacteria. Nisin is gene-encoded and, as such, is amenable to peptide bioengineering, facilitating the generation of novel derivatives that can be screened for desirable properties. It was to this end that we used a site-saturation mutagenesis approach to create a bank of producers of nisin A derivatives that differ with respect to the identity of residue 12 (normally lysine; K12). A number of these producers exhibited enhanced bioactivity and the nisin A K12A producer was deemed of greatest interest. Subsequent investigations with the purified antimicrobial highlighted the enhanced specific activity of this modified nisin against representative target strains from the genera Streptococcus, Bacillus, Lactococcus, Enterococcus and Staphylococcus.	[Molloy, Evelyn M.; Field, Des; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Cork, Ireland; [O'Connor, Paula M.; Cotter, Paul D.; Hill, Colin; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [O'Connor, Paula M.; Cotter, Paul D.; Ross, R. Paul] Teagasc Food Res Ctr, Fermoy, Cork, Ireland	University College Cork; University College Cork; Teagasc	Cotter, PD (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	paul.cotter@teagasc.ie; c.hill@ucc.ie	Hill, Colin/A-5611-2012; Cotter, Paul/B-7781-2008; Field, Des/AAU-6785-2021; Cotter, Paul/AAX-5449-2021; Ross, Paul/A-7584-2015; STANTON, CATHERINE/A-9549-2015	Hill, Colin/0000-0002-8527-1445; Cotter, Paul/0000-0002-5465-9068; Cotter, Paul/0000-0002-5465-9068; Ross, Paul/0000-0003-4876-8839; O'Connor, Paula M./0000-0001-6462-2077; STANTON, CATHERINE/0000-0002-6724-7011; Field, Des/0000-0003-4425-5817; Molloy, Evelyn/0000-0001-8822-7207	Irish Government under the National Development Plan; Irish Research Council for Science Engineering and Technology (IRCSET); Enterprise Ireland; Science Foundation Ireland (SFI), through the Alimentary Pharmabiotic Centre (APC) at University College Cork, Ireland; SFI	Irish Government under the National Development Plan; Irish Research Council for Science Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Enterprise Ireland; Science Foundation Ireland (SFI), through the Alimentary Pharmabiotic Centre (APC) at University College Cork, Ireland(Science Foundation Ireland); SFI(Science Foundation Ireland)	This work was supported by the Irish Government under the National Development Plan; by the Irish Research Council for Science Engineering and Technology (IRCSET); by Enterprise Ireland; and by Science Foundation Ireland (SFI), through the Alimentary Pharmabiotic Centre (APC) at University College Cork, Ireland, which is supported by the SFI-funded Centre for Science, Engineering and Technology (SFI-CSET) and provided P. D. C., C. H. and R. P. R. with SFI Principal Investigator funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abachin E, 2002, MOL MICROBIOL, V43, P1, DOI 10.1046/j.1365-2958.2002.02723.x; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Bartoloni A, 2004, J CHEMOTHERAPY, V16, P119, DOI 10.1179/joc.2004.16.2.119; Begley M, 2010, APPL ENVIRON MICROB, V76, P6541, DOI 10.1128/AEM.00203-10; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Breukink E, 1999, SCIENCE, V286, P2361, DOI 10.1126/science.286.5448.2361; Breukink E, 1998, BIOCHEMISTRY-US, V37, P8153, DOI 10.1021/bi972797l; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; BROADBENT JR, 1989, J DAIRY SCI, V72, P3342, DOI 10.3168/jds.S0022-0302(89)79496-0; Castiglione F, 2008, CHEM BIOL, V15, P22, DOI 10.1016/j.chembiol.2007.11.009; Castiglione F, 2007, BIOCHEMISTRY-US, V46, P5884, DOI 10.1021/bi700131x; Collins B, 2010, ANTIMICROB AGENTS CH, V54, P4658, DOI 10.1128/AAC.00290-10; Collins B, 2010, ANTIMICROB AGENTS CH, V54, P4416, DOI 10.1128/AAC.00503-10; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; de Kwaadsteniet M, 2008, APPL ENVIRON MICROB, V74, P547, DOI 10.1128/AEM.01862-07; Delves-Broughton J, 2005, FOOD AUST, V57, P525; Dodd HM, 1996, MICROBIOL-SGM, V142, P47, DOI 10.1099/13500872-142-1-47; Field D, 2008, MOL MICROBIOL, V69, P218, DOI 10.1111/j.1365-2958.2008.06279.x; Field D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046884; Field D, 2010, MOL MICROBIOL, V78, P1077, DOI 10.1111/j.1365-2958.2010.07406.x; Field D, 2010, MICROB BIOTECHNOL, V3, P473, DOI 10.1111/j.1751-7915.2010.00184.x; Galvez A, 2007, INT J FOOD MICROBIOL, V120, P51, DOI 10.1016/j.ijfoodmicro.2007.06.001; Glaser P, 2001, SCIENCE, V294, P849; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; KALETTA C, 1989, J BACTERIOL, V171, P1597, DOI 10.1128/jb.171.3.1597-1601.1989; Klein G, 2003, INT J FOOD MICROBIOL, V88, P123, DOI 10.1016/S0168-1605(03)00175-2; KUIPERS OP, 1992, J BIOL CHEM, V267, P24340; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Kuipers OP, 1996, ANTON LEEUW INT J G, V69, P161, DOI 10.1007/BF00399421; Kuipers OP, 1994, 2 INT WORKSH LANT AR; Lubelski J, 2008, CELL MOL LIFE SCI, V65, P455, DOI 10.1007/s00018-007-7171-2; Lubelski J, 2009, J BIOL CHEM, V284, P25962, DOI 10.1074/jbc.M109.026690; Maher S, 2006, BIOCHEM PHARMACOL, V71, P1289, DOI 10.1016/j.bcp.2006.01.012; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; Martin I, 1996, EUR J BIOCHEM, V239, P156, DOI 10.1111/j.1432-1033.1996.0156u.x; Molloy EM, 2012, BIOCHEM SOC T, V40, P1492, DOI 10.1042/BST20120193; Mondino SSB, 2003, MICROB DRUG RESIST, V9, P167, DOI 10.1089/107662903765826769; MULDERS JWM, 1991, EUR J BIOCHEM, V201, P581, DOI 10.1111/j.1432-1033.1991.tb16317.x; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Piper C, 2009, J ANTIMICROB CHEMOTH, V64, P546, DOI 10.1093/jac/dkp221; Rink R, 2005, BIOCHEMISTRY-US, V44, P8873, DOI 10.1021/bi050081h; Rink R, 2007, APPL ENVIRON MICROB, V73, P5809, DOI 10.1128/AEM.01104-07; ROLLEMA HS, 1995, APPL ENVIRON MICROB, V61, P2873, DOI 10.1128/AEM.61.8.2873-2878.1995; Rouse S, 2012, MICROB BIOTECHNOL, V5, P501, DOI 10.1111/j.1751-7915.2011.00324.x; SCHNELL N, 1988, NATURE, V333, P276, DOI 10.1038/333276a0; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SEARS PM, 1992, J DAIRY SCI, V75, P3185, DOI 10.3168/jds.S0022-0302(92)78083-7; Severina E, 1998, J ANTIMICROB CHEMOTH, V41, P341, DOI 10.1093/jac/41.3.341; STEVENS KA, 1991, APPL ENVIRON MICROB, V57, P3613, DOI 10.1128/AEM.57.12.3613-3615.1991; Thedieck K, 2006, MOL MICROBIOL, V62, P1325, DOI 10.1111/j.1365-2958.2006.05452.x; van Heusden HE, 2002, BIOCHEMISTRY-US, V41, P12171, DOI 10.1021/bi026090x; van Kraaij C, 2000, EUR J BIOCHEM, V267, P901, DOI 10.1046/j.1432-1327.2000.01075.x; vandenHooven HW, 1996, EUR J BIOCHEM, V235, P382, DOI 10.1111/j.1432-1033.1996.00382.x; VanKraaij C, 1997, EUR J BIOCHEM, V247, P114; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; Wilson-Stanford S, 2009, APPL ENVIRON MICROB, V75, P1381, DOI 10.1128/AEM.01864-08; Wirawan RE, 2006, APPL ENVIRON MICROB, V72, P1148, DOI 10.1128/AEM.72.2.1148-1156.2006; Wu JQ, 2007, ANTIMICROB AGENTS CH, V51, P3131, DOI 10.1128/AAC.00629-07; Yuan J, 2004, APPL MICROBIOL BIOT, V64, P806, DOI 10.1007/s00253-004-1599-1; Zendo T, 2003, BIOSCI BIOTECH BIOCH, V67, P1616, DOI 10.1271/bbb.67.1616	67	44	46	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58530	10.1371/journal.pone.0058530	http://dx.doi.org/10.1371/journal.pone.0058530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505531	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100061
J	Pfaff, KL; King, RW				Pfaff, Kathleen L.; King, Randall W.			Determinants of Human Cyclin B1 Association with Mitotic Chromosomes	PLOS ONE			English	Article							MAMMALIAN-CELLS; NUCLEAR TRANSPORT; BINDING DOMAIN; IN-VITRO; MITOSIS; PHOSPHORYLATION; RCC1; LOCALIZATION; SEPARASE; SPINDLE	Cyclin B1-CDK1 activity is essential for mitotic entry, but questions remain regarding how the activity of this kinase is spatially regulated. Previous studies showed that the cyclin B1 subunit localizes to several compartments of a mitotic cell, including the centrosomes, mitotic spindle, kinetochores and chromosomes via distinct sequence elements. Mitotic chromosome association occurs through the unstructured N-terminal domain of cyclin B1 and is independent of CDK1 binding. Here, we use live cell imaging of human cyclin B1 fused to GFP to precisely define the sequence elements within cyclin B1 that mediate its association with condensed mitotic chromosomes. We find that a short, evolutionarily conserved N-terminal motif is required for cyclin B1 to localize to mitotic chromosomes. We further reveal a role for arginine residues within and near the destruction box sequence in the chromosome association of cyclin B1. Additionally, our data suggest that sequences further downstream in cyclin B1, such as the cytoplasmic retention sequence and the cyclin box, may negatively modulate chromosome association. Because multiple basic residues are required for cyclin B1 association with mitotic chromosomes, electrostatic interactions with DNA may facilitate cyclin B1 localization to chromosomes.	[Pfaff, Kathleen L.; King, Randall W.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School	King, RW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02114 USA.	randy_king@hms.harvard.edu		King, Randall/0000-0001-7882-8180	National Institutes of Health [R01-GM66492]; National Institutes of General Medical Sciences NRSA fellowship [5F32-GM085923]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM085923, R01GM066492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of General Medical Sciences NRSA fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a National Institutes of Health grant R01-GM66492 (to RWK) and a National Institutes of General Medical Sciences NRSA fellowship 5F32-GM085923 (to KLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2011, GENE DEV, V25, P863, DOI 10.1101/gad.2016411; BAILLY E, 1992, J CELL SCI, V101, P529; Bentley AM, 2007, MOL BIOL CELL, V18, P4847, DOI 10.1091/mbc.E06-06-0539; Boos D, 2008, J BIOL CHEM, V283, P816, DOI 10.1074/jbc.M706748200; Chen Q, 2008, CELL RES, V18, P268, DOI 10.1038/cr.2008.11; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Dasso M, 2001, CELL, V104, P321, DOI 10.1016/S0092-8674(01)00218-5; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Escargueil AE, 2001, FASEB J, V15, P2288, DOI 10.1096/fj.00-0726fje; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gorr IH, 2005, MOL CELL, V19, P135, DOI 10.1016/j.molcel.2005.05.022; HARTL P, 1993, J CELL BIOL, V120, P613, DOI 10.1083/jcb.120.3.613; Holland AJ, 2006, J CELL SCI, V119, P3325, DOI 10.1242/jcs.03083; Huang JY, 2007, J CELL SCI, V120, P1990, DOI 10.1242/jcs.006833; Huang JY, 2002, J CELL SCI, V115, P2847; Hutchins JRA, 2004, CURR BIOL, V14, P1099, DOI 10.1016/j.cub.2004.05.021; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jorgensen PM, 1998, MOL CELL BIOL, V18, P468; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Li HY, 2004, GENE DEV, V18, P512, DOI 10.1101/gad.1177304; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Moore WJ, 2002, CURR BIOL, V12, P1442, DOI 10.1016/S0960-9822(02)01076-X; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; NUGENT JHA, 1991, J CELL SCI, V99, P669; PINES J, 1994, EMBO J, V13, P3772, DOI 10.1002/j.1460-2075.1994.tb06688.x; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; RATTNER JB, 1990, CELL MOTIL CYTOSKEL, V17, P227, DOI 10.1002/cm.970170309; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Santos SDM, 2012, CELL, V149, P1500, DOI 10.1016/j.cell.2012.05.028; SEINO H, 1992, J CELL SCI, V102, P393; Stals H, 1997, FEBS LETT, V418, P229, DOI 10.1016/S0014-5793(97)01368-9; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Topper LM, 2002, CELL CYCLE, V1, P282, DOI 10.4161/cc.1.4.139; West SM, 2010, J BIOMOL STRUCT DYN, V27, P861, DOI 10.1080/07391102.2010.10508587; Woods AS, 2005, J PROTEOME RES, V4, P1397, DOI 10.1021/pr050077s; Yang J, 1998, GENE DEV, V12, P2131, DOI 10.1101/gad.12.14.2131; Yang J, 2001, J BIOL CHEM, V276, P3604, DOI 10.1074/jbc.M008151200; Yuan K, 2009, CELL CYCLE, V8, P1433, DOI 10.4161/cc.8.9.8331	47	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e59169	10.1371/journal.pone.0059169	http://dx.doi.org/10.1371/journal.pone.0059169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505570	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100125
J	Figarska, SM; Vonk, JM; Boezen, HM				Figarska, Sylwia M.; Vonk, Judith M.; Boezen, H. Marike			SIRT1 Polymorphism, Long-Term Survival and Glucose Tolerance in the General Population	PLOS ONE			English	Article							LIFE-SPAN; HUMAN LONGEVITY; CALORIE RESTRICTION; CHINESE POPULATION; INSULIN-SECRETION; INCREASED DOSAGE; LUNG-FUNCTION; VARIANTS; SIRTUINS; MICE	Mutations that increase activity of Sir2 (silent information regulator 2) are associated with extended lifespan of yeast, fruit flies and worms. SIRT1, the human homolog of Sir2, that controls numerous physiological processes including the glucose metabolism, is considered a candidate gene for predicting variation in human lifespan. Whereas the role of Sir2 has been extensively investigated in model organisms, less is known about the relation between SIRT1 and lifespan in humans. In the current study we included 1,390 subjects from a general population-based cohort with 18 years of follow-up to investigate associations between variation in single nucleotide polymorphisms (SNPs) in the SIRT1 gene and human survival. Additionally in 535 male subjects with available data we investigated associations between SIRT1 and glucose tolerance. Carriers of the minor allele of rs12778366 had a significantly reduced mortality risk compared to the wild types: Hazard Ratio 0.69 (95% CI 0.50 to 0.96; p = 0.025). The directions of the effect were the same in females and males, never and ever smokers and the effect was significantly protective in overweight/obese subjects. Carriers of the minor allele of SNP rs12778366 had better glucose tolerance indicated by 0.34 mmol/l lower glucose levels compared to wild type subjects (p = 0.03). This study shows that SIRT1 affects human long-term survival and therefore may be an important factor in modulating lifespan not only in lower organisms, but also in humans.	[Figarska, Sylwia M.; Vonk, Judith M.; Boezen, H. Marike] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen	Boezen, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	h.m.boezen@umcg.nl	Vonk, Judith/K-8477-2019; Vonk, Judith M/ABA-3009-2020	Vonk, Judith/0000-0001-7531-4547; Vonk, Judith M/0000-0001-7531-4547; Figarska, Sylwia/0000-0003-3601-1548	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands; Stichting Astma Bestrijding [2005/020]; Netherlands Asthma Foundation [3.2.02.51]	Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands; Stichting Astma Bestrijding; Netherlands Asthma Foundation	This work was supported by the Graduate School for Drug Exploration (GUIDE), University Medical Center Groningen, University of Groningen, the Netherlands. The Vlagtwedde\Vlaardingen study was supported by unrestricted grants of Stichting Astma Bestrijding (grant number 2005/020) and Netherlands Asthma Foundation (grant number 3.2.02.51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2011, NAT MED, V17, P1350, DOI 10.1038/nm1111-1350; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Botden IPG, 2012, DIABETES CARE, V35, P424, DOI 10.2337/dc11-1203; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Clark SJ, 2012, OBESITY, V20, P178, DOI 10.1038/oby.2011.200; Dong Y, 2011, MOL GENET METAB, V104, P661, DOI 10.1016/j.ymgme.2011.08.001; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Flachsbart F, 2006, EXP GERONTOL, V41, P98, DOI 10.1016/j.exger.2005.09.008; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kuningas M, 2007, J GERONTOL A-BIOL, V62, P960, DOI 10.1093/gerona/62.9.960; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Peeters AV, 2008, HUM GENET, V124, P431, DOI 10.1007/s00439-008-0567-8; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Shimoyama Y, 2011, TRANSL RES, V157, P339, DOI 10.1016/j.trsl.2011.02.004; Siedlinski M, 2012, EUR RESPIR J, V39, P385, DOI 10.1183/09031936.00184110; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; van Diemen CC, 2005, AM J RESP CRIT CARE, V172, P329, DOI 10.1164/rccm.200411-1486OC; Weyrich P, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-100; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Zhang WG, 2010, CLIN CHIM ACTA, V411, P1679, DOI 10.1016/j.cca.2010.06.030; Zheng J, 2012, ENDOCR J, V59, P229, DOI 10.1507/endocrj.EJ11-0234; Zillikens MC, 2009, DIABETES, V58, P2828, DOI 10.2337/db09-0536; Zillikens MC, 2009, FREE RADICAL BIO MED, V46, P836, DOI 10.1016/j.freeradbiomed.2008.12.022	36	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58636	10.1371/journal.pone.0058636	http://dx.doi.org/10.1371/journal.pone.0058636			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505545	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500109
J	Hess, CA; Cooper, MJ; Smith, MJ; Trueman, CN; Schutkowski, H				Hess, Catherine A.; Cooper, Matthew J.; Smith, Martin J.; Trueman, Clive N.; Schutkowski, Holger			Lead Exposure in Adult Males in Urban Transvaal Province, South Africa during the Apartheid Era	PLOS ONE			English	Article							BLOOD LEAD; BONE LEAD; UNITED-STATES; CAPE-TOWN; ATMOSPHERIC LEAD; NATIONAL-HEALTH; RISK-FACTORS; TIBIA LEAD; PRESSURE; JOHANNESBURG	Human exposure to lead is a substantial public health hazard worldwide and is particularly problematic in the Republic of South Africa given the country's late cessation of leaded petrol. Lead exposure is associated with a number of serious health issues and diseases including developmental and cognitive deficiency, hypertension and heart disease. Understanding the distribution of lifetime lead burden within a given population is critical for reducing exposure rates. Femoral bone from 101 deceased adult males living in urban Transvaal Province (now Gauteng Province), South Africa between 1960 and 1998 were analyzed for lead concentration by Inductively Coupled Plasma Mass Spectrometry (ICP-MS). Of the 72 black and 29 white individuals sampled, chronic lead exposure was apparent in nearly all individuals. White males showed significantly higher median bone lead concentration (ME = 10.04 mu g.g(-1)), than black males (ME = 3.80 mu g.g(-1)) despite higher socioeconomic status. Bone lead concentration covaries significantly, though weakly, with individual age. There was no significant temporal trend in bone lead concentration. These results indicate that long-term low to moderate lead exposure is the historical norm among South African males. Unexpectedly, this research indicates that white males in the sample population were more highly exposed to lead.	[Hess, Catherine A.; Smith, Martin J.; Schutkowski, Holger] Bournemouth Univ, Sch Appl Sci, Poole BH12 5BB, Dorset, England; [Cooper, Matthew J.; Trueman, Clive N.] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England	Bournemouth University; NERC National Oceanography Centre; University of Southampton	Schutkowski, H (corresponding author), Bournemouth Univ, Sch Appl Sci, Talbot Campus, Poole BH12 5BB, Dorset, England.	hschutkowski@bournemouth.ac.uk	Trueman, Clive/E-6925-2011; Cooper, Matthew/I-8573-2012	Cooper, Matthew/0000-0002-2130-2759	University of Bournemouth Post Graduate Global Exchange Fund; Bournemouth University School of Applied Sciences Hilary Williams Fund; British Council Overseas Student Research Award Scheme	University of Bournemouth Post Graduate Global Exchange Fund; Bournemouth University School of Applied Sciences Hilary Williams Fund; British Council Overseas Student Research Award Scheme	The research was funded, in part, by the University of Bournemouth Post Graduate Global Exchange Fund, the Bournemouth University School of Applied Sciences Hilary Williams Fund, and the British Council Overseas Student Research Award Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGHURST PA, 1992, NEW ENGL J MED, V327, P1279, DOI 10.1056/NEJM199210293271805; Bandeen-Roche K, 2009, EPIDEMIOLOGY, V20, P831, DOI 10.1097/EDE.0b013e3181b5f100; BARANOWSKA I, 1995, SCI TOTAL ENVIRON, V159, P155, DOI 10.1016/0048-9697(95)04218-P; BARRY PSI, 1970, BRIT J IND MED, V27, P339; BARRY PSI, 1975, BRIT J IND MED, V32, P119; BELLINGER DC, 1992, PEDIATRICS, V90, P855; Bergdahl IA, 2008, J TOXICOL ENV HEAL A, V71, P1235, DOI 10.1080/15287390802209525; Brown RW, 2010, J IMMIGR MINOR HEALT, V12, P715, DOI 10.1007/s10903-009-9245-8; BYERLEE D, 1974, INT MIGR REV, V8, P543, DOI 10.2307/3002204; Carpenter DO, 2010, PHYSIOL BEHAV, V99, P260, DOI 10.1016/j.physbeh.2009.09.001; CDC, 2005, PREV LEAD POIS YOUNG; Cheng YW, 2001, AM J EPIDEMIOL, V153, P164, DOI 10.1093/aje/153.2.164; Dayal MR, 2009, AM J PHYS ANTHROPOL, V140, P324, DOI 10.1002/ajpa.21072; DEVEAUX P, 1986, S AFR MED J, V69, P421; Diab RD, 1999, S AFR J SCI, V95, P117; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Faber M, 2007, WATER SA, V33, P393; Glenn BS, 2006, EPIDEMIOLOGY, V17, P538, DOI 10.1097/01.ede.0000231284.19078.4b; GOYER RA, 1995, AM J CLIN NUTR, V61, p646S, DOI 10.1093/ajcn/61.3.646S; Grobler SR, 1996, S AFR MED J, V86, P169; Grosse SD, 2002, ENVIRON HEALTH PERSP, V110, P563, DOI 10.1289/ehp.02110563; HARLAN WR, 1988, ENVIRON HEALTH PERSP, V78, P9; Harper CC, 2003, INT J HYG ENVIR HEAL, V206, P315, DOI 10.1078/1438-4639-00227; Heckman J, 2010, SAMJ S AFR MED J, V100, P445, DOI 10.7196/SAMJ.3579; Herman DS, 2009, J HAZARD MATER, V166, P1410, DOI 10.1016/j.jhazmat.2008.12.070; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P961, DOI 10.2307/3434138; Hu H, 1996, AM J EPIDEMIOL, V144, P749, DOI 10.1093/oxfordjournals.aje.a008999; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Koller K, 2004, ENVIRON HEALTH PERSP, V112, P987, DOI 10.1289/ehp.6941; Kon ZR, 2008, AM J PUBLIC HEALTH, V98, P2272, DOI 10.2105/AJPH.2007.127829; L'Abbe EN, 2005, HOMO, V56, P197, DOI 10.1016/j.jchb.2004.10.004; Lanphear BP, 1996, AM J PUBLIC HEALTH, V86, P1460, DOI 10.2105/AJPH.86.10.1460; Lemon A., 1991, HOMES APART S AFRICA; MAHAFFEY KR, 1983, FED PROC, V42, P1730; Martin D, 2006, AM J EPIDEMIOL, V163, P467, DOI 10.1093/aje/kwj060; Mathee A, 2006, ENVIRON RES, V100, P319, DOI 10.1016/j.envres.2005.08.001; Mathee A, 2002, ENVIRON RES, V90, P181, DOI 10.1016/S0013-9351(02)00010-5; Mathee Angela, 2004, Reviews on Environmental Health, V19, P347; Mathee A, 2007, ENVIRON HEALTH PERSP, V115, P321, DOI 10.1289/ehp.9575; Mathee A, 2009, SAMJ S AFR MED J, V99, P819; Mielke HW, 2012, ENVIRON INT, V43, P48, DOI 10.1016/j.envint.2012.03.005; Monna F, 2006, ATMOS ENVIRON, V40, P6554, DOI 10.1016/j.atmosenv.2006.05.064; Montgomery M, 2005, ENVIRON RES, V98, P279, DOI 10.1016/j.envres.2004.10.006; Morrow L, 2007, ARCH ENVIRON OCCUP H, V62, P183, DOI 10.3200/AEOH.62.4.183-186; Motosue AM, 2009, J ALLERGY CLIN IMMUN, V123, pS20, DOI 10.1016/j.jaci.2008.12.089; Muntner P, 2005, ARCH INTERN MED, V165, P2155, DOI 10.1001/archinte.165.18.2155; Navas-Acien A, 2008, EPIDEMIOLOGY, V19, P496, DOI 10.1097/EDE.0b013e31816a2400; Needleman H, 2004, ANNU REV MED, V55, P209, DOI 10.1146/annurev.med.55.091902.103653; Needleman HL, 1996, JAMA-J AM MED ASSOC, V275, P363, DOI 10.1001/jama.275.5.363; Needleman HL, 2002, NEUROTOXICOL TERATOL, V24, P711, DOI 10.1016/S0892-0362(02)00269-6; Nevin R, 2000, ENVIRON RES, V83, P1, DOI 10.1006/enrs.1999.4045; Nevin R, 2009, ENVIRON RES, V109, P301, DOI 10.1016/j.envres.2008.12.003; Nojilana B, 2007, SAMJ S AFR MED J, V97, P741; Norman R, 2007, SAMJ S AFR MED J, V97, P773; NRIAGU JO, 1992, SCI TOTAL ENVIRON, V121, P1, DOI 10.1016/0048-9697(92)90304-B; Nriagu JO, 1996, SCI TOTAL ENVIRON, V181, P93, DOI 10.1016/0048-9697(95)04954-1; Nweke OC, 2009, ENVIRON HEALTH PERSP, V117, P863, DOI 10.1289/ehp.0800126; Olowoyo JO, 2010, ATMOS ENVIRON, V44, P1826, DOI 10.1016/j.atmosenv.2010.01.048; Olowoyo JO, 2011, ENVIRON SCI POLLUT R, V18, P663, DOI 10.1007/s11356-010-0410-3; Peltzer K, 2002, J R SOC PROMO HEALTH, V122, P187, DOI 10.1177/146642400212200316; Peltzer K, 2001, SOC BEHAV PERSONAL, V29, P249, DOI 10.2224/sbp.2001.29.3.249; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; RABINOWITZ MB, 1991, ENVIRON HEALTH PERSP, V91, P33, DOI 10.2307/3430979; RABINOWITZ MB, 1976, J CLIN INVEST, V58, P260, DOI 10.1172/JCI108467; Smit R, 2001, J COMP FAM STUD, V32, P533, DOI 10.3138/jcfs.32.4.533; Thomas KJA, 2007, INT MIGR REV, V41, P40, DOI 10.1111/j.1747-7379.2007.00056.x; Todd AC, 2000, ENVIRON RES, V84, P282, DOI 10.1006/enrs.1999.4090; van Gemert F, 2011, PRIM CARE RESP J, V20, P240, DOI 10.4104/pcrj.2011.00027; van Wijngaarden E, 2009, NEUROTOXICOLOGY, V30, P572, DOI 10.1016/j.neuro.2009.05.007; VONSCHIRNDING Y, 1991, ENVIRON HEALTH PERSP, V94, P125, DOI 10.2307/3431305; VONSCHIRNDING YER, 1991, S AFR MED J, V79, P454; VonSchirnding YER, 1996, SCI TOTAL ENVIRON, V188, P1, DOI 10.1016/0048-9697(96)05122-4; WEDEEN RP, 1988, ENVIRON HEALTH PERSP, V78, P57, DOI 10.2307/3430500; Weisskopf MG, 2004, AM J EPIDEMIOL, V160, P1184, DOI 10.1093/aje/kwh333; WHITE NW, 1982, S AFR MED J, V62, P799; WITTMERS LE, 1988, ARCH ENVIRON HEALTH, V43, P381, DOI 10.1080/00039896.1988.9935855; Wright JP, 2009, YOUTH VIOLENCE JUV J, V7, P208, DOI 10.1177/1541204009333827	77	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58146	10.1371/journal.pone.0058146	http://dx.doi.org/10.1371/journal.pone.0058146			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505462	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000318334500054
J	Ma, Y; Mi, YJ; Dai, YK; Fu, HL; Cui, DX; Jin, WL				Ma, Yue; Mi, Ya-Jing; Dai, Yun-Kai; Fu, Hua-Lin; Cui, Da-Xiang; Jin, Wei-Lin			The Inverse F-BAR Domain Protein srGAP2 Acts through srGAP3 to Modulate Neuronal Differentiation and Neurite Outgrowth of Mouse Neuroblastoma Cells	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEINS; MIGRATION; SLIT; COMPLEX; GENES; EXPRESSION; MEMBRANE; NUCLEUS; SCHIZOPHRENIA; PROTRUSIONS	The inverse F-BAR (IF-BAR) domain proteins srGAP1, srGAP2 and srGAP3 are implicated in neuronal development and may be linked to mental retardation, schizophrenia and seizure. A partially overlapping expression pattern and highly similar protein structures indicate a functional redundancy of srGAPs in neuronal development. Our previous study suggests that srGAP3 negatively regulates neuronal differentiation in a Rac1-dependent manner in mouse Neuro2a cells. Here we show that exogenously expressed srGAP1 and srGAP2 are sufficient to inhibit valporic acid (VPA)-induced neurite initiation and growth in the mouse Neuro2a cells. While ectopic- or over-expression of RhoGAP-defective mutants, srGAP1(R542A) and srGAP2(R527A) exert a visible inhibitory effect on neuronal differentiation. Unexpectedly, knockdown of endogenous srGAP2 fails to facilitate the neuronal differentiation induced by VPA, but promotes neurite outgrowth of differentiated cells. All three IF-BAR domains from srGAP1-3 can induce filopodia formation in Neuro2a, but the isolated IF-BAR domain from srGAP2, not from srGAP1 and srGAP3, can promote VPA-induced neurite initiation and neuronal differentiation. We identify biochemical and functional interactions of the three srGAPs family members. We propose that srGAP3-Rac1 signaling may be required for the effect of srGAP1 and srGAP2 on attenuating neuronal differentiation. Furthermore, inhibition of Slit-Robo interaction can phenocopy a loss-of-function of srGAP3, indicating that srGAP3 may be dedicated to the Slit-Robo pathway. Our results demonstrate the interplay between srGAP1, srGAP2 and srGAP3 regulates neuronal differentiation and neurite outgrowth. These findings may provide us new insights into the possible roles of srGAPs in neuronal development and a potential mechanism for neurodevelopmental diseases.	[Ma, Yue; Mi, Ya-Jing; Dai, Yun-Kai; Jin, Wei-Lin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Ma, Yue; Fu, Hua-Lin; Cui, Da-Xiang; Jin, Wei-Lin] Shanghai Jiao Tong Univ, Inst Micronano Sci & Technol, Dept Bionanosci & Engn, Shanghai 200030, Peoples R China; [Mi, Ya-Jing] Xian Med Univ, Lab Cell Biol & Translat Med, Xian, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Xi'an Medical University	Jin, WL (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China.	weilinjin@yahoo.com	Jin, Wei-Lin/A-8355-2013	Jin, Wei-Lin/0000-0001-8011-2405	National Natural Science Foundation of China [31171033, 81272801]; National Key Basic Research Program of China ("973" Project) [2010CB933901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China ("973" Project)(National Basic Research Program of China)	National Natural Science Foundation of China (numbers 31171033 and 81272801; http://www.nsfc.gov.cn/Portal0/default166.htm) and National Key Basic Research Program of China ("973" Project) (number 2010CB933901; http://www.973.gov.cn/AreaAppl.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington AM, 2009, CURR PSYCHIAT REP, V11, P156, DOI 10.1007/s11920-009-0024-y; Andrews W, 2008, DEV BIOL, V313, P648, DOI 10.1016/j.ydbio.2007.10.052; Armstrong L, 2004, MECH DEVELOP, V121, P1509, DOI 10.1016/j.mod.2004.07.005; Aspenstrom P, 2009, INT REV CEL MOL BIO, V272, P1, DOI 10.1016/S1937-6448(08)01601-8; Bacon C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019887; Bacon C, 2009, J COMP NEUROL, V513, P224, DOI 10.1002/cne.21955; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chen K, 2011, CELL MOL NEUROBIOL, V31, P675, DOI 10.1007/s10571-011-9664-7; Coutinho-Budd J, 2012, J CELL SCI; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Dingova H, 2009, HISTOCHEM CELL BIOL, V131, P425, DOI 10.1007/s00418-008-0539-z; Diskin SJ, 2009, NATURE, V459, P987, DOI 10.1038/nature08035; Dubash AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017380; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Endris V, 2011, J CELL SCI, V124, P3941, DOI 10.1242/jcs.077081; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Huang P, 2011, CANCER RES, V71, P2938, DOI 10.1158/0008-5472.CAN-10-3524; Kim IH, 2012, J BIOL CHEM; Linkermann A, 2009, BBA-PROTEINS PROTEOM, V1794, P168, DOI 10.1016/j.bbapap.2008.10.013; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; Mason FM, 2011, J BIOL CHEM, V286, P6577, DOI 10.1074/jbc.M110.190397; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Okada H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002189; Pertz OC, 2008, P NATL ACAD SCI USA, V105, P1931, DOI 10.1073/pnas.0706545105; Saitsu H, 2011, AM J MED GENET A; Sawamura N, 2005, P NATL ACAD SCI USA, V102, P1187, DOI 10.1073/pnas.0406543102; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sung P. J., 2012, CANC LETT; Waltereit R, 2012, FASEB J; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wilson NKA, 2011, CASE REPORTS GENETIC, V2011, P5; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Yao Q, 2008, CELL MOL NEUROBIOL, V28, P205, DOI 10.1007/s10571-007-9187-4; Ye BQ, 2010, J IMMUNOL, V185, P6294, DOI 10.4049/jimmunol.1001648; Zhao JC, 2012, J CELL PHYSIOL, V227, P2645, DOI 10.1002/jcp.23006	49	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57865	10.1371/journal.pone.0057865	http://dx.doi.org/10.1371/journal.pone.0057865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505444	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500036
J	Schreinemakers, JRC; Westers, P; van Amerongen, P; Kon, M				Schreinemakers, J. Rieneke C.; Westers, Paul; van Amerongen, Pieter; Kon, Moshe			Oxygen Mask Related Nasal Integument and Osteocartilagenous Disorders in F-16 Fighter Pilots	PLOS ONE			English	Article							NOSE	Background: A preliminary survey showed half of the participating Royal Netherlands Air Force (RNLAF) F-16 fighter pilots to have nasal integument and osteocartilagenous disorders related to wearing in-flight oxygen masks. Aim: To make an inventory of these disorders and possible associated factors. Methods: All RNLAF F-16 pilots were requested to fill out a semi-structured questionnaire for a cross-sectional survey. Additionally, one squadron in The Netherlands and pilots in operational theater were asked to participate in a prospective study that required filling out a pain score after each flight. Pilot- and flight-related variables on all participants were collected from the RNLAF database. A linear mixed model was built to identify associated factors with the post-flight pain score. Results: The response rate to the survey was 83%. Ninety of the 108 participants (88%, 6 missing) reported tenderness, irritation, pain, erythema, skin lesions, callous skin, or swelling of nasal bridge integument or architecture. Seventy-two participants (71%, 6 missing) reported their symptoms to be troublesome after a mean of 6 +/- 3 out of 10 flights (0;10, 54 missing). Sixty-six pilots participated in scoring post-flight pain. Pain scores were significantly higher if a participant had >= 3 nasal disorders, after longer than average flights, after flying abroad, and after flying with night vision goggles (respectively +2.7 points, p = 0.003; +0.2 points, p = 0.027; +1.8 points, p = 0.001; +1.2 points p = 0.005). Longer than average NVG flights and more than average NVG hours per annum decreased painscores (respectively -0.8 points, p = 0.017; -0.04 points, p = 0.005). Conclusions: The majority of the RNLAF F-16 fighter pilot community has nasal disorders in the contact area of the oxygen mask, including pain. Six pilot-or flight-related characteristics influence the experienced level of pain.	[Schreinemakers, J. Rieneke C.; Kon, Moshe] Univ Med Ctr Utrecht, Dept Plast Reconstruct & Hand Surg, Utrecht, Netherlands; [Westers, Paul] Univ Med Ctr Utrecht, Dept Biostat, Utrecht, Netherlands; [Westers, Paul] Univ Med Ctr Utrecht, Res Support Julius Ctr, Utrecht, Netherlands; [van Amerongen, Pieter] Ctr Man Aviat, Soesterberg, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Schreinemakers, JRC (corresponding author), Univ Med Ctr Utrecht, Dept Plast Reconstruct & Hand Surg, Utrecht, Netherlands.	jrcschreinemakers@gmail.com			Central Military Hospital, Utrecht, The Netherlands	Central Military Hospital, Utrecht, The Netherlands	The study was supported by a research grant provided by the Central Military Hospital, Utrecht, The Netherlands. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bevan MG, 2010, NECK TORQUE STUDY IN; Bodor RM, 2008, ANN PLAS SURG, V60, P658, DOI 10.1097/SAP.0b013e31814faf55; Callaghan S, 1998, Prof Nurse, V13, P361; Diesel DA., 1997, SAFE J, V27, P104; Gregoretti C, 2002, INTENS CARE MED, V28, P278, DOI 10.1007/s00134-002-1208-7; Krogman WM, 1973, HUMAN SKELETON FOREN, P244; McGREGOR M W, 1958, J Int Coll Surg, V30, P179; Mudry A, 2009, OTOL NEUROTOL, V30, P116, DOI 10.1097/MAO.0b013e318188e905; Muir P, 2007, BONE, V40, P948, DOI 10.1016/j.bone.2006.11.012; NOE JM, 1981, PLAST RECONSTR SURG, V67, P661, DOI 10.1097/00006534-198105000-00017; Paccagnella O, 2006, EVALUATION REV, DOI [10.1177/0193841X05275649Paccagnella, DOI 10.1177/0193841X05275649PACCAGNELLA2006]; Paice JA, 1997, CANCER NURS, V20, P88, DOI 10.1097/00002820-199704000-00002; Schreinemakers JRC, 2010, J PLAST RECONSTR AES, V63, P1217, DOI 10.1016/j.bjps.2009.10.030; TORRANCE AG, 1994, CALCIFIED TISSUE INT, V54, P241, DOI 10.1007/BF00301686	14	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e56251	10.1371/journal.pone.0056251	http://dx.doi.org/10.1371/journal.pone.0056251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505413	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500006
J	Vink, PM; Smout, WM; Driessen-Engels, LJ; de Bruin, AM; Delsing, D; Krajnc-Franken, MA; Jansen, AJ; Rovers, EF; van Puijenbroek, AA; Kaptein, A; Nolte, MA; Garritsen, A; van Eenennaam, H				Vink, Paul M.; Smout, Wendy M.; Driessen-Engels, Lilian J.; de Bruin, Alex M.; Delsing, Dianne; Krajnc-Franken, Magda A.; Jansen, Aswin J.; Rovers, Eric F.; van Puijenbroek, Andre A.; Kaptein, Allard; Nolte, Martijn A.; Garritsen, Anja; van Eenennaam, Hans			In Vivo Knockdown of TAK1 Accelerates Bone Marrow Proliferation/Differentiation and Induces Systemic Inflammation	PLOS ONE			English	Article							NF-KAPPA-B; ACTIVATED KINASE 1; MEDIATED ACTIVATION; GENE KNOCKDOWN; T-CELLS; BETA; MICE; EXPRESSION; ARTHRITIS; SURVIVAL	TAK1 (TGF-beta Activated Kinase 1) is a MAPK kinase kinase, which activates the p38- and JNK-MAPK and NF-kappa B pathways downstream of receptors such as Toll-Like-, cytokine-and T-cell and B-cell receptors. Representing such an important node in the pro-inflammatory signal-transduction network, the function of TAK1 has been studied extensively. TAK1 knock-out mice are embryonic lethal, while conditional knock-out mice demonstrated either a pro-or anti-inflammatory function. To study the function of TAK1 protein in the adult immune system, we generated and characterized a transgenic mouse expressing TAK1 shRNA under the control of a doxycycline-inducible promoter. Following treatment of TAK-1 shRNA transgenic mice with doxycycline an effective knockdown of TAK1 protein levels was observed in lymphoid organs and cells in the peritoneal cavity (>50% down regulation). TAK1 knockdown resulted in significant changes in leukocyte populations in blood, bone marrow, spleen and peritoneal cavity. Upon TAK1 knockdown mice demonstrated splenomegaly, signs of systemic inflammation (increased levels of circulating cytokines and increase in cellularity of the B-cell areas and in germinal center development in the follicles) and degenerative changes in heart, kidneys and liver. Not surprisingly, TAK1-Tg mice treated with LPS or anti-CD3 antibodies showed enhanced cytokine/chemokine secretion. Finally, analysis of progenitor cells in the bone marrow upon doxycycline treatment showed increased proliferation and differentiation of myeloid progenitor cells. Given the similarity of the phenotype with TGF-beta genetic models, our data suggest that in our model the function of TAK1 in TGF-beta signal-transduction is overruling its function in pro-inflammatory signaling.	[Vink, Paul M.; Smout, Wendy M.; Driessen-Engels, Lilian J.; Delsing, Dianne; Jansen, Aswin J.; Rovers, Eric F.; van Puijenbroek, Andre A.; Garritsen, Anja; van Eenennaam, Hans] MSD, Merck Res Labs, Dept Immune Therapeut, Oss, Netherlands; [de Bruin, Alex M.; Nolte, Martijn A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Krajnc-Franken, Magda A.] MSD, Merck Res Labs, Dept Toxicol & Drug Disposit, Oss, Netherlands; [Kaptein, Allard] MSD, Merck Res Labs, Dept Mol Pharmacol & DMPK, Oss, Netherlands; [Nolte, Martijn A.] Sanquin Res & Landsteiner Lab, Dept Hematopoiesis, Amsterdam, Netherlands	Merck & Company; University of Amsterdam; Academic Medical Center Amsterdam; Merck & Company; Merck & Company; University of Amsterdam	van Eenennaam, H (corresponding author), MSD, Merck Res Labs, Dept Immune Therapeut, Oss, Netherlands.	h.vaneenennaam@bionovion.com	Nolte, Martijn A./AAC-8092-2022	Nolte, Martijn A./0000-0002-5447-0839	VIDI grant from The Netherlands Organization of Scientific Research	VIDI grant from The Netherlands Organization of Scientific Research	M.A.N. was supported by a VIDI grant from The Netherlands Organization of Scientific Research. All authors except for M.A.N. and A.M.d.B. were employees of Merck at the time of these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Ajibade AA, 2012, IMMUNITY, V36, P43, DOI 10.1016/j.immuni.2011.12.010; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Cheung PCF, 2003, EMBO J, V22, P5793, DOI 10.1093/emboj/cdg552; CHRIST M, 1994, J IMMUNOL, V153, P1936; Courties G, 2010, BLOOD, V116, P3505, DOI 10.1182/blood-2010-02-269605; DANG H, 1995, J IMMUNOL, V155, P3205; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Fan QW, 2002, CURR BIOL, V12, P1386, DOI 10.1016/S0960-9822(02)01070-9; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Hammaker D, 2010, ANN RHEUM DIS, V69, P77, DOI 10.1136/ard.2009.119479; Hammaker DR, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2215; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kajino-Sakamoto R, 2010, J IMMUNOL, V185, P4729, DOI 10.4049/jimmunol.0903587; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Kim JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004561; Klatt AR, 2006, BIOMED PHARMACOTHER, V60, P55, DOI 10.1016/j.biopha.2005.08.007; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Letterio JJ, 1996, J CLIN INVEST, V98, P2109, DOI 10.1172/JCI119017; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Moriguchi T, 1996, J BIOL CHEM, V271, P13675, DOI 10.1074/jbc.271.23.13675; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Sayama K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011275; Schuman J, 2009, BLOOD, V113, P4566, DOI 10.1182/blood-2008-08-176057; Seibler J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni065; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Shah AH, 2002, J IMMUNOL, V169, P3485, DOI 10.4049/jimmunol.169.7.3485; Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223; Shinohara H, 2009, IMMUNOL REV, V232, P300, DOI 10.1111/j.1600-065X.2009.00836.x; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Stanford LP, 1997, DEVELOPMENT, V124, P2569; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yaswen L, 1996, BLOOD, V87, P1439, DOI 10.1182/blood.V87.4.1439.bloodjournal8741439	49	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57348	10.1371/journal.pone.0057348	http://dx.doi.org/10.1371/journal.pone.0057348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505428	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500020
J	Yoon, JH; Kim, EK; Moon, HJ; Kwak, JY				Yoon, Jung Hyun; Kim, Eun-Kyung; Moon, Hee Jung; Kwak, Jin Young			Is Follow-up BRAF(V600E) Mutation Analysis Helpful in the Differential Diagnosis of Thyroid Nodules with Negative Results on Initial Analysis?	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; BRAF MUTATION; CLINICAL-IMPLICATIONS; MOLECULAR ANALYSIS; PATHOGENIC ROLE; PREVALENT AREA; CARCINOMA; BIOPSY; MANAGEMENT; CANCER	Background: We evaluated the usefulness of follow-up BRAF(V600E) mutation analysis using ultrasonography-guided fine-needle aspiration (US-FNA) in diagnosis of thyroid nodules showing negative BRAFV600E mutation on prior analysis. Methodology/Principal Finding: A total of 49 patients (men: 6, women: 43, mean age: 50.4 years) with 49 thyroid nodules were included. Patients had undergone initial and follow-up US-FNA and subsequent BRAF(V600E) mutation analysis from US-FNA aspirates. All patients had negative results on initial BRAF(V600E) mutation analysis. Clinicopathologic findings, US assessment, and BRAF(V600E) mutation results were analyzed according to the final pathology. Of the 49 nodules, 12 (24.5%) were malignant and 37 (75.5%) were benign. Seven (58.3%) of the 12 malignant nodules were positive for BRAF(V600E) mutation on follow-up, all showing suspicious US features. Initial US-FNA cytology of the 7 nodules were non-diagnostic (n = 2), benign (n = 2), or atypia (n = 3), while follow-up were benign (n = 1), indeterminate (n = 1), suspicious for malignancy (n = 4), and malignancy (n = 1). Conclusions/Significance: Follow-up BRAF(V600E) mutation analysis may be helpful in the diagnosis of selected thyroid nodules negative for BRAF(V600E) mutation on initial analysis, which are assessed as suspicious malignant on US, diagnosed as non-diagnostic, benign or atypia on follow-up US-FNA.	[Yoon, Jung Hyun; Kim, Eun-Kyung; Moon, Hee Jung; Kwak, Jin Young] Yonsei Univ, Coll Med, Dept Radiol, Res Inst Radiol Sci, Seoul, South Korea; [Yoon, Jung Hyun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University	Kwak, JY (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Res Inst Radiol Sci, Seoul, South Korea.	docjin@yuhs.ac	Kim, Eun-Kyung/E-5211-2017	Kim, Eun-Kyung/0000-0002-3368-5013; Kwak, Jin Young/0000-0002-6212-1495; Yoon, Jung Hyun/0000-0002-2100-3513; Moon, Hee Jung/0000-0002-5643-5885	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0007711]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0007711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung KW, 2006, CLIN ENDOCRINOL, V65, P660, DOI 10.1111/j.1365-2265.2006.02646.x; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Cohen Y, 2004, CLIN CANCER RES, V10, P2761, DOI 10.1158/1078-0432.CCR-03-0273; Colanta A, 2011, ACTA CYTOL, V55, P563, DOI 10.1159/000333272; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Danese D, 1998, THYROID, V8, P15, DOI 10.1089/thy.1998.8.15; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Dincer N, 2012, CYTOPATHOLOGY; GHARIB H, 1993, ANN INTERN MED, V118, P282, DOI 10.7326/0003-4819-118-4-199302150-00007; Haberal AN, 2009, CYTOPATHOLOGY, V20, P103, DOI 10.1111/j.1365-2303.2008.00594.x; HAMBURGER JI, 1986, NEW YORK STATE J MED, V86, P241; Hwang J, 2010, AM J ROENTGENOL, V194, pW425, DOI 10.2214/AJR.09.3512; Kabaker AS, 2012, THYROID; Kim EK, 2002, AM J ROENTGENOL, V178, P687, DOI 10.2214/ajr.178.3.1780687; Kim KH, 2004, YONSEI MED J, V45, P818, DOI 10.3349/ymj.2004.45.5.818; Kim SK, 2008, DIAGN MOL PATHOL, V17, P118, DOI 10.1097/PDM.0b013e31815d059d; Kim SW, 2010, J CLIN ENDOCR METAB, V95, P3693, DOI 10.1210/jc.2009-2795; Kimura ET, 2003, CANCER RES, V63, P1454; Kwak JY, 2010, HEAD NECK-J SCI SPEC, V32, P490, DOI 10.1002/hed.21210; Kwak JY, 2010, RADIOLOGY, V254, P292, DOI 10.1148/radiol.2541090460; Kwak JY, 2009, RADIOLOGY, V253, P854, DOI 10.1148/radiol.2533090471; Kwak JY, 2009, EUR RADIOL; Lee EJ, 2011, CLIN ENDOCRINOL, V75, P844, DOI 10.1111/j.1365-2265.2011.04154.x; Lee MJ, 2011, YONSEI MED J, V52, P838, DOI 10.3349/ymj.2011.52.5.838; Leenhardt L, 2004, THYROID, V14, P1056, DOI 10.1089/thy.2004.14.1056; Mazzaferri E, 2011, CLIN ENDOCRINOL, V75, P740, DOI 10.1111/j.1365-2265.2011.04245.x; Mazzawi SJ, 2000, J OTOLARYNGOL, V29, P95; Moon HJ, 2011, ANN SURG ONCOL, V18, P792, DOI 10.1245/s10434-010-1354-z; Moon HJ, 2009, ANN SURG ONCOL, V16, P3125, DOI 10.1245/s10434-009-0644-9; Moon WJ, 2011, KOREAN J RADIOL, V12, P1, DOI 10.3348/kjr.2011.12.1.1; Nam SY, 2010, THYROID, V20, P273, DOI 10.1089/thy.2009.0226; Nikiforov YE, 2011, J CLIN ENDOCR METAB, V96, P3390, DOI 10.1210/jc.2011-1469; Nikiforov YE, 2011, MODERN PATHOL, V24, pS34, DOI 10.1038/modpathol.2010.167; Ricarte-Filho J, 2011, THYROID; ROSEN IB, 1993, AM J SURG, V166, P346, DOI 10.1016/S0002-9610(05)80329-0; Rowe Leslie R, 2006, Cytojournal, V3, P10, DOI 10.1186/1742-6413-3-10; Sapio MR, 2007, CLIN ENDOCRINOL, V66, P678, DOI 10.1111/j.1365-2265.2007.02800.x; Tang KT, 2010, J CHIN MED ASSOC, V73, P113, DOI 10.1016/S1726-4901(10)70025-3; Trovisco V, 2004, J PATHOL, V202, P247, DOI 10.1002/path.1511; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2004, J CLIN ENDOCR METAB, V89, P2867, DOI 10.1210/jc.2003-032050; Ylagan LR, 2004, THYROID, V14, P35, DOI 10.1089/105072504322783821; Yoon JH, 2011, ANN SURG ONCOL; Yoon JH, 2011, ANN SURG ONCOL, V18, P1282, DOI 10.1245/s10434-011-1605-7	44	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58592	10.1371/journal.pone.0058592	http://dx.doi.org/10.1371/journal.pone.0058592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505540	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500105
J	Jung, KW; Kang, HA; Bahn, YS				Jung, Kwang-Woo; Kang, Hyun Ah; Bahn, Yong-Sun			Essential Roles of the Kar2/BiP Molecular Chaperone Downstream of the UPR Pathway in Cryptococcus neoformans	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; FUNGAL DRUG-RESISTANCE; CANDIDA-ALBICANS; ANTIFUNGAL AGENTS; YEAST; DEGRADATION; MECHANISMS; EVOLUTION; VIRULENCE	The endoplasmic reticulum (ER) is a central hub where secreted or membrane-bound proteins are maturated and folded properly in eukaryotes. Maintenance of ER homeostasis is particularly important for human fungal pathogens, such as Cryptococcus neoformans, which encounter a plethora of host-mediated stresses during infection. Our previous study demonstrated that the unfolded protein response (UPR) pathway, composed of the evolutionarily conserved Ire1 kinase and the unique Hxl1 transcription factor, has pleiotropic roles in ER stress response, thermotolerance, antifungal drug resistance, and virulence in C. neoformans. Here, we functionally characterized an ER-resident molecular chaperone, Kar2/BiP, in C. neoformans. Conditional expression of KAR2 by the copper-regulated promoter revealed that Kar2 is essential for the viability of C. neoformans. Constitutive expression of KAR2 by the strong histone H3 promoter partially restores resistance to ER stress, cell wall stress, thermotolerance, and genotoxic stress in ire1 Delta and hxl1 Delta mutants, suggesting that Kar2 mainly functions downstream of the UPR pathway. Furthermore, Kar2 appears to control azole resistance in C. neoformans downstream of the UPR pathway without regulation of ERG11 or ERG3. Interestingly, we discovered that azole treatment is sensed as ER-stress and subsequently activates the Ire1-dependent Hxl1 splicing event and induction of KAR2 by the UPR pathway. In contrast, the constitutive expression of Kar2 is not sufficient to restore the Ire1-mediated regulation of capsule production in C. neoformans UPR mutants. In conclusion, this study demonstrates that Kar2 is not only essential for vegetative growth but also required for response and adaptation to the environmental stresses and antifungal drugs downstream of the UPR pathway in C. neoformans.	[Jung, Kwang-Woo; Bahn, Yong-Sun] Yonsei Univ, Dept Biotechnol, Ctr Fungal Pathogenesis, Seoul 120749, South Korea; [Kang, Hyun Ah] Chung Ang Univ, Dept Life Sci, Ctr Fungal Pathogenesis, Coll Nat Sci, Seoul 156756, South Korea	Yonsei University; Chung Ang University	Bahn, YS (corresponding author), Yonsei Univ, Dept Biotechnol, Ctr Fungal Pathogenesis, Seoul 120749, South Korea.	ysbahn@yonsei.ac.kr	Bahn, Yong-Sun/C-1211-2012	Bahn, Yong-Sun/0000-0001-9573-5752	National Research Foundation of Korea from MEST [2010-0029117, 2008-0061963]	National Research Foundation of Korea from MEST(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea grants (no. 2010-0029117 and no. 2008-0061963) from MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins RA, 2005, MED MYCOL, V43, P285, DOI 10.1080/13693780500138971; Aksenov S I, 1973, Life Sci Space Res, V11, P55; Alspaugh JA, 2002, EUKARYOT CELL, V1, P75, DOI 10.1128/EC.1.1.75-84.2002; Bahn YS, 2004, EUKARYOT CELL, V3, P1476, DOI 10.1128/EC.3.6.1476-1491.2004; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Cheon SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002177; Colgan SM, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001742; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Csala M, 2010, ANTIOXID REDOX SIGN, V13, P77, DOI 10.1089/ars.2009.2529; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Feng XZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002330; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Henry KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012732; Hicks JK, 2004, EUKARYOT CELL, V3, P14, DOI 10.1128/EC.3.1.14-26.2004; Hsu CL, 2012, MOL BIOL CELL, V23, P630, DOI 10.1091/mbc.E11-04-0297; Jung KW, 2011, FUNGAL GENET BIOL, V48, P154, DOI 10.1016/j.fgb.2010.10.006; Kim MS, 2009, BIOCHEM BIOPH RES CO, V390, P983, DOI 10.1016/j.bbrc.2009.10.089; Ko YJ, 2009, EUKARYOT CELL, V8, P1197, DOI 10.1128/EC.00120-09; Kojima K, 2006, MICROBIOL-SGM, V152, P591, DOI 10.1099/mic.0.28571-0; Lee JW, 2011, EUKARYOT CELL, V10, P998, DOI 10.1128/EC.05124-11; Lee SC, 2012, EUKARYOT CELL, V11, P783, DOI 10.1128/EC.00066-12; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Morrow MW, 2011, CURR GENET, V57, P25, DOI 10.1007/s00294-010-0323-1; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; RITTBERG DAH, 1989, BIOCHEM CELL BIOL, V67, P352, DOI 10.1139/o89-055; Rodrigues ML, 2012, MYCOPATHOLOGIA, V173, P407, DOI 10.1007/s11046-011-9468-9; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sturley SL, 2000, BBA-MOL CELL BIOL L, V1529, P155, DOI 10.1016/S1388-1981(00)00145-1; Sullivan DP, 2006, BIOCHEM SOC T, V34, P356, DOI 10.1042/BST0340356; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; vanGemeren IA, 1997, GENE, V198, P43, DOI 10.1016/S0378-1119(97)00290-4; VOGEL JP, 1990, J CELL BIOL, V110, P1885, DOI 10.1083/jcb.110.6.1885; Wimalasena TT, 2008, FUNGAL GENET BIOL, V45, P1235, DOI 10.1016/j.fgb.2008.06.001; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003	49	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58956	10.1371/journal.pone.0058956	http://dx.doi.org/10.1371/journal.pone.0058956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484059	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100145
J	Koh, GCKW; Hawthorne, G; Turner, AM; Kunst, H; Dedicoat, M				Koh, Gavin C. K. W.; Hawthorne, Gemma; Turner, Alice M.; Kunst, Heinke; Dedicoat, Martin			Tuberculosis Incidence Correlates with Sunshine: An Ecological 28-Year Time Series Study	PLOS ONE			English	Article							VITAMIN-D; DOUBLE-BLIND; SEASONALITY; DISEASES; SUNLIGHT	Background: Birmingham is the largest UK city after London, and central Birmingham has an annual tuberculosis incidence of 80 per 100,000. We examined seasonality and sunlight as drivers of tuberculosis incidence. Hours of sunshine are seasonal, sunshine exposure is necessary for the production of vitamin D by the body and vitamin D plays a role in the host response to tuberculosis. Methods: We performed an ecological study that examined tuberculosis incidence in Birmingham from Dec 1981 to Nov 2009, using publicly-available data from statutory tuberculosis notifications, and related this to the seasons and hours of sunshine (UK Meteorological Office data) using unmeasured component models. Results: There were 9,739 tuberculosis cases over the study period. There was strong evidence for seasonality, with notifications being 24.1% higher in summer than winter (p<0.001). Winter dips in sunshine correlated with peaks in tuberculosis incidence six months later (4.7% increase in incidence for each 100 hours decrease in sunshine, p<0.001). Discussion and Conclusion: A potential mechanism for these associations includes decreased vitamin D levels with consequent impaired host defence arising from reduced sunshine exposure in winter. This is the longest time series of any published study and our use of statutory notifications means this data is essentially complete. We cannot, however, exclude the possibility that another factor closely correlated with the seasons, other than sunshine, is responsible. Furthermore, exposure to sunlight depends not only on total hours of sunshine but also on multiple individual factors. Our results should therefore be considered hypothesis-generating. Confirmation of a potential causal relationship between winter vitamin D deficiency and summer peaks in tuberculosis incidence would require a randomized-controlled trial of the effect of vitamin D supplementation on future tuberculosis incidence.	[Koh, Gavin C. K. W.; Dedicoat, Martin] Heartlands Hosp, Dept Infect & Trop Med, Birmingham, W Midlands, England; [Hawthorne, Gemma; Turner, Alice M.; Kunst, Heinke] Heartlands Hosp, Dept Resp Med, Birmingham, W Midlands, England; [Koh, Gavin C. K. W.; Dedicoat, Martin] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Hawthorne, Gemma; Turner, Alice M.; Kunst, Heinke] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England	Heart of England NHS Foundation Trust; Heart of England NHS Foundation Trust; University of Warwick; University of Birmingham	Koh, GCKW (corresponding author), Heartlands Hosp, Dept Infect & Trop Med, Birmingham, W Midlands, England.	gavin.koh@gmail.com	Dedicoat, Martin/AFC-7815-2022; Turner, Alice M/W-5171-2018	Turner, Alice M/0000-0002-5947-3254; Dedicoat, Martin/0000-0001-9833-4882				Altes HK, 2012, INT J TUBERC LUNG D, V16, P639, DOI 10.5588/ijtld.11.0680; Bennett J, 2001, INT J TUBERC LUNG D, V5, P158; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Douglas A S, 1998, Ethn Health, V3, P247; Douglas AS, 1996, THORAX, V51, P944, DOI 10.1136/thx.51.9.944; Durbin James, 2001, TIME SERIES ANAL STA, Vsecond; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Ganmaa D, 2012, AM J CLIN NUTR, V96, P391, DOI 10.3945/ajcn.112.034967; GRIGG ERN, 1958, AM REV TUBERC PULM, V78, P151; Harvey A. C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Liu PT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005810; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Martineaua AR, 2011, P NATL ACAD SCI USA, V108, P19013, DOI 10.1073/pnas.1111825108; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Parrinello CM, 2012, INT J TUBERC LUNG D, V16, P32, DOI 10.5588/ijtld.11.0145; Pedrazzoli D, 2012, TUBERCULOSIS UK 2012; Visser DH, 2013, EPIDEMIOL INFECT, V141, P459, DOI 10.1017/S0950268812001045; Vynnycky E, 2000, AM J EPIDEMIOL, V152, P247, DOI 10.1093/aje/152.3.247; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373	22	38	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57752	10.1371/journal.pone.0057752	http://dx.doi.org/10.1371/journal.pone.0057752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483924	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100040
J	Lee, MR; Yang, CY; Chang, KP; Keng, LT; Yen, DHT; Wang, JY; Wu, HD; Lee, LN; Yu, CJ				Lee, Meng-Rui; Yang, Ching-Yao; Chang, Kai-Ping; Keng, Li-Ta; Yen, David Hung-Tsang; Wang, Jann-Yuan; Wu, Huey-Dong; Lee, Li-Na; Yu, Chong-Jen			Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease	PLOS ONE			English	Article							FORCED EXPIRATORY VOLUME; QUALITY-OF-LIFE; PERFORMANCE ASSESSMENT; TUBERCULOSIS; BRONCHIECTASIS; INFECTIONS; SPIROMETRY; ADULTS; ABSCESSUS; SMOKING	Background: There is paucity of risk factors on lung function decline among patients with non-tuberculous mycobacteria (NTM) pulmonary disease in literature. Methods: Patients with NTM pulmonary disease between January 2000 and April 2011 were retrospectively selected. Sixty-eight patients had at least two pulmonary function tests within a mean follow-up period of 47 months. Results: Sixty-eight patients were included. They had a median age of 65 years and 65% had impaired lung function (Forced expiratory volume in 1 second [FEV1] <80% of predicted value). The mean FEV1 decline was 48 ml/year. By linear regression, younger age (beta: 0.472, p < 0.001), initial FEV1 >50% of predicted value (beta: 0.349, p = 0.002), male sex (beta: 0.295, p = 0.018), bronchiectasis pattern (beta: 0.232, p = 0.035), and radiographic score >3 (beta: 0.217, p = 0.049) were associated with greater FEV1 decline. Initial FEV1 >50% of predicted value (beta: 0.263, p = 0.032) was also associated with greater FVC annual decline, whereas M. kansasii pulmonary disease was marginally associated with greater annual FVC decline (beta: 0.227, p = 0.062). Conclusions: NTM pulmonary disease is associated with greater decline in lung function in patients who are young, male, with bronchiectasis, and with a high radiographic score. Special attention should be given to patients with these risk factors.	[Lee, Meng-Rui; Yang, Ching-Yao; Chang, Kai-Ping; Keng, Li-Ta; Wang, Jann-Yuan; Wu, Huey-Dong; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lee, Meng-Rui] Taoyuan Gen Hosp, Dept Internal Med, Tao Yuan, Taiwan; [Keng, Li-Ta; Yen, David Hung-Tsang] Kinmen Hosp, Dept Internal Med, Kinmen, Taiwan; [Yen, David Hung-Tsang] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Emergency Med, Taipei 112, Taiwan; [Lee, Li-Na] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital	Wang, JY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	jywang@ntu.edu.tw		Yu, Chong-Jen/0000-0001-5664-9392; Wu, Huey-Dong/0000-0001-6279-0384; WANG, JANN-YUAN/0000-0003-3406-366X; LEE, MENG-RUI/0000-0002-7220-4833; LEE, LI-NA/0000-0002-7654-2450; YANG, CHING-YAO/0000-0003-4927-4814; LI-TA, KENG/0000-0003-2772-8037				Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; BURROWS B, 1986, AM REV RESPIR DIS, V133, P974; BURROWS B, 1987, AM REV RESPIR DIS, V135, P788, DOI 10.1164/arrd.1987.135.4.788; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Chung KP, 2011, CLINICS, V66, P549, DOI 10.1590/S1807-59322011000400005; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Griffith DE, 2012, CLIN CHEST MED, V33, P283, DOI 10.1016/j.ccm.2012.02.002; Huang CT, 2012, INT J TUBERC LUNG D, V16, P539, DOI 10.5588/ijtld.11.0412; Khan Zinobia, 2010, Open Respir Med J, V4, P76, DOI 10.2174/1874306401004010076; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; LANGE P, 1989, EUR RESPIR J, V2, P811; Lee MR, 2012, J CLIN MICROBIOL, V50, P3398, DOI 10.1128/JCM.01862-12; Lee MR, 2012, J INFECTION, V64, P228, DOI 10.1016/j.jinf.2011.11.006; Levy I, 2008, EMERG INFECT DIS, V14, P378, DOI 10.3201/eid1403.061405; Matveychuk A, 2012, RESP MED, V106, P1472, DOI 10.1016/j.rmed.2012.06.023; Mehta M, 2011, RESP MED, V105, P1718, DOI 10.1016/j.rmed.2011.08.004; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Roberts MH, 2012, AM J EPIDEMIOL, V176, P127, DOI 10.1093/aje/kwr503; Sheehan RE, 2002, EUR RESPIR J, V20, P581, DOI 10.1183/09031936.02.00284602; SHERMAN CB, 1992, AM REV RESPIR DIS, V146, P855, DOI 10.1164/ajrccm/146.4.855; Shu CC, 2011, LUNG, V189, P467, DOI 10.1007/s00408-011-9321-4; Shu CC, 2010, MEDICINE, V89, P53, DOI 10.1097/MD.0b013e3181cafcd3; SNIDER GL, 1971, AM REV RESPIR DIS, V103, P625; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Wallace RJ, 1998, AM J RESP CRIT CARE, V158, P1235, DOI 10.1164/ajrccm.158.4.9712098; Wang JY, 2007, MEDICINE, V86, P39, DOI 10.1097/MD.0b013e318030b605; Wang JY, 2004, J CLIN MICROBIOL, V42, P4599, DOI 10.1128/JCM.42.10.4599-4603.2004; WARE JH, 1990, AM J EPIDEMIOL, V132, P685, DOI 10.1093/oxfordjournals.aje.a115710; Weatherall M, 2009, EUR RESPIR J, V33, P1025, DOI 10.1183/09031936.00116808	29	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58214	10.1371/journal.pone.0058214	http://dx.doi.org/10.1371/journal.pone.0058214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483998	Green Submitted, gold, Green Published			2022-12-27	WOS:000316936100090
J	Ma, YQ; Mei, WH; Yin, P; Yang, XH; Rastegar, SK; Yan, JD				Ma, Yu-Quan; Mei, Wen-Hua; Yin, Ping; Yang, Xiao-Hui; Rastegar, Sana Kiani; Yan, Jian-Dong			Prevalence of Hypertension in Chinese Cities: A Meta-Analysis of Published Studies	PLOS ONE			English	Article							RISK-FACTORS; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; GLOBAL BURDEN; PREHYPERTENSION; EPIDEMIOLOGY; POPULATION; PREVENTION; AWARENESS; OBESITY	Background: Hypertension has been recognized as a health concern for developing countries. However, there are no current nationwide surveys on the prevalence of hypertension in China (the latest nationwide survey was ten years ago). The goal of this study was to estimate the pooled prevalence of hypertension in Chinese cities. Methods: We systematically reviewed published epidemiologic studies on the prevalence of hypertension in Chinese cities through meta-analysis. We searched for studies published between January 2002 and June 2012 using PubMed and two Chinese electronic publication libraries. The keywords 'hypertension' and 'prevalence' were used. Before pooling prevalence of hypertension, all raw prevalence data was age adjusted to the 2010 China standard population. Prevalence estimates were stratified by sex and geographic area. Results: 27 studies were identified with of a total of 195,027 study participants. The overall pooled prevalence of hypertension was 21.5% (19.4%, 23.6%). Subgroup analyses showed the following results north 25.8% (21.6%, 30.0%), south 20.4% (18.6%, 22.2%); male 22.2% (19.3%, 25.1%), female 19.9% (17.6%, 22.1%); large cities 18.9% (15.7%, 22.1%), mediumsized cities 24.6% (19.9%, 29.4%), small cities 20.6% (17.5%, 23.7%); study years in 2002-2006, 21.9% (18.9%, 24.8%), and study year in 2007-2011, 20.6% (17.3%, 23.9%). Conclusions: Comparing data from several previous national hypertension surveys, the prevalence of hypertension is higher in cities than the Chinese national average. Subgroup studies also found a higher prevalence of hypertension in northern cities and among males. Also, the prevalence of hypertension in medium-sized and small cities is likely to increase faster than in large cities.	[Ma, Yu-Quan; Mei, Wen-Hua; Yang, Xiao-Hui; Rastegar, Sana Kiani; Yan, Jian-Dong] Jinan Univ, Affiliated Zhuhai Hosptal, Zhuhai Peoples Hosp, Zhuhai, Guangdong, Peoples R China; [Yin, Ping] Huazhong Univ Sci & Technol, Dept Epidemiol & Hlth Stat, Sch Publ Hlth, Tongji Med Coll, Wuhan, Hubei Province, Peoples R China	Jinan University; Huazhong University of Science & Technology	Ma, YQ (corresponding author), Jinan Univ, Affiliated Zhuhai Hosptal, Zhuhai Peoples Hosp, Zhuhai, Guangdong, Peoples R China.	yuquan3562003@yahoo.com.cn						Bell AC, 2002, OBES RES, V10, P277, DOI 10.1038/oby.2002.38; Beunza JJ, 2007, AM J HYPERTENS, V20, P1156, DOI 10.1016/j.amjhyper.2007.06.007; Birkett NJ, 1997, J HYPERTENS, V15, P237, DOI 10.1097/00004872-199715030-00004; [陈斌 CHEN Bin], 2011, [中国公共卫生, China Public Health], V27, P619; Chen LJ, 2006, CHIN J PREVENTION CO, V14, P437; Cheng MinNa, 2012, Journal of Environmental & Occupational Medicine, V29, P339; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Colhoun HM, 1998, J HUM HYPERTENS, V12, P91, DOI 10.1038/sj.jhh.1000558; Conlin PR, 2007, CIRCULATION, V116, P1530, DOI 10.1161/CIRCULATIONAHA.107.729574; Cui MY, 2004, PREVENTION TREATMENT, V4, P42; Department of Disease Control and Prevention Ministry of Health, 2006, REP CHRON DIS CHIN; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fang SY, 2004, PREVENTION TREATMENT, V4, P40; Frisoli TM, 2012, AM J MED, V125, P433, DOI 10.1016/j.amjmed.2011.10.023; Fu FH, 2004, PREV MED, V38, P458, DOI 10.1016/j.ypmed.2003.11.022; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; Gu WL, 2004, CHIN J CHRONIC DIS, V3, P39; Guo XF, 2011, TEX HEART I J, V38, P643; Guo Zhi-Rong, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P554; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong Y, 2007, CHIN J PREV CONTR CH, V15, P356; Hou XH, 2008, ASIA-PAC J PUBLIC HE, V20, P159, DOI 10.1177/1010539507312306; Huang X, 2009, CHIN J PUBLIC HLTH, V25, P25; Jiang PZ, 2004, PREVENTION TREATMENT, V4, P50; Jiao S, 2005, CHIN J PUBLIC HLTH, V21, P1491; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kunes J, 2006, CLIN SCI, V111, P295, DOI 10.1042/CS20050271; Lee LM, 2004, ANNU REV PUBL HEALTH, V25, P327, DOI 10.1146/annurev.publhealth.25.101802.123116; Li CL, 2008, MED J W CHINA, V20, P117; Li L, 2007, CHIN PREV MED, V8, P234; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li SP, 2007, CHIN J HLTH ED, V23, P593; Li XinJian, 2010, Chinese Journal of Prevention and Control of Chronic Diseases, V18, P233; Liu S, 2007, SICHUAN MED J, V28, P1311; Liu WJ, 2007, CHINESE J PREV CONTR, V15, P110; Liu XF, 2007, MODERN PREVENTIVE ME, V34, P3444; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Malinski MK, 2004, ARCH INTERN MED, V164, P623, DOI 10.1001/archinte.164.6.623; Marteau JB, 2005, J HYPERTENS, V23, P2127, DOI 10.1097/01.hjh.0000186024.12364.2e; Meng XJ, 2012, CIRC J, V76, P900, DOI 10.1253/circj.CJ-11-1118; Peng ZhiRi, 2011, China Tropical Medicine, V11, P852; Popkin Barry M, 2003, Forum Nutr, V56, P262; Population Census Office under the State Council Department of Population and Employment Statistics National Bureau of Statistics, 2012, TAB 2010 POP 2010 PO, P52; Schmidt-Trucksass A, 2011, DEUT MED WOCHENSCHR, V136, P2367, DOI 10.1055/s-0031-1292053; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tang XR, 2008, J NEW CHIN MED, V40, P39; The national hypertension sampling investigation group, 1995, J HYPERTENS, V3, P7; United Nations, 2007, WORLD POP PROSP 2007; Van de Poel E, 2009, J URBAN HEALTH, V7, P200; Van de Poel E, 2009, ECON HUM BIOL, V7, P200, DOI 10.1016/j.ehb.2009.05.004; Virdis A, 2010, CURR PHARM DESIGN, V16, P2518, DOI 10.2174/138161210792062920; Wang HX, 2010, INNER MONGOLIA MED, V42, P1234; Wang ZW, 2004, HYPERTENS RES, V27, P703, DOI 10.1291/hypres.27.703; Wu WQ, 2006, CHIN J PUBLIC HLTH, V22, P858; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166; Xu ZX, 2004, PREVENTION TREATMENT, V4, P48; Yan S, 2012, OBES REV, V13, P810, DOI 10.1111/j.1467-789X.2012.01016.x; Yan YuYing, 2010, Modern Preventive Medicine, V37, P2906; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zalesin KC, 2011, MED CLIN N AM, V95, P919, DOI 10.1016/j.mcna.2011.06.005; Zhang J, 2006, CHIN J PUBLIC HLTH, V22, P1344; [张均和 Zhang Junhe], 2006, [中华航海医学与高气压医学杂志, Chinese journal of nautical medicine and hyperbaric medicine], V13, P105; Zhang LY, 2004, PREVENTION TREATMENT, V4, P20; Zhang YF, 2004, PREVENTION TREATMENT, V4, P52; [赵秀丽 ZHAO Xiuli], 2006, [中华医学杂志, National Medical Journal of China], V86, P1148; Zhou Qin, 2010, Chinese Journal of Prevention and Control of Chronic Diseases, V18, P587	68	32	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58302	10.1371/journal.pone.0058302	http://dx.doi.org/10.1371/journal.pone.0058302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484011	gold, Green Submitted, Green Published			2022-12-27	WOS:000316936100101
J	Penolazzi, B; Leone, L; Russo, PM				Penolazzi, Barbara; Leone, Luigi; Russo, Paolo Maria			Individual Differences and Decision Making: When the Lure Effect of Gain Is a Matter of Size	PLOS ONE			English	Article							IOWA-GAMBLING-TASK; BEHAVIORAL ACTIVATION; PREFRONTAL CORTEX; SEX-DIFFERENCES; BAS SCALES; IMPULSIVITY; REWARD; PERSONALITY; DEFICITS; ANXIETY	The Iowa Gambling Task (IGT) is widely used in investigations of decision making. A growing number of studies have linked performance on this task to personality differences, with the aim of explaining the large degree of variability in healthy individuals' performance of the task. However, this line of research has yielded inconsistent results. In the present study, we tested whether increasing the conflict between short-term and long-term gains in the IGT can clarify personality-related modulations of decision making. We assessed performance on the original IGT as a function of the personality traits typically involved in risky decision making (i.e., impulsivity, sensation seeking, sensitivity to reward and punishment). The impact of these same personality traits was also evaluated on a modified version of the task in which the difference in immediate reward magnitude between disadvantageous and advantageous decks was increased, while keeping the net gain fixed. The results showed that only in this latter IGT variant were highly impulsive individuals and high sensation seekers lured into making disadvantageous choices. The opposite seems to be the case for participants who were highly sensitive to punishment, although further data are needed to corroborate this finding. The present preliminary results suggest that the IGT variant used in this study could be more effective than the original task at identifying personality effects in decision making. Implications for dispositional and situational effects on decision making are discussed.	[Penolazzi, Barbara; Russo, Paolo Maria] Univ Bologna, Dept Psychol, Bologna, Italy; [Penolazzi, Barbara] Univ Padua, Dept Gen Psychol, Padua, Italy; [Leone, Luigi] Univ Roma La Sapienza, Dept Dev & Social Psychol, Rome, Italy	University of Bologna; University of Padua; Sapienza University Rome	Russo, PM (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	p.russo@unibo.it	Russo, Paolo/AAO-5351-2021; Leone, Luigi/AAG-7480-2021	RUSSO, PAOLO MARIA/0000-0002-0575-5360; PENOLAZZI, Barbara/0000-0001-8717-6233				BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Brand M, 2005, PSYCHIAT RES, V133, P91, DOI 10.1016/j.psychres.2004.10.003; Brand M, 2008, PERS INDIV DIFFER, V45, P226, DOI 10.1016/j.paid.2008.04.003; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Corr PJ, 2008, REINFORCEMENT SENSITIVITY THEORY OF PERSONALITY, P1; Crone EA, 2003, PERSONALITY INDIVIDU, V34, P1, DOI DOI 10.1016/S0191-8869(02)00386-0; Davis C, 2007, PERS INDIV DIFFER, V42, P279, DOI 10.1016/j.paid.2006.07.006; de Visser L, 2010, NEUROPSYCHOLOGIA, V48, P1598, DOI 10.1016/j.neuropsychologia.2010.01.027; Fossati A, 2001, J CLIN PSYCHOL, V57, P815, DOI 10.1002/jclp.1051; Franken IHA, 2005, PERS INDIV DIFFER, V39, P991, DOI 10.1016/j.paid.2005.04.004; Franken IHA, 2008, PSYCHIAT RES, V158, P155, DOI 10.1016/j.psychres.2007.06.002; Glicksohn J, 2010, PERS INDIV DIFFER, V48, P557, DOI 10.1016/j.paid.2009.12.006; Goudriaan AE, 2007, ALCOHOL CLIN EXP RES, V31, P928, DOI 10.1111/j.1530-0277.2007.00378.x; Leone L., 2002, GIORNALE ITALIANO PS, V29, P413, DOI [10.1421/1245, DOI 10.1421/1245]; Leone L, 2009, J RES PERS, V43, P1101, DOI 10.1016/j.jrp.2009.08.004; Lin CH, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-16; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Miu AC, 2008, BIOL PSYCHOL, V77, P353, DOI 10.1016/j.biopsycho.2007.11.010; Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Penolazzi B, 2012, PERS INDIV DIFFER, V53, P655, DOI 10.1016/j.paid.2012.05.018; Reavis R, 2001, BEHAV NEUROSCI, V115, P196, DOI 10.1037//0735-7044.115.1.196; Smillie LD, 2006, PERS INDIV DIFFER, V40, P1039, DOI 10.1016/j.paid.2005.10.012; Suhr JA, 2007, PERS INDIV DIFFER, V43, P27, DOI 10.1016/j.paid.2006.11.004; Sweitzer MM, 2008, J INT NEUROPSYCH SOC, V14, P878, DOI 10.1017/S1355617708080934; Takano Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009368; van den Bos R, 2006, BIOL PSYCHOL, V71, P155, DOI 10.1016/j.biopsycho.2005.05.003; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; Zermatten A, 2005, J NERV MENT DIS, V193, P647, DOI 10.1097/01.nmd.0000180777.41295.65; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	31	8	8	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58946	10.1371/journal.pone.0058946	http://dx.doi.org/10.1371/journal.pone.0058946			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23484058	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100144
J	Rowbotham, MC; Astin, J; Greene, K; Cummings, SR				Rowbotham, Michael C.; Astin, John; Greene, Kaitlin; Cummings, Steven R.			Interactive Informed Consent: Randomized Comparison with Paper Consents	PLOS ONE			English	Article							INFORMATION	Informed consent is the cornerstone of human research subject protection. Many subjects sign consent documents without understanding the study purpose, procedures, risks, benefits, and their rights. Proof of comprehension is not required and rarely obtained. Understanding might improve by using an interactive system with multiple options for hearing, viewing and reading about the study and the consent form at the subject's own pace with testing and immediate feedback. This prospective randomized study compared the IRB-approved paper ICF for an actual clinical research study with an interactive presentation of the same study and its associated consent form using an iPad device in two populations: clinical research professionals, and patients drawn from a variety of outpatient practice settings. Of the 90 participants, 69 completed the online test and survey questions the day after the session (maximum 36 hours post-session). Among research professionals (n = 14), there was a trend (p = .07) in the direction of iPad subjects testing better on the online test (mean correct = 77%) compared with paper subjects (mean correct = 57%). Among patients (n = 55), iPad subjects had significantly higher test scores than standard paper consent subjects (mean correct = 75% vs 58%, p < .001). For all subjects, the total time spent reviewing the paper consent was 13.2 minutes, significantly less than the average of 22.7 minutes total on the three components to be reviewed using the iPad (introductory video, consent form, interactive quiz). Overall satisfaction and overall enjoyment slightly favored the interactive iPad presentation. This study demonstrates that combining an introductory video, standard consent language, and an interactive quiz on a tablet-based system improves comprehension of research study procedures and risks.	[Rowbotham, Michael C.; Astin, John; Greene, Kaitlin; Cummings, Steven R.] Calif Pacific Med Ctr Res Inst, San Francisco, CA USA; [Cummings, Steven R.] San Francisco Coordinating Ctr, San Francisco, CA USA	California Pacific Medical Center; California Pacific Medical Center Research Institute; California Pacific Medical Center; California Pacific Medical Center Research Institute	Rowbotham, MC (corresponding author), Calif Pacific Med Ctr Res Inst, San Francisco, CA USA.	rowbotm@cpmcri.org	Rowbotham, Michael/AAA-3606-2019		California Pacific Medical Center Research Institute (CPMCRI) under the MCR	California Pacific Medical Center Research Institute (CPMCRI) under the MCR	The study was funded by departmental funds at California Pacific Medical Center Research Institute (CPMCRI) under the control of MCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniou EE, 2011, J MED ETHICS, V37, P557, DOI 10.1136/jme.2010.041871; Baren J, 2010, ANN EMERG MED, V55, P9, DOI 10.1016/j.annemergmed.2009.09.023; Fink AS, 2010, ANN SURG, V252, P27, DOI 10.1097/SLA.0b013e3181e3ec61; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Lee R, 2011, INT J ENV RES PUB HE, V8, P830, DOI 10.3390/ijerph8030830; McNutt LA, 2008, J EMPIR RES HUM RES, V3, P89, DOI 10.1525/jer.2008.3.1.89; RIECKEN HW, 1982, JAMA-J AM MED ASSOC, V248, P344, DOI 10.1001/jama.248.3.344; Schenker Y, 2011, JAMA-J AM MED ASSOC, V305, P1130, DOI 10.1001/jama.2011.333; Tait AR, 2009, ARCH INTERN MED, V169, P1907, DOI 10.1001/archinternmed.2009.390	9	78	79	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58603	10.1371/journal.pone.0058603	http://dx.doi.org/10.1371/journal.pone.0058603			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484041	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100130
J	Sominsky, L; Fuller, EA; Bondarenko, E; Ong, LK; Averell, L; Nalivaiko, E; Dunkley, PR; Dickson, PW; Hodgson, DM				Sominsky, Luba; Fuller, Erin A.; Bondarenko, Evgeny; Ong, Lin Kooi; Averell, Lee; Nalivaiko, Eugene; Dunkley, Peter R.; Dickson, Phillip W.; Hodgson, Deborah M.			Functional Programming of the Autonomic Nervous System by Early Life Immune Exposure: Implications for Anxiety	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; TYROSINE-HYDROXYLASE PHOSPHORYLATION; MESSENGER-RNA EXPRESSION; ENDOTOXIN EXPOSURE; NEONATAL EXPOSURE; RAT HIPPOCAMPUS; GENE-EXPRESSION; STRESS; RECEPTOR; ALTERS	Neonatal exposure of rodents to an immune challenge alters a variety of behavioural and physiological parameters in adulthood. In particular, neonatal lipopolysaccharide (LPS; 0.05 mg/kg, i.p.) exposure produces robust increases in anxiety-like behaviour, accompanied by persistent changes in hypothalamic-pituitary-adrenal (HPA) axis functioning. Altered autonomic nervous system (ANS) activity is an important physiological contributor to the generation of anxiety. Here we examined the long term effects of neonatal LPS exposure on ANS function and the associated changes in neuroendocrine and behavioural indices. ANS function in Wistar rats, neonatally treated with LPS, was assessed via analysis of tyrosine hydroxylase (TH) in the adrenal glands on postnatal days (PNDs) 50 and 85, and via plethysmographic assessment of adult respiratory rate in response to mild stress (acoustic and light stimuli). Expression of genes implicated in regulation of autonomic and endocrine activity in the relevant brain areas was also examined. Neonatal LPS exposure produced an increase in TH phosphorylation and activity at both PNDs 50 and 85. In adulthood, LPS-treated rats responded with increased respiratory rates to the lower intensities of stimuli, indicative of increased autonomic arousal. These changes were associated with increases in anxiety-like behaviours and HPA axis activity, alongside altered expression of the GABA-A receptor alpha 2 subunit, CRH receptor type 1, CRH binding protein, and glucocorticoid receptor mRNA levels in the prefrontal cortex, hippocampus and hypothalamus. The current findings suggest that in addition to the commonly reported alterations in HPA axis functioning, neonatal LPS challenge is associated with a persistent change in ANS activity, associated with, and potentially contributing to, the anxiety-like phenotype. The findings of this study reflect the importance of changes in the perinatal microbial environment on the ontogeny of physiological processes.	[Sominsky, Luba; Fuller, Erin A.; Hodgson, Deborah M.] Univ Newcastle, Lab Neuroimmunol, Sch Psychol, Callaghan, NSW 2308, Australia; [Bondarenko, Evgeny; Ong, Lin Kooi; Nalivaiko, Eugene; Dunkley, Peter R.; Dickson, Phillip W.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Bondarenko, Evgeny; Ong, Lin Kooi; Nalivaiko, Eugene; Dunkley, Peter R.; Dickson, Phillip W.] Univ Newcastle, Hunter Med Res Inst, Callaghan, NSW 2308, Australia; [Averell, Lee] Univ Newcastle, Newcastle Cognit Lab, Sch Psychol, Callaghan, NSW 2308, Australia	University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Sominsky, L (corresponding author), Univ Newcastle, Lab Neuroimmunol, Sch Psychol, Callaghan, NSW 2308, Australia.	luba.sominsky@newcastle.edu.au	Bondarenko, Evgeny/AAA-6088-2019; Ong, Lin Kooi/H-2797-2012; Hodgson, Deborah/C-1950-2008	Bondarenko, Evgeny/0000-0003-0631-8936; Ong, Lin Kooi/0000-0001-8664-0540; Hodgson, Deborah/0000-0002-1522-0212; Fuller, Erin/0000-0001-8653-1002; Sominsky, Luba/0000-0002-0674-8824; Nalivaiko, Eugene/0000-0002-6449-8181	University of Newcastle	University of Newcastle	University of Newcastle Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amath A, 2012, NEUROSCIENCE, V220, P90, DOI 10.1016/j.neuroscience.2012.06.037; Averell L, 2011, J MATH PSYCHOL, V55, P25, DOI 10.1016/j.jmp.2010.08.009; BARUCHIN A, 1990, J NEUROCHEM, V54, P1769, DOI 10.1111/j.1471-4159.1990.tb01232.x; Bilbo SD, 2008, BRAIN BEHAV IMMUN, V22, P451, DOI 10.1016/j.bbi.2007.10.003; Bilbo SD, 2007, BRAIN BEHAV IMMUN, V21, P332, DOI 10.1016/j.bbi.2006.10.005; Bobrovskaya L, 2007, J NEUROCHEM, V100, P479, DOI 10.1111/j.1471-4159.2006.04213.x; Bornstein SR, 2000, P NATL ACAD SCI USA, V97, P14742, DOI 10.1073/pnas.97.26.14742; Brinks Vera, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/90163; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Craske MG, 2001, J AM ACAD CHILD PSY, V40, P556, DOI 10.1097/00004583-200105000-00015; Davies MJ, 2002, TRENDS ENDOCRIN MET, V13, P386, DOI 10.1016/S1043-2760(02)00691-4; Dombrowski SC, 2003, BIRTH DEFECTS RES A, V67, P905, DOI 10.1002/bdra.10096; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; DUNN AJ, 1992, J PHARMACOL EXP THER, V261, P964; Enomoto T, 2011, BIOL PSYCHIAT, V69, P432, DOI 10.1016/j.biopsych.2010.09.038; FLUHARTY SJ, 1983, BRAIN RES, V267, P384, DOI 10.1016/0006-8993(83)90895-8; Gaiarsa JL, 2004, J CELL MOL MED, V8, P31, DOI 10.1111/j.1582-4934.2004.tb00257.x; Girod JP, 2004, CARDIOVASC RES, V64, P217, DOI 10.1016/j.cardiores.2004.07.006; Guo AL, 1996, J ENDOCRINOL INVEST, V19, P83, DOI 10.1007/BF03349841; HERMAN JP, 1995, NEUROENDOCRINOLOGY, V61, P180, DOI 10.1159/000126839; Herman JP, 1998, J NEUROSCI, V18, P7462; Hodgson DM, 2001, PEDIATR RES, V50, P750, DOI 10.1203/00006450-200112000-00020; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Jenkins TA, 2009, BEHAV BRAIN RES, V205, P355, DOI 10.1016/j.bbr.2009.07.014; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kabir MM, 2010, PHYSIOL BEHAV, V101, P22, DOI 10.1016/j.physbeh.2010.04.004; Karrow NA, 2006, BRAIN BEHAV IMMUN, V20, P144, DOI 10.1016/j.bbi.2005.05.003; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Meyer U, 2009, SCHIZOPHRENIA BULL, V35, P959, DOI 10.1093/schbul/sbn022; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Murakami S, 2005, NEUROSCI RES, V53, P129, DOI 10.1016/j.neures.2005.06.008; Nalivaiko E, 2011, RESP RESPONSES ACOUS; Nalivaiko E, 2012, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00114; Ong LK, 2011, NEUROSCIENCE, V192, P20, DOI 10.1016/j.neuroscience.2011.06.087; Ong LK, 2012, NEUROCHEM RES, V37, P1938, DOI 10.1007/s11064-012-0812-3; Pace TWW, 2007, BRAIN BEHAV IMMUN, V21, P9, DOI 10.1016/j.bbi.2006.08.009; Paine TA, 2011, NEUROPSYCHOPHARMACOL, V36, P1703, DOI 10.1038/npp.2011.51; Reul JMHM, 2002, CURR OPIN PHARMACOL, V2, P23, DOI 10.1016/S1471-4892(01)00117-5; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; SAPOLSKY RM, 1985, BRAIN RES, V339, P161, DOI 10.1016/0006-8993(85)90638-9; Seasholtz AF, 2001, PEPTIDES, V22, P743, DOI 10.1016/S0196-9781(01)00387-4; SHANKS N, 1995, J NEUROSCI, V15, P376, DOI 10.1523/jneurosci.15-01-00376.1995; Shanks N, 2000, P NATL ACAD SCI USA, V97, P5645, DOI 10.1073/pnas.090571897; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Sominsky L, 2012, BEHAV BRAIN RES, V226, P351, DOI 10.1016/j.bbr.2011.08.038; Sominsky L, 2012, HORM BEHAV, V62, P345, DOI 10.1016/j.yhbeh.2012.02.005; Stachowiak M K, 1988, Brain Res, V427, P275; Todorovic C, 2005, NEUROSCI BIOBEHAV R, V29, P1323, DOI 10.1016/j.neubiorev.2005.04.014; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; VANDIJKEN HH, 1993, NEUROENDOCRINOLOGY, V58, P57, DOI 10.1159/000126512; Walker AK, 2010, STRESS, V13, P506, DOI 10.3109/10253890.2010.489977; Walker AK, 2012, PSYCHONEUROENDOCRINO, V37, P1320, DOI 10.1016/j.psyneuen.2012.01.005; Walker AK, 2011, BRAIN BEHAV IMMUN, V25, P674, DOI 10.1016/j.bbi.2011.01.004; Walker AK, 2009, PSYCHONEUROENDOCRINO, V34, P1515, DOI 10.1016/j.psyneuen.2009.05.010; Walker FR, 2004, BEHAV BRAIN RES, V154, P63, DOI 10.1016/j.bbr.2004.01.019; Walker FR, 2008, J PSYCHIATR RES, V42, P1094, DOI 10.1016/j.jpsychires.2007.12.006; Weninger SC, 1999, P NATL ACAD SCI USA, V96, P8283, DOI 10.1073/pnas.96.14.8283; Wilhelm FH, 2001, BEHAV MODIF, V25, P513, DOI 10.1177/0145445501254003; Wynne O, 2011, STRESS, V14, P247, DOI 10.3109/10253890.2010.532576	63	47	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57700	10.1371/journal.pone.0057700	http://dx.doi.org/10.1371/journal.pone.0057700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483921	Green Published, gold			2022-12-27	WOS:000316936100037
J	Dan, JQ; Zhang, YJ; Peng, ZW; Huang, JT; Gao, HJ; Xu, L; Chen, MS				Dan, Jiaqiang; Zhang, Yaojun; Peng, Zhenwei; Huang, Junting; Gao, Hengjun; Xu, Li; Chen, Minshan			Postoperative Neutrophil-to-Lymphocyte Ratio Change Predicts Survival of Patients with Small Hepatocellular Carcinoma Undergoing Radiofrequency Ablation	PLOS ONE			English	Article							ELEVATED PREOPERATIVE NEUTROPHIL; PROSPECTIVE RANDOMIZED-TRIAL; RENAL-CELL CARCINOMA; CURATIVE RESECTION; GASTRIC-CANCER; RISK-FACTORS; LOCAL RECURRENCE; THERAPY; TUMOR; METASTASES	Background: An elevated preoperative neutrophil-to-lymphocyte ratio (NLR) has been reported to be a prognostic factor for hepatocellular carcinoma (HCC) patients after treatment. However, the clinical implication of postoperative NLR change remains unclear. Materials and Methods: From May 2005 to Aug 2008, a cohort of consecutive 178 small HCC patients treated with radiofrequency ablation (RFA) was retrospectively reviewed. The NLR was recorded within 3 days before and 1 month after RFA. Baseline characteristics, overall survival (OS) and recurrence free survival (RFS) were compared according to preoperative NLR and/or postoperative NLR change. Prognostic factors were assessed by multivariate analysis. Results: Compared with preoperative NLR level, postoperative NLR decreased in 87 patients and increased in 91 patients after RFA. No significant differences were identified between two groups in commonly used clinic-pathologic features. The 1, 3, 5 years OS was 98.8%, 78.6%, 67.1% for NLR decreased group, and 92.2%, 55.5%, 35.4% for NLR increased group respectively (P<0.001); the corresponding RFS was 94.2%, 65.2%, 33.8% and 81.7%, 46.1%, 12.4% respectively (P<0.001). In subgroup analysis, the survival of patients with lower or higher preoperative NLR can be distinguished more accurate by postoperative NLR change. Multivariate analysis showed that postoperative NLR change, but not preoperative NLR, was an independent prognostic factor for both OS (P<0.001, HR = 2.39, 95% CI 1.53-3.72) and RFS (P = 0.003, HR = 1.69, 95% CI 1.87-8.24). Conclusion: The postoperative NLR change was an independent prognostic factor for small HCC patient undergoing RFA, and patients with decreased NLR indicated better survival than those with increased NLR.	[Dan, Jiaqiang; Zhang, Yaojun; Peng, Zhenwei; Huang, Junting; Gao, Hengjun; Xu, Li; Chen, Minshan] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China; [Dan, Jiaqiang; Zhang, Yaojun; Peng, Zhenwei; Huang, Junting; Gao, Hengjun; Xu, Li; Chen, Minshan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China; [Peng, Zhenwei] Sun Yat Sen Univ, Dept Oncol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Chen, MS (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Surg, Guangzhou 510275, Guangdong, Peoples R China.	Chminsh@mail.sysu.edu.cn	peng-cheng, chen/K-8100-2013; Huang, Junting/Q-4839-2019; Zhang, Yaojun/U-2965-2019	peng-cheng, chen/0000-0001-9763-6459; Huang, Junting/0000-0002-2448-5837; Zhang, Yaojun/0000-0002-9752-4729	Nature Science Foundation of China [30872995]; medical science research grant Guangdong Province [B2010114]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); medical science research grant Guangdong Province	This study was supported by a grant from the Nature Science Foundation of China (No. 30872995) and the medical science research grant Guangdong Province (B2010114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Chen TM, 2012, J GASTROEN HEPATOL, V27, P553, DOI 10.1111/j.1440-1746.2011.06910.x; Chua W, 2011, SUPPORT CARE CANC; den Brok MHMGM, 2004, CANCER RES, V64, P4024, DOI 10.1158/0008-5472.CAN-03-3949; Ding PR, 2010, INT J COLORECTAL DIS, V25, P1427, DOI 10.1007/s00384-010-1052-0; Fagnoni FF, 2008, FRONT BIOSCI-LANDMRK, V13, P369, DOI 10.2741/2686; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fondevila C, 2004, BRIT J CANCER, V90, P206, DOI 10.1038/sj.bjc.6601455; Gomez D, 2008, WORLD J SURG, V32, P1757, DOI 10.1007/s00268-008-9552-6; Guglielmi A, 2008, J GASTROINTEST SURG, V12, P192, DOI 10.1007/s11605-007-0392-8; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; He JR, 2012, HEAD NECK; Hong SN, 2005, J CLIN GASTROENTEROL, V39, P247, DOI 10.1097/01.mcg.0000152746.72149.31; Huang ZL, 2011, J VASC INTERV RADIOL, V22, P702, DOI 10.1016/j.jvir.2010.12.041; Hung HY, 2011, INT J COLORECTAL DIS, V26, P1059, DOI 10.1007/s00384-011-1192-x; Jung MR, 2011, J SURG ONCOL, V104, P504, DOI 10.1002/jso.21986; Kishi Y, 2009, ANN SURG ONCOL, V16, P614, DOI 10.1245/s10434-008-0267-6; Kusumanto Yoka H., 2003, Angiogenesis, V6, P283, DOI 10.1023/B:AGEN.0000029415.62384.ba; Lam VWT, 2008, J AM COLL SURGEONS, V207, P20, DOI 10.1016/j.jamcollsurg.2008.01.020; Lau WY, 2003, ANN SURG, V237, P171, DOI 10.1097/00000658-200302000-00005; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lin SM, 2010, ONCOLOGY-BASEL, V78, P102, DOI 10.1159/000315237; Lupo L, 2007, HPB (Oxford), V9, P429, DOI 10.1080/13651820701713758; Mulier S, 2002, BRIT J SURG, V89, P1206, DOI 10.1046/j.1365-2168.2002.02168.x; Ng KK, 2008, J GASTROINTEST SURG, V12, P183, DOI 10.1007/s11605-007-0276-y; Ohno Y, 2012, J UROLOGY, V187, P411, DOI 10.1016/j.juro.2011.10.026; Peng ZW, 2008, SURG ONCOL, V17, P23, DOI 10.1016/j.suronc.2007.08.002; Rao P, 2011, CARDIOVASC INTER RAD, V34, P424, DOI 10.1007/s00270-010-9896-9; Sanchez-Ortiz RF, 2003, J UROLOGY, V170, P178, DOI 10.1097/01.ju.0000070823.38336.7b; Shiozawa K, 2009, MOL MED REP, V2, P89, DOI 10.3892/mmr_00000067; Takahashi S, 2007, ONCOLOGY-BASEL, V72, P98, DOI 10.1159/000111714; Tateishi R, 2005, CANCER-AM CANCER SOC, V103, P1201, DOI 10.1002/cncr.20892; Thavaramara Thaovalai, 2011, Journal of the Medical Association of Thailand, V94, P871; Wang GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025295; Yamanaka T, 2007, ONCOLOGY-BASEL, V73, P215, DOI 10.1159/000127412; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zhang YJ, 2007, RADIOLOGY, V244, P599, DOI 10.1148/radiol.2442060826; Zhang YJ, 2012, INT J HYPERTHER, V28, P132, DOI 10.3109/02656736.2011.654374	40	98	104	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58184	10.1371/journal.pone.0058184	http://dx.doi.org/10.1371/journal.pone.0058184			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516447	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400021
J	Fairless, R; Beck, A; Kravchenko, M; Williams, SK; Wissenbach, U; Diem, R; Cavalie, A				Fairless, Richard; Beck, Andreas; Kravchenko, Mykola; Williams, Sarah K.; Wissenbach, Ulrich; Diem, Ricarda; Cavalie, Adolfo			Membrane Potential Measurements of Isolated Neurons Using a Voltage-Sensitive Dye	PLOS ONE			English	Article							TRP CHANNELS; FLUORESCENCE; IDENTIFICATION; VALIDATION; INDICATORS; FLIPR; GABA	The ability to monitor changes in membrane potential is a useful tool for studying neuronal function, but there are only limited options available at present. Here, we have investigated the potential of a commercially available FLIPR membrane potential (FMP) dye, developed originally for high throughput screening using a plate reader, for imaging the membrane potential of cultured cells using an epifluorescence-based single cell imaging system. We found that the properties of the FMP dye make it highly suitable for such imaging since 1) its fluorescence displayed a high signal-to-noise ratio, 2) robust signals meant only minimal exposure times of around 5 ms were necessary, and 3) bidirectional changes in fluorescence were detectable resulting from hyper- or depolarising conditions, reaching equilibrium with a time constant of 4-8 s. Measurements were possible independently of whether membrane potential changes were induced by voltage clamping, or manipulating the ionic distribution of either Na+ or K+. Since FMP behaves as a charged molecule which accumulates in the cytosol, equations based on the Boltzmann distribution were developed determining that the apparent charge of FMP which represents a measure of the voltage sensitivity of the dye, is between -0.62 and -0.72. Finally, we demonstrated that FMP is suitable for use in a variety of neuronal cell types and detects membrane potential changes arising from spontaneous firing of action potentials and through stimulation with a variety of excitatory and inhibitory neurotransmitters.	[Fairless, Richard; Williams, Sarah K.; Diem, Ricarda] Univ Clin Heidelberg, Dept Neurooncol, Heidelberg, Germany; [Fairless, Richard; Williams, Sarah K.; Diem, Ricarda] Univ Saarland, Dept Neurol, Homburg, Germany; [Beck, Andreas; Kravchenko, Mykola; Wissenbach, Ulrich; Cavalie, Adolfo] Univ Saarland, Dept Pharmacol & Toxicol, Homburg, Germany	Ruprecht Karls University Heidelberg; Saarland University; Saarland University	Cavalie, A (corresponding author), Univ Saarland, Dept Pharmacol & Toxicol, Homburg, Germany.	adolfo.cavalie@uks.eu			Deutsche Forschungsgemeinschaft [SFB 894, GK 1326]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungsgemeinschaft (SFB 894, GK 1326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADRIAN RH, 1956, J PHYSIOL-LONDON, V133, P631, DOI 10.1113/jphysiol.1956.sp005615; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; ANDREOLI TE, 1967, J GEN PHYSIOL, V50, P2527, DOI 10.1085/jgp.50.11.2527; Baker BJ, 2005, CELL MOL NEUROBIOL, V25, P245, DOI 10.1007/s10571-005-3059-6; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Bodding M, 2007, CELL CALCIUM, V42, P618, DOI 10.1016/j.ceca.2007.03.005; Briggman KL, 2010, MEMBRANE POTENTIAL IMAGING IN THE NERVOUS SYSTEMS: METHODS AND APPLICATIONS, P61, DOI 10.1007/978-1-4419-6558-5_6; Campo-Soria C, 2006, BRIT J PHARMACOL, V148, P984, DOI 10.1038/sj.bjp.0706796; Canepari M, 2010, BIOPHYS J, V98, P2032, DOI 10.1016/j.bpj.2010.01.024; COHEN L, 1989, ANNU REV PHYSIOL, V51, P487, DOI 10.1146/annurev.physiol.51.1.487; Fitch RW, 2003, P NATL ACAD SCI USA, V100, P4909, DOI 10.1073/pnas.0630641100; Goslin K., 1998, CULTURING NERVE CELL, P339; Gross SA, 2009, J BIOL CHEM, V284, P34423, DOI 10.1074/jbc.M109.018192; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Hilgenberg Lutz G W, 2007, J Vis Exp, P562, DOI 10.3791/562; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Homma R, 2011, PHIL T R SOC B, V364, P2453; Jankowski A, 1999, J BIOL CHEM, V274, P26098, DOI 10.1074/jbc.274.37.26098; Joesch C, 2008, J BIOMOL SCREEN, V13, P218, DOI 10.1177/1087057108315036; Kuhn B, 2004, BIOPHYS J, V87, P631, DOI 10.1529/biophysj.104.040477; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Loew LM, 2010, MEMBRANE POTENTIAL IMAGING IN THE NERVOUS SYSTEMS: METHODS AND APPLICATIONS, P13, DOI 10.1007/978-1-4419-6558-5_2; MCCORMICK DA, 1985, P NATL ACAD SCI USA, V82, P6344, DOI 10.1073/pnas.82.18.6344; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MINTA A, 1989, J BIOL CHEM, V264, P19449; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; Nakagawa T, 2006, J NEURAL ENG, V3, P79, DOI 10.1088/1741-2560/3/2/001; Pages S, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00020; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; Schnitzler AC, 2008, NAT PROTOC, V3, P34, DOI 10.1038/nprot.2007.477; Whiteaker KL, 2001, J BIOMOL SCREEN, V6, P305, DOI 10.1177/108705710100600504; Wolff C, 2003, J BIOMOL SCREEN, V8, P533, DOI 10.1177/1087057103257806; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Zhang J, 1998, BIOPHYS J, V74, P48, DOI 10.1016/S0006-3495(98)77765-3; Zheng F, 1996, J NEUROSCI, V16, P6079	41	23	23	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58260	10.1371/journal.pone.0058260	http://dx.doi.org/10.1371/journal.pone.0058260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516458	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200052
J	Lawrenz, E; Silsbe, G; Capuzzo, E; Ylostalo, P; Forster, RM; Simis, SGH; Prasil, O; Kromkamp, JC; Hickman, AE; Moore, CM; Forget, MH; Geider, RJ; Suggett, DJ				Lawrenz, Evelyn; Silsbe, Greg; Capuzzo, Elisa; Ylostalo, Pasi; Forster, Rodney M.; Simis, Stefan G. H.; Prasil, Ondrej; Kromkamp, Jacco C.; Hickman, Anna E.; Moore, C. Mark; Forget, Marie-Helen; Geider, Richard J.; Suggett, David J.			Predicting the Electron Requirement for Carbon Fixation in Seas and Oceans	PLOS ONE			English	Article							FAST REPETITION RATE; DIATOM SKELETONEMA-COSTATUM; CHLOROPHYLL FLUORESCENCE; RATE FLUOROMETRY; IRON LIMITATION; MARINE-PHYTOPLANKTON; PRIMARY PRODUCTIVITY; CYANOBACTERIUM TRICHODESMIUM; PHOTOSYNTHETIC EFFICIENCY; PHAEODACTYLUM-TRICORNUTUM	Marine phytoplankton account for about 50% of all global net primary productivity (NPP). Active fluorometry, mainly Fast Repetition Rate fluorometry (FRRf), has been advocated as means of providing high resolution estimates of NPP. However, not measuring CO2-fixation directly, FRRf instead provides photosynthetic quantum efficiency estimates from which electron transfer rates (ETR) and ultimately CO2-fixation rates can be derived. Consequently, conversions of ETRs to CO2-fixation requires knowledge of the electron requirement for carbon fixation (Phi(e,C), ETR/CO2 uptake rate) and its dependence on environmental gradients. Such knowledge is critical for large scale implementation of active fluorescence to better characterise CO2-uptake. Here we examine the variability of experimentally determined Phi(e,C) values in relation to key environmental variables with the aim of developing new working algorithms for the calculation of Phi(e,C) from environmental variables. Coincident FRRf and C-14-uptake and environmental data from 14 studies covering 12 marine regions were analysed via a meta-analytical, non-parametric, multivariate approach. Combining all studies, Phi(e,C) varied between 1.15 and 54.2 mol e(-) (mol C)(-1) with a mean of 10.9 +/- 6.91 mol e(-) mol C)(-1). Although variability of Phi(e,C) was related to environmental gradients at global scales, region-specific analyses provided far improved predictive capability. However, use of regional Phi(e,C) algorithms requires objective means of defining regions of interest, which remains challenging. Considering individual studies and specific small-scale regions, temperature, nutrient and light availability were correlated with Phi(e,C) albeit to varying degrees and depending on the study/region and the composition of the extant phytoplankton community. At the level of large biogeographic regions and distinct water masses, Phi(e,C) was related to nutrient availability, chlorophyll, as well as temperature and/or salinity in most regions, while light availability was also important in Baltic Sea and shelf waters. The novel Phi(e,C) algorithms provide a major step forward for widespread fluorometry-based NPP estimates and highlight the need for further studying the natural variability of Phi(e,C) to verify and develop algorithms with improved accuracy.	[Lawrenz, Evelyn; Prasil, Ondrej] ASCR, Inst Microbiol, Lab Photosynth, Trebon, Czech Republic; [Silsbe, Greg; Kromkamp, Jacco C.] Netherlands Inst Ecol, Ctr Estuarine & Marine Ecol NIOO CEME, Yerseke, Netherlands; [Capuzzo, Elisa; Forster, Rodney M.] CEFAS, Lowestoft, Suffolk, England; [Ylostalo, Pasi; Simis, Stefan G. H.] Finish Environm Inst SYKE, Helsinki, Finland; [Hickman, Anna E.; Moore, C. Mark] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [Forget, Marie-Helen] Univ Laval, Takuvic Joint Int Lab, Univ Laval Canada, CNRS France,Dept Biol & Quebec Ocean,UMI 3376, Quebec City, PQ, Canada; [Geider, Richard J.; Suggett, David J.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Centre for Environment Fisheries & Aquaculture Science; Finnish Environment Institute; NERC National Oceanography Centre; University of Southampton; Laval University; University of Essex	Lawrenz, E (corresponding author), ASCR, Inst Microbiol, Lab Photosynth, Trebon, Czech Republic.	lawrenz@alga.cz	KROMKAMP, JACCO/A-7319-2013; Silsbe, Greg/AAB-3321-2022; Hickman, Anna E/A-9351-2011; Forster, Rodney/J-1756-2019; Silsbe, Greg/L-1808-2013; Capuzzo, Elisa/AAE-9028-2022; Suggett, David J/G-9212-2017; KNAW, NIOO-KNAW/A-4320-2012; Prasil, Ondrej/H-2454-2014	Forster, Rodney/0000-0001-6990-1673; Capuzzo, Elisa/0000-0002-6055-6970; Suggett, David J/0000-0001-5326-2520; Simis, Stefan/0000-0002-6296-9146; Forget, Marie-Helene/0000-0002-2430-8531; Ylostalo, Pasi/0000-0003-4702-2840; Hickman, Anna/0000-0002-2774-3934; KNAW, NIOO-KNAW/0000-0002-3835-159X; Prasil, Ondrej/0000-0002-0012-4359; Moore, Mark/0000-0002-9541-6046; Geider, Richard/0000-0003-3276-047X	EU FP7 project PROTOOL FP7 [226880]; NERC [NE/H015930/2, NE/G009155/1] Funding Source: UKRI; Natural Environment Research Council [NE/H015930/2, NE/G009155/1, NE/B500966/1] Funding Source: researchfish	EU FP7 project PROTOOL FP7; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work and some of the cruises have been made possible via funding through the EU FP7 project PROTOOL FP7 (grant number 226880). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader MR, 2000, PHILOS T R SOC B, V355, P1433, DOI 10.1098/rstb.2000.0704; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Baker NR, 2004, ADV PHOTO RESPIRAT, V19, P65; Behrenfeld MJ, 2008, PHILOS T R SOC B, V363, P2687, DOI 10.1098/rstb.2008.0019; Behrenfeld MJ, 2006, NATURE, V442, P1025, DOI 10.1038/nature05083; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Behrenfeld MJ, 2004, J PHYCOL, V40, P4, DOI 10.1046/j.1529-8817.2004.03083.x; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Berges JA, 1996, PLANT PHYSIOL, V110, P689, DOI 10.1104/pp.110.2.689; Bibby TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004601; Bonnet S, 2008, BIOGEOSCIENCES, V5, P215, DOI 10.5194/bg-5-215-2008; Boyd PW, 1997, MAR ECOL PROG SER, V149, P215, DOI 10.3354/meps149215; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Carr ME, 2006, DEEP-SEA RES PT II, V53, P741, DOI 10.1016/j.dsr2.2006.01.028; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Corno G, 2006, J PHYCOL, V42, P51, DOI 10.1111/j.1529-8817.2006.00163.x; Cullen J.J., 2003, LIMNOL OCEANOGR B, V12, P29, DOI [10.1002/lob.200413229, DOI 10.1002/LOB.200413229, DOI 10.1002/L0B.200312229]; DUBINSKY Z, 1986, PLANT CELL PHYSIOL, V27, P1335, DOI 10.1093/oxfordjournals.pcp.a077232; EDWARDS GE, 1993, PHOTOSYNTH RES, V37, P89, DOI 10.1007/BF02187468; Estevez-Blanco P, 2006, J PLANKTON RES, V28, P1153, DOI 10.1093/plankt/fbl046; FALKOWSKI PG, 1980, PLANT PHYSIOL, V66, P592, DOI 10.1104/pp.66.4.592; FALKOWSKI PG, 1995, AUST J PLANT PHYSIOL, V22, P341, DOI 10.1071/PP9950341; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; FLAMELING IA, 1994, J PLANKTON RES, V16, P1781, DOI 10.1093/plankt/16.12.1781; FOGG GE, 1989, HYDROBIOLOGIA, V173, P89, DOI 10.1007/BF00015518; GEIDER RJ, 1993, J PHYCOL, V29, P755, DOI 10.1111/j.0022-3646.1993.00755.x; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; Grossman AR, 2010, J PHYCOL, V46, P629, DOI 10.1111/j.1529-8817.2010.00852.x; Halsey KH, 2011, J PHYCOL, V47, P66, DOI 10.1111/j.1529-8817.2010.00945.x; Halsey KH, 2010, PHOTOSYNTH RES, V103, P125, DOI 10.1007/s11120-009-9526-z; Hickman, 2007, THESIS U SOUTHAMPTON; HOLMES JJ, 1989, PLANT PHYSIOL, V91, P331, DOI 10.1104/pp.91.1.331; Kirk J. T. O., 2010, LIGHT PHOTOSYNTHESIS, Vthird; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; KROMKAMP J, 1993, J GEN MICROBIOL, V139, P2277, DOI 10.1099/00221287-139-9-2277; Kromkamp JC, 2008, EUR J PHYCOL, V43, P327, DOI 10.1080/09670260802080895; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Laney SR, 2001, J ATMOS OCEAN TECH, V18, P1924, DOI 10.1175/1520-0426(2001)018<1924:MTNFOP>2.0.CO;2; LAWS EA, 1991, DEEP-SEA RES, V38, P143, DOI 10.1016/0198-0149(91)90059-O; Lessin G, 2007, OCEANOLOGIA, V49, P259; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Levitan O, 2010, PLANT PHYSIOL, V154, P346, DOI 10.1104/pp.110.159285; LEWIS MR, 1983, MAR ECOL PROG SER, V13, P99, DOI 10.3354/meps013099; Li WKW, 2006, P ROY SOC B-BIOL SCI, V273, P1953, DOI 10.1098/rspb.2006.3529; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Liu SW, 2012, MAR BIOL, V159, P519, DOI 10.1007/s00227-011-1832-2; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; MacIntyre H.L., 2005, ALGAL CULTURING TECH, P287, DOI [10.1016/B978-012088426-1/50020-2, DOI 10.1016/B978-012088426-1/50020-2, 10.1007/s10811-017-1254-8]; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; Masojidek J, 2001, J PLANKTON RES, V23, P57, DOI 10.1093/plankt/23.1.57; Melrose DC, 2006, MAR ECOL PROG SER, V311, P37, DOI 10.3354/meps311037; Milligan AJ, 2012, MAR ECOL PROG SER, V448, P67, DOI 10.3354/meps09544; Moore CM, 2006, LIMNOL OCEANOGR, V51, P936, DOI 10.4319/lo.2006.51.2.0936; Moore CM, 2003, MAR ECOL PROG SER, V259, P29, DOI 10.3354/meps259029; Napoleon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040284; Oxborough K, 2012, LIMNOL OCEANOGR-METH, V10, P142, DOI 10.4319/lom.2012.10.142; Pemberton KL, 2006, MAR ECOL PROG SER, V322, P51, DOI 10.3354/meps322051; Raateoja M, 2004, MAR ECOL PROG SER, V267, P9, DOI 10.3354/meps267009; Ryan-Keogh TJ, 2012, J PHYCOL, V48, P145, DOI 10.1111/j.1529-8817.2011.01092.x; Scanlan DJ, 2003, ADV MICROB PHYSIOL, V47, P1, DOI 10.1016/S0065-2911(03)47001-X; Schrader PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018753; SCHREIBER U, 1993, PHOTOSYNTH RES, V36, P65, DOI 10.1007/BF00018076; Serodio J, 2006, PHOTOSYNTH RES, V90, P29, DOI [10.1007/s11120-006-9105-5, 10.1007/s11120-006-9101-9]; Smyth TJ, 2004, J PLANKTON RES, V26, P1337, DOI 10.1093/plankt/fbh124; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Suggett D, 2001, LIMNOL OCEANOGR, V46, P802, DOI 10.4319/lo.2001.46.4.0802; Suggett DJ, 2006, DEEP-SEA RES PT II, V53, P1573, DOI 10.1016/j.dsr2.2006.05.014; Suggett DJ, 2006, LIMNOL OCEANOGR, V51, P2064, DOI 10.4319/lo.2006.51.5.2064; Suggett DJ, 2010, DEVEL APPL PHYCOL, V4, P103, DOI 10.1007/978-90-481-9268-7_6; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Suggett DJ, 2004, LIMNOL OCEANOGR-METH, V2, P316, DOI 10.4319/lom.2004.2.316; Suggett DJ, 2003, EUR J PHYCOL, V38, P371, DOI 10.1080/09670260310001612655; Suggett DJ, 2000, VARIABILITY PHYTOPLA; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Tamminen T, 2007, MAR ECOL PROG SER, V340, P121, DOI 10.3354/meps340121; TING CS, 1994, PLANT PHYSIOL, V106, P763, DOI 10.1104/pp.106.2.763; Tripathy SC, 2010, ESTUAR COAST SHELF S, V87, P163, DOI 10.1016/j.ecss.2010.01.006; van Beusekom JEE, 2009, INT J EARTH SCI, V98, P251, DOI 10.1007/s00531-007-0231-x; VENRICK EL, 1977, J EXP MAR BIOL ECOL, V26, P55, DOI 10.1016/0022-0981(77)90080-6; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Williams PJL, 1996, J PLANKTON RES, V18, P1961, DOI 10.1093/plankt/18.10.1961; Wu YS, 2008, MAR ECOL PROG SER, V355, P9, DOI 10.3354/meps07233; Wu YS, 2007, J PLANKTON RES, V29, P509, DOI 10.1093/plankt/fbm035; Zhai L, 2011, ICES J MAR SCI, V68, P781, DOI 10.1093/icesjms/fsq175	90	75	75	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58137	10.1371/journal.pone.0058137	http://dx.doi.org/10.1371/journal.pone.0058137			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516441	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000316849200036
J	Mathur, A; Blais, S; Goparaju, CMV; Neubert, T; Pass, H; Levon, K				Mathur, Aabhas; Blais, Steven; Goparaju, Chandra M. V.; Neubert, Thomas; Pass, Harvey; Levon, Kalle			Development of a Biosensor for Detection of Pleural Mesothelioma Cancer Biomarker Using Surface Imprinting	PLOS ONE			English	Article							HEPARANASE; HYALURONAN; ANGIOGENESIS; RECOGNITION; GROWTH; EXPRESSION; CARCINOMA; PROTEINS; POLYMERS; PEPTIDE	Hyaluronan-linked protein 1 (HAPLN1) which has been shown to be highly expressed in malignant pleural mesotheliomas (MPM), was detected in serum using an electrochemical surface-imprinting method. First, the detection method was optimized using Bovine serum albumin (BSA) as a model protein to mimic the optimal conditions required to imprint the similar molecular weight protein HAPLN1. BSA was imprinted on the gold electrode with hydroxyl terminated alkane thiols, which formed a self-assembled monolayer (SAM) around BSA. The analyte (BSA) was then washed away and its imprint (empty cavity with shape-memory) was used for detection of BSA in a solution, using electrochemical open-circuit potential method, namely potentiometry. Factors considered to optimize the conditions include incubation time, protein concentration, limit of detection and size of electrode. Matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) was used to confirm selectivity of imprints. With the obtained imprinting control parameters, HAPLN1 was imprinted in duplicate and the detection of spiked HAPLN1 was successfully conducted in serum.	[Mathur, Aabhas; Levon, Kalle] NYU, Polytech Inst, Dept Chem & Biol Sci, Brooklyn, NY 11201 USA; [Blais, Steven; Neubert, Thomas] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY USA; [Blais, Steven; Neubert, Thomas] NYU, Sch Med, Dept Pharmacol, New York, NY USA; [Goparaju, Chandra M. V.; Pass, Harvey] NYU, Med Ctr, Dept Cardiothorac Surg, New York, NY 10016 USA	New York University; New York University Tandon School of Engineering; New York University; New York University; New York University	Levon, K (corresponding author), NYU, Polytech Inst, Dept Chem & Biol Sci, Brooklyn, NY 11201 USA.	kalle.levon@gmail.com	Levon, Kalle/H-7990-2016	Levon, Kalle/0000-0001-6833-6254; Pass, Harvey/0000-0003-3222-3471; neubert, Thomas/0000-0001-7049-2088	 [W911NF-09-1-0499]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study has been funded by an army grant (W911NF-09-1-0499) for Potentiomeric detection of pathogens. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenberg J, 1999, NATURE, V398, P495, DOI 10.1038/19047; Anttila MA, 2000, CANCER RES, V60, P150; ARSHADY R, 1981, MACROMOL CHEM PHYS, V182, P687; Bossi A, 2007, BIOSENS BIOELECTRON, V22, P1131, DOI 10.1016/j.bios.2006.06.023; Cohen I, 2006, INT J CANCER, V118, P1609, DOI 10.1002/ijc.21552; Cohen-Kaplan V, 2012, J BIOL CHEM, V287, P6668, DOI 10.1074/jbc.M111.271346; Creaney J, 2009, CURR OPIN PULM MED, V15, P366, DOI 10.1097/MCP.0b013e32832b98eb; Das K, 2003, LANGMUIR, V19, P3921, DOI 10.1021/la026781u; DICKEY FH, 1949, P NATL ACAD SCI USA, V35, P227, DOI 10.1073/pnas.35.5.227; Du XZ, 2005, BIOSENS BIOELECTRON, V20, P2053, DOI 10.1016/j.bios.2004.08.044; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; Golshani R, 2008, CANCER RES, V68, P483, DOI 10.1158/0008-5472.CAN-07-2140; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Huo H, 2007, ACS SYM SER, V963, P312; Ivanova AV, 2009, CLIN CANCER RES, V15, P2602, DOI 10.1158/1078-0432.CCR-08-2755; JANATA J, 1975, J AM CHEM SOC, V97, P2914, DOI 10.1021/ja00843a058; Jeyachandran YL, 2010, J COLLOID INTERF SCI, V341, P136, DOI 10.1016/j.jcis.2009.09.007; Lavignac N, 2004, ANAL CHIM ACTA, V510, P139, DOI 10.1016/j.aca.2003.12.066; Li X, 2006, LANGMUIR, V22, P9658, DOI 10.1021/la0612163; Liu HC, 2012, TUMOR BIOL, V33, P1327, DOI 10.1007/s13277-012-0380-9; Mirsky VM, 1999, ANGEW CHEM INT EDIT, V38, P1108, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1108::AID-ANIE1108>3.0.CO;2-C; Nelson GM, 2007, NEOPLASIA, V9, P1038, DOI 10.1593/neo.07643; Okawa T, 2005, CLIN CANCER RES, V11, P7995, DOI 10.1158/1078-0432.CCR-05-1103; Piletsky SA, 1999, SENSOR ACTUAT B-CHEM, V60, P216, DOI 10.1016/S0925-4005(99)00273-7; Polyakov M. V., 1931, ZH FIZ KHIM, V2, P799; PORTER MD, 1987, J AM CHEM SOC, V109, P3559, DOI 10.1021/ja00246a011; Quiros RM, 2006, CANCER-AM CANCER SOC, V106, P532, DOI 10.1002/cncr.21648; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Ropponen K, 1998, CANCER RES, V58, P342; Turner NW, 2006, BIOTECHNOL PROGR, V22, P1474, DOI 10.1021/bp060122g; Wang YT, 2008, BIOSENS BIOELECTRON, V24, P162, DOI 10.1016/j.bios.2008.04.010; Wang YT, 2010, SENSOR ACTUAT B-CHEM, V146, P381, DOI 10.1016/j.snb.2010.02.032; WULFF G, 1972, ANGEW CHEM INT EDIT, V11, P341; Xu XM, 2003, CANCER RES, V63, P5685; Zhang J, 2012, ONCOL LETT, V4, P178, DOI 10.3892/ol.2012.703; Zhou YX, 2005, BIOSENS BIOELECTRON, V20, P1851, DOI 10.1016/j.bios.2004.05.005	36	17	18	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57681	10.1371/journal.pone.0057681	http://dx.doi.org/10.1371/journal.pone.0057681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516416	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200018
J	Zubacova, Z; Novak, L; Bublikova, J; Vacek, V; Fousek, J; Ridl, J; Tachezy, J; Dolezal, P; Vlcek, C; Hampl, V				Zubacova, Zuzana; Novak, Lukas; Bublikova, Jitka; Vacek, Vojtech; Fousek, Jan; Ridl, Jakub; Tachezy, Jan; Dolezal, Pavel; Vlcek, Cestmir; Hampl, Vladimir			The Mitochondrion-Like Organelle of Trimastix pyriformis Contains the Complete Glycine Cleavage System	PLOS ONE			English	Article							GENOME SEQUENCE; PROTEINS; EVOLUTION; ULTRASTRUCTURE; HYDROGENOSOMES; BLASTOCYSTIS; METABOLISM; TRANSFORMATION; LOCALIZATION; PURIFICATION	All eukaryotic organisms contain mitochondria or organelles that evolved from the same endosymbiotic event like classical mitochondria. Organisms inhabiting low oxygen environments often contain mitochondrial derivates known as hydrogenosomes, mitosomes or neutrally as mitochondrion-like organelles. The detailed investigation has shown unexpected evolutionary plasticity in the biochemistry and protein composition of these organelles in various protists. We investigated the mitochondrion-like organelle in Trimastix pyriformis, a free-living member of one of the three lineages of anaerobic group Metamonada. Using 454 sequencing we have obtained 7 037 contigs from its transcriptome and on the basis of sequence homology and presence of N-terminal extensions we have selected contigs coding for proteins that putatively function in the organelle. Together with the results of a previous transcriptome survey, the list now consists of 23 proteins = mostly enzymes involved in amino acid metabolism, transporters and maturases of proteins and transporters of metabolites. We have no evidence of the production of ATP in the mitochondrion-like organelle of Trimastix but we have obtained experimental evidence for the presence of enzymes of the glycine cleavage system (GCS), which is part of amino acid metabolism. Using homologous antibody we have shown that H-protein of GCS localizes into vesicles in the cell of Trimastix. When overexpressed in yeast, H- and P-protein of GCS and cpn60 were transported into mitochondrion. In case of H- protein we have demonstrated that the first 16 amino acids are necessary for this transport. Glycine cleavage system is at the moment the only experimentally localized pathway in the mitochondrial derivate of Trimastix pyriformis.	[Zubacova, Zuzana; Novak, Lukas; Bublikova, Jitka; Vacek, Vojtech; Tachezy, Jan; Dolezal, Pavel; Hampl, Vladimir] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [Fousek, Jan; Ridl, Jakub; Vlcek, Cestmir] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Hampl, V (corresponding author), Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic.	vlada@natur.cuni.cz	Dolezal, Pavel/V-1907-2017; Tachezy, Jan/R-4945-2017; Hampl, Vladimir/A-4339-2008; Novák, Lukáš V. F./V-8805-2019; Fousek, Jan/F-8213-2014; Novak, Lukas V. F./U-5687-2017; Vlcek, Cestmir/I-8820-2014	Dolezal, Pavel/0000-0003-1285-9026; Tachezy, Jan/0000-0001-6976-8446; Hampl, Vladimir/0000-0002-5430-7564; Novák, Lukáš V. F./0000-0001-7773-9119; Novak, Lukas V. F./0000-0001-7773-9119; Vacek, Vojtech/0000-0002-3158-0752	Grant Agency of the Charles University [97309]; Czech Science Foundation [P506/12/1010]	Grant Agency of the Charles University; Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by the Grant Agency of the Charles University 97309 (to JB) and by Czech Science Foundation P506/12/1010 (to VH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Yousuf M, 2010, EUKARYOT CELL, V9, P926, DOI 10.1128/EC.00011-10; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; BESSON V, 1995, PLANT PHYSIOL BIOCH, V33, P665; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Brugerolle G, 1997, EUR J PROTISTOL, V33, P121, DOI 10.1016/S0932-4739(97)80029-6; Touz MC, 2008, J CELL SCI, V121, P2930, DOI 10.1242/jcs.026963; Carpenter KJ, 2008, PROTIST, V159, P209, DOI 10.1016/j.protis.2007.09.002; Cavalier-Smith T, 2003, INT J SYST EVOL MICR, V53, P1741, DOI 10.1099/ijs.0.02548-0; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; CLARK CG, 1995, P NATL ACAD SCI USA, V92, P6518, DOI 10.1073/pnas.92.14.6518; Dawson SC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-71; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Dolezal P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000812; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Drmota T, 1996, MOL BIOCHEM PARASIT, V83, P221, DOI 10.1016/S0166-6851(96)02777-6; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fujiwara K, 1997, J BIOL CHEM, V272, P19880, DOI 10.1074/jbc.272.32.19880; Gelius-Dietrich G, 2007, J EUKARYOT MICROBIOL, V54, P42, DOI 10.1111/j.1550-7408.2006.00146.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hampl V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001383; Hampl Vladimir, 2011, Mob Genet Elements, V1, P71; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hjort K, 2010, PHILOS T R SOC B, V365, P713, DOI 10.1098/rstb.2009.0224; HRDY I, 2008, MICROBIOL MONOGR, V9, P113, DOI DOI 10.1007/7171_2007_110; Hug LA, 2010, MOL BIOL EVOL, V27, P311, DOI 10.1093/molbev/msp237; Jedelsky PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017285; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; Lill R, 2000, TRENDS BIOCHEM SCI, V25, P352, DOI 10.1016/S0968-0004(00)01589-9; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Mi-ichi F, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001263; Mogi T, 2010, PARASITOL INT, V59, P305, DOI 10.1016/j.parint.2010.04.005; Morada M, 2011, MOL BIOCHEM PARASIT, V176, P51, DOI 10.1016/j.molbiopara.2010.10.004; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; O'Kelly CJ, 1999, PROTIST, V150, P149, DOI 10.1016/S1434-4610(99)70018-0; OLAUSSON T, 1995, BBA-BIOENERGETICS, V1231, P1, DOI 10.1016/0005-2728(95)00058-Q; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Perez-Brocal V, 2008, MOL BIOL EVOL, V25, P2475, DOI 10.1093/molbev/msn193; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Putz S, 2006, EUKARYOT CELL, V5, P579, DOI 10.1128/EC.5.3.579-586.2006; Rada P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024428; Satre M, 2007, BIOCHIMIE, V89, P1058, DOI 10.1016/j.biochi.2007.03.004; Schneider RE, 2011, INT J PARASITOL, V41, P1421, DOI 10.1016/j.ijpara.2011.10.001; Shiflett AM, 2010, ANNU REV MICROBIOL, V64, P409, DOI 10.1146/annurev.micro.62.081307.162826; Simpson AGB, 2000, EUR J PROTISTOL, V36, P229, DOI 10.1016/S0932-4739(00)80001-2; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stairs CW, 2011, MOL BIOL EVOL, V28, P2087, DOI 10.1093/molbev/msr032; Stechmann A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-101; Stechmann A, 2008, CURR BIOL, V18, P580, DOI 10.1016/j.cub.2008.03.037; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945	54	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e55417	10.1371/journal.pone.0055417	http://dx.doi.org/10.1371/journal.pone.0055417			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516392	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200002
J	Chen, Z; Sun, HB; Li, PF; He, N; Zhu, TC; Li, Y				Chen, Zao; Sun, Hongbing; Li, Pengfei; He, Ning; Zhu, Taicheng; Li, Yin			Enhancement of the Gene Targeting Efficiency of Non-Conventional Yeasts by Increasing Genetic Redundancy	PLOS ONE			English	Article							CELL-WALL INTEGRITY; PICHIA-PASTORIS; YARROWIA-LIPOLYTICA; N-GLYCANS; DISRUPTION; STIPITIS; MAZF	In contrast to model yeasts, gene targeting efficiencies of non-conventional yeasts are usually low, which greatly limits the research and applications of these organisms. In this study, we aimed to enhance the gene targeting efficiency of non-conventional yeasts by improving the fitness of mutant strains, particularly by increasing the genetic redundancy of host cells. To demonstrate this process, OCH1 gene deletion in Pichia pastoris was performed. Extra copies of the OCH1 gene on a helper plasmid were provided for the P. pastoris GS115 strain before the native OCH1 gene in the genomic DNA was knocked out. The redundancy in OCH1 gene significantly eliminated the growth defects of the och1 mutant and increased the deletion efficiency of the OCH1 gene by two orders of magnitude with the same length of homologous flanks. The same strategy was used to delete the KU70 and SGS1 genes. The targeting efficiencies of KU70 and SGS1 were increased by 1- and 23-fold, respectively. Therefore, this study provided an efficient strategy for the deletion of "stubborn" genes in non-conventional yeasts. This study further showed that cellular fitness is potentially an important factor that can limit the efficiency of gene targeting.	[Chen, Zao; He, Ning] Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China; [Sun, Hongbing; Zhu, Taicheng; Li, Yin] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Li, Pengfei] Hainan Univ, Coll Life Sci & Agr, Haikou, Peoples R China	Xiamen University; Chinese Academy of Sciences; Institute of Microbiology, CAS; Hainan University	He, N (corresponding author), Xiamen Univ, Coll Chem & Chem Engn, Dept Chem & Biochem Engn, Xiamen, Peoples R China.	zhutc@im.ac.cn; hening@xmu.edu.cn	Zhu, Taicheng/E-9520-2011; Li, Yin/C-6644-2009	Zhu, Taicheng/0000-0002-3305-1141; Li, Yin/0000-0003-0995-3070	National Natural Science Foundation of China [31000026]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-G-15-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This research was supported by National Natural Science Foundation of China (number 31000026) and the Knowledge Innovation Program of the Chinese Academy of Sciences (number KSCX2-EW-G-15-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Banat BMA, 2010, YEAST, V27, P29, DOI 10.1002/yea.1729; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Branduardi P, 2008, J MOL MICROB BIOTECH, V15, P31, DOI 10.1159/000111990; Choi BK, 2003, P NATL ACAD SCI USA, V100, P5022, DOI 10.1073/pnas.0931263100; Cosano IC, 2001, MOL GENET GENOMICS, V265, P604, DOI 10.1007/s004380100452; CREGG JM, 1985, MOL CELL BIOL, V5, P3376, DOI 10.1128/MCB.5.12.3376; Damasceno LM, 2012, APPL MICROBIOL BIOT, V93, P31, DOI 10.1007/s00253-011-3654-z; De Pourcq K, 2010, APPL MICROBIOL BIOT, V87, P1617, DOI 10.1007/s00253-010-2721-1; Dudasova Z, 2004, FEMS MICROBIOL REV, V28, P581, DOI 10.1016/j.femsre.2004.06.001; Garcia S, 2002, J BIOL CHEM, V277, P37359, DOI 10.1074/jbc.M201091200; Gellissen G, 2005, FEMS YEAST RES, V5, P1079, DOI 10.1016/j.femsyr.2005.06.004; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Higgins D. R., 1998, PICHIA PROTOCOLS; Jeffries TW, 2007, NAT BIOTECHNOL, V25, P319, DOI 10.1038/nbt1290; Klinner U, 2004, FEMS MICROBIOL REV, V28, P201, DOI 10.1016/j.femsre.2003.10.002; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Naatsaari L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039720; Nett JH, 2005, YEAST, V22, P295, DOI 10.1002/yea.1202; Satyanarayana T, 2009, YEAST BIOTECHNOLOGY, P151; Shi NQ, 2002, YEAST, V19, P1203, DOI 10.1002/yea.915; Vervecken W, 2004, APPL ENVIRON MICROB, V70, P2639, DOI 10.1128/AEM.70.5.2639-2646.2004; Wahls WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002887; Wu SX, 2004, BIOTECHNIQUES, V36, P152, DOI 10.2144/04361DD02; Yang JJ, 2009, FEMS YEAST RES, V9, P600, DOI 10.1111/j.1567-1364.2009.00503.x; Zeeman AM, 2003, YEAST, V20, P13, DOI 10.1002/yea.936; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	27	14	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57952	10.1371/journal.pone.0057952	http://dx.doi.org/10.1371/journal.pone.0057952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505447	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500039
J	Kaznadzey, A; Alexandrova, N; Novichkov, V; Kaznadzey, D				Kaznadzey, Anna; Alexandrova, Natalia; Novichkov, Vladimir; Kaznadzey, Denis			PSimScan: Algorithm and Utility for Fast Protein Similarity Search	PLOS ONE			English	Article							SEQUENCE; ALIGNMENT; BLAST; GENERATION; TOOL; PARALIGN	In the era of metagenomics and diagnostics sequencing, the importance of protein comparison methods of boosted performance cannot be overstated. Here we present PSimScan (Protein Similarity Scanner), a flexible open source protein similarity search tool which provides a significant gain in speed compared to BLASTP at the price of controlled sensitivity loss. The PSimScan algorithm introduces a number of novel performance optimization methods that can be further used by the community to improve the speed and lower hardware requirements of bioinformatics software. The optimization starts at the lookup table construction, then the initial lookup table-based hits are passed through a pipeline of filtering and aggregation routines of increasing computational complexity. The first step in this pipeline is a novel algorithm that builds and selects 'similarity zones' aggregated from neighboring matches on small arrays of adjacent diagonals. PSimScan performs 5 to 100 times faster than the standard NCBI BLASTP, depending on chosen parameters, and runs on commodity hardware. Its sensitivity and selectivity at the slowest settings are comparable to the NCBI BLASTP's and decrease with the increase of speed, yet stay at the levels reasonable for many tasks. PSimScan is most advantageous when used on large collections of query sequences. Comparing the entire proteome of Streptocuccus pneumoniae (2,042 proteins) to the NCBI's non-redundant protein database of 16,971,855 records takes 6.5 hours on a moderately powerful PC, while the same task with the NCBI BLASTP takes over 66 hours. We describe innovations in the PSimScan algorithm in considerable detail to encourage bioinformaticians to improve on the tool and to use the innovations in their own software development.	[Kaznadzey, Anna] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow, Russia; [Alexandrova, Natalia] Genome Designs Inc, Walnut Creek, CA USA; [Novichkov, Vladimir] LabNext Inc, Glenview, IL USA; [Kaznadzey, Denis] DOE Joint Genome Inst, Walnut Creek, CA USA	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; United States Department of Energy (DOE)	Alexandrova, N (corresponding author), Genome Designs Inc, Walnut Creek, CA USA.	nat_al@yahoo.com	Kaznadzey, Anna/ABB-4970-2020	Kaznadzey, Anna/0000-0001-8968-029X				Agrawal R., 1993, LECT NOTES COMPUTER, V730; Altschul SF, 1998, PROTEINS, V32, P88, DOI 10.1002/(SICI)1097-0134(19980701)32:1<88::AID-PROT10>3.3.CO;2-X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1993, J MOL EVOL, V36, P290, DOI 10.1007/BF00160485; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baker M, 2010, NAT METHODS, V7, P495, DOI 10.1038/nmeth0710-495; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Brenner SE, 1998, P NATL ACAD SCI USA, V95, P6073, DOI 10.1073/pnas.95.11.6073; Cameron M, 2004, IEEE ACM T COMPUT BI, V1, P116, DOI 10.1109/TCBB.2004.32; Cameron M, 2007, IEEE ACM T COMPUT BI, V4, P349, DOI 10.1109/TCBB.2007.1029; Cameron M, 2007, J COMPUT BIOL, V14, P594, DOI 10.1089/cmb.2007.R005; Cameron M, 2006, J COMPUT BIOL, V13, P965, DOI 10.1089/cmb.2006.13.965; Chandonia JM, 2004, NUCLEIC ACIDS RES, V32, pD189, DOI 10.1093/nar/gkh034; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eddy Sean R, 2009, Genome Inform, V23, P205; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Esteban David J., 2007, V395, P187; Gouveia-Oliveira R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-312; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hochreiter S, 2007, BIOINFORMATICS, V23, P1728, DOI 10.1093/bioinformatics/btm247; Hughey R, 1995, SAM SEQUENCE ALIGNME; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Merkeev IV, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-51; Mott R, 2000, J MOL BIOL, V300, P649, DOI 10.1006/jmbi.2000.3875; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pearson W R, 2000, Methods Mol Biol, V132, P185; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Rajasekaran S, 2002, J COMPUT BIOL, V9, P23, DOI 10.1089/10665270252833172; Rajasekaran S, 2001, J COMB OPTIM, V5, P117, DOI 10.1023/A:1009893719470; Rognes T, 2001, NUCLEIC ACIDS RES, V29, P1647, DOI 10.1093/nar/29.7.1647; Saebo PE, 2005, NUCLEIC ACIDS RES, V33, pW535, DOI 10.1093/nar/gki423; Sedgewick R, 2011, ALGORITHMS; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Wang CL, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-171; WORLEY KC, 1995, GENOME RES, V5, P173, DOI 10.1101/gr.5.2.173; Ye YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-159; Zhang Z, 1998, NUCLEIC ACIDS RES, V26, P3986, DOI 10.1093/nar/26.17.3986; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	46	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58505	10.1371/journal.pone.0058505	http://dx.doi.org/10.1371/journal.pone.0058505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505522	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500094
J	Khrunin, AV; Khokhrin, DV; Filippova, IN; Esko, T; Nelis, M; Bebyakova, NA; Bolotova, NL; Klovins, J; Nikitina-Zake, L; Rehnstrom, K; Ripatti, S; Schreiber, S; Franke, A; Macek, M; Krulisova, V; Lubinski, J; Metspalu, A; Limborska, SA				Khrunin, Andrey V.; Khokhrin, Denis V.; Filippova, Irina N.; Esko, Tonu; Nelis, Mari; Bebyakova, Natalia A.; Bolotova, Natalia L.; Klovins, Janis; Nikitina-Zake, Liene; Rehnstrom, Karola; Ripatti, Samuli; Schreiber, Stefan; Franke, Andre; Macek, Milan; Krulisova, Veronika; Lubinski, Jan; Metspalu, Andres; Limborska, Svetlana A.			A Genome-Wide Analysis of Populations from European Russia Reveals a New Pole of Genetic Diversity in Northern Europe	PLOS ONE			English	Article							DIFFERENTIATION; HOMOZYGOSITY; PATTERNS; RUNS; POLYMORPHISMS; ASSOCIATION; ANCESTRY; LOCUS	Several studies examined the fine-scale structure of human genetic variation in Europe. However, the European sets analyzed represent mainly northern, western, central, and southern Europe. Here, we report an analysis of approximately 166,000 single nucleotide polymorphisms in populations from eastern (northeastern) Europe: four Russian populations from European Russia, and three populations from the northernmost Finno-Ugric ethnicities (Veps and two contrast groups of Komi people). These were compared with several reference European samples, including Finns, Estonians, Latvians, Poles, Czechs, Germans, and Italians. The results obtained demonstrated genetic heterogeneity of populations living in the region studied. Russians from the central part of European Russia (Tver, Murom, and Kursk) exhibited similarities with populations from central-eastern Europe, and were distant from Russian sample from the northern Russia (Mezen district, Archangelsk region). Komi samples, especially Izhemski Komi, were significantly different from all other populations studied. These can be considered as a second pole of genetic diversity in northern Europe (in addition to the pole, occupied by Finns), as they had a distinct ancestry component. Russians from Mezen and the Finnic-speaking Veps were positioned between the two poles, but differed from each other in the proportions of Komi and Finnic ancestries. In general, our data provides a more complete genetic map of Europe accounting for the diversity in its most eastern (northeastern) populations.	[Khrunin, Andrey V.; Khokhrin, Denis V.; Filippova, Irina N.; Limborska, Svetlana A.] Russian Acad Sci, Inst Mol Genet, Dept Mol Bases Human Genet, Moscow 123182, Russia; [Esko, Tonu; Nelis, Mari; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, EE-50090 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Metspalu, Andres] Estonian Bioctr, Tartu, Estonia; [Nelis, Mari] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Bebyakova, Natalia A.] Northern State Med Univ, Deparment Med Biol & Genet, Arkhangelsk, Russia; [Bolotova, Natalia L.] Vologda State Pedag Univ, Deparment Ecol & Zool, Vologda, Russia; [Klovins, Janis; Nikitina-Zake, Liene] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Rehnstrom, Karola; Ripatti, Samuli] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Rehnstrom, Karola; Ripatti, Samuli] Wellcome Trust Sanger Institiute, Hinxton, England; [Schreiber, Stefan] Univ Kiel, Dept Internal Med 1, Popgen Biobank, Kiel, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Macek, Milan; Krulisova, Veronika] Univ Hosp Motol, Dept Biol & Med Genet, Prague, Czech Republic; [Macek, Milan; Krulisova, Veronika] Charles Univ Prague, Sch Med 2, Prague, Czech Republic; [Lubinski, Jan] Pomeranian Med Univ, Szczecin, Poland	Russian Academy of Sciences; University of Tartu; University of Tartu; Estonian Biocentre; University of Geneva; Northern State Medical University; Vologda State University; Latvian Biomedical Research & Study Centre; University of Helsinki; University of Kiel; University of Kiel; Motol University Hospital; Charles University Prague; Pomeranian Medical University	Khrunin, AV (corresponding author), Russian Acad Sci, Inst Mol Genet, Dept Mol Bases Human Genet, Kurchatov Sq, Moscow 123182, Russia.	khrunin@img.ras.ru	Bebyakova, Natalya/C-8180-2018; Franke, Andre/B-2151-2010; Ripatti, Samuli/H-9446-2014; Nelis, Mari/ABG-7775-2020; Limborska, Svetlana/S-2961-2019; Limborska, Svetlana/A-5633-2016; Klovins, Janis/C-5695-2011	Franke, Andre/0000-0003-1530-5811; Ripatti, Samuli/0000-0002-0504-1202; Nelis, Mari/0000-0001-9748-1020; Limborska, Svetlana/0000-0002-1697-6820; Lubinski, Jan/0000-0003-2931-3003; Klovins, Janis/0000-0001-8362-5505; Esko, Tonu/0000-0003-1982-6569	Russian Academy of Sciences; Federal Support of Leading Scientific Schools [4294.2012.4]; Russian Basic Research Foundation; Ministry of education and science of Russian Federation [8805]; ENGAGE; OPENGENE; Estonian Government [SF0180142s08]; Estonian Research Roadmap through Estonian Ministry of Education and Research [3.2.0304.11-0312]; Center of Excellence in Genomics (EXCEGEN); University of Tartu [SP1GVARENG]; Czech Ministry of Health [NT/13770-4];  [CZ.2.16/3.1.00/24022]	Russian Academy of Sciences(Russian Academy of Sciences); Federal Support of Leading Scientific Schools(Leading Scientific Schools Program); Russian Basic Research Foundation(Russian Foundation for Basic Research (RFBR)); Ministry of education and science of Russian Federation(Ministry of Education and Science, Russian Federation); ENGAGE; OPENGENE; Estonian Government; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics (EXCEGEN); University of Tartu; Czech Ministry of Health(Ministry of Health, Czech Republic); 	This study was supported by grants from the Programs 'Molecular and Cell Biology' and 'Fundamental Science for Medicine' of the Russian Academy of Sciences; the Federal Support of Leading Scientific Schools (grant 4294.2012.4); Russian Basic Research Foundation and The Ministry of education and science of Russian Federation (project 8805). EGCUT received financing by (ENGAGE, OPENGENE), targeted financing from Estonian Government SF0180142s08, Estonian Research Roadmap through Estonian Ministry of Education and Research (3.2.0304.11-0312), Center of Excellence in Genomics (EXCEGEN) and Development Fund of University of Tartu (SP1GVARENG). MM was supported by CZ.2.16/3.1.00/24022, Institutional support for UH Motol (0064203) and by NT/13770-4 from the Czech Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-246; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alexeev VP, 1969, ORIGIN NATIONS E EUR; Alexeeva TI, 2002, E SLAVS ANTHR ETHNIC; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Behar DM, 2010, NATURE, V466, P238, DOI 10.1038/nature09103; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; Cavalli-Sforza LL, 1996, HIST GEOGRAPHY HUMAN; Flegontova OV, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-62; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Humphreys K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022547; Huyghe JR, 2011, EUR J HUM GENET, V19, P347, DOI 10.1038/ejhg.2010.179; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Khrunin A V, 2005, Genetika, V41, P1125; Khrunin A, 2007, AM J HUM BIOL, V19, P741, DOI 10.1002/ajhb.20620; Khrunin AV, 2008, GENETIKA, V47, P1565; Konakov ND, 1991, ETHNOAREALIC KOMI GR; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Malyarchuk B, 2004, HUM BIOL, V76, P877, DOI 10.1353/hub.2005.0021; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Milligan B, 1998, MOL GENETIC ANAL POP, P29; Mirabal S, 2009, EUR J HUM GENET, V17, P1260, DOI 10.1038/ejhg.2009.6; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; O'Dushlaine CT, 2010, EUR J HUM GENET, V18, P1248, DOI 10.1038/ejhg.2010.87; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pimenov VV, 1965, VEPS STUDY ETHNIC HI; Pistis G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004654; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Savel'eva EA, 2001, ATLAS KOMI REPUBLIC; Savel'eva EA, 1997, ARCHEOLOGY KOMI REPU; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Spain SL, 2009, CANCER RES, V69, P7422, DOI 10.1158/0008-5472.CAN-09-0659; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Varilo T, 2000, EUR J HUM GENET, V8, P604, DOI 10.1038/sj.ejhg.5200482; Verbenko DA, 2006, ANN HUM BIOL, V33, P570, DOI 10.1080/03014460601012077; Zherebtsov IL, 1996, POPULATION KOMI TERR; Zherebtsov LN, 1982, HIST CULTURAL RELATI	44	21	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58552	10.1371/journal.pone.0058552	http://dx.doi.org/10.1371/journal.pone.0058552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505534	Green Submitted, gold, Green Published			2022-12-27	WOS:000318334500100
J	Clavaud, C; Jourdain, R; Bar-Hen, A; Tichit, M; Bouchier, C; Pouradier, F; El Rawadi, C; Guillot, J; Menard-Szczebara, F; Breton, L; Latge, JP; Mouyna, I				Clavaud, Cecile; Jourdain, Roland; Bar-Hen, Avner; Tichit, Magali; Bouchier, Christiane; Pouradier, Florence; El Rawadi, Charles; Guillot, Jacques; Menard-Szczebara, Florence; Breton, Lionel; Latge, Jean-Paul; Mouyna, Isabelle			Dandruff Is Associated with Disequilibrium in the Proportion of the Major Bacterial and Fungal Populations Colonizing the Scalp	PLOS ONE			English	Article							ATOPIC-DERMATITIS PATIENTS; HEALTHY-HUMAN SKIN; REAL-TIME PCR; SEBORRHEIC DERMATITIS; MOLECULAR ANALYSIS; PSORIATIC LESIONS; MALASSEZIA; MICROBIOME; DIFFERENTIATION; RESTRICTA	The bacterial and fungal communities associated with dandruff were investigated using culture-independent methodologies in the French subjects. The major bacterial and fungal species inhabiting the scalp subject's were identified by cloning and sequencing of the conserved ribosomal unit regions (16S for bacterial and 28S-ITS for fungal) and were further quantified by quantitative PCR. The two main bacterial species found on the scalp surface were Propionibacterium acnes and Staphylococcus epidermidis, while Malassezia restricta was the main fungal inhabitant. Dandruff was correlated with a higher incidence of M. restricta and S. epidermidis and a lower incidence of P. acnes compared to the control population (p < 0.05). These results suggested for the first time using molecular methods, that dandruff is linked to the balance between bacteria and fungi of the host scalp surface.	[Clavaud, Cecile; Latge, Jean-Paul; Mouyna, Isabelle] Inst Pasteur, Unite Aspergillus, Paris, France; [Jourdain, Roland; El Rawadi, Charles; Breton, Lionel] LOreal Res & Innovat, Adv Res, Aulnay Sous Bois, France; [Bar-Hen, Avner] Univ Paris 05, MAP5, UFR Math & Informat, Paris, France; [Tichit, Magali; Bouchier, Christiane] Inst Pasteur, PF1, Paris, France; [Pouradier, Florence] LOreal Res & Innovat, Int Gen Direct Hair Metiers, St Ouen, France; [Guillot, Jacques] ENVA, UMR BIPAR, Ecopham, Maisons Alfort, France; [Menard-Szczebara, Florence] LOreal Res & Innovat, Corp Microbiol, Chevilly Larue, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; L'Oreal Group; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; L'Oreal Group; Ecole Nationale Veterinaire d'Alfort (ENVA); L'Oreal Group	Latge, JP (corresponding author), Inst Pasteur, Unite Aspergillus, Paris, France.	jean-paul.latge@pasteur.fr; isabelle.mouyna@pasteur.fr	Mouyna, Isabelle/O-7697-2018; Latge, Jean Paul/C-9846-2014; Guillot, Jacques/J-9428-2016	Mouyna, Isabelle/0000-0003-3140-5927; Guillot, Jacques/0000-0003-3577-6979	L'Oreal - Research Innovation; L'Oreal	L'Oreal - Research Innovation(L'Oreal Group); L'Oreal(L'Oreal Group)	This study was supported by a grant from L'Oreal - Research & Innovation and has been performed on the basis of a scientific collaboration. The panels of subjects with and without dandruff were selected by L'Oreal Research & Innovation. No additional external funding source was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have declared that no competing interests exist. This work was supported by a grant from L'Oreal. Cecile Clavaud, Roland Jourdain, Florence Pouradier, Charles El Rawadi, Florence Menard-Szczebara and Lionel Breton are employees of L'Oreal Research & Innovation. There are no patents, product in development or marketed product to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akaza N, 2009, MED MYCOL, V47, P618, DOI 10.1080/13693780802398026; [Anonymous], 2010, R LANG ENV STAT COMP; Ashbee HR, 2007, MED MYCOL, V45, P287, DOI 10.1080/13693780701191373; Ashbee HR, 2002, CLIN MICROBIOL REV, V15, P21, DOI 10.1128/CMR.15.1.21-57.2002; Aspiroz C, 1999, MYCOPATHOLOGIA, V145, P69, DOI 10.1023/A:1007017917230; Clermont D, 2009, INT J SYST EVOL MICR, V59, P1016, DOI 10.1099/ijs.0.003160-0; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dawson TL, 2007, J INVEST DERM SYMP P, V12, P15, DOI 10.1038/sj.jidsymp.5650049; DeAngelis YM, 2005, J INVEST DERM SYMP P, V10, P295, DOI 10.1111/j.1087-0024.2005.10119.x; Dekio I, 2005, J MED MICROBIOL, V54, P1231, DOI 10.1099/jmm.0.46075-0; Gallo RL, 2011, J INVEST DERMATOL, V131, P1974, DOI 10.1038/jid.2011.182; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gao Z, 2010, J CLIN MICROBIOL, V48, P3575, DOI 10.1128/JCM.00597-10; Gemmer CM, 2002, J CLIN MICROBIOL, V40, P3350, DOI 10.1128/JCM.40.9.3350-3357.2002; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gupta AK, 2004, J AM ACAD DERMATOL, V51, P785, DOI 10.1016/j.jaad.2003.12.034; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kerr K, 2011, INT J DERMATOL, V50, P102, DOI 10.1111/j.1365-4632.2010.04629.x; Lee YW, 2006, MYCOSES, V49, P405, DOI 10.1111/j.1439-0507.2006.01239.x; MCGINLEY KJ, 1975, J INVEST DERMATOL, V64, P401, DOI 10.1111/1523-1747.ep12512335; Misery L, 2012, ACTA DERM V IN PRESS; Park HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032847, 10.1371/journal.pone.0039921]; Paulino LC, 2008, FEMS YEAST RES, V8, P460, DOI 10.1111/j.1567-1364.2008.00359.x; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Pierard-Franchimont C., 2006, International Journal of Cosmetic Science, V28, P311, DOI 10.1111/j.1467-2494.2006.00326.x; Pierard-Franchimont C, 2000, DERMATOLOGY, V200, P93, DOI 10.1159/000018337; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Sugita T, 2001, J CLIN MICROBIOL, V39, P3486, DOI [10.1128/JCM.39.10.3486-3490.2001, 10.3314/jjmm.42.217]; Sugita T, 2006, MICROBIOL IMMUNOL, V50, P549, DOI 10.1111/j.1348-0421.2006.tb03825.x; Taylor DL, 2008, MOL ECOL RESOUR, V8, P742, DOI 10.1111/j.1755-0998.2008.02094.x; Van Abbe NJ., 1964, J SOC COSMET CHEM, V15, P609; Warner RR, 2001, J AM ACAD DERMATOL, V45, P897, DOI 10.1067/mjd.2001.117849; Xu J, 2007, P NATL ACAD SCI USA, V104, P18730, DOI 10.1073/pnas.0706756104	36	117	126	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58203	10.1371/journal.pone.0058203	http://dx.doi.org/10.1371/journal.pone.0058203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483996	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100088
J	Rapa, RA; Shimmon, R; Djordjevic, SP; Stokes, HW; Labbate, M				Rapa, Rita A.; Shimmon, Ronald; Djordjevic, Steven P.; Stokes, H. W.; Labbate, Maurizio			Deletion of Integron-Associated Gene Cassettes Impact on the Surface Properties of Vibrio rotiferianus DAT722	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; CHOLERAE O1; ARRAYS; SEQUENCE; IDENTIFICATION; HEMAGGLUTININ; CONSTRUCTION; VULNIFICUS; EXPRESSION; RECOVERY	Background: The integron is a genetic recombination system that catalyses the acquisition of genes on mobilisable elements called gene cassettes. In Vibrio species, multiple acquired gene cassettes form a cassette array that can comprise 1-3% of the bacterial genome. Since 75% of these gene cassettes contain genes encoding proteins of uncharacterised function, how the integron has driven adaptation and evolution in Vibrio species remains largely unknown. A feature of cassette arrays is the presence of large indels. Using Vibrio rotiferianus DAT722 as a model organism, the aim of this study was to determine how large cassette deletions affect vibrio physiology with a view to improving understanding into how cassette arrays influence bacterial host adaptation and evolution. Methodology/Principal Findings: Biological assays and proteomic techniques were utilised to determine how artificially engineered deletions in the cassette array of V. rotiferianus DAT722 affected cell physiology. Multiple phenotypes were identified including changes to growth and expression of outer membrane porins/proteins and metabolic proteins. Furthermore, the deletions altered cell surface polysaccharide with Proton Nuclear Magnetic Resonance on whole cell polysaccharide identifying changes in the carbohydrate ring proton region indicating that gene cassette products may decorate host cell polysaccharide via the addition or removal of functional groups. Conclusions/Significance: From this study, it was concluded that deletion of gene cassettes had a subtle effect on bacterial metabolism but altered host surface polysaccharide. Deletion (and most likely rearrangement and acquisition) of gene cassettes may provide the bacterium with a mechanism to alter its surface properties, thus impacting on phenotypes such as biofilm formation. Biofilm formation was shown to be altered in one of the deletion mutants used in this study. Reworking surface properties may provide an advantage to the bacterium's interactions with organisms such as bacteriophage, protozoan grazers or crustaceans.	[Rapa, Rita A.; Djordjevic, Steven P.; Stokes, H. W.; Labbate, Maurizio] Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia; [Shimmon, Ronald] Univ Technol Sydney, Sydney, NSW 2007, Australia	University of Technology Sydney; University of Technology Sydney	Labbate, M (corresponding author), Univ Technol Sydney, Ithree Inst, Sydney, NSW 2007, Australia.	maurizio.labbate@uts.edu.au	djordjevic, steven/GNP-4000-2022; Djordjevic, Steven/A-2024-2013	djordjevic, steven/0000-0001-9301-5372; Djordjevic, Steven/0000-0001-9301-5372; Labbate, Maurizio/0000-0003-1428-3382	UTS; ithree Institute; UTS Faculty of Science Postgraduate Scholarship	UTS; ithree Institute; UTS Faculty of Science Postgraduate Scholarship	The research in this paper was funded by: 1. UTS Early Career Research Grant, 2. ithree Institute internal grant, 3. UTS Faculty of Science Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella Michael A., 2008, V431, P3; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barker A, 1997, MICROBIOL-SGM, V143, P1805, DOI 10.1099/00221287-143-6-1805; BARKER A, 1994, J BACTERIOL, V176, P5450, DOI 10.1128/JB.176.17.5450-5458.1994; Boucher Y, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-3; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Boucher Y, 2006, BIOLOGY OF VIBRIOS, P84; Cambray G, 2010, ANNU REV GENET, V44, P141, DOI 10.1146/annurev-genet-102209-163504; Chen YS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-274; Chowdhury PR, 2011, J BACTERIOL, V193, P3381, DOI 10.1128/JB.05089-11; Deshpande CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016934; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; FRANZON VL, 1993, INFECT IMMUN, V61, P3032, DOI 10.1128/IAI.61.7.3032-3037.1993; Gillings MR, 2005, P NATL ACAD SCI USA, V102, P4419, DOI 10.1073/pnas.0406620102; Guerin E, 2009, SCIENCE, V324, P1034, DOI 10.1126/science.1172914; Hall RM, 1997, CIBA F SYMP, V207, P192; Hazen TH, 2010, FEMS MICROBIOL ECOL, V74, P485, DOI 10.1111/j.1574-6941.2010.00937.x; Heppelmann CJ, 2007, ELECTROPHORESIS, V28, P3988, DOI 10.1002/elps.200700252; Jobbins SE, 2010, J PROTEOME RES, V9, P3832, DOI 10.1021/pr100028t; Joseph LA, 2004, J BACTERIOL, V186, P889, DOI 10.1128/JB.186.3.889-893.2004; Koenig JE, 2008, ENVIRON MICROBIOL, V10, P1024, DOI 10.1111/j.1462-2920.2007.01524.x; Labbate M, 2007, MICROBIOL-SGM, V153, P1488, DOI 10.1099/mic.0.2006/001065-0; Labbate M, 2012, MOB GENET E IN PRESS; Labbate M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-253; Labbate Maurizio, 2009, V532, P103, DOI 10.1007/978-1-60327-853-9_6; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Michael CA, 2004, AM NAT, V164, P1, DOI 10.1086/421733; Michael CA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-82; Nield BS, 2004, PROTEIN SCI, V13, P1651, DOI 10.1110/ps.04638704; Nield BS, 2001, FEMS MICROBIOL LETT, V195, P59, DOI 10.1016/S0378-1097(00)00546-2; OGAWA A, 1993, MICROBIOL IMMUNOL, V37, P607, DOI 10.1111/j.1348-0421.1993.tb01683.x; PaludanMuller C, 1996, MICROBIOL-SGM, V142, P1675, DOI 10.1099/13500872-142-7-1675; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Post DMB, 2012, J BIOL CHEM; POUTREL B, 1995, CLIN DIAGN LAB IMMUN, V2, P166, DOI 10.1128/CDLI.2.2.166-171.1995; Robinson A, 2005, J MOL BIOL, V346, P1229, DOI 10.1016/j.jmb.2004.12.035; Robinson Andrew, 2008, V426, P589, DOI 10.1007/978-1-60327-058-8_39; Shaw MM, 2003, PROTEOMICS, V3, P1408, DOI 10.1002/pmic.200300471; Smith AB, 2003, INFECT IMMUN, V71, P1091, DOI 10.1128/IAI.71.3.1091-1097.2003; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58430	10.1371/journal.pone.0058430	http://dx.doi.org/10.1371/journal.pone.0058430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484028	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100118
J	Zhang, YR; Shi, LF; Li, S; Yang, ZY; Standley, C; Yang, Z; ZhuGe, RH; Savidge, T; Wang, XN; Feng, HP				Zhang, Yongrong; Shi, Lianfa; Li, Shan; Yang, Zhiyong; Standley, Clive; Yang, Zhong; ZhuGe, Ronghua; Savidge, Tor; Wang, Xiaoning; Feng, Hanping			A Segment of 97 Amino Acids within the Translocation Domain of Clostridium difficile Toxin B Is Essential for Toxicity	PLOS ONE			English	Article							CULTURED-CELLS; PORE FORMATION; CLEAVAGE; BINDING; MODEL; RHO	Clostridium difficile toxin B (TcdB) intoxicates target cells by glucosylating Rho GTPases. TcdB (269 kDa) consists of at least 4 functional domains including a glucosyltransferase domain (GTD), a cysteine protease domain (CPD), a translocation domain (TD), and a receptor binding domain (RBD). The function and molecular mode of action of the TD, which is the largest segment of TcdB and comprises nearly 50% of the protein, remain largely unknown. Here we show that a 97-amino-acid segment (AA1756 - 1852, designated as (a) over tilde 97 or D97), located in the C-terminus of the TD and adjacent to the RBD, is essential for the cellular activity of TcdB. Deletion of this segment in TcdB (designated as TxB-D97), did not adversely alter toxin enzymatic activities or its cellular binding and uptake capacity. TxB-D97 bound to and entered cells in a manner similar to TcdB holotoxin. Both wild type and mutant toxins released their GTDs similarly in the presence of inositol hexakisphosphate (InsP(6)), and showed a similar glucosyltransferase activity in a cell-free glucosylating assay. Despite these similarities, the cytotoxic activity of TxB-D97 was reduced by more than 5 logs compared to wild type toxin, supported by the inability of TxB-D97 to glucosylate Rac1 of target cells. Moreover, the mutant toxin failed to elicit tumor necrosis factor alpha (TNF-alpha) in macrophages, a process dependent on the glucosyltransferase activity of the toxin. Cellular fractionation of toxin-exposed cells revealed that TxB-D97 was unable to efficiently release the GTD into cytosol. Thereby, we conclude the 97-amino-acid region of the TD C-terminus of TcdB adjacent to the RBD, is essential for the toxicity of TcdB.	[Zhang, Yongrong; Yang, Zhong; Wang, Xiaoning] E China Univ Sci & Technol, Sch Bioengn, Shanghai 200237, Peoples R China; [Shi, Lianfa; Li, Shan; Yang, Zhiyong; Feng, Hanping] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Standley, Clive; ZhuGe, Ronghua] Univ Massachusetts, Sch Med, Worcester, MA USA; [Savidge, Tor] Baylor Coll Med, Houston, TX 77030 USA	East China University of Science & Technology; University System of Maryland; University of Maryland Baltimore; University of Massachusetts System; University of Massachusetts Worcester; Baylor College of Medicine	Feng, HP (corresponding author), Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA.	hfeng@umaryland.edu		Zhang, Yongrong/0000-0002-8594-4232	National Institutes of Health (NIH) [R01AI088748, R01DK084509, UL1TR000071, R01AI10094001]; John S. Dunn Gulf Coast Consortium for Chemical Genomics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088748, R01AI100914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084509] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S. Dunn Gulf Coast Consortium for Chemical Genomics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by National Institutes of Health (NIH) Grants R01AI088748, R01DK084509, UL1TR000071, R01AI10094001 and John S. Dunn Gulf Coast Consortium for Chemical Genomics Robert A. Welch Collaborative Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARRINGTON WA, 1995, SCIENCE, V268, P1483, DOI 10.1126/science.7770772; Carter GP, 2010, GUT MICROBES, V1, P58, DOI 10.4161/gmic.1.1.10768; ChavesOlarte E, 1997, J CLIN INVEST, V100, P1734, DOI 10.1172/JCI119698; Egerer M, 2007, J BIOL CHEM, V282, P25314, DOI 10.1074/jbc.M703062200; Egerer M, 2009, J BIOL CHEM, V284, P3389, DOI 10.1074/jbc.M806002200; Genisyuerek S, 2011, MOL MICROBIOL, V79, P1643, DOI 10.1111/j.1365-2958.2011.07549.x; Giesemann T, 2006, J BIOL CHEM, V281, P10808, DOI 10.1074/jbc.M512720200; He XY, 2009, INFECT IMMUN, V77, P2294, DOI 10.1128/IAI.01577-08; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; JUST I, 1994, J BIOL CHEM, V269, P10706; JUST I, 1995, NATURE, V375, P500, DOI 10.1038/375500a0; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Lanis JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001061; Leonard JL, 2008, STEROIDS, V73, P1008, DOI 10.1016/j.steroids.2007.12.016; LIFSHITZ Y, 1994, PHYS REV LETT, V72, P2753, DOI 10.1103/PhysRevLett.72.2753; LIMA AAM, 1988, INFECT IMMUN, V56, P582, DOI 10.1128/IAI.56.3.582-588.1988; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; MITCHELL TJ, 1986, GUT, V27, P78, DOI 10.1136/gut.27.1.78; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Qa'Dan M, 2000, INFECT IMMUN, V68, P2470, DOI 10.1128/IAI.68.5.2470-2474.2000; Qa'Dan M, 2002, CELL MICROBIOL, V4, P425, DOI 10.1046/j.1462-5822.2002.00201.x; Reineke J, 2007, NATURE, V446, P415, DOI 10.1038/nature05622; Sun XM, 2009, MICROB PATHOGENESIS, V46, P298, DOI 10.1016/j.micpath.2009.03.002; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192	28	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58634	10.1371/journal.pone.0058634	http://dx.doi.org/10.1371/journal.pone.0058634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484044	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100131
J	Becker, A; Ludwig, N; Keller, A; Tackenberg, B; Eienbroker, C; Oertel, WH; Fassbender, K; Meese, E; Ruprecht, K				Becker, Anne; Ludwig, Nicole; Keller, Andreas; Tackenberg, Bjoern; Eienbroeker, Christian; Oertel, Wolfgang H.; Fassbender, Klaus; Meese, Eckart; Ruprecht, Klemens			Myasthenia Gravis: Analysis of Serum Autoantibody Reactivities to 1827 Potential Human Autoantigens by Protein Macroarrays	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; AUTOIMMUNE-DISEASE; INTERFERON-ALPHA; IMMUNE-RESPONSE; ANTI-TITIN; T-CELLS; ANTIBODIES; THYMOMA; CANCER; IDENTIFICATION	Background: Myasthenia gravis is a disorder of neuromuscular transmission associated with autoantibodies against the nicotinic acetylcholine receptor. We have previously developed a customized protein macroarray comprising 1827 potential human autoantigens, which permitted to discriminate sera of patients with different cancers from sera of healthy controls, but has not yet been evaluated in antibody-mediated autoimmune diseases. Objective: To determine whether autoantibody signatures obtained by protein macroarray separate sera of patients with myasthenia gravis from healthy controls. Methods: Sera of patients with acetylcholine receptor antibody-positive myasthenia gravis (n = 25) and healthy controls (n = 32) were analyzed by protein macroarrays comprising 1827 peptide clones. Results: Autoantibody signatures did not separate patients with myasthenia gravis from controls with sufficient sensitivity, specificity, and accuracy. Intensity values of one antigen (poly A binding protein cytoplasmic 1, p = 0.0045) were higher in patients with myasthenia gravis, but the relevance of this and two further antigens, 40S ribosomal protein S13 (20.8% vs. 0%, p = 0.011) and proteasome subunit alpha type 1 (25% vs. 3.1%, p = 0.035), which were detected more frequently by myasthenia gravis than by control sera, currently remains uncertain. Conclusion: Seroreactivity profiles of patients with myasthenia gravis detected by a customized protein macroarray did not allow discrimination from healthy controls, compatible with the notion that the autoantibody response in myasthenia gravis is highly focussed against the acetylcholine receptor.	[Becker, Anne; Ludwig, Nicole; Meese, Eckart] Univ Saarland, Dept Human Genet, Homburg, Germany; [Keller, Andreas] Siemens Healthcare, Erlangen, Germany; [Tackenberg, Bjoern; Eienbroeker, Christian; Oertel, Wolfgang H.] Univ Marburg, Clin Neuroimmunol Grp, Dept Neurol, Marburg, Germany; [Fassbender, Klaus] Univ Saarland, Dept Neurol, Homburg, Germany; [Ruprecht, Klemens] Charite, Dept Neurol, D-13353 Berlin, Germany	Saarland University; Siemens AG; Siemens Germany; Philipps University Marburg; Saarland University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ruprecht, K (corresponding author), Charite, Dept Neurol, D-13353 Berlin, Germany.	klemens.ruprecht@charite.de	Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895; Fassbender, Klaus/0000-0003-3596-868X	Homburger Forschungsforderungsprogramm (HOMFOR)	Homburger Forschungsforderungsprogramm (HOMFOR)	This study was funded by Homburger Forschungsforderungsprogramm (HOMFOR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARLI JA, 1990, CLIN EXP IMMUNOL, V82, P284; Aarli JA, 1999, ARCH NEUROL-CHICAGO, V56, P25, DOI 10.1001/archneur.56.1.25; Agius MA, 1998, ANN NY ACAD SCI, V841, P516, DOI 10.1111/j.1749-6632.1998.tb10972.x; Anderson KS, 2005, J PROTEOME RES, V4, P1123, DOI 10.1021/pr0500814; Baggi F, 1998, ANN NY ACAD SCI, V841, P538, DOI 10.1111/j.1749-6632.1998.tb10978.x; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Cepok S, 2005, J CLIN INVEST, V115, P1352, DOI 10.1172/JCI200523661; Comtesse N, 2005, P NATL ACAD SCI USA, V102, P9601, DOI 10.1073/pnas.0500404102; Conti-Fine BM, 2006, J CLIN INVEST, V116, P2843, DOI 10.1172/JCI29894; Kemp EH, 2002, BIOCHEM BIOPH RES CO, V298, P169, DOI 10.1016/S0006-291X(02)02421-X; Kijanka G, 2009, J PROTEOMICS, V72, P936, DOI 10.1016/j.jprot.2009.02.006; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Leidinger P, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-18; Leidinger P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-20; Lin HS, 2007, CANCER EPIDEM BIOMAR, V16, P2396, DOI 10.1158/1055-9965.EPI-07-0318; Ludwig N, 2008, CLIN CANCER RES, V14, P4767, DOI 10.1158/1078-0432.CCR-07-4715; Ludwig N, 2011, INT J CANCER, V128, P1493, DOI 10.1002/ijc.25467; Ludwig N, 2009, NEOPLASIA, V11, P1383, DOI 10.1593/neo.91018; Mayo I, 2002, BRAIN, V125, P2658, DOI 10.1093/brain/awf274; Meager A, 1997, LANCET, V350, P1596, DOI 10.1016/S0140-6736(05)64012-3; Meager A, 2003, CLIN EXP IMMUNOL, V132, P128, DOI 10.1046/j.1365-2249.2003.02113.x; MOHAN S, 1994, CLIN IMMUNOL IMMUNOP, V70, P266, DOI 10.1006/clin.1994.1039; Nakano S, 2005, NEUROLOGY, V65, P420, DOI 10.1212/01.wnl.0000171341.76482.15; OHTA M, 1990, CLIN CHIM ACTA, V187, P255, DOI 10.1016/0009-8981(90)90110-E; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Robinson WH, 2002, BIOTECHNIQUES, P66; Romi F, 2005, ARCH NEUROL-CHICAGO, V62, P442, DOI 10.1001/archneur.62.3.442; Scheffler S, 2008, RHEUMATOLOGY, V47, P622, DOI 10.1093/rheumatology/ken042; Schmitt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028951; Sommer N, 2008, HDB CLIN NEUROLOGY, P169; Tackenberg B, 2009, J NEUROIMMUNOL, V216, P85, DOI 10.1016/j.jneuroim.2009.08.018; Tackenberg B, 2007, EUR J IMMUNOL, V37, P849, DOI 10.1002/eji.200636449; Tzartos SJ, 1998, IMMUNOL REV, V163, P89, DOI 10.1111/j.1600-065X.1998.tb01190.x; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916; Vrolix K, 2010, AUTOIMMUNITY, V43, P380, DOI 10.3109/08916930903518073; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; WILLIAMS CL, 1986, J EXP MED, V164, P1043, DOI 10.1084/jem.164.4.1043; Yamamoto AM, 2001, ARCH NEUROL-CHICAGO, V58, P885, DOI 10.1001/archneur.58.6.885; YAMAMOTO T, 1987, NEUROLOGY, V37, P1329, DOI 10.1212/WNL.37.8.1329	40	3	3	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58095	10.1371/journal.pone.0058095	http://dx.doi.org/10.1371/journal.pone.0058095			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483977	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900070
J	Mazerolle, EL; Gawryluk, JR; Dillen, KNH; Patterson, SA; Feindel, KW; Beyea, SD; Stevens, MTR; Newman, AJ; Schmidt, MH; D'Arcy, RCN				Mazerolle, Erin L.; Gawryluk, Jodie R.; Dillen, Kim N. H.; Patterson, Steven A.; Feindel, Kirk W.; Beyea, Steven D.; Stevens, M. Tynan R.; Newman, Aaron J.; Schmidt, Matthias H.; D'Arcy, Ryan C. N.			Sensitivity to White Matter fMRI Activation Increases with Field Strength	PLOS ONE			English	Article							HIGH MAGNETIC-FIELDS; HUMAN-BRAIN; INTERHEMISPHERIC-TRANSFER; CORPUS-CALLOSUM; FUNCTIONAL MRI; 1.5 T; VISUOMOTOR INFORMATION; PHYSIOLOGICAL NOISE; MOTION CORRECTION; MOTOR CORTEX	Functional magnetic resonance imaging (fMRI) activation in white matter is controversial. Given that many of the studies that report fMRI activation in white matter used high field MRI systems, we investigated the field strength dependence of sensitivity to white matter fMRI activation. In addition, we evaluated the temporal signal to noise ratio (tSNR) of the different tissue types as a function of field strength. Data were acquired during a motor task (finger tapping) at 1.5 T and 4 T. Group and individual level activation results were considered in both the sensorimotor cortex and the posterior limb of the internal capsule. We found that sensitivity increases associated with field strength were greater for white matter than gray matter. The analysis of tSNR suggested that white matter might be less susceptible to increases in physiological noise related to increased field strength. We therefore conclude that high field MRI may be particularly advantageous for fMRI studies aimed at investigating activation in both gray and white matter.	[Mazerolle, Erin L.; Gawryluk, Jodie R.; Dillen, Kim N. H.; Patterson, Steven A.; Feindel, Kirk W.; Beyea, Steven D.; Stevens, M. Tynan R.; D'Arcy, Ryan C. N.] CNR, Inst Biodiagnost Atlantic, Halifax, NS, Canada; [Mazerolle, Erin L.; Gawryluk, Jodie R.; Newman, Aaron J.; D'Arcy, Ryan C. N.] Dalhousie Univ, Dept Psychol & Neurosci, Halifax, NS, Canada; [Dillen, Kim N. H.] Res Ctr Juelich, Inst Neurosci & Med, Julich, Germany; [Patterson, Steven A.; Beyea, Steven D.; Stevens, M. Tynan R.] Dalhousie Univ, Dept Phys, Halifax, NS B3H 3J5, Canada; [Feindel, Kirk W.; Beyea, Steven D.] Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada; [Feindel, Kirk W.] IWK Hlth Ctr, Dept Pediat Neurol, Halifax, NS, Canada; [Beyea, Steven D.; Schmidt, Matthias H.] Dalhousie Univ, Dept Radiol, Halifax, NS, Canada; [D'Arcy, Ryan C. N.] Dalhousie Univ, Dept Anat & Neurobiol, Halifax, NS, Canada	National Research Council Canada; Dalhousie University; Helmholtz Association; Research Center Julich; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	D'Arcy, RCN (corresponding author), CNR, Inst Biodiagnost Atlantic, Halifax, NS, Canada.	rdarcy@sfu.ca	Feindel, Kirk/H-9772-2014; Newman, Aaron/A-6835-2011	Feindel, Kirk/0000-0002-4402-0180; Dillen, Kim/0000-0002-0270-3338; Gawryluk, Jodie/0000-0003-4924-7517; Beyea, Steven/0000-0001-7851-0017; Newman, Aaron/0000-0001-5290-8342	National Research Council of Canada Genomics and Health Initiative; Natural Sciences and Engineering Research Council of Canada; Dalhousie Medical Research Foundation; Dalhousie Radiology Research Foundation; Canada Research Chairs	National Research Council of Canada Genomics and Health Initiative; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Dalhousie Medical Research Foundation; Dalhousie Radiology Research Foundation; Canada Research Chairs(Canada Research ChairsCGIAR)	This work was supported by the National Research Council of Canada Genomics and Health Initiative (http://archive.nrc-cnrc.gc.ca/eng/ibp/ghi.html), the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca), the Dalhousie Medical Research Foundation (http://www.dmrf.ca/), the Dalhousie Radiology Research Foundation (http://radiologyfoundation.medicine.dal.ca/), and Canada Research Chairs (http://www.chairs-chaires.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Aramaki Y, 2006, CEREB CORTEX, V16, P1338, DOI 10.1093/cercor/bhj075; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Biswal B, 1996, MAGNET RESON MED, V35, P107, DOI 10.1002/mrm.1910350114; Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039; Chakravarty MM, 2009, HUM BRAIN MAPP, V30, P3574, DOI 10.1002/hbm.20780; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; D'Arcy RCN, 2006, MAGN RESON MED, V55, P952, DOI 10.1002/mrm.20839; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; Di Salle F, 2003, EUR J RADIOL, V48, P138, DOI 10.1016/j.ejrad.2003.08.010; Duong TQ, 2003, MAGN RESON MED, V49, P1019, DOI 10.1002/mrm.10472; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Fabri M, 2011, BRAIN RES, V1370, P99, DOI 10.1016/j.brainres.2010.11.039; Fera F, 2004, J MAGN RESON IMAGING, V19, P19, DOI 10.1002/jmri.10440; Gati JS, 2000, MED RAD DIA IMG, P277; Gati JS, 1997, MAGNET RESON MED, V38, P296, DOI 10.1002/mrm.1910380220; Gawryluk JR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-56; Gawryluk JR, 2011, NEUROIMAGE, V54, P10, DOI 10.1016/j.neuroimage.2010.07.028; Gawryluk JR, 2009, NEUROIMAGE, V45, P83, DOI 10.1016/j.neuroimage.2008.11.005; Gonzalez-Castillo J, 2011, NEUROIMAGE, V54, P2764, DOI 10.1016/j.neuroimage.2010.11.020; Greve DN, 2011, MAGN RESON MED, V65, P1053, DOI 10.1002/mrm.22691; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; Hoenig K, 2005, RADIOLOGY, V234, P860, DOI 10.1148/radiol.2343031565; Hu XP, 2004, ANNU REV BIOMED ENG, V6, P157, DOI 10.1146/annurev.bioeng.6.040803.140017; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Krasnow B, 2003, NEUROIMAGE, V18, P813, DOI 10.1016/S1053-8119(03)00002-8; Kruger G, 2001, MAGNET RESON MED, V45, P595, DOI 10.1002/mrm.1081; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Mazerolle EL, 2010, NEUROIMAGE, V50, P616, DOI 10.1016/j.neuroimage.2009.12.102; Mazerolle EL, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-84; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meindl T, 2008, EUR RADIOL, V18, P1102, DOI 10.1007/s00330-008-0869-1; Menon RS, 2012, NEUROIMAGE, V62, P970, DOI 10.1016/j.neuroimage.2011.09.005; Mosier K, 2001, EXP BRAIN RES, V140, P280, DOI 10.1007/s002210100813; Newman AJ, 2010, P NATL ACAD SCI USA, V107, P7539, DOI 10.1073/pnas.1003174107; Oishi K., 2005, MRI ATLAS HUMAN WHIT; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omura K, 2004, NEUROREPORT, V15, P2707; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Tettamanti M, 2002, J NEUROPHYSIOL, V88, P1051, DOI 10.1152/jn.2002.88.2.1051; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Ugurbil K, 1999, PHILOS T R SOC B, V354, P1195, DOI 10.1098/rstb.1999.0474; van der Zwaag W, 2009, NEUROIMAGE, V47, P1425, DOI 10.1016/j.neuroimage.2009.05.015; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156; Weber B, 2005, J COGNITIVE NEUROSCI, V17, P113, DOI 10.1162/0898929052880002; Weis S, 2011, INT J NEUROSCI, V121, P384, DOI 10.3109/00207454.2011.565892; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, IEEE T MED IMAGING, V23, P213, DOI 10.1109/TMI.2003.823065; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yang YH, 1999, NEUROIMAGE, V9, P446, DOI 10.1006/nimg.1998.0422; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zou KH, 2005, RADIOLOGY, V237, P781, DOI 10.1148/radiol.2373041630	63	37	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58130	10.1371/journal.pone.0058130	http://dx.doi.org/10.1371/journal.pone.0058130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483983	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900072
J	Hong, SY; Jerger, L; Jonas, A; Badi, A; Cohen, S; Nachega, JB; Parienti, JJ; Tang, AM; Wanke, C; Terrin, N; Pereko, D; Blom, A; Trotter, AB; Jordan, MR				Hong, Steven Y.; Jerger, Logan; Jonas, Anna; Badi, Alfons; Cohen, Steven; Nachega, Jean B.; Parienti, Jean-Jacques; Tang, Alice M.; Wanke, Christine; Terrin, Norma; Pereko, Dawn; Blom, Abraham; Trotter, Andrew B.; Jordan, Michael R.			Medication Possession Ratio Associated with Short-Term Virologic Response in Individuals Initiating Antiretroviral Therapy in Namibia	PLOS ONE			English	Article							HIV-INFECTED ADULTS; VIRAL LOAD; ASSESS ADHERENCE; SOUTH-AFRICA; SELF-REPORT; BASE-LINE; RESISTANCE; FAILURE; SUPPRESSION; PREDICTORS	The visual-analogue scale (VAS), Likert item (rating scale), pills identification test (PIT), and medication possession ratio (MPR) provide estimates of antiretroviral therapy (ART) adherence which correlate with HIV viral suppression. These simple adherence measures are inexpensive and easy to administer; however, require validation and adjustment prior to implementation. The objective of this study was to define the optimal adherence assessment measure in Namibia to identify patients at risk for sub-optimal adherence and poor virologic response 6 months after ART initiation. We conducted a cross-sectional survey in HIV-infected adults receiving ART for 6-12 months prior to the adherence assessment. Adherence measures included 30-day VAS, 30-day Likert item, self-reported treatment interruptions, PIT, and MPR. Association of adherence measures with 6-month HIV-1 RNA level was assessed using two thresholds (1000 copies/mL and 5000 copies/mL). Adherence was assessed in 236 patients, mean age 37.3 years, 54% female. Mean adherence was 98.1% by 30-day VAS, 84.7% by 30-day Likert item, 97.0% by self-reported treatment interruptions, 90.6% by PIT, and 98.8% by MPR. Agreement between adherence measures was poor using kappa statistic. 76% had HIV-1 RNA <1000 copies/ml, and 88% had HIV-1 RNA <5000 copies/ml. MPR (continuous) was associated with viral suppression <5000 copies/ml (p = 0.036). MPR <75% was associated with virologic failure at >= 5000 copies/ml with OR 3.89 (1.24, 12.21), p = 0.013. Adherence was high with all measures. Only MPR, was associated with short-term virologic response, suggesting its cross-culturally utility for early identification of patients at high risk for virologic failure.	[Hong, Steven Y.; Wanke, Christine; Trotter, Andrew B.; Jordan, Michael R.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [Hong, Steven Y.; Jerger, Logan; Cohen, Steven; Tang, Alice M.; Wanke, Christine; Trotter, Andrew B.; Jordan, Michael R.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Jonas, Anna; Badi, Alfons; Blom, Abraham] Republ Namibia Minist Hlth & Social Serv, Directorate Special Programmes, Windhoek, Namibia; [Nachega, Jean B.] Johns Hopkins Univ, Ctr Global Hlth, Baltimore, MD USA; [Nachega, Jean B.] Univ Stellenbosch, Fac Hlth Sci, Ctr Infect Dis, Cape Town, South Africa; [Parienti, Jean-Jacques] Univ Hosp Ctr, Dept Biostat & Clin Res, Caen, France; [Terrin, Norma] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Pereko, Dawn] ABT Associates Inc, Strengthening Hlth Outcomes Private Sector, Windhoek, Namibia	Tufts Medical Center; Massachusetts Department of Public Health; Tufts University; Johns Hopkins University; Stellenbosch University; CHU de Caen NORMANDIE; Tufts Medical Center; ABT Associates	Hong, SY (corresponding author), Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA.	shong@tuftsmedicalcenter.org	Parienti, Jean-Jacques/AAD-1701-2021	Parienti, Jean-Jacques/0000-0002-4774-5590; Trotter, Andrew/0000-0001-7069-2979; Nachega, Jean/0000-0002-2862-4443	National Institutes of Health (NIH) [K23 AI074423-05, L30 AI080268-02, 1K23AI097010-01A1];  [T32 AI007438-18]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007438, K23AI097010, K23AI074423, P30AI042853] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by T32 AI007438-18 (ABT), National Institutes of Health (NIH) K23 AI074423-05 (MRJ), and NIH L30 AI080268-02 (SYH), and NIH 1K23AI097010-01A1 (SYH). Publication expenses for this manuscript were supported in part by a gift from the Christine E. Driscoll O'Neill and James M. Driscoll, Driscoll-O'Neill Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD FACTB; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Goldman JD, 2008, AIDS RES HUM RETROV, V24, P1031, DOI 10.1089/aid.2008.0035; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Jordan MR, 2008, ANTIVIR THER, V13, P15; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Luca D, 2011, J ACQUIR IMMUNE DEFI; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Maneesriwongul WL, 2006, JAIDS-J ACQ IMM DEF, V43, pS119, DOI 10.1097/01.qai.0000248346.79888.78; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; McMahon JH, 2011, CLIN INFECT DIS, V52, P493, DOI 10.1093/cid/ciq167; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Orrell C, 2003, AIDS, V17, P1369, DOI 10.1097/00002030-200306130-00011; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Oyugi JH, 2004, JAIDS-J ACQ IMM DEF, V36, P1100, DOI 10.1097/00126334-200408150-00014; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Parienti JJ, 2001, JAMA-J AM MED ASSOC, V285, P412, DOI 10.1001/jama.285.4.412; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Republic of Namibia Ministry of Health and Social Services Directorate of Special Programmes, 2010, NAT GUID ANT THER; ROTH HP, 1978, CLIN PHARMACOL THER, V23, P361; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; The Republic of Namibia Ministry of Health and Social Services, 2010, REP 2010 NAT HIV SEN; UNAIDS, 2012, TOG WE WILL END AIDS; WHO, 2010, ANT THER HIV INF AD; WHO UNAIDS, 2011, UN ACC SCAL PRIOR HI; Wood E, 2006, AIDS, V20, P1117, DOI 10.1097/01.aids.0000226951.49353.ed	35	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56307	10.1371/journal.pone.0056307	http://dx.doi.org/10.1371/journal.pone.0056307			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23509605	Green Published, gold			2022-12-27	WOS:000315524900022
J	Mehta, V; Pei, W; Yang, G; Li, SY; Swamy, E; Boster, A; Schmalbrock, P; Pitt, D				Mehta, Veela; Pei, Wei; Yang, Grant; Li, Suyang; Swamy, Eashwar; Boster, Aaron; Schmalbrock, Petra; Pitt, David			Iron Is a Sensitive Biomarker for Inflammation in Multiple Sclerosis Lesions	PLOS ONE			English	Article							POLARIZATION; DEPOSITION; MACROPHAGES; EXPRESSION; MONOCYTE; DISEASE; PHASE	MRI phase imaging in multiple sclerosis (MS) patients and in autopsy tissue have demonstrated the presence of iron depositions in white matter lesions. The accumulation of iron in some but not all lesions suggests a specific, potentially disease-relevant process, however; its pathophysiological significance remains unknown. Here, we explore the role of lesional iron in multiple sclerosis using multiple approaches: immunohistochemical examination of autoptic MS tissue, an in vitro model of iron-uptake in human cultured macrophages and ultra-highfield phase imaging of highly active and of secondary progressive MS patients. Using Perls' stain and immunohistochemistry, iron was detected in MS tissue sections predominantly in non-phagocytosing macrophages/microglia at the edge of established, demyelinated lesions. Moreover, iron-containing macrophages but not myelin-laden macrophages expressed markers of proinflammatory (M1) polarization. Similarly, in human macrophage cultures, iron was preferentially taken up by non-phagocytosing, M1-polarized macrophages and induced M1 (super) polarization. Iron uptake was minimal in myelin-laden macrophages and active myelin phagocytosis led to depletion of intracellular iron. Finally, we demonstrated in MS patients using GRE phase imaging with ultra-highfield MRI that phase hypointense lesions were significantly more prevalent in patients with active relapsing than with secondary progressive MS. Taken together, our data provide a basis to interpret iron-sensitive GRE phase imaging in MS patients: iron is present in non-phagocytosing, M1-polarized microglia/macrophages at the rim of chronic active white matter demyelinating lesions. Phase imaging may therefore visualize specific, chronic proinflammatory activity in established MS lesions and thus provide important clinical information on disease status and treatment efficacy in MS patients.	[Mehta, Veela; Pei, Wei; Li, Suyang; Swamy, Eashwar; Boster, Aaron; Pitt, David] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Yang, Grant; Schmalbrock, Petra] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Pitt, David] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Yale University	Pitt, D (corresponding author), Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA.	david.pitt@yale.edu			Teva Neuroscience	Teva Neuroscience(Teva Pharmaceutical Industries)	This study was funded in part by Teva Neuroscience. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abduljalil AM, 2003, J MAGN RESON IMAGING, V18, P284, DOI 10.1002/jmri.10362; ADAMS CWM, 1988, J NEUROL NEUROSUR PS, V51, P260, DOI 10.1136/jnnp.51.2.260; Bagnato F, 2011, BRAIN, V134, P3599, DOI 10.1093/brain/awr278; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; BENNETT S, 1994, J LEUKOCYTE BIOL, V56, P236; Bian W, 2012, MULT SCLER; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; Cairo G, 2006, GENES NUTR, V1, P25, DOI 10.1007/BF02829934; Cassetta L, 2011, THESCIENTIFICWORLDJO, V11, P2391, DOI 10.1100/2011/213962; Corna G, 2010, HAEMATOL-HEMATOL J, V95, P1814, DOI 10.3324/haematol.2010.023879; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gaultier A, 2009, J CELL SCI, V122, P1155, DOI 10.1242/jcs.040717; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2009, J MAGN RESON IMAGING, V29, P537, DOI 10.1002/jmri.21676; Hagemeier J, 2012, J MAGN RESON IMAGING, V36, P73, DOI 10.1002/jmri.23603; Hammond KE, 2008, ANN NEUROL, V64, P707, DOI 10.1002/ana.21582; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Jaramillo M, 2005, J IMMUNOL, V174, P475, DOI 10.4049/jimmunol.174.1.475; Larocca Jorge N, 2007, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0325s33; Lassmann H, 2008, NEUROIMAG CLIN N AM, V18, P563, DOI 10.1016/j.nic.2008.06.005; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pitt D, 2010, ARCH NEUROL-CHICAGO, V67, P812, DOI 10.1001/archneurol.2010.148; Recalcati S, 2010, EUR J IMMUNOL, V40, P824, DOI 10.1002/eji.200939889; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Vellinga MM, 2008, BRAIN, V131, P800, DOI 10.1093/brain/awn009; Yao B, 2012, RADIOLOGY, V262, P206, DOI 10.1148/radiol.11110601	31	143	144	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57573	10.1371/journal.pone.0057573	http://dx.doi.org/10.1371/journal.pone.0057573			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516409	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400010
J	Cone, JJ; Chartoff, EH; Potter, DN; Ebner, SR; Roitman, MF				Cone, Jackson J.; Chartoff, Elena H.; Potter, David N.; Ebner, Stephanie R.; Roitman, Mitchell F.			Prolonged High Fat Diet Reduces Dopamine Reuptake without Altering DAT Gene Expression	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; VENTRAL TEGMENTAL AREA; BODY-MASS INDEX; NUCLEUS-ACCUMBENS; CAUDATE-PUTAMEN; ENERGY DENSITY; D2 RECEPTORS; TRANSPORTER; OBESITY; REWARD	The development of diet-induced obesity (DIO) can potently alter multiple aspects of dopamine signaling, including dopamine transporter (DAT) expression and dopamine reuptake. However, the time-course of diet-induced changes in DAT expression and function and whether such changes are dependent upon the development of DIO remains unresolved. Here, we fed rats a high (HFD) or low (LFD) fat diet for 2 or 6 weeks. Following diet exposure, rats were anesthetized with urethane and striatal DAT function was assessed by electrically stimulating the dopamine cell bodies in the ventral tegmental area (VTA) and recording resultant changes in dopamine concentration in the ventral striatum using fast-scan cyclic voltammetry. We also quantified the effect of HFD on membrane associated DAT in striatal cell fractions from a separate group of rats following exposure to the same diet protocol. Notably, none of our treatment groups differed in body weight. We found a deficit in the rate of dopamine reuptake in HFD rats relative to LFD rats after 6 but not 2 weeks of diet exposure. Additionally, the increase in evoked dopamine following a pharmacological challenge of cocaine was significantly attenuated in HFD relative to LFD rats. Western blot analysis revealed that there was no effect of diet on total DAT protein. However, 6 weeks of HFD exposure significantly reduced the 50 kDa DAT isoform in a synaptosomal membrane-associated fraction, but not in a fraction associated with recycling endosomes. Our data provide further evidence for diet-induced alterations in dopamine reuptake independent of changes in DAT production and demonstrates that such changes can manifest without the development of DIO.	[Cone, Jackson J.] Univ Illinois, Grad Program Neurosci, Chicago, IL 60680 USA; [Chartoff, Elena H.; Potter, David N.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA USA; [Ebner, Stephanie R.; Roitman, Mitchell F.] Univ Illinois, Dept Psychol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; McLean Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Roitman, MF (corresponding author), Univ Illinois, Dept Psychol, Chicago, IL 60680 USA.	mroitman@uic.edu		Cone, Jackson/0000-0002-1430-6946	National Institutes of Health (NIH) from the Biomedical Neuroscience Training Program [DA025634, T32-MH067631]; National Center for Research Resources; National Center for Advancing Translational Sciences, NIH [UL1RR029877]; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR029877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025634] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the Biomedical Neuroscience Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, NIH; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project described was supported by National Institutes of Health (NIH) grants DA025634 (MFR) and T32-MH067631 from the Biomedical Neuroscience Training Program (JJC). Additional support was provided by the National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH, through grant UL1RR029877 (JJC) and by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust (JJC). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Chicago Biomedical Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso-Oramas D, 2009, NEUROBIOL DIS, V36, P494, DOI 10.1016/j.nbd.2009.09.002; [Anonymous], 2010, FAT DETECTION TASTE; Badanich KA, 2006, EUR J PHARMACOL, V550, P95, DOI 10.1016/j.ejphar.2006.08.034; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; Brown HD, 2011, EUR J NEUROSCI, V34, P1997, DOI 10.1111/j.1460-9568.2011.07914.x; Chen PS, 2008, NEUROIMAGE, V40, P275, DOI 10.1016/j.neuroimage.2007.11.007; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; Cruz-Muros I, 2009, NEUROBIOL AGING, V30, P973, DOI 10.1016/j.neurobiolaging.2007.09.009; Davis JF, 2008, BEHAV NEUROSCI, V122, P1257, DOI 10.1037/a0013111; Di Ciano P, 2001, J NEUROSCI, V21, P9471, DOI 10.1523/JNEUROSCI.21-23-09471.2001; Dreyer JK, 2010, J NEUROSCI, V30, P14273, DOI 10.1523/JNEUROSCI.1894-10.2010; FIGLEWICZ DP, 1994, BRAIN RES, V644, P331, DOI 10.1016/0006-8993(94)91698-5; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Grabenhorst F, 2010, CEREB CORTEX, V20, P1082, DOI 10.1093/cercor/bhp169; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; JONES SR, 1995, J NEUROCHEM, V64, P2581; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Ledikwe JH, 2006, AM J CLIN NUTR, V83, P1362, DOI 10.1093/ajcn/83.6.1362; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; McCutcheon JE, 2012, SYNAPSE, V66, P346, DOI 10.1002/syn.21519; Mebel DM, 2012, EUR J NEUROSCI, V36, P2336, DOI 10.1111/j.1460-9568.2012.08168.x; Meng SZ, 1999, BRAIN RES, V843, P136, DOI 10.1016/S0006-8993(99)01933-2; Moll GH, 2000, DEV BRAIN RES, V119, P251, DOI 10.1016/S0165-3806(99)00182-0; Morris JK, 2011, EXP NEUROL, V231, P171, DOI 10.1016/j.expneurol.2011.06.005; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Rao A, 2011, MOL CELL NEUROSCI, V46, P148, DOI 10.1016/j.mcn.2010.08.016; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Roitman MF, 2010, PHARMACOL BIOCHEM BE, V97, P138, DOI 10.1016/j.pbb.2010.05.010; Roitman MF, 2008, NAT NEUROSCI, V11, P1376, DOI 10.1038/nn.2219; Rolls BJ, 2009, PHYSIOL BEHAV, V97, P609, DOI 10.1016/j.physbeh.2009.03.011; Shi WX, 2004, NEUROPSYCHOPHARMACOL, V29, P2160, DOI 10.1038/sj.npp.1300534; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Sinkala E, 2012, LAB CHIP, V12, P2403, DOI 10.1039/c2lc40168a; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; South T, 2008, NEUROCHEM RES, V33, P598, DOI 10.1007/s11064-007-9483-x; Speed N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025169; Steffensen SC, 2008, EUR J NEUROSCI, V28, P2028, DOI 10.1111/j.1460-9568.2008.06479.x; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; Szczypka MS, 1999, NEURON, V22, P167, DOI 10.1016/S0896-6273(00)80688-1; Thanos PK, 2010, PHYSIOL BEHAV, V101, P713, DOI 10.1016/j.physbeh.2010.08.011; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Venton BJ, 2006, J NEUROSCI, V26, P4901; Vucetic Z, 2012, J NEUROCHEM, V120, P891, DOI 10.1111/j.1471-4159.2012.07649.x; Wang GJ, 2009, J ADDICT MED, V3, P8, DOI 10.1097/ADM.0b013e31819a86f7; Wellman PJ, 2007, PHARMACOL BIOCHEM BE, V88, P89, DOI 10.1016/j.pbb.2007.07.008; Yorgason JT, 2011, J NEUROSCI METH, V202, P158, DOI 10.1016/j.jneumeth.2011.03.001	54	74	74	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58251	10.1371/journal.pone.0058251	http://dx.doi.org/10.1371/journal.pone.0058251			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516454	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200048
J	Peng, XB; Guo, W; Ren, TT; Lou, ZY; Lu, XC; Zhang, S; Lu, QS; Sun, YF				Peng, Xianbo; Guo, Wei; Ren, Tingting; Lou, Zhiyuan; Lu, Xinchang; Zhang, Shuai; Lu, Qunshan; Sun, Yifeng			Differential Expression of the RANKL/RANK/OPG System Is Associated with Bone Metastasis in Human Non-Small Cell Lung Cancer	PLOS ONE			English	Article							FACTOR-KAPPA-B; HUMAN PROSTATE-CANCER; RECEPTOR ACTIVATOR; OSTEOCLAST DIFFERENTIATION; RANK-FC; OSTEOPROTEGERIN LIGAND; POSSIBLE INVOLVEMENT; IN-VITRO; TUMOR; MIGRATION	Background: Human non-small cell lung cancer (NSCLC) patients exhibit a high propensity to develop skeletal metastasis, resulting in excessive osteolytic activity. The RANKL/RANK/OPG system, which plays a pivotal role in bone remodeling by regulating osteoclast formation and activity, is of potential interest in this context. Materials and Methods: Reverse transcriptase polymerase chain reaction, western blotting, and immunohistochemical analysis were used to examine the expression of RANKL, RANK, and OPG in human NSCLC cell lines with different metastatic potentials, as well as in 52 primary NSCLC samples and 75 NSCLC bone metastasis samples. In primary NSCLC patients, the expression of these proteins was correlated with clinicopathological parameters. Recombinant human RANKL and transfected RANKL cDNA were added to the PAa cell line to evaluate the promoter action of RANKL during the process of metastasis in vitro and in vivo. Results: Up-regulated RANKL, RANK, and OPG expression and increased RANKL:OPG ratio were detected in NSCLC cell lines and in tumor tissues with bone metastasis, and were correlated with higher metastatic potential. The metastatic potential of NSCLC in vitro and in vivo, including migration and invasion ability, was significantly enhanced by recombinant human RANKL and the transfection of RANKL cDNA, and was impaired after OPG was added. The increased expression of RANKL and OPG correlated with tumor stage, lymph node metastasis, and distant metastasis. Conclusions: Differential expression of RANKL, RANK, and OPG is associated with the metastatic potential of human NSCLC to skeleton, raising the possibility that the RANKL/RANK/OPG system could be a therapeutic target for the treatment of metastatic NSCLC patients.	[Peng, Xianbo; Guo, Wei; Ren, Tingting; Lou, Zhiyuan; Lu, Xinchang; Zhang, Shuai; Lu, Qunshan; Sun, Yifeng] Peking Univ, Peoples Hosp, Musculoskeletal Tumor Ctr, Beijing 100871, Peoples R China	Peking University	Guo, W (corresponding author), Peking Univ, Peoples Hosp, Musculoskeletal Tumor Ctr, Beijing 100871, Peoples R China.	guowei_bonetumor@126.com			National Natural Science Foundation of China [30973020, 81001193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (No. 30973020 and 81001193). Http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2010, J PHARM PHARMACOL, V62, P470, DOI 10.1211/jpp.62.04.0009; Bhatia P, 2005, CLIN CANCER RES, V11, P162; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brown JE, 2005, JNCI-J NATL CANCER I, V97, P59, DOI 10.1093/jnci/dji002; Chen G, 2006, CANCER-AM CANCER SOC, V107, P289, DOI 10.1002/cncr.21978; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Demers LM, 2003, CLIN ORTHOP RELAT R, pS138, DOI 10.1097/01.blo.0000092979.12414.54; Dougall WC, 2006, CANCER METAST REV, V25, P541, DOI 10.1007/s10555-006-9021-3; Farrugia AN, 2003, CANCER RES, V63, P5438; Feeley BT, 2006, J BONE MINER RES, V21, P1571, DOI 10.1359/JBMR.060706; Feeley BT, 2006, BONE, V38, P154, DOI 10.1016/j.bone.2005.07.015; Fiumara P, 2001, BLOOD, V98, P2784, DOI 10.1182/blood.V98.9.2784; Grimaud E, 2003, AM J PATHOL, V163, P2021, DOI 10.1016/S0002-9440(10)63560-2; Holen I, 2005, BREAST CANCER RES TR, V92, P207, DOI 10.1007/s10549-005-2419-8; Hsu WK, 2008, J NUCL MED, V49, P414, DOI 10.2967/jnumed.107.045666; Huang L, 2003, J CLIN PATHOL-MOL PA, V56, P116, DOI 10.1136/mp.56.2.116; Huang L, 2000, AM J PATHOL, V156, P761, DOI 10.1016/S0002-9440(10)64942-5; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Karapanagiotou EM, 2010, MED ONCOL, V27, P332, DOI 10.1007/s12032-009-9214-z; Kitazawa S, 2002, J PATHOL, V198, P228, DOI 10.1002/path.1199; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee Y, 2003, J ORTHOP RES, V21, P62, DOI 10.1016/S0736-0266(02)00095-5; Mikami S, 2009, J PATHOL, V218, P530, DOI 10.1002/path.2567; Mori K, 2007, BONE, V40, P981, DOI 10.1016/j.bone.2006.11.006; Mountzios G, 2007, ACTA ONCOL, V46, P221, DOI 10.1080/02841860600635870; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Navolotski A, 1997, CANCER LETT, V118, P181, DOI 10.1016/S0304-3835(97)00329-7; Roodman G David, 2004, Discov Med, V4, P144; Roux S, 2002, AM J CLIN PATHOL, V117, P210; Santini D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019234; Siegel G, 1998, MICROSC RES TECHNIQ, V43, P276, DOI 10.1002/(SICI)1097-0029(19981101)43:3<276::AID-JEMT10>3.0.CO;2-G; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sordillo EM, 2003, CANCER-AM CANCER SOC, V97, P802, DOI 10.1002/cncr.11134; Tada T, 2005, INT J CANCER, V116, P253, DOI 10.1002/ijc.21008; Tang XD, 2010, EUR J CANCER PREV, V19, P466, DOI 10.1097/CEJ.0b013e32833d942f; Tsuda E, 1997, BIOCHEM BIOPH RES CO, V234, P137, DOI 10.1006/bbrc.1997.6603; Virk MS, 2009, BONE, V44, P160, DOI 10.1016/j.bone.2008.09.009; Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040; Whang PG, 2005, J ORTHOP RES, V23, P1475, DOI 10.1016/j.orthres.2005.05.004; Yin JJ, 2005, CELL RES, V15, P57, DOI 10.1038/sj.cr.7290266; Yoneda T, 2005, BIOCHEM BIOPH RES CO, V328, P679, DOI 10.1016/j.bbrc.2004.11.070; Yoshino I, 2001, Ann Thorac Cardiovasc Surg, V7, P204; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593; Zhang J, 2003, CANCER RES, V63, P7883	46	52	57	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58361	10.1371/journal.pone.0058361	http://dx.doi.org/10.1371/journal.pone.0058361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516466	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200058
J	Shalom, DE; Serro, MGD; Giaconia, M; Martinez, LM; Rieznik, A; Sigman, M				Shalom, Diego E.; de Sousa Serro, Maximiliano G.; Giaconia, Maximiliano; Martinez, Luis M.; Rieznik, Andres; Sigman, Mariano			Choosing in Freedom or Forced to Choose? Introspective Blindness to Psychological Forcing in Stage-Magic	PLOS ONE			English	Article							INATTENTIONAL BLINDNESS; CHOICE BLINDNESS; MISDIRECTION; ATTENTION; CONSTRUCTION; CONFIDENCE; AWARENESS; OVERT; GAZE; GAP	We investigated an individual ability to identify whether choices were made freely or forced by external parameters. We capitalized on magical setups where the notion of psychological forcing constitutes a well trodden path. In live stage magic, a magician guessed cards from spectators while inquiring how freely they thought they had made the choice. Our data showed a marked blindness in the introspection of free choice. Spectators assigned comparable ratings when choosing the card that the magician deliberately forced them compared to any other card, even in classical forcing, where the magician literally handles a card to the participant This observation was paralleled by a laboratory experiment where we observed modest changes in subjective reports by factors with drastic effect in choice. Pupil dilatation, which is known to tag slow cognitive events related to memory and attention, constitutes an efficient fingerprint to index subjective and objective aspects of choice.	[Shalom, Diego E.; de Sousa Serro, Maximiliano G.; Giaconia, Maximiliano; Rieznik, Andres; Sigman, Mariano] Univ Buenos Aires, Dept Phys, Lab Integrat Neurosci, Buenos Aires, DF, Argentina; [Martinez, Luis M.] Univ Miguel Hernandez, Inst Neurociencias Alicante, Consejo Super Invest Cient, Sant Joan dAlacant, Spain	University of Buenos Aires; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Shalom, DE (corresponding author), Univ Buenos Aires, Dept Phys, Lab Integrat Neurosci, Buenos Aires, DF, Argentina.	diego@df.uba.ar			CONSOLIDER (European Regional Development Fund) [CSD2007-00023]; Spanish Ministry of Economy and Competitiveness [BFU2010-22220]; Argentine National Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET)	CONSOLIDER (European Regional Development Fund); Spanish Ministry of Economy and Competitiveness(Spanish Government); Argentine National Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	L.M.M. is supported by grants CONSOLIDER CSD2007-00023 (European Regional Development Fund) and BFU2010-22220 (Spanish Ministry of Economy and Competitiveness). M.S. and D.E.S. are partially supported by the Argentine National Research Council (Consejo Nacional de Investigaciones Cientificas y Tecnicas, CONICET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTONJONES G, 1981, J NEUROSCI, V1, P887; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CLARKE FR, 1959, J ACOUST SOC AM, V31, P629, DOI 10.1121/1.1907764; Corallo G, 2008, PSYCHOL SCI, V19, P1110, DOI 10.1111/j.1467-9280.2008.02211.x; Cui J, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00103; DaOrtiz D., 2010, LIBERTAD EXPRESION F; Ebbinghaus H., 1913, MEMORY CONTRIBUTION; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; FRIED I, 1991, J NEUROSCI, V11, P3656; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Ganson Lewis, 1959, DAI VERNONS INNER SE; Graziano M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004909; Hall L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045457; Hall L, 2010, COGNITION, V117, P54, DOI 10.1016/j.cognition.2010.06.010; Hergovich A, 2011, PERCEPTION, V40, P358, DOI 10.1068/p6866; Johansson P, 2005, SCIENCE, V310, P116, DOI 10.1126/science.1111709; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Kuhn G, 2008, TRENDS COGN SCI, V12, P349, DOI 10.1016/j.tics.2008.05.008; Kuhn G, 2008, VIS COGN, V16, P391, DOI 10.1080/13506280701479750; Kuhn G, 2006, CURR BIOL, V16, pR950, DOI 10.1016/j.cub.2006.10.012; Kuhn G, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00172; Kuhn G, 2010, PSYCHOL SCI, V21, P1487, DOI 10.1177/0956797610383435; Kuhn G, 2009, VIS COGN, V17, P925, DOI 10.1080/13506280902826775; Lamont P, 1999, MAGIC THEORY INTRO T; Macknik SL, 2010, SLEIGHTS MIND; Macknik SL, 2008, NAT REV NEUROSCI, V9, P871, DOI 10.1038/nrn2473; Macknik SL, 2009, NAT REV NEUROSCI, V10, DOI 10.1038/nrn2473-c2; Marti S, 2010, COGNITION, V115, P303, DOI 10.1016/j.cognition.2010.01.003; Memmert D, 2010, CONSCIOUS COGN, V19, P1097, DOI 10.1016/j.concog.2010.01.001; Moore J, 2006, CONSCIOUS COGN, V15, P693, DOI 10.1016/j.concog.2006.09.003; Moran A, 2010, CONSCIOUS COGN, V19, P1105, DOI 10.1016/j.concog.2010.03.011; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Otero-Millan J, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00133; Parris BA, 2009, NEUROIMAGE, V45, P1033, DOI 10.1016/j.neuroimage.2008.12.036; Rahnev D, 2012, J NEUROPHYSIOL, V107, P1556, DOI 10.1152/jn.00985.2011; Raz A, 2001, USING MAGIC VEHICLE; Rounis E, 2010, COGN NEUROSCI-UK, V1, P165, DOI 10.1080/17588921003632529; SWETS JA, 1973, SCIENCE, V182, P990, DOI 10.1126/science.182.4116.990; Tamariz J, 2005, ARTE VERBIMAGIA; Tamariz J, 1987, ENCICLOPEDIA FORZAJE; Tarbell H, 1927, TARBELL COURSE MAGIC; Triplett N, 1900, AM J PSYCHOL, V11, P439, DOI [DOI 10.2307/1412365, 10.2307/1412365]; Wegner DM, 2002, BRADFORD BOOKS, P1; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wiseman R, 1996, PSYCHOLOGIST, V9, P61; Zylberberg A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00079	48	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58254	10.1371/journal.pone.0058254	http://dx.doi.org/10.1371/journal.pone.0058254			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516455	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200049
J	Ali, JAM; Tagoe, DNA; Munday, JC; Donachie, A; Morrison, LJ; de Koning, HP				Ali, Juma A. M.; Tagoe, Daniel N. A.; Munday, Jane C.; Donachie, Anne; Morrison, Liam J.; de Koning, Harry P.			Pyrimidine Biosynthesis Is Not an Essential Function for Trypanosoma brucei Bloodstream Forms	PLOS ONE			English	Article							HIGH-AFFINITY NUCLEOSIDE; NUCLEOBASE TRANSPORTERS; LEISHMANIA-DONOVANI; AFRICAN TRYPANOSOMIASIS; TOXOPLASMA-GONDII; SLEEPING SICKNESS; DRUG TARGET; PURINE; INHIBITORS; SALVAGE	Background: African trypanosomes are capable of both pyrimidine biosynthesis and salvage of preformed pyrimidines from the host, but it is unknown whether either process is essential to the parasite. Methodology/Principal Findings: Pyrimidine requirements for growth were investigated using strictly pyrimidine-free media, with or without single added pyrimidine sources. Growth rates of wild-type bloodstream form Trypanosoma brucei brucei were unchanged in pyrimidine-free medium. The essentiality of the de novo pyrimidine biosynthesis pathway was studied by knocking out the PYR6-5 locus that produces a fusion product of orotate phosphoribosyltransferase (OPRT) and Orotidine Monophosphate Decarboxylase (OMPDCase). The pyrimidine auxotroph was dependent on a suitable extracellular pyrimidine source. Pyrimidine starvation was rapidly lethal and non-reversible, causing incomplete DNA content in new cells. The phenotype could be rescued by addition of uracil; supplementation with uridine, 2'deoxyuridine, and cytidine allowed a diminished growth rate and density. PYR6-5(-)/(-) trypanosomes were more sensitive to pyrimidine antimetabolites and displayed increased uracil transport rates and uridine phosphorylase activity. Pyrimidine auxotrophs were able to infect mice although the infection developed much more slowly than infection with the parental, prototrophic trypanosome line. Conclusions/Significance: Pyrimidine salvage was not an essential function for bloodstream T. b. brucei. However, trypanosomes lacking de novo pyrimidine biosynthesis are completely dependent on an extracellular pyrimidine source, strongly preferring uracil, and display reduced infectivity. As T. brucei are able to salvage sufficient pyrimidines from the host environment, the pyrimidine biosynthesis pathway is not a viable drug target, although any interruption of pyrimidine supply was lethal.	[Ali, Juma A. M.; Tagoe, Daniel N. A.; Munday, Jane C.; Donachie, Anne; de Koning, Harry P.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Ali, Juma A. M.] Al Jabal Al Gharbi Univ, Fac Sci, Dept Zool, Gharyan, Libya; [Munday, Jane C.; Morrison, Liam J.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Morrison, Liam J.] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland	University of Glasgow; University of Glasgow; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	de Koning, HP (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	Harry.de-Koning@glasgow.ac.uk	Tagoe, Daniel Nii Aryee/P-9478-2019	Tagoe, Daniel Nii Aryee/0000-0001-6268-7838; De Koning, Harry/0000-0002-9963-1827; Munday, Jane/0000-0001-7792-2749; Morrison, Liam/0000-0002-8304-9066	Wellcome Trust [085349]; Libyan Government; Medical Research Council [84733]; MRC [G0701258] Funding Source: UKRI; Medical Research Council [G0701258] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Libyan Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust. The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust [085349], and DNAT is the recipient of a Wellcome Trust scholarship. The authors also gratefully acknowledge financial support from the Libyan Government (studentship to JAMA) and the Medical Research Council (contract number 84733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salabi MI, 2007, MOL PHARMACOL, V71, P921, DOI 10.1124/mol.106.031559; Ali JA, 2013, MOL PHARM; Arakaki TL, 2008, MOL MICROBIOL, V68, P37, DOI 10.1111/j.1365-2958.2008.06131.x; ARONOW B, 1987, MOL BIOCHEM PARASIT, V22, P29, DOI 10.1016/0166-6851(87)90066-1; Balasegaram M, 2009, T ROY SOC TROP MED H, V103, P280, DOI 10.1016/j.trstmh.2008.09.005; Bellofatto V, 2007, TRENDS PARASITOL, V23, P187, DOI 10.1016/j.pt.2007.03.003; Berens Randolph L., 1995, P89, DOI 10.1016/B978-012473345-9/50007-6; Berg M, 2010, CURR MED CHEM, V17, P2456, DOI 10.2174/092986710791556023; Berg M, 2010, ANTIMICROB AGENTS CH, V54, P1900, DOI 10.1128/AAC.01787-09; Bi DQ, 2000, J CHROMATOGR B, V738, P249, DOI 10.1016/S0378-4347(99)00528-9; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Castillo-Acosta VM, 2008, INT J BIOCHEM CELL B, V40, P2901, DOI 10.1016/j.biocel.2008.06.009; de Koning HP, 2007, TRENDS PARASITOL, V23, P190, DOI 10.1016/j.pt.2007.03.004; de Koning HP, 2005, FEMS MICROBIOL REV, V29, P987, DOI 10.1016/j.femsre.2005.03.004; De Koning HP, 2003, INT J PARASITOL, V33, P821, DOI 10.1016/S0020-7519(03)00091-2; de Koning HP, 1998, BIOCHEM CELL BIOL, V76, P853, DOI 10.1139/bcb-76-5-853; de Koning HP, 2000, MOL BIOCHEM PARASIT, V106, P93, DOI 10.1016/S0166-6851(99)00203-0; deKoning HP, 1997, MOL BIOCHEM PARASIT, V89, P245, DOI 10.1016/S0166-6851(97)00129-1; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Fox BA, 2002, NATURE, V415, P926, DOI 10.1038/415926a; French JB, 2011, J BIOL CHEM, V286, P20930, DOI 10.1074/jbc.M111.228213; Gao GH, 1999, J MOL BIOL, V285, P149, DOI 10.1006/jmbi.1998.2293; Gould MK, 2008, ANAL BIOCHEM, V382, P87, DOI 10.1016/j.ab.2008.07.036; Gudin S, 2006, EXP PARASITOL, V114, P118, DOI 10.1016/j.exppara.2006.02.018; HAMMOND DJ, 1982, BIOCHIM BIOPHYS ACTA, V718, P1, DOI 10.1016/0304-4165(82)90002-2; HASSAN HF, 1988, FEMS MICROBIOL LETT, V54, P47, DOI 10.1111/j.1574-6968.1988.tb02709.x; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hofer A, 2001, P NATL ACAD SCI USA, V98, P6412, DOI 10.1073/pnas.111139498; Ibrahim HMS, 2011, J ANTIMICROB CHEMOTH, V66, P111, DOI 10.1093/jac/dkq401; Landfear SM, 2004, EUKARYOT CELL, V3, P245, DOI 10.1128/EC.3.2.245-254.2004; Larson ET, 2010, J MOL BIOL, V396, P1244, DOI 10.1016/j.jmb.2010.01.013; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Martin DW, 1981, HARPERS REV BIOCH, P331; Martin KL, 2006, BIOCHEM J, V396, P287, DOI 10.1042/BJ20051825; Natto MJ, 2005, EXP PARASITOL, V109, P80, DOI 10.1016/j.exppara.2004.11.004; Papageorgiou IG, 2005, PARASITOLOGY, V130, P275, DOI 10.1017/S0031182004006626; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Rodenko B, 2007, ANTIMICROB AGENTS CH, V51, P3796, DOI 10.1128/AAC.00425-07; Scahill MD, 2008, MOL BIOCHEM PARASIT, V157, P73, DOI 10.1016/j.molbiopara.2007.10.003; Sienkiewicz N, 2008, MOL MICROBIOL, V69, P520, DOI 10.1111/j.1365-2958.2008.06305.x; STERNBERG N, 1981, J MOL BIOL, V150, P487, DOI 10.1016/0022-2836(81)90376-4; VANDYKE K, 1970, AM J TROP MED HYG, V19, P202, DOI 10.4269/ajtmh.1970.19.202; Wallace LJM, 2002, J BIOL CHEM, V277, P26149, DOI 10.1074/jbc.M202835200; WANG CC, 1984, MOL BIOCHEM PARASIT, V10, P171, DOI 10.1016/0166-6851(84)90005-7; Wilson ZN, 2012, J BIOL CHEM, V287, P12759, DOI 10.1074/jbc.M112.346502	47	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58034	10.1371/journal.pone.0058034	http://dx.doi.org/10.1371/journal.pone.0058034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505454	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000318334500046
J	Castaneda, LE; Nespolo, RF				Castaneda, Luis E.; Nespolo, Roberto F.			Phenotypic and Genetic Effects of Contrasting Ethanol Environments on Physiological and Developmental Traits in Drosophila melanogaster	PLOS ONE			English	Article							QUANTITATIVE GENETICS; DIRECTIONAL SELECTION; ENERGY-METABOLISM; NATURAL-SELECTION; DEVELOPMENT TIME; GRYLLUS-FIRMUS; TRADE-OFFS; BODY-SIZE; MORPHOLOGY; EVOLUTION	A central problem in evolutionary physiology is to understand the relationship between energy metabolism and fitness-related traits. Most attempts to do so have been based on phenotypic correlations that are not informative for the evolutionary potential of natural populations. Here, we explored the effect of contrasting ethanol environments on physiological and developmental traits, their genetic (co)variances and genetic architecture in Drosophila melanogaster. Phenotypic and genetic parameters were estimated in two populations (San Fernando and Valdivia, Chile), using a half-sib family design where broods were split into ethanol-free and ethanol-supplemented conditions. Our findings show that metabolic rate, body mass and development times were sensitive (i.e., phenotypic plasticity) to ethanol conditions and dependent on population origin. Significant heritabilities were found for all traits, while significant genetic correlations were only found between larval and total development time and between development time and metabolic rate for flies of the San Fernando population developed in ethanol-free conditions. Posterior analyses indicated that the G matrices differed between ethanol conditions for the San Fernando population (mainly explained by differences in genetic (co)variances of developmental traits), whereas the Valdivia population exhibited similar G matrices between ethanol conditions. Our findings suggest that ethanol-free environment increases the energy available to reduce development time. Therefore, our results indicate that environmental ethanol could modify the process of energy allocation, which could have consequences on the evolutionary response of natural populations of D. melanogaster.	[Castaneda, Luis E.] Univ Autonoma Barcelona, GBE, Dept Genet & Microbiol, Bellaterra, Barcelona, Spain; [Nespolo, Roberto F.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile	Autonomous University of Barcelona; Universidad Austral de Chile	Castaneda, LE (corresponding author), Univ Autonoma Barcelona, GBE, Dept Genet & Microbiol, Bellaterra, Barcelona, Spain.	lecastane@gmail.com	Nespolo, Roberto/D-5601-2015; Castañeda, Luis/G-5340-2011; Nespolo, Roberto/D-5601-2015	Nespolo, Roberto/0000-0001-9337-0606; Castañeda, Luis/0000-0001-5484-4573; Nespolo, Roberto/0000-0003-0825-9618	FONDECYT [3090056, 1090423]; Ministerio de Ciencia e Innovacion (Spain) [JCI-2010-06156]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by FONDECYT Postdoctoral grant No. 3090056 to L. E. C. and FONDECYT grant No. 1090423 to R.F.N. L.E.C is currently a Juan de la Cierva fellow (JCI-2010-06156) funded by the Ministerio de Ciencia e Innovacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Arnold SJ, 2008, EVOLUTION, V62, P2451, DOI 10.1111/j.1558-5646.2008.00472.x; Artacho P, 2009, EVOLUTION, V63, P1044, DOI 10.1111/j.1558-5646.2008.00603.x; Begin M, 2004, J EVOLUTION BIOL, V17, P1255, DOI 10.1111/j.1420-9101.2004.00772.x; Blanckenhorn WU, 2004, EVOL ECOL, V18, P385, DOI 10.1007/s10682-004-2680-z; CODY ML, 1966, EVOLUTION, V20, P174, DOI 10.1111/j.1558-5646.1966.tb03353.x; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; DAVID JR, 1986, GENET SEL EVOL, V18, P405, DOI 10.1186/1297-9686-18-4-405; Doroszuk A, 2008, AM NAT, V171, P291, DOI 10.1086/527478; ETGES WJ, 1989, PHYSIOL ZOOL, V62, P170, DOI 10.1086/physzool.62.1.30160004; Folguera G, 2010, J INSECT PHYSIOL, V56, P1679, DOI 10.1016/j.jinsphys.2010.06.015; Fry JD, 2008, EVOLUTION, V62, P66, DOI 10.1111/j.1558-5646.2007.00288.x; Fry JD, 2001, J EVOLUTION BIOL, V14, P296, DOI 10.1046/j.1420-9101.2001.00271.x; Gebhardt MD, 1988, J EVOLUTION BIOL, V6, P1; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; HAYES JP, 1992, FUNCT ECOL, V6, P5, DOI 10.2307/2389765; Hereford J, 2004, EVOLUTION, V58, P2133; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; Hoffmann AA, 1999, TRENDS ECOL EVOL, V14, P96, DOI 10.1016/S0169-5347(99)01595-5; Jumbo-Lucioni P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-297; Kause A, 2001, EVOLUTION, V55, P1992, DOI 10.1111/j.0014-3820.2001.tb01316.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Kraft PG, 2006, J EVOLUTION BIOL, V19, P1813, DOI 10.1111/j.1420-9101.2006.01185.x; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lynch Michael, 1998; Malherbe Y, 2005, J EVOLUTION BIOL, V18, P811, DOI 10.1111/j.1420-9101.2004.00877.x; MCKECHNIE SW, 1984, INSECT BIOCHEM, V14, P231, DOI 10.1016/0020-1790(84)90034-9; Messina FJ, 2003, J EVOLUTION BIOL, V16, P501, DOI 10.1046/j.1420-9101.2003.00535.x; Miller C, 2000, DROSOPHILA MELANOGAS; Nespolo RF, 2005, EVOLUTION, V59, P1829, DOI 10.1111/j.0014-3820.2005.tb01829.x; Nespolo RF, 2007, BIOL RES, V40, P5, DOI 10.4067/S0716-97602007000100001; OAKESHOTT JG, 1985, THEOR APPL GENET, V69, P603, DOI 10.1007/BF00251111; PARSONS PA, 1979, AUST J ZOOL, V27, P747, DOI 10.1071/ZO9790747; Pecsenye K, 2004, HEREDITY, V93, P215, DOI 10.1038/sj.hdy.6800497; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rantala MJ, 2006, J EVOLUTION BIOL, V19, P834, DOI 10.1111/j.1420-9101.2005.01048.x; Revell LJ, 2007, EVOLUTION, V61, P1857, DOI 10.1111/j.1558-5646.2007.00161.x; Roff D, 2002, EVOLUTION, V56, P1286; Roff D.A., 1997, EVOLUTIONARY QUANTIT; ROFF DA, 1987, HEREDITY, V58, P103, DOI 10.1038/hdy.1987.15; Roff Derek, 2002, pi; Santos M, 2004, J EVOLUTION BIOL, V17, P841, DOI 10.1111/j.1420-9101.2004.00721.x; Schwarzenbach GA, 2006, EVOLUTION, V60, P1612, DOI 10.1111/j.0014-3820.2006.tb00506.x; Serbezov D, 2010, J EVOLUTION BIOL, V23, P1631, DOI 10.1111/j.1420-9101.2010.02028.x; Sgro CM, 2004, HEREDITY, V93, P241, DOI 10.1038/sj.hdy.6800532; Shafiei M, 2001, PHYSIOL ENTOMOL, V26, P173, DOI 10.1046/j.1365-3032.2001.00231.x; Stanley SM, 1981, P ECOL SOC AUST, V11, P121; Statsoft Inc, 2004, STATISTICA VERS 6 1; Stearns S.C., 1992, pi; TEJEDO M, 1994, HERPETOLOGICA, V50, P113; Wilson AJ, 2010, J ANIM ECOL, V79, P13, DOI 10.1111/j.1365-2656.2009.01639.x; ZIOLO LK, 1982, GENETICA, V57, P231, DOI 10.1007/BF00056488	54	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58920	10.1371/journal.pone.0058920	http://dx.doi.org/10.1371/journal.pone.0058920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505567	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500132
J	Longarela, OL; Schmidt, TT; Schoeneweis, K; Romeo, R; Wedemeyer, H; Urban, S; Schulze, A				Longarela, Oscar Lamas; Schmidt, Tobias T.; Schoeneweis, Katrin; Romeo, Raffaella; Wedemeyer, Heiner; Urban, Stephan; Schulze, Andreas			Proteoglycans Act as Cellular Hepatitis Delta Virus Attachment Receptors	PLOS ONE			English	Article							LARGE SURFACE PROTEIN; B-VIRUS; INFECTION; SURAMIN; BINDING; DOMAIN; GLYCOSAMINOGLYCANS; DETERMINANTS; REPLICATION; INHIBITORS	The hepatitis delta virus (HDV) is a small, defective RNA virus that requires the presence of the hepatitis B virus (HBV) for its life cycle. Worldwide more than 15 million people are co-infected with HBV and HDV. Although much effort has been made, the early steps of the HBV/HDV entry process, including hepatocyte attachment and receptor interaction are still not fully understood. Numerous possible cellular HBV/HDV binding partners have been described over the last years; however, so far only heparan sulfate proteoglycans have been functionally confirmed as cell-associated HBV attachment factors. Recently, it has been suggested that ionotrophic purinergic receptors (P2XR) participate as receptors in HBV/HDV entry. Using the HBV/HDV susceptible HepaRG cell line and primary human hepatocytes (PHH), we here demonstrate that HDV entry into hepatocytes depends on the interaction with the glycosaminoglycan (GAG) side chains of cellular heparan sulfate proteoglycans. We furthermore provide evidence that P2XR are not involved in HBV/HDV entry and that effects observed with inhibitors for these receptors are a consequence of their negative charge. HDV infection was abrogated by soluble GAGs and other highly sulfated compounds. Enzymatic removal of defined carbohydrate structures from the cell surface using heparinase III or the obstruction of GAG synthesis by sodium chlorate inhibited HDV infection of HepaRG cells. Highly sulfated P2XR antagonists blocked HBV/HDV infection of HepaRG cells and PHH. In contrast, no effect on HBV/HDV infection was found when uncharged P2XR antagonists or agonists were applied. In summary, HDV infection, comparable to HBV infection, requires binding to the carbohydrate side chains of hepatocyte-associated heparan sulfate proteoglycans as attachment receptors, while P2XR are not actively involved.	[Longarela, Oscar Lamas; Schmidt, Tobias T.; Schoeneweis, Katrin; Urban, Stephan; Schulze, Andreas] Univ Heidelberg Hosp, Dept Infect Dis Mol Virol, Heidelberg, Germany; [Romeo, Raffaella] Univ Milan, Fdn IRCCS Cagranda Osped Maggiore Policlin, Div Gastroenterol 1, Milan, Italy; [Wedemeyer, Heiner] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany	Ruprecht Karls University Heidelberg; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Hannover Medical School	Urban, S (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis Mol Virol, Heidelberg, Germany.	stephan.urban@med.uni-heidelberg.de	Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973; Romeo, Raffaella/0000-0002-7858-4670; Schmidt, Tobias/0000-0002-9064-6192	Sheila Dame Postdoctoral Grant; European Association for the Study of the Liver (EASL)	Sheila Dame Postdoctoral Grant; European Association for the Study of the Liver (EASL)	Oscar Lamas was supported by a Sheila Dame Postdoctoral Grant awarded by the European Association for the Study of the Liver (EASL) (www.easl.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Jaoude G, 2005, J VIROL, V79, P10460, DOI 10.1128/JVI.79.16.10460-10644.2005; Aguilar JS, 1999, VIROLOGY, V258, P141, DOI 10.1006/viro.1999.9723; BAEUERLE PA, 1986, BIOCHEM BIOPH RES CO, V141, P870, DOI 10.1016/S0006-291X(86)80253-4; BALZARINI J, 1986, INT J CANCER, V37, P451, DOI 10.1002/ijc.2910370318; Barrera A, 2005, J VIROL, V79, P9786, DOI 10.1128/JVI.79.15.9786-9798.2005; Blanchet M, 2007, J VIROL, V81, P5841, DOI 10.1128/JVI.00096-07; Bradley HJ, 2010, FEBS LETT, V584, P4740, DOI 10.1016/j.febslet.2010.11.007; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Croon J J, 1982, Acta Leiden, V48, P5; DECLERCQ E, 1987, ANTIVIR RES, V7, P1, DOI 10.1016/0166-3542(87)90034-9; Emmett DS, 2008, HEPATOLOGY, V47, P698, DOI 10.1002/hep.22035; Engelke M, 2006, HEPATOLOGY, V43, P750, DOI 10.1002/hep.21112; Fleck SL, 2003, J BIOL CHEM, V278, P47670, DOI 10.1074/jbc.M306603200; Funk A, 2004, J VIROL, V78, P3977, DOI 10.1128/JVI.78.8.3977-3983.2004; Germi R, 2002, J MED VIROL, V68, P206, DOI 10.1002/jmv.10196; Glebe D, 2007, WORLD J GASTROENTERO, V13, P22, DOI 10.3748/wjg.v13.i1.22; Gripon P, 2005, J VIROL, V79, P1613, DOI 10.1128/JVI.79.3.1613-1622.2005; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; GRIPON P, 1995, VIROLOGY, V213, P292, DOI 10.1006/viro.1995.0002; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Le Duff Y, 2009, J VIROL, V83, P12443, DOI 10.1128/JVI.01594-09; Le Seyec J, 1999, J VIROL, V73, P2052, DOI 10.1128/JVI.73.3.2052-2057.1999; Leistner CM, 2008, CELL MICROBIOL, V10, P122, DOI 10.1111/j.1462-5822.2007.01023.x; Lutgehetmann M, 2012, HEPATOLOGY, V55, P685, DOI 10.1002/hep.24758; LYON M, 1994, J BIOL CHEM, V269, P11208; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; OFFENSPERGER WB, 1993, ANTIMICROB AGENTS CH, V37, P1539, DOI 10.1128/AAC.37.7.1539; PETCU DJ, 1988, VIROLOGY, V167, P385, DOI 10.1016/0042-6822(88)90099-2; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Rizzetto M, 2009, J HEPATOL, V50, P1043, DOI 10.1016/j.jhep.2009.01.004; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; Schulze A, 2007, HEPATOLOGY, V46, P1759, DOI 10.1002/hep.21896; Schulze A, 2010, J VIROL, V84, P1989, DOI 10.1128/JVI.01902-09; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; STOW JL, 1985, J CELL BIOL, V100, P975, DOI 10.1083/jcb.100.3.975; Sureau C, 2006, CURR TOP MICROBIOL, V307, P113; Sureau C, 2013, HEPATOLOGY, V57, P985, DOI 10.1002/hep.26125; Taylor JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015784; TSIQUAYE K, 1985, J HEPATOL, V1, P663, DOI 10.1016/S0168-8278(85)80009-X; Vongchan P, 2005, BBA-GEN SUBJECTS, V1721, P1, DOI 10.1016/j.bbagen.2004.09.007; VOOGD TE, 1993, PHARMACOL REV, V45, P177; Wedemeyer H, 2011, LIVER INT, V31, P140, DOI 10.1111/j.1478-3231.2010.02408.x; Wilson HL, 2007, BRIT J PHARMACOL, V151, P96, DOI 10.1038/sj.bjp.0707213; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	46	49	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58340	10.1371/journal.pone.0058340	http://dx.doi.org/10.1371/journal.pone.0058340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505490	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500070
J	Torda, G; Schmidt-Roach, S; Peplow, LM; Lundgren, P; van Oppen, MJH				Torda, Gergely; Schmidt-Roach, Sebastian; Peplow, Lesa M.; Lundgren, Petra; van Oppen, Madeleine J. H.			A Rapid Genetic Assay for the Identification of the Most Common Pocillopora damicornis Genetic Lineages on the Great Barrier Reef	PLOS ONE			English	Article							LUNAR PERIODICITY; CORAL; SCLERACTINIA; CNIDARIA; MORPHOLOGY; SHOW	Pocillopora damicornis (Linnaeus, 1758; Scleractinia, Pocilloporidae) has recently been found to comprise at least five distinct genetic lineages in Eastern Australia, some of which likely represent cryptic species. Due to similar and plastic gross morphology of these lineages, field identification is often difficult. Here we present a quick, cost effective genetic assay as well as three novel microsatellite markers that distinguish the two most common lineages found on the Great Barrier Reef. The assay is based on PCR amplification of two regions within the mitochondrial putative control region, which show consistent and easily identifiable fragment size differences for the two genetic lineages after Alu1 restriction enzyme digestion of the amplicons.	[Torda, Gergely] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Torda, Gergely; Schmidt-Roach, Sebastian; Peplow, Lesa M.; Lundgren, Petra; van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Torda, Gergely; van Oppen, Madeleine J. H.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Torda, Gergely; van Oppen, Madeleine J. H.] James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia; [Schmidt-Roach, Sebastian] Univ Tasmania, Inst Antarctic & So Ocean Studies, Hobart, Tas, Australia; [Lundgren, Petra] Great Barrier Reef Marine Pk Author, Townsville, Qld, Australia	James Cook University; Australian Institute of Marine Science; James Cook University; James Cook University; University of Tasmania	van Oppen, MJH (corresponding author), Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia.	m.vanoppen@aims.gov.au	Torda, Gergely/ABE-6400-2020; Schmidt-Roach, Sebastian/N-7129-2013; Torda, Gergely/ABE-6388-2020; van Oppen, Madeleine JH/C-3261-2008	Torda, Gergely/0000-0002-4585-3045; Schmidt-Roach, Sebastian/0000-0002-7783-0198; van Oppen, Madeleine/0000-0003-4607-0744; Lundgren, Petra/0000-0002-1270-2005	Australian Government's Marine and Tropical Sciences Research Fund (MTSRF); AIMS@JCU; Australian Institute for Marine Science; James Cook University; Endeavour International Postgraduate Research Scholarship	Australian Government's Marine and Tropical Sciences Research Fund (MTSRF)(Australian Government); AIMS@JCU; Australian Institute for Marine Science; James Cook University; Endeavour International Postgraduate Research Scholarship(Australian Government)	This work has been funded by the Australian Government's Marine and Tropical Sciences Research Fund (MTSRF), and AIMS@JCU, a collaborative scheme between the Australian Institute for Marine Science and James Cook University. G.T. is supported by the James Cook University Postgraduate Research Scholarship, and both G.T. and S.S-R. are supported by an Endeavour International Postgraduate Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, 5000 CNRS UMR; Babcock RC, 2003, ZOOL STUD, V42, P211; Bruno JF, 1997, ECOLOGY, V78, P2177, DOI 10.2307/2265954; COLEMAN AW, 1994, J PHYCOL, V30, P80, DOI 10.1111/j.0022-3646.1994.00080.x; Combosch DJ, 2008, MOL ECOL, V17, P1304, DOI 10.1111/j.1365-294X.2007.03672.x; Flot JF, 2008, CORAL REEFS, V27, P789, DOI 10.1007/s00338-008-0407-2; Flot JF, 2008, CR BIOL, V331, P239, DOI 10.1016/j.crvi.2007.12.003; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harriott V.J., 1983, Coral Reefs, V2, P151, DOI 10.1007/BF00336721; Magalon H, 2004, MOL ECOL NOTES, V4, P206, DOI 10.1111/j.1471-8286.2004.00618.x; Medina M, 1999, MAR BIOTECHNOL, V1, P89, DOI 10.1007/PL00011756; Negri A, 2005, MAR POLLUT BULL, V51, P370, DOI 10.1016/j.marpolbul.2004.10.053; Nunes F, 2008, CORAL REEFS, V27, P423, DOI 10.1007/s00338-007-0349-0; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pritchard JK, 2000, GENETICS, V155, P945; RICHMOND RH, 1984, B MAR SCI, V34, P280; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Souter P, 2010, MAR BIOL, V157, P875, DOI 10.1007/s00227-009-1370-3; Starger CJ, 2008, MOL ECOL RESOUR, V8, P619, DOI 10.1111/j.1471-8286.2007.02017.x; STOBART B, 1994, MAR BIOL, V118, P183, DOI 10.1007/BF00349784; STODDART JA, 1985, MAR ECOL PROG SER, V23, P153, DOI 10.3354/meps023153; Tanner JE, 1996, CORAL REEFS, V15, P59, DOI 10.1007/s003380050028; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Veron J.J., 1976, SCLERACTINIA E AUS 1; WARD S, 1992, MAR BIOL, V112, P641, DOI 10.1007/BF00346182; Willis BL, 1985, P 5 INT COR REEF S, V4; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0	31	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58447	10.1371/journal.pone.0058447	http://dx.doi.org/10.1371/journal.pone.0058447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505507	Green Published, Green Accepted, gold			2022-12-27	WOS:000318334500084
J	Esslinger, C; Braun, U; Schirmbeck, F; Santos, A; Meyer-Lindenberg, A; Zink, M; Kirsch, P				Esslinger, Christine; Braun, Urs; Schirmbeck, Frederike; Santos, Andreia; Meyer-Lindenberg, Andreas; Zink, Mathias; Kirsch, Peter			Activation of Midbrain and Ventral Striatal Regions Implicates Salience Processing during a Modified Beads Task	PLOS ONE			English	Article							REWARD PREDICTION; DECISION-MAKING; LINKING BIOLOGY; SCHIZOPHRENIA; DELUSIONS; PSYCHOSIS; METACOGNITION; CONCLUSIONS; FMRI; PHENOMENOLOGY	Introduction: Metacognition, i.e. critically reflecting on and monitoring one's own reasoning, has been linked behaviorally to the emergence of delusions and is a focus of cognitive therapy in patients with schizophrenia. However, little is known about the neural processing underlying metacognitive function. To address this issue, we studied brain activity during a modified beads task which has been used to measure a "Jumping to Conclusions'' (JTC) bias in schizophrenia patients. Methods: We used functional magnetic resonance imaging to identify neural systems active in twenty-five healthy subjects when solving a modified version of the "beads task'', which requires a probabilistic decision after a variable amount of data has been requested by the participants. We assessed brain activation over the duration of a trial and at the time point of decision making. Results: Analysis of activation during the whole process of probabilistic reasoning showed an extended network including the prefronto-parietal executive functioning network as well as medial parieto-occipital regions. During the decision process alone, activity in midbrain and ventral striatum was detected, as well as in thalamus, medial occipital cortex and anterior insula. Conclusions: Our data show that probabilistic reasoning shares neural substrates with executive functions. In addition, our finding that brain regions commonly associated with salience processing are active during probabilistic reasoning identifies a candidate mechanism that could underlie the behavioral link between dopamine-dependent aberrant salience and JTC in schizophrenia. Further studies with delusional schizophrenia patients will have to be performed to substantiate this link.	[Esslinger, Christine; Braun, Urs; Schirmbeck, Frederike; Santos, Andreia; Meyer-Lindenberg, Andreas; Zink, Mathias; Kirsch, Peter] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Germany; [Kirsch, Peter] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Clin Psychol, Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Esslinger, C (corresponding author), Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany.	christine.esslinger@web.de	Schirmbeck, Frederike/G-8187-2016; Braun, Urs/AAS-8631-2021; Kirsch, Peter/C-2499-2008; Meyer-Lindenberg, Andreas/H-1076-2011	Kirsch, Peter/0000-0002-0817-1248; Meyer-Lindenberg, Andreas/0000-0001-5619-1123; Schirmbeck, Frederike/0000-0003-1700-0958	Deutsche Forschungsgesellschaft (DFG); Fyssen foundation (France); Deutsche Forschungsgesellschaft (DFG) [1253/3-1]	Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); Fyssen foundation (France); Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG))	C.E. was funded by the Deutsche Forschungsgesellschaft (DFG, http://www.dfg.de, Sonderforschungsbereich (SFB) 636, subproject B7). A.S. was supported by the Fyssen foundation (France www.fondationfyssen.fr). M.Z., A.M.-L., and P.K. were funded by the Deutsche Forschungsgesellschaft (DFG, http://www.dfg.de, project 1253/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Averbeck BB, 2011, SCHIZOPHR RES, V127, P115, DOI 10.1016/j.schres.2010.08.009; Baker CA, 1998, PSYCHOL MED, V28, P1199, DOI 10.1017/S0033291798007314; Bell V, 2006, TRENDS COGN SCI, V10, P219, DOI 10.1016/j.tics.2006.03.004; Blackwood N, 2004, COGNITIVE BRAIN RES, V20, P46, DOI 10.1016/j.cogbrainres.2003.12.009; Buck KD, 2012, PSYCHOPATHOLOGY, V45, P271, DOI 10.1159/000330892; Dudley REJ, 1997, BRIT J CLIN PSYCHOL, V36, P243, DOI 10.1111/j.2044-8260.1997.tb01410.x; Duvernoy H, 1995, HUMAN BRAINSTEM CERE; Fine Cordelia, 2007, Cogn Neuropsychiatry, V12, P46, DOI 10.1080/13546800600750597; Flavell J H, 1970, Adv Child Dev Behav, V5, P181, DOI 10.1016/S0065-2407(08)60467-X; Furl N, 2011, J NEUROSCI, V31, P17572, DOI 10.1523/JNEUROSCI.4236-11.2011; Garety PA, 2005, J ABNORM PSYCHOL, V114, P373, DOI 10.1037/0021-843X.114.3.373; Guitart-Masip M, 2010, J NEUROSCI, V30, P1721, DOI 10.1523/JNEUROSCI.5331-09.2010; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; HEMSLEY DR, 1986, BRIT J PSYCHIAT, V149, P51, DOI 10.1192/bjp.149.1.51; HUQ SF, 1988, Q J EXP PSYCHOL-A, V40, P801, DOI 10.1080/14640748808402300; Jensen J, 2009, PSYCHOL MED, V39, P197, DOI 10.1017/S0033291708003899; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Kapur S, 2005, SCHIZOPHR RES, V79, P59, DOI 10.1016/j.schres.2005.01.003; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Lincoln TM, 2010, SCHIZOPHRENIA BULL, V36, P1140, DOI 10.1093/schbul/sbp029; Lysaker PH, 2008, J NERV MENT DIS, V196, P384, DOI 10.1097/NMD.0b013e3181710916; Lysaker PH, 2009, SCHIZOPHRENIA RES; Menon Mahesh, 2006, Cogn Neuropsychiatry, V11, P521, DOI 10.1080/13546800544000046; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Moritz S, 2005, BRIT J CLIN PSYCHOL, V44, P193, DOI 10.1348/014466505X35678; Moritz Steffen, 2006, Curr Psychiatry Rep, V8, P184, DOI 10.1007/s11920-006-0022-2; Moritz S, 2007, COGNITIVE THER RES, V31, P371, DOI 10.1007/s10608-006-9070-5; Moritz S, 2007, CURR OPIN PSYCHIATR, V20, P619, DOI 10.1097/YCO.0b013e3282f0b8ed; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Pohlack ST, 2012, BIOL PSYCHOL, V91, P74, DOI 10.1016/j.biopsycho.2012.04.004; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Speechley WJ, 2010, J PSYCHIATR NEUROSCI, V35, P7, DOI 10.1503/jpn.090025; Stratta P, 2009, SCHIZOPHR RES, V108, P301, DOI 10.1016/j.schres.2008.10.005; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Woodward TS, 2009, PSYCHIAT RES, V170, P119, DOI 10.1016/j.psychres.2008.10.018; Woodward TS, 2009, PSYCHIAT RES, V170, P124, DOI 10.1016/j.psychres.2008.10.020; Ziegler M, 2008, PSYCHOL PSYCHOTHER-T, V81, P237, DOI 10.1348/147608308X297104; Zink CF, 2006, NEUROIMAGE, V29, P977, DOI 10.1016/j.neuroimage.2005.08.006; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7; Zink CF, 2003, J NEUROSCI, V23, P8092	47	26	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58536	10.1371/journal.pone.0058536	http://dx.doi.org/10.1371/journal.pone.0058536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484034	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100122
J	Goto, M; Morita, A; Goto, A; Deura, K; Sasaki, S; Aiba, N; Shimbo, T; Terauchi, Y; Miyachi, M; Noda, M; Watanabe, S				Goto, Maki; Morita, Akemi; Goto, Atsushi; Deura, Kijo; Sasaki, Satoshi; Aiba, Naomi; Shimbo, Takuro; Terauchi, Yasuo; Miyachi, Motohiko; Noda, Mitsuhiko; Watanabe, Shaw		SCOP Study Grp	Reduction in Adiposity, beta-Cell Function, Insulin Sensitivity, and Cardiovascular Risk Factors: A Prospective Study among Japanese with Obesity	PLOS ONE			English	Article							MILD GLUCOSE-INTOLERANCE; CORONARY-HEART-DISEASE; DIABETES-MELLITUS; VISCERAL FAT; WEIGHT-LOSS; MEN; TOLERANCE; RESISTANCE; SECRETION; DIAGNOSIS	Background: A reduction in adiposity may be associated with an improvement in insulin sensitivity and beta-cell function as well as cardiovascular disease (CVD) risk factors; however, few studies have investigated these associations in a longitudinal setting. Methods: To investigate these associations over a 1-year period, we conducted an observational analysis of 196 Japanese subjects with obesity in the Saku Control Obesity Program. We investigated the relations between changes in adiposity (body mass index [BMI], waist circumference, subcutaneous fat area [SFAT], and visceral fat area [VFAT]) and changes in HbA1c, fasting plasma glucose (FPG), insulin sensitivity index (ISI), the homeostasis model assessment beta cell function (HOMA-beta), lipids, and blood pressure. Results: All adiposity changes were positively associated with HbA1c and FPG changes. Reductions in BMI and VFAT were associated with HOMA-beta reduction. Reductions in all adiposity measures were associated with an improvement in the ISI. Changes in most adiposity measures were positively associated with changes in blood pressure and lipid levels, except for LDL. Conclusion: The present findings provide additional supportive evidence indicating that a reduction in adiposity may lead to an improvement in insulin sensitivity and the reduction of CVD risk factors in obese individuals.	[Goto, Maki; Goto, Atsushi; Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan; [Goto, Maki; Goto, Atsushi; Terauchi, Yasuo] Yokohama City Univ, Grad Sch Med, Dept Endocrinol & Metab, Yokohama, Kanagawa 232, Japan; [Goto, Maki; Morita, Akemi; Goto, Atsushi; Miyachi, Motohiko; Watanabe, Shaw] Natl Inst Hlth & Nutr, Tokyo 162, Japan; [Morita, Akemi] Koshien Univ, Coll Nutr, Dept Nutr, Hyogo, Japan; [Deura, Kijo] Saku Cent Hosp, Nagano, Japan; [Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo, Japan; [Aiba, Naomi] Kanagawa Inst Technol, Dept Nutr & Life Sci, Kanagawa, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Dept Clin Res & Informat, Tokyo, Japan; [Noda, Mitsuhiko] Natl Ctr Global Hlth & Med, Ctr Hosp, Dept Diabet & Metab Med, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Yokohama City University; National Institute of Health & Nutrition - Japan; University of Tokyo; Kanagawa Institute Technology; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Noda, M (corresponding author), Natl Ctr Global Hlth & Med, Diabet Res Ctr, Dept Diabet Res, Tokyo, Japan.	mnoda@hosp.ncgm.go.jp	Noda, Mitsuhiko/W-3905-2019; Miyachi, Motohiko/AAW-3403-2020; Terauchi, Yasuo/AAO-4347-2020	Noda, Mitsuhiko/0000-0003-0413-4631; Miyachi, Motohiko/0000-0002-1146-0905; Goto, Atsushi/0000-0003-0669-654X				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albu JB, 1997, DIABETES, V46, P456, DOI 10.2337/diabetes.46.3.456; Carr DB, 2005, DIABETES, V54, P340, DOI 10.2337/diabetes.54.2.340; DeFronzo RA, 2010, DIABETES CARE, V33, P951, DOI [10.2337/dc09-1521, 10.2337/dc10-0646]; DONAHUE RP, 1987, LANCET, V1, P821; FUJIMOTO WY, 1990, AM J MED, V89, P761, DOI 10.1016/0002-9343(90)90219-4; Goncalves FB, 2011, LANCET, V378, P227, DOI 10.1016/S0140-6736(11)61121-5; Hayashi T, 2008, DIABETES, V57, P1269, DOI 10.2337/db07-1378; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Kosaka K, 1996, DIABETIC MED, V13, pS109; KOSAKA K, 1977, DIABETES, V26, P944, DOI 10.2337/diab.26.10.944; Matsumoto K, 1997, DIABETES CARE, V20, P1562, DOI 10.2337/diacare.20.10.1562; Matsushita Y, 2012, DIABETES CARE, V35, P1139, DOI 10.2337/dc11-1320; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morita A, 2008, ANTIAGING MED, V5, P13, DOI 10.3793/jaam.5.13; Nakade M, 2012, ASIA PAC J CLIN NUTR, V21, P22; Poobalan A, 2004, Obes Rev, V5, P43, DOI 10.1111/j.1467-789X.2004.00127.x; POULIOT MC, 1992, DIABETES, V41, P826, DOI 10.2337/diabetes.41.7.826; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Tanaka T, 2011, ENDOCRINE J; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wareham N J, 1995, Diabet Med, V12, P931; Watanabe S, 2007, ANTIAGING MED, V4, P70; White WB, 2001, BLOOD PRESS MONIT, V6, P107, DOI 10.1097/00126097-200104000-00007; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; YONEDA H, 1992, DIABETES CARE, V15, P1517, DOI 10.2337/diacare.15.11.1517	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57964	10.1371/journal.pone.0057964	http://dx.doi.org/10.1371/journal.pone.0057964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483954	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100060
J	Hermes, R; Saragusty, J; Goritz, F; Bartels, P; Potier, R; Baker, B; Streich, WJ; Hildebrandt, TB				Hermes, Robert; Saragusty, Joseph; Goeritz, Frank; Bartels, Paul; Potier, Romain; Baker, Barbara; Streich, W. Juergen; Hildebrandt, Thomas B.			Freezing African Elephant Semen as a New Population Management Tool	PLOS ONE			English	Article							SUCCESSFUL ARTIFICIAL-INSEMINATION; FROZEN-THAWED SEMEN; ASIAN ELEPHANT; MAXIMUS SPERMATOZOA; LOXODONTA-AFRICANA; GENETIC DIVERSITY; VIABILITY; BEHAVIOR; MUSTH; CRYOPRESERVATION	Background: The captive elephant population is not self-sustaining and with a limited number of breeding bulls, its genetic diversity is in decline. One way to overcome this is to import young and healthy animals from the wild. We introduce here a more sustainable alternative method - importation of semen from wild bulls without removing them from their natural habitat. Due to the logistics involved, the only practical option would be to transport cryopreserved sperm. Despite some early reports on African elephant semen cryopreservation, the utility of this new population management tool has not been evaluated. Methodology/Principal Findings: Semen was collected by electroejaculation from 14 wild African savanna elephant (Loxodonta africana) bulls and cryopreserved using the directional freezing technique. Sperm treatments evaluated included the need for centrifugation, the use of hen or quail yolk, the concentration of glycerol (3%, 5% or 7%) in the extender, and maintenance of motility over time after thawing. Our results suggest that dilution in an extender containing hen yolk and 7% glycerol after centrifugation best preserved post-thaw sperm motility when compared to all other treatments (P <= 0.012 for all). Using this approach we were able to achieve after thawing (mean +/- SD) 54.6 +/- 3.9% motility, 85.3 +/- 2.4% acrosome integrity, and 86.8 +/- 4.6% normal morphology with no decrease in motility over 1 h incubation at 37 degrees C. Sperm cryopreserved during this study has already lead to a pregnancy of a captive female elephant following artificial insemination. Conclusions/Significance: With working techniques for artificial insemination and sperm cryopreservation of both African and Asian elephants in hand, population managers can now enrich captive or isolated wild elephant populations without removing valuable individuals from their natural habitat.	[Hermes, Robert; Saragusty, Joseph; Goeritz, Frank; Streich, W. Juergen; Hildebrandt, Thomas B.] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany; [Bartels, Paul] Natl Res Fdn, NZG Biobank, Natl Zool Gardens South Africa, Pretoria, South Africa; [Potier, Romain] ZooParc Beauval, St Aignan Sur Cher, France; [Baker, Barbara] Pittsburgh Zoo & PPG Aquarium, Pittsburgh, PA USA	Leibniz Institut fur Zoo und Wildtierforschung; National Research Foundation - South Africa; National Zoological Gardens of South Africa	Hermes, R (corresponding author), Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany.	hermes@izw-berlin.de	Saragusty, Joseph/M-5030-2016; Moreira, Nei/AAK-1357-2020	Saragusty, Joseph/0000-0002-9274-7800; Moreira, Nei/0000-0002-9236-667X	Association Beauval Conservation et Recherche (ABCR); Pittsburgh Zoo; PPG Aquarium; One Wild Place, Pittsburgh, PA, USA; Riverview Homes, Inc.	Association Beauval Conservation et Recherche (ABCR); Pittsburgh Zoo; PPG Aquarium; One Wild Place, Pittsburgh, PA, USA; Riverview Homes, Inc.	This study was funded by three entities: (1) The Association Beauval Conservation et Recherche (ABCR) which is the non-profit conservation organization adjunct to ZooParc de Beauval, 41110 Saint Aignan s/Cher, France; (2) The Pittsburgh Zoo and PPG Aquarium (also a non-profit organization), One Wild Place, Pittsburgh, PA 15206-1178, USA; and (3) Robert and Kim Fanelli of Riverview Homes, Inc., 2623 River Road, Vandergrift, PA 15690-0475, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors' therefore believe that these facts do not alter their adherence to all the PLOS ONE policies on sharing data and materials.; This study was partly supported by Riverview Homes, Inc. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. One of the authors of this report (RP) is employed by ZooParc de Beauval and not by its financing arm (ABCR), and another (BB) is the president and CEO of the Pittsburgh Zoo.	Bal P, 2011, ENVIRON MANAGE, V47, P789, DOI 10.1007/s00267-011-9636-1; BALLOU JD, 1992, CRYOBIOLOGY, V29, P19, DOI 10.1016/0011-2240(92)90003-K; Belterman R, 2011, EUROPEAN REGIONAL EA; BLOTTNER S, 1995, THERIOGENOLOGY, V44, P321, DOI 10.1016/0093-691X(95)00187-D; BLOTTNER S, 1998, ADV ETHOL S, V33, P9; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Brown JL, 1999, BIOL REPROD, V61, P1294, DOI 10.1095/biolreprod61.5.1294; Brown JL, 2004, ZOO BIOL, V23, P45, DOI 10.1002/zoo.10116; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; Darwin C., 1871, P423; EISENBERG JF, 1971, BEHAVIOUR, V38, P193, DOI 10.1163/156853971X00087; Evans KE, 2008, ANIM BEHAV, V76, P779, DOI 10.1016/j.anbehav.2008.03.019; Faust LJ, 2006, ZOO BIOL, V25, P201, DOI 10.1002/zoo.20054; Goeritz F, 2003, THERIOGENOLOGY, V59, P1487, DOI 10.1016/S0093-691X(02)01201-3; HANKS J, 1973, J ZOOL, V169, P29; Hermes R, 2009, THERIOGENOLOGY, V71, P393, DOI 10.1016/j.theriogenology.2008.10.008; Hildebrandt T. B., 2006, International Zoo Yearbook, V40, P20, DOI 10.1111/j.1748-1090.2006.00020.x; Hildebrandt TB, 2012, THERIOGENOLOGY, V78, P1398, DOI 10.1016/j.theriogenology.2012.06.014; Hildebrandt TB, 2009, THERIOGENOLOGY, V72, P1065, DOI 10.1016/j.theriogenology.2009.06.026; Hildebrandt TB, 1999, SUCCESSFUL ARTIFICIA, P41; Hildebrandt TB, 1998, ARTIFICIAL INSEMINAT, P546; Hodges JK, 1998, ANIM REPROD SCI, V53, P3, DOI 10.1016/S0378-4320(98)00123-7; Hollister-Smith JA, 2007, ANIM BEHAV, V74, P287, DOI 10.1016/j.anbehav.2006.12.008; HOWARD JG, 1986, J REPROD FERTIL, V78, P295, DOI 10.1530/jrf.0.0780295; Howard JG, 2002, GENOME RESOURCE BANK, V70; JONES RC, 1973, NATURE, V243, P38, DOI 10.1038/243038a0; Kapustin N, 1996, BIOL REPROD, V55, P1147, DOI 10.1095/biolreprod55.5.1147; KEELE M., 2010, ASIAN ELEPHANT ELEPH; Kiso WK, 2012, REPROD FERT DEVELOP, V24, P1134, DOI 10.1071/RD11266; Kutvolgyi G, 2006, BIOTECH HISTOCHEM, V81, P109, DOI 10.1080/10520290600931007; Laws R. M., 1969, Journal of Reproduction and Fertility Suppl, VNo. 6, P193; Lei R, 2008, J ZOOL, V275, P252, DOI 10.1111/j.1469-7998.2008.00437.x; Leimgruber P, 2008, ANIM CONSERV, V11, P198, DOI 10.1111/j.1469-1795.2008.00172.x; Mpanduji Donald G., 2003, Pachyderm, V35, P140; Olson D., 2011, N AM REGION STUDBOOK; Oswin perera B.M.A., 2009, Gajah, V30, P41; POOLE JH, 1981, NATURE, V292, P830, DOI 10.1038/292830a0; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; POOLE JH, 1987, BEHAVIOUR, V102, P283, DOI 10.1163/156853986X00171; SANTIAPILLAI C, 1984, BIOL CONSERV, V29, P47, DOI 10.1016/0006-3207(84)90013-2; Saragusty J, 2010, THERIOGENOLOGY, V74, P1256, DOI 10.1016/j.theriogenology.2010.05.031; Saragusty J, 2006, THERIOGENOLOGY, V66, P775, DOI 10.1016/j.theriogenology.2006.01.055; Saragusty J, 2009, ANIM REPROD SCI, V115, P255, DOI 10.1016/j.anireprosci.2008.11.010; Schmitt DL, 1998, ANIM REPROD SCI, V53, P309, DOI 10.1016/S0378-4320(98)00120-1; Schulte BA, 2000, ZOO BIOL, V19, P447, DOI 10.1002/1098-2361(2000)19:5&lt;447::AID-ZOO12&gt;3.0.CO;2-#; Schwammer HM, 2011, AFRICAN ELEPHANT EEP; Stoops MA, 2011, THERIOGENOLOGY, V76, P1258, DOI 10.1016/j.theriogenology.2011.05.032; Stoops MA, 2011, J ZOO WILDLIFE MED, V42, P723, DOI 10.1638/2010-0186.1; Thongtip N, 2004, THERIOGENOLOGY, V62, P748, DOI 10.1016/j.theriogenology.2003.11.021; Thongtip N, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-9; Wiese RJ, 2000, ZOO BIOL, V19, P299, DOI 10.1002/1098-2361(2000)19:5<299::AID-ZOO2>3.0.CO;2-Z	51	28	31	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57616	10.1371/journal.pone.0057616	http://dx.doi.org/10.1371/journal.pone.0057616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483917	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100033
J	Narendra, A; Reid, SF; Raderschall, CA				Narendra, Ajay; Reid, Samuel F.; Raderschall, Chloe A.			Navigational Efficiency of Nocturnal Myrmecia Ants Suffers at Low Light Levels	PLOS ONE			English	Article							AUSTRALIAN DESERT ANT; ACTIVITY SCHEDULES; VISUAL NAVIGATION; VISION; NIGHT; ADAPTATIONS; FLIGHT; ORIENTATION; INFORMATION; BEHAVIOR	Insects face the challenge of navigating to specific goals in both bright sun-lit and dim-lit environments. Both diurnal and nocturnal insects use quite similar navigation strategies. This is despite the signal-to-noise ratio of the navigational cues being poor at low light conditions. To better understand the evolution of nocturnal life, we investigated the navigational efficiency of a nocturnal ant, Myrmecia pyriformis, at different light levels. Workers of M. pyriformis leave the nest individually in a narrow light-window in the evening twilight to forage on nest-specific Eucalyptus trees. The majority of foragers return to the nest in the morning twilight, while few attempt to return to the nest throughout the night. We found that as light levels dropped, ants paused for longer, walked more slowly, the success in finding the nest reduced and their paths became less straight. We found that in both bright and dark conditions ants relied predominantly on visual landmark information for navigation and that landmark guidance became less reliable at low light conditions. It is perhaps due to the poor navigational efficiency at low light levels that the majority of foragers restrict navigational tasks to the twilight periods, where sufficient navigational information is still available.	[Narendra, Ajay; Reid, Samuel F.; Raderschall, Chloe A.] Australian Natl Univ, ARC Ctr Excellence Vis Sci, Res Sch Biol, Canberra, ACT, Australia; [Reid, Samuel F.] Ctr Genom Regulat, EMBL CRG Syst Biol Unit, Barcelona, Spain	Australian National University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Narendra, A (corresponding author), Australian Natl Univ, ARC Ctr Excellence Vis Sci, Res Sch Biol, Canberra, ACT, Australia.	ajay.narendra@anu.edu.au	Raderschall, Chloe/AFH-9100-2022; Narendra, Ajay/A-4960-2008	Raderschall, Chloe/0000-0003-2005-1705; Narendra, Ajay/0000-0002-1286-5373	Australian Research Council's (ARC) Centres of Excellence Scheme; ARC Discovery Project; Australian Postdoctoral Fellowship [DP0986606]; ARC Discovery Early Career Award [DE120100019]; Hermon Slade Foundation; Defence Science and Technology Organization	Australian Research Council's (ARC) Centres of Excellence Scheme(Australian Research Council); ARC Discovery Project(Australian Research Council); Australian Postdoctoral Fellowship; ARC Discovery Early Career Award(Australian Research Council); Hermon Slade Foundation; Defence Science and Technology Organization	AN acknowledges funding support from the Australian Research Council's (ARC) Centres of Excellence Scheme, ARC Discovery Project and Australian Postdoctoral Fellowship (DP0986606), ARC Discovery Early Career Award (DE120100019), Hermon Slade Foundation and The Defence Science and Technology Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson S, 2002, J EXP BIOL, V205, P1971; [Anonymous], 2008, R LANG ENV STAT COMP, P1; Baird E, 2011, BIOL LETTERS, V7, P499, DOI 10.1098/rsbl.2010.1205; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Cheung A, 2007, BIOL CYBERN, V97, P47, DOI 10.1007/s00422-007-0158-0; Dacke M, 2011, PHILOS T R SOC B, V366, P697, DOI 10.1098/rstb.2010.0191; Dacke M, 2003, NATURE, V424, P33, DOI 10.1038/424033a; Frederiksen R, 2008, CURR BIOL, V18, P349, DOI 10.1016/j.cub.2008.01.057; Graham P, 2009, CURR BIOL, V19, pR935, DOI 10.1016/j.cub.2009.08.015; Greiner B, 2005, CELL TISSUE RES, V322, P313, DOI 10.1007/s00441-005-0034-y; Greiner B, 2004, CELL TISSUE RES, V318, P429, DOI 10.1007/s00441-004-0945-z; Greiner B, 2004, CELL TISSUE RES, V316, P377, DOI 10.1007/s00441-004-0883-9; Greiner B, 2007, CURR BIOL, V17, pR879, DOI 10.1016/j.cub.2007.08.015; Greiner B, 2006, INT REV CYTOL, V250, P1, DOI 10.1016/S0074-7696(06)50001-4; Heatwole H, 1996, ENERGETICS DESERT IN; Jayatilaka P, 2011, J EXP BIOL, V214, P2730, DOI 10.1242/jeb.053710; Johnsen S, 2006, J EXP BIOL, V209, P789, DOI 10.1242/jeb.02053; Jonson ACJ, 1998, J COMP PHYSIOL A, V182, P1, DOI 10.1007/s003590050152; Kelber A, 2006, J EXP BIOL, V209, P781, DOI 10.1242/jeb.02060; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; Land MF, 2002, ANIMAL EYES; McIntyre P, 1998, J COMP PHYSIOL A, V183, P45, DOI 10.1007/s003590050233; Merlin C, 2012, CURR OPIN NEUROBIOL, V22, P353, DOI 10.1016/j.conb.2011.11.009; Moser JC, 2004, J ZOOL, V264, P69, DOI 10.1017/S0952836904005527; Narendra A, 2007, BEHAV ECOL SOCIOBIOL, V61, P1543, DOI 10.1007/s00265-007-0386-2; Narendra A, 2011, P ROY SOC B-BIOL SCI, V278, P1141, DOI 10.1098/rspb.2010.1378; Narendra A, 2010, P ROY SOC B-BIOL SCI, V277, P1531, DOI 10.1098/rspb.2009.2324; Norgaard T, 2008, J EXP BIOL, V211, P816, DOI 10.1242/jeb.010546; Reid SF, 2011, J EXP BIOL, V214, P363, DOI 10.1242/jeb.049338; Reid SF, 2010, THESIS AUSTR NATL U; ROSSEL S, 1986, NATURE, V323, P128, DOI 10.1038/323128a0; Schwarz S, 2011, ARTHROPOD STRUCT DEV, V40, P128, DOI 10.1016/j.asd.2010.10.003; Somanathan H, 2008, CURR BIOL, V18, pR996, DOI 10.1016/j.cub.2008.08.023; Somanathan H, 2009, J COMP PHYSIOL A, V195, P571, DOI 10.1007/s00359-009-0432-9; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Theobald JC, 2007, J EXP BIOL, V210, P4034, DOI 10.1242/jeb.003756; Wajnberg E, 2010, J R SOC INTERFACE, V7, pS207, DOI 10.1098/rsif.2009.0526.focus; Warrant EJ, 2004, CURR BIOL, V14, P1309, DOI 10.1016/j.cub.2004.07.057; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Warrant E, 2011, ANNU REV ENTOMOL, V56, P239, DOI 10.1146/annurev-ento-120709-144852; Warrant EJ, 2008, J EXP BIOL, V211, P1737, DOI 10.1242/jeb.015396; WEHNER R, 1989, TRENDS NEUROSCI, V12, P353, DOI 10.1016/0166-2236(89)90043-X; Wittlinger M, 2006, SCIENCE, V312, P1965, DOI 10.1126/science.1126912	43	33	34	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58801	10.1371/journal.pone.0058801	http://dx.doi.org/10.1371/journal.pone.0058801			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484052	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100138
J	Yau, WL; Lam, CSC; Ng, L; Chow, AKM; Chan, STC; Chan, JYK; Wo, JYH; Ng, KTP; Man, K; Poon, RTP; Pang, RWC				Yau, Wing Lung; Lam, Colin Siu Chi; Ng, Lui; Chow, Ariel Ka Man; Chan, Sylvia Tsz Ching; Chan, Jacky Yu Ki; Wo, Jana Yim Hung; Ng, Kevin Tak Pan; Man, Kwan; Poon, Ronnie Tung Ping; Pang, Roberta Wen Chi			Over-Expression of miR-106b Promotes Cell Migration and Metastasis in Hepatocellular Carcinoma by Activating Epithelial-Mesenchymal Transition Process	PLOS ONE			English	Article							MICRORNA EXPRESSION; RHO GTPASES; CANCER; HEPATITIS; INVASION; MIR-21; IDENTIFICATION; CLUSTER; FAMILY; MODEL	Hepatocellular carcinoma (HCC) is one the the most fatal cancers worldwide. The poor prognosis of HCC is mainly due to the developement of distance metastasis. To investigate the mechanism of metastasis in HCC, an orthotopic HCC metastasis animal model was established. Two sets of primary liver tumor cell lines and corresponding lung metastasis cell lines were generated. In vitro functional analysis demonstrated that the metastatic cell line had higher invasion and migration ability when compared with the primary liver tumor cell line. These cell lines were subjected to microRNA (miRNAs) microarray analysis to identify differentially expressed miRNAs which were associated with the developement of metastasis in vivo. Fifteen human miRNAs, including miR-106b, were differentially expressed in 2 metastatic cell lines compared with the primary tumor cell lines. The clinical significance of miR-106b in 99 HCC clinical samples was studied. The results demonstrated that miR-106b was over-expressed in HCC tumor tissue compared with adjacent non-tumor tissue (p = 0.0005), and overexpression of miR-106b was signficantly correlated with higher tumor grade (p = 0.018). Further functional studies demonstrated that miR-106b could promote cell migration and stress fiber formation by over-expressing RhoGTPases, RhoA and RhoC. In vivo functional studies also showed that over-expression of miR-106b promoted HCC metastasis. These effects were related to the activation of the epithelial-mesenchymal transition (EMT) process. Our results suggested that miR-106b expression contributed to HCC metastasis by activating the EMT process promoting cell migration in vitro and metastasis in vivo.	[Yau, Wing Lung; Lam, Colin Siu Chi; Ng, Lui; Chow, Ariel Ka Man; Chan, Sylvia Tsz Ching; Chan, Jacky Yu Ki; Wo, Jana Yim Hung; Ng, Kevin Tak Pan; Man, Kwan; Poon, Ronnie Tung Ping; Pang, Roberta Wen Chi] Univ Hong Kong, Dept Surg, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Yau, Wing Lung; Lam, Colin Siu Chi; Ng, Lui; Chow, Ariel Ka Man; Chan, Sylvia Tsz Ching; Chan, Jacky Yu Ki; Ng, Kevin Tak Pan; Man, Kwan; Poon, Ronnie Tung Ping; Pang, Roberta Wen Chi] Univ Hong Kong, Ctr Canc Res, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Yau, WL (corresponding author), Univ Hong Kong, Dept Surg, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	robertap@hku.hk	Chow, Ariel/HGF-2363-2022; NG, Kevin Tak-Pan/J-1510-2018; Ng, Lui/AAG-4397-2019	NG, Kevin Tak-Pan/0000-0001-9822-1335; Ng, Lui/0000-0002-9010-2654; Chow, Ariel/0000-0002-5729-5415				Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Brown JJ, 2000, HEPATOLOGY, V31, P173, DOI 10.1002/hep.510310126; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Cai KM, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-73; Carraro G, 2009, DEV BIOL, V333, P238, DOI 10.1016/j.ydbio.2009.06.020; Connolly E, 2008, AM J PATHOL, V173, P856, DOI 10.2353/ajpath.2008.080096; FIDLER IJ, 1995, J NATL CANCER I, V87, P1588, DOI 10.1093/jnci/87.21.1588; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Lee TK, 2006, CLIN CANCER RES, V12, P6910, DOI 10.1158/1078-0432.CCR-06-0489; Li BQ, 2011, PROSTATE, V71, P567, DOI 10.1002/pros.21272; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Poon Ronnie Tung-Ping, 2004, Liver Transpl, V10, pS39, DOI 10.1002/lt.20040; Tomimaru Y, 2010, BRIT J CANCER, V103, P1617, DOI 10.1038/sj.bjc.6605958; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Xu JA, 2011, MOL CARCINOGEN, V50, P136, DOI 10.1002/mc.20712; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Ziske C, 2008, PANCREAS, V36, P146, DOI 10.1097/MPA.0b013e3181586cd9	27	82	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57882	10.1371/journal.pone.0057882	http://dx.doi.org/10.1371/journal.pone.0057882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483935	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100051
J	Li, B; Li, F; Chi, LY; Zhang, LW; Zhu, SG				Li, Bo; Li, Feng; Chi, Lingyi; Zhang, Liangwen; Zhu, Shugan			The Expression of SPARC in Human Intracranial Aneurysms and Its Relationship with MMP-2/-9	PLOS ONE			English	Article							SECRETED PROTEIN; RISK-FACTORS; CYSTEINE SPARC; GROWTH-FACTOR; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; CEREBRAL ANEURYSMS; CANCER; RICH; RUPTURE	Objective: SPARC is a key determinant of invasion and metastasis in some tumors, such as gliomas, melanomas and prostate tumors. SPARC can change the composition and structure of the matrix and promote angiogenesis; these effects are closely related to clinical stage and the prognosis of tumors such as meningiomas. However, little is known about the expression of SPARC in intracranial aneurysms. The goal of this study was to establish the role of SPARC in human intracranial aneurysms. Methods: Thirty-one intracranial aneurysms were immunohistochemically stained for SPARC, MMP-2 and MMP-9. As controls, normal Circle of Willis arteries were similarly immunostained. All specimens were retrieved during autopsies and were embedded in paraffin. To evaluate the expression levels of SPARC, MMP-2 and MMP-9, western blotting was also performed in three available intracranial aneurysm specimens. The limited availability of fresh intracranial aneurysm tissue was the result of the majority of patients choosing endovascular embolization. Results: The results showed that SPARC, MMP-2 and MMP-9 were strongly expressed in intracranial aneurysm tissues; however, these proteins were expressed minimally or not at all in normal Circle of Willis arteries. The western blot results showed that the expression levels of SPARC, MMP-2 and MMP-9 were significantly up-regulated in intracranial aneurysms relative to the expression levels in the normal Circle of Willis arteries. Data analysis showed that SPARC was significantly correlated with MMP-2 and MMP-9, also with age and risk factors but not with the Hunt-Hess grade or with sex. Conclusion: The results indicate that SPARC is widely expressed in human intracranial aneurysms, and its expression correlates with MMP-2 and MMP-9 expression, age and risk factors but not with the Hunt-Hess grade. The results of this study suggest that SPARC has a pathogenic role in the alteration of the extracellular matrix of intracranial arteries during aneurysm formation.	[Li, Bo; Li, Feng; Chi, Lingyi; Zhang, Liangwen; Zhu, Shugan] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan 250100, Peoples R China	Shandong University	Zhu, SG (corresponding author), Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan 250100, Peoples R China.	libo5479937@yahoo.cn			National Natural Science Foundation of Chin [81171172]	National Natural Science Foundation of Chin(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81171172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhoopathi P, 2010, BRIT J CANCER, V102, P530, DOI 10.1038/sj.bjc.6605538; Biros E, 2008, NEUROSCI LETT, V431, P31, DOI 10.1016/j.neulet.2007.11.014; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Brekken Rolf A., 2001, Matrix Biology, V19, P816; Caird J, 2006, EUR J NEUROL, V13, P1098, DOI 10.1111/j.1468-1331.2006.01469.x; Capper D, 2010, NEUROPATH APPL NEURO, V36, P183, DOI 10.1111/j.1365-2990.2010.01072.x; Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3; Chen G, 2010, BRIT J CANCER, V102, P188, DOI 10.1038/sj.bjc.6605440; Chlenski A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-138; D'Armiento FP, 2001, STROKE, V32, P2472, DOI 10.1161/hs1101.098520; DiMartino JF, 2006, LEUKEMIA, V20, P426, DOI 10.1038/sj.leu.2404102; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gilles C, 1998, CANCER RES, V58, P5529; Ginsbach CG, 2002, STROKE, V33, P2192, DOI 10.1161/01.STR.000026863.51751.DE; HIROTA S, 1993, AM J PATHOL, V143, P1003; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; Iwamoto H, 1999, STROKE, V30, P1390, DOI 10.1161/01.STR.30.7.1390; Jin DS, 2007, SURG NEUROL, V68, P11, DOI 10.1016/j.sumeu.2007.02.060; JUVELA S, 1993, STROKE, V24, P639, DOI 10.1161/01.STR.24.5.639; Juvela S, 2003, STROKE, V34, P1852, DOI 10.1161/01.STR.0000080380.56799.DD; Kassam AB, 2004, NEUROSURGERY, V54, P1450, DOI 10.1227/01.NEU.0000125005.67850.F8; Kataoka K, 1999, STROKE, V30, P1396, DOI 10.1161/01.STR.30.7.1396; Koukourakis MI, 2003, CANCER RES, V63, P5376; Krischek B, 2008, ADV TECH STAND NEURO, V33, P131, DOI 10.1007/978-3-211-72283-1_3; Kupprion C, 1998, J BIOL CHEM, V273, P29635, DOI 10.1074/jbc.273.45.29635; LANE TF, 1994, FASEB J, V8, P163, DOI 10.1096/fasebj.8.2.8119487; Le Bail B, 1999, J PATHOL, V189, P46; Ledda F, 1997, J INVEST DERMATOL, V108, P210, DOI 10.1111/1523-1747.ep12334263; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; McCurdy S, 2010, J MOL CELL CARDIOL, V48, P544, DOI 10.1016/j.yjmcc.2009.06.018; Montaner J, 2001, STROKE, V32, P1759, DOI 10.1161/01.STR.32.8.1759; Motamed K, 2003, J CELL BIOCHEM, V90, P408, DOI 10.1002/jcb.10645; Nahed BV, 2005, NEUROSURGERY, V57, P676, DOI 10.1227/01.NEU.0000175549.96530.59; Napoli C, 2005, NEUROBIOL AGING, V26, P293, DOI 10.1016/j.neurobiolaging.2004.02.031; Nishie A, 2001, CLIN CANCER RES, V7, P2145; Peters DG, 2001, STROKE, V32, P1036, DOI 10.1161/01.STR.32.4.1036; Pichler RH, 1996, KIDNEY INT, V50, P1978, DOI 10.1038/ki.1996.520; Podhajcer OL, 2008, CANCER METAST REV, V27, P691, DOI 10.1007/s10555-008-9146-7; Porte H, 1998, CLIN CANCER RES, V4, P1375; PORTER PL, 1995, J HISTOCHEM CYTOCHEM, V43, P791, DOI 10.1177/43.8.7622842; Puolakkainen PA, 2004, MOL CANCER RES, V2, P215; Rahme RJ, 2010, NEUROSURGERY, V67, pN15, DOI 10.1227/01.NEU.0000386963.24172.F7; RAINES EW, 1992, P NATL ACAD SCI USA, V89, P1281, DOI 10.1073/pnas.89.4.1281; Rempel SA, 1998, J NEUROPATH EXP NEUR, V57, P1112, DOI 10.1097/00005072-199812000-00002; Ribourtout E, 2004, STROKE, V35, P786, DOI 10.1161/01.STR.0000117577.94345.CC; Rivera LB, 2011, CELL MOL LIFE SCI, V68, P3165, DOI 10.1007/s00018-011-0781-8; Seet LF, 2012, J CELL MOL MED, V16, P1245, DOI 10.1111/j.1582-4934.2011.01400.x; Seet LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009415; TAYLOR CL, 1995, J NEUROSURG, V83, P812, DOI 10.3171/jns.1995.83.5.0812; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Thomas R, 2000, CLIN CANCER RES, V6, P1140; Wang WJ, 2006, NEPHROL DIAL TRANSPL, V21, P1278, DOI 10.1093/ndt/gfk036; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Xu HW, 2011, STROKE, V42, P204, DOI 10.1161/STROKEAHA.110.578740; Yamanaka M, 2001, J UROLOGY, V166, P2495, DOI 10.1016/S0022-5347(05)65623-6; Yang EN, 2007, INT J CANCER, V121, P567, DOI 10.1002/ijc.22706; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571	58	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58490	10.1371/journal.pone.0058490	http://dx.doi.org/10.1371/journal.pone.0058490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516489	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400034
J	Li, QL; Kang, T; Tian, XH; Ma, YM; Li, M; Richards, J; Bythwood, T; Wang, YL; Li, X; Liu, D; Ma, L; Song, Q				Li, Qiling; Kang, Ting; Tian, Xiaohua; Ma, Yamin; Li, Min; Richards, Jendai; Bythwood, Tameka; Wang, Yueling; Li, Xu; Liu, Dong; Ma, Li; Song, Qing			Multimeric Stability of Human C-reactive Protein in Archived Specimens	PLOS ONE			English	Article							GIANT-CELL ARTERITIS; COMPLEMENT FACTOR-H; PENTAMERIC SYMMETRY; HUMAN-NEUTROPHILS; POLYMYALGIA-RHEUMATICA; CARDIOVASCULAR-DISEASE; MACULAR DEGENERATION; DIABETES-MELLITUS; DNA-SEQUENCE; INFLAMMATION	Background: C-reactive protein (CRP) is a marker of inflammation and a risk predictor of cardiovascular disease. Current CRP assays are focused on the quantification of the CRP levels as pentamers. However, CRP can be present as other multimeric forms. There will be a market need to measure the CRP multimeric structure in addition to the levels in human populations. To meet this need, we investigated whether the long-term archived samples could be used instead of freshly collected samples. Methodology/Principal Findings: The specimens of serum, plasma and tissues were collected from transgenic rats expressing the human CRP. These samples were stored at 4 degrees C, -20 degrees C and -80 degrees C for different periods. Non-denaturing Western blot analysis was used to observe the influence of storage conditions to multimeric structures of human CRP. Our results showed that there was no difference on multimeric structures of human CRP between samples stored at 4 degrees C, -20 degrees C and -80 degrees C, between samples stored at -80 degrees C for twenty-four hours and three months, and between plasma and serum. Conclusions/Significance: This study implicated that archived samples stored at these conditions in those large longitudinal studies could be used for investigating the multimeric structures of CRP. Our report may speed up these researches and save labors and budget by enabling them to use currently available archived samples rather than freshly collected samples.	[Li, Qiling; Wang, Yueling; Li, Xu] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian 710049, Shaanxi, Peoples R China; [Li, Qiling; Kang, Ting; Tian, Xiaohua; Ma, Yamin; Richards, Jendai; Bythwood, Tameka; Liu, Dong; Ma, Li; Song, Qing] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Li, Min] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China	Xi'an Jiaotong University; Morehouse School of Medicine; Central South University	Song, Q (corresponding author), Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA.	qsong@msm.edu	Ma, Li/AIF-3892-2022; LI, MIN/U-3131-2018	LI, MIN/0000-0002-0188-1394; Li, Qiling/0000-0003-3763-4456	United States National Institutes of Health [R21HG006173, RC4MD005964, HL003676, HL095098, RR014758, RR003034, GM74913]; American Heart Association grant [09GRNT2300003]; Baltimore Research Enhancement Award Program in Stroke; Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR014758, G12RR003034] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [RC4MD005964] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL003676, SC2HL095098] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074913] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant(American Heart Association); Baltimore Research Enhancement Award Program in Stroke; Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by United States National Institutes of Health grants (R21HG006173, RC4MD005964, HL003676, HL095098, RR014758, RR003034, GM74913), an American Heart Association grant (09GRNT2300003), and in part by the Baltimore Research Enhancement Award Program in Stroke and the Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy TJ, 1941, J EXP MED, V73, P173, DOI 10.1084/jem.73.2.173; Bhutto IA, 2011, BRIT J OPHTHALMOL, V95, P1323, DOI 10.1136/bjo.2010.199216; Dehghan A, 2007, DIABETES, V56, P872, DOI 10.2337/db06-0922; Diehl EE, 2000, AM J MED SCI, V319, P79, DOI 10.1097/00000441-200002000-00002; Dobson CM, 2004, SCIENCE, V304, P1259, DOI 10.1126/science.1093078; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Goel R, 2010, CLIN RHEUMATOL, V29, P329, DOI 10.1007/s10067-009-1333-6; Harada Kensuke, 1991, Acta Paediatrica Japonica, V33, P805; Kelly JW, 2006, NATURE, V442, P255, DOI 10.1038/442255a; Kermani TA, 2012, SEMIN ARTHRITIS RHEU, V41, P866, DOI 10.1016/j.semarthrit.2011.10.005; Khreiss T, 2004, CIRCULATION, V110, P2713, DOI 10.1161/01.CIR.0000146846.00816.DD; Khreiss T, 2005, CIRC RES, V97, P690, DOI 10.1161/01.RES.0000183881.11739.CB; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Khreiss T, 2002, J BIOL CHEM, V277, P40775, DOI 10.1074/jbc.M205378200; KILPATRICK JM, 1991, IMMUNOL RES, V10, P43, DOI 10.1007/BF02918166; Kones R, 2010, DRUG DES DEV THER, V4, P383, DOI 10.2147/DDDT.S10812; Koyanagi H, 1997, ACTA PAEDIATR, V86, P613, DOI 10.1111/j.1651-2227.1997.tb08944.x; Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004; Lee GY, 2012, INT J CARDIOL, V159, P14, DOI 10.1016/j.ijcard.2011.01.094; LEI KJ, 1985, J BIOL CHEM, V260, P3377; Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562; Merz CNB, 2009, J AM COLL CARDIOL, V54, P1336, DOI 10.1016/j.jacc.2009.05.019; Molins B, 2008, ARTERIOSCL THROM VAS, V28, P2239, DOI 10.1161/ATVBAHA.108.174359; Nothnagl T, 2006, DRUG AGING, V23, P391, DOI 10.2165/00002512-200623050-00003; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Park YS, 2012, J KOREAN MED SCI, V27, P243, DOI 10.3346/jkms.2012.27.3.243; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pfutzner A, 2006, DIABETES TECHNOL THE, V8, P28, DOI 10.1089/dia.2006.8.28; Pirro M, 2012, J INTERN MED, V272, P177, DOI 10.1111/j.1365-2796.2011.02510.x; POTEMPA LA, 1988, INFLAMMATION, V12, P391, DOI 10.1007/BF00915774; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; ROBEY FA, 1984, J BIOL CHEM, V259, P7311; Robman L, 2010, OPHTHALMOLOGY, V117, P1982, DOI 10.1016/j.ophtha.2010.02.003; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Sims M, 2012, AM J PUBLIC HLTH; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; TILLETT WILLIAM S., 1930, JOUR EXP MED, V52, P561, DOI 10.1084/jem.52.4.561; Visvanathan S, 2011, RHEUMATOLOGY, V50, P2061, DOI 10.1093/rheumatology/ker163; WOO P, 1985, J BIOL CHEM, V260, P3384; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Zhao J, 2010, CELL MOL BIOL LETT, V15, P485, DOI 10.2478/s11658-010-0022-4; Zouki C, 2001, J IMMUNOL, V167, P5355, DOI 10.4049/jimmunol.167.9.5355	46	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58094	10.1371/journal.pone.0058094	http://dx.doi.org/10.1371/journal.pone.0058094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516433	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400016
J	Rusk, CL; Walters, EL; Koenig, WD				Rusk, Caroline L.; Walters, Eric L.; Koenig, Walter D.			Cooperative Breeding and Long-Distance Dispersal: A Test Using Vagrant Records	PLOS ONE			English	Article							GENETICAL EVOLUTION; LIFE-HISTORY; BIRDS	Cooperative breeding is generally associated with increased philopatry and sedentariness, presumably because short-distance dispersal facilitates the maintenance of kin groups. There are, however, few data on long-distance dispersal in cooperative breeders-the variable likely to be important for genetic diversification and speciation. We tested the hypothesis that cooperative breeders are less likely to engage in long-distance dispersal events by comparing records of vagrants outside their normal geographic range for matched pairs (cooperatively vs. non-cooperatively breeding) of North American species of birds. Results failed to support the hypothesis of reduced long-distance dispersal among cooperative breeders. Thus, our results counter the conclusion that the lower rate of speciation among cooperative breeding taxa found in recent analyses is a consequence of reduced vagility.	[Rusk, Caroline L.; Koenig, Walter D.] Cornell Lab Ornithol, Ithaca, NY USA; [Walters, Eric L.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Koenig, Walter D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University; Old Dominion University; Cornell University	Walters, EL (corresponding author), Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.	ewalters@odu.edu	Amoroso, Caroline R./AAV-7410-2021; Walters, Eric L./C-1685-2008	Amoroso, Caroline R./0000-0001-5456-7975; Walters, Eric L./0000-0002-9414-5758; Koenig, Walter/0000-0001-6207-1427	National Science Foundation [IOS-0918944]; Division Of Integrative Organismal Systems [0918944] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support for this project came from National Science Foundation grant IOS-0918944. There were no other external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold KE, 1998, P ROY SOC B-BIOL SCI, V265, P739, DOI 10.1098/rspb.1998.0355; Brown J.L., 1987, HELPING COMMUNAL BRE; Cockburn A, 2003, P ROY SOC B-BIOL SCI, V270, P2207, DOI 10.1098/rspb.2003.2503; Deetz C. H., 1934, ELEMENTS MAP PROJECT, V4; ESRI, 2011, ARCGIS DESKT REL 10; Guinan J.A., 2008, BIRDS N AM ONLINE; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hatchwell BJ, 2009, PHILOS T R SOC B, V364, P3217, DOI 10.1098/rstb.2009.0109; Kesler DC, 2010, BEHAV ECOL, V21, P1337, DOI 10.1093/beheco/arq158; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Koenig WD, 2000, CONDOR, V102, P492, DOI 10.1650/0010-5422(2000)102[0492:NDITCB]2.0.CO;2; LIGON JD, 1989, AUK, V106, P700; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; NGA, 2006, VECT MAP VMAP LEV 0; Power H. W., 1996, BIRDS N AM ONLINE; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rich T. D., 2004, PARTNERS FLIGHT LAND; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; United States Geological Survey (USGS), 2010, GEOGR NAM INF SYST; Veit RR, 2000, AUK, V117, P242, DOI 10.1642/0004-8038(2000)117[0242:VATEFO]2.0.CO;2; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; ZACK S, 1990, ETHOLOGY, V86, P265; [No title captured]	24	6	6	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58624	10.1371/journal.pone.0058624	http://dx.doi.org/10.1371/journal.pone.0058624			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516519	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400042
J	Lu, SY; Wang, Y; Huang, H; Pan, YJ; Chaney, EJ; Boppart, SA; Ozer, H; Strongin, AY; Wang, YX				Lu, Shaoying; Wang, Yi; Huang, He; Pan, Yijia; Chaney, Eric J.; Boppart, Stephen A.; Ozer, Howard; Strongin, Alex Y.; Wang, Yingxiao			Quantitative FRET Imaging to Visualize the Invasiveness of Live Breast Cancer Cells	PLOS ONE			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; RESONANCE ENERGY-TRANSFER; TUMOR-CELLS; BONE-MARROW; MT1-MMP; INVASION; ACTIVATION; EXPRESSION; LINES; PROGRESSION	Matrix metalloproteinases (MMPs) remodel tumor microenvironment and promote cancer metastasis. Among the MMP family proteases, the proteolytic activity of the pro-tumorigenic and pro-metastatic membrane-type 1 (MT1)-MMP constitutes a promising and targetable biomarker of aggressive cancer tumors. In this study, we systematically developed and characterized several highly sensitive and specific biosensors based on fluorescence resonant energy transfer (FRET), for visualizing MT1-MMP activity in live cells. The sensitivity of the AHLR-MT1-MMP biosensor was the highest and five times that of a reported version. Hence, the AHLR biosensor was employed to quantitatively profile the MT1-MMP activity in multiple breast cancer cell lines, and to visualize the spatiotemporal MT1-MMP activity simultaneously with the underlying collagen matrix at the single cell level. We detected a significantly higher level of MT1-MMP activity in invasive cancer cells than those in benign or non-invasive cells. Our results further show that the high MT1-MMP activity was stimulated by the adhesion of invasive cancer cells onto the extracellular matrix, which is precisely correlated with the cell's ability to degrade the collagen matrix. Thus, we systematically optimized a FRET-based biosensor, which provides a powerful tool to detect the pro-invasive MT1-MMP activity at single cell levels. This readout can be applied to profile the invasiveness of single cells from clinical samples, and to serve as an indicator for screening anti-cancer inhibitors.	[Lu, Shaoying; Wang, Yi; Huang, He; Chaney, Eric J.; Boppart, Stephen A.; Wang, Yingxiao] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Pan, Yijia; Wang, Yingxiao] Univ Illinois, Neurosci Program, Urbana, IL USA; [Chaney, Eric J.; Boppart, Stephen A.; Wang, Yingxiao] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Wang, Yingxiao] Univ Illinois, Dept Mol & Integrat Physiol, Ctr Biophys & Computat Biol, Dept Chem Engn, Urbana, IL USA; [Ozer, Howard] Univ Illinois, Ctr Canc, Chicago, IL USA; [Ozer, Howard] Univ Illinois, Dept Med, Chicago, IL USA; [Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Wang, Yingxiao] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Wang, YX (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	yiw015@ucsd.edu	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016; Boppart, Stephen/0000-0002-9386-5630	NIH [HL098472, CA139272, NS063405, NSF CBET0846429, CMMI0800870]; UIC Cancer Center Seed Grant; NATIONAL CANCER INSTITUTE [R21CA139272] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UIC Cancer Center Seed Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grants from NIH HL098472, CA139272, NS063405, NSF CBET0846429, CMMI0800870 (Yingxiao W. and S.L.), and the UIC Cancer Center Seed Grant (Yingxiao W. and H.O.). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte SS, 1997, J BIOL CHEM, V272, P25511, DOI 10.1074/jbc.272.41.25511; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Binder C, 2002, MOL HUM REPROD, V8, P789, DOI 10.1093/molehr/8.9.789; Brekhman V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-415; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Figueira RCS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-20; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2011, BIOCHEM J, V440, P319, DOI 10.1042/BJ20110424; Jabaiah A, 2011, CHEM BIOL, V18, P392, DOI 10.1016/j.chembiol.2010.12.017; Jang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-391; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jiang WG, 2006, INT J MOL MED, V17, P583; Kachgal S, 2012, J CELL PHYSIOL, V227, P3546, DOI 10.1002/jcp.24056; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Kovarik ML, 2011, TRENDS BIOTECHNOL, V29, P222, DOI 10.1016/j.tibtech.2011.01.003; Lafleur MA, 2006, J BIOL CHEM, V281, P6826, DOI 10.1074/jbc.M513084200; Lu SY, 2010, CLIN CANCER RES, V16, P3822, DOI 10.1158/1078-0432.CCR-10-1333; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; Martin MD, 2007, CANCER METAST REV, V26, P717, DOI 10.1007/s10555-007-9089-4; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Mimori K, 2008, ANN SURG ONCOL, V15, P2934, DOI 10.1245/s10434-008-9916-z; Nagakawa O, 2000, CANCER LETT, V155, P173, DOI 10.1016/S0304-3835(00)00425-0; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Ouyang MX, 2008, J BIOL CHEM, V283, P17740, DOI 10.1074/jbc.M709872200; Ouyang MX, 2010, CANCER RES, V70, P2204, DOI 10.1158/0008-5472.CAN-09-3698; Packard BZ, 2009, MATRIX BIOL, V28, P3, DOI 10.1016/j.matbio.2008.10.001; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Perentes JY, 2011, CANCER RES, V71, P4527, DOI 10.1158/0008-5472.CAN-10-4376; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Qin Y, 2011, P NATL ACAD SCI USA, V108, P7351, DOI 10.1073/pnas.1015686108; Ratnikov Boris, 2009, V539, P93, DOI 10.1007/978-1-60327-003-8_6; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Rezaeipoor R, 2009, J INNOV OPT HEAL SCI, V2, P387, DOI 10.1142/S1793545809000693; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Sato H, 1996, FEBS LETT, V393, P101, DOI 10.1016/0014-5793(96)00861-7; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Somiari SB, 2006, INT J CANCER, V119, P1403, DOI 10.1002/ijc.21989; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Sroka IC, 2007, NEOPLASIA, V9, P406, DOI 10.1593/neo.07193; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Wang YX, 2008, ANNU REV BIOMED ENG, V10, P1, DOI 10.1146/annurev.bioeng.010308.161731; Yamamoto M, 1998, J MED CHEM, V41, P1209, DOI 10.1021/jm970404a; Yana I, 2002, CLIN EXP METASTAS, V19, P209, DOI 10.1023/A:1015527220537; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231	56	24	24	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58569	10.1371/journal.pone.0058569	http://dx.doi.org/10.1371/journal.pone.0058569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516511	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200091
J	Stoet, G; Geary, DC				Stoet, Gijsbert; Geary, David C.			Sex Differences in Mathematics and Reading Achievement Are Inversely Related: Within- and Across-Nation Assessment of 10 Years of PISA Data	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; STEREOTYPE THREAT; MATH PERFORMANCE; GENDER EQUALITY; SCIENCE; GAP; METAANALYSIS; VARIABILITY; INTERESTS; DIVERSITY	We analyzed one decade of data collected by the Programme for International Student Assessment (PISA), including the mathematics and reading performance of nearly 1.5 million 15 year olds in 75 countries. Across nations, boys scored higher than girls in mathematics, but lower than girls in reading. The sex difference in reading was three times as large as in mathematics. There was considerable variation in the extent of the sex differences between nations. There are countries without a sex difference in mathematics performance, and in some countries girls scored higher than boys. Boys scored lower in reading in all nations in all four PISA assessments (2000, 2003, 2006, 2009). Contrary to several previous studies, we found no evidence that the sex differences were related to nations' gender equality indicators. Further, paradoxically, sex differences in mathematics were consistently and strongly inversely correlated with sex differences in reading: Countries with a smaller sex difference in mathematics had a larger sex difference in reading and vice versa. We demonstrate that this was not merely a between-nation, but also a within-nation effect. This effect is related to relative changes in these sex differences across the performance continuum: We did not find a sex difference in mathematics among the lowest performing students, but this is where the sex difference in reading was largest. In contrast, the sex difference in mathematics was largest among the higher performing students, and this is where the sex difference in reading was smallest. The implication is that if policy makers decide that changes in these sex differences are desired, different approaches will be needed to achieve this for reading and mathematics. Interventions that focus on high-achieving girls in mathematics and on low achieving boys in reading are likely to yield the strongest educational benefits.	[Stoet, Gijsbert] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Geary, David C.] Univ Missouri, Dept Psychol Sci, Interdisciplinary Neurosci Program, Columbia, MO USA	University of Leeds; University of Missouri System; University of Missouri Columbia	Stoet, G (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	g.stoet@leeds.ac.uk	Stoet, Gijsbert/D-6710-2016	Stoet, Gijsbert/0000-0002-7557-483X	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R37 HD045914]	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was undertaken using the Advanced Research Computing facilities at The University of Leeds. Geary acknowledges support from the R37 HD045914 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER DP, 1993, SOCIOL EDUC, V66, P91, DOI 10.2307/2112795; BENBOW C P, 1980, Science (Washington D C), V210, P1262, DOI 10.1126/science.7434028; BENBOW CP, 1983, SCIENCE, V222, P1029, DOI 10.1126/science.6648516; Bosacki S, 1999, SOC DEV, V8, P237, DOI 10.1111/1467-9507.00093; Ceci SJ, 2005, AM PSYCHOL, V60, P149, DOI 10.1037/0003-066X.60.2.149; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; Eagly AH, 1999, AM PSYCHOL, V54, P408, DOI 10.1037/0003-066X.54.6.408; Else-Quest NM, 2010, PSYCHOL BULL, V136, P103, DOI 10.1037/a0018053; Freeman CatherineE., 2004, ED STAT Q, V6, P357; Fryer RG, 2010, AM ECON J-APPL ECON, V2, P210, DOI 10.1257/app.2.2.210; Geary D.C., 2010, MALE FEMALE EVOLUTIO; Geary DC, 1996, BEHAV BRAIN SCI, V19, P229, DOI 10.1017/S0140525X00042400; Gottfredson LS, 2003, J CAREER ASSESSMENT, V11, P115, DOI 10.1177/1069072703011002001; Guiso L, 2008, SCIENCE, V320, P1164, DOI 10.1126/science.1154094; Halpern D.F., 2012, SEX DIFFERENCES COGN, V4th; HATCHER R, 1990, J YOUTH ADOLESCENCE, V19, P307, DOI 10.1007/BF01537075; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; HUMPHREYS LG, 1988, BEHAV BRAIN SCI, V11, P195, DOI 10.1017/S0140525X00049402; Hunt E, 2008, INTELLIGENCE, V36, P1, DOI 10.1016/j.intell.2006.11.002; Hyde JS, 2008, SCIENCE, V321, P494, DOI 10.1126/science.1160364; Hyde JS, 2009, P NATL ACAD SCI USA, V106, P8801, DOI 10.1073/pnas.0901265106; Kane JM., 2012, NOT AM MATH SOC, V59, P10, DOI [DOI 10.1090/N0TI790, 10.1090/noti790, DOI 10.1090/NOTI790]; Lippa R, 1998, J PERS SOC PSYCHOL, V74, P996, DOI 10.1037/0022-3514.74.4.996; Lippa RA, 2010, ARCH SEX BEHAV, V39, P990, DOI 10.1007/s10508-008-9460-8; Lubinski D, 2000, ANNU REV PSYCHOL, V51, P405, DOI 10.1146/annurev.psych.51.1.405; Lubinski D, 2006, PERSPECT PSYCHOL SCI, V1, P316, DOI 10.1111/j.1745-6916.2006.00019.x; Lubinski D, 2010, J COUNS PSYCHOL, V57, P226, DOI 10.1037/a0019163; Marks GN, 2008, OXFORD REV EDUC, V34, P89, DOI 10.1080/03054980701565279; Reilly D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039904; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Stoet G, 2012, REV GEN PSYCHOL, V16, P93, DOI 10.1037/a0026617; Su R, 2009, PSYCHOL BULL, V135, P859, DOI 10.1037/a0017364; Taylor M, 2005, GUARDIAN BRIT N 0127; Wai J, 2010, J EDUC PSYCHOL, V102, P860, DOI 10.1037/a0019454; Wai J, 2010, INTELLIGENCE, V38, P412, DOI 10.1016/j.intell.2010.04.006; Wu M, 2004, RASCH MEAS T, V18, P976	37	211	214	5	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57988	10.1371/journal.pone.0057988	http://dx.doi.org/10.1371/journal.pone.0057988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516422	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000316849200022
J	Vollmer, S; Holzmann, H; Ketterer, F; Klasen, S; Canning, D				Vollmer, Sebastian; Holzmann, Hajo; Ketterer, Florian; Klasen, Stephan; Canning, David			The Emergence of Three Human Development Clubs	PLOS ONE			English	Article							GROWTH; CONVERGENCE; DYNAMICS; TRAPS; MODEL	We examine the joint distribution of levels of income per capita, life expectancy, and years of schooling across countries in 1960 and in 2000. In 1960 countries were clustered in two groups; a rich, highly educated, high longevity "developed" group and a poor, less educated, high mortality, "underdeveloped" group. By 2000 however we see the emergence of three groups; one underdeveloped group remaining near 1960 levels, a developed group with higher levels of education, income, and health than in 1960, and an intermediate group lying between these two. This finding is consistent with both the ideas of a new "middle income trap" that countries face even if they escape the "low income trap", as well as the notion that countries which escaped the poverty trap form a temporary "transition regime" along their path to the "developed" group.	[Vollmer, Sebastian; Klasen, Stephan] Univ Gottingen, Dept Econ, D-37073 Gottingen, Germany; [Vollmer, Sebastian; Klasen, Stephan] Univ Gottingen, Courant Res Ctr Poverty Equ & Growth Developing C, D-37073 Gottingen, Germany; [Vollmer, Sebastian; Canning, David] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Holzmann, Hajo; Ketterer, Florian] Univ Marburg, Dept Math & Comp Sci, Marburg, Germany	University of Gottingen; University of Gottingen; Harvard University; Harvard T.H. Chan School of Public Health; Philipps University Marburg	Vollmer, S (corresponding author), Univ Gottingen, Dept Econ, D-37073 Gottingen, Germany.	svollmer@uni-goettingen.de	Canning, David/A-1917-2008; Vollmer, Sebastian/U-6496-2017	Vollmer, Sebastian/0000-0002-7863-0462; Canning, David/0000-0003-4041-1229	German Research Foundation [HO 3260/3-1, KL 1260/9-1, VO 1592/3-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation, grant numbers HO 3260/3-1, KL 1260/9-1 and VO 1592/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, DEV FREEDOM; BANERJEE AV, 1993, J POLIT ECON, V101, P274, DOI 10.1086/261876; BARRO RJ, 1991, Q J ECON, V106, P407, DOI 10.2307/2937943; Baudry JP, 2010, J COMPUT GRAPH STAT, V19, P332, DOI 10.1198/jcgs.2010.08111; Biernacki C, 2000, IEEE T PATTERN ANAL, V22, P719, DOI 10.1109/34.865189; Bloom DE, 2007, P NATL ACAD SCI USA, V104, P16044, DOI 10.1073/pnas.0702012104; Bloom DE, 2003, J ECON GROWTH, V8, P355, DOI 10.1023/A:1026294316581; Cohen D, 2007, J ECON GROWTH, V12, P51, DOI 10.1007/s10887-007-9011-5; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Fraley C, 2012, 504 U WASH DEP STAT; GALOR O, 1993, REV ECON STUD, V60, P35, DOI 10.2307/2297811; Galor O, 2010, INT ECON REV, V51, P1, DOI 10.1111/j.1468-2354.2009.00569.x; Griffith B, 2011, FRONTIERS IN DEVELOPMENT POLICY: A PRIMER ON EMERGING ISSUES, P39; Heston Alan, 2011, PENN WORLD TABLE VER; Kremer M, 1993, Q J ECON, V108, P681, DOI 10.2307/2118405; Mayer-Foulkes D, 2003, PERSPECTIVES ON GROWTH AND POVERTY, P144; MCLACHLAN GJ, 1987, APPL STAT-J ROY ST C, V36, P318, DOI DOI 10.2307/2347790; MURPHY KM, 1992, Q J ECON, V107, P889, DOI 10.2307/2118367; Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149; QUAH D, 1993, SCAND J ECON, V95, P427, DOI 10.2307/3440905; Quah D.T., 1997, J ECON GROWTH, V2, P27, DOI [10.1023/a:1009781613339, DOI 10.1023/A:1009781613339]; Quah DT, 1996, ECON J, V106, P1045, DOI 10.2307/2235377; UN, 2022, WORLD POP PROSP; Vollmer S, 2013, REV DEV EC IN PRESS	24	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57624	10.1371/journal.pone.0057624	http://dx.doi.org/10.1371/journal.pone.0057624			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516413	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200015
J	Futamura, M; Thomas, KS; Grindlay, DJC; Doney, EJ; Torley, D; Williams, HC				Futamura, Masaki; Thomas, Kim S.; Grindlay, Douglas J. C.; Doney, Elizabeth J.; Torley, Donna; Williams, Hywel C.			Mapping Systematic Reviews on Atopic Eczema-An Essential Resource for Dermatology Professionals and Researchers	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-SIGNIFICANCE; FOOD INTOLERANCE; GUIDELINES; DERMATITIS; MANAGEMENT; PREVENTION; DISEASE; ACNE; METAANALYSES	Background: Many research studies have been published on atopic eczema and these are often summarised in systematic reviews (SRs). Identifying SRs can be time-consuming for health professionals, and researchers. In order to facilitate the identification of important research, we have compiled an on-line resource that includes all relevant eczema reviews published since 2000. Methods: SRs were searched for in MEDLINE (Ovid), EMBASE (Ovid), PubMed, the Cochrane Database of Systematic Reviews, DARE and NHS Evidence. Selected SRs were assessed against the pre-defined eligibility criteria and relevant articles were grouped by treatment category for the included interventions. All identified systematic reviews are included in the Global Resource of EczemA Trials (GREAT) database (www.greatdatabase.org.uk) and key clinical messages are summarised here. Results: A total of 128 SRs reviews were identified, including three clinical guidelines. Of these, 46 (36%) were found in the Cochrane Library. No single database contained all of the SRs found. The number of SRs published per year has increased substantially over the last thirteen years, and reviews were published in a variety of clinical journals. Of the 128 SRs, 1 (1%) was on mechanism, 37 (29%) were on epidemiology, 40 (31%) were on eczema prevention, 29 (23%) were on topical treatments, 31 (24%) were on systemic treatments, and 24 (19%) were on other treatments. All SRs included searches of MEDLINE in their search methods. One hundred six SRs (83%) searched more than one electronic database. There were no language restrictions reported in the search methods of 52 of the SRs (41%). Conclusions: This mapping of atopic eczema reviews is a valuable resource. It will help healthcare practitioners, guideline writers, information specialists, and researchers to quickly identify relevant up-to-date evidence in the field for improving patient care.	[Futamura, Masaki; Thomas, Kim S.; Doney, Elizabeth J.; Williams, Hywel C.] Univ Nottingham, Ctr Evidence Based Dermatol, Nottingham NG7 2RD, England; [Futamura, Masaki] Natl Ctr Child Hlth & Dev, Div Allergy, Tokyo, Japan; [Grindlay, Douglas J. C.] Univ Nottingham, Ctr Evidence Based Vet Med, Loughborough, Leics, England; [Torley, Donna] So Gen Hosp, Alan Lyell Ctr Dermatol, Glasgow G51 4TF, Lanark, Scotland	University of Nottingham; National Center for Child Health & Development - Japan; University of Nottingham; University of Glasgow	Futamura, M (corresponding author), Univ Nottingham, Ctr Evidence Based Dermatol, Kings Meadow Campus, Nottingham NG7 2RD, England.	masaki.futamura@nottingham.ac.uk		Doney, Liz/0000-0002-3420-5034; Futamura, Masaki/0000-0002-7442-9649; Thomas, Kim/0000-0001-7785-7465; Grindlay, Douglas/0000-0002-0992-7182; williams, hywel/0000-0002-5646-3093	National Center for Child Health and Development; National Institute for Health Research (NIHR) [RP-PG-0407-10177]; NHS; National Institute for Health Research [RP-PG-0407-10177] Funding Source: researchfish	National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NHS; National Institute for Health Research(National Institute for Health Research (NIHR))	MF conducted this work as part of a research sabbatical funded by the National Center for Child Health and Development. Some of the searches for systematic reviews included in this study were carried out by DG in his previous role producing Annual Evidence Updates for the National Library for Health and NHS Evidence. The GREAT Database has been developed as part of independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10177). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. This work was partially supported by NHS evidence. No other external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COCHRANE HDB SYSTEMA; Baron SE, 2012, CLIN EXP DERMATOL, V37, P7, DOI 10.1111/j.1365-2230.2012.04336.x; Batchelor JM, 2010, CLIN EXP DERMATOL, V35, P823, DOI 10.1111/j.1365-2230.2010.03901.x; Chiu YW, 2009, INFORM HEALTH SOC CA, V34, P127, DOI 10.1080/17538150903102372; Collier A, 2006, BRIT J DERMATOL, V155, P1230, DOI 10.1111/j.1365-2133.2006.07496.x; Cox L, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.09.034; Darsow U, 2010, J EUR ACAD DERMATOL, V24, P317, DOI 10.1111/j.1468-3083.2009.03415.x; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Flohr C, 2011, J INVEST DERMATOL, V131, P557, DOI 10.1038/jid.2010.369; Foulkes AC, 2011, CLIN EXP DERMATOL, V36, P585, DOI 10.1111/j.1365-2230.2011.04108.x; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Hanifin JM, 2004, J AM ACAD DERMATOL, V50, P391, DOI 10.1016/j.jaad.2003.08.003; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; Hon KLE, 2012, ITAL J PEDIATR, V38, DOI 10.1186/1824-7288-38-26; Ingram JR, 2010, CLIN EXP DERMATOL, V35, P351, DOI 10.1111/j.1365-2230.2009.03683.x; Katayama Ichiro, 2011, Allergology International, V60, P205, DOI [10.2332/allergolint. 11-RAI-0333, 10.2332/allergolint.11-RAI-0333]; Krakowski AC, 2008, PEDIATRICS, V122, P812, DOI 10.1542/peds.2007-2232; Kramer MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000133.pub2; Macbeth AE, 2011, CLIN EXP DERMATOL, V36, P453, DOI 10.1111/j.1365-2230.2011.04087.x; Moher D, 2006, LANCET, V367, P881, DOI 10.1016/S0140-6736(06)68358-X; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nankervis H, 2011, BMC DERMATOL, V11, DOI 10.1186/1471-5945-11-10; National Institute for Health and Clinical Excellence, 2011, IMPR OUTC PEOPL SKIN; National Institute for Health and Clinical Excellence, 2007, AT ECZ CHILDR MAN AT; Olsen O, 2001, BRIT MED J, V323, P829, DOI 10.1136/bmj.323.7317.829; Osborn DA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003741.pub4; Osborn DA, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003664.pub3; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1176, DOI 10.1111/j.1468-3083.2012.04636.x; Ring J, 2012, J EUR ACAD DERMATOL, V26, P1045, DOI 10.1111/j.1468-3083.2012.04635.x; Saeki H, 2009, J DERMATOL, V36, P563, DOI 10.1111/j.1346-8138.2009.00706.x; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Scottish Intercollegiate Guidelines Network, 2011, MAN AT ECZ PRIM CAR; Shams K, 2011, CLIN EXP DERMATOL, V36, P573, DOI 10.1111/j.1365-2230.2011.04078.x; Simpson RC, 2011, CLIN EXP DERMATOL, V36, P840, DOI 10.1111/j.1365-2230.2011.04218.x; Sinclair W, 2008, SAMJ S AFR MED J, V98, P303; Smith EV, 2011, CLIN EXP DERMATOL, V36, P119, DOI 10.1111/j.1365-2230.2010.03921.x; Tsay MY, 2005, J MED LIBR ASSOC, V93, P450; Warren RB, 2010, CLIN EXP DERMATOL, V35, P688, DOI 10.1111/j.1365-2230.2010.03880.x; Werfel Thomas, 2009, J Dtsch Dermatol Ges, V7, P265, DOI 10.1111/j.1610-0387.2008.06901.x; Williams HC, 2008, CLIN EXP DERMATOL, V33, P685, DOI 10.1111/j.1365-2230.2008.02906.x; Williams HC, 2010, CLIN EXP DERMATOL, V35, P223, DOI 10.1111/j.1365-2230.2009.03734.x; Williams HC, 2010, CLIN EXP DERMATOL, V35, P12, DOI 10.1111/j.1365-2230.2009.03733.x	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58484	10.1371/journal.pone.0058484	http://dx.doi.org/10.1371/journal.pone.0058484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505516	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100054
J	Carvalho, SM; Kuipers, OP; Neves, AR				Carvalho, Sandra M.; Kuipers, Oscar P.; Neves, Ana Rute			Environmental and Nutritional Factors That Affect Growth and Metabolism of the Pneumococcal Serotype 2 Strain D39 and Its Nonencapsulated Derivative Strain R6	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; STREPTOCOCCUS-PNEUMONIAE; LACTOCOCCUS-LACTIS; IN-VIVO; PYRUVATE OXIDASE; SACCHAROMYCES-CEREVISIAE; SUGAR METABOLISM; SYNTHETIC MEDIUM; GENOME SEQUENCE; GENE-EXPRESSION	Links between carbohydrate metabolism and virulence in Streptococcus pneumoniae have been recurrently established. To investigate these links further we developed a chemically defined medium (CDM) and standardized growth conditions that allowed for high growth yields of the related pneumococcal strains D39 and R6. The utilization of the defined medium enabled the evaluation of different environmental and nutritional factors on growth and fermentation patterns under controlled conditions of pH, temperature and gas atmosphere. The same growth conditions impacted differently on the nonencapsulated R6, and its encapsulated progenitor D39. A semi-aerobic atmosphere and a raised concentration of uracil, a fundamental component of the D39 capsule, improved considerably D39 growth rate and biomass. In contrast, in strain R6, the growth rate was enhanced by strictly anaerobic conditions and uracil had no effect on biomass. In the presence of oxygen, the difference in the growth rates was mainly attributed to a lower activity of pyruvate oxidase in strain D39. Our data indicate an intricate connection between capsule production in strain D39 and uracil availability. In this study, we have also successfully applied the in vivo NMR technique to study sugar metabolism in S. pneumoniae R6. Glucose consumption, end-products formation and evolution of intracellular metabolite pools were monitored online by C-13-NMR. Additionally, the pools of NTP and inorganic phosphate were followed by P-31-NMR after a pulse of glucose. These results represent the first metabolic profiling data obtained non-invasively for S. pneumoniae, and pave the way to a better understanding of regulation of central metabolism.	[Carvalho, Sandra M.; Neves, Ana Rute] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	Universidade Nova de Lisboa; University of Groningen	Neves, AR (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark.	rute@biosustain.dtu.dk	Kuipers, Oscar/B-6752-2009	Kuipers, Oscar/0000-0001-5596-7735; Carvalho, Sandra/0000-0002-3144-411X	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/35947/2007]; Fundacao para a Ciencia e a Tecnologia, Portugal (FCT); FEDER [PDCT/BIA-MIC/56235/2004, PTDC/BIA-MIC/099963/2008, PTDC/SAU-MII/100964/2008, PEst-OE/EQB/LA0004/2011]; Programa Operacional Ciencia e Inovacao (POCTI); FCT	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e a Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); FEDER(European Commission); Programa Operacional Ciencia e Inovacao (POCTI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	S. M. Carvalho was supported by a Fundacao para a Ciencia e a Tecnologia (FCT) Ph. D. grant (SFRH/BD/35947/2007). This work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) and FEDER, projects PDCT/BIA-MIC/56235/2004, PTDC/BIA-MIC/099963/2008 and PTDC/SAU-MII/100964/2008 and grant PEst-OE/EQB/LA0004/2011. The NMR spectrometers are part of The National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao (POCTI) 2010" and FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOING G, 1994, J MOL BIOL, V241, P44, DOI 10.1006/jmbi.1994.1472; Auzat I, 1999, MOL MICROBIOL, V34, P1018, DOI 10.1046/j.1365-2958.1999.01663.x; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Balachandran P, 2001, J BACTERIOL, V183, P3108, DOI 10.1128/JB.183.10.3108-3116.2001; BEAL C, 1989, APPL MICROBIOL BIOT, V32, P148, DOI 10.1007/BF00165879; Belanger AE, 2004, J BACTERIOL, V186, P8164, DOI 10.1128/JB.186.24.8164-8171.2004; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; COCAIGNBOUSQUET M, 1995, J APPL BACTERIOL, V79, P108, DOI 10.1111/j.1365-2672.1995.tb03131.x; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Echenique JR, 2000, MOL MICROBIOL, V36, P688, DOI 10.1046/j.1365-2958.2000.01891.x; Gaspar P, 2007, FEBS J, V274, P5924, DOI 10.1111/j.1742-4658.2007.06115.x; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; GIUDICELLI S, 1984, J BACTERIOL, V158, P1188, DOI 10.1128/JB.158.3.1188-1190.1984; Goncalves VMM, 2003, BIOTECHNOL APPL BIOC, V37, P283, DOI 10.1042/BA20020075; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Hathaway LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002574; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; HIGUCHI M, 1993, J GEN MICROBIOL, V139, P2343, DOI 10.1099/00221287-139-10-2343; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Iannelli F, 1999, J BACTERIOL, V181, P2652, DOI 10.1128/JB.181.8.2652-2654.1999; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Kaufman GE, 2007, J BACTERIOL, V189, P5183, DOI 10.1128/JB.00449-07; Kilstrup M, 2005, FEMS MICROBIOL REV, V29, P555, DOI 10.1016/j.femsre.2005.04.006; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Marion C, 2011, INFECT IMMUN, V79, P1262, DOI 10.1128/IAI.00832-10; Massaldi H, 2010, BIOTECHNOL APPL BIOC, V55, P37, DOI 10.1042/BA20090218; Meiattini F, 1988, METHOD ENZYMAT AN, VVII, P566; Mercade M, 2000, INT J FOOD MICROBIOL, V55, P161, DOI 10.1016/S0168-1605(00)00190-2; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Neves AR, 1999, BIOTECHNOL BIOENG, V64, P200, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;200::AID-BIT9&gt;3.0.CO;2-K; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Neves AR, 2005, FEMS MICROBIOL REV, V29, P531, DOI 10.1016/j.femsre.2005.04.005; Papagianni M, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-16; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Quatravaux S, 2006, J APPL MICROBIOL, V101, P903, DOI 10.1111/j.1365-2672.2006.02955.x; Ramos-Montanez S, 2008, MOL MICROBIOL, V67, P729, DOI 10.1111/j.1365-2958.2007.06082.x; Ramos-Montanez S, 2010, J BACTERIOL, V192, P6390, DOI 10.1128/JB.00995-10; Regev-Yochay G, 2007, J BACTERIOL, V189, P6532, DOI 10.1128/JB.00813-07; Seki M, 2004, J BACTERIOL, V186, P2046, DOI 10.1128/JB.186.7.2046-2051.2004; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; SICARD AM, 1964, GENETICS, V50, P31; SIMMONDS RJ, 1981, J CHROMATOGR, V226, P369, DOI 10.1016/S0378-4347(00)86071-5; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Taniai H, 2008, J BACTERIOL, V190, P3572, DOI 10.1128/JB.01882-07; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; TOMASZ A, 1967, SCIENCE, V157, P694, DOI 10.1126/science.157.3789.694; TOMASZ A, 1964, BACTERIOL P, V64, P29; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Yesilkaya H, 2009, INFECT IMMUN, V77, P5418, DOI 10.1128/IAI.00178-09; Yu J, 2001, MICROBIOL-UK, V147, P431, DOI 10.1099/00221287-147-2-431; Zhang GY, 2009, APPL ENVIRON MICROB, V75, P1080, DOI 10.1128/AEM.01416-08	55	28	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58492	10.1371/journal.pone.0058492	http://dx.doi.org/10.1371/journal.pone.0058492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505518	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500091
J	Dorea, FC; Muckle, CA; Kelton, D; McClure, JT; McEwen, BJ; McNab, WB; Sanchez, J; Revie, CW				Dorea, Fernanda C.; Muckle, C. Anne; Kelton, David; McClure, J. T.; McEwen, Beverly J.; McNab, W. Bruce; Sanchez, Javier; Revie, Crawford W.			Exploratory Analysis of Methods for Automated Classification of Laboratory Test Orders into Syndromic Groups in Veterinary Medicine	PLOS ONE			English	Article							SURVEILLANCE; BIOTERRORISM	Background: Recent focus on earlier detection of pathogen introduction in human and animal populations has led to the development of surveillance systems based on automated monitoring of health data. Real-or near real-time monitoring of pre-diagnostic data requires automated classification of records into syndromes-syndromic surveillance-using algorithms that incorporate medical knowledge in a reliable and efficient way, while remaining comprehensible to end users. Methods: This paper describes the application of two of machine learning (Naive Bayes and Decision Trees) and rule-based methods to extract syndromic information from laboratory test requests submitted to a veterinary diagnostic laboratory. Results: High performance (F-1-macro = 0.9995) was achieved through the use of a rule-based syndrome classifier, based on rule induction followed by manual modification during the construction phase, which also resulted in clear interpretability of the resulting classification process. An unmodified rule induction algorithm achieved an F1-micro score of 0.979 though this fell to 0.677 when performance for individual classes was averaged in an unweighted manner (F1-macro), due to the fact that the algorithm failed to learn 3 of the 16 classes from the training set. Decision Trees showed equal interpretability to the rule-based approaches, but achieved an F1-micro score of 0.923 (falling to 0.311 when classes are given equal weight). A Naive Bayes classifier learned all classes and achieved high performance (F1-micro = 0.994 and F1-macro = .955), however the classification process is not transparent to the domain experts. Conclusion: The use of a manually customised rule set allowed for the development of a system for classification of laboratory tests into syndromic groups with very high performance, and high interpretability by the domain experts. Further research is required to develop internal validation rules in order to establish automated methods to update model rules without user input.	[Dorea, Fernanda C.; McClure, J. T.; Sanchez, Javier; Revie, Crawford W.] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Muckle, C. Anne] Univ Prince Edward Isl, Dept Pathol & Microbiol, Charlottetown, PE C1A 4P3, Canada; [Kelton, David] Univ Guelph, Dept Populat Med, Guelph, ON N1G 2W1, Canada; [McEwen, Beverly J.] Univ Guelph, Hlth Anim Lab, Guelph, ON N1G 2W1, Canada; [McNab, W. Bruce] Ontario Minist Agr Food & Rural Affairs, Anim Hlth & Welf Branch, Guelph, ON, Canada	University of Prince Edward Island; University of Prince Edward Island; University of Guelph; University of Guelph	Dorea, FC (corresponding author), Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada.	dorea.meyer@gmail.com	sanchez, javier/AAA-4179-2022; Revie, Crawford/B-5002-2011	Revie, Crawford/0000-0002-5018-0340; Dorea, Fernanda/0000-0001-8638-8525	Animal Health Strategic Investment grant (OMAFRA/AHL) [09/21]; Canadian Regulatory Veterinary Epidemiology Network (CRVE-Net)	Animal Health Strategic Investment grant (OMAFRA/AHL); Canadian Regulatory Veterinary Epidemiology Network (CRVE-Net)	This project is funded by an Animal Health Strategic Investment grant (OMAFRA/AHL) (grant number 09/21) and the support of Canadian Regulatory Veterinary Epidemiology Network (CRVE-Net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INFECT DIS INFORM BI; BABIN S, 2003, NAT MULT S ON MED AP; Bravata DM, 2004, ANN INTERN MED, V140, P910, DOI 10.7326/0003-4819-140-11-200406010-00013; Centers for Disease Control and Prevention (CDC), 2006, ANN BIBL SYNDR SURV; Chapman WW, 2005, ARTIF INTELL MED, V33, P31, DOI 10.1016/j.artmed.2004.04.001; Dara J, 2008, J BIOMED INFORM, V41, P613, DOI 10.1016/j.jbi.2007.11.004; Davis RG, 2004, JAVMA-J AM VET MED A, V224, P1084, DOI 10.2460/javma.2004.224.1084; Dorea FC, 2011, PREV VET MED, V101, P1, DOI 10.1016/j.prevetmed.2011.05.004; Duda R.O., 2006, PATTERN CLASSIFICATI; Farkas R, 2009, J AM MED INFORM ASSN, V16, P601, DOI 10.1197/jamia.M3097; Glickman LT, 2006, VECTOR-BORNE ZOONOT, V6, P14, DOI 10.1089/vbz.2006.6.14; Goplin J., 2007, ADV DIS SURVEIL, V4, P8; Ivanov O, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P345; Kelly TK, 2004, OFFICE SCI TECHNOLOG; Lober William B, 2004, MMWR Suppl, V53, P203; Ma Haobo, 2005, MMWR Suppl, V54, P27; Mandl Kenneth D, 2004, MMWR Suppl, V53, P130; North Carolina Department of Agriculture and Consumer Services, 2010, MULT THREAT DAT MHTD; Reis BY, 2004, ANN EMERG MED, V44, P235, DOI 10.1016/j.annemergmed.2004.03.030; Rohatgi PK, 2011, CURR OPIN PULM MED, V17, P337, DOI 10.1097/MCP.0b013e328347c16a; Rokach L, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P165, DOI 10.1007/0-387-25465-X_9; Sebastiani F, 2002, ACM COMPUT SURV, V34, P1, DOI 10.1145/505282.505283; Shaffer LE, 2008, ADV DIS SURVEILL, V6, P1; Shiraishi J, 2011, SEMIN NUCL MED, V41, P449, DOI 10.1053/j.semnuclmed.2011.06.004; Shmilovici A, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P257, DOI 10.1007/0-387-25465-X_12; Shmueli G, 2010, TECHNOMETRICS, V52, P39, DOI 10.1198/TECH.2010.06134; Solt I, 2009, J AM MED INFORM ASSN, V16, P580, DOI 10.1197/jamia.M3087; Uzuner O, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; Wagner M M, 2001, J Public Health Manag Pract, V7, P51; Wagner Michael M, 2004, MMWR Suppl, V53, P28; Wesolowski M, 2012, J AOAC INT, V95, P652, DOI 10.5740/jaoacint.SGE_Wesolowski_ANN; Zhang PG, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P487, DOI 10.1007/0-387-25465-X_22	32	25	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57334	10.1371/journal.pone.0057334	http://dx.doi.org/10.1371/journal.pone.0057334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505427	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000318334500019
J	Ikegami, K; Iigo, M; Yoshimura, T				Ikegami, Keisuke; Iigo, Masayuki; Yoshimura, Takashi			Circadian Clock Gene Per2 Is Not Necessary for the Photoperiodic Response in Mice	PLOS ONE			English	Article							PARS TUBERALIS; SUPRACHIASMATIC NUCLEUS; MELATONIN RECEPTOR; SIGNAL-TRANSDUCTION; PINEAL MELATONIN; SYRIAN-HAMSTER; EXPRESSION; LIGHT; RHYTHMS; PHOTORECEPTORS	In mammals, light information received by the eyes is transmitted to the pineal gland via the circadian pacemaker, i.e., the suprachiasmatic nucleus (SCN). Melatonin secreted by the pineal gland at night decodes night length and regulates seasonal physiology and behavior. Melatonin regulates the expression of the beta-subunit of thyroid-stimulating hormone (TSH; Tshb) in the pars tuberalis (PT) of the pituitary gland. Long day-induced PT TSH acts on ependymal cells in the mediobasal hypothalamus to induce the expression of type 2 deiodinase (Dio2) and reduce type 3 deiodinase (Dio3) that are thyroid hormone-activating and hormone-inactivating enzymes, respectively. The long day-activated thyroid hormone T-3 regulates seasonal gonadotropin-releasing hormone secretion. It is well established that the circadian clock is involved in the regulation of photoperiodism. However, the involvement of the circadian clock gene in photoperiodism regulation remains unclear. Although mice are generally considered non-seasonal animals, it was recently demonstrated that mice are a good model for the study of photoperiodism. In the present study, therefore, we examined the effect of changing day length in Per2 deletion mutant mice that show shorter wheel-running rhythms under constant darkness followed by arhythmicity. Although the amplitude of clock gene (Per1, Cry1) expression was greatly attenuated in the SCN, the expression profile of arylalkylamine N-acetyltransferase, a rate-limiting melatonin synthesis enzyme, was unaffected in the pineal gland, and robust photoperiodic responses of the Tshb, Dio2, and Dio3 genes were observed. These results suggested that the Per2 clock gene is not necessary for the photoperiodic response in mice.	[Ikegami, Keisuke; Yoshimura, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Physiol Anim Lab, Nagoya, Aichi 4648601, Japan; [Iigo, Masayuki] Utsunomiya Univ, Dept Appl Biochem, Utsunomiya, Tochigi 321, Japan; [Yoshimura, Takashi] Nagoya Univ, Grad Sch Bioagr Sci, Avian Biosci Res Ctr, Nagoya, Aichi 4648601, Japan; [Yoshimura, Takashi] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648601, Japan	Nagoya University; Utsunomiya University; Nagoya University; Nagoya University	Yoshimura, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Physiol Anim Lab, Nagoya, Aichi 4648601, Japan.	takashiy@agr.nagoya-u.ac.jp	Iigo, Masayuki/I-7110-2013; Yoshimura, Takashi/C-8306-2012	Yoshimura, Takashi/0000-0001-7018-9652; Ikegami, Keisuke/0000-0001-5606-3965; Iigo, Masayuki/0000-0001-8251-4141	Funding Program for Next Generation World Leading Researchers (NEXT Program); Council for Science and Technology Policy (CSTP) [LS055]; World Premier International Research Center Initiative (WPI), MEXT, Japan;  [22005794]	Funding Program for Next Generation World Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); World Premier International Research Center Initiative (WPI), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	Takashi Yoshimura is supported by the Funding Program for Next Generation World Leading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy (CSTP)(LS055) and Keisuke Ikegami is supported by Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Fellows (22005794). WPI-ITbM is supported by the World Premier International Research Center Initiative (WPI), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari N, 2009, EUR J NEUROSCI, V29, P477, DOI 10.1111/j.1460-9568.2008.06605.x; Baggerman B., 1972, General and Comparative Endocrinology, V3, P466, DOI 10.1016/0016-6480(72)90177-3; BRONSON FH, 1985, BIOL REPROD, V32, P1, DOI 10.1095/biolreprod32.1.1; Brown TM, 2009, J BIOL RHYTHM, V24, P44, DOI 10.1177/0748730408327918; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; CARTER DS, 1983, ENDOCRINOLOGY, V113, P1268, DOI 10.1210/endo-113-4-1268; Christ E, 2010, NEUROSCIENCE, V171, P398, DOI 10.1016/j.neuroscience.2010.09.009; Dardente H, 2003, MOL BRAIN RES, V114, P101, DOI 10.1016/S0169-328X(03)00134-7; Dardente H, 2010, CURR BIOL, V20, P2193, DOI 10.1016/j.cub.2010.10.048; Dawson A, 2007, GEN COMP ENDOCR, V153, P378, DOI 10.1016/j.ygcen.2007.01.043; EBIHARA S, 1986, SCIENCE, V231, P491, DOI 10.1126/science.3941912; ELLIOTT JA, 1972, SCIENCE, V178, P771, DOI 10.1126/science.178.4062.771; FOLLETT BK, 1969, NATURE, V223, P968, DOI 10.1038/223968b0; Garner WW, 1919, J AGRIC RES, V18, P0553; Gorman Michael R., 2001, Handbook of Behavioral Neurobiology, V12, P481; Guerrero HY, 2000, NEUROENDOCRINOLOGY, V71, P163, DOI 10.1159/000054533; HAMNER WM, 1966, GEN COMP ENDOCR, V7, P224, DOI 10.1016/0016-6480(66)90043-8; HAMNER WM, 1963, SCIENCE, V142, P1294, DOI 10.1126/science.142.3597.1294; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; HASTINGS MH, 1987, J ENDOCRINOL, V114, P221, DOI 10.1677/joe.0.1140221; Hazlerigg DG, 2005, CURR BIOL, V15, pR449, DOI 10.1016/j.cub.2005.06.010; HOFFMAN RA, 1965, SCIENCE, V148, P1609, DOI 10.1126/science.148.3677.1609; Ikegami K, 2009, J COMP NEUROL, V517, P397, DOI 10.1002/cne.22165; Inagaki N, 2007, P NATL ACAD SCI USA, V104, P7664, DOI 10.1073/pnas.0607713104; Jilg A, 2005, EUR J NEUROSCI, V22, P2845, DOI 10.1111/j.1460-9568.2005.04485.x; Johnston JD, 2006, ENDOCRINOLOGY, V147, P959, DOI 10.1210/en.2005-1100; Johnston JD, 2005, EUR J NEUROSCI, V21, P2967, DOI 10.1111/j.1460-9568.2005.04148.x; Johnston JD, 2003, FASEB J, V17, P810, DOI 10.1096/fj.02-0837com; KEAST J. A., 1954, PROC ZOOL SOC LONDON, V124, P493; Lincoln G, 2002, P NATL ACAD SCI USA, V99, P13890, DOI 10.1073/pnas.212517599; Masumoto K, 2010, CURR BIOL, V20, P2199, DOI 10.1016/j.cub.2010.11.038; Messager S, 1999, P NATL ACAD SCI USA, V96, P9938, DOI 10.1073/pnas.96.17.9938; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Naito E, 2008, J BIOL RHYTHM, V23, P140, DOI 10.1177/0748730408314572; Nakahara D, 2003, P NATL ACAD SCI USA, V100, P9584, DOI 10.1073/pnas.1631069100; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Nuesslein-Hildesheim B, 2000, EUR J NEUROSCI, V12, P2856, DOI 10.1046/j.1460-9568.2000.00173.x; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Ono H, 2008, P NATL ACAD SCI USA, V105, P18238, DOI 10.1073/pnas.0808952105; PITTENDRIGH CS, 1964, AM NAT, V98, P261, DOI 10.1086/282327; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reiter R J, 1980, Endocr Rev, V1, P109; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Rowan W, 1925, NATURE, V115, P494, DOI 10.1038/115494b0; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Sosniyenko S, 2009, EUR J NEUROSCI, V30, P1802, DOI 10.1111/j.1460-9568.2009.06945.x; STIRLAND JA, 1995, BIOL REPROD, V53, P361, DOI 10.1095/biolreprod53.2.361; Stirland JA, 1996, ENDOCRINOLOGY, V137, P2183, DOI 10.1210/en.137.5.2183; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; UNDERWOOD H, 1990, J COMP PHYSIOL A, V167, P231; Unfried C, 2009, ENDOCRINOLOGY, V150, P4653, DOI 10.1210/en.2009-0609; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VanderLeest HT, 2007, CURR BIOL, V17, P468, DOI 10.1016/j.cub.2007.01.048; Vansteensel MJ, 2008, BRAIN RES REV, V58, P18, DOI 10.1016/j.brainresrev.2007.10.009; von Gall C, 2002, NAT NEUROSCI, V5, P234, DOI 10.1038/nn806; Von Gall C, 2005, ANN NY ACAD SCI, V1040, P508, DOI 10.1196/annals.1327.105; Yamamura T, 2004, ENDOCRINOLOGY, V145, P4264, DOI 10.1210/en.2004-0366; Yasuo S, 2005, ENDOCRINOLOGY, V146, P2551, DOI 10.1210/en.2005-0057; Yasuo S, 2009, J NEUROSCI, V29, P2885, DOI 10.1523/JNEUROSCI.0145-09.2009; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797; ZANN RA, 1995, EMU, V95, P208, DOI 10.1071/MU9950208; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zucker Irving, 2001, Handbook of Behavioral Neurobiology, V12, P509	67	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58482	10.1371/journal.pone.0058482	http://dx.doi.org/10.1371/journal.pone.0058482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505514	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500089
J	Zhang, JP; Raij, T; Hamalainen, M; Yao, DZ				Zhang, Junpeng; Raij, Tommi; Haemaelaeinen, Matti; Yao, Dezhong			MEG Source Localization Using Invariance of Noise Space	PLOS ONE			English	Article							SOURCE REGION SUPPRESSION; EEG SOURCE LOCALIZATION; SOURCE MODEL; HUMAN BRAIN; RECONSTRUCTION; RESOLUTION; BEAMFORMERS; ALGORITHM; MUSIC	We propose INvariance of Noise (INN) space as a novel method for source localization of magnetoencephalography (MEG) data. The method is based on the fact that modulations of source strengths across time change the energy in signal subspace but leave the noise subspace invariant. We compare INN with classical MUSIC, RAP-MUSIC, and beamformer approaches using simulated data while varying signal-to-noise ratios as well as distance and temporal correlation between two sources. We also demonstrate the utility of INN with actual auditory evoked MEG responses in eight subjects. In all cases, INN performed well, especially when the sources were closely spaced, highly correlated, or one source was considerably stronger than the other.	[Zhang, Junpeng; Yao, Dezhong] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Zhang, Junpeng; Raij, Tommi; Haemaelaeinen, Matti] MGH MIT HMS Athinoula A Martinos Ctr Biomed Imagi, Boston, MA USA; [Zhang, Junpeng] Chengdu Med Coll, Dept Biomed Engn, Chengdu, Peoples R China	University of Electronic Science & Technology of China; Chengdu Medical College	Yao, DZ (corresponding author), Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China.	dyao@uestc.edu.cn	Hamalainen, Matti S/C-8507-2013; Zhang, Junpeng/C-5457-2012	Raij, Tommi/0000-0001-7439-7491; Zhang, Junpeng/0000-0002-9478-8243; Yao, Dezhong/0000-0002-8042-879X	National Basic Research 973 Program [2011CB 707803]; National Nature Science Foundation of China [31070881, 31271204]; Chinese PCSIRT and '111' Project; National Institutes of Health [R01 NS048279, R01 HD040712, R01 NS037462, P41 RR014075, R01 EB006385, R01 EB0009048]; National Science Council, Taiwan [NSC 97-2320-B-002-058-MY3, NSC 98-2320-B-002-004-MY3]; National Health Research Institute, Taiwan [NHRI-EX100-9715EC)]; Academy of Finland (FiDiPro Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040712] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006385, R01EB009048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048279, R01NS037462] Funding Source: NIH RePORTER	National Basic Research 973 Program(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese PCSIRT and '111' Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); Academy of Finland (FiDiPro Program)(Academy of Finland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Basic Research 973 Program (No. 2011CB 707803), National Nature Science Foundation of China (Contract grant number: 31070881, 31271204), and the Chinese PCSIRT and '111' Project; National Institutes of Health grants R01 NS048279, R01 HD040712, R01 NS037462, P41 RR014075, R01 EB006385, and R01 EB0009048; National Science Council, Taiwan (NSC 97-2320-B-002-058-MY3, NSC 98-2320-B-002-004-MY3), National Health Research Institute, Taiwan (NHRI-EX100-9715EC); Academy of Finland (FiDiPro Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no	Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; BORGIOTTI GV, 1979, IEEE T ANTENN PROPAG, V27, P842, DOI 10.1109/TAP.1979.1142176; Brookes MJ, 2007, NEUROIMAGE, V34, P1454, DOI 10.1016/j.neuroimage.2006.11.012; Dalal SS, 2006, IEEE T BIO-MED ENG, V53, P1357, DOI 10.1109/TBME.2006.873752; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Darvas F, 2004, NEUROIMAGE, V23, pS289, DOI 10.1016/j.neuroimage.2004.07.014; Golub GH., 2013, MATRIX COMPUTATIONS; Gorodnitsky IF, 1997, IEEE T SIGNAL PROCES, V45, P600, DOI 10.1109/78.558475; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hamalainen M, 1984, INTERPRETING MEASURE; HARI R, 1987, INT J AUDIOL, V26, P31; Herdman AT, 2003, NEUROIMAGE, V20, P995, DOI 10.1016/S1053-8119(03)00403-8; Horn RA., 1985, MATRIX ANAL; Huang MX, 2004, BRAIN TOPOGR, V16, P139; Lei X, 2010, HUMAN BRAIN MAPPING; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; MOSHER JC, 1992, IEEE T BIO-MED ENG, V39, P541, DOI 10.1109/10.141192; Mosher JC, 1998, IEEE T BIO-MED ENG, V45, P1342, DOI 10.1109/10.725331; Mosher JC, 1999, IEEE T SIGNAL PROCES, V47, P332, DOI 10.1109/78.740118; Olfat A, 2004, SIGNAL PROCESS, V84, P721, DOI 10.1016/j.sigpro.2003.12.009; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Popescu M, 2008, IEEE T BIO-MED ENG, V55, P1092, DOI 10.1109/TBME.2007.906504; Quraan MA, 2010, NEUROIMAGE, V49, P2387, DOI 10.1016/j.neuroimage.2009.10.012; Raij T, 2010, EUR J NEUROSCI, V31, P1772, DOI 10.1111/j.1460-9568.2010.07213.x; ROBINSON SE, 1992, INT CONGR SER, V988, P761; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; SCHERG M, 1985, ELECTROEN CLIN NEURO, V62, P32, DOI 10.1016/0168-5597(85)90033-4; Scherg M, 1990, AUDITORY EVOKED MAGN, P40; SCHMIDT RO, 1986, IEEE T ANTENN PROPAG, V34, P276, DOI 10.1109/TAP.1986.1143830; Sekihara K, 2005, NEUROIMAGE, V25, P1056, DOI 10.1016/j.neuroimage.2004.11.051; Sekihara K, 2001, IEEE T BIO-MED ENG, V48, P760, DOI 10.1109/10.930901; Trujillo-Barreto NJ, 2004, NEUROIMAGE, V21, P1300, DOI 10.1016/j.neuroimage.2003.11.008; Tuomisto T, 1983, IL NUOVO CIMENTO D, V2, P471; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Xu P, 2007, IEEE T BIO-MED ENG, V54, P400, DOI 10.1109/TBME.2006.886640; Xu P, 2010, NEUROIMAGE, V51, P183, DOI 10.1016/j.neuroimage.2010.01.106; Xu P, 2008, ANN BIOMED ENG, V36, P2051, DOI 10.1007/s10439-008-9570-4; Yao DZ, 1998, P ANN INT IEEE EMBS, V20, P2108, DOI 10.1109/IEMBS.1998.747024; Yao DZ, 2001, ANN BIOMED ENG, V29, P1019, DOI 10.1114/1.1415526; Zhang JP, 2010, BIOMED ENG-APP BAS C, V22, P351, DOI 10.4015/S1016237210002110; Zhang JP, 2010, BIOMED ENG-APP BAS C, V22, P239, DOI 10.4015/S1016237210001955	41	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58408	10.1371/journal.pone.0058408	http://dx.doi.org/10.1371/journal.pone.0058408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505502	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500079
J	Zhao, SX; Liu, W; Zhan, M; Song, ZY; Yang, SY; Xue, LQ; Pan, CM; Gu, ZH; Liu, BL; Wang, HN; Liang, LM; Liang, J; Zhang, XM; Yuan, GY; Li, CG; Chen, MD; Chen, JL; Gao, GQ; Song, HD				Zhao, Shuang-Xia; Liu, Wei; Zhan, Ming; Song, Zhi-Yi; Yang, Shao-Ying; Xue, Li-Qiong; Pan, Chun-Ming; Gu, Zhao-Hui; Liu, Bing-Li; Wang, Hai-Ning; Liang, Liming; Liang, Jun; Zhang, Xiao-Mei; Yuan, Guo-Yue; Li, Chang-Gui; Chen, Ming-Dao; Chen, Jia-Lun; Gao, Guan-Qi; Song, Huai-Dong		China Consortium Genetics	A Refined Study of FCRL Genes from a Genome-Wide Association Study for Graves' Disease	PLOS ONE			English	Article							AUTOIMMUNE THYROID-DISEASE; THYROTROPIN RECEPTOR; SUSCEPTIBILITY; POPULATION; CHROMOSOME; SNPS; EXPRESSION; MOLECULES; LOCUS; CELLS	To pinpoint the exact location of the etiological variant/s present at 1q21.1 harboring FCRL1-5 and CD5L genes, we carried out a refined association study in the entire FCRL region in 1,536 patients with Graves' disease (GD) and 1,516 sex-matched controls by imputation analysis, logistic regression, and cis-eQTL analysis. Among 516 SNPs with P<0.05 in the initial GWAS scan, the strongest signals associated with GD and correlated to FCRL3 expression were located at a cluster of SNPs including rs7528684 and rs3761959. And the allele-specific effects for rs3761959 and rs7528684 on FCRL3 expression level revealed that the risk alleles A of rs3761959 and C of rs7528684 were correlated with the elevated expression level of FCRL3 whether in PBMCs or its subsets, especially in CD19(+) B cells and CD8(+) T subsets. Next, the combined analysis with 5,300 GD cases and 4,916 control individuals confirmed FCRL3 was a susceptibility gene of GD in Chinese Han populations, and rs3761959 and rs7528684 met the genome-wide association significance level (P-combined = 2.27 x 10(-12) and 7.11 x 10(-13), respectively). Moreover, the haplotypes with the risk allele A of rs3761959 and risk allele C of rs7528684 were associated with GD risk. Finally, our epigenetic analysis suggested the disease-associated C allele of rs7528684 increased affinity for NF-KB transcription factor. Above data indicated that FCRL3 gene and its proxy SNP rs7528684 may be involved in the pathogenesis of GD by excessive inhibiting B cell receptor signaling and the impairment of suppressing function of Tregs.	[Zhao, Shuang-Xia; Liu, Wei; Zhan, Ming; Song, Zhi-Yi; Yang, Shao-Ying; Xue, Li-Qiong; Pan, Chun-Ming; Gu, Zhao-Hui; Liu, Bing-Li; Wang, Hai-Ning; Song, Huai-Dong] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, State Key Lab Med Genom,Mol Med Ctr, Shanghai 200030, Peoples R China; [Zhao, Shuang-Xia; Chen, Ming-Dao; Chen, Jia-Lun; Song, Huai-Dong] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Endocrinol,Shanghai Inst Endocrinol & Metab, Shanghai 200030, Peoples R China; [Gu, Zhao-Hui] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02115 USA; [Liang, Jun] Xuzhou Med Coll, Cent Hosp Xuzhou, Dept Endocrinol, Xuzhou, Jiangsu, Peoples R China; [Zhang, Xiao-Mei] Bengbu Med Coll, Hosp 1, Dept Endocrinol, Bengbu, Anhui, Peoples R China; [Yuan, Guo-Yue] Jiangsu Univ, Hosp Affiliated, Dept Endocrinol, Zhenjiang, Jiangsu, Peoples R China; [Li, Chang-Gui] Qingdao Univ, Med Sch Hosp, Dept Endocrinol, Gout Lab, Qingdao 266071, Shandong, Peoples R China; [Gao, Guan-Qi] Linyi Peoples Hosp, Dept Endocrinol, Linyi, Shandong, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Harvard University; Harvard T.H. Chan School of Public Health; Xuzhou Medical University; Bengbu Medical College; Jiangsu University; Qingdao University	Gao, GQ (corresponding author), Linyi Peoples Hosp, Dept Endocrinol, Linyi, Shandong, Peoples R China.	lygqgao@163.com; huaidong_s1966@163.com	Gu, Zhaohui/L-8586-2015	Song, Huai-Dong/0000-0002-9609-5803; Yang, Shaoying/0000-0001-9091-4209	National Natural Science Foundation of China [30971595, 30971383, 81100553, 81200568, 81270863, 31171127]; National Basic Research Program of China (973) [2010CB529204, 2012CB517604]; Shanghai Science and Technology Committee [10JC1410400]; Program for Graves' Disease Innovative Research Team of Shanghai Municipal Education Commission; Natural Science Foundation of Jiangsu Province, China [BK2009208, SBK201221245]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973)(National Basic Research Program of China); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Program for Graves' Disease Innovative Research Team of Shanghai Municipal Education Commission; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This work was supported in part by the National Natural Science Foundation of China (30971595, 30971383, 81100553, 81200568, 81270863, and 31171127), National Basic Research Program of China (973) (2010CB529204 and 2012CB517604), Shanghai Science and Technology Committee (10JC1410400), Program for Graves' Disease Innovative Research Team of Shanghai Municipal Education Commission, and Natural Science Foundation of Jiangsu Province, China (BK2009208 and SBK201221245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbesino G, 1998, J CLIN ENDOCR METAB, V83, P3290, DOI 10.1210/jc.83.9.3290; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; Breslow N E, 1980, IARC Sci Publ, P5; Cappelli C, 2007, ENDOCR J, V54, P713, DOI 10.1507/endocrj.K06-069; Chistiakov DA, 2010, J APPL GENET, P1; Chistiakov DA, 2007, HUM IMMUNOL, V68, P375, DOI 10.1016/j.humimm.2007.01.013; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Davis RS, 2007, ANNU REV IMMUNOL, V25, P525, DOI 10.1146/annurev.immunol.25.022106.141541; De Velde VV, 2010, BIOMARKERS, V15, P619, DOI 10.3109/1354750X.2010.508842; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eisenbarth George S., 2002, Autoimmunity Reviews, V1, P139, DOI 10.1016/S1568-9972(02)00035-6; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Imrie H, 2001, J CLIN ENDOCR METAB, V86, P626, DOI 10.1210/jc.86.2.626; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kochi Y, 2009, J IMMUNOL, V183, P5502, DOI 10.4049/jimmunol.0901982; Kocjan T, 2000, PFLUG ARCH EUR J PHY, V440, pR94, DOI 10.1007/s004240000019; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Mao C, 2010, MOL BIOL REP, V37, P191, DOI 10.1007/s11033-009-9591-6; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Matesanz-Isabel J, 2011, IMMUNOL LETT, V134, P104, DOI 10.1016/j.imlet.2010.09.019; McGonagle D, 2006, PLOS MED, V3, P1242, DOI 10.1371/journal.pmed.0030297; Miller I, 2002, BLOOD, V99, P2662, DOI 10.1182/blood.V99.8.2662; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Owen CJ, 2007, J CLIN ENDOCR METAB, V92, P1106, DOI 10.1210/jc.2006-2183; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sgarbi JA, 2010, THYROID, V20, P1151, DOI 10.1089/thy.2009.0424; Simmonds MJ, 2007, HUM MOL GENET, V16, P2149, DOI 10.1093/hmg/ddm165; Simmonds MJ, 2010, THYROID, V20, P413, DOI 10.1089/thy.2009.0375; Simmonds MJ, 2005, AM J HUM GENET, V76, P157, DOI 10.1086/426947; Song HD, 2009, HUM MOL GENET, V18, P1156, DOI 10.1093/hmg/ddn442; Swainson LA, 2010, J IMMUNOL, V184, P3639, DOI 10.4049/jimmunol.0903943; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhao SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009821	39	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57758	10.1371/journal.pone.0057758	http://dx.doi.org/10.1371/journal.pone.0057758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505439	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500031
J	Zhou, XS; Kannisto, K; Curbo, S; von Dobeln, U; Hultenby, K; Isetun, S; Gafvels, M; Karlsson, A				Zhou, Xiaoshan; Kannisto, Kristina; Curbo, Sophie; von Dobeln, Ulrika; Hultenby, Kjell; Isetun, Sindra; Gafvels, Mats; Karlsson, Anna			Thymidine Kinase 2 Deficiency-Induced mtDNA Depletion in Mouse Liver Leads to Defect beta-Oxidation	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DEPLETION; TANDEM MASS-SPECTROMETRY; DEOXYGUANOSINE KINASE; TK2 DEFICIENCY; MYOPATHY; MUTATIONS; GENE; MICE; COMPENSATION; METABOLISM	Thymidine kinase 2 (TK2) deficiency in humans causes mitochondrial DNA (mtDNA) depletion syndrome. To study the molecular mechanisms underlying the disease and search for treatment options, we previously generated and described a TK2 deficient mouse strain (TK2(-/-)) that progressively loses its mtDNA. The TK2(-/-) mouse model displays symptoms similar to humans harboring TK2 deficient infantile fatal encephalomyopathy. Here, we have studied the TK2(-/-) mouse model to clarify the pathological role of progressive mtDNA depletion in liver for the severe outcome of TK2 deficiency. We observed that a gradual depletion of mtDNA in the liver of the TK2(-/-) mice was accompanied by increasingly hypertrophic mitochondria and accumulation of fat vesicles in the liver cells. The levels of cholesterol and nonesterified fatty acids were elevated and there was accumulation of long chain acylcarnitines in plasma of the TK2(-/-) mice. In mice with hepatic mtDNA levels below 20%, the blood sugar and the ketone levels dropped. These mice also exhibited reduced mitochondrial beta-oxidation due to decreased transport of long chain acylcarnitines into the mitochondria. The gradual loss of mtDNA in the liver of the TK2(-/-) mice causes impaired mitochondrial function that leads to defect beta-oxidation and, as a result, insufficient production of ketone bodies and glucose. This study provides insight into the mechanism of encephalomyopathy caused by TK2 deficiency-induced mtDNA depletion that may be used to explore novel therapeutic strategies.	[Zhou, Xiaoshan; Curbo, Sophie; Karlsson, Anna] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol F68, Huddinge, Sweden; [Kannisto, Kristina; Gafvels, Mats] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Chem, Huddinge, Sweden; [von Dobeln, Ulrika; Isetun, Sindra] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Metab Dis, Huddinge, Sweden; [Hultenby, Kjell] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Res Ctr, Huddinge, Sweden; [Gafvels, Mats] Lund Univ, Dept Lab Med, Div Clin Chem, Lund, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University	Curbo, S (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Clin Microbiol F68, Huddinge, Sweden.	Sophie.Curbo@ki.se	Karlsson, Anna/E-7945-2018; curbo, sophie/AAA-8614-2020	curbo, sophie/0000-0002-0964-0712; Karlsson, Anna/0000-0001-6843-6685	Swedish Research Council [2010-2828]; Medical Faculty of Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty of Karolinska Institutet	This work was supported by grants from the Swedish Research Council [A.K. grant number 2010-2828] and the Medical Faculty of Karolinska Institutet [A.K., S.C.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman HO, 2008, HUM MOL GENET, V17, P2433, DOI 10.1093/hmg/ddn143; Bartesaghi S, 2010, HUM MOL GENET, V19, P1669, DOI 10.1093/hmg/ddq043; Boudina S, 2005, CIRCULATION, V112, P2686, DOI 10.1161/CIRCULATIONAHA.105.554360; Carrozzo R, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9135; Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178; Chace DH, 2001, CLIN CHEM, V47, P1166; DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008; Dorado B, 2011, HUM MOL GENET, V20, P155, DOI 10.1093/hmg/ddq453; Durham SE, 2005, NEUROLOGY, V65, P453, DOI 10.1212/01.wnl.0000171861.30277.88; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghoshal AK, 2005, CLIN CHIM ACTA, V358, P104, DOI 10.1016/j.cccn.2005.02.011; Gotz A, 2008, BRAIN, V131, P2841, DOI 10.1093/brain/awn236; HALESTRAP AP, 1989, BIOCHIM BIOPHYS ACTA, V973, P355, DOI 10.1016/S0005-2728(89)80378-0; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Lesko N, 2010, NEUROMUSCULAR DISORD, V20, P198, DOI 10.1016/j.nmd.2009.11.013; Lim KHH, 2002, J PHYSIOL-LONDON, V545, P961, DOI 10.1113/jphysiol.2002.031484; Mancuso M, 2002, NEUROLOGY, V59, P1197, DOI 10.1212/01.WNL.0000028689.93049.9A; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; McFarland R, 2002, LANCET NEUROL, V1, P343, DOI 10.1016/S1474-4422(02)00159-X; MORAES CT, 1991, AM J HUM GENET, V48, P492; Muller-Hocker J, 2002, HUM PATHOL, V33, P247, DOI 10.1053/hupa.2002.31477; Oskoui M, 2006, ARCH NEUROL-CHICAGO, V63, P1122, DOI 10.1001/archneur.63.8.1122; Parini P, 2006, EUR J CLIN INVEST, V36, P98, DOI 10.1111/j.1365-2362.2006.01597.x; Parini R, 2009, J HEPATOL, V50, P215, DOI 10.1016/j.jhep.2008.08.019; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pronicka E, 2011, J APPL GENET, V52, P61, DOI 10.1007/s13353-010-0008-y; Rao JN, 2011, J BIOL CHEM, V286, P42545, DOI 10.1074/jbc.M111.306951; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Saada Ann, 2009, Biochem J, V422, pe3, DOI 10.1042/BJ20091194; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Vila MR, 2008, J NEUROL SCI, V267, P137, DOI 10.1016/j.jns.2007.10.019; Villarroya J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029691; Wang LY, 2005, MOL GENET METAB, V84, P75, DOI 10.1016/j.ymgme.2004.09.005; Weibel E, 1979, STEREOLOGICAL METHOD, V1, P91; Wibom R, 2002, ANAL BIOCHEM, V311, P139, DOI 10.1016/S0003-2697(02)00424-4; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Zhou XS, 2008, HUM MOL GENET, V17, P2329, DOI 10.1093/hmg/ddn133	39	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58843	10.1371/journal.pone.0058843	http://dx.doi.org/10.1371/journal.pone.0058843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505564	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500129
J	Chou, IC; Chang, YT; Chin, ZN; Muo, CH; Sung, FC; Kuo, HT; Tsai, CH; Kao, CH				Chou, I-Ching; Chang, Yu-Tzu; Chin, Zheng-Nan; Muo, Chih-Hsin; Sung, Fung-Chang; Kuo, Huang-Tsung; Tsai, Chang-Hai; Kao, Chia-Hung			Correlation between Epilepsy and Attention Deficit Hyperactivity Disorder: A Population-Based Cohort Study	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; BEHAVIOR PROBLEMS; CHILDREN; ADHD; SEIZURES; ADOLESCENTS; SCHOOL	Background: This study presents an evaluation of the bidirectional correlation between attention deficit hyperactivity disorder (ADHD) and epilepsy using 2 cohorts from the same population database. Methods: We used data from the Taiwan National Health Insurance Research Database to establish 2 separate cohort studies with participants,19 years old. We subdivided Cohort 1 in 2 groups: (1) 2468 patients initially diagnosed with epilepsy during the period 1999-2008, and (2) 9810 randomly selected sex-and age-matched non-epileptic controls. We subdivided Cohort 2 into 2 groups: (1) 3664 patients with newly diagnosed ADHD and (2) 14 522 sex-and age-matched non-ADHD patients. We evaluated the risk of subsequent ADHD in relationship to epilepsy and vice versa in the 2 cohorts at the end of 2008. Results: The ADHD incidence in Cohort 1 was 7.76 in patients with epilepsy and 3.22 in those without epilepsy (per 1000 person-years) after a median follow-up of 7-7.5 years. The adjusted hazard ratio (HR) for ADHD was 2.54 (95% CI 2.02-3.18) in the epilepsy group compared to the non-epilepsy group. In Cohort 2, the incidence of epilepsy was 3.24 in patients with ADHD and 0.78 in those without ADHD (per 1000 person-years) after a median follow-up of 3-3.5 years and an HR of 3.94 (95% CI 2.58-6.03). Conclusion: This study shows a bidirectional association between ADHD and epilepsy in the 2 cohort studies. Causative factors may be common between these 2 disorders, leading to a cascade of transcriptional changes in the brain that alter behavior or cognition prior to seizures.	[Chou, I-Ching; Chang, Yu-Tzu; Chin, Zheng-Nan; Kuo, Huang-Tsung; Tsai, Chang-Hai] China Med Univ Hosp, Childrens Med Ctr, Taichung, Taiwan; [Chou, I-Ching] China Med Univ, Coll Chinese Med, Grad Inst Integrated Med, Taichung, Taiwan; [Muo, Chih-Hsin; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Tsai, Chang-Hai] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Department of Health Clinical Trial and Research Center and for Excellence [DOH102-TD-B-111-004]; Taiwan Department of Health Cancer Research Center for Excellence [DOH102-TD-C-111-005]; International Research-Intensive Centers of Excellence in Taiwan (I-RiCE) [NSC101-2911-I-002-303];  [DMR-101-045]	Taiwan Department of Health Clinical Trial and Research Center and for Excellence; Taiwan Department of Health Cancer Research Center for Excellence; International Research-Intensive Centers of Excellence in Taiwan (I-RiCE); 	The study was supported in part by the study project (DMR-101-045) in our hospital; Taiwan Department of Health Clinical Trial and Research Center and for Excellence (DOH102-TD-B-111-004), Taiwan Department of Health Cancer Research Center for Excellence (DOH102-TD-C-111-005); and International Research-Intensive Centers of Excellence in Taiwan (I-RiCE) (NSC101-2911-I-002-303). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicardi J, 1998, DIS NERVOUS SYSTEM C, P575; Aircardi J., 1996, ACTA NEUROPEDIATRICA, V2, P249; Aldenkamp AP, 2001, J CHILD NEUROL, V16, P119, DOI 10.2310/7010.2001.6990; [Anonymous], 1998, NIH CONSENS STATEMEN, V16, P1; Austin JK, 2001, PEDIATRICS, V107, P115, DOI 10.1542/peds.107.1.115; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Chang YT, 2011, EPILEPSIA, V52, P2036, DOI 10.1111/j.1528-1167.2011.03268.x; Cowan LD, 2002, MENT RETARD DEV D R, V8, P171, DOI 10.1002/mrdd.10035; Dunn DW, 1997, SEIZURE, V6, P283, DOI 10.1016/S1059-1311(97)80075-1; Gilby KL, 2008, EPILEPSIA, V49, P108, DOI 10.1111/j.1528-1167.2008.01851.x; Hesdorffer DC, 2004, ARCH GEN PSYCHIAT, V61, P731, DOI 10.1001/archpsyc.61.7.731; HOLDSWORTH L, 1974, DEV MED CHILD NEUROL, V16, P746; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; McIntyre DC, 2007, EPILEPSIA, V48, P30, DOI 10.1111/j.1528-1167.2007.01398.x; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Richer LP, 2002, PEDIATR NEUROL, V26, P125, DOI 10.1016/S0887-8994(01)00370-8; Rubia K, 2005, AM J PSYCHIAT, V162, P1067, DOI 10.1176/appi.ajp.162.6.1067; Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019; Semrud-Clikeman M, 1999, EPILEPSIA, V40, P211, DOI 10.1111/j.1528-1157.1999.tb02077.x; STORES G, 1978, EPILEPSIA, V19, P169, DOI 10.1111/j.1528-1157.1978.tb05027.x; Swanson JM, 1998, LANCET, V351, P429, DOI 10.1016/S0140-6736(97)11450-7; Thome-Souza S, 2004, EPILEPSY BEHAV, V5, P988, DOI 10.1016/j.yebeh.2004.09.001; Williams J, 2001, CLIN PEDIATR, V40, P221, DOI 10.1177/000992280104000408; Zang YF, 2005, BRAIN DEV-JPN, V27, P544, DOI 10.1016/j.braindev.2004.11.009	25	56	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57926	10.1371/journal.pone.0057926	http://dx.doi.org/10.1371/journal.pone.0057926			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483944	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100055
J	Holmes, KJ; Lourenco, SF				Holmes, Kevin J.; Lourenco, Stella F.			When Numbers Get Heavy: Is the Mental Number Line Exclusively Numerical?	PLOS ONE			English	Article							PARIETAL CORTEX; MAGNITUDE REPRESENTATION; HUMAN INFANTS; TIME; SPACE; ORGANIZATION; PERCEPTION; ATTENTION; QUANTITY; TASKS	The mental number line, with its left-to-right orientation of increasing numerical values, is often regarded as evidence for a unique connection between space and number. Yet left-to-right orientation has been shown to extend to other dimensions, consistent with a general magnitude system wherein different magnitudes share neural and conceptual resources. Such observations raise a fundamental, yet relatively unexplored, question about spatial-numerical associations: What is the nature of the information represented along the mental number line? Here we show that this information is not exclusive to number, simultaneously accommodating numerical and non-numerical magnitudes. Participants completed the classic SNARC (Spatial-Numerical Association of Response Codes) task while sometimes wearing wrist weights. Weighting the left wrist-thereby linking less and more weight to right and left, respectively-worked against left-to-right orientation of number, leaving no behavioral trace of the mental number line. Our findings point to the dynamic integration of magnitude dimensions, with spatial organization instantiating representational currency (i.e., more/less relations) shared across magnitudes.	[Holmes, Kevin J.] Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA; [Lourenco, Stella F.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	University of California System; University of California Berkeley; Emory University	Holmes, KJ (corresponding author), Univ Calif Berkeley, Dept Linguist, Berkeley, CA 94720 USA.	kjholmes@berkeley.edu	Holmes, Kevin/AEJ-8579-2022		John Merck Fund	John Merck Fund	This research was supported by a Scholars Award from the John Merck Fund (www.jmfund.org) to SFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Cappelletti M, 2011, NEUROPSYCHOLOGIA, V49, P3078, DOI 10.1016/j.neuropsychologia.2011.07.014; Casarotti M, 2007, COGNITION, V102, P101, DOI 10.1016/j.cognition.2006.09.001; Castronovo J, 2007, Q J EXP PSYCHOL, V60, P101, DOI 10.1080/17470210600598635; de Hevia MD, 2010, PSYCHOL SCI, V21, P653, DOI 10.1177/0956797610366091; de Hevia MD, 2009, COGNITION, V110, P198, DOI 10.1016/j.cognition.2008.11.003; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Di Bono MG, 2012, J EXP PSYCHOL HUMAN, V38, P838, DOI 10.1037/a0028346; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Fabbri M, 2012, ACTA PSYCHOL, V139, P111, DOI 10.1016/j.actpsy.2011.09.006; Fias W., 2005, HDB MATH COGNITION, P43; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2008, CORTEX, V44, P386, DOI 10.1016/j.cortex.2007.08.004; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; HENIK A, 1982, MEM COGNITION, V10, P389, DOI 10.3758/BF03202431; Holmes KJ, 2012, Q J EXP PSYCHOL, V65, P1044, DOI 10.1080/17470218.2012.685079; Holmes KJ, 2011, BRAIN COGNITION, V77, P315, DOI 10.1016/j.bandc.2011.07.002; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Hurewitz F, 2006, P NATL ACAD SCI USA, V103, P19599, DOI 10.1073/pnas.0609485103; Ishihara M, 2008, CORTEX, V44, P454, DOI 10.1016/j.cortex.2007.08.010; Kadosh RC, 2008, PROG NEUROBIOL, V84, P132, DOI 10.1016/j.pneurobio.2007.11.001; Kadosh RC, 2009, BEHAV BRAIN SCI, V32, P313, DOI 10.1017/S0140525X09990938; Loetscher T, 2008, CURR BIOL, V18, pR60, DOI 10.1016/j.cub.2007.11.015; Longo MR, 2010, BRAIN COGNITION, V72, P362, DOI 10.1016/j.bandc.2009.10.016; Lourenco SF, 2012, P NATL ACAD SCI USA, V109, P18737, DOI 10.1073/pnas.1207212109; Lourenco SF, 2011, ATTENTION PERFORM, P225, DOI 10.1016/B978-0-12-385948-8.00015-3; Lourenco SF, 2010, PSYCHOL SCI, V21, P873, DOI 10.1177/0956797610370158; Lu AT, 2011, J EXP PSYCHOL HUMAN, V37, P1855, DOI 10.1037/a0024673; Lu AT, 2009, COGNITION, V113, P117, DOI 10.1016/j.cognition.2009.07.001; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2008, NEUROSCI LETT, V438, P308, DOI 10.1016/j.neulet.2008.04.051; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023553; Shaki S, 2008, COGNITION, V108, P590, DOI 10.1016/j.cognition.2008.04.001; Srinivasan M, 2010, COGNITION, V116, P217, DOI 10.1016/j.cognition.2010.05.005; Tudusciuc O, 2007, P NATL ACAD SCI USA, V104, P14513, DOI 10.1073/pnas.0705495104; Vallesi A, 2008, COGNITION, V107, P501, DOI 10.1016/j.cognition.2007.10.011; Vicario CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001716; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wood G., 2008, PSYCHOL SCI Q, V50, P489; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2	44	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58381	10.1371/journal.pone.0058381	http://dx.doi.org/10.1371/journal.pone.0058381			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23484023	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100113
J	Tilani, N; De Costa, S; Heemstra, JM				Tilani, N.; De Costa, S.; Heemstra, Jennifer M.			Evaluating the Effect of Ionic Strength on Duplex Stability for PNA Having Negatively or Positively Charged Side Chains	PLOS ONE			English	Article							PEPTIDE NUCLEIC-ACIDS; SEQUENCE B-DNA; STRAND INVASION; MIXED-SEQUENCE; HYBRIDIZATION PROPERTIES; CRYSTAL-STRUCTURE; MELTING CURVES; GAMMA-PNA; RECOGNITION; OLIGONUCLEOTIDES	The enhanced thermodynamic stability of PNA:DNA and PNA: RNA duplexes compared with DNA: DNA and DNA: RNA duplexes has been attributed in part to the lack of electrostatic repulsion between the uncharged PNA backbone and negatively charged DNA or RNA backbone. However, there are no previously reported studies that systematically evaluate the effect of ionic strength on duplex stability for PNA having a charged backbone. Here we investigate the role of charge repulsion in PNA binding by synthesizing PNA strands having negatively or positively charged side chains, then measuring their duplex stability with DNA or RNA at varying salt concentrations. At low salt concentrations, positively charged PNA binds more strongly to DNA and RNA than does negatively charged PNA. However, at medium to high salt concentrations, this trend is reversed, and negatively charged PNA shows higher affinity for DNA and RNA than does positively charged PNA. These results show that charge screening by counterions in solution enables negatively charged side chains to be incorporated into the PNA backbone without reducing duplex stability with DNA and RNA. This research provides new insight into the role of electrostatics in PNA binding, and demonstrates that introduction of negatively charged side chains is not significantly detrimental to PNA binding affinity at physiological ionic strength. The ability to incorporate negative charge without sacrificing binding affinity is anticipated to enable the development of PNA therapeutics that take advantage of both the inherent benefits of PNA and the multitude of charge-based delivery technologies currently being developed for DNA and RNA.	[Heemstra, Jennifer M.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; Univ Utah, Ctr Cell & Genome Sci, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Heemstra, JM (corresponding author), Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.	heemstra@chem.utah.edu			University of Utah	University of Utah	This research was funded by the University of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avitabile C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035774; Bentin T, 2003, BIOCHEMISTRY-US, V42, P13987, DOI 10.1021/bi0351918; Boxer MB, 2010, CHEMMEDCHEM, V5, P730, DOI 10.1002/cmdc.200900531; Boyarskaya NP, 2006, DOKL CHEM, V408, P57, DOI 10.1134/S0012500806050016; Braasch DA, 2002, CURR PROTOC NUCL ACI; BROWN SC, 1994, SCIENCE, V265, P777, DOI 10.1126/science.7519361; Cheatham TE, 1997, J AM CHEM SOC, V119, P4805, DOI 10.1021/ja963641w; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; Dragulescu-Andrasi A, 2006, J AM CHEM SOC, V128, P10258, DOI 10.1021/ja0625576; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Efimov VA, 2005, NUCLEOS NUCLEOT NUCL, V24, P1853, DOI 10.1080/15257770500268830; Efimov VA, 1998, NUCLEIC ACIDS RES, V26, P566, DOI 10.1093/nar/26.2.566; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Englund EA, 2007, ANGEW CHEM INT EDIT, V46, P1414, DOI 10.1002/anie.200603483; Eriksson M, 1996, NAT STRUCT BIOL, V3, P410, DOI 10.1038/nsb0596-410; Grimm EL, 2004, BIOORGAN MED CHEM, V12, P845, DOI 10.1016/j.bmc.2004.01.007; Haaima G, 1996, ANGEW CHEM INT EDIT, V35, P1939; He GF, 2009, J AM CHEM SOC, V131, P12088, DOI 10.1021/ja900228j; Hyrup B, 1996, BIOORG MED CHEM LETT, V6, P1083, DOI 10.1016/0960-894X(96)00176-X; Ishihara T, 1999, J AM CHEM SOC, V121, P2012, DOI 10.1021/ja983834e; Janson CG, 2006, PEPTIDE NUCL ACIDS M; Joshi R, 2011, J PEPT SCI, V17, P8, DOI 10.1002/psc.1305; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Kaihatsu K, 2003, BIOCHEMISTRY-US, V42, P13996, DOI 10.1021/bi035194k; Kleiner RE, 2008, J AM CHEM SOC, V130, P4646, DOI 10.1021/ja0753997; MANNING GS, 1972, BIOPOLYMERS, V11, P937, DOI 10.1002/bip.1972.360110502; Marchelli R., 2011, TARGETS GENE THERAPY, P29; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Menchise V, 2003, P NATL ACAD SCI USA, V100, P12021, DOI 10.1073/pnas.2034746100; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Mitra R, 2011, CHEM COMMUN, V47, P1198, DOI 10.1039/c0cc03988h; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Nielsen PE, 2004, PEPTIDE NUCL ACIDS P, V2nd; PARIKH JR, 1967, J AM CHEM SOC, V89, P5505, DOI 10.1021/ja00997a067; Peyman A, 1997, ANGEW CHEM INT EDIT, V36, P2809, DOI 10.1002/anie.199728091; Rapireddy S, 2007, J AM CHEM SOC, V129, P15596, DOI 10.1021/ja074886j; Rapireddy S, 2011, BIOCHEMISTRY-US, V50, P3913, DOI 10.1021/bi2002554; Sahu B, 2011, J ORG CHEM, V76, P5614, DOI 10.1021/jo200482d; Sahu B, 2009, J ORG CHEM, V74, P1509, DOI 10.1021/jo802211n; SCHILDKRAUT C, 1965, BIOPOLYMERS, V3, P195, DOI 10.1002/bip.360030207; Sforza S, 1999, EUR J ORG CHEM, V1999, P197; Shiraishi T, 2008, NUCLEIC ACIDS RES, V36, P4424, DOI 10.1093/nar/gkn401; THOMSON SA, 1995, TETRAHEDRON, V51, P6179, DOI 10.1016/0040-4020(95)00286-H; Tomac S, 1996, J AM CHEM SOC, V118, P5544, DOI 10.1021/ja960495l; Topham CM, 2007, BIOPHYS J, V92, P769, DOI 10.1529/biophysj.105.079723; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wu Y, 2001, TETRAHEDRON, V57, P8107, DOI 10.1016/S0040-4020(01)00789-X; Yeh JI, 2010, J AM CHEM SOC, V132, P10717, DOI 10.1021/ja907225d; Zhou P, 2003, J AM CHEM SOC, V125, P6878, DOI 10.1021/ja029665m	51	14	20	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58670	10.1371/journal.pone.0058670	http://dx.doi.org/10.1371/journal.pone.0058670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484047	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100134
J	Cao, YK; Zhang, SF; Zou, SE; Xia, X				Cao, Yuankui; Zhang, Shaofen; Zou, Shien; Xia, Xian			The Relationship between Endogenous Androgens and Body Fat Distribution in Early and Late Postmenopausal Women	PLOS ONE			English	Article							HORMONE-BINDING GLOBULIN; PERIPHERAL TARGET TISSUES; X-RAY ABSORPTIOMETRY; METABOLIC-SYNDROME; DEHYDROEPIANDROSTERONE-SULFATE; MENOPAUSE TRANSITION; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; FREE TESTOSTERONE; HEALTHY WOMEN	Objectives: To investigate the relationship between endogenous androgens and body fat distribution in early and late postmenopausal women. Materials and Methods: We enrolled postmenopausal women consisting of an early group (<= 5 years since menopause, n = 105) and a late group (>= 10 years since menopause, n = 107). Each group was subdivided into normal weight (BMI<24 kg/m(2)) group, overweight and obese (BMI >= 24 kg/m(2)) group. Fasting total testosterone (T), dehydroepiandrosterone-sulfate (DHEA-S) and sex hormone-binding globulin (SHBG) levels were measured. Body fat distribution was evaluated by dual-energy X-ray absorptiometry (DEXA). Results: Late postmenopausal women had a higher proportion of body fat than early postmenopausal women. The body fat of the overweight and obese women had a greater tendency to accumulate in the abdomen compared with the normal weight women both in early and late postmenopausal groups. The overweight and obese women had a higher free testosterone (FT) than the normal weight women in early postmenopausal women (P<0.05). In late postmenopausal women, the overweight and obese women had higher DHEA-S levels than normal weight women (P<0.05). No direct relationship was observed between the T levels and body fat distribution both in early and late postmenopausal groups (P>0.05). The FT in early postmenopausal women and the DHEA- S levels in late postmenopausal women correlated positively with the trunk/leg fat ratio (T/L) and the proportion of android fat whereas correlated negatively with the proportion of gynoid fat in the partial correlation and multiple linear regression analyses (all P<0.05). Conclusions: Serum T levels do not correlate directly with body fat distribution, the FT in early postmenopausal women and DHEA- S levels in late postmenopausal women correlate positively with abdominal fat accumulation.	[Cao, Yuankui; Zhang, Shaofen; Zou, Shien; Xia, Xian] Hosp Fudan Univ, Dept Gynecol Obstet & Gynecol, Shanghai 200433, Peoples R China	Fudan University	Zhang, SF (corresponding author), Hosp Fudan Univ, Dept Gynecol Obstet & Gynecol, Shanghai 200433, Peoples R China.	zhangshaofen@163.com			Shanghai Science Committee's Innovation Program [08411966000]	Shanghai Science Committee's Innovation Program	This work was supported by research funding from the Shanghai Science Committee's Innovation Program (08411966000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin F, 2009, EUR J INTERN MED, V20, P162, DOI 10.1016/j.ejim.2007.09.023; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Belanger C, 2002, HORM METAB RES, V34, P737, DOI 10.1055/s-2002-38265; Blouin K, 2008, J STEROID BIOCHEM, V108, P272, DOI 10.1016/j.jsbmb.2007.09.001; Burger HG, 2000, J CLIN ENDOCR METAB, V85, P2832, DOI 10.1210/jc.85.8.2832; Cobin Rhoda H, 2006, Endocr Pract, V12, P315; Davis SR, 2011, J CLIN ENDOCR METAB, V96, P1642, DOI 10.1210/jc.2010-2888; DEPERGOLA G, 1994, INT J OBESITY, V18, P659; Douchi T, 2002, MATURITAS, V42, P301, DOI 10.1016/S0378-5122(02)00161-5; Fogle RH, 2007, J CLIN ENDOCR METAB, V92, P3040, DOI 10.1210/jc.2007-0581; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Genazzam AR, 2010, CLIMACTERIC, V13, P314, DOI 10.3109/13697137.2010.492496; Golden SH, 2007, J CLIN ENDOCR METAB, V92, P1289, DOI 10.1210/jc.2006-1895; Hackbert L, 2002, J WOMEN HEALTH GEN-B, V11, P155, DOI 10.1089/152460902753645290; Hajamor S, 2003, METABOLISM, V52, P724, DOI 10.1016/S0026-0495(03)00066-0; Harlow SD, 2012, CLIMACTERIC, V15, P105, DOI [10.3109/13697137.2011.650656, 10.1016/j.fertnstert.2012.01.128, 10.1210/jc.2011-3362, 10.1097/gme.0b013e31824d8f40]; He Q, 2002, CIRCULATION, V105, P1093, DOI 10.1161/hc0902.104706; Ivandic A, 2002, WIEN KLIN WOCHENSCHR, V114, P321; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Kahwati LC, 2005, J FAM PRACTICE, V54, P1000; Kirchengast S, 2004, FERTIL STERIL, V81, P539, DOI 10.1016/j.fertnstert.2003.08.018; Kirchengast S, 1997, ANN HUM BIOL, V24, P45, DOI 10.1080/03014469700004762; Labrie F, 1998, STEROIDS, V63, P322, DOI 10.1016/S0039-128X(98)00007-5; Labrie F, 2003, ANN ENDOCRINOL-PARIS, V64, P95; Labrie F, 2001, FRONT NEUROENDOCRIN, V22, P185, DOI 10.1006/frne.2001.0216; Labrie F, 2007, J STEROID BIOCHEM, V103, P178, DOI 10.1016/j.jsbmb.2006.09.034; Labrie F, 2011, MENOPAUSE, V18, P30, DOI 10.1097/gme.0b013e3181e195a6; Llaneza P, 2007, MATURITAS, V58, P387, DOI 10.1016/j.maturitas.2007.09.013; LUUTHE V, 1995, DNA CELL BIOL, V14, P511, DOI 10.1089/dna.1995.14.511; NESTLER JE, 1988, J CLIN ENDOCR METAB, V66, P57, DOI 10.1210/jcem-66-1-57; Panotopoulos G, 1996, MATURITAS, V25, P11, DOI 10.1016/0378-5122(96)01119-X; POEHLMAN ET, 1995, ANN INTERN MED, V123, P673, DOI 10.7326/0003-4819-123-9-199511010-00005; Salpeter SR, 2006, DIABETES OBES METAB, V8, P538, DOI 10.1111/j.1463-1326.2005.00545.x; Schmidt PJ, 2005, ARCH GEN PSYCHIAT, V62, P154, DOI 10.1001/archpsyc.62.2.154; Shelling AN, 2010, REPRODUCTION, V140, P633, DOI 10.1530/REP-09-0567; Soules M R, 2001, Climacteric, V4, P267; SVENDSEN OL, 1995, METABOLISM, V44, P369, DOI 10.1016/0026-0495(95)90168-X; Tchernof A, 1999, DIABETES CARE, V22, P1875, DOI 10.2337/diacare.22.11.1875; Tchernof A, 1998, OBES RES, V6, P246, DOI 10.1002/j.1550-8528.1998.tb00344.x; Toth MJ, 2000, ANN NY ACAD SCI, V904, P502; Tremollieres FA, 1996, AM J OBSTET GYNECOL, V175, P1594, DOI 10.1016/S0002-9378(96)70111-4; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; VERMEULEN A, 1976, J CLIN ENDOCR METAB, V42, P247, DOI 10.1210/jcem-42-2-247; Weinberg ME, 2006, METABOLISM, V55, P1473, DOI 10.1016/j.metabol.2006.06.017; Zhou Beifan, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P5	45	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58448	10.1371/journal.pone.0058448	http://dx.doi.org/10.1371/journal.pone.0058448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484029	Green Submitted, gold, Green Published			2022-12-27	WOS:000315634900089
J	Sinici, I; Yonekawa, S; Tkachyova, I; Gray, SJ; Samulski, RJ; Wakarchuk, W; Mark, BL; Mahuran, DJ				Sinici, Incilay; Yonekawa, Sayuri; Tkachyova, Ilona; Gray, Steven J.; Samulski, R. Jude; Wakarchuk, Warren; Mark, Brian L.; Mahuran, Don J.			In Cellulo Examination of a Beta-Alpha Hybrid Construct of Beta-Hexosaminidase A Subunits, Reported to Interact with the GM2 Activator Protein and Hydrolyze GM2 Ganglioside	PLOS ONE			English	Article							TAY-SACHS-DISEASE; G(M2) GANGLIOSIDE; CRYSTAL-STRUCTURE; SANDHOFF-DISEASE; NONHUMAN-PRIMATES; MOUSE MODELS; GENE-THERAPY; DELIVERY; FIBROBLASTS; BRAIN	The hydrolysis in lysosomes of GM2 ganglioside to GM3 ganglioside requires the correct synthesis, intracellular assembly and transport of three separate gene products; i.e., the alpha and beta subunits of heterodimeric beta-hexosaminidase A, E. C. # 3.2.1.52 (encoded by the HEXA and HEXB genes, respectively), and the GM2-activator protein (GM2AP, encoded by the GM2A gene). Mutations in any one of these genes can result in one of three neurodegenerative diseases collectively known as GM2 gangliosidosis (HEXA, Tay-Sachs disease, MIM # 272800; HEXB, Sandhoff disease, MIM # 268800; and GM2A, AB-variant form, MIM # 272750). Elements of both of the hexosaminidase A subunits are needed to productively interact with the GM2 ganglioside-GM2AP complex in the lysosome. Some of these elements have been predicted from the crystal structures of hexosaminidase and the activator. Recently a hybrid of the two subunits has been constructed and reported to be capable of forming homodimers that can perform this reaction in vivo, which could greatly simplify vector-mediated gene transfer approaches for Tay-Sachs or Sandhoff diseases. A cDNA encoding a hybrid hexosaminidase subunit capable of dimerizing and hydrolyzing GM2 ganglioside could be incorporated into a single vector, whereas packaging both subunits of hexosaminidase A into vectors, such as adeno-associated virus, would be impractical due to size constraints. In this report we examine the previously published hybrid construct (H1) and a new more extensive hybrid (H2), with our documented in cellulo (live cell-based) assay utilizing a fluorescent GM2 ganglioside derivative. Unfortunately when Tay-Sachs cells were transfected with either the H1 or H2 hybrid construct and then were fed the GM2 derivative, no significant increase in its turnover was detected. In vitro assays with the isolated H1 or H2 homodimers confirmed that neither was capable of human GM2AP-dependent hydrolysis of GM2 ganglioside.	[Sinici, Incilay] Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey; [Yonekawa, Sayuri; Tkachyova, Ilona; Mahuran, Don J.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Tkachyova, Ilona; Mahuran, Don J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Gray, Steven J.; Samulski, R. Jude] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC USA; [Wakarchuk, Warren] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	Hacettepe University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of North Carolina; University of North Carolina Chapel Hill; Toronto Metropolitan University; University of Manitoba	Mahuran, DJ (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	hex@sickkids.ca	Wakarchuk, Warren/Q-9514-2017; LAY, INCILAY/I-8315-2013; Wakarchuk, Warren/AAO-2774-2020	Wakarchuk, Warren/0000-0002-1539-1679; LAY, INCILAY/0000-0002-1466-5746; Wakarchuk, Warren/0000-0002-1539-1679; Mark, Brian/0000-0002-7344-1355	New Hope Research Foundation (USA); Canadian Institutes of Health Research (CIHR) Team Grant [CTP-82944]; Scientific and Technical Research Council of Turkey (TUBITAK)	New Hope Research Foundation (USA); Canadian Institutes of Health Research (CIHR) Team Grant(Canadian Institutes of Health Research (CIHR)); Scientific and Technical Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by grants from the New Hope Research Foundation (USA) and a Canadian Institutes of Health Research (CIHR) Team Grant (CTP-82944) to DM. Salary and expenses for IS were supplied by a scholarship from the Scientific and Technical Research Council of Turkey (TUBITAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertoni C, 1999, J BIOL CHEM, V274, P28612, DOI 10.1074/jbc.274.40.28612; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Cachon-Gonzalez MB, 2006, P NATL ACAD SCI USA, V103, P10373, DOI 10.1073/pnas.0603765103; CALLAHAN JW, 1970, BIOCHEM MED METAB B, V4, P295, DOI 10.1016/0006-2944(70)90056-6; Duque S, 2009, MOL THER, V17, P1187, DOI 10.1038/mt.2009.71; Federici T, 2012, GENE THER, V19, P852, DOI 10.1038/gt.2011.130; Fernandes MJG, 1997, J BIOL CHEM, V272, P814, DOI 10.1074/jbc.272.2.814; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gray SJ, 2012, NEUROPHARMA IN PRESS; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Guidotti JE, 1999, HUM MOL GENET, V8, P831, DOI 10.1093/hmg/8.5.831; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HIRABAYASHI Y, 1983, J NEUROCHEM, V40, P168, DOI 10.1111/j.1471-4159.1983.tb12667.x; Hou YM, 1998, J BIOL CHEM, V273, P21386, DOI 10.1074/jbc.273.33.21386; Igdoura SA, 1999, HUM MOL GENET, V8, P1111, DOI 10.1093/hmg/8.6.1111; KORNELUK RG, 1986, J BIOL CHEM, V261, P8407; Lacorazza HD, 1996, NAT MED, V2, P424, DOI 10.1038/nm0496-424; Lemieux MJ, 2006, J MOL BIOL, V359, P913, DOI 10.1016/j.jmb.2006.04.004; Liu YJ, 1997, P NATL ACAD SCI USA, V94, P8138, DOI 10.1073/pnas.94.15.8138; MAHURAN DJ, 1988, J BIOL CHEM, V263, P4612; MAHURAN DJ, 1991, BIOCHIM BIOPHYS ACTA, V1096, P87, DOI 10.1016/0925-4439(91)90044-A; Maier T, 2003, J MOL BIOL, V328, P669, DOI 10.1016/S0022-2836(03)00311-5; Mark BL, 2003, J MOL BIOL, V327, P1093, DOI 10.1016/S0022-2836(03)00216-X; Martin DR, 2004, EXP NEUROL, V187, P30, DOI 10.1016/j.expneurol.2004.01.008; Martino S, 2005, HUM MOL GENET, V14, P2113, DOI 10.1093/hmg/ddi216; Matsuoka K, 2011, MOL THER, V19, P1017, DOI 10.1038/mt.2011.27; NEOTE K, 1990, J BIOL CHEM, V265, P20799; Phaneuf D, 1996, HUM MOL GENET, V5, P1, DOI 10.1093/hmg/5.1.1; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Samaranch L, 2012, HUM GENE THER, V23, P382, DOI 10.1089/hum.2011.200; SANGO K, 1995, NAT GENET, V11, P170, DOI 10.1038/ng1095-170; Sharma R, 2003, BBA-MOL BASIS DIS, V1637, P113, DOI 10.1016/S0925-4439(02)00221-1; Sharma R, 2001, BIOCHEMISTRY-US, V40, P5440, DOI 10.1021/bi0029200; SmiljanicGeorgijev N, 1997, BBA-PROTEIN STRUCT M, V1339, P192, DOI 10.1016/S0167-4838(97)00002-2; SUZUKI Y, 1978, HUM GENET, V43, P127, DOI 10.1007/BF00293589; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Tropak MB, 2010, GLYCOBIOLOGY, V20, P356, DOI 10.1093/glycob/cwp183; Wright CS, 2000, J MOL BIOL, V304, P411, DOI 10.1006/jmbi.2000.4225; Yuziuk JA, 1998, J BIOL CHEM, V273, P66, DOI 10.1074/jbc.273.1.66; Zarghooni M, 2004, BIOCHEM BIOPH RES CO, V324, P1048, DOI 10.1016/j.bbrc.2004.09.159	40	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57908	10.1371/journal.pone.0057908	http://dx.doi.org/10.1371/journal.pone.0057908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483939	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900053
J	Mudau, M; Jacobson, R; Minenza, N; Kuonza, L; Morris, V; Engelbrecht, H; Nicol, MP; Bamford, C				Mudau, Maanda; Jacobson, Rachael; Minenza, Nadia; Kuonza, Lazarus; Morris, Vida; Engelbrecht, Heather; Nicol, Mark P.; Bamford, Colleen			Outbreak of Multi-Drug Resistant Pseudomonas aeruginosa Bloodstream Infection in the Haematology Unit of a South African Academic Hospital	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; INTENSIVE-CARE-UNIT; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; NOSOCOMIAL OUTBREAK; CANCER; TRANSMISSION; BACTEREMIA; MECHANISMS; THERAPY	Objective: To describe an outbreak of multi-resistant Pseudomonas aeruginosa bloodstream infections (MRPA-BSI) that occurred in the haematology ward of a tertiary academic hospital in Cape Town, South Africa, and determine risk factors for acquisition of MRPA-BSI. Methods: The outbreak investigation included a search for additional cases, review of patient records, environmental and staff screening, molecular typing using pulsed-field gel electrophoresis (PFGE) and Multi-locus sequencing (MLST) and a retrospective case-control study. Results: Ten MRPA-BSI cases occurred in the haematology ward between January 2010 and January 2011. The case fatality rate was 80%. Staff screening specimens were negative for MRPA and an environmental source was not identified. PFGE showed that 9/10 isolates were related. MLST showed that 3 of these 9 isolates belonged to Sequence type (ST) 233 while the unrelated isolate belonged to ST260. Conclusion: We have described an outbreak of MRPA-BSI occurring over an extended period of time among neutropenic haematology patients. Molecular typing confirms that the outbreak was predominantly due to a single strain. The source of the outbreak was not identified, but the outbreak appears to have been controlled following intensive infection control measures.	[Mudau, Maanda; Jacobson, Rachael; Nicol, Mark P.; Bamford, Colleen] Ctr Trop Opportunist & Hosp Infect, Natl Inst Communicable Dis, Johannesburg, South Africa; [Minenza, Nadia; Nicol, Mark P.; Bamford, Colleen] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Mudau, Maanda; Kuonza, Lazarus] South African Field Epidemiol & Lab Training Prog, Johannesburg, South Africa; [Mudau, Maanda; Kuonza, Lazarus] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Fac Hlth Sci, ZA-0002 Pretoria, South Africa; [Morris, Vida; Engelbrecht, Heather] Prov Govt Western Cape Dept Hlth, Cape Town, South Africa	National Institute for Communicable Diseases (NICD); University of Cape Town; University of Pretoria	Bamford, C (corresponding author), Ctr Trop Opportunist & Hosp Infect, Natl Inst Communicable Dis, Johannesburg, South Africa.	colleen.bamford@nhls.ac.za	Nicol, Mark/W-4149-2019; Mudau, Maanda/U-9649-2017	Nicol, Mark/0000-0002-1366-4805; Mudau, Maanda/0000-0003-0697-2460; Kuonza, Lazarus/0000-0001-5338-320X	National Research Foundation, South Africa; University of Cape Town, South Africa	National Research Foundation, South Africa(National Research Foundation - South Africa); University of Cape Town, South Africa	Nadia Minenza received financial support from the National Research Foundation, South Africa and from the University of Cape Town, South Africa (both unrestricted educational grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cortes JA, 2009, BRAZ J INFECT DIS, V13, P99, DOI 10.1590/S1413-86702009000200005; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Clinical and Laboratory Standards Institute, 2010, PERF STAND ANT SUSC; Crespo MP, 2004, J CLIN MICROBIOL, V42, P5094, DOI 10.1128/JCM.42.11.5094-5101.2004; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Dwivedi M, 2009, INDIAN J PATHOL MICR, V52, P509, DOI 10.4103/0377-4929.56143; Engelhart S, 2002, J HOSP INFECT, V52, P93, DOI 10.1053/jhin.2002.1279; Hammami S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-106; Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152; Harris AD, 2002, CLIN INFECT DIS, V34, P1558, DOI 10.1086/340533; Harris AD, 2002, ANTIMICROB AGENTS CH, V46, P854, DOI 10.1128/AAC.46.3.854-858.2002; Jacobson RK, 2012, J ANTIMICROB CHEMOTH, V67, P1797, DOI 10.1093/jac/dks100; Joo EJ, 2011, J INFECTION, V63, P207, DOI 10.1016/j.jinf.2011.06.011; Klastersky J, 2000, INT J ANTIMICROB AG, V16, P131, DOI 10.1016/S0924-8579(00)00238-7; KOMINOS SD, 1972, APPL MICROBIOL, V23, P309, DOI 10.1128/AEM.23.2.309-312.1972; Lambert PA, 2002, J ROY SOC MED, V95, P22; Micol JB, 2006, HAEMATOLOGICA, V91, P1134; National Health Laboratory Service Standard Operating Procedure MIC1605v1, 2011, TEST PATH WAT MEMBR; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Pitout JDD, 2008, CLIN MICROBIOL INFEC, V14, P755, DOI 10.1111/j.1469-0691.2008.02030.x; Poirel L, 2002, J ANTIMICROB CHEMOTH, V49, P561, DOI 10.1093/jac/49.3.561; Samuelsen O, 2010, ANTIMICROB AGENTS CH, V54, P346, DOI 10.1128/AAC.00824-09; SCHIMPFF S, 1971, NEW ENGL J MED, V284, P1061, DOI 10.1056/NEJM197105132841904; SCHIMPFF SC, 1986, AM J MED, V80, P13; TANCREDE CH, 1985, J INFECT DIS, V152, P99, DOI 10.1093/infdis/152.1.99; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tsutsui A, 2011, J HOSP INFECT, V78, P317, DOI 10.1016/j.jhin.2011.04.013; WIDMER AF, 1993, CLIN INFECT DIS, V16, P372, DOI 10.1093/clind/16.3.372	28	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e55985	10.1371/journal.pone.0055985	http://dx.doi.org/10.1371/journal.pone.0055985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516393	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400004
J	Lin, MW; Ho, JWK; Harrison, LC; dos Remedios, CG; Adelstein, S				Lin, Ming-Wei; Ho, Joshua W. K.; Harrison, Leonard C.; dos Remedios, Cristobal G.; Adelstein, Stephen			An Antibody-Based Leukocyte-Capture Microarray for the Diagnosis of Systemic Lupus Erythematosus	PLOS ONE			English	Article							PERIPHERAL-BLOOD LYMPHOCYTES; ANTIGEN MICROARRAY; DISEASE-ACTIVITY; EXPRESSION; CLASSIFICATION; DISCOVERY; LEUKEMIAS; CLUSTER; CANCER; SLE	The diagnosis of Systemic Lupus Erythematosus (SLE) is challenging due to its heterogeneous clinical presentation and the lack of robust biomarkers to distinguish it from other autoimmune diseases. Further, currently used laboratory tests do not readily distinguish active and inactive disease. Several groups have attempted to apply emerging high throughput profiling technologies to diagnose and monitor SLE. Despite showing promise, many are expensive and technically challenging for routine clinical use. The goal of this work is to develop a better diagnostic and monitoring tool for SLE. We report a highly customisable antibody microarray that consists of a duplicate arrangement of 82 antibodies directed against surface antigens on peripheral blood mononuclear cells (PMBCs). This high-throughput array was used to profile SLE patients (n = 60) with varying disease activity, compared to healthy controls (n = 24), patients with rheumatoid arthritis (n = 25), and other autoimmune diseases (n = 28). We used a computational algorithm to calculate a score from the entire microarray profile and correlated it with SLE disease activity. Our results demonstrate that leukocyte-capture microarray profiles can readily distinguish active SLE patients from healthy controls (AUROC = 0.84). When combined with the standard laboratory tests (serum anti-dsDNA, complements C3 and C4), the microarrays provide significantly increased discrimination. The antibody microarrays can be enhanced by the addition of other markers for potential application to the diagnosis and stratification of SLE, paving the way for the customised and accurate diagnosis and monitoring of SLE.	[Lin, Ming-Wei; Adelstein, Stephen] Royal Prince Alfred Hosp, Dept Clin Immunol, Sydney, NSW, Australia; [Lin, Ming-Wei; Adelstein, Stephen] Univ Sydney, Sydney Med Sch, Discipline Med, Sydney, NSW 2006, Australia; [Ho, Joshua W. K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [Harrison, Leonard C.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Dept Clin Immunol, Parkville, Vic 3050, Australia; [Harrison, Leonard C.] Royal Melbourne Hosp, Burnet Clin Res Unit, Parkville, Vic 3050, Australia; [dos Remedios, Cristobal G.] Univ Sydney, Bosch Inst, Discipline Anat, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; University of Sydney	Adelstein, S (corresponding author), Royal Prince Alfred Hosp, Dept Clin Immunol, Sydney, NSW, Australia.	stephen.adelstein@sydney.edu.au	Adelstein, Stephen/I-7936-2016; Ho, Joshua W. K./AAK-7759-2020	Adelstein, Stephen/0000-0001-7221-6298; Ho, Joshua W. K./0000-0003-2331-7011	NWG Macintosh Memorial Fund of the Department of Anatomy Histology; University of Sydney; Special Purposes Trust Fund	NWG Macintosh Memorial Fund of the Department of Anatomy Histology; University of Sydney(University of Sydney); Special Purposes Trust Fund	Studies were supported by the NWG Macintosh Memorial Fund of the Department of Anatomy & Histology, University of Sydney and the Special Purposes Trust Fund and generous donors to the Department of Clinical Immunology, Royal Prince Alfred Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belov L, 2001, CANCER RES, V61, P4483; Belov L, 2006, BRIT J HAEMATOL, V135, P184, DOI 10.1111/j.1365-2141.2006.06266.x; Bijl M, 2001, LUPUS, V10, P866, DOI 10.1191/096120301701548517; Bijl M, 2001, ANN RHEUM DIS, V60, P523, DOI 10.1136/ard.60.5.523; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Brown A, 2008, PROTEOM CLIN APPL, V2, P90, DOI 10.1002/prca.200780090; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristianani N, 2000, INTRO SUPPORT VECTOR; Fattal I, 2010, IMMUNOLOGY, V130, P337, DOI 10.1111/j.1365-2567.2010.03245.x; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Ho JWK, 2010, PROTEOM CLIN APPL, V4, P179, DOI 10.1002/prca.200900165; Ho JWK, 2008, GENOME INFORM SER, V21, P126; Huang RP, 2001, ANAL BIOCHEM, V294, P55, DOI 10.1006/abio.2001.5156; Hueber W, 2005, ARTHRITIS RHEUM-US, V52, P2645, DOI 10.1002/art.21269; Joos TO, 2000, ELECTROPHORESIS, V21, P2641, DOI 10.1002/1522-2683(20000701)21:13<2641::AID-ELPS2641>3.3.CO;2-X; Lal S, 2004, PROTEOMICS, V4, P1918, DOI 10.1002/pmic.200300756; Lal S, 2009, MOL CELL PROTEOMICS, V8, P799, DOI 10.1074/mcp.M800335-MCP200; LUI R, 2008, CLIN PROTEOMICS DIAG, P571; Mohamed AN, 2010, CARDIOL RES CLIN DEV, P195; Morris DL, 2009, GENES IMMUN, V10, P404, DOI 10.1038/gene.2009.17; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Robinson WH, 2002, NAT MED, V8, P295, DOI 10.1038/nm0302-295; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359	27	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							SICI e58199	10.1371/journal.pone.0058199	http://dx.doi.org/10.1371/journal.pone.0058199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516448	Green Published, gold			2022-12-27	WOS:000316849200041
J	Qian, LW; Zheng, HR; Zhou, H; Qin, RB; Li, JL				Qian, Liwei; Zheng, Haoran; Zhou, Hong; Qin, Ruibin; Li, Jinlong			Classification of Time Series Gene Expression in Clinical Studies via Integration of Biological Network	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; INTERFERON-BETA; MICROARRAY DATA; RT-PCR; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDICTION; PROTEOMICS; PROFILES	The increasing availability of time series expression datasets, although promising, raises a number of new computational challenges. Accordingly, the development of suitable classification methods to make reliable and sound predictions is becoming a pressing issue. We propose, here, a new method to classify time series gene expression via integration of biological networks. We evaluated our approach on 2 different datasets and showed that the use of a hidden Markov model/Gaussian mixture models hybrid explores the time-dependence of the expression data, thereby leading to better prediction results. We demonstrated that the biclustering procedure identifies function-related genes as a whole, giving rise to high accordance in prognosis prediction across independent time series datasets. In addition, we showed that integration of biological networks into our method significantly improves prediction performance. Moreover, we compared our approach with several state-of-the-art algorithms and found that our method outperformed previous approaches with regard to various criteria. Finally, our approach achieved better prediction results on early-stage data, implying the potential of our method for practical prediction.	[Qian, Liwei; Zheng, Haoran; Zhou, Hong; Qin, Ruibin; Li, Jinlong] Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei 230026, Peoples R China; [Zheng, Haoran] Univ Sci & Technol China, Anhui Key Lab Software Engn Comp & Commun, Hefei 230026, Peoples R China; [Zheng, Haoran] Univ Sci & Technol China, Dept Syst Biol, Hefei 230026, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zheng, HR (corresponding author), Univ Sci & Technol China, Sch Comp Sci & Technol, Hefei 230026, Peoples R China.	hrzheng@ustc.edu.cn			National Key Technologies RD Program [2011CB910200]	National Key Technologies RD Program(National Key Technology R&D Program)	The authors gratefully acknowledge funding support from the National Key Technologies R&D Program (2011CB910200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraldi E, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-30; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Borgwardt Karsten M, 2006, Pac Symp Biocomput, P547, DOI 10.1142/9789812701626_0051; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Carreiro AV, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-175; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cleator S, 2006, BREAST CANCER RES TR, V95, P229, DOI 10.1007/s10549-005-9009-7; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costa IG, 2009, BIOINFORMATICS, V25, pI6, DOI 10.1093/bioinformatics/btp222; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Dao P, 2011, BIOINFORMATICS, V27, pI205, DOI 10.1093/bioinformatics/btr245; Dudoit S, 2002, GENOME BIOL, V3; Espinosa E, 2012, CANCER METAST REV, P1; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Friedman J, 2001, SPRINGER SERIES STAT, V10; Ginsburg GS, 2001, TRENDS BIOTECHNOL, V19, P491, DOI 10.1016/S0167-7799(01)01814-5; Goertsches RH, 2010, PHARMACOGENOMICS, V11, P147, DOI [10.2217/pgs.09.152, 10.2217/PGS.09.152]; Goldenberg A, 2011, BIOINFORMATICS, V27, P3166, DOI 10.1093/bioinformatics/btr533; Hemmer B, 2002, NAT REV NEUROSCI, V3, P291, DOI 10.1038/nrn784; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Ji LP, 2005, BIOINFORMATICS, V21, P509, DOI 10.1093/bioinformatics/bti026; Ji-Bin Qu, 2011, 2011 IEEE International Conference on Systems Biology (ISB), P388, DOI 10.1109/ISB.2011.6033184; Junjie S, 2010, BMC BIOINFORMATICS, V11; Kaminski N, 2007, J COMPUT BIOL, V14, P324, DOI 10.1089/cmb.2007.0001; Koczan D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2419; Langer-Gould A, 2004, NEUROLOGY, V63, pS35, DOI 10.1212/WNL.63.11_suppl_5.S35; Li WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033653; Li YF, 2011, LECT N BIOINFORMAT, V6685, P275, DOI 10.1007/978-3-642-21946-7_22; Lin TH, 2008, BIOINFORMATICS, V24, pI147, DOI 10.1093/bioinformatics/btn152; Lottaz Claudio, 2008, V453, P281, DOI 10.1007/978-1-60327-429-6_15; Madeira S. C, 2005, 42 I ENG SIST COMP I; Madeira SC, 2010, IEEE ACM T COMPUT BI, V7, P153, DOI 10.1109/TCBB.2008.34; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Moreau Y, 2003, TRENDS GENET, V19, P570, DOI 10.1016/j.tig.2003.08.006; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Olson D.L., 2008, TECHNIQUES, DOI [10.1007/978-3-540-76917-0, DOI 10.1007/978-3-540-76917-0]; Ostrowski J, 2009, EXPERT REV MOL DIAGN, V9, P623, DOI 10.1586/ERM.09.41; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Rio J, 2002, ANN NEUROL, V52, P400, DOI 10.1002/ana.10290; Rodriguez E, 1997, LECT NOTES COMPUT SC, V1206, P227, DOI 10.1007/BFb0016000; Ruiz-Pena JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-3; Schliep A, 2005, IEEE ACM T COMPUT BI, V2, P179, DOI 10.1109/TCBB.2005.31; Schliep A, 2003, BIOINFORMATICS, V19, pi255, DOI 10.1093/bioinformatics/btg1036; Storey John D, 2003, Methods Mol Biol, V224, P149; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Weston AD, 2004, J PROTEOME RES, V3, P179, DOI 10.1021/pr0499693; Zhang H., 2006, IEEE INT C COMP VIS, V2, P2126; Zhang Y, 2005, INF TECHN COD COMP I, P32	55	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58383	10.1371/journal.pone.0058383	http://dx.doi.org/10.1371/journal.pone.0058383			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516469	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200061
J	Vahabi, B; Sellers, DJ; Bijos, DA; Drake, MJ				Vahabi, Bahareh; Sellers, Donna J.; Bijos, Dominika A.; Drake, Marcus J.			Phasic Contractions in Urinary Bladder from Juvenile versus Adult Pigs	PLOS ONE			English	Article							GUINEA-PIG; SMOOTH-MUSCLE; INTERSTITIAL-CELLS; RAT BLADDERS; DETRUSOR; INHIBITOR; GLIVEC; STRIPS; CAJAL	Aims: Alterations in properties of the bladder with maturation are relevant physiologically and pathophysiologically. The aim of this study was to investigate alterations in bladder properties with maturation in juvenile vs. adult pig, focussing on differences between layers of the bladder wall (mucosa vs. detrusor) and the presence and functional contribution of interstitial cells (ICs). Methods: Basal and cholinergic-induced phasic contractions (PCs) in mucosal and denuded-detrusor strips from juvenile and adult pigs were assessed. Expression of c-kit, a marker of ICs, was investigated in the mucosa and the detrusor layers of the pig bladder. The functional role of ICs in mediating PCs was examined using imatinib. Results: Mucosal strips from juvenile and adult pig bladders demonstrated basal PCs whilst denuded-detrusor strips did not. PCs of mucosal strips from juvenile pigs were significantly greater than those from adult bladders. Immunoreactivity for c-kit was detected in mucosa and detrusor layers of pig bladder. Histological studies demonstrated a distinct layer of smooth muscle between the urothelium and bladder detrusor, termed the muscularis mucosa. Imatinib was only effective in inhibiting PCs in mucosal strips from juvenile pigs. Imatinib inhibited the carbachol-induced PCs of both juvenile and adult denuded-detrusor strips, although strips from juvenile bladders demonstrated a trend towards being more sensitive to this inhibition. Conclusions: We confirm the presence of c-kit positive ICs in pig urinary bladder. The enhanced PCs of mucosal strips from juvenile animals could be due to altered properties of ICs or the muscularis mucosa in the bladders of these animals.	[Vahabi, Bahareh] Univ W England, Dept Appl Sci, Bristol BS16 1QY, Avon, England; [Vahabi, Bahareh; Bijos, Dominika A.; Drake, Marcus J.] Southmead Hosp, Bristol Urol Inst, Bristol, Avon, England; [Sellers, Donna J.] Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia; [Drake, Marcus J.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England	University of West England; Southmead Hospital; Bond University; University of Bristol	Vahabi, B (corresponding author), Univ W England, Dept Appl Sci, Bristol BS16 1QY, Avon, England.	Bahareh.vahabi@uwe.ac.uk	; Drake, Marcus/C-4542-2014	Sellers, Donna/0000-0002-0082-4216; Drake, Marcus/0000-0002-6230-2552	University of the West of England (Early Career Researcher grant); North Bristol NHS Trust	University of the West of England (Early Career Researcher grant); North Bristol NHS Trust	The University of the West of England (Early Career Researcher grant) and North Bristol NHS Trust provided the funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino H, 2008, BJU INT, V102, P1168, DOI 10.1111/j.1464-410X.2008.07782.x; Andersson K-E, 2011, Handb Exp Pharmacol, P319, DOI 10.1007/978-3-642-16499-6_16; Andersson KE, 2010, NEUROUROL URODYNAM, V29, P97, DOI 10.1002/nau.20784; [Anonymous], 2012, NEUROUROL URODYNAM, V31, P709; Biers SM, 2006, BJU INT, V97, P612, DOI 10.1111/j.1464-410X.2005.05988.x; Birder Lori A, 2011, Handb Exp Pharmacol, P207, DOI 10.1007/978-3-642-16499-6_10; Buckner SA, 2002, BRIT J PHARMACOL, V135, P639, DOI 10.1038/sj.bjp.0704499; Deng J, 2012, UROLOGY; Hashitani H, 2008, BRIT J PHARMACOL, V154, P451, DOI 10.1038/bjp.2008.91; Heppner TJ, 2011, AM J PHYSIOL-REG I, V301, pR351, DOI 10.1152/ajpregu.00656.2010; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Ikeda Y, 2008, AM J PHYSIOL-RENAL, V295, pF454, DOI 10.1152/ajprenal.90315.2008; Ikeda Y, 2007, AM J PHYSIOL-RENAL, V293, pF1018, DOI 10.1152/ajprenal.00183.2007; Imai T, 2001, ACTA PHYSIOL SCAND, V173, P323, DOI 10.1046/j.1365-201X.2001.00908.x; Johnston L, 2008, AM J PHYSIOL-RENAL, V294, pF645, DOI 10.1152/ajprenal.00526.2007; Kanai A, 2007, AM J PHYSIOL-RENAL, V292, pF1065, DOI 10.1152/ajprenal.00229.2006; Kitamura Y, 2008, J GASTROENTEROL, V43, P499, DOI 10.1007/s00535-008-2200-y; Kubota Y, 2004, AUTON NEUROSCI-BASIC, V115, P64, DOI 10.1016/j.autneu.2004.08.004; Kubota Y, 2008, NEUROUROL URODYNAM, V27, P330, DOI 10.1002/nau.20502; LEVIN RM, 1986, J UROLOGY, V136, P517, DOI 10.1016/S0022-5347(17)44934-2; LONGHURST PA, 1990, COMP BIOCHEM PHYS A, V96, P221, DOI 10.1016/0300-9629(90)90069-5; McCloskey Karen D, 2011, Handb Exp Pharmacol, P233, DOI 10.1007/978-3-642-16499-6_11; Metzger R, 2008, PEDIATR SURG INT, V24, P67, DOI 10.1007/s00383-007-2043-2; Min YZ, 2011, J SURG RES, V171, pE193, DOI 10.1016/j.jss.2011.07.048; Monaghan KP, 2012, J UROL; Moro C, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.08.039; Ng YK, 2007, AM J PHYSIOL-REG I, V292, pR2100, DOI 10.1152/ajpregu.00779.2006; Sadananda P, 2008, BRIT J PHARMACOL, V153, P1465, DOI 10.1038/bjp.2008.29; SIBLEY GNA, 1985, BRIT J UROL, V57, P292, DOI 10.1111/j.1464-410X.1985.tb06347.x; Szell EA, 2003, AM J PHYSIOL-REG I, V285, pR809, DOI 10.1152/ajpregu.00641.2002; Szigeti GP, 2005, J MUSCLE RES CELL M, V26, P23, DOI 10.1007/s10974-005-9003-z; Templeman L, 2003, BJU INT, V92, P787, DOI 10.1046/j.1464-410X.2003.04458.x; Vahabi B, 2011, BJU INT, V107, P1480, DOI 10.1111/j.1464-410X.2010.09507.x; Wuest M, 2005, EUR J PHARMACOL, V524, P145, DOI 10.1016/j.ejphar.2005.09.040	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58611	10.1371/journal.pone.0058611	http://dx.doi.org/10.1371/journal.pone.0058611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516515	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200095
J	Ashbaugh, AR; Herbert, CF; Saimon, E; Azoulay, N; Olivera-Figueroa, L; Brunet, A				Ashbaugh, Andrea R.; Herbert, Christophe F.; Saimon, Elena; Azoulay, Nelson; Olivera-Figueroa, Lening; Brunet, Alain			The Decision to Vaccinate or Not during the H1N1 Pandemic: Selecting the Lesser of Two Evils?	PLOS ONE			English	Article							OBSESSIONAL-COMPULSIVE INVENTORY; ANXIETY STRESS SCALES; HEALTH-CARE WORKERS; INFLUENZA VACCINATION; SWINE FLU; PSYCHOMETRIC PROPERTIES; PUBLIC PERCEPTIONS; RISK; BEHAVIORS; IMPACT	Background: With the release of the H1N1 vaccine, there was much controversy surrounding its use despite strong encouragements to be vaccinated in the media. Though studies have examined factors influencing people's decision to be vaccinated, few have focused on how general beliefs about the world or where an individual gathers information might influence that decision. Methodology/Principal Findings: A cross-sectional web-based survey (N = 817) was conducted during the H1N1 outbreak after the vaccine was available. Variables examined included sociodemographic information, health related behaviours, specific beliefs concerning the H1N1 virus and its vaccine, as well as general beliefs, such as fear of contamination, intolerance of uncertainty, emotional states, coping behaviour, and the source of information concerning the virus. Three converging statistical methods were used to examine the associations - analysis of variance, logistic regression, and recursive partition modelling. The most consistent and strongest association was that negative beliefs about the H1N1 vaccine (e.g. fear of its side effects) was related to the decision not to be vaccinated, whereas beliefs about the dangers of the H1N1 virus was related to the decision to be vaccinated. Most notably, having very strong negative beliefs about the vaccine was a more powerful predictor than even strong beliefs about the dangers of the H1N1 virus. Furthermore, obtaining information from the Internet, as compared to more traditional sources of information (e.g., TV, newspapers) was related to the decision not to be vaccinated. Conclusions/Significance: These results are consistent with the Health Belief Model. Importantly they suggest that during future pandemics public health officials should not only discuss the dangers of the pandemic but also (i) take additional steps to reassure the public about the safety of vaccines and (ii) monitor the information disseminated over the Internet rather than strictly relying on the more traditional mass media.	[Ashbaugh, Andrea R.; Herbert, Christophe F.; Saimon, Elena; Azoulay, Nelson; Brunet, Alain] Douglas Mental Hlth Univ Inst, Res Ctr, Montreal, PQ, Canada; [Ashbaugh, Andrea R.; Herbert, Christophe F.; Azoulay, Nelson; Brunet, Alain] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Olivera-Figueroa, Lening] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA; [Olivera-Figueroa, Lening] US Dept Vet Affairs Connecticut Healthcare Syst, Dept Psychiat, West Haven, CT USA	McGill University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Ashbaugh, AR (corresponding author), Douglas Mental Hlth Univ Inst, Res Ctr, Montreal, PQ, Canada.	andrea.ashbaugh@mail.mcgill.ca		Olivera-Figueroa, Lening/0000-0001-6325-9819	Fonds de recherche du Quebec - Sante; Canadian Institutes of Health Research	Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Alain Brunet acknowledges receiving a salary award from the Fonds de recherche du Quebec - Sante (formerly the FRSQ) while working on this manuscript. Andrea R. Ashbaugh acknowledges receiving a post-doctoral award from the Canadian Institutes of Health Research while working on this manuscript. Portions of this manuscript were presented at the 2011 annual convention of the Association for Behavioral and Cognitive Therapies in Toronto, Ontario. We would like to thank David Lightbown for help in creating the Figure.	[Anonymous], 2009, PAND H1N1 2009 UPD 7; [Anonymous], 2009, CBS NEWS; [Anonymous], INT US BROADB TEL RE; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Arda B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-87; Aufderheide JJ, 2009, INGREDIENTS FOUND SP; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brewer NT, 2006, CLIN INFECT DIS, V43, P1379, DOI 10.1086/508466; Brien S, 2012, VACCINE, V30, P1255, DOI 10.1016/j.vaccine.2011.12.089; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Community and Hospital Infection Control Association - Canada, 2010, PAND H1N1 2009 VIR; COOK EF, 1984, J CHRON DIS, V37, P721, DOI 10.1016/0021-9681(84)90041-9; Dube Eve, 2010, BMC Res Notes, V3, P102, DOI 10.1186/1756-0500-3-102; Fabry P, 2011, VACCINE, V29, P1824, DOI 10.1016/j.vaccine.2010.12.109; Fikretoglu D, 2006, J TRAUMA STRESS, V19, P847, DOI 10.1002/jts.20164; Finset A., 2002, PSYCHOL HEALTH MED, V7, P75, DOI [10.1080/13548500120101577, DOI 10.1080/13548500120101577]; Fox S., 2006, ONLINE HLTH SEARCH 2; Health Canada, 2009, HLTH CAN APPR PAND H; Helferty M, 2010, CAN MED ASSOC J, V182, P1981, DOI 10.1503/cmaj.100746; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Jones S., 2009, GENERATIONS ONLINE 2; Kiernan M, 2001, PSYCHOL METHODS, V6, P35, DOI 10.1037//1082-989X.6.1.35; Kusch L, 2009, GET READY ROLL YOUR; Lau JTF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-139; Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Page LA, 2011, J MENT HEALTH, V20, P60, DOI 10.3109/09638237.2010.542787; Public Health Agency of Canada, 2009, CAN READ WHO MOV PHA; Public Health Agency of Canada, 2009, GUID H1N1 FLU VIR; Quinn SC, 2009, BIOSECUR BIOTERROR, V7, P275, DOI 10.1089/bsp.2009.0041; Radomsky Adam S., 2006, Cognitive Behaviour Therapy, V35, P164, DOI 10.1080/16506070600827198; Rosen NO, 2007, PSYCHOL HEALTH, V22, P413, DOI 10.1080/14768320600941038; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Savas E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-281; Schwarzinger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010199; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Seale H, 2009, MED J AUSTRALIA, V191, P267, DOI 10.5694/j.1326-5377.2009.tb02781.x; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; SHERBOURNE CD, 1992, J BEHAV MED, V15, P447, DOI 10.1007/BF00844941; Statistics Canada, 2010, CAN COMM HLTH SURV H; Steketee G, 2001, BEHAV RES THER, V39, P987; Thordarson DS, 2004, BEHAV RES THER, V42, P1289, DOI 10.1016/j.brat.2003.08.007; Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; Wolfe RM, 2005, J HEALTH COMMUN, V10, P537, DOI 10.1080/10810730500228847	50	22	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58852	10.1371/journal.pone.0058852	http://dx.doi.org/10.1371/journal.pone.0058852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23505565	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500130
J	Belluoccio, D; Rowley, L; Little, CB; Bateman, JF				Belluoccio, Daniele; Rowley, Lynn; Little, Christopher B.; Bateman, John F.			Maintaining mRNA Integrity during Decalcification of Mineralized Tissues	PLOS ONE			English	Article							CARTILAGE; EXPRESSION	Biomineralization of the extracellular matrix occurs inappropriately in numerous pathological conditions such as cancer and vascular disease, but during normal mammalian development calcification is restricted to the formation of the skeleton and dentition. The comprehensive study of gene expression in mineralized skeletal tissues has been compromized by the traditional decalcification/fixation methods that result in significant mRNA degradation. In this study we developed a novel RNAlater/EDTA decalcification method that protects the integrity of the mRNA in mature mouse tibial epiphyses. Furthermore, this method preserves the tissue structure to allow histological sectioning and microdissection to determine region-specific gene expression, in addition to immuno- and in situ histology. This method will be widely applicable to the molecular analysis of calcified tissues in various pathological conditions, and will be of particular importance in dissection of the gene expression in mouse bone and joint tissues during development and in important clinical conditions such as arthritis.	[Belluoccio, Daniele; Rowley, Lynn; Bateman, John F.] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Bateman, John F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Little, Christopher B.] Royal N Shore Hosp, Kolling Inst Med Res, Raymond Purves Bone & Joint Res Labs, St Leonards, NSW 2065, Australia	Murdoch Children's Research Institute; University of Melbourne; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Bateman, JF (corresponding author), Murdoch Childrens Res Inst, Parkville, Vic, Australia.	john.bateman@mcri.edu.au	Little, Christopher B/A-9280-2015	Little, Christopher B/0000-0002-0353-7634; Bateman, John/0000-0001-8542-0730	National Health and Medical Research Council of Australia [1002797, 607399]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by Project Grants (#607399) and a Research Fellowship (#1002797) to JFB from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au), the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belluoccio D, 2008, BBA-GENE REGUL MECH, V1779, P330, DOI 10.1016/j.bbagrm.2008.02.010; Cameron TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024600; Goldring SR, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3135; Little CB, 2008, CURR RHEUMATOL REV, V4, P175, DOI 10.2174/157339708785133523; Melrose J, 2008, BIOTECH HISTOCHEM, V83, P47, DOI 10.1080/10520290801990414; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Salmon CR, 2012, DIAGNOSTIC MOL PAT B; Shao YY, 2006, LAB INVEST, V86, P1089, DOI 10.1038/labinvest.3700459	8	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58154	10.1371/journal.pone.0058154	http://dx.doi.org/10.1371/journal.pone.0058154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505463	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500055
J	Brackett, DM; Qing, F; Amieux, PS; Sellers, DL; Horner, PJ; Morris, DR				Brackett, David M.; Qing, Feng; Amieux, Paul S.; Sellers, Drew L.; Horner, Philip J.; Morris, David R.			Fmr1 Transcript Isoforms: Association with Polyribosomes; Regional and Developmental Expression in Mouse Brain	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; FRAGILE-X-SYNDROME; RNA-BINDING; ADULT NEUROGENESIS; DIFFERENT TISSUES; MESSENGER-RNA; GENE; TRANSLATION; NEURONS; NUCLEAR	The primary transcript of the mammalian Fragile X Mental Retardation-1 gene (Fmr1), like many transcripts in the central nervous system, is alternatively spliced to yield mRNAs encoding multiple proteins, which can possess quite different biochemical properties. Despite the fact that the relative levels of the 12 Fmr1 transcript isoforms examined here vary by as much as two orders of magnitude amongst themselves in both adult and embryonic mouse brain, all are associated with polyribosomes, consistent with translation into the corresponding isoforms of the protein product, FMRP ( Fragile X Mental Retardation Protein). Employing the RiboTag methodology developed in our laboratory, the relative proportions of the 7 most abundant transcript isoforms were measured specifically in neurons and found to be similar to those identified in whole brain. Measurements of isoform profiles across 11 regions of adult brain yielded similar distributions, with the exceptions of the hippocampus and the olfactory bulb. These two regions differ from most of the brain in relative amounts of transcripts encoding an alternate form of one of the KH RNA binding domains. A possible relationship between patterns of expression in the hippocampus and olfactory bulb and the presence of neuroblasts in these two regions is suggested by the isoform patterns in early embryonic brain and in cultured neural progenitor cells. These results demonstrate that the relative levels of the Fmr1 isoforms are modulated according to developmental stage, highlighting the complex ramifications of losing all the protein isoforms in individuals with Fragile X Syndrome. It should also be noted that, of the eight most prominent FMRP isoforms (1-3, 6-9 and 12) in mouse, only two have the major site of phosphorylation at Ser-499, which is thought to be involved in some of the regulatory interactions of this protein.	[Brackett, David M.; Qing, Feng; Morris, David R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Amieux, Paul S.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Sellers, Drew L.; Horner, Philip J.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Morris, DR (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dmorris@u.washington.edu	Amieux, Paul/AAG-4102-2021; Horner, Philip J./AAF-7012-2021	Feng, Qing/0000-0001-9166-2760	Fragile X Research Foundation; NIH/NICHD [P30 HD02274-S]; NIH [1R21RR021704-02]; FRAXA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR021704] Funding Source: NIH RePORTER	Fragile X Research Foundation; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FRAXA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Fragile X Research Foundation; NIH/NICHD P30 HD02274-S. A portion of this work was support by NIH grant 1R21RR021704-02 (to DRM). DMB acknowledges a postdoctoral fellowship from FRAXA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 1999, J NEUROPATH EXP NEUR, V58, P867, DOI 10.1097/00005072-199908000-00009; Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2009, HUM MOL GENET, V18, P3164, DOI 10.1093/hmg/ddp255; Denman RB, 2004, CELL MOL LIFE SCI, V61, P1714, DOI 10.1007/s00018-004-4059-2; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Dolzhanskaya N, 2008, BIOCHEMISTRY-US, V47, P8491, DOI 10.1021/bi702298f; Dolzhanskaya N, 2006, BIOCHEMISTRY-US, V45, P10385, DOI 10.1021/bi0525019; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; EICHLER EE, 1993, HUM MOL GENET, V2, P1147, DOI 10.1093/hmg/2.8.1147; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; HINDS HL, 1993, NAT GENET, V3, P36, DOI 10.1038/ng0193-36; Jacobs S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-132; Jacobs S, 2010, J NEUROSCI, V30, P4508, DOI 10.1523/JNEUROSCI.5027-09.2010; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; MacKay VL, 2004, MOL CELL PROTEOMICS, V3, P478, DOI 10.1074/mcp.M300129-MCP200; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Pacey LKK, 2007, GLIA, V55, P1601, DOI 10.1002/glia.20573; Petit A, 2007, P NATL ACAD SCI USA, V104, P17837, DOI 10.1073/pnas.0703240104; Raingo J, 2007, NAT NEUROSCI, V10, P285, DOI 10.1038/nn1848; Raymond CK, 2004, J BIOL CHEM, V279, P46234, DOI 10.1074/jbc.M406387200; Rebrikov D V, 2006, Prikl Biokhim Mikrobiol, V42, P520; Richter, 1997, ANAL MRNA FORMATION, P305, DOI 10.1016/B978-012587545-5/50017-3; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Tian HJ, 2005, MOL BRAIN RES, V137, P174, DOI 10.1016/j.molbrainres.2005.03.001; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Valverde R, 2007, STRUCTURE, V15, P1090, DOI 10.1016/j.str.2007.06.022; Vanderklish PW, 2005, GENES BRAIN BEHAV, V4, P360, DOI 10.1111/j.1601-183X.2005.00134.x; VERHEIJ C, 1995, HUM MOL GENET, V4, P895, DOI 10.1093/hmg/4.5.895; VERKERK AJMH, 1993, HUM MOL GENET, V2, P399, DOI 10.1093/hmg/2.4.399; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; Wen X, 2009, NEUROBIOL DIS, V35, P52, DOI 10.1016/j.nbd.2009.03.015; Yang Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003172; ZOMZELY CE, 1968, J BIOL CHEM, V243, P5396; ZOMZELY CE, 1966, J MOL BIOL, V19, P455, DOI 10.1016/S0022-2836(66)80016-5	59	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58296	10.1371/journal.pone.0058296	http://dx.doi.org/10.1371/journal.pone.0058296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505481	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500065
J	Dranchak, P; MacArthur, R; Guha, R; Zuercher, WJ; Drewry, DH; Auld, DS; Inglese, J				Dranchak, Patricia; MacArthur, Ryan; Guha, Rajarshi; Zuercher, William J.; Drewry, David H.; Auld, Douglas S.; Inglese, James			Profile of the GSK Published Protein Kinase Inhibitor Set Across ATP-Dependent and-Independent Luciferases: Implications for Reporter-Gene Assays	PLOS ONE			English	Article							FIREFLY LUCIFERASE; CHEMICAL LIBRARIES; RENILLA LUCIFERASE; POTENT INHIBITORS; TYROSINE KINASE; ENERGY-TRANSFER; IN-VITRO; DISCOVERY; IDENTIFICATION; BIOLUMINESCENCE	A library of 367 protein kinase inhibitors, the GSK Published Kinase Inhibitor Set (PKIS), which has been annotated for protein kinase family activity and is available for public screening efforts, was assayed against the commonly used luciferase reporter enzymes from the firefly, Photinus pyralis (FLuc) and marine sea pansy, Renilla reniformis (RLuc). A total of 22 compounds (similar to 6% of the library) were found to inhibit FLuc with 10 compounds showing potencies <= 1 mu M. Only two compounds were found to inhibit RLuc, and these showed relatively weak potency values (similar to 10 mu M). An inhibitor series of the VEGFR2/TIE2 protein kinase family containing either an aryl oxazole or benzimidazole-urea core illustrate the different structure activity relationship profiles FLuc inhibitors can display for kinase inhibitor chemotypes. Several FLuc inhibitors were broadly active toward the tyrosine kinase and CDK families. These data should aid in interpreting the results derived from screens employing the GSK PKIS in cell-based assays using the FLuc reporter. The study also underscores the general need for strategies such as the use of orthogonal reporters to identify kinase or non-kinase mediated cellular responses.	[Dranchak, Patricia; MacArthur, Ryan; Guha, Rajarshi; Auld, Douglas S.; Inglese, James] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Inglese, James] NHGRI, NIH, Bethesda, MD 20892 USA; [Zuercher, William J.; Drewry, David H.] GlaxoSmithKline, Dept Biol Chem, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); GlaxoSmithKline	Inglese, J (corresponding author), NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA.	jinglese@mail.nih.gov		Drewry, David Harold/0000-0001-5973-5798	NIH Roadmap for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the NIH Roadmap for Medical Research (J.I. and D.S.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angell R, 2008, BIOORG MED CHEM LETT, V18, P4428, DOI 10.1016/j.bmcl.2008.06.048; Angell RM, 2007, BIOORG MED CHEM LETT, V17, P1296, DOI 10.1016/j.bmcl.2006.12.003; Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Auld DS, 2008, ACS CHEM BIOL, V3, P463, DOI 10.1021/cb8000793; Auld DS, 2008, J MED CHEM, V51, P2372, DOI 10.1021/jm701302v; Auld DS, 2010, P NATL ACAD SCI USA, V107, P4878, DOI 10.1073/pnas.0909141107; Auld DS, 2009, P NATL ACAD SCI USA, V106, P3585, DOI 10.1073/pnas.0813345106; Bamborough P, 2007, BIOORG MED CHEM LETT, V17, P4363, DOI 10.1016/j.bmcl.2007.04.029; Bramson HN, 2001, J MED CHEM, V44, P4339, DOI 10.1021/jm010117d; Cheng KCC, 2012, NAT METHODS, V9, P937, DOI 10.1038/nmeth.2170; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Guiguemde WA, 2012, CHEM BIOL, V19, P116, DOI 10.1016/j.chembiol.2012.01.004; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Harris PA, 2005, J MED CHEM, V48, P1610, DOI 10.1021/jm049538w; HART RC, 1979, BIOCHEMISTRY-US, V18, P2204, DOI 10.1021/bi00578a011; Hasegawa M, 2007, J MED CHEM, V50, P4453, DOI 10.1021/jm0611051; Herbst KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005642; Hert J, 2004, ORG BIOMOL CHEM, V2, P3256, DOI 10.1039/b409865j; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jang SW, 2012, ACS CHEM BIOL, V7, P1205, DOI 10.1021/cb300048d; Liu Y, 2012, BIOORGAN MED CHEM, V20, P5473, DOI 10.1016/j.bmc.2012.07.035; LORENZ WW, 1991, P NATL ACAD SCI USA, V88, P4438, DOI 10.1073/pnas.88.10.4438; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; MCELROY WD, 1967, SCIENCE, V157, P150, DOI 10.1126/science.157.3785.150; Michelini E, 2010, ANAL BIOANAL CHEM, V398, P227, DOI 10.1007/s00216-010-3933-z; Peat AJ, 2004, BIOORG MED CHEM LETT, V14, P2121, DOI 10.1016/j.bmcl.2004.02.036; Sammond DM, 2005, BIOORG MED CHEM LETT, V15, P3519, DOI 10.1016/j.bmcl.2005.05.096; Shukla SJ, 2009, ASSAY DRUG DEV TECHN, V7, P143, DOI 10.1089/adt.2009.193; Southall N. A., 2009, HDB DRUG SCREENING, P442; Stables J, 1999, J RECEPT SIGNAL TR R, V19, P395, DOI 10.3109/10799899909036660; Stavenger RA, 2007, J MED CHEM, V50, P2, DOI 10.1021/jm060873p; Stevens KL, 2008, BIOORG MED CHEM LETT, V18, P5758, DOI 10.1016/j.bmcl.2008.09.069; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Thorne N, 2012, CHEM BIOL, V19, P1060, DOI 10.1016/j.chembiol.2012.07.015; Thorne N, 2010, CHEM BIOL, V17, P646, DOI 10.1016/j.chembiol.2010.05.012; Thorne N, 2010, CURR OPIN CHEM BIOL, V14, P315, DOI 10.1016/j.cbpa.2010.03.020; Witherington J, 2003, BIOORG MED CHEM LETT, V13, P3055, DOI 10.1016/S0960-894X(03)00645-0; Wood ER, 2004, BIOORG MED CHEM LETT, V14, P953, DOI 10.1016/j.bmcl.2003.12.002; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Xiao JB, 2011, J MED CHEM, V54, P6215, DOI 10.1021/jm200497t	44	45	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57888	10.1371/journal.pone.0057888	http://dx.doi.org/10.1371/journal.pone.0057888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505445	Green Submitted, gold, Green Published			2022-12-27	WOS:000318334500037
J	Amirian, ES; Fickey, PA; Scheurer, ME; Chiao, EY				Amirian, E. Susan; Fickey, Paul A., Jr.; Scheurer, Michael E.; Chiao, Elizabeth Y.			Anal Cancer Incidence and Survival: Comparing the Greater San-Francisco Bay Area to Other SEER Cancer Registries	PLOS ONE			English	Article							SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS INFECTION; COST-EFFECTIVENESS; RISK-FACTORS; MEN; SEX; EPIDEMIOLOGY; INDIVIDUALS; PREVALENCE	The incidence of squamous cell carcinoma of the anus, anal canal, and anorectum (SCCA) has increased over time. However, there are still no national guidelines on screening for SCCA among high-risk populations. Providers at University of California, San Francisco have been at the forefront of providing anal dysplasia screening. To determine whether such a screening program allows for earlier detection of abnormalities and consequently, improves patient survival, we conducted an ecological study using data from the Surveillance, Epidemiology, and End Results (SEER) program to compare the San Francisco-Oakland catchment area (SF-O) to other SEER sites where routine screening has not been as accessible. Cox regression models were utilized to assess the impact of residing in the SF-O region, versus other SEER sites, on cause-specific mortality hazard. Logistic regression was used to determine if site was associated with the probability of having an in situ versus invasive tumor among SCCA cases. All analyses were stratified on calendar time (1985-1995 and 1996-2008) to compare differences pre- and post-highly active anti-retroviral therapy. Among SCCA cases, being reported by the SF-O registry was associated with a four fold higher probability of having an in situ tumor (rather than an invasive tumor) [95% CI: 3.48-4.61], compared to sites outside of California, between 1996 and 2008. Cases reported from the SF-O region between 1996 and 2008 had a 39% lower mortality risk than those reported from registries outside California (95% CI: 0.51-0.72). However, there was no decrease in the rate of invasive SCCA over this period. This is the first ecological study to evaluate whether access to anal cancer screening programs may help improve patient survival by allowing for earlier detection of lesions. Our results imply that routine screening programs may help detect SCCA at an earlier stage and thus, potentially impact patient survival.	[Amirian, E. Susan; Scheurer, Michael E.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Amirian, E. Susan; Scheurer, Michael E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Fickey, Paul A., Jr.; Chiao, Elizabeth Y.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Scheurer, ME (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.	scheurer@bcm.edu		Scheurer, Michael/0000-0002-8379-6088; Chiao, Elizabeth/0000-0001-5752-2916	NCI NIH HHS [R01 CA163103] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA163103] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barroso LF, 2012, LANCET ONCOL, V13, pE278, DOI 10.1016/S1470-2045(12)70169-9; Bedimo RJ, 2009, JAIDS-J ACQ IMM DEF, V52, P203, DOI 10.1097/QAI.0b013e3181b033ab; Chiao EY, 2006, CLIN INFECT DIS, V43, P223, DOI 10.1086/505219; Chiao EY, 2005, JAIDS-J ACQ IMM DEF, V40, P451, DOI 10.1097/01.qai.0000159669.80207.12; Chin-Hong PV, 2008, ANN INTERN MED, V149, P300, DOI 10.7326/0003-4819-149-5-200809020-00004; Chin-Hong Peter V, 2005, Dermatol Ther, V18, P67, DOI 10.1111/j.1529-8019.2005.05009.x; Clark MA, 2004, LANCET ONCOL, V5, P149, DOI 10.1016/S1470-2045(04)01410-X; D'Souza G, 2008, J GEN INTERN MED, V23, P1452, DOI 10.1007/s11606-008-0698-6; Daibata M, 1998, LEUKEMIA, V12, P1002, DOI 10.1038/sj.leu.2401036; Goldie SJ, 2000, AM J MED, V108, P634, DOI 10.1016/S0002-9343(00)00349-1; Goldie SJ, 1999, JAMA-J AM MED ASSOC, V281, P1822, DOI 10.1001/jama.281.19.1822; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Holly EA, 2001, J NATL CANCER I, V93, P843, DOI 10.1093/jnci/93.11.843; Howlader N, 2012, SEER CANC STAT REV 1; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Nielsen A, 2012, INT J CANCER, V130, P1168, DOI 10.1002/ijc.26115; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Palefsky J, 2012, LANCET ONCOL, V13, pE279, DOI 10.1016/S1470-2045(12)70215-2; Palefsky JM, 2009, OBSTET GYN CLIN N AM, V36, P187, DOI 10.1016/j.ogc.2009.02.003; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; UCSF Department of Medicine Anal Cancer Information, COMPL LIST HRA PROV	23	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58919	10.1371/journal.pone.0058919	http://dx.doi.org/10.1371/journal.pone.0058919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484057	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100143
J	Biswas, A; Elmatari, D; Rothman, J; LaMunyon, CW; Said, HM				Biswas, Arundhati; Elmatari, Daniel; Rothman, Jason; LaMunyon, Craig W.; Said, Hamid M.			Identification and Functional Characterization of the Caenorhabditis elegans Riboflavin Transporters rft-1 and rft-2	PLOS ONE			English	Article							VAN-LAERE-SYNDROME; FOLATE TRANSPORTER; LIFE-SPAN; EXPRESSION; MUTATIONS; DEFICIENCY; RELEVANCE; HRFT-2; PCR	Two potential orthologs of the human riboflavin transporter 3 (hRFVT3) were identified in the C. elegans genome, Y47D7A. 16 and Y47D7A. 14, which share 33.7 and 30.5% identity, respectively, with hRFVT3. The genes are tandemly arranged, and we assign them the names rft-1 (for Y47D7A. 16) and rft-2 (for Y47D7A. 14). Functional characterization of the coding sequences in a heterologous expression system demonstrated that both were specific riboflavin transporters, although the rft-1 encoded protein had greater transport activity. A more detailed examination of rft-1 showed its transport of riboflavin to have an acidic pH dependence, saturability (apparent Km=1.4 +/- 0.5 mu M), inhibition by riboflavin analogues, and Na+ independence. The expression of rft-1 mRNA was relatively higher in young larvae than in adults, and mRNA expression dropped in response to RF supplementation. Knocking down the two transporters individually via RNA interference resulted in a severe loss of fertility that was compounded in a double knockdown. Transcriptional fusions constructed with two fluorophores (rft-1::GFP, and rft-2::mCherry) indicated that rft-1 is expressed in the intestine and a small subset of neuronal support cells along the entire length of the animal. Expression of rft-2 is localized mainly to the intestine and pharynx. We also observed a drop in the expression of the two reporters in animals that were maintained in high riboflavin levels. These results report for the first time the identification of two riboflavin transporters in C. elegans and demonstrate their expression and importance to metabolic function in worms. Absence of transporter function renders worms sterile, making them useful in understanding human disease associated with mutations in hRFVT3.	[Biswas, Arundhati; Said, Hamid M.] Univ Calif Irvine, Sch Med, Dept Med, Irvine, CA 92717 USA; [Biswas, Arundhati; Said, Hamid M.] Univ Calif Irvine, Sch Med, Dept Physiol Biophys, Irvine, CA 92717 USA; [Biswas, Arundhati; Said, Hamid M.] Vet Affairs Med Ctr, Long Beach, CA USA; [Elmatari, Daniel; Rothman, Jason] Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; California State University System; California State Polytechnic University Pomona	LaMunyon, CW (corresponding author), Calif State Polytech Univ Pomona, Dept Biol Sci, Pomona, CA 91768 USA.	cwlamunyon@csupomona.edu	Rothman, Jason/I-2382-2019	Rothman, Jason/0000-0002-4848-8901	NIH [DK58057, 5SC3GM087212-04]; DVA [AA18071]; California State University Agricultural Research Institute [10-4-179-33]; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058057, R37DK056061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM087212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018071] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DVA; California State University Agricultural Research Institute; NIH Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the NIH (DK58057 to HMS and 5SC3GM087212-04 to CWL), from the DVA (AA18071 to HMS) and from the California State University Agricultural Research Institute (10-4-179-33 to CWL). Additionally, some strains used in this work were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MU, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-46; Balamurugan K, 2007, AM J PHYSIOL-CELL PH, V293, pC670, DOI 10.1152/ajpcell.00516.2006; Bargmann C. I., 2006, WORMBOOK; Blumenthal T, 2005, WORMBOOK; BRENNER S, 1974, GENETICS, V77, P71; Cooperman J.M., 1984, HDB VITAMINS NUTR BI, P299; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fei YJ, 2004, BIOCHEM J, V379, P191, DOI 10.1042/BJ20031807; Fei YJ, 2003, J BIOL CHEM, V278, P6136, DOI 10.1074/jbc.M208763200; Fujimura M, 2010, J NUTR, V140, P1722, DOI 10.3945/jn.110.128330; Ghosal A, AM J PHYSL IN PRESS; GLODSMITH GA, 1975, RIBOFLAVIN, P221; Grad LI, 2004, HUM MOL GENET, V13, P303, DOI 10.1093/hmg/ddh027; Green P, 2010, AM J HUM GENET, V86, P485, DOI 10.1016/j.ajhg.2010.02.006; He YT, 2009, ASIAN PAC J CANCER P, V10, P619; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Lim S, 2001, BIOTECHNOL BIOPROC E, V8, P75; LIU TP, 1993, CANCER EPIDEM BIOMAR, V2, P525; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCGHEE JD, 2007, WORMBOOK; Nabokina SM, 2012, MOL GENET METAB, V105, P652, DOI 10.1016/j.ymgme.2011.12.021; PANGREKAR J, 1993, FOOD CHEM TOXICOL, V31, P745, DOI 10.1016/0278-6915(93)90146-P; Sathasivam S, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-9; Spagnoli C, 2012, DEV MED CHILD NEUROL, V54, P292, DOI 10.1111/j.1469-8749.2011.04179.x; Subramanian VS, 2011, BBA-BIOMEMBRANES, V1808, P3016, DOI 10.1016/j.bbamem.2011.08.004; SULSTON J, 1988, COLD SPRING HARBOR L, V17, P591; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vaidya S M, 1998, Indian J Med Sci, V52, P244; Vanfleteren J. R., 2009, WORMBOOK; Wu X, 1999, BBA-BIOMEMBRANES, V1418, P239, DOI 10.1016/S0005-2736(99)00020-6	30	10	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58190	10.1371/journal.pone.0058190	http://dx.doi.org/10.1371/journal.pone.0058190			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483992	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100085
J	de Juan-Sanz, J; Nunez, E; Lopez-Corcuera, B; Aragon, C				de Juan-Sanz, Jaime; Nunez, Enrique; Lopez-Corcuera, Beatriz; Aragon, Carmen			Constitutive Endocytosis and Turnover of the Neuronal Glycine Transporter GlyT2 Is Dependent on Ubiquitination of a C-Terminal Lysine Cluster	PLOS ONE			English	Article							DOPAMINE TRANSPORTER; SUBCELLULAR-LOCALIZATION; TRAFFICKING; INTERNALIZATION; HYPEREKPLEXIA; RECEPTORS; UCH-L1; UBIQUITYLATION; DEGRADATION; MUTATIONS	Inhibitory glycinergic neurotransmission is terminated by sodium and chloride-dependent plasma membrane glycine transporters (GlyTs). The mainly glial glycine transporter GlyT1 is primarily responsible for the completion of inhibitory neurotransmission and the neuronal glycine transporter GlyT2 mediates the reuptake of the neurotransmitter that is used to refill synaptic vesicles in the terminal, a fundamental role in the physiology and pathology of glycinergic neurotransmission. Indeed, inhibitory glycinergic neurotransmission is modulated by the exocytosis and endocytosis of GlyT2. We previously reported that constitutive and Protein Kinase C (PKC)-regulated endocytosis of GlyT2 is mediated by clathrin and that PKC accelerates GlyT2 endocytosis by increasing its ubiquitination. However, the role of ubiquitination in the constitutive endocytosis and turnover of this protein remains unexplored. Here, we show that ubiquitination of a C-terminus four lysine cluster of GlyT2 is required for constitutive endocytosis, sorting into the slow recycling pathway and turnover of the transporter. Ubiquitination negatively modulates the turnover of GlyT2, such that increased ubiquitination driven by PKC activation accelerates transporter degradation rate shortening its half-life while decreased ubiquitination increases transporter stability. Finally, ubiquitination of GlyT2 in neurons is highly responsive to the free pool of ubiquitin, suggesting that the deubiquitinating enzyme (DUB) ubiquitin C-terminal hydrolase-L1 (UCHL1), as the major regulator of neuronal ubiquitin homeostasis, indirectly modulates the turnover of GlyT2. Our results contribute to the elucidation of the mechanisms underlying the dynamic trafficking of this important neuronal protein which has pathological relevance since mutations in the GlyT2 gene (SLC6A5) are the second most common cause of human hyperekplexia.	[de Juan-Sanz, Jaime; Nunez, Enrique; Lopez-Corcuera, Beatriz; Aragon, Carmen] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain; [de Juan-Sanz, Jaime; Nunez, Enrique; Lopez-Corcuera, Beatriz; Aragon, Carmen] ISCIII, Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain; [de Juan-Sanz, Jaime; Nunez, Enrique; Lopez-Corcuera, Beatriz; Aragon, Carmen] IdiPAZ Hosp Univ La Paz, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitario La Paz	Aragon, C (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, Madrid, Spain.	caragon@cbm.uam.es	Corcuera, Beatriz López/D-5188-2009; Aragon, Carmen/K-9783-2014; de Juan-Sanz, Jaime/L-7990-2017	Corcuera, Beatriz López/0000-0002-0383-4241; Aragon, Carmen/0000-0001-8287-9386; de Juan-Sanz, Jaime/0000-0002-1212-5623	Spanish Direccion General de Investigacion Cientifica y Tecnica [SAF2008-05436, SAF2011-28674]; Fondo de Investigaciones Sanitarias (CIBERER); Comunidad Autonoma de Madrid; Fundacion Ramon Areces	Spanish Direccion General de Investigacion Cientifica y Tecnica(Spanish Government); Fondo de Investigaciones Sanitarias (CIBERER)(Instituto de Salud Carlos III); Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion Ramon Areces	Spanish Direccion General de Investigacion Cientifica y Tecnica (Grant numbers: SAF2008-05436; SAF2011-28674). Grant sponsors: Fondo de Investigaciones Sanitarias (CIBERER), Comunidad Autonoma de Madrid, Fundacion Ramon Areces. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon C, 2005, TRENDS PHARMACOL SCI, V26, P283, DOI 10.1016/j.tips.2005.04.007; Aragon C, 2003, EUR J PHARMACOL, V479, P249, DOI 10.1016/j.ejphar.2003.08.074; Arancibia-Carcamo IL, 2009, P NATL ACAD SCI USA, V106, P17552, DOI 10.1073/pnas.0905502106; Armsen W, 2007, MOL CELL NEUROSCI, V36, P369, DOI 10.1016/j.mcn.2007.07.011; Blakely RD, 2000, CURR OPIN NEUROBIOL, V10, P328, DOI 10.1016/S0959-4388(00)00088-X; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; Carta E, 2012, J BIOL CHEM, V287, P28975, DOI 10.1074/jbc.M112.372094; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Chen PC, 2011, J NEUROSCI, V31, P17505, DOI 10.1523/JNEUROSCI.2922-11.2011; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; de Juan-Sanz J, 2011, TRAFFIC, V12, P1850, DOI 10.1111/j.1600-0854.2011.01278.x; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Fernandez-Sanchez E, 2009, J BIOL CHEM, V284, P19482, DOI 10.1074/jbc.M109.005165; Fornes A, 2004, J BIOL CHEM, V279, P22934, DOI 10.1074/jbc.M401337200; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Fujimuro M, 2005, METHOD ENZYMOL, V399, P75, DOI 10.1016/S0076-6879(05)99006-X; Geerlings A, 2002, J NEUROCHEM, V82, P58, DOI 10.1046/j.1471-4159.2002.00930.x; Geerlings A, 2001, J BIOL CHEM, V276, P17584, DOI 10.1074/jbc.M010602200; Gill JL, 2011, NEUROBIOL DIS, V43, P184, DOI 10.1016/j.nbd.2011.03.010; Gimenez C, 2012, J BIOL CHEM, V287, P28986, DOI 10.1074/jbc.M111.319244; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Harvey RJ, 2008, TRENDS GENET, V24, P439, DOI 10.1016/j.tig.2008.06.005; Harvey RJ, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.001.2008; Jimenez E, 2011, J BIOL CHEM, V286, P10712, DOI 10.1074/jbc.M110.167056; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kurihara LJ, 2001, HUM MOL GENET, V10, P1963, DOI 10.1093/hmg/10.18.1963; Magalhaes AC, 2010, NAT NEUROSCI, V13, P622, DOI 10.1038/nn.2529; Martinez-Villarreal J, 2012, GLIA, V60, P1356, DOI 10.1002/glia.22354; Michaely P, 2007, EMBO J, V26, P3273, DOI 10.1038/sj.emboj.7601769; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nunez E, 2009, TRAFFIC, V10, P829, DOI 10.1111/j.1600-0854.2009.00911.x; Ohno K, 2004, MOL CELL NEUROSCI, V26, P518, DOI 10.1016/j.mcn.2004.04.007; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Schwarz LA, 2012, MOL CELL NEUROSCI, V49, P387, DOI 10.1016/j.mcn.2011.08.006; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385; Walters BJ, 2008, MOL CELL NEUROSCI, V39, P539, DOI 10.1016/j.mcn.2008.07.028; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; ZAFRA F, 1995, J NEUROSCI, V15, P3952; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39	52	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58863	10.1371/journal.pone.0058863	http://dx.doi.org/10.1371/journal.pone.0058863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484054	Green Published, gold			2022-12-27	WOS:000316936100140
J	Swami, V; Tovee, MJ				Swami, Viren; Tovee, Martin J.			Resource Security Impacts Men's Female Breast Size Preferences	PLOS ONE			English	Article							TO-HIP RATIO; PHYSICAL ATTRACTIVENESS; BODY-WEIGHT; SEXUAL SELECTION; MAMMARY-GLAND; CANCER RISK; PERCEPTIONS; JUDGMENTS; PROFILE; WOMEN	It has been suggested human female breast size may act as signal of fat reserves, which in turn indicates access to resources. Based on this perspective, two studies were conducted to test the hypothesis that men experiencing relative resource insecurity should perceive larger breast size as more physically attractive than men experiencing resource security. In Study 1, 266 men from three sites in Malaysia varying in relative socioeconomic status ( high to low) rated a series of animated figures varying in breast size for physical attractiveness. Results showed that men from the low socioeconomic context rated larger breasts as more attractive than did men from the medium socioeconomic context, who in turn perceived larger breasts as attractive than men from a high socioeconomic context. Study 2 compared the breast size judgements of 66 hungry versus 58 satiated men within the same environmental context in Britain. Results showed that hungry men rated larger breasts as significantly more attractive than satiated men. Taken together, these studies provide evidence that resource security impacts upon men's attractiveness ratings based on women's breast size.	[Swami, Viren] Univ Westminster, Dept Psychol, London W1R 8AL, England; [Swami, Viren] HELP Univ Coll, Dept Psychol, Kuala Lumpur, Malaysia; [Tovee, Martin J.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Westminster; Help University; Newcastle University - UK	Swami, V (corresponding author), Univ Westminster, Dept Psychol, London W1R 8AL, England.	v.swami@westminster.ac.uk		Tovee, Martin/0000-0001-9642-4462				Adkins L., 1996, SEX SENSIBILITY GEND, P99, DOI DOI 10.1007/978-1-349-24536-9_6; Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; Bomalaski JJ, 2001, CURR OPIN OBSTET GYN, V13, P15, DOI 10.1097/00001703-200102000-00003; Brown N, 2012, AM J HUM BIOL, V24, P158, DOI 10.1002/ajhb.22212; CANT JGH, 1981, AM NAT, V117, P199, DOI 10.1086/283699; Cornelissen PL, 2009, EVOL HUM BEHAV, V30, P417, DOI 10.1016/j.evolhumbehav.2009.04.003; den Daas C, SOC PSYCHOL IN PRESS; Dettwyler Kathy A., 1995, BREASTFEEDING BIOCUL, P167, DOI DOI 10.4324/9781315081984-7; Dixson BJ, 2011, ARCH SEX BEHAV, V40, P1271, DOI 10.1007/s10508-010-9680-6; Dixson BJ, 2011, ARCH SEX BEHAV, V40, P51, DOI 10.1007/s10508-010-9601-8; Einon, 2007, BODY BEAUTIFUL EVOLU, P131; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Ford C. S., 1952, PATTERNS SEXUAL BEHA; Furnham A, 1998, SEX ROLES, V39, P311, DOI 10.1023/A:1018810723493; Furnham A., 2008, PSYCHOL PHYS ATTRACT; Furnham A, 2007, SOC BEHAV PERSONAL, V35, P1, DOI 10.2224/sbp.2007.35.1.1; Gallup G. G., 1982, J HUM EVOL, V19, P111; Gerald W., 2009, SPACES DIFFERENCE IN, V2, P3; GITTER AG, 1983, J SOC PSYCHOL, V121, P7, DOI 10.1080/00224545.1983.9924460; Government of Malaysia, 2001, 8 MAL PLAN 2001 2005; Gray PB, 2012, EVOL PSYCHOL-US, V10, P631, DOI 10.1177/147470491201000319; Halik M, 2011, J ECON PSYCHOL, V32, P231, DOI 10.1016/j.joep.2009.02.006; HORVATH T, 1981, ARCH SEX BEHAV, V10, P21, DOI 10.1007/BF01542671; HSIEH CC, 1991, EUR J CANCER, V27, P131, DOI 10.1016/0277-5379(91)90469-T; Huss-ashmore R, 1980, Yearb Phys Anthropol, V23, P65; Hytten FE, 1971, PHYSL HUMAN PREGNANC; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; KLEINKE CL, 1980, J SOC PSYCHOL, V110, P123, DOI 10.1080/00224545.1980.9924231; Koff E, 1998, SEX ROLES, V38, P655, DOI 10.1023/A:1018802928210; LOW BS, 1987, ETHOL SOCIOBIOL, V8, P249, DOI 10.1016/0162-3095(87)90027-6; Marlowe FW, 1998, HUM NATURE-INT BIOS, V9, P263, DOI 10.1007/s12110-998-1005-2; Merrill EP, 2002, APPETITE, V39, P181, DOI 10.1006/appe.2002.0496; Morris D., 1967, NAKED APE ZOOLOGISTS; NEIFERT MR, 1985, PEDIATRICS, V76, P823; Nelson LD, 2005, PSYCHOL SCI, V16, P167, DOI 10.1111/j.0956-7976.2005.00798.x; Nelson LD, 2007, BODY BEAUTIFUL EVOLU, P185; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Ortigosa A, 2002, ANIM BEHAV, V64, P369, DOI 10.1006/anbe.2002.3065; PATTON S, 1976, BIOMEDICAL ASPECTS L; Pawlowski B, 1999, HOMO, V50, P149; Pettijohn II T. F., 2003, N AM J PSYCHOL, V5, P335; Pettijohn II T. F., 1999, MEDIA PSYCHOL, V1, P229, DOI [10.1207/s1532785xmep0103_3, DOI 10.1207/S1532785XMEP0103_3]; Pettijohn T. F., 2009, J SOC EVOL CULT PSYC, V3, P216, DOI [DOI 10.1037/H0099321, 10.1037/h0099321]; Pettijohn TE, 2005, J SOC PSYCHOL, V145, P547, DOI 10.3200/SOCP.145.5.547-570; Pettijohn TF, 2004, PERS SOC PSYCHOL B, V30, P1186, DOI 10.1177/0146167204264078; Ramsay DT, 2005, J ANAT, V206, P525, DOI 10.1111/j.1469-7580.2005.00417.x; Seifert T, 2005, INT J EAT DISORDER, V37, P271, DOI 10.1002/eat.20086; Short R. V., 1980, REPROD ANIMALS BOOK; Singh D, 1995, ETHOL SOCIOBIOL, V16, P483, DOI 10.1016/0162-3095(95)00074-7; Smith N., 1986, J HUM EVOL, V1, P285; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Sugiyama LS, 2004, EVOL HUM BEHAV, V25, P51, DOI 10.1016/S1090-5138(03)00083-7; Swami V., 2011, EVOLUTIONARY PSYCHOL, P131; Swami V, 2012, ENCY BODY IMAGE HUMA, P622; Swami V., 2007, J EVOLUTIONARY PSYCH, V5, P149, DOI [10.1556/JEP.2007.1005, DOI 10.1556/JEP.2007.1005]; Swami V, ARCH SEX BE IN PRESS; Swami V., 2006, J ARTIC SUPPORT NULL, V4, P17; Swami V, 2007, BODY IMAGE, V4, P391, DOI 10.1016/j.bodyim.2007.07.002; Swami V, 2007, BODY IMAGE, V4, P219, DOI 10.1016/j.bodyim.2007.01.002; Swami V, 2007, SCAND J PSYCHOL, V48, P43, DOI 10.1111/j.1467-9450.2006.00526.x; Swami Viren, 2005, Body Image, V2, P115, DOI 10.1016/j.bodyim.2005.02.002; Swami V, 2006, BRIT J PSYCHOL, V97, P353, DOI 10.1348/000712605X80713; Swami V, 2012, INT J SOC PSYCHIATR, V58, P568, DOI 10.1177/0020764011415208; Swami V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042593; Swami Viren, 2005, Body Image, V2, P383, DOI 10.1016/j.bodyim.2005.08.001; Swami V, 2010, LEARN INDIVID DIFFER, V20, P51, DOI 10.1016/j.lindif.2009.11.002; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702; Swami V, 2009, BRIT J PSYCHOL, V100, P313, DOI 10.1348/000712608X329525; Swami Viren, 2007, BODY BEAUTIFUL EVOLU; Tantleff-Dunn S, 2001, SEX ROLES, V45, P231, DOI 10.1023/A:1013505928458; Tantleff-Dunn S, 2002, J APPL SOC PSYCHOL, V32, P2253, DOI 10.1111/j.1559-1816.2002.tb01862.x; TOBON H, 1975, J CLIN ENDOCR METAB, V40, P834, DOI 10.1210/jcem-40-5-834; Tovee MJ, 2006, EVOL HUM BEHAV, V27, P443, DOI 10.1016/j.evolhumbehav.2006.05.004; Tovee MJ, 2001, BRIT J PSYCHOL, V92, P391, DOI 10.1348/000712601162257; TRICHOPOULOS D, 1992, EPIDEMIOLOGY, V3, P523, DOI 10.1097/00001648-199211000-00011; Wade TD, 2010, TWIN RES HUM GENET, V13, P450, DOI 10.1375/twin.13.5.450; Ward LM, 2006, SEX ROLES, V55, P703, DOI 10.1007/s11199-006-9125-9; WIGGINS JS, 1968, J PERS SOC PSYCHOL, V10, P82, DOI 10.1037/h0026394; Zelazniewicz AM, 2011, ARCH SEX BEHAV, V40, P1129, DOI 10.1007/s10508-011-9850-1	79	23	23	5	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57623	10.1371/journal.pone.0057623	http://dx.doi.org/10.1371/journal.pone.0057623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483919	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000316936100035
J	Downes, CE; Wong, CHY; Henley, KJ; Guio-Aguilar, PL; Zhang, M; Ates, R; Mansell, A; Kile, BT; Crack, PJ				Downes, Catherine E.; Wong, Connie H. Y.; Henley, Katya J.; Guio-Aguilar, Pedro L.; Zhang, Moses; Ates, Robert; Mansell, Ashley; Kile, Benjamin T.; Crack, Peter J.			MyD88 Is a Critical Regulator of Hematopoietic Cell-Mediated Neuroprotection Seen after Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TOLL-LIKE RECEPTOR-4; NF-KAPPA-B; BRAIN-INJURY; RECRUITMENT; MICE; ADAPTER; MODEL; TOLL-LIKE-RECEPTOR-2	Neuroinflammation is critical in the neural cell death seen in stroke. It has been shown that CNS and peripheral responses drive this neuroinflammatory response in the brain. The Toll-like receptors (TLRs) are important regulators of inflammation in response to both exogenous and endogenous stressors. Taking advantage of a downstream adapter molecule that controls the majority of TLR signalling, this study investigated the role of the TLR adaptor protein myeloid differentiation factor 88 (MyD88) in the control of CNS and peripheral inflammation. Reversible middle-cerebral artery occlusion was used as the model of stroke in vivo; in vitro primary cultured neurons and glia were subject to four hours of oxygen and glucose deprivation (OGD). Both in vitro and in vivo Myd88(-/-) animals or cells were compared with wild type (WT). We found that after stroke Myd88(-/-) animals have a larger infarct volume compared to WT animals. Interestingly, in vitro there was no difference between the survival of Myd88(-/-) and WT cells following OGD, suggesting that peripheral responses were influencing stroke outcome. We therefore generated bone marrow chimeras and found that Myd88(-/-) animals have a smaller stroke infarct than their radiation naive counterparts if their hematopoietic cells are WT. Furthermore, WT animals have a larger stroke than their radiation naive counterparts if the hematopoietic cells are Myd88(-/-). We have demonstrated that MyD88-dependent signalling in the hematopoietic cell lineage reduces infarct size following stroke and that infiltrating cells to the site of neuroinflammation are neuroprotective following stroke.	[Downes, Catherine E.; Wong, Connie H. Y.; Guio-Aguilar, Pedro L.; Zhang, Moses; Ates, Robert; Crack, Peter J.] Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia; [Henley, Katya J.; Kile, Benjamin T.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Henley, Katya J.; Kile, Benjamin T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Mansell, Ashley] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia	University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; Monash University	Crack, PJ (corresponding author), Univ Melbourne, Dept Pharmacol, Parkville, Vic 3052, Australia.	pcrack@unimelb.edu	Kile, Benjamin T/F-6593-2011; Kile, Benjamin/GNP-3246-2022; Crack, Peter/ABE-2065-2020; Mansell, Ashley/B-9553-2008	Kile, Benjamin T/0000-0002-8836-8947; Kile, Benjamin/0000-0002-8836-8947; Crack, Peter/0000-0002-5030-0330; Mansell, Ashley/0000-0002-6540-1281; Wong, Connie/0000-0002-9020-1847	National Health and Medical Research Council (NHMRC) of Australia; National Heart Foundation of Australia; Australian Research Council (ARC) Future Fellowship; NHMRC; Sylvia and Charles Viertel Foundation	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia); Australian Research Council (ARC) Future Fellowship(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation	JC is supported by the National Health and Medical Research Council (NHMRC) of Australia, the National Heart Foundation of Australia and is a holder of an Australian Research Council (ARC) Future Fellowship. AM is supported by the NHMRC. BTK is supported by the NHMRC and the Sylvia and Charles Viertel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; Famakin BM, 2011, BRAIN RES, V1388, P148, DOI 10.1016/j.brainres.2011.02.074; Feng Y, 2008, AM J PHYSIOL-HEART C, V295, pH1311, DOI 10.1152/ajpheart.00119.2008; Flentjar NJ, 2002, EXP NEUROL, V177, P9, DOI 10.1006/exnr.2002.7927; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; Kim D, 2007, J BIOL CHEM, V282, P14975, DOI 10.1074/jbc.M607277200; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Lelekov-Boissard T, 2009, PHILOS T R SOC A, V367, P4699, DOI 10.1098/rsta.2009.0184; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Ma QY, 2011, J CEREBR BLOOD F MET, V31, P881, DOI 10.1038/jcbfm.2010.167; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Ohashi K, 2000, J IMMUNOL, V164, P558, DOI 10.4049/jimmunol.164.2.558; Phillips JB, 2000, STROKE, V31, P1686, DOI 10.1161/01.STR.31.7.1686; Schilling M, 2009, NEUROSCIENCE, V161, P806, DOI 10.1016/j.neuroscience.2009.04.025; Sharma S, 2010, J NEUROSCI RES, V88, P2869, DOI 10.1002/jnr.22452; Spera PA, 1998, NEUROSCI LETT, V251, P189, DOI 10.1016/S0304-3940(98)00537-0; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; UEDA A, 1994, J IMMUNOL, V153, P2052; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744, DOI 10.1002/jlb.65.6.744; YAMASAKI Y, 1994, ACTA NEUROCHIR, P300; Yang QW, 2008, J CEREBR BLOOD F MET, V28, P1588, DOI 10.1038/jcbfm.2008.50; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Ziegler G, 2010, J CEREB BLOOD FLOW M; Ziegler G, 2007, BIOCHEM BIOPH RES CO, V359, P574, DOI 10.1016/j.bbrc.2007.05.157	33	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57948	10.1371/journal.pone.0057948	http://dx.doi.org/10.1371/journal.pone.0057948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483951	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900058
J	Monteith, A; Marszalec, W; Chan, P; Logan, J; Yu, WM; Schwarz, N; Wokosin, D; Hockberger, P				Monteith, Andrew; Marszalec, William; Chan, Philip; Logan, Juliette; Yu, Weiming; Schwarz, Nicholas; Wokosin, David; Hockberger, Philip			Imaging of Mitochondrial and Non-Mitochondrial Responses in Cultured Rat Hippocampal Neurons Exposed to Micromolar Concentrations of TMRM	PLOS ONE			English	Article							ISOLATED BRAIN; CALCIUM; THAPSIGARGIN; DEPOLARIZATION; OSCILLATIONS; METABOLISM; MODULATION; ACTIVATION; GRADIENT; RELEASE	Tetramethylrhodamine methyl ester (TMRM) is a fluorescent dye used to study mitochondrial function in living cells. Previously, we reported that TMRM effectively labeled mitochondria of neurons deep within mouse brain slices. Use of micromolar concentration of dye, which was required to get sufficient staining for two-photon imaging, resulted in typical fluctuations of TMRM. With prolonged exposure, we recorded additional responses in some neurons that included slow oscillations and propagating waves of fluorescence. (Note: We use the terms "fluctuation" to refer to a change in the fluorescent state of an individual mitochondrion, "oscillation" to refer to a localized change in fluorescence in the cytosol, and "wave" to refer to a change in cytosolic fluorescence that propagated within a cell. Use of these terms does not imply any underlying periodicity.) In this report we describe similar results using cultured rat hippocampal neurons. Prolonged exposure of cultures to 2.5 mu M TMRM produced a spontaneous increase in fluorescence in some neurons, but not glial cells, after 45-60 minutes that was followed by slow oscillations, waves, and eventually apoptosis. Spontaneous increases in fluorescence were insensitive to high concentrations of FCCP (100 mu M) and thapsigargin (10 mu M) indicating that they originated, at least in part, from regions outside of mitochondria. The oscillations did not correlate with changes in intracellular Ca2+, but did correlate with differences in fluorescence lifetime of the dye. Fluorescence lifetime and one-photon ratiometric imaging of TMRM suggested that the spontaneous increase and subsequent oscillations were due to movement of dye between quenched (hydrophobic) and unquenched (hydrophilic) compartments. We propose that these movements may be correlates of intracellular events involved in early stages of apoptosis.	[Monteith, Andrew; Chan, Philip; Logan, Juliette; Yu, Weiming; Schwarz, Nicholas; Wokosin, David; Hockberger, Philip] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Marszalec, William] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Hockberger, P (corresponding author), Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA.	p-hockberger@northwestern.edu	Monteith, Andrew Joseph/ABF-3164-2021	Monteith, Andrew/0000-0002-7259-6574; Hockberger, Philip/0000-0002-4013-4885	National Institutes of Health (NIH) under NINDS [NS88450]	National Institutes of Health (NIH) under NINDS	The National Institutes of Health (NIH) funded development of the instruments and personnel involved in this study under an NINDS P-30 grant (NS88450, PI: D.J. Surmeier). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistrup GL, 1999, MOL PHARMACOL, V55, P39, DOI 10.1124/mol.55.1.39; Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; BRIGHT GR, 1989, METHOD CELL BIOL, V30, P157; Buckman JF, 2001, J NEUROSCI, V21, P5054, DOI 10.1523/JNEUROSCI.21-14-05054.2001; Collins A, 2005, J CELL PHYSIOL, V202, P76, DOI 10.1002/jcp.20093; Colyer RA, 2008, MICROSC RES TECHNIQ, V71, P201, DOI 10.1002/jemt.20540; Cortassa S, 2004, BIOPHYS J, V87, P2060, DOI 10.1529/biophysj.104.041749; Deldicque L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020993; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Fall CP, 2007, BIOPHYS J A S; Gendron PO, 2008, J FLUORESC, V18, P1093, DOI 10.1007/s10895-008-0357-7; Gerencser AA, 2005, BIOPHYS J, V88, P698, DOI 10.1529/biophysj.104.050062; Gomez JP, 1996, J CARDIOVASC PHARM, V27, P335, DOI 10.1097/00005344-199603000-00005; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hayakawa Y, 2005, CELL CALCIUM, V37, P359, DOI 10.1016/j.ceca.2004.11.005; Heytler P G, 1979, Methods Enzymol, V55, P462; Hockberger P, 2009, BIOPHYS J A S; Hockberger PE, 1999, P NATL ACAD SCI USA, V96, P6255, DOI 10.1073/pnas.96.11.6255; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kasibhatla S., 2006, COLD SPRING HARB PRO; Kindmark H, 2001, J BIOL CHEM, V276, P34530, DOI 10.1074/jbc.M102492200; Korkotian E, 1998, EUR J NEUROSCI, V10, P2076, DOI 10.1046/j.1460-9568.1998.00219.x; Kuimova MK, 2009, NAT CHEM, V1, P69, DOI [10.1038/nchem.120, 10.1038/NCHEM.120]; Lamarca V, 2009, EMBO J, V28, P1681, DOI 10.1038/emboj.2009.135; LOEW LM, 1993, BIOPHYS J, V65, P2396, DOI 10.1016/S0006-3495(93)81318-3; Loontiens FG, 1990, BIOCHEM, V29, P9032; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705; LYTTON J, 1991, J BIOL CHEM, V266, P17067; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Murray JD, 2007, MATH BIOL, P257; O'Reilly CM, 2003, BIOPHYS J, V85, P3350, DOI 10.1016/S0006-3495(03)74754-7; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Petty HR, 2000, PHYS REV LETT, V84, P2754, DOI 10.1103/PhysRevLett.84.2754; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Tretter L, 1998, MOL PHARMACOL, V53, P734, DOI 10.1124/mol.53.4.734; VERCESI AE, 1993, J BIOL CHEM, V268, P8564; Vergun O, 2005, BBA-BIOENERGETICS, V1709, P127, DOI 10.1016/j.bbabio.2005.07.006; Vergun O, 2004, BIOPHYS J, V87, P3585, DOI 10.1529/biophysj.104.042671; Vergun O, 2003, BIOPHYS J, V85, P3358, DOI 10.1016/S0006-3495(03)74755-9; Wiedemann N, 2009, SCIENCE, V325, P403, DOI 10.1126/science.1178016; Wokosin DL, 2004, BIOPHYS J, V86, P1726, DOI 10.1016/S0006-3495(04)74241-1; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Yu W, 2000, ADV OPTICAL MEASUREM, P139; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	51	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58059	10.1371/journal.pone.0058059	http://dx.doi.org/10.1371/journal.pone.0058059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483968	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900066
J	Buttigieg, PL; Hankeln, W; Kostadinov, I; Kottmann, R; Yilmaz, P; Duhaime, MB; Glockner, FO				Buttigieg, Pier Luigi; Hankeln, Wolfgang; Kostadinov, Ivaylo; Kottmann, Renzo; Yilmaz, Pelin; Duhaime, Melissa Beth; Gloeckner, Frank Oliver			Ecogenomic Perspectives on Domains of Unknown Function: Correlation-Based Exploration of Marine Metagenomes	PLOS ONE			English	Article							COMMUNITY STRUCTURE; BIOLOGICAL DATA; DNA-DAMAGE; GLUTATHIONE; METABOLISM; GLUTAREDOXINS; PATTERNS; FAMILIES; BACTERIA; INSIGHTS	Background: The proportion of conserved DNA sequences with no clear function is steadily growing in bioinformatics databases. Studies of sequence and structural homology have indicated that many uncharacterized protein domain sequences are variants of functionally described domains. If these variants promote an organism's ecological fitness, they are likely to be conserved in the genome of its progeny and the population at large. The genetic composition of microbial communities in their native ecosystems is accessible through metagenomics. We hypothesize the co-variation of protein domain sequences across metagenomes from similar ecosystems will provide insights into their potential roles and aid further investigation. Methodology/Principal findings: We calculated the correlation of Pfam protein domain sequences across the Global Ocean Sampling metagenome collection, employing conservative detection and correlation thresholds to limit results to well-supported hits and associations. We then examined intercorrelations between domains of unknown function (DUFs) and domains involved in known metabolic pathways using network visualization and cluster-detection tools. We used a cautious "guilty-by-association'' approach, referencing knowledge-level resources to identify and discuss associations that offer insight into DUF function. We observed numerous DUFs associated to photobiologically active domains and prevalent in the Cyanobacteria. Other clusters included DUFs associated with DNA maintenance and repair, inorganic nutrient metabolism, and sodium-translocating transport domains. We also observed a number of clusters reflecting known metabolic associations and cases that predicted functional reclassification of DUFs. Conclusion/Significance: Critically examining domain covariation across metagenomic datasets can grant new perspectives on the roles and associations of DUFs in an ecological setting. Targeted attempts at DUF characterization in the laboratory or in silico may draw from these insights and opportunities to discover new associations and corroborate existing ones will arise as more large-scale metagenomic datasets emerge.	[Buttigieg, Pier Luigi; Hankeln, Wolfgang; Kottmann, Renzo; Yilmaz, Pelin; Gloeckner, Frank Oliver] Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Grp, Bremen, Germany; [Buttigieg, Pier Luigi; Gloeckner, Frank Oliver] Jacobs Univ gGmbH, Bremen, Germany; [Kostadinov, Ivaylo] Inst Ciencias Mar, Dept Biol Marina & Oceanog, E-08039 Barcelona, Spain; [Duhaime, Melissa Beth] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Max Planck Society; Jacobs University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Michigan System; University of Michigan	Buttigieg, PL (corresponding author), Max Planck Inst Marine Microbiol, Microbial Genom & Bioinformat Grp, Bremen, Germany.	pbuttigi@mpi-bremen.de		Buttigieg, Pier Luigi/0000-0002-4366-3088; Duhaime, Melissa/0000-0001-7884-5087; Kostadinov, Ivaylo/0000-0003-4476-6764; Yilmaz, Pelin/0000-0003-4724-323X	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was funded by the Max Planck Society (http://www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Bornke F, 2008, ANAL BIOL NETWORKS, P207; Breitling R, 2008, NAT REV MICROBIOL, V6, P156, DOI 10.1038/nrmicro1797; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Delmont TO, 2011, ISME J, V5, P1837, DOI 10.1038/ismej.2011.61; DeLong EF, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000359; Deng H, 2009, CHEMBIOCHEM, V10, P2455, DOI 10.1002/cbic.200900369; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Fuhrman JA, 2008, AQUAT MICROB ECOL, V53, P69, DOI 10.3354/ame01222; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Galperin MY, 2010, TRENDS BIOTECHNOL, V28, P398, DOI 10.1016/j.tibtech.2010.05.006; Gilbert JA, 2011, ANNU REV MAR SCI, V3, P347, DOI 10.1146/annurev-marine-120709-142811; Goonesekere NCW, 2010, COMPUT BIOL CHEM, V34, P210, DOI 10.1016/j.compbiolchem.2010.04.001; Iyer LM, 2009, MOL BIOSYST, V5, P1636, DOI 10.1039/b917682a; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Kannan R, 1996, J BIOL CHEM, V271, P9754, DOI 10.1074/jbc.271.16.9754; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; LASH LH, 1984, J BIOL CHEM, V259, P4508; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Meador JA, 2009, PHOTOCHEM PHOTOBIOL, V85, P412, DOI 10.1111/j.1751-1097.2008.00462.x; Merico D, 2009, NAT BIOTECHNOL, V27, P921, DOI 10.1038/nbt.1567; Milligan JR, 2003, NUCLEIC ACIDS RES, V31, P6258, DOI 10.1093/nar/gkg816; Miyazono K, 2009, PROTEINS, V74, P256, DOI 10.1002/prot.22255; Morris JH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-436; Polz MF, 2006, PHILOS T R SOC B, V361, P2009, DOI 10.1098/rstb.2006.1928; Roberts RJ, 2011, NUCLEIC ACIDS RES, V39, pD11, DOI 10.1093/nar/gkq1168; Roberts RJ, 2004, PLOS BIOL, V2, P293, DOI 10.1371/journal.pbio.0020042; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Slamovits CH, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1188; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Toulza E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030931; Villarreal-Chiu JF, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00019; Weinitschke S, 2007, MICROBIOL-SGM, V153, P3055, DOI 10.1099/mic.0.2007/009845-0; Wittkop T, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.197; Wittkop T, 2010, NAT METHODS, V7, P419, DOI 10.1038/nmeth0610-419; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656	46	9	9	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e50869	10.1371/journal.pone.0050869	http://dx.doi.org/10.1371/journal.pone.0050869			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516388	gold, Green Published			2022-12-27	WOS:000316407400001
J	Christensen, JB; Hendricks, O; Chaki, S; Mukherjee, S; Das, A; Pal, TK; Dastidar, SG; Kristiansen, JE				Christensen, Jorn B.; Hendricks, Oliver; Chaki, Shaswati; Mukherjee, Sayanti; Das, Ayan; Pal, Tapan K.; Dastidar, Sujata G.; Kristiansen, Jette E.			A comparative Analysis of In Vitro and In Vivo Efficacies of the Enantiomers of Thioridazine and Its Racemate	PLOS ONE			English	Article							CLINICAL CONCENTRATIONS; NON-ANTIBIOTICS; ANTIBACTERIAL; METHDILAZINE; SYNERGISM; AGENT	A long list of chemotherapeutical drugs used in the treatment of the peripheral and the central nervous systems possess anti-microbial activity. Some of these neurotropic compounds are chiral, with the one stereo isomeric form exaggerating reduced neurotropism. This is the case for the levorotatory form of thioridazine. The phenothiazine thioridazine is an interesting compound, characterized by exhibiting a significant growth inhibiting activity on a wide array of microorganisms. Thioridazine is characterized by another challenging feature, because the compound is concentrated in certain human tissue cells. The present study describes a comparative study of the two enantiomers as well as the racemic form of thioridazine. The study exploits the stereochemical aspect and the in vitro and in vivo potential of these compounds, with a focus on the effects on Gram negative organism Salmonella enterica serover Typhimurium. In summary, the results of this study yielded a significant antibacterial activity of all forms of thioridazine, indicating the levorotatory (-)-form to be superior in terms of both its in vitro and in vivo efficacies.	[Christensen, Jorn B.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Hendricks, Oliver] Univ So Denmark, King Christian X Hosp Rheumat Dis, Grasten, Denmark; [Chaki, Shaswati; Mukherjee, Sayanti; Dastidar, Sujata G.] Herbicure Healthcare Bioherbal Res Fdn, Dept Microbiol, Kolkata, India; [Das, Ayan; Pal, Tapan K.] Jadavpur Univ, Dept Pharmaceut Technol, Bioequivalence Study Ctr, Kolkata, India	University of Copenhagen; University of Southern Denmark; Jadavpur University		jbc@chem.ku.dk	Christensen, Jørn B./J-8124-2012	Christensen, Jørn B./0000-0002-7641-8302				Amaral L, 2000, INT J ANTIMICROB AG, V14, P225, DOI 10.1016/S0924-8579(00)00136-9; Basu LR, 2005, MICROBIOL RES, V160, P95, DOI 10.1016/j.micres.2004.10.002; CHATTOPADHYAY D, 1988, ARZNEIMITTEL-FORSCH, V38-2, P869; Clinical and Laboratory Standards Institute, 2009, M7A7 CLIN LAB STAND; Dasgupta A, 2010, EUR J CLIN MICROBIOL, V29, P239, DOI 10.1007/s10096-009-0845-y; Dasgupta A, 2008, TOP HETEROCYCL CHEM, V15, P67, DOI 10.1007/7081_2007_108; Dasgupta A, 2010, INT J ANTIMICROB AG, V35, P174, DOI 10.1016/j.ijantimicag.2009.09.027; DASTIDAR SG, 1995, J CHEMOTHERAPY, V7, P201, DOI 10.1179/joc.1995.7.3.201; DASTIDAR SG, 1976, J APPL BACTERIOL, V41, P209, DOI 10.1111/j.1365-2672.1976.tb00621.x; Dastidar SG, 2000, INT J ANTIMICROB AG, V14, P249, DOI 10.1016/S0924-8579(99)00159-4; Dastidar Sujata G., 2004, Acta Microbiologica et Immunologica Hungarica, V51, P75; Dastidar Sujata G., 1997, Acta Microbiologica et Immunologica Hungarica, V44, P241; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; HENDRICKS O, 2007, THESIS U SO DENMARK; Jeyaseeli L, 2006, INT J ANTIMICROB AG, V27, P58, DOI 10.1016/j.ijantimicag.2005.08.014; Jeyaseeli L, 2012, EUR J CLIN MICROBIOL, V31, P1243, DOI 10.1007/s10096-011-1435-3; JORTANI SA, 1994, FORENSIC SCI INT, V64, P165, DOI 10.1016/0379-0738(94)90227-5; KRISTIANSEN JE, 1992, APMIS, V100, P7; Kristiansen JE, 1997, J ANTIMICROB CHEMOTH, V40, P319, DOI 10.1093/jac/40.3.319; Kumar K. Asok, 2003, Acta Microbiologica Polonica, V52, P285; Kumar KA, 2004, BIOL PHARM BULL, V27, P1116, DOI 10.1248/bpb.27.1116; Mazumder R, 2001, INT J ANTIMICROB AG, V18, P403, DOI 10.1016/S0924-8579(01)00324-7; MOLNAR J, 1976, ACTA MICROBIOL HUNG, V23, P45; Molnar J, 1992, THIAZINES STRUCTURAL, P197; Ordway D, 2003, ANTIMICROB AGENTS CH, V47, P917, DOI 10.1128/AAC.47.3.917-922.2003; Ordway D, 2002, INT J ANTIMICROB AG, V20, P34, DOI 10.1016/S0924-8579(02)00110-3; Radhakrishnan V., 1999, Indian Journal of Experimental Biology, V37, P671; SVENDSEN CN, 1988, NEUROPHARMACOLOGY, V27, P1117, DOI 10.1016/0028-3908(88)90006-8	28	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57493	10.1371/journal.pone.0057493	http://dx.doi.org/10.1371/journal.pone.0057493			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505431	Green Submitted, gold, Green Published			2022-12-27	WOS:000318334500023
J	Goni, J; Avena-Koenigsberger, A; de Mendizabal, NV; van den Heuvel, MP; Betzel, RF; Sporns, O				Goni, Joaquin; Avena-Koenigsberger, Andrea; de Mendizabal, Nieves Velez; van den Heuvel, Martijn P.; Betzel, Richard F.; Sporns, Olaf			Exploring the Morphospace of Communication Efficiency in Complex Networks	PLOS ONE			English	Article							SMALL-WORLD; OPTIMIZATION	Graph theoretical analysis has played a key role in characterizing global features of the topology of complex networks, describing diverse systems such as protein interactions, food webs, social relations and brain connectivity. How system elements communicate with each other depends not only on the structure of the network, but also on the nature of the system's dynamics which are constrained by the amount of knowledge and resources available for communication processes. Complementing widely used measures that capture efficiency under the assumption that communication preferentially follows shortest paths across the network ("routing''), we define analytic measures directed at characterizing network communication when signals flow in a random walk process ("diffusion''). The two dimensions of routing and diffusion efficiency define a morphospace for complex networks, with different network topologies characterized by different combinations of efficiency measures and thus occupying different regions of this space. We explore the relation of network topologies and efficiency measures by examining canonical network models, by evolving networks using a multi-objective optimization strategy, and by investigating real-world network data sets. Within the efficiency morphospace, specific aspects of network topology that differentially favor efficient communication for routing and diffusion processes are identified. Charting regions of the morphospace that are occupied by canonical, evolved or real networks allows inferences about the limits of communication efficiency imposed by connectivity and dynamics, as well as the underlying selection pressures that have shaped network topology.	[Goni, Joaquin; Avena-Koenigsberger, Andrea; Betzel, Richard F.; Sporns, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [de Mendizabal, Nieves Velez] Indiana Univ, Dept Med, Indianapolis, IN USA; [de Mendizabal, Nieves Velez] Indiana Clin & Translat Sci Inst, Indianapolis, IN USA; [van den Heuvel, Martijn P.] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [van den Heuvel, Martijn P.] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Sporns, O (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	osporns@indiana.edu	Sporns, Olaf/A-1667-2010; van den Heuvel, Martijn/AFR-3213-2022	Sporns, Olaf/0000-0001-7265-4036; van den Heuvel, Martijn/0000-0003-1570-1195	James S. McDonnell Foundation	James S. McDonnell Foundation	This project was funded by the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2001, PHYS REV LETT, V86, P3196, DOI 10.1103/PhysRevLett.86.3196; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy M, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/07/L07002; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058701; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Cajueiro DO, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/58004; Cajueiro DO, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046103; Cancho RFI, 2003, LECT NOTES PHYS, V625, P114; Colizza V, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198701; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Costa LD, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016102; Criado R, 2005, J MATH MODELLING ALG, V4, P307, DOI DOI 10.1007/S10852-005-9006-1; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fronczak A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016107; Goldberg DE, 1989, GENETIC ALGORITHMS S, DOI DOI 10.1111/J.1365-2486.2009.02080.X; Gomez-Gardenes J, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.065102; Goni J, 2010, INT J BIFURCAT CHAOS, V20, P913, DOI 10.1142/S0218127410026204; GRUHL D., 2004, SIGKDD EXPLORATIONS, V13, P491, DOI DOI 10.1145/1046456.1046462; Guimera R, 2001, PHYSICA A, V299, P247, DOI 10.1016/S0378-4371(01)00302-8; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Kostka J, 2008, LECT NOTES COMPUT SC, V5058, P185, DOI 10.1007/978-3-540-69355-0_16; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; McGhee GR, 1999, PERS PALEOB; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Rosvall M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.066111; Rosvall M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028701; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Santana R, 2011, NEUROINFORMATICS, V9, P3, DOI 10.1007/s12021-010-9085-7; Shannon C.E., 1949, MATH THEORY INFORM; Snell, 2003, INTRO PROBABILITY; Sole RV, 2004, LECT NOTES PHYS, V650, P189; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vragovic I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036122; Wang B, 2006, PHYSICA A, V363, P591, DOI 10.1016/j.physa.2005.08.025; Wang SP, 2008, PHYSICA A, V387, P4699, DOI 10.1016/j.physa.2008.03.032; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	44	82	83	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58070	10.1371/journal.pone.0058070	http://dx.doi.org/10.1371/journal.pone.0058070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505455	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500047
J	Fuermaier, ABM; Tucha, L; Koerts, J; Aschenbrenner, S; Westermann, C; Weisbrod, M; Lange, KW; Tucha, O				Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; Aschenbrenner, Steffen; Westermann, Celina; Weisbrod, Matthias; Lange, Klaus W.; Tucha, Oliver			Complex Prospective Memory in Adults with Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHOLOGICAL ASSESSMENT; RESPONSE-INHIBITION; CHILDREN; ADHD; METHYLPHENIDATE; INTENTIONS; METAANALYSIS; PERFORMANCE; INTERFERENCE	Objectives: Attention deficit hyperactivity disorder (ADHD) in adults has been associated with disturbances of attention and executive functions. Furthermore, impairments of verbal and figural retrospective memory were reported. However, little is known about the effects of ADHD on prospective memory, the execution of delayed intentions in the future. Methods: The present study compared the performance of 45 adult patients with ADHD not treated with stimulant medication with the performance of 45 matched healthy individuals on a paradigm of complex prospective memory which measured task planning, plan recall, self-initiation and execution. Furthermore, the contribution of other cognitive functions to prospective memory functioning was assessed, including measures of attention, executive functions and memory. Results: A large-scale impairment could be observed in task planning abilities in patients with ADHD. Only negligible to small effects were found for plan recall, self-initiation and execution. Inhibition was identified to contribute significantly to performance on task planning. Conclusions: The present findings suggest that four cognitive components contribute to the performance of prospective memory. Impairments of prospective memory mainly emerged from deficient planning abilities in adults with ADHD. Implications on behavioral based intervention strategies are discussed.	[Fuermaier, Anselm B. M.; Tucha, Lara; Koerts, Janneke; Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Aschenbrenner, Steffen; Westermann, Celina] SRH Clin Karlsbad Langensteinbach, Dept Clin Psychol & Neuropsychol, Karlsbad, Germany; [Weisbrod, Matthias] SRH Clin Karlsbad Langensteinbach, Dept Psychiat & Psychotherapy, Karlsbad, Germany; [Weisbrod, Matthias] Heidelberg Univ, Ctr Psychosocial Med, Sect Expt Psychopathol, Heidelberg, Germany; [Lange, Klaus W.] Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany	University of Groningen; Ruprecht Karls University Heidelberg; University of Regensburg	Lange, KW (corresponding author), Univ Regensburg, Dept Expt Psychol, D-93053 Regensburg, Germany.	klaus.lange@psychologie.uni-regensburg.de	Tucha, Oliver/AAD-1403-2019	Groen, Yvonne/0000-0002-7242-0317; Fuermaier, Anselm/0000-0002-2331-0840				Altgassen M, J ATTENTION IN PRESS; Barkley RA, 2006, ATTENTION DEFICIT HY; BENSON DF, 1991, J CHILD NEUROL, V6, pS9, DOI 10.1177/0883073891006001S02; Boonstra AM, 2010, NEUROPSYCHOLOGY, V24, P209, DOI 10.1037/a0017670; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Boucugnani LL, 1989, ARCH CLIN NEUROPSYCH, V4, P161, DOI DOI 10.1093/ARCLIN/4.2.161; Brandimonte MA, 2011, MEMORY, V19, P56, DOI 10.1080/09658211.2010.535657; Brickenkamp R., 1998, D2 TEST ATTENTION, V1st; Clark C, 2000, J ABNORM CHILD PSYCH, V28, P403, DOI 10.1023/A:1005176320912; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craik FIM, 2000, INT J PSYCHOL, V35, P184; CROVITZ HF, 1984, B PSYCHONOMIC SOC, V22, P413; Dinn WM, 2001, BRAIN COGNITION, V46, P114, DOI 10.1016/S0278-2626(01)80046-4; Einstein G.O., 1996, PROSPECTIVE MEMORY T; Ellis J., 1996, PROSPECTIVE MEMORY T, P1; Epstein JN, 2001, J CLIN EXP NEUROPSYC, V23, P362, DOI 10.1076/jcen.23.3.362.1186; Faraone SV, 2010, J CLIN PSYCHIAT, V71, P754, DOI 10.4088/JCP.08m04902pur; Faraone SV, 2004, J CLIN PSYCHOPHARM, V24, P24, DOI 10.1097/01.jcp.0000108984.11879.95; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; HOUX PJ, 1993, EXP AGING RES, V19, P209, DOI 10.1080/03610739308253934; Kerns KA, 2001, CHILD NEUROPSYCHOL, V7, P162, DOI 10.1076/chin.7.3.162.8744; Kliegel M, 2000, MEM COGNITION, V28, P1041, DOI 10.3758/BF03209352; Kliegel M, 2005, J NEUROL NEUROSUR PS, V76, P1501, DOI 10.1136/jnnp.2004.051268; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2003, INT J PSYCHOL, V38, P193, DOI 10.1080/00207590344000114; Kliegel M, 2006, CHILD NEUROPSYCHOL, V12, P407, DOI 10.1080/09297040600696040; Lange KW, 2007, J NEURAL TRANSM-SUPP, P249; Lange KW, 2010, ADHD-ATTEND DEFICIT, V2, P241, DOI 10.1007/s12402-010-0045-8; Lehrl S., 1995, MEHRFACHWAHL WORTSCH; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Murphy KR, 2001, NEUROPSYCHOLOGY, V15, P211, DOI 10.1037//0894-4105.15.2.211; Radford KA, 2011, CLIN NEUROPSYCHOL, V25, P127, DOI 10.1080/13854046.2010.529463; Raskin S., 2004, J INT NEUROPSYCH SOC, V10, P110, DOI [10.1017/S1355617704040019, DOI 10.1017/S1355617704040019]; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Riccio CA, 2004, ARCH CLIN NEUROPSYCH, V19, P661, DOI 10.1016/j.acn.2003.09.001; Rosler M., 2008, HOMBURGER ADHS SKALE; Schoechlin C, 2005, ARCH CLIN NEUROPSYCH, V20, P727, DOI 10.1016/j.acn.2005.04.005; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Siklos S, 2004, ARCH CLIN NEUROPSYCH, V19, P347, DOI 10.1016/S0887-6177(03)00071-4; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tannock R, 1998, J CHILD PSYCHOL PSYC, V39, P65, DOI 10.1017/S0021963097001777; TERRY WS, 1988, PSYCHOL REP, V62, P299, DOI 10.2466/pr0.1988.62.1.299; Tucha L, 2011, J ATTEN DISORD, V15, P161, DOI 10.1177/1087054709356391; Tucha L, 2009, J ATTEN DISORD, V12, P410, DOI 10.1177/1087054708315065; Tucha O, 2006, J NEURAL TRANSM, V113, P1575, DOI 10.1007/s00702-005-0437-7; Tucha Oliver, 2005, Cogn Neuropsychiatry, V10, P231, DOI 10.1080/13546800444000047; Verster JC, 2010, PSYCHOPHARMACOLOGY, V212, P277, DOI 10.1007/s00213-010-1952-2; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wilson B., 2004, J INT NEUROPSYCH SOC, V10, P44; Wilson BA, 2005, CAMBRIDGE PROSPECTIV; Woods SP, 2002, CLIN NEUROPSYCHOL, V16, P12, DOI 10.1076/clin.16.1.12.8336; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Zimmermann P, 2002, TEST BATTERY ATTENTI; Zinke K, 2010, CHILD NEUROPSYCHOL, V16, P338, DOI 10.1080/09297041003631451; Zogg JB, 2012, J BEHAV MED, V35, P47, DOI 10.1007/s10865-011-9341-9	59	26	27	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58338	10.1371/journal.pone.0058338	http://dx.doi.org/10.1371/journal.pone.0058338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23484020	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100110
J	Mansour, H; McColm, JR; Cole, L; Weible, M; Korlimbinis, A; Chan-Ling, T				Mansour, Hussein; McColm, Janet R.; Cole, Louise; Weible, Michael, II; Korlimbinis, Anastasia; Chan-Ling, Tailoi			Connexin 30 Expression and Frequency of Connexin Heterogeneity in Astrocyte Gap Junction Plaques Increase with Age in the Rat Retina	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CULTURED ASTROCYTES; GLIAL-CELLS; VESSEL STABILITY; FREEZE-FRACTURE; MAUTHNER CELL; HUMAN BRAIN; BLOOD-FLOW; CHANNELS; RODENT	We investigated age-associated changes in retinal astrocyte connexins (Cx) by assaying Cx numbers, plaque sizes, protein expression levels and heterogeneity of gap junctions utilizing six-marker immunohistochemistry (IHC). We compared Wistar rat retinal wholemounts in animals aged 3 (young adult), 9 (middle-aged) and 22 months (aged). We determined that retinal astrocytes have gap junctions composed of Cx26, -30, -43 and -45. Cx30 was consistently elevated at 22 months compared to younger ages both when associated with parenchymal astrocytes and vascular-associated astrocytes. Not only was the absolute number of Cx30 plaques significantly higher (P<0.05) but the size of the plaques was significantly larger at 22 months compared to younger ages (p<0.05). With age, Cx26 increased significantly initially, but returned to basal levels; whereas Cx43 expression remained low and stable with age. Evidence that astrocytes alter connexin compositions of gap junctions was demonstrated by the significant increase in the number of Cx26/Cx45 gap junctions with age. We also found gap junctions comprised of 1, 2, 3 or 4 Cx proteins suggesting that retinal astrocytes use various connexin protein combinations in their gap junctions during development and aging. These data provides new insight into the dynamic and extensive Cx network utilized by retinal astrocytes for communication within both the parenchyma and vasculature for the maintenance of normal retinal physiology with age. This characterisation of the changes in astrocytic gap junctional communication with age in the CNS is crucial to the understanding of physiological aging and age-related neurodegenerative diseases.	[Mansour, Hussein; McColm, Janet R.; Weible, Michael, II; Korlimbinis, Anastasia; Chan-Ling, Tailoi] Univ Sydney, Sch Med Sci, Dept Anat, Sydney, NSW 2006, Australia; [Mansour, Hussein; McColm, Janet R.; Weible, Michael, II; Korlimbinis, Anastasia; Chan-Ling, Tailoi] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Cole, Louise] Univ Sydney, Adv Microscopy Facil, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Chan-Ling, T (corresponding author), Univ Sydney, Sch Med Sci, Dept Anat, Sydney, NSW 2006, Australia.	tailoi@anatomy.usyd.edu.au	Chan-Ling, Tailoi/X-2718-2019; Chan-Ling, Tailoi/A-2177-2008; Mansour, Hussein/S-2883-2019	Chan-Ling, Tailoi/0000-0002-8225-3671; Mansour, Hussein/0000-0002-9559-3229; Higgins, Janet/0000-0002-5342-382X; Cole, Louise/0000-0001-9206-9272	National Health and Medical Research Council of Australia [1005730, 571100]; Baxter Charitable Foundation; Rebecca L. Cooper Medical Research Foundation (Sydney, Australia); Brian M. Kirby Foundation (Gift of Sight Initiative); University of Sydney Medical Foundation/Blues and Research Scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Baxter Charitable Foundation; Rebecca L. Cooper Medical Research Foundation (Sydney, Australia); Brian M. Kirby Foundation (Gift of Sight Initiative); University of Sydney Medical Foundation/Blues and Research Scholarship(University of Sydney)	This work was supported by grants to TC-L from the National Health and Medical Research Council of Australia (Nos. 1005730 and 571100), the Baxter Charitable Foundation, the Rebecca L. Cooper Medical Research Foundation (Sydney, Australia) and the Brian M. Kirby Foundation (Gift of Sight Initiative). HM was the recipient of a University of Sydney Medical Foundation/Blues and Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010; Altevogt BM, 2004, J NEUROSCI, V24, P4313, DOI 10.1523/JNEUROSCI.3303-03.2004; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Ball KK, 2011, J NEUROSCIENCE RES; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Bevans CG, 1998, J BIOL CHEM, V273, P2808, DOI 10.1074/jbc.273.5.2808; Beyer EC, 2001, CELL COMMUN ADHES, V8, P199, DOI 10.3109/15419060109080723; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Bobbie MW, 2010, INVEST OPHTH VIS SCI, V51, P3758, DOI 10.1167/iovs.09-4489; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Chan-Ling T, 2004, AM J PATHOL, V165, P1301, DOI 10.1016/S0002-9440(10)63389-5; Chan-Ling T, 2007, MICROCIRCULATION, V14, P63, DOI 10.1080/10739680601073451; Chan-Ling T, 2009, GLIA, V57, P39, DOI 10.1002/glia.20733; ChanLing T, 1997, MICROSC RES TECHNIQ, V36, P1; COLLIER TJ, 1991, NEUROBIOL AGING, V12, P685, DOI 10.1016/0197-4580(91)90122-Z; Cotrina ML, 2001, BRAIN RES, V901, P55, DOI 10.1016/S0006-8993(01)02258-2; Dermietzel R, 2000, BRAIN RES REV, V32, P45, DOI 10.1016/S0165-0173(99)00067-3; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; GIAUME C, 1991, NEURON, V6, P133, DOI 10.1016/0896-6273(91)90128-M; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Harman AM, 2003, GERONTOLOGY, V49, P350, DOI 10.1159/000073762; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Hughes S, 2000, MICROCIRCULATION, V7, P317, DOI 10.1038/sj.mn.7300119; Hughes S, 2006, NEUROBIOL AGING, V27, P1838, DOI 10.1016/j.neurobiolaging.2005.10.021; Janssen-Bienhold U, 1998, J COMP NEUROL, V396, P310, DOI 10.1002/(SICI)1096-9861(19980706)396:3<310::AID-CNE3>3.0.CO;2-5; Kerr NM, 2010, INVEST OPHTH VIS SCI, V51, P4028, DOI 10.1167/iovs.09-4847; Koulakoff A, 2008, GLIA, V56, P1299, DOI 10.1002/glia.20698; Kruger O, 2000, DEVELOPMENT, V127, P4179; Kunzelmann P, 1999, GLIA, V25, P111, DOI 10.1002/(SICI)1098-1136(19990115)25:2<111::AID-GLIA2>3.0.CO;2-I; Kuo IY, 2008, J COMP NEUROL, V511, P773, DOI 10.1002/cne.21873; Li X, 2001, AM J PHYSIOL-HEART C, V281, pH1890, DOI 10.1152/ajpheart.2001.281.5.H1890; Li X, 2008, J NEUROSCI, V28, P9769, DOI 10.1523/JNEUROSCI.2137-08.2008; Mansour H, 2008, AGING CELL, V7, P526, DOI 10.1111/j.1474-9726.2008.00402.x; Manthey D, 2001, J MEMBRANE BIOL, V181, P137, DOI 10.1007/s00232-001-0017-1; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Nagy JI, 2001, J COMP NEUROL, V441, P302, DOI 10.1002/cne.1414; NAKAJIMA Y, 1987, J ELECTRON MICR TECH, V6, P143, DOI 10.1002/jemt.1060060205; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Rash JE, 2001, J NEUROSCI, V21, P1983, DOI 10.1523/JNEUROSCI.21-06-01983.2001; ROBINSON SR, 1993, SCIENCE, V262, P1072; Rouach N, 2004, NEUROCHEM INT, V45, P265, DOI 10.1016/j.neuint.2003.07.004; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Theis M, 2005, TRENDS NEUROSCI, V28, P188, DOI 10.1016/j.tins.2005.02.006; Theiss C, 2002, EXP CELL RES, V281, P197, DOI 10.1006/excr.2002.5652; TUTTLE R, 1986, J COMP NEUROL, V246, P202, DOI 10.1002/cne.902460206; Vis JC, 1998, CELL BIOL INT, V22, P837, DOI 10.1006/cbir.1998.0388; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Zahs KR, 2006, VISUAL NEUROSCI, V23, P1, DOI 10.1017/S0952523806231018; Zahs KR, 2003, J COMP NEUROL, V455, P531, DOI 10.1002/cne.10524	50	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57038	10.1371/journal.pone.0057038	http://dx.doi.org/10.1371/journal.pone.0057038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516399	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400006
J	Chen, J; Ingham, N; Clare, S; Raisen, C; Vancollie, VE; Ismail, O; McIntyre, RE; Tsang, SH; Mahajan, VB; Dougan, G; Adams, DJ; White, JK; Steel, KP				Chen, Jing; Ingham, Neil; Clare, Simon; Raisen, Claire; Vancollie, Valerie E.; Ismail, Ozama; McIntyre, Rebecca E.; Tsang, Stephen H.; Mahajan, Vinit B.; Dougan, Gordon; Adams, David J.; White, Jacqueline K.; Steel, Karen P.			Mcph1-Deficient Mice Reveal a Role for MCPH1 in Otitis Media	PLOS ONE			English	Article							MIDDLE-EAR MUCOSA; EUSTACHIAN-TUBE; MITOTIC ENTRY; MOUSE MODEL; INNER-EAR; HEARING; ULTRASTRUCTURE; SUSCEPTIBILITY; HERITABILITY; DYSFUNCTION	Otitis media is a common reason for hearing loss, especially in children. Otitis media is a multifactorial disease and environmental factors, anatomic dysmorphology and genetic predisposition can all contribute to its pathogenesis. However, the reasons for the variable susceptibility to otitis media are elusive. MCPH1 mutations cause primary microcephaly in humans. So far, no hearing impairment has been reported either in the MCPH1 patients or mouse models with Mcph1 deficiency. In this study, Mcph1-deficient (Mcph1(tm1a/tm1a)) mice were produced using embryonic stem cells with a targeted mutation by the Sanger Institute's Mouse Genetics Project. Auditory brainstem response measurements revealed that Mcph1(tm1a/tm1a) mice had mild to moderate hearing impairment with around 70% penetrance. We found otitis media with effusion in the hearing-impaired Mcph1(tm1a/tm1a) mice by anatomic and histological examinations. Expression of Mcph1 in the epithelial cells of middle ear cavities supported its involvement in the development of otitis media. Other defects of Mcph1(tm1a/tm1a) mice included small skull sizes, increased micronuclei in red blood cells, increased B cells and ocular abnormalities. These findings not only recapitulated the defects found in other Mcph1-deficient mice or MCPH1 patients, but also revealed an unexpected phenotype, otitis media with hearing impairment, which suggests Mcph1 is a new gene underlying genetic predisposition to otitis media.	[Chen, Jing; Ingham, Neil; Clare, Simon; Raisen, Claire; Vancollie, Valerie E.; Ismail, Ozama; McIntyre, Rebecca E.; Dougan, Gordon; Adams, David J.; White, Jacqueline K.; Steel, Karen P.] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Tsang, Stephen H.] Columbia Univ, Edward S Harkness Eye Inst, New York, NY USA; [Mahajan, Vinit B.] Univ Iowa, Dept Ophthalmol & Visual Sci, Omics Lab, Iowa City, IA USA	Wellcome Trust Sanger Institute; Columbia University; University of Iowa	Steel, KP (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England.	karen.steel@kcl.ac.uk	Ismail, Ozama/AFQ-9517-2022	Mahajan, Vinit/0000-0003-1886-1741; Ismail, Ozama/0000-0002-0871-3924; Adams, David/0000-0001-9490-0306	Wellcome Trust [098051]; Medical Research Council [G0300212]; European Commission (EUMODIC) [LSHG-CT-2006-037188]; Cancer Research UK [C20510/A13031]; NATIONAL EYE INSTITUTE [R01EY018213, P30EY019007] Funding Source: NIH RePORTER; Cancer Research UK [13031, 12401] Funding Source: researchfish; Medical Research Council [MC_qA137918] Funding Source: researchfish; MRC [G0300212, MC_qA137918] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission (EUMODIC)(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (grant number 098051) www.wellcome.ac.uk, Medical Research Council (grant number G0300212) http://www.mrc.ac.uk, European Commission (EUMODIC contract no. LSHG-CT-2006-037188) www.eumodic.org and Cancer Research UK (grant number C20510/A13031) http://www.cancerresearchuk.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; CHOLE RA, 1985, ACTA OTO-LARYNGOL, V100, P273, DOI 10.3109/00016488509104790; Daly KA, 2004, AM J HUM GENET, V75, P988, DOI 10.1086/426061; Depreux FFS, 2008, J CLIN INVEST, V118, P651, DOI 10.1172/JCI32899; GLODDEK B, 1992, LARYNGOSCOPE, V102, P177; Gruber R, 2011, NAT CELL BIOL, V13, P1325, DOI 10.1038/ncb2342; Harkness P, 1998, LARYNGOSCOPE, V108, P1539, DOI 10.1097/00005537-199810000-00021; HENTZER E, 1984, ACTA OTO-LARYNGOL, P19; Hilton JM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r90; HUNTERDUVAR IM, 1978, ACTA OTO-LARYNGOL, P3; Ibanez-Tallon I, 2002, HUM MOL GENET, V11, P715, DOI 10.1093/hmg/11.6.715; IZHAR M, 1990, INFECT IMMUN, V58, P2258, DOI 10.1128/IAI.58.7.2258-2261.1990; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595; Jero J, 2001, ACTA OTO-LARYNGOL, V121, P585, DOI 10.1080/000164801316878863; Juhn SK, 1997, ANN NY ACAD SCI, V830, P130, DOI 10.1111/j.1749-6632.1997.tb51885.x; Kawauchi H, 1989, ACTA OTO-LARYNGOL, V457, P100; Kubba H, 2000, CLIN OTOLARYNGOL, V25, P181, DOI 10.1046/j.1365-2273.2000.00350.x; Kvaerner KJ, 1997, ANN OTO RHINOL LARYN, V106, P624, DOI 10.1177/000348949710600802; Liang YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000826; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lukens A, 2012, EUR RADIOL, V22, P533, DOI 10.1007/s00330-011-2303-3; MacArthur CJ, 2006, HEARING RES, V219, P12, DOI 10.1016/j.heares.2006.05.012; Mahajan VB, 2011, J VIS EXP; Marseglia GL, 2011, INT J IMMUNOPATH PH, V24, P1, DOI 10.1177/03946320110240S401; Miura M, 2002, INT J PEDIATR OTORHI, V64, P207, DOI 10.1016/S0165-5876(02)00070-8; Parkinson N, 2006, PLOS GENET, V2, P1556, DOI 10.1371/journal.pgen.0020149; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Ryding M, 2002, ANN OTO RHINOL LARYN, V111, P261, DOI 10.1177/000348940211100311; Rye MS, 2011, MAMM GENOME, V22, P66, DOI 10.1007/s00335-010-9295-1; Scharschmidt TC, 2009, J INVEST DERMATOL, V129, P2435, DOI 10.1038/jid.2009.104; Shima N, 2003, GENETICS, V163, P1031; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; SORRI M, 1995, ACTA OTO-LARYNGOL, V115, P193, DOI 10.3109/00016489509139290; STEEL KP, 1992, NAT GENET, V2, P75, DOI 10.1038/ng0992-75; SUZUKI M, 1989, ANN OTO RHINOL LARYN, V98, P980, DOI 10.1177/000348948909801212; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Trimborn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009242; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Wiles S, 2004, CELL MICROBIOL, V6, P963, DOI 10.1111/j.1462-5822.2004.00414.x; Wood JL, 2008, J BIOL CHEM, V283, P29586, DOI 10.1074/jbc.M804080200; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Yoshida K, 1999, HEARING RES, V137, P155, DOI 10.1016/S0378-5955(99)00134-3	45	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58156	10.1371/journal.pone.0058156	http://dx.doi.org/10.1371/journal.pone.0058156			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516444	Green Published, gold			2022-12-27	WOS:000316849200039
J	Maki-Marttunen, T; Kesseli, J; Nykter, M				Maki-Marttunen, Tuomo; Kesseli, Juha; Nykter, Matti			Balance between Noise and Information Flow Maximizes Set Complexity of Network Dynamics	PLOS ONE			English	Article								Boolean networks have been used as a discrete model for several biological systems, including metabolic and genetic regulatory networks. Due to their simplicity they offer a firm foundation for generic studies of physical systems. In this work we show, using a measure of context-dependent information, set complexity, that prior to reaching an attractor, random Boolean networks pass through a transient state characterized by high complexity. We justify this finding with a use of another measure of complexity, namely, the statistical complexity. We show that the networks can be tuned to the regime of maximal complexity by adding a suitable amount of noise to the deterministic Boolean dynamics. In fact, we show that for networks with Poisson degree distributions, all networks ranging from subcritical to slightly supercritical can be tuned with noise to reach maximal set complexity in their dynamics. For networks with a fixed number of inputs this is true for near-to-critical networks. This increase in complexity is obtained at the expense of disruption in information flow. For a large ensemble of networks showing maximal complexity, there exists a balance between noise and contracting dynamics in the state space. In networks that are close to critical the intrinsic noise required for the tuning is smaller and thus also has the smallest effect in terms of the information processing in the system. Our results suggest that the maximization of complexity near to the state transition might be a more general phenomenon in physical systems, and that noise present in a system may in fact be useful in retaining the system in a state with high information content.	[Maki-Marttunen, Tuomo; Kesseli, Juha; Nykter, Matti] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Maki-Marttunen, Tuomo] Tampere Univ Technol, Dept Math, FIN-33101 Tampere, Finland	Tampere University; Tampere University	Maki-Marttunen, T (corresponding author), Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland.	tuomo.maki-marttunen@tut.fi		Maki-Marttunen, Tuomo/0000-0002-7082-2507	TISE doctoral school; Academy of Finland [132877, 251937]	TISE doctoral school; Academy of Finland(Academy of Finland)	This work was funded by TISE doctoral school and Academy of Finland projects 132877, 251937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldana M., 2003, BOOLEAN DYNAMICS RAN, P23; ALON N, 1987, COMBINATORICA, V7, P1, DOI 10.1007/BF02579196; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; CLEARY JG, 1984, IEEE T COMMUN, V32, P396, DOI 10.1109/TCOM.1984.1096090; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; DERRIDA B, 1986, J PHYS-PARIS, V47, P1297, DOI 10.1051/jphys:019860047080129700; DERRIDA B, 1986, EUROPHYS LETT, V2, P739, DOI 10.1209/0295-5075/2/10/001; Galas DJ, 2010, IEEE T INFORM THEORY, V56, P667, DOI 10.1109/TIT.2009.2037046; GALBIATI G, 1981, THEOR COMPUT SCI, V16, P177, DOI 10.1016/0304-3975(81)90074-8; Gershenson C, 2004, ARTIFICIAL LIFE IX, P238; Gong XW, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066107; GRASSBERGER P, 1986, INT J THEOR PHYS, V25, P907, DOI 10.1007/BF00668821; Hahne L, 2011, TICSP SERIES; Harvey I, 1997, FROM ANIM ANIMAT, P67; Ignac TM, 2012, COMPLEXITY, V17, P23, DOI 10.1002/cplx.21383; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klemm K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.055101; Kolmogorov A. N., 1968, International Journal of Computer Mathematics, V2, P157, DOI 10.1080/00207166808803030; Krawitz P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.158701; Li M, 2004, IEEE T INFORM THEORY, V50, P3250, DOI 10.1109/TIT.2004.838101; Lizier JT, 2011, ARTIF LIFE, V17, P293, DOI 10.1162/artl_a_00040; LopezRuiz R, 1995, PHYS LETT A, V209, P321, DOI 10.1016/0375-9601(95)00867-5; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maki-Marttunen T., 2011, TICSP SERIES; Maki-Marttunen T, 2011, FRONTIERS COMPUTATIO, P5; Mesot B, 2003, LECT NOTES ARTIF INT, V2801, P367; Nykter M, 2008, P NATL ACAD SCI USA, V105, P1897, DOI 10.1073/pnas.0711525105; Nykter M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.058702; Otu HH, 2003, BIOINFORMATICS, V19, P2122, DOI 10.1093/bioinformatics/btg295; Peixoto TP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036108; Ramo P, 2007, PHYSICA D, V227, P100, DOI 10.1016/j.physd.2006.12.005; Ribeiro AS, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011901; Sakhanenko NA, 2011, COMPLEXITY, V17, P51, DOI 10.1002/cplx.20382; Serra R, 2010, J THEOR BIOL, V265, P185, DOI 10.1016/j.jtbi.2010.04.012; SHALIZI C. R, 2003, DISCRETE MATH THEOR, VAB, P11; Shalizi CR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.118701; Shiner JS, 1999, PHYS REV E, V59, P1459, DOI 10.1103/PhysRevE.59.1459; Shmulevich I, 2005, P NATL ACAD SCI USA, V102, P13439, DOI 10.1073/pnas.0506771102; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	46	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e56523	10.1371/journal.pone.0056523	http://dx.doi.org/10.1371/journal.pone.0056523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516395	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200004
J	Wood, M; Rae, GM; Wu, RM; Walton, EF; Xue, B; Hellens, RP; Uversky, VN				Wood, Marion; Rae, Georgina M.; Wu, Rong-Mei; Walton, Eric F.; Xue, Bin; Hellens, Roger P.; Uversky, Vladimir N.			Actinidia DRM1-An Intrinsically Disordered Protein Whose mRNA Expression Is Inversely Correlated with Spring Budbreak in Kiwifruit	PLOS ONE			English	Article							AXILLARY BUD OUTGROWTH; COLD-ACCLIMATION; HYDROGEN CYANAMIDE; DORMANCY INDUCTION; RELEASE; IDENTIFICATION; GROWTH; PHOTOPERIOD; DISCOVERY; GENES	Intrinsically disordered proteins (IDPs) are a relatively recently defined class of proteins which, under native conditions, lack a unique tertiary structure whilst maintaining essential biological functions. Functional classification of IDPs have implicated such proteins as being involved in various physiological processes including transcription and translation regulation, signal transduction and protein modification. Actinidia DRM1 (Ade DORMANCY ASSOCIATED GENE 1), represents a robust dormancy marker whose mRNA transcript expression exhibits a strong inverse correlation with the onset of growth following periods of physiological dormancy. Bioinformatic analyses suggest that DRM1 is plant specific and highly conserved at both the nucleotide and protein levels. It is predicted to be an intrinsically disordered protein with two distinct highly conserved domains. Several Actinidia DRM1 homologues, which align into two distinct Actinidia-specific families, Type I and Type II, have been identified. No candidates for the Arabidopsis DRM1-Homologue (AtDRM2) an additional family member, has been identified in Actinidia.	[Wood, Marion; Rae, Georgina M.; Wu, Rong-Mei; Hellens, Roger P.] New Zealand Inst Plant & Food Res Ltd, Genom Res, Auckland, New Zealand; [Walton, Eric F.] Univ Otago, Auckland, New Zealand; [Xue, Bin; Uversky, Vladimir N.] Univ S Florida, Dept Mol Med, Tampa, FL USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142292, Moscow Region, Russia	New Zealand Institute for Plant & Food Research Ltd; University of Otago; State University System of Florida; University of South Florida; Russian Academy of Sciences	Wood, M (corresponding author), New Zealand Inst Plant & Food Res Ltd, Genom Res, Auckland, New Zealand.	marion.wood@plantandfood.co.nz	Wood, Marion/A-5995-2019; Uversky, Vladimir N./F-4515-2011	Wood, Marion/0000-0002-7161-315X; Uversky, Vladimir N./0000-0002-4037-5857; Hellens, Roger/0000-0003-2094-0887	New Zealand Kiwifruit Royalty Investment Programme KRIP: Regulation of Dormancy; Programs of the Russian Academy of Sciences for the 'Molecular and Cellular Biology'	New Zealand Kiwifruit Royalty Investment Programme KRIP: Regulation of Dormancy; Programs of the Russian Academy of Sciences for the 'Molecular and Cellular Biology'	This work was funded by the New Zealand Kiwifruit Royalty Investment Programme KRIP: Regulation of Dormancy and supported in part by the Programs of the Russian Academy of Sciences for the 'Molecular and Cellular Biology' (to V.N.U). The funders had no role in study design, data collection and analysis, decision to publish to preparation of the manuscript.	Arora R, 2003, HORTSCIENCE, V38, P911, DOI 10.21273/HORTSCI.38.5.911; BRUNDELL D J, 1976, Scientia Horticulturae (Amsterdam), V4, P175, DOI 10.1016/S0304-4238(76)80010-6; Chakravarthy S, 2010, MOL PLANT MICROBE IN, V23, P715, DOI 10.1094/MPMI-23-6-0715; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crowhurst RN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-351; Emes Michael J, 2009, Biochem J, V422, pe1, DOI 10.1042/BJ20091063; Faust M, 1997, HORTSCIENCE, V32, P623, DOI 10.21273/HORTSCI.32.4.623; FENNELL A, 1991, J AM SOC HORTIC SCI, V116, P270, DOI 10.21273/JASHS.116.2.270; Finlayson SA, 2007, PLANT CELL PHYSIOL, V48, P667, DOI 10.1093/pcp/pcm044; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Halaly T, 2008, PLANTA, V228, P79, DOI 10.1007/s00425-008-0720-6; Heide OM, 2005, TREE PHYSIOL, V25, P109, DOI 10.1093/treephys/25.1.109; Horvath D, 2009, PLANT SCI, V177, P523, DOI 10.1016/j.plantsci.2009.09.002; Huang F, 2012, BIOCOMPUT-PAC SYM, P128; Hwang EW, 2005, J BIOSCIENCE, V30, P101; Kebrom TH, 2010, PLANT CELL ENVIRON, V33, P48, DOI 10.1111/j.1365-3040.2009.02050.x; Kim HB, 2007, MOL CELLS, V23, P115; Kovalchuk I., 2010, REACTIVE OXYGEN SPEC, P31, DOI DOI 10.1201/9781439854082-3; Li CY, 2003, PHYSIOL PLANTARUM, V117, P206, DOI 10.1034/j.1399-3054.2003.00002.x; Liu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-158; McPherson HG, 2001, NEW ZEAL J CROP HORT, V29, P277, DOI 10.1080/01140671.2001.9514189; McPherson HG, 1997, ANN BOT-LONDON, V80, P411, DOI 10.1006/anbo.1997.0455; Ner-Gaon H, 2004, PLANT J, V39, P877, DOI 10.1111/j.1365-313X.2004.02172.x; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Pang XQ, 2007, J EXP BOT, V58, P3249, DOI 10.1093/jxb/erm172; Park S, 2003, TREE PHYSIOL, V23, P815, DOI 10.1093/treephys/23.12.815; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rohde A, 2007, TRENDS PLANT SCI, V12, P217, DOI 10.1016/j.tplants.2007.03.012; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Rozen S, 2000, Methods Mol Biol, V132, P365; Schranz ME, 2006, PLANT CELL, V18, P1152, DOI 10.1105/tpc.106.041111; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Stafstrom JP, 1998, PLANTA, V205, P547, DOI 10.1007/s004250050354; Steiner C, 2003, BBA-GENE STRUCT EXPR, V1625, P123, DOI 10.1016/S0167-4781(02)00598-5; Sun XL, 2010, J BIOL CHEM, V285, P11557, DOI 10.1074/jbc.M109.027011; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Toth-Petroczy A, 2008, OPEN PROTEOM J, V1, P46, DOI [10.2174/1875039700801010046, DOI 10.2174/1875039700801010046]; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vergara R, 2012, J EXP BOT, V63, P4123, DOI 10.1093/jxb/ers094; Walton EF, 2009, J EXP BOT, V60, P3835, DOI 10.1093/jxb/erp231; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Welling A, 2006, PHYSIOL PLANTARUM, V127, P167, DOI 10.1111/j.1399-3054.2006.00672.x; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue B, 2009, FEBS LETT, V583, P1469, DOI 10.1016/j.febslet.2009.03.070	48	14	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57354	10.1371/journal.pone.0057354	http://dx.doi.org/10.1371/journal.pone.0057354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516402	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200008
J	Resch, G; Francois, P; Morisset, D; Stojanov, M; Bonetti, EJ; Schrenzel, J; Sakwinska, O; Moreillon, P				Resch, Gregory; Francois, Patrice; Morisset, Delphine; Stojanov, Milos; Bonetti, Eve J.; Schrenzel, Jacques; Sakwinska, Olga; Moreillon, Philippe			Human-to-Bovine Jump of Staphylococcus aureus CC8 Is Associated with the Loss of a beta-Hemolysin Converting Prophage and the Acquisition of a New Staphylococcal Cassette Chromosome	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; MOLECULAR CHARACTERIZATION; BIOFILM FORMATION; HOST; VIRULENCE; RESISTANCE; STRAINS; LIPOPROTEIN; ADAPTATION; GENES	Staphylococcus aureus can colonize and infect both humans and animals, but isolates from both hosts tend to belong to different lineages. Our recent finding of bovine-adapted S. aureus showing close genetic relationship to the human S. aureus clonal complex 8 (CC8) allowed us to examine the genetic basis of host adaptation in this particular CC. Using total chromosome microarrays, we compared the genetic makeup of 14 CC8 isolates obtained from cows suffering subclinical mastitis, with nine CC8 isolates from colonized or infected human patients, and nine S. aureus isolates belonging to typical bovine CCs. CC8 isolates were found to segregate in a unique group, different from the typical bovine CCs. Within this CC8 group, human and bovine isolates further segregated into three subgroups, among which two contained a mix of human and bovine isolates, and one contained only bovine isolates. This distribution into specific clusters and subclusters reflected major differences in the S. aureus content of mobile genetic elements (MGEs). Indeed, while the mixed human-bovine clusters carried commonly human-associated beta-hemolysin converting prophages, the bovine-only isolates were devoid of such prophages but harbored an additional new non-mec staphylococcal cassette chromosome (SCC) unique to bovine CC8 isolates. This composite cassette carried a gene coding for a new LPXTG-surface protein sharing homologies with a protein found in the environmental bacterium Geobacillus thermoglucosidans. Thus, in contrast to human CC8 isolates, the bovine-only CC8 group was associated with the combined loss of b-hemolysin converting prophages and gain of a new SCC probably acquired in the animal environment. Remaining questions are whether the new LPXTG-protein plays a role in bovine colonization or infection, and whether the new SCC could further acquire antibiotic-resistance genes and carry them back to human.	[Resch, Gregory; Morisset, Delphine; Stojanov, Milos; Sakwinska, Olga; Moreillon, Philippe] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [Francois, Patrice; Bonetti, Eve J.; Schrenzel, Jacques] Univ Hosp Geneva, Genom Res Lab, Geneva, Switzerland; [Schrenzel, Jacques] Univ Hosp Geneva, Bacteriol Lab, Geneva, Switzerland; [Morisset, Delphine] RUWAG Handels AG, Bettlach, Switzerland; [Sakwinska, Olga] Nestle Res Ctr, CH-1000 Lausanne, Switzerland	University of Lausanne; University of Geneva; University of Geneva; Nestle SA	Resch, G (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	gregory.resch@unil.ch	francois, patrice/AAL-5583-2020; Schrenzel, Jacques/P-8525-2017; Stojanov, Milos/C-8163-2016; Schrenzel, Jacques/AAC-5685-2021	Schrenzel, Jacques/0000-0001-5464-7764; Stojanov, Milos/0000-0002-5166-5841; Schrenzel, Jacques/0000-0001-5464-7764; Sakwinska, Olga/0000-0002-3142-9542; resch, gregory/0000-0003-2341-4591; francois, patrice/0000-0002-0540-750X	Swiss National Science Foundation grant (SNF) [PMPDA-106195]; SNF grant [32003B-113854]	Swiss National Science Foundation grant (SNF); SNF grant	This work was supported by the Swiss National Science Foundation grant (SNF) PMPDA-106195 (Marie Heim Voegtlin) to O.S. and SNF grant 32003B-113854 to P. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar SL, 2009, MICROBIOL-SGM, V155, P3247, DOI 10.1099/mic.0.029124-0; Alves PDD, 2009, VET MICROBIOL, V137, P190, DOI 10.1016/j.vetmic.2008.12.014; Argudin MA, 2010, TOXINS, V2, P1751, DOI 10.3390/toxins2071751; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bae Taeok, 2008, V416, P103, DOI 10.1007/978-1-59745-321-9_7; Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206; Burgess SA, 2010, INT J FOOD MICROBIOL, V144, P215, DOI 10.1016/j.ijfoodmicro.2010.09.027; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Cipollone R, 2008, J MOL MICROB BIOTECH, V15, P199, DOI 10.1159/000121331; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; DEVRIESE LA, 1976, RES VET SCI, V21, P284, DOI 10.1016/S0034-5288(18)33337-X; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Fan B, 2002, J BIOL CHEM, V277, P46987, DOI 10.1074/jbc.M208490200; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; FRANCIOLLI M, 1991, J INFECT DIS, V163, P514, DOI 10.1093/infdis/163.3.514; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Hiramatsu K, 2002, INT J MED MICROBIOL, V292, P67, DOI 10.1078/1438-4221-00192; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; KAPUR V, 1995, J CLIN MICROBIOL, V33, P376, DOI 10.1128/JCM.33.2.376-380.1995; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koessler T, 2006, J CLIN MICROBIOL, V44, P1040, DOI 10.1128/JCM.44.3.1040-1048.2006; Kozytska S, 2010, VET MICROBIOL, V145, P360, DOI 10.1016/j.vetmic.2010.03.020; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Loeffler A, 2010, EPIDEMIOL INFECT, V138, P595, DOI 10.1017/S0950268809991476; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mattew A, 2006, M2A9 CLSI; McCarthy AJ, 2011, GENOME BIOL EVOL; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Rose WE, 2008, ANTIMICROB AGENTS CH, V52, P831, DOI 10.1128/AAC.00869-07; Sakwinska O, 2011, APPL ENVIRON MICROB, V77, P5908, DOI 10.1128/AEM.00238-11; Scherl A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-296; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Smyth DS, 2005, J MED MICROBIOL, V54, P401, DOI 10.1099/jmm.0.45863-0; Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Talaat AM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf103; Tidhar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007023; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Viana D, 2010, MOL MICROBIOL, V77, P1583, DOI 10.1111/j.1365-2958.2010.07312.x; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Ythier M, 2010, INFECT IMMUN, V78, P1711, DOI 10.1128/IAI.01274-09; Zhao Y, 2012, J BACTERIOL, V194, P4118, DOI 10.1128/JB.00318-12	56	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58187	10.1371/journal.pone.0058187	http://dx.doi.org/10.1371/journal.pone.0058187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505465	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100031
J	Atemnkeng, VA; Pink, M; Schmitz-Spanke, S; Wu, XJ; Dong, LL; Zhao, KH; May, C; Laufer, S; Langer, B; Kaiser, A				Atemnkeng, Veronika Anyigoh; Pink, Mario; Schmitz-Spanke, Simone; Wu, Xian-Jun; Dong, Liang-Liang; Zhao, Kai-Hong; May, Caroline; Laufer, Stefan; Langer, Barbara; Kaiser, Annette			Deoxyhypusine Hydroxylase from Plasmodium vivax, the Neglected Human Malaria Parasite: Molecular Cloning, Expression and Specific Inhibition by the 5-LOX Inhibitor Zileuton	PLOS ONE			English	Article							PROTEIN; 5-LIPOXYGENASE; BIOSYNTHESIS; FALCIPARUM; THERAPY	Primaquine, an 8-aminoquinoline, is the only drug which cures the dormant hypnozoites of persistent liver stages from P. vivax. Increasing resistance needs the discovery of alternative pathways as drug targets to develop novel drug entities. Deoxyhypusine hydroxylase (DOHH) completes hypusine biosynthesis in eukaryotic initiation factor (eIF-5A) which is the only cellular protein known to contain the unusual amino acid hypusine. Modified EIF-5A is important for proliferation of the malaria parasite. Here, we present the first successful cloning and expression of DOHH from P. vivax causing tertiary malaria. The nucleic acid sequence of 1041 bp encodes an open reading frame of 346 amino acids. Histidine tagged expression of P. vivax DOHH detected a protein of 39.01 kDa in E. coli. The DOHH protein from P. vivax shares significant amino acid identity to the simian orthologues from P. knowlesi and P. yoelii strain H. In contrast to P. falciparum only four E-Z-type HEAT-like repeats are present in P. vivax DOHH with different homology to phycocyanin lyase subunits from cyanobacteria and in proteins participating in energy metabolism of Archaea and Halobacteria. However, phycocyanin lyase activity is absent in P. vivax DOHH. The dohh gene is present as a single copy gene and transcribed throughout the whole erythrocytic cycle. Specific inhibition of recombinant P. vivax DOHH is possible by complexing the ferrous iron with zileuton, an inhibitor of mammalian 5-lipoxygenase (5-LOX). Ferrous iron in the active site of 5-LOX is coordinated by three conserved histidines and the carboxylate of isoleucine(673). Zileuton inhibited the P. vivax DOHH protein with an IC50 of 12,5 nmol determined by a relative quantification by GC/MS. By contrast, the human orthologue is only less affected with an IC50 of 90 nmol suggesting a selective iron-complexing strategy for the parasitic enzyme.	[Atemnkeng, Veronika Anyigoh; Langer, Barbara; Kaiser, Annette] Univ Duisburg Essen, Inst Pharmacogenet, Essen, Germany; [Pink, Mario; Schmitz-Spanke, Simone] Univ Duisburg Essen, Essen, Germany; [Wu, Xian-Jun; Dong, Liang-Liang; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [May, Caroline] Ruhr Univ Bochum, Med Proteom Ctr, Bochum, Germany; [Laufer, Stefan] Univ Tubingen, Inst Pharmazeut, Tubingen, Germany	University of Duisburg Essen; University of Duisburg Essen; Huazhong Agricultural University; Ruhr University Bochum; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kaiser, A (corresponding author), Univ Duisburg Essen, Inst Pharmacogenet, Essen, Germany.	annette.kaiser@uk-essen.de		Laufer, Stefan/0000-0001-6952-1486; Kaiser, Annette/0000-0001-7873-3958	DAAD (German Academic Exchange Service) [PI:56154387]; P.U.R.E. (Protein Unit for Research in Europe)	DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); P.U.R.E. (Protein Unit for Research in Europe)	This work was funded by a DAAD grant PI:56154387 (German Academic Exchange Service) to AK and a grant from P.U.R.E. (Protein Unit for Research in Europe) to CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparoy P, 2008, J COMPUT AID MOL DES, V22, P611, DOI 10.1007/s10822-008-9180-0; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chawla B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033138; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; de Miranda Aline Silva, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P285; Dong ZZ, 2005, MOL CELL PROTEOMICS, V4, P993, DOI 10.1074/mcp.M500044-MCP200; Foth BJ, 2003, INT REV CYTOL, V224, P57, DOI 10.1016/S0074-7696(05)24003-2; Frommholz D, 2009, FEBS J, V276, P5881, DOI 10.1111/j.1742-4658.2009.07272.x; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Kaiser A, 2006, MINI-REV MED CHEM, V6, P1231, DOI 10.2174/138955706778742795; Kerscher B, 2010, AMINO ACIDS, V38, P471, DOI 10.1007/s00726-009-0406-9; Kippert F, 2008, PLOS ONE, V4, P1; Krotoski W A, 1989, Prog Clin Parasitol, V1, P1; Kubavat AH, 2012, AM J THER, V23; Kupka M, 2009, J BIOL CHEM, V284, P36405, DOI 10.1074/jbc.M109.056382; LEE BC, 1992, J GEN MICROBIOL, V138, P2647, DOI 10.1099/00221287-138-12-2647; Njuguna JT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-91; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Park JH, 2006, P NATL ACAD SCI USA, V103, P51, DOI 10.1073/pnas.0509348102; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2011, CURR OPIN INFECT DIS, V24, P578, DOI 10.1097/QCO.0b013e32834c61e3; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rossi A, 2010, BRIT J PHARMACOL, V161, P555, DOI 10.1111/j.1476-5381.2010.00930.x; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Sasaki K, 1996, FEBS LETT, V384, P151, DOI 10.1016/0014-5793(96)00310-9; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Sievert H, 2012, MOL CELL PROTEOMICS; Udomsangpetch R, 2007, PARASITOL INT, V56, P65, DOI 10.1016/j.parint.2006.12.005; Wu YR, 2012, J MED CHEM, V55, P2597, DOI 10.1021/jm201497k; Zhao K, 2005, J BIOL CHEM, V280, P17758, DOI 10.1074/jbc.M500393200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2004, BBA-BIOENERGETICS, V1657, P131, DOI 10.1016/j.bbabio.2004.04.010	40	10	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58318	10.1371/journal.pone.0058318	http://dx.doi.org/10.1371/journal.pone.0058318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505486	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500068
J	Bode, F; Burgdorf, C; Schunkert, H; Kurowski, V				Bode, Frank; Burgdorf, Christof; Schunkert, Heribert; Kurowski, Volkhard			24 Hour ST Segment Analysis in Transient Left Ventricular Apical Ballooning	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; TAKO-TSUBO CARDIOMYOPATHY; TAKOTSUBO CARDIOMYOPATHY; EMOTIONAL-STRESS; ENDOTHELIAL DYSFUNCTION; AMPULLA CARDIOMYOPATHY; ANIMAL-MODEL; WOMEN; ELEVATION; ISCHEMIA	Objective: The etiologic basis of transient left ventricular apical ballooning, a novel cardiac syndrome, is not clear. Among the proposed pathomechanisms is coronary vasospasm. Long-term ST segment analysis may detect vasospastic episodes but has not been reported. Methods: 30 consecutive patients with transient left ventricular apical ballooning, left ventricular dysfunction and normal or near-normal coronary arteries were investigated. A 24-hour Holter ECG was obtained after emergency admission. ST segment analysis was performed automatically in 2 leads and confirmed by visual inspection. Criteria for an ischemic event were: 1. ST elevation or 2. horizontal or down-sloping ST segments >= 1 min duration and >= 100 mu V J+80 point deviation corrected for baseline ST-deviation. Results: Patients presented with ST segment elevation (n = 19) and/or T wave inversion (n = 20) on admission ECG. Ejection fraction was 50 +/- 12%. No transient ST elevations were observed during Holter ECG analysis. In 3 patients, 8 transient episodes of ST depression were recorded. Durations of episodes varied between 75s and 790s (mean 229s). Maximal ST deviation averaged -191 +/- 71 mu V. Ischemic burden was -1 to -22 mVs (mean -8 mVs). 27 patients showed no ischemic events. Conclusions: ST segment analysis of 24 h Holter recordings revealed minor ischemic events in only 10% of patients with transient left ventricular apical ballooning. Overall, ST segment changes were not indicative of recurrent coronary spasm playing a major role in the genesis of transient left ventricular apical ballooning.	[Bode, Frank; Burgdorf, Christof; Schunkert, Heribert; Kurowski, Volkhard] Univ Lubeck, Med Dept II, Lubeck, Germany	University of Lubeck	Bode, F (corresponding author), Univ Lubeck, Med Dept II, Lubeck, Germany.	frank.bode@uk-sh.de	Bode, Frank/A-6395-2015					Abe Y, 2003, J AM COLL CARDIOL, V41, P737, DOI 10.1016/S0735-1097(02)02925-X; Ako J, 2001, JPN HEART J, V42, P355, DOI 10.1536/jhj.42.355; Angelini P, 2008, CATHETER CARDIO INTE, V71, P342, DOI 10.1002/ccd.21338; Bahlmann E, 2008, INT J CARDIOL, V124, P32, DOI 10.1016/j.ijcard.2006.12.090; Bonnemeier H, 2006, EUR HEART J, V27, P2246, DOI 10.1093/eurheartj/ehi820; Bybee KA, 2004, AM J CARDIOL, V94, P343, DOI 10.1016/j.amjcard.2004.04.030; Bybee KA, 2004, ANN INTERN MED, V141, P858, DOI 10.7326/0003-4819-141-11-200412070-00010; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P471, DOI 10.1016/0735-1097(94)90305-0; Crawford MH, 1999, CIRCULATION, V100, P886, DOI 10.1161/01.CIR.100.8.886; Desmet WJR, 2003, HEART, V89, P1027, DOI 10.1136/heart.89.9.1027; Dote K, 1991, J Cardiol, V21, P203; Elesber AA, 2006, J AM COLL CARDIOL, V47, P1082, DOI 10.1016/j.jacc.2005.12.004; Gianni M, 2006, EUR HEART J, V27, P1523, DOI 10.1093/eurheartj/ehl032; Gill JB, 1996, NEW ENGL J MED, V334, P65, DOI 10.1056/NEJM199601113340201; GOTTLIEB SO, 1986, NEW ENGL J MED, V314, P1214, DOI 10.1056/NEJM198605083141903; Hurst RT, 2006, J AM COLL CARDIOL, V48, P579, DOI 10.1016/j.jacc.2006.06.015; Ito K, 2003, ANN NUCL MED, V17, P115, DOI 10.1007/BF02988449; Ito K, 2001, ANN NUCL MED, V15, P351, DOI 10.1007/BF02988242; Kume T, 2005, CIRC J, V69, P934, DOI 10.1253/circj.69.934; Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403; Kurisu S, 2004, CIRC J, V68, P77, DOI 10.1253/circj.68.77; Kurisu S, 2003, J AM COLL CARDIOL, V41, P743, DOI 10.1016/S0735-1097(02)02924-8; Kurowski V, 2007, CHEST, V132, P809, DOI 10.1378/chest.07-0608; Lee YP, 2009, INT J CARDIOL, V133, P272, DOI 10.1016/j.ijcard.2007.11.039; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Ortak J, 2005, J AM COLL CARDIOL, V46, P1959, DOI 10.1016/j.jacc.2005.08.026; Pilgrim TM, 2008, INT J CARDIOL, V124, P283, DOI 10.1016/j.ijcard.2007.07.002; Sader MA, 2002, CARDIOVASC RES, V53, P597, DOI 10.1016/S0008-6363(01)00473-4; Samniah N, 1997, J ELECTROCARDIOL, V30, P197, DOI 10.1016/S0022-0736(97)80004-0; Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB; Taddei S, 1996, HYPERTENSION, V28, P576, DOI 10.1161/01.HYP.28.4.576; Takizawa M, 2007, INT J CARDIOL, V114, pE15, DOI 10.1016/j.ijcard.2006.07.125; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Ueyama T, 2003, J CARDIOVASC PHARM, V42, pS117, DOI 10.1097/00005344-200312001-00024; Ueyama T, 2002, CIRC J, V66, P712, DOI 10.1253/circj.66.712; WHITE M, 1995, CIRCULATION, V92, P2183, DOI 10.1161/01.CIR.92.8.2183; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046; WOLF E, 1974, BRIT HEART J, V36, P90; Yanagi Shiro, 2002, J Cardiol, V39, P305	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58349	10.1371/journal.pone.0058349	http://dx.doi.org/10.1371/journal.pone.0058349			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505493	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500072
J	Friedrich, K; Rupp, C; Hov, JR; Steinebrunner, N; Weiss, KH; Stiehl, A; Brune, M; Schaefer, PKY; Schemmer, P; Sauer, P; Schirmacher, P; Runz, H; Karlsen, TH; Stremmel, W; Gotthardt, DN				Friedrich, Kilian; Rupp, Christian; Hov, Johannes Roksund; Steinebrunner, Niels; Weiss, Karl-Heinz; Stiehl, Adolf; Brune, Maik; Schaefer, Petra Kloeters Yvonne; Schemmer, Peter; Sauer, Peter; Schirmacher, Peter; Runz, Heiko; Karlsen, Tom Hemming; Stremmel, Wolfgang; Gotthardt, Daniel Nils			A Frequent PNPLA3 Variant Is a Sex Specific Disease Modifier in PSC Patients with Bile Duct Stenosis	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; FATTY LIVER-DISEASE; WIDE ASSOCIATION ANALYSIS; HISTOLOGICAL SEVERITY; SUSCEPTIBILITY; ADIPONUTRIN	Background & Aims: Primary sclerosing cholangitis predominantly affects males and is an important indication for liver transplantation. The rs738409 variant (I148M) of the PNPLA3 gene is associated with alcoholic and non-alcoholic liver disease and we evaluated its impact on the disease course of PSC. Methods: The I148M polymorphism was genotyped in 121 German PSC patients of a long-term prospective cohort and 347 Norwegian PSC patients. Results: In the prospective German cohort, actuarial survival free of liver transplantation was significantly reduced for I148M carriers (p = 0.011) compared to wildtype patients. This effect was restricted to patients with severe disease, as defined by development of dominant stenosis (DS) requiring endoscopic intervention. DS patients showed markedly decreased survival (p = 0.004) when carrying the I148M variant (I148M: mean 13.8 years; 95% confidence interval: 11.6-16.0 vs. wildtype: mean 18.6 years; 95% confidence interval: 16.3-20.9) while there was no impact on survival in patients without a DS (p = 0.87). In line with previous observations of sex specific effects of the I148M polymorphism, the effect on survival was further restricted to male patients (mean survival 11.9 years; 95% confidence interval: 10.0-14.0 in I148M carriers vs. 18.8 years; 95% confidence interval: 16.2-21.5 in wildtype; p<0.001) while female patients were unaffected by the polymorphism (p = 0.65). These sex specific findings were validated in the Norwegian cohort (p = 0.013). Conclusions: In male PSC patients with severe disease with bile duct stenosis requiring intervention, the common I148M variant of the PNPLA3 gene is a risk factor for reduced survival.	[Friedrich, Kilian; Rupp, Christian; Steinebrunner, Niels; Weiss, Karl-Heinz; Stiehl, Adolf; Sauer, Peter; Stremmel, Wolfgang; Gotthardt, Daniel Nils] Univ Heidelberg Hosp, Dept Internal Med 4, Heidelberg, Baden Wuerttemb, Germany; [Brune, Maik] Univ Heidelberg Hosp, Dept Internal Med 1, Heidelberg, Baden Wuerttemb, Germany; [Schemmer, Peter] Univ Heidelberg Hosp, Dept Gen Surg, Heidelberg, Baden Wuerttemb, Germany; [Schirmacher, Peter] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Baden Wuerttemb, Germany; [Runz, Heiko] Univ Heidelberg Hosp, Inst Human Genet, Heidelberg, Baden Wuerttemb, Germany; [Hov, Johannes Roksund; Karlsen, Tom Hemming] Oslo Univ Hosp, Internal Med Res Inst, Norwegian PSC Res Ctr, Oslo, Norway; [Hov, Johannes Roksund; Karlsen, Tom Hemming] Oslo Univ Hosp, Div Canc Surg & Transplantat, Dept Gastroenterol, Oslo, Norway; [Hov, Johannes Roksund] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Karlsen, Tom Hemming] Univ Bergen, Fac Med & Dent, Inst Med, Bergen, Norway	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Oslo; University of Oslo; University of Oslo; University of Bergen	Gotthardt, DN (corresponding author), Univ Heidelberg Hosp, Dept Internal Med 4, Heidelberg, Baden Wuerttemb, Germany.	Daniel.Gotthardt@med.uni-heidelberg.de	Hov, Johannes R/J-1480-2019; Weiss, Karl Heinz/AAA-9117-2022; Rupp, Christian/E-7652-2019	Hov, Johannes R/0000-0002-5900-8096; Rupp, Christian/0000-0003-2808-9230; Stremmel, Wolfgang/0000-0002-8545-1753	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	D.N.G. was funded by a grant of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambha K, 2003, GASTROENTEROLOGY, V125, P1364, DOI 10.1016/j.gastro.2003.07.011; Bergquist A, 2005, J HEPATOL, V42, P252, DOI 10.1016/j.jhep.2004.10.011; Boonstra K, 2012, J HEPATOL; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; Gotthardt DN, 2010, GASTROINTEST ENDOSC, V71, P527, DOI 10.1016/j.gie.2009.10.041; Huang YC, 2010, P NATL ACAD SCI USA, V107, P7892, DOI 10.1073/pnas.1003585107; Karlsen TH, 2010, GASTROENTEROLOGY, V138, P1102, DOI 10.1053/j.gastro.2009.11.046; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Lazaridis KN, 2006, SEMIN LIVER DIS, V26, P42, DOI 10.1055/s-2006-933562; Li Q, 2012, CLIN INVEST MED, V35, pL237; Liu YM, 2004, J CLIN ENDOCR METAB, V89, P2684, DOI 10.1210/jc.2003-031978; Melum E, 2011, NAT GENET, V43, P17, DOI 10.1038/ng.728; Pollheimer MJ, 2011, BEST PRACT RES CL GA, V25, P727, DOI 10.1016/j.bpg.2011.10.009; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Rudolph G, 2009, J HEPATOL, V51, P149, DOI 10.1016/j.jhep.2009.01.023; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Storm Niels, 2003, Methods Mol Biol, V212, P241; Tian C, 2010, NAT GENET, V42, P21, DOI 10.1038/ng.488; Tischendorf JJW, 2007, AM J GASTROENTEROL, V102, P107, DOI 10.1111/j.1572-0241.2006.00872.x; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200	22	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58734	10.1371/journal.pone.0058734	http://dx.doi.org/10.1371/journal.pone.0058734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505555	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500120
J	Gillberg, L; Jacobsen, S; Ribel-Madsen, R; Gjesing, AP; Boesgaard, TW; Ling, C; Pedersen, O; Hansen, T; Vaag, A				Gillberg, Linn; Jacobsen, Stine; Ribel-Madsen, Rasmus; Gjesing, Anette Prior; Boesgaard, Trine W.; Ling, Charlotte; Pedersen, Oluf; Hansen, Torben; Vaag, Allan			Does DNA Methylation of PPARGC1A Influence Insulin Action in First Degree Relatives of Patients with Type 2 Diabetes?	PLOS ONE			English	Article							GENE-EXPRESSION; SKELETAL-MUSCLE; MITOCHONDRIAL DENSITY; 1ST-DEGREE RELATIVES; GLUCOSE-TOLERANCE; COACTIVATOR PGC-1; ADIPOSE-TISSUE; RESISTANCE; PGC-1-ALPHA; PHOSPHORYLATION	Epigenetics may play a role in the pathophysiology of type 2 diabetes (T2D), and increased DNA methylation of the metabolic master regulator peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) has been reported in muscle and pancreatic islets from T2D patients and in muscle from individuals at risk of T2D. This study aimed to investigate DNA promoter methylation and gene expression of PPARGC1A in skeletal muscle from first degree relatives (FDR) of T2D patients, and to determine the association with insulin action as well as the influence of family relation. We included 124 Danish FDR of T2D patients from 46 different families. Skeletal muscle biopsies were excised from vastus lateralis and insulin action was assessed by oral glucose tolerance tests. DNA methylation and mRNA expression levels were measured using bisulfite sequencing and quantitative real-time PCR, respectively. The average PPARGC1A methylation at four CpG sites situated 867-624 bp from the transcription start was associated with whole-body insulin sensitivity in a paradoxical positive manner (beta = 0.12, P = 0.03), supported by a borderline significant inverse correlation with fasting insulin levels (beta = -0.88, P = 0.06). Excluding individuals with prediabetes and overt diabetes did not affect the overall result. DNA promoter methylation was not associated with PPARGC1A gene expression. The familiality estimate of PPARGC1A gene expression was high (h(2) = 79 +/- 27% (h(2) +/- SE), P = 0.002), suggesting genetic regulation to play a role. No significant effect of familiality on DNA methylation was found. Taken together, increased DNA methylation of the PPARGC1A promoter is unlikely to play a major causal role for the development of insulin resistance in FDR of patients with T2D.	[Gillberg, Linn; Jacobsen, Stine; Vaag, Allan] Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark; [Gillberg, Linn; Jacobsen, Stine; Boesgaard, Trine W.; Vaag, Allan] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Ribel-Madsen, Rasmus; Gjesing, Anette Prior; Pedersen, Oluf; Hansen, Torben] Univ Copenhagen, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark; [Boesgaard, Trine W.; Pedersen, Oluf] Hagedorn Res Inst, Gentofte, Denmark; [Ling, Charlotte] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Vaag, Allan] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Steno Diabetes Center; Novo Nordisk Foundation; University of Copenhagen; Novo Nordisk; Hagedorn Research Institute; Lund University; Aarhus University; University of Southern Denmark; University of Copenhagen	Gillberg, L (corresponding author), Rigshosp, Dept Endocrinol, DK-2100 Copenhagen, Denmark.	linn.gillberg@rh.regionh.dk	Gjesing, Anette/ACC-7521-2022; Ling, Charlotte/Q-2432-2015; Pedersen, Oluf/AAG-8015-2020; Gillberg, Linn/A-1417-2017	Gjesing, Anette/0000-0003-4580-1576; Ling, Charlotte/0000-0003-0587-7154; Pedersen, Oluf/0000-0002-3321-3972; Hansen, Torben/0000-0001-8748-3831; Gillberg, Linn/0000-0003-0588-1663; Vaag, Allan Arthur/0000-0002-3690-2191	Danish Strategic Research Council; Danish Council for Independent Research; EASD; Exgenesis; Rigshospitalets forskningsudvalg; Steno Diabetes Center	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); EASD; Exgenesis(European Commission); Rigshospitalets forskningsudvalg; Steno Diabetes Center	This work was supported by The Danish Strategic Research Council, The Danish Council for Independent Research, EASD, Exgenesis, Rigshospitalets forskningsudvalg and Steno Diabetes Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibegovic AC, 2010, AM J PHYSIOL-ENDOC M, V299, pE752, DOI 10.1152/ajpendo.00590.2009; Alibegovic AC, 2009, DIABETES, V58, P2749, DOI 10.2337/db09-0369; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Boesgaard TW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007236; Brons C, 2010, J CLIN ENDOCR METAB, V95, P3048, DOI 10.1210/jc.2009-2413; Carey AL, 2006, DIABETOLOGIA, V49, P1000, DOI 10.1007/s00125-006-0178-7; De Filippis E, 2008, AM J PHYSIOL-ENDOC M, V294, pE607, DOI 10.1152/ajpendo.00729.2007; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gervin K, 2011, GENOME RES, V21, P1813, DOI 10.1101/gr.119685.110; Hammarstedt A, 2003, BIOCHEM BIOPH RES CO, V301, P578, DOI 10.1016/S0006-291X(03)00014-7; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Lomba A, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-60; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mcrae AF, 2007, HUM MOL GENET, V16, P364, DOI 10.1093/hmg/ddl456; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575; Patti ME, 2004, CURR OPIN CLIN NUTR, V7, P383, DOI 10.1097/01.mco.0000134359.23288.72; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; Rhinn H, 2008, ANAL BIOCHEM, V372, P116, DOI 10.1016/j.ab.2007.08.023; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Ribel-Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051302; SLUITER WJ, 1976, DIABETES, V25, P241, DOI 10.2337/diabetes.25.4.241; VAAG A, 1992, J CLIN INVEST, V89, P782, DOI 10.1172/JCI115656; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	43	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58384	10.1371/journal.pone.0058384	http://dx.doi.org/10.1371/journal.pone.0058384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505498	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500076
J	Kao, A; Meenderink, SWF; Bozovic, D				Kao, Albert; Meenderink, Sebastiaan W. F.; Bozovic, Dolores			Mechanical Overstimulation of Hair Bundles: Suppression and Recovery of Active Motility	PLOS ONE			English	Article							MECHANOELECTRICAL-TRANSDUCTION CHANNELS; THRESHOLD SHIFT TTS; COCHLEAR AMPLIFIER; SPONTANEOUS OSCILLATIONS; BULLFROGS SACCULUS; CELL TRANSDUCTION; ADAPTATION; AMPLIFICATION; EAR; STIMULATION	We explore the effects of high-amplitude mechanical stimuli on hair bundles of the bullfrog sacculus. Under in vitro conditions, these bundles exhibit spontaneous limit cycle oscillations. Prolonged deflection exerted two effects. First, it induced an offset in the position of the bundle. Recovery to the original position displayed two distinct time scales, suggesting the existence of two adaptive mechanisms. Second, the stimulus suppressed spontaneous oscillations, indicating a change in the hair bundle's dynamic state. After cessation of the stimulus, active bundle motility recovered with time. Both effects were dependent on the duration of the imposed stimulus. External calcium concentration also affected the recovery to the oscillatory state. Our results indicate that both offset in the bundle position and calcium concentration control the dynamic state of the bundle.	[Kao, Albert; Meenderink, Sebastiaan W. F.; Bozovic, Dolores] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Bozovic, Dolores] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Bozovic, D (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	bozovic@physics.ucla.edu		Meenderink, Bas/0000-0001-5487-2232	National Institutes of Health (NIH) [R01DC011380]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011380] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) under grant R01DC011380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashmore J, 2010, HEARING RES, V266, P1, DOI 10.1016/j.heares.2010.05.001; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Benser ME, 1996, J NEUROSCI, V16, P5629; Beurg M, 2008, BIOPHYS J, V94, P2639, DOI 10.1529/biophysj.107.123257; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; Camalet S, 2000, P NATL ACAD SCI USA, V97, P3183, DOI 10.1073/pnas.97.7.3183; Cheung ELM, 2006, BIOPHYS J, V90, P124, DOI 10.1529/biophysj.105.061226; Choe Y, 1998, P NATL ACAD SCI USA, V95, P15321, DOI 10.1073/pnas.95.26.15321; CLARK WW, 1991, J ACOUST SOC AM, V90, P155, DOI 10.1121/1.401309; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; DALLOS P, 1992, J NEUROSCI, V12, P4575; DENK W, 1992, HEARING RES, V60, P89, DOI 10.1016/0378-5955(92)90062-R; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; Fettiplace R, 2001, TRENDS NEUROSCI, V24, P169, DOI 10.1016/S0166-2236(00)01740-9; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; Han LJ, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041913; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kandel E. R., 2000, PRINCIPLES NEURAL SC, V4, P590; Kennedy HJ, 2006, J NEUROSCI, V26, P2757, DOI 10.1523/JNEUROSCI.3808-05.2006; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; LEWIS ER, 1988, BIOPHYS J, V53, P441, DOI 10.1016/S0006-3495(88)83120-5; Lichtenhan JT, 2008, J ACOUST SOC AM, V123, P2200, DOI 10.1121/1.2885748; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; Manley GA, 2001, J NEUROPHYSIOL, V86, P541, DOI 10.1152/jn.2001.86.2.541; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Martin P, 2003, J NEUROSCI, V23, P4533; Martin P, 2001, P NATL ACAD SCI USA, V98, P14380, DOI 10.1073/pnas.251530598; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; MELNICK W, 1991, J ACOUST SOC AM, V90, P147, DOI 10.1121/1.401308; Nadrowski B, 2004, P NATL ACAD SCI USA, V101, P12195, DOI 10.1073/pnas.0403020101; NARINS PM, 1984, J ACOUST SOC AM, V76, P1384, DOI 10.1121/1.391455; Nuttall AL, 2002, AUDIOL NEURO-OTOL, V7, P21, DOI 10.1159/000046858; Patuzzi R, 2002, AUDIOL NEURO-OTOL, V7, P17, DOI 10.1159/000046857; Rabbitt RD, 2010, P NATL ACAD SCI USA, V107, P3864, DOI 10.1073/pnas.0906765107; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Roongthumskul Y, 2011, BIOPHYS J, V101, P603, DOI 10.1016/j.bpj.2011.06.027; RUSSELL IJ, 1992, P ROY SOC B-BIOL SCI, V250, P217, DOI 10.1098/rspb.1992.0152; Shlomovitz R, 2013, BIOPHY J UNPUB; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tinevez JY, 2007, BIOPHYS J, V93, P4053, DOI 10.1529/biophysj.107.108498; Vilfan A, 2003, BIOPHYS J, V85, P191, DOI 10.1016/S0006-3495(03)74465-8; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171	51	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58143	10.1371/journal.pone.0058143	http://dx.doi.org/10.1371/journal.pone.0058143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505461	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500053
J	Osei-Kwakye, K; Asante, KP; Mahama, E; Apanga, S; Owusu, R; Kwara, E; Adjei, G; Abokyi, L; Yeetey, E; Dosoo, DK; Punguyire, D; Owusu-Agyei, S				Osei-Kwakye, Kingsley; Asante, Kwaku Poku; Mahama, Emmanuel; Apanga, Stephen; Owusu, Ruth; Kwara, Evans; Adjei, George; Abokyi, Livesy; Yeetey, Enuameh; Dosoo, David Kwame; Punguyire, Damien; Owusu-Agyei, Seth			The Benefits or Otherwise of Managing Malaria Cases with or without Laboratory Diagnosis: The Experience in a District Hospital in Ghana	PLOS ONE			English	Article							COST-EFFECTIVENESS; FEBRILE ILLNESS; TESTS; TANZANIA; AREA; MISDIAGNOSIS; COMMUNITY; CHILDREN; BURDEN; UGANDA	Background: This study was conducted at the Kintampo Municipal Hospital in Ghana to determine whether there was any benefit (or otherwise) in basing the management of cases of suspected malaria solely on laboratory confirmation (microscopy or by RDT) as compared with presumptive diagnosis. Method: Children under five years who reported at the Out-Patient Department of the Hospital with axillary temperature >= 37.5 degrees C or with a 48 hr history of fever were enrolled and had malaria microscopy and RDT performed. The attending clinician was blinded from laboratory results unless a request for these tests had been made earlier. Diagnosis of malaria was based on three main methods: presumptive or microscopy and/or RDT. Cost implication for adopting laboratory diagnosis or not was determined to inform malaria control programmes. Results: In total, 936 children were enrolled in the study. Proportions of malaria diagnosed presumptively, by RDT and microscopy were 73.6% (689/936), 66.0% (618/936) and 43.2% (404/936) respectively. Over 50% (170/318) of the children who were RDT negative and 60% (321/532) who were microscopy negative were treated for malaria when presumptive diagnoses were used. Comparing the methods of diagnoses, the cost of malaria treatment could have been reduced by 24% and 46% in the RDT and microscopy groups respectively; the reduction was greater in the dry season (43% vs. 50%) compared with the wet season (20% vs. 45%) for the RDT and microscopy confirmed cases respectively. Discussion/Conclusion: Over-diagnosis of malaria was prevalent in Kintampo during the period of the study. Though the use of RDT for diagnosis of malaria might have improved the quality of care for children, it appeared not to have a cost saving effect on the management of children with suspected malaria. Further research may be needed to confirm this.	[Osei-Kwakye, Kingsley; Asante, Kwaku Poku; Mahama, Emmanuel; Apanga, Stephen; Owusu, Ruth; Kwara, Evans; Adjei, George; Abokyi, Livesy; Yeetey, Enuameh; Dosoo, David Kwame; Owusu-Agyei, Seth] Minist Hlth, Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana; [Owusu-Agyei, Seth] London Sch Hyg & Trop Med, Dis Control Dept, London WC1, England; [Punguyire, Damien] Minist Hlth, Kintampo Municipal Hosp, Ghana Hlth Serv, Kintampo, Ghana	Ghana Health Service; Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine; Ghana Health Service	Owusu-Agyei, S (corresponding author), Minist Hlth, Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana.	seth.owusu-agyei@kintampo-hrc.org	Enuameh, Yeetey/AAO-7304-2020	Enuameh, Yeetey/0000-0003-3772-7425; Owusu-Agyei, Seth/0000-0002-0807-1781	Kintampo Health Research Centre	Kintampo Health Research Centre	The study was funded by the Kintampo Health Research Centre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Asante KP, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-409; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Ghana Statistical Service (GSS) Ghana Health Service (GHS) ICF Macro., 2009, GHAN DEM HLTH SURV 2; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; Murray Clinton K, 2009, Interdiscip Perspect Infect Dis, V2009, P415953, DOI 10.1155/2009/415953; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Ndyomugyenyi R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-39; OLIVAR M, 1991, T ROY SOC TROP MED H, V85, P729, DOI 10.1016/0035-9203(91)90432-X; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Polage CR, 2006, AM J TROP MED HYG, V75, P526, DOI 10.4269/ajtmh.2006.75.526; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; ROOTH I, 1992, T ROY SOC TROP MED H, V86, P479, DOI 10.1016/0035-9203(92)90076-O; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Webster J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-S1-S8; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wongsrichanalai C, 2001, TRENDS PARASITOL, V17, P307, DOI 10.1016/S1471-4922(01)01925-0	28	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58107	10.1371/journal.pone.0058107	http://dx.doi.org/10.1371/journal.pone.0058107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505457	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000318334500049
J	Kashima, Y; Takahashi, M; Shiba, Y; Itano, N; Izawa, A; Koyama, J; Nakayama, J; Taniguchi, S; Kimata, K; Ikeda, U				Kashima, Yuichiro; Takahashi, Masafumi; Shiba, Yuji; Itano, Naoki; Izawa, Atsushi; Koyama, Jun; Nakayama, Jun; Taniguchi, Shun'ichiro; Kimata, Koji; Ikeda, Uichi			Crucial Role of Hyaluronan in Neointimal Formation after Vascular Injury	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; BONE-MARROW-CELLS; 4-METHYLUMBELLIFERONE; ATHEROSCLEROSIS; MICE; PROLIFERATION; MIGRATION; PROMOTES; SYSTEM; HYPERPLASIA	Background: Hyaluronan (HA) is a primary component of the extracellular matrix of cells, and it is involved in the pathogenesis of atherosclerosis. The purpose of this study was to investigate the role of HA in neointimal formation after vascular injury and determine its tissue-specific role in vascular smooth muscle cells (VSMCs) by using a cre-lox conditional transgenic (cTg) strategy. Methods and Results: HA was found to be expressed in neointimal lesions in humans with atherosclerosis and after wire-mediated vascular injury in mice. Inhibition of HA synthesis using 4-methylumbelliferone markedly inhibited neointimal formation after injury. In vitro experiments revealed that low-molecular-weight HA (LMW-HA) induced VSMC activation, including migration, proliferation, and production of inflammatory cytokines, and reactive oxygen species (ROS). The migration and proliferation of VSMCs were mediated by the CD44/RhoA and CD44/ERK1/2 pathways, respectively. Because HA synthase 2 (HAS2) is predominantly expressed in injured arteries, we generated cTg mice that overexpress the murine HAS2 gene specifically in VSMCs (cHAS2/CreSM22 alpha mice) and showed that HA overexpression markedly enhanced neointimal formation after cuff-mediated vascular injury. Further, HA-overexpressing VSMCs isolated from cHAS2/CreSM22 alpha mice showed augmented migration, proliferation, and production of inflammatory cytokines and ROS. Conclusion: VSMC-derived HA promotes neointimal formation after vascular injury, and HA may be a potential therapeutic target for cardiovascular disease.	[Kashima, Yuichiro; Takahashi, Masafumi; Shiba, Yuji; Izawa, Atsushi; Koyama, Jun; Ikeda, Uichi] Shinshu Univ, Dept Cardiovasc Med, Grad Sch Med, Matsumoto, Nagano 390, Japan; [Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Bioimaging Sci, Shimotsuke, Tochigi, Japan; [Itano, Naoki] Kyoto Sangyo Univ, Dept Mol Biosci, Fac Life Sci, Kyoto 603, Japan; [Nakayama, Jun] Shinshu Univ, Dept Mol Pathol, Grad Sch Med, Matsumoto, Nagano 390, Japan; [Taniguchi, Shun'ichiro] Shinshu Univ, Dept Mol Oncol, Grad Sch Med, Matsumoto, Nagano 390, Japan; [Kimata, Koji] Aichi Med Univ, Aichi, Japan	Shinshu University; Jichi Medical University; Kyoto Sangyo University; Shinshu University; Shinshu University; Aichi Medical University	Takahashi, M (corresponding author), Shinshu Univ, Dept Cardiovasc Med, Grad Sch Med, Matsumoto, Nagano 390, Japan.	masafumi2@jichi.ac.jp		Shiba, Yuji/0000-0002-0311-2919	Japan Society for the Promotion of Science (JSPS); Council for Science and Technology Policy (CSTP); Vehicle Racing Commemorative Foundation; Daiichi-Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research [23590566, 23591035] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Vehicle Racing Commemorative Foundation; Daiichi-Sankyo Foundation of Life Science; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for Next Generation World-Leading Researchers (NEXT Program)," initiated by the Council for Science and Technology Policy (CSTP) (to M. T.), the Vehicle Racing Commemorative Foundation (to M. T.), and the Daiichi-Sankyo Foundation of Life Science (to M. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; Curcio A, 2011, CIRC J, V75, P1287, DOI 10.1253/circj.CJ-11-0366; Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x; Fischer JW, 2007, THROMB HAEMOSTASIS, V98, P287, DOI 10.1160/TH07-02-0155; FONTAINE L, 1968, Therapie (London/Paris), V23, P51; Goueffic Y, 2006, CARDIOVASC RES, V72, P339, DOI 10.1016/j.cardiores.2006.07.017; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jain M, 1996, J CLIN INVEST, V98, P877; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Koyama H, 2008, AM J PATHOL, V172, P179, DOI 10.2353/ajpath.2008.070360; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Murayama H, 2008, CARDIOVASC RES, V80, P175, DOI 10.1093/cvr/cvn250; Nagy N, 2010, CIRCULATION, V122, P2313, DOI 10.1161/CIRCULATIONAHA.110.972653; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; SAVANI RC, 1995, J CLIN INVEST, V95, P1158, DOI 10.1172/JCI117764; Shiba Y, 2007, ARTERIOSCL THROM VAS, V27, P283, DOI 10.1161/01.ATV.0000250606.70669.14; Stacchino C, 1983, Boll Chim Farm, V122, P158; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052; Yajima N, 2008, CIRCULATION, V117, P3079, DOI 10.1161/CIRCULATIONAHA.107.746453; Yokouchi K, 2006, ARTERIOSCL THROM VAS, V26, P2231, DOI 10.1161/01.ATV.0000239441.29687.97; Yoshihara S, 2005, FEBS LETT, V579, P2722, DOI 10.1016/j.febslet.2005.03.079; Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013; Zhao L, 2008, ARTERIOSCL THROM VAS, V28, P1283, DOI 10.1161/ATVBAHA.108.165753	33	32	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58760	10.1371/journal.pone.0058760	http://dx.doi.org/10.1371/journal.pone.0058760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484050	gold, Green Submitted, Green Published			2022-12-27	WOS:000316936100136
J	Lv, ZH; Tek, A; Da Silva, F; Empereur-mot, C; Chavent, M; Baaden, M				Lv, Zhihan; Tek, Alex; Da Silva, Franck; Empereur-mot, Charly; Chavent, Matthieu; Baaden, Marc			Game On, Science - How Video Game Technology May Help Biologists Tackle Visualization Challenges	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SCIENTIFIC-RESEARCH; MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; GALACTOSIDASE; SIMULATIONS; INTEGRATION; REVEALS; PLAYERS; BINDING	The video games industry develops ever more advanced technologies to improve rendering, image quality, ergonomics and user experience of their creations providing very simple to use tools to design new games. In the molecular sciences, only a small number of experts with specialized know-how are able to design interactive visualization applications, typically static computer programs that cannot easily be modified. Are there lessons to be learned from video games? Could their technology help us explore new molecular graphics ideas and render graphics developments accessible to non-specialists? This approach points to an extension of open computer programs, not only providing access to the source code, but also delivering an easily modifiable and extensible scientific research tool. In this work, we will explore these questions using the Unity3D game engine to develop and prototype a biological network and molecular visualization application for subsequent use in research or education. We have compared several routines to represent spheres and links between them, using either built-in Unity3D features or our own implementation. These developments resulted in a stand-alone viewer capable of displaying molecular structures, surfaces, animated electrostatic field lines and biological networks with powerful, artistic and illustrative rendering methods. We consider this work as a proof of principle demonstrating that the functionalities of classical viewers and more advanced novel features could be implemented in substantially less time and with less development effort. Our prototype is easily modifiable and extensible and may serve others as starting point and platform for their developments. A webserver example, standalone versions for MacOS X, Linux and Windows, source code, screen shots, videos and documentation are available at the address: http://unitymol.sourceforge.net/.	[Lv, Zhihan; Tek, Alex; Da Silva, Franck; Empereur-mot, Charly; Baaden, Marc] Univ Paris Diderot Sorbonne Paris Cite, UPR9080, CNRS, Lab Biochim Theor, Paris, France; [Lv, Zhihan] Ocean Univ China, Qingdao, Peoples R China; [Chavent, Matthieu] CEA, DAM, DIF, Arpajon, France; [Tek, Alex] Sorbonne Univ, Univ Paris 06, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Ocean University of China; CEA; UDICE-French Research Universities; Sorbonne Universite	Chavent, M (corresponding author), CEA, DAM, DIF, Arpajon, France.	chavent@ibpc.fr; baaden@smplinux.de	Lv, Zhihan/GLR-6000-2022; Baaden, Marc/C-6623-2008; Chavent, Matthieu/AAM-9860-2020; Lv, Zhihan/I-3187-2014	Lv, Zhihan/0000-0003-2525-3074; Baaden, Marc/0000-0001-6472-0486; Lv, Zhihan/0000-0003-2525-3074; Chavent, Matthieu/0000-0003-4524-4773; Empereur-mot, Charly/0000-0001-6972-8225	French Agency for Research [ANR-07-CIS7-003, ANR-11-MONU-003]; China Scholarship Council [2010633093]	French Agency for Research(French National Research Agency (ANR)); China Scholarship Council(China Scholarship Council)	This work was supported by the French Agency for Research (grants ANR-07-CIS7-003 and ANR-11-MONU-003) and the China Scholarship Council (scholarship 2010633093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir A, 2011, BIOORGAN MED CHEM, V19, P6107, DOI 10.1016/j.bmc.2011.08.028; Andrei RM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S16; Bainbridge WS, 2007, SCIENCE, V317, P472, DOI 10.1126/science.1146930; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barends TRM, 2006, J BIOL CHEM, V281, P5804, DOI 10.1074/jbc.M511187200; Bartalesi I, 2002, BIOCHEMISTRY-US, V41, P5112, DOI 10.1021/bi015984z; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonetta L, 2009, CELL, V138, P1043, DOI 10.1016/j.cell.2009.09.007; Bruckner S, 2007, COMPUT GRAPH FORUM, V26, P715, DOI 10.1111/j.1467-8659.2007.01095.x; Chavent M, 2008, J MOL GRAPH MODEL, V27, P209, DOI 10.1016/j.jmgm.2008.04.007; Chavent M, 2011, BRIEF BIOINFORM, V12, P689, DOI 10.1093/bib/bbq089; Chavent M, 2011, J COMPUT CHEM, V32, P2924, DOI 10.1002/jcc.21861; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Delalande O, 2009, J COMPUT CHEM, V30, P2375, DOI 10.1002/jcc.21235; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dugdale ML, 2010, BIOCHEM CELL BIOL, V88, P969, DOI 10.1139/O10-144; Eiben CB, 2012, NAT BIOTECHNOL, V30, P190, DOI 10.1038/nbt.2109; FERNANDO R, 2003, CG TUTORIAL; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; GARCIASAEZ I, 1994, J MOL BIOL, V237, P298, DOI 10.1006/jmbi.1994.1232; Gehlenborg N, 2010, NAT METHODS, V7, pS56, DOI [10.1038/NMETH.1436, 10.1038/nmeth.1436]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ince DC, 2012, NATURE, V482, P485, DOI 10.1038/nature10836; Iwasa JH, 2010, TRENDS CELL BIOL, V20, P699, DOI 10.1016/j.tcb.2010.08.005; Johnson GT, 2011, STRUCTURE, V19, P293, DOI 10.1016/j.str.2010.12.023; Kawrykow A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031362; Khatib F, 2011, NAT STRUCT MOL BIOL, V18, P1175, DOI 10.1038/nsmb.2119; KRIEGER E, 2003, YASARA; Krone M., 2012, EUROVIS SHORT PAPERS, P67, DOI [10.2312/PE/EuroVisShort/, DOI 10.2312/PE/EUROVISSHORT/EUROVISSHORT2012/067-071, 10.2312/pe/eurovisshort/eurovisshort2012/067-071]; Krone M, 2009, IEEE T VIS COMPUT GR, V15, P1391, DOI 10.1109/TVCG.2009.157; Lewis M, 2002, COMMUN ACM, V45, P27; Lindow N, 2010, COMPUT GRAPH FORUM, V29, P943, DOI 10.1111/j.1467-8659.2009.01693.x; Lintott C, 2011, MON NOT R ASTRON SOC, V410, P166, DOI 10.1111/j.1365-2966.2010.17432.x; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Mayo MJ, 2009, SCIENCE, V323, P79, DOI 10.1126/science.1166900; McGill G, 2008, CELL, V133, P1127, DOI 10.1016/j.cell.2008.06.013; Meng GY, 2011, EMBO J, V30, P3864, DOI 10.1038/emboj.2011.279; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Monroe N, 2011, J STRUCT BIOL, V174, P269, DOI 10.1016/j.jsb.2011.01.014; O'Donoghue SI, 2010, NAT METHODS, V7, pS42, DOI [10.1038/NMETH.1427, 10.1038/nmeth.1427]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rinaldi A, 2012, EMBO REP, V13, P895, DOI 10.1038/embor.2012.135; Rost R, 2006, OPENGL R SHADING LAN; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sanner MF, 1996, AID BIP4 3 0 CO 2 Y; Sansom C, 2011, NAT BIOTECHNOL, V29, P201, DOI 10.1038/nbt.1792; Santavy M, J CHEM COMPUTING GRO; Sloan P, 2001, LIT SPHERE MODEL CAP; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Weber JR, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-19; Wojtas M, 2011, BIOCHEM SOC T, V39, P25, DOI 10.1042/BST0390025; Wong H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000877; Zoppe M, 2009, P BLEND C AMST 2009	55	184	185	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57990	10.1371/journal.pone.0057990	http://dx.doi.org/10.1371/journal.pone.0057990			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483961	Green Submitted, gold, Green Published			2022-12-27	WOS:000316936100066
J	Pazzaglia, M; Galli, G; Scivoletto, G; Molinari, M				Pazzaglia, Mariella; Galli, Giulia; Scivoletto, Giorgio; Molinari, Marco			A Functionally Relevant Tool for the Body following Spinal Cord Injury	PLOS ONE			English	Article							SPATIAL REQUIREMENTS; INDEPENDENCE MEASURE; RE-EMBODIMENT; WHEELCHAIR; BRAIN; REORGANIZATION; DISTORTIONS; DISABILITY; LOCOMOTION; REPRESENTATION	A tool such as a prosthetic device that extends or restores movement may become part of the identity of the person to whom it belongs. For example, some individuals with spinal cord injury (SCI) adapt their body and action representation to incorporate their wheelchairs. However, it remains unclear whether the bodily assimilation of a relevant external tool develops as a consequence of altered sensory and motor inputs from the body or of prolonged confinement sitting or lying in the wheelchair. To explore such relationships, we used a principal component analysis (PCA) on collected structured reports detailing introspective experiences of wheelchair use in 55 wheelchair-bound individuals with SCI. Among all patients, the regular use of a wheelchair induced the perception that the body's edges are not fixed, but are instead plastic and flexible to include the wheelchair. The PCA revealed the presence of three major components. In particular, the functional aspect of the sense of embodiment concerning the wheelchair appeared to be modulated by disconnected body segments. Neither an effect of time since injury nor an effect of exposure to/experience of was detected. Patients with lesions in the lower spinal cord and with loss of movement and sensation in the legs but who retained upper body movement showed a higher degree of functional embodiment than those with lesions in the upper spinal cord and impairment in the entire body. In essence, the tool did not become an extension of the immobile limbs; rather, it became an actual tangible substitution of the functionality of the affected body part. These findings suggest that the brain can incorporate relevant artificial tools into the body schema via the natural process of continuously updating bodily signals. The ability to embody new essential objects extends the potentiality of physically impaired persons and can be used for their rehabilitation.	[Pazzaglia, Mariella; Galli, Giulia] Univ Roma La Sapienza, Dept Psychol, Rome, Italy; [Pazzaglia, Mariella; Scivoletto, Giorgio; Molinari, Marco] Fdn Santa Lucia, IRCCS, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia	Pazzaglia, M (corresponding author), Univ Roma La Sapienza, Dept Psychol, Rome, Italy.	mariella.pazzaglia@uniroma1.it	Galli, Giulia/K-8109-2016; Pazzaglia, Mariella/C-9388-2011; Molinari, Marco/A-9624-2010; Scivoletto, Giorgio/J-3030-2018	Galli, Giulia/0000-0002-4684-0908; Pazzaglia, Mariella/0000-0002-9196-7078; Molinari, Marco/0000-0001-9808-9688; Scivoletto, Giorgio/0000-0001-5766-6952	International Foundation for Research in Paraplegie [IRP, P133]; EU Information and Communication Technologies [FP7-ICT-2009-5]	International Foundation for Research in Paraplegie; EU Information and Communication Technologies	Funded by the International Foundation for Research in Paraplegie (IRP, P133) and EU Information and Communication Technologies Grant (VERE project, FP7-ICT-2009-5, Prot. Num. 257695. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti S, 1996, NEUROREPORT, V8, P293, DOI 10.1097/00001756-199612200-00058; Anderson KD, 2011, SPINAL CORD, V49, P880, DOI 10.1038/sc.2011.20; Andre JM, 2001, REV NEUROL-FRANCE, V157, P1237; ARNHOFF FN, 1963, J NERV MENT DIS, V137, P88, DOI 10.1097/00005053-196307000-00010; Arrindell WA, 1985, APPL PSYCHOL MEASURE, V9; Arzy S, 2006, J NEUROSCI, V26, P8074, DOI 10.1523/JNEUROSCI.0745-06.2006; Avillion A E, 1986, Rehabil Nurs, V11, P11; Bassolino M, 2010, NEUROPSYCHOLOGIA, V48, P803, DOI 10.1016/j.neuropsychologia.2009.11.009; BATES PS, 1993, AM J OCCUP THER, V47, P1014, DOI 10.5014/ajot.47.11.1014; Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; Blanke O, 2005, NEUROSCIENTIST, V11, P16, DOI 10.1177/1073858404270885; Blanke O, 2004, BRAIN, V127, P243, DOI 10.1093/brain/awh040; Blanke O, 2012, NAT REV NEUROSCI, V13, P556, DOI 10.1038/nrn3292; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Bryant F.B., 1995, READING UNDERSTANDIN, P99, DOI DOI 10.3109/07420528.2010.540363; Cardinali L, 2012, EXP BRAIN RES, V218, P259, DOI 10.1007/s00221-012-3028-5; Cardinali L, 2009, CURR BIOL, V19, pR478, DOI 10.1016/j.cub.2009.05.009; Catz A, 1997, SPINAL CORD, V35, P850, DOI 10.1038/sj.sc.3100504; Cole J., 2004, STILL LIVES; Curt A, 2002, BRAIN, V125, P2567, DOI 10.1093/brain/awf250; De Preester H, 2011, FOUND SCI, V16, P119, DOI 10.1007/s10699-010-9188-5; de Vignemont F, 2011, CONSCIOUS COGN, V20, P82, DOI 10.1016/j.concog.2010.09.004; de Vignemont F, 2010, NEUROPSYCHOLOGIA, V48, P669, DOI 10.1016/j.neuropsychologia.2009.09.022; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; EVERITT BS, 1975, BRIT J PSYCHIAT, V126, P237, DOI 10.1192/bjp.126.3.237; Field A, 2013, DISCOVERING STAT USI; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, EUR J NEUROSCI, V34, P1839, DOI 10.1111/j.1460-9568.2011.07895.x; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Fuentes CT, 2013, J NEUROL NEUROSUR PS, V84, P201, DOI 10.1136/jnnp-2012-304001; Gandevia SC, 1999, J PHYSIOL-LONDON, V514, P609, DOI 10.1111/j.1469-7793.1999.609ae.x; Gimbel L, 1975, Can J Psychiatr Nurs, V16, P12; Gorsuch R., 1983, FACTOR ANAL; Hair J.F., 1998, MULTIVARIATE DATA AN, V5, P207; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Higuchi T, 2004, J EXP PSYCHOL-APPL, V10, P55, DOI 10.1037/1076-898X.10.1.55; Higuchi T, 2006, EXP BRAIN RES, V175, P50, DOI 10.1007/s00221-006-0525-4; Higuchi Takahiro, 2009, Journal of Physiological Anthropology, V28, P15, DOI 10.2114/jpa2.28.15; Jauregui-Renaud K, 2008, J NEUROL NEUROSUR PS, V79, P276, DOI 10.1136/jnnp.2007.122119; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Kulig K, 2001, CLIN BIOMECH, V16, P744, DOI 10.1016/S0268-0033(01)00066-3; Lenggenhager B, 2006, REV NEUROSCIENCE, V17, P643; Lenggenhager B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050757; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Longo MR, 2012, BEHAV BRAIN SCI, V35, P229, DOI 10.1017/S0140525X11001907; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Marino RJ., 2003, J SPINAL CORD MED S1, V26, pS50, DOI [10.1080/10790268.2003.11754575, DOI 10.1080/10790268.2003.11754575]; Merleau-Ponty M., 1962, PHENOMENOLOGY PERCEP; Murray CD, 2004, DISABIL REHABIL, V26, P963, DOI 10.1080/09638280410001696764; Navarro X, 2009, INT REV NEUROBIOL, V87, P483, DOI 10.1016/S0074-7742(09)87027-X; Newport R, 2010, PERCEPTION, V39, P1296, DOI 10.1068/p6742; Nizzi MC, 2012, CONSCIOUS COGN, V21, P431, DOI 10.1016/j.concog.2011.10.010; Olsson CJ, 2012, EXP NEUROL, V236, P46, DOI 10.1016/j.expneurol.2012.03.022; Papadimitriou C, 2008, DISABIL SOC, V23, P691, DOI 10.1080/09687590802469420; Paqueron X, 2003, BRAIN, V126, P702, DOI 10.1093/brain/awg063; Pereira BP, 1996, J HAND SURG-AM, V21A, P222, DOI 10.1016/S0363-5023(96)80104-3; Standal OF, 2011, MED HEALTH CARE PHIL, V14, P177, DOI 10.1007/s11019-010-9286-8; Truccolo W, 2008, J NEUROSCI, V28, P1163, DOI 10.1523/JNEUROSCI.4415-07.2008; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Winance M, 2006, SCI TECHNOL HUM VAL, V31, P52, DOI 10.1177/0162243905280023; Winance M, 2006, DISABIL REHABIL, V28, P1109, DOI 10.1080/09638280500531800	64	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58312	10.1371/journal.pone.0058312	http://dx.doi.org/10.1371/journal.pone.0058312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23484015	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100105
J	Li, CY; Wu, Q; Liu, B; Yao, YT; Chen, Y; Zhang, HL; Wang, CQ; Cao, JM; Ge, SF				Li, Chuanyin; Wu, Qing; Liu, Bo; Yao, Yuting; Chen, Ying; Zhang, Huili; Wang, Changqiang; Cao, Jiumei; Ge, Shengfang			Detection and Validation of Circulating Endothelial Cells, a Blood-based Diagnostic Marker of Acute Myocardial Infarction	PLOS ONE			English	Article							PERIPHERAL-BLOOD; PROGENITOR CELLS; CANCER-PATIENTS; ANGIOGENESIS; DISEASE; CHEMOTHERAPY; MONOCYTES; GROWTH; CD146	Background: Circulating endothelial cells (CECs) are markers of vascular damage that have clinical relevance in many including acute myocardial infarction (AMI), and may be predictors of treatment responses. Herein, we investigated the diagnostic and prognostic value of CEC monitoring in AMI patients and a murine model. Methodology/ Principal Findings: CECs were defined as Hoechst 33342(+)/CD45(-)/CD31(+)/CD146(+)/CD133(-) in human blood samples and Hoechst 33342(+)/CD45-(/)CD31(+)/KDR+/CD117(-) in murine samples. To evaluate the validity and variability of our CEC detection system, peripheral blood samples of vascular endothelial growth factor-treated athymic nude mice and AMI patients were collected and subjected to intra-assay analysis. CEC detection by flow cytometry and real-time PCR were compared. Blood samples were obtained from 61 AMI patients, 45 healthy volunteers and 19 samples of the original AMI patients accepted one month treatment, via flow cytometry and expressed as a percentage of peripheral blood mononuclear cells. Results: Our CEC detection method was validated and had limited variability. CEC concentrations were higher in AMI patients compared to healthy controls. One month post-treatment, CECs levels decreased significantly. Conclusions/Significance: CEC levels may be useful as a diagnostic and prognostic biomarker in AMI patients.	[Li, Chuanyin; Wu, Qing; Liu, Bo; Yao, Yuting; Ge, Shengfang] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Ophthalmol, Shanghai 200030, Peoples R China; [Zhang, Huili; Wang, Changqiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China; [Cao, Jiumei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Geratol, Shanghai 200030, Peoples R China; [Li, Chuanyin; Wu, Qing; Liu, Bo; Yao, Yuting; Chen, Ying; Ge, Shengfang] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Mol Biol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, CQ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China.	wcqian@hotmail.com; jiumeicao@hotmail.com; geshengfang@sjtu.edu.cn	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Wu, Qing/0000-0003-2606-6668	The National Key Program for Basic Research of China [2010CB529902]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01040411]; The National Natural Science Foundation of China [81270376]; The Shanghai Pujiang Project [12PJ1406200]	The National Key Program for Basic Research of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); The National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Shanghai Pujiang Project(Shanghai Pujiang Program)	This study was supported by The National Key Program for Basic Research of China (2010CB529902), and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01040411) to SG; The National Natural Science Foundation of China (81270376) to CW; The Shanghai Pujiang Project (12PJ1406200) to JC.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Beaudry P, 2005, CLIN CANCER RES, V11, P3514, DOI 10.1158/1078-0432.CCR-04-2271; Beerepoot LV, 2004, ANN ONCOL, V15, P139, DOI 10.1093/annonc/mdh017; Bertolini F, 2003, CANCER RES, V63, P4342; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Calleri A, 2009, CLIN CANCER RES, V15, P7652, DOI 10.1158/1078-0432.CCR-09-1493; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Damani S., 2012, SCI TRANSL MED, V4; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Doroszewski Witold, 2007, Pol Arch Med Wewn, V117, P213; DuBois SG, 2012, PEDIATR BLOOD CANCER, V58, P181, DOI 10.1002/pbc.23046; Elshal MF, 2005, BLOOD, V106, P2923, DOI 10.1182/blood-2005-06-2307; Fleitas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047365; Kondo S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-268; Malyszko J, 2004, J CLIN ENDOCR METAB, V89, P4620, DOI 10.1210/jc.2004-0387; Mancuso P, 2003, ADV EXP MED BIOL, V522, P83; Mancuso P, 2001, BLOOD, V97, P3658, DOI 10.1182/blood.V97.11.3658; Nanda A, 2006, P NATL ACAD SCI USA, V103, P3351, DOI 10.1073/pnas.0511306103; Ring A, 2004, LANCET ONCOL, V5, P79, DOI 10.1016/S1470-2045(04)01381-6; Rodriguez-Osorio X, 2012, NEUROLOGY, V79, P474, DOI 10.1212/WNL.0b013e31826170ce; Rowand JL, 2007, CYTOM PART A, V71A, P105, DOI 10.1002/cyto.a.20364; Shaked Y, 2007, CANCER RES, V67, P7055, DOI 10.1158/0008-5472.CAN-07-0905; Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693; Smadja DM, 2009, CIRCULATION, V119, P374, DOI 10.1161/CIRCULATIONAHA.108.808246; St Croix B, 2000, SCIENCE, V289, P1197; Sun X, 2012, MICROVASC RES, V84, P149, DOI 10.1016/j.mvr.2012.06.003; Woywodt A, 2006, J THROMB HAEMOST, V4, P671, DOI 10.1111/j.1538-7836.2006.01794.x; Yao YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046627	28	15	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58478	10.1371/journal.pone.0058478	http://dx.doi.org/10.1371/journal.pone.0058478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484031	gold, Green Submitted, Green Published			2022-12-27	WOS:000315634900092
J	Wyckoff, AC; Lockwood, KL; Meyerett-Reid, C; Michel, BA; Bender, H; VerCauteren, KC; Zabel, MD				Wyckoff, A. Christy; Lockwood, Krista L.; Meyerett-Reid, Crystal; Michel, Brady A.; Bender, Heather; VerCauteren, Kurt C.; Zabel, Mark D.			Estimating Prion Adsorption Capacity of Soil by BioAssay of Subtracted Infectivity from Complex Solutions (BASICS)	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; SCRAPIE AGENT; IN-VITRO; ENVIRONMENTAL SOURCES; HUMIC SUBSTANCES; PROTEIN; DEER; FATE; PRP; TRANSMISSION	Prions, the infectious agent of scrapie, chronic wasting disease and other transmissible spongiform encephalopathies, are misfolded proteins that are highly stable and resistant to degradation. Prions are known to associate with clay and other soil components, enhancing their persistence and surprisingly, transmissibility. Currently, few detection and quantification methods exist for prions in soil, hindering an understanding of prion persistence and infectivity in the environment. Variability in apparent infectious titers of prions when bound to soil has complicated attempts to quantify the binding capacity of soil for prion infectivity. Here, we quantify the prion adsorption capacity of whole, sandy loam soil (SLS) typically found in CWD endemic areas in Colorado; and purified montmorillonite clay (Mte), previously shown to bind prions, by BioAssay of Subtracted Infectivity in Complex Solutions (BASICS). We incubated prion positive 10% brain homogenate from terminally sick mice infected with the Rocky Mountain Lab strain of mouse-adapted prions (RML) with 10% SLS or Mte. After 24 hours samples were centrifuged five minutes at 200xg and soil-free supernatant was intracerebrally inoculated into prion susceptible indicator mice. We used the number of days post inoculation to clinical disease to calculate the infectious titer remaining in the supernatant, which we subtracted from the starting titer to determine the infectious prion binding capacity of SLS and Mte. BASICS indicated SLS bound and removed >= 95% of infectivity. Mte bound and removed lethal doses (99.98%) of prions from inocula, effectively preventing disease in the mice. Our data reveal significant prion-binding capacity of soil and the utility of BASICS to estimate prion loads and investigate persistence and decomposition in the environment. Additionally, since Mte successfully rescued the mice from prion disease, Mte might be used for remediation and decontamination protocols.	[Wyckoff, A. Christy; Lockwood, Krista L.; Meyerett-Reid, Crystal; Michel, Brady A.; Bender, Heather; Zabel, Mark D.] Colorado State Univ, Prion Res Ctr, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Wyckoff, A. Christy; VerCauteren, Kurt C.] Wildlife Serv, Natl Wildlife Res Ctr, USDA, Ft Collins, CO USA	Colorado State University; United States Department of Agriculture (USDA)	Zabel, MD (corresponding author), Colorado State Univ, Prion Res Ctr, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	mark.zabel@colostate.edu			United States Department of Agriculture Animal and Plant Health Inspection Services [08-7488-0680]	United States Department of Agriculture Animal and Plant Health Inspection Services	United States Department of Agriculture Animal and Plant Health Inspection Services Cooperative Agreement number 08-7488-0680 (CA) funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Brown P, 1991, LANCET; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Clark KJ, 1998, VET MICROBIOL, V63, P137, DOI 10.1016/S0378-1135(98)00241-7; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cooke CM, 2007, ENVIRON SCI TECHNOL, V41, P811, DOI 10.1021/es0618189; de Motes CM, 2008, WATER RES, V42, P2465, DOI 10.1016/j.watres.2008.01.031; Dexter G, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-38; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Genovesi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001069; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Hinckley GT, 2008, ENVIRON SCI TECHNOL, V42, P5254, DOI 10.1021/es703186e; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Maddison BC, 2010, J VIROL, V84, P11560, DOI 10.1128/JVI.01133-10; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; May BCH, 2007, J MED CHEM, V50, P65, DOI 10.1021/jm061045z; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; Michel B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00440; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 1998, J WILDLIFE DIS, V34, P532, DOI 10.7589/0090-3558-34.3.532; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nagaoka K, 2010, BIOCHEM BIOPH RES CO, V397, P626, DOI 10.1016/j.bbrc.2010.06.013; Nelson J., 1992, EXPANSIVE SOILS PROB; Nichols TA, 2009, PRION, V3, P171, DOI 10.4161/pri.3.3.9819; O'Rourke KI, 2000, J CLIN MICROBIOL, V38, P3254, DOI 10.1128/JCM.38.9.3254-3259.2000; Phillips G, 2007, J WILDLIFE; Polano M, 2008, BIOCHEM BIOPH RES CO, V367, P323, DOI 10.1016/j.bbrc.2007.12.143; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1978, BIOCHEMISTRY-US, V17, P4987, DOI 10.1021/bi00616a020; REED L. J., 1938, AMER JOUR HYG, V27, P493; Revault M, 2005, BBA-GEN SUBJECTS, V1724, P367, DOI 10.1016/j.bbagen.2005.05.005; Rigou P, 2006, ENVIRON SCI TECHNOL, V40, P1497, DOI 10.1021/es0516965; Rodriguez CM, 2012, PRION, V6, P11, DOI 10.4161/pri.6.1.17414; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Saunders S, 2011, J VIROLOGY; Saunders SE, 2008, ENVIRON SCI TECHNOL, V42, P6573, DOI 10.1021/es800590k; Saunders SE, 2011, APPL ENVIRON MICROB, V77, P4313, DOI 10.1128/AEM.00421-11; Saunders SE, 2010, ENVIRON SCI TECHNOL, V44, P4129, DOI 10.1021/es903520d; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P7728, DOI 10.1021/es901385t; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P5242, DOI 10.1021/es900502f; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; SENESI N, 1992, SCI TOTAL ENVIRON, V123, P63, DOI 10.1016/0048-9697(92)90133-D; Shaban IS, 1998, J RADIOANAL NUCL CH, V229, P73, DOI 10.1007/BF02389449; Tuo WB, 2001, J BIOL CHEM, V276, P18229, DOI 10.1074/jbc.M008887200; Vasina EN, 2005, BIOMACROMOLECULES, V6, P3425, DOI 10.1021/bm050492d; Violante A, 1995, CLAY MINER, V30, P325, DOI 10.1180/claymin.1995.030.4.06; Walter WD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1203; Wiggins RC, 2009, NEUROCHEM RES, V34, P158, DOI 10.1007/s11064-008-9741-6; Wildlife CPA, 2012, COLORADO GAME MANAGE, P1; Williams ES, 2003, REV SCI TECH OIE, V22, P145, DOI 10.20506/rst.22.1.1385; Zabel MD, 2007, J IMMUNOL, V179, P6144, DOI 10.4049/jimmunol.179.9.6144	59	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58630	10.1371/journal.pone.0058630	http://dx.doi.org/10.1371/journal.pone.0058630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484043	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900096
J	Silva, EM; Conde, JN; Allonso, D; Nogueira, ML; Mohana-Borges, R				Silva, Emiliana M.; Conde, Jonas N.; Allonso, Diego; Nogueira, Mauricio L.; Mohana-Borges, Ronaldo			Mapping the Interactions of Dengue Virus NS1 Protein with Human Liver Proteins Using a Yeast Two-Hybrid System: Identification of C1q as an Interacting Partner	PLOS ONE			English	Article							NONSTRUCTURAL GLYCOPROTEIN NS1; ANTIBODY-DEPENDENT ENHANCEMENT; HUMAN ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; WEST-NILE-VIRUS; NF-KAPPA-B; HEMORRHAGIC-FEVER; COMPLEMENT ACTIVATION; INFECTED PATIENTS; SERUM-LEVELS	Dengue constitutes a global health concern. The clinical manifestation of this disease varies from mild febrile illness to severe hemorrhage and/or fatal hypovolemic shock. Flavivirus nonstructural protein 1 (NS1) is a secreted glycoprotein that is displayed on the surface of infected cells but is absent in viral particles. NS1 accumulates at high levels in the plasma of dengue virus (DENV)-infected patients, and previous reports highlight its involvement in immune evasion, dengue severity, liver dysfunction and pathogenesis. In the present study, we performed a yeast two-hybrid screen to search for DENV2 NS1-interacting partners using a human liver cDNA library. We identified fifty genes, including human complement component 1 (C1q), which was confirmed by coimmunoprecipitation, ELISA and immunofluorescence assays, revealing for the first time the direct binding of this protein to NS1. Furthermore, the majority of the identified genes encode proteins that are secreted into the plasma of patients, and most of these proteins are classified as acute-phase proteins (APPs), such as plasminogen, haptoglobin, hemopexin, a-2-HS-glycoprotein, retinol binding protein 4, transferrin, and C4. The results presented here confirm the direct interaction of DENV NS1 with a key protein of the complement system and suggest a role for this complement protein in the pathogenesis of DENV infection.	[Silva, Emiliana M.; Conde, Jonas N.; Allonso, Diego; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941 Rio De Janeiro, Brazil; [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Dept Doencas Dermatol Infecciosas & Parasitarias, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro	Mohana-Borges, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941 Rio De Janeiro, Brazil.	mohana@biof.ufrj.br	Nascimento conde, Jonas/D-4481-2019; Nogueira, Mauricio L/B-7599-2012; Borges, Ronaldo S Mohana/C-5575-2013; Allonso, Diego/Y-3446-2018	Nogueira, Mauricio L/0000-0003-1102-2419; Allonso, Diego/0000-0002-1410-480X; Nascimento Conde, Jonas/0000-0001-5895-1114	Brazilian Health Ministry; CNPq; FAPERJ; IMBEBB; FINEP (GENOPROT Dengue); National Institutes of Science and Technology in Structural Biology and Bioimaging (INCT-INBEB)	Brazilian Health Ministry; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); IMBEBB; FINEP (GENOPROT Dengue)(Financiadora de Inovacao e Pesquisa (Finep)); National Institutes of Science and Technology in Structural Biology and Bioimaging (INCT-INBEB)	This work was supported by the following funding agencies: the Brazilian Health Ministry, CNPq, FAPERJ, IMBEBB, FINEP (GENOPROT Dengue), and the National Institutes of Science and Technology in Structural Biology and Bioimaging (INCT-INBEB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Alcon-LePoder S, 2005, J VIROL, V79, P11403, DOI 10.1128/JVI.79.17.11403-11411.2005; Allonso D, 2012, J CLIN VIROL, V55, P214, DOI 10.1016/j.jcv.2012.07.010; Allonso D, 2011, J VIROL METHODS, V175, P109, DOI 10.1016/j.jviromet.2011.04.029; Armbrust T, 1997, HEPATOLOGY, V26, P98; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Avirutnan P, 1998, J IMMUNOL, V161, P6338; Avirutnan P, 2008, VACCINE, V26, pI100, DOI 10.1016/j.vaccine.2008.11.061; Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750; Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545; BARTHOLOMEW RM, 1978, J EXP MED, V147, P844, DOI 10.1084/jem.147.3.844; Black PH, 2003, BRAIN BEHAV IMMUN, V17, P350, DOI 10.1016/S0889-1591(03)00048-5; BOKISCH VA, 1973, NEW ENGL J MED, V289, P996, DOI 10.1056/NEJM197311082891902; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; CHANG NS, 1994, J LEUKOCYTE BIOL, V55, P778, DOI 10.1002/jlb.55.6.778; Chua JJE, 2005, VIRUS RES, V112, P85, DOI 10.1016/j.virusres.2005.03.025; Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103; DUNCAN AR, 1988, NATURE, V332, P738, DOI 10.1038/332738a0; EBENBICHLER CF, 1991, J EXP MED, V174, P1417, DOI 10.1084/jem.174.6.1417; Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127; Falconar AKI, 2008, CLIN VACCINE IMMUNOL, V15, P549, DOI 10.1128/CVI.00351-07; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Huerta-Zepeda A, 2008, THROMB HAEMOSTASIS, V99, P936, DOI [10.1160/TH07-08-0483, 10.1160/TH07-08-0438]; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603; Juffrie M, 2001, AM J TROP MED HYG, V65, P70, DOI 10.4269/ajtmh.2001.65.70; Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395; Loos M, 1989, Behring Inst Mitt, P32; Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307; Mehlhop E, 2007, CELL HOST MICROBE, V2, P417, DOI 10.1016/j.chom.2007.09.015; Mehlhop E, 2009, CELL HOST MICROBE, V6, P381, DOI 10.1016/j.chom.2009.09.003; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006782; Noisakran S, 2008, J GEN VIROL, V89, P2492, DOI 10.1099/vir.0.83620-0; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; PRYOR MJ, 1994, J GEN VIROL, V75, P1183, DOI 10.1099/0022-1317-75-5-1183; Restrepo BN, 2008, REV SOC BRAS MED TRO, V41, P6, DOI 10.1590/S0037-86822008000100002; Rosen L, 1999, AM J TROP MED HYG, V61, P720, DOI 10.4269/ajtmh.1999.61.720; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Silva BM, 2011, ARCH VIROL, V156, P1275, DOI 10.1007/s00705-011-0969-0; SUSAL C, 1994, J IMMUNOL, V152, P6028; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Volanakis JE, 2002, CURR TOP MICROBIOL, V266, P41; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704; World Health Organization, 2009, DENGUE GUIDELINES DI; Yamanaka A, 2008, J VIROL, V82, P927, DOI 10.1128/JVI.00992-07; Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000	62	29	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57514	10.1371/journal.pone.0057514	http://dx.doi.org/10.1371/journal.pone.0057514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516407	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400008
J	Zhao, W; Zhang, JT; Xing, XW; Huang, DH; Tian, CL; Jia, WQ; Huang, XS; Wu, WP; Pu, CQ; Lang, SY; Yu, SY				Zhao, Wei; Zhang, Jia-Tang; Xing, Xiao-Wei; Huang, De-Hui; Tian, Cheng-Lin; Jia, Wei-Quan; Huang, Xu-Sheng; Wu, Wei-Ping; Pu, Chuan-Qiang; Lang, Sen-Yang; Yu, Sheng-Yuan			Chinese Specific Characteristics of Sporadic Creutzfeldt-Jakob Disease: A Retrospective Analysis of 57 Cases	PLOS ONE			English	Article							DIAGNOSTIC-VALUE; 14-3-3 PROTEIN; UNITED-STATES; LIFE; PHYSICIANS; DECISIONS; JAPANESE; END; EEG; CJD	Objective: Sporadic Creutzfeldt-Jakob disease (sCJD) is a fatal and transmissible neurodegenerative disorder. However, no studies have reported Chinese specific characteristics of sCJD. We aimed to identify differences in sCJD between Chinese patients and patients from other countries. Methods: The data from 57 Chinese sCJD patients were retrospectively analyzed, including demographic data, clinical manifestations, laboratory examinations, electroencephalograms (EEGs), diffusion-weighted imaging (DWI) scans, positron emission tomography (PET) scans, and pathological results. Result: The disease was pathologically confirmed in 11 patients. 39 cases were diagnosed as probable sCJD, and 7 were possible. Of the total cases, 33 were male, and 24 were female. The onset age ranged from 36 to 75 years (mean: 55.5, median: 57). Disease onset before the age of 60 occurred in 57.9% of patients. The disease duration from onset to death ranged 5-22 months (mean: 11.6, median: 11), and 51.9% of patients died 7 to 12 months after disease onset. The majority of patients presented with sub-acute onset with progressive dementia. 3 of the 9 patients who took 14-3-3 protein analysis had positive results (33.3%). The sensitivity of EEG was 79.6% (43/54). For DWI and PET examinations, the sensitivities were 94% (47/50) and 94.1% (16/17), respectively. In seven patients who did not show typical hyper-intensities on the first DWI examination, abnormalities of hypo-metabolism in the cerebral cortex were clearly detected by PET. In 13 out of the 17 patients, PET detected extra abnormal regions in addition to the hyper-intense areas observed in DWI. Conclusion: This is the first study to indicate that Chinese sCJD patients have a much earlier onset age and a longer disease duration than other populations, which is most likely related to racial differences. The longer disease duration may also be a probable characteristic of Asian populations. PET had high sensitivity for the diagnosis of sCJD.	[Zhao, Wei; Zhang, Jia-Tang; Xing, Xiao-Wei; Huang, De-Hui; Tian, Cheng-Lin; Jia, Wei-Quan; Huang, Xu-Sheng; Wu, Wei-Ping; Pu, Chuan-Qiang; Lang, Sen-Yang; Yu, Sheng-Yuan] Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Zhang, JT (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Neurol, Beijing, Peoples R China.	edwin-zhang@263.net		Zhang, Jia-Tang/0000-0002-9714-0944; Xing, Xiao-Wei/0000-0002-2573-1446				Asai A, 1997, J MED ETHICS, V23, P323, DOI 10.1136/jme.23.5.323; ASAI A, 1995, LANCET, V346, P356, DOI 10.1016/S0140-6736(95)92230-X; Baldeiras IE, 2009, J NEUROL, V256, P1540, DOI 10.1007/s00415-009-5160-0; Belay ED, 2003, NEUROLOGY, V60, P176, DOI 10.1212/01.WNL.0000036913.87823.D6; Chen HL, 2008, J CLIN NEUROL, V21, P345; Collins S, 2002, NEUROLOGY, V59, P1365, DOI 10.1212/01.WNL.0000031793.11602.8C; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; Geschwind MD, 2003, ARCH NEUROL-CHICAGO, V60, P813, DOI 10.1001/archneur.60.6.813; Henkel K, 2002, J NEUROL, V249, P699, DOI 10.1007/s00415-002-0695-3; Hirose Y, 1998, Rinsho Shinkeigaku, V38, P779; Iwasaki Yasushi, 2009, Rinsho Shinkeigaku, V49, P463; Kamogawa Kenji, 2009, Nihon Ronen Igakkai Zasshi, V46, P458; Ko K. F., 2010, Hong Kong Medical Journal, V16, P487; Li S, 2007, J BRAIN NERVOUS DIS, V15; Maddox RA, 2006, NEUROLOGY, V66, P439, DOI 10.1212/01.wnl.0000196473.46805.61; Meissner B, 2004, NEUROLOGY, V63, P450, DOI 10.1212/01.WNL.0000136225.80445.C9; Nagoshi K, 2011, J EPIDEMIOL, V21, P255, DOI 10.2188/jea.JE20100085; Panagariya A, 1999, J Assoc Physicians India, V47, P548; Shiga Y, 2004, NEUROLOGY, V63, P443, DOI 10.1212/01.WNL.0000134555.59460.5D; Smyth A, 1997, J NEUROL SCI, V152, pS93, DOI 10.1016/S0022-510X(97)00253-0; Steinhoff BJ, 2004, ANN NEUROL, V56, P702, DOI 10.1002/ana.20261; Tian Chan, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P713; Vitali P, 2011, NEUROLOGY, V76, P1711, DOI 10.1212/WNL.0b013e31821a4439; Wieser HG, 2004, CLIN NEUROPHYSIOL, V115, P2467, DOI 10.1016/j.clinph.2004.05.032; Zerr I, 2000, NEUROLOGY, V55, P811, DOI 10.1212/WNL.55.6.811; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191; Zhang JT, 2008, MED J CHIN PLA, V33	28	8	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58442	10.1371/journal.pone.0058442	http://dx.doi.org/10.1371/journal.pone.0058442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516482	gold, Green Submitted, Green Published			2022-12-27	WOS:000316407400030
J	Chen, L; Wang, L; Qiu, XH; Yang, XX; Qiao, ZX; Yang, YJ; Liang, Y				Chen, Lu; Wang, Lin; Qiu, Xiao Hui; Yang, Xiu Xian; Qiao, Zheng Xue; Yang, Yan Jie; Liang, Yuan			Depression among Chinese University Students: Prevalence and Socio-Demographic Correlates	PLOS ONE			English	Article							COMORBIDITY SURVEY REPLICATION; GENDER DIFFERENCES; COLLEGE-STUDENTS; MEDICAL-STUDENTS; MENTAL-HEALTH; SYMPTOMS; ANXIETY; STRESS; DISORDER; SYMPTOMATOLOGY	The purpose of the present study was to estimate the prevalence of depression in Chinese university students, and to identify the socio-demographic factors associated with depression in this population. A multi-stage stratified sampling procedure was used to select university students (N = 5245) in Harbin (Heilongjiang Province, Northeastern China), who were aged 16-35 years. The Beck Depression Inventory (BDI) was used to determine depressive symptoms of the participants. BDI scores of 14 or higher were categorized as depressive for logistic regression analysis. Depression was diagnosed by the Structured Clinical Interview (SCID) for the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition (DSM-IV). 11.7% of the participants had a BDI score 14 or higher. Major Depressive Disorder was seen in 4.0% of Chinese university students. There were no statistical differences in the incidence of depression when gender, ethnicity, and university classification were analyzed. Multivariate analysis showed that age, study year, satisfaction with major, family income situation, parental relationship and mother's education were significantly associated with depression. Moderate depression is prevalent in Chinese university students. The students who were older, dissatisfied with their major, had a lower family income, poor parental relationships, and a lower level of mother's education were susceptible to depression.	[Chen, Lu; Wang, Lin] Huazhong Univ Sci & Technol, Clin Dept, Tong Ji Med Coll, Wuhan 430074, Peoples R China; [Qiu, Xiao Hui; Yang, Xiu Xian; Qiao, Zheng Xue; Yang, Yan Jie; Liang, Yuan] Harbin Med Univ, Dept Psychol, Inst Publ Hlth, Harbin, Peoples R China	Huazhong University of Science & Technology; Harbin Medical University	Yang, YJ (corresponding author), Harbin Med Univ, Dept Psychol, Inst Publ Hlth, Harbin, Peoples R China.	yanjie1965@yahoo.com.cn; liangyuan217@163.com			overseas scholars program of the Education Department of Heilongjiang Province [1151hz043]; China Medical Board of New York Incorporated [05-813]; Provincial Science Foundation Council [D200806]; National Natural Science Foundation of China [81072381, 81102175, 31271093]	overseas scholars program of the Education Department of Heilongjiang Province; China Medical Board of New York Incorporated; Provincial Science Foundation Council; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by overseas scholars program of the Education Department of Heilongjiang Province (1151hz043), China Medical Board of New York Incorporated (05-813), Provincial Science Foundation Council general project grant (D200806), National Natural Science Foundation of China (81072381) to Prof. YJY, National Natural Science Foundation of China (81102175) to XHQ, and National Natural Science Foundation of China (31271093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association A. P., 2000, DIAGN CRIT DSM 4 TR; Bakir B, 1997, J PSYCHIAT NEUROLOGI, V10, P5; Bayram N, 2008, SOC PSYCH PSYCH EPID, V43, P667, DOI 10.1007/s00127-008-0345-x; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; Bennett DS, 1997, J AFFECT DISORDERS, V45, P127, DOI 10.1016/S0165-0327(97)00045-1; Birmaher B, 1996, J AM ACAD CHILD PSY, V35, P1575, DOI 10.1097/00004583-199612000-00008; Bostanci M, 2005, CROAT MED J, V46, P96; Chiu SH, 2007, SUICIDE LIFE-THREAT, V37, P585, DOI 10.1521/suli.2007.37.5.585; Dahlin M, 2005, MED EDUC, V39, P594, DOI 10.1111/j.1365-2929.2005.02176.x; Dalrymple KL, 2007, J AFFECT DISORDERS, V100, P241, DOI 10.1016/j.jad.2006.10.014; Dogan ODS, 1994, J CUMHURIYET U MED F, V16, P148; Du Zhaoyun, 2000, CHIN J SCH HEAL, V21, P345; Dyson R, 2006, J CLIN PSYCHOL, V62, P1231, DOI 10.1002/jclp.20295; Eisenberg D, 2007, AM J ORTHOPSYCHIAT, V77, P534, DOI 10.1037/0002-9432.77.4.534; Eller T, 2006, DEPRESS ANXIETY, V23, P250, DOI 10.1002/da.20166; Franko DL, 2005, J ADOLESCENT HEALTH, V37, P526, DOI 10.1016/j.jadohealth.2004.08.028; Furr SR, 2001, PROF PSYCHOL-RES PR, V32, P97, DOI 10.1037/0735-7028.32.1.97; Grant K, 2002, J ADOLESCENCE, V25, P613, DOI 10.1006/jado.2002.0508; Hu T. W., 2004, AUSTR PSYCHIAT, V12, P11; Hysenbegasi A, 2005, J MENT HEALTH POLICY, V8, P145; Kessler R C, 1998, Depress Anxiety, V7, P3, DOI 10.1002/(SICI)1520-6394(1998)7:1<3::AID-DA2>3.0.CO;2-F; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Khalil Afaf H, 2010, Child Adolesc Psychiatry Ment Health, V4, P26, DOI 10.1186/1753-2000-4-26; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Mikolajczyk RT, 2008, SOC PSYCH PSYCH EPID, V43, P105, DOI 10.1007/s00127-007-0282-0; Nair M. K. C., 2004, Indian Journal of Pediatrics, V71, P523, DOI 10.1007/BF02724294; Ovuga E, 2006, WORLD PSYCHIATRY, V5, P51; Poch FV, 2004, SOC PSYCH PSYCH EPID, V39, P326, DOI 10.1007/s00127-004-0756-2; Richter P, 1998, PSYCHOPATHOLOGY, V31, P160, DOI 10.1159/000066239; Rosenthal BS, 2000, J AM COLL HEALTH, V49, P12, DOI 10.1080/07448480009596277; Sobocki P, 2007, EUR PSYCHIAT, V22, P146, DOI 10.1016/j.eurpsy.2006.10.006; Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87; Spiessl H, 2006, DEUT MED WOCHENSCHR, V131, P35, DOI 10.1055/s-2006-924919; Steptoe A, 2007, INT J BEHAV MED, V14, P97, DOI 10.1007/BF03004175; Stewart-Brown S, 2000, J PUBLIC HEALTH MED, V22, P492, DOI 10.1093/pubmed/22.4.492; Tomoda A, 2000, PSYCHIAT CLIN NEUROS, V54, P583, DOI 10.1046/j.1440-1819.2000.00757.x; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Vazquez FL, 2008, J AM COLL HEALTH, V57, P165, DOI 10.3200/JACH.57.2.165-172; Voelker R, 2003, JAMA-J AM MED ASSOC, V289, P2055, DOI 10.1001/jama.289.16.2055; Wade TJ, 2002, J AM ACAD CHILD PSY, V41, P190, DOI 10.1097/00004583-200202000-00013; Wong JGWS, 2006, AUST NZ J PSYCHIAT, V40, P777, DOI 10.1111/j.1440-1614.2006.01883.x	42	80	82	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58379	10.1371/journal.pone.0058379	http://dx.doi.org/10.1371/journal.pone.0058379			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516468	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200060
J	Molfetti, E; Vilaca, ST; Georges, JY; Plot, V; Delcroix, E; Le Scao, R; Lavergne, A; Barrioz, S; dos Santos, FR; de Thoisy, B				Molfetti, Erica; Vilaca, Sibelle Torres; Georges, Jean-Yves; Plot, Virginie; Delcroix, Eric; Le Scao, Rozen; Lavergne, Anne; Barrioz, Sebastien; dos Santos, Fabricio Rodrigues; de Thoisy, Benoit			Recent Demographic History and Present Fine-Scale Structure in the Northwest Atlantic Leatherback (Dermochelys coriacea) Turtle Population	PLOS ONE			English	Article							SEA-TURTLES; GENETIC DIVERSITY; CLIMATE-CHANGE; METAPOPULATION DYNAMICS; GLOBAL PHYLOGEOGRAPHY; NEUTRAL THEORY; EFFECTIVE SIZE; FRENCH-GUIANA; ISLAND MODEL; NULL ALLELES	The leatherback turtle Dermochelys coriacea is the most widely distributed sea turtle species in the world. It exhibits complex life traits: female homing and migration, migrations of juveniles and males that remain poorly known, and a strong climatic influence on resources, breeding success and sex-ratio. It is consequently challenging to understand population dynamics. Leatherbacks are critically endangered, yet the group from the Northwest Atlantic is currently considered to be under lower risk than other populations while hosting some of the largest rookeries. Here, we investigated the genetic diversity and the demographic history of contrasted rookeries from this group, namely two large nesting populations in French Guiana, and a smaller one in the French West Indies. We used 10 microsatellite loci, of which four are newly isolated, and mitochondrial DNA sequences of the control region and cytochrome b. Both mitochondrial and nuclear markers revealed that the Northwest Atlantic stock of leatherbacks derives from a single ancestral origin, but show current genetic structuration at the scale of nesting sites, with the maintenance of migrants amongst rookeries. Low nuclear genetic diversities are related to founder effects that followed consequent bottlenecks during the late Pleistocene/Holocene. Most probably in response to climatic oscillations, with a possible influence of early human hunting, female effective population sizes collapsed from 2 million to 200. Evidence of founder effects and high numbers of migrants make it possible to reconsider the population dynamics of the species, formerly considered as a metapopulation model: we propose a more relaxed island model, which we expect to be a key element in the currently observed recovering of populations. Although these Northwest Atlantic rookeries should be considered as a single evolutionary unit, we stress that local conservation efforts remain necessary since each nesting site hosts part of the genetic diversity and species history.	[Molfetti, Erica; dos Santos, Fabricio Rodrigues] Univ Fed Minas Gerais, ICB, Dept Biol Geral, BR-31270010 Belo Horizonte, MG, Brazil; [Vilaca, Sibelle Torres] Univ Ferrara, Sez Biol Evolutiva, Dipartimento Biol & Evoluz, I-44100 Ferrara, Italy; [Georges, Jean-Yves; Plot, Virginie] Univ Strasbourg, IPHC, F-67087 Strasbourg, France; [Georges, Jean-Yves; Plot, Virginie] CNRS, UMR 7178, F-67087 Strasbourg, France; [Delcroix, Eric] Off Natl Chasse & Faune Sauvage Guadeloupe, F-97129 Lamentin, Guadeloupe, France; [Le Scao, Rozen] Off Natl Chasse & Faune Sauvage, F-97200 Martinique, Martinique, France; [Lavergne, Anne; de Thoisy, Benoit] Inst Pasteur, Cayenne 97300, French Guiana; [Barrioz, Sebastien; de Thoisy, Benoit] Kwata NGO, Cayenne 97300, French Guiana	Universidade Federal de Minas Gerais; University of Ferrara; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	de Thoisy, B (corresponding author), Inst Pasteur, Cayenne 97300, French Guiana.	benoit@kwata.net	Vilaca, Sibelle/AAA-4573-2020; Vilaça, Sibelle Torres/K-1965-2012; Santos, Fabrício Rodrigues/H-2370-2011	Vilaca, Sibelle/0000-0002-6887-4703; Vilaça, Sibelle Torres/0000-0002-6887-4703; Santos, Fabrício Rodrigues/0000-0001-9088-1750; GEORGES, Jean Yves/0000-0003-1161-2275	DEAL Guyane; Kwata NGO; CNPq; Fapemig; CNPq (Brazil); Agence Nationale pour la Recherche through the MIRETTE project [ANR-07-JCJC-0122]	DEAL Guyane; Kwata NGO; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fapemig(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Agence Nationale pour la Recherche through the MIRETTE project(French National Research Agency (ANR))	Part of the laboratory work (processing of West Indies, Cayenne and Awala samples) was funded by DEAL Guyane and Kwata NGO (www.kwata.net). The authors thank CNPq and Fapemig for fundings for the part of the research realized in Brazil (microsatellite databank). EM, FRS and STV were supported by CNPq (Brazil). The authors' thanks go to CNPq and Fapemig for their funding of the research carried out in Brazil (microsatellite databank). EM, FRS and STV were supported by CNPq (Brazil) and to Agence Nationale pour la Recherche through the MIRETTE project (http://projetmirette.fr, ANR-07-JCJC-0122) led by JYG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2004, MOL ECOL NOTES, V4, P77, DOI 10.1046/j.1471-8286.2003.00574.x; ALLARD MW, 1994, COPEIA, P34; Alstad TI, 2011, CONSERV GENET RESOUR, V3, P457, DOI 10.1007/s12686-010-9378-z; Avens Larisa, 2009, Endangered Species Research, V8, P165, DOI 10.3354/esr00202; Bailey H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036401; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beerli P., 2008, MIGRATE VERSION 3 0; Billotte N., 1999, Fruits (Paris), V54, P277; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; BOWEN BW, 1994, EVOLUTION, V48, P1820, DOI 10.1111/j.1558-5646.1994.tb02217.x; Brook BW, 2002, P NATL ACAD SCI USA, V99, P14624, DOI 10.1073/pnas.232126899; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Clarke AL, 2001, POPUL DEV REV, V27, P633, DOI 10.1111/j.1728-4457.2001.00633.x; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Cole CT, 2003, ANNU REV ECOL EVOL S, V34, P213, DOI 10.1146/annurev.ecolsys.34.030102.151717; Cornuet JM, 1996, GENETICS, V144, P2001; Crim JL, 2002, MOL ECOL, V11, P2097, DOI 10.1046/j.1365-294X.2002.01591.x; de Bruyn M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000554; Delcroix Eric, 2011, Bulletin de la Societe Herpetologique de France, P21; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duffaud Marc-Henri, 2011, Bulletin de la Societe Herpetologique de France, P71; Dutton DL, 2005, BIOL CONSERV, V126, P186, DOI 10.1016/j.biocon.2005.05.013; Dutton PH, 2007, CHELONIAN CONSERV BI, V6, P47, DOI 10.2744/1071-8443(2007)6[47:SAGSON]2.0.CO;2; Dutton PH, 1999, J ZOOL, V248, P397, DOI 10.1111/j.1469-7998.1999.tb01038.x; Dutton PH, 1995, THESIS; Dutton PH, 1996, P INT S SEA TURTL CO; ECKERT KL, 1989, HERPETOLOGICA, V45, P190; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Esler D, 2000, CONSERV BIOL, V14, P366, DOI 10.1046/j.1523-1739.2000.98147.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferraroli S, 2004, NATURE, V429, P521, DOI 10.1038/429521a; Fitzsimmons NN, 1998, MOL ECOL, V7, P575, DOI 10.1046/j.1365-294x.1998.00355.x; Fossette S, 2008, J EXP MAR BIOL ECOL, V356, P69, DOI 10.1016/j.jembe.2007.12.024; Frankham R, 2012, HEREDITY, V108, P167, DOI 10.1038/hdy.2011.66; Gaspar P, 2012, MAR ECOL PROG SER, V457, P265, DOI 10.3354/meps09689; Georges JY, 2007, MAR ECOL PROG SER, V338, P225, DOI 10.3354/meps338225; GILPIN M, 1991, BIOL J LINN SOC, V42, P165, DOI 10.1111/j.1095-8312.1991.tb00558.x; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Girondot Marc, 1996, Chelonian Conservation and Biology, V2, P204; Godley B. J., 2008, Endangered Species Research, V4, P3, DOI 10.3354/esr00060; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; HASTINGS A, 1994, ANNU REV ECOL SYST, V25, P167; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hoelzel AR, 2002, P ROY SOC B-BIOL SCI, V269, P1467, DOI 10.1098/rspb.2002.2033; IUCN, 2012, IUCN RED LIST THREAT; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones TT, 2011, J EXP MAR BIOL ECOL, V399, P84, DOI 10.1016/j.jembe.2011.01.007; LANDE R, 1992, EVOLUTION, V46, P381, DOI 10.1111/j.1558-5646.1992.tb02046.x; LATTER BDH, 1973, GENETICS, V73, P147; Le Corre V, 1998, J EVOLUTION BIOL, V11, P495, DOI 10.1007/s000360050102; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; McClenachan L, 2006, FRONT ECOL ENVIRON, V4, P290, DOI 10.1890/1540-9295(2006)4[290:CIOHST]2.0.CO;2; Moore MK, 2003, CONSERV GENET, V4, P95, DOI 10.1023/A:1021881319271; Nance HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021459; Naro-Maciel E, 2008, MOL PHYLOGENET EVOL, V49, P659, DOI 10.1016/j.ympev.2008.08.004; Nesje A, 2005, GEOPH MONOG SERIES, V158, P289; Nylander JAA., 2004, BIOINFORMATICS; Oleas NH, 2012, J HERED, V103, P557, DOI 10.1093/jhered/ess020; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Parham JF, 1996, J HERPETOL, V30, P401, DOI 10.2307/1565178; Plot V, 2012, J ANIM ECOL, V81, P341, DOI 10.1111/j.1365-2656.2011.01915.x; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD PCH, 1976, COPEIA, P749; Rambaut A., 2007, TRACER V1 4; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Reis EC, 2010, CONSERV GENET, V11, P1467, DOI 10.1007/s10592-009-9975-0; Rimbu N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016570; Rivalan P, 2006, BIOL CONSERV, V130, P1, DOI 10.1016/j.biocon.2005.11.027; Roden SE, 2011, CONSERV GENET RESOUR, V3, P49, DOI 10.1007/s12686-010-9284-4; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; SAMBROOK E, 1989, MOL CLONING LAB MANU; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.1093/sysbio/46.2.235; Shamblin BM, 2007, MOL ECOL NOTES, V7, P784, DOI 10.1111/j.1471-8286.2007.01701.x; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Stewart K, 2011, ECOL APPL, V21, P263, DOI 10.1890/09-1838.1; Storz JF, 2002, EVOLUTION, V56, P154; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thornalley DJR, 2009, NATURE, V457, P711, DOI 10.1038/nature07717; Troeng S, 2004, ORYX, V38, P395, DOI 10.1017/S0030605304000766; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vargas SM, 2008, J HERED, V99, P215, DOI 10.1093/jhered/esm120; Wakeley J, 2001, GENETICS, V159, P893; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Ware DH, 2002, PLANT PHYSIOL, V130, P1606, DOI 10.1104/pp.015248; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Whitlock MC, 1997, GENETICS, V146, P427; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Wright S, 1943, GENETICS, V28, P114; Wu CH, 2011, GENETICS, V188, P151, DOI 10.1534/genetics.110.125260; YASUDA N, 1968, BIOMETRICS, V24, P915, DOI 10.2307/2528880	105	19	20	2	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58061	10.1371/journal.pone.0058061	http://dx.doi.org/10.1371/journal.pone.0058061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516429	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200029
J	Diaz-Hernandez, ME; Bustamante, M; Galvan-Hernandez, CI; Chimal-Monroy, J				Elena Diaz-Hernandez, Martha; Bustamante, Marcia; Ivan Galvan-Hernandez, Claudio; Chimal-Monroy, Jesus			Irx1 and Irx2 Are Coordinately Expressed and Regulated by Retinoic Acid, TGF beta and FGF Signaling during Chick Hindlimb Development	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MOLECULAR CASCADE; VERTEBRATE LIMB; IROQUOIS FAMILY; PATTERN; GENES; CHONDROGENESIS; MORPHOGENESIS; MUTATION; DIGITS	The Iroquois homeobox (Irx) genes play a crucial role in the regionalization and patterning of tissues and organs during metazoan development. The Irx1 and Irx2 gene expression pattern during hindlimb development has been investigated in different species, but its regulation during hindlimb morphogenesis has not been explored yet. The aim of this study was to evaluate the gene expression pattern of Irx1 and Irx2 as well as their regulation by important regulators of hindlimb development such as retinoic acid (RA), transforming growth factor beta (TGF beta) and fibroblast growth factor (FGF) signaling during chick hindlimb development. Irx1 and Irx2 were coordinately expressed in the interdigital tissue, digital primordia, joints and in the boundary between cartilage and non-cartilage tissue. Down-regulation of Irx1 and Irx2 expression at the interdigital tissue coincided with the onset of cell death. RA was found to down-regulate their expression by a bone morphogenetic protein-independent mechanism before any evidence of cell death. Furthermore, TGF beta protein regulated Irx1 and Irx2 in a stage-dependent manner at the interdigital tissue, it inhibited their expression when it was administered to the interdigital tissue at developing stages before their normal down-regulation. TGF beta administered to the interdigital tissue at developing stages after normal down-regulation of Irx1 and Irx2 evidenced that expression of these genes marked the boundary between cartilage tissue and non-cartilage tissue. It was also found that at early stages of hindlimb development FGF signaling inhibited the expression of Irx2. In conclusion, the present study demonstrates that Irx1 and Irx2 are coordinately expressed and regulated during chick embryo hindlimb development as occurs in other species of vertebrates supporting the notion that the genomic architecture of Irx clusters is conserved in vertebrates.	[Elena Diaz-Hernandez, Martha; Bustamante, Marcia; Ivan Galvan-Hernandez, Claudio; Chimal-Monroy, Jesus] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Chimal-Monroy, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City 04510, DF, Mexico.	jchimal@unam.mx		Chimal-Monroy, Jesus/0000-0002-6511-7408	CONACyT [168642, 53484, 42568-Q, 34334-N]; DGAPA, UNAM [IN220808, IN200205, IX200410, IN214511]; CONACYT, UNAM; Red de desarrollo de farmacos y metodos de diagnostico (FARMED)	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA, UNAM(Universidad Nacional Autonoma de Mexico); CONACYT, UNAM(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Universidad Nacional Autonoma de Mexico); Red de desarrollo de farmacos y metodos de diagnostico (FARMED)	This work was partially supported by grants 168642, 53484, 42568-Q, 34334-N from CONACyT, and by grants IN220808, IN200205, IX200410, IN214511 from DGAPA, UNAM. MEDH was the recipient of a scholarship from CONACYT, UNAM. MEDH and CIGH were the recipient of a scholarship from Red de desarrollo de farmacos y metodos de diagnostico (FARMED). DGAPA, UNAM IN214511, IX200410, CONACYT 168842. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca-Buis RF, 2011, DEV GROWTH DIFFER, V53, P780, DOI 10.1111/j.1440-169X.2011.01285.x; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Cheng CW, 2007, DEV DYNAM, V236, P2661, DOI 10.1002/dvdy.21272; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Chimal-Monroy J, 2011, IUBMB LIFE, V63, P922, DOI 10.1002/iub.563; Chuang HN, 2010, DEV DYNAM, V239, P639, DOI 10.1002/dvdy.22187; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Glavic A, 2001, DEV DYNAM, V222, P368, DOI 10.1002/dvdy.1189; Feijoo CG, 2009, MOL CELL NEUROSCI, V40, P328, DOI 10.1016/j.mcn.2008.11.003; Gomez-Skarmeta JL, 2002, CURR OPIN GENET DEV, V12, P403, DOI 10.1016/S0959-437X(02)00317-9; Gomez-Skarmeta JL, 2001, DEVELOPMENT, V128, P551; Goriely A, 1999, MECH DEVELOP, V87, P203, DOI 10.1016/S0925-4773(99)00149-5; Grotewold L, 2002, DEV BIOL, V251, P129, DOI 10.1006/dbio.2002.0817; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hernandez-Martinez R, 2009, DEVELOPMENT, V136, P3669, DOI 10.1242/dev.041954; Houweling AC, 2001, MECH DEVELOP, V107, P169, DOI 10.1016/S0925-4773(01)00451-8; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Liu Y, 2002, DEVELOPMENT, V129, P5289; Macias D, 1997, DEVELOPMENT, V124, P1109; McDonald LA, 2010, J ANAT, V216, P683, DOI 10.1111/j.1469-7580.2010.01233.x; Merino R, 1998, DEV BIOL, V200, P35, DOI 10.1006/dbio.1998.8946; Merino R, 1999, DEVELOPMENT, V126, P5515; Montero JA, 2001, DEVELOPMENT, V128, P2075; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Montero JA, 2007, BIOESSAYS, V29, P725, DOI 10.1002/bies.20607; Newman Stuart A., 2007, Birth Defects Research, V81, P305, DOI 10.1002/bdrc.20112; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Rodriguez-Leon J, 1999, NAT CELL BIOL, V1, P125, DOI 10.1038/10098; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; Tena JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1301; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; van Tuyl M, 2006, AM J PHYSIOL-LUNG C, V290, pL777, DOI 10.1152/ajplung.00293.2005; Villa-Cuesta E, 2005, DEVELOPMENT, V132, P4087, DOI 10.1242/dev.01977; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Zulch A, 2001, MECH DEVELOP, V106, P159, DOI 10.1016/S0925-4773(01)00411-7	37	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58549	10.1371/journal.pone.0058549	http://dx.doi.org/10.1371/journal.pone.0058549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505533	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100062
J	Chakrabarti, R; Rawat, PS; Cooke, BM; Coppel, RL; Patankar, S				Chakrabarti, Rimi; Rawat, Parkash S.; Cooke, Brian M.; Coppel, Ross L.; Patankar, Swati			Cellular Effects of Curcumin on Plasmodium falciparum Include Disruption of Microtubules	PLOS ONE			English	Article							NF-KAPPA-B; IN-VITRO; ERYTHROCYTIC DEVELOPMENT; COLCHICINE-BINDING; ENDOTHELIAL-CELLS; INHIBITION; EXPRESSION; TUBULIN; LOCALIZATION; ACTIVATION	Curcumin has been widely investigated for its myriad cellular effects resulting in reduced proliferation of various eukaryotic cells including cancer cells and the human malaria parasite Plasmodium falciparum. Studies with human cancer cell lines HT-29, Caco-2, and MCF-7 suggest that curcumin can bind to tubulin and induce alterations in microtubule structure. Based on this finding, we investigated whether curcumin has any effect on P. falciparum microtubules, considering that mammalian and parasite tubulin are 83% identical. IC50 of curcumin was found to be 5 mu M as compared to 20 mu M reported before. Immunofluorescence images of parasites treated with 5 or 20 mu M curcumin showed a concentration-dependent effect on parasite microtubules resulting in diffuse staining contrasting with the discrete hemispindles and subpellicular microtubules observed in untreated parasites. The effect on P. falciparum microtubules was evident only in the second cycle for both concentrations tested. This diffuse pattern of tubulin fluorescence in curcumin treated parasites was similar to the effect of a microtubule destabilizing drug vinblastine on P. falciparum. Molecular docking predicted the binding site of curcumin at the interface of alpha and beta tubulin, similar to another destabilizing drug colchicine. Data from predicted drug binding is supported by results from drug combination assays showing antagonistic interactions between curcumin and colchicine, sharing a similar binding site, and additive/synergistic interactions of curcumin with paclitaxel and vinblastine, having different binding sites. This evidence suggests that cellular effects of curcumin are at least, in part, due to its perturbing effect on P. falciparum microtubules. The action of curcumin, both direct and indirect, on P. falciparum microtubules is discussed.	[Chakrabarti, Rimi; Rawat, Parkash S.; Patankar, Swati] IITB, Dept Biosci & Bioengn, Mumbai, Maharashtra, India; [Chakrabarti, Rimi; Cooke, Brian M.; Coppel, Ross L.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Chakrabarti, Rimi] Indian Inst Technol, IITB Monash Res Acad, Mumbai, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Monash University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Patankar, S (corresponding author), IITB, Dept Biosci & Bioengn, Mumbai, Maharashtra, India.	patankar@iitb.ac.in	Coppel, Ross L/A-6626-2008	Coppel, Ross L/0000-0002-4476-9124	Australian National Health and Medical Research Council (NHMRC); IITB-Monash Research Academy; IIT Bombay	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); IITB-Monash Research Academy; IIT Bombay	This work has been supported in part by an Australian National Health and Medical Research Council (NHMRC) project grant to RLC, an IITB-Monash Research Academy project grant to RC and IIT Bombay intramural funding to SP. BMC is supported by a Senior Research Fellowship from the Australian National Health and Medical Research Council(NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aditya NP, 2010, EUR J PHARM SCI, V40, P448, DOI 10.1016/j.ejps.2010.05.007; Agrawal DK, 2010, MED RES REV, V30, P818, DOI 10.1002/med.20188; [Anonymous], BIOL MODEL SYSTEMS T; Bejon PA, 1997, PARASITOLOGY, V114, P1, DOI 10.1017/S0031182096008050; BELL A, 1993, PARASITOL RES, V79, P146, DOI 10.1007/BF00932261; Bell A, 1998, PARASITOL TODAY, V14, P234, DOI 10.1016/S0169-4758(98)01246-0; Bentzen PJ, 2007, CELL PHYSIOL BIOCHEM, V19, P153, DOI 10.1159/000099203; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; Cui L, 2007, ANTIMICROB AGENTS CH, V51, P488, DOI 10.1128/AAC.01238-06; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; DHAMODHARAN R, 1995, MOL BIOL CELL, V6, P1215, DOI 10.1091/mbc.6.9.1215; DIECKMANNSCHUPPERT A, 1989, CELL BIOL INT REP, V13, P411, DOI 10.1016/0309-1651(89)90135-5; Fennell BJ, 2006, MOL BIOCHEM PARASIT, V145, P226, DOI 10.1016/j.molbiopara.2005.08.020; Fennell BJ, 2003, J ANTIMICROB CHEMOTH, V51, P833, DOI 10.1093/jac/dkg151; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; GARLAND DL, 1978, BIOCHEMISTRY-US, V17, P4266, DOI 10.1021/bi00613a024; Goel A, 2001, CANCER LETT, V172, P111, DOI 10.1016/S0304-3835(01)00655-3; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Gupta KK, 2006, FEBS J, V273, P5320, DOI 10.1111/j.1742-4658.2006.05525.x; Holy JM, 2002, MUTAT RES-GEN TOX EN, V518, P71, DOI 10.1016/S1383-5718(02)00076-1; Ji HF, 2009, BIOORG MED CHEM LETT, V19, P2453, DOI 10.1016/j.bmcl.2009.03.060; Jobin C, 1999, J IMMUNOL, V163, P3474; JORDAN MA, 1990, BIOCHEMISTRY-US, V29, P2730, DOI 10.1021/bi00463a016; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Kappes B, 2007, FUTURE MICROBIOL, V2, P409, DOI 10.2217/17460913.2.4.409; KORUTLA L, 1995, CARCINOGENESIS, V16, P1741, DOI 10.1093/carcin/16.8.1741; KUNCHANDY E, 1990, INT J PHARM, V58, P237, DOI 10.1016/0378-5173(90)90201-E; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LU YP, 1994, CARCINOGENESIS, V15, P2363, DOI 10.1093/carcin/15.10.2363; Macindoe G, 2010, NUCLEIC ACIDS RES, V38, pW445, DOI 10.1093/nar/gkq311; Mimche PN, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S10; Mohan R, 2000, J BIOL CHEM, V275, P10405, DOI 10.1074/jbc.275.14.10405; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; Nandakumar DN, 2006, ANTIMICROB AGENTS CH, V50, P1859, DOI 10.1128/AAC.50.5.1859-1860.2006; Payton F, 2007, J NAT PROD, V70, P143, DOI 10.1021/np060263s; POUVELLE B, 1994, J CLIN INVEST, V94, P413, DOI 10.1172/JCI117338; Rai SS, 1996, J BIOL CHEM, V271, P14707, DOI 10.1074/jbc.271.25.14707; Reddy RC, 2005, BIOCHEM BIOPH RES CO, V326, P472, DOI 10.1016/j.bbrc.2004.11.051; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Sasin JM, 2004, NUCLEIC ACIDS RES, V32, pW586, DOI 10.1093/nar/gkh440; SCHREVEL J, 1994, P NATL ACAD SCI USA, V91, P8472, DOI 10.1073/pnas.91.18.8472; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SINDEN RE, 1979, PARASITOLOGY, V79, P277, DOI 10.1017/S003118200005335X; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Sinou V, 1998, J EUKARYOT MICROBIOL, V45, P171, DOI 10.1111/j.1550-7408.1998.tb04522.x; Sinou V, 1996, ANTIMICROB AGENTS CH, V40, P358, DOI 10.1128/AAC.40.2.358; Striepen B, 2000, J CELL BIOL, V151, P1423, DOI 10.1083/jcb.151.7.1423; Thaloor D, 1998, CELL GROWTH DIFFER, V9, P305; TONNESEN HH, 1994, INT J PHARM, V110, P161, DOI 10.1016/0378-5173(94)90154-6; UPPULURI S, 1993, P NATL ACAD SCI USA, V90, P11598, DOI 10.1073/pnas.90.24.11598; Urscher M, 2010, MOL MICROBIOL, V76, P92, DOI 10.1111/j.1365-2958.2010.07082.x; USANGA EA, 1986, FEBS LETT, V209, P23, DOI 10.1016/0014-5793(86)81077-8; Van Erk Marjan J, 2004, J Carcinog, V3, P8, DOI 10.1186/1477-3163-3-8	56	43	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57302	10.1371/journal.pone.0057302	http://dx.doi.org/10.1371/journal.pone.0057302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505424	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500016
J	Janke, D; Jankowski, J; Ruth, M; Buschmann, I; Lemke, HD; Jacobi, D; Knaus, P; Spindler, E; Zidek, W; Lehmann, K; Jankowski, V				Janke, Doreen; Jankowski, Joachim; Rueth, Marieke; Buschmann, Ivo; Lemke, Horst-Dieter; Jacobi, Dorit; Knaus, Petra; Spindler, Ernst; Zidek, Walter; Lehmann, Kerstin; Jankowski, Vera			The "Artificial Artery" as In Vitro Perfusion Model	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; SHEAR-STRESS; MECHANICAL-PROPERTIES; TUBULAR CONSTRUCTS; ENDOTHELIAL-CELLS; COLLAGEN-GEL; EXPRESSION; MEDIA; FABRICATION; DIFFERENTIATION	Metabolic stimuli, pressure, and fluid shear stress (FSS) are major mediators of vascular plasticity. The exposure of the vessel wall to increased laminar FSS is the main trigger of arteriogenesis, the remodelling of pre-existent arterio-arteriolar anastomoses to functional conductance arteries. In this study, we have used an in vitro bioreactor to investigate cell-specific interactions, molecular mechanisms as well as time-dependent effects under laminar FSS conditions. This bioreactor termed "artificial artery" can be used for screening potential arterio-protective substances, pro-arteriogenic factors, and for investigating biomarkers of cardiovascular diseases such as cardiac diseases. The bioreactor is built up out of 14 hollow fiber membranes colonized with endothelial cells (HUVECs) on the inside and smooth muscle cells (HUASMCs) on the outside. By means of Hoechst 33342 staining as well as immunocytochemistry of beta-catenin and alpha-smooth-muscle-actin, a microporous polypropylene membrane was characterized as being the appropriate polymer for co-colonization. Defined arterial flow conditions (0.1 N/m2 and 3 N/m2), metabolic exchange, and cross-talk of HUVECs and HUASMCs through hollow fibers mimic physiological in vivo conditions of the vasculature. Analysing mono-and co-culture secretomes by MALDI-TOF-TOF mass spectrometry, we could show that HUVECs secreted Up4A upon 3 N/m2. A constant cellular secretion of randomly chosen peptides verified viability of the "artificial artery" for a cultivation period up to five days. qRT-PCR analyses revealed an up-regulation of KLF2 and TIMP1 as mechano-regulated genes and demonstrated arterio-protective, homeostatic FSS conditions by a down-regulation of EDN1. Expression analyses of VWF and EDN1 furthermore confirmed that RNA of both cell types could separately be isolated without cross-contamination. CCND1 mRNA expression in HUVECs did not change upon FSS indicating a quiescent endothelial phenotype. Taken together, the "artificial artery" provides a solid in vitro model to test pharmacological active compounds for their impact on arterio-damaging or arterio-protective properties on vascular response.	[Janke, Doreen; Jacobi, Dorit; Lehmann, Kerstin] Charite, Julius Wolff Inst, D-13353 Berlin, Germany; [Janke, Doreen; Jacobi, Dorit; Lehmann, Kerstin] Charite, Berlin Brandenburg Ctr Regenerat Therapies CVK, D-13353 Berlin, Germany; [Jankowski, Joachim; Rueth, Marieke; Zidek, Walter; Jankowski, Vera] Charite, Med Klin CBF 4, D-13353 Berlin, Germany; [Rueth, Marieke; Lemke, Horst-Dieter; Spindler, Ernst] eXcorlab GmbH, Ind Ctr Obernburg, Obernburg, Germany; [Buschmann, Ivo] Charite, Ctr Cardiovasc Res CCM, D-13353 Berlin, Germany; [Knaus, Petra] FU Berlin, Inst Chem & Biochem, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Jankowski, V (corresponding author), Charite, Med Klin CBF 4, D-13353 Berlin, Germany.	Vera.Jankowski@charite.de		Ruth, Marieke/0000-0002-2369-1639	Federal Ministry of Education and Research (BMBF) [13920B, 01GR0807]; Rahel-Hirsch-scholarship from the Charite (Germany); Sonnenfeld Stiftung; German Research Foundation; graduate school 203 "Berlin-Brandenburg School of Regenerative Therapies"	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Rahel-Hirsch-scholarship from the Charite (Germany); Sonnenfeld Stiftung; German Research Foundation(German Research Foundation (DFG)); graduate school 203 "Berlin-Brandenburg School of Regenerative Therapies"	This study was supported from Federal Ministry of Education and Research (BMBF; 13920B and 01GR0807 (KL/JJ)). VJ is recipient of a Rahel-Hirsch-scholarship from the Charite (Germany) and Sonnenfeld Stiftung (VJ). DJ was partially supported through the German Research Foundation by funding through the graduate school 203 "Berlin-Brandenburg School of Regenerative Therapies". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avvisato CL, 2007, J CELL SCI, V120, P2672, DOI 10.1242/jcs.03476; BALLERMANN BJ, 1995, BLOOD PURIFICAT, V13, P125, DOI 10.1159/000170195; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Boon RA, 2009, HAMOSTASEOLOGIE, V29, P39, DOI 10.1055/s-0037-1616937; BREVIARIO F, 1995, ARTERIOSCL THROM VAS, V15, P1229, DOI 10.1161/01.ATV.15.8.1229; Burnstock G, 2008, CIRC RES, V103, P1056, DOI 10.1161/CIRCRESAHA.108.187963; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cai WJ, 2004, MOL CELL BIOCHEM, V264, P201, DOI 10.1023/B:MCBI.0000044389.65590.57; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2005, AM J PATHOL, V167, P609, DOI 10.1016/S0002-9440(10)63002-7; Donovan D., 2001, Angiogenesis, V4, P113, DOI 10.1023/A:1012218401036; Dudash LA, 2012, J BIOMED MATER RES A, V100A, P2204, DOI 10.1002/jbm.a.34119; Elbjeirami WM, 2003, J BIOMED MATER RES A, V66A, P513, DOI 10.1002/jbm.a.10021; Galbusera M, 1997, BLOOD, V90, P1558, DOI 10.1182/blood.V90.4.1558.1558_1558_1564; Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; Godbey WT, 2002, ANN NY ACAD SCI, V961, P10, DOI 10.1111/j.1749-6632.2002.tb03041.x; Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589; Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Gupta S, 2007, N-S ARCH PHARMACOL, V375, P29, DOI 10.1007/s00210-007-0137-y; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Hillmeister P, 2008, J CEREBR BLOOD F MET, V28, P1811, DOI 10.1038/jcbfm.2008.69; HIRAI J, 1995, CELL TRANSPLANT, V4, P597, DOI 10.1016/0963-6897(95)00029-1; Hoerstrup SP, 2001, EUR J CARDIO-THORAC, V20, P164, DOI 10.1016/S1010-7940(01)00706-0; Huddleson JP, 2005, J BIOL CHEM, V280, P23371, DOI 10.1074/jbc.M413839200; Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662; Ito A, 2005, TISSUE ENG, V11, P1553, DOI 10.1089/ten.2005.11.1553; Jankowski J, 1999, ANAL BIOCHEM, V269, P72, DOI 10.1006/abio.1999.3097; Jankowski J, 2003, RAPID COMMUN MASS SP, V17, P1189, DOI 10.1002/rcm.1035; Jankowski J, 2001, ANAL BIOCHEM, V290, P324, DOI 10.1006/abio.2001.5001; Jankowski V, 2005, NAT MED, V11, P223, DOI 10.1038/nm1188; Jankowski V, 2007, ARTERIOSCL THROM VAS, V27, P297, DOI 10.1161/01.ATV.0000253889.09765.5f; Jankowski V, 2011, FASEB J, V25, P2987, DOI 10.1096/fj.11-185470; Jeong SI, 2005, BIOMATERIALS, V26, P1405, DOI 10.1016/j.biomaterials.2004.04.036; Jian-Wei X, 2005, PLAST RECONSTR SURG, V116, P577, DOI 10.1097/01.prs.0000172985.81897.dc; Jiang RZ, 2006, CHINESE MED J-PEKING, V119, P384, DOI 10.1097/00029330-200603010-00006; Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671; Kinard F, 1997, IN VITRO CELL DEV-AN, V33, P92; Lampugnani MG, 1997, CURR OPIN CELL BIOL, V9, P674, DOI 10.1016/S0955-0674(97)80121-4; MALEK A, 1992, AM J PHYSIOL, V263, pC389, DOI 10.1152/ajpcell.1992.263.2.C389; Malek AM, 1996, J CELL SCI, V109, P713; Matsumoto T, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/435132; McCulloch AD, 2004, TISSUE ENG, V10, P565, DOI 10.1089/107632704323061924; Mendis Shanthi, 2011, GLOB ATL CARD DIS PR; Messner B, 2010, BIOMETALS, V23, P811, DOI 10.1007/s10534-010-9314-4; Moeinzadeh S, 2012, BIOMACROMOLECULES, V13, P2073, DOI 10.1021/bm300453k; Morawietz H, 2000, J PHYSIOL-LONDON, V525, P761, DOI 10.1111/j.1469-7793.2000.00761.x; Neidert MR, 2002, BIOMATERIALS, V23, P3717, DOI 10.1016/S0142-9612(02)00106-0; NICOSIA RF, 1990, LAB INVEST, V63, P115; Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Owens NC, 1996, EXP BRAIN RES, V110, P55; Park J, 2010, AUTON NEUROSCI-BASIC, V152, P11, DOI 10.1016/j.autneu.2009.08.008; Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje; Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107; Ratcliffe A, 2002, ANN NY ACAD SCI, V961, P210, DOI 10.1111/j.1749-6632.2002.tb03087.x; REDMOND EM, 1995, IN VITRO CELL DEV-AN, V31, P601; Russell WMSB, 1959, HUMANE EXPT TECHNIQU, P238; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sakai S, 2012, BIOTECHNOL BIOENG, V109, P2911, DOI 10.1002/bit.24550; Salabei JK, 2012, TOXICOL APPL PHARM, V262, P265, DOI 10.1016/j.taap.2012.04.036; Satoh H, 1999, BIOCHEM BIOPH RES CO, V254, P757, DOI 10.1006/bbrc.1998.0126; Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275; SPRAGUE EA, 1987, CIRCULATION, V76, P648, DOI 10.1161/01.CIR.76.3.648; Su JC, 2012, INT J NANOMED, V7, P2547, DOI 10.2147/IJN.S29819; Takagi Mutsumi, 2003, J Artif Organs, V6, P222, DOI 10.1007/s10047-003-0218-8; Takei T, 2007, J BIOSCI BIOENG, V104, P435, DOI 10.1263/jbb.104.435; Takei T, 2006, BIOTECHNOL BIOENG, V95, P1, DOI 10.1002/bit.20903; THIE M, 1991, EUR J CELL BIOL, V55, P295; Ucuzian AA, 2007, WORLD J SURG, V31, P654, DOI 10.1007/s00268-006-0763-4; Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhang SC, 2012, J MATER SCI-MATER M, V23, P2001, DOI 10.1007/s10856-012-4673-8	74	19	19	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57227	10.1371/journal.pone.0057227	http://dx.doi.org/10.1371/journal.pone.0057227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505419	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500011
J	Pornwilard, MM; Weiskirchen, R; Gassler, N; Bosserhoff, AK; Becker, JS				Pornwilard, M-M; Weiskirchen, Ralf; Gassler, Nikolaus; Bosserhoff, Anja K.; Becker, J. Sabine			Novel Bioimaging Techniques of Metals by Laser Ablation Inductively Coupled Plasma Mass Spectrometry for Diagnosis Of Fibrotic and Cirrhotic Liver Disorders	PLOS ONE			English	Article							WILSON-DISEASE; TRACE-ELEMENTS; ICP-MS; COPPER; IRON; ZINC; MANGANESE; FIBROSIS; TISSUE; BRAIN	Background and Aims: Hereditary disorders associated with metal overload or unwanted toxic accumulation of heavy metals can lead to morbidity and mortality. Patients with hereditary hemochromatosis or Wilson disease for example may develop severe hepatic pathology including fibrosis, cirrhosis or hepatocellular carcinoma. While relevant disease genes are identified and genetic testing is applicable, liver biopsy in combination with metal detecting techniques such as energy-dispersive X-ray spectroscopy (EDX) is still applied for accurate diagnosis of metals. Vice versa, several metals are needed in trace amounts for carrying out vital functions and their deficiency due to rapid growth, pregnancy, excessive blood loss, and insufficient nutritional or digestive uptake results in organic and systemic shortcomings. Established in situ techniques, such as EDX-ray spectroscopy, are not sensitive enough to analyze trace metal distribution and the quantification of metal images is difficult. Methods: In this study, we developed a quantitative biometal imaging technique of human liver tissue by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) in order to compare the distribution of selected metals in cryosections of healthy and fibrotic/cirrhotic livers. Results: Most of the metals are homogeneous distributed within the normal tissue, while they are redirected within fibrotic livers resulting in significant metal deposits. Moreover, total iron and copper concentrations in diseased liver were found about 3-5 times higher than in normal liver samples. Conclusions: Biometal imaging via LA-ICP-MS is a sensitive innovative diagnostic tool that will impact clinical practice in identification and evaluation of hepatic metal disorders and to detect subtle metal variations during ongoing hepatic fibrogenesis.	[Pornwilard, M-M; Weiskirchen, Ralf] RWTH Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany; [Pornwilard, M-M; Becker, J. Sabine] Forschungszentrum Julich, Cent Div Analyt Chem, D-52425 Julich, Germany; [Pornwilard, M-M] Mahidol Univ, Dept Chem, Bangkok 10700, Thailand; [Pornwilard, M-M] Mahidol Univ, Ctr Innovat Chem, Bangkok 10700, Thailand; [Gassler, Nikolaus] RWTH Univ Hosp Aachen, Inst Pathol, Aachen, Germany; [Bosserhoff, Anja K.] Univ Hosp Regensburg, Inst Pathol, Regensburg, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; Research Center Julich; Mahidol University; Mahidol University; RWTH Aachen University; RWTH Aachen University Hospital; University of Regensburg	Weiskirchen, R (corresponding author), RWTH Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, Aachen, Germany.	rweiskirchen@ukaachen.de	Weiskirchen, Ralf/O-1734-2018; Bosserhoff, Anja/GNH-4801-2022	Weiskirchen, Ralf/0000-0003-3888-0931; Bosserhoff, Anja/0000-0001-8147-394X	Deutsche Forschungsgemeinschaft (DFG) [BE 2649/5-1]; IZKF Aachen;  [SFB/TRR 57]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IZKF Aachen; 	The authors are grateful to the Deutsche Forschungsgemeinschaft (DFG grant number BE 2649/5-1) for instrumental support of the BrainMet laboratory. RW is sponsored by the SFB/TRR 57 and the IZKF Aachen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alustiza JM, 2007, EUR J RADIOL, V61, P499, DOI 10.1016/j.ejrad.2006.11.012; Barst BD, 2011, ENVIRON SCI TECHNOL, V45, P8982, DOI 10.1021/es201641x; Becker J.S., 2007, INORGANIC MASS SPECT; Becker JS, 2010, INT J MASS SPECTROM, V289, P65, DOI 10.1016/j.ijms.2009.10.011; Becker JS, 2010, MASS SPECTROM REV, V29, P156, DOI 10.1002/mas.20239; Becker JS, 2011, INT J MASS SPECTROM, V307, P3, DOI 10.1016/j.ijms.2011.01.015; Brissot P, 2011, TRENDS MOL MED, V17, P707, DOI 10.1016/j.molmed.2011.07.004; Buiakova OI, 1999, HUM MOL GENET, V8, P1665, DOI 10.1093/hmg/8.9.1665; CAPOCACCIA L, 1991, ITAL J GASTROENTEROL, V23, P386; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Corradini E, 2012, J GASTROEN HEPATOL, V27, P42, DOI 10.1111/j.1440-1746.2011.07014.x; de Sousa Isadora Karolina Freitas, 2012, Vet Med Int, V2012, P207950, DOI 10.1155/2012/207950; Desmet VJ, 2003, J HEPATOL, V38, P382, DOI 10.1016/S0168-8278(03)00005-9; Feldmann J, 2002, J ANAL ATOM SPECTROM, V17, P813, DOI 10.1039/b201960d; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Guerra MBB, 2011, J ANAL ATOM SPECTROM, V26, P2238, DOI 10.1039/c1ja10198f; Gunter TE, 2004, J NEUROCHEM, V88, P266, DOI 10.1046/j.1471-4159.2003.02122.x; HAUSER RA, 1994, ANN NEUROL, V36, P871, DOI 10.1002/ana.410360611; Ishikawa T, 2012, WORLD J GASTROENTERO, V18, P3196, DOI 10.3748/wjg.v18.i25.3196; Kindness A, 2003, CLIN CHEM, V49, P1916, DOI 10.1373/clinchem.2003.022046; Kinoshita H, 2010, MED MOL MORPHOL, V43, P19, DOI 10.1007/s00795-009-0474-7; KRIEGER D, 1995, LANCET, V346, P270, DOI 10.1016/S0140-6736(95)92164-8; LECHENE CP, 1977, ANNU REV BIOPHYS BIO, V6, P57, DOI 10.1146/annurev.bb.06.060177.000421; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Matusch A, 2012, ANAL CHEM, V84, P3170, DOI 10.1021/ac203112c; Matusch A, 2010, J AM SOC MASS SPECTR, V21, P161, DOI 10.1016/j.jasms.2009.09.022; Maxwell KL, 2012, CURR OPIN GASTROEN, V28, P217, DOI 10.1097/MOG.0b013e3283521d82; Nelson James E, 2012, Curr Gastroenterol Rep, V14, P8, DOI 10.1007/s11894-011-0234-4; Nobili V, 2013, J PEDIATR GASTR NUTR, V56, P370, DOI 10.1097/MPG.0b013e31827aced4; Osterholt T, 2011, INT J MASS SPECTROM, V307, P232, DOI 10.1016/j.ijms.2011.03.010; Philippe MA, 2007, WORLD J GASTROENTERO, V13, P4746, DOI 10.3748/wjg.v13.i35.4746; Pietrangelo A, 2002, J BIOENERG BIOMEMBR, V34, P67, DOI 10.1023/A:1013874804911; Pietrangelo A, 2011, SEMIN LIVER DIS, V31, P302, DOI 10.1055/s-0031-1286061; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Qin ZY, 2011, METALLOMICS, V3, P28, DOI 10.1039/c0mt00048e; Rashed MN, 2011, J TRACE ELEM MED BIO, V25, P181, DOI 10.1016/j.jtemb.2011.07.001; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Rosencrantz R, 2011, SEMIN LIVER DIS, V31, P245, DOI 10.1055/s-0031-1286056; SCHILSKY ML, 1994, HEPATOLOGY, V19, P583, DOI 10.1002/hep.1840190307; Sebastiani G, 2012, J VIRAL HEPATITIS, V19, pE170, DOI 10.1111/j.1365-2893.2011.01508.x; SETH TD, 1976, B ENVIRON CONTAM TOX, V16, P190, DOI 10.1007/BF01685226; Sirlin CB, 2010, MAGN RESON IMAGING C, V18, P359, DOI 10.1016/j.mric.2010.08.014; Song M, 2011, J PHARMACOL EXP THER, V339, P298, DOI 10.1124/jpet.111.184325; SPICKETT JT, 1979, B ENVIRON CONTAM TOX, V23, P627, DOI 10.1007/BF01770016; Stamoulis I, 2007, DIGEST DIS SCI, V52, P1595, DOI 10.1007/s10620-006-9462-0; Sussulini A, 2013, CONTRAST MEDIA MOL I, V8, P204, DOI 10.1002/cmmi.1509; van den Berghe PVE, 2009, NUTR REV, V67, P658, DOI 10.1111/j.1753-4887.2009.00250.x; VERSIECK J, 1974, CLIN CHEM, V20, P1141; Wang YF, 2011, ADV NUTR, V2, P129, DOI 10.3945/an.110.000273; Zoriy MV, 2007, INT J MASS SPECTROM, V264, P175, DOI 10.1016/j.ijms.2007.04.009	50	36	37	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58702	10.1371/journal.pone.0058702	http://dx.doi.org/10.1371/journal.pone.0058702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505552	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500117
J	Song, AP; Lou, WH; Jiang, JF; Chen, SM; Sun, ZX; Guan, ZY; Fang, WM; Teng, NJ; Chen, FD				Song, Aiping; Lou, Wanghuai; Jiang, Jiafu; Chen, Sumei; Sun, Zuxia; Guan, Zhiyong; Fang, Weimin; Teng, Nianjun; Chen, Fadi			An Isoform of Eukaryotic Initiation Factor 4E from Chrysanthemum morifolium Interacts with Chrysanthemum Virus B Coat Protein	PLOS ONE			English	Article							TURNIP-MOSAIC-VIRUS; CAP-BINDING PROTEIN; RECESSIVE BYMOVIRUS RESISTANCE; TRANSLATION INITIATION; ARABIDOPSIS-THALIANA; MESSENGER-RNA; POTYVIRUS RESISTANCE; FACTORS EIF(ISO)4E; GENE-EXPRESSION; FACTOR EIF4E	Background: Eukaryotic translation initiation factor 4E (eIF4E) plays an important role in plant virus infection as well as the regulation of gene translation. Methodology/Principal Findings: Here, we describe the isolation of a cDNA encoding CmeIF(iso)4E (GenBank accession no. JQ904592), an isoform of eIF4E from chrysanthemum, using RACE PCR. We used the CmeIF(iso)4E cDNA for expression profiling and to analyze the interaction between CmeIF(iso)4E and the Chrysanthemum virus B coat protein (CVBCP). Multiple sequence alignment and phylogenetic tree analysis showed that the sequence similarity of CmeIF(iso)4E with other reported plant eIF(iso)4E sequences varied between 69.12% and 89.18%, indicating that CmeIF(iso)4E belongs to the eIF(iso)4E subfamily of the eIF4E family. CmeIF(iso) 4E was present in all chrysanthemum organs, but was particularly abundant in the roots and flowers. Confocal microscopy showed that a transiently transfected CmeIF(iso)4E-GFP fusion protein distributed throughout the whole cell in onion epidermis cells. A yeast two hybrid assay showed CVBCP interacted with CmeIF(iso)4E but not with CmeIF4E. BiFC assay further demonstrated the interaction between CmeIF(iso)4E and CVBCP. Luminescence assay showed that CVBCP increased the RLU of Luc-CVB, suggesting CVBCP might participate in the translation of viral proteins. Conclusions/Significance: These results inferred that CmeIF(iso)4E as the cap-binding subunit eIF(iso)4F may be involved in Chrysanthemum Virus B infection in chrysanthemum through its interaction with CVBCP in spatial.	[Song, Aiping; Lou, Wanghuai; Jiang, Jiafu; Chen, Sumei; Sun, Zuxia; Guan, Zhiyong; Fang, Weimin; Teng, Nianjun; Chen, Fadi] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chen, FD (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	chenfd@njau.edu.cn			Program for New Century Excellent Talents in University of Chinese Ministry of Education [NCET-10-0492]; Sci-Tech Support Plan of Jiangsu Province [BE2011325]; 863 Project [2011AA100208]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Fundamental Research Funds for the Central Universities [KYZ201147]; Youth Science and Technology Innovation Fund [KJ2011009]	Program for New Century Excellent Talents in University of Chinese Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Sci-Tech Support Plan of Jiangsu Province; 863 Project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Youth Science and Technology Innovation Fund	This study is supported by the Program for New Century Excellent Talents in University of Chinese Ministry of Education (Grant No. NCET-10-0492), Sci-Tech Support Plan of Jiangsu Province (BE2011325), 863 Project (2011AA100208), a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and the Fundamental Research Funds for the Central Universities (KYZ201147) and Youth Science and Technology Innovation Fund (KJ2011009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MJ, 2005, VIRUS TAXONOMY, P1089; Ala-Poikela M, 2011, J VIROL, V85, P6784, DOI 10.1128/JVI.00485-11; Ayme V, 2007, J GEN VIROL, V88, P1594, DOI 10.1099/vir.0.82702-0; Boisnard A, 2007, THEOR APPL GENET, V116, P53, DOI 10.1007/s00122-007-0646-6; Bol JF, 1999, J GEN VIROL, V80, P1089, DOI 10.1099/0022-1317-80-5-1089; Bol JF, 2003, MOL PLANT PATHOL, V4, P1, DOI 10.1046/j.1364-3703.2003.00146.x; Browning KS, 2004, BIOCHEM SOC T, V32, P589, DOI 10.1042/BST0320589; BROWNING KS, 1992, J BIOL CHEM, V267, P10096; Bushell M, 2002, J CELL BIOL, V158, P395, DOI 10.1083/jcb.200205044; Chen MH, 2000, EMBO J, V19, P913, DOI 10.1093/emboj/19.5.913; Culjkovic B, 2007, CELL CYCLE, V6, P65, DOI 10.4161/cc.6.1.3688; Dadlani NK., 2000, COMMERCIAL FLORICULT, P1; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fujikawa Y, 2007, PLANT J, V52, P185, DOI 10.1111/j.1365-313X.2007.03214.x; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Gallois JL, 2010, J GEN VIROL, V91, P288, DOI 10.1099/vir.0.015321-0; Gao ZH, 2004, PLANT J, V40, P376, DOI 10.1111/j.1365-313X.2004.02215.x; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Jaspars EMJ, 1999, ARCH VIROL, V144, P843, DOI 10.1007/s007050050551; Jenner CE, 2010, MOL PLANT MICROBE IN, V23, P1498, DOI 10.1094/MPMI-05-10-0104; Kang BC, 2005, PLANT J, V42, P392, DOI 10.1111/j.1365-313X.2005.02381.x; Kanyuka K, 2005, MOL PLANT PATHOL, V6, P449, DOI [10.1111/j.1364-3703.2005.00294.x, 10.1111/J.1364-3703.2005.00294.X]; Khan MA, 2006, J BIOL CHEM, V281, P28002, DOI 10.1074/jbc.M605479200; Krab IM, 2005, J GEN VIROL, V86, P1841, DOI 10.1099/vir.0.80796-0; LANG V, 1994, J BIOL CHEM, V269, P6117; LEJBKOWICZ F, 1992, P NATL ACAD SCI USA, V89, P9612, DOI 10.1073/pnas.89.20.9612; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Malik PS, 2005, VIROLOGY, V337, P273, DOI 10.1016/j.virol.2005.04.030; McKendrick L, 1999, INT J BIOCHEM CELL B, V31, P31, DOI 10.1016/S1357-2725(98)00129-0; Miyoshi H, 2008, BIOCHIMIE, V90, P1427, DOI 10.1016/j.biochi.2008.03.013; Neeleman L, 2001, P NATL ACAD SCI USA, V98, P14286, DOI 10.1073/pnas.251542798; Nicaise V, 2003, PLANT PHYSIOL, V132, P1272, DOI 10.1104/pp.102.017855; Nieto C, 2006, PLANT J, V48, P452, DOI 10.1111/j.1365-313X.2006.02885.x; Ren T, 2005, VIROLOGY, V331, P316, DOI 10.1016/j.virol.2004.10.039; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rodriguez CM, 1998, PLANT J, V13, P465, DOI 10.1046/j.1365-313X.1998.00047.x; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Ruffel S, 2005, MOL GENET GENOMICS, V274, P346, DOI 10.1007/s00438-005-0003-x; Ruffel S, 2004, GENE, V338, P209, DOI 10.1016/j.gene.2004.05.010; Ruffel S, 2002, PLANT J, V32, P1067, DOI 10.1046/j.1365-313X.2002.01499.x; Sato M, 2005, FEBS LETT, V579, P1167, DOI 10.1016/j.febslet.2004.12.086; Singh L, 2007, ARCH VIROL, V152, P405, DOI 10.1007/s00705-006-0854-4; Singh L, 2012, ARCH VIROL, V157, P531, DOI 10.1007/s00705-011-1190-x; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Thivierge K, 2005, PLANT PHYSIOL, V138, P1822, DOI 10.1104/pp.105.064105; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshii M, 2004, J VIROL, V78, P6102, DOI 10.1128/JVI.78.12.6102-6111.2004; Zhang YY, 2006, J INTEGR PLANT BIOL, V48, P1129, DOI 10.1111/j.1744-7909.2006.00322.x; Zhang YY, 2009, PLANT MOL BIOL REP, V27, P400, DOI 10.1007/s11105-009-0090-7	54	17	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57229	10.1371/journal.pone.0057229	http://dx.doi.org/10.1371/journal.pone.0057229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505421	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500013
J	Zhong, JH; Mo, XS; Xiang, BD; Yuan, WP; Jiang, JF; Xie, GS; Li, LQ				Zhong, Jian-Hong; Mo, Xin-Shao; Xiang, Bang-De; Yuan, Wei-Ping; Jiang, Jin-Fang; Xie, Gui-Sheng; Li, Le-Qun			Postoperative Use of the Chemopreventive Vitamin K2 Analog in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							GAMMA-CARBOXY PROTHROMBIN; SURGICAL RESECTION; GROWTH-INHIBITION; RECURRENCE RATES; MENATETRENONE; METAANALYSIS; COMBINATION; SURVIVAL; ABLATION; DISEASE	Aim: To evaluate the chemopreventive efficacy of vitamin K2 (VK2) analog in patients with hepatocellular carcinoma (HCC) after curative hepatic resection or local ablation, since a recent randomized control trial (RCT) and systematic review have given contradictory results. Methods: MEDLINE, EMBASE and Cochrane library databases were systematically searched through the end of May 2012. Meta-analysis of RCTs and cohort studies was performed to estimate the effects of the VK2 analog on tumor recurrence rate and overall survival (OS). Risk ratios (RRs) and 95% confidence intervals (95% CIs) were calculated. Results: Six RCTs and one cohort study involving a total of 930 patients were included. VK2 analog therapy did not reduce the 1-year recurrence rate, with a pooled RR of 0.67 (95% CI 0.39-1.13, p = 0.13). However, VK2 analog therapy was associated with a significant reduction in the 2-and 3-year tumor recurrence rates, with respective pooled RRs of 0.65 (95% CI 0.51-0.83, p<0.001) and 0.70 (95% CI=0.58-0.85, p<0.001). The therapy was also associated with a significant improvement in 1-, 2-, and 3-year OS, with respective pooled RRs of 1.03 (95% CI 1.01-1.05, p = 0.02), 1.11 (95% CI 1.03-1.19, p = 0.005) and 1.14 (95% CI 1.02-1.28, p = 0.02). None of the studies reported adverse effects attributable to VK2 analog therapy. Conclusion: The VK2 analog may reduce recurrence rate after 1 year and improve OS in HCC patients as early as 1 year. However, these findings should be considered preliminary since the majority of patients came from an RCT with survival data out to only 1 year. More extensive studies with larger sample sizes and longer follow-up are needed.	[Zhong, Jian-Hong; Mo, Xin-Shao; Xiang, Bang-De; Yuan, Wei-Ping; Li, Le-Qun] Guangxi Med Univ, Tumor Hosp, Hepatobiliary Surg Dept, Nanning, Peoples R China; [Jiang, Jin-Fang] Guangxi Med Univ, Tumor Hosp, Dept Chemotherapy, Nanning, Peoples R China; [Xie, Gui-Sheng] Guangxi Med Univ, Affiliated Hosp 3, Dept Gen Surg, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, LQ (corresponding author), Guangxi Med Univ, Tumor Hosp, Hepatobiliary Surg Dept, Nanning, Peoples R China.	xitongpingjia@163.com	Zhong, Jian-Hong/D-6641-2018; Li, Li/AEM-3636-2022; LI, LI QING/GRR-8855-2022; li, li/HII-4157-2022; LI, LI/GVS-5344-2022	Zhong, Jian-Hong/0000-0002-1494-6396; 	National Natural Science Foundation of China [81160262/H1602]; Guangxi Natural Science Foundation [2011GXNSFD018032]; Ministry of Health of Guangxi Province [Z2012345]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Ministry of Health of Guangxi Province	This work was supported by the grants from the National Natural Science Foundation of China (Project No: 81160262/H1602) and Guangxi Natural Science Foundation (Project No: 2011GXNSFD018032) to LQL, and the Self-raised Scientific Research Fund of the Ministry of Health of Guangxi Province (Project No: Z2012345) to JHZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2009, ENDOCR J, V56, P843, DOI 10.1507/endocrj.K09E-108; Bertino G, 2010, DRUG NEWS PERSPECT, V23, P498, DOI 10.1358/dnp.2010.23.8.1444236; Chu KJ, 2010, ASIAN J SURG, V33, P120, DOI 10.1016/S1015-9584(10)60021-8; Habu D, 2004, JAMA-J AM MED ASSOC, V292, P358, DOI 10.1001/jama.292.3.358; Hosho K, 2008, YONAGO ACTA MED, V51, P95; Hotta N, 2007, HEPATO-GASTROENTEROL, V54, P2073; Ishizuka M, 2012, ANTICANCER RES, V32, P5415; Kakizaki S, 2007, J GASTROEN HEPATOL, V22, P518, DOI 10.1111/j.1440-1746.2007.04844.x; Kim HS, 2009, J CLIN GASTROENTEROL, V43, P482, DOI 10.1097/MCG.0b013e318182015a; Kubota K, 2011, EUR J CANCER, V47, pS470, DOI 10.1016/S0959-8049(11)71905-0; Lang HK, 2007, J AM COLL SURGEONS, V205, P27, DOI 10.1016/j.jamcollsurg.2007.03.002; Li L, 2010, MOL CELL BIOCHEM, V342, P125, DOI 10.1007/s11010-010-0476-8; Mizuta T, 2006, CANCER, V106, P867, DOI 10.1002/cncr.21667; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Nakamura M, 2006, HEPATOL RES, V35, P289, DOI 10.1016/j.hepres.2006.04.014; Ozaki I, 2007, CLIN CANCER RES, V13, P2236, DOI 10.1158/1078-0432.CCR-06-2308; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Prabhoo Ram, 2010, J Indian Med Assoc, V108, P253; Sakaguchi T, 2010, SURG TODAY, V40, P638, DOI 10.1007/s00595-009-4109-3; Singal AK, 2010, ALIMENT PHARM THER, V32, P851, DOI 10.1111/j.1365-2036.2010.04414.x; Takahashi Shunsuke, 2008, Oncology, V75 Suppl 1, P91, DOI 10.1159/000173429; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; Yamamoto T, 2009, J GASTROENTEROL, V44, P228, DOI 10.1007/s00535-008-2304-4; Yoshida H, 2011, HEPATOLOGY, V54, P532, DOI 10.1002/hep.24430; Yoshiji H, 2009, J HEPATOL, V51, P315, DOI 10.1016/j.jhep.2009.04.011; Zerbini A, 2010, GASTROENTEROLOGY, V138, P1931, DOI 10.1053/j.gastro.2009.12.051; Zhong JH, 2010, HEPATOL RES, V40, P943, DOI 10.1111/j.1872-034X.2010.00710.x	27	24	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58082	10.1371/journal.pone.0058082	http://dx.doi.org/10.1371/journal.pone.0058082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505456	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500048
J	Duan, WX; Yang, Y; Yi, W; Yan, JJ; Liang, ZX; Wang, N; Li, Y; Chen, WS; Yu, SQ; Jin, ZX; Yi, DH				Duan, Weixun; Yang, Yang; Yi, Wei; Yan, Juanjuan; Liang, Zhenxin; Wang, Ning; Li, Yue; Chen, Wensheng; Yu, Shiqiang; Jin, Zhenxiao; Yi, Dinghua			New Role of JAK2/STAT3 Signaling in Endothelial Cell Oxidative Stress Injury and Protective Effect of Melatonin	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ISCHEMIA-REPERFUSION; HEME OXYGENASE-1; GLIOMA-CELLS; PC12 CELLS; PATHWAY; APOPTOSIS; ACTIVATION; STAT3; EXPRESSION	Previous studies have shown that the JAK2/STAT3 signaling pathway plays a regulatory role in cellular oxidative stress injury (OSI). In this study, we explored the role of the JAK2/STAT3 signaling pathway in hydrogen peroxide (H2O2)-induced OSI and the protective effect of melatonin against (H2O2)-induced injury in human umbilical vein endothelial cells (HUVECs). AG490 (a specific inhibitor of the JAK2/STAT3 signaling pathway) and JAK2 siRNA were used to manipulate JAK2/STAT3 activity, and the results showed that AG490 and JAK2 siRNA inhibited OSI and the levels of p-JAK2 and p-STAT3. HUVECs were then subjected to H2O2 in the absence or presence of melatonin, the main secretory product of the pineal gland. Melatonin conferred a protective effect against H2O2, which was evidenced by improvements in cell viability, adhesive ability and migratory ability, decreases in the apoptotic index and reactive oxygen species (ROS) production and several biochemical parameters in HUVECs. Immunofluorescence and Western blotting showed that H2O2 treatment increased the levels of p-JAK2, p-STAT3, Cytochrome c, Bax and Caspase3 and decreased the levels of Bcl2, whereas melatonin treatment partially reversed these effects. We, for the first time, demonstrate that the inhibition of the JAK2/STAT3 signaling pathway results in a protective effect against endothelial OSI. The protective effects of melatonin against OSI, at least partially, depend upon JAK2/STAT3 inhibition.	[Duan, Weixun; Yang, Yang; Yi, Wei; Liang, Zhenxin; Wang, Ning; Li, Yue; Chen, Wensheng; Yu, Shiqiang; Jin, Zhenxiao; Yi, Dinghua] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian, Shanxi Province, Peoples R China; [Yang, Yang] Beijing Mil Area Command, Beidaihe Sanat, Dept Med Adm, Qinhuangdao, Hebei Province, Peoples R China; [Yan, Juanjuan] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian, Shanxi Province, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Jin, ZX (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian, Shanxi Province, Peoples R China.	jinzx1026cn@yahoo.com.cn; dinghuayi210@126.com	Jin, Zhenxiao/AAJ-5777-2020; Li, Yue/AAU-1580-2021	Yu, Shiqiang/0000-0003-3519-0943; Yi, Wei/0000-0002-4349-910X	12th National Five Years Supporting Project of China [2011BAI11B20]; National Natural Science Foundation of China [81102687, 81070198]; Academic Promotion Project of Xijing Hospital [XJZT09 M16, XJZT10 M12]; Social Development Project of Shaanxi Province [2012JQ4001]	12th National Five Years Supporting Project of China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Promotion Project of Xijing Hospital; Social Development Project of Shaanxi Province	This study was supported by grants from the 12th National Five Years Supporting Project of China (2011BAI11B20), the National Natural Science Foundation of China (81102687 and 81070198), the Academic Promotion Project of Xijing Hospital (XJZT09 M16 and XJZT10 M12), and Social Development Project of Shaanxi Province (2012JQ4001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Garcia V, 2012, J PINEAL RES, V52, P282, DOI 10.1111/j.1600-079X.2011.00940.x; Arany I, 2006, KIDNEY INT, V70, P669, DOI 10.1038/sj.ki.5001604; Carballo M, 1999, J BIOL CHEM, V274, P17580, DOI 10.1074/jbc.274.25.17580; Chen G, 2009, CYTOKINE, V45, P162, DOI 10.1016/j.cyto.2008.11.015; Chen SD, 2012, FREE RADICAL RES, V46, P940, DOI 10.3109/10715762.2012.674640; Cheong SM, 2012, EXP CELL RES, V318, P550, DOI 10.1016/j.yexcr.2012.01.013; Chetsawang B, 2006, J PINEAL RES, V41, P116, DOI 10.1111/j.1600-079X.2006.00335.x; Chiu MH, 2012, TRANSPL P, V44, P962, DOI 10.1016/j.transproceed.2012.01.097; Choi JS, 2009, J AGR FOOD CHEM, V57, P2079, DOI 10.1021/jf803390m; Coto-Montes A, 2012, MOL CELL ENDOCRINOL, V361, P12, DOI 10.1016/j.mce.2012.04.009; Dominguez-Rodriguez A, 2012, EXPERT OPIN INVESTIG; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Du W, 2012, J CELL MOL MED, V16, P1878, DOI 10.1111/j.1582-4934.2011.01483.x; Duan WX, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0263-7; Gitto E, 2012, J PINEAL RES, V52, P291, DOI 10.1111/j.1600-079X.2011.00941.x; Gorina R, 2005, J NEUROCHEM, V92, P505, DOI 10.1111/j.1471-4159.2004.02878.x; Gorina R, 2007, GLIA, V55, P1313, DOI 10.1002/glia.20542; Huang PH, 2011, J MOL CELL CARDIOL, V51, P109, DOI 10.1016/j.yjmcc.2011.03.008; Jung KH, 2010, J PINEAL RES, V48, P239, DOI 10.1111/j.1600-079X.2010.00748.x; Kang JW, 2012, J PINEAL RES, V53, P67, DOI 10.1111/j.1600-079X.2012.00972.x; Kim US, 2010, JPN J OPHTHALMOL, V54, P151, DOI 10.1007/s10384-009-0772-6; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Koksal M, 2012, EUR REV MED PHARMACO, V16, P582; Lamont KT, 2011, J PINEAL RES, V50, P374, DOI 10.1111/j.1600-079X.2010.00853.x; Lau WWI, 2012, J PINEAL RES, V52, P477, DOI 10.1111/j.1600-079X.2011.00965.x; Li JX, 2008, J BIOL CHEM, V283, P34260, DOI 10.1074/jbc.M806087200; Li R, 2012, INT IMMUNOPHARMACOL, V14, P157, DOI 10.1016/j.intimp.2012.07.001; Lim HD, 2012, J PINEAL RES; Lim HD, 2012, J PINEAL RES, V53, P225, DOI 10.1111/j.1600-079X.2012.00991.x; Liu HT, 2009, PHARMACOL RES, V59, P167, DOI 10.1016/j.phrs.2008.12.001; Liu J, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-80; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037841; Luchetti F, 2009, FREE RADICAL BIO MED, V46, P339, DOI 10.1016/j.freeradbiomed.2008.09.017; Luo P, 2012, FREE RADICAL RES, V46, P766, DOI 10.3109/10715762.2012.678340; Nduhirabandi F, 2011, J PINEAL RES, V50, P171, DOI 10.1111/j.1600-079X.2010.00826.x; Ponnusamy M, 2009, AM J PHYSIOL-RENAL, V297, pF1361, DOI 10.1152/ajprenal.00251.2009; Shi DB, 2012, J PINEAL RES, V53, P154, DOI 10.1111/j.1600-079X.2012.00982.x; Sonmez MF, 2012, RENAL FAILURE, V34, P480, DOI 10.3109/0886022X.2011.649678; Tanaka T, 2009, CHEM-BIOL INTERACT, V177, P128, DOI 10.1016/j.cbi.2008.10.047; Tao RR, 2012, J PINEAL RES; Tawfik A, 2005, VASC PHARMACOL, V43, P320, DOI 10.1016/j.vph.2005.08.018; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Valdembri D, 2001, FASEB J, V15, P225, DOI 10.1096/fj.01-0633fje; Wang JT, 2012, J PINEAL RES, V53, P180, DOI 10.1111/j.1600-079X.2012.00985.x; Wang Z, 2012, J PINEAL RES, V52, P253, DOI 10.1111/j.1600-079X.2011.00952.x; Wang Z, 2012, J PINEAL RES, V53, P129, DOI 10.1111/j.1600-079X.2012.00978.x; Wu CC, 2012, J PINEAL RES, V52, P460, DOI 10.1111/j.1600-079X.2011.00960.x; Xu SC, 2011, J PINEAL RES, V51, P426, DOI 10.1111/j.1600-079X.2011.00906.x; Yoo YM, 2010, J PINEAL RES, V48, P83, DOI 10.1111/j.1600-079X.2009.00730.x; Yu HM, 2006, APOPTOSIS, V11, P931, DOI 10.1007/s10495-006-6578-9; Yuan XC, 2011, J PINEAL RES, V51, P220, DOI 10.1111/j.1600-079X.2011.00882.x; Zhai L, 2011, PHARMACOL REP, V63, P1469, DOI 10.1016/S1734-1140(11)70711-3; Zhao Mei, 2011, Zhonghua Yi Xue Za Zhi, V91, P375; Zhu HQ, 2008, J PINEAL RES, V45, P328, DOI 10.1111/j.1600-079X.2008.00595.x	54	63	65	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57941	10.1371/journal.pone.0057941	http://dx.doi.org/10.1371/journal.pone.0057941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483946	Green Submitted, gold, Green Published			2022-12-27	WOS:000316936100056
J	Jiang, W; Crossman, DK; Mitchell, EH; Sohn, P; Crowley, MR; Serra, R				Jiang, Wen; Crossman, David K.; Mitchell, Elizabeth H.; Sohn, Philip; Crowley, Michael R.; Serra, Rosa			WNT5A Inhibits Metastasis and Alters Splicing of Cd44 in Breast Cancer Cells	PLOS ONE			English	Article							SIGNALING PATHWAY; EPITHELIAL-CELLS; RNA-SEQ; EXPRESSION; MOTILITY; ADHESION; WNT-5A; SURVIVAL; INVASION; NETWORK	Wnt5a is a non-canonical signaling Wnt. Low expression of WNT5A is correlated with poor prognosis in breast cancer patients. The highly invasive breast cancer cell lines, MDA-MB-231 and 4T1, express very low levels of WNT5A. To determine if enhanced expression of WNT5A would affect metastatic behavior, we generated WNT5A expressing cells from the 4T1 and MDA-MB-231 parental cell lines. WNT5A expressing cells demonstrated cobblestone morphology and reduced in vitro migration relative to controls. Cell growth was not altered. Metastasis to the lung via tail vein injection was reduced in the 4T1-WNT5A expressing cells relative to 4T1-vector controls. To determine the mechanism of WNT5A action on metastasis, we performed microarray and whole-transcriptome sequence analysis (RNA-seq) to compare gene expression in 4T1-WNT5A and 4T1-vector cells. Analysis indicated highly significant alterations in expression of genes associated with cellular movement. Down-regulation of a subset of these genes, Mmp13, Nos2, Il1a, Cxcl2, and Lamb3, in WNT5A expressing cells was verified by semi-quantitative RT-PCR. Significant differences in transcript splicing were also detected in cell movement associated genes including Cd44. Cd44 is an adhesion molecule with a complex genome structure. Variable exon usage is associated with metastatic phenotype. Alternative spicing of Cd44 in WNT5A expressing cells was confirmed using RT-PCR. We conclude that WNT5A inhibits metastasis through down-regulation of multiple cell movement pathways by regulating transcript levels and splicing of key genes like Cd44.	[Jiang, Wen; Mitchell, Elizabeth H.; Sohn, Philip; Serra, Rosa] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Crossman, David K.; Crowley, Michael R.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Serra, R (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA.	rserra@uab.edu	Jiang, Wen G./AAF-1876-2020; jiang, wen/GYI-9662-2022	Jiang, Wen G./0000-0002-3283-1111; Crossman, David/0000-0002-0981-169X	NIH [R01 CA126942]; NATIONAL CANCER INSTITUTE [R01CA126942] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was through NIH grant R01 CA126942 to R.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Benhaj K, 2006, ONCOL REP, V15, P701; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Brown RL, 2011, J CLIN INVEST, V121, P1064, DOI 10.1172/JCI44540; Carpenter PM, 2009, MOL CANCER RES, V7, P462, DOI 10.1158/1541-7786.MCR-08-0148; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dejmek J, 2003, INT J CANCER, V103, P344, DOI 10.1002/ijc.10752; Dejmek J, 2005, CLIN CANCER RES, V11, P520; Ellsworth RE, 2009, CLIN EXP METASTAS, V26, P205, DOI 10.1007/s10585-008-9232-9; Glynn SA, 2010, J CLIN INVEST, V120, P3843, DOI 10.1172/JCI42059; Han W, 2010, ONCOL REP, V23, P763, DOI 10.3892/or_00000696; Hansen C, 2009, J BIOL CHEM, V284, P27533, DOI 10.1074/jbc.M109.048884; Hebbard L, 2000, J CELL SCI, V113, P2619; Jansson M, 2001, J CELL SCI, V114, P2043; Jonsson M, 2002, CANCER RES, V62, P409; Katoh M, 2005, ONCOL REP, V14, P1583; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lapuk A, 2010, MOL CANCER RES, V8, P961, DOI 10.1158/1541-7786.MCR-09-0528; Leris ACA, 2005, ANTICANCER RES, V25, P731; Mao SH, 2012, BIOTECHNIQUES, V53, P91, DOI 10.2144/0000113903; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Prosperi JR, 2010, CURR DRUG TARGETS, V11, P1074; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Serra R, 2011, J MAMMARY GLAND BIOL, V16, P157, DOI 10.1007/s10911-011-9205-5; Shah M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029615; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wansleeben C, 2011, DEV DYNAM, V240, P616, DOI 10.1002/dvdy.22564; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Yae T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1892	40	32	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58329	10.1371/journal.pone.0058329	http://dx.doi.org/10.1371/journal.pone.0058329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484019	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100109
J	Korner, R; Preuss, KD; Fadle, N; Madjidi, D; Neumann, F; Bergeler, L; Graber, S; Muller, CSL; Grunhage, F; Pfreundschuh, M; Lammert, F; Vogt, T; Pfohler, C				Koerner, Rebecca; Preuss, Klaus-Dieter; Fadle, Natalie; Madjidi, Darius; Neumann, Frank; Bergeler, Lennart; Graeber, Stefan; Mueller, Cornelia S. L.; Gruenhage, Frank; Pfreundschuh, Michael; Lammert, Frank; Vogt, Thomas; Pfoehler, Claudia			Serum Antibodies against CD28-A New Potential Marker of Dismal Prognosis in Melanoma Patients	PLOS ONE			English	Article							T-CELL-ACTIVATION; INTERFERON; AUTOIMMUNITY; EXPRESSION; MEMORY	Background: Autoantibodies against CD28 have been found in patients with autoimmune and atopic diseases. These antibodies may act as superagonists and activate T cells but may also be antagonistic or induce immunosuppressive effects by activating regulatory T cells. Autoimmunity in melanoma patients has been discussed controversially. Objective: We investigated 230 melanoma patients for the occurrence of CD28 antibodies and the effect of the latter on overall and progress-free survival. Methods: We constructed an ELISA assay to measure CD28 serum antibodies. 230 patients with melanoma and a control-group of 625 patients consistent of 212 patients with virus hepatitis b or c, 149 patients with allergies, 78 patients with psoriasis, 46 patients with plasmocytoma and 140 healthy blood donors were investigated for the occurrence of CD28 antibodies. Results: CD28 abs occur at a higher percentage in patients with melanoma and in patients with viral hepatitis than in other groups investigated (p< 0.001). Occurrence of CD28 abs is significantly higher in patients receiving interferons independent from the underlying disease (p< 0.001). In vitro CD28 serum antibodies have an inhibitory effect on the CD28 receptor as they lead to reduced stimulation of Jurkat cells. Presence of CD28 was correlated with a higher risk of dying from melanoma (p = 0.043), but not with a significantly shortened overall survival or progression-free survival. Conclusion: Interferon therapy appears to induce the production of CD28 abs. In light of reports that these CD28 abs induce immunosuppressive Tregs and - as our data show - that they are inhibitors of CD28 receptor mediated stimulation, the continuation of therapies with interferons in melanoma patients developing CD28 antibodies should be critically reconsidered, since our data indicate a worse outcome of patients with CD28 abs.	[Koerner, Rebecca; Madjidi, Darius; Bergeler, Lennart; Mueller, Cornelia S. L.; Vogt, Thomas; Pfoehler, Claudia] Saarland Univ Hosp, Dept Dermatol, Homburg, Germany; [Preuss, Klaus-Dieter; Fadle, Natalie; Neumann, Frank; Pfreundschuh, Michael] Saarland Univ Hosp, Dept Internal Med 1, Homburg, Germany; [Preuss, Klaus-Dieter; Fadle, Natalie; Neumann, Frank; Pfreundschuh, Michael] Saarland Univ Hosp, Jose Carreras Ctr Immuno & Gene Therapy, Homburg, Germany; [Graeber, Stefan] Saarland Univ Hosp, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany; [Gruenhage, Frank; Lammert, Frank] Saarland Univ Hosp, Dept Internal Med 2, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Korner, R (corresponding author), Saarland Univ Hosp, Dept Dermatol, Homburg, Germany.	rebecca.koerner@uks.eu						Bakacs T, 2011, IMMUNOBIOLOGY; Bouwhuis MG, 2011, CURR OPIN ONCOL, V23, P170, DOI 10.1097/CCO.0b013e328341edff; Bouwhuis MG, 2010, J CLIN ONCOL, V28, P2460, DOI 10.1200/JCO.2009.24.6264; Bouwhuis MG, 2009, JNCI-J NATL CANCER I, V101, P869, DOI 10.1093/jnci/djp132; Critchley-Thorne RJ, 2007, PLOS MED, V4, P897, DOI 10.1371/journal.pmed.0040176; Critchley-Thorne RJ, 2009, P NATL ACAD SCI USA, V106, P9010, DOI 10.1073/pnas.0901329106; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Eastwood D, 2010, BRIT J PHARMACOL, V161, P512, DOI 10.1111/j.1476-5381.2010.00922.x; Effros RB, 2000, MECH AGEING DEV, V121, P161; Feng X, 2002, J NEUROIMMUNOL, V129, P205, DOI 10.1016/S0165-5728(02)00182-0; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Hakansson A, 2002, CANCER IMMUNOL IMMUN, V51, P499, DOI 10.1007/s00262-002-0304-4; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Holzel M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1055; Luhder F, 2003, J EXP MED, V197, P955, DOI 10.1084/jem.20021024; Margulies DH, 2003, J EXP MED, V197, P949, DOI 10.1084/jem.20030303; Marshall E, 2006, SCIENCE, V311, P1688, DOI 10.1126/science.311.5768.1688; Neuber K, 2006, CLIN EXP IMMUNOL, V146, P262, DOI 10.1111/j.1365-2249.2006.03218.x; Pfohler C, 2008, BRIT J DERMATOL, V159, P735, DOI 10.1111/j.1365-2133.2008.08675.x; Riley JL, 2005, BLOOD, V105, P13, DOI 10.1182/blood-2004-04-1596; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Stuckert JJ, 2007, P AM SOC CLIN ONCOL, V25; Urbaniak-Kujda D, 2009, POSTEP HIG MED DOSW, V63, P355; Wolchok JD, 2008, ONCOLOGIST, V13, P2, DOI 10.1634/theoncologist.13-S4-2	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58087	10.1371/journal.pone.0058087	http://dx.doi.org/10.1371/journal.pone.0058087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483974	gold, Green Submitted, Green Published			2022-12-27	WOS:000316936100075
J	Ling, XY; Spaeth, E; Chen, Y; Shi, YX; Zhang, WG; Schober, W; Hail, N; Konopleva, M; Andreeff, M				Ling, Xiaoyang; Spaeth, Erika; Chen, Ye; Shi, Yuexi; Zhang, Weiguo; Schober, Wendy; Hail, Numsen, Jr.; Konopleva, Marina; Andreeff, Michael			The CXCR4 Antagonist AMD3465 Regulates Oncogenic Signaling and Invasiveness In Vitro and Prevents Breast Cancer Growth and Metastasis In Vivo	PLOS ONE			English	Article							CHEMOKINE RECEPTOR; TUMOR-GROWTH; CELLS; EXPRESSION; INHIBITION; MICROENVIRONMENT; LEUKEMIA; KINASE; DIFFERENTIATION; IDENTIFICATION	CXCR4, the receptor for stromal-derived factor-1, is reportedly involved in breast carcinogenesis. However, the mechanisms through which CXCR4 contributes to breast cancer cell growth and metastases are poorly understood. In this study, we examined the putative in vitro and in vivo anti-cancer effects of the specific CXCR4 inhibitor AMD3465. Here, we report that AMD3465 triggers a reduction in breast cancer cell invasiveness in vitro, and promotes marked changes in oncogenic signaling proteins including a reduction in STAT3, JAK2, AKT, and CXCR4 phosphorylation and the reduced expression of GSK3 and cMYC. Using three breast cancer cell lines as murine syngeneic immunocompetent breast cancer models, we found that AMD3465 inhibited breast tumor formation and reduced tumor cell metastases to the lung and liver. Furthermore, treatment with AMD3465 significantly reduced the infiltration of myeloid CD11b positive cells at the aforementioned metastatic sites as well as the spleen implying this agent could regulate the formation of the tumor microenvironment and conceivably the premetastatic niche. In conclusion, our studies suggest that AMD3465 inhibits breast cancer growth and metastases by acting on tumor cells as well as immune cells that constitute the tumor microenvironment. This process appears to be regulated, at least in part, through the modulation of oncogenic signaling that includes the STAT3 pathway. Thus, CXCR4 could be a novel target for breast cancer therapy.	[Ling, Xiaoyang; Spaeth, Erika; Chen, Ye; Shi, Yuexi; Zhang, Weiguo; Schober, Wendy; Hail, Numsen, Jr.; Konopleva, Marina; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Andreeff, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	mandreef@mdanderson.org	Chen, Ye/D-1164-2015	Chen, Ye/0000-0003-3671-2504; Spaeth, Erika/0000-0002-5397-3493	NCI [CCSG CA106672]; Paul and Mary Haas Chair in Genetics; Anderson Breast SPORE; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Paul and Mary Haas Chair in Genetics; Anderson Breast SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by NCI CCSG CA106672. Breast SPORE (Michael Andreeff) and by the Paul and Mary Haas Chair in Genetics (MA), in part by a Career Developmental Award of the MD Anderson Breast SPORE grant (to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr B, 2005, J BIOL CHEM, V280, P6692, DOI 10.1074/jbc.M408481200; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; AZZAM HS, 1993, J NATL CANCER I, V85, P1758, DOI 10.1093/jnci/85.21.1758; Bachelder RE, 2002, CANCER RES, V62, P7203; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Fidler IJ, 2007, J CELL BIOCHEM, V101, P927, DOI 10.1002/jcb.21148; Fiegl M, 2009, BLOOD, V113, P1504, DOI 10.1182/blood-2008-06-161539; Hail N, 2008, FREE RADICAL BIO MED, V44, P1382, DOI 10.1016/j.freeradbiomed.2007.12.034; Harvey JR, 2007, CLIN CANCER RES, V13, P1562, DOI 10.1158/1078-0432.CCR-06-1987; Hatse S, 2005, BIOCHEM PHARMACOL, V70, P752, DOI 10.1016/j.bcp.2005.05.035; Hesselgesser J, 1998, J BIOL CHEM, V273, P15687, DOI 10.1074/jbc.273.25.15687; Hinton CV, 2008, J CELL MOL MED, V12, P1517, DOI 10.1111/j.1582-4934.2008.00300.x; Jin FY, 2012, MOL CANCER RES, V10, P1021, DOI 10.1158/1541-7786.MCR-11-0498; Kaplan RN, 2006, CANCER RES, V66, P11089, DOI 10.1158/0008-5472.CAN-06-2407; Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591; Konoplev S, 2011, CANCER-AM CANCER SOC, V117, P4689, DOI 10.1002/cncr.26113; Konopleva M, 2009, DRUG RESIST UPDATE, V12, P103, DOI 10.1016/j.drup.2009.06.001; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Libura J, 2002, BLOOD, V100, P2597, DOI 10.1182/blood-2002-01-0031; Ling XY, 2007, CANCER RES, V67, P4210, DOI 10.1158/0008-5472.CAN-06-3629; Ling XY, 2005, CANCER RES, V65, P2532, DOI 10.1158/0008-5472.CAN-04-2425; Mannello F, 2006, STEM CELLS, V24, P1904, DOI 10.1634/stemcells.2005-0608; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Patocs A, 2007, NEW ENGL J MED, V357, P2543, DOI 10.1056/NEJMoa071825; Rahimi M, 2010, INT J CANCER, V126, P1850, DOI 10.1002/ijc.24964; Rhodes LV, 2011, CANCER RES, V71, P603, DOI 10.1158/0008-5472.CAN-10-3185; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yang LH, 2007, CANCER RES, V67, P651, DOI 10.1158/0008-5472.CAN-06-2762; Yoon Y, 2007, CANCER RES, V67, P7518, DOI 10.1158/0008-5472.CAN-06-2263; Zeng Z, 2006, MOL CANCER THER, V5, P3113, DOI 10.1158/1535-7163.MCT-06-0228; Zeng ZH, 2009, BLOOD, V113, P6215, DOI 10.1182/blood-2008-05-158311; Zhang M, 2012, ULTRASTRUCT PATHOL, V36, P381, DOI 10.3109/01913123.2012.728687	42	58	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58426	10.1371/journal.pone.0058426	http://dx.doi.org/10.1371/journal.pone.0058426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484027	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100117
J	Mabry, KE; Shelley, EL; Davis, KE; Blumstein, DT; Van Vuren, DH				Mabry, Karen E.; Shelley, Erin L.; Davis, Katie E.; Blumstein, Daniel T.; Van Vuren, Dirk H.			Social Mating System and Sex-Biased Dispersal in Mammals and Birds: A Phylogenetic Analysis	PLOS ONE			English	Article							CORRELATED EVOLUTION; INBREEDING AVOIDANCE; DISCRETE CHARACTERS; SPATIAL DYNAMICS; BEHAVIOR; REAPPRAISAL; COMPETITION; PHILOPATRY; REVOLUTION; MONOGAMY	The hypothesis that patterns of sex-biased dispersal are related to social mating system in mammals and birds has gained widespread acceptance over the past 30 years. However, two major complications have obscured the relationship between these two behaviors: 1) dispersal frequency and dispersal distance, which measure different aspects of the dispersal process, have often been confounded, and 2) the relationship between mating system and sex-biased dispersal in these vertebrate groups has not been examined using modern phylogenetic comparative methods. Here, we present a phylogenetic analysis of the relationship between mating system and sex-biased dispersal in mammals and birds. Results indicate that the evolution of female-biased dispersal in mammals may be more likely on monogamous branches of the phylogeny, and that females may disperse farther than males in socially monogamous mammalian species. However, we found no support for a relationship between social mating system and sex-biased dispersal in birds when the effects of phylogeny are taken into consideration. We caution that although there are larger-scale behavioral differences in mating system and sex-biased dispersal between mammals and birds, mating system and sex-biased dispersal are far from perfectly associated within these taxa.	[Mabry, Karen E.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Shelley, Erin L.; Blumstein, Daniel T.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Davis, Katie E.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Van Vuren, Dirk H.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	New Mexico State University; University of California System; University of California Los Angeles; University of Bath; University of California System; University of California Davis	Mabry, KE (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	kmabry@nmsu.edu		Blumstein, Daniel/0000-0001-5793-9244	National Science Foundation (NSF) [IOS-1149056]; NSF [DEB-1119660]; Direct For Biological Sciences [1149056] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	During the preparation of this work, KEM was partially supported by National Science Foundation (NSF) IOS-1149056 and DTB was partially supported by NSF DEB-1119660. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, MOL PHYLOGENET EVOL, V54, P726, DOI 10.1016/j.ympev.2009.10.033; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bradley RD, 2007, J MAMMAL, V88, P1146, DOI 10.1644/06-MAMM-A-342R.1; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Clutton-Brock TH, 2012, MOL ECOL, V21, P472, DOI 10.1111/j.1365-294X.2011.05232.x; Clutton-Brock T, 2009, PHILOS T R SOC B, V364, P3229, DOI 10.1098/rstb.2009.0120; Crawford JC, 2008, J MAMMAL, V89, P575, DOI 10.1644/07-MAMM-A-251R1.1; Davis KE, 2010, BMC RES NOTES, V3; Dobson FS, 2010, BEHAV ECOL, V21, P747, DOI 10.1093/beheco/arq048; DOBSON FS, 1982, ANIM BEHAV, V30, P1183; DOBSON FS, 1985, EVOLUTION, V39, P1384, DOI 10.1111/j.1558-5646.1985.tb05703.x; DOBSON FS, 1985, AM NAT, V126, P855, DOI 10.1086/284457; Dobson FS, 1980, ANIMAL BEHA IN PRESS; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fink S, 2006, P NATL ACAD SCI USA, V103, P10956, DOI 10.1073/pnas.0602380103; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Harrison Richard G., 2003, Journal of Mammalian Evolution, V10, P249, DOI 10.1023/B:JOMM.0000015105.96065.f0; Helgen KM, 2009, J MAMMAL, V90, P270, DOI 10.1644/07-MAMM-A-309.1; Hughes C, 1998, ECOLOGY, V79, P383, DOI 10.1890/0012-9658(1998)079[0383:IMTWFM]2.0.CO;2; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Le Galliard JF, 2012, MOL ECOL, V21, P505, DOI 10.1111/j.1365-294X.2011.05410.x; Maddison WP, 2011, MESQUITE MODULAR SYS; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Midford P. E., 2005, PDAP PACKAGE MESQUIT; Miller JR, 2008, J MAMMAL, V89, P1279, DOI 10.1644/07-MAMM-A-195.1; MOORE J, 1984, ANIM BEHAV, V32, P94, DOI 10.1016/S0003-3472(84)80328-0; Nunn CL, 2001, EVOL ANTHROPOL, V10, P81, DOI 10.1002/evan.1019; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Perrin N, 1999, AM NAT, V154, P282, DOI 10.1086/303236; Solomon NG, 2004, CAN J ZOOL, V82, P1667, DOI 10.1139/Z04-142; Stamps Judy A., 2001, P230; WASER PM, 1985, ECOLOGY, V66, P1170, DOI 10.2307/1939169; Weber JN, 2009, ANIM BEHAV, V77, P603, DOI 10.1016/j.anbehav.2008.10.031; Wolff JO, 1998, OIKOS, V83, P327, DOI 10.2307/3546844	39	94	95	2	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57980	10.1371/journal.pone.0057980	http://dx.doi.org/10.1371/journal.pone.0057980			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483957	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100063
J	Valle, D; Clark, J				Valle, Denis; Clark, James			Conservation Efforts May Increase Malaria Burden in the Brazilian Amazon	PLOS ONE			English	Article							ANOPHELES-DARLINGI; DEFORESTATION; BIODIVERSITY; TRANSMISSION; FRONTIER; FORESTS; POVERTY; VECTOR; PARKS	Background: Large-scale forest conservation projects are underway in the Brazilian Amazon but little is known regarding their public health impact. Current literature emphasizes how land clearing increases malaria incidence, leading to the conclusion that forest conservation decreases malaria burden. Yet, there is also evidence that proximity to forest fringes increases malaria incidence, which implies the opposite relationship between forest conservation and malaria. We compare the effect of these environmental factors on malaria and explore its implications. Methods and Findings: Using a large malaria dataset (similar to 1,300,000 positive malaria tests collected over similar to 4.5 million km(2)), satellite imagery, permutation tests, and hierarchical Bayesian regressions, we show that greater forest cover (as a proxy for proximity to forest fringes) tends to be associated with higher malaria incidence, and that forest cover effect was 25 times greater than the land clearing effect, the often cited culprit of malaria in the region. These findings have important implications for land use/land cover (LULC) policies in the region. We find that cities close to protected areas (PA's) tend to have higher malaria incidence than cities far from PA's. Using future LULC scenarios, we show that avoiding 10% of deforestation through better governance might result in an average 2-fold increase in malaria incidence by 2050 in urban health posts. Conclusions: Our results suggest that cost analysis of reduced carbon emissions from conservation efforts in the region should account for increased malaria morbidity, and that conservation initiatives should consider adopting malaria mitigation strategies. Coordinated actions from disparate science fields, government ministries, and global initiatives (e. g., Reduced Emissions from Deforestation and Degradation; Millenium Development Goals; Roll Back Malaria; and Global Fund to Fight AIDS, Tuberculosis and Malaria), will be required to decrease malaria toll in the region while preserving these important ecosystems.	[Valle, Denis] Duke Univ, Univ Program Ecol, Durham, NC 27706 USA; [Clark, James] Duke Univ, Nicholas Sch Environm, Dept Biol, Dept Stat Sci, Durham, NC 27708 USA	Duke University; Duke University	Valle, D (corresponding author), Duke Univ, Univ Program Ecol, Durham, NC 27706 USA.	drv4@duke.edu		Valle, Denis/0000-0002-9830-8876	Duke Global Health Initiative	Duke Global Health Initiative	Denis Valle was partly supported by a pilot project grant from the Duke Global Health Initiative. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, HAMBURGER CONNECTION; [Anonymous], **NON-TRADITIONAL**; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Barbieri AF, 2005, HUM ECOL, V33, P847, DOI 10.1007/s10745-005-8213-8; Barreto ML, 2011, LANCET, V377, P1877, DOI 10.1016/S0140-6736(11)60202-X; Barreto P., 2006, HUMAN PRESSURE BRAZI; Barrett MA, 2011, FRONT ECOL ENVIRON, V9, P239, DOI 10.1890/090159; Barros FSM, 2011, B ENTOMOL RES, V101, P643, DOI 10.1017/S0007485311000265; Barros FSM, 2011, PLOS ONE, V6; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Brandao AO, 2006, INT J REMOTE SENS, V27, P177, DOI 10.1080/01431160500353841; Camargo LMA, 1996, AM J TROP MED HYG, V55, P32, DOI 10.4269/ajtmh.1996.55.32; CBD PAHO/WHO, 2012, REG WORKSH INT HUM H; Clark J. S, 2007, MODELS ECOLOGICAL DA; Coimbra CEA, 1988, HUM FACTORS, V47; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; de Castro MC, 2007, HEALTH PLACE, V13, P368, DOI 10.1016/j.healthplace.2006.03.006; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; Dobson A, 2006, PLOS MED, V3, P714, DOI 10.1371/journal.pmed.0030231; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Ferraro PJ, 2011, ENVIRON RESOUR ECON, V48, P269, DOI 10.1007/s10640-010-9408-z; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; Gelman A., 2003, BAYESIAN DATA ANAL; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Guerra CA, 2006, ANN TROP MED PARASIT, V100, P189, DOI 10.1179/136485906X91512; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; INPE [Brazilian National Space Research Institute], 2010, PROJ PROD MON FLOR A; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Kindermann G, 2008, P NATL ACAD SCI USA, V105, P10302, DOI 10.1073/pnas.0710616105; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16; Ministerio da Saude, 2010, SIVEP MAL; Ministerio da Saude. SecretarYa de vigilancia em saude, 2005, GUIA VIG EP, P07; de Barros FSM, 2011, J VECTOR ECOL, V36, P159, DOI 10.1111/j.1948-7134.2011.00153.x; Moutinho PR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-174; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NASA, 2010, 3B43 MONTHL 0 25 X 0; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Nepstad D, 2009, SCIENCE, V326, P1350, DOI 10.1126/science.1182108; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Olson SH, 2010, EMERG INFECT DIS, V16, P1108, DOI 10.3201/eid1607.091785; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6; Povoa MM, 2003, J MED ENTOMOL, V40, P379, DOI 10.1603/0022-2585-40.4.379; Pruss-Ustun A., 2006, WORLD HEALTH; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Ricketts TH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000331; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Singer B, 2006, AM J TROP MED HYG, V74, P1; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Tiwari Piyusha, 2001, Journal of Human Ecology, V12, P371; Tollefson J, 2009, NATURE, V460, P936, DOI 10.1038/460936a; Unger A, 2007, PLOS MED, V4, P1561, DOI 10.1371/journal.pmed.0040295; USAID, 2012, AM MAL IN OV; Valle D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027462; Vittor AY, 2009, AM J TROP MED HYG, V81, P5; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	71	42	42	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57519	10.1371/journal.pone.0057519	http://dx.doi.org/10.1371/journal.pone.0057519			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483912	Green Submitted, gold, Green Published			2022-12-27	WOS:000316936100028
J	Quartino, ML; Deregibus, D; Campana, GL; Latorre, GEJ; Momo, FR				Liliana Quartino, Maria; Deregibus, Dolores; Laura Campana, Gabriela; Juan Latorre, Gustavo Edgar; Roberto Momo, Fernando			Evidence of Macroalgal Colonization on Newly Ice-Free Areas following Glacial Retreat in Potter Cove (South Shetland Islands), Antarctica	PLOS ONE			English	Article							CORALLINE ALGAE; COMMUNITIES; PENINSULA; ABUNDANCE; RESPONSES; PATTERNS; BIOMASS; LIGHT	Climate warming has been related to glacial retreat along the Western Antarctic Peninsula. Over the last years, a visible melting of Fourcade Glacier (Potter Cove, South Shetland Islands) has exposed newly ice-free hard bottom areas available for benthic colonization. However, ice melting produces a reduction of light penetration due to an increase of sediment input and higher ice impact. Seventeen years ago, the coastal sites close to the glacier cliffs were devoid of macroalgae. Are the newly ice-free areas suitable for macroalgal colonization? To tackle this question, underwater video transects were performed at six newly ice-free areas with different degree of glacial influence. Macroalgae were found in all sites, even in close proximity to the retreating glacier. We can show that: 1. The complexity of the macroalgal community is positively correlated to the elapsed time from the ice retreat, 2. Algae development depends on the optical conditions and the sediment input in the water column; some species are limited by light availability, 3. Macroalgal colonization is negatively affected by the ice disturbance, 4. The colonization is determined by the size and type of substrate and by the slope of the bottom. As macroalgae are probably one of the main energy sources for the benthos, an expansion of the macroalgal distribution can be expected to affect the matter and energy fluxes in Potter Cove ecosystem.	[Liliana Quartino, Maria; Deregibus, Dolores; Laura Campana, Gabriela] Inst Antartico Argentino, Dept Biol Costera, Buenos Aires, DF, Argentina; [Liliana Quartino, Maria] Museo Argentino Ciencias Nat Bernardino Rivadavia, Buenos Aires, DF, Argentina; [Laura Campana, Gabriela] Univ Nacl Lujan, Dept Ciencias Basicas, Lujan, Argentina; [Juan Latorre, Gustavo Edgar] Univ Nacl La Plata, Fac Ciencias Nat & Museo, La Plata, Buenos Aires, Argentina; [Roberto Momo, Fernando] Univ Nacl Gen Sarmiento, Inst Ciencias, Los Polvorines, Argentina	Instituto Antartico Argentino; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Universidad Nacional de Lujan; National University of La Plata; Museo La Plata	Quartino, ML (corresponding author), Inst Antartico Argentino, Dept Biol Costera, Buenos Aires, DF, Argentina.	lquartino@dna.gov.ar	Momo, Fernando/A-5984-2015; Momo, Fernando R/E-3426-2012	Momo, Fernando R/0000-0003-0710-1149	DNA-IAA [PICTA 7/2008-2011]; ANPCyT-DNA [PICTO 0116/2012-2015]	DNA-IAA; ANPCyT-DNA	This research was supported by grants from DNA-IAA (PICTA 7/2008-2011) and ANPCyT-DNA (PICTO 0116/2012-2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSLER CD, 1995, PHYCOLOGIA, V34, P424, DOI 10.2216/i0031-8884-34-5-424.1; BARNES DKA, 1995, MAR BIOL, V121, P565, DOI 10.1007/BF00349467; Barnes DKA, 1996, J EXP MAR BIOL ECOL, V196, P251, DOI 10.1016/0022-0981(95)00132-8; Becker S, 2011, ANTARCT SCI, V23, P419, DOI 10.1017/S0954102011000575; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; de Aranzamendi C, 2010, 31 SCAR 4 OP SCI C 2; Eriksson BK, 2005, OECOLOGIA, V143, P438, DOI 10.1007/s00442-004-1810-1; Gomez I, 2009, BOT MAR, V52, P593, DOI 10.1515/BOT.2009.073; Huang YM, 2007, POLAR BIOL, V30, P1417, DOI 10.1007/s00300-007-0303-1; Iken K, 1999, MAR ECOL-P S Z N I, V20, P11, DOI 10.1046/j.1439-0485.1999.00060.x; Iken K., 2011, BIOL POLAR BENTHIC A; Iken K, 1996, REP POLAR RES, V201, P1; Irving AD, 2005, MAR BIOL, V147, P1075, DOI 10.1007/s00227-005-0007-4; Johnston EL, 2007, POLAR BIOL, V30, P781, DOI 10.1007/s00300-006-0237-z; Kirk J. T. O., 1983, LIGHT PHOTOSYNTHESIS; Kloser H, 1996, HYDROBIOLOGIA, V333, P1, DOI 10.1007/BF00020959; Kuffner IB, 2008, NAT GEOSCI, V1, P114, DOI 10.1038/ngeo100; Campana GL, 2009, BOT MAR, V52, P655, DOI 10.1515/BOT.2009.076; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; McDonald JI, 2006, J ENVIRON MANAGE, V80, P148, DOI 10.1016/j.jenvman.2005.08.021; Quartino ML, 2008, POLAR BIOL, V31, P281, DOI 10.1007/s00300-007-0356-1; Quartino ML, 2005, BOT MAR, V48, P187, DOI 10.1515/BOT.2005.029; Ruckamp M, 2011, GLOBAL PLANET CHANGE, V79, P99, DOI 10.1016/j.gloplacha.2011.06.009; Schloss IR, 2002, POLAR BIOL, V25, P41, DOI 10.1007/s003000100309; Schloss IR, 2012, J MARINE SYST, V92, P53, DOI 10.1016/j.jmarsys.2011.10.006; Schwarz AM, 2005, MAR ECOL PROG SER, V294, P131, DOI 10.3354/meps294131; Smale DA, 2008, ECOGRAPHY, V31, P289, DOI 10.1111/j.0906-7590.2008.05456.x; Spurkland T, 2011, J COASTAL RES, V27, P133, DOI 10.2112/JCOASTRES-D-10-00194.1; SYVITSKI JPM, 1989, ARCTIC, V42, P232; Tatian M, 2004, ANTARCT SCI, V16, P123, DOI 10.1017/S0954102004001890; Turner J., 2010, ANTARCTIC CLIMATE CH; Wiencke C., 2002, SYNOPSES ANTARCTIC B; Zacher K, 2010, 31 SCAR 4 OP SCI C 2; ZIELINSKI K, 1990, Polish Polar Research, V11, P95	34	86	87	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58223	10.1371/journal.pone.0058223	http://dx.doi.org/10.1371/journal.pone.0058223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484000	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900077
J	Lake, JE; Tseng, CH; Currier, JS				Lake, Jordan E.; Tseng, Chi-Hong; Currier, Judith S.			A Pilot Study of Telmisartan for Visceral Adiposity in HIV Infection: The Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) Trial	PLOS ONE			English	Article							HORMONE-RELEASING FACTOR; RANDOMIZED CONTROLLED-TRIAL; ABDOMINAL FAT ACCUMULATION; RENIN-ANGIOTENSIN SYSTEM; TYPE-2 DIABETIC-PATIENTS; GROWTH-HORMONE; INDEPENDENT PREDICTOR; HYPERTENSIVE PATIENTS; INSULIN SENSITIVITY; LIPOPROTEIN LEVELS	Background: Visceral adiposity in the setting of HIV infection and antiretroviral therapy (ART) is not fully understood, and treatment options remain limited. Telmisartan, an angiotensin receptor blocker and partial PPAR-gamma agonist, has been shown to decrease visceral fat and improve metabolic and inflammatory parameters in HIV-uninfected subjects. Methods: HIV-infected subjects with HIV-1 RNA <50 copies/mL on ART and (women/men) waist circumference >94/95 cm or waist: hip ratio >0.88/0.94 received open-label telmisartan 40 mg po daily for 24 weeks. Adipose tissue (AT) volumes were quantified by L4-L5 single slice computed tomography. Metabolic and inflammatory markers were obtained fasting. Thirty-five subjects provided 80% power to detect a 10% 24-week decrease in visceral AT (VAT, two-sided alpha = 0.05). Results: Thirty-five subjects enrolled and completed the protocol. At entry (median or %): age 49 years, 43% female, 77% non-white, 91% non-smokers, CD4+ T cell count 590 cells/mm(3), BMI 31 kg/m(2). AT responses were heterogeneous, with statistically significant losses of median (IQR) total (TAT, 2.9% (-9.8, 0.7), p = 0.03) and subcutaneous (SAT, -2.7% (-9.8, 1.1), p = 0.03) AT, but not VAT (-2.7% (-20.5, 14.2), p = 0.53). Significant decreases in waist circumference and waist: hip ratio occurred (both p<0.001) without BMI or weight changes. In an exploratory analysis, significant increases in TNF-alpha occurred among female subjects without changes in other inflammatory or metabolic markers. No related adverse events occurred. Conclusions: Telmisartan was well tolerated. Small losses of AT from all depots were observed after 24 weeks of telmisartan therapy. Further study is needed to determine whether HIV-infected patients can receive metabolic benefits from telmisartan.	[Lake, Jordan E.; Currier, Judith S.] Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA; [Tseng, Chi-Hong] Univ Calif Los Angeles, Dept Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lake, JE (corresponding author), Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA.	jlake@mednet.ucla.edu			California HIV/AIDS Research Program; National Institutes of Health [K24 AI56933, P30-AG028748, M01-RR000865, T32 MH080634]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000424] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697, K24AI056933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH080634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028748] Funding Source: NIH RePORTER	California HIV/AIDS Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the California HIV/AIDS Research Program. Additional support was provided by the National Institutes of Health (K24 AI56933 to J.S.C., P30-AG028748, M01-RR000865, and T32 MH080634). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro G, 2007, CURR PHARM DESIGN, V13, P2208, DOI 10.2174/138161207781039661; Boccara F, 2010, ANTIVIR THER, V15, P363, DOI 10.3851/IMP1533; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Caron M, 2009, PPAR RES, V2009, DOI 10.1155/2009/507141; Chappell MC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3052; Chujo D, 2007, HYPERTENS RES, V30, P1205, DOI 10.1291/hypres.30.1205; Currier J, 2008, JAIDS-J ACQ IMM DEF, V48, P35, DOI 10.1097/QAI.0b013e318164227f; Derosa G, 2007, J CLIN PHARM THER, V32, P261, DOI 10.1111/j.1365-2710.2007.00820.x; Dolan SE, 2005, JAIDS-J ACQ IMM DEF, V39, P44, DOI 10.1097/01.qai.0000159323.59250.83; Falutz J, 2011, ANTIVIR THER, V16, pA29; Falutz J, 2008, AIDS, V22, P1719, DOI 10.1097/QAD.0b013e32830a5058; Falutz J, 2007, NEW ENGL J MED, V357, P2359, DOI 10.1056/NEJMoa072375; Feldman JG, 2003, JAIDS-J ACQ IMM DEF, V32, P210, DOI 10.1097/00126334-200302010-00014; Fichtenbaum Carl J, 2011, Curr Infect Dis Rep, V13, P94, DOI 10.1007/s11908-010-0153-9; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Gelato MC, 2002, JAIDS-J ACQ IMM DEF, V31, P163, DOI 10.1097/00126334-200210010-00006; Hadigan C, 2000, JAMA-J AM MED ASSOC, V284, P472, DOI 10.1001/jama.284.4.472; Hadigan C, 2003, CLIN INFECT DIS, V36, P909, DOI 10.1086/368185; Huang GZ, 2011, SAUDI MED J, V32, P1017; Kohli R, 2007, HIV MED, V8, P420, DOI 10.1111/j.1468-1293.2007.00488.x; Kubik M, 2012, KIDNEY BLOOD PRESS R, V35, P281, DOI 10.1159/000334951; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lake JE, 2011, AIDS CARE, V23, P929, DOI 10.1080/09540121.2010.543885; Lemoine M, 2009, PPAR RES, V2009, DOI 10.1155/2009/906167; Lo J, 2008, JAMA-J AM MED ASSOC, V300, P509, DOI 10.1001/jama.300.5.509; Macallan DC, 2008, HIV CLIN TRIALS, V9, P254, DOI 10.1310/hct0904-254; Makino H, 2008, HYPERTENS RES, V31, P657, DOI 10.1291/hypres.31.657; MEADE TW, 1983, CLIN SCI, V64, P273, DOI 10.1042/cs0640273; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Mori Y, 2007, AM J HYPERTENS, V20, P431, DOI 10.1016/j.amjhyper.2006.09.016; Nakagami H, 2011, CURR VASC PHARMACOL, V9, P162, DOI 10.2174/157016111794519291; Ohashi K, 2011, AM J HYPERTENS, V24, P263, DOI 10.1038/ajh.2010.216; Ostrowski SR, 2003, AIDS, V17, P521, DOI 10.1097/00002030-200303070-00007; Rodriguez A, 2007, CURR PHARM DESIGN, V13, P2169; Sharma AM, 2006, AM J MED, V119, p17S, DOI 10.1016/j.amjmed.2006.01.010; Shimabukuro M, 2007, J HYPERTENS, V25, P841, DOI 10.1097/HJH.0b013e3280287a83; Shuster A, 2012, BRIT J RADIOL, V85, P1, DOI 10.1259/bjr/38447238; Sugimoto K, 2006, HYPERTENSION, V47, P1003, DOI 10.1161/01.HYP.0000215181.60228.f7; Tien PC, 2010, JAIDS-J ACQ IMM DEF, V55, P316, DOI 10.1097/QAI.0b013e3181e66216; Ucciferri C, 2012, EUR REV MED PHARMACO, V16, P491; Vecchiet J, 2011, ANTIVIR THER, V16, P639, DOI 10.3851/IMP1809; Walther T, 2007, CURR HYPERTENS REP, V9, P128, DOI 10.1007/s11906-007-0023-5; Wei F, 2011, HEART, V97, P479, DOI 10.1136/hrt.2009.192104; Wohl D, 2008, JAIDS-J ACQ IMM DEF, V48, P44, DOI 10.1097/QAI.0b013e31816d9ba1	44	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58135	10.1371/journal.pone.0058135	http://dx.doi.org/10.1371/journal.pone.0058135			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516440	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400019
J	Vakorin, VA; McIntosh, AR; Misic, B; Krakovska, O; Poulsen, C; Martinu, K; Paus, T				Vakorin, Vasily A.; McIntosh, Anthony R.; Misic, Bratislav; Krakovska, Olga; Poulsen, Catherine; Martinu, Kristina; Paus, Tomas			Exploring Age-Related Changes in Dynamical Non-Stationarity in Electroencephalographic Signals during Early Adolescence	PLOS ONE			English	Article							SPATIOTEMPORAL ANALYSIS; TIME; EEG; BRAIN; NONSTATIONARITY; ENTROPY; SERIES; METASTABILITY; CONNECTIVITY; DELAY	Dynamics of brain signals such as electroencephalogram (EEG) can be characterized as a sequence of quasi-stable patterns. Such patterns in the brain signals can be associated with coordinated neural oscillations, which can be modeled by non-linear systems. Further, these patterns can be quantified through dynamical non-stationarity based on detection of qualitative changes in the state of the systems underlying the observed brain signals. This study explored age-related changes in dynamical non-stationarity of the brain signals recorded at rest, longitudinally with 128-channel EEG during early adolescence (10 to 13 years of age, 56 participants). Dynamical non-stationarity was analyzed based on segmentation of the time series with subsequent grouping of the segments into clusters with similar dynamics. Age-related changes in dynamical non-stationarity were described in terms of the number of stationary states and the duration of the stationary segments. We found that the EEG signal became more non-stationary with age. Specifically, the number of states increased whereas the mean duration of the stationary segment decreased with age. These two effects had global and parieto-occipital distribution, respectively, with the later effect being most dominant in the alpha (around 10 Hz) frequency band.	[Vakorin, Vasily A.; McIntosh, Anthony R.; Misic, Bratislav; Paus, Tomas] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [McIntosh, Anthony R.; Misic, Bratislav; Paus, Tomas] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Krakovska, Olga] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Poulsen, Catherine; Paus, Tomas] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Martinu, Kristina] Inst Univ Geriatrie Montreal, Ctr Rech, Montreal, PQ, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; York University - Canada; McGill University; Universite de Montreal	Vakorin, VA (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	vvakorin@research.baycrest.org	Vakorin, Vasily/AAY-3249-2021	Vakorin, Vasily/0000-0003-0489-1552; McIntosh, Anthony/0000-0002-1784-5662	J.S. McDonnell Foundation	J.S. McDonnell Foundation	This research was supported by research grants from the J.S. McDonnell Foundation to Dr. Anthony R. McIntosh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cragg L, 2011, DEVELOPMENTAL SCI, V14, P935, DOI 10.1111/j.1467-7687.2010.01031.x; Deco G, 2009, P NATL ACAD SCI USA, V106, P10302, DOI 10.1073/pnas.0901831106; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dikanev T, 2005, CLIN NEUROPHYSIOL, V116, P1796, DOI 10.1016/j.clinph.2005.04.013; Duzel E, 2003, NEUROIMAGE, V18, P185, DOI 10.1016/S1053-8119(02)00031-9; Fingelkurts AA, 2004, INT J NEUROSCI, V114, P843, DOI 10.1080/00207450490450046; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Freyer F, 2011, J NEUROSCI, V31, P6353, DOI 10.1523/JNEUROSCI.6693-10.2011; Freyer F, 2009, J NEUROSCI, V29, P8512, DOI 10.1523/JNEUROSCI.0754-09.2009; Ghosh A, 2008, COGN NEURODYNAMICS, V2, P115, DOI 10.1007/s11571-008-9044-2; GRASSBERGER P, 1983, PHYS REV A, V28, P2591, DOI 10.1103/PhysRevA.28.2591; Gribkov D, 2000, PHYS REV E, V6; HAKEN H, 1996, PRINCIPLES BRAIN FUN, DOI [10.1007/978-3-642-79570-1_11, DOI 10.1007/978-3-642-79570-1_11]; Hay JF, 2002, NEUROPSYCHOLOGIA, V40, P260, DOI 10.1016/S0028-3932(01)00127-0; Kaffashi F, 2008, PHYSICA D, V237, P3069, DOI 10.1016/j.physd.2008.06.005; Kaplan A. Ya, 1998, Uspekhi Fiziologicheskikh Nauk, V29, P35; Kaplan AY, 2005, SIGNAL PROCESS, V85, P2190, DOI 10.1016/j.sigpro.2005.07.010; Koenig T, 2002, NEUROIMAGE, V16, P41, DOI 10.1006/nimg.2002.1070; Kohlmorgen J, 2000, BIOL CYBERN, V83, P73, DOI 10.1007/s004220000144; KOLMOGOROV AN, 1959, DOKL AKAD NAUK SSSR+, V124, P754; Kudryavtsev L, 1989, COURSE MATH ANAL; Latchoumane CFV, 2008, LECT NOTES COMPUT SC, V4985, P921; Le van Quyen M, 2003, LANCET, V361, P970, DOI 10.1016/S0140-6736(03)12755-9; LEHMANN D, 1987, ELECTROEN CLIN NEURO, V67, P271, DOI 10.1016/0013-4694(87)90025-3; Lippe S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.048.2009; Lobaugh NJ, 2001, PSYCHOPHYSIOLOGY, V38, P517, DOI 10.1017/S0048577201991681; Manuca R, 1996, PHYSICA D, V99, P134, DOI 10.1016/S0167-2789(96)00139-X; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Nunez P.L., 2005, ELECT FIELDS BRAIN N; Schreiber T, 1997, PHYS REV LETT, V79, P1475, DOI 10.1103/PhysRevLett.79.1475; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Vakorin VA, 2011, J NEUROSCI, V31, P6405, DOI 10.1523/JNEUROSCI.3153-10.2011; Werner G, 2007, BIOSYSTEMS, V90, P496, DOI 10.1016/j.biosystems.2006.12.001	35	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57217	10.1371/journal.pone.0057217	http://dx.doi.org/10.1371/journal.pone.0057217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516400	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400007
J	Hokke, SN; Armitage, JA; Puelles, VG; Short, KM; Jones, L; Smyth, IM; Bertram, JF; Cullen-McEwen, LA				Hokke, Stacey N.; Armitage, James A.; Puelles, Victor G.; Short, Kieran M.; Jones, Lynelle; Smyth, Ian M.; Bertram, John F.; Cullen-McEwen, Luise A.			Altered Ureteric Branching Morphogenesis and Nephron Endowment in Offspring of Diabetic and Insulin-Treated Pregnancy	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; LOW-BIRTH-WEIGHT; GLOMERULAR NUMBER; GLYCEMIC CONTROL; BLOOD-PRESSURE; RENAL-FUNCTION; MELLITUS; EXPOSURE; GLUCOSE; QUANTIFICATION	There is strong evidence from human and animal models that exposure to maternal hyperglycemia during in utero development can detrimentally affect fetal kidney development. Notwithstanding this knowledge, the precise effects of diabetic pregnancy on the key processes of kidney development are unclear due to a paucity of studies and limitations in previously used methodologies. The purpose of the present study was to elucidate the effects of hyperglycemia on ureteric branching morphogenesis and nephrogenesis using unbiased techniques. Diabetes was induced in pregnant C57Bl/6J mice using multiple doses of streptozotocin (STZ) on embryonic days (E) 6.5-8.5. Branching morphogenesis was quantified ex vivo using Optical Projection Tomography, and nephrons were counted using unbiased stereology. Maternal hyperglycemia was recognised from E12.5. At E14.5, offspring of diabetic mice demonstrated fetal growth restriction and a marked deficit in ureteric tip number (control 283.7 +/- 23.3 vs. STZ 153.2 +/- 24.6, mean +/- SEM, p<0.01) and ureteric tree length (control 33.1 +/- 2.6 mm vs. STZ 17.6 +/- 2.7 mm, p=0.001) vs. controls. At E18.5, fetal growth restriction was still present in offspring of STZ dams and a deficit in nephron endowment was observed (control 1246.2 +/- 64.9 vs. STZ 822.4 +/- 74.0, p<0.001). Kidney malformations in the form of duplex ureter and hydroureter were a common observation (26%) in embryos of diabetic pregnancy compared with controls (0%). Maternal insulin treatment from E13.5 normalised maternal glycaemia but did not normalise fetal weight nor prevent the nephron deficit. The detrimental effect of hyperglycemia on ureteric branching morphogenesis and, in turn, nephron endowment in the growth-restricted fetus highlights the importance of glycemic control in early gestation and during the initial stages of renal development.	[Hokke, Stacey N.; Armitage, James A.; Puelles, Victor G.; Smyth, Ian M.; Bertram, John F.; Cullen-McEwen, Luise A.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Short, Kieran M.; Smyth, Ian M.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Armitage, James A.; Jones, Lynelle] Deakin Univ, Sch Med Optometry, Waurn Ponds, Vic, Australia	Monash University; Monash University; Deakin University	Cullen-McEwen, LA (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.	luise.cullen-mcewen@monash.edu	Short, Kieran/A-2604-2012; Bertram, John F/I-2588-2014; Short, Kieran/O-4476-2019; Armitage, James/AAX-1294-2021	Short, Kieran/0000-0001-9137-008X; Bertram, John F/0000-0001-5863-6464; Short, Kieran/0000-0001-9137-008X; Hokke, Stacey/0000-0003-1338-0156; Puelles, Victor/0000-0002-7735-5462; Armitage, James/0000-0002-3762-0911; Smyth, Ian/0000-0002-1727-7829; Cullen-McEwen, Luise/0000-0003-2229-5762	John Shaw Postdoctoral Fellow (National Heart Foundation); Monash Fellow; ARC Future fellowship; Monash Fellowship; Human Frontiers Science Program [RGP0039/2011]	John Shaw Postdoctoral Fellow (National Heart Foundation); Monash Fellow; ARC Future fellowship(Australian Research Council); Monash Fellowship(Monash University); Human Frontiers Science Program(Human Frontier Science Program)	James A. Armitage acknowledges support as a John Shaw Postdoctoral Fellow (National Heart Foundation) and Monash Fellow. Ian M. Smyth acknowledges an ARC Future fellowship and a Monash Fellowship, and project grant support from the Human Frontiers Science Program (RGP0039/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTS L, 1990, DIABETES METAB REV, V6, P147, DOI 10.1002/dmr.5610060303; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Amri R, 1999, DIABETES, V48, P2240, DOI 10.2337/diabetes.48.11.2240; Ballas J, 2012, CURR DIABETES REP, V12, P33, DOI 10.1007/s11892-011-0249-0; BECERRA JE, 1990, PEDIATRICS, V85, P1; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Chen YW, 2011, AM J PHYSIOL-RENAL, V300, pF147, DOI 10.1152/ajprenal.00361.2010; Chen YW, 2010, PEDIATR NEPHROL, V25, P1319, DOI 10.1007/s00467-010-1506-1; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; Correa A, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.028; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Cullen-McEwen LA, 2011, AM J PHYSIOL-RENAL, V300, pF1448, DOI 10.1152/ajprenal.00055.2011; Cunha AR, 2008, INT J EXP PATHOL, V89, P284, DOI 10.1111/j.1365-2613.2008.00593.x; Davis EM, 2010, BIRTH DEFECTS RES A, V88, P722, DOI 10.1002/bdra.20702; Eriksson UJ, 2009, SEMIN FETAL NEONAT M, V14, P85, DOI 10.1016/j.siny.2008.11.001; Ferenc B, 2010, CONGENIT ANOM, V50, P115, DOI 10.1111/j.1741-4520.2010.00275.x; Festing MFW, 2006, ILAR J, V47, P5, DOI 10.1093/ilar.47.1.5; Giuliani S, 2008, J UROLOGY, V179, P365, DOI 10.1016/j.juro.2007.08.092; HINCHLIFFE SA, 1992, BRIT J OBSTET GYNAEC, V99, P296, DOI 10.1111/j.1471-0528.1992.tb13726.x; Howarth C, 2007, DIABETIC MED, V24, P1229, DOI 10.1111/j.1464-5491.2007.02254.x; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; Kamdem AF, 2005, PROG UROL, V15, P53; Kanwar YS, 2005, PEDIATR NEPHROL, V20, P858, DOI 10.1007/s00467-005-1888-7; Kanwar YS, 1996, J CLIN INVEST, V98, P2478, DOI 10.1172/JCI119066; Kaufman M.H., 1992, ATLAS MOUSE DEV; Khalil CA, 2010, DIABETES, V59, P2631, DOI 10.2337/db10-0419; Khan NA, 2006, J AUTOIMMUN, V26, P268, DOI 10.1016/j.jaut.2006.03.003; LANGER O, 1989, AM J OBSTET GYNECOL, V161, P646, DOI 10.1016/0002-9378(89)90371-2; Lawrence JM, 2008, DIABETES CARE, V31, P899, DOI 10.2337/dc07-2345; Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x; MERLETBENICHOU C, 1994, PEDIATR NEPHROL, V8, P175, DOI 10.1007/BF00865473; Merzouk H, 2000, CLIN SCI, V98, P21, DOI 10.1042/cs0980021; Moritz KM, 2008, ADV ANAT EMBRYOL CEL, V196, P1; Myrie SB, 2011, NEONATOLOGY, V100, P380, DOI 10.1159/000326341; Nehiri T, 2008, DIABETES, V57, P2167, DOI 10.2337/db07-0780; Nelson RG, 1998, DIABETES, V47, P1489, DOI 10.2337/diabetes.47.9.1489; Nielsen GL, 2005, DIABETIC MED, V22, P693, DOI 10.1111/j.1464-5491.2005.01477.x; Padmanabhan R, 2001, Arch Physiol Biochem, V109, P260, DOI 10.1076/apab.109.3.260.11596; Parikh RM, 2007, MED HYPOTHESES, V69, P203, DOI 10.1016/j.mehy.2006.10.020; Pavkov ME, 2010, DIABETES CARE, V33, P2396, DOI 10.2337/dc10-0811; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622; Rocha SO, 2005, PEDIATR RES, V58, P1274, DOI 10.1203/01.pdr.0000188698.58021.ff; Rosenn B M, 2000, J Matern Fetal Med, V9, P29, DOI 10.1002/(SICI)1520-6661(200001/02)9:1<29::AID-MFM7>3.0.CO;2-Z; ROSSINI AA, 1977, P NATL ACAD SCI USA, V74, P2485, DOI 10.1073/pnas.74.6.2485; Schreuder MF, 2005, J AM SOC NEPHROL, V16, P2913, DOI 10.1681/ASN.2004100875; Shnorhavorian M, 2011, UROLOGY, V78, P1156, DOI 10.1016/j.urology.2011.04.022; Short K, 2013, DEVELOPMENT, V140, P471, DOI 10.1242/dev.088500; Short Kieran M, 2012, Methods Mol Biol, V886, P95, DOI 10.1007/978-1-61779-851-1_9; Short KM, 2010, KIDNEY INT, V77, P1132, DOI 10.1038/ki.2010.42; Silverman BL, 1998, DIABETES CARE, V21, pB142; Tein MSC, 1998, EXP PHYSIOL, V83, P165, DOI 10.1113/expphysiol.1998.sp004099; Tran S, 2008, J AM SOC NEPHROL, V19, P943, DOI 10.1681/ASN.2007080864; Weintrob N, 1996, J DIABETES COMPLICAT, V10, P294, DOI 10.1016/1056-8727(95)00080-1; Zhang SL, 2007, J AM SOC NEPHROL, V18, P2105, DOI 10.1681/ASN.2006101124; Zimyani MA, 2000, IMAGE ANAL STEREOL, V19, P219	56	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58243	10.1371/journal.pone.0058243	http://dx.doi.org/10.1371/journal.pone.0058243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516451	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200044
J	Luo, YP; Li, C; Gong, X; Wang, YL; Zhang, KS; Cui, YR; Sun, YE; Li, SG				Luo, Yuping; Li, Chun; Gong, Xi; Wang, Yanlu; Zhang, Kunshan; Cui, Yaru; Sun, Yi Eve; Li, Siguang			Splicing-Related Features of Introns Serve to Propel Evolution	PLOS ONE			English	Article							NONCODING RNAS REVEALS; SPLICEOSOMAL INTRONS; GENOME EVOLUTION; GENES; IDENTIFICATION; ANNOTATION; SEQUENCE; ELEMENTS; YEAST	The role of spliceosomal intronic structures played in evolution has only begun to be elucidated. Comparative genomic analyses of fungal snoRNA sequences, which are often contained within introns and/or exons, revealed that about one-third of snoRNA-associated introns in three major snoRNA gene clusters manifested polymorphisms, likely resulting from intron loss and gain events during fungi evolution. Genomic deletions can clearly be observed as one mechanism underlying intron and exon loss, as well as generation of complex introns where several introns lie in juxtaposition without intercalating exons. Strikingly, by tracking conserved snoRNAs in introns, we found that some introns had moved from one position to another by excision from donor sites and insertion into target sties elsewhere in the genome without needing transposon structures. This study revealed the origin of many newly gained introns. Moreover, our analyses suggested that intron-containing sequences were more prone to sustainable structural changes than DNA sequences without introns due to intron's ability to jump within the genome via unknown mechanisms. We propose that splicing-related structural features of introns serve as an additional motor to propel evolution.	[Luo, Yuping; Zhang, Kunshan; Cui, Yaru; Sun, Yi Eve; Li, Siguang] Tongji Univ, Sch Med, Tongji Hosp, Stem Cell Translat Res Ctr, Shanghai 200092, Peoples R China; [Luo, Yuping; Gong, Xi; Wang, Yanlu; Li, Siguang] Nanchang Univ, Coll Life Sci, Nanchang, Peoples R China; [Li, Chun] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai Stem Cell Inst, Shanghai 200030, Peoples R China	Tongji University; Nanchang University; Shanghai Jiao Tong University	Luo, YP (corresponding author), Tongji Univ, Sch Med, Tongji Hosp, Stem Cell Translat Res Ctr, Shanghai 200092, Peoples R China.	luoyuping@163.com; yi.eve.sun@gmail.com; siguangli@163.com			National Key Basic Research Program of China [2011CBA01106, 2011CB965102, 2010CB945600]; National Natural Foundation of China [31171317, 30971473, 31271375, 31271450]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research Program of China Grants 2011CBA01106, 2011CB965102 and 2010CB945600; National Natural Foundation of China Grants 31171317, 30971473, 31271375 and 31271450. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNSTEIN LB, 1983, CELL, V32, P461, DOI 10.1016/0092-8674(83)90466-X; Bhattacharya D, 2000, MOL BIOL EVOL, V17, P1971, DOI 10.1093/oxfordjournals.molbev.a026298; Brown JWS, 2008, TRENDS PLANT SCI, V13, P335, DOI 10.1016/j.tplants.2008.04.010; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cho SC, 2004, GENOME RES, V14, P1207, DOI 10.1101/gr.2639304; Coghlan A, 2004, P NATL ACAD SCI USA, V101, P11362, DOI 10.1073/pnas.0308192101; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Derr LK, 1998, GENETICS, V148, P937; DOOLITTLE WF, 1978, NATURE, V272, P581, DOI 10.1038/272581a0; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hirschman JE, 2006, NUCLEIC ACIDS RES, V34, pD442, DOI 10.1093/nar/gkj117; JEFFREYS AJ, 1977, CELL, V12, P1097, DOI 10.1016/0092-8674(77)90172-6; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Khaldi N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r18; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Koonin EV, 2009, J HERED, V100, P618, DOI 10.1093/jhered/esp056; Kuang HH, 2009, GENOME RES, V19, P42, DOI [10.1101/gr.07816.108, 10.1101/gr.078196.108]; Kupfer DM, 2004, EUKARYOT CELL, V3, P1088, DOI 10.1128/EC.3.5.1088-1100.2004; LEWIN R, 1983, SCIENCE, V219, P1052, DOI 10.1126/science.6186029; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Mitrovich QM, 2010, SCIENCE, V330, P838, DOI 10.1126/science.1194554; Nicolas E, 2010, J BACTERIOL, V192, P4233, DOI 10.1128/JB.00477-10; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; TANI T, 1989, NATURE, V337, P87, DOI 10.1038/337087a0; Torriani SFF, 2011, CURR BIOL, V21, P2017, DOI 10.1016/j.cub.2011.10.041; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wolfe KH, 2006, PHILOS T ROY SOC B, V361, P403, DOI 10.1098/rstb.2005.1799; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yenerall P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-364	35	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58547	10.1371/journal.pone.0058547	http://dx.doi.org/10.1371/journal.pone.0058547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516505	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200084
J	Mann, DL; Spratford, W; Abernethy, B				Mann, David L.; Spratford, Wayne; Abernethy, Bruce			The Head Tracks and Gaze Predicts: How the World's Best Batters Hit a Ball	PLOS ONE			English	Article							INFORMATION; EYE; MOVEMENTS; PERFORMANCE; TARGET; TIME	Hitters in fast ball-sports do not align their gaze with the ball throughout ball-flight; rather, they use predictive eye movement strategies that contribute towards their level of interceptive skill. Existing studies claim that (i) baseball and cricket batters cannot track the ball because it moves too quickly to be tracked by the eyes, and that consequently (ii) batters do not - and possibly cannot - watch the ball at the moment they hit it. However, to date no studies have examined the gaze of truly elite batters. We examined the eye and head movements of two of the world's best cricket batters and found both claims do not apply to these batters. Remarkably, the batters coupled the rotation of their head to the movement of the ball, ensuring the ball remained in a consistent direction relative to their head. To this end, the ball could be followed if the batters simply moved their head and kept their eyes still. Instead of doing so, we show the elite batters used distinctive eye movement strategies, usually relying on two predictive saccades to anticipate (i) the location of ball-bounce, and (ii) the location of bat-ball contact, ensuring they could direct their gaze towards the ball as they hit it. These specific head and eye movement strategies play important functional roles in contributing towards interceptive expertise.	[Mann, David L.] Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands; [Mann, David L.; Abernethy, Bruce] Univ Hong Kong, Inst Human Performance, Pokfulam, Hong Kong, Peoples R China; [Spratford, Wayne] Australian Inst Sport, Canberra, ACT, Australia; [Spratford, Wayne] Cricket Australia Ctr Excellence, Brisbane, Qld, Australia; [Abernethy, Bruce] Univ Queensland, Sch Human Movement Studies, Brisbane, Qld, Australia	Vrije Universiteit Amsterdam; University of Hong Kong; Australian Institute of Sport; University of Queensland	Mann, DL (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst Amsterdam, Fac Human Movement Sci, Amsterdam, Netherlands.	d.mann@vu.nl	Mann, David/D-1429-2011	Mann, David/0000-0001-7476-6939; Spratford, Wayne/0000-0002-6207-8829	Rubicon Grant [446-10-029]; Netherlands Organisation for Scientific Research (NWO); Marie Curie Actions Cofund	Rubicon Grant; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Marie Curie Actions Cofund	David Mann was supported by a Rubicon Grant (446-10-029) awarded by The Netherlands Organisation for Scientific Research (NWO) and the Marie Curie Actions Cofund (www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHILL AT, 1984, AM SCI, V72, P249; Bates BT, 1996, MED SCI SPORT EXER, V28, P631, DOI 10.1097/00005768-199605000-00016; Beilock SL, 2002, J EXP PSYCHOL-APPL, V8, P6, DOI 10.1037/1076-898X.8.1.6; Benguigui N, 2003, J EXP PSYCHOL HUMAN, V29, P1083, DOI 10.1037/0096-1523.29.6.1083; Bongers RM, 2008, J EXP PSYCHOL HUMAN, V34, P1515, DOI 10.1037/a0011974; BOOTSMA RJ, 1990, J EXP PSYCHOL HUMAN, V16, P21, DOI 10.1037/0096-1523.16.1.21; Croft JL, 2010, HUM MOVEMENT SCI, V29, P751, DOI 10.1016/j.humov.2009.10.004; de Oliveira RF, 2007, EXP PSYCHOL, V54, P180, DOI 10.1027/1618-3169.54.3.180; De Wit MM, 2012, CONSCIOUS COGN, V21, P1410, DOI 10.1016/j.concog.2012.07.008; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; Gibson J.J., 1966, SENSES CONSIDERED PE; Gray R, 2009, REV HUMAN FACTORS ER, V5, P114, DOI DOI 10.1518/155723409X448035; Hayhoe MM, 2012, EXP BRAIN RES, V217, P125, DOI 10.1007/s00221-011-2979-2; HELD R, 1963, SCIENCE, V142, P455, DOI 10.1126/science.142.3591.455; Herlihey TA, 2012, J VISION, V12, DOI 10.1167/12.3.4; Hubbard AW, 1954, RES QUART, V25, P42, DOI 10.1080/10671188.1954.10624942; LaFont D, 2007, WATCH BALL ITF COACH, V43, P11; Land MF, 2001, CURR BIOL, V11, P1215, DOI 10.1016/S0960-9822(01)00351-7; LEE DN, 1983, Q J EXP PSYCHOL-A, V35, P333, DOI 10.1080/14640748308402138; LEE DN, 1992, J EXP PSYCHOL HUMAN, V18, P1195, DOI 10.1037/0096-1523.18.4.1195; Mann DL, 2010, ACTA PSYCHOL, V135, P17, DOI 10.1016/j.actpsy.2010.04.006; Mann DL, 2010, ATTEN PERCEPT PSYCHO, V72, P1317, DOI 10.3758/APP.72.5.1317; Mann DL, 2010, HUM MOVEMENT SCI, V29, P386, DOI 10.1016/j.humov.2010.02.007; MCBEATH MK, 1995, SCIENCE, V268, P569, DOI 10.1126/science.7725104; MCLEOD P, 1987, PERCEPTION, V16, P49, DOI 10.1068/p160049; Milner A. D., 1995, VISUAL BRAIN ACTION; Muller S, 2006, J SCI MED SPORT, V9, P446, DOI 10.1016/j.jsams.2006.03.029; Oudejans RRD, 1999, J EXP PSYCHOL HUMAN, V25, P531, DOI 10.1037/0096-1523.25.2.531; Pinder RA, 2011, ATTEN PERCEPT PSYCHO, V73, P1242, DOI 10.3758/s13414-011-0102-1; Pinder RA, 2009, HUM MOVEMENT SCI, V28, P468, DOI 10.1016/j.humov.2009.02.003; Regan D, 1997, J SPORT SCI, V15, P533, DOI 10.1080/026404197366985; RIPOLL H, 1988, ERGONOMICS, V31, P1647, DOI 10.1080/00140138808966814; RIPOLL H, 1986, HUM MOVEMENT SCI, V5, P47, DOI 10.1016/0167-9457(86)90005-9; Rushton SK, 1998, CURR BIOL, V8, P1191, DOI 10.1016/S0960-9822(07)00492-7; Sarpeshkar V, 2011, SPORT BIOMECH, V10, P306, DOI 10.1080/14763141.2011.629207; Shim J, 2005, J MOTOR BEHAV, V37, P164, DOI 10.3200/JMBR.37.2.164-175; TYLDESLEY DA, 1975, J HUMAN MOVEMENT STU, V1, P172; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; Zaal FTJM, 2003, J EXP PSYCHOL HUMAN, V29, P537, DOI 10.1037/0096-1523.29.3.537	40	100	100	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58289	10.1371/journal.pone.0058289	http://dx.doi.org/10.1371/journal.pone.0058289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516460	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200053
J	Kaiser, BK; Carleton, M; Hickman, JW; Miller, C; Lawson, D; Budde, M; Warrener, P; Paredes, A; Mullapudi, S; Navarro, P; Cross, F; Roberts, JM				Kaiser, Brett K.; Carleton, Michael; Hickman, Jason W.; Miller, Cameron; Lawson, David; Budde, Mark; Warrener, Paul; Paredes, Angel; Mullapudi, Srinivas; Navarro, Patricia; Cross, Fred; Roberts, James M.			Fatty Aldehydes in Cyanobacteria Are a Metabolically Flexible Precursor for a Diversity of Biofuel Products	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; ESCHERICHIA-COLI; DEHYDROGENASE GENES; LIPID-PEROXIDATION; ACID SYNTHESIS; WAX ESTER; PURIFICATION; EXPRESSION; COENZYME; BIOSYNTHESIS	We describe how pathway engineering can be used to convert a single intermediate derived from lipid biosynthesis, fatty aldehydes, into a variety of biofuel precursors including alkanes, free fatty acids and wax esters. In cyanobacteria, long-chain acyl-ACPs can be reduced to fatty aldehydes, and then decarbonylated to alkanes. We discovered a cyanobacteria class-3 aldehyde-dehydrogenase, AldE, that was necessary and sufficient to instead oxidize fatty aldehyde precursors into fatty acids. Overexpression of enzymes in this pathway resulted in production of 50 to 100 fold more fatty acids than alkanes, and the fatty acids were secreted from the cell. Co-expression of acyl-ACP reductase, an alcohol-dehydrogenase and a wax-ester-synthase resulted in a third fate for fatty aldehydes: conversion to wax esters, which accumulated as intracellular lipid bodies. Conversion of acyl-ACP to fatty acids using endogenous cyanobacterial enzymes may allow biofuel production without transgenesis.	[Kaiser, Brett K.; Carleton, Michael; Hickman, Jason W.; Miller, Cameron; Lawson, David; Budde, Mark; Warrener, Paul] Matrix Genet, Seattle, WA USA; [Roberts, James M.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Paredes, Angel; Mullapudi, Srinivas; Navarro, Patricia] Univ Texas Hlth Sci Ctr, Dept Pathol & Lab Med, Houston, TX USA; [Cross, Fred] Rockefeller Univ, New York, NY 10021 USA; [Roberts, James M.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; Rockefeller University; Fred Hutchinson Cancer Center	Roberts, JM (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	jroberts@fhcrc.org	Roberts, James/AAI-3283-2020	Roberts, James/0000-0002-2671-3207	Matrix Genetics	Matrix Genetics	This work was carried out by Matrix Genetics, a privately held biotechnology company who funded this study. The funders had no role in study design, data collection and analysis. Jim Roberts became a stockholder (funder) in Matrix at a later date.	Achterholt S, 1998, J BACTERIOL, V180, P4387, DOI 10.1128/JB.180.17.4387-4391.1998; Andersson CR, 2000, METHOD ENZYMOL, V305, P527; [Anonymous], 1998, [No title captured]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bozzola J. J., 1992, ELECT MICROSCOPY PRI; BUSTOS SA, 1991, J BACTERIOL, V173, P7525, DOI 10.1128/jb.173.23.7525-7533.1991; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; CHO HS, 1995, J BIOL CHEM, V270, P4216, DOI 10.1074/jbc.270.9.4216; Davis MS, 2001, J BACTERIOL, V183, P1499, DOI 10.1128/JB.183.4.1499-1503.2001; DeLaurenzi V, 1996, NAT GENET, V12, P52; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Eser BE, 2011, BIOCHEMISTRY-US, V50, P10743, DOI 10.1021/bi2012417; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOLDEN SS, 1987, METHOD ENZYMOL, V153, P215; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; Heath RJ, 1996, J BIOL CHEM, V271, P10996, DOI 10.1074/jbc.271.18.10996; Holtman CK, 2005, DNA RES, V12, P103, DOI 10.1093/dnares/12.2.103; JIANG P, 1994, J BACTERIOL, V176, P2814, DOI 10.1128/JB.176.10.2814-2821.1994; Kaczmarzyk D, 2010, PLANT PHYSIOL, V152, P1598, DOI 10.1104/pp.109.148007; Kaiser BK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00156; Kalscheuer R, 2003, J BIOL CHEM, V278, P8075, DOI 10.1074/jbc.M210533200; Kelson TL, 1997, BBA-GEN SUBJECTS, V1335, P99, DOI 10.1016/S0304-4165(96)00126-2; Kirch HH, 2001, PLANT J, V28, P555, DOI 10.1046/j.1365-313X.2001.01176.x; KOK M, 1989, J BIOL CHEM, V264, P5442; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; Li N, 2012, BIOCHEMISTRY-US, V51, P7908, DOI 10.1021/bi300912n; Li N, 2011, J AM CHEM SOC, V133, P6158, DOI 10.1021/ja2013517; LINDAHL R, 1991, BIOCHEM PHARMACOL, V41, P1583, DOI 10.1016/0006-2952(91)90157-Z; Liu XY, 2011, P NATL ACAD SCI USA, V108, P6899, DOI 10.1073/pnas.1103014108; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; MITCHELL DY, 1987, TOXICOL APPL PHARM, V87, P403, DOI 10.1016/0041-008X(87)90245-6; NAKAYASU H, 1978, BIOCHEM BIOPH RES CO, V83, P697, DOI 10.1016/0006-291X(78)91045-8; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Robertson DE, 2011, PHOTOSYNTH RES, V107, P269, DOI 10.1007/s11120-011-9631-7; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Vidal R, 2009, J BACTERIOL, V191, P4383, DOI 10.1128/JB.00183-09; VOELKER TA, 1994, J BACTERIOL, V176, P7320, DOI 10.1128/JB.176.23.7320-7327.1994; Waltermann M, 2005, J BACTERIOL, V187, P3607, DOI 10.1128/JB.187.11.3607-3619.2005; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467	46	49	50	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58307	10.1371/journal.pone.0058307	http://dx.doi.org/10.1371/journal.pone.0058307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505484	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100044
J	Rey, O; Estoup, A; Facon, B; Loiseau, A; Aebi, A; Duron, O; Vavre, F; Foucaud, J				Rey, Olivier; Estoup, Arnaud; Facon, Benoit; Loiseau, Anne; Aebi, Alexandre; Duron, Olivier; Vavre, Fabrice; Foucaud, Julien			Distribution of Endosymbiotic Reproductive Manipulators Reflects Invasion Process and Not Reproductive System Polymorphism in the Little Fire Ant Wasmannia auropunctata	PLOS ONE			English	Article							WOLBACHIA; SYMBIONTS; POPULATIONS; HYMENOPTERA; FORMICIDAE; EVOLUTION; INFECTION; GENETICS; APHIDS; COST	Endosymbiotic reproductive manipulators may have drastic effects on the ecological and evolutionary dynamics of their hosts. The prevalence of these endosymbionts reflects both their ability to manipulate their hosts and the history of the host populations. The little fire ant Wasmannia auropunctata displays a polymorphism in both its reproductive system (sexual versus clonal populations) and the invasive status of its populations (associated to a habitat shift). We first screened for the presence of a diverse array of reproductive parasites in sexual and clonal populations of W. auropunctata, as a means to investigate the role of endosymbionts in reproductive phenotypes. Wolbachia was the only symbiont found and we then focused on its worldwide distribution and diversity in natural populations of W. auropunctata. Using a multilocus scheme, we further characterized the Wolbachia strains present in these populations. We found that almost all the native sexual populations and only a few clonal populations are infected by Wolbachia. The presence of similar Wolbachia strains in both sexual and clonal populations indicates that they are probably not the cause of the reproductive system polymorphism. The observed pattern seems rather associated to the invasion process of W. auropunctata. In particular, the observed loss of Wolbachia in clonal populations, that recurrently emerged from sexual populations, likely resulted from natural heat treatment and/or relaxed selection during the shift in habitat associated to the invasion process.	[Rey, Olivier; Estoup, Arnaud; Facon, Benoit; Loiseau, Anne; Foucaud, Julien] INRA, CBGP, UMR1062, F-34060 Montpellier, France; [Aebi, Alexandre] Univ Neuchatel, Lab Biol Sol, CH-2000 Neuchatel, Switzerland; [Duron, Olivier] Univ Montpellier 2, Inst Sci Evolut, CNRS, UMR5554, Montpellier, France; [Vavre, Fabrice] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR5558, F-69622 Villeurbanne, France	INRAE; Institut de Recherche pour le Developpement (IRD); University of Neuchatel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Rey, O (corresponding author), INRA, CBGP, UMR1062, F-34060 Montpellier, France.	olivier.rey.1@gmail.com	vavre, fabrice/N-2945-2017; Rey, olivier/R-5453-2016	vavre, fabrice/0000-0003-0909-2936; Duron, Olivier/0000-0002-7426-782X; Foucaud, Julien/0000-0003-2272-3149; Rey, olivier/0000-0003-3699-7204	French Ministere de l'Ecologie et du Developpement Durable (ECOTROP programme); French Agropolis foundation (RTRA- Montpellier, BIOFIS project) [1001-001]	French Ministere de l'Ecologie et du Developpement Durable (ECOTROP programme); French Agropolis foundation (RTRA- Montpellier, BIOFIS project)	This work was supported by grants from the French Ministere de l'Ecologie et du Developpement Durable (ECOTROP programme) awarded to AE and from the French Agropolis foundation (RTRA- Montpellier, BIOFIS project 1001-001) to AE and BF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldo L, 2007, CURR MICROBIOL, V55, P81, DOI 10.1007/s00284-007-0055-8; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Cordaux R, 2004, HEREDITY, V93, P78, DOI 10.1038/sj.hdy.6800482; Cordaux R, 2011, TRENDS GENET, V27, P332, DOI 10.1016/j.tig.2011.05.002; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Delabie JHC, 2007, BIODIVERS CONSERV, V16, P2359, DOI 10.1007/s10531-007-9190-6; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Fleury F, 2000, PARASITOLOGY, V121, P493, DOI 10.1017/S0031182099006599; Foucaud J, 2010, HEREDITY; Foucaud J, 2007, MOL BIOL EVOL, V24, P2465, DOI 10.1093/molbev/msm180; Foucaud J, 2010, EVOL APPL, V3, P363, DOI 10.1111/j.1752-4571.2010.00119.x; Foucaud J, 2009, MOL ECOL, V18, P5059, DOI 10.1111/j.1365-294X.2009.04440.x; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Jaenike J, 2012, TRENDS ECOL EVOL, V27, P226, DOI 10.1016/j.tree.2011.10.005; Jaenike J, 2011, ECOL LETT, V14, P150, DOI 10.1111/j.1461-0248.2010.01564.x; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Ohkawara K, 2006, BIOL LETTERS, V2, P359, DOI 10.1098/rsbl.2006.0491; Oliver KM, 2008, P R SOC B, V275, P293, DOI 10.1098/rspb.2007.1192; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Orivel J, 2009, ECOL ENTOMOL, V34, P504, DOI 10.1111/j.1365-2311.2009.01096.x; Pearcy M, 2011, P ROY SOC B-BIOL SCI, V278, P2677, DOI 10.1098/rspb.2010.2562; Reuter M, 2005, HEREDITY, V94, P364, DOI 10.1038/sj.hdy.6800601; Rey O, 2012, ECOL LETT, V15, P1266, DOI 10.1111/j.1461-0248.2012.01849.x; Rey O, 2011, MOL BIOL EVOL, V28, P2591, DOI 10.1093/molbev/msr082; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Russell JA, 2012, MYRMECOL NEWS, V16, P7; Sebastien A, 2012, INSECT SOC, V59, P33, DOI 10.1007/s00040-011-0184-8; Shoemaker DD, 2000, INSECT MOL BIOL, V9, P661, DOI 10.1046/j.1365-2583.2000.00233.x; Sirvio A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-335; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmermans MJTN, 2009, EVOL ECOL, V23, P931, DOI 10.1007/s10682-008-9282-0; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; Vorburger C, 2011, J EVOLUTION BIOL, V24, P1611, DOI 10.1111/j.1420-9101.2011.02292.x; Ward Philip S., 2005, Myrmecologische Nachrichten, V7, P87; Weeks AR, 2001, P ROY SOC B-BIOL SCI, V268, P2245, DOI 10.1098/rspb.2001.1797; Wenseleers T, 2002, P ROY SOC B-BIOL SCI, V269, P623, DOI 10.1098/rspb.2001.1927; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; White TA, 2012, FUNCT ECOL, V26, P1313, DOI 10.1111/1365-2435.12012; Yang CC, 2010, BIOL INVASIONS, V12, P3307, DOI 10.1007/s10530-010-9724-9	48	18	18	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58467	10.1371/journal.pone.0058467	http://dx.doi.org/10.1371/journal.pone.0058467			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505512	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100053
J	Kulkarni, R; Randis, TM; Antala, S; Wang, A; Amaral, FE; Ratner, AJ				Kulkarni, Ritwij; Randis, Tara M.; Antala, Swati; Wang, Alice; Amaral, Fabio E.; Ratner, Adam J.			beta-Hemolysin/Cytolysin of Group B Streptococcus Enhances Host Inflammation but Is Dispensable for Establishment of Urinary Tract Infection	PLOS ONE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; PATHOGENESIS; MECHANISMS; BACTERIA; DISEASE	Group B Streptococcus (GBS; Streptococcus agalactiae) is a major human pathogen that disproportionately affects neonates and women in the peripartum period and is an emerging cause of infection in older adults. The primary toxin of GBS, beta-hemolysin/cytolysin (beta H/C), has a well-defined role in the pathogenesis of invasive disease, but its role in urinary tract infection (UTI) is unknown. Using both in vitro and in vivo models, we analyzed the importance of beta H/C in GBS uropathogenesis. There were no significant differences in bacterial density from the bladders or kidneys from mice infected with wild-type or isogenic beta H/C-deficient GBS, and competitive indices from co-infection experiments were near 1. Thus, beta H/C is dispensable for the establishment of GBS-UTI. However, beta H/C-sufficient GBS induced a more robust proinflammatory cytokine response in cultured bladder epithelial cells and in the urinary tracts of infected mice. Given the near ubiquity of beta H/C-expressing strains in epidemiologic studies and the importance of local inflammation in dictating outcomes and sequelae of UTI, we hypothesize that beta H/C-driven inflammatory signaling may be important in the clinical course of GBS-UTI.	[Kulkarni, Ritwij; Randis, Tara M.; Antala, Swati; Wang, Alice; Amaral, Fabio E.; Ratner, Adam J.] Columbia Univ, Dept Pediat, New York, NY 10027 USA	Columbia University	Ratner, AJ (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10027 USA.	ar127@columbia.edu		Ratner, Adam/0000-0003-1761-794X; Randis, Tara/0000-0003-0348-6766; Amaral, Fabio/0000-0002-1547-8213	National Institutes of Health [R01 AI092743, R21 AI098654, K23 HD065844, UL1 TR000040]; Flight Attendant Medical Research Institute [YCSA_092417]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD065844] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI098654, R21AI098654, R01AI092743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (R01 AI092743, R21 AI098654 to A.J.R.; K23 HD065844, UL1 TR000040 (formerly UL1 UU024156) to T.M.R.). R.K. was supported by the Flight Attendant Medical Research Institute (YCSA_092417). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P109; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Doran KS, 2002, J INFECT DIS, V185, P196, DOI 10.1086/338475; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Jahnukainen T, 2005, PEDIATR NEPHROL, V20, P1043, DOI 10.1007/s00467-005-1898-5; Kessous R, 2012, J MATERN-FETAL NEO M, V25, P1983, DOI 10.3109/14767058.2012.671872; Kline KA, 2011, INFECT IMMUN, V79, P3588, DOI 10.1128/IAI.00122-11; Kulkarni R, 2010, INFECT IMMUN, V78, P2146, DOI 10.1128/IAI.01410-09; LINDER H, 1990, INFECT IMMUN, V58, P2056, DOI 10.1128/IAI.58.7.2056-2060.1990; Melin P, 2011, CLIN MICROBIOL INFEC, V17, P1294, DOI 10.1111/j.1469-0691.2011.03576.x; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Tan CK, 2012, INFECT IMMUN; Ulett GC, 2010, J INFECT DIS, V201, P866, DOI 10.1086/650696; Van Dyke MK, 2009, NEW ENGL J MED, V360, P2626, DOI 10.1056/NEJMoa0806820; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; WILKINSON HW, 1977, J CLIN MICROBIOL, V6, P183	18	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e59091	10.1371/journal.pone.0059091	http://dx.doi.org/10.1371/journal.pone.0059091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505569	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500134
J	Steinhauser, G; Schauer, V; Shozugawa, K				Steinhauser, Georg; Schauer, Viktoria; Shozugawa, Katsumi			Concentration of Strontium-90 at Selected Hot Spots in Japan	PLOS ONE			English	Article							FUKUSHIMA-DERIVED RADIONUCLIDES; DEPOSITION; PACIFIC; CS-134; SEAWATER; FISSION; I-131	This study is dedicated to the environmental monitoring of radionuclides released in the course of the Fukushima nuclear accident. The activity concentrations of beta(-) -emitting Sr-90 and beta(-)/gamma-emitting Cs-134 and Cs-137 from several hot spots in Japan were determined in soil and vegetation samples. The Sr-90 contamination levels of the samples were relatively low and did not exceed the Bq.g(-1) range. They were up four orders of magnitude lower than the respective Cs-137 levels. This study, therefore, experimentally confirms previous predictions indicating a low release of Sr-90 from the Fukushima reactors, due to its low volatility. The radiocesium contamination could be clearly attributed to the Fukushima nuclear accident via its activity ratio fingerprint (Cs-134/Cs-137). Although the correlation between Sr-90 and Cs-137 is relatively weak, the data set suggests an intrinsic coexistence of both radionuclides in the contaminations caused by the Fukushima nuclear accident. This observation is of great importance not only for remediation campaigns but also for the current food monitoring campaigns, which currently rely on the assumption that the activity concentrations of beta(-)-emitting Sr-90 (which is relatively laborious to determine) is not higher than 10% of the level of gamma-emitting Cs-137 (which can be measured quickly). This assumption could be confirmed for the samples investigated herein.	[Steinhauser, Georg] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Steinhauser, Georg; Schauer, Viktoria] Vienna Univ Technol, Atominst, A-1040 Vienna, Austria; [Shozugawa, Katsumi] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	Colorado State University; Technische Universitat Wien; University of Tokyo	Steinhauser, G (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	georg.steinhauser@ati.ac.at	Steinhauser, Georg/O-7283-2014; Steinhauser, Georg/HHS-2636-2022	Steinhauser, Georg/0000-0002-6114-5890; 	Austrian Federal Ministry for Agriculture, Forestry, Environment and Water Management (BMLFUW); Dr. Michael-Haupl-Fonds	Austrian Federal Ministry for Agriculture, Forestry, Environment and Water Management (BMLFUW); Dr. Michael-Haupl-Fonds	Partial funding of this work by the Austrian Federal Ministry for Agriculture, Forestry, Environment and Water Management (BMLFUW) and the Dr. Michael-Haupl-Fonds is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama Michio, 2004, ScientificWorldJournal, V4, P200; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Caffrey JA, 2012, J ENVIRON RADIOACTIV, V111, P120, DOI 10.1016/j.jenvrad.2011.12.015; Hamada N, 2012, J ENVIRON RADIOACTIV, V111, P83, DOI 10.1016/j.jenvrad.2011.08.008; Higaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034766; Hirose K, 2012, J ENVIRON RADIOACTIV, V111, P13, DOI 10.1016/j.jenvrad.2011.09.003; Inoue M, 2012, J ENVIRON RADIOACTIV, V111, P116, DOI 10.1016/j.jenvrad.2011.09.012; Inoue M, 2012, J ENVIRON RADIOACTIV, V109, P45, DOI 10.1016/j.jenvrad.2012.01.004; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Kim CK, 2012, J ENVIRON RADIOACTIV, V111, P70, DOI 10.1016/j.jenvrad.2011.10.018; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; KODAIRA K, 1964, J Radiat Res, V5, P116, DOI 10.1269/jrr.5.116; Madigan DJ, 2012, P NATL ACAD SCI USA, V109, P9483, DOI 10.1073/pnas.1204859109; Manley SL, 2012, ENVIRON SCI TECHNOL, V46, P3731, DOI 10.1021/es203598r; Masson O, 2011, ENVIRON SCI TECHNOL, V45, P7670, DOI 10.1021/es2017158; Merz S, 2013, ENVIRON SCI TECHNOL, V47, P1248, DOI 10.1021/es3037498; MEXT, 2011, RES NUCL AN PLUT STR; MEXT: Ministry of Education Culture Sports Science and Technology-Japan, 2011, MON INF ENV RAD LEV; Norman EB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024330; Povinec PP, 2012, ENVIRON SCI TECHNOL, V46, P10356, DOI 10.1021/es301997c; Povinec PP, 2004, J ENVIRON RADIOACTIV, V76, P113, DOI 10.1016/j.jenvrad.2004.03.022; Schwantes JM, 2012, ENVIRON SCI TECHNOL, V46, P8621, DOI 10.1021/es300556m; Schwantes JM, 2009, ANAL CHEM, V81, P1297, DOI 10.1021/ac802286a; Shimura H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044200; Shozugawa K, 2012, ENVIRON POLLUT, V163, P243, DOI 10.1016/j.envpol.2012.01.001; Steinhauser G, 2008, APPL RADIAT ISOTOPES, V66, P1, DOI 10.1016/j.apradiso.2007.07.010; Steinhauser G, 2007, APPL RADIAT ISOTOPES, V65, P488, DOI 10.1016/j.apradiso.2006.12.004; Steinhauser G, 2013, ENVIRON SCI POLLUT R, V20, P2527, DOI 10.1007/s11356-012-1140-5; Steinhauser G, 2012, ENVIRON SCI TECHNOL, V46, P12890, DOI 10.1021/es303280g; TEPCO, 2011, HAND PRESS C; Vesterlund A, 2009, J RADIOANAL NUCL CH, V282, P951, DOI 10.1007/s10967-009-0184-6; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108	32	88	89	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57760	10.1371/journal.pone.0057760	http://dx.doi.org/10.1371/journal.pone.0057760			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505440	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500032
J	Buffa, R; Saragat, B; Cabras, S; Rinaldi, AC; Marini, E				Buffa, Roberto; Saragat, Bruno; Cabras, Stefano; Rinaldi, Andrea C.; Marini, Elisabetta			Accuracy of Specific BIVA for the Assessment of Body Composition in the United States Population	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE VECTOR; NUTRITIONAL-STATUS; MASS INDEX; NORMAL VALUES; BIOIMPEDANCE; AGE; CHILDREN; ADULT; FAT; RESISTIVITY	Background: Bioelectrical impedance vector analysis (BIVA) is a technique for the assessment of hydration and nutritional status, used in the clinical practice. Specific BIVA is an analytical variant, recently proposed for the Italian elderly population, that adjusts bioelectrical values for body geometry. Objective: Evaluating the accuracy of specific BIVA in the adult U.S. population, compared to the 'classic' BIVA procedure, using DXA as the reference technique, in order to obtain an interpretative model of body composition. Design: A cross-sectional sample of 1590 adult individuals (836 men and 754 women, 21-49 years old) derived from the NHANES 2003-2004 was considered. Classic and specific BIVA were applied. The sensitivity and specificity in recognizing individuals below the 5th and above the 95th percentiles of percent fat (FMDXA%) and extracellular/intracellular water (ECW/ICW) ratio were evaluated by receiver operating characteristic (ROC) curves. Classic and specific BIVA results were compared by a probit multiple-regression. Results: Specific BIVA was significantly more accurate than classic BIVA in evaluating FMDXA% (ROC areas: 0.84-0.92 and 0.49-0.61 respectively; p = 0.002). The evaluation of ECW/ICW was accurate (ROC areas between 0.83 and 0.96) and similarly performed by the two procedures (p = 0.829). The accuracy of specific BIVA was similar in the two sexes (p = 0.144) and in FMDXA% and ECW/ICW (p = 0.869). Conclusions: Specific BIVA showed to be an accurate technique. The tolerance ellipses of specific BIVA can be used for evaluating FM% and ECW/ICW in the U.S. adult population.	[Buffa, Roberto; Saragat, Bruno; Marini, Elisabetta] Univ Cagliari, Dept Environm & Life Sci, Cagliari, Italy; [Cabras, Stefano] Univ Carlos III Madrid, Dept Stat, E-28903 Getafe, Spain; [Cabras, Stefano] Univ Cagliari, Dept Math, Cagliari, Italy; [Rinaldi, Andrea C.] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy	University of Cagliari; Universidad Carlos III de Madrid; University of Cagliari; University of Cagliari	Marini, E (corresponding author), Univ Cagliari, Dept Environm & Life Sci, Cagliari, Italy.	emarini@unica.it	Rinaldi, Andrea/N-1007-2019; Cabras, Stefano/AAA-2477-2019	Rinaldi, Andrea/0000-0002-9352-1037; Cabras, Stefano/0000-0001-6690-8378; Marini, Elisabetta/0000-0001-8779-8745; BUFFA, Roberto/0000-0001-7082-859X	University of Cagliari; "Regione Autonoma della Sardegna'' [L.R.7/2007]	University of Cagliari; "Regione Autonoma della Sardegna''(Regione Sardegna)	This research was financially supported by the University of Cagliari. ACR acknowledges financial support from "Regione Autonoma della Sardegna'' through a research grant on fundings of the Project PO Sardegna FSE 2007-2013, L.R.7/2007 Promozione della ricerca scientifica e dell'innovazione tecnologica in Sardegna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, Am J Clin Nutr, V64, p524S, DOI 10.1093/ajcn/64.3.524S; Barbosa-Silva MCG, 2005, CURR OPIN CLIN NUTR, V8, P311, DOI 10.1097/01.mco.0000165011.69943.39; Barufaldi LA, 2011, REV PANAM SALUD PUBL, V30, P39; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Biggs J, 2001, PHYSIOL MEAS, V22, P365, DOI 10.1088/0967-3334/22/2/308; Bosy-Westphal A, 2005, AM J CLIN NUTR, V82, P60, DOI 10.1093/ajcn/82.1.60; Bracco D, 1996, J APPL PHYSIOL, V81, P2580, DOI 10.1152/jappl.1996.81.6.2580; Bronhara B, 2012, CLIN NUTR, V31, P710, DOI 10.1016/j.clnu.2012.02.014; Buffa R, 2003, NUTRITION, V19, P917, DOI 10.1016/S0899-9007(03)00180-1; Buffa R, 2002, NUTRITION, V18, P474, DOI 10.1016/S0899-9007(02)00755-4; Buffa R, 2010, J NUTR HEALTH AGING, V14, P97, DOI 10.1007/s12603-010-0018-9; Buffa R, 2013, NUTRITION, V29, P132, DOI 10.1016/j.nut.2012.05.007; Buffa R, 2009, J TROP PEDIATRICS, V55, P406, DOI 10.1093/tropej/fmp032; Castillo-Martinez L, 2012, NUTRITION, V28, P886, DOI 10.1016/j.nut.2011.11.024; CHERTOW GM, 1995, J AM SOC NEPHROL, V6, P75; CHUMLEA WC, 1988, AM J CLIN NUTR, V48, P7, DOI 10.1093/ajcn/48.1.7; Cole KS, 1997, MEMBRANES IONS AND I; Espinosa-Cuevas MD, 2007, REV INVEST CLIN, V59, P15; De Palo T, 2000, NUTRITION, V16, P417, DOI 10.1016/S0899-9007(00)00269-0; Dittmar M, 2001, AM J PHYSIOL-ENDOC M, V281, pE1005, DOI 10.1152/ajpendo.2001.281.5.E1005; Dobson AJ, 2002, AN INTRODUCTION TO G; Fuller NJ, 2002, INT J OBESITY, V26, P684, DOI 10.1038/sj.ijo.0801988; Gatterer H, 2011, J SPORT MED PHYS FIT, V51, P89; Guida B, 2001, INT J OBESITY, V25, P265, DOI 10.1038/sj.ijo.0801475; Guida B, 2008, NUTR METAB CARDIOVAS, V18, P133, DOI 10.1016/j.numecd.2006.08.008; Guida B, 2007, NUTR METAB CARDIOVAS, V17, P175, DOI 10.1016/j.numecd.2005.11.001; Haas V, 2012, EUR EAT DISORD REV, V20, P400, DOI 10.1002/erv.1166; Heo M, 2012, AM J CLIN NUTR, V95, P594, DOI 10.3945/ajcn.111.025171; Kehayias JJ, 2012, J NUTR HEALTH AGING, V16, P35, DOI 10.1007/s12603-011-0079-4; Kim CH, 2010, IEEE ENG MED BIO, P3872, DOI 10.1109/IEMBS.2010.5627664; Krzanowski WJ, 2009, MONOGR STAT APPL PRO, V111, P1; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; L'Abee C, 2010, CLIN NUTR, V29, P222, DOI 10.1016/j.clnu.2009.08.007; Margutti AVB, 2010, BRIT J NUTR, V104, P1508, DOI 10.1017/S000711451000245X; Marini E, 2013, J NUTR HEALTH AGING, V17, P515, DOI 10.1007/s12603-012-0411-7; Marini E, 1992, THESIS; Marini E, 2007, AM J TROP MED HYG, V76, P534, DOI 10.4269/ajtmh.2007.76.534; Marini E, 2012, CLIN INTERV AGING, V7, P585, DOI 10.2147/CIA.S38488; National Center for Complementary and Integrative Health, 2012, NAT HLTH INT SURV; Nescolarde L, 2011, IEEE ENG MED BIO, P1137, DOI 10.1109/IEMBS.2011.6090266; NHANES, 2004, BODY COMPOSITION PRO; NHANES, 2004, ANTHROPOMETRY PROCED; Norman K, 2012, CLIN NUTR, V31, P854, DOI 10.1016/j.clnu.2012.05.008; Piccoli A, 2002, NUTRITION, V18, P153, DOI 10.1016/S0899-9007(01)00665-7; Piccoli A, 1996, MED SCI SPORT EXER, V28, P1517, DOI 10.1097/00005768-199612000-00012; PICCOLI A, 1995, AM J CLIN NUTR, V61, P269, DOI 10.1093/ajcn/61.2.269; PICCOLI A, 1994, KIDNEY INT, V46, P534, DOI 10.1038/ki.1994.305; Piccoli A, 1998, INT J OBESITY, V22, P97, DOI 10.1038/sj.ijo.0800551; Piccoli A., 2002, BIVA SOFTWARE; Piccoli A, 2007, BRIT J NUTR, V97, P182, DOI 10.1017/S0007114507243077; Saragat B, 2012, J NUTR HEALTH AGING, V16, P231, DOI 10.1007/s12603-011-0347-3; Savino F, 2003, NUTRITION, V19, P492, DOI 10.1016/S0899-9007(02)00947-4; Siervo M, 2010, INT J OBESITY, V34, P908, DOI 10.1038/ijo.2010.9; Tanabe RF, 2012, CLIN NUTR, V31, P144, DOI 10.1016/j.clnu.2011.08.006; Walter-Kroker A, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-35	55	69	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58533	10.1371/journal.pone.0058533	http://dx.doi.org/10.1371/journal.pone.0058533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484033	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100121
J	Kulma, K; Saddler, A; Koella, JC				Kulma, Katarzyna; Saddler, Adam; Koella, Jacob C.			Effects of Age and Larval Nutrition on Phenotypic Expression of Insecticide-Resistance in Anopheles Mosquitoes	PLOS ONE			English	Article							MALARIA VECTOR; PERMETHRIN RESISTANCE; PYRETHROID RESISTANCE; DDT RESISTANCE; GAMBIAE; SUSCEPTIBILITY	Insecticide-resistance threatens the control of mosquito-borne diseases like malaria or dengue fever. To ensure sustainable vector control we need a full understanding of the factors driving the evolution of resistance. We test the hypothesis that the expression of insecticide-resistance depends on the available resources by rearing genetically DDT-resistant and sensitive larvae of Anopheles mosquitoes at three diet regimes, which correspond to 40%, 70% and 100% of the normal diet and exposing the adult females to DDT 5, 10 and 15 days after emergence. In both colonies post-exposure survival decreased with age at exposure. Additionally, the food levels and DDT-resistance were positively correlated in both colonies, although only in the DDT-resistant one was this relationship statistically significant. The impact of larval diet was smaller than the effect of age at exposure. We discuss our results and explain the implication of this study to resistance monitoring for public health and vector management.	[Kulma, Katarzyna] Uppsala Univ, Dept Anim Ecol, Uppsala, Sweden; [Saddler, Adam; Koella, Jacob C.] Imperial Coll London, Div Biol, Ascot, Berks, England	Uppsala University; Imperial College London	Saddler, A (corresponding author), Imperial Coll London, Div Biol, Ascot, Berks, England.	a.saddler09@imperial.ac.uk	Saddler, Adam/AGZ-4740-2022	Saddler, Adam/0000-0001-7750-3958; Kulma, Katarzyna/0000-0002-2952-9720	Leverhulme Trust [F/07058/BC]; Zoologiska Stiftelse (Uppsala University); Graduate School on Genomes and Phenotypes; Helge Ax:son Johnsons Stiftelse	Leverhulme Trust(Leverhulme Trust); Zoologiska Stiftelse (Uppsala University); Graduate School on Genomes and Phenotypes; Helge Ax:son Johnsons Stiftelse	This work was funded by grant F/07058/BC of the Leverhulme Trust to JCK, Zoologiska Stiftelse (Uppsala University), Graduate School on Genomes and Phenotypes (UU) and Helge Ax:son Johnsons Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye-Antwi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-225; [Anonymous], 1998, WHOCDCMAL98; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Chouaibou MS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-214; Christian RN, 2011, GENET MOL RES, V10, P3220, DOI 10.4238/2011.December.21.4; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Farenhorst M, 2009, P NATL ACAD SCI; Hardstone MC, 2010, J MED ENTOMOL, V47, P188, DOI 10.1603/ME09131; Hardstone MC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-42; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Hodjati MH, 1999, MED VET ENTOMOL, V13, P415, DOI 10.1046/j.1365-2915.1999.00198.x; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Kikuchi Y, 2012, P NATL ACAD SCI; Lorenz LM, 2011, EVOL APPL, V4, P783, DOI 10.1111/j.1752-4571.2011.00199.x; McCart C, 2005, CURR BIOL, V15, pR587, DOI 10.1016/j.cub.2005.07.054; Rajatileka S, 2011, T ROY SOC TROP MED H, V105, P247, DOI 10.1016/j.trstmh.2011.01.009; Ranson H, 2000, INSECT MOL BIOL, V9, P499, DOI 10.1046/j.1365-2583.2000.00214.x; Rivero A, 2011, J MED ENTOMOL, V48, P694, DOI 10.1603/ME10121; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x	19	35	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58322	10.1371/journal.pone.0058322	http://dx.doi.org/10.1371/journal.pone.0058322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484017	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100107
J	Raal, A; Volmer, D; Soukand, R; Hratkevits, S; Kalle, R				Raal, Ain; Volmer, Daisy; Soukand, Renata; Hratkevits, Sofia; Kalle, Raivo			Complementary Treatment of the Common Cold and Flu with Medicinal Plants - Results from Two Samples of Pharmacy Customers in Estonia	PLOS ONE			English	Article								The aim of the current survey was to investigate the complementary self-treatment of the common cold and flu with medicinal plants among pharmacy customers in Estonia. A multiple-choice questionnaire listing 10 plants and posing questions on the perceived characteristics of cold and flu, the effectiveness of plants, help-seeking behaviour, self-treatment and sources of information, was distributed to a sample of participants in two medium size pharmacies. The participants were pharmacy customers: 150 in Tallinn (mostly Russian speaking) and 150 in Kuressaare (mostly Estonian speaking). The mean number of plants used by participants was 4.1. Of the respondents, 69% self-treated the common cold and flu and 28% consulted with a general practitioner. In general, medicinal plants were considered effective in the treatment of the above-mentioned illnesses and 56% of the respondents had used exclusively medicinal plants or their combination with OTC medicines and other means of folk medicine for treatment. The use of medicinal plants increased with age and was more frequent among female than male respondents. Among Estonian-speaking customers lime flowers, blackcurrant and camomile were more frequently used, and among Russian speaking customers raspberry and lemon fruits. Regardless of some statistically significant differences in preferred species among different age, education, sex and nationality groups, the general attitude towards medicinal plants for self-treatment of the common cold and flu in Estonia was very favourable.	[Raal, Ain; Volmer, Daisy; Hratkevits, Sofia] Univ Tartu, Dept Pharm, EE-50090 Tartu, Estonia; [Soukand, Renata; Kalle, Raivo] Estonian Literary Museum, Tartu, Estonia	University of Tartu; Estonian Literary Museum	Soukand, R (corresponding author), Estonian Literary Museum, Tartu, Estonia.	renata@folklore.ee	Raal, Ain/G-5755-2016; Soukand, Renata/G-8243-2012; Sõukand, Renata/H-3243-2019	Raal, Ain/0000-0001-8731-7366; Soukand, Renata/0000-0002-0413-8723; Sõukand, Renata/0000-0002-0413-8723; Volmer, Daisy/0000-0001-6742-5044; Kalle, Raivo/0000-0002-2175-8617				Barnes JA, 2004, MOL CELL BIOCHEM, V263, P3, DOI 10.1023/B:MCBI.0000041961.57973.e0; Eccles R, 2005, LANCET INFECT DIS, V5, P718, DOI 10.1016/S1473-3099(05)70270-X; Fintelmann V., 2000, HERBAL MED; Giovannini P, 2011, SOC SCI MED, V72, P928, DOI 10.1016/j.socscimed.2011.01.007; Hershenson MB, 2006, AM J RESP CRIT CARE, V174, P1284, DOI 10.1164/rccm.200609-1387ED; Kook O., 1962, EESTI NSV RAVIMTAIME; Kukk T, 1999, EESTITAIMESTIK VASCU; Mahlajuk VP, 1967, MED PLANTS ETHNOMEDI; Mathes Angelo, 2010, J Pharm Pract, V23, P117, DOI 10.1177/0897190009358711; Pohlebkin W, 2001, HIST MOST IMPORTANT; Pratter MR, 2006, CHEST, V129, p72S, DOI 10.1378/chest.129.1_suppl.72S; R Development Core Team, 2012, R LANG ENV STAT COMP; Soukand R, 2008, HIST DATABASE ESTONI; Soukand R, 2012, APPETITE, V59, P523, DOI 10.1016/j.appet.2012.06.017; Soukand Renata, 2012, Estonian Journal of Ecology, V61, P20, DOI 10.3176/eco.2012.1.04; Soukand R, 2011, J ETHNOPHARMACOL, V135, P251, DOI 10.1016/j.jep.2011.02.030; Soukand R, 2010, BIOSEMIOTICS-NETH, V3, P299, DOI 10.1007/s12304-010-9078-9; Tammeorg J., 1984, EESTI NSV RAVIMTAIME; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; van Elden LJR, 2001, BRIT J GEN PRACT, V51, P630; Volmer D, 2007, MED LITH, V43, P70; Volmer D, 2011, PHYTOTHER RES, V25, P381, DOI 10.1002/ptr.3266	22	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58642	10.1371/journal.pone.0058642	http://dx.doi.org/10.1371/journal.pone.0058642			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484045	Green Published, gold			2022-12-27	WOS:000316936100132
J	Spaapen, F; van den Akker, GGH; Caron, MMJ; Prickaerts, P; Rofel, C; Dahlmans, VEH; Surtel, DAM; Paulis, Y; Schweizer, F; Welting, TJM; Eijssen, LM; Voncken, JW				Spaapen, Frank; van den Akker, Guus G. H.; Caron, Marjolein M. J.; Prickaerts, Peggy; Rofel, Celine; Dahlmans, Vivian E. H.; Surtel, Don A. M.; Paulis, Yvette; Schweizer, Finja; Welting, Tim J. M.; Eijssen, Lars M.; Voncken, Jan Willem			The Immediate Early Gene Product EGR1 and Polycomb Group Proteins Interact in Epigenetic Programming during Chondrogenesis	PLOS ONE			English	Article							ONCOGENE-INDUCED SENESCENCE; TRANSCRIPTION FACTOR; HISTONE H3; PROMOTER ACTIVITY; GROWTH-FACTOR; TARGET GENES; HOX GENES; FACTOR-I; NGFI-A; EXPRESSION	Initiation of and progression through chondrogenesis is driven by changes in the cellular microenvironment. At the onset of chondrogenesis, resting mesenchymal stem cells are mobilized in vivo and a complex, step-wise chondrogenic differentiation program is initiated. Differentiation requires coordinated transcriptomic reprogramming and increased progenitor proliferation; both processes require chromatin remodeling. The nature of early molecular responses that relay differentiation signals to chromatin is poorly understood. We here show that immediate early genes are rapidly and transiently induced in response to differentiation stimuli in vitro. Functional ablation of the immediate early factor EGR1 severely deregulates expression of key chondrogenic control genes at the onset of differentiation. In addition, differentiating cells accumulate DNA damage, activate a DNA damage response and undergo a cell cycle arrest and prevent differentiation associated hyper-proliferation. Failed differentiation in the absence of EGR1 affects global acetylation and terminates in overall histone hypermethylation. We report novel molecular connections between EGR1 and Polycomb Group function: Polycomb associated histone H3 lysine27 trimethylation (H3K27me3) blocks chromatin access of EGR1. In addition, EGR1 ablation results in abnormal Ezh2 and Bmi1 expression. Consistent with this functional interaction, we identify a number of co-regulated targets genes in a chondrogenic gene network. We here describe an important role for EGR1 in early chondrogenic epigenetic programming to accommodate early gene-environment interactions in chondrogenesis.	[Spaapen, Frank; van den Akker, Guus G. H.; Prickaerts, Peggy; Rofel, Celine; Dahlmans, Vivian E. H.; Paulis, Yvette; Voncken, Jan Willem] Maastricht Univ Med Ctr, Dept Mol Genet, Maastricht, Netherlands; [Caron, Marjolein M. J.; Surtel, Don A. M.; Schweizer, Finja; Welting, Tim J. M.] Maastricht Univ Med Ctr, Dept Orthopaed Surg, Maastricht, Netherlands; [Eijssen, Lars M.] Maastricht Univ Med Ctr, Dept Bioinformat BiGCaT, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Voncken, JW (corresponding author), Maastricht Univ Med Ctr, Dept Mol Genet, Maastricht, Netherlands.	w.voncken@maastrichtuniversity.nl	van den Akker, Guus/A-1642-2016; van den Akker, Guus/AAD-9536-2019	van den Akker, Guus/0000-0002-7071-1487; 	European Molecular Biology Organization (Germany) [ASTF5-2009]; Rene Vogels foundation (FS); Dutch Scientific Organization (ZonMW-NWO) [016.046.362]; tUL Grant; Netherlands Reuma foundation [LLP14]; University of Limburg	European Molecular Biology Organization (Germany)(European Molecular Biology Organization (EMBO)); Rene Vogels foundation (FS); Dutch Scientific Organization (ZonMW-NWO); tUL Grant; Netherlands Reuma foundation; University of Limburg	This work was supported by European Molecular Biology Organization (Germany) ASTF5-2009 (FS) and the Rene Vogels foundation (FS); Dutch Scientific Organization (ZonMW-NWO): VIDI grant 016.046.362 (JWV); tUL Grant (JWV). LLP14 Grant Netherlands Reuma foundation (JWV, LWvR) and a transnational University of Limburg grant (JWV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUSHAKRA SR, 1993, MOL BRAIN RES, V18, P216, DOI 10.1016/0169-328X(93)90192-R; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Akiyama H, 2011, J BONE MINER METAB, V29, P390, DOI 10.1007/s00774-011-0273-9; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Belluoccio D, 2008, BBA-GENE REGUL MECH, V1779, P330, DOI 10.1016/j.bbagrm.2008.02.010; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bougault C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036964; Boyle KB, 2009, CELL DEATH DIFFER, V16, P782, DOI 10.1038/cdd.2009.11; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burdan F, 2009, FOLIA HISTOCHEM CYTO, V47, P5, DOI 10.2478/v10042-009-0007-1; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; CAO XM, 1990, MOL CELL BIOL, V10, P1931, DOI 10.1128/MCB.10.5.1931; Caron MMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033467; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; CARTER DA, 1992, MOL BRAIN RES, V16, P111, DOI 10.1016/0169-328X(92)90200-U; Carter JH, 2007, J IMMUNOL, V178, P3038, DOI 10.4049/jimmunol.178.5.3038; Chen L, 2006, EXP CELL RES, V312, P1727, DOI 10.1016/j.yexcr.2006.02.013; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Deschamps J, 2004, SCIENCE, V304, P1610, DOI 10.1126/science.1099162; Deschamps J, 1999, INT J DEV BIOL, V43, P635; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5; Erno H, 1996, MECH DEVELOP, V60, P139, DOI 10.1016/S0925-4773(96)00605-3; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giri S, 2012, BRIEF FUNCT GENOMICS, V11, P188, DOI 10.1093/bfgp/elr047; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Goodliffe JM, 2005, GENE DEV, V19, P2941, DOI 10.1101/gad.1352305; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grigolo B, 2005, J BONE JOINT SURG AM, V87A, P46, DOI 10.2106/JBJS.C.01685; Hemenway CS, 1998, ONCOGENE, V16, P2541, DOI 10.1038/sj.onc.1202042; Hong DS, 2007, CANCER-AM CANCER SOC, V110, P1911, DOI 10.1002/cncr.22999; Hutchison MR, 2007, ENDOCRINOLOGY, V148, P3122, DOI 10.1210/en.2006-1264; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kawamata A, 2008, J CELL BIOCHEM, V103, P1037, DOI 10.1002/jcb.21660; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Koay EJ, 2008, OSTEOARTHR CARTILAGE, V16, P1450, DOI 10.1016/j.joca.2008.04.007; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Langmann T, 2009, NEUROMOL MED, V11, P87, DOI 10.1007/s12017-009-8061-6; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Ma JJ, 2009, J BIOL CHEM, V284, P34600, DOI 10.1074/jbc.M109.016246; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nagarajan R, 2001, NEURON, V30, P355, DOI 10.1016/S0896-6273(01)00282-3; Nakamura K, 1999, EXP CELL RES, V250, P351, DOI 10.1006/excr.1999.4535; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nebbaki SS, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3788; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Niessen HEC, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-10; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Perez-Cadahia B, 2011, BIOCHEM CELL BIOL, V89, P61, DOI 10.1139/O10-138; Prickaerts P, 2012, MK3 CONTROL IN PRESS; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Reumann MK, 2011, BONE, V49, P743, DOI 10.1016/j.bone.2011.06.023; Reumann MK, 2011, CALCIFIED TISSUE INT, V89, P1, DOI 10.1007/s00223-011-9486-0; Rockel JS, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2595; Rodier F, 2009, NAT CELL BIOL; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shin SY, 2010, MOL CANCER RES, V8, P507, DOI 10.1158/1541-7786.MCR-09-0454; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; Silverman ES, 1998, BIOCHEM J, V336, P183, DOI 10.1042/bj3360183; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Srinivasan R, 2006, J BIOL CHEM, V281, P15129, DOI 10.1074/jbc.M600775200; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Svaren J, 1996, MOL CELL BIOL, V16, P3545; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; Thiel G, 2000, BBA-GENE STRUCT EXPR, V1493, P289, DOI 10.1016/S0167-4781(00)00207-4; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; van Lohuizen M, 1998, CELL MOL LIFE SCI, V54, P71, DOI 10.1007/s000180050126; Vincenti MP, 2001, ARTHRITIS RES, V3, P381, DOI 10.1186/ar331; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wahl M, 2004, GENOMICS, V83, P45, DOI 10.1016/S0888-7543(03)00201-5; Walters JN, 2012, BIOCHEM J, V443, P561, DOI 10.1042/BJ20111801; Wang FL, 2000, OSTEOARTHR CARTILAGE, V8, P161, DOI 10.1053/joca.1999.0295; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Welting T J M, 2011, Eur Cell Mater, V22, P420; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yu JX, 2004, MOL CELL, V15, P83, DOI 10.1016/j.molcel.2004.06.030; Zheng CG, 2009, CANCER RES, V69, P2324, DOI 10.1158/0008-5472.CAN-08-4113; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	112	32	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58083	10.1371/journal.pone.0058083	http://dx.doi.org/10.1371/journal.pone.0058083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483971	gold, Green Submitted, Green Published			2022-12-27	WOS:000316936100072
J	Cirilo, PDR; Marchi, FA; Barros, MD; Rocha, RM; Domingues, MAC; Jurisica, I; Pontes, A; Rogatto, SR				Ramos Cirilo, Priscila Daniele; Marchi, Fabio Albuquerque; Barros Filho, Mateus de Camargo; Rocha, Rafael Malagoli; Custodio Domingues, Maria Aparecida; Jurisica, Igor; Pontes, Anagloria; Rogatto, Silvia Regina			An Integrative Genomic and Transcriptomic Analysis Reveals Potential Targets Associated with Cell Proliferation in Uterine Leiomyomas	PLOS ONE			English	Article							BINDING-PROTEIN IGFBP; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; GROWTH-FACTORS; COPY NUMBER; RECEPTOR; PATHOGENESIS; INHIBITOR; DELETION; TUMORS	Background: Uterine Leiomyomas (ULs) are the most common benign tumours affecting women of reproductive age. ULs represent a major problem in public health, as they are the main indication for hysterectomy. Approximately 40-50% of ULs have non-random cytogenetic abnormalities, and half of ULs may have copy number alterations (CNAs). Gene expression microarrays studies have demonstrated that cell proliferation genes act in response to growth factors and steroids. However, only a few genes mapping to CNAs regions were found to be associated with ULs. Methodology: We applied an integrative analysis using genomic and transcriptomic data to identify the pathways and molecular markers associated with ULs. Fifty-one fresh frozen specimens were evaluated by array CGH (JISTIC) and gene expression microarrays (SAM). The CONEXIC algorithm was applied to integrate the data. Principal Findings: The integrated analysis identified the top 30 significant genes (P, 0.01), which comprised genes associated with cancer, whereas the protein-protein interaction analysis indicated a strong association between FANCA and BRCA1. Functional in silico analysis revealed target molecules for drugs involved in cell proliferation, including FGFR1 and IGFBP5. Transcriptional and protein analyses showed that FGFR1 (P = 0.006 and P, 0.01, respectively) and IGFBP5 (P = 0.0002 and P = 0.006, respectively) were up-regulated in the tumours when compared with the adjacent normal myometrium. Conclusions: The integrative genomic and transcriptomic approach indicated that FGFR1 and IGFBP5 amplification, as well as the consequent up-regulation of the protein products, plays an important role in the aetiology of ULs and thus provides data for potential drug therapies development to target genes associated with cellular proliferation in ULs.	[Ramos Cirilo, Priscila Daniele] UNESP Sao Paulo State Univ, Dept Genet, Inst Biosci, Sao Paulo, Brazil; [Ramos Cirilo, Priscila Daniele; Marchi, Fabio Albuquerque; Barros Filho, Mateus de Camargo; Rogatto, Silvia Regina] Fundacao Antonio Prudente, CIPE NeoGene Lab, AC Camargo Hosp, Sao Paulo, Brazil; [Marchi, Fabio Albuquerque] Univ Sao Paulo, Interinst Grad Program Bioinformat, Inst Math & Stat, Sao Paulo, Brazil; [Rocha, Rafael Malagoli] Fundacao Antonio Prudente, Dept Anat Pathol, AC Camargo Hosp, Sao Paulo, Brazil; [Custodio Domingues, Maria Aparecida] UNESP Sao Paulo State Univ, Dept Pathol, Sch Med, Sao Paulo, Brazil; [Jurisica, Igor] Campbell Family Inst Canc Res, Ontario Canc Inst, Toronto, ON, Canada; [Jurisica, Igor] Univ Hlth Network, Techna Inst, Toronto, ON, Canada; [Pontes, Anagloria] Sao Paulo State Univ, Dept Obstet & Gynaecol, Sch Med, Sao Paulo, Brazil; [Rogatto, Silvia Regina] UNESP Sao Paulo State Univ, Dept Urol, Sch Med, Sao Paulo, Brazil	Universidade Estadual Paulista; A.C.Camargo Cancer Center; Universidade de Sao Paulo; A.C.Camargo Cancer Center; Universidade Estadual Paulista; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universidade Estadual Paulista; Universidade Estadual Paulista	Rogatto, SR (corresponding author), Fundacao Antonio Prudente, CIPE NeoGene Lab, AC Camargo Hosp, Sao Paulo, Brazil.	rogatto@fmb.unesp.br	Marchi, Fabio A/N-9288-2018; Rogatto, Silvia R/E-6535-2012; Filho, Mateus C Barros/J-1544-2015; Cirillo, Priscila Daniele Ramos/AAH-4246-2020	Marchi, Fabio A/0000-0001-5815-8423; Filho, Mateus C Barros/0000-0003-3893-5269; Cirillo, Priscila Daniele Ramos/0000-0001-5453-3978; Rogatto, Silvia/0000-0003-4637-5687; Custodio Domingues, Maria Aparecida/0000-0002-4023-3410	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2007/51643-8, 2008/58835-2]; Conselho Nacional de Pesquisa [485032/2007-4]; Ontario Research Fund [GL2-01-030]; Canada Foundation for Innovation (CFI) [12301, 203373]; CIHR Research Grant [93579]; Ontario Ministry of Health and Long Term Care; Canada Research Chair Program	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa; Ontario Research Fund; Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); CIHR Research Grant(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Canada Research Chair Program(Canada Research Chairs)	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2007/51643-8 to PDRC, 2008/58835-2 to SRR), and Conselho Nacional de Pesquisa (485032/2007-4 to SRR). Computational analysis was supported in part by Ontario Research Fund (GL2-01-030 to IJ), Canada Foundation for Innovation (CFI #12301, CFI #203373 to IJ), CIHR Research Grant (#93579 to IJ), the Ontario Ministry of Health and Long Term Care. IJ is funded by Canada Research Chair Program. The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesanya OO, 1996, J CLIN ENDOCR METAB, V81, P2495, DOI 10.1210/jc.81.7.2495; Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Anania CA, 1997, MOL HUM REPROD, V3, P685, DOI 10.1093/molehr/3.8.685; Arslan AA, 2005, HUM REPROD, V20, P852, DOI 10.1093/humrep/deh698; Baird DD, 2003, EPIDEMIOLOGY, V14, P247; Becker MA, 2012, CLIN CANCER RES, V18, P1808, DOI 10.1158/1078-0432.CCR-11-1806; Behera Millie A, 2007, Reprod Sci, V14, P63, DOI 10.1177/1933719107309591; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonatz G, 1998, AM J OBSTET GYNECOL, V179, P591, DOI 10.1016/S0002-9378(98)70050-X; Brown KR, 2009, BIOINFORMATICS, V25, P3327, DOI 10.1093/bioinformatics/btp595; Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273; Bussey KJ, 2006, MOL CANCER THER, V5, P853, DOI 10.1158/1535-7163.MCT-05-0155; Canevari RA, 2007, ASIAN J CANC, V6, P15; Canevari RD, 2005, MOL CARCINOGEN, V42, P177, DOI 10.1002/mc.20074; Collins NB, 2009, BLOOD, V113, P2181, DOI 10.1182/blood-2008-05-154294; Cook H, 2010, Minerva Ginecol, V62, P225; Courjal F, 1997, CANCER RES, V57, P4360; Crabtree JS, 2009, CANCER RES, V69, P6171, DOI 10.1158/0008-5472.CAN-08-4471; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Desai SS, 2011, J HAND SURG-AM, V36A, P936, DOI 10.1016/j.jhsa.2011.03.002; Dimitrova IK, 2009, FERTIL STERIL, V91, P2650, DOI 10.1016/j.fertnstert.2008.03.071; Dixon D, 2000, ENVIRON HEALTH PERSP, V108, P795, DOI 10.2307/3454309; El-Gharib MN, 2010, J OBSTET GYNAECOL RE, V36, P101, DOI 10.1111/j.1447-0756.2009.01099.x; Elsheikh SE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1665; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Georgieva B, 2012, GENOMICS, V99, P275, DOI 10.1016/j.ygeno.2012.03.003; GIUDICE LC, 1993, HUM REPROD, V8, P1796, DOI 10.1093/oxfordjournals.humrep.a137937; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Gullu G, 2012, CHIN J CANCER, V31, P266, DOI 10.5732/cjc.011.10405; Haugsten EM, 2010, MOL CANCER RES, V8, P1439, DOI 10.1158/1541-7786.MCR-10-0168; Hodge JC, 2012, HUM MOL GENET, V21, P2312, DOI 10.1093/hmg/dds051; Hodge JC, 2009, GENE CHROMOSOME CANC, V48, P865, DOI 10.1002/gcc.20692; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Ishikawa H, 2010, ENDOCRINOLOGY, V151, P2433, DOI 10.1210/en.2009-1225; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Keisner SV, 2011, DRUGS, V71, P443, DOI 10.2165/11588960-000000000-00000; Levy B, 2000, CANCER GENET CYTOGEN, V121, P1, DOI 10.1016/S0165-4608(00)00225-9; Lin N, 2011, AM J PHYSIOL-CELL PH, V301, pC469, DOI 10.1152/ajpcell.00452.2010; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Luo XP, 2005, ENDOCRINOLOGY, V146, P1097, DOI 10.1210/en.2004-1377; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Malik M, 2010, SEMIN REPROD MED, V28, P168, DOI 10.1055/s-0030-1251475; Mantovani MS, 1999, GYNECOL ONCOL, V72, P71, DOI 10.1006/gyno.1998.5222; MCGUIRE WL, 1992, J NATL CANCER I, V84, P1336, DOI 10.1093/jnci/84.17.1336; Nikitenko LL, 2006, CLIN CANCER RES, V12, P5648, DOI 10.1158/1078-0432.CCR-06-0852; Packenham JP, 1997, MOL CARCINOGEN, V19, P273, DOI 10.1002/(SICI)1098-2744(199708)19:4<273::AID-MC9>3.0.CO;2-D; Pascale A, 2012, CELL MOL LIFE SCI, V69, P501, DOI 10.1007/s00018-011-0810-7; Quade BJ, 2004, GENE CHROMOSOME CANC, V40, P97, DOI 10.1002/gcc.20018; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rosa FE, 2008, HUM PATHOL, V39, P720, DOI 10.1016/j.humpath.2007.09.019; Sanchez-Garcia F, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-189; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shah, 1996, Medscape Womens Health, V1, P8; Solyom S, 2011, CANCER LETT, V302, P113, DOI 10.1016/j.canlet.2010.12.020; Sozen I, 2002, FERTIL STERIL, V78, P1, DOI 10.1016/S0015-0282(02)03154-0; Staaf J, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2568; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorvaldsdottir H., 2012, BRIEF BIOIN IN PRESS; Tsibris JCM, 2002, FERTIL STERIL, V78, P114, DOI 10.1016/S0015-0282(02)03191-6; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vanharanta S, 2005, ONCOGENE, V24, P6545, DOI 10.1038/sj.onc.1208784; Vanharanta S, 2007, GENE CHROMOSOME CANC, V46, P451, DOI 10.1002/gcc.20427; Yu LD, 2008, MOL MED, V14, P264, DOI 10.2119/2007-00101.Yu; Zavadil J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012362	69	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57901	10.1371/journal.pone.0057901	http://dx.doi.org/10.1371/journal.pone.0057901			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483937	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900051
J	Boman, KK; Kjallander, Y; Eksborg, S; Becker, J				Boman, Krister K.; Kjallander, Ylva; Eksborg, Staffan; Becker, Jeremy			Impact of Prior Traumatic Life Events on Parental Early Stage Reactions following a Child's Cancer	PLOS ONE			English	Article							POSTTRAUMATIC STRESS SYMPTOMS; RISK-FACTORS; DISTRESS; SURVIVORS; DISORDER; ILLNESS; MODEL; VULNERABILITY; ASSOCIATIONS; DEPRESSION	Background: In pediatric oncology, effective clinic-based management of acute and long-term distress in families calls for investigation of determinants of parents' psychological response to the child's cancer. We examined the relationship between parents' prior exposure to traumatic life events (TLE) and the occurrence of posttraumatic stress symptoms (PTSS) following their child's cancer diagnosis. Factors mediating the TLE-PTSS relationship were analyzed. Methodology: The study comprised 169 parents (97 mothers, 72 fathers) of 103 cancer diagnosed children (median age: 5,9 years; range 0.1-19.7 years). Thirty five parents were of immigrant origin (20.7%). Prior TLE were collated using a standardized questionnaire, PTSS was assessed using the Impact of Events-Revised (IES-R) questionnaire covering intrusion, avoidance and hyperarousal symptoms. The predictive significance of prior TLE on PTSS was tested in adjusted regression models. Results: Mothers demonstrated more severe PTSS across all symptom dimensions. TLE were associated with significantly increased hyperarousal symptoms. Parents' gender, age and immigrant status did not significantly influence the TLE-PTSS relationship. Conclusions: Prior traumatic life-events aggravate posttraumatic hyperarousal symptoms. In clinic-based psychological care of parents of high-risk pediatric patients, attention needs to be paid to life history, and to heightened vulnerability to PTSS associated with female gender.	[Boman, Krister K.; Kjallander, Ylva; Eksborg, Staffan; Becker, Jeremy] Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden; [Boman, Krister K.] Aastrid Lindgren Childrens Hosp, Stockholm, Sweden; [Kjallander, Ylva] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden	Karolinska Institutet; Stockholm University	Boman, KK (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Childhood Canc Res Unit, Stockholm, Sweden.	krister.boman@ki.se		Eksborg, Staffan/0000-0001-7326-9471; Boman, Krister K./0000-0003-1287-2626	Swedish Childhood Cancer Foundation; Cancer and Traffic Injury Fund Sweden; Karolinska Institutet institutional	Swedish Childhood Cancer Foundation(European Commission); Cancer and Traffic Injury Fund Sweden; Karolinska Institutet institutional	This study was granted by The Swedish Childhood Cancer Foundation, The Cancer and Traffic Injury Fund Sweden, and Karolinska Institutet institutional grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P1257; Best M, 2001, J PEDIATR PSYCHOL, V26, P299, DOI 10.1093/jpepsy/26.5.299; Boman K, 2003, ACTA ONCOL, V42, P137, DOI 10.1080/02841860310004995; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; Coffey Jean Sheerin, 2006, Pediatr Nurs, V32, P51; Courtois CA, 2004, PSYCHOTHERAPY, V41, P412, DOI 10.1037/0033-3204.41.4.412; Duffey-Lind Eileen C, 2006, J Pediatr Oncol Nurs, V23, P335, DOI 10.1177/1043454206293267; EISER C, 1990, J CHILD PSYCHOL PSYC, V31, P85, DOI 10.1111/j.1469-7610.1990.tb02274.x; GOLDBERG S, 1990, J PEDIATR PSYCHOL, V15, P347, DOI 10.1093/jpepsy/15.3.347; Gudmundsdottir E, 2010, ACTA ONCOLOGICA; Hardy KK, 2008, J PEDIAT HEMATOL ONC, V30, P153, DOI 10.1097/MPH.0b013e31815814d9; Hatcher S, 2003, PSYCHOL MED, V33, P1185, DOI 10.1017/S0033291703008274; HERMAN JL, 1992, J TRAUMA STRESS, V5, P377, DOI 10.1007/BF00977235; Hoekstra-Weebers JEHM, 1999, J AM ACAD CHILD PSY, V38, P1526, DOI 10.1097/00004583-199912000-00014; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hoven E, 2008, J PEDIAT HEMATOL ONC, V30, P807, DOI 10.1097/MPH.0b013e31818a9553; Ingram RE., 2005, VULNERABILITY STRESS, P32, DOI DOI 10.4135/9781452231655.N2; Kazak A. E., 1992, ADV PEDIAT PSYCHOL S, P262; KAZAK AE, 1989, J CONSULT CLIN PSYCH, V57, P25, DOI 10.1037/0022-006X.57.1.25; Kazak AE, 1999, FAM PROCESS, V38, P175; Kazak AE, 2004, J PEDIATR PSYCHOL, V29, P211, DOI 10.1093/jpepsy/jsh022; Kessing LV, 2003, PSYCHOL MED, V33, P1177, DOI 10.1017/S0033291703007852; Landolt MA, 2003, J CHILD PSYCHOL PSYC, V44, P1199, DOI 10.1111/1469-7610.00201; Liberman RP, 2008, RECOVERY DISABILITY; Lopez A, 2011, WORK, V38, P33, DOI 10.3233/WOR-2011-1102; McGrath Pam, 2002, Oncol Nurs Forum, V29, P988, DOI 10.1188/02.ONF.988-996; MORROW GR, 1984, J PEDIATR PSYCHOL, V9, P317, DOI 10.1093/jpepsy/9.3.317; Norberg AL, 2005, ACTA ONCOL, V44, P382, DOI 10.1080/02841860510029789; Norberg AL, 2008, ACTA ONCOL, V47, P267, DOI 10.1080/02841860701558773; NUECHTERLEIN KH, 1984, SCHIZOPHRENIA BULL, V10, P300, DOI 10.1093/schbul/10.2.300; Patino-Fernandez AM, 2008, PEDIATR BLOOD CANCER, V50, P289, DOI 10.1002/pbc.21262; Pizur-Barnekow K, 2010, AM J OCCUP THER, V64, P642, DOI 10.5014/ajot.2010.08160; Poder U, 2007, PSYCHOONCOLOGY; POST RM, 1992, AM J PSYCHIAT, V149, P999; Statistics S, 1989, REPORTS STAT COORDIN; Sundquist J, 1997, SOC SCI MED, V44, P189, DOI 10.1016/S0277-9536(96)00145-1; ULLMAN SE, 1994, J COMMUNITY PSYCHOL, V22, P328, DOI 10.1002/1520-6629(199410)22:4<328::AID-JCOP2290220405>3.0.CO;2-L; Updegraff JA, 2000, LOSS TRAUMA GEN CLOS, P3, DOI DOI 10.4324/9781315783345-2; Van Dongen-Melman JEWM, 1995, THESIS ERASMUS U ROT; VANDVIK IH, 1991, J DEV BEHAV PEDIATR, V12, P84; Wallander JL, 1998, J CHILD PSYCHOL PSYC, V39, P29, DOI 10.1111/1469-7610.00302; Weiss D. S., 2007, ASSESSING PSYCHOL TR, P219, DOI [10.1007/978-0-387-70990-1_10, DOI 10.1007/978-0-387-70990-1_10]; Yalug I, 2008, PEDIATR HEMAT ONCOL, V25, P27, DOI 10.1080/08880010701704048; Young B, 2002, SOC SCI MED, V55, P1835, DOI 10.1016/S0277-9536(01)00318-5; ZILBERG NJ, 1982, J CONSULT CLIN PSYCH, V50, P407, DOI 10.1037/0022-006X.50.3.407; ZUBIN J, 1977, J ABNORM PSYCHOL, V86, P103, DOI 10.1037/0021-843X.86.2.103	48	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57556	10.1371/journal.pone.0057556	http://dx.doi.org/10.1371/journal.pone.0057556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109YM	23516408	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400009
J	Lamber, EP; Beuron, F; Morris, EP; Svergun, DI; Mittnacht, S				Lamber, Ekaterina P.; Beuron, Fabienne; Morris, Edward P.; Svergun, Dmitri I.; Mittnacht, Sibylle			Structural Insights into the Mechanism of Phosphoregulation of the Retinoblastoma Protein	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; CELL-CYCLE CONTROL; TUMOR-SUPPRESSOR; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; PHOSPHORYLATION; CANCER; DOMAIN; E2F; RB	The retinoblastoma susceptibility protein RB1 is a key regulator of cell proliferation and fate. RB1 operates through nucleating the formation of multi-component protein complexes involved in the regulation of gene transcription, chromatin structure and protein stability. Phosphorylation of RB1 by cyclin-dependent kinases leads to conformational alterations and inactivates the capability of RB1 to bind partner protein. Using small angle X-ray scattering in combination with single particle analysis of transmission electron microscope images of negative-stained material we present the first three-dimensional reconstruction of non-phosphorylated RB1 revealing an extended architecture and deduce the domain arrangement within the molecule. Phosphorylation results in an overt alteration of the molecular shape and dimensions, consistent with the transition to a compact globular architecture. The work presented provides what is to our knowledge the first description of the relative domain arrangement in active RB1 and predicts the molecular movement that leads to RB1 inactivation following protein phosphorylation.	[Lamber, Ekaterina P.; Mittnacht, Sibylle] Inst Canc Res, Div Canc Biol, London SW3 6JB, England; [Beuron, Fabienne; Morris, Edward P.] Inst Canc Res, Div Struct Biol, London SW3 6JB, England; [Svergun, Dmitri I.] DESY, European Mol Biol Lab, Hamburg Outstn, Hamburg, Germany; [Mittnacht, Sibylle] UCL Canc Inst, Res Dept Canc Biol, London, England; [Mittnacht, Sibylle] Univ Coll London Hosp, Biomed Res Ctr, Univ Coll London, Natl Inst Hlth Res, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Lamber, EP (corresponding author), Univ London Birkbeck Coll, Dept Biol Sci, Inst Struct & Mol Biol, London WC1E 7HX, England.	e.lamber@mail.cryst.bbk.ac.uk; s.mittnacht@cancer.ucl.ac.uk	Lamber, Ekaterina/AAD-3490-2019	Svergun, Dmitri/0000-0003-0830-5696; Morris, Edward/0000-0003-3544-0041	International Human Frontier Science Program fellowship [LT000665/2009-L]; Cancer Research UK [CRUK/A7640, CRUK/A15043]; National Institute for Health Research, University College London Hospitals Biomedical Research Centre; Institute of Cancer Research; EU [261572]	International Human Frontier Science Program fellowship; Cancer Research UK(Cancer Research UK); National Institute for Health Research, University College London Hospitals Biomedical Research Centre; Institute of Cancer Research; EU(European Commission)	Ekaterina Lamber acknowledges financial support from The International Human Frontier Science Program fellowship LT000665/2009-L (web: http://www.hfsp.org/). This work was supported by Cancer Research UK grants CRUK/A7640 and CRUK/A15043 to Sibylle Mittnacht (web: http://www.cancerresearchuk.org/), with further support from the National Institute for Health Research, University College London Hospitals Biomedical Research Centre. Ed Morris acknowledges support from the Institute of Cancer Research (web: http://www.icr.ac.uk/). Dmitri Svergun acknowledges support from the EU FP7 e-Infrastructure grant WeNMR, contract number 261572 (web: http://www.wenmr.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Batsche E, 2005, J BIOL CHEM, V280, P19746, DOI 10.1074/jbc.M413428200; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Burke JR, 2012, GENE DEV, V26, P1156, DOI 10.1101/gad.189837.112; Chemes LB, 2012, J MOL BIOL, V422, P336, DOI 10.1016/j.jmb.2012.05.036; Chinnam M, 2011, CURR TOP DEV BIOL, V94, P129, DOI 10.1016/B978-0-12-380916-2.00005-X; CHOUBEY D, 1995, J BIOL CHEM, V270, P6134, DOI 10.1074/jbc.270.11.6134; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; Classon M, 2001, EXP CELL RES, V264, P135, DOI 10.1006/excr.2000.5135; Cuomo ME, 2008, NAT CELL BIOL, V10, P723, DOI 10.1038/ncb1735; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Goo YH, 2004, J BIOL CHEM, V279, P7131, DOI 10.1074/jbc.M312563200; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Lohmann D, 2010, ADV EXP MED BIOL, V685, P220; LUDLOW JW, 1989, CELL, V56, P57, DOI 10.1016/0092-8674(89)90983-5; MITTNACHT S, 1994, EMBO J, V13, P118, DOI 10.1002/j.1460-2075.1994.tb06241.x; Mittnacht S, 2005, EUR J CELL BIOL, V84, P97, DOI 10.1016/j.ejcb.2004.12.012; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; Moll AC, 1997, OPHTHALMIC GENET, V18, P27, DOI 10.3109/13816819709057880; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Palmero I, 1996, CANCER SURV, V27, P351; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Shao ZH, 1997, ONCOGENE, V15, P385, DOI 10.1038/sj.onc.1201204; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wong FL, 1997, JAMA-J AM MED ASSOC, V278, P1262, DOI 10.1001/jama.278.15.1262; Xiao B, 2003, P NATL ACAD SCI USA, V100, P2363, DOI 10.1073/pnas.0436813100; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhu LA, 2005, EUR J CANCER, V41, P2415, DOI 10.1016/j.ejca.2005.08.009	46	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58463	10.1371/journal.pone.0058463	http://dx.doi.org/10.1371/journal.pone.0058463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516486	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400032
J	Das, T; Kutty, SK; Kumar, N; Manefield, M				Das, Theerthankar; Kutty, Samuel K.; Kumar, Naresh; Manefield, Mike			Pyocyanin Facilitates Extracellular DNA Binding to Pseudomonas aeruginosa Influencing Cell Surface Properties and Aggregation	PLOS ONE			English	Article							BACTERIAL ADHESION; BIOFILM FORMATION; RELEASE; FORCES; DEATH; MODE	Pyocyanin is an electrochemically active metabolite produced by the human pathogen Pseudomonas aeruginosa. It is a recognized virulence factor and is involved in a variety of significant biological activities including gene expression, maintaining fitness of bacterial cells and biofilm formation. It is also recognized as an electron shuttle for bacterial respiration and as an antibacterial and antifungal agent. eDNA has also been demonstrated to be a major component in establishing P. aeruginosa biofilms. In this study we discovered that production of pyocyanin influences the binding of eDNA to P. aeruginosa PA14 cells, mediated through intercalation of pyocyanin with eDNA. P. aeruginosa cell surface properties including cell size (hydrodynamic diameter), hydrophobicity and attractive surface energies were influenced by eDNA in the presence of pyocyanin, affecting physico-chemical interactions and promoting aggregation. A Delta phzA-G PA14 mutant, deficient in pyocynain production, could not bind with eDNA resulting in a reduction in hydrodynamic diameter, a decrease in hydrophobicity, repulsive physico-chemical interactions and reduction in aggregation in comparison to the wildtype strain. Removal of eDNA by DNase I treatment on the PA14 wildtype strain resulted in significant reduction in aggregation, cell surface hydrophobicity and size and an increase in repulsive physico-chemical interactions, similar to the level of the Delta phzA-G mutant. The cell surface properties of the Delta phzA-G mutant were not affected by DNase I treatment. Based on these findings we propose that pyocyanin intercalation with eDNA promotes cell-to-cell interactions in P. aeruginosa cells by influencing their cell surface properties and physico-chemical interactions.	[Das, Theerthankar; Manefield, Mike] Univ New S Wales, Sch Biotechnol & Biomol Sci BABS, Ctr Marine BioInnovat, Sydney, NSW, Australia; [Kutty, Samuel K.; Kumar, Naresh] Univ New S Wales, Sch Chem, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Das, T (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci BABS, Ctr Marine BioInnovat, Sydney, NSW, Australia.	theerthankar_das11@rediffmail.com		Kumar, Naresh/0000-0002-0951-9621; Kutty, Samuel/0000-0001-8137-9988	Australian Research Council (ARC) [FT100100078]	Australian Research Council (ARC)(Australian Research Council)	This work was funded by Australian Research Council (ARC) Future Fellowship Project ID FT100100078, http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Bakker E M, 2007, Expert Rev Respir Med, V1, P317, DOI 10.1586/17476348.1.3.317; Beech WB, 2004, CURR OPIN BIOTECH, V15, P181, DOI 10.1016/j.copbio.2004.05.001; Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0; Carrozzo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015638; Das T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046718; Das T, 2011, LANGMUIR, V27, P10113, DOI 10.1021/la202013m; Das T, 2011, SOFT MATTER, V7, P2927, DOI 10.1039/c0sm01142h; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Dhanasekaran D, 2009, INT J ENVIRON SCI TE, V6, P197; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; KHOLODENKO AL, 1995, PHYS REV E, V51, P1081, DOI 10.1103/PhysRevE.51.1081; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Liu HH, 2008, CURR MICROBIOL, V57, P139, DOI 10.1007/s00284-008-9166-0; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Petersen FC, 2004, J BACTERIOL, V186, P6327, DOI 10.1128/JB.186.18.6327-6331.2004; Price-Whelan A, 2006, NAT CHEM BIOL, V2, P71, DOI 10.1038/nchembio764; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Ramos I, 2010, RES MICROBIOL, V161, P187, DOI 10.1016/j.resmic.2010.01.003; Sharma PK, 2003, COLLOID SURFACE B, V29, P21, DOI 10.1016/S0927-7765(02)00180-7; SUH D, 1995, BIOORGAN MED CHEM, V3, P723, DOI 10.1016/0968-0896(95)00053-J; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Tsuneda S, 2003, FEMS MICROBIOL LETT, V223, P287, DOI 10.1016/S0378-1097(03)00399-9; VANOSS CJ, 1995, COLLOID SURFACE B, V5, P91, DOI 10.1016/0927-7765(95)01217-7; Venkataraman A, 2010, ELECTROCHEM COMMUN, V12, P459, DOI 10.1016/j.elecom.2010.01.019; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Zheng LY, 2011, J BACTERIOL, V193, P516, DOI 10.1128/JB.01131-10	34	68	73	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58299	10.1371/journal.pone.0058299	http://dx.doi.org/10.1371/journal.pone.0058299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505483	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100043
J	Dearth, CL; Goh, Q; Marino, JS; Cicinelli, PA; Torres-Palsa, MJ; Pierre, P; Worth, RG; Pizza, FX				Dearth, Christopher L.; Goh, Qingnian; Marino, Joseph S.; Cicinelli, Peter A.; Torres-Palsa, Maria J.; Pierre, Philippe; Worth, Randall G.; Pizza, Francis X.			Skeletal Muscle Cells Express ICAM-1 after Muscle Overload and ICAM-1 Contributes to the Ensuing Hypertrophic Response	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; DYSTROPHIN-GLYCOPROTEIN COMPLEX; CYTOKINE-INDUCED EXPRESSION; ENDOTHELIAL-CELLS; SATELLITE CELLS; HUMAN MYOBLASTS; IN-VITRO; LENGTHENING CONTRACTIONS; INFLAMMATORY MYOPATHIES; PASSIVE STRETCHES	We previously reported that leukocyte specific beta 2 integrins contribute to hypertrophy after muscle overload in mice. Because intercellular adhesion molecule-1 (ICAM-1) is an important ligand for beta 2 integrins, we examined ICAM-1 expression by murine skeletal muscle cells after muscle overload and its contribution to the ensuing hypertrophic response. Myofibers in control muscles of wild type mice and cultures of skeletal muscle cells (primary and C2C12) did not express ICAM-1. Overload of wild type plantaris muscles caused myofibers and satellite cells/myoblasts to express ICAM-1. Increased expression of ICAM-1 after muscle overload occurred via a beta 2 integrin independent mechanism as indicated by similar gene and protein expression of ICAM-1 between wild type and beta 2 integrin deficient (CD18-/-) mice. ICAM-1 contributed to muscle hypertrophy as demonstrated by greater (p<0.05) overload-induced elevations in muscle protein synthesis, mass, total protein, and myofiber size in wild type compared to ICAM-1-/-mice. Furthermore, expression of ICAM-1 altered (p, 0.05) the temporal pattern of Pax7 expression, a marker of satellite cells/myoblasts, and regenerating myofiber formation in overloaded muscles. In conclusion, ICAM-1 expression by myofibers and satellite cells/ myoblasts after muscle overload could serve as a mechanism by which ICAM-1 promotes hypertrophy by providing a means for cell-to-cell communication with beta 2 integrin expressing myeloid cells.	[Dearth, Christopher L.; Goh, Qingnian; Marino, Joseph S.; Cicinelli, Peter A.; Torres-Palsa, Maria J.; Pizza, Francis X.] Univ Toledo, Dept Kinesiol, Toledo, OH 43606 USA; [Pierre, Philippe] Aix Marseille Univ, Ctr Immunol Marseille Luminy U2M, Marseille, France; [Pierre, Philippe] INSERM, Inst Natl Sante & Rech Med, U631, F-13258 Marseille, France; [Pierre, Philippe] CNRS, Ctr Natl Rech Sci, UMR6102, Marseille, France; [Worth, Randall G.] Univ Toledo, Coll Med & Life Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); University System of Ohio; University of Toledo	Pizza, FX (corresponding author), Univ Toledo, Dept Kinesiol, 2801 W Bancroft St, Toledo, OH 43606 USA.	Francis.Pizza@utoledo.edu	Dearth, Christopher L./AAG-6877-2020	Dearth, Christopher L./0000-0003-3701-0950; Pizza, Francis/0000-0002-0857-6384; Marino, Joseph/0000-0002-6207-5986; pierre, philippe/0000-0003-0863-8255; Goh, Qingnian/0000-0003-4108-2957; Worth, Randall/0000-0002-2626-7964	American College of Sports Medicine Doctoral Student Research Program; University of Toledo Interdisciplinary Research Initiation Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR064858] Funding Source: NIH RePORTER	American College of Sports Medicine Doctoral Student Research Program; University of Toledo Interdisciplinary Research Initiation Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by grants from the American College of Sports Medicine Doctoral Student Research Program (C. L. Dearth) and the University of Toledo Interdisciplinary Research Initiation Program (F. X. Pizza). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; BARTOCCIONI E, 1994, CLIN EXP IMMUNOL, V95, P166; Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Brickson S, 2003, J APPL PHYSIOL, V95, P969, DOI 10.1152/japplphysiol.00005.2003; Bruusgaard JC, 2010, P NATL ACAD SCI USA, V107, P15111, DOI 10.1073/pnas.0913935107; Charlton CA, 2000, DEV BIOL, V221, P112, DOI 10.1006/dbio.2000.9654; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Cheng JJ, 1996, HYPERTENSION, V28, P386, DOI 10.1161/01.HYP.28.3.386; Clayton A, 1998, J CELL SCI, V111, P443; DEBLEECKER JL, 1994, J NEUROPATH EXP NEUR, V53, P369, DOI 10.1097/00005072-199407000-00008; DiPasquale DM, 2007, AM J PHYSIOL-CELL PH, V293, pC1278, DOI 10.1152/ajpcell.00201.2007; Dumont N, 2010, AM J PATHOL, V176, P2228, DOI 10.2353/ajpath.2010.090884; Esser K., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P338; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; GOEBELS N, 1992, J IMMUNOL, V149, P661; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Guerette B, 1997, J IMMUNOL, V159, P2522; Hardy KM, 2009, AM J PHYSIOL-REG I, V296, pR1855, DOI 10.1152/ajpregu.00076.2009; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hubbard AK, 2000, FREE RADICAL BIO MED, V28, P1379, DOI 10.1016/S0891-5849(00)00223-9; Huey KA, 2007, J APPL PHYSIOL, V102, P2307, DOI 10.1152/japplphysiol.00021.2007; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; KLIETSCH R, 1993, CIRC RES, V72, P349, DOI 10.1161/01.RES.72.2.349; Koyama Y, 1996, J IMMUNOL, V157, P5097; Kukreti S, 1997, BLOOD, V89, P4104, DOI 10.1182/blood.V89.11.4104; Lawson C, 1999, J IMMUNOL, V162, P2990; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lockhart NC, 2008, J APPL PHYSIOL, V104, P1109, DOI 10.1152/japplphysiol.00850.2007; Marino JS, 2008, AM J PHYSIOL-CELL PH, V295, pC1026, DOI 10.1152/ajpcell.212.2008; Marino M, 2003, J NEUROIMMUNOL, V134, P151, DOI 10.1016/S0165-5728(02)00399-5; Marino M, 2001, J NEUROIMMUNOL, V116, P94, DOI 10.1016/S0165-5728(01)00287-9; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McLoughlin TJ, 2003, CELL TISSUE RES, V313, P313, DOI 10.1007/s00441-003-0767-4; McLoughlin TJ, 2003, J APPL PHYSIOL, V94, P876, DOI 10.1152/japplphysiol.00766.2002; MEERSCHAERT J, 1995, J IMMUNOL, V154, P4099; MICHAELIS D, 1993, AM J PATHOL, V143, P1142; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; NAGEL T, 1994, J CLIN INVEST, V94, P885, DOI 10.1172/JCI117410; Nguyen HX, 2003, J PHYSIOL-LONDON, V547, P125, DOI 10.1113/jphysiol.2002.031450; O'Connor RS, 2007, J APPL PHYSIOL, V103, P1099, DOI 10.1152/japplphysiol.00101.2007; OHLENDIECK K, 1991, J CELL BIOL, V112, P135, DOI 10.1083/jcb.112.1.135; Panes J, 1995, AM J PHYSIOL-HEART C, V269, pH1955, DOI 10.1152/ajpheart.1995.269.6.H1955; Pattillo CB, 2010, FREE RADICAL BIO MED, V49, P1119, DOI 10.1016/j.freeradbiomed.2010.06.030; PAVLATH GK, 1994, J CELL BIOL, V127, P1923, DOI 10.1083/jcb.127.6.1923; Peterson JM, 2009, J APPL PHYSIOL, V106, P130, DOI 10.1152/japplphysiol.90584.2008; Pizza FX, 2005, J PHYSIOL-LONDON, V562, P899, DOI 10.1113/jphysiol.2004.073965; Pizza FX, 2002, J APPL PHYSIOL, V92, P1873, DOI 10.1152/japplphysiol.01055.2001; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; ROBERTSON TA, 1993, EXP CELL RES, V207, P321, DOI 10.1006/excr.1993.1199; Robker RL, 2004, OBES RES, V12, P936, DOI 10.1038/oby.2004.114; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Smith RE, 1997, J LEUKOCYTE BIOL, V62, P612, DOI 10.1002/jlb.62.5.612; Thompson RW, 2006, EXP GERONTOL, V41, P1136, DOI 10.1016/j.exger.2006.08.013; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Tsivitse SK, 2005, AM J PHYSIOL-CELL PH, V288, pC721, DOI 10.1152/ajpcell.00237.2004; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; WILSON RW, 1993, J IMMUNOL, V151, P1571; Zoico E, 2002, NUTR REV, V60, P39, DOI 10.1301/00296640260085949	62	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58486	10.1371/journal.pone.0058486	http://dx.doi.org/10.1371/journal.pone.0058486			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505517	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100055
J	Okazawa, S; Furusawa, Y; Kariya, A; Hassan, MA; Arai, M; Hayashi, R; Tabuchi, Y; Kondo, T; Tobe, K				Okazawa, Seisuke; Furusawa, Yukihiro; Kariya, Ayako; Hassan, Mariame Ali; Arai, Mie; Hayashi, Ryuji; Tabuchi, Yoshiaki; Kondo, Takashi; Tobe, Kazuyuki			Inactivation of DNA-Dependent Protein Kinase Promotes Heat-Induced Apoptosis Independently of Heat-Shock Protein Induction in Human Cancer Cell Lines	PLOS ONE			English	Article							NF-KAPPA-B; ARYL-HYDROCARBON RECEPTOR; LYMPHOMA U937 CELLS; GENE-EXPRESSION; REGIONAL HYPERTHERMIA; CYTOKINE EXPRESSION; ACTIVATION; STRESS; IDENTIFICATION; DEATH	The inhibition of DNA damage response pathway seems to be an attractive strategy for cancer therapy. It was previously reported that in rodent cells exposed to heat stress, cell growth was promoted by the activity of DNA-dependent protein kinase (DNA-PK), an enzyme involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair. The absence of a functioning DNA-PK was associated with down regulation of heat shock protein 70 (HSP70). The objective of this study is thus to investigate the role of DNA-PK inhibition in heat-induced apoptosis in human cell lines. The inhibitors of phosphorylation of the DNA-PK catalytic subunit (DNA-PKcs) at Ser2056, such as NU7026 and NU7441, were utilized. Furthermore, knock down of DNA-PKcs was carried out using small interfering RNA (siDNA-PKcs). For heat exposure, cells were placed in water bath at 44 degrees C for 60 min. Apoptosis was evaluated after 24 h incubation flow cytometrically. Proteins were extracted after 24 h and analyzed for HSP70 and HSP40 expression by Western blotting. Total RNA was extracted 6 h after treatment and analyzed using a GeneChip (R) microarray system to identify and select the up-regulated genes (>= 1.5 fold). The results showed an enhancement in heat-induced apoptosis in absence of functioning DNA-PKcs. Interestingly, the expression levels of HSP70 and HSP40 were elevated in the absence of DNA-PKcs under heat stress. The results of genetic network analysis showed that HSPs and JUN genes were up-regulated independently of DNA-PKcs in exposed parent and knock out cells. In the presence of functioning DNA-PKcs, there was an observed up-regulation of anti-apoptotic genes, such as NR1D1, whereas in the absence of DNA-PKcs the pro-apoptotic genes, such as EGR2, were preferentially up-regulated. From these findings, we concluded that in human cells, the inactivation of DNA-PKcs can promote heat-induced apoptosis independently of heat-shock proteins.	[Okazawa, Seisuke; Hayashi, Ryuji; Tobe, Kazuyuki] Toyama Univ, Grad Sch Med Pharmaceut Sci, Dept Internal Med 1, Toyama 930, Japan; [Okazawa, Seisuke; Furusawa, Yukihiro; Kariya, Ayako; Hassan, Mariame Ali; Arai, Mie; Kondo, Takashi] Toyama Univ, Dept Radiol Sci, Grad Sch Med Pharmaceut Sci, Toyama 930, Japan; [Hassan, Mariame Ali] Cairo Univ, Dept Pharmaceut & Ind Pharm, Fac Pharm, Cairo, Egypt; [Tabuchi, Yoshiaki] Toyama Univ, Div Mol Genet Res, Life Sci Res Ctr, Grad Sch Med Pharmaceut Sci, Toyama 930, Japan	University of Toyama; University of Toyama; Egyptian Knowledge Bank (EKB); Cairo University; University of Toyama	Tobe, K (corresponding author), Toyama Univ, Grad Sch Med Pharmaceut Sci, Dept Internal Med 1, Toyama 930, Japan.	tobe@med.u-toyama.ac.jp		Tabuchi, Yoshiaki/0000-0002-6007-6176	Japan Society for the Promotion of Science [22390229]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Financial support for this study was provided by a Grant-in-Aid for Scientific Research (B) (22390229), Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Dietrich C, 2010, CARCINOGENESIS, V31, P1319, DOI 10.1093/carcin/bgq028; Fontaine C, 2008, MOL ENDOCRINOL, V22, P1797, DOI 10.1210/me.2007-0439; Furusawa Y, 2012, CANCER LETT, V322, P107, DOI 10.1016/j.canlet.2012.02.020; Furusawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029012; Furusawa Y, 2011, INT J MOL MED, V28, P143, DOI 10.3892/ijmm.2011.702; Furusawa Y, 2010, CANCER LETT, V288, P107, DOI 10.1016/j.canlet.2009.06.029; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; He LS, 2006, J BIOL CHEM, V281, P11235, DOI 10.1074/jbc.M508779200; Huang F, 2007, J IMMUNOL, V179, P6504, DOI 10.4049/jimmunol.179.10.6504; Huang GM, 2012, MOL PHARMACOL, V81, P338, DOI 10.1124/mol.111.075952; Huang JR, 1997, J BIOL CHEM, V272, P26009, DOI 10.1074/jbc.272.41.26009; Issels RD, 2010, LANCET ONCOL, V11, P561, DOI 10.1016/S1470-2045(10)70071-1; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jalal S, 2011, CLIN CANCER RES, V17, P6973, DOI 10.1158/1078-0432.CCR-11-0761; Ju JH, 2010, J BIOL CHEM, V285, P41152, DOI 10.1074/jbc.M110.158352; Kourtidis A, 2010, CANCER RES, V70, P1783, DOI 10.1158/0008-5472.CAN-09-1550; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Leahy JJJ, 2004, BIOORG MED CHEM LETT, V14, P6083, DOI 10.1016/j.bmcl.2004.09.060; Li T, 2002, J BIOL CHEM, V277, P32668, DOI 10.1074/jbc.M203519200; McCarthy JV, 1998, J BIOL CHEM, V273, P16968, DOI 10.1074/jbc.273.27.16968; Meixner A, 2004, EMBO J, V23, P1325, DOI 10.1038/sj.emboj.7600133; Menendez JA, 2010, BBA-MOL CELL BIOL L, V1801, P381, DOI 10.1016/j.bbalip.2009.09.005; Miyakoda M, 2002, ONCOGENE, V21, P1090, DOI 10.1038/sj.onc.1205196; Nueda A, 1999, J BIOL CHEM, V274, P14988, DOI 10.1074/jbc.274.21.14988; Oshita C, 2012, ONCOL REP, V28, P1131, DOI 10.3892/or.2012.1956; Palma JP, 2009, CLIN CANCER RES, V15, P7277, DOI 10.1158/1078-0432.CCR-09-1245; Petersen SL, 2010, P NATL ACAD SCI USA, V107, P11936, DOI 10.1073/pnas.1005667107; Pimentel-Muinos FX, 1999, IMMUNITY, V11, P783, DOI 10.1016/S1074-7613(00)80152-1; Prager GW, 2009, BLOOD, V113, P1383, DOI 10.1182/blood-2008-06-164210; Puga A, 2002, CHEM-BIOL INTERACT, V141, P117, DOI 10.1016/S0009-2797(02)00069-8; Schroeder C, 2012, INT J HYPERTHER, V28, P707, DOI 10.3109/02656736.2012.722263; Strebovsky J, 2011, FASEB J, V25, P863, DOI 10.1096/fj.10-170597; Suk K, 2001, J BIOL CHEM, V276, P13153, DOI 10.1074/jbc.M007646200; Sung HH, 2012, PROSTATE, V72, P1399, DOI 10.1002/pros.22491; Tabuchi Y, 2008, CANCER LETT, V270, P286, DOI 10.1016/j.canlet.2008.05.018; Tabuchi Y, 2006, BIOCHEM BIOPH RES CO, V345, P1044, DOI 10.1016/j.bbrc.2006.04.177; Takahashi A, 2004, CANCER RES, V64, P8839, DOI 10.1158/0008-5472.CAN-04-1876; Unoki M, 2003, ONCOGENE, V22, P2172, DOI 10.1038/sj.onc.1206222; van der Zee J, 2000, LANCET, V355, P1119, DOI 10.1016/S0140-6736(00)02059-6; Wada S, 2007, FREE RADICAL RES, V41, P73, DOI 10.1080/10715760600946432; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasunaga J, 2004, CANCER RES, V64, P6002, DOI 10.1158/0008-5472.CAN-04-1422; Zhou H, 2007, CELL PROLIFERAT, V40, P431, DOI 10.1111/j.1365-2184.2007.00444.x	49	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58325	10.1371/journal.pone.0058325	http://dx.doi.org/10.1371/journal.pone.0058325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505488	Green Published, gold, Green Submitted			2022-12-27	WOS:000316251100046
J	Sdek, P; Oyama, K; Angelis, E; Chan, SS; Schenke-Layland, K; MacLellan, WR				Sdek, Patima; Oyama, Kyohei; Angelis, Ekaterini; Chan, Shing S.; Schenke-Layland, Katja; MacLellan, W. Robb			Epigenetic Regulation of Myogenic Gene Expression by Heterochromatin Protein 1 Alpha	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; II HISTONE DEACETYLASES; TERMINAL DIFFERENTIATION; HP1; DROSOPHILA; TRANSCRIPTION; ASSOCIATION; DOMAIN; CYCLE; PRB	Heterochromatin protein 1 (HP1) is an essential heterochromatin-associated protein typically involved in the epigenetic regulation of gene silencing. However, recent reports have demonstrated that HP1 can also activate gene expression in certain contexts including differentiation. To explore the role of each of the three mammalian HP1 family members (alpha, beta and gamma) in skeletal muscle, their expression was individually disrupted in differentiating skeletal myocytes. Among the three isoforms of HP1, HP1 alpha was specifically required for myogenic gene expression in myoblasts only. Knockdown of HP1 alpha led to a defect in transcription of skeletal muscle-specific genes including Lbx1, MyoD and myogenin. HP1 alpha binds to the genomic region of myogenic genes and depletion of HP1 alpha results in a paradoxical increase in histone H3 lysine 9 trimethylation (H3K9me3) at these sites. JHDM3A, a H3K9 demethylase also binds to myogenic gene's genomic regions in myoblasts in a HP1 alpha-dependent manner. JHDM3A interacts with HP1 alpha and knockdown of JHDM3A in myoblasts recapitulates the decreased myogenic gene transcription seen with HP1 alpha depletion. These results propose a novel mechanism for HP1 alpha-dependent gene activation by interacting with the demethylase JHDM3A and that HP1 alpha is required for maintenance of myogenic gene expression in myoblasts.	[Sdek, Patima; Oyama, Kyohei; Angelis, Ekaterini; Chan, Shing S.; Schenke-Layland, Katja; MacLellan, W. Robb] Univ Washington, Sch Med, Inst Stem Cell Res, Dept Med Cardiol,Ctr Cardiovasc Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	MacLellan, WR (corresponding author), Univ Washington, Sch Med, Inst Stem Cell Res, Dept Med Cardiol,Ctr Cardiovasc Biol, Seattle, WA 98195 USA.	WRMacLellan@cardiology.washington.edu	Schenke-Layland, Katja/E-5940-2013	Schenke-Layland, Katja/0000-0001-8066-5157; Oyama, Kyohei/0000-0002-8478-4417	 [NIHR01 HL70748]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070748] Funding Source: NIH RePORTER	; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the NIHR01 HL70748 to WRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Angelis E, 2008, CIRC RES, V102, P1222, DOI 10.1161/CIRCRESAHA.107.163550; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; de Wit E, 2007, PLOS GENET, V3, P346, DOI 10.1371/journal.pgen.0030038; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Forcales SV, 2005, SEMIN CELL DEV BIOL, V16, P596, DOI 10.1016/j.semcdb.2005.07.005; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gross MK, 2000, DEVELOPMENT, V127, P413; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Lee H, 2004, SCIENCE, V304, P1675, DOI 10.1126/science.1098096; Lin CH, 2008, MOL CELL, V32, P696, DOI 10.1016/j.molcel.2008.11.008; Lomberk G, 2006, NAT CELL BIOL, V8, P407, DOI 10.1038/ncb1383; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; MacLellan WR, 2000, MOL CELL BIOL, V20, P8903, DOI 10.1128/MCB.20.23.8903-8915.2000; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Mennerich D, 2001, EMBO J, V20, P7174, DOI 10.1093/emboj/20.24.7174; Minc E, 1999, CHROMOSOMA, V108, P220, DOI 10.1007/s004120050372; Minc E., 2001, Methods in Cell Science, V23, P171, DOI 10.1023/A:1013168323754; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Novitch BG, 1999, CURR BIOL, V9, P449, DOI 10.1016/S0960-9822(99)80210-3; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Schafer K, 1999, NAT GENET, V23, P213, DOI 10.1038/13843; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wakimoto BT, 1998, CELL, V93, P321, DOI 10.1016/S0092-8674(00)81159-9; Yahi H, 2008, J BIOL CHEM, V283, P23692, DOI 10.1074/jbc.M802647200; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yamano S, 2010, MOL BIOTECHNOL, V46, P287, DOI 10.1007/s12033-010-9302-5; Yun KS, 1996, CURR OPIN CELL BIOL, V8, P877, DOI 10.1016/S0955-0674(96)80091-3; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	45	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58319	10.1371/journal.pone.0058319	http://dx.doi.org/10.1371/journal.pone.0058319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505487	Green Submitted, gold, Green Published			2022-12-27	WOS:000316251100045
J	Chiu, PS; Lai, SC				Chiu, Ping-Sung; Lai, Shih-Chan			Matrix Metalloproteinase-9 Leads to Claudin-5 Degradation via the NF-kappa B Pathway in BALB/c Mice with Eosinophilic Meningoencephalitis Caused by Angiostrongylus cantonensis	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CEREBROSPINAL FLUID BARRIER; ENDOTHELIAL-CELLS; IN-VITRO; PLASMINOGEN ACTIVATORS; TIGHT JUNCTIONS; MENINGITIS; EXPRESSION; INDUCTION; OCCLUDIN	The epithelial barrier regulates the movement of ions, macromolecules, immune cells and pathogens. The objective of this study was to investigate the role of the matrix metalloproteinase (MMP)-9 in the degradation of tight junction protein during infection with rat nematode lungworm Angiostrongylus cantonensis. The results showed that phosphorylation of I kappa B and NF-kappa B was increased in mice with eosinophilic meningoencephalitis. Treatment with MG132 reduced the phosphorylation of NF-kappa B and the activity of MMP-9, indicating upregulation of MMP-9 through the NF-kappa B signaling pathway. Claudin-5 was reduced in the brain but elevated in the cerebrospinal fluid (CSF), implying that A. cantonensis infection caused tight junction breakdown and led to claudin-5 release into the CSF. Degradation of claudin-5 coincided with alteration of the blood-CSF barrier permeability and treatment with the MMP inhibitor GM6001 attenuated the degradation of claudin-5. These results suggested that degradation of claudin-5 was caused by MMP-9 in angiostrongyliasis meningoencephalitis. Claudin-5 could be used for the pathophysiologic evaluation of the blood-CSF barrier breakdown and tight junction disruption after infection with A. cantonensis.	[Chiu, Ping-Sung] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lai, Shih-Chan] Chung Shan Med Univ, Dept Parasitol, Taichung, Taiwan; [Lai, Shih-Chan] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lai, SC (corresponding author), Chung Shan Med Univ, Dept Parasitol, Taichung, Taiwan.	shih@csmu.edu.tw			National Science Council, Republic of China [NSC 101-2320-B-040-021]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported in part by research grant No. NSC 101-2320-B-040-021 from the National Science Council, Republic of China. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andras IE, 2003, J NEUROSCI RES, V74, P255, DOI 10.1002/jnr.10762; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Chen F, 2009, HEPATOLOGY, V50, P1914, DOI 10.1002/hep.23203; Chen KM, 2006, INT J EXP PATHOL, V87, P113, DOI 10.1111/j.0959-9673.2006.00459.x; Deng Xiao-Lu, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P908; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GARDINER CH, 1990, AM J TROP MED HYG, V42, P70, DOI 10.4269/ajtmh.1990.42.70; Girard M, 2005, MOL BIOCHEM PARASIT, V139, P41, DOI 10.1016/j.molbiopara.2004.09.008; Hartz AMS, 2012, STROKE, V43, P514, DOI 10.1161/STROKEAHA.111.627562; Hou RF, 2004, INT J PARASITOL, V34, P1355, DOI 10.1016/j.ijpara.2004.08.010; HSU WY, 1990, PEDIATR INFECT DIS J, V9, P443, DOI 10.1097/00006454-199006000-00016; Lai SC, 2004, ANN TROP MED PARASIT, V98, P715, DOI 10.1179/000349804225021479; Lan KP, 2004, J HELMINTHOL, V78, P311, DOI 10.1079/JOH2004256; Lee HH, 2000, EXP PARASITOL, V95, P202, DOI 10.1006/expr.2000.4530; Lee HH, 2004, PARASITOL RES, V94, P321, DOI 10.1007/s00436-004-1196-3; Liao CW, 2008, PARASITE IMMUNOL, V30, P525, DOI 10.1111/j.1365-3024.2008.01048.x; Lippoldt A, 2000, NEUROREPORT, V11, P1427, DOI 10.1097/00001756-200005150-00015; Louboutin JP, 2010, J NEUROPATH EXP NEUR, V69, P801, DOI 10.1097/NEN.0b013e3181e8c96f; MACKERRAS MJ, 1954, NATURE, V173, P956, DOI 10.1038/173956a0; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; PARSONS JC, 1990, J PARASITOL, V76, P53, DOI 10.2307/3282627; Tenenbaum T, 2005, FEMS IMMUNOL MED MIC, V44, P25, DOI 10.1016/j.femsim.2004.12.006; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; Wei PC, 2011, INT J PARASITOL, V41, P1175, DOI 10.1016/j.ijpara.2011.07.002; Wewer C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-51; Xu RF, 2012, BRAIN RES, V1436, P13, DOI 10.1016/j.brainres.2011.11.052; Zeni P, 2007, AM J PHYSIOL-CELL PH, V293, pC855, DOI 10.1152/ajpcell.00470.2006	27	44	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e53370	10.1371/journal.pone.0053370	http://dx.doi.org/10.1371/journal.pone.0053370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505411	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500003
J	Mhedbi-Hajri, N; Hajri, A; Boureau, T; Darrasse, A; Durand, K; Brin, C; Fischer-Le Saux, M; Manceau, C; Poussier, S; Pruvost, O; Lemaire, C; Jacques, MA				Mhedbi-Hajri, Nadia; Hajri, Ahmed; Boureau, Tristan; Darrasse, Armelle; Durand, Karine; Brin, Chrystelle; Fischer-Le Saux, Marion; Manceau, Charles; Poussier, Stephane; Pruvost, Olivier; Lemaire, Christophe; Jacques, Marie-Agnes			Evolutionary History of the Plant Pathogenic Bacterium Xanthomonas axonopodis	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; PSEUDOMONAS-SYRINGAE; POPULATION-STRUCTURE; MOSAIC STRUCTURE; CROP DEBRIS; RECOMBINATION; GENE; RELATEDNESS; DIVERGENCE; INFERENCE	Deciphering mechanisms shaping bacterial diversity should help to build tools to predict the emergence of infectious diseases. Xanthomonads are plant pathogenic bacteria found worldwide. Xanthomonas axonopodis is a genetically heterogeneous species clustering, into six groups, strains that are collectively pathogenic on a large number of plants. However, each strain displays a narrow host range. We address the question of the nature of the evolutionary processes geographical and ecological speciation - that shaped this diversity. We assembled a large collection of X. axonopodis strains that were isolated over a long period, over continents, and from various hosts. Based on the sequence analysis of seven housekeeping genes, we found that recombination occurred as frequently as point mutation in the evolutionary history of X. axonopodis. However, the impact of recombination was about three times greater than the impact of mutation on the diversity observed in the whole dataset. We then reconstructed the clonal genealogy of the strains using coalescent and genealogy approaches and we studied the diversification of the pathogen using a model of divergence with migration. The suggested scenario involves a first step of generalist diversification that spanned over the last 25 000 years. A second step of ecology-driven specialization occurred during the past two centuries. Eventually, secondary contacts between host-specialized strains probably occurred as a result of agricultural development and intensification, allowing genetic exchanges of virulence-associated genes. These transfers may have favored the emergence of novel pathotypes. Finally, we argue that the largest ecological entity within X. axonopodis is the pathovar.	[Mhedbi-Hajri, Nadia; Hajri, Ahmed; Boureau, Tristan; Darrasse, Armelle; Durand, Karine; Brin, Chrystelle; Fischer-Le Saux, Marion; Manceau, Charles; Poussier, Stephane; Lemaire, Christophe; Jacques, Marie-Agnes] INRA, Inst Rech Hort & Semences UMR1345, Beaucouze, France; [Mhedbi-Hajri, Nadia; Hajri, Ahmed; Boureau, Tristan; Darrasse, Armelle; Durand, Karine; Brin, Chrystelle; Fischer-Le Saux, Marion; Manceau, Charles; Poussier, Stephane; Lemaire, Christophe; Jacques, Marie-Agnes] Univ Angers, Inst Rech Hort & Semences UMR1345, PRES LUNAM, QUASAV SFR4207, Angers, France; [Mhedbi-Hajri, Nadia; Hajri, Ahmed; Boureau, Tristan; Darrasse, Armelle; Durand, Karine; Brin, Chrystelle; Fischer-Le Saux, Marion; Manceau, Charles; Poussier, Stephane; Lemaire, Christophe; Jacques, Marie-Agnes] AgroCampus Ouest, Inst Rech Hort & Semences UMR1345, Angers, France; [Pruvost, Olivier] CIRAD, UMR PVBMT, St Pierre, Reunion, France	INRAE; Universite d'Angers; Institut Agro; Agrocampus Ouest; CIRAD	Jacques, MA (corresponding author), INRA, Inst Rech Hort & Semences UMR1345, Beaucouze, France.	marie-agnes.jacques@angers.inra.fr	Manceau, Charles/AAS-8130-2021; Darrasse, Armelle/ABB-3712-2021; Hajri, Ahmed/F-7603-2011	Hajri, Ahmed/0000-0002-1516-3852; Fischer-Le Saux, Marion/0000-0002-9567-9444; Pruvost, Olivier/0000-0002-3175-9795; Poussier, Stephane/0000-0003-0273-3518; DURAND, KARINE/0000-0001-6518-8401; Manceau, Charles/0000-0003-3590-6454	Tunisian Government; CG Maine et Loire; INRA; Region Pays de la Loire (Xanthost); Plant Health and Environment Department of INRA [SPE 2007-0077-01, AIP Bioressources 2008-077-01]	Tunisian Government; CG Maine et Loire(Region Pays de la Loire); INRA; Region Pays de la Loire (Xanthost)(Region Pays de la Loire); Plant Health and Environment Department of INRA	N. Mhedbi-Hajri and A. Hajri were supported by grants from the Tunisian Government, from CG Maine et Loire and from INRA. This study was funded by the Region Pays de la Loire (Xanthost) and the Plant Health and Environment Department of INRA (SPE 2007-0077-01, AIP Bioressources 2008-077-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2009, GENETICS, V183, P249, DOI 10.1534/genetics.109.104042; Achtman M, 2012, PHILOS T R SOC B, V367, P860, DOI 10.1098/rstb.2011.0303; Ah-You N, 2009, INT J SYST EVOL MICR, V59, P306, DOI 10.1099/ijs.0.65453-0; Alavi SM, 2008, APPL ENVIRON MICROB, V74, P3295, DOI 10.1128/AEM.02507-07; Alavi SM, 2007, APPL ENVIRON MICROB, V73, P1678, DOI 10.1128/AEM.02031-06; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; Barak JD, 2001, PLANT DIS, V85, P169, DOI 10.1094/PDIS.2001.85.2.169; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bucheli E, 2001, MOL ECOL, V10, P285, DOI 10.1046/j.1365-294x.2001.01146.x; BURDON JJ, 1989, ANNU REV ECOL SYST, V20, P119, DOI 10.1146/annurev.es.20.110189.001003; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Cohan FM, 2002, GENETICA, V116, P359, DOI 10.1023/A:1021232409545; Cohan FM, 2008, CURR BIOL, V18, pR1024, DOI 10.1016/j.cub.2008.09.014; Comas I, 2006, MOL BIOL EVOL, V23, P2049, DOI 10.1093/molbev/msl075; Costechareyre D, 2009, MOL BIOL EVOL, V26, P167, DOI 10.1093/molbev/msn236; Coyne J.A., 2004, SPECIATION; Darrasse A, 2010, APPL ENVIRON MICROB, V76, P6787, DOI 10.1128/AEM.01098-10; Deitsch KW, 2009, NAT REV MICROBIOL, V7, P493, DOI 10.1038/nrmicro2145; Didelot X, 2010, BACTERIAL POPULATION, P103; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Ding F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-158; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dye D. W., 1980, Review of Plant Pathology, V59, P153; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; FU YX, 1993, GENETICS, V133, P693; Gent DH, 2005, PHYTOPATHOLOGY, V95, P918, DOI 10.1094/PHYTO-95-0918; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Giraud T, 2010, TRENDS ECOL EVOL, V25, P387, DOI 10.1016/j.tree.2010.03.006; Gladieux P, 2011, MOL BIOL EVOL, V28, P459, DOI 10.1093/molbev/msq235; Grunwald NJ, 2011, ANNU REV PHYTOPATHOL, V49, P249, DOI 10.1146/annurev-phyto-072910-095246; Hajri A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006632; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hancock JF, 2006, PLANT EVOLUTION; Hayward A. C., 1993, Xanthomonas., P1; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; HUDSON RR, 1985, GENETICS, V111, P147; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kuhner MK, 2009, TRENDS ECOL EVOL, V24, P86, DOI 10.1016/j.tree.2008.09.007; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lovell HC, 2011, MOL PLANT PATHOL, V12, P167, DOI 10.1111/j.1364-3703.2010.00658.x; Maddison WP, 2019, MESQUITE MODULAR SYS; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mhedbi-Hajri N, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-67; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Nei M., 1987, MOL EVOLUTIONARY GEN; Ngoc LBT, 2010, INT J SYST EVOL MICR, V60, P515, DOI 10.1099/ijs.0.009514-0; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P264, DOI 10.1099/ijs.0.65825-0; Parkinson N, 2007, INT J SYST EVOL MICR, V57, P2881, DOI 10.1099/ijs.0.65220-0; Passerini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015306; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Pritchard JK, 2000, GENETICS, V155, P945; Rademaker JLW, 2005, PHYTOPATHOLOGY, V95, P1098, DOI 10.1094/PHYTO-95-1098; Rademaker JLW, 2000, INT J SYST EVOL MICR, V50, P665, DOI 10.1099/00207713-50-2-665; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sarkar SF, 2004, APPL ENVIRON MICROB, V70, P1999, DOI 10.1128/AEM.70.4.1999-2012.2004; Scally M, 2005, APPL ENVIRON MICROB, V71, P8491, DOI 10.1128/AEM.71.12.8491-8499.2005; Sheppard SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015708; Sikirou R, 2004, EUR J PLANT PATHOL, V110, P939, DOI 10.1007/s10658-004-8949-9; SMITH JM, 1992, J MOL EVOL, V34, P126; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Stukenbrock EH, 2007, MOL BIOL EVOL, V24, P398; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VAUTERIN L, 1995, INT J SYST BACTERIOL, V45, P472, DOI 10.1099/00207713-45-3-472; Vauterin L, 2000, PHYTOPATHOLOGY, V90, P677, DOI 10.1094/PHYTO.2000.90.7.677; Vos M, 2009, ISME J, V3, P199, DOI 10.1038/ismej.2008.93; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yan SC, 2008, APPL ENVIRON MICROB, V74, P3171, DOI 10.1128/AEM.00180-08; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004; Zdziarski J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001078; Zeller KA, 2004, MOL ECOL, V13, P563, DOI 10.1046/j.1365-294X.2004.02098.x	87	58	58	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58474	10.1371/journal.pone.0058474	http://dx.doi.org/10.1371/journal.pone.0058474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505513	Green Published, gold			2022-12-27	WOS:000318334500088
J	Lopez, RP; Valdivia, S; Rivera, ML; Rios, RS				Pablo Lopez, Ramiro; Valdivia, Sergio; Rivera, Monica L.; Rios, Rodrigo S.			Co-occurrence Patterns along a Regional Aridity Gradient of the Subtropical Andes Do Not Support Stress Gradient Hypotheses	PLOS ONE			English	Article							DESERT PLANT-COMMUNITIES; POSITIVE INTERACTIONS; SPECIES RICHNESS; ABIOTIC STRESS; INTERACTIONS INCREASE; BIOTIC INTERACTIONS; NURSE PLANTS; FACILITATION; ENVIRONMENTS; SHRUB	The stress gradient hypothesis posits that facilitation and stress are positively correlated. The hump-shaped hypothesis, on the contrary, proposes that facilitation is greater at intermediate stress levels. The relationship between facilitation and environmental stress is commonly studied at small spatial scales and/or considering few species; thus, the implications of facilitation at a community level remain poorly understood. Here, we analyzed local co-occurrence patterns of all plant species at 25 sites within the subtropical Andes to evaluate the role of facilitation and competition as drivers of community structure. We considered a wide latitudinal gradient (19-26 degrees S) that incorporates great variation in aridity. No previous studies have attempted to study these patterns across such a broad scale in warm deserts. Each locality was sampled at two scales (quadrat and patch), and co-occurrence was analyzed via null models. Furthermore, we tested for a relationship between plant co-occurrences and environmental aridity. Resulting patterns depended on life form. When all species were considered, negative associations were found, indicating competition. Woody/cactus life forms tended to be associated across communities, suggesting that there is facilitation between these life forms. Additionally, and unlike previous studies, we found positive associations among shrubs. The strength of the association between woody species changed non-monotonically with aridity. Herbs showed an inverted hump-shaped relationship, albeit ranging mostly among neutral values. Independent of the association type exhibited by different life forms, our community level results do not support current stress gradient hypotheses.	[Pablo Lopez, Ramiro; Rios, Rodrigo S.] Inst Ecol UMSA, Herbario Nacl Bolivia, La Paz, Bolivia; [Valdivia, Sergio] Inst Ecol, CPEC, La Paz, Bolivia; [Pablo Lopez, Ramiro; Rivera, Monica L.] Univ La Serena, Dept Biol, Inst Ecol & Biodiversidad IEB, Lab Ecofisiol Vegetal, La Serena, Chile; [Rios, Rodrigo S.] Univ La Serena, Dept Biol, Lab Ecol Func, La Serena, Chile	Universidad Mayor de San Andres; Universidad de La Serena; Universidad de La Serena	Lopez, RP (corresponding author), Inst Ecol UMSA, Herbario Nacl Bolivia, La Paz, Bolivia.	rlopez@userena.cl	Rios, Rodrigo/G-4937-2013; Lopez, Ramiro Pablo/O-3491-2019; Rios, Rodrigo S./C-5098-2015	Rios, Rodrigo S./0000-0003-3068-0118	IFS [AD/21235]	IFS(International Foundation for Science)	The study was supported by IFS Grant to S. Valdivia (No. AD/21235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar MR, 1997, ECOLOGY, V78, P93, DOI 10.1890/0012-9658(1997)078[0093:SDCTDO]2.0.CO;2; Anthelme F, 2009, BASIC APPL ECOL, V10, P437, DOI 10.1016/j.baae.2008.10.008; Armas C, 2011, J VEG SCI, V22, P818, DOI 10.1111/j.1654-1103.2011.01301.x; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bowker MA, 2010, J ECOL, V98, P551, DOI 10.1111/j.1365-2745.2010.01647.x; Brooker R, 2005, OIKOS, V109, P63, DOI 10.1111/j.0030-1299.2005.13557.x; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Cabrera A. L., 1980, BIOGEOGRAFIA AM LATI; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; Cuesta B, 2010, J ECOL, V98, P687, DOI 10.1111/j.1365-2745.2010.01655.x; de Viana ML, 2001, PLANT ECOL, V156, P193, DOI 10.1023/A:1012621106009; Dullinger S, 2007, J ECOL, V95, P1284, DOI 10.1111/j.1365-2745.2007.01288.x; Eccles NS, 1999, PLANT ECOL, V142, P71, DOI 10.1023/A:1009857824912; Flores J, 2003, J VEG SCI, V14, P911, DOI 10.1111/j.1654-1103.2003.tb02225.x; Garcia D, 2000, BIOL CONSERV, V95, P31, DOI 10.1016/S0006-3207(00)00016-1; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Gotelli NJ, 2006, ECOSIM NULL MODELS S; Gross N, 2010, PERSPECT PLANT ECOL, V12, P9, DOI 10.1016/j.ppees.2009.09.001; Holmgren M, 2010, J ECOL, V98, P1269, DOI 10.1111/j.1365-2745.2010.01709.x; Holzapfel C, 2006, BASIC APPL ECOL, V7, P268, DOI 10.1016/j.baae.2005.08.003; Kikvidze Z, 2011, ALPINE BOT, V121, P63, DOI 10.1007/s00035-010-0085-x; Le Bagousse-Pinguet Y, 2013, J VEG SCI, V24, P375, DOI 10.1111/j.1654-1103.2012.01462.x; Liancourt P, 2005, ECOLOGY, V86, P1611, DOI 10.1890/04-1398; Lopez R. P., 2000, Ecologia en Bolivia, P45; Lopez RP, 2007, OECOLOGIA, V152, P779, DOI 10.1007/s00442-007-0698-y; Lopez Ramiro Pablo, 2002, Candollea, V57, P77; Lopez RP, 2009, J VEG SCI, V20, P728, DOI 10.1111/j.1654-1103.2009.01067.x; Luzuriaga AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041270; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2004, P ROY SOC B-BIOL SCI, V271, pS331, DOI 10.1098/rsbl.2004.0181; Maltez-Mouro S, 2010, ACTA OECOL, V36, P80, DOI 10.1016/j.actao.2009.10.003; MCAULIFFE JR, 1988, AM NAT, V131, P459, DOI 10.1086/284802; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Mueller-Dombois H., 1974, AIMS METHODS VEGETAT; Lopez RP, 2010, J ARID ENVIRON, V74, P1534, DOI 10.1016/j.jaridenv.2010.06.008; Rayburn AP, 2012, ECOGRAPHY, V35, P341, DOI 10.1111/j.1600-0587.2011.07058.x; Rousset O, 1999, J VEG SCI, V10, P493, DOI 10.2307/3237184; Schenk HJ, 2003, J ECOL, V91, P383, DOI 10.1046/j.1365-2745.2003.00782.x; Seifan M, 2010, OIKOS, V119, P1601, DOI 10.1111/j.1600-0706.2010.18206.x; Smit C, 2009, J ECOL, V97, P1215, DOI 10.1111/j.1365-2745.2009.01555.x; Soliveres S, 2011, PERSPECT PLANT ECOL, V13, P247, DOI 10.1016/j.ppees.2011.06.001; Tielborger K, 2000, ECOLOGY, V81, P1544, DOI 10.2307/177305; Tirado R, 2005, OIKOS, V111, P437, DOI 10.1111/j.1600-0706.2005.14094.x; VALIENTEBANUET A, 1991, J VEG SCI, V2, P15, DOI 10.2307/3235893; WELDEN CW, 1986, Q REV BIOL, V61, P23, DOI 10.1086/414724; YEATON RI, 1978, J ECOL, V66, P651, DOI 10.2307/2259156	52	37	39	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58518	10.1371/journal.pone.0058518	http://dx.doi.org/10.1371/journal.pone.0058518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505527	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500097
J	Yuan, JM; Jin, CH; Qin, HD; Wang, JD; Sha, WW; Wang, MZ; Zhang, YB; Zhang, FQ; Li, JJ; Li, JF; Yu, S; Qi, SG; Shugart, YY				Yuan, Jianmin; Jin, Chunhui; Qin, Hai-De; Wang, Jidong; Sha, Weiwei; Wang, Mingzhong; Zhang, Yunbiao; Zhang, Fuquan; Li, Jijiang; Li, Jianfeng; Yu, Shui; Qi, Shuguang; Shugart, Yin Yao			Replication Study Confirms Link between TSPAN18 Mutation and Schizophrenia in Han Chinese	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; MENTAL-RETARDATION; BIPOLAR DISORDER; RISK	Schizophrenia (SCZ) is a severe psychiatric disorder associated with many different risk factors, both genetic and environmental. A recent genome-wide association study (GWAS) of Han Chinese identified three single-nucleotide polymorphisms (SNPs rs11038167, rs11038172, and rs835784) in the tetraspanins gene TSPAN18 as possible susceptibility loci for schizophrenia. Hoping to validate these findings, we conducted a case-control study of Han Chinese with 1093 schizophrenia cases and 1022 healthy controls. Using the LDR-PCR method to genotype polymorphisms in TSPAN18, we found no significant differences (P>0.05) between patients and controls in either the allele or genotype frequency of the SNPs rs11038167 and rs11038172. We did find, however, that the frequency of the 'A' allele of SNP rs835784 is significantly higher in patients than in controls. We further observed a significant association (OR = 1.197, 95% CI = 1.047-1.369) between risk for SCZ and this 'A' allele. These results confirm the significant association, in Han Chinese populations, of increased SCZ risk and the variant of the TSPAN18 gene containing the 'A' allele of SNP rs835784.	[Yuan, Jianmin; Jin, Chunhui; Wang, Jidong; Zhang, Yunbiao; Zhang, Fuquan; Yu, Shui; Qi, Shuguang] Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China; [Jin, Chunhui] Jiangsu Inst Psychol, Wuxi, Jiangsu, Peoples R China; [Qin, Hai-De; Shugart, Yin Yao] NIMH, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Sha, Weiwei; Li, Jijiang] Yangzhou Wutaishan Hosp, Yangzhou, Jiangsu, Peoples R China; [Wang, Mingzhong; Li, Jianfeng] Nanjing Qinglongshan Mental Hosp, Nanjing, Jiangsu, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Qi, SG (corresponding author), Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China.	shuguangqi0208@126.com; kay1yao@mail.nih.gov		YAO, YIN/0000-0003-3053-8429; Zhang, Fuquan/0000-0003-3204-8191	Key Characteristic Specialty/Discipline of Wuxi Hospital Management Center; Wuxi Municipal Health Bureau [Q201208]; Intramural Research Program at the National Institute of Mental Health (NIMH); NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002930, ZIAMH002934, ZIAMH002929] Funding Source: NIH RePORTER	Key Characteristic Specialty/Discipline of Wuxi Hospital Management Center; Wuxi Municipal Health Bureau; Intramural Research Program at the National Institute of Mental Health (NIMH); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the Key Characteristic Specialty/Discipline of Wuxi Hospital Management Center, from the Research Project of the Wuxi Municipal Health Bureau (Q201208). HDQ and YYS are supported by supported by the Intramural Research Program at the National Institute of Mental Health (NIMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this presentation do not necessarily represent the views of the NIMH, National Institutes of Health, Health and Human Services, or the United States Government.	Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Ma L, 2012, MOL PSYCHIATR, P1; Maranduba CMD, 2004, AM J MED GENET A, V124A, P413, DOI 10.1002/ajmg.a.20401; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Scholz CJ, 2010, AM J MED GENET B, V153B, P967, DOI 10.1002/ajmg.b.31057; Scholz CJ, 2009, CANCER LETT, V275, P198, DOI 10.1016/j.canlet.2008.10.014; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Thaker GK, 2001, NAT MED, V7, P667, DOI 10.1038/89040; Vacic V, 2011, NATURE, V471, P499, DOI 10.1038/nature09884; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhou Z, 2008, CLIN EXP METASTAS, V25, P537, DOI 10.1007/s10585-008-9168-0	19	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58785	10.1371/journal.pone.0058785	http://dx.doi.org/10.1371/journal.pone.0058785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505562	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500127
J	Allan, BJM; Domenici, P; McCormick, MI; Watson, SA; Munday, PL				Allan, Bridie J. M.; Domenici, Paolo; McCormick, Mark I.; Watson, Sue-Ann; Munday, Philip L.			Elevated CO2 Affects Predator-Prey Interactions through Altered Performance	PLOS ONE			English	Article							CORAL-REEF FISH; OCEAN ACIDIFICATION DISRUPTS; CLIMATE-CHANGE; POMACENTRUS AMBOINENSIS; COLOR POLYMORPHISM; CARBONIC-ACID; MARINE FISH; BEHAVIOR; ESCAPE; START	Recent research has shown that exposure to elevated carbon dioxide (CO2) affects how fishes perceive their environment, affecting behavioral and cognitive processes leading to increased prey mortality. However, it is unclear if increased mortality results from changes in the dynamics of predator-prey interactions or due to prey increasing activity levels. Here we demonstrate that ocean pCO(2) projected to occur by 2100 significantly effects the interactions of a predator-prey pair of common reef fish: the planktivorous damselfish Pomacentrus amboinensis and the piscivorous dottyback Pseudochromis fuscus. Prey exposed to elevated CO2 (880 mu atm) or a present-day control (440 matm) interacted with similarly exposed predators in a cross-factored design. Predators had the lowest capture success when exposed to elevated CO2 and interacting with prey exposed to present-day CO2. Prey exposed to elevated CO2 had reduced escape distances and longer reaction distances compared to prey exposed to present-day CO2 conditions, but this was dependent on whether the prey was paired with a CO2 exposed predator or not. This suggests that the dynamics of predator-prey interactions under future CO2 environments will depend on the extent to which the interacting species are affected and can adapt to the adverse effects of elevated CO2.	[Allan, Bridie J. M.; McCormick, Mark I.; Watson, Sue-Ann; Munday, Philip L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Allan, Bridie J. M.; McCormick, Mark I.; Watson, Sue-Ann; Munday, Philip L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Domenici, Paolo] CNR IAMC, Ist Ambiente Marino Costiero, Torregrande, Oristano, Italy	James Cook University; James Cook University; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Allan, BJM (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	bridie.allan@my.jcu.edu.au	Watson, Sue-Ann/C-3172-2013; McCormick, Mark I/J-8301-2014; Domenici, Paolo/F-6958-2010; Munday, Philip L/F-5443-2011	Watson, Sue-Ann/0000-0002-9818-7429; McCormick, Mark I/0000-0001-9289-1645; Munday, Philip L/0000-0001-9725-2498	Australian Research Council; ARC Centre of Excellence for Coral Reef Studies [CE0561432]	Australian Research Council(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	Funding was provided by the Australian Research Council (MIM) and the ARC Centre of Excellence for Coral Reef Studies (Grant No. CE0561432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengtson Stefan, 2002, Paleontological Society Papers, V8, P289; Bibby R, 2007, BIOLOGY LETT, V3, P699, DOI 10.1098/rsbl.2007.0457; Briffa M, 2012, MAR POLLUT BULL, V64, P1519, DOI 10.1016/j.marpolbul.2012.05.032; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; de la Haye KL, 2011, ANIM BEHAV, V82, P495, DOI 10.1016/j.anbehav.2011.05.030; DIAMOND J, 1968, J PHYSIOL-LONDON, V194, P669, DOI 10.1113/jphysiol.1968.sp008432; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; DILL LM, 1974, ANIM BEHAV, V22, P711, DOI 10.1016/S0003-3472(74)80022-9; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; Doherty PJ, 2004, ECOLOGY, V85, P2422, DOI 10.1890/04-0366; Domenici P, 1997, J EXP BIOL, V200, P1165; Domenici P, 2012, BIOL LETTERS, V8, P78, DOI 10.1098/rsbl.2011.0591; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Ferrari MCO, 2011, GLOBAL CHANGE BIOL, V17, P2980, DOI 10.1111/j.1365-2486.2011.02439.x; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; Kerrigan BA, 1996, MAR ECOL PROG SER, V135, P27, DOI 10.3354/meps135027; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Lanczos C., 1956, APPL ANAL; Landes A, 2012, MAR ECOL PROG SER, V450, P1, DOI 10.3354/meps09666; Langerhans RB, 2009, ECOLOGY EVOLUTION SW, P200; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Meekan MG, 2001, MAR BIOL, V139, P373; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Messmer V, 2005, CORAL REEFS, V24, P392, DOI 10.1007/s00338-005-0001-9; Munday P.L., 2012, J EXPT BIOL IN PRESS; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; Munday PL, 1997, J FISH BIOL, V51, P931, DOI 10.1006/jfbi.1997.0498; Munday PL, 2003, OECOLOGIA, V137, P519, DOI 10.1007/s00442-003-1356-7; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Pierrot D., 2006, ORNLCDIAC105A US DEP; Planes S, 2004, MOL ECOL, V13, P2049, DOI 10.1111/j.1365-294X.2004.02202.x; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; SWEATMAN HPA, 1984, COPEIA, P187; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; WEBB PW, 1976, J EXP BIOL, V65, P157; WEBB PW, 1982, J COMP PHYSIOL, V147, P371, DOI 10.1007/BF00609671; Wisenden BD, 2012, FUNCT ECOL, V26, P551, DOI 10.1111/j.1365-2435.2011.01956.x; Wohl S, 2007, J EXP BIOL, V210, P311, DOI 10.1242/jeb.02646	43	77	79	1	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58520	10.1371/journal.pone.0058520	http://dx.doi.org/10.1371/journal.pone.0058520			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484032	gold, Green Published, Green Accepted			2022-12-27	WOS:000316936100120
J	Catry, I; Franco, AMA; Rocha, P; Alcazar, R; Reis, S; Cordeiro, A; Ventim, R; Teodosio, J; Moreira, F				Catry, Ines; Franco, Aldina M. A.; Rocha, Pedro; Alcazar, Rita; Reis, Susana; Cordeiro, Ana; Ventim, Rita; Teodosio, Joaquim; Moreira, Francisco			Foraging Habitat Quality Constrains Effectiveness of Artificial Nest-Site Provisioning in Reversing Population Declines in a Colonial Cavity Nester	PLOS ONE			English	Article							LAND-USE CHANGES; BREEDING SUCCESS; LESSER KESTRELS; CONSERVATION; BIRDS; MANAGEMENT; SELECTION; AVAILABILITY; ABUNDANCE; DENSITY	Among birds, breeding numbers are mainly limited by two resources of major importance: food supply and nest-site availability. Here, we investigated how differences in land-use and nest-site availability affected the foraging behaviour, breeding success and population trends of the colonial cavity-dependent lesser kestrel Falco naumanni inhabiting two protected areas. Both areas were provided with artificial nests to increase nest-site availability. The first area is a pseudosteppe characterized by traditional extensive cereal cultivation, whereas the second area is a previous agricultural zone now abandoned or replaced by forested areas. In both areas, lesser kestrels selected extensive agricultural habitats, such as fallows and cereal fields, and avoided scrubland and forests. In the second area, tracked birds from one colony travelled significantly farther distances (6.2 km +/- 1.7 vs. 1.8 km +/- 0.4 and 1.9 km +/- 0.6) and had significant larger foraging-ranges (144 km(2) vs. 18.8 and 14.8 km(2)) when compared to the birds of two colonies in the extensive agricultural area. Longer foraging trips were reflected in lower chick feeding rates, lower fledging success and reduced chick fitness. Availability and occupation of artificial nests was high in both areas but population followed opposite trends, with a positive increment recorded exclusively in the first area with a large proportion of agricultural areas. Progressive habitat loss around the studied colony in the second area (suitable habitat decreased from 32% in 1990 to only 7% in 2002) is likely the main driver of the recorded population decline and suggests that the effectiveness of bird species conservation based on nest-site provisioning is highly constrained by habitat quality in the surrounding areas. Therefore, the conservation of cavitydependent species may be enhanced firstly by finding the best areas of remaining habitat and secondly by increasing the carrying capacity of high-quality habitat areas through safe nest-site provisioning.	[Catry, Ines; Moreira, Francisco] Univ Tecn Lisboa, Inst Super Agron, Ctr Ecol Aplicada Prof Baeta Neves, P-1100 Lisbon, Portugal; [Catry, Ines; Franco, Aldina M. A.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Rocha, Pedro] ICNF PNVG, Mertola, Portugal; [Alcazar, Rita] Environm Educ Ctr Vale Goncalinho, League Protect Nat LPN, Castro Verde, Portugal; [Reis, Susana] Praca Capitaes Abril, Cova Da Piedade, Portugal; [Teodosio, Joaquim] Portuguese Soc Study Birds SPEA, Nordeste, Acores, Portugal	Universidade de Lisboa; University of East Anglia	Catry, I (corresponding author), Univ Tecn Lisboa, Inst Super Agron, Ctr Ecol Aplicada Prof Baeta Neves, P-1100 Lisbon, Portugal.	inescatry@gmail.com	Franco, Aldina M/G-2144-2010; Moreira, Francisco/B-2873-2008; Catry, Ines/A-8073-2012; Azenha Rocha, Pedro/C-5051-2018	Franco, Aldina M/0000-0001-6055-7378; Moreira, Francisco/0000-0003-4393-8018; Catry, Ines/0000-0002-5593-5001; Azenha Rocha, Pedro/0000-0002-6089-0290; Chiaradia, Andre/0000-0002-6178-4211	Fundacao para a Ciencia e Tecnologia [SFRH/BPD/76514/2011]; ICN	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); ICN	Field-work conducted between 2003 and 2006 was financed by Project LIFE2002/NAT/P8481: Re-establishment of the Lesser Kestrel Falco naumanni in Portugal. IC was funded by a Portuguese post-doctoral grant from Fundacao para a Ciencia e Tecnologia (SFRH/BPD/76514/2011). SR was funded by ICN in 2000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar R, 2004, CARTOGRAFIA AREAS SE; Amar A, 2005, BIRD STUDY, V52, P18, DOI 10.1080/00063650509461370; Araujo A, 1990, DADOS EVOLUCAO POPUL; BIBER J., 1990, 41 ICBP; BirdLife International, 2012, SPEC FACTSH FALC NAU; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bustamante J, 1997, BIOL CONSERV, V80, P153, DOI 10.1016/S0006-3207(96)00136-X; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; Catry I, 2012, J APPL ECOL, V49, P99, DOI 10.1111/j.1365-2664.2011.02071.x; Catry I, 2009, BIOL CONSERV, V142, P2782, DOI 10.1016/j.biocon.2009.07.011; CMCV, 2010, PLAN ZON CASTR VERD; CNIG, 1990, CART OC SOL COS 90; Cramp S., 1980, BIRDS W PALAEARCTIC, V2; Daan S., 1989, P INT ORNITHOLOGICAL, V1, P392; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; DONAZAR JA, 1993, J APPL ECOL, V30, P515, DOI 10.2307/2404191; DRENT RH, 1980, ARDEA, V68, P225; ESRI, 1999, ARCVIEW GIS 3 2 COMP; Fehervari P, 2012, ANIM CONSERV, V15, P648, DOI 10.1111/j.1469-1795.2012.00559.x; Franco AMA, 2005, IBIS, V147, P657, DOI 10.1111/j.1474-919x.2005.00437.x; Franco AMA, 2004, ANIM CONSERV, V7, P291, DOI 10.1017/S1367943004001465; Franco AMA, 2004, BIOL CONSERV, V120, P63, DOI 10.1016/j.biocon.2004.01.026; Garcia JT, 2006, BIRD CONSERV INT, V16, P83, DOI 10.1017/S0959270906000013; GONZALEZ J., 1990, CERNICALO PRIMILLA F; Guixe D, 2011, ANIM CONSERV, V14, P391, DOI 10.1111/j.1469-1795.2011.00441.x; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; HIRALDO F, 1994, J FIELD ORNITHOL, V65, P466; Inigo A., 2010, ACTION PLAN LESSER K; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; Johst K, 2001, ECOL APPL, V11, P60, DOI 10.1890/1051-0761(2001)011[0060:FIAPAD]2.0.CO;2; Jones CG, 2004, TECH ECOL CONSERVAT, P269; Kenward R., 1987, WILDLIFE RADIO TAGGI; Kenward R., 1996, RANGES 5 ANAL SYSTEM; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kerbiriou C, 2006, IBIS, V148, P352, DOI 10.1111/j.1474-919X.2006.00543.x; Kie J. G., 1994, CALHOME HOME RANGE A; Libois E, 2012, BIOL CONSERV, V155, P39, DOI 10.1016/j.biocon.2012.05.020; Loyola RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006807; Manly B., 1993, RESOURCE SELECTION A; Martinez JE, 2007, BIODIVERS CONSERV, V16, P3481, DOI 10.1007/s10531-006-9053-6; Montevecchi W.A., 1993, P217; NEGRO JJ, 1993, BIRD STUDY, V40, P115, DOI 10.1080/00063659309477136; Negro JJ, 1993, BIOL CONSERVATION SM; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Newton I., 1998, POPULATION LIMITATIO; Newton I., 1979, POPULATION ECOLOGY R; Peet N. B., 2000, ACTION PLAN LESSER K; PERRINS CM, 1970, IBIS, V112, P242, DOI 10.1111/j.1474-919X.1970.tb00096.x; Perrins CM., 1991, BIRD POPULATION STUD; Poysa H, 2002, J APPL ECOL, V39, P502, DOI 10.1046/j.1365-2664.2002.00726.x; PRICE T, 1988, SCIENCE, V240, P798, DOI 10.1126/science.3363360; Rodriguez C, 2003, J ANIM ECOL, V72, P793, DOI 10.1046/j.1365-2656.2003.00757.x; Rodriguez C, 2006, J APPL ECOL, V43, P587, DOI 10.1111/j.1365-2664.2006.01152.x; Sara M, 2010, ARDEOLA, V57, P3; Savage R. E., 1931, Fisheries Investigations London Ser 2, V12, P1; Siriwardena GM, 2010, IBIS, V152, P515, DOI 10.1111/j.1474-919X.2010.01034.x; Smith MD, 2005, WILDLIFE SOC B, V33, P454, DOI 10.2193/0091-7648(2005)33[454:BONPAC]2.0.CO;2; Tella J.L., 1996, P53, DOI 10.1016/B978-012100130-8/50009-2; Tella JL, 1998, CONSERV BIOL, V12, P593, DOI 10.1046/j.1523-1739.1998.96288.x; Traba J, 2007, BIODIVERS CONSERV, V16, P3255, DOI 10.1007/s10531-006-9138-2; Vickery JA, 2004, BIOL CONSERV, V119, P19, DOI 10.1016/j.biocon.2003.06.004; VILLAGE A, 1983, J ANIM ECOL, V52, P635, DOI 10.2307/4577; Vorisek P, 2010, EUROPEAN TRENDS FARM, VIII; White G.C., 1990, ANAL WILDLIFE RADIO	65	35	39	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58320	10.1371/journal.pone.0058320	http://dx.doi.org/10.1371/journal.pone.0058320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484016	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100106
J	Kudgus, RA; Szabolcs, A; Khan, JA; Walden, CA; Reid, JM; Robertson, JD; Bhattacharya, R; Mukherjee, P				Kudgus, Rachel A.; Szabolcs, Annamaria; Khan, Jameel Ahmad; Walden, Chad A.; Reid, Joel M.; Robertson, J. David; Bhattacharya, Resham; Mukherjee, Priyabrata			Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics	PLOS ONE			English	Article							PHASE-III TRIAL; FACTOR-RECEPTOR; NUCLEOSIDE TRANSPORTERS; COMPARING GEMCITABINE; CANCER NANOTECHNOLOGY; CLINICAL BENEFIT; NANOPARTICLES; SIZE; CHEMISTRY; MECHANISM	Background: Pancreatic cancer is one of the deadliest of all human malignancies with limited options for therapy. Here, we report the development of an optimized targeted drug delivery system to inhibit advanced stage pancreatic tumor growth in an orthotopic mouse model. Method/Principal Findings: Targeting specificity in vitro was confirmed by preincubation of the pancreatic cancer cells with C225 as well as Nitrobenzylthioinosine (NBMPR - nucleoside transporter (NT) inhibitor). Upon nanoconjugation functional activity of gemcitabine was retained as tested using a thymidine incorporation assay. Significant stability of the nanoconjugates was maintained, with only 12% release of gemcitabine over a 24-hour period in mouse plasma. Finally, an in vivo study demonstrated the inhibition of tumor growth through targeted delivery of a low dose of gemcitabine in an orthotopic model of pancreatic cancer, mimicking an advanced stage of the disease. Conclusion: We demonstrated in this study that the gold nanoparticle-based therapeutic containing gemcitabine inhibited tumor growth in an advanced stage of the disease in an orthotopic model of pancreatic cancer. Future work would focus on understanding the pharmacokinetics and combining active targeting with passive targeting to further improve the therapeutic efficacy and increase survival.	[Kudgus, Rachel A.; Szabolcs, Annamaria; Khan, Jameel Ahmad; Bhattacharya, Resham; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Walden, Chad A.; Reid, Joel M.; Mukherjee, Priyabrata] Mayo Clin, Coll Med, Dept Physiol & Biomed Engn, Rochester, MN USA; [Robertson, J. David] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Robertson, J. David] Univ Missouri, Univ Missouri Res Reactor, Columbia, MO USA; [Mukherjee, Priyabrata] Mayo Clin, Coll Med, Mayo Clin Canc Ctr, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Mayo Clinic	Mukherjee, P (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Mukherjee.priyabrata@mayo.edu		Robertson, John/0000-0002-6675-8469	National Institutes of Health [CA135011, CA136494]; NATIONAL CANCER INSTITUTE [R01CA135011, R01CA136494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by National Institutes of Health CA135011, CA136494 (PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvizo RR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033650; Arvizo RR, 2012, CHEM SOC REV, V41, P2943, DOI 10.1039/c2cs15355f; Arvizo RR, 2011, NANOMED-NANOTECHNOL, V7, P580, DOI 10.1016/j.nano.2011.01.011; Bayraktar S, 2010, WORLD J GASTROENTERO, V16, P673, DOI 10.3748/wjg.v16.i6.673; Bhattacharya R, 2008, ADV DRUG DELIVER REV, V60, P1289, DOI 10.1016/j.addr.2008.03.013; Bhattacharyya S, 2011, PHARM RES-DORDR, V28, P237, DOI 10.1007/s11095-010-0318-0; Bramhall SR, 2002, BRIT J CANCER, V87, P161, DOI 10.1038/sj.bjc.6600446; Brigger I, 2012, ADV DRUG DELIV REV; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Burris H, 1997, EUR J CANCER, V33, pS18, DOI 10.1016/S0959-8049(96)00324-3; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cobley CM, 2011, CHEM SOC REV, V40, P44, DOI 10.1039/b821763g; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Dreaden EC, 2012, CHEM SOC REV, V41, P2740, DOI 10.1039/c1cs15237h; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Griffiths M, 1997, NAT MED, V3, P89, DOI 10.1038/nm0197-89; Han G, 2007, NANOMEDICINE-UK, V2, P113, DOI 10.2217/17435889.2.1.113; Herbst RS, 2001, EXPERT OPIN BIOL TH, V1, P719, DOI 10.1517/14712598.1.4.719; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Khan JA, 2007, CHEMBIOCHEM, V8, P1237, DOI 10.1002/cbic.200700165; Khan JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020347; Kim ES, 2001, LUNG CANCER-J IASLC, V34, P427, DOI 10.1016/S0169-5002(01)00278-1; Kim ES, 2001, CURR OPIN ONCOL, V13, P506, DOI 10.1097/00001622-200111000-00014; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Kleeff J, 2006, PANCREAS, V33, P111, DOI 10.1097/01.mpa.0000229010.62538.f2; Kudgus RA, 2011, ANTI-CANCER AGENT ME, V11, P965; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liao HJ, 2009, CANCER RES, V69, P6179, DOI 10.1158/0008-5472.CAN-09-0049; Mackey JR, 1998, CANCER RES, V58, P4349; Mackey JR, 1998, DRUG RESIST UPDATE, V1, P310, DOI 10.1016/S1368-7646(98)80047-2; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Mangeney C, 2002, J AM CHEM SOC, V124, P5811, DOI 10.1021/ja010796h; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Mukherjee Priyabrata, 2007, Journal of Nanobiotechnology, V5, P4, DOI 10.1186/1477-3155-5-4; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Paciotti GF, 2004, DRUG DELIV, V11, P169, DOI 10.1080/10717540490433895; Paproski RJ, 2008, MOL PHARMACOL, V74, P1372, DOI 10.1124/mol.108.048900; Patra CR, 2008, CANCER RES, V68, P1970, DOI 10.1158/0008-5472.CAN-07-6102; Patra CR, 2010, ADV DRUG DELIVER REV, V62, P346, DOI 10.1016/j.addr.2009.11.007; Patra CR, 2010, J MATER CHEM, V20, P547, DOI 10.1039/b913224d; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Philip PA, 2010, J CLIN ONCOL, V28, P3605, DOI 10.1200/JCO.2009.25.7550; Philip PA, 2010, SURG ONCOL CLIN N AM, V19, P419, DOI 10.1016/j.soc.2009.11.012; PLUNKETT W, 1995, SEMIN ONCOL, V22, P3; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Rathos MJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-161; Rocha-Lima Caio M, 2007, Cancer Control, V14, P295; Saha K, 2011, SMALL, V7, P1903, DOI 10.1002/smll.201100478; Sardar R, 2009, LANGMUIR, V25, P13840, DOI 10.1021/la9019475; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; Shore S, 2004, SURG ONCOL, V13, P201, DOI 10.1016/j.suronc.2004.11.001; Walczyk D, 2010, J AM CHEM SOC, V132, P5761, DOI 10.1021/ja910675v; Whitesides GM, 2003, NAT BIOTECHNOL, V21, P1161, DOI 10.1038/nbt872; Wong A, 2009, DRUG METAB REV, V41, P77, DOI 10.1080/03602530902741828; Yao SYM, 1997, J BIOL CHEM, V272, P28423, DOI 10.1074/jbc.272.45.28423; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]	60	28	29	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57522	10.1371/journal.pone.0057522	http://dx.doi.org/10.1371/journal.pone.0057522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483913	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100029
J	Li, XR; Wang, SH; Sitaram, RT; Andersson, C; Ljungberg, B; Li, AH				Li, Xingru; Wang, Sihan; Sitaram, Raviprakash T.; Andersson, Charlotta; Ljungberg, Borje; Li, Aihong			Single Nucleotide Polymorphisms in the Wilms' Tumour Gene 1 in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; MINIMAL RESIDUAL DISEASE; WT1 GENE; GERMLINE MUTATIONS; PROGNOSTIC IMPACT; SUPPRESSOR GENE; GROUP-B; CANCER; EXPRESSION; CHEMOTHERAPY	The Wilms' tumour gene 1 (WT1) single nucleotide polymorphism (SNP) rs16754 has recently been described as an independent prognostic factor in acute myeloid leukaemia (AML) patients. It is of great interest to test whether WT1 SNPs can be used as a molecular marker in other cancer types in order to improve risk and treatment stratification. We performed sequencing analysis on all 10 exons of the WT1 gene in a total of 182 patients with clear cell renal cell carcinoma (ccRCC). Six different SNPs were identified, in descending order for minor allele frequency: rs2234582, rs16754, rs1799925, rs5030315, rs2234583, and rs2234581. At least one minor allele for WT1 SNP was identified in 61% of ccRCC patients. In the entire study population, only 6% carried two copies of the minor allele. The genotypes of WT1 SNPs in 78 tumour-free kidney tissue specimens were found to be in 95% concordance with corresponding tumour samples. No correlation was observed between WT1 SNP genotypes and RNA expression level. WT1 SNP genotypes did not associate with clinical and pathological characteristics. We found favourable outcomes associated with the homozygous minor allele for WT1 SNP. However, SNP genotypes did not show to be of prognostic significance when comparing wild-type versus homozygous or heterozygous for the minor allele in the entire cohort. None of the previously reported WT1 mutations in AML was found in the present study. A novel WT1 missense mutation was identified in only one patient. Our data suggest that common WT1 mutations are not involved in ccRCC. Due to too few cases harbouring the homozygous minor allele, the prognostic impact needs to be verified in larger study populations.	[Li, Xingru; Wang, Sihan; Andersson, Charlotta; Li, Aihong] Umea Univ, Dept Med Biosci, Umea, Sweden; [Sitaram, Raviprakash T.; Ljungberg, Borje] Umea Univ, Dept Perioperat Sci Urol & Androl, Umea, Sweden	Umea University; Umea University	Li, AH (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	aihong.li@medbio.umu.se		Ljungberg, Borje/0000-0002-4121-3753	Children's Cancer Foundation in Sweden; Lion's Cancer Research Foundation, Umea, Sweden; County Council of Vasterbotten, Umea, Sweden	Children's Cancer Foundation in Sweden; Lion's Cancer Research Foundation, Umea, Sweden; County Council of Vasterbotten, Umea, Sweden	This study was supported by the Children's Cancer Foundation in Sweden, the Lion's Cancer Research Foundation, Umea, Sweden and the County Council of Vasterbotten, Umea, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Andersson C, 2012, DIAGN MOL PATHOL, V21, P225, DOI 10.1097/PDM.0b013e318257ddb9; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Becker H, 2011, HAEMATOL-HEMATOL J, V96, P1488, DOI 10.3324/haematol.2011.041905; Chen X, 2012, LEUK LYMPHOMA; Choi YS, 2012, MEAT SCI, V91, P1, DOI 10.1016/j.meatsci.2011.11.011; Cilloni D, 2008, HAEMATOLOGICA, V93, P921, DOI 10.3324/haematol.12165; Cilloni D, 2009, J CLIN ONCOL, V27, P5195, DOI 10.1200/JCO.2009.22.4865; Dallosso AR, 2004, HUM MOL GENET, V13, P405, DOI 10.1093/hmg/ddh038; Damm F, 2010, J CLIN ONCOL, V28, P578, DOI 10.1200/JCO.2009.23.0342; Engholm G, 2012, NORDCAN CANC INCIDEN; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gaidzik VI, 2009, BLOOD, V113, P4505, DOI 10.1182/blood-2008-10-183392; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Greene FL, 2002, J SURG ONCOL, V80, P119, DOI 10.1002/jso.10114; HABER DA, 1990, CELL, V61, P1257, DOI 10.1016/0092-8674(90)90690-G; Ho PA, 2011, J CLIN ONCOL, V29, P704, DOI 10.1200/JCO.2010.31.9327; Hollink IHIM, 2010, J CLIN ONCOL, V28, pE523, DOI 10.1200/JCO.2010.29.3860; Hollink IHIM, 2009, BLOOD, V113, P5951, DOI 10.1182/blood-2008-09-177949; Hou HA, 2010, BLOOD, V115, P5222, DOI 10.1182/blood-2009-12-259390; Huff V, 2011, NAT REV CANCER, V11, P111, DOI 10.1038/nrc3002; Iliopoulos O, 1997, MOL MED, V3, P289, DOI 10.1007/BF03401807; Inoue K, 1997, BLOOD, V89, P1405, DOI 10.1182/blood.V89.4.1405; INOUE K, 1994, BLOOD, V84, P3071, DOI 10.1182/blood.V84.9.3071.3071; KAGEYAMA Y, 1995, JPN J CLIN ONCOL, V25, P173; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KingUnderwood L, 1996, BLOOD, V87, P2171, DOI 10.1182/blood.V87.6.2171.bloodjournal8762171; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G; Little M, 1997, HUM MUTAT, V9, P209, DOI 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2; Ljungberg B, 2007, EUR UROL, V51, P1502, DOI 10.1016/j.eururo.2007.03.035; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Osaka M, 1997, INT J CANCER, V72, P696, DOI 10.1002/(SICI)1097-0215(19970807)72:4<696::AID-IJC23>3.0.CO;2-8; Ostergaard M, 2004, BRIT J HAEMATOL, V125, P590, DOI 10.1111/j.1365-2141.2004.04952.x; Paschka P, 2008, J CLIN ONCOL, V26, P4595, DOI 10.1200/JCO.2007.15.2058; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; Renneville A, 2010, LEUKEMIA, V24, P476, DOI 10.1038/leu.2009.221; Royer-Pokora B, 2004, AM J MED GENET A, V127A, P249, DOI 10.1002/ajmg.a.30015; Sauna ZE, 2007, CANCER RES, V67, P9609, DOI 10.1158/0008-5472.CAN-07-2377; Scharnhorst V, 2001, GENE, V273, P141, DOI 10.1016/S0378-1119(01)00593-5; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sitaram RT, 2010, BRIT J CANCER, V103, P1255, DOI 10.1038/sj.bjc.6605878; Sugiyama H, 2001, INT J HEMATOL, V73, P177, DOI 10.1007/BF02981935; Tosello V, 2009, BLOOD, V114, P1038, DOI 10.1182/blood-2008-12-192039; Virappane P, 2008, J CLIN ONCOL, V26, P5429, DOI 10.1200/JCO.2008.16.0333; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58396	10.1371/journal.pone.0058396	http://dx.doi.org/10.1371/journal.pone.0058396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484026	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100116
J	Wang, RY; Shi, ZY; Guo, YY; Chen, JC; Chen, GQ				Wang, Rui-Yan; Shi, Zhen-Yu; Guo, Ying-Ying; Chen, Jin-Chun; Chen, Guo-Qiang			DNA Fragments Assembly Based on Nicking Enzyme System	PLOS ONE			English	Article							LIGATION-INDEPENDENT CLONING; ESCHERICHIA-COLI; PCR PRODUCTS; HOMOLOGOUS RECOMBINATION; SYNTHETIC BIOLOGY; URACIL-EXCISION; USER FUSION; IN-VITRO; ENDONUCLEASES; PLASMIDS	A couple of DNA ligation-independent cloning (LIC) methods have been reported to meet various requirements in metabolic engineering and synthetic biology. The principle of LIC is the assembly of multiple overlapping DNA fragments by single-stranded (ss) DNA overlaps annealing. Here we present a method to generate single-stranded DNA overlaps based on Nicking Endonucleases (NEases) for LIC, the method was termed NE-LIC. Factors related to cloning efficiency were optimized in this study. This NE-LIC allows generating 3'-end or 5'-end ss DNA overlaps of various lengths for fragments assembly. We demonstrated that the 10 bp/15 bp overlaps had the highest DNA fragments assembling efficiency, while 5 bp/10 bp overlaps showed the highest efficiency when T4 DNA ligase was added. Its advantage over Sequence and Ligation Independent Cloning (SLIC) and Uracil-Specific Excision Reagent (USER) was obvious. The mechanism can be applied to many other LIC strategies. Finally, the NEases based LIC (NE-LIC) was successfully applied to assemble a pathway of six gene fragments responsible for synthesizing microbial poly-3-hydroxybutyrate (PHB).	[Wang, Rui-Yan; Guo, Ying-Ying; Chen, Jin-Chun; Chen, Guo-Qiang] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Dept Biol Sci & Biotechnol,MOE Key Lab Bioinforma, Beijing 100084, Peoples R China; [Chen, Guo-Qiang] Tsinghua Univ, Ctr Nano & Micro Mech, Beijing 100084, Peoples R China; [Shi, Zhen-Yu] Synthenome Com, Dingley Village, Vic, Australia	Tsinghua University; Tsinghua University	Chen, GQ (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Life Sci, Dept Biol Sci & Biotechnol,MOE Key Lab Bioinforma, Beijing 100084, Peoples R China.	chengq@mail.tsinghua.edu.cn	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	National Basic Research 973 Program of China [2012CB725201]; Natural Science Foundation of China [31270146]	National Basic Research 973 Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research 973 Program of China (Grant No. 2012CB725201 to GQC and JCC). GQC was also supported by Natural Science Foundation of China (Grant No. 31270146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annaluru Narayana, 2012, Methods Mol Biol, V852, P77, DOI 10.1007/978-1-61779-564-0_7; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; Bitinaite Jurate, 2009, Curr Protoc Mol Biol, VChapter 3, DOI 10.1002/0471142727.mb0321s86; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Forster AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100090; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Higgins LS, 2001, NUCLEIC ACIDS RES, V29, P2492, DOI 10.1093/nar/29.12.2492; Joneja A, 2011, ANAL BIOCHEM, V414, P58, DOI 10.1016/j.ab.2011.02.025; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Li ZJ, 2009, APPL MICROBIOL BIOT, V83, P939, DOI 10.1007/s00253-009-1943-6; Liu Q, 2011, METAB ENG, V13, P11, DOI 10.1016/j.ymben.2010.10.004; Luzzietti N, 2012, NAT PROTOC, V7, P643, DOI 10.1038/nprot.2012.008; Luzzietti N, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1004; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; Shao Zengyi, 2012, Methods Mol Biol, V898, P251, DOI 10.1007/978-1-61779-918-1_17; Shao ZY, 2011, MOL BIOSYST, V7, P1056, DOI 10.1039/c0mb00338g; Shi ZY, 2012, THESIS U MELBOURNE; Tachibana A, 2009, J BIOSCI BIOENG, V107, P668, DOI 10.1016/j.jbiosc.2009.01.019; Too PHM, 2010, NUCLEIC ACIDS RES, V38, P1294, DOI 10.1093/nar/gkp1092; Tsvetanova B, 2011, METHOD ENZYMOL, V498, P327, DOI 10.1016/B978-0-12-385120-8.00014-0; Xu SY, 2007, NUCLEIC ACIDS RES, V35, P4608, DOI 10.1093/nar/gkm481; Yang J, 2010, BIOTECHNIQUES, V49, P817, DOI 10.2144/000113520; Zheleznaya LA, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1457, DOI 10.1134/S0006297909130033; Zhou Q, 2011, METAB ENG, V13, P777, DOI 10.1016/j.ymben.2011.10.002; Zhu ZY, 2004, J MOL BIOL, V337, P573, DOI 10.1016/j.jmb.2004.02.003	34	23	31	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57943	10.1371/journal.pone.0057943	http://dx.doi.org/10.1371/journal.pone.0057943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483947	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100057
J	Arroyo, X; Goldflam, M; Feliz, M; Belda, I; Giralt, E				Arroyo, Xavier; Goldflam, Michael; Feliz, Miguel; Belda, Ignasi; Giralt, Ernest			Computer-Aided Design of Fragment Mixtures for NMR-Based Screening	PLOS ONE			English	Article							PEPTIDE DESIGN	Fragment-based drug discovery is widely applied both in industrial and in academic screening programs. Several screening techniques rely on NMR to detect binding of a fragment to a target. NMR-based methods are among the most sensitive techniques and have the further advantage of yielding a low rate of false positives and negatives. However, NMR is intrinsically slower than other screening techniques; thus, to increase throughput in NMR-based screening, researchers often assay mixtures of fragments, rather than single fragments. Herein we present a fast and straightforward computer-aided method to design mixtures of fragments taken from a library that have minimized NMR signal overlap. This approach enables direct identification of one or several active fragments without the need for deconvolution. Our approach entails encoding of NMR spectra into a computer-readable format that we call a fingerprint, and minimizing the global signal overlap through a Monte Carlo algorithm. The scoring function used favors a homogenous distribution of the global signal overlap. The method does not require additional experimental work: the only data required are NMR spectra, which are generally recorded for each compound as a quality control measure before its insertion into the library.	[Arroyo, Xavier; Goldflam, Michael; Giralt, Ernest] Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Feliz, Miguel] Univ Barcelona, Serv Cient Tecn, Barcelona, Spain; [Belda, Ignasi] Intelligent Pharma, Barcelona, Spain; [Giralt, Ernest] Univ Barcelona, Dept Quim Organ, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; University of Barcelona	Giralt, E (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona, Spain.	ernest.giralt@irbbarcelona.org	Feliz, Miguel/F-3792-2016; Belda, Ignasi/U-4051-2019; giralt, ernest/N-1669-2014; Belda, Ignasi/Y-3425-2019	Feliz, Miguel/0000-0002-7676-3309; giralt, ernest/0000-0001-8381-1797; 	Ministerio de Economia y Competitividad, Espana (MINECO) [BIO2008-00799]	Ministerio de Economia y Competitividad, Espana (MINECO)	This work has been funded by Ministerio de Economia y Competitividad, Espana (MINECO) http://www.mineco.gob.es/ grant #BIO2008-00799. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belda I, 2005, J COMPUT AID MOL DES, V19, P585, DOI 10.1007/s10822-005-9015-1; Belda I, 2007, MOL DIVERS, V11, P7, DOI 10.1007/s11030-006-9053-1; Dalvit C, 2009, DRUG DISCOV TODAY, V14, P1051, DOI 10.1016/j.drudis.2009.07.013; Fejzo J, 1999, CHEM BIOL, V6, P755, DOI 10.1016/S1074-5521(00)80022-8; Garey MR, 1979, SERIES BOOKS MATH SC; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Lepre CA, 2004, CHEMINFORM, V35; Mercier KA, 2006, J AM CHEM SOC, V128, P15292, DOI 10.1021/ja0651759; Silvano M., 1990, KNAPSACK PROBLEMS AL	10	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58571	10.1371/journal.pone.0058571	http://dx.doi.org/10.1371/journal.pone.0058571			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516512	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200092
J	Kohaya, N; Fujiwara, K; Ito, J; Kashiwazaki, N				Kohaya, Natsuki; Fujiwara, Katsuyoshi; Ito, Junya; Kashiwazaki, Naomi			Generation of Live Offspring from Vitrified Mouse Oocytes of C57BL/6J Strain	PLOS ONE			English	Article							HIGHLY EFFICIENT VITRIFICATION; SUCCESSFUL CRYOPRESERVATION; PREIMPLANTATION DEVELOPMENT; EMBRYOS; FERTILIZATION; SURVIVAL; ZYGOTES; INVITRO; FROZEN; TRANSGENESIS	In mammals, unfertilized oocytes are one of the most available stages for cryopreservation because the cryopreserved oocytes can be used for assisted reproductive technologies, including in vitro fertilization (IVF) and intracytoplasmic sperm injection. However, it has generally been reported that the fertility and developmental ability of the oocytes are reduced by cryopreservation. C57BL/6J mice, an inbred strain, are used extensively for the production of transgenic and knockout mice. If the oocytes from C57BL/6J mice can be successfully cryopreserved, the cryopreservation protocol used will contribute to the high-speed production of not only gene-modified mice but also hybrid mice. Very recently, we succeeded in the vitrification of mouse oocytes derived from ICR (outbred) mice. However, our protocol can be applied to the vitrification of oocytes from an inbred strain. The aim of the present study was to establish the vitrification of oocytes from C57BL/6J mice. First, the effect of cumulus cells on the ability of C57BL/6J mouse oocytes to fertilize and develop in vitro was examined. The fertility and developmental ability of oocyte-removed cumulus cells (i.e., denuded oocytes, or DOs) after IVF were reduced compared to cumulus oocyte complexes (COCs) in both fresh and cryopreserved groups. Vitrified COCs showed significantly (P<0.05) higher fertility and ability to develop into the 2-cell and blastocyst stages compared to the vitrified DOs with cumulus cells and vitrified DOs alone. The vitrified COCs developed to term at a high success rate, equivalent to the rate obtained with IVF using fresh COCs. Taken together, our results demonstrate that we succeeded for the first time in the vitrification of mouse oocytes from C57BL/6J mice. Our findings will also contribute to the improvement of oocyte vitrification not only in animals but also in clinical applications for human infertility.	[Kohaya, Natsuki; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Sch Vet Med, Lab Anim Reprod, Sagamihara, Kanagawa, Japan; [Fujiwara, Katsuyoshi; Ito, Junya; Kashiwazaki, Naomi] Azabu Univ, Grad Sch Vet Sci, Sagamihara, Kanagawa, Japan	Azabu University; Azabu University	Ito, J (corresponding author), Azabu Univ, Sch Vet Med, Lab Anim Reprod, Sagamihara, Kanagawa, Japan.	itoj@azabu-u.ac.jp			JSPS (KAKENHI) [21780253, 22658085]; Azabu University Research Services Division; Grants-in-Aid for Scientific Research [12J10249] Funding Source: KAKEN	JSPS (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Azabu University Research Services Division; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from JSPS (KAKENHI, 21780253 to J.I. and 22658085 to N.K.). This research was partially supported by a research project grant awarded by the Azabu University Research Services Division to J.I. and N.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2005, BIOL REPROD, V72, P1416, DOI 10.1095/biolreprod.104.037051; ALHASANI S, 1989, HUM REPROD, V4, P77; Brown SDM, 1998, HUM MOL GENET, V7, P1627, DOI 10.1093/hmg/7.10.1627; CHEN C, 1986, LANCET, V1, P884, DOI 10.1016/S0140-6736(86)90989-X; Endoh K, 2007, J REPROD DEVELOP, V53, P1199, DOI 10.1262/jrd.19058; Eroglu A, 2009, BIOL REPROD, V80, P70, DOI 10.1095/biolreprod.108.070383; FUKU E, 1992, CRYOBIOLOGY, V29, P485, DOI 10.1016/0011-2240(92)90051-3; HO YG, 1995, MOL REPROD DEV, V41, P232, DOI 10.1002/mrd.1080410214; Hochi S, 2004, THERIOGENOLOGY, V61, P267, DOI 10.1016/S0093-691X(03)00232-2; Hochi S, 2003, J REPROD DEVELOP, V49, P13; Ito J, 2010, J REPROD ENG, V13, P21; Ito J, 2010, ANIM SCI J, V81, P34, DOI 10.1111/j.1740-0929.2009.00699.x; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Katayama KP, 2003, FERTIL STERIL, V80, P223, DOI 10.1016/S0015-0282(03)00551-X; Kohaya N, 2011, J REPROD DEVELOP, V57, P675, DOI 10.1262/jrd.11-066H; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P300, DOI 10.1016/S1472-6483(10)60837-1; Kuwayama M, 2008, FERTIL STERIL, V90, P281; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Lane M, 1999, FERTIL STERIL, V72, P1073, DOI 10.1016/S0015-0282(99)00418-5; Liu Y, 2008, CRYOLETTERS, V29, P315; Martino A, 1996, BIOL REPROD, V54, P1059, DOI 10.1095/biolreprod54.5.1059; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; PALMITER RD, 1985, CELL, V41, P343, DOI 10.1016/S0092-8674(85)80004-0; Papis K, 2000, THERIOGENOLOGY, V54, P651, DOI 10.1016/S0093-691X(00)00380-0; Park SE, 2001, FERTIL STERIL, V75, P1177, DOI 10.1016/S0015-0282(01)01809-X; PARKENING TA, 1977, BIOL REPROD, V17, P527, DOI 10.1095/biolreprod17.4.527; Perry ACF, 1999, SCIENCE, V284, P1180, DOI 10.1126/science.284.5417.1180; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; RALL WF, 1987, CRYOBIOLOGY, V24, P387, DOI 10.1016/0011-2240(87)90042-3; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sanchez-Partida LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021597; Seita Y, 2009, CRYOBIOLOGY, V59, P226, DOI 10.1016/j.cryobiol.2009.07.007; Sheehan CB, 2006, HUM REPROD, V21, P2978, DOI 10.1093/humrep/del253; Shimada M, 2008, DEVELOPMENT, V135, P2001, DOI 10.1242/dev.020461; Somfai T, 2009, BIOL REPROD, V80, P42, DOI 10.1095/biolreprod.108.070235; TAKESHIMA T, 1991, EXP ANIM TOKYO, V40, P493, DOI 10.1538/expanim1978.40.4_493; Tamba S, 2008, P NATL ACAD SCI USA, V105, P14539, DOI 10.1073/pnas.0805699105; Vajta G, 1997, ACTA VET SCAND, V38, P349; Varani S, 2002, MOL ENDOCRINOL, V16, P1154, DOI 10.1210/me.16.6.1154; WHITTINGHAM DG, 1977, J REPROD FERTIL, V49, P89, DOI 10.1530/jrf.0.0490089; WHITTINGHAM DG, 1972, SCIENCE, V178, P411, DOI 10.1126/science.178.4059.411; Yoda Y., 1971, JAPANESE J ANIM REPR, V16, P147, DOI [DOI 10.1262/JRD1955.16.147, 10.1262/jrd1955.16.147]	43	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58063	10.1371/journal.pone.0058063	http://dx.doi.org/10.1371/journal.pone.0058063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516430	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200030
J	Lericollais, R; Gauthier, A; Bessot, N; Zouabi, A; Davenne, D				Lericollais, Romain; Gauthier, Antoine; Bessot, Nicolas; Zouabi, Amira; Davenne, Damien			Morning Anaerobic Performance Is Not Altered by Vigilance Impairment	PLOS ONE			English	Article							NIGHTS SLEEP-DEPRIVATION; BREAKFAST INTAKE PRIOR; PHYSICAL PERFORMANCE; CIRCADIAN-RHYTHM; CORE TEMPERATURE; WAKING TIME; MUSCLE; EXERCISE; POWER; PSYCHOMOTOR	The aim of this study was to determine the role played by vigilance on the anaerobic performance recorded during a Wingate test performed at the bathyphase (nadir) of the circadian rhythmicity. Twenty active male participants performed a 60-s Wingate test at 6 a. m. during 3 test sessions in counter-balanced order the day after either (i) a normal reference night, (ii) a total sleep deprivation night, or (iii) a total sleep deprivation night associated with an extended simulated driving task from 9 p.m. to 5 a.m. During this task, the number of inappropriate line crossings (ILCs) was used to control and quantify the effective decrease in the level of vigilance. The main findings show that (i) vigilance of each participant was significantly altered (i.e., a drastic and progressive increase in ILCs is shown during the 7.5 hours of driving) by the sleep deprivation night associated with an extended driving task; (ii) the subjective evaluation of vigilance performed by self-rated scale revealed an increased impairment of the vigilance level between the normal reference night, the total sleep deprivation night and the total sleep deprivation night associated with an extended driving task; and (iii) the morning following this last condition, during the Wingate test, the recorded cycling biomechanical parameters (peak power, mean power and fatigue index values, power decrease, and cycling kinetic and kinematic patterns) were not significantly different from the two other conditions. Consequently, these results show that anaerobic performances recorded during a Wingate test performed at the bathyphase of the circadian rhythmicity are not altered by a drastic impairment in vigilance. These findings seem to indicate that vigilance is probably not a factor that contributes to circadian variations in anaerobic performance.	[Lericollais, Romain; Gauthier, Antoine; Bessot, Nicolas; Zouabi, Amira; Davenne, Damien] Normandie Univ, Caen, France; [Lericollais, Romain; Gauthier, Antoine; Bessot, Nicolas; Zouabi, Amira; Davenne, Damien] UniCaen, Unite Rech COMETE, Caen, France; [Lericollais, Romain; Gauthier, Antoine; Bessot, Nicolas; Zouabi, Amira; Davenne, Damien] INSERM, Unite Rech COMETE U1075, Caen, France; [Lericollais, Romain] CHU Caen, Dept Clin Physiol, F-14000 Caen, France	Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Caen NORMANDIE; Universite de Caen Normandie	Davenne, D (corresponding author), Normandie Univ, Caen, France.	damien.davenne@unicaen.fr	Davenne, Damien/K-2959-2015; Bessot, Nicolas/O-2265-2015; bessot, nicolas/AFQ-7881-2022; Davenne, Damien/K-2432-2019	Davenne, Damien/0000-0002-9399-9970; Davenne, Damien/0000-0002-9399-9970; Bessot, Nicolas/0000-0002-0587-2022	French Ministry of Higher Education and Research (Ministere de l'Enseignement Superieur et de la Recherche); French National Agency for Research (ANR) (VIGISIM) [0566C0136]	French Ministry of Higher Education and Research (Ministere de l'Enseignement Superieur et de la Recherche); French National Agency for Research (ANR) (VIGISIM)(French National Research Agency (ANR))	This study was funded by the French Ministry of Higher Education and Research (Ministere de l'Enseignement Superieur et de la Recherche) and a small part of a grant from the French National Agency for Research (ANR) (VIGISIM; No. 0566C0136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Bessot N, 2007, J ELECTROMYOGR KINES, V17, P176, DOI 10.1016/j.jelekin.2006.01.007; Bini RR, 2010, J ELECTROMYOGR KINES, V20, P102, DOI 10.1016/j.jelekin.2008.10.003; Bougard C, 2009, CHRONOBIOL INT, V26, P324, DOI 10.1080/07420520902774540; Bougard C, 2009, CHRONOBIOL INT, V26, P307, DOI 10.1080/07420520902774532; Brisswalter J, 2007, CHRONOBIOL INT, V24, P495, DOI 10.1080/07420520701420691; Davenne D, 2012, ACCIDENT ANAL PREV, V45, P677, DOI 10.1016/j.aap.2011.09.046; DAVENNE D, 1995, MED SCI RES, V23, P767; Dorel S, 2009, SCAND J MED SCI SPOR, V19, P44, DOI 10.1111/j.1600-0838.2007.00765.x; Drummond SPA, 2005, PSYCHIAT RES-NEUROIM, V140, P211, DOI 10.1016/j.pscychresns.2005.06.007; Drummond SPA, 2004, SLEEP, V27, P445; Gauthier A, 1996, CHRONOBIOL INT, V13, P135, DOI 10.3109/07420529609037077; Hill DW, 1994, J SPORT SCI, V12, P455, DOI 10.1080/02640419408732195; HILL DW, 1991, CAN J SPORT SCI, V16, P30; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Lericollais R, 2011, SCAND J MED SCI SPOR, V21, pE106, DOI 10.1111/j.1600-0838.2010.01172.x; Lericollais R, 2009, CHRONOBIOL INT, V26, P1622, DOI 10.3109/07420520903534492; Lim CL, 2008, ANN ACAD MED SINGAP, V37, P347; Martin JC, 2009, J BIOMECH, V42, P474, DOI 10.1016/j.jbiomech.2008.11.015; McKenzie JE, 2004, J THERM BIOL, V29, P605, DOI 10.1016/j.jtherbio.2004.08.020; McLester JR, 2004, J STRENGTH COND RES, V18, P816; MELHIM AF, 1993, INT J SPORTS MED, V14, P303, DOI 10.1055/s-2007-1021182; Meney I, 1998, CHRONOBIOL INT, V15, P349, DOI 10.3109/07420529808998695; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Nicolas A, 2005, CHRONOBIOL INT, V22, P997, DOI 10.1080/07420520500397892; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; Peveler WW, 2007, J STRENGTH COND RES, V21, P1023; Portaluppi F, 2008, CHRONOBIOL INT, V25, P999, DOI 10.1080/07420520802544530; Raasch CC, 1999, J NEUROPHYSIOL, V82, P515, DOI 10.1152/jn.1999.82.2.515; Racinais S, 2005, CHRONOBIOL INT, V22, P1029, DOI 10.1080/07420520500397918; REILLY T, 1983, J HUM MOVEMENT STUD, V9, P157; RODGERS CD, 1995, SLEEP, V18, P30, DOI 10.1093/sleep/18.1.30; Sagaspe P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003493; SHEPHARD RJ, 1984, SPORTS MED, V1, P11, DOI 10.2165/00007256-198401010-00003; Souissi N, 2004, INT J SPORTS MED, V25, P14; Souissi N, 2003, EUR J APPL PHYSIOL, V89, P359, DOI 10.1007/s00421-003-0793-7; Souissi N, 2007, CHRONOBIOL INT, V24, P739, DOI 10.1080/07420520701535811; SYMONS JD, 1988, CAN J SPORT SCI, V13, P225; SYMONS JD, 1988, MED SCI SPORT EXER, V20, P374, DOI 10.1249/00005768-198808000-00008; VANDEWALLE H, 1987, SPORTS MED, V4, P268, DOI 10.2165/00007256-198704040-00004; Wakeling JM, 2009, J NEUROPHYSIOL, V101, P843, DOI 10.1152/jn.90679.2008; Waterhouse J, 2005, CHRONOBIOL INT, V22, P207, DOI 10.1081/CBI-200053477; WITHERS RT, 1991, EUR J APPL PHYSIOL, V63, P354, DOI 10.1007/BF00364462; WITHERS RT, 1993, EUR J APPL PHYSIOL O, V67, P185, DOI 10.1007/BF00376665	45	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58638	10.1371/journal.pone.0058638	http://dx.doi.org/10.1371/journal.pone.0058638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516522	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200097
J	Liu, X; Pei, XH; Li, NS; Zhang, YN; Zhang, X; Chen, JX; Lv, LS; Ma, HJ; Wu, XM; Zhao, WH; Lou, TQ				Liu, Xun; Pei, Xiaohua; Li, Ningshan; Zhang, Yunong; Zhang, Xiang; Chen, Jinxia; Lv, Linsheng; Ma, Huijuan; Wu, Xiaoming; Zhao, Weihong; Lou, Tanqi			Improved Glomerular Filtration Rate Estimation by an Artificial Neural Network	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CKD-EPI EQUATION; SERUM CREATININE; PREDICTION; PREVALENCE; VALIDATION; MODEL; GAMMA; MDRD; RISK	Background: Accurate evaluation of glomerular filtration rates (GFRs) is of critical importance in clinical practice. A previous study showed that models based on artificial neural networks (ANNs) could achieve a better performance than traditional equations. However, large-sample cross-sectional surveys have not resolved questions about ANN performance. Methods: A total of 1,180 patients that had chronic kidney disease (CKD) were enrolled in the development data set, the internal validation data set and the external validation data set. Additional 222 patients that were admitted to two independent institutions were externally validated. Several ANNs were constructed and finally a Back Propagation network optimized by a genetic algorithm (GABP network) was chosen as a superior model, which included six input variables; i.e., serum creatinine, serum urea nitrogen, age, height, weight and gender, and estimated GFR as the one output variable. Performance was then compared with the Cockcroft-Gault equation, the MDRD equations and the CKD-EPI equation. Results: In the external validation data set, Bland-Altman analysis demonstrated that the precision of the six-variable GABP network was the highest among all of the estimation models; i.e., 46.7 ml/min/1.73 m(2) vs. a range from 71.3 to 101.7 ml/min/1.73 m(2), allowing improvement in accuracy (15% accuracy, 49.0%; 30% accuracy, 75.1%; 50% accuracy, 90.5% [P<0.001 for all]) and CKD stage classification (misclassification rate of CKD stage, 32.4% vs. a range from 47.3% to 53.3% [P<0.001 for all]). Furthermore, in the additional external validation data set, precision and accuracy were improved by the six-variable GABP network. Conclusions: A new ANN model (the six-variable GABP network) for CKD patients was developed that could provide a simple, more accurate and reliable means for the estimation of GFR and stage of CKD than traditional equations. Further validations are needed to assess the ability of the ANN model in diverse populations.	[Liu, Xun; Chen, Jinxia; Ma, Huijuan; Lou, Tanqi] Sun Yat Sen Univ, Dept Internal Med, Div Nephrol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Xun; Li, Ningshan; Wu, Xiaoming] S China Univ Technol, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Pei, Xiaohua; Zhao, Weihong] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Div Nephrol, Nanjing, Jiangsu, Peoples R China; [Li, Ningshan] Chengdu Int Canc Treatment Hosp, Dept Radiat Oncol, Chengdu, Peoples R China; [Zhang, Yunong] Sun Yat Sen Univ, Sch Informat Sci & Technol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xiang] JieYang Peoples Hosp, Dept Internal Med, Jieyang, Peoples R China; [Lv, Linsheng] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; South China University of Technology; Nanjing Medical University; Sun Yat Sen University; Sun Yat Sen University	Wu, XM (corresponding author), S China Univ Technol, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.	bmxmwus@scut.edu.cn; zhaoweihong_1@medmail.com.cn; naturestyle@163.com		Li, Ningshan/0000-0003-1916-2563	National Natural Science Foundation of China [81070612]; China Postdoctoral Science Foundation [201104335]; Guangdong Science and Technology Plan [2011B031800084]; Fundamental Research Funds for the Central Universities [11ykpy38]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI10B00]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Guangdong Science and Technology Plan; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program)	Project 81070612 supported by National Natural Science Foundation of China. This work was also supported by the China Postdoctoral Science Foundation (Grant No. 201104335), Guangdong Science and Technology Plan (Grant No. 2011B031800084), the Fundamental Research Funds for the Central Universities (Grant No. 11ykpy38) and the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (Grant No. 2011BAI10B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxt WG, 1996, LANCET, V347, P12, DOI 10.1016/S0140-6736(96)91555-X; Botev R, 2011, CLIN J AM SOC NEPHRO, V6, P937, DOI 10.2215/CJN.09241010; Carlsen O, 2004, NUCL MED COMMUN, V25, P1021, DOI 10.1097/00006231-200410000-00006; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Du X, 2012, NEPHROLOGY, V17, P407, DOI 10.1111/j.1440-1797.2012.01568.x; Du X, 2011, RENAL FAILURE, V33, P859, DOI 10.3109/0886022X.2011.605533; Dybowski R, 1996, LANCET, V347, P1146, DOI 10.1016/S0140-6736(96)90609-1; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Emoto T, 2012, PHYSIOL MEAS, V33, P1675, DOI 10.1088/0967-3334/33/10/1675; Gaweda AE, 2008, AM J KIDNEY DIS, V51, P71, DOI 10.1053/j.ajkd.2007.10.003; Goldfarb-Rumyantzev AS, 2002, AM J KIDNEY DIS, V40, P252, DOI 10.1053/ajkd.2002.34503; Guh JY, 1998, AM J KIDNEY DIS, V31, P638, DOI 10.1053/ajkd.1998.v31.pm9531180; Hagan MT., 1997, NEURAL NETWORK DESIG; Hu K, 2012, J ENVIRON SCI HEAL A, V47, P744, DOI 10.1080/10934529.2012.660102; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu X, 2012, INTERN MED J, V42, pe59, DOI 10.1111/j.1445-5994.2010.02398.x; Liu Xun, 2012, Proceedings of the 2012 International Conference on Computer Science and Electronics Engineering (ICCSEE 2012), P334, DOI 10.1109/ICCSEE.2012.104; Liu Xun, 2010, 2010 International Conference on Computer Application and System Modeling (ICCASM 2010), P332, DOI 10.1109/ICCASM.2010.5622616; Magosso E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042503; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Seguritan V, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002657; Shi H, 2012, DIABETES TECHNOL THE, V14, P293, DOI 10.1089/dia.2011.0071; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Tong DL, 2011, ARTIF INTELL MED, V53, P47, DOI 10.1016/j.artmed.2011.06.008; Vickery S, 2006, NEPHROL DIAL TRANSPL, V21, P2439, DOI 10.1093/ndt/gfl249; Xie FB, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-11; Young J, 2012, J ACOUST SOC AM, V132, P3234, DOI 10.1121/1.4754556; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	36	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58242	10.1371/journal.pone.0058242	http://dx.doi.org/10.1371/journal.pone.0058242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516450	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200043
J	Tiukova, IA; Petterson, ME; Tellgren-Roth, C; Bunikis, I; Eberhard, T; Pettersson, OV; Passoth, V				Tiukova, Ievgeniia A.; Petterson, Mats E.; Tellgren-Roth, Christian; Bunikis, Ignas; Eberhard, Thomas; Pettersson, Olga Vinnere; Passoth, Volkmar			Transcriptome of the Alternative Ethanol Production Strain Dekkera bruxellensis CBS 11270 in Sugar Limited, Low Oxygen Cultivation	PLOS ONE			English	Article							BUDDING YEAST TRANSCRIPTOME; SACCHAROMYCES-CEREVISIAE; BRETTANOMYCES-BRUXELLENSIS; ALDEHYDE DEHYDROGENASES; ANAEROBIC CONDITIONS; HEXOSE TRANSPORTERS; GENE-EXPRESSION; PICHIA-STIPITIS; HXT GENES; GENOME	Dekkera bruxellensis can outcompete Saccharomyces cerevisiae in environments with low sugar concentrations. It is usually regarded as a spoilage yeast but has lately been identified as an alternative ethanol production organism. In this study, global gene expression in the industrial isolate D. bruxellensis CBS 11270 under oxygen and glucose limitation was investigated by whole transcriptome sequencing using the AB SOLiD technology. Among other observations, we noted expression of respiratory complex I NADH-ubiquinone reductase although D. bruxellensis is a Crabtree positive yeast. The observed higher expression of NADH-generating enzymes compared to NAD(+)-generating enzymes might be the reason for the previously observed NADH imbalance and resulting Custer effect in D. bruxellensis. Low expression of genes involved in glycerol production is probably the molecular basis for high efficiency of D. bruxellensis metabolism under nutrient limitation. No D. bruxellensis homologs to the genes involved in the final reactions of glycerol biosynthesis were detected. A high number of expressed sugar transporter genes is consistent with the hypothesis that the competitiveness of D. bruxellensis is due to a higher affinity for the limiting substrate.	[Tiukova, Ievgeniia A.; Eberhard, Thomas; Passoth, Volkmar] Swedish Univ Agr Sci, Uppsala Bioctr, Dept Microbiol, Uppsala, Sweden; [Petterson, Mats E.] Swedish Univ Agr Sci, Uppsala Bioctr, Dept Anim Breeding & Genet, Uppsala, Sweden; [Tellgren-Roth, Christian; Bunikis, Ignas; Pettersson, Olga Vinnere] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Rudbeck Lab,Uppsala Genome Ctr, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Uppsala University	Passoth, V (corresponding author), Swedish Univ Agr Sci, Uppsala Bioctr, Dept Microbiol, Uppsala, Sweden.	Volkmar.Passoth@slu.se	Passoth, Volkmar/AFP-0775-2022; Pettersson, Mats E/E-4523-2011; Pettersson, Olga Vinnere/AAD-3212-2021	Passoth, Volkmar/0000-0002-2059-9044; Tellgren-Roth, Christian/0000-0003-0502-3693; Vinnere Pettersson, Olga/0000-0002-5597-1870	Swedish Energy Authority (Statens Energimyndigheten, STEM) [34134-1]; Research program MicroDrivE at the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences; RFI/VR "SNISS" (Swedish National Infrastructure for large Scale Sequencing and Science for Life Laboratory) Uppsala	Swedish Energy Authority (Statens Energimyndigheten, STEM); Research program MicroDrivE at the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences; RFI/VR "SNISS" (Swedish National Infrastructure for large Scale Sequencing and Science for Life Laboratory) Uppsala	This study has been supported by the Swedish Energy Authority (Statens Energimyndigheten, STEM), project number 34134-1 and the Research program MicroDrivE at the Faculty for Natural Resources and Agriculture at the Swedish University of Agricultural Sciences. Work performed at Uppsala Genome Center has been funded by RFI/VR "SNISS" (Swedish National Infrastructure for large Scale Sequencing and Science for Life Laboratory) Uppsala. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blomqvist J, 2011, LETT APPL MICROBIOL, V53, P73, DOI 10.1111/j.1472-765X.2011.03067.x; Blomqvist J, 2012, YEAST, V29, P265, DOI 10.1002/yea.2904; Blomqvist J, 2010, APPL MICROBIOL BIOT, V87, P1487, DOI 10.1007/s00253-010-2619-y; Conterno L, 2006, AM J ENOL VITICULT, V57, P139; Curtin CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033840; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Pita WD, 2011, ANTON LEEUW INT J G, V100, P99, DOI 10.1007/s10482-011-9568-z; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Diderich JA, 1999, J BIOL CHEM, V274, P15350, DOI 10.1074/jbc.274.22.15350; Fiaux J, 2003, EUKARYOT CELL, V2, P170, DOI 10.1128/EC.2.1.170-180.2003; Fredlund E, 2004, APPL ENVIRON MICROB, V70, P5905, DOI 10.1128/AEM.70.10.5905-5911.2004; Galafassi S, 2011, J IND MICROBIOL BIOT, V38, P1079, DOI 10.1007/s10295-010-0885-4; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; Greatrix BW, 2006, CURR GENET, V49, P205, DOI 10.1007/s00294-005-0046-x; Ito T, 2008, IUBMB LIFE, V60, P775, DOI 10.1002/iub.121; Martens H, 1997, J I BREWING, V103, P85, DOI 10.1002/j.2050-0416.1997.tb00939.x; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navarro-Avino JP, 1999, YEAST, V15, P829, DOI 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9; NEIGEBORN L, 1984, GENETICS, V108, P845; Ni T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015271; Passoth V, 1996, APPL BIOCHEM BIOTECH, V57-8, P201, DOI 10.1007/BF02941701; Passoth V, 2007, APPL ENVIRON MICROB, V73, P4354, DOI 10.1128/AEM.00437-07; Piskur J, 2012, INT J FOOD MICROBIOL, V157, P202, DOI 10.1016/j.ijfoodmicro.2012.05.008; Prochazka E, 2010, FEMS YEAST RES, V10, P545, DOI 10.1111/j.1567-1364.2010.00644.x; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Rintala E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-53; SCHEFFER.WA, 1966, NATURE, V210, P533, DOI 10.1038/210533a0; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; Shah T, 2006, GENE, V366, P104, DOI 10.1016/j.gene.2005.08.011; Silva P, 2004, AM J ENOL VITICULT, V55, P65; SMITH MT, 1990, YEAST, V6, P299, DOI 10.1002/yea.320060403; Tessier WD, 1998, FEMS MICROBIOL LETT, V164, P29, DOI 10.1111/j.1574-6968.1998.tb13063.x; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; VANDIJKEN JP, 1986, FEMS MICROBIOL LETT, V32, P199, DOI 10.1016/0378-1097(86)90291-0; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang XP, 1997, ADV EXP MED BIOL, V414, P277; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Woolfit M, 2007, EUKARYOT CELL, V6, P721, DOI 10.1128/EC.00338-06; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Xue YT, 2004, YEAST, V21, P25, DOI 10.1002/yea.1053; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106	43	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58455	10.1371/journal.pone.0058455	http://dx.doi.org/10.1371/journal.pone.0058455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516483	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200069
J	Aki, K; Fujii, N; Fujii, N				Aki, Kenzo; Fujii, Norihiko; Fujii, Noriko			Kinetics of Isomerization and Inversion of Aspartate 58 of alpha A-Crystallin Peptide Mimics under Physiological Conditions	PLOS ONE			English	Article							ACID-CONTAINING PROTEINS; HUMAN LENS; IMMUNOHISTOCHEMICAL LOCALIZATION; SIMULTANEOUS STEREOINVERSION; RACEMIZATION; RESIDUES; AGE; DEAMIDATION; DEGRADATION; ASPARAGINYL	Although proteins consist exclusively of L-amino acids, we have reported that aspartyl (Asp) 58 and Asp 151 residues of alpha A-crystallin of eye lenses from elderly cataract donors are highly inverted and isomerized to D-beta, D-alpha and L-beta-Asp residues through succinimide intermediates. Of these Asp isomers, large amounts of D-beta- and L-beta-isomers are present but the amount of D-alpha-isomer is not significant. The difference in abundance of the Asp isomers in the protein may be due to the rate constants for the formation of the isomers. However, the kinetics have not been well defined. Therefore, in this study, we synthesized a peptide corresponding to human alpha A-crystallin residues 55 to 65 (T(55)VLD(58)SGISEVR(65)) and its isomers in which L-alpha-Asp at position 58 was replaced with L-beta-, D-beta- and D-alpha-Asp and determined the rate of isomerization and inversion of Asp residues under physiological conditions (37 degrees C, pH7.4). The rate constant for dehydration from L-alpha-Asp peptide to L-succinimidyl peptide was 3 times higher than the rate constant for dehydration from L-beta-Asp peptide to L-succinimidyl peptide. The rate constant for hydrolysis from L-succinimidyl peptide to L-beta-Asp peptide was about 5 times higher than the rate constant for hydrolysis from L-succinimidyl peptide to L-alpha-Asp peptide. The rate constant for dehydration from L-alpha-Asp peptide to L-succinimidyl peptide was 2 times higher than the rate constant for dehydration from D-alpha-Asp peptide to D-succinimidyl peptide. The rate constants for hydrolysis from L-succinimidyl peptide to L-beta-Asp peptide and for hydrolysis from D-succinimidyl peptide to D-beta-Asp peptide were almost equal. Using these rate constants, we calculated the change in the abundance ratios of the 4 Asp isomers during a human lifespan. This result is consistent with the fact that isomerized Asp residues accumulate in proteins during the ageing process.	[Aki, Kenzo; Fujii, Norihiko; Fujii, Noriko] Kyoto Univ, Inst Res Reactor, Osaka 59004, Japan	Kyoto University	Fujii, N (corresponding author), Kyoto Univ, Inst Res Reactor, Osaka 59004, Japan.	nfujii@rri.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capasso S, 1996, THERMOCHIM ACTA, V286, P41, DOI 10.1016/0040-6031(96)02937-1; Cloos PAC, 2000, BIOCHEM J, V345, P473, DOI 10.1042/0264-6021:3450473; FISHER GH, 1992, NEUROSCI LETT, V143, P215, DOI 10.1016/0304-3940(92)90268-C; Fujii N, 2007, AMINO ACIDS, V32, P87, DOI 10.1007/s00726-006-0303-4; Fujii N, 1999, BIOCHEM BIOPH RES CO, V263, P322, DOI 10.1006/bbrc.1999.1279; FUJII N, 1994, J BIOCHEM-TOKYO, V116, P663, DOI 10.1093/oxfordjournals.jbchem.a124577; Fujii N, 2002, BIOCHEM BIOPH RES CO, V294, P1047, DOI 10.1016/S0006-291X(02)00597-1; FUJII N, 1994, BBA-PROTEIN STRUCT M, V1204, P157, DOI 10.1016/0167-4838(94)90003-5; Fujii N, 2012, J BIOL CHEM; Fujii N, 2011, BIOCHEMISTRY-US, V50, P8628, DOI 10.1021/bi200983g; GEIGER T, 1987, J BIOL CHEM, V262, P785; HELFMAN PM, 1976, NATURE, V262, P279; Kaji Y, 2009, BRIT J OPHTHALMOL, V93, P977, DOI 10.1136/bjo.2008.144212; Kaji Y, 2009, BRIT J OPHTHALMOL, V93, P974, DOI 10.1136/bjo.2007.135889; Kaji Y, 2007, INVEST OPHTH VIS SCI, V48, P3923, DOI 10.1167/iovs.06-1284; MASTERS PM, 1978, P NATL ACAD SCI USA, V75, P1204, DOI 10.1073/pnas.75.3.1204; Miura Y, 2004, J CUTAN PATHOL, V31, P51, DOI 10.1046/j.0303-6987.2004.0144.x; Mori Y, 2011, J CHROMATOGR B, V879, P3303, DOI 10.1016/j.jchromb.2011.05.010; Ohtani S, 1998, GROWTH DEVELOP AGING, V62, P141; POWELL JT, 1992, ATHEROSCLEROSIS, V97, P201, DOI 10.1016/0021-9150(92)90132-Z; Ritz-Timme S, 2003, INT J LEGAL MED, V117, P96, DOI 10.1007/s00414-002-0355-2; ROHER AE, 1993, J BIOL CHEM, V268, P3072; Sadakane Y, 2011, J CHROMATOGR B, V879, P3240, DOI 10.1016/j.jchromb.2011.03.020; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; Young GW, 2005, J BIOL CHEM, V280, P26094, DOI 10.1074/jbc.M503624200	26	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58515	10.1371/journal.pone.0058515	http://dx.doi.org/10.1371/journal.pone.0058515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505525	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500096
J	Hagglund, MGA; Roshanbin, S; Lofqvist, E; Hellsten, SV; Nilsson, VCO; Todkar, A; Zhu, YN; Stephansson, O; Drgonova, J; Uhl, GR; Schioth, HB; Fredriksson, R				Hagglund, Maria G. A.; Roshanbin, Sahar; Lofqvist, Erik; Hellsten, Sofie V.; Nilsson, Victor C. O.; Todkar, Aniruddha; Zhu, Yinan; Stephansson, Olga; Drgonova, Jana; Uhl, George R.; Schioth, Helgi B.; Fredriksson, Robert			B(0)AT2 (SLC6A15) Is Localized to Neurons and Astrocytes, and Is Involved in Mediating the Effect of Leucine in the Brain	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; COA-BINDING PROTEIN; ORPHAN TRANSPORTER; EXPRESSION PATTERN; V7-3 SLC6A15; RAT; CHAIN; IDENTIFICATION; HYPOTHALAMUS; METABOLISM	The B(0)AT2 protein is a product of the SLC6A15 gene belonging to the SLC6 subfamily and has been shown to be a transporter of essential branched-chain amino acids. We aimed to further characterize the B(0)AT2 transporter in CNS, and to use Slc6a15 knock out (KO) mice to investigate whether B(0)AT2 is important for mediating the anorexigenic effect of leucine. We used the Slc6a15 KO mice to investigate the role of B(0)AT2 in brain in response to leucine and in particular the effect on food intake. Slc6a15 KO mice show lower reduction of food intake as well as lower neuronal activation in the ventromedial hypothalamic nucleus (VMH) in response to leucine injections compared to wild type mice. We also used RT-PCR on rat tissues, in situ hybridization and immunohistochemistry on mouse CNS tissues to document in detail the distribution of SLC6A15 on gene and protein levels. We showed that B(0)AT2 immunoreactivity is mainly neuronal, including localization in many GABAergic neurons and spinal cord motor neurons. B(0)AT2 immunoreactivity was also found in astrocytes close to ventricles, and co-localized with cytokeratin and diazepam binding inhibitor (DBI) in epithelial cells of the choroid plexus. The data suggest that B(0)AT2 play a role in leucine homeostasis in the brain.	[Hagglund, Maria G. A.; Roshanbin, Sahar; Lofqvist, Erik; Hellsten, Sofie V.; Nilsson, Victor C. O.; Todkar, Aniruddha; Zhu, Yinan; Stephansson, Olga; Schioth, Helgi B.; Fredriksson, Robert] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Drgonova, Jana; Uhl, George R.] NIDA, Mol Neurobiol Branch, NIH, Baltimore, MD USA	Uppsala University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Fredriksson, R (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	Robert.Fredriksson@neuro.uu.se	Fredriksson, Robert/AAH-3921-2019; Schioth, Helgi/AAQ-7239-2020	Fredriksson, Robert/0000-0002-2810-3226; Drgonova, Jana/0000-0002-4623-8466	Swedish Research Council; Ahlens Foundation; Novo Nordisk Foundation; Goran Gustafsson Foundation; Engkvist Foundation; Magnus Bergvall Foundation; National Institutes of Health Intramural Research Program (NIDA); Novo Nordisk Fonden [NNF12OC1016287] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000165] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ahlens Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Goran Gustafsson Foundation; Engkvist Foundation; Magnus Bergvall Foundation; National Institutes of Health Intramural Research Program (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Swedish Research Council as well as the Ahlens Foundation, the Novo Nordisk Foundation, the Goran Gustafsson Foundation, Engkvist Foundation and Magnus Bergvall Foundation, and the National Institutes of Health Intramural Research Program (NIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardis LL, 1998, P SOC EXP BIOL MED, V218, P284; Blais A, 2003, J NUTR, V133, P2156, DOI 10.1093/jn/133.7.2156; Blouet C, 2009, J NEUROSCI, V29, P8302, DOI 10.1523/JNEUROSCI.1668-09.2009; Broer A, 2006, BIOCHEM J, V393, P421, DOI 10.1042/BJ20051273; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; BUSCH AE, 1994, J BIOL CHEM, V269, P25581; Catania C, 2011, INT J OBESITY, V35, P751, DOI 10.1038/ijo.2010.208; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Cowley MA, 2003, EUR J PHARMACOL, V480, P3, DOI 10.1016/j.ejphar.2003.08.087; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Drgonova J, 2007, BRAIN RES, V1183, P10, DOI 10.1016/j.brainres.2007.09.001; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Faipoux R, 2008, J NUTR, V138, P1172, DOI 10.1093/jn/138.6.1172; Farmer MK, 2000, GENOMICS, V70, P241, DOI 10.1006/geno.2000.6387; Fischer J, 1999, NEUROSCIENCE, V92, P729, DOI 10.1016/S0306-4522(99)00017-2; Franklin K., 2007, MOUSE BRAIN STEREOTA; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; Fukasawa Y, 2000, J BIOL CHEM, V275, P9690, DOI 10.1074/jbc.275.13.9690; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; GRILL V, 1992, METABOLISM, V41, P28, DOI 10.1016/0026-0495(92)90186-E; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; He Lei, 2009, Human Genomics, V3, P195; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Hoglund PJ, 2005, BIOCHEM BIOPH RES CO, V336, P175, DOI 10.1016/j.bbrc.2005.08.048; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue K, 1996, MOL BRAIN RES, V37, P217, DOI 10.1016/0169-328X(95)00298-7; KAUFMAN DL, 1991, J NEUROCHEM, V56, P720, DOI 10.1111/j.1471-4159.1991.tb08211.x; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; KNUDSEN J, 1989, BIOCHEM J, V262, P513, DOI 10.1042/bj2620513; KNUDSEN J, 1993, MOL CELL BIOCHEM, V123, P129, DOI 10.1007/BF01076484; Lagerstrom MC, 2007, J NEUROCHEM, V100, P1129, DOI 10.1111/j.1471-4159.2006.04281.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Luque JM, 1996, EUR J NEUROSCI, V8, P127, DOI 10.1111/j.1460-9568.1996.tb01173.x; Masson J, 1999, EUR J NEUROSCI, V11, P1349, DOI 10.1046/j.1460-9568.1999.00540.x; Masson J, 1996, RECEPTOR CHANNEL, V4, P227; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Parra LA, 2008, MOL PHARMACOL, V74, P1521, DOI 10.1124/mol.108.050005; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Ropelle ER, 2008, DIABETES, V57, P594, DOI 10.2337/db07-0573; Rossier G, 1999, J BIOL CHEM, V274, P34948, DOI 10.1074/jbc.274.49.34948; Sakai R, 2004, J NEUROCHEM, V88, P612, DOI 10.1111/j.1471-4159.2004.02179.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; Sweatt AJ, 2004, J COMP NEUROL, V477, P360, DOI 10.1002/cne.20200; Takanaga H, 2005, BIOCHEM BIOPH RES CO, V337, P892, DOI 10.1016/j.bbrc.2005.09.128; Tome D, 2004, BRIT J NUTR, V92, pS27, DOI 10.1079/BJN20041138; UHL GR, 1992, MOL BRAIN RES, V16, P353, DOI 10.1016/0169-328X(92)90246-8; UHL GR, 1994, J EXP BIOL, V196, P229; VONOVERBECK J, 1985, VIRCHOWS ARCH A, V407, P1; Watts J, 2005, J PHYSIOL-LONDON, V562, P89, DOI 10.1113/jphysiol.2004.076984; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Yanase H, 2001, ARCH HISTOL CYTOL, V64, P449, DOI 10.1679/aohc.64.449; Yudkoff M, 2005, J NUTR, V135, p1531S, DOI 10.1093/jn/135.6.1531S; Zaia KA, 2009, J BIOL CHEM, V284, P8439, DOI 10.1074/jbc.M806407200; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	64	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58651	10.1371/journal.pone.0058651	http://dx.doi.org/10.1371/journal.pone.0058651			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505546	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500110
J	Rajadas, J; Sun, WC; Li, H; Inayathullah, M; Cereghetti, D; Tan, A; Coelho, VD; Chrest, FJ; Kusiak, JW; Smith, WW; Taub, D; Wu, JC; Rifkind, JM				Rajadas, Jayakumar; Sun, Wenchao; Li, Hai; Inayathullah, Mohammed; Cereghetti, Damiano; Tan, Aaron; Coelho, Valeria de Mello; Chrest, Francis J.; Kusiak, John W.; Smith, Wanli Wei; Taub, Dennis; Wu, Joseph C.; Rifkind, Joseph M.			Enhanced A beta(1-40) Production in Endothelial Cells Stimulated with Fibrillar A beta(1-42)	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; BLOOD-BRAIN-BARRIER; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; POSSIBLE INVOLVEMENT; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; IN-VITRO	Amyloid accumulation in the brain of Alzheimer's patients results from altered processing of the 39- to 43-amino acid amyloid beta protein (A beta). The mechanisms for the elevated amyloid (A beta(1-42)) are considered to be over-expression of the amyloid precursor protein (APP), enhanced cleavage of APP to A beta, and decreased clearance of A beta from the central nervous system (CNS). We report herein studies of A beta stimulated effects on endothelial cells. We observe an interesting and as yet unprecedented feedback effect involving A beta(1-42) fibril-induced synthesis of APP by Western blot analysis in the endothelial cell line Hep-1. We further observe an increase in the expression of A beta(1-40) by flow cytometry and fluorescence microscopy. This phenomenon is reproducible for cultures grown both in the presence and absence of serum. In the former case, flow cytometry reveals that A beta(1-40) accumulation is less pronounced than under serum-free conditions. Immunofluorescence staining further corroborates these observations. Cellular responses to fibrillar A beta(1-42) treatment involving eNOS upregulation and increased autophagy are also reported.	[Rifkind, Joseph M.] NIA, Mol Dynam Sect, Baltimore, MD 21224 USA; [Coelho, Valeria de Mello; Taub, Dennis] NIA, Immunol Lab, Baltimore, MD 21224 USA; [Chrest, Francis J.; Kusiak, John W.; Smith, Wanli Wei] NIA, Res Resources Branch, Baltimore, MD 21224 USA; [Rajadas, Jayakumar; Sun, Wenchao; Li, Hai; Inayathullah, Mohammed; Cereghetti, Damiano] Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA; [Tan, Aaron] UCL, UCL Med Sch, UCL Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London WC1E 6BT, England; [Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Stanford University; University of London; University College London; Stanford University; Stanford University	Rajadas, J (corresponding author), Stanford Univ, Sch Med, Biomat & Adv Drug Delivery Lab, Stanford, CA 94305 USA.	jayraja@stanford.edu; rifkindj@mail.nih.gov	Sun, Wenchao/H-7738-2017; de Mello Coelho, Valeria/ABA-1201-2021; Rajadas, Jayakumar/AHC-0630-2022; Inayathullah, Mohammed/C-6953-2015; Li, Haitong/S-9629-2019; Wu, Joseph/H-1067-2013; de Mello-Coelho, Valeria/N-2242-2014	Sun, Wenchao/0000-0003-4306-2896; Inayathullah, Mohammed/0000-0001-7646-1709; Rajadas, Jayakumar/0000-0001-6520-3923; Wu, Joseph/0000-0002-6068-8041; de Mello-Coelho, Valeria/0000-0002-9367-8181; Tan, Aaron/0000-0002-8935-0773	Intramural Research Program the National Institute of Health; National Institute on Aging; National Institute of Health [HL095571]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000047] Funding Source: NIH RePORTER	Intramural Research Program the National Institute of Health; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was in part supported by the Intramural Research Program the National Institute of Health, National Institute on Aging and National Institute of Health HL095571. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman R, 2010, CLIN SCI, V119, P407, DOI 10.1042/CS20100094; Ansari MA, 2011, FREE RADICAL BIO MED, V51, P171, DOI 10.1016/j.freeradbiomed.2011.03.025; Armstrong RA, 2006, CURR NEUROVASC RES, V3, P289, DOI 10.2174/156720206778792948; Austin SA, 2010, CIRC RES, V107, P1498, DOI 10.1161/CIRCRESAHA.110.233080; Bar-Am O, 2005, FASEB J, V19, P1899, DOI 10.1096/fj.05-3794fje; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Biffi A, 2011, J CLIN NEUROL, V7, P1, DOI 10.3988/jcn.2011.7.1.1; Breton-Romero R, 2012, FREE RADICAL BIO MED, V52, P1093, DOI 10.1016/j.freeradbiomed.2011.12.026; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cai ZY, 2011, NEUROMOL MED, V13, P223, DOI 10.1007/s12017-011-8155-9; Cecchi C, 2007, NEUROBIOL AGING, V28, P863, DOI 10.1016/j.neurobiolaging.2006.05.014; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; DAVISSALINAS J, 1995, J NEUROCHEM, V65, P931; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Dewachter I, 2000, J NEUROSCI, V20, P6452, DOI 10.1523/JNEUROSCI.20-17-06452.2000; Drummond GR, 2000, CIRC RES, V86, P347, DOI 10.1161/01.RES.86.3.347; Eisenhauer PB, 2000, J NEUROSCI RES, V60, P804, DOI 10.1002/1097-4547(20000615)60:6<804::AID-JNR13>3.3.CO;2-T; EVIN G, 1995, BIOCHEMISTRY-US, V34, P14185, DOI 10.1021/bi00043a024; Francis P, 2006, ALZ DIS ASSOC DIS, V20, pS3, DOI 10.1097/01.wad.0000213803.82058.46; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Guo QX, 2012, CELL RES, V22, P78, DOI 10.1038/cr.2011.116; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; HEFFELFINGER SC, 1992, IN VITRO CELL DEV-AN, V28A, P136; Husemann J, 2001, AM J PATHOL, V158, P825, DOI 10.1016/S0002-9440(10)64030-8; Iadecola C, 1999, NAT NEUROSCI, V2, P157, DOI 10.1038/5715; Jaeger PA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011102; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kisilevsky R, 2000, NAT MED, V6, P633, DOI 10.1038/76203; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; LeBlanc A, 1995, J NEUROSCI, V15, P7837; MAJUMDAR A, 2007, NEUROBIOL AGING; Mattson MP, 2002, METHOD ENZYMOL, V352, P455; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Naiki H, 1996, LAB INVEST, V74, P374; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Olivieri G, 2000, J NEUROCHEM, V74, P231, DOI 10.1046/j.1471-4159.2000.0740231.x; Origlia N, 2009, EXPERT REV NEUROTHER, V9, P1635, DOI [10.1586/ern.09.107, 10.1586/ERN.09.107]; Parvathy S, 2009, NEUROBIOL AGING, V30, P1792, DOI 10.1016/j.neurobiolaging.2008.01.011; Reed-Cossairt A, 2012, CURR GERONTOL GERIAT, V2012; Rockenstein E, 2005, J NEURAL TRANSM, V112, P269, DOI 10.1007/s00702-004-0181-4; Rogers JT, 1999, J BIOL CHEM, V274, P6421, DOI 10.1074/jbc.274.10.6421; Saido T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006379; Thomas T, 1997, NEUROREPORT, V8, P1387, DOI 10.1097/00001756-199704140-00014; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; Ueno M, 2010, CURR MED CHEM, V17, P1125, DOI 10.2174/092986710790827816; Vinters Harry V, 2003, Adv Neurol, V92, P105; Vinters HV, 1998, ACTA NEUROPATHOL, V95, P235, DOI 10.1007/s004010050793; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan YL, 2006, J MOL BIOL, V364, P853, DOI 10.1016/j.jmb.2006.09.046; Yu D, 2012, NEUROBIOL AGING; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114; ZLOKOVIC BV, 1993, BIOCHEM BIOPH RES CO, V197, P1034, DOI 10.1006/bbrc.1993.2582	56	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58194	10.1371/journal.pone.0058194	http://dx.doi.org/10.1371/journal.pone.0058194			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505467	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500058
J	Rao, K; Walk, ST; Micic, D; Chenoweth, E; Deng, LL; Galecki, AT; Jain, R; Trivedi, I; Yu, M; Santhosh, K; Ring, C; Young, VB; Huffnagle, GB; Aronoff, DM				Rao, Krishna; Walk, Seth T.; Micic, Dejan; Chenoweth, Elizabeth; Deng, Lili; Galecki, Andrzej T.; Jain, Ruchika; Trivedi, Itishree; Yu, Marie; Santhosh, Kavitha; Ring, Cathrin; Young, Vincent B.; Huffnagle, Gary B.; Aronoff, David M.			Procalcitonin Levels Associate with Severity of Clostridium difficile Infection	PLOS ONE			English	Article							INTENSIVE-CARE PATIENTS; ANTIBIOTIC-TREATMENT; SERUM PROCALCITONIN; TREATMENT DURATION; DISEASE SEVERITY; CONTROLLED-TRIAL; NORTH-AMERICA; SEVERE SEPSIS; SHORT-TERM; MORTALITY	Objective: Clostridium difficile infection (CDI) is a major cause of morbidity and biomarkers that predict severity of illness are needed. Procalcitonin (PCT), a serum biomarker with specificity for bacterial infections, has been little studied in CDI. We hypothesized that PCT associated with CDI severity. Design: Serum PCT levels were measured for 69 cases of CDI. Chart review was performed to evaluate the presence of severity markers and concurrent acute bacterial infection (CABI). We defined the binary variables clinical score as having fever (T > 38 degrees C), acute organ dysfunction (AOD), and/or WBC > 15,000 cells/mm(3) and expanded score, which included the clinical score plus the following: ICU admission, no response to therapy, colectomy, and/or death. Results: In univariate analysis log(10) PCT associated with clinical score (OR 3.13, 95% CI 1.69-5.81, P<.001) and expanded score (OR 3.33, 95% CI 1.77-6.23, P<.001). In a multivariable model including the covariates log(10) PCT, enzyme immunoassay for toxin A/B, ribotype 027, age, weighted Charlson-Deyo comorbidity index, CABI, and extended care facility residence, log(10) PCT associated with clinical score (OR 3.09, 95% CI 1.5-6.35, P = .002) and expanded score (OR 3.06, 95% CI 1.49-6.26, P = .002). PCT >0.2 ng/mL was 81% sensitive/73% specific for a positive clinical score and had a negative predictive value of 90%. Conclusion: An elevated PCT level associated with the presence of CDI severity markers and CDI was unlikely to be severe with a serum PCT level below 0.2 ng/mL. The extent to which PCT changes during CDI therapy or predicts recurrent CDI remains to be quantified.	[Rao, Krishna; Walk, Seth T.; Micic, Dejan; Deng, Lili; Galecki, Andrzej T.; Jain, Ruchika; Trivedi, Itishree; Yu, Marie; Santhosh, Kavitha; Ring, Cathrin; Young, Vincent B.; Huffnagle, Gary B.; Aronoff, David M.] Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI USA; [Rao, Krishna; Walk, Seth T.; Jain, Ruchika; Yu, Marie; Santhosh, Kavitha; Ring, Cathrin; Young, Vincent B.; Aronoff, David M.] Univ Michigan Hlth Syst, Div Infect Dis, Ann Arbor, MI USA; [Deng, Lili; Galecki, Andrzej T.] Univ Michigan Hlth Syst, Div Geriatr Med, Ann Arbor, MI USA; [Huffnagle, Gary B.] Univ Michigan Hlth Syst, Div Pulm & Crit Care, Ann Arbor, MI USA; [Deng, Lili; Galecki, Andrzej T.] Univ Michigan Hlth Syst, Dept Biostat, Ann Arbor, MI USA; [Young, Vincent B.; Huffnagle, Gary B.; Aronoff, David M.] Univ Michigan Hlth Syst, Dept Microbiol & Immunol, Ann Arbor, MI USA; [Yu, Marie] Univ Michigan Hlth Syst, Dept Pharm Serv, Ann Arbor, MI USA; [Chenoweth, Elizabeth] Univ Michigan, Sch Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Aronoff, DM (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI USA.	daronoff@umich.edu	Huffnagle, Gary B./ABF-1323-2020; Young, Vincent B/B-3179-2009; Rao, Krishna/R-3726-2019; Young, Vincent Bensan/M-9916-2019	Young, Vincent B/0000-0003-3687-2364; Rao, Krishna/0000-0002-9213-7850; Young, Vincent Bensan/0000-0003-3687-2364; Aronoff, David/0000-0003-4587-6121; Trivedi, Itishree/0000-0002-5338-5528	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [5U19AI090871-02]; bioMerieux, Inc., Durham, NC; bioMerieux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI097281, U19AI090871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); bioMerieux, Inc., Durham, NC; bioMerieux; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (grant number 5U19AI090871-02) and by bioMerieux, Inc. (www.biomerieux-usa.com, Durham, NC), who provided research reagents for PCT measurements. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received support from a commercial source, bioMerieux. The support granted by this commercial funder (to provide raw materials for measuring procalcitonin) did not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Akerlund T, 2006, J CLIN MICROBIOL, V44, P353, DOI 10.1128/JCM.44.2.353-358.2006; [Anonymous], 2008, AM J RESP CRIT CARE, DOI DOI 10.1164/rccm.200708-1238OC; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; Belmares J, 2008, EXPERT REV ANTI-INFE, V6, P897, DOI 10.1586/14787210.6.6.897; Burckhardt F, 2008, EMERG INFECT DIS, V14, P691, DOI 10.3201/eid1404.071023; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cloud J, 2009, CLIN GASTROENTEROL H, V7, P868, DOI 10.1016/j.cgh.2009.05.018; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Crook DW, 2012, CLIN INFECT DIS, V55, pS93, DOI 10.1093/cid/cis499; Das R, 2010, AM J GASTROENTEROL, V105, P2040, DOI 10.1038/ajg.2010.142; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dubberke ER, 2008, CLIN INFECT DIS, V46, P497, DOI 10.1086/526530; Dubberke ER, 2007, INFECT CONT HOSP EP, V28, P208, DOI 10.1086/511792; Eyre DW, 2012, CLIN INFECT DIS, V55, pS77, DOI 10.1093/cid/cis356; Goldenberg SD, 2011, J INFECTION, V62, P355, DOI 10.1016/j.jinf.2011.03.001; Gould CV, 2008, CRIT CARE, V12, DOI 10.1186/cc6207; Gravel D, 2009, CLIN INFECT DIS, V48, P568, DOI 10.1086/596703; Henrich TJ, 2009, EMERG INFECT DIS, V15, P415, DOI 10.3201/eid1503.080312; Herrlinger KR, 2004, INFLAMM BOWEL DIS, V10, P229, DOI 10.1097/00054725-200405000-00008; Hochreiter M, 2009, CRIT CARE, V13, DOI 10.1186/cc7903; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Humphries RM, 2012, J CLIN MICROBIOL; Korczowski B, 2004, ACTA PAEDIATR, V93, P169, DOI 10.1080/08035250310021127; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kyne L, 2002, INFECT CONT HOSP EP, V23, P653, DOI 10.1086/501989; Kyne L, 1999, AGE AGEING, V28, P107, DOI 10.1093/ageing/28.2.107; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Meisner M, 1997, EUR J CLIN CHEM CLIN, V35, P597; Morgan OW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001812; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Schroeder S, 2009, LANGENBECK ARCH SURG, V394, P221, DOI 10.1007/s00423-008-0432-1; Schuetz P, 2010, CLIN BIOCHEM, V43, P341, DOI 10.1016/j.clinbiochem.2009.08.029; Schuetz P, 2009, JAMA-J AM MED ASSOC, V302, P1059, DOI 10.1001/jama.2009.1297; Simon P, 2008, CRIT CARE, V12, DOI 10.1186/cc7124; Stolz D, 2009, EUR RESPIR J, V34, P1364, DOI 10.1183/09031936.00053209; Venugopal AA, 2012, SCAND J INFECT DIS, V44, P243, DOI 10.3109/00365548.2011.631029; Verdoorn BP, 2010, DIAGN MICR INFEC DIS, V66, P24, DOI 10.1016/j.diagmicrobio.2009.08.015; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Welfare MR, 2011, J HOSP INFECT, V79, P359, DOI 10.1016/j.jhin.2011.08.015; Wilcox MH, 2012, CLIN MICROBIOL INFEC, V18, P13, DOI 10.1111/1469-0691.12057	43	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58265	10.1371/journal.pone.0058265	http://dx.doi.org/10.1371/journal.pone.0058265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505476	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500062
J	Suez, J; Porwollik, S; Dagan, A; Marzel, A; Schorr, YI; Desai, PT; Agmon, V; McClelland, M; Rahav, G; Gal-Mor, O				Suez, Jotham; Porwollik, Steffen; Dagan, Amir; Marzel, Alex; Schorr, Yosef Ilan; Desai, Prerak T.; Agmon, Vered; McClelland, Michael; Rahav, Galia; Gal-Mor, Ohad			Virulence Gene Profiling and Pathogenicity Characterization of Non-Typhoidal Salmonella Accounted for Invasive Disease in Humans	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHI; HOST ADAPTATION; BACTERIAL VIRULENCE; EPITHELIAL-CELLS; GENOMIC ISLAND; TYPHIMURIUM; EVOLUTION; MICE; IDENTIFICATION; INFECTION	Human infection with non-typhoidal Salmonella serovars (NTS) infrequently causes invasive systemic disease and bacteremia. To understand better the nature of invasive NTS (iNTS), we studied the gene content and the pathogenicity of bacteremic strains from twelve serovars (Typhimurium, Enteritidis, Choleraesuis, Dublin, Virchow, Newport, Bredeney, Heidelberg, Montevideo, Schwarzengrund, 9,12:l,v:- and Hadar). Comparative genomic hybridization using a Salmonella enterica microarray revealed a core of 3233 genes present in all of the iNTS strains, which include the Salmonella pathogenicity islands 1-5, 9, 13, 14; five fimbrial operons (bcf, csg, stb, sth, sti); three colonization factors (misL, bapA, sinH); and the invasion gene, pagN. In the iNTS variable genome, we identified 16 novel genomic islets; various NTS virulence factors; and six typhoid-associated virulence genes (tcfA, cdtB, hlyE, taiA, STY1413, STY1360), displaying a wider distribution among NTS than was previously known. Characterization of the bacteremic strains in C3H/HeN mice showed clear differences in disease manifestation. Previously unreported characterization of serovars Schwarzengrund, 9,12: l, v:-, Bredeney and Virchow in the mouse model showed low ability to elicit systemic disease, but a profound and elongated shedding of serovars Schwarzengrund and 9,12:l, v:-(as well as Enteritidis and Heidelberg) due to chronic infection of the mouse. Phenotypic comparison in macrophages and epithelial cell lines demonstrated a remarkable intra-serovar variation, but also showed that S. Typhimurium bacteremic strains tend to present lower intracellular growth than gastroenteritis isolates. Collectively, our data demonstrated a common core of virulence genes, which might be required for invasive salmonellosis, but also an impressive degree of genetic and phenotypic heterogeneity, highlighting that bacteremia is a complex phenotype, which cannot be attributed merely to an enhanced invasion or intracellular growth of a particular strain.	[Suez, Jotham; Dagan, Amir; Marzel, Alex; Rahav, Galia; Gal-Mor, Ohad] Chaim Sheba Med Ctr, Infect Dis Res Lab, IL-52621 Tel Hashomer, Israel; [Suez, Jotham; Marzel, Alex; Rahav, Galia] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Porwollik, Steffen; Desai, Prerak T.; McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [Schorr, Yosef Ilan; Agmon, Vered] Minist Hlth, Govt Cent Labs, Jerusalem, Israel; [McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of California System; University of California Irvine	Gal-Mor, O (corresponding author), Chaim Sheba Med Ctr, Infect Dis Res Lab, IL-52621 Tel Hashomer, Israel.	Ohad.Gal-Mor@sheba.health.gov.il	Suez, Jotham/AAZ-5433-2020; Desai, Prerak/ABF-8529-2020; dagan, amir/AAF-4295-2021; dagan, amir/L-4250-2018	Suez, Jotham/0000-0003-3836-972X; dagan, amir/0000-0002-6572-8110; dagan, amir/0000-0002-6572-8110; Gal-Mor, Ohad/0000-0002-2540-6790; McClelland, Michael/0000-0003-1788-9347; Marzel, Alex/0000-0002-4795-6224	European Community's Seventh Framework Program [1096.39.11/2010]; United States National Institute of Allergy and Infectious Diseases; United States Department of Agriculture; United States - Israel Binational Agricultural Research and Development Fund	European Community's Seventh Framework Program; United States National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Department of Agriculture(United States Department of Agriculture (USDA)); United States - Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation)	Work in the Infectious Diseases Research Laboratory was supported by grant number 249241 from the European Community's Seventh Framework Program (PF7/2007-2013) and a GIF Research grant number 1096.39.11/2010 to O.G. Work in the McClelland lab was supported by grants from the United States National Institute of Allergy and Infectious Diseases, the United States Department of Agriculture, and the United States - Israel Binational Agricultural Research and Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba M, 2006, JPN J INFECT DIS, V59, P341; Anjum MF, 2005, INFECT IMMUN, V73, P7894, DOI 10.1128/IAI.73.12.7894-7905.2005; Baumler AJ, 1998, INFECT IMMUN, V66, P4579; Baumler AJ, 1997, ADV EXP MED BIOL, V412, P149; Boyd DA, 2000, FEMS MICROBIOL LETT, V189, P285, DOI 10.1111/j.1574-6968.2000.tb09245.x; Bronowski C, 2009, FEMS MICROBIOL LETT, V298, P29, DOI 10.1111/j.1574-6968.2009.01697.x; COLLINS FM, 1966, J EXP MED, V124, P601, DOI 10.1084/jem.124.4.601; den Bakker HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-425; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Faucher SP, 2009, MICROBIOL-SGM, V155, P477, DOI 10.1099/mic.0.022988-0; Feasey NA, 2012, LANCET; Folkesson A, 1999, MOL MICROBIOL, V33, P612, DOI 10.1046/j.1365-2958.1999.01508.x; Fuentes JA, 2008, RES MICROBIOL, V159, P279, DOI 10.1016/j.resmic.2008.02.006; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Gal-Mor O, 2006, MICROBES INFECT, V8, P2154, DOI 10.1016/j.micinf.2006.04.015; Galan JE, 2000, P NATL ACAD SCI USA, V97, P8754, DOI 10.1073/pnas.97.16.8754; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Gordon MA, 2011, CURR OPIN INFECT DIS, V24, P484, DOI 10.1097/QCO.0b013e32834a9980; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; Guiney DG, 1997, J CLIN INVEST, V99, P565, DOI 10.1172/JCI119196; GULIG PA, 1993, MOL MICROBIOL, V7, P825, DOI 10.1111/j.1365-2958.1993.tb01172.x; Haghjoo E, 2004, P NATL ACAD SCI USA, V101, P4614, DOI 10.1073/pnas.0400932101; HELMUTH R, 1985, INFECT IMMUN, V48, P175, DOI 10.1128/IAI.48.1.175-182.1985; Hensel M, 2004, INT J MED MICROBIOL, V294, P95, DOI 10.1016/j.ijmm.2004.06.025; Ibarra JA, 2010, MICROBIOL-SGM, V156, P1120, DOI 10.1099/mic.0.032896-0; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Karasova D, 2009, VET MICROBIOL, V139, P304, DOI 10.1016/j.vetmic.2009.06.023; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Lawrence JG, 2005, CURR OPIN GENET DEV, V15, P584, DOI 10.1016/j.gde.2005.09.007; Mastroeni P, 2011, INFECT IMMUN, V79, P636, DOI 10.1128/IAI.00954-10; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Oscarsson J, 2002, INFECT IMMUN, V70, P5759, DOI 10.1128/IAI.70.10.5759-5769.2002; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Petermann SR, 2008, MICROB PATHOGENESIS, V45, P110, DOI 10.1016/j.micpath.2008.04.001; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; ROUDIER C, 1990, INFECT IMMUN, V58, P1180, DOI 10.1128/IAI.58.5.1180-1185.1990; Sabbagh SC, 2010, FEMS MICROBIOL LETT, V305, P1, DOI 10.1111/j.1574-6968.2010.01904.x; Silva CA, 2012, INFECT IMMUN, V80, P839, DOI 10.1128/IAI.05497-11; Spano S, 2008, CELL HOST MICROBE, V3, P30, DOI 10.1016/j.chom.2007.11.001; Suar M, 2006, INFECT IMMUN, V74, P632, DOI 10.1128/IAI.74.1.632-644.2006; Swearingen MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036043; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Townsend SM, 2001, INFECT IMMUN, V69, P2894, DOI 10.1128/IAI.69.5.2894-2901.2001; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Zhang SP, 2003, INFECT IMMUN, V71, P1, DOI 10.1128/IAI.71.1.1-12.2003	48	114	119	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58449	10.1371/journal.pone.0058449	http://dx.doi.org/10.1371/journal.pone.0058449			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505508	Green Published, gold			2022-12-27	WOS:000318334500085
J	Varga, Z; Sinn, P; Fritzsche, F; von Hochstetter, A; Noske, A; Schraml, P; Tausch, C; Trojan, A; Moch, H				Varga, Zsuzsanna; Sinn, Peter; Fritzsche, Florian; von Hochstetter, Arthur; Noske, Aurelia; Schraml, Peter; Tausch, Christoph; Trojan, Andreas; Moch, Holger			Comparison of EndoPredict and Oncotype DX Test Results in Hormone Receptor Positive Invasive Breast Cancer	PLOS ONE			English	Article							GENE-EXPRESSION; ESTROGEN-RECEPTOR; RECURRENCE SCORE; PROGESTERONE-RECEPTOR; PROGNOSTIC-FACTORS; RISK; CHEMOTHERAPY; PREDICTORS; ASSAY; KNOWLEDGE	Aim: Several multigene expression-based tests offering prognostic and predictive information in hormone-receptor positive early breast cancer were established during the last years. These tests provide prognostic information on distant recurrences and can serve as an aid in therapy decisions. We analyzed the recently validated reverse-transcription-quantitative-real-time PCR-based multigene-expression Endopredict (EP)-test on 34 hormone-receptor positive breast-cancer cases and compared the EP scores with the Oncotype DX Recurrence-scores (RS) obtained from the same cancer samples. Methods: Formalin-fixed, paraffin-embedded invasive breast-cancer tissues from 34 patients were analyzed by the EP-test. Representative tumor blocks were analyzed with Oncotype DX prior to this study. Tumor tissue was removed from unstained slides, total-RNA was isolated and EP-analysis was performed blinded to Oncotype DX results. Results: Extraction of sufficient amounts of RNA and generation of valid EP-scores were possible for all 34 samples. EP classified 11 patients as low-risk and 23 patients as high-risk. RS Score defined 15 patients as low-risk, 10 patients as intermediate-risk in and 9 patients as high-risk. Major-discrepancy occurred in 6 of 34 cases (18%): Low-risk RS was classified as high-risk by EP in 6 cases. Combining the RS intermediate-risk and high-risk groups to a common group, the concordance between both tests was 76%. Correlation between continuous EP and RS-scores was moderate (Pearson-coefficient: 0.65 (p<0.01). Conclusion: We observed a significant but moderate concordance (76%) and moderate correlation (0.65) between RS and EP Score. Differences in results can be explained by different weighting of biological motives covered by the two tests. Further studies are needed to explore the clinical relevance of discrepant test results with respect of outcome.	[Varga, Zsuzsanna; Noske, Aurelia; Schraml, Peter; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Sinn, Peter] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Fritzsche, Florian; von Hochstetter, Arthur] Pathol Inst Enge, Zurich, Switzerland; [Tausch, Christoph; Trojan, Andreas] Breast Canc Ctr Seefeld, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Ruprecht Karls University Heidelberg	Varga, Z (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	zsuzsanna.varga@usz.ch	Sinn, Hans-Peter/C-5661-2008	Sinn, Hans-Peter/0000-0003-2836-6699	Sividon Diagnostics, Cologne; Sividion Diagnostics, Cologne, Germany	Sividon Diagnostics, Cologne; Sividion Diagnostics, Cologne, Germany	The funders of Sividion Diagnostics, Cologne, Germany conducted the Endopredict assay on all 16 tissue samples in a blinded way upon request of the authors. The data of the Endopredict tests were subsequently transferred to the corresponding author of the manusrcipt. Funders provided laboratory data to Endopredict testing. The manuscript except the laboratory data concerning Endopredict testing, was written by the authors. The funders had no role in study design, data collection, or in the decision to publish.; Hereby the authors confirm that the Sividon Diagnostics, Cologne funded and performed the EndoPredict analysis on the 34 study patients upon request of the Institute of Surgical Pathology, University Hospital Zurich. The funding was restricted only to this study. The authors further confirm that this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Ademuyiwa FO, 2011, BREAST CANCER RES TR, V126, P797, DOI 10.1007/s10549-010-1329-6; Albain KS, 2009, BREAST, V18, pS141, DOI 10.1016/S0960-9776(09)70290-5; Albanell J, 2011, ANN ONCOL; Azim Jr HA, 2013, ANN ONCOL; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Denkert C, 2012, VIRCHOWS ARCH, V460, P251, DOI 10.1007/s00428-012-1204-4; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Flanagan MB, 2008, MODERN PATHOL, V21, P1255, DOI 10.1038/modpathol.2008.54; Geradts J, 2010, CANCER INVEST, V28, P969, DOI 10.3109/07357907.2010.512600; Habel LA, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1412; Italiano A, 2011, J CLIN ONCOL, V29, P4718, DOI 10.1200/JCO.2011.38.3729; Kamal AH, 2011, ONCOLOGIST, V16, P1359, DOI 10.1634/theoncologist.2011-0048; Kelly CM, 2012, ONCOLOGIST, V17, P492, DOI 10.1634/theoncologist.2012-0007; Kelly CM, 2010, CANCER-AM CANCER SOC, V116, P5161, DOI 10.1002/cncr.25269; Lipkus IM, 2011, J CANCER EDUC, V26, P664, DOI 10.1007/s13187-011-0248-5; Marchionni L, 2008, ANN INTERN MED, V148, P358, DOI 10.7326/0003-4819-148-5-200803040-00208; Mehta R, 2011, CLIN BREAST CANCER, V11, P20, DOI 10.3816/CBC.2011.n.004; Morris SR, 2007, REV ENDOCR METAB DIS, V8, P185, DOI 10.1007/s11154-007-9035-3; Muller BM, 2011, DIAGN MOL PATHOL, V20, P1, DOI 10.1097/PDM.0b013e3181e3630c; O'Connor SM, 2010, APPL IMMUNOHISTO M M, V18, P268, DOI 10.1097/PAI.0b013e3181cddde9; Oakman C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2238; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Paik S, 2011, BREAST, V20, pS87, DOI 10.1016/S0960-9776(11)70301-0; Rayhanabad JA, 2008, AM SURGEON, V74, P887; Richman AR, 2011, PSYCHO-ONCOLOGY, V20, P28, DOI 10.1002/pon.1699; Ross JS, 2008, ONCOLOGIST, V13, P477, DOI 10.1634/theoncologist.2007-0248; Ross JS, 2009, ADV ANAT PATHOL, V16, P204, DOI 10.1097/PAP.0b013e3181a9d4bf; Sahebjam S, 2011, BRIT J CANCER, V105, P1342, DOI 10.1038/bjc.2011.402; Tang G, 2011, BREAST CANCER RES TR, V127, P133, DOI 10.1007/s10549-010-1331-z; Turaga K, 2010, CANCER CONTROL, V17, P177, DOI 10.1177/107327481001700306; Tzeng JP, 2010, CANCER-AM CANCER SOC, V116, P1992, DOI 10.1002/cncr.24990; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Varga Z, 2005, VIRCHOWS ARCH, V446, P136, DOI 10.1007/s00428-004-1164-4; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; Weigelt B, 2012, ANN ONCOL, V23, P211, DOI 10.1093/annonc/mds323; Williams DJ, 2011, APPL IMMUNOHISTO M M, V19, P431, DOI 10.1097/PAI.0b013e318206d23d; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yorozuya K, 2010, J CANCER RES CLIN, V136, P939, DOI 10.1007/s00432-009-0736-8	41	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58483	10.1371/journal.pone.0058483	http://dx.doi.org/10.1371/journal.pone.0058483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505515	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000318334500090
J	Wu, B; Yang, HX				Wu, Bo; Yang, Hongxiao			Spatial Patterns and Natural Recruitment of Native Shrubs in a Semi-arid Sandy Land	PLOS ONE			English	Article							PLANT-POPULATIONS; SOIL-MOISTURE; ECOLOGICAL RESTORATION; SEEDLING EMERGENCE; DESERT; COMPETITION; CHINA; FACILITATION; DESERTIFICATION; LANDSCAPE	Passive restoration depending on native shrubs is an attractive approach for restoring desertified landscapes in semi-arid sandy regions. We sought to understand the relationships between spatial patterns of native shrubs and their survival ability in sandy environments. Furthermore, we applied our results to better understand whether passive restoration is feasible for desertified landscapes in semi-arid sandy regions. The study was conducted in the semi-arid Mu Us sandy land of northern China with the native shrub Artemisia ordosica. We analyzed population structures and patterns of A. ordosica at the edges and centers of land patches where sand was stabilized by A. ordosica-dominated vegetation. Saplings were more aggregated than adults, and both were more aggregated at the patch edges than at the patch centers. At the patch edges, spatial association of the saplings with the adults was mostly positive at distances 0.3-6.6 m, and turned from positive to neutral, and even negative, at other distances. At the patch centers, the saplings were spaced almost randomly around the adults, and their distances from the adults did not seem to affect their locations. A greater number of A. ordosica individuals emerged at the patch edges than at the patch centers. Such patterns may have resulted from their integrative adjustment to specific conditions of soil water supply and sand drift intensity. These findings suggest that in semi-arid sandy regions, native shrubs that are well-adapted to local environments may serve as low-cost and competent ecological engineers that can promote the passive restoration of surrounding patches of mobile sandy land.	[Wu, Bo] Chinese Acad Forestry, Inst Desertificat Studies, Beijing, Peoples R China; [Yang, Hongxiao] Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Shandong, Peoples R China	Chinese Academy of Forestry; Institute of Desertification Studies, CAF; Qingdao Agricultural University	Yang, HX (corresponding author), Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Shandong, Peoples R China.	yanghxny@gmail.com						BERKOWITZ AR, 1995, ECOLOGY, V76, P1156, DOI 10.2307/1940923; BERTNESS MD, 1989, ECOLOGY, V70, P257, DOI 10.2307/1938431; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Bradshaw A, 2000, LANDSCAPE URBAN PLAN, V51, P89, DOI 10.1016/S0169-2046(00)00099-2; Brandle J.R., 1991, WINDBREAKS WORK; Breshears DD, 1997, ECOL APPL, V7, P1201, DOI 10.1890/1051-0761(1997)007[1201:OIHISR]2.0.CO;2; Byers JE, 2006, TRENDS ECOL EVOL, V21, P493, DOI 10.1016/j.tree.2006.06.002; Callaway RM, 1996, ECOLOGY, V77, P2130, DOI 10.2307/2265707; Cao SX, 2008, ENVIRON SCI TECHNOL, V42, P1826, DOI 10.1021/es0870597; Cui LQ, 2010, J ARID LAND RESOURCE, V24, P77; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; Guo K., 2000, ACTA ECOL SIN, V24, P275; HEISLER GM, 1988, AGR ECOSYST ENVIRON, V22-3, P41, DOI 10.1016/0167-8809(88)90007-2; HU XL, 1996, INNER MONGOLIA FORES, V3, P32; Jia X, 2011, OIKOS, V120, P472, DOI 10.1111/j.1600-0706.2010.18674.x; Jia ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045902; Kobayashi T, 2005, LANDSC ECOL ENG, V1, P17; Li SL, 2010, ECOL RES, V25, P655, DOI 10.1007/s11284-010-0699-x; Li XR, 2006, ECOL ENG, V28, P149, DOI 10.1016/j.ecoleng.2006.05.020; [凌裕泉 Ling Yuquan], 2003, [中国沙漠, Journal of Desert Research], V23, P12; Liu T, 2011, HYDROL EARTH SYST SC, V15, P3511, DOI [10.5194/hess-15-3511-2011, 10.5194/hess-15-1865-2011]; [马骥 Ma Ji], 2002, [中国沙漠, Journal of Desert Research], V22, P586; Ma Quan-lin, 2012, Shengtaixue Zazhi, V31, P1639; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Montane F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028652; Murrell DJ, 2001, TRENDS ECOL EVOL, V16, P529, DOI 10.1016/S0169-5347(01)02292-3; PHILLIPS DL, 1981, J ECOL, V69, P97, DOI 10.2307/2259818; Rodhouse TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028635; Schurr FM, 2004, PLANT ECOL, V173, P271, DOI 10.1023/B:VEGE.0000029335.13948.87; Shen W. S., 1986, J DESERT RES, V6, P13; Spasojevic MJ, 2012, J ECOL, V100, P652, DOI 10.1111/j.1365-2745.2011.01945.x; Stoll P, 2005, J ECOL, V93, P395, DOI 10.1111/j.0022-0477.2005.00989.x; Svoray T, 2007, LANDSCAPE ECOL, V22, P105, DOI 10.1007/s10980-006-9004-3; Tilman D, 1997, SPATIAL ECOLOGY ROLE; Tobe K, 2005, ANN BOT-LONDON, V95, P649, DOI 10.1093/aob/mci060; Tobe K, 2007, AUST J BOT, V55, P55, DOI 10.1071/BT06060; Wang XM, 2004, J ARID ENVIRON, V58, P559, DOI 10.1016/j.jaridenv.2003.11.009; [王妍 Wang Yan], 2011, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V25, P167; [魏宝 Wei Bao], 2012, [干旱区研究, Arid Zone Research], V29, P213; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wiegand T, 2009, AM NAT, V174, pE106, DOI 10.1086/605368; Wu B, 2002, J ARID ENVIRON, V50, P429, DOI 10.1006/jare.2001.0847; Wu B, 2001, J ECOL, V21, P191; [吴晓旭 WU Xiaoxu], 2011, [中国沙漠, Journal of Desert Research], V31, P828; Xu JX, 2006, CATENA, V65, P279, DOI 10.1016/j.catena.2005.12.006; Yang H, 2006, J ARID ENVIRON, V65, P619, DOI 10.1016/j.jaridenv.2005.08.010; [杨洪晓 Yang Hongxiao], 2004, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University], V40, P684; Yang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034597; Zhang GL, 2012, ECOL ENG, V38, P20, DOI 10.1016/j.ecoleng.2011.09.005; Zhang Q, 1983, CHINESE J ECOL, V2, P14; Zhang Xin-Shi, 2010, Chinese Journal of Plant Ecology, V34, P112, DOI 10.3773/j.issn.1005-264x.2010.01.014; Zhao HL, 2007, ECOL ENG, V31, P1, DOI 10.1016/j.ecoleng.2007.04.010; Zhao JZ, 2002, INT J SUST DEV WORLD, V9, P292, DOI 10.1080/13504500209470124; [No title captured]	56	20	23	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58331	10.1371/journal.pone.0058331	http://dx.doi.org/10.1371/journal.pone.0058331			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505489	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500069
J	Chen, X; Liu, P; Chou, HH				Chen, Xi; Liu, Peng; Chou, Hui-Hsien			Whole-Genome Thermodynamic Analysis Reduces siRNA Off-Target Effects	PLOS ONE			English	Article							NEAREST-NEIGHBOR THERMODYNAMICS; DNA DUPLEX STABILITY; DOT-T MISMATCHES; RNA INTERFERENCE; FUNCTIONAL SIRNA; PASSENGER-STRAND; SELECTION; DESIGN; MICROARRAY; PARAMETERS	Small interfering RNAs (siRNAs) are important tools for knocking down targeted genes, and have been widely applied to biological and biomedical research. To design siRNAs, two important aspects must be considered: the potency in knocking down target genes and the off-target effect on any nontarget genes. Although many studies have produced useful tools to design potent siRNAs, off-target prevention has mostly been delegated to sequence-level alignment tools such as BLAST. We hypothesize that whole-genome thermodynamic analysis can identify potential off-targets with higher precision and help us avoid siRNAs that may have strong off-target effects. To validate this hypothesis, two siRNA sets were designed to target three human genes IDH1, ITPR2 and TRIM28. They were selected from the output of two popular siRNA design tools, siDirect and siDesign. Both siRNA design tools have incorporated sequence-level screening to avoid off-targets, thus their output is believed to be optimal. However, one of the sets we tested has off-target genes predicted by PICKY, a whole-genome thermodynamic analysis tool. PICKY can identify off-target genes that may hybridize to a siRNA within a user-specified melting temperature range. Our experiments validated that some off-target genes predicted by PICKY can indeed be inhibited by siRNAs. Similar experiments were performed using commercially available siRNAs and a few off-target genes were also found to be inhibited as predicted by PICKY. In summary, we demonstrate that whole-genome thermodynamic analysis can identify off-target genes that are missed in sequence-level screening. Because PICKY prediction is deterministic according to thermodynamics, if a siRNA candidate has no PICKY predicted off-targets, it is unlikely to cause off-target effects. Therefore, we recommend including PICKY as an additional screening step in siRNA design.	[Chen, Xi; Chou, Hui-Hsien] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Liu, Peng] Iowa State Univ, Dept Stat, Ames, IA USA; [Chou, Hui-Hsien] Iowa State Univ, Dept Comp Sci, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Chou, HH (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	hhchou@iastate.edu			National Science Foundation [DBI-0850195]; Div Of Biological Infrastructure [0850195] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by National Science Foundation grant DBI-0850195. http://www.nsf.gov/awardsearch/showAward. do? AwardNumber = 0850195 NSF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allawi HT, 1998, BIOCHEMISTRY-US, V37, P9435, DOI 10.1021/bi9803729; Allawi HT, 1998, BIOCHEMISTRY-US, V37, P2170, DOI 10.1021/bi9724873; Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c; Allawi HT, 1998, NUCLEIC ACIDS RES, V26, P2694, DOI 10.1093/nar/26.11.2694; Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Birmingham A, 2007, NAT PROTOC, V2, P2068, DOI 10.1038/nprot.2007.278; Bommarito S, 2000, NUCLEIC ACIDS RES, V28, P1929, DOI 10.1093/nar/28.9.1929; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chaudhary A, 2011, BIOCHEM BIOPH RES CO, V404, P313, DOI 10.1016/j.bbrc.2010.11.114; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Chou HH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-196; Chou HH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-347; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Doddapaneni H, 2005, MOL GENET GENOMICS, V274, P454, DOI 10.1007/s00438-005-0051-2; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Kaderali L, 2002, BIOINFORMATICS, V18, P1340, DOI 10.1093/bioinformatics/18.10.1340; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Levenkova N, 2004, BIOINFORMATICS, V20, P430, DOI 10.1093/bioinformatics/btg437; Li FG, 2001, BIOINFORMATICS, V17, P1067, DOI 10.1093/bioinformatics/17.11.1067; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Muhonen P, 2010, METHODS MOL BIOL, V623, P93, DOI 10.1007/978-1-60761-588-0_6; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Naito Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-392; Onoue H, 2000, BIOCHEM BIOPH RES CO, V267, P928, DOI 10.1006/bbrc.1999.2065; Paredes CJ, 2007, APPL ENVIRON MICROB, V73, P4631, DOI 10.1128/AEM.00144-07; Patzel V, 2005, NAT BIOTECHNOL, V23, P1440, DOI 10.1038/nbt1151; Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rose SD, 2005, NUCLEIC ACIDS RES, V33, P4140, DOI 10.1093/nar/gki732; Rossetto M, 2011, REV NEUROL-FRANCE, V167, P699, DOI 10.1016/j.neurol.2011.08.002; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; Sato M, 2007, PLANT J, V49, P565, DOI 10.1111/j.1365-313X.2006.02972.x; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Tellmann G., 2006, NAT METHODS, P1, DOI [10.1038/nmeth894, DOI 10.1038/NMETH894]; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Wang LQ, 2004, BIOINFORMATICS, V20, P1818, DOI 10.1093/bioinformatics/bth164; Yamada Tomoyuki, 2004, J Bioinform Comput Biol, V2, P21, DOI 10.1142/S0219720004000454; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	58	7	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58326	10.1371/journal.pone.0058326	http://dx.doi.org/10.1371/journal.pone.0058326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484018	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100108
J	Kim, RB; Phillips, A; Herrick, K; Helou, M; Rafie, C; Anscher, MS; Mikkelsen, RB; Ning, Y				Kim, Roy B.; Phillips, Allison; Herrick, Kirsten; Helou, Marieka; Rafie, Carlin; Anscher, Mitchell S.; Mikkelsen, Ross B.; Ning, Yi			Physical Activity and Sedentary Behavior of Cancer Survivors and Non-Cancer Individuals: Results from a National Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH BEHAVIORS; STATISTICS; FATIGUE; MEN	Increasing physical activity and decreasing sedentary behavior are associated with a higher quality of life and lower mortality rates for cancer survivors, a growing population group. Studies detailing the behavior of cancer survivors are limited. Therefore, we investigated physical activity and sedentary behavior of cancer survivors using data from the National Health and Nutrition Examination Survey (NHANES) 2007-2010. Participants were those who provided physical activity and sedentary behavior data. Those who were pregnant, <20 years old, or <3 years from their cancer diagnosis were excluded. A cancer case was a self-reported diagnosis by a physician. We identified 741 cancer survivors and 10,472 non-cancer participants. After adjustment for age, race, gender, education status, body mass index, and smoking status, cancer survivors (n = 10,472) reported significantly longer duration of sedentary behavior (OR = 1.42, 95% CI (1.12, 1.80) for 8 or more hours, p-value for trend = 0.09), compared to non-cancer participants (n = 741). They also reported non-significant increases in maximum intensity, duration, frequency, and energy expenditure, whereas they reported significant increases in moderate intensity (OR = 1.26, 95% CI (1.01, 1.57)), moderate frequency (1-4 times/week) (OR = 1.32, 95% CI (1.00, 1.74)), and moderate energy expenditure (4018.5-7623.5 kcal) (OR = 1.30, 95% CI (1.00, 1.71)) of physical activity, compared to non-cancer participants. These patterns are similar for breast and prostate cancer survivors, with prostate cancer survivors more likely to engage in physical activity for more than one hour per day (OR = 1.98, 95% CI (1.05, 3.71)). Our findings suggest that cancer survivors tend to have more physical activity, but they are also more likely to engage in sedentary behavior.	[Kim, Roy B.] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; [Phillips, Allison; Herrick, Kirsten; Helou, Marieka; Ning, Yi] Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Sch Med, Richmond, VA 23284 USA; [Helou, Marieka] Virginia Commonwealth Univ, Dept Pediat Oncol, Med Ctr, Richmond, VA USA; [Rafie, Carlin] Virginia Commonwealth Univ, Massey Canc Ctr, Med Ctr, Richmond, VA USA; [Anscher, Mitchell S.; Mikkelsen, Ross B.] Virginia Commonwealth Univ, Dept Radiat Oncol, Med Ctr, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Ning, Y (corresponding author), Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Sch Med, Richmond, VA 23284 USA.	yning2@vcu.edu	Rafie, Carlin/AAS-3063-2021	Rafie, Carlin/0000-0002-1402-5650; Herrick, Kirsten A./0000-0001-8646-599X; Anscher, Mitchell/0000-0003-4480-111X	VCU School of Medicine; National Institutes of Health (NIH) through CTSA award from the National Center for Advancing Translational Sciences [UL1TR000058]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER	VCU School of Medicine; National Institutes of Health (NIH) through CTSA award from the National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors would like to thank the VCU School of Medicine for its support in this project. Partial support was provided by the National Institutes of Health (NIH) through CTSA award No. UL1TR000058 from the National Center for Advancing Translational Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2009, CANC FACTS FIG 2009; Aziz NM, 2003, SEMIN RADIAT ONCOL, V13, P248, DOI 10.1016/S1053-4296(03)00024-9; Bellizzi KM, 2005, J CLIN ONCOL, V23, P8884, DOI 10.1200/JCO.2005.02.2343; Blanchard CM, 2008, J CLIN ONCOL, V26, P2198, DOI 10.1200/JCO.2007.14.6217; Blanchard CM, 2003, AM J HEALTH BEHAV, V27, P246, DOI 10.5993/AJHB.27.3.6; Bray F, 2012, LANCET ONCOLOGY; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Coups EJ, 2005, PREV MED, V40, P702, DOI 10.1016/j.ypmed.2004.09.011; Courneya KS, 2003, J CLIN ONCOL, V21, P1660, DOI 10.1200/JCO.2003.04.093; Demark-Wahnefried W, 2000, CANCER-AM CANCER SOC, V88, P674, DOI 10.1002/(SICI)1097-0142(20000201)88:3&lt;674::AID-CNCR26&gt;3.0.CO;2-R; Eakin EG, 2007, CANCER CAUSE CONTROL, V18, P881, DOI 10.1007/s10552-007-9033-5; Garcia M, 2007, GLOBAL CANC FACTS FI; GOTAY CC, 1984, SOC SCI MED, V18, P605, DOI 10.1016/0277-9536(84)90076-5; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kendall AR, 2005, QUAL LIFE RES, V14, P361, DOI 10.1007/s11136-004-1468-5; Lee CD, 2011, ANN EPIDEMIOL, V21, P749, DOI 10.1016/j.annepidem.2011.04.010; Mock V, 2000, ONCOLOGY-NY, V14, P151; Park CL, 2008, J HEALTH PSYCHOL, V13, P1198, DOI 10.1177/1359105308095978; Petrelli NJ, 2009, J CLIN ONCOL, V27, P6052, DOI 10.1200/JCO.2009.26.6171; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; STEPHENS T, 1985, PUBLIC HEALTH REP, V100, P147; Vogelzang NJ, 1997, SEMIN HEMATOL, V34, P4; Webster K, 1998, ONCOLOGY-NY, V12, P697; Yabroff KR, 2004, JNCI-J NATL CANCER I, V96, P1322, DOI 10.1093/jnci/djh255	24	56	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57598	10.1371/journal.pone.0057598	http://dx.doi.org/10.1371/journal.pone.0057598			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483916	Green Published, gold			2022-12-27	WOS:000316936100032
J	Meybohm, P; Herrmann, E; Nierhoff, J; Zacharowski, K				Meybohm, Patrick; Herrmann, Eva; Nierhoff, Julia; Zacharowski, Kai			Aprotinin May Increase Mortality in Low and Intermediate Risk but Not in High Risk Cardiac Surgical Patients Compared to Tranexamic Acid and epsilon-Aminocaproic Acid - A Meta-Analysis of Randomised and Observational Trials of over 30.000 Patients	PLOS ONE			English	Article							LOW-DOSE APROTININ; BLOOD-LOSS; TRANSFUSION REQUIREMENTS; METHODOLOGICAL QUALITY; POSTOPERATIVE OUTCOMES; DOUBLE-BLIND; BYPASS; SURGERY; FIBRINOLYSIS; ASPIRIN	Background: To compare the effect of aprotinin with the effect of lysine analogues (tranexamic acid and e-aminocaproic acid) on early mortality in three subgroups of patients: low, intermediate and high risk of cardiac surgery. Methods and Findings: We performed a meta-analysis of randomised controlled trials and observational with the following data sources: Medline, Cochrane Library, and reference lists of identified articles. The primary outcome measure was early (in-hospital/30-day) mortality. The secondary outcome measures were any transfusion of packed red blood cells within 24 hours after surgery, any re-operation for bleeding or massive bleeding, and acute renal dysfunction or failure within the selected cited publications, respectively. Out of 328 search results, 31 studies (15 trials and 16 observational studies) included 33,501 patients. Early mortality was significantly increased after aprotinin vs. lysine analogues with a pooled risk ratio (95% CI) of 1.58 (1.13-2.21), p<0.001 in the low (n = 14,297) and in the intermediate risk subgroup (1.42 (1.09-1.84), p<0.001; n = 14,427), respectively. Contrarily, in the subgroup of high risk patients (n = 4,777), the risk for mortality did not differ significantly between aprotinin and lysine analogues (1.03 (0.67-1.58), p = 0.90). Conclusion: Aprotinin may be associated with an increased risk of mortality in low and intermediate risk cardiac surgery, but presumably may has no effect on early mortality in a subgroup of high risk cardiac surgery compared to lysine analogues. Thus, decisions to re-license aprotinin in lower risk patients should critically be debated. In contrast, aprotinin might probably be beneficial in high risk cardiac surgery as it reduces risk of transfusion and bleeding complications.	[Meybohm, Patrick; Zacharowski, Kai] Univ Hosp Frankfurt, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Herrmann, Eva; Nierhoff, Julia] Univ Hosp Frankfurt, Inst Biostat & Math Modelling, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Meybohm, P (corresponding author), Univ Hosp Frankfurt, Clin Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany.	patrick.meybohm@kgu.de	Meybohm, Patrick/K-4066-2017	Meybohm, Patrick/0000-0002-2666-8696				Bernet F, 1999, J CARDIAC SURG, V14, P92, DOI 10.1111/j.1540-8191.1999.tb00956.x; BLAUHUT B, 1994, J THORAC CARDIOV SUR, V108, P1083, DOI 10.1016/S0022-5223(12)70192-7; Casati V, 2000, J THORAC CARDIOV SUR, V120, P520, DOI 10.1067/mtc.2000.108016; DeAnda A, 2012, J THORAC CARDIOV SUR, V144, P998, DOI 10.1016/j.jtcvs.2012.06.035; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DeSantis SM, 2011, CIRCULATION, V124, pS62, DOI 10.1161/CIRCULATIONAHA.110.002543; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; European Medicines Agency, 2012, EUR MED AG REC LIFT; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Ferraris VA, 2013, J THORAC CARDIOV SUR, V145, P240, DOI 10.1016/j.jtcvs.2012.09.026; Greilich PE, 2009, ANESTH ANALG, V109, P15, DOI 10.1213/ane.0b013e3181a40b5d; Hekmat K, 2004, CURR MED RES OPIN, V20, P121, DOI 10.1185/030079903125002658; Henry David A, 2011, Cochrane Database Syst Rev, pCD001886, DOI 10.1002/14651858.CD001886.pub4; Karkouti K, 2010, ANESTH ANALG, V110, P21, DOI 10.1213/ANE.0b013e3181c0ea6d; Kuitunen A, 2005, ACTA ANAESTH SCAND, V49, P1272, DOI 10.1111/j.1399-6576.2005.00809.x; Landymore RW, 1997, EUR J CARDIO-THORAC, V11, P798; Liakopoulos OJ, 2008, EUR HEART J, V29, P1548, DOI 10.1093/eurheartj/ehn198; Lindvall G, 2008, ANN THORAC SURG, V86, P13, DOI 10.1016/j.athoracsur.2008.03.033; Misfeld M, 1998, ANN THORAC SURG, V66, P792, DOI 10.1016/S0003-4975(98)00646-8; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Mongan PD, 1998, ANESTH ANALG, V87, P258, DOI 10.1097/00000539-199808000-00005; Mouton R, 2008, LANCET, V371, P475, DOI 10.1016/S0140-6736(08)60237-8; Murkin JM, 2010, ANESTH ANALG, V110, P350, DOI 10.1213/ANE.0b013e3181c92b23; Reeves BC, 2008, CURR OPIN CARDIOL, V23, P607, DOI 10.1097/HCO.0b013e328310fc95; ROYSTON D, 1987, LANCET, V2, P1289; Sander M, 2010, CRIT CARE, V14, DOI 10.1186/cc9216; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Shaw AD, 2008, NEW ENGL J MED, V358, P784, DOI 10.1056/NEJMoa0707768; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Sniecinski RM, 2010, J CARDIOTHOR VASC AN, V24, P959, DOI 10.1053/j.jvca.2010.02.018; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008	31	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58009	10.1371/journal.pone.0058009	http://dx.doi.org/10.1371/journal.pone.0058009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483965	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100069
J	Kerenyi, A; Bihary, D; Venturi, V; Pongor, S				Kerenyi, Adam; Bihary, Dora; Venturi, Vittorio; Pongor, Sandor			Stability of Multispecies Bacterial Communities: Signaling Networks May Stabilize Microbiomes	PLOS ONE			English	Article							TO-CELL COMMUNICATION; QUORUM; EVOLUTION; FAMILY	Multispecies bacterial communities can be remarkably stable and resilient even though they consist of cells and species that compete for environmental resources. In silico models suggest that common signals released into the environment may help selected bacterial species cluster at common locations and that sharing of public goods (i.e. molecules produced and released for mutual benefit) can stabilize this coexistence. In contrast, unilateral eavesdropping on signals produced by a potentially invading species may protect a community by keeping invaders away from limited resources. Shared bacterial signals, such as those found in quorum sensing systems, may thus play a key role in fine tuning competition and cooperation within multi-bacterial communities. We suggest that in addition to metabolic complementarity, signaling dynamics may be important in further understanding complex bacterial communities such as the human, animal as well as plant microbiomes.	[Kerenyi, Adam] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Bihary, Dora; Pongor, Sandor] Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary; [Venturi, Vittorio] Int Ctr Genet Engn & Biotechnol, Grp Bacteriol & Plant Bacteriol, I-34012 Trieste, Italy; [Pongor, Sandor] Int Ctr Genet Engn & Biotechnol, Grp Prot Struct & Bioinformat, I-34012 Trieste, Italy	Hungarian Academy of Sciences; Hungarian Biological Research Center; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB)	Venturi, V (corresponding author), Int Ctr Genet Engn & Biotechnol, Grp Bacteriol & Plant Bacteriol, Padriciano 99, I-34012 Trieste, Italy.	venturi@icgeb.org; pongor@icgeb.org	Venturi, Vittorio/AAO-3069-2021	Venturi, Vittorio/0000-0003-4307-5697	OTKA [K. 84335]; ICGEB;  [TET 10-1-2011-0058];  [TAMOP-4.2.1.B-11/2/KMR-2011-0002];  [TAMOP-4.2.2/B-10/1-2010-0014]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ICGEB; ; ; 	Work at the Biological Research Centre of Szeged was partly funded by OTKA grant K. 84335. The research at Pazmany Peter Catholic University, Budapest was partially supported by grants TET 10-1-2011-0058, TAMOP-4.2.1.B-11/2/KMR-2011-0002, and TAMOP-4.2.2/B-10/1-2010-0014. Funding for open access charge and for the services of a scientific writer/editor was provided by ICGEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Bihary D, 2012, SCALABLE COMPUT-PRAC, V13, P21; Chalupowicz L, 2009, MOL PLANT MICROBE IN, V22, P849, DOI 10.1094/MPMI-22-7-0849; Chandler JR, 2012, ISME J, V6, P2219, DOI 10.1038/ismej.2012.69; Degrassi G, 2007, FEMS MICROBIOL LETT, V269, P213, DOI 10.1111/j.1574-6968.2006.00624.x; Duan K, 2009, CONTRIB MICROBIOL, V16, P1, DOI 10.1159/000219369; Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Fuqua C., 2002, MODERN MICROBIAL GEN, P362; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Gause GF, 1932, J EXP BIOL, V9, P389; GAVINI F, 1989, INT J SYST BACTERIOL, V39, P337, DOI 10.1099/00207713-39-3-337; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hosni T, 2011, ISME J, V5, P1857, DOI 10.1038/ismej.2011.65; Jakubovics NS, 2010, ORAL DIS, V16, P729, DOI 10.1111/j.1601-0825.2010.01701.x; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Kerenyi A, 2010, MED MYCOL, V17, P113; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Larsen PE, 2012, FEMS MICROBIOL LETT, V332, P91, DOI 10.1111/j.1574-6968.2012.02588.x; Licciardello G, 2009, MOL PLANT MICROBE IN, V22, P1514, DOI 10.1094/MPMI-22-12-1514; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; Mitri S, 2011, P NATL ACAD SCI USA, V108, P10839, DOI 10.1073/pnas.1100292108; Nadell CD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000716; Netotea S, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-6; Pacheco AR, 2009, CURR OPIN MICROBIOL, V12, P192, DOI 10.1016/j.mib.2009.01.006; Pacheco AR, 2012, NATURE; Ramsey MM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002012; Rojas AM, 2004, INT J SYST EVOL MICR, V54, P2217, DOI 10.1099/ijs.0.02924-0; Shank EA, 2009, CURR OPIN MICROBIOL, V12, P205, DOI 10.1016/j.mib.2009.01.003; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Venturi V, 2012, TRENDS MICROBIOL, V20, P160, DOI 10.1016/j.tim.2012.02.003; Venturi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009998; Visick KL, 2005, J BACTERIOL, V187, P5507, DOI 10.1128/JB.187.16.5507-5519.2005; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	39	15	15	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57947	10.1371/journal.pone.0057947	http://dx.doi.org/10.1371/journal.pone.0057947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483950	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000315634900057
J	Nallagatla, SR; Jones, CN; Ghosh, SKB; Sharma, SD; Cameron, CE; Spremulli, LL; Bevilacqua, PC				Nallagatla, Subba Rao; Jones, Christie N.; Ghosh, Saikat Kumar B.; Sharma, Suresh D.; Cameron, Craig E.; Spremulli, Linda L.; Bevilacqua, Philip C.			Native Tertiary Structure and Nucleoside Modifications Suppress tRNA's Intrinsic Ability to Activate the Innate Immune Sensor PKR	PLOS ONE			English	Article							PROTEIN-KINASE PKR; DOUBLE-STRANDED-RNA; MITOCHONDRIAL TRANSFER-RNAS; ESCHERICHIA-COLI; 5'-TRIPHOSPHATE-DEPENDENT ACTIVATION; SUBSTRATE RECOGNITION; BINDING DOMAIN; IN-VITRO; TRANSLATION; DIMERIZATION	Interferon inducible protein kinase PKR is an essential component of innate immunity. It is activated by long stretches of dsRNA and provides the first line of host defense against pathogens by inhibiting translation initiation in the infected cell. Many cellular and viral transcripts contain nucleoside modifications and/or tertiary structure that could affect PKR activation. We have previously demonstrated that a 5'-end triphosphate-a signature of certain viral and bacterial transcripts-confers the ability of relatively unstructured model RNA transcripts to activate PKR to inhibit translation, and that this activation is abrogated by certain modifications present in cellular RNAs. In order to understand the biological implications of native RNA tertiary structure and nucleoside modifications on PKR activation, we study here the heavily modified cellular tRNAs and the unmodified or the lightly modified mitochondrial tRNAs (mt-tRNA). We find that both a T7 transcript of yeast tRNA(Phe) and natively extracted total bovine liver mt-tRNA activate PKR in vitro, whereas native E. coli, bovine liver, yeast, and wheat tRNA(Phe) do not, nor do a variety of base-or sugar-modified T7 transcripts. These results are further supported by activation of PKR by a natively folded T7 transcript of tRNA(Phe) in vivo supporting the importance of tRNA modification in suppressing PKR activation in cells. We also examine PKR activation by a T7 transcript of the A14G pathogenic mutant of mt-tRNA(Leu), which is known to dimerize, and find that the misfolded dimeric form activates PKR in vitro while the monomeric form does not. Overall, the in vitro and in vivo findings herein indicate that tRNAs have an intrinsic ability to activate PKR and that nucleoside modifications and native RNA tertiary folding may function, at least in part, to suppress such activation, thus serving to distinguish self and non-self tRNA in innate immunity.	[Nallagatla, Subba Rao; Ghosh, Saikat Kumar B.; Bevilacqua, Philip C.] Penn State Univ, Dept Chem, University Pk, PA USA; [Nallagatla, Subba Rao; Ghosh, Saikat Kumar B.; Bevilacqua, Philip C.] Penn State Univ, Ctr RNA Mol Biol, University Pk, PA USA; [Jones, Christie N.; Spremulli, Linda L.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA; [Sharma, Suresh D.; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bevilacqua, PC (corresponding author), Penn State Univ, Dept Chem, University Pk, PA USA.	pcb5@psu.edu	SHARMA, Suresh/C-4431-2008; Ghosh, Saikat/AAD-1176-2022; SHARMA, Suresh D./AAD-7723-2022	SHARMA, Suresh/0000-0002-8633-4145; SHARMA, Suresh D./0000-0002-8633-4145; Bevilacqua, Philip/0000-0001-8074-3434	NIH [GM58709, GM 32734]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032734, R01GM058709] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by NIH GM58709 to PCB and NIH GM 32734 to LLS (https://commonfund.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347; Ben-Asouli Y, 2002, CELL, V108, P221, DOI 10.1016/S0092-8674(02)00616-5; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; Bjork Glenn R., 1995, P165; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Bullido MJ, 2008, NEUROBIOL AGING, V29, P1160, DOI 10.1016/j.neurobiolaging.2007.02.023; Byrne RT, 2010, NUCLEIC ACIDS RES, V38, P4154, DOI 10.1093/nar/gkq133; Cohen-Chalamish S, 2009, NAT CHEM BIOL, V5, P896, DOI 10.1038/nchembio.234; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dauber B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000473; Davis S, 1996, P NATL ACAD SCI USA, V93, P508, DOI 10.1073/pnas.93.1.508; Dey M, 2005, CELL, V122, P901, DOI 10.1016/j.cell.2005.06.041; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gehrig S, 2012, J EXP MED, V209, P225, DOI 10.1084/jem.20111044; Graham RL, 2005, J VIROL, V79, P13399, DOI 10.1128/JVI.79.21.13399-13411.2005; Heinicke LA, 2012, RNA, V18, P2157, DOI 10.1261/rna.034744.112; Heinicke LA, 2011, RNA, V17, P957, DOI 10.1261/rna.2636911; Heinicke LA, 2009, J MOL BIOL, V390, P319, DOI 10.1016/j.jmb.2009.05.005; HOVANESSIAN AG, 1993, SEMIN VIROL, V4, P237, DOI 10.1006/smvy.1993.1020; Huichalaf C, 2010, FASEB J, V24, P3706, DOI 10.1096/fj.09-151159; Hunter SE, 2004, BBA-PROTEINS PROTEOM, V1699, P173, DOI 10.1016/j.bbapap.2004.02.015; JEFFREY IW, 1995, EXP CELL RES, V218, P17, DOI 10.1006/excr.1995.1126; Jones CN, 2008, J BIOL CHEM, V283, P34445, DOI 10.1074/jbc.M806992200; Jones CI, 2006, J MOL BIOL, V362, P771, DOI 10.1016/j.jmb.2006.07.036; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Lemaire PA, 2005, J MOL BIOL, V345, P81, DOI 10.1016/j.jmb.2004.10.031; Lemaire PA, 2008, J MOL BIOL, V381, P351, DOI 10.1016/j.jmb.2008.05.056; LOEHR JS, 1968, P NATL ACAD SCI USA, V61, P1115, DOI 10.1073/pnas.61.3.1115; Madore E, 1999, NUCLEIC ACIDS RES, V27, P3583, DOI 10.1093/nar/27.17.3583; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Morel M, 2009, J CELL MOL MED, V13, P1476, DOI 10.1111/j.1582-4934.2009.00849.x; Mouton-Liger F, 2012, BBA-MOL BASIS DIS, V1822, P885, DOI 10.1016/j.bbadis.2012.01.009; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nallagatla SR, 2008, RNA, V14, P1201, DOI 10.1261/rna.1007408; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Nallagatla SR, 2011, CURR OPIN STRUC BIOL, V21, P119, DOI 10.1016/j.sbi.2010.11.003; Nallagatla SR, 2008, RNA BIOL, V5, P140, DOI 10.4161/rna.5.3.6839; Nie YZ, 2007, J VIROL, V81, P917, DOI 10.1128/JVI.01527-06; Nobles KN, 2002, NUCLEIC ACIDS RES, V30, P4751, DOI 10.1093/nar/gkf595; Nussbaum JM, 2002, NUCLEIC ACIDS RES, V30, P1205, DOI 10.1093/nar/30.5.1205; Peel AL, 2001, HUM MOL GENET, V10, P1531, DOI 10.1093/hmg/10.15.1531; Pindel A., 2010, J INTERFERON CYTOKIN, V31, P59, DOI DOI 10.1089/JIR.2010.009921166592; Puthenveetil S, 2006, NUCLEIC ACIDS RES, V34, P4900, DOI 10.1093/nar/gkl464; Roy MD, 2005, RNA, V11, P254, DOI 10.1261/rna.7143305; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sadler AJ, 2007, CURR TOP MICROBIOL, V316, P253; Sadler AJ, 2010, J INTERF CYTOK RES, V30, P195, DOI 10.1089/jir.2010.0005; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Shimoike T, 2009, ANTIVIR RES, V83, P228, DOI 10.1016/j.antiviral.2009.05.004; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Sohm N, 2004, J MOL BIOL, V339, P17, DOI 10.1016/j.jmb.2004.03.066; Spencer AC, 2004, BIOCHEMISTRY-US, V43, P9743, DOI 10.1021/bi049639w; STEIN A, 1976, BIOCHEMISTRY-US, V15, P160, DOI 10.1021/bi00646a025; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Toroney R, 2012, RNA, V18, P1862, DOI 10.1261/rna.034520.112; Toroney R, 2010, J MOL BIOL, V400, P393, DOI 10.1016/j.jmb.2010.04.059; VanOudenhove J, 2009, J MOL BIOL, V387, P910, DOI 10.1016/j.jmb.2009.02.019; WAKITA K, 1994, NUCLEIC ACIDS RES, V22, P347, DOI 10.1093/nar/22.3.347; Wang XX, 2009, J VIROL, V83, P12462, DOI 10.1128/JVI.01546-09; Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820; YANG SK, 1972, BIOCHEMISTRY-US, V11, P2311, DOI 10.1021/bi00762a016; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zheng XF, 2004, RNA, V10, P1934, DOI 10.1261/rna.7150804	66	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57905	10.1371/journal.pone.0057905	http://dx.doi.org/10.1371/journal.pone.0057905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483938	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900052
J	Tanner, GJ; Blundell, MJ; Colgrave, ML; Howitt, CA				Tanner, Gregory J.; Blundell, Malcolm J.; Colgrave, Michelle L.; Howitt, Crispin A.			Quantification of Hordeins by ELISA: The Correct Standard Makes a Magnitude of Difference	PLOS ONE			English	Article							CELIAC-DISEASE; STRUCTURAL BASIS; WHEAT PROTEINS; GLUTEN; BARLEY; GLIADIN; MALT; IMMUNOASSAY; EXTRACTION; BEER	Background: Coeliacs require a life-long gluten-free diet supported by accurate measurement of gluten (hordein) in gluten-free food. The gluten-free food industry, with a value in excess of $6 billion in 2011, currently depends on two ELISA protocols calibrated against standards that may not be representative of the sample being assayed. Aim: The factors affecting the accuracy of ELISA analysis of hordeins in beer were examined. Results: A simple alcohol-dithiothreitol extraction protocol successfully extracts the majority of hordeins from barley flour and malt. Primary hordein standards were purified by FPLC. ELISA detected different classes of purified hordeins with vastly different sensitivity. The dissociation constant (Kd) for a given ELISA reaction with different hordeins varied by three orders of magnitude. The Kd of the same hordein determined by ELISA using different antibodies varied by up to two orders of magnitude. The choice of either ELISA kit or hordein standard may bias the results and confound interpretation. Conclusions: Accurate determination of hordein requires that the hordein standard used to calibrate the ELISA reaction be identical in composition to the hordeins present in the test substance. In practice it is not feasible to isolate a representative hordein standard from each test food. We suggest that mass spectrometry is more reliable than ELISA, as ELISA enumerates only the concentration of particular amino-acid epitopes which may vary between different hordeins and may not be related to the absolute hordein concentration. MS quantification is undertaken using peptides that are specific and unique enabling the quantification of individual hordein isoforms.	[Tanner, Gregory J.; Blundell, Malcolm J.; Colgrave, Michelle L.; Howitt, Crispin A.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT, Australia; [Tanner, Gregory J.; Blundell, Malcolm J.; Howitt, Crispin A.] Commonwealth Sci & Ind Res Org Food Futures Flags, N Ryde, NSW, Australia; [Colgrave, Michelle L.] Commonwealth Sci & Ind Res Org Anim Food & Hlth, St Lucia, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Tanner, GJ (corresponding author), Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT, Australia.	Tanner@csiro.au	Howitt, Crispin/B-6058-2009; Tanner, Greg J/A-3210-2010; Colgrave, Michelle/A-5710-2012	Howitt, Crispin/0000-0002-1533-6602; Colgrave, Michelle/0000-0001-8463-805X	Grains Research and Development Commission (Australia) [CSP00051, CSP00067, CSP00088, CSP00113]; Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship	Grains Research and Development Commission (Australia)(Grains R&D Corp); Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship	This work was supported by grants CSP00051, CSP00067, CSP00088, and CSP00113 from the Grains Research and Development Commission (Australia), and appropriation funds from the Commonwealth Scientific and Industrial Research Organisation Food Futures National Research Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Bobalova J, 2007, J CHROMATOGR A, V1163, P80, DOI 10.1016/j.chroma.2007.06.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugyi Z, 2012, J AOAC INT, V95, P382, DOI 10.5740/jaoacint.SGE_Bugyi; Colgrave ML, 2012, J PROTEOME RES, V11, P386, DOI 10.1021/pr2008434; Comino I, 2012, J SCI FOOD AGR; DOLL H, 1973, HEREDITAS, V74, P293; Doll H, 1983, SEED PROTEINS, P207; Dona VV, 2008, EUR FOOD RES TECHNOL, V226, P591, DOI 10.1007/s00217-007-0597-9; Dostalek P, 2006, FOOD ADDIT CONTAM, V23, P1074, DOI 10.1080/02652030600740637; Dostalek P, 2009, J FOOD COMPOS ANAL, V22, P762, DOI 10.1016/j.jfca.2009.01.018; ELLIS HJ, 1990, CLIN CHIM ACTA, V189, P123, DOI 10.1016/0009-8981(90)90082-4; Garcia E, 2005, EUR J GASTROEN HEPAT, V17, P529, DOI 10.1097/00042737-200505000-00010; GenStat, 2011, GENSTAT WINDOWS; Gessendorfer B, 2010, J CEREAL SCI, V52, P331, DOI 10.1016/j.jcs.2010.04.010; Green PHR, 2009, JAMA-J AM MED ASSOC, V302, P1225, DOI 10.1001/jama.281.24.2344; Green PHR, 2003, AM J MED, V115, P191, DOI 10.1016/S0002-9343(03)00302-4; Guerdrum LJ, 2011, FOOD CHEM, V129, P1783, DOI 10.1016/j.foodchem.2011.06.021; Haas-Lauterbach S, 2012, J AOAC INT, V95, P377, DOI 10.5740/jaoacint.SGE_Haas-Lauterbach; Halbmayr-Jech E, 2012, J AOAC INT, V95, P372, DOI 10.5740/jaoacint.SGE_Halbmayr-Jech; HEJGAARD J, 1983, J I BREWING, V89, P402, DOI 10.1002/j.2050-0416.1983.tb04215.x; HILL A S, 1990, Food and Agricultural Immunology, V2, P21, DOI 10.1080/09540109009354699; Holopainen URM, 2012, J SCI FOOD AGR, V92, P2944, DOI 10.1002/jsfa.5706; Jin B, 2012, J FOOD PROCESS PRES, V36, P169, DOI 10.1111/j.1745-4549.2011.00571.x; Kahlenberg F, 2006, EUR FOOD RES TECHNOL, V222, P78, DOI 10.1007/s00217-005-0100-4; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Lastovickova M, 2010, J I BREWING, V116, P245, DOI 10.1002/j.2050-0416.2010.tb00427.x; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; Lukaskova ZR, 2011, FOOD ADDIT CONTAM A, V28, P817, DOI 10.1080/19440049.2011.572292; Mena MC, 2012, TALANTA, V91, P33, DOI 10.1016/j.talanta.2011.12.073; Mendez E, 2005, EUR J GASTROEN HEPAT, V17, P1053; Moron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002294; Moron B, 2008, AM J CLIN NUTR, V87, P405, DOI 10.1093/ajcn/87.2.405; Naiyer AJ, 2009, J CLIN GASTROENTEROL, V43, P225, DOI 10.1097/MCG.0b013e31816200e5; Ohlund K, 2010, J HUM NUTR DIET, V23, P294, DOI 10.1111/j.1365-277X.2010.01060.x; Perrocheau L, 2005, PROTEOMICS, V5, P2849, DOI 10.1002/pmic.200401153; Petry-Podgorska I, 2010, J CHROMATOGR B, V878, P3143, DOI 10.1016/j.jchromb.2010.09.023; Sealey-Voyksner JA, 2010, J CHROMATOGR A, V1217, P4167, DOI 10.1016/j.chroma.2010.01.067; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sharma GM, 2012, J AOAC INT, V95, P364, DOI 10.5740/jaoacint.SGE_Sharma; Shewry PR, 2001, PLANT GROWTH REGUL, V34, P105, DOI 10.1023/A:1013382803849; Shewry PR, 1999, SEED PROTEINS, P35; SKERRITT JH, 1992, J CEREAL SCI, V16, P219, DOI 10.1016/S0733-5210(09)80086-6; SKERRITT JH, 1991, J ASSOC OFF ANA CHEM, V74, P257; Skerritt JH, 2000, J CEREAL SCI, V32, P259, DOI 10.1006/jcrs.2000.0316; Snegaroff J, 2006, INT ARCH ALLERGY IMM, V139, P201, DOI 10.1159/000091165; Snegaroff J, 2012, BIOCH BIOPHYS ACTA; Sunwoo HH, 2012, FOOD AGR IMMUNOL, V23, P169, DOI 10.1080/09540105.2011.608121; Tanner GJ, 2010, ALIMENT PHARM THER, V32, P1184, DOI 10.1111/j.1365-2036.2010.04452.x; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; TURLEY RH, 1986, CROP SCI, V26, P778, DOI 10.2135/cropsci1986.0011183X002600040032x; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Voyksner RD, 2012, NOVEL APPROACHES DIS; Wild D, 2010, ALIMENT PHARM THER, V32, P573, DOI 10.1111/j.1365-2036.2010.04386.x; Wu MJ, 2012, J CEREAL SCI, V55, P53, DOI 10.1016/j.jcs.2011.08.015; Zhao FJ, 2006, J CEREAL SCI, V43, P369, DOI 10.1016/j.jcs.2005.12.003	57	42	44	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56456	10.1371/journal.pone.0056456	http://dx.doi.org/10.1371/journal.pone.0056456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23509607	gold, Green Published			2022-12-27	WOS:000315524900026
J	Chebli, Y; Pujol, L; Shojaeifard, A; Brouwer, I; van Loon, JJWA; Geitmann, A				Chebli, Youssef; Pujol, Lauranne; Shojaeifard, Anahid; Brouwer, Iman; van Loon, Jack J. W. A.; Geitmann, Anja			Cell Wall Assembly and Intracellular Trafficking in Plant Cells Are Directly Affected by Changes in the Magnitude of Gravitational Acceleration	PLOS ONE			English	Article							POLLEN-TUBE; SPATIAL-DISTRIBUTION; CELLULOSE; GRAVITY; GROWTH; ENDOCYTOSIS; DYNAMICS; TIP; VISUALIZATION; CALLOSE	Plants are able to sense the magnitude and direction of gravity. This capacity is thought to reside in selected cell types within the plant body that are equipped with specialized organelles called statoliths. However, most plant cells do not possess statoliths, yet they respond to changes in gravitational acceleration. To understand the effect of gravity on the metabolism and cellular functioning of non-specialized plant cells, we investigated a rapidly growing plant cell devoid of known statoliths and without gravitropic behavior, the pollen tube. The effects of hyper-gravity and omnidirectional exposure to gravity on intracellular trafficking and on cell wall assembly were assessed in Camellia pollen tubes, a model system with highly reproducible growth behavior in vitro. Using an epi-fluorescence microscope mounted on the Large Diameter Centrifuge at the European Space Agency, we were able to demonstrate that vesicular trafficking is reduced under hyper-gravity conditions. Immuno-cytochemistry confirmed that both in hyper and omnidirectional gravity conditions, the characteristic spatial profiles of cellulose and callose distribution in the pollen tube wall were altered, in accordance with a dose-dependent effect on pollen tube diameter. Our findings suggest that in response to gravity induced stress, the pollen tube responds by modifying cell wall assembly to compensate for the altered mechanical load. The effect was reversible within few minutes demonstrating that the pollen tube is able to quickly adapt to changing stress conditions.	[Chebli, Youssef; Pujol, Lauranne; Shojaeifard, Anahid; Geitmann, Anja] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ H3C 3J7, Canada; [Brouwer, Iman] Epona Med, Rotterdam, Netherlands; [van Loon, Jack J. W. A.] Univ Amsterdam, Acad Ctr Tandheelkunde Amsterdam ACTA, Dept Craniofacial Surg & Oral Cell Biol, Amsterdam, Netherlands; [van Loon, Jack J. W. A.] Vrije Univ Amsterdam, Res Inst MOVE, Amsterdam, Netherlands; [van Loon, Jack J. W. A.] European Space Agcy ESA, Life & Phys Sci Instrumentat & Life Support Sect, Noordwijk, Netherlands	Universite de Montreal; University of Amsterdam; Vrije Universiteit Amsterdam; European Space Agency	Geitmann, A (corresponding author), Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, CP 6128, Montreal, PQ H3C 3J7, Canada.	anja.geitmann@umontreal.ca	Geitmann, Anja/D-4696-2012	Geitmann, Anja/0000-0003-0390-0517; Chebli, Youssef/0000-0001-6508-5250; van Loon, Jack/0000-0001-9051-6016	European Space Agency Spin Your Thesis! programme; Natural Sciences and Engineering Research Council of Canada (NSERC); Ann Oaks doctoral scholarship of The Canadian Society of Plant Biologists/La Societe canadienne de biologie vegetale; Microgravity Research Program of NWO-Netherlands Space Office (NSO) [ALW-GO-MG-057]	European Space Agency Spin Your Thesis! programme; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ann Oaks doctoral scholarship of The Canadian Society of Plant Biologists/La Societe canadienne de biologie vegetale; Microgravity Research Program of NWO-Netherlands Space Office (NSO)	This project was financed by the European Space Agency Spin Your Thesis! programme. Research in the Geitmann lab is supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC). Youssef Chebli is funded by the Ann Oaks doctoral scholarship of The Canadian Society of Plant Biologists/La Societe canadienne de biologie vegetale. Van Loon is supported by Microgravity Research Program of NWO-Netherlands Space Office (NSO), grant ALW-GO-MG-057. Personnel of ESA assisted with the study design and data collection on the Large Diameter Centrifuge. The funders had no role in decision to publish, or preparation of the manuscript.	Anderson JR, 2002, J PLANT PHYSIOL, V159, P61, DOI 10.1078/0176-1617-00651; Aouar L, 2010, SEX PLANT REPROD, V23, P15, DOI 10.1007/s00497-009-0110-7; Baluska F, 1997, PLANTA, V203, pS69, DOI 10.1007/PL00008117; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Bove J, 2008, PLANT PHYSIOL, V147, P1646, DOI 10.1104/pp.108.120212; Chebli Y., 2007, FUNCT PLANT SCI BIOT, V1, P232; Chebli Y, 2012, PLANT PHYSIOL, V160, P1940, DOI 10.1104/pp.112.199729; Chebli Y, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00056; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Daher FB, 2011, TRAFFIC, V12, P1537, DOI 10.1111/j.1600-0854.2011.01256.x; De Micco V, 2006, PROTOPLASMA, V228, P121, DOI 10.1007/s00709-006-0161-7; Eggen E, 2011, J THEOR BIOL, V283, P113, DOI 10.1016/j.jtbi.2011.05.034; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Geitmann A, 2004, SEX PLANT REPROD, V17, P9, DOI 10.1007/s00497-004-0210-3; Geitmann A, 2006, PLANT CELL MONOGR, V3, P177, DOI 10.1007/7089_049; Geitmann A, 2010, SEX PLANT REPROD, V23, P63, DOI 10.1007/s00497-009-0121-4; Geitmann A, 2009, TRENDS PLANT SCI, V14, P467, DOI 10.1016/j.tplants.2009.07.006; HESLOPHARRISON J, 1987, INT REV CYTOL, V107, P1, DOI 10.1016/S0074-7696(08)61072-4; Kroeger JH, 2009, BIOPHYS J, V97, P1822, DOI 10.1016/j.bpj.2009.07.038; Kuang AX, 1996, PLANTA, V198, P588; Lazzaro MD, 2003, PROTOPLASMA, V220, P201, DOI 10.1007/s00709-002-0042-7; Lisboa S, 2008, PLANT CELL REP, V27, P21, DOI 10.1007/s00299-007-0437-1; LISBOA YS, 2002, J GRAVIT PHYSL, V9, P239; Lovy-Wheeler A, 2005, PLANTA, V221, P95, DOI 10.1007/s00425-004-1423-2; Matsumoto S, 2010, PLANT PHYSIOL, V152, P918, DOI 10.1104/pp.109.147330; Morita MT, 2010, ANNU REV PLANT BIOL, V61, P705, DOI 10.1146/annurev.arplant.043008.092042; Musgrave ME, 2009, PLANTA, V230, P863, DOI 10.1007/s00425-009-0992-5; Parre E, 2005, PLANTA, V220, P582, DOI 10.1007/s00425-004-1368-5; Parre E, 2005, PLANT PHYSIOL, V137, P274, DOI 10.1104/pp.104.050773; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; SCHLUPMANN H, 1994, PLANT PHYSIOL, V105, P659, DOI 10.1104/pp.105.2.659; Van Loon J., 2008, P LIF SPAC LIF EARTH, P22; van Loon JJWA, 2007, ADV SPACE RES, V39, P1161, DOI 10.1016/j.asr.2007.02.016; VANDERWOUDE WJ, 1971, J CELL SCI, V8, P331; Volkmann D, 2006, PROTOPLASMA, V229, P143, DOI 10.1007/s00709-006-0200-4; Zerzour R, 2009, DEV BIOL, V334, P437, DOI 10.1016/j.ydbio.2009.07.044; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007	38	18	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58246	10.1371/journal.pone.0058246	http://dx.doi.org/10.1371/journal.pone.0058246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516452	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200045
J	Kruger, R; Schutte, R; Huisman, HW; Hindersson, P; Olsen, MH; Eugen-Olsen, J; Schutte, AE				Kruger, Ruan; Schutte, Rudolph; Huisman, Hugo W.; Hindersson, Peter; Olsen, Michael H.; Eugen-Olsen, Jesper; Schutte, Aletta E.			NT-proBNP, C-Reactive Protein and Soluble uPAR in a Bi-Ethnic Male Population: The SAfrEIC Study	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; ATHEROSCLEROSIS; RISK; HYPERTENSION; INFLAMMATION; PREDICTORS; BIOMARKERS; RECEPTOR; DISEASE; BURDEN	Objective and design: This cross-sectional study aimed to investigate associations between a marker of cardiac strain, the N-terminal prohormone B-type natriuretic peptide (NT-proBNP), and inflammation as reflected by either a conventional or novel inflammatory marker in a bi-ethnic South African cohort. Methods and subjects: We measured NT-proBNP, C-reactive protein (CRP) and plasma-soluble urokinase plasminogen activator receptor (suPAR) levels along with conventional biomarkers in black (n = 117) and white (n = 116) men. Results: NT-proBNP, CRP and suPAR levels were higher in black compared to white men. NT-proBNP was significantly associated with both CRP (r = 0.38; p = 0.001) and suPAR (r = 0.42; p<0.001) in black men only. After full adjustment in multiple regression analyses, the above associations of NT-proBNP with CRP (beta = 0.199; p = 0.018) and suPAR (beta = 0.257; p<0.01) were confirmed in black men. Conclusion: These results suggest that a low-grade inflammatory state as reflected by both a conventional and novel marker of inflammation may contribute to higher cardiovascular risk as reflected by the associations obtained with a marker of cardiac strain in black South African men.	[Kruger, Ruan; Schutte, Rudolph; Huisman, Hugo W.; Olsen, Michael H.; Schutte, Aletta E.] North West Univ, Dept Physiol, HART, Potchefstroom, North West Prov, South Africa; [Hindersson, Peter] Hosp Vendsyssel, Dept Biochem, Hjorring, Denmark; [Olsen, Michael H.] Univ So Denmark, Odense Univ Hosp, Dept Endocrinol, Cardiovasc Prevent Clin, Odense, Denmark; [Eugen-Olsen, Jesper] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr 136, DK-2650 Hvidovre, Denmark	North West University - South Africa; University of Southern Denmark; Odense University Hospital; University of Copenhagen	Kruger, R (corresponding author), North West Univ, Dept Physiol, HART, Potchefstroom, North West Prov, South Africa.	ruan.kruger@nwu.ac.za	Kruger, Ruan/N-7618-2015; Schutte, Aletta E/E-5126-2018; Olsen, Michael H/H-8176-2014	Kruger, Ruan/0000-0001-7680-2032; Schutte, Aletta E/0000-0001-9217-4937; Olsen, Michael Hecht/0000-0003-2230-5780; Eugen-Olsen, Jesper/0000-0002-4630-4275; Huisman, Hugo/0000-0002-2114-4789	South African National Research Foundation Grant [GUN 2073040]; Medical Research Council (South Africa); Africa Unit for Trans-disciplinary Health Research of the North-West University (Potchefstroom campus, South Africa); Novo Nordisk Fonden [NNF13OC0003736] Funding Source: researchfish	South African National Research Foundation Grant; Medical Research Council (South Africa); Africa Unit for Trans-disciplinary Health Research of the North-West University (Potchefstroom campus, South Africa); Novo Nordisk Fonden(Novo Nordisk Foundation)	The SAfrEIC study was supported by the South African National Research Foundation Grant (GUN 2073040), the Medical Research Council (South Africa) and the Africa Unit for Trans-disciplinary Health Research of the North-West University (Potchefstroom campus, South Africa). The funding parties had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder BR, 2007, THROMB HAEMOSTASIS, V97, P336, DOI 10.1160/TH06-11-0669; Crimmins EM, 2006, P NATL ACAD SCI USA, V103, P498, DOI 10.1073/pnas.0501470103; Eugen-Olsen J, 2010, J INTERN MED, V268, P296, DOI 10.1111/j.1365-2796.2010.02252.x; Fourie CMT, 2012, INFLAMMATION, V35, P221, DOI 10.1007/s10753-011-9308-6; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Guelen I, 2008, J HYPERTENS, V26, P1321, DOI 10.1097/HJH.0b013e3282fe1d28; Hall C, 2005, J CARD FAIL, V11, pS81, DOI 10.1016/j.cardfail.2005.04.019; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Imholz BPM, 1998, CARDIOVASC RES, V38, P605, DOI 10.1016/S0008-6363(98)00067-4; Jensen J, 2010, CLIN RES CARDIOL, V99, P445, DOI 10.1007/s00392-010-0140-z; Kengne AP, 2006, INT J STROKE, V1, P180, DOI 10.1111/j.1747-4949.2006.00064.x; Marfell-Jones M, 2006, INT STANDARDS ANTHRO, P32; McCullough PA, 2003, HEART FAIL REV, V8, P355, DOI 10.1023/A:1026195332025; McDade TW, 2003, YEARB PHYS ANTHROPOL, V46, P100, DOI 10.1002/ajpa.10398; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Morrow DA, 2003, CIRCULATION, V108, P250, DOI 10.1161/01.CIR.0000078080.37974.D2; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Nielsen SE, 2013, J RENIN-ANGIO-ALDO S, V14, P161, DOI 10.1177/1470320312460290; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; Opie LH, 2005, CIRCULATION, V112, P3562, DOI 10.1161/CIRCULATIONAHA.105.539569; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Pemberton CJ, 2000, HYPERTENSION, V36, P355, DOI 10.1161/01.HYP.36.3.355; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Prager GW, 2004, BLOOD, V103, P955, DOI 10.1182/blood-2003-07-2214; Raizada V, 2001, MOL CELL BIOCHEM, V216, P137, DOI 10.1023/A:1011027231702; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Sackner-Bernstein J D, 2000, Curr Cardiol Rep, V2, P112, DOI 10.1007/s11886-000-0007-4; Sehestedt T, 2011, ATHEROSCLEROSIS, V216, P237, DOI 10.1016/j.atherosclerosis.2011.01.049; Tamakoshi K, 2003, INT J OBESITY, V27, P443, DOI 10.1038/sj.ijo.0802260; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Uusimaa P, 2004, INT J CARDIOL, V97, P251, DOI 10.1016/j.ijcard.2003.10.015; Yap LB, 2004, HEART FAIL REV, V9, P99, DOI 10.1023/B:HREV.0000046364.68371.b0; Yu H, 2000, CLIN BIOCHEM, V33, P601, DOI 10.1016/S0009-9120(00)00186-7	35	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58506	10.1371/journal.pone.0058506	http://dx.doi.org/10.1371/journal.pone.0058506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516493	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849200075
J	Best, RJ; Stachowicz, JJ				Best, Rebecca J.; Stachowicz, John J.			Phylogeny as a Proxy for Ecology in Seagrass Amphipods: Which Traits Are Most Conserved?	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; RNA SECONDARY STRUCTURE; SUBUNIT RIBOSOMAL DNA; MORPHOLOGICAL EVOLUTION; COMMUNITY ECOLOGY; STABLE-ISOTOPE; CRUSTACEA; DIVERSITY; PATTERNS; SIGNAL	Increasingly, studies of community assembly and ecosystem function combine trait data and phylogenetic relationships to gain novel insight into the ecological and evolutionary constraints on community dynamics. However, the key to interpreting these two types of information is an understanding of the extent to which traits are phylogenetically conserved. In this study, we develop the necessary framework for community phylogenetics approaches in a system of marine crustacean herbivores that play an important role in the ecosystem functioning of seagrass systems worldwide. For 16 species of amphipods and isopods, we (1) reconstructed phylogenetic relationships using COI, 16S, and 18S sequences and Bayesian analyses, (2) measured traits that are potentially important for assembling species between and within habitats, and (3) compared the degree to which each of these traits are evolutionarily conserved. Despite poor phylogenetic resolution for the order Amphipoda as a whole, we resolved almost all of the topology for the species in our system, and used a sampling of ultrametric trees from the posterior distribution to account for remaining uncertainty in topology and branch lengths. We found that traits varied widely in their degree of phylogenetic signal. Body mass, fecundity, and tube building showed very strong phylogenetic signal, and temperature tolerance and feeding traits showed much less. As such, the degree of signal was not predictable based on whether the trait is related to environmental filtering or to resource partitioning. Further, we found that even with strong phylogenetic signal in body size, (which may have large impacts on ecosystem function), the predictive relationship between phylogenetic diversity and ecosystem function is not straightforward. We show that patterns of phylogenetic diversity in communities of seagrass mesograzers could lead to a variety of interpretations and predictions, and that detailed study of trait similarities and differences will be necessary to interpret these patterns.	[Best, Rebecca J.; Stachowicz, John J.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Best, RJ (corresponding author), Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA.	rjbest@ucdavis.edu	Best, Rebecca/D-2934-2013	Best, Rebecca/0000-0003-2103-064X	Fulbright Science and Technology PhD Award; NSERC PGS-D; UC Davis Center for Population Biology; College of Biological Sciences; Bodega Marine Laboratory; National Science Foundation [OCE 08-50707]	Fulbright Science and Technology PhD Award; NSERC PGS-D(Natural Sciences and Engineering Research Council of Canada (NSERC)); UC Davis Center for Population Biology; College of Biological Sciences; Bodega Marine Laboratory; National Science Foundation(National Science Foundation (NSF))	This project was supported by a Fulbright Science and Technology PhD Award (http://scienceandtech.fulbrightonline.org/), an NSERC PGS-D Award (www.nserc.ca), the UC Davis Center for Population Biology (http://cpb.ucdavis.edu/), a College of Biological Sciences Dean's Mentorship Award, and the Bodega Marine Laboratory (http://bml.ucdavis.edu/)(grants to RJB). Additional funding was provided through the National Science Foundation (OCE 08-50707 to JJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Alfaro ME, 2006, ANNU REV ECOL EVOL S, V37, P19, DOI 10.1146/annurev.ecolsys.37.091305.110021; BARNARD J L, 1974, Crustaceana (Leiden), V27, P137, DOI 10.1163/156854074X00343; BARNARD JL, 1987, P BIOL SOC WASH, V100, P856; Benson DA, 2012, NUCLEIC ACIDS RES, V40, pD48, DOI 10.1093/nar/gkr1202; Best RJ, 2013, ECOL LETT, V16, P72, DOI 10.1111/ele.12016; Best RJ, 2012, MAR ECOL PROG SER, V456, P29, DOI 10.3354/meps09678; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bohning-Gaese K, 1999, EVOL ECOL RES, V1, P347; Bousfield E.L., 1982, P254; Bousfield Edward L., 2001, Amphipacifica, V3, P49; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; CAINE EA, 1980, MAR BIOL, V56, P327, DOI 10.1007/BF00386871; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chapman John W., 2007, P545; Dangles O, 2012, ECOLOGY, V93, P2615, DOI 10.1890/12-0510.1; Davies TJ, 2012, ECOLOGY, V93, P242, DOI 10.1890/11-1360.1; De Broyer Claude, 2007, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V77, P1; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Drummond A. J., 2011, GENEIOUS V5 4; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; DUFFY JE, 1994, ECOLOGY, V75, P1304, DOI 10.2307/1937456; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Englisch U, 2001, ORG DIVERS EVOL, V1, P139, DOI 10.1078/1439-6092-00011; Englisch U, 2003, J NAT HIST, V37, P2461, DOI 10.1080/00222930210144352; Englisch U, 2001, THESIS RUHR U BOCHUM; Farlin JP, 2010, MAR ECOL PROG SER, V420, P277, DOI 10.3354/meps08873; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRANCE RL, 1995, MAR ECOL PROG SER, V124, P307, DOI 10.3354/meps124307; Glazier DS, 1999, ARCH HYDROBIOL, V146, P257; Glor RE, 2003, EVOLUTION, V57, P2383; Harmon L, 2009, GEIGER ANAL EVOLUTIO; Hart EA, 2003, ECOLOGY, V84, P3317, DOI 10.1890/02-0629; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI 10.1017/CBO9780511525551; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hou ZG, 2007, MOL PHYLOGENET EVOL, V45, P596, DOI 10.1016/j.ympev.2007.06.006; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hultgren KM, 2012, ECOL LETT, V15, P704, DOI 10.1111/j.1461-0248.2012.01788.x; Ives AR, 2007, SYST BIOL, V56, P252, DOI 10.1080/10635150701313830; Jaschinski S, 2008, MAR ECOL PROG SER, V358, P103, DOI 10.3354/meps07327; Jeong S, 2012, MAR BIOL, P1; Johnson MA, 2008, ANIM BEHAV, V75, P555, DOI 10.1016/j.anbehav.2007.06.012; Kjer KM, 2007, SYST BIOL, V56, P133, DOI 10.1080/10635150601156305; KJER KM, 1995, MOL PHYLOGENET EVOL, V4, P314, DOI 10.1006/mpev.1995.1028; Kjer KM, 2004, SYST BIOL, V53, P506, DOI 10.1080/10635150490445922; Korpinen S, 2010, MAR BIOL, V157, P361, DOI 10.1007/s00227-009-1323-x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Letsch HO, 2010, MOL BIOL EVOL, V27, P2507, DOI 10.1093/molbev/msq140; Limen H, 2005, J GREAT LAKES RES, V31, P97, DOI 10.1016/S0380-1330(05)70241-0; Littell R.C., 1996, SAS SYSTEM MIXED MOD; Losos JB, 1996, ECOLOGY, V77, P1344, DOI 10.2307/2265532; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lowry J, 2012, WORLD AMPHIPODA DATA; Macdonald KS, 2005, MOL PHYLOGENET EVOL, V35, P323, DOI 10.1016/j.ympev.2005.01.013; Mahler DL, 2010, EVOLUTION, V64, P2731, DOI 10.1111/j.1558-5646.2010.01026.x; Mattern D, 2001, MOL PHYLOGENET EVOL, V18, P54, DOI 10.1006/mpev.2000.0861; Miller M.A., 2010, P GAT COMP ENV WORKS; Moncreiff CA, 2001, MAR ECOL PROG SER, V215, P93, DOI 10.3354/meps215093; Myers AA, 2003, J CRUSTACEAN BIOL, V23, P443, DOI 10.1651/0278-0372(2003)023[0443:APAANC]2.0.CO;2; Nawrocki EP, 2009, THESIS; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; NELSON WG, 1980, SARSIA, V65, P61; Nylander J.A.A, 2004, MRMODELTEST V2; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Poore AGB, 2008, EVOLUTION, V62, P21, DOI 10.1111/j.1558-5646.2007.00261.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rabosky DL, 2011, AM NAT, V178, P579, DOI 10.1086/662162; Rambaut A., 2007, TRACER V1 4; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2008, SYST BIOL, V57, P591, DOI 10.1080/10635150802302427; SAS Institute Inc, 2008, SAS WIND 9 2; SCHONIGER M, 1994, MOL PHYLOGENET EVOL, V3, P240, DOI 10.1006/mpev.1994.1026; SCHRAM FR, 1970, SCIENCE, V169, P854, DOI 10.1126/science.169.3948.854; Silvertown J, 2001, J ECOL, V89, P428, DOI 10.1046/j.1365-2745.2001.00553.x; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Smit AJ, 2006, AQUAT BOT, V84, P277, DOI 10.1016/j.aquabot.2005.11.005; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Spears T, 2005, P BIOL SOC WASH, V118, P117, DOI 10.2988/0006-324X(2005)118[117:PMAIPI]2.0.CO;2; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Therneau T.M., 2012, PACKAGE SURVIVAL ANA; Valentine JF, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P463; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Verdu M, 2012, P ROY SOC B-BIOL SCI, V279, P1761, DOI 10.1098/rspb.2011.2268; WATLING L, 1993, J NAT HIST, V27, P837, DOI 10.1080/00222939300770511; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240	92	34	34	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57550	10.1371/journal.pone.0057550	http://dx.doi.org/10.1371/journal.pone.0057550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505433	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500025
J	Kalinowska, M; Bazdar, DA; Lederman, MM; Funderburg, N; Sieg, SF				Kalinowska, Magdalina; Bazdar, Douglas A.; Lederman, Michael M.; Funderburg, Nicholas; Sieg, Scott F.			Decreased IL-7 Responsiveness Is Related to Oxidative Stress in HIV Disease	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; NAIVE T-CELLS; INFECTED PATIENTS; CD127 EXPRESSION; MICROBIAL TRANSLOCATION; IL-7R-ALPHA EXPRESSION; LIPID-PEROXIDATION; IMMUNE ACTIVATION; EPITHELIAL-CELLS; DOWN-REGULATION	HIV disease results in decreased IL-7 receptor expression and IL-7 responsiveness in T cells. To explore mechanisms of these deficiencies, we compared CD127 expression and IL-7 induction of P-STAT5 in T cells from HIV-infected persons with serum concentrations of cytokines (IL-7, IL-6 and IL-15), markers of microbial translocation (sCD14 and LPS), and with an indicator of oxidative stress (malondialdehyde (MDA) adducts). CD127 expression was directly related to IL-7 responsiveness in most CD8+ T cell subsets but not in CD4+ T cells from HIV-infected persons. MDA adducts were increased in serum of HIV-infected patients and were inversely related to IL-7 responsiveness in CD8+ T cells and in central memory CD4+ T cells. Incubation of T cells from healthy controls with hydrogen peroxide resulted in impairments in IL-7 induction of P-STAT5. These findings suggest that oxidative stress that is characteristic of HIV disease could contribute to impairments in IL-7 responsiveness and disrupt T cell homeostasis.	[Kalinowska, Magdalina] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Bazdar, Douglas A.; Lederman, Michael M.; Funderburg, Nicholas; Sieg, Scott F.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Bazdar, Douglas A.; Lederman, Michael M.; Funderburg, Nicholas; Sieg, Scott F.] Univ Hosp Cleveland, Cleveland, OH 44106 USA	Yeshiva University; Albert Einstein College of Medicine; Case Western Reserve University; University Hospitals of Cleveland	Sieg, SF (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	scott.sieg@case.edu	Funderburg, Nicholas/L-8022-2013; Sieg, Scott/AAV-2429-2021	Funderburg, Nicholas/0000-0003-3113-1217	National Institutes of Health [AI 076174]; Center for AIDS Research [AI 36219]; James B. Pendleton Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL108743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, P01AI076174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research; James B. Pendleton Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the National Institutes of Health (AI 076174), the Center for AIDS Research (AI 36219) and a grant from the James B. Pendleton Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUKRUST P, 1995, BLOOD, V86, P258, DOI 10.1182/blood.V86.1.258.bloodjournal861258; Bai F, 2010, AIDS, V24, P2581, DOI 10.1097/QAD.0b013e32833f9d64; Bazdar DA, 2009, J INFECT DIS, V199, P1019, DOI 10.1086/597210; Benito JM, 2008, J INFECT DIS, V198, P1466, DOI 10.1086/592716; Benoit A, 2009, AIDS, V23, P1341, DOI 10.1097/QAD.0b013e32832b51be; Bingisser RM, 1998, J IMMUNOL, V160, P5729; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Colle JH, 2007, AIDS, V21, P101, DOI 10.1097/QAD.0b013e3280115b6a; Colle JH, 2006, CLIN EXP IMMUNOL, V143, P398, DOI 10.1111/j.1365-2249.2006.03022.x; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Di Bona D, 2006, J HEPATOL, V45, P271, DOI 10.1016/j.jhep.2006.01.037; Duhe RJ, 1998, P NATL ACAD SCI USA, V95, P126, DOI 10.1073/pnas.95.1.126; Frossi B, 2003, EUR J IMMUNOL, V33, P2168, DOI 10.1002/eji.200323995; Frossi B, 2008, MOL IMMUNOL, V45, P58, DOI 10.1016/j.molimm.2007.05.008; Gil L, 2006, FREE RADICAL RES, V40, P495, DOI 10.1080/10715760600592962; Gil L, 2003, PHARMACOL RES, V47, P217, DOI 10.1016/S1043-6618(02)00320-1; Gil L, 2010, BIOMED PHARMACOTHER; Juffroy O, 2010, J VIROL, V84, P96, DOI 10.1128/JVI.01475-09; Kim MJ, 1997, J NUTR, V127, P2293, DOI 10.1093/jn/127.12.2293; Koesters SA, 2006, EUR J IMMUNOL, V36, P336, DOI 10.1002/eji.200535111; Lahdenpohja N, 1996, CELL IMMUNOL, V173, P282; Malmberg KJ, 2001, J IMMUNOL, V167, P2595, DOI 10.4049/jimmunol.167.5.2595; Mehmetcik G, 1997, ARCH GERONTOL GERIAT, V25, P305, DOI 10.1016/S0167-4943(97)00023-X; Mutlu-Turkoglu U, 2003, CLIN BIOCHEM, V36, P397, DOI 10.1016/S0009-9120(03)00035-3; Napolitano LA, 2001, NAT MED, V7, P73, DOI 10.1038/83381; Okoye A, 2007, J EXP MED, V204, P2171, DOI 10.1084/jem.20070567; Paiardini M, 2005, J IMMUNOL, V174, P2900, DOI 10.4049/jimmunol.174.5.2900; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Read SW, 2006, JAIDS-J ACQ IMM DEF, V42, P537, DOI 10.1097/01.qai.0000223027.47456.d0; Requena JR, 1997, BIOCHEM J, V322, P317, DOI 10.1042/bj3220317; Rethi B, 2005, AIDS, V19, P2077, DOI 10.1097/01.aids.0000189848.75699.0f; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Rodriguez B, 2011, J LEUKOCYTE BIOL, V90, P621, DOI 10.1189/jlb.1210661; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Seddon B, 2002, J IMMUNOL, V169, P3752, DOI 10.4049/jimmunol.169.7.3752; Simeonova PP, 1997, J IMMUNOL, V159, P3921; Slatter DA, 1999, J BIOL CHEM, V274, P19661, DOI 10.1074/jbc.274.28.19661; SONNERBORG A, 1988, SCAND J INFECT DIS, V20, P287, DOI 10.3109/00365548809032453; STAAL FJT, 1992, AIDS RES HUM RETROV, V8, P305, DOI 10.1089/aid.1992.8.305; Takahashi A, 2005, J IMMUNOL, V174, P6080, DOI 10.4049/jimmunol.174.10.6080; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098; Vranjkovic A, 2011, J LEUKOCYTE BIOL, V89, P499, DOI 10.1189/jlb.0710430; Wu WC, 2010, MOL VIS, V16, P1864; Yamamoto Y, 2002, NEPHROL DIAL TRANSPL, V17, P630, DOI 10.1093/ndt/17.4.630	46	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58764	10.1371/journal.pone.0058764	http://dx.doi.org/10.1371/journal.pone.0058764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505558	Green Submitted, gold, Green Published			2022-12-27	WOS:000318334500123
J	Kasalicky, V; Jezbera, J; Hahn, MW; Simek, K				Kasalicky, Vojtech; Jezbera, Jan; Hahn, Martin W.; Simek, Karel			The Diversity of the Limnohabitans Genus, an Important Group of Freshwater Bacterioplankton, by Characterization of 35 Isolated Strains	PLOS ONE			English	Article							BACTERIAL COMMUNITY COMPOSITION; INTERNAL TRANSCRIBED SPACER; NICHE SEPARATION; POLYNUCLEOBACTER-NECESSARIUS; PHOSPHORUS AVAILABILITY; ORGANIC-MATTER; ABUNDANT GROUP; LAKE; DYNAMICS; PATTERNS	Bacteria of the genus Limnohabitans, more precisely the R-BT lineage, have a prominent role in freshwater bacterioplankton communities due to their high rates of substrate uptake and growth, growth on algal-derived substrates and high mortality rates from bacterivory. Moreover, due to their generally larger mean cell volume, compared to typical bacterioplankton cells, they contribute over-proportionally to total bacterioplankton biomass. Here we present genetic, morphological and ecophysiological properties of 35 bacterial strains affiliated with the Limnohabitans genus newly isolated from 11 non-acidic European freshwater habitats. The low genetic diversity indicated by the previous studies using the ribosomal SSU gene highly contrasted with the surprisingly rich morphologies and different patterns in substrate utilization of isolated strains. Therefore, the intergenic spacer between 16S and 23S rRNA genes was successfully tested as a fine-scale marker to delineate individual lineages and even genotypes. For further studies, we propose the division of the Limnohabitans genus into five lineages (provisionally named as LimA, LimB, LimC, LimD and LimE) and also additional sublineages within the most diversified lineage LimC. Such a delineation is supported by the morphology of isolated strains which predetermine large differences in their ecology.	[Kasalicky, Vojtech; Simek, Karel] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Kasalicky, Vojtech; Jezbera, Jan; Simek, Karel] Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vvi, Ceske Budejovice, Czech Republic; [Hahn, Martin W.] Univ Innsbruck, Res Inst Limnol, A-6020 Innsbruck, Austria	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Innsbruck	Kasalicky, V (corresponding author), Acad Sci Czech Republ, Inst Hydrobiol, Ctr Biol, Vv I, Ceske Budejovice, Czech Republic.	vojtech.ves@post.cz	Hahn, Martin W./B-9998-2008; Šimek, Karel/AAB-1956-2021; Jezbera, Jan/B-5657-2015; Kasalicky, Vojtech/F-8578-2014; Kasalicky, Vojtech/AAC-2903-2021; Simek, Karel/F-8930-2014	Hahn, Martin W./0000-0003-0501-2556; Šimek, Karel/0000-0002-7058-9063; Kasalicky, Vojtech/0000-0002-9132-8321; Kasalicky, Vojtech/0000-0002-9132-8321; 	Grant Agency of the Czech Republic [206/08/0015, P504/10/0566]; institutional project of the ASCR [AV0Z 60170517]; Czech-Austrian mobility found KONTAKT [MEB 060602/CZ 05-2007, MEB 060901/WTZ, 406600]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); institutional project of the ASCR; Czech-Austrian mobility found KONTAKT	This study was largely supported by the Grant Agency of the Czech Republic under research grants 206/08/0015 (granted to KS) and P504/10/0566 (granted to JJ), the institutional project of the ASCR No. AV0Z 60170517. The authors also profited from the Czech-Austrian mobility found KONTAKT projects MEB 060602/CZ 05-2007 (granted to KS and MWH) and MEB 060901/WTZ project 406600 (granted to JJ and MWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2009, ENVIRON MICROBIOL, V11, P867, DOI 10.1111/j.1462-2920.2008.01807.x; Boenigk J, 2004, APPL ENVIRON MICROB, V70, P5787, DOI 10.1128/AEM.70.10.5787-5793.2004; Boyer SL, 2001, MOL BIOL EVOL, V18, P1057, DOI 10.1093/oxfordjournals.molbev.a003877; Buck U, 2009, ENVIRON MICROBIOL, V11, P1854, DOI 10.1111/j.1462-2920.2009.01910.x; Crump BC, 2003, APPL ENVIRON MICROB, V69, P2253, DOI 10.1128/AEM.69.4.2253-2268.2003; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Freese HM, 2011, MICROB ECOL, V62, P882, DOI 10.1007/s00248-011-9886-8; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Giroldo D, 2005, J PLANKTON RES, V27, P695, DOI 10.1093/plankt/fbi043; Giroldo D, 2002, J APPL PHYCOL, V14, P185, DOI 10.1023/A:1019972109619; Glaeser SP, 2010, ENVIRON MICROBIOL, V12, P3124, DOI 10.1111/j.1462-2920.2010.02285.x; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Glockner FO, 2000, APPL ENVIRON MICROB, V66, P5053, DOI 10.1128/AEM.66.11.5053-5065.2000; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hahn MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032772; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P2946, DOI 10.1099/ijs.0.022384-0; Hahn MW, 2010, INT J SYST EVOL MICR, V60, P1358, DOI 10.1099/ijs.0.013292-0; Hahn MW, 2009, INT J SYST EVOL MICR, V59, P2002, DOI 10.1099/ijs.0.005801-0; Hahn MW, 2005, APPL ENVIRON MICROB, V71, P4539, DOI 10.1128/AEM.71.8.4539-4547.2005; Hahn MW, 2004, J MICROBIOL METH, V57, P379, DOI 10.1016/j.mimet.2004.02.004; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hortnagl P, 2010, FEMS MICROBIOL ECOL, V73, P458, DOI 10.1111/j.1574-6941.2010.00904.x; Hoffmann M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-90; Hornak K, 2008, AQUAT MICROB ECOL, V52, P107, DOI 10.3354/ame01210; Hornak K, 2006, AQUAT MICROB ECOL, V45, P277, DOI 10.3354/ame045277; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jezbera J, 2006, ENVIRON MICROBIOL, V8, P1330, DOI 10.1111/j.1462-2920.2006.01026.x; Jezbera J, 2011, ENVIRON MICROBIOL, V13, P922, DOI 10.1111/j.1462-2920.2010.02396.x; Kasalicky V, 2010, INT J SYST EVOL MICR, V60, P2710, DOI 10.1099/ijs.0.018952-0; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Loferer-Krossbacher M, 1998, APPL ENVIRON MICROB, V64, P688; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Mueller-Spitz SR, 2009, FEMS MICROBIOL ECOL, V67, P511, DOI 10.1111/j.1574-6941.2008.00639.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Page KA, 2004, APPL ENVIRON MICROB, V70, P6542, DOI 10.1128/AEM.70.11.6542-6550.2004; Percent SF, 2008, APPL ENVIRON MICROB, V74, P1856, DOI 10.1128/AEM.01719-07; Perez MT, 2006, LIMNOL OCEANOGR, V51, P2527, DOI 10.4319/lo.2006.51.6.2527; Perez MT, 2010, ENVIRON MICROBIOL, V12, P74, DOI 10.1111/j.1462-2920.2009.02043.x; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Posch T, 1997, APPL ENVIRON MICROB, V63, P867, DOI 10.1128/AEM.63.3.867-873.1997; Posch T, 2009, AQUAT MICROB ECOL, V54, P113, DOI 10.3354/ame01269; Risso C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-447; Salcher MM, 2008, ENVIRON MICROBIOL, V10, P2074, DOI 10.1111/j.1462-2920.2008.01628.x; Salcher MM, 2007, FEMS MICROBIOL ECOL, V60, P40, DOI 10.1111/j.1574-6941.2006.00274.x; Salcher MM, 2010, LIMNOL OCEANOGR, V55, P846, DOI 10.4319/lo.2009.55.2.0846; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Simek K, 2005, APPL ENVIRON MICROB, V71, P2381, DOI 10.1128/AEM.71.5.2381-2390.2005; Simek K, 2001, APPL ENVIRON MICROB, V67, P2723, DOI 10.1128/AEM.67.6.2723-2733.2001; Simek K, 2008, AQUAT MICROB ECOL, V51, P249, DOI 10.3354/ame01193; Simek K, 2007, ENVIRON MICROBIOL, V9, P789, DOI 10.1111/j.1462-2920.2006.01201.x; Simek K, 2006, ENVIRON MICROBIOL, V8, P1613, DOI 10.1111/j.1462-2920.2006.01053.x; Simek K, 2011, APPL ENVIRON MICROB, V77, P7307, DOI 10.1128/AEM.05107-11; Simek K, 2010, APPL ENVIRON MICROB, V76, P1406, DOI 10.1128/AEM.02517-09; Simek K, 2010, APPL ENVIRON MICROB, V76, P631, DOI 10.1128/AEM.02203-09; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Stewart FJ, 2007, J MOL EVOL, V65, P44, DOI 10.1007/s00239-006-0235-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Urbanczyk H, 2007, INT J SYST EVOL MICR, V57, P2823, DOI 10.1099/ijs.0.65081-0; Vannini C, 2007, ENVIRON MICROBIOL, V9, P347, DOI 10.1111/j.1462-2920.2006.01144.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu QLL, 2006, ENVIRON MICROBIOL, V8, P1660, DOI 10.1111/j.1462-2920.2006.01049.x; Wu QLL, 2010, MICROB ECOL, V59, P614, DOI 10.1007/s00248-009-9603-z; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Zeng YH, 2012, J BACTERIOL, V194, P6302, DOI 10.1128/JB.01481-12; Zwart G, 2002, AQUAT MICROB ECOL, V28, P141, DOI 10.3354/ame028141	72	123	126	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58209	10.1371/journal.pone.0058209	http://dx.doi.org/10.1371/journal.pone.0058209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505469	Green Submitted, gold, Green Published			2022-12-27	WOS:000318334500059
J	Tseng, HC; Lee, IT; Lin, CC; Chi, PL; Cheng, SE; Shih, RH; Hsiao, LD; Yang, CM				Tseng, Hui-Ching; Lee, I-Ta; Lin, Chih-Chung; Chi, Pei-Ling; Cheng, Shin-Ei; Shih, Ruey-Horng; Hsiao, Li-Der; Yang, Chuen-Mao			IL-1 beta Promotes Corneal Epithelial Cell Migration by Increasing MMP-9 Expression through NF-kappa B- and AP-1-Dependent Pathways	PLOS ONE			English	Article							VIRUS INDUCES MATRIX-METALLOPROTEINASE-9; MATRIX METALLOPROTEINASES; OCULAR SURFACE; P38 MAPK; INTERLEUKIN-1; ACTIVATION; ACID; CASCADE; ERK1/2; AP-1	Interleukin-1 beta (IL-1 beta) plays a critical mediator in the pathogenesis of eye diseases. The implication of IL-1 beta in inflammatory responses has been shown to be mediated through up-regulation of inflammatory genes, including matrix metalloproteinase-9 (MMP-9). However, the detailed mechanisms of IL-1 beta-induced MMP-9 expression in Statens Seruminstitut Rabbit Corneal Cells (SIRCs) are largely unclear. Here, we demonstrated that in SIRCs, IL-1 beta induced MMP-9 promoter activity and mRNA expression associated with an increase in the secretion of pro-MMP-9. IL-1 beta-induced pro-MMP-9 expression and MMP-9 mRNA levels were attenuated by pretreatment with the inhibitor of MEK1/2 (U0126), JNK1/2 (SP600125), NF-kappa B (Bay11-7082), or AP-1 (Tanshinone IIA) and transfection with siRNA of p42 or JNK2. Moreover, IL-1 beta markedly stimulated p42/p44 MAPK and JNK1/2 phosphorylation in SIRCs. In addition, IL-1 beta also enhanced p42/p44 MAPK translocation from the cytosol into the nucleus. On the other hand, IL-1 beta induced c-Jun and c-Fos mRNA expression, c-Jun phosphorylation, and AP-1 promoter activity. NF-kappa B translocation, I kappa B alpha degradation, and NF-kappa B promoter activity were also enhanced by IL-1 beta. Pretreatment with U0126 or SP600125 inhibited IL-1 beta-induced AP-1 and NF-kappa B promoter activity, but not NF-kappa B translocation from the cytosol into the nucleus. Finally, we established that IL-1 beta could stimulate SIRCs migration via p42/p44 MAPK-, JNK1/2-, AP-1-, and NF-kappa B-dependent MMP-9 induction. These results suggested that NF-kappa B and AP-1 activated by JNK1/2 and p42/p44 MAPK cascade are involved in IL-1 beta-induced MMP-9 expression in SIRCs.	[Tseng, Hui-Ching; Lee, I-Ta; Chi, Pei-Ling; Cheng, Shin-Ei; Shih, Ruey-Horng; Hsiao, Li-Der; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Tseng, Hui-Ching; Lee, I-Ta; Chi, Pei-Ling; Cheng, Shin-Ei; Shih, Ruey-Horng; Hsiao, Li-Der; Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Hlth Aging Res Ctr, Tao Yuan, Taiwan; [Lee, I-Ta; Lin, Chih-Chung] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Dept Anesthet, Tao Yuan, Taiwan; [Lee, I-Ta; Lin, Chih-Chung] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Yang, CM (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan.	chuenmao@mail.cgu.edu.tw		Yang, Chuen-Mao/0000-0002-3208-5438; Chi, Belinda/0000-0003-0332-6682	National Science Council, Taiwan [NSC101-2314-B-182A-112, NSC98-2321-B-182-004, NSC99-2321-B-182-003, NSC98-2320-B-182-004-MY3, NSC98-2314-B-182-021-MY3]; Ministry of Education, Taiwan [EMRPD1B0311, EMRPD1B0321]; Chang Gung Medical Research Foundation, Taiwan [CMRPG391032, CMRPG381522, CMRPD170493, CMRPD180373, CMRPD1A0151, CMRPD1B0381, CMRPG3B1091]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan); Chang Gung Medical Research Foundation, Taiwan	This work was supported by NSC101-2314-B-182A-112, NSC98-2321-B-182-004, NSC99-2321-B-182-003, NSC98-2320-B-182-004-MY3, and NSC98-2314-B-182-021-MY3, from National Science Council, Taiwan; EMRPD1B0311, and EMRPD1B0321 from Ministry of Education, Taiwan; and CMRPG391032, CMRPG381522, CMRPD170493, CMRPD180373, CMRPD1A0151, CMRPD1B0381, and CMRPG3B1091 from Chang Gung Medical Research Foundation, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Adachi T, 2012, ARCH BIOCHEM BIOPHYS, V520, P30, DOI 10.1016/j.abb.2012.01.014; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Chang SJ, 2007, J ENDOCRINOL, V193, P393, DOI 10.1677/JOE-06-0168; Chen Y, 2011, MOL VIS, V17, P3072; Chen YT, 2010, AM J PATHOL, V177, P1333, DOI 10.2353/ajpath.2010.100227; Cheng CY, 2010, BRIT J PHARMACOL, V160, P1595, DOI 10.1111/j.1476-5381.2010.00858.x; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Gozdecka M, 2012, BIOCHEM SOC T, V40, P230, DOI 10.1042/BST20110630; Hassan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037912; Jauhonen HM, 2011, MOL VIS, V17, P2311; Jeong S, 2012, AM J PATHOL, V180, P2028, DOI 10.1016/j.ajpath.2012.01.025; Kowluru RA, 2012, EXPERT OPIN INV DRUG, V21, P797, DOI 10.1517/13543784.2012.681043; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee EJ, 2012, ONCOL REP, V28, P1084, DOI 10.3892/or.2012.1857; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lee IT, 2009, AM J PATHOL, V175, P519, DOI 10.2353/ajpath.2009.090016; Matache C, 2003, J AUTOIMMUN, V20, P323, DOI 10.1016/S0896-8411(03)00037-4; Muhlen S, 2009, VIRUS RES, V139, P100, DOI 10.1016/j.virusres.2008.09.007; Narayanan S, 2008, CORNEA, V27, P811, DOI 10.1097/ICO.0b013e31816bf46c; Okanobo A, 2012, AM J OPHTHALMOL, V154, P63, DOI 10.1016/j.ajo.2012.01.034; Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68; Suh SJ, 2012, CHEM-BIOL INTERACT, V199, P112, DOI 10.1016/j.cbi.2012.06.003; Tung WH, 2010, BRIT J PHARMACOL, V161, P1566, DOI 10.1111/j.1476-5381.2010.00982.x; Wu CY, 2008, J NEUROCHEM, V105, P1499, DOI 10.1111/j.1471-4159.2008.05318.x; Yang CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-12	25	64	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57955	10.1371/journal.pone.0057955	http://dx.doi.org/10.1371/journal.pone.0057955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505448	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500040
J	Wagner, AK; Graves, AJ; Fan, ZY; Walker, S; Zhang, F; Ross-Degnan, D				Wagner, Anita K.; Graves, Amy J.; Fan, Zhengyu; Walker, Saul; Zhang, Fang; Ross-Degnan, Dennis			Need for and Access to Health Care and Medicines: Are There Gender Inequities?	PLOS ONE			English	Article							QUALITY-OF-CARE; MANAGEMENT; PERSPECTIVES; COUNTRIES; DISEASE; IMPACT; INCOME	Objective: Differences between women and men in political and economic empowerment, education, and health risks are well-documented. Similar gender inequities in access to care and medicines have been hypothesized but evidence is lacking. Methods: We analyzed 2002 World Health Survey data for 257,922 adult respondents and 80,932 children less than 5 years old from 53 mostly low and middle-income countries. We constructed indicators of need for, access to, and perceptions of care, and we described the number of countries with equal and statistically different proportions of women and men for each indicator. Using multivariate logistic regression models, we estimated effects of gender on our study outcomes, overall and by household poverty. Findings: Women reported significantly more need for care for three of six chronic conditions surveyed, and they were more likely to have at least one of the conditions (OR 1.41 [95% CI 1.38, 1.44]). Among those with reported need for care, there were no consistent differences in access to care between women and men overall (e. g., treatment for all reported chronic conditions, OR 1.00 [0.96, 1.04]) or by household poverty. Of concern, access to care for chronic conditions was distressingly low among both men and women in many countries, as was access to preventive services among boys and girls less than 5 years old. Conclusions: These cross-country results do not suggest a systematic disadvantage of women in access to curative care and medicines for treating selected chronic conditions or acute symptoms, or to preventive services among boys and girls.	[Wagner, Anita K.; Graves, Amy J.; Fan, Zhengyu; Zhang, Fang; Ross-Degnan, Dennis] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Wagner, Anita K.; Graves, Amy J.; Fan, Zhengyu; Zhang, Fang; Ross-Degnan, Dennis] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Walker, Saul] UK Dept Int Dev, Maputo, Mozambique	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Wagner, AK (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA.	Anita_Wagner@hms.harvard.edu	Zhang, Fang/HHN-2153-2022		U.K. Government Department for International Development	U.K. Government Department for International Development	The U.K. Government Department for International Development supported the research project. The funder had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. SW critically reviewed the manuscript in his capacity as independent co-author, not on behalf of the funder.	[Anonymous], 2010, LANCET, V375, P1939, DOI 10.1016/S0140-6736(10)60905-1; Baghdadi G, 2005, J WOMENS HEALTH, V14, P82, DOI 10.1089/jwh.2005.14.82; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Bisilliat J, 2001, INTRO GENDER PERSPEC; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Damanhori AHH, 2008, J POSTGRAD MED, V54, P252; DfID, 2010, MDGS FOC MDG 3 PROM; El Arifeen S, 2008, J HEALTH POPUL NUTR, V26, P22; Fernandez-Liz E, 2008, BRIT J CLIN PHARMACO, V65, P407, DOI 10.1111/j.1365-2125.2007.03029.x; Gakidou E, 2011, B WORLD HEALTH ORGAN, V89, P172, DOI 10.2471/BLT.10.080820; Gómez Gómez Elsa, 2002, Rev Panam Salud Publica, V11, P327; Greig A., 2000, GENDER DEV MONOGRAPH, V10; Hausmann R., 2012, GLOBAL GENDER GAP RE; Masanja H, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-142; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Murray C., 2003, HLTH SYSTEMS PERFORM, P115; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Ostlin P, 2004, B WORLD HEALTH ORGAN, V82, P740; Raj A, 2011, LANCET, V377, P618, DOI 10.1016/S0140-6736(10)62112-5; Risberg G, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-28; Rowe AK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-275; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; UNICEF, 2011, BOYS GIRLS LIF CYL S; Ustun TB, 2001, WHO MULT SURV STUD H; vanWijk CMTG, 1996, SOC SCI MED, V43, P707, DOI 10.1016/0277-9536(96)00115-3; Wagner AK, 2011, HEALTH POLICY, V100, P151, DOI 10.1016/j.healthpol.2010.08.004; *WHO, 2003, WORLD HLTH SURV; World Bank, 2011, GEND EQ DEV; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; World Health Organization, GEND WOM HLTH; World Health Organization, 2011, 10 FACTS WOM HLTH 10 FACTS WOM HLTH; World Health Organization, 2013, HLTH STAT INF SYST W; World Health Organization, DEV COUNTR PROF MON; World Health Organization, 2013, WORLD HLTH SURV SAMP; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; Zaidi SA, 1996, SOC SCI MED, V43, P721, DOI 10.1016/0277-9536(96)00116-5	38	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57228	10.1371/journal.pone.0057228	http://dx.doi.org/10.1371/journal.pone.0057228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23505420	Green Submitted, gold, Green Published			2022-12-27	WOS:000318334500012
J	Walter, P; Metzger, J; Thiel, C; Helms, V				Walter, Peter; Metzger, Jennifer; Thiel, Christoph; Helms, Volkhard			Predicting where Small Molecules Bind at Protein-Protein Interfaces	PLOS ONE			English	Article							HOT-SPOTS; EVOLUTIONARY CONSERVATION; TRANSIENT POCKETS; IDENTIFICATION; PRINCIPLES; DISCOVERY; SEQUENCE; SERVER	Small molecules that bind at protein-protein interfaces may either block or stabilize protein-protein interactions in cells. Thus, some of these binding interfaces may turn into prospective targets for drug design. Here, we collected 175 pairs of protein-protein (PP) complexes and protein-ligand (PL) complexes with known three-dimensional structures for which (1) one protein from the PP complex shares at least 40% sequence identity with the protein from the PL complex, and (2) the interface regions of these proteins overlap at least partially with each other. We found that those residues of the interfaces that may bind the other protein as well as the small molecule are evolutionary more conserved on average, have a higher tendency of being located in pockets and expose a smaller fraction of their surface area to the solvent than the remaining protein-protein interface region. Based on these findings we derived a statistical classifier that predicts patches at binding interfaces that have a higher tendency to bind small molecules. We applied this new prediction method to more than 10 000 interfaces from the protein data bank. For several complexes related to apoptosis the predicted binding patches were in direct contact to co-crystallized small molecules.	[Walter, Peter; Metzger, Jennifer; Thiel, Christoph; Helms, Volkhard] Univ Saarland, Ctr Bioinformat, D-66123 Saarbrucken, Germany	Saarland University	Helms, V (corresponding author), Univ Saarland, Ctr Bioinformat, D-66123 Saarbrucken, Germany.	volkhard.helms@bioinformatik-uni-saarland.de		Helms, Volkhard/0000-0002-2180-9154				Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Cho KI, 2009, NUCLEIC ACIDS RES, V37, P2672, DOI 10.1093/nar/gkp132; Choi YS, 2009, PROTEINS, V77, P14, DOI 10.1002/prot.22410; Davis FP, 2011, MOL BIOSYST, V7, P545, DOI 10.1039/c0mb00200c; Davis FP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000668; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Fry DC, 2005, J MOL MED, V83, P955, DOI 10.1007/s00109-005-0705-x; Geppert T, 2012, J COMPUT CHEM, V33, P573, DOI 10.1002/jcc.22894; Gruber J, 2007, ACTA CRYSTALLOGR D, V63, P50, DOI 10.1107/S0907444906046762; Higueruelo AP, 2009, CHEM BIOL DRUG DES, V74, P457, DOI 10.1111/j.1747-0285.2009.00889.x; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hubbard S, 1996, NACCESS VERSION 2 1; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Illingworth CJR, 2010, J COMPUT CHEM, V31, P2677, DOI 10.1002/jcc.21561; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Klebe G, 2009, WIRKSTOFFDESIGN ENTW; Koes DR, 2012, BIOINFORMATICS, V28, P784, DOI 10.1093/bioinformatics/btr717; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; Metz A, 2012, J CHEM INF MODEL, V52, P120, DOI 10.1021/ci200322s; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Pintar A, 2002, BIOINFORMATICS, V18, P980, DOI 10.1093/bioinformatics/18.7.980; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Schmidtke P, 2010, J MED CHEM, V53, P5858, DOI 10.1021/jm100574m; Sugaya N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-263; Tuncbag N, 2010, NUCLEIC ACIDS RES, V38, pW402, DOI 10.1093/nar/gkq323; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; Walter P, 2007, J INTEGR BIOINFORMAT, V4; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Zhong SJ, 2007, CURR TOP MED CHEM, V7, P63, DOI 10.2174/156802607779318334	42	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58583	10.1371/journal.pone.0058583	http://dx.doi.org/10.1371/journal.pone.0058583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505538	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500103
J	Wanic, K; Krolewski, B; Ju, WJ; Placha, G; Niewczas, MA; Walker, W; Warram, JH; Kretzler, M; Krolewski, AS				Wanic, Krzysztof; Krolewski, Bozena; Ju, Wenjun; Placha, Grzegorz; Niewczas, Monika A.; Walker, William; Warram, James H.; Kretzler, Matthias; Krolewski, Andrzej S.			Transcriptome Analysis of Proximal Tubular Cells (HK-2) Exposed to Urines of Type 1 Diabetes Patients at Risk of Early Progressive Renal Function Decline	PLOS ONE			English	Article							TNF RECEPTORS 1; NEPHROTIC SYNDROME; URINARY PROTEINS; EPITHELIAL-CELLS; NECROSIS-FACTOR; NEPHROPATHY; MICROALBUMINURIA; EXPRESSION; DISEASE; VEGF	Background: In patients with Type 1 Diabetes (T1D) who develop microalbuminuria, progressive decline in glomerular filtration rate (GFR) may be initiated by leakage into the urine of toxic proteins (txUPs). This study tested this hypothesis. Methods: After archiving baseline urine, we followed T1D patients with microalbuminuria for 8-12 years to distinguish those in whom GFR declined (Decliners) and those in whom it remained stable (Non-decliners). Human proximal tubular cells (HK-2 cells) were grown in serum-free medium enriched with pooled urines from Decliners or Non-decliners. We determined genome-wide expression profiles in extracted mRNA. Results: The two pooled urines induced differential expression of 312 genes. In terms of gene ontology, molecular functions of the 119 up-regulated genes were enriched for protein binding and peptidase inhibitor activities. Their biologic processes were enriched for defense response, responses to other organisms, regulation of cellular processes, or response to stress or stimulus, and programmed cell death. The 195 down-regulated genes were disproportionately represented in molecular functions of cation binding, hydrolase activity, and DNA binding. They were disproportionately represented in biological processes for regulation of metabolic processes, nucleic acid metabolic processes, cellular response to stress and macromolecule biosynthesis. The set of up-regulated genes in HK-2 cells overlaps significantly with sets of over-expressed genes in tubular and interstitial compartments of kidney biopsies from patients with advanced DN (33 genes in one study and 25 in the other compared with 10.3 expected by chance, p<10(-9) and p<10(-4), respectively). The overlap included genes encoding chemokines and cytokines. Overlap of down-regulated genes was no more than expected by chance. Conclusions: Molecular processes in tubules and interstitium seen in advanced diabetic nephropathy can be induced in vitro by exposure to urine from patients with minimal microalbuminuria who subsequently developed progressive renal function decline, presumably due to putative txUPs.	[Wanic, Krzysztof; Krolewski, Bozena; Placha, Grzegorz; Niewczas, Monika A.; Walker, William; Warram, James H.; Krolewski, Andrzej S.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA; [Wanic, Krzysztof; Krolewski, Bozena; Placha, Grzegorz; Niewczas, Monika A.; Krolewski, Andrzej S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Wanic, Krzysztof] Jagiellonian Univ, Dept Metab Dis, Krakow, Poland; [Ju, Wenjun; Kretzler, Matthias] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA; [Placha, Grzegorz] Warsaw Med Univ, Dept Hypertens, Warsaw, Poland	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Jagiellonian University; University of Michigan System; University of Michigan; Medical University of Warsaw	Krolewski, AS (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Div Res, Boston, MA 02115 USA.	Andrzej.Krolewski@joslin.harvard.edu		Ju, Wenjun/0000-0002-9136-8454	NIH [DK41526, DK67638]; JDRF [JDRF 3-2005-908, JDRF 3-2004-631]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041526, P30DK081943, R01DK067638, P30DK020572] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by NIH grants DK41526 & DK67638 (to ASK); KW and GP were supported by the JDRF fellowships (JDRF 3-2005-908, & JDRF 3-2004-631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines RJ, 2008, NEPHRON EXP NEPHROL, V110, pE67, DOI 10.1159/000161982; Baines RJ, 2011, NAT REV NEPHROL, V7, P177, DOI 10.1038/nrneph.2010.174; Bonventre JV, 2012, SEMIN NEPHROL, V32, P452, DOI 10.1016/j.semnephrol.2012.07.008; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ficociello LH, 2010, DIABETES CARE, V33, P1337, DOI 10.2337/dc10-0227; Gekle M, 2005, ANNU REV PHYSIOL, V67, P573, DOI 10.1146/annurev.physiol.67.031103.154845; Gerritsma JSJ, 1996, CLIN EXP IMMUNOL, V103, P289, DOI 10.1046/j.1365-2249.1996.d01-617.x; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; HASEGAWA G, 1991, KIDNEY INT, V40, P1007, DOI 10.1038/ki.1991.308; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Huang Z, 2008, CYTOKINE, V42, P222, DOI 10.1016/j.cyto.2008.02.005; Li C, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-8-RESEARCH0032; Lindenmeyer MT, 2007, J AM SOC NEPHROL, V18, P1765, DOI 10.1681/ASN.2006121304; Merchant ML, 2009, J AM SOC NEPHROL, V20, P2065, DOI 10.1681/ASN.2008121233; Mogensen CE, 1999, DIABETOLOGIA, V42, P263, DOI 10.1007/s001250051151; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Perkins BA, 2007, J AM SOC NEPHROL, V18, P1353, DOI 10.1681/ASN.2006080872; Pollock CA, 2007, CURR OPIN NEPHROL HY, V16, P359, DOI 10.1097/MNH.0b013e3281eb9059; Reich H, 2005, J AM SOC NEPHROL, V16, P1266, DOI 10.1681/ASN.2004030222; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Wen Q, 2010, NEPHROLOGY, V15, P63, DOI 10.1111/j.1440-1797.2009.01152.x; Wolkow PP, 2008, J AM SOC NEPHROL, V19, P789, DOI 10.1681/ASN.2007050556; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181	26	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57751	10.1371/journal.pone.0057751	http://dx.doi.org/10.1371/journal.pone.0057751			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505438	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500030
J	Mboma, SM; Houben, RMGJ; Glynn, JR; Sichali, L; Drobniewski, F; Mpunga, J; Fine, PEM; French, N; Crampin, AC				Mboma, Sebastian M.; Houben, Rein M. G. J.; Glynn, Judith R.; Sichali, Lifted; Drobniewski, Francis; Mpunga, James; Fine, Paul E. M.; French, Neil; Crampin, Amelia C.			Control of (Multi) Drug Resistance and Tuberculosis Incidence over 23 Years in the Context of a Well-Supported Tuberculosis Programme in Rural Malawi	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; UNDERMINES POTENTIAL IMPACT; HIGH HIV PREVALENCE; XPERT(R) MTB/RIF; NORTHERN MALAWI; KARONGA DISTRICT; MYCOBACTERIUM-TUBERCULOSIS; CENTRALIZED LABORATORIES; TRENDS; INFECTION	Background: The rise in tuberculosis (TB) incidence following generalized HIV epidemics can overwhelm TB control programmes in resource-limited settings, sometimes accompanied by rising rates of drug resistance. This has led to claims that DOTS-based TB control has failed in such settings. However, few studies have described the effect of a sustained and well-supported DOTS programme on TB incidence and drug resistance over a long period. We present long-term trends in incidence and drug resistance in rural Malawi. Methods: Karonga District in northern Malawi has an adult HIV prevalence of similar to 10%. A research group, the Karonga Prevention Study, collaborates with the National Tuberculosis Programme to support core TB control activities. Bacteriological, demographic and clinical (including HIV status) information from all patients starting TB treatment in the District have been recorded since 1988. During that period isolates from each culture-positive TB patient were exported for drug sensitivity testing. Antiretroviral therapy (ART) has been widely available since 2005. Results: Incidence of new smear-positive adult TB peaked at 124/100,000/year in the mid-90s, but has since fallen to 87/100,000/year. Drug sensitivity information was available for 95% (3132/3307) of all culture-positive cases. Initial resistance to isoniazid was around 6% with no evidence of an increase. Fewer than 1% of episodes involved a multi-drug resistant strain. Discussion: In this setting with a generalised HIV epidemic and medium TB burden, a well-supported DOTS programme enhanced by routine culture and drug sensitivity testing may well have reduced TB incidence and maintained drug resistance at low levels.	[Mboma, Sebastian M.; Houben, Rein M. G. J.; Sichali, Lifted; Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi; [Houben, Rein M. G. J.; Glynn, Judith R.; Fine, Paul E. M.; Crampin, Amelia C.] London Sch Hyg & Trop Med, London WC1, England; [Mpunga, James] Natl TB Control Programme, Lilongwe, Malawi; [French, Neil] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Drobniewski, Francis] Hlth Protect Agcy, Natl Mycobacterium Reference Lab, London, England	Malawi Epidemiology and Intervention Research Unit; University of London; London School of Hygiene & Tropical Medicine; University of Liverpool; Health Protection Agency	Houben, RMGJ (corresponding author), Karonga Prevent Study, Chilumba, Malawi.	rein.houben@lshtm.ac.uk		French, Neil/0000-0003-4814-8293; Crampin, Amelia/0000-0002-1513-4330	LEPRA (The British Leprosy Relief Association); Wellcome Trust	LEPRA (The British Leprosy Relief Association); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was primarily funded by LEPRA (The British Leprosy Relief Association) and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, GUID SURV DRUG RES T; [Anonymous], MAL POP HOUS CENS; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Crampin AC, 2009, INT J TUBERC LUNG D, V13, P153; Crampin AC, 2001, INT J TUBERC LUNG D, V5, P994; Cuevas LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000443; Evans CA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001064; Floyd S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013499; Glynn JR, 2005, J INFECT DIS, V192, P480, DOI 10.1086/431517; Glynn JR, 2004, AIDS, V18, P1459, DOI 10.1097/01.aids.0000131336.15301.06; GLYNN JR, 1995, LANCET, V345, P907, DOI 10.1016/S0140-6736(95)90016-0; Glynn JR, 2008, EMERG INFECT DIS, V14, P1060, DOI 10.3201/eid1407.060468; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kenyon TA, 1999, INT J TUBERC LUNG D, V3, P4; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Lukoye D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016130; Mulenga C., 2010, TUBERC RES TREAT, V2010; Mwaungulu FD, 2002, MALAWI MED J, V13, P3; Ngwira B, 2002, MALAWI MED J, V13, P14; NTP, 2007, MAL NAT TUB CONTR PR; Peters D, 2012, INT J TUBERC LUNG D, V16, P702, DOI 10.5588/ijtld.12.0034; Ponnighaus J M, 1986, Lepr Rev, V57 Suppl 2, P285; PONNIGHAUS JM, 1993, LEPROSY REV, V64, P338; Talbot EA, 2003, INT J TUBERC LUNG D, V7, P72; Trebucq A, 2012, INT J TUBERC LUNG D, V16, P703, DOI 10.5588/ijtld.12.0034-2; Trebucq A, 2012, INT J TUBERC LUNG D, V16, P702, DOI 10.5588/ijtld.12.0131-2; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Warndorff DK, 2000, INT J TUBERC LUNG D, V4, P752; White RG, 2007, EPIDEMIOL INFECT, V135, P922, DOI 10.1017/S0950268806007680; World Health Organization, 2010, GLOB TUB CONTR WHO R; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	33	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58192	10.1371/journal.pone.0058192	http://dx.doi.org/10.1371/journal.pone.0058192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483994	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000316936100087
J	Virostko, J; Radhika, A; Poffenberger, G; Dula, AN; Moore, DJ; Powers, AC				Virostko, John; Radhika, Armandla; Poffenberger, Greg; Dula, Adrienne N.; Moore, Daniel J.; Powers, Alvin C.			Bioluminescence Imaging Reveals Dynamics of Beta Cell Loss in the Non-Obese Diabetic (NOD) Mouse Model	PLOS ONE			English	Article							MICE; ONSET; DISEASE; EXPRESSION; PREVENTION; STRAINS; PREDICT	We generated a mouse model (MIP-Luc-VU-NOD) that enables non-invasive bioluminescence imaging (BLI) of beta cell loss during the progression of autoimmune diabetes and determined the relationship between BLI and disease progression. MIP-Luc-VU-NOD mice displayed insulitis and a decline in bioluminescence with age which correlated with beta cell mass, plasma insulin, and pancreatic insulin content. Bioluminescence declined gradually in female MIP-Luc-VU-NOD mice, reaching less than 50% of the initial BLI at 10 weeks of age, whereas hyperglycemia did not ensue until mice were at least 16 weeks old. Mice that did not become diabetic maintained insulin secretion and had less of a decline in bioluminescence than mice that became diabetic. Bioluminescence measurements predicted a decline in beta cell mass prior to the onset of hyperglycemia and tracked beta cell loss. This model should be useful for investigating the fundamental processes underlying autoimmune diabetes and developing new therapies targeting beta cell protection and regeneration.	[Virostko, John; Dula, Adrienne N.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Radhika, Armandla; Poffenberger, Greg; Powers, Alvin C.] Vanderbilt Univ, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN USA; [Moore, Daniel J.] Vanderbilt Univ, Dept Pathol Immunol & Microbiol, Nashville, TN USA; [Moore, Daniel J.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Powers, Alvin C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Powers, Alvin C.] VA Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Virostko, J (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA.	jack.virostko@Vanderbilt.edu; Al.Powers@Vanderbilt.edu	Moore, Daniel J/A-4924-2008; Moore, Daniel/V-6145-2019; Virostko, Jack/AAR-5947-2021	Moore, Daniel J/0000-0002-6889-9345; Moore, Daniel/0000-0002-6889-9345; Virostko, Jack/0000-0003-3413-8801	Juvenile Diabetes Research Foundation; VA Research Service [BX000666]; National Institutes of Health [DK072473, DK69603, DK68764, DK66636, DK89572, DK89583]; South-Eastern Center for small animal imaging [U24CA126588]; Vanderbilt Mouse Metabolic Phenotyping Center [DK59637]; Vanderbilt Diabetes Research and Training Center [DK20593]; NATIONAL CANCER INSTITUTE [U24CA126588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068764, U01DK089572, P60DK020593, R33DK066636, U24DK059637, R01DK094199, R21DK066636, U2CDK059637, P30DK057516, P30DK020593, R01DK069603] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000666] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); VA Research Service(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South-Eastern Center for small animal imaging; Vanderbilt Mouse Metabolic Phenotyping Center; Vanderbilt Diabetes Research and Training Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The study was supported by grants from the Juvenile Diabetes Research Foundation, the VA Research Service (BX000666), the National Institutes of Health (DK072473, DK69603, DK68764, DK66636, DK89572, DK89583), the South-Eastern Center for small animal imaging (U24CA126588), the Vanderbilt Mouse Metabolic Phenotyping Center (DK59637), and the Vanderbilt Diabetes Research and Training Center (DK20593). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru N, 2001, J AUTOIMMUN, V17, P1, DOI 10.1006/jaut.2001.0530; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Andralojc K, 2012, DIABETOLOGIA, V55, P1247, DOI 10.1007/s00125-012-2491-7; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Angstetra E, 2009, IMMUNOL CELL BIOL, V87, P178, DOI 10.1038/icb.2008.81; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; BAXTER AG, 1991, CLIN EXP IMMUNOL, V85, P464; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; ELLIOTT RB, 1988, DIABETOLOGIA, V31, P62; Fowler M, 2005, TRANSPLANTATION, V79, P768, DOI 10.1097/01.TP.0000152798.03204.5C; Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; KIKUTANI H, 1992, ADV IMMUNOL, V51, P285, DOI 10.1016/S0065-2776(08)60490-3; Klinke DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001374; KLOPPEL G, 1984, VIRCHOWS ARCH A, V403, P441, DOI 10.1007/BF00737292; Melanitou E, 2004, J IMMUNOL, V173, P6603, DOI 10.4049/jimmunol.173.11.6603; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; Park SY, 2005, GENESIS, V43, P80, DOI 10.1002/gene.20157; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Sever D, 2011, FASEB J, V25, P676, DOI 10.1096/fj.10-158121; Smith SJ, 2006, MOL IMAGING, V5, P65, DOI 10.2310/7290.2006.00007; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Virostko J, 2004, MOL IMAGING, V3, P333, DOI 10.1162/1535350042973508; Virostko J, 2011, P NATL ACAD SCI USA, V108, P20719, DOI 10.1073/pnas.1109480108; Virostko J, 2010, MOL IMAGING BIOL, V12, P42, DOI 10.1007/s11307-009-0240-1; Virostko J, 2009, GASTROENTEROLOGY, V136, P407, DOI 10.1053/j.gastro.2008.12.024; WILLIAMS AJK, 1990, DIABETOLOGIA, V33, P635, DOI 10.1007/BF00400211; Wong GT, 2002, NEUROPEPTIDES, V36, P230, DOI 10.1054/npep.2002.0905	34	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57784	10.1371/journal.pone.0057784	http://dx.doi.org/10.1371/journal.pone.0057784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483929	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100045
J	Tanner, GJ; Colgrave, ML; Blundell, MJ; Goswami, HP; Howitt, CA				Tanner, Gregory J.; Colgrave, Michelle L.; Blundell, Malcolm J.; Goswami, Hareshwar P.; Howitt, Crispin A.			Measuring Hordein (Gluten) in Beer - A Comparison of ELISA and Mass Spectrometry	PLOS ONE			English	Article							T-CELL EPITOPES; CELIAC-DISEASE; BREAD WHEAT; GLIADIN; BARLEY; VARIETIES; PROTEINS; GLYCATION; TOXICITY; SORGHUM	Background: Subjects suffering from coeliac disease, gluten allergy/intolerance must adopt a lifelong avoidance of gluten. Beer contains trace levels of hordeins (gluten) which are too high to be safely consumed by most coeliacs. Accurate measurement of trace hordeins by ELISA is problematic. Methods: We have compared hordein levels in sixty beers, by sandwich ELISA, with the level determined using multiple reaction monitoring mass spectrometry (MRM-MS). Results: Hordein levels measured by ELISA varied by four orders of magnitude, from zero (for known gluten-free beers) to 47,000 mu g/mL (ppm; for a wheat-based beer). Half the commercial gluten-free beers were free of hordein by MS and ELISA. Two gluten-free and two low-gluten beers had zero ELISA readings, but contained significant hordein levels (p<0.05), or near average (60-140%) hordein levels, by MS, respectively. Six beers gave false negatives, with zero ELISA readings but near average hordein content by MS. Approximately 20% of commercial beers had ELISA readings less than 1 ppm, but a near average hordein content by MS. Several barley beers also contained undeclared wheat proteins. Conclusions: ELISA results did not correlate with the relative content of hordein peptides determined by MS, with all barley based beers containing hordein. We suggest that mass spectrometry is more reliable than ELISA, as ELISA enumerates only the concentration of particular amino-acid epitopes; this may vary between different hordeins and may not be related to the absolute hordein concentration. MS quantification is undertaken using peptides that are specific and unique, enabling the quantification of individual hordein isoforms. This outlines the problem of relying solely on ELISA determination of gluten in beverages such as beer and highlights the need for the development of new sensitive and selective quantitative assay such as MS.	[Tanner, Gregory J.; Blundell, Malcolm J.; Howitt, Crispin A.] Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT, Australia; [Tanner, Gregory J.; Colgrave, Michelle L.; Blundell, Malcolm J.; Goswami, Hareshwar P.; Howitt, Crispin A.] Commonwealth Sci & Ind Res Org Food Futures Flags, N Ryde, NSW, Australia; [Colgrave, Michelle L.; Goswami, Hareshwar P.] Commonwealth Sci & Ind Res Org Anim Food & Hlth S, St Lucia, Qld, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Tanner, GJ (corresponding author), Commonwealth Sci & Ind Res Org Plant Ind, Canberra, ACT, Australia.	Greg.Tanner@csiro.au	Tanner, Greg J/A-3210-2010; Howitt, Crispin/B-6058-2009; Colgrave, Michelle/A-5710-2012	Howitt, Crispin/0000-0002-1533-6602; Colgrave, Michelle/0000-0001-8463-805X	Grains Research and Development Commission (Australia) [CSP00051, CSP00067, CSP00088, CSP00113]; Commonwealth Scientific and ndustrial Research Organisation Food Futures National Research Flagship	Grains Research and Development Commission (Australia)(Grains R&D Corp); Commonwealth Scientific and ndustrial Research Organisation Food Futures National Research Flagship	This work was supported by grants CSP00051, CSP00067, CSP00088, and CSP00113 from the Grains Research and Development Commission (Australia), and appropriation funds from by Commonwealth Scientific and ndustrial Research Organisation Food Futures National Research Flagship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, GASTROENTEROLOGY, V124, pA15, DOI 10.1016/S0016-5085(03)80077-X; Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Bobalova J, 2010, EUR FOOD RES TECHNOL, V230, P665, DOI 10.1007/s00217-009-1205-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Colgrave ML, 2012, J PROTEOME RES, V11, P386, DOI 10.1021/pr2008434; Comino I, 2012, J SCI FOOD AGR; Comino I, 2012, MOL NUTR FOOD RES, V56, P1697, DOI 10.1002/mnfr.201200358; Comino I, 2011, GUT, V60, P915, DOI 10.1136/gut.2010.225268; DOLL H, 1973, HEREDITAS, V74, P293; Doll H, 1983, SEED PROTEINS, P207; Dostalek P, 2006, FOOD ADDIT CONTAM, V23, P1074, DOI 10.1080/02652030600740637; Ehren J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006313; Evans DE, 2011, J I BREWING, V117, P335, DOI 10.1002/j.2050-0416.2011.tb00477.x; GenStat, 2011, GENSTAT WINDOWS; Gianfrani C, 2007, GASTROENTEROLOGY, V133, P780, DOI 10.1053/j.gastro.2007.06.023; Guerdrum LJ, 2012, J AM SOC BREW CHEM, V70, P35, DOI 10.1094/ASBCJ-2012-0130-01; HILL A S, 1990, Food and Agricultural Immunology, V2, P21, DOI 10.1080/09540109009354699; Jegou S, 2000, J AGR FOOD CHEM, V48, P5023, DOI 10.1021/jf000075m; Jegou S, 2001, J AGR FOOD CHEM, V49, P4942, DOI 10.1021/jf010487a; Kabbani TA, 2012, ALIMENT PHARM THER, V35, P723, DOI 10.1111/j.1365-2036.2012.05001.x; Kahlenberg F, 2006, EUR FOOD RES TECHNOL, V222, P78, DOI 10.1007/s00217-005-0100-4; Klose C, 2011, J I BREWING, V117, P411, DOI 10.1002/j.2050-0416.2011.tb00487.x; Kupper C, 2005, GASTROENTEROLOGY, V128, pS121, DOI 10.1053/j.gastro.2005.02.024; Landschoot Av, 2011, CEREVISIA, V36, P93; Lastovickova M, 2010, J I BREWING, V116, P245, DOI 10.1002/j.2050-0416.2010.tb00427.x; Marti T, 2005, J PHARMACOL EXP THER, V312, P19, DOI 10.1124/jpet.104.073312; Mazzarella G, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/329150; Mitea C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015637; Molberg O, 2005, GASTROENTEROLOGY, V128, P393, DOI 10.1053/j.gastro.2004.11.003; Moron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002294; Obeta JAN, 2000, J I BREWING, V106, P295, DOI 10.1002/j.2050-0416.2000.tb00069.x; Okungbowa J, 2002, J I BREWING, V108, P362, DOI 10.1002/j.2050-0416.2002.tb00562.x; Petry-Podgorska I, 2010, J CHROMATOGR B, V878, P3143, DOI 10.1016/j.jchromb.2010.09.023; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; Shewry PR, 1999, SEED PROTEINS, P35; Siebert KJ, 2008, J AM SOC BREW CHEM, V66, P48, DOI 10.1094/ASBCJ-2007-1116-02; Spaenij-Dekking L, 2005, GASTROENTEROLOGY, V129, P797, DOI 10.1053/j.gastro.2005.06.017; Tanner GJ, 2010, ALIMENT PHARM THER, V32, P1184, DOI 10.1111/j.1365-2036.2010.04452.x; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Tye-Din JA, 2010, CLIN IMMUNOL, V134, P289, DOI 10.1016/j.clim.2009.11.001; van den Broeck H, 2010, MOL BIOSYST, V6, P2206, DOI 10.1039/c0mb00046a; van den Broeck HC, 2010, THEOR APPL GENET, V121, P1527, DOI 10.1007/s00122-010-1408-4; van den Broeck HC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-41; van Herpen TWJM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-1; Wijngaard H., 2007, Brewer & Distiller International, V3, P31; Wild D, 2010, ALIMENT PHARM THER, V32, P573, DOI 10.1111/j.1365-2036.2010.04386.x; Zarnkow M, 2010, J AM SOC BREW CHEM, V68, P152, DOI 10.1094/ASBCJ-2010-0625-01	47	65	65	2	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e56452	10.1371/journal.pone.0056452	http://dx.doi.org/10.1371/journal.pone.0056452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098DA	23509606	Green Published, Green Submitted, gold			2022-12-27	WOS:000315524900025
J	Diehl, WE; Johnson, WE; Hunter, E				Diehl, William E.; Johnson, Welkin E.; Hunter, Eric			Elevated Rate of Fixation of Endogenous Retroviral Elements in Haplorhini TRIM5 and TRIM22 Genomic Sequences: Impact on Transcriptional Regulation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-2; OLD-WORLD; TRIM5-ALPHA DETERMINES; POSTENTRY RESTRICTION; TRANSPOSABLE ELEMENTS; B30.2(SPRY) DOMAIN; POSITIVE SELECTION; L1 RETROTRANSPOSON; ANTIVIRAL ACTIVITY; B30.2/SPRY DOMAIN	All genes in the TRIM6/TRIM34/TRIM5/TRIM22 locus are type I interferon inducible, with TRIM5 and TRIM22 possessing antiviral properties. Evolutionary studies involving the TRIM6/34/5/22 locus have predominantly focused on the coding sequence of the genes, finding that TRIM5 and TRIM22 have undergone high rates of both non-synonymous nucleotide replacements and in-frame insertions and deletions. We sought to understand if divergent evolutionary pressures on TRIM6/34/5/22 coding regions have selected for modifications in the non-coding regions of these genes and explore whether such non-coding changes may influence the biological function of these genes. The transcribed genomic regions, including the introns, of TRIM6, TRIM34, TRIM5, and TRIM22 from ten Haplorhini primates and one prosimian species were analyzed for transposable element content. In Haplorhini species, TRIM5 displayed an exaggerated interspecies variability, predominantly resulting from changes in the composition of transposable elements in the large first and fourth introns. Multiple lineage-specific endogenous retroviral long terminal repeats (LTRs) were identified in the first intron of TRIM5 and TRIM22. In the prosimian genome, we identified a duplication of TRIM5 with a concomitant loss of TRIM22. The transposable element content of the prosimian TRIM5 genes appears to largely represent the shared Haplorhini/prosimian ancestral state for this gene. Furthermore, we demonstrated that one such differentially fixed LTR provides for species-specific transcriptional regulation of TRIM22 in response to p53 activation. Our results identify a previously unrecognized source of species-specific variation in the antiviral TRIM genes, which can lead to alterations in their transcriptional regulation. These observations suggest that there has existed long-term pressure for exaptation of retroviral LTRs in the non-coding regions of these genes. This likely resulted from serial viral challenges and provided a mechanism for rapid alteration of transcriptional regulation. To our knowledge, this represents the first report of persistent evolutionary pressure for the capture of retroviral LTR insertions.	[Diehl, William E.; Hunter, Eric] Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Diehl, William E.; Hunter, Eric] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Johnson, Welkin E.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Emory University; Emory University; Boston College	Hunter, E (corresponding author), Emory Univ, Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	eric.hunter2@emory.edu		Diehl, William/0000-0001-7943-1214	National Institutes of Health [R01 CA27834, R01 AI095092]; National Center for Research Resources [P51RR165]; Office of Research Infrastructure Programs [OD P51OD11132]; NATIONAL CANCER INSTITUTE [R01CA027834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083118, R01AI095092] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; National Institute for Health Research [ACF-2009-07-008] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by research grants R01 CA27834 (EH), R01 AI095092 (WEJ) from the National Institutes of Health. This project was also funded in part by the National Center for Research Resources P51RR165 and is currently supported by the Office of Research Infrastructure Programs/OD P51OD11132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Belancio VP, 2008, GENE, V411, P38, DOI 10.1016/j.gene.2007.12.022; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; Cagliani R, 2010, HUM GENET; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Carthagena L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-59; Chen CJ, 2009, MOL BIOL EVOL, V26, P327, DOI 10.1093/molbev/msn249; Diaz-Griffero F, 2008, VIROLOGY, V378, P233, DOI 10.1016/j.virol.2008.05.008; Diehl WE, 2008, J VIROL, V82, P11140, DOI 10.1128/JVI.00269-08; Eldin P, 2009, J GEN VIROL, V90, P536, DOI 10.1099/vir.0.006288-0; Gao B, 2009, HEPATOLOGY, V50, P424, DOI 10.1002/hep.23011; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Han K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002388; Hatziioannou T, 2004, J VIROL, V78, P1006, DOI 10.1128/JVI.78.2.1006-1011.2004; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; JUVEN T, 1993, ONCOGENE, V8, P3411; Kajaste-Rudnitski A, 2011, J VIROL, V85, P5183, DOI 10.1128/JVI.02302-10; Kaneshiro K, 2007, GENOMICS, V89, P178, DOI 10.1016/j.ygeno.2006.09.001; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kono K, 2008, VIROLOGY, V373, P447, DOI 10.1016/j.virol.2007.12.022; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landry JR, 2002, MOL BIOL EVOL, V19, P1934, DOI 10.1093/oxfordjournals.molbev.a004017; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Leib-Mosch C, 2005, MOL B INT U, P123; LEIBMOSCH C, 1993, GENOMICS, V18, P261, DOI 10.1006/geno.1993.1464; Li X, 2007, VIROLOGY, V360, P419, DOI 10.1016/j.virol.2006.10.035; Liao CH, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000304692.09143.1b; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lynch VJ, 2011, NAT GENET, V43, P1154, DOI 10.1038/ng.917; Mager DL, 2005, MOL B INT U, P104; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Medstrand P, 2001, J BIOL CHEM, V276, P1896, DOI 10.1074/jbc.M006557200; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; MURNANE JP, 1995, NUCLEIC ACIDS RES, V23, P2837, DOI 10.1093/nar/23.15.2837; Nakayama EE, 2005, J VIROL, V79, P8870, DOI 10.1128/JVI.79.14.8870-8877.2005; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Newman RM, 2006, P NATL ACAD SCI USA, V103, P19134, DOI 10.1073/pnas.0605838103; Newman RM, 2007, AIDS REV, V9, P114; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Obad S, 2004, ONCOGENE, V23, P4050, DOI 10.1038/sj.onc.1207524; Owens CM, 2004, J VIROL, V78, P5423, DOI 10.1128/JVI.78.10.5423-5437.2004; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Perron MJ, 2007, J VIROL, V81, P2138, DOI 10.1128/JVI.02318-06; Perron MJ, 2006, J VIROL, V80, P5631, DOI 10.1128/JVI.00219-06; PERRY ME, 1993, P NATL ACAD SCI USA, V90, P11623, DOI 10.1073/pnas.90.24.11623; Pi WH, 2010, P NATL ACAD SCI USA, V107, P12992, DOI 10.1073/pnas.1004139107; Rahm N, 2011, J VIROL, V85, P4173, DOI 10.1128/JVI.00075-11; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Saenz DT, 2005, J VIROL, V79, P15175, DOI 10.1128/JVI.79.24.15175-15188.2005; Samuelson LC, 1996, MOL BIOL EVOL, V13, P767, DOI 10.1093/oxfordjournals.molbev.a025637; Sanville B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000974; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Sawyer SL, 2007, PLOS PATHOG, V3, P1918, DOI 10.1371/journal.ppat.0030197; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Schaller T, 2007, J VIROL, V81, P11713, DOI 10.1128/JVI.01468-07; Sebastian S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-40; Si ZH, 2006, P NATL ACAD SCI USA, V103, P7454, DOI 10.1073/pnas.0600771103; Singer SS, 2004, J MOL BIOL, V341, P883, DOI 10.1016/j.jmb.2004.06.070; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; STOYE JP, 1988, CELL, V54, P383, DOI 10.1016/0092-8674(88)90201-2; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tareen SU, 2009, VIROLOGY, V385, P473, DOI 10.1016/j.virol.2008.12.018; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; van der Aa LM, 2012, DEV COMP IMMUNOL, V36, P433, DOI 10.1016/j.dci.2011.08.010; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Wilson SJ, 2008, P NATL ACAD SCI USA, V105, P3557, DOI 10.1073/pnas.0709003105; Yap MW, 2008, J VIROL, V82, P5429, DOI 10.1128/JVI.02462-07; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Ylinen LMJ, 2006, J VIROL, V80, P7332, DOI 10.1128/JVI.00516-06; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005	91	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58532	10.1371/journal.pone.0058532	http://dx.doi.org/10.1371/journal.pone.0058532			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516500	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400037
J	Macedo, TA; Pedrosa, RP; Costa-Hong, V; Kajita, LJ; Morais, GR; De Lima, JJG; Drager, LF; Bortolotto, LA				Macedo, Thiago A.; Pedrosa, Rodrigo P.; Costa-Hong, Valeria; Kajita, Luiz J.; Morais, Gustavo R.; De Lima, Jose J. G.; Drager, Luciano F.; Bortolotto, Luiz A.			Renal Artery Stenosis Predicts Coronary Artery Disease in Patients with Hypertension	PLOS ONE			English	Article							CARDIAC-CATHETERIZATION; VASCULAR-DISEASE; TASK-FORCE; ANGIOGRAPHY; RISK; CARDIOLOGY; PREVALENCE; GUIDELINES; DIAGNOSIS	In hypertensive patients with indication of renal arteriography to investigate renal artery stenosis (RAS) there are no recommendations regarding when to investigate coronary artery disease (CAD). Moreover, the predictors of CAD in patients with RAS are not clear. We aimed to evaluate the frequency and the determinants of CAD in hypertensive patients referred to renal angiography. Eighty-two consecutive patients with high clinical risk suggesting the presence of RAS systematically underwent renal angiography and coronary angiography during the same procedure. Significant arterial stenosis was defined by an obstruction >= 70% to both renal and coronary territories. Significant CAD was present in 32/82 (39%) and significant RAS in 32/82 (39%) patients. Both CAD and RAS were present in 25.6% from the 82 patients. Patients with severe CAD were older (63 +/- 12 vs. 56 +/- 13 years; p = 0.03) and had more angina (41 vs. 16%; p = 0.013) compared to patients without severe CAD. Significant RAS was associated with an increased frequency of severe CAD compared to patients without significant RAS (66% vs. 22%, respectively; p<0.001). Myocardial scintigraphy showed ischemia in 21.8% of the patients with CAD. Binary logistic regression analysis showed that RAS >= 70% was independently associated with CAD >= 70% (OR: 11.48; 95% CI 3.2-40.2; p<0.001), even in patients without angina (OR: 13.48; 95% CI 2.6-12.1; p<0.001). Even considering a small number of patients with significant RAS, we conclude that in hypertensive patients referred to renal angiography, RAS >= 70% may be a strong predictor of severe CAD, independently of angina, and dual investigation should be considered.	[Macedo, Thiago A.; Pedrosa, Rodrigo P.; Costa-Hong, Valeria; De Lima, Jose J. G.; Drager, Luciano F.; Bortolotto, Luiz A.] Univ Sao Paulo, Fac Med, Hosp Clin, Hypertens Unit,Cardiol Div,Heart Inst InCor, Sao Paulo, Brazil; [Kajita, Luiz J.; Morais, Gustavo R.] Univ Sao Paulo, Fac Med, Hosp Clin, Hemodynam Lab,Cardiol Div,Heart Inst InCor, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Macedo, TA (corresponding author), Univ Sao Paulo, Fac Med, Hosp Clin, Hypertens Unit,Cardiol Div,Heart Inst InCor, Sao Paulo, Brazil.	thiago.cardio@gmail.com	Drager, Luciano F/A-1535-2014; Bortolotto, Luiz A/S-1940-2017; Hong, Valeria A C/S-9645-2017; Pedrosa, Rodrigo P/G-4593-2013	Bortolotto, Luiz A/0000-0002-4865-6442; Hong, Valeria A C/0000-0003-1639-8095; Kajita, Luiz Junya/0000-0002-4448-4911	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Fundacao Zerbini	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao Zerbini	The authors declare that this work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Fundacao Zerbini. There is no relationship with the pharmaceutical industry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aqel RA, 2003, J HYPERTENS, V21, P1157, DOI 10.1097/00004872-200306000-00016; Chrysochou C, 2010, J RENAL CARE, V36, P146, DOI 10.1111/j.1755-6686.2010.00161.x; Colyer WR, 2009, PROG CARDIOVASC DIS, V52, P238, DOI 10.1016/j.pcad.2009.09.004; Conlon PJ, 1998, J AM SOC NEPHROL, V9, P252; de Carvalho FC, 2006, AM J HYPERTENS, V19, P1125, DOI 10.1016/j.amjhyper.2006.04.011; De Lima JJG, 2003, HYPERTENSION, V42, P263, DOI 10.1161/01.HYP.0000087889.60760.87; Drager LF, 2004, NEPHROL DIAL TRANSPL, V19, P1803, DOI 10.1093/ndt/gfh261; Dzielinska Z, 2007, J HYPERTENS, V25, P663, DOI 10.1097/HJH.0b013e328011dc6c; GottsaunerWolf M, 1996, EUR HEART J, V17, P1167; Iglesias JI, 2000, AM J MED, V109, P642, DOI 10.1016/S0002-9343(00)00605-7; Kuroda S, 2000, STROKE, V31, P61, DOI 10.1161/01.STR.31.1.61; Liang F, 2012, Indian J Nephrol, V22, P13, DOI 10.4103/0971-4065.91181; Przewlocki T, 2008, KARDIOL POL, V66, P856; Rihal CS, 2002, MAYO CLIN PROC, V77, P309, DOI 10.4065/77.4.309; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Ruilope LM, 2007, J HYPERTENS, V25, P1473, DOI 10.1097/HJH.0b013e328133246c; Shamkhalova MS, 2010, TERAPEVT ARKH, V82, P15; Soulez G, 2000, RADIOGRAPHICS, V20, P1355, DOI 10.1148/radiographics.20.5.g00se131355; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; White CJ, 2006, CIRCULATION, V114, P1892, DOI 10.1161/CIRCULATIONAHA.106.178777	20	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58635	10.1371/journal.pone.0058635	http://dx.doi.org/10.1371/journal.pone.0058635			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516521	gold, Green Published			2022-12-27	WOS:000316407400043
J	Pruett, JR; Hoertel, S; Constantino, JN; Moll, AL; McVey, K; Squire, E; Feczko, E; Povinelli, DJ; Petersen, SE				Pruett, John R., Jr.; Hoertel, Sarah; Constantino, John N.; Moll, Angela LaMacchia; McVey, Kelly; Squire, Emma; Feczko, Eric; Povinelli, Daniel J.; Petersen, Steven E.			Impaired Eye Region Search Accuracy in Children with Autistic Spectrum Disorders	PLOS ONE			English	Article							SUPERIOR VISUAL-SEARCH; FACE RECOGNITION; WILLIAMS-SYNDROME; ATTENTION; GAZE; INDIVIDUALS; PERCEPTION; SYSTEM; POPULATION; FEATURES	To explore mechanisms underlying reduced fixation of eyes in autism, children with Autistic Spectrum Disorders (ASD) and typically developing children were tested in five visual search experiments: simple color feature; color-shape conjunction; face in non-face objects; mouth region; and eye region. No group differences were found for reaction time profile shapes in any of the five experiments, suggesting intact basic search mechanics in children with ASD. Contrary to early reports in the literature, but consistent with other more recent findings, we observed no superiority for conjunction search in children with ASD. Importantly, children with ASD did show reduced accuracy for eye region search (p=.005), suggesting that eyes contribute less to high-level face representations in ASD or that there is an eye region-specific disruption to attentional processes engaged by search in ASD.	[Pruett, John R., Jr.; Hoertel, Sarah; Constantino, John N.; Moll, Angela LaMacchia; Squire, Emma; Feczko, Eric] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Constantino, John N.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [McVey, Kelly; Petersen, Steven E.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Povinelli, Daniel J.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Petersen, Steven E.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Petersen, Steven E.] Washington Univ, Sch Med, Dept Psychol, St Louis, MO USA; [Petersen, Steven E.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Petersen, Steven E.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Louisiana Lafayette; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pruett, JR (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	pruettj@psychiatry.wustl.edu	Petersen, Steve/ABF-1368-2020		National Institute of Mental Health [R21 MH079958]; National Eye Institute [K12 EY16336]; Autism Speaks Foundation; NATIONAL EYE INSTITUTE [K12EY016336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH079958] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Autism Speaks Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research funding included National Institute of Mental Health R21 MH079958 and National Eye Institute K12 EY16336 (John Pruett). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all of the families who generously participated in this study. We thank Sridhar Kandala for study coordination, Teddi Gray for help with recruiting, Fran Miezin for computer engineering, and Patricia LaVesser and Anna Abbacchi for clinical assessments. Subjects were recruited with the assistance of the Interactive Autism Network (IAN) Research Database at the Kennedy Krieger Institute and Johns Hopkins Medicine-Baltimore, sponsored by the Autism Speaks Foundation. We thank the Washington University School of Medicine Volunteers for Health (VFH) program; Autism Speaks; Missouri Families for Effective Autism Treatment (MO-FEAT); the Illinois Center for Autism; and other local research laboratories, clinics, schools, and community doctors' offices for their help in advertising the studies.	Achenbach T, 2001, CBLC 6 18 PROFILE BO; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Ashwin C, 2006, BRAIN COGNITION, V61, P78, DOI 10.1016/j.bandc.2005.12.008; Baldassi S, 2009, VISION RES, V49, P2151, DOI 10.1016/j.visres.2009.06.007; BARONCOHEN S, 1996, BRIT J PSYCHIAT, V168, P158, DOI DOI 10.1192/BJP.168.2.158; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Constantino JN., 2002, SOCIAL RESPONSIVENES; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cornish KM, 2005, MOL PSYCHIATR, V10, P686, DOI 10.1038/sj.mp.4001641; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Freeth M, 2010, J AUTISM DEV DISORD, V40, P534, DOI 10.1007/s10803-009-0893-2; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Hershler O, 2006, VISION RES; HOBSON RP, 1988, BRIT J PSYCHOL, V79, P441, DOI 10.1111/j.2044-8295.1988.tb02745.x; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Howlin P, 2009, AJIDD-AM J INTELLECT, V114, P23, DOI [10.1352/2009.114:23-41, 10.1352/2009.114:23;nd41]; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Joseph RM, 2003, J CHILD PSYCHOL PSYC, V44, P529, DOI 10.1111/1469-7610.00142; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; Kingstone A, 2004, BRAIN COGNITION, V55, P269, DOI 10.1016/j.bandc.2004.02.037; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Kogan MD, 2009, PEDIATRICS, V124, P1395, DOI 10.1542/peds.2009-1522; Kylliainen A, 2006, J AUTISM DEV DISORD, V36, P517, DOI 10.1007/s10803-006-0091-4; Lewis MB, 2005, VIS COGN, V12, P1309, DOI 10.1080/13506280444000535; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Mottron L, 2004, J AUTISM DEV DISORD, V34, P19, DOI 10.1023/B:JADD.0000018070.88380.83; Nation K, 2008, DEV PSYCHOPATHOL, V20, P79, DOI 10.1017/S0954579408000047; O'Riordan M, 2001, Q J EXP PSYCHOL-A, V54, P961, DOI 10.1080/02724980042000543; O'Riordan MA, 2001, J EXP PSYCHOL HUMAN, V27, P719, DOI 10.1037//0096-1523.27.3.719; O'Riordan MA, 2004, AUTISM, V8, P229, DOI 10.1177/1362361304045219; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozonoff S, 2010, J AM ACAD CHILD PSY, V49, P256, DOI 10.1016/j.jaac.2009.11.009; Pellicano E, 2009, PSYCHON B REV, V16, P1094, DOI 10.3758/PBR.16.6.1094; Plaisted K, 1998, J CHILD PSYCHOL PSYC, V39, P777, DOI 10.1017/S0021963098002613; Posner M.I., 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Pruett JR, 2011, J AUTISM DEV DISORD, V41, P715, DOI 10.1007/s10803-010-1090-z; Remington A, 2009, PSYCHOL SCI, V20, P1388, DOI 10.1111/j.1467-9280.2009.02454.x; RHODES G, 1993, COGNITION, V47, P25, DOI 10.1016/0010-0277(93)90061-Y; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Riby DM, 2009, J AUTISM DEV DISORD, V39, P421, DOI 10.1007/s10803-008-0641-z; Rouse H, 2004, J CHILD PSYCHOL PSYC, V45, P1246, DOI 10.1111/j.1469-7610.2004.00317.x; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Senju A, 2008, BRAIN COGNITION, V67, P127, DOI 10.1016/j.bandc.2007.12.001; Swettenham J, 2003, PHILOS T R SOC B, V358, P325, DOI 10.1098/rstb.2002.1203; Tanaka JW, 2010, J CHILD PSYCHOL PSYC, V51, P944, DOI 10.1111/j.1469-7610.2010.02258.x; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201, DOI 10.1080/02724988843000104; van der Geest JN, 2002, J CHILD PSYCHOL PSYC, V43, P669, DOI 10.1111/1469-7610.00055; VanRullen R., 2005, VISION RES; Wechsler D, 1974, WECHSLER INTELLIGENC; WENT LN, 1985, HUM GENET, V69, P255, DOI 10.1007/BF00293036; Wolf JM, 2008, AUTISM RES, V1, P329, DOI 10.1002/aur.56; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; YOUNG AW, 1987, PERCEPTION, V16, P747, DOI 10.1068/p160747	59	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58167	10.1371/journal.pone.0058167	http://dx.doi.org/10.1371/journal.pone.0058167			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109YM	23516446	gold, Green Published			2022-12-27	WOS:000316407400020
J	Moody, RM; Cebrian, J; Heck, KL				Moody, Ryan M.; Cebrian, Just; Heck, Kenneth L., Jr.			Interannual Recruitment Dynamics for Resident and Transient Marsh Species: Evidence for a Lack of Impact by the Macondo Oil Spill	PLOS ONE			English	Article							SALT MARSHES; BIODEGRADATION; HABITATS; NEKTON; FISH; BAY	The emulsification of oil at the Deepwater Horizon (DWH) well head relegated a large proportion of resultant hydrocarbon plumes to the deep sea, facilitated the incorporation of oil droplets into microbial and planktonic food web, and limited the severity of direct, wetland oiling to coastal Louisiana. Nevertheless, many transient fish and invertebrate species rely on offshore surface waters for egg and larval transport before settling in coastal habitats, thereby potentially impacting the recruitment of transient species to coastal nursery habitats quite distant from the well site. We compared the utilization of salt-marsh habitats by transient and resident nekton before and after the DWH accident using data obtained from an oyster reef restoration project in coastal Alabama. Our sampling activities began in the summer preceding the DWH spill and continued almost two years following the accident. Overall, we did not find significant differences in the recruitment of marsh-associated resident and transient nekton in coastal Alabama following the DWH accident. Our results, therefore, provide little evidence for severe acute or persistent oil-induced impacts on organisms that complete their life cycle within the estuary and those that spent portions of their life history in potentially contaminated offshore surface waters prior to their recruitment to nearshore habitats. Our negative findings are consistent with other assessments of nekton in coastal vegetated habitats and bolster the notion that, despite the presence of localized hydrocarbon enrichments in coastal habitats outside of Louisiana the most severe oil impacts were relegated to coastal Louisiana and the deep sea. Analyzing all the information learned from this accident will undoubtedly provide a synthesis of what has or has not been affected in the Northern Gulf of Mexico, which when put in context with oil spill studies elsewhere should improve our ability to avert and manage the negative consequences of such accidents.	[Moody, Ryan M.; Cebrian, Just; Heck, Kenneth L., Jr.] Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA; [Cebrian, Just; Heck, Kenneth L., Jr.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	Dauphin Island Sea Lab; University of South Alabama	Moody, RM (corresponding author), Dauphin Isl Sea Lab, Dauphin Isl, AL 36528 USA.	rmoody@disl.org			NOAA Fisheries Emergency Disaster Relief Program (EDRP) Funds; BP/The Gulf of Mexico Research Initiative through the Florida Institute of Oceanography; BP	NOAA Fisheries Emergency Disaster Relief Program (EDRP) Funds; BP/The Gulf of Mexico Research Initiative through the Florida Institute of Oceanography; BP	This work was supported by funding provided by NOAA Fisheries Emergency Disaster Relief Program (EDRP) Funds, administered through the Alabama Department of Conservation and Natural Resources; BP grants made to the Marine Environmental Science Consortium and the Northern Gulf Institute; and in part by a grant from BP/The Gulf of Mexico Research Initiative through the Florida Institute of Oceanography to the Florida Institute of Technology. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript, nor does this alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.; Just Cebrian is currently on the PLOS One editorial board. This work was partly supported by BP grants made to the Marine Environmental Science Consortium and the Northern Gulf Institute. This does not alter the authors' adherence to all the PLOS One policies on sharing data and materials.	AKIN S, 2003, ESTUAR COAST SHELF S, V56, P1; [Anonymous], 2012, ENV RESPONSE MANAGEM; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; Beazley MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041305; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Carmichael RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041155; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Fodrie FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021609; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; Hayworth JS, 2011, HYDROL EARTH SYST SC, V15, P3639, DOI 10.5194/hess-15-3639-2011; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Heck KL, 2001, MAR ECOL PROG SER, V222, P163, DOI 10.3354/meps222163; HETTLER WF, 1989, MAR ECOL PROG SER, V56, P111, DOI 10.3354/meps056111; Kocan RM, 1996, CAN J FISH AQUAT SCI, V53, P2366, DOI 10.1139/cjfas-53-10-2366; McCall BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032735; Miller BS, 2009, EARLY LIFE HISTORY OF MARINE FISHES, P1, DOI 10.1525/california/9780520249721.001.0001; Minello TJ, 2003, MAR ECOL PROG SER, V246, P39, DOI 10.3354/meps246039; Oil Spill Commission, 2011, DEEP WAT GULF OIL DI; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; ROGERS BD, 1993, ESTUAR COAST SHELF S, V36, P377, DOI 10.1006/ecss.1993.1023; Roth AMF, 2009, ESTUAR COAST, V32, P565, DOI 10.1007/s12237-009-9135-2; Rozas LP, 2000, MAR POLLUT BULL, V40, P1148, DOI 10.1016/S0025-326X(00)00075-8; Scyphers SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022396; Shervette VR, 2008, ESTUAR COAST, V31, P584, DOI 10.1007/s12237-008-9049-4; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; TUVIKENE A, 1995, ANN ZOOL FENN, V32, P295; Whitehead A, 2012, P NATL ACAD SCI USA, V109, P20298, DOI 10.1073/pnas.1109545108	27	39	39	0	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58376	10.1371/journal.pone.0058376	http://dx.doi.org/10.1371/journal.pone.0058376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516467	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200059
J	Ruttiger, L; Singer, W; Panford-Walsh, R; Matsumoto, M; Lee, SC; Zuccotti, A; Zimmermann, U; Jaumann, M; Rohbock, K; Xiong, H; Knipper, M				Ruettiger, Lukas; Singer, Wibke; Panford-Walsh, Rama; Matsumoto, Masahiro; Lee, Sze Chim; Zuccotti, Annalisa; Zimmermann, Ulrike; Jaumann, Mirko; Rohbock, Karin; Xiong, Hao; Knipper, Marlies			The Reduced Cochlear Output and the Failure to Adapt the Central Auditory Response Causes Tinnitus in Noise Exposed Rats	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; ARC MESSENGER-RNA; HOMEOSTATIC SYNAPTIC PLASTICITY; NORMAL-HEARING PATIENTS; NEUROTROPHIC FACTOR; NEURAL ACTIVITY; BRAIN-STEM; PHYSIOLOGICAL EVIDENCE; ACOUSTIC TRAUMA; TONOTOPIC AXIS	Tinnitus is proposed to be caused by decreased central input from the cochlea, followed by increased spontaneous and evoked subcortical activity that is interpreted as compensation for increased responsiveness of central auditory circuits. We compared equally noise exposed rats separated into groups with and without tinnitus for differences in brain responsiveness relative to the degree of deafferentation in the periphery. We analyzed (1) the number of CtBP2/RIBEYE-positive particles in ribbon synapses of the inner hair cell (IHC) as a measure for deafferentation; (2) the fine structure of the amplitudes of auditory brainstem responses (ABR) reflecting differences in sound responses following decreased auditory nerve activity and (3) the expression of the activity-regulated gene Arc in the auditory cortex (AC) to identify long-lasting central activity following sensory deprivation. Following moderate trauma, 30% of animals exhibited tinnitus, similar to the tinnitus prevalence among hearing impaired humans. Although both tinnitus and no-tinnitus animals exhibited a reduced ABR wave I amplitude (generated by primary auditory nerve fibers), IHCs ribbon loss and high-frequency hearing impairment was more severe in tinnitus animals, associated with significantly reduced amplitudes of the more centrally generated wave IV and V and less intense staining of Arc mRNA and protein in the AC. The observed severe IHCs ribbon loss, the minimal restoration of ABR wave size, and reduced cortical Arc expression suggest that tinnitus is linked to a failure to adapt central circuits to reduced cochlear input.	[Ruettiger, Lukas; Singer, Wibke; Panford-Walsh, Rama; Matsumoto, Masahiro; Lee, Sze Chim; Zuccotti, Annalisa; Zimmermann, Ulrike; Jaumann, Mirko; Rohbock, Karin; Xiong, Hao; Knipper, Marlies] Univ Tubingen, Hearing Res Ctr Tubingen, Dept Otolaryngol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Knipper, M (corresponding author), Univ Tubingen, Hearing Res Ctr Tubingen, Dept Otolaryngol, Tubingen, Germany.	marlies.knipper@uni-tuebingen.de		Lee, Sze Chim/0000-0001-5822-6633	Marie Curie Research Training Network CavNET [MRTN-CT-2006-035367]; Deutsche Forschungsgemeinschaft [DFG-Kni-316-4-1]; Hahn Stiftung (Index AG); Open Access Publishing Fund of Tuebingen University	Marie Curie Research Training Network CavNET(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hahn Stiftung (Index AG); Open Access Publishing Fund of Tuebingen University	This work was supported by the Marie Curie Research Training Network CavNET MRTN-CT-2006-035367, the Deutsche Forschungsgemeinschaft DFG-Kni-316-4-1 and Hahn Stiftung (Index AG). The authors acknowledge support by Deutsche Forschungsgemeinschaft and the Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATHERLEY GR, 1968, J ACOUST SOC AM, V44, P1503, DOI 10.1121/1.1911288; Bauer CA, 2007, J NEUROSCI RES, V85, P1489, DOI 10.1002/jnr.21259; Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Brozoski TJ, 2002, J NEUROSCI, V22, P2383, DOI 10.1523/JNEUROSCI.22-06-02383.2002; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Cai SQ, 2009, JARO-J ASSOC RES OTO, V10, P5, DOI 10.1007/s10162-008-0142-y; Daberkow DP, 2007, EUR J NEUROSCI, V26, P228, DOI 10.1111/j.1460-9568.2007.05630.x; Dehmel S, 2012, J NEUROSCI, V32, P1660, DOI 10.1523/JNEUROSCI.4608-11.2012; Dominguez M, 2006, NEURAL COMPUT, V18, P2942, DOI 10.1162/neco.2006.18.12.2942; DON M, 1978, J ACOUST SOC AM, V63, P1084, DOI 10.1121/1.381816; Dong S, 2009, NEUROSCIENCE, V159, P1164, DOI 10.1016/j.neuroscience.2009.01.043; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Engel J, 2006, NEUROSCIENCE, V143, P837, DOI 10.1016/j.neuroscience.2006.08.060; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Geven LI, 2011, OTOL NEUROTOL, V32, P315, DOI 10.1097/MAO.0b013e3181fcf180; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Goel A, 2007, J NEUROSCI, V27, P6692, DOI 10.1523/JNEUROSCI.5038-06.2007; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Jastreboff PJ, 2007, PROG BRAIN RES, V166, P415, DOI 10.1016/S0079-6123(07)66040-3; JOHNSON DH, 1976, BIOPHYS J, V16, P719, DOI 10.1016/S0006-3495(76)85724-4; Kaltenbach JA, 2007, PROG BRAIN RES, V166, P89, DOI 10.1016/S0079-6123(07)66009-9; Kehrle HM, 2008, ARCH OTOLARYNGOL, V134, P647, DOI 10.1001/archotol.134.6.647; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kim DK, 2011, ANN OTO RHINOL LARYN, V120, P523, DOI 10.1177/000348941112000806; Knipper M, 2000, J NEUROPHYSIOL, V83, P3101, DOI 10.1152/jn.2000.83.5.3101; Knipper M, 2012, SPRINGER HDB AUDIDOR, P49; Knipper M, 2010, HEARING RES, V266, P60, DOI 10.1016/j.heares.2009.07.013; Konig O, 2006, HEARING RES, V221, P59, DOI 10.1016/j.heares.2006.07.007; Korb E, 2011, TRENDS NEUROSCI, V34, P591, DOI 10.1016/j.tins.2011.08.007; Kozlovsky N, 2008, EUR NEUROPSYCHOPHARM, V18, P107, DOI 10.1016/j.euroneuro.2007.04.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Langguth B, 2009, EXPERT OPIN EMERG DR, V14, P687, DOI 10.1517/14728210903206975; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Lockwood AH, 2002, NEW ENGL J MED, V347, P904, DOI 10.1056/NEJMra013395; LOEB M, 1967, J ACOUST SOC AM, V42, P453, DOI 10.1121/1.1910600; Lonergan ME, 2010, NEURAL PLAST, V2010, P1, DOI 10.1155/2010/139891; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; McFeely WJ, 1999, OTOLARYNG HEAD NECK, V121, P367, DOI 10.1016/S0194-5998(99)70222-6; Melcher JR, 1996, HEARING RES, V93, P52, DOI 10.1016/0378-5955(95)00200-6; Meltser I, 2009, J NEUROTRAUM, V26, P1835, DOI 10.1089/neu.2008.0874; Middleton JW, 2011, P NATL ACAD SCI USA, V108, P7601, DOI 10.1073/pnas.1100223108; Moga DE, 2006, HIPPOCAMPUS, V16, P990, DOI 10.1002/hipo.20227; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; Mrena R, 2004, ACTA OTO-LARYNGOL, V124, P946, DOI 10.1080/00016480310017045; MULLER M, 1991, HEARING RES, V51, P247, DOI 10.1016/0378-5955(91)90041-7; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Nottet JB, 2006, LARYNGOSCOPE, V116, P970, DOI 10.1097/01.MLG.0000216823.77995.13; Ochi K, 1997, HEARING RES, V105, P105, DOI 10.1016/S0378-5955(96)00201-8; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Ons S, 2010, EUR J NEUROSCI, V31, P2043, DOI 10.1111/j.1460-9568.2010.07242.x; Panford-Walsh R, 2008, MOL PHARMACOL, V74, P595, DOI 10.1124/mol.108.046375; Parra LC, 2007, J ACOUST SOC AM, V121, P1632, DOI 10.1121/1.2431346; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; PENNER MJ, 1986, J SPEECH HEAR RES, V29, P400, DOI 10.1044/jshr.2903.400; PETTIGREW AM, 1984, ANN OTO RHINOL LARYN, V93, P83, DOI 10.1177/00034894840930S416; Pinaud R, 2001, MOL BRAIN RES, V91, P50, DOI 10.1016/S0169-328X(01)00121-8; Porcher C, 2011, J BIOL CHEM, V286, P21667, DOI 10.1074/jbc.M110.201582; Puel JL, 2007, PROG BRAIN RES, V166, P141, DOI 10.1016/S0079-6123(07)66012-9; Qiu CX, 2000, HEARING RES, V139, P153, DOI 10.1016/S0378-5955(99)00171-9; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Schaette R, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00034; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Schaette R, 2009, J NEUROPHYSIOL, V101, P3042, DOI 10.1152/jn.91256.2008; Schecklmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034878; Schimmang T, 2003, DEVELOPMENT, V130, P4741, DOI 10.1242/dev.00676; Schreiber BE, 2010, LANCET, V375, P1203, DOI 10.1016/S0140-6736(09)62071-7; Sheets L, 2011, DEVELOPMENT, V138, P1309, DOI 10.1242/dev.059451; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Singer W, 2012, MOL NEUROBIOL; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Szczepaniak WS, 1996, EVOKED POTENTIAL, V100, P158, DOI 10.1016/0013-4694(95)00234-0; Tan J, 2007, NEUROSCIENCE, V145, P715, DOI 10.1016/j.neuroscience.2006.11.067; Turner JG, 2007, PROG BRAIN RES, V166, P147, DOI 10.1016/S0079-6123(07)66013-0; Tzingounis AV, 2006, NEURON, V52, P403, DOI 10.1016/j.neuron.2006.10.016; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Wang Y, 2002, HEARING RES, V165, P96, DOI 10.1016/S0378-5955(02)00289-7; Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003; WESTERMAN LA, 1984, HEARING RES, V15, P249, DOI 10.1016/0378-5955(84)90032-7; Yang SC, 2011, P NATL ACAD SCI USA, V108, P14974, DOI 10.1073/pnas.1107998108; YATES GK, 1990, HEARING RES, V45, P203, DOI 10.1016/0378-5955(90)90121-5; Yilmaz-Rastoder E, 2011, HIPPOCAMPUS, V21, P1290, DOI 10.1002/hipo.20838; Zeng FG, 2012, HEAR RES; Zenner HP, 2006, OTOL NEUROTOL, V27, P1054, DOI 10.1097/01.mao.0000231604.64079.77; Zuccotti A, 2012, J NEUROSCI, V32, P8545, DOI 10.1523/JNEUROSCI.1247-12.2012	97	109	114	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57247	10.1371/journal.pone.0057247	http://dx.doi.org/10.1371/journal.pone.0057247			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516401	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200007
J	von Hoermann, C; Steiger, S; Muller, JK; Ayasse, M				von Hoermann, Christian; Steiger, Sandra; Mueller, Josef K.; Ayasse, Manfred			Too Fresh Is Unattractive! The Attraction of Newly Emerged Nicrophorus vespilloides Females to Odour Bouquets of Large Cadavers at Various Stages of Decomposition	PLOS ONE			English	Article							CARRION BEETLES COLEOPTERA; COLORADO POTATO BEETLE; SILPHIDAE; ORIENTATION; STRATEGIES; INSECTS; DISTANT	The necrophagous burying beetle Nicrophorus vespilloides reproduces on small carcasses that are buried underground to serve as food for their offspring. Cadavers that are too large to bury have previously been postulated to be important food sources for newly emerged beetles; however, the attractiveness of distinct successive stages of decomposition were not further specified. Therefore, we investigated the potential preference of newly emerged N. vespilloides females for odour bouquets of piglet cadavers at specific stages of decomposition. Analyses of walking tracks on a Kramer sphere revealed a significantly higher mean walking speed and, consequently, a higher mean total track length when beetles were confronted with odour plumes of the decomposition stages 'post-bloating', 'advanced decay' or 'dry remains' in comparison with the solvent control. Such a change of the walking speed of newly emerged N. vespilloides females indicates a higher motivation to locate such food sources. In contrast to less discriminating individuals this behaviour provides the advantage of not wasting time at unsuitable food sources. Furthermore, in the advanced decay stage, we registered a significantly higher preference of beetles for upwind directions to its specific odour plume when compared with the solvent control. Such a change to upwind walking behaviour increases the likelihood that a large cadaver will be quickly located. Our findings are of general importance for applied forensic entomology: newly emerged N. vespilloides females on large cadavers can and should be regarded as potential indicators of prolonged post mortem intervals as our results clearly show that they prefer emitted odour bouquets of later decomposition stages.	[von Hoermann, Christian; Steiger, Sandra; Ayasse, Manfred] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Mueller, Josef K.] Univ Freiburg, Dept Evolutionary Biol & Ecol, D-79106 Freiburg, Germany	Ulm University; University of Freiburg	von Hoermann, C (corresponding author), Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany.	christian.hoermann-von-und@uni-ulm.de			Evangelisches Studienwerk Villigst (Protestant Academic Foundation); Robert Bosch foundation	Evangelisches Studienwerk Villigst (Protestant Academic Foundation); Robert Bosch foundation	CvH was supported by the Evangelisches Studienwerk Villigst (Protestant Academic Foundation) and SS was supported by the Robert Bosch foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce AN, 2012, J EVOLUTION BIOL, V25, P930, DOI 10.1111/j.1420-9101.2012.02486.x; Baker TC, 1996, PHYSIOL ENTOMOL, V21, P20, DOI 10.1111/j.1365-3032.1996.tb00831.x; Barata EN, 2001, PHYSIOL ENTOMOL, V26, P26, DOI 10.1046/j.1365-3032.2001.00213.x; Bohm H., 1988, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V6, P91; Bolter CJ, 1997, J CHEM ECOL, V23, P1003, DOI 10.1023/B:JOEC.0000006385.70652.5e; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Degenkolb T, 2011, J CHEM ECOL, V37, P724, DOI 10.1007/s10886-011-9978-4; Dekeirsschieter J, 2009, FORENSIC SCI INT, V189, P46, DOI 10.1016/j.forsciint.2009.03.034; Dekeirsschieter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039005; Dekeirsschieter J, 2011, BIOTECHNOL AGRON SOC, V15, P435; Dobler S, 2000, MOL PHYLOGENET EVOL, V15, P390, DOI 10.1006/mpev.1999.0765; Eggert Anne-Katrin, 1997, P216; FARKAS SR, 1972, SCIENCE, V178, P67, DOI 10.1126/science.178.4056.67; Goff ML, 2009, EXP APPL ACAROL, V49, P21, DOI 10.1007/s10493-009-9284-9; Grebennikov VV, 2009, EUR J ENTOMOL, V106, P275, DOI 10.14411/eje.2009.035; HANGART.W, 1967, Z VERGL PHYSIOL, V57, P103, DOI 10.1007/BF00303068; Hanski I., 1987, P837; HEINZEL HG, 1989, J COMP PHYSIOL A, V164, P775, DOI 10.1007/BF00616749; HEYMONS R., 1932, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V24, P259, DOI 10.1007/BF00491793; HEYMONS R., 1928, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V10, P330, DOI 10.1007/BF00410270; HEYMONS R., 1927, ZEITSCHR WISS BIOL ABT A MORPHOL U OKOL TIERE, V9, P271, DOI 10.1007/BF00424725; Kalinova B, 2009, NATURWISSENSCHAFTEN, V96, P889, DOI 10.1007/s00114-009-0545-6; KENTNER E, 1990, PEDOBIOLOGIA, V34, P347; Kocarek P, 2001, BIOL RHYTHM RES, V32, P431, DOI 10.1076/brhm.32.4.431.1333; KRAMER E, 1976, PHYSIOL ENTOMOL, V1, P27, DOI 10.1111/j.1365-3032.1976.tb00883.x; Matuszewski S, 2008, FORENSIC SCI INT, V180, P61, DOI 10.1016/j.forsciint.2008.06.015; Matuszewski S, 2010, FORENSIC SCI INT, V195, P42, DOI 10.1016/j.forsciint.2009.11.007; Milne Lorus J., 1944, JOUR NEW YORK ENT SOC, V52, P311; MULLER JK, 1990, ANIM BEHAV, V40, P491, DOI 10.1016/S0003-3472(05)80529-9; MULLER JK, 1987, ETHOLOGY, V76, P297; Okada J, 2006, J COMP PHYSIOL A, V192, P715, DOI 10.1007/s00359-006-0106-9; Paczkowski S, 2011, APPL MICROBIOL BIOT, V91, P917, DOI 10.1007/s00253-011-3417-x; PESCHKE K, 1987, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V114, P241; Petruska, 1975, ACTA U PALACKIANAE O, V51, P155; PUKOWSKI ERNA, 1933, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V27, P518, DOI 10.1007/BF00403155; REED H. B., 1958, AMER MIDLAND NAT, V59, P213, DOI 10.2307/2422385; REITER C, 1982, Z RECHTSMED, V89, P197, DOI 10.1007/BF01873802; Rozen DE, 2008, P NATL ACAD SCI USA, V105, P17890, DOI 10.1073/pnas.0805403105; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; Steenvoorde P, 2004, J Tissue Viability, V14, P97; Stensmyr MC, 2002, NATURE, V420, P625, DOI 10.1038/420625a; Takken W, 2010, ECOL CONT VECTOR-BOR, V2, P1, DOI 10.3920/978-90-8686-698-4; THIERY D, 1987, J CHEM ECOL, V13, P1139, DOI 10.1007/BF01020544; TRUMBO ST, 1994, AM MIDL NAT, V131, P169, DOI 10.2307/2426619; von Hoermann C, 2011, FORENSIC SCI INT, V212, P173, DOI 10.1016/j.forsciint.2011.06.009; von Hoermann C, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-18; WILSON DS, 1984, ANN ENTOMOL SOC AM, V77, P165, DOI 10.1093/aesa/77.2.165	47	21	22	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58524	10.1371/journal.pone.0058524	http://dx.doi.org/10.1371/journal.pone.0058524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516497	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200078
J	Costa-Urrutia, P; Sanvito, S; Victoria-Cota, N; Enriquez-Paredes, L; Gendron, D				Costa-Urrutia, Paula; Sanvito, Simona; Victoria-Cota, Nelva; Enriquez-Paredes, Luis; Gendron, Diane			Fine-Scale Population Structure of Blue Whale Wintering Aggregations in the Gulf of California	PLOS ONE			English	Article							SOUTHERN RIGHT WHALES; GENETIC-STRUCTURE; BALAENOPTERA-MUSCULUS; HUMPBACK WHALES; SITE FIDELITY; MEGAPTERA-NOVAEANGLIAE; NYCTIPHANES-SIMPLEX; BREEDING GROUNDS; SPERM-WHALES; MITOCHONDRIAL	Population differentiation in environments without well-defined geographical barriers represents a challenge for wildlife management. Based on a comprehensive database of individual sighting records (1988-2009) of blue whales from the winter/calving Gulf of California, we assessed the fine-scale genetic and spatial structure of the population using individual-based approaches. Skin samples of 187 individuals were analyzed for nine microsatellite loci. A single population with no divergence among years and months and no isolation by distance (Rxy = 0.1-0.001, p>0.05) were found. We ran two Bayesian clustering methods using Structure and Geneland softwares in two different ways: 1) a general analysis including all individuals in which a single cluster was identified with both softwares; 2) a specific analysis of females only in which two main clusters (Loreto Bay and northern areas, and San Jose-La Paz Bay area) were revealed by Geneland program. This study provides information indicating that blue whales wintering in the Gulf of California are part of a single population unit and showed a fine-scale structure among females, possibly associated with their high site fidelity, particularly when attending calves. It is likely that the loss of genetic variation is minimized by male mediated gene flow, which may reduce the genetic drift effect. Opportunities for kin selection may also influence calf survival and, in consequence, have a positive impact on population demography in this small and endangered population.	[Costa-Urrutia, Paula; Sanvito, Simona; Enriquez-Paredes, Luis] Univ Autonoma Baja California, Fac Ciencias Marinas, Lab Ecol Mol, Mexicali 21100, Baja California, Mexico; [Victoria-Cota, Nelva] Univ Autonoma Baja California, Escuela Ciencias Salud, Lab Ecol & Epidemiol Mol, Mexicali 21100, Baja California, Mexico; [Gendron, Diane] Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Lab Ecol Cetaceos & Quelonios, Mexico City, DF, Mexico	Universidad Autonoma de Baja California; Universidad Autonoma de Baja California; Instituto Politecnico Nacional - Mexico	Gendron, D (corresponding author), Inst Politecn Nacl, Ctr Interdisciplinario Ciencias Marinas, Lab Ecol Cetaceos & Quelonios, Mexico City, DF, Mexico.	dgendron@ipn.mx		Enriquez-Paredes, Luis Manuel/0000-0002-9835-1225; Costa-Urrutia, Paula/0000-0002-6747-5380	Instituto Politecnico Nacional Consejo Nacional de Ciencias y Tecnologia [SEMARNAT-2002-C01-0628]; Universidad Autonoma de Baja California [12C-0351]; American Cetacean Society - Monterey Bay Whales and Dolphin Conservation Society [081209]	Instituto Politecnico Nacional Consejo Nacional de Ciencias y Tecnologia; Universidad Autonoma de Baja California; American Cetacean Society - Monterey Bay Whales and Dolphin Conservation Society	Instituto Politecnico Nacional Consejo Nacional de Ciencias y Tecnologia (SEMARNAT-2002-C01-0628. Universidad Autonoma de Baja California (Project 12C-0351). The American Cetacean Society - Monterey Bay (081209) Whales and Dolphin Conservation Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; AMOS B, 1991, P99; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; Andersen LW, 2003, MAR ECOL PROG SER, V247, P263, DOI 10.3354/meps247263; Attard CRM, 2010, CONSERV GENET, V11, P2437, DOI 10.1007/s10592-010-0121-9; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; BAKER CS, 1990, NATURE, V344, P238, DOI 10.1038/344238a0; BEKOFF M, 1984, BEHAV RES METH INS C, V16, P32, DOI 10.3758/BF03201046; Benjamini Y, 2001, ANN STAT, V29, P1165; Berube M, 1998, MOL ECOL, V7, P585, DOI 10.1046/j.1365-294x.1998.00359.x; Berube M, 2005, CONSERV GENET, V6, P631, DOI 10.1007/s10592-005-9017-5; Berube M, 2000, MOL ECOL, V9, P2181; Berube M, 1996, MOL ECOL, V5, P283; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Brinton E, 1980, CALCOFI REP, V21, P212; Buchanan FC, 1996, MOL ECOL, V5, P571; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; CALAMBOKIDIS J, 1990, REPORTS INT WHALING, V12, P343; Campbell RA, 2008, BIOL LETTERS, V4, P139, DOI 10.1098/rsbl.2007.0487; Carroll EL, 2012, MOL ECOL, V21, P3960, DOI 10.1111/j.1365-294X.2012.05676.x; Clapham PJ, 2000, CETACEAN SOCIETIES, P173; Clapham PJ, 1996, MAMMAL REV, V26, P27, DOI 10.1111/j.1365-2907.1996.tb00145.x; Coltman DW, 2003, MOL ECOL, V12, P733, DOI 10.1046/j.1365-294X.2003.01762.x; Craig AS, 1997, CAN J ZOOL, V75, P1923, DOI 10.1139/z97-822; Croll DA, 2005, MAR ECOL PROG SER, V289, P117, DOI 10.3354/meps289117; de Silva-Davila R, 1998, J CRUSTACEAN BIOL, V18, P490, DOI 10.2307/1549413; Elwen SH, 2004, MAR MAMMAL SCI, V20, P567, DOI 10.1111/j.1748-7692.2004.tb01180.x; Elwen SH, 2004, MAR ECOL PROG SER, V269, P289, DOI 10.3354/meps269289; Escorza-Trevino S, 2004, J MAMMAL, V85, P347, DOI 10.1644/1545-1542(2004)085<0347:MAOTTA>2.0.CO;2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Frasier Timothy R., 2011, Endangered Species Research, V14, P39, DOI 10.3354/esr00340; Gaskin DE., 1982, ECOLOGY WHALES DOLPH; Gendron D., 2012, Journal of Cetacean Research and Management, V12, P79; GENDRON D, 1992, MAR ECOL PROG SER, V87, P1, DOI 10.3354/meps087001; GENDRON D, 2002, THESIS CTR INVESTIGA; Goerlitz DS, 2003, CAN J ZOOL, V81, P1965, DOI 10.1139/Z03-203; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hoelzel AR, 1998, J HERED, V89, P451, DOI 10.1093/jhered/89.5.451; Hucke-Gaete R, 2004, P ROY SOC B-BIOL SCI, V271, pS170, DOI 10.1098/rsbl.2003.0132; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; LAMBERTSEN RH, 1987, J MAMMAL, V68, P443, DOI 10.2307/1381495; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Leduc R.G., 2007, Journal of Cetacean Research and Management, V9, P73; Lockyer C.H., 1981, Society for Experimental Biology Seminar Series, P105; Lynch M, 1999, GENETICS, V152, P1753; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; Lyrholm T, 1998, P ROY SOC B-BIOL SCI, V265, P1679, DOI 10.1098/rspb.1998.0488; Mendez M, 2010, MOL ECOL, V19, P2212, DOI 10.1111/j.1365-294X.2010.04647.x; Nussey DH, 2005, MOL ECOL, V14, P3395, DOI 10.1111/j.1365-294X.2005.02692.x; Okello JBA, 2008, MOL ECOL, V17, P3788, DOI 10.1111/j.1365-294X.2008.03871.x; Palsboll PJ, 1999, GENETICS, V151, P285; Patenaude NJ, 2007, J HERED, V98, P147, DOI 10.1093/jhered/esm005; Payne R., 1986, Reports of the International Whaling Commission Special Issue, P161; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REILLY SB, 1990, MAR MAMMAL SCI, V6, P265, DOI 10.1111/j.1748-7692.1990.tb00357.x; Reilly SB, 2008, IUCN 2010 IUCN RED L, P4; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Roden GI, 1964, AAPG BULL, V3, P30; Rodgers A. R., 2005, HRT HOME RANGE TOOLS; Rosenbaum HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007318; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Safner T, 2011, INT J MOL SCI, V12, P865, DOI 10.3390/ijms12020865; SANTAMARIADELANGEL E, 1994, J GEOPHYS RES-OCEANS, V99, P7411, DOI 10.1029/93JC02154; SCHAEFF CM, 1993, CAN J ZOOL, V71, P339, DOI 10.1139/z93-047; Sears RJ, 1990, REPORT INT WHALING C, P335; SLATKIN M, 1995, GENETICS, V139, P457; Sremba AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032579; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stafford KM, 1999, J ACOUST SOC AM, V106, P3687, DOI 10.1121/1.428220; THOMAS PO, 1984, BEHAVIOUR, V88, P42, DOI 10.1163/156853984X00470; Tiedemann R, 2000, MOL ECOL, V9, P1159, DOI 10.1046/j.1365-294x.2000.00975.x; Valenzuela LO, 2009, MOL ECOL, V18, P782, DOI 10.1111/j.1365-294X.2008.04069.x; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang IJ, 2009, MOL ECOL, V18, P3847, DOI 10.1111/j.1365-294X.2009.04338.x; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wright S., 1978, EVOLUTION GENETICS P	87	17	17	1	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58315	10.1371/journal.pone.0058315	http://dx.doi.org/10.1371/journal.pone.0058315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505485	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500067
J	Mera-Varela, A; Ferreiro-Iglesias, A; Perez-Pampin, E; Porto-Silva, M; Gomez-Reino, JJ; Gonzalez, A				Mera-Varela, Antonio; Ferreiro-Iglesias, Aida; Perez-Pampin, Eva; Porto-Silva, Marisol; Gomez-Reino, Juan J.; Gonzalez, Antonio			Ultrasonographic Assessment of Enthesitis in HLA-B27 Positive Patients with Rheumatoid Arthritis, a Matched Case-Only Study	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; REAL-TIME PCR; ANKYLOSING-SPONDYLITIS; PSORIATIC-ARTHRITIS; PERIPHERAL ENTHESITIS; CLINICAL-FEATURES; POWER DOPPLER; DISEASE ONSET; HLA ALLELES; SPONDYLOARTHRITIS	Introduction: HLA-B27 has a modifier effect on the phenotype of multiple diseases, both associated and non-associated with it. Among these effects, an increased frequency of clinical enthesitis in patients with Rheumatoid Arthritis (RA) has been reported but never explored again. We aimed to replicate this study with a sensitive and quantitative assessment of enthesitis by using standardized ultrasonography (US). Methods: The Madrid Sonography Enthesitis Index (MASEI) was applied to the US assessment of 41 HLA-B27 positive and 41 matched HLA-B27 negative patients with longstanding RA. Clinical characteristics including explorations aimed to evaluate spondyloarthrtitis and laboratory tests were also done. Results: A significant degree of abnormalities in the entheses of the patients with RA were found, but the MASEI values, and each of its components including the Doppler signal, were similar in HLA-B27 positive and negative patients. An increase of the MASEI scores with age was identified. Differences in two clinical features were found: a lower prevalence of rheumatoid factor and a more common story of low back pain in the HLA-B27 positive patients than in the negative. The latter was accompanied by radiographic sacroiliitis in two HLA-B27 positive patients. No other differences were detected. Conclusion: We have found that HLA-B27 positive patients with RA do not have more enthesitis as assessed with US than the patients lacking this HLA allele. However, HLA-B27 could be shaping the RA phenotype towards RF seronegativity and axial involvement.	[Mera-Varela, Antonio; Ferreiro-Iglesias, Aida; Perez-Pampin, Eva; Porto-Silva, Marisol; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Res Lab 10, Santiago De Compostela, Spain; [Mera-Varela, Antonio; Ferreiro-Iglesias, Aida; Perez-Pampin, Eva; Porto-Silva, Marisol; Gomez-Reino, Juan J.; Gonzalez, Antonio] Hosp Clin Univ Santiago, Inst Invest Sanitaria, Rheumatol Unit, Santiago De Compostela, Spain; [Mera-Varela, Antonio; Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Gonzalez, A (corresponding author), Hosp Clin Univ Santiago, Inst Invest Sanitaria, Res Lab 10, Santiago De Compostela, Spain.	antonio.gonzalez.martinez-pedrayo@sergas.es	Perez-Pampin, Eva/ABF-7200-2020; Gomez-Reino, Juan/ABI-2853-2020; VARELA, ANTONIO MERA/ABH-1886-2020; Gonzalez, Antonio/C-4444-2008	VARELA, ANTONIO MERA/0000-0001-9380-6975; Gonzalez, Antonio/0000-0002-2624-0606; Gomez-Reino, Juan/0000-0001-5229-6294; Perez-Pampin, Eva/0000-0003-0319-4456	Xunta de Galicia [10CSA918040PR]; Instituto de Salud Carlos III [PI08/0744]; European Regional Development Fund of the European Union; Instituto de Salud Carlos III (Spain)	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund of the European Union; Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III)	The study was supported by grants 10CSA918040PR from the Xunta de Galicia (http://www.sergas.e/MostrarContidos_N3_T01.aspx?IdPaxina=10142) and PI08/0744 of the Instituto de Salud Carlos III (http://www.isciii.es/) that are partially financed by the European Regional Development Fund of the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors acknowledge the patients with RA participating in this study by their availability and generosity. AF-I has a pre-doctoral bursary from the Instituto de Salud Carlos III (Spain).	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Balint PV, 2002, ANN RHEUM DIS, V61, P905, DOI 10.1136/ard.61.10.905; Berntson L, 2008, J RHEUMATOL, V35, P2055; Bon MAM, 2000, CLIN CHEM, V46, P1000; Chung HY, 2011, ANN RHEUM DIS, V70, P1930, DOI 10.1136/ard.2011.152975; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; D'Agostino MA, 2003, ARTHRITIS RHEUM, V48, P523, DOI 10.1002/art.10812; D'Agostino MA, 2011, ANN RHEUM DIS, V70, P1433, DOI 10.1136/ard.2010.138701; DAHLQVIST SR, 1984, J RHEUMATOL, V11, P27; de Miguel E, 2009, ANN RHEUM DIS, V68, P169, DOI 10.1136/ard.2007.084251; de Miguel E, 2011, ANN RHEUM DIS, V70, P434, DOI 10.1136/ard.2010.134965; Dougados M, 2011, LANCET, V377, P2127, DOI 10.1016/S0140-6736(11)60071-8; El-Gabalawy HS, 1999, ARTHRITIS RHEUM-US, V42, P1696, DOI 10.1002/1529-0131(199908)42:8<1696::AID-ANR19>3.0.CO;2-K; Falsetti P, 2003, SCAND J RHEUMATOL, V32, P229, DOI 10.1080/03009740310003721; Faner R, 2004, HUM IMMUNOL, V65, P826, DOI 10.1016/j.humimm.2004.05.009; Feldtkeller E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4; Flato B, 2002, ARTHRITIS RHEUM, V46, P986, DOI 10.1002/art.10146; Genc H, 2005, CLIN RHEUMATOL, V24, P272, DOI 10.1007/s10067-004-0997-1; Gregersen PK, 2010, BULL HOSP JT DIS, V68, P179; Gutierrez M, 2011, CLIN RHEUMATOL, V30, P907, DOI 10.1007/s10067-011-1703-8; JAJIC Z, 1991, Acta Medica Iugoslavica, V45, P195; JARAQUEMADA D, 1986, ANN RHEUM DIS, V45, P627, DOI 10.1136/ard.45.8.627; JURIK AG, 1987, FORTSCHR RONTG NEUEN, V147, P14; Kaarela K, 2009, CLIN EXP RHEUMATOL, V27, P325; Kasifoglu T, 2009, CLIN RHEUMATOL, V28, P41, DOI 10.1007/s10067-008-0980-3; Knevel R, 2012, ANN RHEUM DIS; Maksymowych WP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2665; Mathieu A, 2009, AUTOIMMUN REV, V8, P420, DOI 10.1016/j.autrev.2009.01.003; McGonagle D, 1998, LANCET, V352, P1137, DOI 10.1016/S0140-6736(97)12004-9; MOLL JMH, 1971, ANN RHEUM DIS, V30, P381, DOI 10.1136/ard.30.4.381; Munoz-Fernandez S, 2009, ARTHRITIS RHEUM-US, V60, P1985, DOI 10.1002/art.24636; Naredo E, 2011, RHEUMATOLOGY, V50, P1838, DOI 10.1093/rheumatology/ker078; Orchard TR, 2009, ALIMENT PHARM THER, V29, P193, DOI 10.1111/j.1365-2036.2008.03868.x; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Plant D, 2011, ARTHRITIS RHEUM-US, V63, P645, DOI 10.1002/art.30130; Plenge RM, 2010, RHEUM DIS CLIN N AM, V36, P259, DOI 10.1016/j.rdc.2010.03.002; Queiro R, 2003, J RHEUMATOL, V30, P505; Queiro R, 2002, SEMIN ARTHRITIS RHEU, V31, P413, DOI 10.1053/sarh.2002.33470; Reveille JD, 2009, ADV EXP MED BIOL, V649, P159; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; RUNDBACK JH, 1993, SKELETAL RADIOL, V22, P263; Ruta S, 2011, JCR-J CLIN RHEUMATOL, V17, P18, DOI 10.1097/RHU.0b013e318204a6f8; Saraux A, 1997, SCAND J RHEUMATOL, V26, P269, DOI 10.3109/03009749709105315; Seddighzadeh M, 2012, J RHEUMATOL, V39, P1509, DOI 10.3899/jrheum.111284; SHAIBANI A, 1993, CLIN EXP RHEUMATOL, V11, P399; Skare TL, 2012, CLIN EXP RHEUMATOL, V30, P351; Rodriguez-Reyna TS, 2009, WORLD J GASTROENTERO, V15, P5517, DOI 10.3748/wjg.15.5517; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2242, DOI 10.1002/art.24721	48	10	11	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58616	10.1371/journal.pone.0058616	http://dx.doi.org/10.1371/journal.pone.0058616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505543	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500107
J	Taniguchi, M; Fukunaka, A; Hagihara, M; Watanabe, K; Kamino, S; Kambe, T; Enomoto, S; Hiromura, M				Taniguchi, Masanari; Fukunaka, Ayako; Hagihara, Mitsue; Watanabe, Keiko; Kamino, Shinichiro; Kambe, Taiho; Enomoto, Shuichi; Hiromura, Makoto			Essential Role of the Zinc Transporter ZIP9/SLC39A9 in Regulating the Activations of Akt and Erk in B-Cell Receptor Signaling Pathway in DT40 Cells	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; SECRETORY PATHWAY; VERTEBRATE CELLS; TYROSINE PHOSPHATASES; ALKALINE-PHOSPHATASES; ANTIGEN RECEPTOR; IMMUNE FUNCTION; T-CELLS; PROTEIN; HOMEOSTASIS	The essential trace element zinc is important for all living organisms. Zinc functions not only as a nutritional factor, but also as a second messenger. However, the effects of intracellular zinc on the B cell-receptor (BCR) signaling pathway remain poorly understood. Here, we present data indicating that the increase in intracellular zinc level induced by ZIP9/SLC39A9 (a ZIP Zrt-/Irt-like protein) plays an important role in the activation of Akt and Erk in response to BCR activation. In DT40 cells, the enhancement of Akt and Erk phosphorylation following BCR activation requires intracellular zinc. To clarify this event, we used chicken ZnT5/6/7-gene-triple-knockout DT40 (TKO) cells and chicken Zip9-knockout DT40 (cZip9KO) cells. The levels of Akt and ERK phosphorylation significantly decreased in cZip9KO cells. In addition, the enzymatic activity of protein tyrosine phosphatase (PTPase) increased in cZip9KO cells. These biochemical events were restored by overexpressing the human Zip9 (hZip9) gene. Moreover, we found that the increase in intracellular zinc level depends on the expression of ZIP9. This observation is in agreement with the increased levels of Akt and Erk phosphorylation and the inhibition of total PTPase activity. We concluded that ZIP9 regulates cytosolic zinc level, resulting in the enhancement of Akt and Erk phosphorylation. Our observations provide new mechanistic insights into the BCR signaling pathway underlying the regulation of intracellular zinc level by ZIP9 in response to the BCR activation.	[Taniguchi, Masanari; Enomoto, Shuichi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Taniguchi, Masanari; Fukunaka, Ayako; Hagihara, Mitsue; Watanabe, Keiko; Kamino, Shinichiro; Enomoto, Shuichi; Hiromura, Makoto] RIKEN, Ctr Mol Imaging Sci, Multiple Mol Imaging Res Lab, Kobe, Hyogo, Japan; [Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan	Okayama University; RIKEN; Kyoto University	Enomoto, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	senomoto@pharm.okayama-u.ac.jp; mhiromura@riken.jp	Enomoto, Shuichi/G-8524-2012	Hagihara, Mitsue/0000-0002-7613-5054	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan; Kieikai Research Foundation; Salt Science Research Foundation; Grants-in-Aid for Scientific Research [24790936] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Kieikai Research Foundation(Kieikai Research Foundation); Salt Science Research Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a consignment expense for the Molecular Imaging Research Programs entitled "Research Base for Exploring New Drugs" and "Kobe Cluster" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to SE), grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to SE and TK), from the Ministry of Health, Labor, and Welfare of Japan for scientific research (to SE), the Kieikai Research Foundation (to TK), and The Salt Science Research Foundation (to SE and MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydemir TB, 2009, J LEUKOCYTE BIOL, V86, P337, DOI 10.1189/jlb.1208759; Besecker B, 2008, AM J PHYSIOL-LUNG C, V294, pL1127, DOI 10.1152/ajplung.00057.2008; Bin BH, 2011, J BIOL CHEM, V286, P40255, DOI 10.1074/jbc.M111.256784; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Clegg MS, 2005, IUBMB LIFE, V57, P661, DOI 10.1080/15216540500264554; Colvin RA, 2006, BRAIN RES, V1085, P1, DOI 10.1016/j.brainres.2006.02.043; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Eide DJ, 2004, PFLUG ARCH EUR J PHY, V447, P796, DOI 10.1007/s00424-003-1074-3; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Haase H, 2005, BIOMETALS, V18, P333, DOI 10.1007/s10534-005-3707-9; Haase H, 2006, ANAL BIOCHEM, V352, P222, DOI 10.1016/j.ab.2006.02.009; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Kaltenberg J, 2010, EUR J IMMUNOL, V40, P1496, DOI 10.1002/eji.200939574; Kambe Taiho, 2006, Genomics Proteomics & Bioinformatics, V4, P1, DOI 10.1016/S1672-0229(06)60010-7; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Knoell DL, 2010, INT J VITAM NUTR RES, V80, P271, DOI 10.1024/0300-9831/a000034; Kurosaki T, 2011, MOL IMMUNOL, V48, P1287, DOI 10.1016/j.molimm.2010.12.007; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; Kurosaki T, 2009, IMMUNOL REV, V228, P132, DOI 10.1111/j.1600-065X.2008.00748.x; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; Limnander A, 2011, NAT IMMUNOL, V12, P425, DOI 10.1038/ni.2016; Matsuura W, 2009, BIOSCI BIOTECH BIOCH, V73, P1142, DOI 10.1271/bbb.80910; Morita T, 2004, BIOCHEM J, V382, P793, DOI 10.1042/BJ20031970; Morita T, 2009, J CELL SCI, V122, P1220, DOI 10.1242/jcs.041640; Numaga T, 2010, J CELL SCI, V123, P927, DOI 10.1242/jcs.061051; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Rink L, 2000, J NUTR, V130, p1407S, DOI 10.1093/jn/130.5.1407S; Samet JM, 1999, AM J RESP CELL MOL, V21, P357, DOI 10.1165/ajrcmb.21.3.3656; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Watjen W, 2002, ENVIRON HEALTH PERSP, V110, P865, DOI 10.1289/ehp.110-1241262; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yu M, 2002, NAT GENET, V31, P239; Zalewski P D, 1994, Chem Biol, V1, P153, DOI 10.1016/1074-5521(94)90005-1	50	66	68	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58022	10.1371/journal.pone.0058022	http://dx.doi.org/10.1371/journal.pone.0058022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505453	Green Published, gold			2022-12-27	WOS:000318334500045
J	Yadav, S; Hasan, N; Marjot, T; Khan, MS; Prasad, K; Bentley, P; Sharma, P				Yadav, Sunaina; Hasan, Nazeeha; Marjot, Thomas; Khan, Muhammad S.; Prasad, Kameshwar; Bentley, Paul; Sharma, Pankaj			Detailed Analysis of Gene Polymorphisms Associated with Ischemic Stroke in South Asians	PLOS ONE			English	Article							REDUCTASE C677T POLYMORPHISM; VENO-SINUS THROMBOSIS; INDIAN POPULATION; RISK-FACTORS; METHYLENETETRAHYDROFOLATE REDUCTASE; HOMOCYSTEINE LEVELS; HEMORRHAGIC STROKE; PDE4D GENE; MENDELIAN RANDOMIZATION; COMMON VARIANTS	The burden of stroke is disproportionately high in the South Asian subcontinent with South Asian ethnicity conferring a greater risk of ischemic stroke than European ancestry regardless of country inhabited. While genes associated with stroke in European populations have been investigated, they remain largely unknown in South Asians. We conducted a comprehensive meta-analysis of known genetic polymorphisms associated with South Asian ischemic stroke, and compared effect size of the MTHFR C677T-stroke association with effect sizes predicted from homocysteine-stroke association. Electronic databases were searched up to August 2012 for published case control studies investigating genetic polymorphisms associated with ischemic stroke in South Asians. Pooled odds ratios (OR) for each gene-disease association were calculated using a random-effects model. We identified 26 studies (approximately 2529 stroke cases and 2881 controls) interrogating 33 independent genetic polymorphisms in 22 genes. Ten studies described MTHFR C677T (108 with TT genotype and 2018 with CC genotype) -homocysteine relationship and six studies (735 stroke cases and 713 controls) described homocysteine-ischemic stroke relationship. Risk association ORs were calculated for ACE I/D (OR 5.00; 95% CI, 1.17-21.37; p = 0.03), PDE4D SNP 83 (OR 2.20; 95% CI 1.21-3.99; p = 0.01), PDE4D SNP 32 (OR 1.57; 95% CI 1.01-2.45, p = 0.045) and IL10 G1082A (OR 1.44; 95% CI, 1.09-1.91, p = 0.01). Significant association was observed between elevated plasma homocysteine levels and MTHFR/677 TT genotypes in healthy South Asians (Mean difference (Delta X) 5.18 mu mol/L; 95% CI 2.03-8.34: p = 0.001). Our results demonstrate that the genetic etiology of ischemic stroke in South Asians is broadly similar to the risk conferred in Europeans, although the dataset is considerably smaller and warrants the same clinical considerations for risk profiling.	[Yadav, Sunaina; Hasan, Nazeeha; Marjot, Thomas; Khan, Muhammad S.; Bentley, Paul; Sharma, Pankaj] Univ London Imperial Coll Sci Technol & Med, ICCRU, London, England; [Prasad, Kameshwar] All India Inst Med Sci, Dept Neurol, New Delhi, India	Imperial College London; All India Institute of Medical Sciences (AIIMS) New Delhi	Sharma, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, ICCRU, London, England.	pankaj.sharma@imperial.ac.uk	sharma, pankaj/HGE-4423-2022	Bentley, Paul/0000-0001-8036-7010; Marjot, Thomas/0000-0002-6542-6323	Dept of Health (UK); United Kingdom-India Education and Research Initiative award (UKIERI); Medical Research Council (MRC)	Dept of Health (UK); United Kingdom-India Education and Research Initiative award (UKIERI); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PS and PB hold senior fellowships from the Dept of Health (UK). SY is funded by the United Kingdom-India Education and Research Initiative award (UKIERI). NH is funded by the Medical Research Council (MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alluri RV, 2005, EUR J NEUROL, V12, P40, DOI 10.1111/j.1468-1331.2004.00938.x; Babu MS, 2012, GENE; Banerjee I, 2008, BRAIN RES BULL, V75, P158, DOI 10.1016/j.brainresbull.2007.08.007; Banerjee TK, 2001, NEUROEPIDEMIOLOGY, V20, P201, DOI 10.1159/000054788; Banerjee TK, 2006, NEUROL ASIA, V11, P1; Baweja G, 2004, AM J CARDIOL, V93, P267, DOI 10.1016/j.amjcard.2003.09.060; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Bentley P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009136; Bevan S, 2008, STROKE, V39, P1966, DOI 10.1161/STROKEAHA.107.509992; Bevan S, 2012, STROKE, V43, P3161, DOI 10.1161/STROKEAHA.112.665760; Bhattacharya Susanta, 2005, J Indian Med Assoc, V103, P655; Bissoli L, 2002, ANN NUTR METAB, V46, P73, DOI 10.1159/000057644; Biswas A, 2009, J STROKE CEREBROVASC, V18, P103, DOI 10.1016/j.jstrokecerebrovasdis.2008.09.014; Biswas A, 2009, ANN HEMATOL, V88, P473, DOI 10.1007/s00277-008-0613-6; Biswas M, 2009, NEUROL ASIA, V14, P81; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036; Casas JP, 2004, ARCH NEUROL-CHICAGO, V61, P1652, DOI 10.1001/archneur.61.11.1652; Casas JP, 2005, LANCET, V365, P224, DOI 10.1016/S0140-6736(05)70152-5; Chambers JC, 2000, ARTERIOSCL THROM VAS, V20, P2448, DOI 10.1161/01.ATV.20.11.2448; Chandalia M, 2003, J CLIN ENDOCR METAB, V88, P1089, DOI 10.1210/jc.2002-021133; Chandra G, 2006, NEUROL INDIA, V54, P446; Chang LT, 2010, NEUROIMMUNOMODULAT, V17, P223, DOI 10.1159/000290038; Chowdhury A H, 2001, J Epidemiol, V11, P131; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Das SK, 2007, STROKE, V38, P906, DOI 10.1161/01.STR.0000258111.00319.58; Deeks JJ, 2008, SYSTEMATIC REV HLTH; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhamija RK, 2009, J NEUROL SCI, V281, P64, DOI 10.1016/j.jns.2009.02.341; Dhillon VS, 2007, MOL HUM REPROD, V13, P213, DOI 10.1093/molehr/gal118; Dindagur N, 2007, THROMB RES, V119, P497, DOI 10.1016/j.thromres.2006.04.008; Dindagur N, 2006, J NEUROL SCI, V249, P25, DOI 10.1016/j.jns.2006.05.061; Dziedzic T, 2002, STROKE, V33, P2334, DOI 10.1161/01.STR.0000027211.73567.FA; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ezzati M, 2012, SCIENCE, V337, P1482, DOI 10.1126/science.1227001; Gourie-Devi M, 2004, NEUROEPIDEMIOLOGY, V23, P261, DOI 10.1159/000080090; Goverment of India, 2008, NAT HLTH PROF 2008, P102; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gunarathne A, 2009, STROKE, V40, pE415, DOI 10.1161/STROKEAHA.108.535724; Hall S, 2000, GENET EPIDEMIOL, V18, P203, DOI 10.1002/(SICI)1098-2272(200003)18:3<203::AID-GEPI2>3.0.CO;2-I; Holliday EG, 2012, NAT GENET, V44, P1147, DOI 10.1038/ng.2397; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; Hughes K, 2000, J EPIDEMIOL COMMUN H, V54, P31, DOI 10.1136/jech.54.1.31; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Iqbal M Perwaiz, 2005, J Mol Genet Med, V1, P26; Kain K, 2005, THROMB HAEMOSTASIS, V93, P394; Kalita J, 2006, NEUROL INDIA, V54, P260; Kalita J, 2011, CLIN CHIM ACTA, V412, P642, DOI 10.1016/j.cca.2010.12.022; Kalita J, 2009, CLIN NEUROL NEUROSUR, V111, P364, DOI 10.1016/j.clineuro.2008.12.010; Kelemen LE, 2004, ATHEROSCLEROSIS, V176, P361, DOI 10.1016/j.atherosclerosis.2004.06.003; Kumar J, 2005, J HUM GENET, V50, P655, DOI 10.1007/s10038-005-0313-1; Liew SC, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-1; Lin BK, 2006, AM J EPIDEMIOL, V164, P1, DOI 10.1093/aje/kwj175; Luthra K, 2002, CLIN GENET, V62, P39, DOI 10.1034/j.1399-0004.2002.620105.x; Majumdar V, 2009, J ATHEROSCLEROSIS TH, V17; Majumdar V, 2010, BIOCHEM BIOPH RES CO, V403, P412, DOI 10.1016/j.bbrc.2010.11.045; Mamatha SN, 2011, CLIN CHIM ACTA, V412, P139, DOI 10.1016/j.cca.2010.09.026; Matsushita T, 2009, STROKE, V40, P1245, DOI 10.1161/STROKEAHA.108.527408; Micheal S, 2009, MOL VIS, V15, P2268; Misra UK, 2010, BIOCHEM GENET, V48, P229, DOI 10.1007/s10528-009-9312-9; Modi M, 2005, NEUROL INDIA, V53, P297; Mohamed EHM, 2011, ANN ACAD MED SINGAP, V40, P186; Munshi A, 2011, EUR J NEUROL, V18, P1053, DOI 10.1111/j.1468-1331.2010.03334.x; Munshi A, 2010, BRAIN RES B; Munshi A, 2008, J NEUROL SCI, V272, P132, DOI 10.1016/j.jns.2008.05.017; Munshi A, 2012, MOL BIOL REP, V39, P1677, DOI 10.1007/s11033-011-0907-y; Munshi A, 2010, CYTOKINE, V52, P221, DOI 10.1016/j.cyto.2010.09.013; Munshi A, 2010, CLIN CHIM ACTA, V411, P1817, DOI 10.1016/j.cca.2010.08.001; Munshi A, 2010, J NEUROL SCI, V296, P34, DOI 10.1016/j.jns.2010.06.013; Munshi A, 2009, J NEUROL SCI, V285, P142, DOI 10.1016/j.jns.2009.06.024; Munshi A, 2009, THROMB RES, V124, P245, DOI 10.1016/j.thromres.2008.09.013; Narang AP, 2009, INDIAN J PHYSL PHARM, V53; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Panigrahi I, 2006, NEUROLOGY INDIA, V54; Potluri R, 2009, J CLIN NEUROSCI, V16, P605, DOI 10.1016/j.jocn.2008.07.067; Radha Rama DA, 2004, CURR SCI, V86; Rao R, 2009, EUR NEUROL, V61, P76, DOI 10.1159/000177939; Rao S, 1971, P 1 ALL IND C STROK, P25; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rosand J, 2006, NAT GENET, V38, P1091, DOI 10.1038/ng1006-1091; Sacco RL, 2001, STROKE, V32, P1725, DOI 10.1161/01.STR.32.8.1725; Saha Shankar Prasad, 2003, J Indian Med Assoc, V101, P299; Saleheen D, 2005, STROKE, V36, P2275, DOI 10.1161/01.STR.0000182242.59466.ee; Sharma V, 2011, J NEUROL SCI; Somarajan BI, 2011, J NEUROL SCI, V304, P67, DOI 10.1016/j.jns.2011.02.010; Somarajan BI, 2010, J NEUROL SCI, V290, P57, DOI 10.1016/j.jns.2009.11.009; Sukla KK, 2012, EUR J CLIN NUTR, V66, P111, DOI 10.1038/ejcn.2011.152; Sultana S, 2011, J GENET, V90, P361, DOI 10.1007/s12041-011-0079-5; Tao HM, 2009, CAN J NEUROL SCI, V36, P20, DOI 10.1017/S0317167100006259; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Tripathi R, 2010, GENET MOL BIOL, V33, P224, DOI 10.1590/S1415-47572010005000026; Wald DS, 2003, THROMB RES, V111, P55, DOI 10.1016/j.thromres.2003.08.015; Worrall BB, 2006, STROKE, V37, P1955, DOI 10.1161/01.STR.0000234048.04053.39; Xu XW, 2010, NEUROGENETICS, V11, P327, DOI 10.1007/s10048-010-0235-8; Yoon D, 2011, NEUROEPIDEMIOLOGY, V36, P213, DOI 10.1159/000327915	97	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57305	10.1371/journal.pone.0057305	http://dx.doi.org/10.1371/journal.pone.0057305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505425	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500017
J	Craft, ME; Beyer, HL; Haydon, DT				Craft, Meggan E.; Beyer, Hawthorne L.; Haydon, Daniel T.			Estimating the Probability of a Major Outbreak from the Timing of Early Cases: An Indeterminate Problem?	PLOS ONE			English	Article							DISEASE; MODELS; DISTRIBUTIONS; EPIDEMICS; DYNAMICS	Conservation biologists, as well as veterinary and public health officials, would benefit greatly from being able to forecast whether outbreaks of infectious disease will be major. For values of the basic reproductive number (R-0) between one and two, infectious disease outbreaks have a reasonable chance of either fading out at an early stage or, in the absence of intervention, spreading widely within the population. If it were possible to predict when fadeout was likely to occur, the need for costly precautionary control strategies could be minimized. However, the predictability of even simple epidemic processes remains largely unexplored. Here we conduct an examination of simulated data from the early stages of a fatal disease outbreak and explore how observable information might be useful for predicting major outbreaks. Specifically, would knowing the time of deaths for the first few cases allow us to predict whether an outbreak will be major? Using two approaches, trajectory matching and discriminant function analysis, we find that even in our best-case scenario (with accurate knowledge of epidemiological parameters, and precise times of death), it was not possible to reliably predict the outcome of a stochastic Susceptible-Exposed-Infectious-Recovered (SEIR) process.	[Craft, Meggan E.; Beyer, Hawthorne L.; Haydon, Daniel T.] Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland; [Craft, Meggan E.] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Beyer, Hawthorne L.] Univ Queensland, ARC Ctr Excellence Environm Decis, Brisbane, Qld, Australia	University of Glasgow; University of Minnesota System; University of Minnesota Twin Cities; University of Queensland	Craft, ME (corresponding author), Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland.	craft@umn.edu	Craft, Meggan E/A-9393-2012; Beyer, Hawthorne/F-8050-2013	Craft, Meggan E/0000-0001-5333-8513; Beyer, Hawthorne/0000-0002-5430-0784; Haydon, Daniel/0000-0002-1240-1886	National Science Foundation [OISE-0804186]; Leverhulme Trust	National Science Foundation(National Science Foundation (NSF)); Leverhulme Trust(Leverhulme Trust)	Financial support for MC was provided by the National Science Foundation (OISE-0804186) and for HLB was provided by the Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON D, 1980, BIOMETRIKA, V67, P191; ANDERSON R M, 1991; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; BAILEY NTJ, 1953, BIOMETRIKA, V40, P279; Barlow ND, 1996, J APPL ECOL, V33, P303, DOI 10.2307/2404752; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Conlan AJK, 2010, J R SOC INTERFACE, V7, P623, DOI 10.1098/rsif.2009.0284; Cox D. R., 1965, THEORY STOCHASTIC PR; Drake JM, 2006, PLOS MED, V3, P57, DOI 10.1371/journal.pmed.0030003; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Handel A, 2007, P ROY SOC B-BIOL SCI, V274, P833, DOI 10.1098/rspb.2006.0015; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; Haydon DT, 2003, P ROY SOC B-BIOL SCI, V270, P121, DOI 10.1098/rspb.2002.2191; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kenah E, 2011, INTERDISCIPLINARY PE, V2011; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lloyd AL, 2001, P ROY SOC B-BIOL SCI, V268, P985, DOI 10.1098/rspb.2001.1599; Meyers LA, 2006, J THEOR BIOL, V240, P400, DOI 10.1016/j.jtbi.2005.10.004; MOLLISON D, 1994, J R STAT SOC A STAT, V157, P115, DOI 10.2307/2983509; R Development Core Team, 2012, R LANG ENV STAT COMP; Trapman P, 2009, MATH BIOSCI, V219, P15, DOI 10.1016/j.mbs.2009.02.001; Venables WN., 2002, MODERN APPL STAT S 4	24	15	15	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57878	10.1371/journal.pone.0057878	http://dx.doi.org/10.1371/journal.pone.0057878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483934	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000316936100050
J	Newman, J; Seabrook, S; Surjadi, R; Williams, CC; Lucent, D; Wilding, M; Scott, C; Peat, TS				Newman, Janet; Seabrook, Shane; Surjadi, Regina; Williams, Charlotte C.; Lucent, Del; Wilding, Matthew; Scott, Colin; Peat, Thomas S.			Determination of the Structure of the Catabolic N-Succinylornithine Transaminase (AstC) from Escherichia coli	PLOS ONE			English	Article							ARGININE SUCCINYLTRANSFERASE PATHWAY; PSEUDOMONAS-AERUGINOSA; BACILLUS-SUBTILIS; ACETYLORNITHINE AMINOTRANSFERASE; ORNITHINE EXCHANGER; ARC OPERON; ENZYMES; PROTEIN; PUTIDA; GENE	Escherichia coli possesses two acyl ornithine aminotransferases, one catabolic (AstC) and the other anabolic (ArgD), that participate in L-arginine metabolism. Although only 58% identical, the enzymes have been shown to be functionally interchangeable. Here we have purified AstC and have obtained X-ray crystal structures of apo and holo-AstC and of the enzyme complexed with its physiological substrate, succinylornithine. We compare the structures obtained in this study with those of ArgD from Salmonella typhimurium obtained elsewhere, finding several notable differences. Docking studies were used to explore the docking modes of several substrates (ornithine, succinylornithine and acetylornithine) and the co-substrate glutamate/alpha-ketogluterate. The docking studies support our observations that AstC has a strong preference for acylated ornithine species over ornithine itself, and suggest that the increase in specificity associated with acylation is caused by steric and desolvation effects rather than specific interactions between the substrate and enzyme.	[Newman, Janet; Seabrook, Shane; Surjadi, Regina; Williams, Charlotte C.; Lucent, Del; Peat, Thomas S.] CSIRO Mat Sci & Engn, Parkville, Vic, Australia; [Wilding, Matthew; Scott, Colin] CSIRO Ecosyst Sci, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Peat, TS (corresponding author), CSIRO Mat Sci & Engn, Parkville, Vic, Australia.	tom.peat@csiro.au	Scott, Colin/A-4682-2009; Seabrook, Shane/M-2399-2013; Wilding, Matthew A/D-4173-2012; Newman, Janet M/D-1857-2011; Peat, Thomas S/F-9817-2010; Williams, Charlotte C/G-5077-2013	Scott, Colin/0000-0001-6110-6982; Wilding, Matthew A/0000-0002-3921-7771; Newman, Janet M/0000-0003-2666-3219; Peat, Thomas S/0000-0002-6488-0831; Williams, Charlotte C/0000-0003-0807-3864				BAUMBERG S, 1979, J BACTERIOL, V137, P189, DOI 10.1128/JB.137.1.189-196.1979; Bergmeyer H-U, 1985, AMMONIA METHODS ENZY, V8, P454; BOURDINEAUD JP, 1993, J BIOL CHEM, V268, P5417; CALOGERO S, 1994, J BACTERIOL, V176, P1234, DOI 10.1128/jb.176.5.1234-1241.1994; CHEN SS, 1975, BIOCHEM J, V151, P297, DOI 10.1042/bj1510297; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FAN CL, 1975, J BACTERIOL, V124, P1302, DOI 10.1128/JB.124.3.1302-1311.1975; Fraley CD, 1998, J BACTERIOL, V180, P4287, DOI 10.1128/JB.180.16.4287-4290.1998; GARDAN R, 1995, J MOL BIOL, V249, P843, DOI 10.1006/jmbi.1995.0342; Itoh Y, 1997, J BACTERIOL, V179, P7280, DOI 10.1128/jb.179.23.7280-7290.1997; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kim J, 2007, BIOCHEMISTRY-US, V46, P12501, DOI 10.1021/bi7014629; Kiupakis AK, 2002, J BACTERIOL, V184, P2940, DOI 10.1128/JB.184.11.2940-2950.2002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ledwidge R, 1999, BIOCHEMISTRY-US, V38, P3019, DOI 10.1021/bi982574a; Lu CD, 2006, APPL MICROBIOL BIOT, V70, P261, DOI 10.1007/s00253-005-0308-z; LUTHI E, 1990, GENE, V87, P37, DOI 10.1016/0378-1119(90)90493-B; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGann M, 2011, J CHEM INF MODEL, V51, P578, DOI 10.1021/ci100436p; METZLER CM, 1980, J AM CHEM SOC, V102, P6075, DOI 10.1021/ja00539a017; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nasvall J, 2012, SCIENCE, V338, P384, DOI 10.1126/science.1226521; Newman J, 2004, ACTA CRYSTALLOGR D, V60, P610, DOI 10.1107/S0907444903029640; Qian ZG, 2009, BIOTECHNOL BIOENG, V104, P651, DOI 10.1002/bit.22502; Rajaram V, 2008, PROTEINS, V70, P429, DOI 10.1002/prot.21567; Schneider BL, 1998, J BACTERIOL, V180, P4278, DOI 10.1128/JB.180.16.4278-4286.1998; STALON V, 1984, J GEN MICROBIOL, V130, P69; TABOR H, 1969, J BIOL CHEM, V244, P2286; Tiwari N, 2010, PROTEIN EXPRES PURIF, V70, P191, DOI 10.1016/j.pep.2009.10.018; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; TRICOT C, 1991, J GEN MICROBIOL, V137, P2911, DOI 10.1099/00221287-137-12-2911; Tufvesson P, 2011, BIOTECHNOL BIOENG, V108, P1479, DOI 10.1002/bit.23154; VANDERBILT AS, 1975, J BIOL CHEM, V250, P5322; VERHOOGT HJC, 1992, J BACTERIOL, V174, P1568, DOI 10.1128/jb.174.5.1568-1573.1992; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401	40	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58298	10.1371/journal.pone.0058298	http://dx.doi.org/10.1371/journal.pone.0058298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484010	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100100
J	Dowling, DJ; Tan, Z; Prokopowicz, ZM; Palmer, CD; Matthews, MAH; Dietsch, GN; Hershberg, RM; Levy, O				Dowling, David J.; Tan, Zhen; Prokopowicz, Zofia M.; Palmer, Christine D.; Matthews, Maura-Ann H.; Dietsch, Gregory N.; Hershberg, Robert M.; Levy, Ofer			The Ultra-Potent and Selective TLR8 Agonist VTX-294 Activates Human Newborn and Adult Leukocytes	PLOS ONE			English	Article							YELLOW-FEVER VACCINE; TOLL-LIKE RECEPTORS; T-CELL RESPONSES; INNATE IMMUNITY; CYTOKINE RESPONSES; BASIC MECHANISMS; DISTINCT; EXPRESSION; ADJUVANTS; EFFICACY	Background: Newborns display distinct immune responses that contribute to susceptibility to infection and reduced vaccine responses. Toll-like receptor (TLR) agonists may serve as vaccine adjuvants, when given individually or in combination, but responses of neonatal leukocytes to many TLR agonists are diminished. TLR8 agonists are more effective than other TLR agonists in activating human neonatal leukocytes in vitro, but little is known about whether different TLR8 agonists may distinctly activate neonatal leukocytes. We characterized the in vitro immuno-stimulatory activities of a novel benzazepine TLR8 agonist, VTX-294, in comparison to imidazoquinolines that activate TLR8 (R-848; (TLR7/8) CL075; (TLR8/7)), with respect to activation of human newborn and adult leukocytes. Effects of VTX-294 and R-848 in combination with monophosphoryl lipid A (MPLA; TLR4) were also assessed. Methods: TLR agonist specificity was assessed using TLR-transfected HEK293 cells expressing a NF-kappa B reporter gene. TLR agonist-induced cytokine production was measured in human newborn cord and adult peripheral blood using ELISA and multiplex assays. Newborn and adult monocytes were differentiated into monocyte-derived dendritic cells (MoDCs) and TLR agonist-induced activation assessed by cytokine production (ELISA) and co-stimulatory molecule expression (flow cytometry). Results: VTX-294 was similar to 100x more active on TLR8-than TLR7-transfected HEK cells (EC50, similar to 50 nM vs. similar to 5700 nM). VTX-294-induced TNF and IL-1 beta production were comparable in newborn cord and adult peripheral blood, while VTX-294 was similar to 1 log more potent in inducing TNF and IL-1 beta production than MPLA, R848 or CL075. Combination of VTX-294 and MPLA induced greater blood TNF and IL-1 beta responses than combination of R-848 and MPLA. VTX-294 also potently induced expression of cytokines and co-stimulatory molecules HLA-DR and CD86 in human newborn MoDCs. Conclusions: VTX-294 is a novel ultra-potent TLR8 agonist that activates newborn and adult leukocytes and is a candidate vaccine adjuvant in both early life and adulthood.	[Dowling, David J.; Tan, Zhen; Prokopowicz, Zofia M.; Palmer, Christine D.; Levy, Ofer] Boston Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA USA; [Dowling, David J.; Tan, Zhen; Prokopowicz, Zofia M.; Palmer, Christine D.; Levy, Ofer] Harvard Univ, Sch Med, Boston, MA USA; [Tan, Zhen] Shanghai Jiao Tong Univ, Div Pediat, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Matthews, Maura-Ann H.; Dietsch, Gregory N.; Hershberg, Robert M.] VentiRx Pharmaceut Inc, Seattle, WA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Shanghai Jiao Tong University	Levy, O (corresponding author), Boston Childrens Hosp, Dept Med, Div Infect Dis, Boston, MA USA.	ofer.levy@childrens.harvard.edu	Palmer, Christine/GXH-4415-2022	Dowling, David/0000-0003-1095-6156; Levy, Ofer/0000-0002-5859-1945; Palmer, Christine Denise/0000-0003-3213-0398	VentiRx Pharmaceuticals; National Institutes of Health [RO1 AI067353-01A1, 3R01AI067353-05S1]; Global Health Awards from Bill & Melinda Gates Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067353, R01AI100135] Funding Source: NIH RePORTER	VentiRx Pharmaceuticals; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Health Awards from Bill & Melinda Gates Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by sponsored research support from VentiRx Pharmaceuticals. OL's laboratory is supported by grants from National Institutes of Health grants RO1 AI067353-01A1 and Administrative Supplement 3R01AI067353-05S1 as well as a Global Health Awards from the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; [Anonymous], 2012, N ENGL J MED; Bowen RS, 2005, J SOC GYNECOL INVEST, V12, P428, DOI 10.1016/j.jsgi.2005.04.001; Burl S, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012287, 10.1371/journal.pone.0018185]; Cervantes JL, 2011, P NATL ACAD SCI USA, V108, P3683, DOI 10.1073/pnas.1013776108; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Coombs MRP, 2011, EXPERT REV ANTI-INFE, V9, P261, DOI [10.1586/eri.10.158, 10.1586/ERI.10.158]; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; Dasari P, 2011, PEDIAT ALLERG IMM-UK, V22, P221, DOI 10.1111/j.1399-3038.2010.01091.x; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Demirjian A, 2009, EUR J IMMUNOL, V39, P36, DOI 10.1002/eji.200838620; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Embry CA, 2011, SCI SIGNAL, V4, P20, DOI 10.1126/scisignal.2001486; Ghosh TK, 2007, INT IMMUNOPHARMACOL, V7, P1111, DOI 10.1016/j.intimp.2007.04.006; Ghosh TK, 2006, CELL IMMUNOL, V243, P48, DOI 10.1016/j.cellimm.2006.12.002; Godaly G, 2005, CELL MICROBIOL, V7, P591, DOI 10.1111/j.1462-5822.2004.00489.x; Goriely S, 2004, J EXP MED, V199, P1011, DOI 10.1084/jem.20031272; Govindaraj RG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025118; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hood JD, 2010, HUM VACCINES, V6, P322, DOI 10.4161/hv.6.4.10866; Horak F, 2011, EXPERT OPIN INV DRUG, V20, P981, DOI 10.1517/13543784.2011.583237; Howbert JJ, 2010, METHODS SYNTHESIS BE; Itoh H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028500; Jacobson KA, 2000, J BIOL CHEM, V275, P30272, DOI 10.1074/jbc.M001520200; Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kwissa M, 2012, BLOOD, V119, P2044, DOI 10.1182/blood-2011-10-388579; Lavoie PM, 2010, J INFECT DIS, V202, P1754, DOI 10.1086/657143; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Levy O, 2005, J ENDOTOXIN RES, V11, P113, DOI 10.1179/096805105X37376; Levy O, 2004, J IMMUNOL, V173, P4627, DOI 10.4049/jimmunol.173.7.4627; Levy O., 2012, VACCINE; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, BLOOD, V108, P1284, DOI 10.1182/blood-2005-12-4821; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lu H, 2011, CLIN CANC RES; Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439; Ma YF, 2010, IMMUNOLOGY, V130, P374, DOI 10.1111/j.1365-2567.2009.03237.x; Marodi L, 2006, CLIN IMMUNOL, V118, P137, DOI 10.1016/j.clim.2005.10.012; Moresco EMY, 2011, CURR BIOL, V21, pR488, DOI 10.1016/j.cub.2011.05.039; NAGASHIMA K, 1986, BIOL NEONATE, V49, P307; Philbin VJ, 2012, J ALLERGY CLIN IMMUN, V130, P195, DOI 10.1016/j.jaci.2012.02.042; Philbin VJ, 2009, PEDIATR RES, V65, p98R, DOI 10.1203/PDR.0b013e31819f195d; Philbin VJ, 2005, IMMUNOLOGY, V114, P507, DOI 10.1111/j.1365-2567.2005.02125.x; Philbin VJ, 2012, J ALLERGY CLIN IMMUN; PrabhuDas M, 2011, NAT IMMUNOL, V12, P189, DOI 10.1038/ni0311-189; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Schwarz H, 2012, IMMUNOBIOLOGY; Shi C, 2012, ACS MED CHEM LETT, V3, P501, DOI 10.1021/ml300079e; Siegrist CA, 2007, J COMP PATHOL, V137, pS4, DOI 10.1016/j.jcpa.2007.04.004; Smirnov D, 2011, VACCINE, V29, P5434, DOI 10.1016/j.vaccine.2011.05.061; Tomai MA, 2011, EXPERT REV VACCINES, V10, P405, DOI [10.1586/erv.11.26, 10.1586/ERV.11.26]; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van den Biggelaar AHJ, 2009, VACCINE, V27, P1340, DOI 10.1016/j.vaccine.2008.12.046; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105	62	51	53	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58164	10.1371/journal.pone.0058164	http://dx.doi.org/10.1371/journal.pone.0058164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483986	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900073
J	Nan, HR; Lee, PH; Ni, MY; Chan, BHY; Lam, TH				Nan, Hairong; Lee, Paul H.; Ni, Michael Y.; Chan, Brandford H. Y.; Lam, Tai-Hing			Effects of Depressive Symptoms and Family Satisfaction on Health Related Quality of Life: The Hong Kong FAMILY Study	PLOS ONE			English	Article							SOCIAL SUPPORT; PHYSICAL-ACTIVITY; MENTAL-HEALTH; OLDER-ADULTS; RISK-FACTORS; SHORT-FORM; CHINESE; PEOPLE; PREVALENCE; GENDER	Objective: To examine the effect of depressive symptoms and satisfaction with family support (FS) on physical and mental Health Related Quality of Life (HRQoL). Methods: Data were obtained from the Hong Kong FAMILY Project baseline survey in 2009-2011, which included 16,039 community residents (age >= 20). The FS was measured using the Family Adaptation, Partnership, Growth, Affection, Resolve (APGAR, range 0-10) Questionnaire. HRQoL were assessed using the SF-12 version 2. Depressive symptoms were recorded using the Patient Health Questionnaire-9 (PHQ-9). Demographic and lifestyle variables, stressful life events, perceived neighborhood cohesion were also assessed. Results: In a multilevel regression model, socio-demographic and behavioral variables explained 21% and 19% of the variance in physical and mental HRQoL. The presence of depressive symptoms (PHQ-9 score >= 10, standardized coefficients, beta of -1.73) and high FS (APGAR score 7-10, 1.15) were associated with mental HRQoL, after adjustment for age, education, household monthly income, drinking status, physical activity, chronic conditions, life stress and neighborhood cohesion. Not FS but the presence of depressive symptoms (beta of -0.88) was associated with physical HRQoL. The presence of depressive symptoms in women than men were more associated with a poorer physical HRQoL (p<0.01) while depressive symptoms in men were associated with a decrease in mental HRQoL (p<0.001). The interaction between FS and depressive symptoms was nonsignificant in relation to HRQoL. Among those with depressive symptoms, high FS was associated with a better mental HRQoL (41.1 vs. 37.9, p<0.001) in women but not contribute to variance in men. Conclusions: Higher FS and presence of depressive symptoms were significantly associated with HRQoL in general population in Hong Kong. Among those with depressive symptoms, high FS was associated with a favorable mental HRQoL in women but not men.	[Nan, Hairong; Lee, Paul H.; Ni, Michael Y.; Chan, Brandford H. Y.; Lam, Tai-Hing] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Dept Community Med, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hku.hk	Lee, Paul H/F-2549-2010; Lam, Tai Hing/C-4317-2009	Lee, Paul H/0000-0002-5729-6450; Ni, Michael/0000-0002-1217-5858; Lam, Tai Hing/0000-0002-2033-9971	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	This project was funded by The Hong Kong Jockey Club Charities Trust (http://charities.hkjc.com/charities/lending-a-hand-and-volunteering/english/related-projects/projects/family.aspx#bottom_nav_charities). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blazer D. G., 2009, FOCUS, VVII, P118, DOI DOI 10.1176/FOC.7.1.FOC118; Chan DH, 1988, HONG KONG PRACT, V10, P3295; Chi I, 2001, INT J AGING HUM DEV, V52, P231, DOI 10.2190/V5K8-CNMG-G2UP-37QV; Choi NG, 2011, AGING MENT HEALTH, V15, P307, DOI 10.1080/13607863.2010.513042; Chou KL, 2012, J AFFECT DISORDERS, V138, P63, DOI 10.1016/j.jad.2011.12.029; Chou KL, 2004, AGING MENT HEALTH, V8, P212, DOI 10.1080/13607860410001669741; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; DuPertuis LL, 2001, J AGING HEALTH, V13, P494, DOI 10.1177/089826430101300403; Fong DYT, 2010, J CLIN EPIDEMIOL, V63, P1020, DOI 10.1016/j.jclinepi.2009.11.011; Gallegos-Carrillo K, 2009, J PSYCHOSOM RES, V66, P127, DOI 10.1016/j.jpsychores.2008.07.007; Giordano A, 2012, EUR J NEUROL, V19, P847, DOI 10.1111/j.1468-1331.2011.03638.x; Goodwin RD, 2003, PREV MED, V36, P698, DOI 10.1016/S0091-7435(03)00042-2; Hegadoren KM, 2009, NEUROPEPTIDES, V43, P341, DOI 10.1016/j.npep.2009.06.004; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; IPAQ RC, 2004, GUIDELINES FOR DATA; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lam CLK, 2005, QUAL LIFE RES, V14, P539, DOI 10.1007/s11136-004-0704-3; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-81; Lee S, 2010, INT J PSYCHIAT MED, V40, P339, DOI 10.2190/PM.40.3.h; Li YM, 2012, INT J GERIATR PSYCH, V27, P31, DOI 10.1002/gps.2685; McDaniel SH, 1990, HOW FAMILIES AFFECT, P28; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; Nan HR, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-198; Organization WH, 2009, GLOB HLTH RISKS MORT; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Pinquart M, 2006, QUAL LIFE RES, V15, P1565, DOI 10.1007/s11136-006-0016-x; Qin ZH, 2009, CLIN NEUROL NEUROSUR, V111, P733, DOI 10.1016/j.clineuro.2009.07.001; Reyes-Gibby CC, 2012, J WOMENS HEALTH, V21, P311, DOI 10.1089/jwh.2011.2852; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; SARTORIUS N, 1993, QUALITY OF LIFE ASSESSMENT : KEY ISSUES IN THE 1990S, P201; SHERBOURNE CD, 1988, SOC SCI MED, V27, P1393, DOI 10.1016/0277-9536(88)90205-5; SMILKSTEIN G, 1978, J FAM PRACTICE, V6, P1231; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; The FAMILY Project Cohort team, 2013, FAMILY PROJECT COHOR; Ware J.E., 2007, QUALITY METRIC INCOR; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wikman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018952; Wong OMH, 2005, J AGING STUD, V19, P375, DOI 10.1016/j.jaging.2004.07.007; World Health Organization, 2010, GLOB STAT REP NONC D; Yu J, 2012, INT J GERIATR PSYCH, V27, P305, DOI 10.1002/gps.2721; Yu XN, 2012, COMPR PSYCHIAT, V53, P95, DOI 10.1016/j.comppsych.2010.11.002; Zhang BS, 2011, AGING MENT HEALTH, V15, P844, DOI 10.1080/13607863.2011.569481; Zhou ES, 2010, J PSYCHOSOM RES, V69, P587, DOI 10.1016/j.jpsychores.2010.04.019	44	31	31	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58436	10.1371/journal.pone.0058436	http://dx.doi.org/10.1371/journal.pone.0058436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109YM	23516480	gold, Green Published			2022-12-27	WOS:000316407400029
J	Peng, H; Li, WC; Seth, DM; Nair, AR; Francis, J; Feng, YM				Peng, Hua; Li, Wencheng; Seth, Dale M.; Nair, Anand R.; Francis, Joseph; Feng, Yumei			(Pro)renin Receptor Mediates Both Angiotensin II-Dependent and -Independent Oxidative Stress in Neuronal Cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; RENIN/PRORENIN-RECEPTOR; GENE-EXPRESSION; NADPH OXIDASES; RENIN RELEASE; PRORENIN; HYPERTENSION; RESPONSES; BRAIN	The binding of renin or prorenin to the (pro) renin receptor (PRR) promotes angiotensin (Ang) II formation and mediates Ang II-independent signaling pathways. In the central nervous system (CNS), Ang II regulates blood pressure via inducing oxidative stress; however, the role of PRR-mediated Ang II-independent signaling pathways in oxidative stress in the CNS remains undefined. To address this question, Neuro-2A cells were infected with control virus or an adeno-associated virus encoding the human PRR. Human PRR over-expression alone increased ROS levels, NADPH oxidase activity, as well as NADPH oxidase (NOX) isoforms 2 and 4 mRNA expression levels and these effects were not blocked by losartan. Moreover, the increase in NOX 2 and NOX 4 mRNA levels, NADPH oxidase activity, and ROS levels induced by PRR over-expression was prevented by mitogen activated protein kinase/extracellular signal-regulated kinase 1 and 2 (MAPK/ERK1/2) inhibition, and phosphoinositide 3 kinase/Akt (IP3/Akt) inhibition, indicating that PRR regulates NOX activity and ROS formation in neuro-2A cells through Ang II-independent ERK1/2 and IP3/Akt activation. Interestingly, at a concentration of 2 nM or higher, prorenin promoted Ang II formation, and thus further increased the ROS levels in cultured Neuro-2A cells via PRR. In conclusion, human PRR over-expression induced ROS production through both angiotensin II-dependent and -independent mechanisms. We showed that PRR-mediated angiotensin II-independent ROS formation is associated with activation of the MAPK/ERK1/2 and PI3/Akt signaling pathways and up-regulation of mRNA level of NOX 2 and NOX4 isoforms in neuronal cells.	[Peng, Hua; Li, Wencheng; Seth, Dale M.; Feng, Yumei] Tulane Univ, Sch Med, Dept Physiol, Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA; [Nair, Anand R.; Francis, Joseph] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA	Tulane University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Feng, YM (corresponding author), Tulane Univ, Sch Med, Dept Physiol, Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA.	yfeng1@tulane.edu			American Heart Association National Center [11SDG4880005]; NHLBI [1P30HL101285-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	American Heart Association National Center(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the American Heart Association National Center (11SDG4880005) to Y. Feng and the NHLBI (1P30HL101285-01) L.G. Navar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batenburg WW, 2011, HYPERTENSION, V58, P1111, DOI 10.1161/HYPERTENSIONAHA.111.180737; Biswas Kazal Boron, 2010, Front Biosci (Elite Ed), V2, P1234; Cardinale JP, 2012, HYPERTENSION, V59, P113, DOI 10.1161/HYPERTENSIONAHA.111.182154; Clavreul N, 2011, AM J PHYSIOL-RENAL, V300, pF1310, DOI 10.1152/ajprenal.00119.2010; Danser AHJ, 2005, J RENIN-ANGIO-ALDO S, V6, P163, DOI 10.3317/jraas.2005.025; Datla SR, 2010, HYPERTENSION, V56, P325, DOI 10.1161/HYPERTENSIONAHA.109.142422; Feng YM, 2008, CIRC RES, V102, P729, DOI 10.1161/CIRCRESAHA.107.169110; GENAIN CP, 1985, J CLIN INVEST, V76, P1939, DOI 10.1172/JCI112191; Guggilam A, 2011, BASIC RES CARDIOL, V106, P273, DOI 10.1007/s00395-010-0146-8; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Hoffmann A, 2003, J RECEPT SIG TRANSD, V23, P111, DOI 10.1081/RRS-120018764; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Ismail S, 2009, AM J PHYSIOL-LUNG C, V296, pL489, DOI 10.1152/ajplung.90488.2008; Kaneshiro Y, 2006, KIDNEY INT, V70, P641, DOI 10.1038/sj.ki.5001627; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; KURTZ A, 1986, P NATL ACAD SCI USA, V83, P4769, DOI 10.1073/pnas.83.13.4769; Kurtz A, 2011, ANNU REV PHYSIOL, V73, P377, DOI 10.1146/annurev-physiol-012110-142238; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Li WC, 2012, HYPERTENSION, V59, P1188, DOI 10.1161/HYPERTENSIONAHA.111.190108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakagami H, 2003, J MOL CELL CARDIOL, V35, P851, DOI 10.1016/S0022-2828(03)00145-7; Nguyen G, 2004, CURR HYPERTENS REP, V6, P129, DOI 10.1007/s11906-004-0088-3; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2008, CURR OPIN PHARMACOL, V8, P127, DOI 10.1016/j.coph.2007.12.009; Nguyen G, 2011, CLIN SCI, V120, P169, DOI 10.1042/CS20100432; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; OKAMURA T, 1981, P NATL ACAD SCI-BIOL, V78, P6940, DOI 10.1073/pnas.78.11.6940; Ortiz-Capisano MC, 2007, HYPERTENSION, V49, P618, DOI 10.1161/01.HYP.0000255172.84842.d2; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Park S, 2010, J MOL MED, V88, P807, DOI 10.1007/s00109-010-0622-5; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Schefe JH, 2006, CIRC RES, V99, P1355, DOI 10.1161/01.RES.0000251700.00994.0d; SPECK G, 1981, BRAIN RES, V219, P371, DOI 10.1016/0006-8993(81)90300-0; Touyz RM, 2004, HYPERTENSION, V44, P248, DOI 10.1161/01.HYP.0000138070.47616.9d; Zhuo JL, 2011, AM J PHYSIOL-RENAL, V301, pF1193, DOI 10.1152/ajprenal.00555.2011; Zimmerman MC, 2004, CIRC RES, V95, P210, DOI 10.1161/01.RES.0000135483.12297.e4; Zimmerman MC, 2004, PROG BIOPHYS MOL BIO, V84, P125, DOI 10.1016/j.pbiomolbio.2003.11.009	37	52	54	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58339	10.1371/journal.pone.0058339	http://dx.doi.org/10.1371/journal.pone.0058339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516464	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400023
J	Galvan, VV; Vessal, RS; Golley, MT				Galvan, Veronica V.; Vessal, Rosa S.; Golley, Matthew T.			The Effects of Cell Phone Conversations on the Attention and Memory of Bystanders	PLOS ONE			English	Article							INATTENTIONAL BLINDNESS; PERCEPTUAL LOAD; DRIVER; WORDS	The pervasive use of cell phones impacts many people-both cell phone users and bystanders exposed to conversations. This study examined the effects of overhearing a one-sided (cell phone) conversation versus a two-sided conversation on attention and memory. In our realistic design, participants were led to believe they were participating in a study examining the relationship between anagrams and reading comprehension. While the participant was completing an anagram task, the researcher left the room and participants overheard a scripted conversation, either two confederates talking with each other or one confederate talking on a cell phone. Upon the researcher's return, the participant took a recognition memory task with words from the conversation, and completed a questionnaire measuring the distracting nature of the conversation. Participants who overheard the one-sided conversation rated the conversation as significantly higher in distractibility than those who overheard the two-sided conversation. Also, participants in the one-sided condition scored higher on the recognition task. In particular they were more confident and accurate in their responses to words from the conversation than participants in the two-sided condition. However, participants' scores on the anagram task were not significantly different between conditions. As in real world situations, individual participants could pay varying amounts of attention to the conversation since they were not explicitly instructed to ignore it. Even though the conversation was irrelevant to the anagram task and contained less words and noise, one-sided conversations still impacted participants' self-reported distractibility and memory, thus showing people are more attentive to cell phone conversations than two-sided conversations. Cell phone conversations may be a common source of distraction causing negative consequences in workplace environments and other public places.	[Galvan, Veronica V.; Vessal, Rosa S.] Univ San Diego, Coll Arts & Sci, Dept Psychol Sci, San Diego, CA 92110 USA; [Golley, Matthew T.] DYouville Coll, Dept Liberal Arts, Buffalo, NY USA	University of San Diego; D'Youville College	Galvan, VV (corresponding author), Univ San Diego, Coll Arts & Sci, Dept Psychol Sci, San Diego, CA 92110 USA.	vgalvan@sandiego.edu			University of San Diego	University of San Diego	V.V. Galvan received a Faculty Research Grant from her institution, the University of San Diego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1984, PROCESSING RESOURCES; Association CTW, 2012, CTIA WIR ASS SEM ANN; Cooper JM, 2008, HUM FACTORS, V50, P893, DOI 10.1518/001872008X374983; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Decuypere M, 2011, INT J QUAL IN PRESS; Emberson LL, 2010, PSYCHOL SCI, V21, P1383, DOI 10.1177/0956797610382126; Fear WJ, 1997, BEHAV RES METH INS C, V29, P425, DOI 10.3758/BF03200595; FOLEY MA, 1989, MEM COGNITION, V17, P755, DOI 10.3758/BF03202636; Forster S, 2011, PSYCHON B REV, V18, P1064, DOI 10.3758/s13423-011-0172-z; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Green DM, 1966, SIGNAL DETECTION THE; Hatfield J, 2007, ACCIDENT ANAL PREV, V39, P197, DOI 10.1016/j.aap.2006.07.001; Hay EL, 2010, PSYCHOL AGING, V25, P118, DOI 10.1037/a0018747; Hoffman Y, 2011, PSYCHOL SCI, V22, P1490, DOI 10.1177/0956797611419674; Hughes RW, 2007, J EXP PSYCHOL LEARN, V33, P1050, DOI 10.1037/0278-7393.33.6.1050; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; Hyman IE, 2010, APPL COGNITIVE PSYCH, V24, P597, DOI 10.1002/acp.1638; Ingenio & Harris Interactive, 2007, AM US CALL DEM NEW A; Kolsaker A., 2009, J MARK COMMUN, V15, P267, DOI DOI 10.1080/13527260802479664; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 2009, J EXP PSYCHOL HUMAN, V35, P1346, DOI 10.1037/a0016454; Lenhart A., 2010, CELL PHONES AM ADULT; Leung L., 1999, TELEMATICS INFORMATI, V16, P11, DOI DOI 10.1016/S0736-5853(99)00016-7; Macmillan N. A., 1991, DETECTION THEORY USE; MATTHEWS KA, 1980, J PERS SOC PSYCHOL, V38, P525, DOI 10.1037/0022-3514.38.3.525; MAYZNER MS, 1962, J EXP PSYCHOL, V63, P510, DOI 10.1037/h0043721; MCKNIGHT AJ, 1993, ACCIDENT ANAL PREV, V25, P259, DOI 10.1016/0001-4575(93)90020-W; Monk A, 2004, BEHAV INFORM TECHNOL, V23, P301, DOI 10.1080/01449290410001712744; Monk A, 2004, BEHAV INFORM TECHNOL, V23, P33, DOI 10.1080/01449290310001638496; Nasar J, 2008, ACCIDENT ANAL PREV, V40, P69, DOI 10.1016/j.aap.2007.04.005; PAIVIO A, 1968, J EXP PSYCHOL, V76, P1, DOI 10.1037/h0025327; Peters ML, 1998, PSYCHONEUROENDOCRINO, V23, P1, DOI 10.1016/S0306-4530(97)00082-6; Rainie L., 2006, AM USE THEIR CELL PH; Redelmeier DA, 1997, NEW ENGL J MED, V336, P453, DOI 10.1056/NEJM199702133360701; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Ruz M, 2005, NEUROIMAGE, V27, P852, DOI 10.1016/j.neuroimage.2005.05.031; Smith CN, 2011, J NEUROSCI, V31, P15693, DOI 10.1523/JNEUROSCI.3438-11.2011; Stavrinos D, 2011, J SAFETY RES; Strayer DL, 2007, CURR DIR PSYCHOL SCI, V16, P128, DOI 10.1111/j.1467-8721.2007.00489.x; Strayer DL, 2006, HUM FACTORS, V48, P381, DOI 10.1518/001872006777724471; Strayer DL, 2003, J EXP PSYCHOL-APPL, V9, P23, DOI 10.1037/1076-898X.9.1.23; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Vincent J., 2006, KNOWLEDGE TECHNOLOGY, V19, P39, DOI [10.1007/s12130-006-1013-7, DOI 10.1007/S12130-006-1013-7]	43	9	9	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58579	10.1371/journal.pone.0058579	http://dx.doi.org/10.1371/journal.pone.0058579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516514	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849200094
J	Newell, DA; Goldingay, RL; Brooks, LO				Newell, David Alan; Goldingay, Ross Lindsay; Brooks, Lyndon Owen			Population Recovery following Decline in an Endangered Stream-Breeding Frog (Mixophyes fleayi) from Subtropical Australia	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; CHYTRIDIOMYCOSIS; DYNAMICS; SURVIVAL; MORTALITY; DISEASE; SENSITIVITY; PERSISTENCE; EXTINCTION; INFECTION	Amphibians have undergone dramatic declines and extinctions worldwide. Prominent among these have been the stream-breeding frogs in the rainforests of eastern Australia. The amphibian chytrid fungus Batrachochytrium dendrobatidis (Bd) has been postulated as the primary cause of these declines. We conducted a capture-mark-recapture study over a 7-year period on the endangered Fleay's barred frog (Mixophyes fleayi) at two independent streams (30 km apart) in order to assess the stability of these populations. This species had undergone a severe decline across its narrow geographic range. Mark-recapture modelling showed that the number of individuals increased 3-10 fold along stream transects over this period. Frog detection probabilities were frequently above 50% but declined as the populations increased. Adult survival was important to overall population persistence in light of low recruitment events, suggesting that longevity may be a key factor in this recovery. One male and female were present in the capture record for >6 years. This study provides an unambiguous example of population recovery in the presence of Bd.	[Newell, David Alan; Goldingay, Ross Lindsay] So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia; [Brooks, Lyndon Owen] So Cross Univ, Marine Ecol Res Ctr, Lismore, NSW 2480, Australia	Southern Cross University; Southern Cross University	Newell, DA (corresponding author), So Cross Univ, Sch Environm Sci & Engn, Lismore, NSW 2480, Australia.	david.newell@scu.edu.au	Newell, David A/E-7790-2011	Newell, David A/0000-0003-0419-057X; Goldingay, Ross/0000-0002-6684-9299	NSW Department of Environment Climate Change; Co-operative Research Centre for Sustainable Tourism; Declining Frog Working Group of the NSW National Parks and Wildlife Service (NPWS); Northern Rivers Catchment Management Authority via the Commonwealth governments Natural Heritage Trust	NSW Department of Environment Climate Change; Co-operative Research Centre for Sustainable Tourism(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Declining Frog Working Group of the NSW National Parks and Wildlife Service (NPWS); Northern Rivers Catchment Management Authority via the Commonwealth governments Natural Heritage Trust	The work was supported by the NSW Department of Environment & Climate Change, the Co-operative Research Centre for Sustainable Tourism and the Declining Frog Working Group of the NSW National Parks and Wildlife Service (NPWS). The Northern Rivers Catchment Management Authority provided funding via the Commonwealth governments Natural Heritage Trust for the final 2 years of data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Berger L., 1999, DECLINES DISAPPEARAN, V1999, P23; Biek R, 2002, CONSERV BIOL, V16, P728, DOI 10.1046/j.1523-1739.2002.00433.x; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham K. P., 1987, AM FISHERIES SOC MON, V5, P437; Conroy SDS, 2003, POPUL ECOL, V45, P105, DOI 10.1007/s10144-003-0145-9; Daskin JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026215; Forrest MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028444; Goldingay R., 1999, DECLINES DISAPPEARAN, P64; Grafe TU, 2004, OECOLOGIA, V141, P40, DOI 10.1007/s00442-004-1639-7; Hero Jean-Marc, 2006, Pacific Conservation Biology, V12, P313; Hines H, 1999, DECLINES DISAPPEARAN, P44; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Lampo M, 2012, BIOTROPICA, V44, P420, DOI 10.1111/j.1744-7429.2011.00830.x; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lewis BD, 2005, AUST J ZOOL, V53, P185, DOI 10.1071/ZO03063; McDonald K, 1999, DECLINES DISAPPEARAN, P14; McDonald K. R., 2005, PAC CONSERV BIOL, V11, P114, DOI DOI 10.1071/PC050114; Murray K., 2010, Ecology, V91, P1557, DOI 10.1890/09-1608.1; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Muths E, 2011, J APPL ECOL, V48, P873, DOI 10.1111/j.1365-2664.2011.02005.x; PECHMANN JHK, 1994, HERPETOLOGICA, V50, P65; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Pilliod DS, 2010, CONSERV BIOL, V24, P1259, DOI 10.1111/j.1523-1739.2010.01506.x; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Richards SJ, 2005, AUST J ZOOL, V53, P229, DOI 10.1071/ZO03036; Richards Stephen J., 1993, Pacific Conservation Biology, V1, P66; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Rowley JJL, 2007, WILDLIFE RES, V34, P371, DOI 10.1071/WR07014; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Schmidt BR, 2004, HERPETOL J, V14, P167; Schmidt BR, 2005, CONSERV BIOL, V19, P1149, DOI 10.1111/j.1523-1739.2005.00164.x; Schmidt BR, 2003, CR BIOL, V326, pS119, DOI 10.1016/S1631-0691(03)00048-9; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Shirose LJ, 1995, CAN J ZOOL, V73, P1878, DOI 10.1139/z95-220; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stockwell MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036942; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Symonds EP, 2007, J WILDLIFE DIS, V43, P48, DOI 10.7589/0090-3558-43.1.48; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2010, DIVERS DISTRIB, V16, P703, DOI 10.1111/j.1472-4642.2010.00666.x	50	41	43	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58559	10.1371/journal.pone.0058559	http://dx.doi.org/10.1371/journal.pone.0058559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516509	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200088
J	Wang, IK; Lin, CL; Lin, PC; Liang, CC; Liu, YL; Chang, CT; Yen, TH; Morisky, DE; Huang, CC; Sung, FC				Wang, I-Kuan; Lin, Cheng-Li; Lin, Po-Chang; Liang, Chih-Chia; Liu, Yao-Lung; Chang, Chiz-Tzung; Yen, Tzung-Hai; Morisky, Donald E.; Huang, Chiu-Ching; Sung, Fung-Chang			Effectiveness of Influenza Vaccination in Patients with End-Stage Renal Disease Receiving Hemodialysis: A Population-Based Study	PLOS ONE			English	Article							RISK MEDICAL CONDITIONS; PNEUMOCOCCAL VACCINATION; ANTIBODY-RESPONSE; DIALYSIS PATIENTS; HEALTH-CARE; MORTALITY; IMMUNIZATION; HOSPITALIZATIONS; INFLAMMATION; ASSOCIATION	Background: Little is known on the effectiveness of influenza vaccine in ESRD patients. This study compared the incidence of hospitalization, morbidity, and mortality in end-stage renal disease (ESRD) patients undergoing hemodialysis (HD) between cohorts with and without influenza vaccination. Methods: We used the insurance claims data from 1998 to 2009 in Taiwan to determine the incidence of these events within one year after influenza vaccination in the vaccine (N = 831) and the non-vaccine (N = 3187) cohorts. The vaccine cohort to the non-vaccine cohort incidence rate ratio and hazard ratio (HR) of morbidities and mortality were measured. Results: The age-specific analysis showed that the elderly in the vaccine cohort had lower hospitalization rate (100.8 vs. 133.9 per 100 person-years), contributing to an overall HR of 0.81 (95% confidence interval (CI) 0.72-0.90). The vaccine cohort also had an adjusted HR of 0.85 [95% CI 0.75-0.96] for heart disease. The corresponding incidence of pneumonia and influenza was 22.4 versus 17.2 per 100 person-years, but with an adjusted HR of 0.80 (95% CI 0.64-1.02). The vaccine cohort had lowered risks than the non-vaccine cohort for intensive care unit (ICU) admission (adjusted HR 0.20, 95% CI 0.12-0.33) and mortality (adjusted HR 0.50, 95% CI 0.41-0.60). The time-dependent Cox model revealed an overall adjusted HR for mortality of 0.30 (95% CI 0.26-0.35) after counting vaccination for multi-years. Conclusions: ESRD patients with HD receiving the influenza vaccination could have reduced risks of pneumonia/influenza and other morbidities, ICU stay, hospitalization and death, particularly for the elderly.	[Wang, I-Kuan] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Wang, I-Kuan; Liang, Chih-Chia; Liu, Yao-Lung; Chang, Chiz-Tzung; Huang, Chiu-Ching] China Med Univ Hosp, Div Nephrol, Taichung, Taiwan; [Wang, I-Kuan] China Med Univ, Coll Med, Dept Internal Med, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Lin, Po-Chang] China Med Univ Hosp, Div Infect, Taichung, Taiwan; [Yen, Tzung-Hai] Chang Gung Mem Hosp, Div Nephrol, Taipei 10591, Taiwan; [Yen, Tzung-Hai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Morisky, Donald E.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; University of California System; University of California Los Angeles	Huang, CC (corresponding author), China Med Univ Hosp, Div Nephrol, Taichung, Taiwan.	cch@mail.cmuh.org.tw; fcsung1008@yahoo.com	Yen, Tzung-Hai/AAQ-4525-2020; Morisky, Donald/AAU-4679-2021	Yen, Tzung-Hai/0000-0002-0907-1505; 	Executive Yuan National Science Council [NSC 100-2621-M-039 -001]; Department of Health [DOH101-TD-B- 111-004, DOH101-TD-C-111-005]; China Medical University Hospital [1MS1]	Executive Yuan National Science Council; Department of Health; China Medical University Hospital	Executive Yuan National Science Council (grant number NSC 100-2621-M-039 -001), the Department of Health (grant numbers DOH101-TD-B- 111-004 and DOH101-TD-C-111-005) and the China Medical University Hospital (grant number 1MS1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonen JA, 2000, NEPHRON, V86, P56, DOI 10.1159/000045713; Bond TC, 2012, AM J KIDNEY DIS, V60, P959, DOI 10.1053/j.ajkd.2012.04.018; Brydak LB, 2000, VACCINE, V18, P3280, DOI 10.1016/S0264-410X(00)00126-2; Cavdar C, 2003, SCAND J UROL NEPHROL, V37, P71, DOI 10.1080/00365590310008749; Collins AJ, 2010, AM J KIDNEY DIS, V55, p[1, A426], DOI DOI 10.1053/J.AJKD.2009.10.009; Descamps-Latscha B, 1993, Curr Opin Nephrol Hypertens, V2, P883, DOI 10.1097/00041552-199311000-00005; Engstrom G, 2003, DIABETES, V52, P442, DOI 10.2337/diabetes.52.2.442; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gilbertson DT, 2011, NEPHROL DIAL TRANSPL, V26, P2934, DOI 10.1093/ndt/gfq853; Gilbertson DT, 2003, KIDNEY INT, V63, P738, DOI 10.1046/j.1523-1755.2003.00787.x; Hak E, 2005, ARCH INTERN MED, V165, P274, DOI 10.1001/archinte.165.3.274; Hak E, 2002, CLIN INFECT DIS, V35, P370, DOI 10.1086/341403; JOHNSON DW, 1992, CLIN PHARMACOKINET, V22, P434, DOI 10.2165/00003088-199222060-00003; Kausz A, 2004, SEMIN DIALYSIS, V17, P9, DOI 10.1111/j.1525-139X.2004.17104.x; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; McGrath LJ, 2012, AM J KIDNEY DIS, V60, P890, DOI 10.1053/j.ajkd.2012.09.001; McGrath LJ, 2012, ARCH INTERN MED, V172, P548, DOI 10.1001/archinternmed.2011.2238; Naqvi SB, 2006, ADV CHRONIC KIDNEY D, V13, P199, DOI 10.1053/j.ackd.2006.04.004; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Ritger K. A., 2009, Morbidity and Mortality Weekly Report, V58, P913; Sarnak MJ, 2001, CHEST, V120, P1883, DOI 10.1378/chest.120.6.1883; Scharpe J, 2009, AM J KIDNEY DIS, V54, P77, DOI 10.1053/j.ajkd.2008.11.032; Snyder JJ, 2009, J AM SOC NEPHROL, V20, P1614, DOI 10.1681/ASN.2008090954; Song JY, 2006, AM J NEPHROL, V26, P206, DOI 10.1159/000093306; Tanzi E, 2007, J MED VIROL, V79, P1176, DOI 10.1002/jmv.20936; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Vanholder R, 2002, BLOOD PURIFICAT, V20, P477, DOI 10.1159/000063556; Vogtlander NPJ, 2004, VACCINE, V22, P2199, DOI 10.1016/j.vaccine.2003.11.046	30	38	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58317	10.1371/journal.pone.0058317	http://dx.doi.org/10.1371/journal.pone.0058317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516462	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200055
J	Prowse, PDH; Elliott, CG; Hutter, J; Hamilton, DW				Prowse, Paul D. H.; Elliott, Christopher G.; Hutter, Jeff; Hamilton, Douglas W.			Inhibition of Rac and ROCK Signalling Influence Osteoblast Adhesion, Differentiation and Mineralization on Titanium Topographies	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ACTIN STRESS FIBERS; DENTAL IMPLANTS; CYTOSKELETAL ORGANIZATION; NANOSCALE TOPOGRAPHY; SURFACE-ENERGY; RHO GTPASES; ACTIVATION; EXPRESSION; KINASE	Reducing the time required for initial integration of bone-contacting implants with host tissues would be of great clinical significance. Changes in osteoblast adhesion formation and reorganization of the F-actin cytoskeleton in response to altered topography are known to be upstream of osteoblast differentiation, and these processes are regulated by the Rho GTPases. Rac and RhoA (through Rho Kinase (ROCK)). Using pharmacological inhibitors, we tested how inhibition of Rac and ROCK influenced osteoblast adhesion, differentiation and mineralization on PT (Pre-treated) and SLA (sandblasted large grit, acid etched) topographies. Inhibition of ROCK, but not Rac, significantly reduced adhesion number and size on PT, with adhesion size consistent with focal complexes. After 1 day, ROCK, but not Rac inhibition increased osteocalcin mRNA levels on SLA and PT, with levels further increasing at 7 days post seeding. ROCK inhibition also significantly increased bone sialoprotein expression at 7 days, but not BMP-2 levels. Rac inhibition significantly reduced BMP-2 mRNA levels. ROCK inhibition increased nuclear translocation of Runx2 independent of surface roughness. Mineralization of osteoblast cultures was greater on SLA than on PT, but was increased by ROCK inhibition and attenuated by Rac inhibition on both topographies. In conclusion, inhibition of ROCK signalling significantly increases osteoblast differentiation and biomineralization in a topographic dependent manner, and its pharmacological inhibition could represent a new therapeutic to speed bone formation around implanted metals and in regenerative medicine applications.	[Prowse, Paul D. H.; Hamilton, Douglas W.] Univ Western Ontario, Dept Anat, Grad Program Biomed Engn, London, ON, Canada; [Elliott, Christopher G.; Hamilton, Douglas W.] Univ Western Ontario, Dept Cell Biol, Grad Program Biomed Engn, London, ON, Canada; [Hutter, Jeff] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada; [Hamilton, Douglas W.] Univ Western Ontario, Div Oral Biol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Hamilton, DW (corresponding author), Univ Western Ontario, Dept Anat, Grad Program Biomed Engn, London, ON, Canada.	dhamil2@uwo.ca	Hamilton, Douglas W/L-8932-2015	Hamilton, Douglas W/0000-0002-9798-5197	Canadian Foundation for Innovation Leaders Opportunity Fund [18742]; Natural Sciences and Engineering Research Council of Canada [355615-2009]; Ontario Ministry of Research and Innovation Early Researcher Award; Joint Motion Program(JuMP) - A CIHR Training Program in Musculoskeletal Health Research and Leadership	Canadian Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Research and Innovation Early Researcher Award(Ministry of Research and Innovation, Ontario); Joint Motion Program(JuMP) - A CIHR Training Program in Musculoskeletal Health Research and Leadership(Canadian Institutes of Health Research (CIHR))	This work was funded by the Canadian Foundation for Innovation Leaders Opportunity Fund(Grant no: 18742) and the Natural Sciences and Engineering Research Council of Canada(Grant Number: 355615-2009) to DWH. DWH is a recipient of the Ontario Ministry of Research and Innovation Early Researcher Award. This work was also supported by the Joint Motion Program(JuMP) - A CIHR Training Program in Musculoskeletal Health Research and Leadership. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves RDAM, 2010, J PROTEOME RES, V9, P4688, DOI 10.1021/pr100400d; Anselme K, 2004, BIO-MED MATER ENG, V14, P545; Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Berenjeno IM, 2008, CLIN TRANSL ONCOL, V10, P726, DOI 10.1007/s12094-008-0279-5; Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035; Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6; Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196; Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bornstein MM, 2008, CLIN ORAL IMPLAN RES, V19, P1034, DOI 10.1111/j.1600-0501.2008.01573.x; Bornstein MM, 2005, CLIN ORAL IMPLAN RES, V16, P631, DOI 10.1111/j.1600-0501.2005.01209.x; Chen NX, 2010, AM J PHYSIOL-RENAL, V299, pF674, DOI 10.1152/ajprenal.00730.2009; de Vicente JC, 2006, INT J ORAL MAX SURG, V35, P1047, DOI 10.1016/j.ijom.2006.06.008; Elias BC, 2010, CELL ADHES MIGR, V4, P419, DOI 10.4161/cam.4.3.12043; Galli C, 2012, ACTA BIOMATER, V8, P2963, DOI 10.1016/j.actbio.2012.04.043; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamamura K, 2012, CONNECT TISSUE RES; Hamilton DW, 2006, CALCIFIED TISSUE INT, V78, P314, DOI 10.1007/s00223-005-0238-x; Hamilton DW, 2007, BIOMATERIALS, V28, P1806, DOI 10.1016/j.biomaterials.2006.11.041; Harmey D, 2004, J BONE MINER RES, V19, P661, DOI 10.1359/JBMR.040105; Higuchi C, 2009, J BONE MINER METAB, V27, P158, DOI 10.1007/s00774-009-0037-y; Javed F, 2011, IMPLANT DENT, V20, P40, DOI 10.1097/ID.0b013e31820867da; Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013; Jung UW, 2008, J PERIODONTOL, V79, P1857, DOI [10.1902/jop.2008.070632, 10.1902/jop.2008.070632 ]; Kanazawa I, 2010, ENDOCR J, V57, P415, DOI 10.1507/endocrj.K09E-328; Kanazawa I, 2009, AM J PHYSIOL-ENDOC M, V296, pE139, DOI 10.1152/ajpendo.90677.2008; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Koh RU, 2010, IMPLANT DENT, V19, P98, DOI 10.1097/ID.0b013e3181d47eaf; Lai HC, 2010, J BIOMED MATER RES A, V93A, P289, DOI 10.1002/jbm.a.32542; Lamers E, 2010, EUR CELLS MATER, V20, P329; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Lethaus B, 2011, INT J ORAL MAX IMPL, V26, P887; Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]; Miron RJ, 2010, BIOMATERIALS, V31, P449, DOI 10.1016/j.biomaterials.2009.09.075; Neto PT, 2004, QUINTESSENCE INT, V35, P717; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olivares-Navarrete R, 2011, BIOMATERIALS, V32, P6399, DOI 10.1016/j.biomaterials.2011.05.036; PARR GR, 1985, J PROSTHET DENT, V54, P410, DOI 10.1016/0022-3913(85)90562-1; Passeri G, 2010, CLIN ORAL IMPLAN RES, V21, P756, DOI 10.1111/j.1600-0501.2009.01906.x; Qu J, 1996, Oral Dis, V2, P102; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518; Schwarz F, 2007, J PERIODONTOL, V78, P2171, DOI 10.1902/jop.2007.070157; Vincent S, 1997, MOL CELL BIOL, V17, P2247, DOI 10.1128/MCB.17.4.2247; Wang GY, 2004, J BIOL CHEM, V279, P13205, DOI 10.1074/jbc.M311427200; Wennerberg A, 2010, INT J ORAL MAX IMPL, V25, P63; Wieland M, 2005, BIOMATERIALS, V26, P1119, DOI 10.1016/j.biomaterials.2004.04.020; Wieland M, 2001, INT J ORAL MAX IMPL, V16, P163; Yamanouchi K, 1997, J BONE MINER METAB, V15, P23, DOI DOI 10.1007/BF02439451; Yoshikawa H, 2009, CLIN ORTHOP RELAT R, V467, P3087, DOI 10.1007/s11999-009-0976-6; Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024; Zimmerman AW, 2004, J CELL SCI, V117, P2841, DOI 10.1242/jcs.01139; Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035	58	34	35	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58898	10.1371/journal.pone.0058898	http://dx.doi.org/10.1371/journal.pone.0058898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505566	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500131
J	Qin, GH; Jia, M; Liu, T; Zhang, XY; Guo, YP; Zhu, KY; Ma, EB; Zhang, JZ				Qin, Guohua; Jia, Miao; Liu, Ting; Zhang, Xueyao; Guo, Yaping; Zhu, Kun Yan; Ma, Enbo; Zhang, Jianzhen			Characterization and Functional Analysis of Four Glutathione S-Transferases from the Migratory Locust, Locusta migratoria	PLOS ONE			English	Article							2 FIELD POPULATIONS; HETEROLOGOUS EXPRESSION; EPSILON-CLASS; BIOCHEMICAL-CHARACTERIZATION; GENOMIC ORGANIZATION; MOLECULAR-CLONING; RAT-LIVER; IDENTIFICATION; MANILENSIS; RESISTANCE	Glutathione S-transferases (GSTs) play an important role in detoxification of xenobiotics in both prokaryotic and eukaryotic cells. In this study, four GSTs (LmGSTd1, LmGSTs5, LmGSTt1, and LmGSTu1) representing different classes were identified from the migratory locust, Locusta migratoria. These four proteins were heterologously expressed in Escherichia coli as soluble fusion proteins, purified by Ni2+-nitrilotriacetic acid agarose column and biochemically characterized. LmGSTd1, LmGSTs5, and LmGSTu1 showed high activities with 1-chloro-2, 4-dinitrobenzene (CDNB), detectable activity with p-nitro-benzyl chloride (p-NBC) and 1, 2-dichloro-4-nitrobenzene (DCNB), whereas LmGSTt1 showed high activity with p-NBC and detectable activity with CDNB. The optimal pH of the locust GSTs ranged between 7.0 to 9.0. Ethacrynic acid and reactive blue effectively inhibited all four GSTs. LmGSTs5 was most sensitive to heavy metals (Cu2+ and Cd2+). The maximum expression of the four GSTs was observed in Malpighian tubules and fat bodies as evaluated by western blot. The nymph mortalities after carbaryl treatment increased by 28 and 12% after LmGSTs5 and LmGSTu1 were silenced, respectively. The nymph mortalities after malathion and chlorpyrifos treatments increased by 26 and 18% after LmGSTs5 and LmGSTu1 were silenced, respectively. These results suggest that sigma GSTs in L. migratoria play a significant role in carbaryl detoxification, whereas some of other GSTs may also involve in the detoxification of carbaryl and chlorpyrifos.	[Qin, Guohua; Jia, Miao; Liu, Ting; Zhang, Xueyao; Guo, Yaping; Ma, Enbo; Zhang, Jianzhen] Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi Province, Peoples R China; [Qin, Guohua] Shanxi Univ, Coll Environm Sci & Resources, Taiyuan, Shanxi Province, Peoples R China; [Zhu, Kun Yan] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Shanxi University; Shanxi University; Kansas State University	Ma, EB (corresponding author), Shanxi Univ, Res Inst Appl Biol, Taiyuan, Shanxi Province, Peoples R China.	maenbo2003@sxu.edu.cn; zjz@sxu.edu.cn		Zhu, Kun Yan/0000-0001-9372-8030	National Natural Science Foundation of China [30810103907, 31172161, 21007036, 31101463]; Natural Science Foundation of Shanxi Province [2011011033-1, 2012011036-6]; Public Welfare Fund for Agriculture [200903021]; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi [20120303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); Public Welfare Fund for Agriculture; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi	This research was supported by the National Natural Science Foundation of China (International Cooperation and Exchange Program, Grant number 30810103907; Regular Research Program, Grant number 31172161, 21007036, 31101463), the Natural Science Foundation of Shanxi Province (Grant number 2011011033-1, 2012011036-6), the Public Welfare Fund for Agriculture (Grant number 200903021), and Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi (Grant number 20120303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AWASTHI S, 1993, BIOCHIM BIOPHYS ACTA, V1164, P173, DOI 10.1016/0167-4838(93)90245-M; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHRISTIE NT, 1984, BIOL TRACE ELEM RES, V6, P139, DOI 10.1007/BF02916931; CLARK AG, 1989, COMP BIOCHEM PHYS B, V92, P419, DOI 10.1016/0305-0491(89)90114-4; CLARK AG, 1984, PESTIC BIOCHEM PHYS, V22, P249, DOI 10.1016/0048-3575(84)90018-X; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Deng HM, 2009, J INSECT PHYSIOL, V55, P1174, DOI 10.1016/j.jinsphys.2009.08.017; DIERICKX PJ, 1982, ENZYME, V27, P25, DOI 10.1159/000459018; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; DIRR H, 1994, EUR J BIOCHEM, V220, P645, DOI 10.1111/j.1432-1033.1994.tb18666.x; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Ferrari A, 2007, PESTIC BIOCHEM PHYS, V88, P134, DOI 10.1016/j.pestbp.2006.10.005; Friedman R, 2011, MOL PHYLOGENET EVOL, V61, P924, DOI 10.1016/j.ympev.2011.08.027; Fujioka K, 2007, CHEM RES TOXICOL, V20, P1211, DOI 10.1021/tx700133c; Gullipalli D, 2010, COMP BIOCHEM PHYS B, V156, P33, DOI 10.1016/j.cbpb.2010.01.016; Gunasekara AS, 2008, REV ENVIRON CONTAM T, V196, P95, DOI 10.1007/978-0-387-78444-1_4; HARRISON JF, 1994, PHYSIOL ZOOL, V67, P120, DOI 10.1086/physzool.67.1.30163838; He YP, 2004, PESTIC BIOCHEM PHYS, V78, P103, DOI 10.1016/j.pestbp.2003.09.009; Huang YF, 2011, J INSECT PHYSIOL, V57, P1033, DOI 10.1016/j.jinsphys.2011.05.001; Ivarsson Y, 2003, J BIOL CHEM, V278, P8733, DOI 10.1074/jbc.M211776200; Jirajaroenrat K, 2001, INSECT BIOCHEM MOLEC, V31, P867, DOI 10.1016/S0965-1748(01)00032-7; Keeley L.L., 1985, P211; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lyubenova L, 2007, INT J PHYTOREMEDIAT, V9, P465, DOI 10.1080/15226510701709556; Ma EB, 2004, PESTIC BIOCHEM PHYS, V78, P67, DOI 10.1016/j.pestbp.2003.09.001; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; Miyamoto T, 2005, J PESTIC SCI, V30, P31, DOI 10.1584/jpestics.30.31; Qin GH, 2012, J INSECT PHYSIOL, V58, P220, DOI 10.1016/j.jinsphys.2011.10.011; Qin GH, 2011, PEST MANAG SCI, V67, P697, DOI 10.1002/ps.2110; Ranson H, 1997, BIOCHEM J, V324, P97, DOI 10.1042/bj3240097; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Rauch N, 2004, INSECT BIOCHEM MOLEC, V34, P321, DOI 10.1016/j.ibmb.2003.12.001; Saisawang C, 2012, BIOCHEM J, V442, P181, DOI 10.1042/BJ20111747; Salazar-Medina AJ, 2010, J BIOCHEM MOL TOXIC, V24, P218, DOI 10.1002/jbt.20326; Samra AI, 2012, PEST MANAG SCI, V68, P764, DOI 10.1002/ps.2324; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; SERAFINI MT, 1991, BIOCHEM INT, V24, P497; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; TANG AH, 1994, J BIOL CHEM, V269, P27876; Udomsinprasert R, 2005, BIOCHEM J, V388, P763, DOI 10.1042/BJ20042015; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Vontas JG, 2002, BIOCHEM J, V362, P329, DOI 10.1042/bj3620329; Wang Y, 2012, PESTIC BIOCH PHYSL; Wang YJ, 2008, J STRUCT BIOL, V164, P228, DOI 10.1016/j.jsb.2008.08.003; Yamamoto K, 2005, COMP BIOCHEM PHYS B, V141, P340, DOI 10.1016/j.cbpc.2005.04.012; Yamamoto K, 2007, BIOSCI BIOTECH BIOCH, V71, P553, DOI 10.1271/bbb.60592; Yang ML, 2008, PESTIC BIOCHEM PHYS, V91, P32, DOI 10.1016/j.pestbp.2007.12.004; Yong ML, 2009, ARCH INSECT BIOCHEM, V71, P3, DOI 10.1002/arch.20254; Yu QY, 2008, INSECT BIOCHEM MOLEC, V38, P1158, DOI 10.1016/j.ibmb.2008.08.002; Yu SJ, 2002, PESTIC BIOCHEM PHYS, V72, P100, DOI 10.1006/pest.2001.2585; Yu SJ, 2000, PESTIC BIOCHEM PHYS, V67, P36, DOI 10.1006/pest.1999.2472; Zou FM, 2011, MOL BIOL REP, V38, P639, DOI 10.1007/s11033-010-0150-y	53	58	64	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58410	10.1371/journal.pone.0058410	http://dx.doi.org/10.1371/journal.pone.0058410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505503	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500080
J	Sonthiphand, P; Neufeld, JD				Sonthiphand, Puntipar; Neufeld, Josh D.			Evaluating Primers for Profiling Anaerobic Ammonia Oxidizing Bacteria within Freshwater Environments	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; IN-SITU DETECTION; ANAMMOX BACTERIA; OXIDATION ANAMMOX; MARINE-SEDIMENTS; BLACK-SEA; MOLECULAR-DETECTION; SEQUENCE ALIGNMENT; NITROGEN LOSS; DIVERSITY	Anaerobic ammonia oxidizing (anammox) bacteria play an important role in transforming ammonium to nitrogen gas and contribute to fixed nitrogen losses in freshwater environments. Understanding the diversity and abundance of anammox bacteria requires reliable molecular tools, and these are not yet well established for these important Planctomycetes. To help validate PCR primers for the detection of anammox bacteria within freshwater ecosystems, we analyzed representative positive controls and selected samples from Grand River and groundwater sites, both from Ontario, Canada. The objectives of this study were to identify a suitable anammox denaturing gradient gel electrophoresis (DGGE) fingerprint method by using GC-clamp modifications to existing primers, and to verify the specificity of anammox-specific primers used for DGGE, cloning and qPCR methods. Six primer combinations were tested from four published primer sets (i.e. A438f/A684r, Amx368f/Amx820r, An7f/An1388r, and Pla46/1392r) for both direct and nested PCR amplifications. All PCR products were run subsequently on DGGE gels to compare the resulting patterns. Two anammox-specific primer combinations were also used to generate clone libraries and quantify anammox bacterial 16S rRNA genes with qPCR. The primer set A438f/A684r was highly specific to anammox bacteria, provided reliable DGGE fingerprints and generated a high proportion of anammox-related clones. A second primer set (Amx368f/Amx820r) was anammox specific, based on clone library analysis, but PCR products from different candidate species of anammox bacteria resolved poorly using DGGE analysis. Both DGGE and cloning results revealed that Ca. Brocadia and an uncharacterized anammox bacterial cluster represented the majority of anammox bacteria found in Grand River sediment and groundwater samples, respectively. Together, our results demonstrate that although Amx368f/Amx820r was useful for anammox-specific qPCR and clone library analysis, A438f/A684r was the most suitable primer set for multiple molecular assessments of anammox bacteria in freshwater environments.	[Sonthiphand, Puntipar; Neufeld, Josh D.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Neufeld, JD (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	jneufeld@uwaterloo.ca			National Science and Engineering Research Council of Canada (NSERC)	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a Strategic Projects Grant from the National Science and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2007, MICROBES ENVIRON, V22, P232, DOI 10.1264/jsme2.22.232; Bae H, 2010, PROCESS BIOCHEM, V45, P323, DOI 10.1016/j.procbio.2009.10.004; Brandsma J, 2011, ENV MICROBIOL REP, V3, P360, DOI 10.1111/j.1758-2229.2010.00233.x; BRODA E, 1977, Z ALLG MIKROBIOL, V17, P491, DOI 10.1002/jobm.3630170611; Dale OR, 2009, ENVIRON MICROBIOL, V11, P1194, DOI 10.1111/j.1462-2920.2008.01850.x; Dalsgaard T, 2005, RES MICROBIOL, V156, P457, DOI 10.1016/j.resmic.2005.01.011; Dang HY, 2010, APPL ENVIRON MICROB, V76, P7036, DOI 10.1128/AEM.01264-10; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engstrom P, 2009, LIMNOL OCEANOGR, V54, P1643, DOI 10.4319/lo.2009.54.5.1643; Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340, DOI 10.1128/AEM.62.2.340-346.1996; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Green SJ, 2010, HDB HYDROCARBON LIPI, P4137, DOI DOI 10.1007/978-3-540-77587-4_323; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamersley MR, 2009, SYST APPL MICROBIOL, V32, P571, DOI 10.1016/j.syapm.2009.07.009; Harhangi HR, 2012, APPL ENVIRON MICROB, V78, P752, DOI 10.1128/AEM.07113-11; Helmer C, 1999, WATER SCI TECHNOL, V39, P13, DOI 10.2166/wst.1999.0317; Hirsch MD, 2011, MICROB ECOL, V61, P264, DOI 10.1007/s00248-010-9743-1; Hong YG, 2011, MICROB ECOL, V62, P36, DOI 10.1007/s00248-011-9849-0; Hong YG, 2011, APPL MICROBIOL BIOT, V89, P1233, DOI 10.1007/s00253-010-2925-4; Hu BL, 2011, APPL ENVIRON MICROB, V77, P966, DOI 10.1128/AEM.02402-10; Hu BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033826; Humbert S, 2012, ENV MICROBIOL REP, V4, P484, DOI 10.1111/j.1758-2229.2012.00347.x; Humbert S, 2010, ISME J, V4, P450, DOI 10.1038/ismej.2009.125; Jetten MSM, 2003, APPL MICROBIOL BIOT, V63, P107, DOI 10.1007/s00253-003-1422-4; Kirkpatrick J, 2006, APPL ENVIRON MICROB, V72, P3079, DOI 10.1128/AEM.72.4.3079-3083.2006; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Lam P, 2007, P NATL ACAD SCI USA, V104, P7104, DOI 10.1073/pnas.0611081104; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Li H, 2010, MICROB ECOL, V60, P771, DOI 10.1007/s00248-010-9733-3; Li M, 2011, ECOTOXICOLOGY, V20, P1780, DOI 10.1007/s10646-011-0711-4; Li M, 2011, ENVIRON SCI TECHNOL, V45, P3547, DOI 10.1021/es103826w; Li M, 2010, APPL MICROBIOL BIOT, V86, P781, DOI 10.1007/s00253-009-2361-5; Lynch MDJ, 2013, GIGASCIENCE IN PRESS; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Mohamed NM, 2010, ISME J, V4, P38, DOI 10.1038/ismej.2009.84; Moore TA, 2011, ENVIRON SCI TECHNOL, V45, P7217, DOI 10.1021/es201243t; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1016/0168-6496(94)00081-7; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Neef A, 1998, MICROBIOL-UK, V144, P3257, DOI 10.1099/00221287-144-12-3257; Neufeld JD, 2007, ISME J, V1, P480, DOI 10.1038/ismej.2007.65; Penton CR, 2006, APPL ENVIRON MICROB, V72, P6829, DOI 10.1128/AEM.01254-06; Rich JJ, 2008, MICROB ECOL, V55, P311, DOI 10.1007/s00248-007-9277-3; Richards F.A., 1965, CHEM OCEANOGRAPHY, P611; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Schmid M, 2003, SYST APPL MICROBIOL, V26, P529, DOI 10.1078/072320203770865837; Schmid M, 2001, ENVIRON MICROBIOL, V3, P450, DOI 10.1046/j.1462-2920.2001.00211.x; Schmid MC, 2007, ENVIRON MICROBIOL, V9, P1476, DOI 10.1111/j.1462-2920.2007.01266.x; Schmid MC, 2005, APPL ENVIRON MICROB, V71, P1677, DOI 10.1128/AEM.71.4.1677-1684.2005; Schubert CJ, 2006, ENVIRON MICROBIOL, V8, P1857, DOI 10.1111/j.1462-2920.2006.01074.x; Sonthiphand P, 2012, ENV MICROBIOL UNPUB; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Strous M, 1998, APPL MICROBIOL BIOT, V50, P589, DOI 10.1007/s002530051340; Tal Y, 2006, APPL ENVIRON MICROB, V72, P2896, DOI 10.1128/AEM.72.4.2896-2904.2006; Tal Y, 2005, APPL ENVIRON MICROB, V71, P1816, DOI 10.1128/AEM.71.4.1816-1821.2005; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Trimmer M, 2009, LIMNOL OCEANOGR, V54, P577, DOI 10.4319/lo.2009.54.2.0577; van der Star WRL, 2008, BIOTECHNOL BIOENG, V101, P286, DOI 10.1002/bit.21891; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Woebken D, 2008, ENVIRON MICROBIOL, V10, P3106, DOI 10.1111/j.1462-2920.2008.01640.x; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Yoshinaga I, 2011, MICROBES ENVIRON, V26, P189, DOI 10.1264/jsme2.ME10184; Zhang Y, 2007, ENVIRON MICROBIOL, V9, P2375, DOI 10.1111/J.1462-2920.2007.01357.x; Zhu GB, 2011, ENVIRON SCI TECHNOL, V45, P9951, DOI 10.1021/es202183w; Zhu GB, 2011, ISME J, V5, P1905, DOI 10.1038/ismej.2011.63	64	27	29	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57242	10.1371/journal.pone.0057242	http://dx.doi.org/10.1371/journal.pone.0057242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505422	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500014
J	Buchalski, MR; Fontaine, JB; Heady, PA; Hayes, JP; Frick, WF				Buchalski, Michael R.; Fontaine, Joseph B.; Heady, Paul A., III; Hayes, John P.; Frick, Winifred F.			Bat Response to Differing Fire Severity in Mixed-Conifer Forest California, USA	PLOS ONE			English	Article							WESTERN OREGON; SURROGATE TREATMENTS; INSECTIVOROUS BATS; EVERGREEN FOREST; PRESCRIBED FIRE; SITE OCCUPANCY; PREY SELECTION; CONSERVATION; HABITAT; STANDS	Wildlife response to natural disturbances such as fire is of conservation concern to managers, policy makers, and scientists, yet information is scant beyond a few well-studied groups (e.g., birds, small mammals). We examined the effects of wildfire severity on bats, a taxon of high conservation concern, at both the stand (<1 ha) and landscape scale in response to the 2002 McNally fire in the Sierra Nevada region of California, USA. One year after fire, we conducted surveys of echolocation activity at 14 survey locations, stratified in riparian and upland habitat, in mixed-conifer forest habitats spanning three levels of burn severity: unburned, moderate, and high. Bat activity in burned areas was either equivalent or higher than in unburned stands for all six phonic groups measured, with four groups having significantly greater activity in at least one burn severity level. Evidence of differentiation between fire severities was observed with some Myotis species having higher levels of activity in stands of high-severity burn. Larger-bodied bats, typically adapted to more open habitat, showed no response to fire. We found differential use of riparian and upland habitats among the phonic groups, yet no interaction of habitat type by fire severity was found. Extent of high-severity fire damage in the landscape had no effect on activity of bats in unburned sites suggesting no landscape effect of fire on foraging site selection and emphasizing stand-scale conditions driving bat activity. Results from this fire in mixed-conifer forests of California suggest that bats are resilient to landscape-scale fire and that some species are preferentially selecting burned areas for foraging, perhaps facilitated by reduced clutter and increased post-fire availability of prey and roosts.	[Buchalski, Michael R.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Fontaine, Joseph B.] Murdoch Univ, Sch Environm Sci, Perth, WA, Australia; [Heady, Paul A., III] Cent Coast Bat Res Grp, Aptos, CA USA; [Hayes, John P.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Frick, Winifred F.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	Western Michigan University; Murdoch University; State University System of Florida; University of Florida; University of California System; University of California Santa Cruz	Buchalski, MR (corresponding author), Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA.	michael.buchalski@wmich.edu	Fontaine, Joseph/O-2758-2019; Fontaine, Joseph B/M-9186-2013; Hayes, John/C-7967-2016; Frick, Winifred/ABA-3519-2020	Fontaine, Joseph/0000-0002-6515-7864; Fontaine, Joseph B/0000-0002-6515-7864; Hayes, John/0000-0002-6462-6876; Frick, Winifred/0000-0002-9469-1839	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	W. Frick was funded by National Science Foundation during parts of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agee J. K., 1993, FIRE ECOLOGY PACIFIC; Armitage DW, 2012, J MAMMAL, V93, P102, DOI 10.1644/11-MAMM-A-169.1; Barclay RMR, 1999, J MAMMAL, V80, P290, DOI 10.2307/1383229; Betts BJ, 1998, J MAMMAL, V79, P643, DOI 10.2307/1382994; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; Boyles JG, 2006, FOREST ECOL MANAG, V222, P108, DOI 10.1016/j.foreco.2005.09.024; Brigham RM, 1997, CAN J ZOOL, V75, P131, DOI 10.1139/z97-017; Brigham RM, 1997, J MAMMAL, V78, P1231, DOI 10.2307/1383066; BRIGHAM RM, 1992, J MAMMAL, V73, P640, DOI 10.2307/1382036; Broders HG, 2003, ACTA CHIROPTEROL, V5, P235, DOI 10.3161/001.005.0206; Carter T.C., 2002, FIRE BATS SE MIDATLA, P139; Clark DA, 2011, J RAPTOR RES, V45, P38, DOI 10.3356/JRR-10-42.1; Clarke FM, 2005, J APPL ECOL, V42, P409, DOI 10.1111/j.1365-2664.2005.01024.x; Cooper IA, 2003, ECOLOGICAL RESTORATI, V21, P204; Crampton LH, 1998, CONSERV BIOL, V12, P1347, DOI 10.1046/j.1523-1739.1998.97209.x; Donato DC, 2009, J ECOL, V97, P142, DOI 10.1111/j.1365-2745.2008.01456.x; Erickson JL, 2003, BIOL CONSERV, V109, P95, DOI 10.1016/S0006-3207(02)00141-6; FENTON MB, 1970, CAN J ZOOLOG, V48, P847, DOI 10.1139/z70-148; Fenton MB, 1997, J MAMMAL, V78, P1, DOI 10.2307/1382633; Fisher JT, 2005, MAMMAL REV, V35, P51, DOI 10.1111/j.1365-2907.2005.00053.x; Fontaine JB, 2012, ECOL APPL, V22, P1547, DOI 10.1890/12-0009.1; Fontaine JB, 2009, FOREST ECOL MANAG, V257, P1496, DOI 10.1016/j.foreco.2008.12.030; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; Goodman K, 2008, ENCY ENTOMOLOGY, P3090; Halofsky JE, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00184.1; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hayes JP, 1997, J MAMMAL, V78, P514, DOI 10.2307/1382902; Hayes JP, 2000, ACTA CHIROPTEROL, V2, P225; Humes ML, 1999, J WILDLIFE MANAGE, V63, P553, DOI 10.2307/3802642; Hutto RL, 2008, ECOL APPL, V18, P1827, DOI 10.1890/08-0895.1; Jung TS, 2000, J WILDLIFE MANAGE, V64, P1099; Kalcounis MC, 1998, J WILDLIFE MANAGE, V62, P603, DOI 10.2307/3802336; Key CH, 2005, LANDSCAPE ASSESSMENT; Kotliar NB, 2007, ECOL APPL, V17, P491, DOI 10.1890/06-0253; Lacki MJ, 2007, NORTHWEST SCI, V81, P199, DOI 10.3955/0029-344X-81.3.199; Lacki MJ, 2009, J MAMMAL, V90, P1165, DOI 10.1644/08-MAMM-A-349.1; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; Loeb SC, 2008, FOREST ECOL MANAG, V255, P3185, DOI 10.1016/j.foreco.2007.10.060; Loeb SC, 2011, MANAG FOR ECOSYST, V21, P167, DOI 10.1007/978-94-007-1620-9_10; Malison RL, 2010, J N AM BENTHOL SOC, V29, P1324, DOI 10.1899/09-022.1; Malison RL, 2010, CAN J FISH AQUAT SCI, V67, P570, DOI 10.1139/F10-006; Mickleburgh SP, 2002, ORYX, V36, P18, DOI 10.1017/S0030605301000011; Nimmo DG, 2012, CONSERV BIOL; Ober HK, 2008, J MAMMAL, V89, P1191, DOI 10.1644/08-MAMM-A-025.1; Odion DC, 2006, ECOSYSTEMS, V9, P1177, DOI 10.1007/s10021-003-0134-z; Owen SF, 2004, NORTH J APPL FOR, V21, P154, DOI 10.1093/njaf/21.3.154; Parr CL, 2006, CONSERV BIOL, V20, P1610, DOI 10.1111/j.1523-1739.2006.00492.x; Perry DA, 2011, FOREST ECOL MANAG, V262, P703, DOI 10.1016/j.foreco.2011.05.004; Peters SL, 2006, CONSERV BIOL, V20, P1410, DOI 10.1111/j.1523-1739.2006.00526.x; Powell EN, 2012, ECOL MONOGR, V82, P69, DOI 10.1890/11-0607.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Reed CC, 1997, NAT AREA J, V17, P380; Roberts SL, 2011, BIOL CONSERV, V144, P610, DOI 10.1016/j.biocon.2010.11.002; Saab VA, 2005, FIRE AVIAN ECOLOGY N; Safford HD, 2008, ECOSYSTEMS, V11, P1, DOI 10.1007/s10021-007-9094-z; Schurbon JM, 2003, CONSERV BIOL, V17, P1338, DOI 10.1046/j.1523-1739.2003.01514.x; Sleep DJH, 2003, J MAMMAL, V84, P216, DOI 10.1644/1545-1542(2003)084<0216:AETOCT>2.0.CO;2; Stephens SL, 2012, BIOSCIENCE, V62, P549, DOI 10.1525/bio.2012.62.6.6; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1141, DOI 10.1023/A:1016683807033; Taylor RS, 2012, DIVERS DISTRIB, V18, P519, DOI 10.1111/j.1472-4642.2011.00842.x; TURNER MG, 1994, J VEG SCI, V5, P731, DOI 10.2307/3235886; U. S. Forest Service [USFS], 2006, MCNALLY FIR RDNBR VE; Webala PW, 2011, J APPL ECOL, V48, P398, DOI 10.1111/j.1365-2664.2010.01934.x; WILSON DE, 1993, MAMMALIAN SPECIES WO; Yates MD, 2006, J WILDLIFE MANAGE, V70, P1238, DOI 10.2193/0022-541X(2006)70[1238:EOFSAF]2.0.CO;2; Zeiner D. C., 1990, CALIFORNIAS WILDLIFE, VIII; Zielinski WJ, 2004, J MAMMAL, V85, P649, DOI 10.1644/BOS-126; [No title captured]	71	51	54	3	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57884	10.1371/journal.pone.0057884	http://dx.doi.org/10.1371/journal.pone.0057884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483936	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100052
J	Jamin, EL; Riu, A; Douki, T; Debrauwer, L; Cravedi, JP; Zalko, D; Audebert, M				Jamin, Emilien L.; Riu, Anne; Douki, Thierry; Debrauwer, Laurent; Cravedi, Jean-Pierre; Zalko, Daniel; Audebert, Marc			Combined Genotoxic Effects of a Polycyclic Aromatic Hydrocarbon (B(a)P) and an Heterocyclic Amine (PhIP) in Relation to Colorectal Carcinogenesis	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; COLON EPITHELIAL-CELLS; INTESTINAL NEOPLASIA MICE; ADDUCT FORMATION; DNA-ADDUCTS; APC(MIN) MUTATION; GAMMA-H2AX ASSAY; MEAT CONSUMPTION; CANCER; RISK	Colorectal neoplasia is the third most common cancer worldwide. Environmental factors such as diet are known to be involved in the etiology of this cancer. Several epidemiological studies have suggested that specific neo-formed mutagenic compounds related to meat consumption are an underlying factor involved in the association between diet and colorectal cancer. Heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs) are known mutagens and possible human carcinogens formed at the same time in meat during cooking processes. We studied the genotoxicity of the model PAH benzo(a) pyrene (B(a) P) and HCA 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), alone or in mixture, using the mouse intestinal cell line Apc(Min/+), mimicking the early step of colorectal carcinogenesis, and control Apc(+/+) cells. The genotoxicity of B(a) P and PhIP was investigated using both cell lines, through the quantification of B(a) P and PhIP derived DNA adducts, as well as the use of a genotoxic assay based on histone H2AX phosphorylation quantification. Our results demonstrate that heterozygous Apc mutated cells are more effective to metabolize B(a) P. We also established in different experiments that PhIP and B(a) P were more genotoxic on Apc(Min/+) cells compared to Apc(+/+). Moreover when tested in mixture, we observed a combined genotoxicity of B(a) P and PhIP on the two cell lines, with an increase of PhIP derived DNA adducts in the presence of B(a) P. Because of their genotoxic effects observed on heterozygous Apc mutated cells and their possible combined genotoxic effects, both B(a) P and PhIP, taken together, could be implicated in the observed association between meat consumption and colorectal cancer.	[Jamin, Emilien L.; Riu, Anne; Debrauwer, Laurent; Cravedi, Jean-Pierre; Zalko, Daniel; Audebert, Marc] INRA, Toxalim, Res Ctr Food Toxicol, UMR1331, F-31931 Toulouse, France; [Jamin, Emilien L.; Riu, Anne; Debrauwer, Laurent; Cravedi, Jean-Pierre; Zalko, Daniel; Audebert, Marc] Univ Toulouse, INPT, UPS, UMR1331, Toulouse, France; [Douki, Thierry] Univ Grenoble 1, CEA, Inst Nanosci & Cryogenie, SCIB,Lab Les Acides Nucl,UMR E3, Grenoble, France	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Audebert, M (corresponding author), INRA, Toxalim, Res Ctr Food Toxicol, UMR1331, F-31931 Toulouse, France.	marc.audebert@toulouse.inra.fr	Jamin, Emilien L/AAI-4388-2021; AUDEBERT, Marc A/C-1153-2008; Thierry, Douki/H-2108-2018; Debrauwer, Laurent/H-7807-2013; Jamin, Emilien L/B-7407-2009	Jamin, Emilien L/0000-0002-4568-9177; AUDEBERT, Marc A/0000-0001-7898-6912; Thierry, Douki/0000-0002-5022-071X; 	NeoMeaTox Inca program	NeoMeaTox Inca program	This research was funded in part by the NeoMeaTox Inca program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alexandrov K, 1996, CARCINOGENESIS, V17, P2081, DOI 10.1093/carcin/17.9.2081; Audebert M, 2012, TOXICOL APPL PHARM, V260, P58, DOI 10.1016/j.taap.2012.01.022; Audebert M, 2010, TOXICOL LETT, V199, P182, DOI 10.1016/j.toxlet.2010.08.022; Audebert M, 2011, ARCH TOXICOL, V85, P1463, DOI 10.1007/s00204-011-0721-2; Baradat M, 2011, CHEM RES TOXICOL, V24, P1984, DOI 10.1021/tx2003036; Bellocq D, 2008, MUTAT RES-GEN TOX EN, V653, P34, DOI 10.1016/j.mrgentox.2008.02.010; Bellocq D, 2010, STEROIDS, V75, P665, DOI 10.1016/j.steroids.2010.04.003; Brown K, 2001, P NATL ACAD SCI USA, V98, P8507, DOI 10.1073/pnas.151251898; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; COSMAN M, 1992, P NATL ACAD SCI USA, V89, P1914, DOI 10.1073/pnas.89.5.1914; Cross AJ, 2004, ENVIRON MOL MUTAGEN, V44, P44, DOI 10.1002/em.20030; Diggs DL, 2012, TUMOR BIOL, V33, P1255, DOI 10.1007/s13277-012-0375-6; Dingley KH, 1999, CANCER EPIDEM BIOMAR, V8, P507; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fenton JI, 2006, CARCINOGENESIS, V27, P893, DOI 10.1093/carcin/bgi355; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ferrucci LM, 2012, BRIT J CANCER, V106, P608, DOI 10.1038/bjc.2011.549; Fontana RJ, 1999, GASTROENTEROLOGY, V117, P89, DOI 10.1016/S0016-5085(99)70554-8; Forest V, 2003, CELL IMMUNOL, V223, P70, DOI 10.1016/S0008-8749(03)00149-7; Forest V, 2003, NUTR CANCER, V45, P84, DOI 10.1207/S15327914NC4501_10; Garner RC, 1999, CANCER LETT, V143, P161, DOI 10.1016/S0304-3835(99)00118-4; Gil J, 2012, MOL BIOL REP, V39, P527, DOI 10.1007/s11033-011-0767-5; Girard H, 2008, MUTAT RES-FUND MOL M, V644, P56, DOI 10.1016/j.mrfmmm.2008.07.002; Graillot V, 2012, MUTAT RES-GEN TOX EN, V748, P8, DOI 10.1016/j.mrgentox.2012.05.014; Graillot V, 2012, ENVIRON MOL MUTAGEN, V53, P173, DOI 10.1002/em.21676; Hakura A, 1998, MUTAT RES-FUND MOL M, V398, P123, DOI 10.1016/S0027-5107(97)00248-0; Jacques C, 2010, ANAL BIOANAL CHEM, V396, P1691, DOI 10.1007/s00216-009-3389-1; Jamin EL, 2007, J AM SOC MASS SPECTR, V18, P2107, DOI 10.1016/j.jasms.2007.09.008; Joshi AD, 2009, CARCINOGENESIS, V30, P472, DOI 10.1093/carcin/bgn260; Keating GA, 2004, J CHROMATOGR B, V802, P127, DOI 10.1016/j.jchromb.2003.10.047; Kemp MG, 2011, J BIOL CHEM, V286, P19237, DOI 10.1074/jbc.M111.235036; Knize M G, 1999, Adv Exp Med Biol, V459, P179; Loeppen S, 2005, CARCINOGENESIS, V26, P239, DOI 10.1093/carcin/bgh298; Louiz I, 2008, SCI TOTAL ENVIRON, V402, P318, DOI 10.1016/j.scitotenv.2008.05.005; Marian B, 2002, FOOD CHEM TOXICOL, V40, P1099, DOI 10.1016/S0278-6915(02)00061-3; Marie C, 2008, J APPL TOXICOL, V28, P579, DOI 10.1002/jat.1306; Martinez ME, 2007, CARCINOGENESIS, V28, P2019, DOI 10.1093/carcin/bgm179; McGregor WG, 1997, MUTAT RES-FUND MOL M, V376, P143, DOI 10.1016/S0027-5107(97)00037-7; Nagao M, 1996, ENVIRON HEALTH PERSP, V104, P497, DOI 10.2307/3432812; Narayan Satya, 2003, Mol Cancer, V2, P41, DOI 10.1186/1476-4598-2-41; Pierre F, 2007, CARCINOGENESIS, V28, P321, DOI 10.1093/carcin/bgl127; Ravanat JL, 2002, CARCINOGENESIS, V23, P1911, DOI 10.1093/carcin/23.11.1911; Reeves DA, 2011, NUCLEIC ACIDS RES, V39, P8752, DOI 10.1093/nar/gkr537; RINDGEN D, 1995, CHEM RES TOXICOL, V8, P1005, DOI 10.1021/tx00050a003; Shimada T, 2006, CHEM RES TOXICOL, V19, P288, DOI 10.1021/tx050291v; Sinha R, 2005, CANCER EPIDEM BIOMAR, V14, P2030, DOI 10.1158/1055-9965.EPI-04-0854; Sinha R, 2005, CANCER RES, V65, P8034, DOI 10.1158/0008-5472.CAN-04-3429; Slyskova J, 2012, MUTAGENESIS, V27, P225, DOI 10.1093/mutage/ger088; Smart DJ, 2011, MUTAT RES-FUND MOL M, V715, P25, DOI 10.1016/j.mrfmmm.2011.07.001; Steffensen IL, 2001, CANCER RES, V61, P8689; Steffensen IL, 1997, CARCINOGENESIS, V18, P1049, DOI 10.1093/carcin/18.5.1049; Steffensen IL, 2006, CANCER LETT, V240, P289, DOI 10.1016/j.canlet.2005.09.015; Toyota M, 1996, CANCER, V77, P1593; Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s; Turteltaub KW, 1999, CANCER LETT, V143, P149, DOI 10.1016/S0304-3835(99)00116-0; Watters GP, 2009, MUTAT RES-GEN TOX EN, V679, P50, DOI 10.1016/j.mrgentox.2009.07.007; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006; Yilmaz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022986; Zhou CX, 2006, MUTAT RES-GEN TOX EN, V604, P8, DOI 10.1016/j.mrgentox.2005.12.004	60	41	43	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58591	10.1371/journal.pone.0058591	http://dx.doi.org/10.1371/journal.pone.0058591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484039	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100127
J	Pacagnella, RC; Souza, JP; Durocher, J; Perel, P; Blum, J; Winikoff, B; Gulmezoglu, AM				Pacagnella, Rodolfo Carvalho; Souza, Joao Paulo; Durocher, Jill; Perel, Pablo; Blum, Jennifer; Winikoff, Beverly; Guelmezoglu, Ahmet Metin			A Systematic Review of the Relationship between Blood Loss and Clinical Signs	PLOS ONE			English	Review							SHOCK INDEX; MASSIVE TRANSFUSION; VITAL SIGNS; HEART-RATE; TRAUMA; HYPOTENSION; HEMORRHAGE; MORTALITY; PRESSURE; VOLUME	Introduction: This systematic review examines the relationship between blood loss and clinical signs and explores its use to trigger clinical interventions in the management of obstetric haemorrhage. Methods: A systematic review of the literature was carried out using a comprehensive search strategy to identify studies presenting data on the relationship of clinical signs & symptoms and blood loss. Methodological quality was assessed using the STROBE checklist and the general guidelines of MOOSE. Results: 30 studies were included and five were performed in women with pregnancy-related haemorrhage (other studies were carried in non-obstetric populations). Heart rate (HR), systolic blood pressure (SBP) and shock index were the parameters most frequently studied. An association between blood loss and HR changes was observed in 22 out of 24 studies, and between blood loss and SBP was observed in 17 out of 23 studies. An association was found in all papers reporting on the relationship of shock index and blood loss. Seven studies have used Receiver Operating Characteristic Curves to determine the accuracy of clinical signs in predicting blood loss. In those studies the AUC ranged from 0.56 to 0.74 for HR, from 0.56 to 0.79 for SBP and from 0.77 to 0.84 for shock index. In some studies, HR, SBP and shock index were associated with increased mortality. Conclusion: We found a substantial variability in the relationship between blood loss and clinical signs, making it difficult to establish specific cut-off points for clinical signs that could be used as triggers for clinical interventions. However, the shock index can be an accurate indicator of compensatory changes in the cardiovascular system due to blood loss. Considering that most of the evidence included in this systematic review is derived from studies in non-obstetric populations, further research on the use of the shock index in obstetric populations is needed.	[Pacagnella, Rodolfo Carvalho] Univ Fed Sao Carlos, BR-13560 Sao Carlos, SP, Brazil; [Souza, Joao Paulo; Guelmezoglu, Ahmet Metin] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Durocher, Jill; Blum, Jennifer; Winikoff, Beverly] Gynu Hlth Projects, New York, NY USA; [Perel, Pablo] London Sch Hyg & Trop Med, London WC1, England	Universidade Federal de Sao Carlos; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Pacagnella, RC (corresponding author), Univ Fed Sao Carlos, BR-13560 Sao Carlos, SP, Brazil.	rodolfopacagnella@gmail.com	de Carvalho Pacagnella, Rodolfo/H-9390-2019; Pacagnella, Rodolfo/H-6247-2012; Souza, João Paulo/G-1982-2010	de Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Pacagnella, Rodolfo/0000-0002-5739-0009; Souza, João Paulo/0000-0002-2288-4244; /0000-0002-2342-301X; Durocher, Jill/0000-0002-5572-8133	Gynuity Health Projects; World Health Organization	Gynuity Health Projects; World Health Organization(World Health Organization)	Work on this systematic review was financially and technically supported by Gynuity Health Projects and the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Surgeons Trauma Committee, 2008, ADV TRAUM LIF SUPP D; Baron BJ, 2004, J TRAUMA, V57, P69, DOI 10.1097/01.TA.0000090754.94232.2C; BASKETT PJF, 1990, BRIT MED J, V300, P1453, DOI 10.1136/bmj.300.6737.1453; Benedetti T, 2002, POCKET COMPANION OBS, P217; Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029; Birkhahn RH, 2003, AM J OBSTET GYNECOL, V189, P1293, DOI 10.1067/S0002-9378(03)00663-X; Birkhahn RH, 2002, ACAD EMERG MED, V9, P115, DOI 10.1197/aemj.9.2.115; Bonnar J, 2000, BEST PRACT RES CL OB, V14, P1, DOI 10.1053/beog.1999.0060; Brasel KJ, 2007, J TRAUMA, V62, P812, DOI 10.1097/TA.0b013e31803245a1; Bruns B, 2007, J TRAUMA, V63, P312, DOI 10.1097/TA.0b013e31812389d6; Bruns B, 2008, J TRAUMA, V65, P1217, DOI 10.1097/TA.0b013e318184ee63; Cancio LC, 2008, J TRAUMA, V64, pS51, DOI 10.1097/TA.0b013e3181608c21; Cannon CM, 2009, J TRAUMA, V67, P1426, DOI 10.1097/TA.0b013e3181bbf728; Chen LY, 2007, P ANN INT IEEE EMBS, P3748, DOI 10.1109/IEMBS.2007.4353147; Chen LY, 2008, IEEE ENG MED BIO, P2865, DOI 10.1109/IEMBS.2008.4649800; Coker A, 2006, TXB POSTPARTUM HEMOR, P11; Convertino VA, 2006, J TRAUMA, V61, P629, DOI 10.1097/01.ta.0000196663.34175.33; Convertino VA, 2009, AVIAT SPACE ENVIR MD, V80, P1012, DOI 10.3357/ASEM.2598.2009; deBenoist B, 2008, WORLDWIDE PREVALENCE; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Edelman DA, 2007, SHOCK, V27, P134, DOI 10.1097/01.shk.0000239772.18151.18; Edwards M, 2010, AM SURGEON, V76, P1035; Ganatra BR, 1998, B WORLD HEALTH ORGAN, V76, P591; Guly HR, 2011, RESUSCITATION, V82, P556, DOI 10.1016/j.resuscitation.2011.01.013; Guly HR, 2010, RESUSCITATION, V81, P1142, DOI 10.1016/j.resuscitation.2010.04.007; Hagiwara A, 2010, J TRAUMA, V69, P1161, DOI 10.1097/TA.0b013e3181d27c94; Hick JL, 2001, AM J EMERG MED, V19, P488, DOI 10.1053/ajem.2001.27133; Jaramillo S, 2011, INT J GYNECOL OBSTET, V112, P68, DOI 10.1016/j.ijgo.2010.08.005; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lee AI, 2011, HEMATOL ONCOL CLIN N, V25, P241, DOI 10.1016/j.hoc.2011.02.001; LUNA GK, 1989, AM J SURG, V157, P512, DOI 10.1016/0002-9610(89)90649-1; Maine D, 1991, SAFE MOTHERHOOD PROG; McGee S, 1999, JAMA-J AM MED ASSOC, V281, P1022, DOI 10.1001/jama.281.11.1022; McLaughlin DF, 2008, J TRAUMA, V64, pS57, DOI 10.1097/TA.0b013e318160a566; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mousa HA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003249.pub2; Opreanu RC, 2010, AM SURGEON, V76, P296; Parks JK, 2006, AM J SURG, V192, P727, DOI 10.1016/j.amjsurg.2006.08.034; PRITCHAR.JA, 1965, ANESTHESIOLOGY, V26, P393, DOI 10.1097/00000542-196507000-00004; Quinones JN, 2010, CLIN OBSTET GYNECOL, V53, P157, DOI 10.1097/GRF.0b013e3181cd5d36; Rickards CA, 2008, AVIAT SPACE ENVIR MD, V79, P670, DOI 10.3357/ASEM.2223.2008; ROBSON SC, 1989, OBSTET GYNECOL, V74, P234; ROBSON SC, 1987, BRIT MED J, V295, P1169, DOI 10.1136/bmj.295.6607.1169; SCALEA TM, 1990, J TRAUMA, V30, P1539, DOI 10.1097/00005373-199012000-00018; Schorn MN, 2010, J MIDWIFERY WOM HEAL, V55, P20, DOI 10.1016/j.jmwh.2009.02.014; SECHER NH, 1984, CIRC SHOCK, V14, P267; Stafford I, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.049; UELAND K, 1976, AM J OBSTET GYNECOL, V126, P671, DOI 10.1016/0002-9378(76)90517-2; Vandromme MJ, 2011, AM SURGEON, V77, P155; Vandromme MJ, 2011, J TRAUMA, V70, P384, DOI 10.1097/TA.0b013e3182095a0a; Vandromme MJ, 2010, J AM COLL SURGEONS, V210, P861, DOI 10.1016/j.jamcollsurg.2010.01.012; Victorino GP, 2003, J AM COLL SURGEONS, V196, P679, DOI 10.1016/S1072-7515(03)00128-5; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Ward KR, 2010, RESUSCITATION, V81, P987, DOI 10.1016/j.resuscitation.2010.03.027; World Health Organization, 1989, PREV MAN POSTP HAEM; Zarzaur BL, 2008, J SURG RES, V147, P229, DOI 10.1016/j.jss.2008.03.025	56	126	133	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57594	10.1371/journal.pone.0057594	http://dx.doi.org/10.1371/journal.pone.0057594			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483915	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000316936100031
J	van Beelen, MEJ; Beirens, TMJ; den Hertog, P; van Beeck, EF; Raat, H				van Beelen, Mirjam E. J.; Beirens, Tinneke M. J.; den Hertog, Paul; van Beeck, Eduard F.; Raat, Hein			First-Time Parents Are Not Well Enough Prepared for the Safety of Their Infant	PLOS ONE			English	Article							INJURY; CHILDHOOD; HOMES; DETERMINANTS	Background: Unintentional falls and poisonings are major causes of death and disability among infants. Although guidelines are available to prevent these injuries, safety behaviours are not performed by parents, causing unnecessary risks. Little is known about safety behaviours of first-time parents and whether they behave according to these guidelines. Aims/Objectives/Purpose: The objective of this study was to compare safety behaviours of first-time parents with those of non-first-time parents and to determine correlates of unsafe behaviour of parents of infants. We used self-report questionnaires to assess safety behaviours in a cross-sectional study sample. Methods: A total of 1439 parents visiting a preventive youth healthcare centre in the Netherlands were invited to complete a questionnaire with regard to the prevention of falls and poisonings. Parents were categorized into first-time parents and non-first-time parents. Correlates of parents' child safety behaviours were determined using multiple logistic regression analyses. Results/Outcome: Most respondents were mothers (93.2%); 48.2% of families were first-time parents. The mean age of the infants was 7.2 months (SD 1.1; range 4-12), 51.8% were boys, and 34.5% of infants could crawl. First-time parents were more likely not to have a stair gate installed (OR 16.46; 95% CI 12.36-21.93); were more likely to store cleaning products unsafely (OR 4.55; 95% CI 3.59-5.76); and were more likely to store medicines unsafely (OR 2.90; 95% CI 2.31-3.63) than non-first-time parents. First-time parents were more likely to not have a window guard installed (OR 1.52; 95% CI 1.08-2.15) (all P<0.05). Discussion/Conclusion: First-time parents are not well prepared for the safety of their infant, causing unnecessary risks. The various parents' safety behaviours were influenced by different variables, for example, age of the infant, crawling of the infant, mother's educational level, mother's ethnicity, self-efficacy, vulnerability, severity.	[van Beelen, Mirjam E. J.; Beirens, Tinneke M. J.; van Beeck, Eduard F.; Raat, Hein] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Beirens, Tinneke M. J.] Dutch Assoc Youth Hlth Care Phys, Utrecht, Netherlands; [den Hertog, Paul] Consumer Safety Inst, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Raat, H (corresponding author), Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	h.raat@erasmusmc.nl			ZonMw [50-50205-98-25028000]	ZonMw(Netherlands Organization for Health Research and Development)	This study is funded by a grant from ZonMw (project no. 50-50205-98-25028000). Website: http://www.zonmw.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beirens TMJ, 2008, HEALTH EDUC RES, V23, P723, DOI 10.1093/her/cym058; Beirens TMJ, 2007, ACCIDENT ANAL PREV, V39, P964, DOI 10.1016/j.aap.2007.01.001; Beirens TMJ, 2006, ACCIDENT ANAL PREV, V38, P772, DOI 10.1016/j.aap.2006.02.007; Branche C., 2008, WORLD REPORT CHILD I; Brice JH, 2006, PREHOSP EMERG CARE, V10, P397, DOI 10.1080/10903120600726007; Centers for Disease Control and Prevention [CDC], 2009, WEB BAS INJ STAT QUE; Chen LH, 2003, INJ PREV, V9, P73, DOI 10.1136/ip.9.1.73; Floyd DL, 2000, J APPL SOC PSYCHOL, V30, P407, DOI 10.1111/j.1559-1816.2000.tb02323.x; Gielen AC, 2001, ARCH PEDIAT ADOL MED, V155, P42, DOI 10.1001/archpedi.155.1.42; Harris VA, 2011, PEDIATRICS, V128, P455, DOI 10.1542/peds.2010-2687; McKenzie LB, 2010, PEDIATRICS, V126, P509, DOI 10.1542/peds.2009-3392; Morrongiello BA, 2004, J PEDIATR PSYCHOL, V29, P285, DOI 10.1093/jpepsy/jsh030; Polinder S, 2005, PEDIATRICS, V116, pE810, DOI 10.1542/peds.2005-1035; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-45; Rogers R.W., 1997, HDB HLTH BEHAV RES, P113; Rogers R. W., 1983, COGNITIVE PHYSL PROC; Sellstrom E, 1996, ACTA PAEDIATR, V85, P702, DOI 10.1111/j.1651-2227.1996.tb14130.x; van Beelen MEJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-466; Watson M, 2003, INJ PREV, V9, P180, DOI 10.1136/ip.9.2.180; Weiss J, 2010, PEDIATRICS, V126, pE253, DOI 10.1542/peds.2010-1265; WORTEL E, 1995, SCAND J PSYCHOL, V36, P306, DOI 10.1111/j.1467-9450.1995.tb00989.x	21	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58062	10.1371/journal.pone.0058062	http://dx.doi.org/10.1371/journal.pone.0058062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483969	Green Published, gold			2022-12-27	WOS:000316936100071
J	Werdelin, L; Lewis, ME				Werdelin, Lars; Lewis, Margaret E.			Temporal Change in Functional Richness and Evenness in the Eastern African Plio-Pleistocene Carnivoran Guild	PLOS ONE			English	Article							MAMMALIAN EVOLUTION; HOMINID; HYPERCARNIVORY; TURNOVER; DIET	We analyze functional richness and functional evenness of the carnivoran guild in eastern Africa from 3.5 Ma to 1.5 Ma, and compare them to the present day. The data consist of characters of the craniodental apparatus of 76 species of fossil and extant carnivorans, divided into four 0.5 Ma time slices from 3.5 to 1.5 Ma, together with the modern fauna. Focus is on large (>21.5 kg) carnivores. Results show that the large carnivore guild has lost nearly 99% of its functional richness since 3.5 Ma, in a process starting prior to 2 Ma. Measurement of functional evenness shows the modern large carnivore guild to be unique in being randomly distributed in morphospace while in all past time slices there is significant clustering of species. The results are analyzed in the light of known changes to climate and environment in eastern Africa. We conclude that climate change is unlikely to explain all of the changes found and suggest that the evolution of early hominins into carnivore niche space, especially the evolution of derived dietary strategies after 2 Ma, played a significant part in the reduction of carnivore functional richness.	[Werdelin, Lars] Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden; [Lewis, Margaret E.] Richard Stockton Coll New Jersey, NAMS Biol, Galloway, NJ USA	Swedish Museum of Natural History	Werdelin, L (corresponding author), Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden.	werdelin@nrm.se	Lewis, Margaret E/P-8243-2016	Lewis, Margaret E/0000-0002-2661-1489	Swedish Research Council; LSB Leakey Foundation; Stockton Distinguished Faculty Fellowships	Swedish Research Council(Swedish Research CouncilEuropean Commission); LSB Leakey Foundation; Stockton Distinguished Faculty Fellowships	This research was supported by a series of grants from the Swedish Research Council (www.vr.se) to LW, a grant from the LSB Leakey Foundation (leakeyfoundation.org) to MEL and K.E. Reed, and Stockton Distinguished Faculty Fellowships to MEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barnosky AD, 2010, QUATERN INT, V217, P10, DOI 10.1016/j.quaint.2009.11.017; Behrensmeyer AK, 1997, SCIENCE, V278, P1589, DOI 10.1126/science.278.5343.1589; Benzecri J.-P., 1980, PRATIQUE ANAL DONNEE; BLUMENSCHINE RJ, 1994, J HUM EVOL, V27, P197, DOI 10.1006/jhev.1994.1042; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bobe R, 2002, J HUM EVOL, V42, P475, DOI 10.1006/jhev.2001.0535; Brantingham PJ, 1998, J ANTHROPOL ARCHAEOL, V17, P327, DOI 10.1006/jaar.1998.0326; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; Cunnane SC, 2005, SURVIVAL OF THE FATTEST: THE KEY TO HUMAN BRAIN EVOLUTION, P1; Davis J.C., 1986, STAT DATA ANAL GEOLO; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Feakins Sarah J., 2010, P45; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Grayson DK, 2003, J ARCHAEOL SCI, V30, P585, DOI 10.1016/S0305-4403(02)00205-4; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herries AIR, 2011, J HUM EVOL, V60, P523, DOI 10.1016/j.jhevol.2010.09.001; Holliday JA, 2004, PALEOBIOLOGY, V30, P108, DOI 10.1666/0094-8373(2004)030<0108:EOHTEO>2.0.CO;2; Holliday Jill A., 2010, P189; Illian J, 2008, STAT ANAL MODELLING; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; Lariviere Serge, 2001, Mammalian Species, V671, P1, DOI 10.1644/1545-1410(2001)671<0001:AC>2.0.CO;2; Lewis ME, 2007, VERTEBR PALEOBIOL PA, P77, DOI 10.1007/978-1-4020-3098-7_4; Lewis ME, 1997, J HUM EVOL, V32, P257, DOI 10.1006/jhev.1996.0103; MAREAN CW, 1989, J HUM EVOL, V18, P559, DOI 10.1016/0047-2484(89)90018-3; Mason NWH, 2005, OIKOS, V111, P112, DOI 10.1111/j.0030-1299.2005.13886.x; Mouillot D, 2005, OECOLOGIA, V142, P353, DOI 10.1007/s00442-004-1744-7; Palombo MR, 2008, QUATERN INT, V179, P176, DOI 10.1016/j.quaint.2007.08.029; Palombo MR, 2006, QUATERN INT, V149, P94, DOI 10.1016/j.quaint.2005.11.022; Palombo MR, 2009, EVOL ECOL, V23, P569, DOI 10.1007/s10682-008-9256-2; PETTER G., 1973, FOSSIL VERTEBRATES A, V3, P44; Pickering R, 2010, J HUM EVOL, V59, P70, DOI 10.1016/j.jhevol.2010.03.014; Pobiner Briana L., 2003, Journal of Taphonomy, V1, P115; RIPLEY BD, 1979, J ROY STAT SOC B MET, V41, P368; Ripple WJ, 2010, BIOSCIENCE, V60, P516, DOI 10.1525/bio.2010.60.7.7; Rose L, 1996, CURR ANTHROPOL, V37, P307, DOI 10.1086/204494; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; TURNER A, 1990, GEOBIOS-LYON, V23, P349, DOI 10.1016/0016-6995(90)80006-2; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Vrba ES, 2000, OXFORD MGR GEOL GEOP, P277; Walker A., 1984, P119; Werdelin L, 2005, ZOOL J LINN SOC-LOND, V144, P121, DOI 10.1111/j.1096-3642.2005.00165.x; Werdelin L, 2010, CENOZOIC MAMMALS AFR, P603, DOI DOI 10.1525/CALIF0RNIA/9780520257214.003.0032; Werdelin Lars, 2010, P225; Wesley-Hunt GD, 2005, PALEOBIOLOGY, V31, P35, DOI 10.1666/0094-8373(2005)031<0035:TMDOCI>2.0.CO;2; Wesley-Hunt Gina D., 2010, P246; Wood B, 2000, J ANAT, V197, P19, DOI 10.1046/j.1469-7580.2000.19710019.x	51	67	67	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57944	10.1371/journal.pone.0057944	http://dx.doi.org/10.1371/journal.pone.0057944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483948	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100058
J	Abbas, M; Ebeling, A; Oelmann, Y; Ptacnik, R; Roscher, C; Weigelt, A; Weisser, WW; Wilcke, W; Hillebrand, H				Abbas, Maike; Ebeling, Anne; Oelmann, Yvonne; Ptacnik, Robert; Roscher, Christiane; Weigelt, Alexandra; Weisser, Wolfgang W.; Wilcke, Wolfgang; Hillebrand, Helmut			Biodiversity Effects on Plant Stoichiometry	PLOS ONE			English	Article							PRODUCTIVITY RELATIONSHIPS; EXPERIMENTAL GRASSLANDS; DIVERSITY; NITROGEN; TERRESTRIAL; PHOSPHORUS; SELECTION; HERBIVORY; PATTERNS; SOIL	In the course of the biodiversity-ecosystem functioning debate, the issue of multifunctionality of species communities has recently become a major focus. Elemental stoichiometry is related to a variety of processes reflecting multiple plant responses to the biotic and abiotic environment. It can thus be expected that the diversity of a plant assemblage alters community level plant tissue chemistry. We explored elemental stoichiometry in aboveground plant tissue (ratios of carbon, nitrogen, phosphorus, and potassium) and its relationship to plant diversity in a 5-year study in a large grassland biodiversity experiment (Jena Experiment). Species richness and functional group richness affected community stoichiometry, especially by increasing C:P and N:P ratios. The primacy of either species or functional group richness effects depended on the sequence of testing these terms, indicating that both aspects of richness were congruent and complementary to expected strong effects of legume presence and grass presence on plant chemical composition. Legumes and grasses had antagonistic effects on C:N (-27.7% in the presence of legumes, +32.7% in the presence of grasses). In addition to diversity effects on mean ratios, higher species richness consistently decreased the variance of chemical composition for all elemental ratios. The diversity effects on plant stoichiometry has several non-exclusive explanations:The reduction in variance can reflect a statistical averaging effect of species with different chemical composition or a optimization of nutrient uptake at high diversity, leading to converging ratios at high diversity. The shifts in mean ratios potentially reflect higher allocation to stem tissue as plants grew taller at higher richness. By showing a first link between plant diversity and stoichiometry in a multiyear experiment, our results indicate that losing plant species from grassland ecosystems will lead to less reliable chemical composition of forage for herbivorous consumers and belowground litter input.	[Abbas, Maike; Ptacnik, Robert; Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Wilhelmshaven, Germany; [Ebeling, Anne; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany; [Oelmann, Yvonne] Univ Tubingen, Tubingen, Germany; [Roscher, Christiane] Helmholtz Ctr Environm Res, UFZ, Dept Community Ecol, Halle, Germany; [Weigelt, Alexandra] Univ Leipzig, Inst Biol, D-04109 Leipzig, Germany; [Weisser, Wolfgang W.] Tech Univ Munich, Dept Ecol & Ecosyst Management, Ctr Life & Food Sci Weihenstephan, Freising Weihenstephan, Germany; [Wilcke, Wolfgang] Univ Bern, Inst Geog, Bern, Switzerland	Carl von Ossietzky Universitat Oldenburg; Friedrich Schiller University of Jena; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University; Technical University of Munich; University of Bern	Abbas, M (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Wilhelmshaven, Germany.	maike.abbas1@uni-oldenburg.de	Ptacnik, Robert/B-1347-2012; Weisser, Wolfgang W/B-9718-2014; Oelmann, Yvonne/J-8730-2016; Wilcke, Wolfgang/P-4620-2016; Hillebrand, Helmut/I-1717-2014	Ptacnik, Robert/0000-0001-7176-7653; Weisser, Wolfgang W/0000-0002-2757-8959; Oelmann, Yvonne/0000-0003-3513-6568; Wilcke, Wolfgang/0000-0002-6031-4613; Hillebrand, Helmut/0000-0001-7449-1613	German Science Foundation [FOR 456,1451]	German Science Foundation(German Research Foundation (DFG))	The Jena Experiment is funded by the German Science Foundation, FOR 456,1451 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; [Anonymous], 2010, R LANG ENV STAT COMP; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Broadley MR, 2004, J EXP BOT, V55, P321, DOI 10.1093/jxb/erh002; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cebrian J, 2004, ECOL MONOGR, V74, P237, DOI 10.1890/03-4019; Cebrian J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004929; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Ellenberg H., 2010, OKOLOGISCHER DYNAMIS; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gubsch M, 2011, ANN BOT-LONDON, V107, P157, DOI 10.1093/aob/mcq220; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hillebrand H, 2009, ECOL LETT, V12, P516, DOI 10.1111/j.1461-0248.2009.01304.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Muller-Westermeier G, 2000, BERICHTE DTSCH WETTE, V213; Novotny AM, 2007, OECOLOGIA, V151, P687, DOI 10.1007/s00442-006-0599-5; Oelmann Y, 2007, SOIL SCI SOC AM J, V71, P720, DOI 10.2136/sssaj2006.0205; Oelmann Y, 2007, J ENVIRON QUAL, V36, P396, DOI 10.2134/jeq2006.0217; Oelmann Y, 2011, GEODERMA, V167-68, P178, DOI 10.1016/j.geoderma.2011.09.012; Oelmann Y, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003869; Oelmann Y, 2010, PLANT SOIL, V326, P199, DOI 10.1007/s11104-009-9997-x; Persson J, 2010, OIKOS, V119, P741, DOI 10.1111/j.1600-0706.2009.18545.x; Ptacnik R, 2010, ADV ECOL RES, V43, P1, DOI 10.1016/S0065-2504(10)43001-9; Reich PB, 2010, P ROY SOC B-BIOL SCI, V277, P877, DOI 10.1098/rspb.2009.1818; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2011, PLANT BIOLOGY, V13, P134, DOI 10.1111/j.1438-8677.2010.00338.x; Roscher C, 2011, PLANT SOIL, V341, P333, DOI 10.1007/s11104-010-0647-0; Roscher C, 2011, OECOLOGIA, V165, P437, DOI 10.1007/s00442-010-1735-9; Scheiner Samuel M., 1993, P94; Schmidtke A, 2010, OECOLOGIA, V164, P665, DOI 10.1007/s00442-010-1688-z; Stasinopoulos D. M., 2007, J STAT SOFTW, V23, P1, DOI [DOI 10.18637/JSS.V023.I07, 10.18637/jss.v023.i07.]; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Striebel M, 2009, ECOLOGY, V90, P2025, DOI 10.1890/08-1409.1; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Vitousek PM, 2002, BIOGEOCHEMISTRY, V57, P1, DOI 10.1023/A:1015798428743; Weigelt A, 2010, ECOLOGY, V91, P929	45	64	68	12	208	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58179	10.1371/journal.pone.0058179	http://dx.doi.org/10.1371/journal.pone.0058179			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483990	Green Published, Green Submitted, gold			2022-12-27	WOS:000315634900074
J	Stijntjes, M; de Craen, AJM; van Heemst, D; Meskers, CGM; van Buchem, MA; Westendorp, RGJ; Slagboom, PE; Maier, AB				Stijntjes, Marjon; de Craen, Anton J. M.; van Heemst, Diana; Meskers, Carel G. M.; van Buchem, Mark A.; Westendorp, Rudi G. J.; Slagboom, P. Eline; Maier, Andrea B.			Familial Longevity Is Marked by Better Cognitive Performance at Middle Age: The Leiden Longevity Study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; BIOLOGICAL AGE; DEMENTIA; DECLINE; IMPAIRMENT; RISK; APOE; SURVIVAL; LIFE	Background: Decline in cognitive performance is a highly prevalent health condition in elderly. We studied whether offspring of nonagenarian siblings with a familial history of longevity, perform better on cognitive tests compared to their partners as controls. This is relevant since it could provide insights into determinants underlying decline in cognitive performance. Methods: Cross-sectional analysis within the longitudinal cohort of the Leiden Longevity Study consisting of middle-aged offspring of nonagenarian siblings together with their partners (n = 500, mean age (SD) 66.3 (6.1) and 65.7 (7.2) years, respectively) as controls. Memory function, attention and processing speed were tested using the 15-Picture Learning Test, Stroop test and Digit Symbol Substitution Test. Data were analyzed with regression adjusted for age, gender, years of education and additionally for diabetes mellitus, cardiovascular diseases, alcohol use, smoking, inflammatory markers and apolipoprotein E genotype. Robust standard errors were used to account for familial relationships among the offspring. Results: Cognitive performance was worse at higher calendar age (p<0.001, all except Stroop test part 1). The offspring performed better compared to their partners on trial 3 (p = 0.005), the immediate (p = 0.016) and delayed (p = 0.004) recall of the 15-Picture Learning Test as well as on the interference and combined interference score of the Stroop test (p = 0.014 and p = 0.036, respectively) in the fully adjusted model. The difference between offspring and partners was estimated to be more than three years according to the observed difference in calendar age. Conclusions: Offspring of nonagenarian siblings with a familial history of longevity have better cognitive performance compared to the group of their partners of comparable age. This effect is independent of age-related diseases and known possible confounders. Possible explanations might be differences in subclinical vascular pathology between both groups.	[Stijntjes, Marjon; de Craen, Anton J. M.; van Heemst, Diana; Westendorp, Rudi G. J.; Maier, Andrea B.] Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands; [Stijntjes, Marjon; Maier, Andrea B.] Vrije Univ Amsterdam, Dept Internal Med, Sect Gerontol & Geriatr, Med Ctr, Amsterdam, Netherlands; [Stijntjes, Marjon; de Craen, Anton J. M.; van Heemst, Diana; van Buchem, Mark A.; Westendorp, Rudi G. J.; Slagboom, P. Eline; Maier, Andrea B.] Netherlands Consortium Healthy Ageing, Leiden, Netherlands; [Meskers, Carel G. M.] Leiden Univ, Dept Rehabil Med, Med Ctr, Leiden, Netherlands; [van Buchem, Mark A.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Westendorp, Rudi G. J.] Leyden Acad Vital & Ageing, Leiden, Netherlands; [Slagboom, P. Eline] Leiden Univ, Dept Med Stat, Sect Mol Epidemiol, Med Ctr, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Maier, AB (corresponding author), Leiden Univ, Dept Gerontol & Geriatr, Med Ctr, Leiden, Netherlands.	a.maier@vumc.nl	van Buchem, Mark/AAC-9843-2022; Maier, Andrea B./Q-5548-2019; Slagboom, P. Eline/R-4790-2016; Maier, Andrea/W-7060-2019	van Buchem, Mark/0000-0003-1881-1998; Slagboom, P. Eline/0000-0002-2875-4723; Maier, Andrea/0000-0001-7206-1724; Meskers, Carel/0000-0002-5056-5611	Innovation Oriented research Program on Genomics (SenterNovem) [IGE01014, IGE5007]; Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO) [05040202, 050-060-810]; Netherlands Consortium for Healthy Aging (NCHA); European Commission [HEALTH-2007-2.4.5-10, Health-F2-2010-259772]	Innovation Oriented research Program on Genomics (SenterNovem); Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Consortium for Healthy Aging (NCHA); European Commission(European CommissionEuropean Commission Joint Research Centre)	Funding provided by The Leiden Longevity Study was funded by the Innovation Oriented research Program on Genomics (SenterNovem; www.agentschapnl.nl; IGE01014 and IGE5007), the Centre for Medical Systems Biology (CMSB; www.cmsb.nl), the Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO; www.genomics.nl/www.nwo.nl; 05040202 and 050-060-810 Netherlands Consortium for Healthy Aging (NCHA; www.healty-ageing.nl)), the European Commission funded project Myoage (FP7, HEALTH-2007-2.4.5-10; www.myoage.eu) and Switchbox (FP7, Health-F2-2010-259772; www.switchbox-online.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann-Schneider I, 2013, STROKE, V44, P9, DOI 10.1161/STROKEAHA.112.671438; Basta NE, 2008, EUR J PUBLIC HEALTH, V18, P48, DOI 10.1093/eurpub/ckm076; Beeri Michal Schnaider, 2009, Dialogues Clin Neurosci, V11, P201; Bennett Susan J, 2003, J Cardiovasc Nurs, V18, P219; BORKAN GA, 1980, J GERONTOL, V35, P177, DOI 10.1093/geronj/35.2.177; Campbell IL, 1997, MOL PSYCHIATR, V2, P125, DOI 10.1038/sj.mp.4000225; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Dekker P, 2009, AGING CELL, V8, P595, DOI 10.1111/j.1474-9726.2009.00506.x; Derhovanessian E, 2010, J IMMUNOL, V185, P4618, DOI 10.4049/jimmunol.1001629; Eikelenboom P, 1999, EXP GERONTOL, V34, P453, DOI 10.1016/S0531-5565(99)00022-4; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; HENDERSON AS, 1995, LANCET, V346, P1387, DOI 10.1016/S0140-6736(95)92405-1; Koster A, 2005, ANN EPIDEMIOL, V15, P564, DOI 10.1016/j.annepidem.2005.02.008; Marengoni A, 2011, J ALZHEIMERS DIS, V24, P559, DOI 10.3233/JAD-2011-101863; Marshall RS, 2011, STROKE, V42, P221, DOI 10.1161/STROKEAHA.110.595645; Nilsson LG, 2009, NEUROBIOL AGING, V30, P521, DOI 10.1016/j.neurobiolaging.2008.11.013; Raber J, 2004, NEUROBIOL AGING, V25, P641, DOI 10.1016/j.neurobiolaging.2003.12.023; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; Rozing MP, 2011, AGE, V33, P623, DOI 10.1007/s11357-011-9206-8; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; STROOP JR, 1992, J EXP PSYCHOL GEN, V121, P15; Waaijer MEC, 2012, AGE, V34, P1543, DOI 10.1007/s11357-011-9314-5; Westendorp RGJ, 2009, J AM GERIATR SOC, V57, P1634, DOI 10.1111/j.1532-5415.2009.02381.x; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wijsman CA, 2011, AGING CELL, V10, P114, DOI 10.1111/j.1474-9726.2010.00650.x	30	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57962	10.1371/journal.pone.0057962	http://dx.doi.org/10.1371/journal.pone.0057962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	099PY	23483953	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900060
J	Salama, AKS; de Rosa, N; Scheri, RP; Pruitt, SK; Herndon, JE; Marcello, J; Tyler, DS; Abernethy, AP				Salama, April K. S.; de Rosa, Nicole; Scheri, Randall P.; Pruitt, Scott K.; Herndon, James E., II; Marcello, Jennifer; Tyler, Douglas S.; Abernethy, Amy P.			Hazard-Rate Analysis and Patterns of Recurrence in Early Stage Melanoma: Moving towards a Rationally Designed Surveillance Strategy	PLOS ONE			English	Article							LYMPH-NODE BIOPSY; FOLLOW-UP; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; SURVIVAL; RELAPSE	Background: While curable at early stages, few treatment options exist for advanced melanoma. Currently, no consensus exists regarding the optimal surveillance strategy for patients after resection. The objectives of this study were to identify patterns of metastatic recurrence, to determine the influence of metastatic site on survival, and to identify high-risk periods for recurrence. Methods: A retrospective review of the Duke Melanoma Database from 1970 to 2004 was conducted that focused on patients who were initially diagnosed without metastatic disease. The time to first recurrence was computed from the date of diagnosis, and the associated hazard function was examined to determine the peak risk period of recurrence. Metastatic sites were coded by the American Joint Committee on Cancer (AJCC) system including local skin, distant skin and nodes (M1a), lung (M1b), and other distant (M1c). Results: Of 11,615 patients initially diagnosed without metastatic disease, 4616 (40%) had at least one recurrence. Overall the risk of initial recurrence peaked at 12 months. The risk of initial recurrence at the local skin, distant skin, and nodes peaked at 8 months, and the risk at lung and other distant sites peaked at 24 months. Patients with a cutaneous or nodal recurrence had improved survival compared to other recurrence types. Conclusions: The risk of developing recurrent melanoma peaked at one year, and the site of first recurrence had a significant impact on survival. Defining the timing and expected patterns of recurrence will be important in creating an optimized surveillance strategy for this patient population.	[Salama, April K. S.; Abernethy, Amy P.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Salama, April K. S.; de Rosa, Nicole; Scheri, Randall P.; Pruitt, Scott K.; Herndon, James E., II; Tyler, Douglas S.] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA; [de Rosa, Nicole; Scheri, Randall P.; Pruitt, Scott K.; Tyler, Douglas S.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Herndon, James E., II; Marcello, Jennifer] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Abernethy, AP (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	amy.abernethy@duke.edu		Salama, April/0000-0002-8105-5374; Abernethy, Amy/0000-0001-6930-8722	Pfizer, Inc.	Pfizer, Inc.(Pfizer)	This study was funded through an Outcomes Research service agreement with Pfizer, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; CALLAWAY MP, 1989, BRIT J PLAST SURG, V42, P46, DOI 10.1016/0007-1226(89)90111-2; Carlson GW, 2008, ANN SURG, V248, P378, DOI 10.1097/SLA.0b013e3181855718; CROWLEY NJ, 1990, ANN SURG, V212, P173, DOI 10.1097/00000658-199008000-00010; Dalal KM, 2007, ANN SURG ONCOL, V14, P1934, DOI 10.1245/s10434-007-9357-0; Francken AB, 2007, ANN SURG ONCOL, V14, P1924, DOI 10.1245/s10434-007-9347-2; Gershenwald JE, 1998, J CLIN ONCOL, V16, P2253, DOI 10.1200/JCO.1998.16.6.2253; Hansel G, 2010, J EUR ACAD DERMATOL, V24, P833, DOI 10.1111/j.1468-3083.2009.03536.x; Howlader N., 2016, SEER CANC STAT REV; KOH HK, 1984, JAMA-J AM MED ASSOC, V251, P1859, DOI 10.1001/jama.251.14.1859; MCCARTHY WH, 1988, SURG GYNECOL OBSTET, V166, P497; Morton RL, 2009, ANN SURG ONCOL, V16, P571, DOI 10.1245/s10434-008-0207-5; Nieweg OE, 2006, SURG ONCOL CLIN N AM, V15, P319, DOI 10.1016/j.soc.2005.12.005; Petersen RP, 2007, J THORAC CARDIOV SUR, V133, P104, DOI 10.1016/j.jtcvs.2006.08.065; REINTGEN DS, 1992, ANN PLAS SURG, V28, P45, DOI 10.1097/00000637-199201000-00013; Romano E, 2010, J CLIN ONCOL, V28, P3042, DOI 10.1200/JCO.2009.26.2063; SHAW HM, 1985, ARCH SURG-CHICAGO, V120, P1155; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Tas F, 2012, J ONCOL, V2012, DOI 10.1155/2012/647684; Tejera-Vaquerizo A, 2007, ACTAS DERMO-SIFILOGR, V98, P531, DOI 10.1016/S0001-7310(07)70128-X; Turner RM, 2011, J CLIN ONCOL; WEISS M, 1995, JAMA-J AM MED ASSOC, V274, P1703, DOI 10.1001/jama.274.21.1703; Xing Y, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq455; Zogakis TG, 2007, ANN SURG ONCOL, V14, P1604, DOI 10.1245/s10434-006-9267-6	25	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57665	10.1371/journal.pone.0057665	http://dx.doi.org/10.1371/journal.pone.0057665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516415	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200017
J	Yurgel, SN; Rice, J; Kahn, ML				Yurgel, Svetlana N.; Rice, Jennifer; Kahn, Michael L.			Transcriptome Analysis of the Role of GlnD/GlnBK in Nitrogen Stress Adaptation by Sinorhizobium meliloti Rm1021	PLOS ONE			English	Article							LEGUMINOSARUM BV VICIAE; AMINO-ACID PERMEASE; RHIZOBIUM-LEGUMINOSARUM; GLUTAMINE-SYNTHETASE; ESCHERICHIA-COLI; GENE-CLUSTER; SUCCINOGLYCAN BIOSYNTHESIS; ENVIRONMENTAL SIGNALS; TRANSPORT-SYSTEM; EXOYFQ OPERON	Transcriptional changes in the nitrogen stress response (NSR) of wild type S. meliloti Rm1021, and isogenic strains missing both PII proteins, GlnB and GlnK, or carrying a Delta glnD-sm2 mutation were analyzed using whole-genome microarrays. This approach allowed us to identify a number of new genes involved in the NSR and showed that the response of these bacteria to nitrogen stress overlaps with other stress responses, including induction of the fixK2 transcriptional activator and genes that are part of the phosphate stress response. Our data also show that GlnD and GlnBK proteins may regulate many genes that are not part of the NSR. Analysis of transcriptome profiles of the Rm1021 Delta glnD-sm2 strain allowed us to identify several genes that appear to be regulated by GlnD without the participation of the PII proteins.	[Yurgel, Svetlana N.; Rice, Jennifer; Kahn, Michael L.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Kahn, Michael L.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University; Washington State University	Yurgel, SN (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	syurgel@wsu.edu		Yurgel, Svetlana/0000-0002-6979-1619; Kahn, Michael/0000-0002-5204-561X	Agricultural Research Center at Washington State University; Energy Biosciences Program at the United States Department of Energy [DE-FG03-96ER20225]	Agricultural Research Center at Washington State University; Energy Biosciences Program at the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Agricultural Research Center at Washington State University and grant DE-FG03-96ER20225 from the Energy Biosciences Program at the United States Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AMAR M, 1994, MOL MICROBIOL, V11, P685, DOI 10.1111/j.1365-2958.1994.tb00346.x; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Atkinson MR, 1998, MOL MICROBIOL, V29, P431, DOI 10.1046/j.1365-2958.1998.00932.x; Barnett MJ, 2001, P NATL ACAD SCI USA, V98, P9883, DOI 10.1073/pnas.161294798; Barnett MJ, 2004, P NATL ACAD SCI USA, V101, P16636, DOI 10.1073/pnas.0407269101; Barnett MJ, 1998, GENETICS, V148, P19; Bartels FW, 2003, J STRUCT BIOL, V143, P145, DOI 10.1016/S1047-8477(03)00127-8; BATUT J, 1994, ANTON LEEUW INT J G, V66, P129, DOI 10.1007/BF00871636; Becker A, 1995, MOL GEN GENET, V249, P487, DOI 10.1007/BF00290574; Becker A, 1997, J BACTERIOL, V179, P1375, DOI 10.1128/jb.179.4.1375-1384.1997; BECKER A, 1993, MOL GEN GENET, V241, P367, DOI 10.1007/BF00284690; Bobik C, 2006, J BACTERIOL, V188, P4890, DOI 10.1128/JB.00251-06; Carter RA, 2002, MOL PLANT MICROBE IN, V15, P69, DOI 10.1094/MPMI.2002.15.1.69; Cheng HP, 2004, FEMS MICROBIOL LETT, V231, P131, DOI 10.1016/S0378-1097(03)00952-2; Davalos M, 2004, FEMS MICROBIOL LETT, V241, P33, DOI 10.1016/j.femsle.2004.09.041; de Bruijn FJ, 2006, ENVIRON MICROBIOL, V8, P1371, DOI 10.1111/j.1462-2920.2006.01030.x; DEBRUIJN FJ, 1989, J BACTERIOL, V171, P1673, DOI 10.1128/jb.171.3.1673-1682.1989; DOHERTY D, 1988, J BACTERIOL, V170, P4249, DOI 10.1128/jb.170.9.4249-4256.1988; DUSHA I, 1993, MOL GEN GENET, V240, P435, DOI 10.1007/BF00280398; Ferrieres L, 2004, MICROBIOL-SGM, V150, P2335, DOI 10.1099/mic.0.27081-0; FISCHER HM, 1994, MICROBIOL REV, V58, P352, DOI 10.1128/MMBR.58.3.352-386.1994; Galibert F, 2001, SCIENCE, V293, P668, DOI 10.1126/science.1060966; Hosie AHF, 2002, J BACTERIOL, V184, P4071, DOI 10.1128/JB.184.15.4071-4080.2002; HUCK S, 1984, J NEUROSCI, V4, P2650; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2006, J BIOCHEM, V139, P11, DOI 10.1093/jb/mvj020; Jamet A, 2005, J BACTERIOL, V187, P376, DOI 10.1128/JB.187.1.376-381.2005; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; Lodwig E, 2004, J BACTERIOL, V186, P842, DOI 10.1128/JB.186.3.842-849.2004; Marroqui S, 2001, J BACTERIOL, V183, P854, DOI 10.1128/JB.183.3.854-864.2001; Moreira LM, 2000, MICROBIOL-UK, V146, P2237, DOI 10.1099/00221287-146-9-2237; MULLER P, 1993, MOL PLANT MICROBE IN, V6, P55, DOI 10.1094/MPMI-6-055; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Napolitani C, 2004, FEBS LETT, V558, P45, DOI 10.1016/S0014-5793(03)01511-4; Nellen-Anthamatten D, 1998, J BACTERIOL, V180, P5251, DOI 10.1128/JB.180.19.5251-5255.1998; Ninfa AJ, 2000, TRENDS MICROBIOL, V8, P172, DOI 10.1016/S0966-842X(00)01709-1; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Patriarca EJ, 2002, MICROBIOL MOL BIOL R, V66, P203, DOI 10.1128/MMBR.66.2.203-222.2002; Pickering BS, 2008, J BACTERIOL, V190, P6409, DOI 10.1128/JB.00757-08; PISTOCCHI R, 1993, J BIOL CHEM, V268, P146; Prell J, 2009, P NATL ACAD SCI USA, V106, P12477, DOI 10.1073/pnas.0903653106; Quester I, 2004, J MOL MICROB BIOTECH, V7, P115, DOI 10.1159/000078655; REED JW, 1991, J BACTERIOL, V173, P3776, DOI 10.1128/JB.173.12.3776-3788.1991; Ruberg S, 2003, J BIOTECHNOL, V106, P255, DOI 10.1016/j.jbiotec.2003.08.005; Rudnick PA, 2001, J BACTERIOL, V183, P2682, DOI 10.1128/JB.183.8.2682-2685.2001; Schluter A, 2000, MICROBIOL-SGM, V146, P2987, DOI 10.1099/00221287-146-11-2987; Schmitz RA, 2002, J MOL MICROB BIOTECH, V4, P235; SHATTERS RG, 1993, J BIOL CHEM, V268, P469; SOMERVILLE JE, 1983, J BACTERIOL, V156, P168, DOI 10.1128/JB.156.1.168-176.1983; Soutourina OA, 2003, FEMS MICROBIOL REV, V27, P505, DOI 10.1016/S0168-6445(03)00064-0; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; Walshaw DL, 1996, MOL MICROBIOL, V21, P1239, DOI 10.1046/j.1365-2958.1996.00078.x; Wei XM, 1998, APPL ENVIRON MICROB, V64, P1708; White JP, 2009, J BACTERIOL, V191, P1547, DOI 10.1128/JB.00926-08; York GM, 1997, MOL MICROBIOL, V25, P117, DOI 10.1046/j.1365-2958.1997.4481804.x; Yuan ZC, 2006, NUCLEIC ACIDS RES, V34, P2686, DOI 10.1093/nar/gkl365; Yurgel SN, 2011, MOL PLANT MICROBE IN; Yurgel SN, 2010, J BACTERIOL, V192, P2473, DOI 10.1128/JB.01657-09; Yurgel SN, 2008, P NATL ACAD SCI USA, V105, P18958, DOI 10.1073/pnas.0808048105; Zaheer R, 2009, ENVIRON MICROBIOL, V11, P1572, DOI 10.1111/j.1462-2920.2009.01885.x	62	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58028	10.1371/journal.pone.0058028	http://dx.doi.org/10.1371/journal.pone.0058028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516427	gold, Green Submitted, Green Published			2022-12-27	WOS:000316849200027
J	Al-Faqheri, W; Ibrahim, F; Thio, THG; Moebius, J; Joseph, K; Arof, H; Madou, M				Al-Faqheri, Wisam; Ibrahim, Fatimah; Thio, Tzer Hwai Gilbert; Moebius, Jacob; Joseph, Karunan; Arof, Hamzah; Madou, Marc			Vacuum/Compression Valving (VCV) Using Parrafin-Wax on a Centrifugal Microfluidic CD Platform	PLOS ONE			English	Article							VALVES	This paper introduces novel vacuum/compression valves (VCVs) utilizing paraffin wax. A VCV is implemented by sealing the venting channel/hole with wax plugs (for normally-closed valve), or to be sealed by wax (for normally-open valve), and is activated by localized heating on the CD surface. We demonstrate that the VCV provides the advantages of avoiding unnecessary heating of the sample/reagents in the diagnostic process, allowing for vacuum sealing of the CD, and clear separation of the paraffin wax from the sample/reagents in the microfluidic process. As a proof of concept, the microfluidic processes of liquid flow switching and liquid metering is demonstrated with the VCV. Results show that the VCV lowers the required spinning frequency to perform the microfluidic processes with high accuracy and ease of control.	[Al-Faqheri, Wisam; Ibrahim, Fatimah; Thio, Tzer Hwai Gilbert; Moebius, Jacob; Joseph, Karunan; Madou, Marc] Univ Malaya, Dept Biomed Engn, Med Informat & Biol Microelectromech Syst Special, Fac Engn, Kuala Lumpur, Malaysia; [Arof, Hamzah] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia; [Moebius, Jacob; Madou, Marc] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Madou, Marc] Univ Calif Irvine, Dept Mech & Aerosp Engn, Irvine, CA 92717 USA; [Madou, Marc] World Class Univ, Ulsan Natl Inst Sci & Technol, Ulsan, South Korea	Universiti Malaya; Universiti Malaya; University of California System; University of California Irvine; University of California System; University of California Irvine; Ulsan National Institute of Science & Technology (UNIST)	Ibrahim, F (corresponding author), Univ Malaya, Dept Biomed Engn, Med Informat & Biol Microelectromech Syst Special, Fac Engn, Kuala Lumpur, Malaysia.	fatimah@um.edu.my	AROF, HAMZAH/ABI-1052-2020; Madou, Marc J./E-5869-2013; Thio, Tzer Hwai Gilbert/AGG-4429-2022; IBRAHIM, FATIMAH/B-8506-2010	Madou, Marc J./0000-0003-4847-3117; IBRAHIM, FATIMAH/0000-0003-1804-4362; Thio, Tzer Hwai Gilbert/0000-0002-4192-3720	University of Malaya, Ministry of Higher Education High Impact Research [UM/HIR/MOHE/ENG/05]; University of Malaya Research Grant [UMRG: RG023/09AET]; grant "Hitsto-Lead: Designing Dengue Virus Inhibitors, National Biotechnology Directorate (NBD) Initiative-Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), Ministry of Science, Technology and Innovation" [MOSTI IPHARM 53-02-03-1049]; WCU (World Class University) program through the National Research Foundation of Korea [R32-2008-000-20054-0]; Ministry of Education, Science and Technology	University of Malaya, Ministry of Higher Education High Impact Research; University of Malaya Research Grant; grant "Hitsto-Lead: Designing Dengue Virus Inhibitors, National Biotechnology Directorate (NBD) Initiative-Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), Ministry of Science, Technology and Innovation"; WCU (World Class University) program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was financially supported by University of Malaya, Ministry of Higher Education High Impact Research (UM/HIR/MOHE/ENG/05), and University of Malaya Research Grant (UMRG: RG023/09AET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to acknowledge Prof. Dr. Noorsaadah Abd Rahman from Department of Chemistry, Faculty of Science, University of Malaya and her grant "Hitsto-Lead: Designing Dengue Virus Inhibitors, National Biotechnology Directorate (NBD) Initiative-Malaysian Institute of Pharmaceuticals and Nutraceuticals (IPharm), Ministry of Science, Technology and Innovation (MOSTI IPHARM 53-02-03-1049)" for partially sponsoring the initial set-up of the CD Spin Test System. MM also acknowledges support of WCU (World Class University) program (R32-2008-000-20054-0) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology.	Abi-Samra K, 2011, LAB CHIP, V11, P723, DOI 10.1039/c0lc00160k; Allen BP, 2005, Patent No US, Patent No. [2007/0227592 A1, 20070227592]; Amasia M, 2012, SENSOR ACTUAT B-CHEM, V161, P1191, DOI 10.1016/j.snb.2011.11.080; Benito-Lopez F, 2010, LAB CHIP, V10, P195, DOI 10.1039/b914709h; Burger R, 2012, LAB CHIP, V12, P1289, DOI 10.1039/c2lc21170j; Cho YC, 2008, Patent No US, Patent No. [8,057,759 B2, 8057759]; Ducree J, 2007, J MICROMECH MICROENG, V17, pS103, DOI 10.1088/0960-1317/17/7/S07; Focke M, 2010, LAB CHIP, V10, P2519, DOI 10.1039/c004954a; Ibrahim F., 2010, 2010 IEEE EMBS Conference on Biomedical Engineering and Sciences (IECBES 2010), P466, DOI 10.1109/IECBES.2010.5742282; Imaad SM, 2011, LAB CHIP, V11, P1448, DOI 10.1039/c0lc00451k; Kim J, 2008, SENSOR ACTUAT B-CHEM, V128, P613, DOI 10.1016/j.snb.2007.07.079; Kong MCR, 2011, ANAL CHEM, V83, P1148, DOI 10.1021/ac102563g; Lai S, 2004, ANAL CHEM, V76, P1832, DOI 10.1021/ac0348322; Liu RH, 2004, SENSOR ACTUAT B-CHEM, V98, P328, DOI 10.1016/j.snb.2003.09.037; Madou M, 2006, ANNU REV BIOMED ENG, V8, P601, DOI 10.1146/annurev.bioeng.8.061505.095758; Mark D, 2011, MICROFLUID NANOFLUID, V10, P1279, DOI 10.1007/s10404-010-0759-0; Mark D, 2009, LAB CHIP, V9, P3599, DOI 10.1039/b914415c; Morijiri T, 2012, MICROFLUID NANOFLUID, P722; Oh K.W., 2005, MICROTOTAL ANAL SYST, V1, P554; Oh KW, 2006, J MICROMECH MICROENG, V16, pR13, DOI 10.1088/0960-1317/16/5/R01; Siegrist J, 2010, MICROFLUID NANOFLUID, V9, P55, DOI 10.1007/s10404-009-0523-5; Sugiura S, 2009, LAB CHIP, V9, P196, DOI 10.1039/b810717c; Thio T, 2011, IFMBE PROC, V35, P578, DOI 10.1007/978-3-642-21729-6_144; Thio THG, 2013, MED BIOL ENG COMPUT, V51, P525, DOI 10.1007/s11517-012-1020-7; Yang EH, 1996, SENSOR ACTUAT A-PHYS, V57, P75, DOI 10.1016/S0924-4247(97)80097-0; Yusoff Nurul Aini, 2009, 2009 IEEE Symposium on Industrial Electronics & Applications (ISIEA 2009), P946, DOI 10.1109/ISIEA.2009.5356330; Zoval JV, 2004, P IEEE, V92, P140, DOI 10.1109/JPROC.2003.820541	27	49	50	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58523	10.1371/journal.pone.0058523	http://dx.doi.org/10.1371/journal.pone.0058523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505528	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000316251100059
J	Guiraldelli, MF; Franca, CN; de Souza, DA; da Silva, EZM; Toso, VD; Carvalho, CC; Jamur, MC; Oliver, C				Guiraldelli, Michel Farchi; Franca, Carolina Nunes; de Souza, Devandir Antonio, Jr.; Marcelino da Silva, Elaine Zayas; Toso, Vanina Danuza; Carvalho, Celiane Cardoso; Jamur, Maria Celia; Oliver, Constance			Rat Embryonic Mast Cells Originate in the AGM	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; BASOPHILIC LEUKEMIA-CELLS; GONAD-MESONEPHROS REGION; MONOCLONAL-ANTIBODY AA4; YOLK-SAC; BONE-MARROW; MOUSE EMBRYO; FETAL LIVER; PRECURSORS; BINDING	Mast cells originate from pluripotent hematopoietic stem cells. Two mast cell specific antibodies, mAbsAA4 and BGD6, have previously been used to identify and study committed mast cell precursors (MCcps) in the bone marrow of adult mice and rats. However, the embryonic origin of MCcps is still not known. In the present study, we identified MCcps in rat embryos using these previously characterized mast cell specific antibodies. The MCcps were found in the AGM (aorta-gonad-mesonephros) region of rat embryos at E11.5. These cells were BGD6+, CD34(+), c-kit(+), CD13(+), Fc epsilon RI-, AA4(-) CD40(-), and Thy-1(-). By PCR the cells contained message for the alpha and beta subunits of Fc epsilon RI and mast cell specific proteases. In vitro, the MCcps differentiated into metachromatic mast cells. With age of gestation the percent of MCcps diminished while the percent of mast cell progenitors increased. An increased knowledge of the biology and embryonic origin of mast cells may contribute to a greater understanding of allergy, asthma, and other mast cell related diseases.	[Guiraldelli, Michel Farchi; Franca, Carolina Nunes; de Souza, Devandir Antonio, Jr.; Marcelino da Silva, Elaine Zayas; Toso, Vanina Danuza; Carvalho, Celiane Cardoso; Jamur, Maria Celia; Oliver, Constance] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol & Pathogen Bioagents, BR-14049 Ribeirao Preto, Brazil	Universidade de Sao Paulo	Oliver, C (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cell & Mol Biol & Pathogen Bioagents, BR-14049 Ribeirao Preto, Brazil.	coliver@fmrp.usp.br	França, Carolina Nunes/J-2429-2015; Da Silva, Elaine Z/O-5535-2015; Jamur, Maria Celia/L-5520-2016; Guiraldelli, Michel/H-1710-2013	França, Carolina Nunes/0000-0002-4167-4293; Da Silva, Elaine Z/0000-0002-2749-6275; Jamur, Maria Celia/0000-0001-7065-8543; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP 03/00543-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br/) and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 03/00543-2, http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317, DOI 10.1002/eji.1830110410; BASCIANO LK, 1986, J BIOL CHEM, V261, P1823; BEAUPAIN D, 1979, BLOOD, V53, P212; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Boisset JC, 2012, STEM CELL RES, V8, P1, DOI 10.1016/j.scr.2011.07.002; Combs JW, 1966, J CELL BIOL, V48, P676; Costa G, 2012, TRENDS IMMUNOL, V33, P215, DOI 10.1016/j.it.2012.01.012; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Dzierzak E, 1998, IMMUNOL TODAY, V19, P228, DOI 10.1016/S0167-5699(98)01258-4; Frossi B, 2010, TRENDS IMMUNOL, V31, P97, DOI 10.1016/j.it.2009.12.007; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; Guiraldelli MF, 2008, MOL IMMUNOL, V45, P2411, DOI 10.1016/j.molimm.2007.07.041; GUO N, 1989, J BIOL CHEM, V264, P13267; Ivanovs A, 2011, J EXP MED, V208, P2417, DOI 10.1084/jem.20111688; Jamur MC, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-32; Jamur MC, 1997, J HISTOCHEM CYTOCHEM, V45, P1715, DOI 10.1177/002215549704501215; Jamur MC, 2001, J HISTOCHEM CYTOCHEM, V49, P219, DOI 10.1177/002215540104900209; Jamur MC, 2005, BLOOD, V105, P4282, DOI 10.1182/blood-2004-02-0756; JOHNSON GR, 1975, NATURE, V258, P726, DOI 10.1038/258726a0; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; KITAMURA Y, 1979, DEV BIOL, V70, P510, DOI 10.1016/0012-1606(79)90042-3; KITAMURA Y, 1979, J EXP MED, V150, P482, DOI 10.1084/jem.150.3.482; LASSILA O, 1982, BLOOD, V59, P377; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; OLIVER C, 1992, J CELL BIOL, V116, P635, DOI 10.1083/jcb.116.3.635; Palis J, 1999, DEVELOPMENT, V126, P5073; Palis J, 2001, P NATL ACAD SCI USA, V98, P4528, DOI 10.1073/pnas.071002398; SONODA T, 1983, DEV BIOL, V97, P89, DOI 10.1016/0012-1606(83)90066-0; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Tavian M, 2001, IMMUNITY, V15, P487, DOI 10.1016/S1074-7613(01)00193-5; Taylor E, 2010, INT J DEV BIOL, V54, P1055, DOI 10.1387/ijdb.103152et; TURPEN JB, 1981, DEV BIOL, V85, P99, DOI 10.1016/0012-1606(81)90239-6; WONG PMC, 1986, P NATL ACAD SCI USA, V83, P3851, DOI 10.1073/pnas.83.11.3851; Yong LCJ, 1997, EXP TOXICOL PATHOL, V49, P409, DOI 10.1016/S0940-2993(97)80129-7; Yuan Q, 1998, J IMMUNOL, V161, P5143	45	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57862	10.1371/journal.pone.0057862	http://dx.doi.org/10.1371/journal.pone.0057862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505443	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500035
J	Hebert, SL; Daniel, ML; McLoon, LK				Hebert, Sadie L.; Daniel, Mark L.; McLoon, Linda K.			The Role of Pitx2 in Maintaining the Phenotype of Myogenic Precursor Cells in the Extraocular Muscles	PLOS ONE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; MUSCULAR-DYSTROPHY; GENE-EXPRESSION; HETEROGENEITY; PROLIFERATION; SPECIFICATION; MYOBLASTS; PATHOLOGY; MYOFIBERS	Many differences exist between extraocular muscles (EOM) and non-cranial skeletal muscles. One striking difference is the sparing of EOM in various muscular dystrophies compared to non-cranial skeletal muscles. EOM undergo continuous myonuclear remodeling in normal, uninjured adults, and distinct transcription factors are required for the early determination, development, and maintenance of EOM compared to limb skeletal muscle. Pitx2, a bicoid-like homeobox transcription factor, is required for the development of EOM and the maintenance of characteristic properties of the adult EOM phenotype, but is not required for the development of limb muscle. We hypothesize that these unique properties of EOM contribute to the constitutive differences between EOM and non-craniofacial skeletal muscles. Using flow cytometry, CD34(+)/Sca1(-/)CD45(-/)CD31(-) cells (EECD34 cells) were isolated from extraocular and limb skeletal muscle and in vitro, EOM EECD34 cells proliferated faster than limb muscle EECD34 cells. To further define these myogenic precursor cells from EOM and limb skeletal muscle, they were analyzed for their expression of Pitx2. Western blotting and immunohistochemical data demonstrated that EOM express higher levels of Pitx2 than limb muscle, and 80% of the EECD34 cells expressed Pitx2. siRNA knockdown of Pitx2 expression in EECD34 cells in vitro decreased proliferation rates and impaired the ability of EECD34 cells to fuse into multinucleated myotubes. High levels of Pitx2 were retained in dystrophic and aging mouse EOM and the EOM EECD34 cells compared to limb muscle. The differential expression of Pitx2 between EOM and limb skeletal muscle along with the functional changes in response to lower levels of Pitx2 expression in the myogenic precursor cells suggest a role for Pitx2 in the maintenance of constitutive differences between EOM and limb skeletal muscle that may contribute to the sparing of EOM in muscular dystrophies.	[Hebert, Sadie L.; Daniel, Mark L.; McLoon, Linda K.] Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA; [McLoon, Linda K.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	McLoon, LK (corresponding author), Univ Minnesota, Dept Ophthalmol & Visual Neurosci, Minneapolis, MN 55455 USA.	mcloo001@tc.umn.edu		McLoon, LInda/0000-0001-9714-4681	National Eye Institute from NIDCR [EY55137, EY11375, T32DE007288]; Medical School; Minnesota Medical Foundation; Minnesota Lions; Lionesses; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [P30EY011374, R01EY015313] Funding Source: NIH RePORTER	National Eye Institute from NIDCR; Medical School; Minnesota Medical Foundation; Minnesota Lions; Lionesses; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by EY55137 and EY11375 from the National Eye Institute, T32DE007288 from NIDCR (SLH), Medical School Grant-in-Aid, Minnesota Medical Foundation, Minnesota Lions and Lionesses, and an unrestricted grant to the Department of Ophthalmology from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; BEHR T, 1994, CLIN INVESTIGATOR, V72, P150; Biressi S, 2010, SEMIN CELL DEV BIOL, V21, P845, DOI 10.1016/j.semcdb.2010.09.003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Diehl AG, 2006, INVEST OPHTH VIS SCI, V47, P1785, DOI 10.1167/iovs.05-1424; Fischer MD, 2002, PHYSIOL GENOMICS, V9, P71, DOI 10.1152/physiolgenomics.00115.2001; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gherzi R, 2010, CELL DEATH DIFFER, V17, P975, DOI 10.1038/cdd.2009.194; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Grefte S, 2012, EUR J ORAL SCI, V120, P38, DOI 10.1111/j.1600-0722.2011.00920.x; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Kallestad KM, 2011, EXP CELL RES, V317, P873, DOI 10.1016/j.yexcr.2011.01.018; KAMINSKI HJ, 1992, ANN NEUROL, V32, P586, DOI 10.1002/ana.410320418; KARPATI G, 1988, MUSCLE NERVE, V11, P795, DOI 10.1002/mus.880110802; KAUFMAN SJ, 1988, P NATL ACAD SCI USA, V85, P9606, DOI 10.1073/pnas.85.24.9606; KHURANA TS, 1995, J EXP MED, V182, P467, DOI 10.1084/jem.182.2.467; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kitamura K, 1999, DEVELOPMENT, V126, P5749; L'Honore A, 2007, DEV BIOL, V307, P421, DOI 10.1016/j.ydbio.2007.04.034; Lagord C, 1998, CELL TISSUE RES, V291, P455, DOI 10.1007/s004410051015; Lucas CA, 1997, INVEST OPHTH VIS SCI, V38, P2817; Martinez-Fernandez S, 2006, DEV DYNAM, V235, P2930, DOI 10.1002/dvdy.20924; McLoon Linda K, 2002, Trans Am Ophthalmol Soc, V100, P119; McLoon LK, 2004, MUSCLE NERVE, V29, P707, DOI 10.1002/mus.20012; McLoon LK, 2003, INVEST OPHTH VIS SCI, V44, P1927, DOI 10.1167/iovs.02-0673; McLoon LK, 2002, MUSCLE NERVE, V25, P348, DOI 10.1002/mus.10056; McLoon LK, 2011, ADLERS PHYSL EYE, P182; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Pavlath GK, 1998, DEV DYNAM, V212, P495, DOI 10.1002/(SICI)1097-0177(199808)212:4<495::AID-AJA3>3.3.CO;2-I; Perie S, 2006, NEUROMUSCULAR DISORD, V16, P770, DOI 10.1016/j.nmd.2006.07.022; Porter JD, 2001, P NATL ACAD SCI USA, V98, P12062, DOI 10.1073/pnas.211257298; Porter JD, 2003, FASEB J, V17, P893, DOI 10.1096/fj.02-0810fje; Ragusa RJ, 1997, NEUROMUSCULAR DISORD, V7, P379, DOI 10.1016/S0960-8966(97)00096-5; Sambasivan R, 2009, DEV CELL, V16, P810, DOI 10.1016/j.devcel.2009.05.008; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shih HP, 2007, P NATL ACAD SCI USA, V104, P5907, DOI 10.1073/pnas.0701122104; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Ugalde I, 2005, INVEST OPHTH VIS SCI, V46, P4114, DOI 10.1167/iovs.05-0549; Wehling M, 1998, NEUROMUSCULAR DISORD, V8, P22, DOI 10.1016/S0960-8966(97)00136-3; Zacharias AL, 2011, DEV BIOL, V349, P395, DOI 10.1016/j.ydbio.2010.10.028; Zhou YF, 2011, J PHYSIOL-LONDON, V589, P4601, DOI 10.1113/jphysiol.2011.207076; Zhou YF, 2009, INVEST OPHTH VIS SCI, V50, P4531, DOI 10.1167/iovs.08-2950	44	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58405	10.1371/journal.pone.0058405	http://dx.doi.org/10.1371/journal.pone.0058405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505501	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500078
J	La Marca, A; Sighinolfi, G; Papaleo, E; Cagnacci, A; Volpe, A; Faddy, MJ				La Marca, Antonio; Sighinolfi, Giovanna; Papaleo, Enrico; Cagnacci, Angelo; Volpe, Annibale; Faddy, Malcolm J.			Prediction of Age at Menopause from Assessment of Ovarian Reserve May Be Improved by Using Body Mass Index and Smoking Status	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; ANTIMULLERIAN HORMONE; NATURAL MENOPAUSE; BREAST-CANCER; WOMEN; POPULATION; TRANSITION; NUMBER; BIRTH; RISK	Objective: Menopause is the consequence of exhaustion of the ovarian follicular pool. AMH, an indirect hormonal marker of ovarian reserve, has been recently proposed as a predictor for age at menopause. Since BMI and smoking status are relevant independent factors associated with age at menopause we evaluated whether a model including all three of these variables could improve AMH-based prediction of age at menopause. Methods: In the present cohort study, participants were 375 eumenorrheic women aged 19-44 years and a sample of 2,635 Italian menopausal women. AMH values were obtained from the eumenorrheic women. Results: Regression analysis of the AMH data showed that a quadratic function of age provided a good description of these data plotted on a logarithmic scale, with a distribution of residual deviates that was not normal but showed significant left-skewness. Under the hypothesis that menopause can be predicted by AMH dropping below a critical threshold, a model predicting menopausal age was constructed from the AMH regression model and applied to the data on menopause. With the AMH threshold dependent on the covariates BMI and smoking status, the effects of these covariates were shown to be highly significant. Conclusions: In the present study we confirmed the good level of conformity between the distributions of observed and AMH-predicted ages at menopause, and showed that using BMI and smoking status as additional variables improves AMH-based prediction of age at menopause.	[La Marca, Antonio; Sighinolfi, Giovanna; Cagnacci, Angelo; Volpe, Annibale] Univ Modena, Inst Obstet & Gynaecol, Mother Infant Dept, I-41100 Modena, Italy; [La Marca, Antonio; Sighinolfi, Giovanna; Cagnacci, Angelo; Volpe, Annibale] Reggio Emilia, Modena, Italy; [Papaleo, Enrico] Hosp San Raffaele, Ctr Natalita, Dept Obstet Gynecol, I-20132 Milan, Italy; [Faddy, Malcolm J.] Queensland Univ Technol, Brisbane, Qld 4001, Australia	Universita di Modena e Reggio Emilia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Queensland University of Technology (QUT)	La Marca, A (corresponding author), Univ Modena, Inst Obstet & Gynaecol, Mother Infant Dept, I-41100 Modena, Italy.	antlamarca@libero.it	La Marca, Antonio/A-5940-2015; Sighinolfi, Giovanna/AAM-4723-2021; Cagnacci, Angelo/Q-7432-2016; Papaleo, Enrico/AAN-9591-2021	La Marca, Antonio/0000-0001-7921-9547; Cagnacci, Angelo/0000-0003-2714-623X; Papaleo, Enrico/0000-0003-0281-9143				BAILEY A, 1977, LANCET, V2, P722; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Broekmans Frank J, 2004, Menopause, V11, P607, DOI 10.1097/01.GME.0000123643.76105.27; Broekmans FJM, 2010, FERTIL STERIL, V94, P1044, DOI 10.1016/j.fertnstert.2009.04.040; Broer SL, 2011, J CLIN ENDOCR METAB, V96, P2532, DOI 10.1210/jc.2010-2776; Cagnacci A, SEASONAL ONSET MENOP; DANIELL HW, 1978, LANCET, V2, P373; Farley T, 2006, HUM REPROD UPDATE, V12, P483, DOI 10.1093/humupd/dml028; Gougeon A, 1998, MATURITAS, V30, P137, DOI 10.1016/S0378-5122(98)00069-3; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Hansen KR, 2011, FERTIL STERIL, V95, P170, DOI 10.1016/j.fertnstert.2010.04.006; Hardy R, 2000, INT J EPIDEMIOL, V29, P845, DOI 10.1093/ije/29.5.845; Jones MC, 2003, J R STAT SOC B, V65, P159, DOI 10.1111/1467-9868.00378; Kok HS, 2006, MENOPAUSE, V13, P19, DOI 10.1097/01.gme.0000196592.36711.a0; KRITZSILVERSTEIN D, 1993, AM J PUBLIC HEALTH, V83, P983, DOI 10.2105/AJPH.83.7.983; La Marca A, 2010, REPROD BIOMED ONLINE, V21, P463, DOI 10.1016/j.rbmo.2010.05.009; La Marca A, 2012, EUR J OBSTET GYN R B, V163, P180, DOI 10.1016/j.ejogrb.2012.04.013; Lambalk CB, 1998, MATURITAS, V30, P215, DOI 10.1016/S0378-5122(98)00076-0; Monninkhof EM, 1999, BREAST CANCER RES TR, V55, P285, DOI 10.1023/A:1006277207963; Nelson SM, 2011, FERTIL STERIL, V95, P736, DOI 10.1016/j.fertnstert.2010.08.022; Parazzini F, 2007, MATURITAS, V56, P280, DOI 10.1016/j.maturitas.2006.09.003; Plante BJ, 2010, MENOPAUSE, V17, P571, DOI 10.1097/gme.0b013e3181c7deba; Schildkraut JM, 2001, OBSTET GYNECOL, V98, P85, DOI 10.1016/S0029-7844(01)01388-6; SHERMAN B, 1981, J CLIN ENDOCR METAB, V52, P488, DOI 10.1210/jcem-52-3-488; Sowers MR, 2008, J CLIN ENDOCR METAB, V93, P3478, DOI 10.1210/jc.2008-0567; Tehrani FR, 2011, MENOPAUSE, V18, P766, DOI 10.1097/gme.0b013e318205e2ac; Tehrani FR, 2009, MENOPAUSE, V16, P797, DOI 10.1097/gme.0b013e318193e95d; van Disseldorp J, 2008, J CLIN ENDOCR METAB, V93, P2129, DOI 10.1210/jc.2007-2093; van Disseldorp J, 2010, HUM REPROD, V25, P221, DOI 10.1093/humrep/dep366; van Wayenburg CAM, 2000, EPIDEMIOLOGY, V11, P304, DOI 10.1097/00001648-200005000-00013; vanNoord PAH, 1997, FERTIL STERIL, V68, P95, DOI 10.1016/S0015-0282(97)81482-3; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772; Waylen AL, 2010, REPROD BIOMED ONLINE, V20, P861, DOI 10.1016/j.rbmo.2010.02.021	33	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57005	10.1371/journal.pone.0057005	http://dx.doi.org/10.1371/journal.pone.0057005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505417	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500009
J	Scorza, P; Stevenson, A; Canino, G; Mushashi, C; Kanyanganzi, F; Munyanah, M; Betancourt, T				Scorza, Pamela; Stevenson, Anne; Canino, Glorisa; Mushashi, Christine; Kanyanganzi, Fredrick; Munyanah, Morris; Betancourt, Theresa			Validation of the "World Health Organization Disability Assessment Schedule for Children, WHODAS-Child" in Rwanda	PLOS ONE			English	Article							MENTAL-HEALTH; SAMPLE-SIZE; DEPRESSION; SCALE; PREVALENCE; SYMPTOM; PARENT	Overview: The World Health Organization Disability Assessment Schedule for children (WHODAS-Child) is a disability assessment instrument based on the WHO's International Classification of Functioning, Disability and Health for children and youth. It is modified from the original adult version specifically for use with children. The aim of this study was to assess the WHODAS-Child structure and metric properties in a community sample of children with and without reported psychosocial problems in rural Rwanda. Methods: The WHODAS-Child was first translated into Kinyarwanda through a detailed committee translation process and back-translation. Cognitive interviewing was used to assess the comprehension of the translated items. Test-retest reliability was assessed in a group of 64 children. The translated WHODAS-Child was then administered to a final sample of 367 children in southern Kayonza district in rural southeastern Rwanda within a larger psychosocial assessment battery. The latent structure was assessed through confirmatory factor analysis. Reliability was evaluated in terms of internal consistency (Cronbach's alpha) and test-retest reliability (Pearson's correlation coefficient). Construct validity was explored by examining convergence between WHODAS-Child scores and mental disorder status, and divergence of WHODAS-Child scores with protective factors and prosocial behaviors. Concordance between parent and child scores was also assessed. Results: The six-factor structure of the WHODAS-Child was confirmed in a population sample of Rwandan children. Test-retest and inter-rater reliability were high (r = .83 and ICC = .88). WHODAS-Child scores were moderately positively correlated with presence of depression (r = .42, p<.001) and post-traumatic stress disorder (r = .31, p<.001) and moderately negatively correlated with prosocial behaviors (r = .47, p<.001). The Kinyarwanda version of the WHODAS-Child was found to be a reliable and acceptable self-report tool for assessment of functional impairment among children largely referred for psychosocial problems in the study district in rural Rwanda. Further research in low-resource settings and with more general populations is recommended.	[Scorza, Pamela; Stevenson, Anne; Betancourt, Theresa] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Canino, Glorisa] Univ Puerto Rico, San Juan, PR 00936 USA; [Mushashi, Christine; Kanyanganzi, Fredrick; Munyanah, Morris] Hlth Inshuti Mu Buzima, Rwinkwavu, Rwanda	Harvard University; Harvard T.H. Chan School of Public Health; University of Puerto Rico	Betancourt, T (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	Theresa_Betancourt@harvard.edu		Scorza, Pamela/0000-0001-8895-8675	National Institute of Mental Health [1K01MH07724601 A2, 1R34MH084679-01 A1]; Peter C. Alderman Foundation; Harvard Center for the Developing Child; Center for AIDS Research at Harvard University; Francois-Xavier Bagnoud Center for Health and Human Rights; Harvard School of Public Health Career Incubator Fund; Julie Henry Family Development Fund; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH096724, R34MH084679] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Peter C. Alderman Foundation; Harvard Center for the Developing Child; Center for AIDS Research at Harvard University; Francois-Xavier Bagnoud Center for Health and Human Rights; Harvard School of Public Health Career Incubator Fund; Julie Henry Family Development Fund; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this research was provided by grant number 1K01MH07724601 A2 and grant number 1R34MH084679-01 A1 from the National Institute of Mental Health, the Peter C. Alderman Foundation, the Harvard Center for the Developing Child, the Center for AIDS Research at Harvard University, Francois-Xavier Bagnoud Center for Health and Human Rights, the Harvard School of Public Health Career Incubator Fund, and the Julie Henry Family Development Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson M, 2013, INT J SOC WELF, V22, P195, DOI 10.1111/j.1468-2397.2012.00876.x; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; Benjet C, 2010, CURR OPIN PSYCHIATR, V23, P356, DOI 10.1097/YCO.0b013e32833ad79b; Betancourt T, 2012, J AM ACAD CHILD PSY, V51, P1284, DOI 10.1016/j.jaac.2012.09.003; Betancourt TS, 2011, AIDS CARE, V23, P401, DOI 10.1080/09540121.2010.516333; Betancourt TS, 2011, SOC SCI MED, V73, P693, DOI 10.1016/j.socscimed.2011.06.053; Bird HR, 1999, DIAGNOSTIC ASSESSMENT IN CHILD AND ADOLESCENT PSYCHOPATHOLOGY, P209; Bloom D CD, 2007, REALIZING DEMO UNPUB; Bolton P, 2002, SOC PSYCH PSYCH EPID, V37, P537, DOI 10.1007/s00127-002-0580-5; Bolton P, 2002, J NERV MENT DIS, V190, P631, DOI 10.1097/00005053-200209000-00009; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Cremeens J, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-58; DIMDI, 2005, INT CLASS FUNCT DIS; Harkness J., 2004, METHODS TESTING EVAL; Heckman JJ, 2006, J LABOR ECON, V24, P411, DOI 10.1086/504455; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ingstad B, 1995, DISABILITY CULTURE; Kohrt BA, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-127; Kramer TL, 2004, J CHILD PSYCHOL PSYC, V45, P248, DOI 10.1111/j.1469-7610.2004.00217.x; Lee J, 2012, CONDUCTING COGNITIVE; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Matias-Carrelo LE, 2003, CULT MED PSYCHIAT, V27, P291, DOI 10.1023/A:1025399115023; McDermott BM, 2005, CAN J PSYCHIAT, V50, P137, DOI 10.1177/070674370505000302; Murphy K. R., 1996, PSYCHOL TESTING PRIN; Murray, 2002, SUMMARY MEASURES POP, P205; Muthen B., 2010, MPLUS USERS GUIDE; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Prince M, 2008, EPIDEMIOL PSICHIAT S, V17, P211, DOI 10.1017/S1121189X00001305; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Sheehan D., 2009, MINI INT NEUROPSYCHI; StataCorp, 2009, STAT STAT SOFTW; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; Von Korff M, 2008, J CLIN EPIDEMIOL, V61, P1132, DOI 10.1016/j.jclinepi.2007.12.009; Winters NC, 2005, J AM ACAD CHILD PSY, V44, P309, DOI 10.1097/01.chi.0000153230.57344.cd; World Health Organization, 2008, MHGAP SCAL CAR MENT	36	38	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57725	10.1371/journal.pone.0057725	http://dx.doi.org/10.1371/journal.pone.0057725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23505437	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500029
J	Shull, AY; Clendenning, ML; Ghoshal-Gupta, S; Farrell, CL; Vangapandu, HV; Dudas, L; Wilkerson, BJ; Buckhaults, PJ				Shull, Austin Y.; Clendenning, Megan L.; Ghoshal-Gupta, Sampa; Farrell, Christopher L.; Vangapandu, Hima V.; Dudas, Larry; Wilkerson, Brent J.; Buckhaults, Phillip J.			Somatic Mutations, Allele Loss, and DNA Methylation of the Cub and Sushi Multiple Domains 1 (CSMD1) Gene Reveals Association with Early Age of Diagnosis in Colorectal Cancer Patients	PLOS ONE			English	Article							STEM-CELLS; HOMOZYGOUS DELETION; COUNTING ALLELES; HUMAN BREAST; EARLY-STAGE; HEAD; NECK; INACTIVATION; INSTABILITY; SEQUENCES	Background: The Cub and Sushi Multiple Domains 1 (CSMD1) gene, located on the short arm of chromosome 8, codes for a type I transmembrane protein whose function is currently unknown. CSMD1 expression is frequently lost in many epithelial cancers. Our goal was to characterize the relationships between CSMD1 somatic mutations, allele imbalance, DNA methylation, and the clinical characteristics in colorectal cancer patients. Methods: We sequenced the CSMD1 coding regions in 54 colorectal tumors using the 454FLX pyrosequencing platform to interrogate 72 amplicons covering the entire coding sequence. We used heterozygous SNP allele ratios at multiple CSMD1 loci to determine allelic balance and infer loss of heterozygosity. Finally, we performed methylation-specific PCR on 76 colorectal tumors to determine DNA methylation status for CSMD1 and known methylation targets ALX4, RUNX3, NEUROG1, and CDKN2A. Results: Using 454FLX sequencing and confirming with Sanger sequencing, 16 CSMD1 somatic mutations were identified in 6 of the 54 colorectal tumors (11%). The nonsynonymous to synonymous mutation ratio of the 16 somatic mutations was 15:1, a ratio significantly higher than the expected 2:1 ratio (p = 0.014). This ratio indicates a presence of positive selection for mutations in the CSMD1 protein sequence. CSMD1 allelic imbalance was present in 19 of 37 informative cases (56%). Patients with allelic imbalance and CSMD1 mutations were significantly younger (average age, 41 years) than those without somatic mutations (average age, 68 years). The majority of tumors were methylated at one or more CpG loci within the CSMD1 coding sequence, and CSMD1 methylation significantly correlated with two known methylation targets ALX4 and RUNX3. C:G>T:A substitutions were significantly overrepresented (47%), suggesting extensive cytosine methylation predisposing to somatic mutations. Conclusions: Deep amplicon sequencing and methylation-specific PCR reveal that CSMD1 alterations can correlate with earlier clinical presentation in colorectal tumors, thus further implicating CSMD1 as a tumor suppressor gene.	[Shull, Austin Y.; Clendenning, Megan L.; Ghoshal-Gupta, Sampa; Buckhaults, Phillip J.] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA USA; [Shull, Austin Y.; Buckhaults, Phillip J.] Georgia Hlth Sci Univ, Dept Biochem & Canc Biol, Augusta, GA USA; [Farrell, Christopher L.] Presbyterian Coll Sch Pharm, Dept Pharmaceut & Adm Sci, Clinton, SC USA; [Vangapandu, Hima V.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Dudas, Larry] Northeast Georgia Med Ctr, Dept Internal Med, Gainesville, GA USA; [Wilkerson, Brent J.] Univ Calif Davis, Med Ctr, Dept Otolaryngol Head & Neck Surg, Sacramento, CA 95817 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis	Buckhaults, PJ (corresponding author), Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA USA.	phillip.buckhaults@gmail.com		Vangapandu, Hima/0000-0003-4762-1990	National Institutes of Health [7R21CA127683]; NATIONAL CANCER INSTITUTE [U01CA158428, R21CA127683] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for this project was provided by National Institutes of Health grant 7R21CA127683. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi R, 2008, NEOPLASIA, V10, P1170, DOI 10.1593/neo.08572; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Beckman RA, 2006, P NATL ACAD SCI USA, V103, P14140, DOI 10.1073/pnas.0606271103; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Benvenuti S, 2008, HUM MUTAT, V29, P284, DOI 10.1002/humu.20648; Beuten J, 2009, CARCINOGENESIS, V30, P1372, DOI 10.1093/carcin/bgp148; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan MWY, 2004, BIOTECHNOL LETT, V26, P1289, DOI 10.1023/B:BILE.0000044922.43572.2d; Cheng XD, 2011, PROG MOL BIOL TRANSL, V101, P1, DOI 10.1016/B978-0-12-387685-0.00001-9; Cooper DN, 2010, HUM MUTAT, V31, P631, DOI 10.1002/humu.21260; Dyachenko OV, 2010, EPIGENETICS-US, V5, P569, DOI 10.4161/epi.5.7.12702; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Farrell CL, 2008, CANCER BIOL THER, V7, P609, DOI 10.4161/cbt.7.4.5623; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Herbst A, 2011, AM J GASTROENTEROL, V106, P1110, DOI 10.1038/ajg.2011.6; Hogan LE, 2011, BLOOD, V118, P5218, DOI 10.1182/blood-2011-04-345595; Hornstein Max, 2008, Cancer Genomics & Proteomics, V5, P123; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamal M, 2010, BREAST CANCER RES TR, V121, P555, DOI 10.1007/s10549-009-0500-4; Kashuba VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005231; Kim YH, 2011, ANN SURG ONCOL, V18, P2338, DOI 10.1245/s10434-011-1573-y; Kodach LL, 2010, CARCINOGENESIS, V31, P1567, DOI 10.1093/carcin/bgq147; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Kuo KT, 2009, CANCER RES, V69, P4036, DOI 10.1158/0008-5472.CAN-08-3913; Lang MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036248; Lau WL, 2003, GENOMICS, V82, P412, DOI 10.1016/S0888-7543(03)00149-6; Lorente A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-61; Ma CQ, 2009, CANCER BIOL THER, V8, P907, DOI 10.4161/cbt.8.10.8132; Mancini D, 1997, AM J HUM GENET, V61, P80, DOI 10.1086/513898; Midorikawa Y, 2009, HEPATOLOGY, V49, P513, DOI 10.1002/hep.22698; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pavlicek A, 2002, GENE, V300, P189, DOI 10.1016/S0378-1119(02)01047-8; Peltomaki P, 2012, EXP CELL RES, V318, P299, DOI 10.1016/j.yexcr.2011.12.001; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Richter TM, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-29; Scholnick SB, 2003, GENE CHROMOSOME CANC, V38, P281, DOI 10.1002/gcc.10279; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Shih IM, 2001, CANCER RES, V61, P818; Siegmund KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021657; Siegmund KD, 2009, P NATL ACAD SCI USA, V106, P4828, DOI 10.1073/pnas.0810276106; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stratton MR, 2004, NATURE, V430, P30, DOI 10.1038/430030a; Sun PC, 2001, GENOMICS, V75, P17, DOI 10.1006/geno.2001.6587; Toomes C, 2003, GENE CHROMOSOME CANC, V37, P132, DOI 10.1002/gcc.10191; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zeitoun G, 2008, ANTICANCER RES, V28, P3609; Zhou W, 2002, LANCET, V359, P219, DOI 10.1016/S0140-6736(02)07448-2; Zhou W, 2001, NAT BIOTECHNOL, V19, P78, DOI 10.1038/83572; Zou Hongzhi, 2002, Zhonghua Yu Fang Yi Xue Za Zhi, V36, P499	62	24	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58731	10.1371/journal.pone.0058731	http://dx.doi.org/10.1371/journal.pone.0058731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505554	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500119
J	Ueda, Y; Kaido, T; Ogura, Y; Ogawa, K; Yoshizawa, A; Hata, K; Fujimoto, Y; Miyagawa-Hayashino, A; Haga, H; Marusawa, H; Teramukai, S; Uemoto, S; Chiba, T				Ueda, Yoshihide; Kaido, Toshimi; Ogura, Yasuhiro; Ogawa, Kohei; Yoshizawa, Atsushi; Hata, Koichiro; Fujimoto, Yasuhiro; Miyagawa-Hayashino, Aya; Haga, Hironori; Marusawa, Hiroyuki; Teramukai, Satoshi; Uemoto, Shinji; Chiba, Tsutomu			Pretransplant Serum Hepatitis C Virus RNA Levels Predict Response to Antiviral Treatment after Living Donor Liver Transplantation	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; RIBAVIRIN THERAPY; GENOTYPE 1B; PEGYLATED INTERFERON; PLUS RIBAVIRIN; COMBINATION THERAPY; NATURAL-HISTORY; PEG-INTERFERON; RECURRENCE; INFECTION	Background: Given the limited efficacy and high adverse event rate associated with treatment of recurrent hepatitis C after liver transplantation, an individualized treatment strategy should be considered. The aim of this study was to identify predictors of response to antiviral therapy for hepatitis C after living donor liver transplantation (LDLT) and to study the associated adverse events. Methods: A retrospective chart review was performed on 125 hepatitis C virus (HCV)-positive LDLT recipients who received interferon plus ribavirin and/or peginterferon plus ribavirin therapy at Kyoto University between January 2001 and June 2011. Results: Serum HCV RNA reached undetectable levels within 48 weeks in 77 (62%) of 125 patients, and these patients were defined as showing virological response (VR). Of 117 patients, 50 (43%) achieved sustained VR (SVR). Predictive factors associated with both VR and SVR by univariate analysis included low pretransplant serum HCV RNA levels, a non-1 HCV genotype, and low pretreatment serum HCV RNA levels. In addition, LDLT from ABO-mismatched donors was significantly associated with VR, and white cell and neutrophil counts before interferon therapy were associated with SVR. Multivariate analysis showed that 2 variables-pretransplant serum HCV RNA level less than 500 kIU/mL and a non-1 HCV genotype-remained in models of both VR and SVR and that an ABO mismatch was associated with VR. No variables with a significant effect on treatment withdrawal were found. Conclusions: Virological response to antiviral therapy in patients with hepatitis C recurring after LDLT can be predicted prior to transplant, based on pretransplant serum HCV-RNA levels and HCV genotype. LDLT from ABO-mismatched donors may contribute to more efficacious interferon therapy.	[Ueda, Yoshihide; Marusawa, Hiroyuki; Chiba, Tsutomu] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Kaido, Toshimi; Ogura, Yasuhiro; Ogawa, Kohei; Yoshizawa, Atsushi; Hata, Koichiro; Fujimoto, Yasuhiro; Uemoto, Shinji] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Miyagawa-Hayashino, Aya; Haga, Hironori] Kyoto Univ Hosp, Dept Diagnost Pathol, Kyoto 606, Japan; [Teramukai, Satoshi] Kyoto Univ Hosp, Translat Res Ctr, Div Clin Trial Design & Management, Kyoto 606, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University	Ueda, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan.	yueda@kuhp.kyoto-u.ac.jp	Ueda, Yoshihide/S-7620-2016; Teramukai, Satoshi/I-2249-2019; Ogura, Yasuhiro/A-2557-2016	Ueda, Yoshihide/0000-0003-3196-3494; Teramukai, Satoshi/0000-0003-2184-0597; Ogura, Yasuhiro/0000-0001-5768-6160; Marusawa, Hiroyuki/0000-0002-4286-2712; Hata, Koichiro/0000-0002-3609-6396; Haga, Hironori/0000-0003-4322-9561	Japan Society for the Promotion of Science (JSPS) [21229009, 23590972]; Health and Labour Sciences Research Grants for Research on Intractable Diseases; Research on Hepatitis from the Ministry of Health, Labour and Welfare, Japan	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Sciences Research Grants for Research on Intractable Diseases; Research on Hepatitis from the Ministry of Health, Labour and Welfare, Japan	This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-aid for Scientific Research 21229009 and 23590972, and Health and Labour Sciences Research Grants for Research on Intractable Diseases, and Research on Hepatitis from the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Berardi S, 2007, GUT, V56, P237, DOI 10.1136/gut.2006.092064; Berenguer M, 2002, HEPATOLOGY, V36, P202, DOI 10.1053/jhep.2002.33993; Berenguer M, 2008, J HEPATOL, V49, P274, DOI 10.1016/j.jhep.2008.05.002; Berenguer M, 2006, LIVER TRANSPLANT, V12, P1067, DOI 10.1002/lt.20737; Carrion JA, 2007, GASTROENTEROLOGY, V132, P1746, DOI 10.1053/j.gastro.2007.03.041; Charlton MR, 2011, HEPATOLOGY, V53, P317, DOI 10.1002/hep.24074; Egawa H, 2008, HEPATOLOGY, V47, P143, DOI 10.1002/hep.21928; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Feray C, 1999, GASTROENTEROLOGY, V117, P619, DOI 10.1016/S0016-5085(99)70454-3; Fernandez I, 2009, LIVER TRANSPLANT, V15, P948, DOI 10.1002/lt.21780; Forman LM, 2002, GASTROENTEROLOGY, V122, P889, DOI 10.1053/gast.2002.32418; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fukuhara T, 2010, GASTROENTEROLOGY, V139, P1577, DOI 10.1053/j.gastro.2010.07.058; Fukuhara T, 2010, J HEPATOL, V52, P672, DOI 10.1016/j.jhep.2009.10.034; Gane E, 2003, LIVER TRANSPLANT, V9, pS28, DOI 10.1053/jlts.2003.50248; Garg V, 2011, HEPATOLOGY, V54, P20, DOI 10.1002/hep.24443; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gordon FD, 2009, LIVER TRANSPLANT, V15, P126, DOI 10.1002/lt.21694; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Neumann U, 2006, TRANSPLANTATION, V82, P43, DOI 10.1097/01.tp.0000225827.18034.be; Ohno T, 1997, J CLIN MICROBIOL, V35, P201, DOI 10.1128/JCM.35.1.201-207.1997; Oton E, 2006, AM J TRANSPLANT, V6, P2348, DOI 10.1111/j.1600-6143.2006.01470.x; Picciotto FP, 2007, J HEPATOL, V46, P459, DOI 10.1016/j.jhep.2006.10.017; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Prieto M, 1999, HEPATOLOGY, V29, P250, DOI 10.1002/hep.510290122; Raut V, 2012, TRANSPLANTATION, V93, P99, DOI 10.1097/TP.0b013e318239e8e4; Rodriguez-Luna H, 2004, TRANSPLANTATION, V77, P190, DOI 10.1097/01.TP.0000100481.14514.BB; Sanchez-Fueyo A, 2002, TRANSPLANTATION, V73, P56, DOI 10.1097/00007890-200201150-00010; Sharma P, 2007, LIVER TRANSPLANT, V13, P1100, DOI 10.1002/lt.21121; Stanca CM, 2007, TRANSPLANTATION, V84, P180, DOI 10.1097/01.tp.0000269609.08495.45; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Terrault NA, 2008, LIVER TRANSPLANT, V14, pS58, DOI 10.1002/lt.21624; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Triantos C, 2005, TRANSPLANTATION, V79, P261, DOI 10.1097/01.TP.0000149696.76204.38; Ueda Y, 2010, J VIRAL HEPAT; Ueda Y, 2008, TRANSPLANTATION, V85, P855, DOI 10.1097/TP.0b013e3181671df0; Ueda Y, 2010, TRANSPLANTATION, V90, P661, DOI 10.1097/TP.0b013e3181d2bfca; Velidedeoglu E, 2004, TRANSPLANTATION, V77, P1834, DOI 10.1097/01.tp.0000130468.36131.0d; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	48	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58380	10.1371/journal.pone.0058380	http://dx.doi.org/10.1371/journal.pone.0058380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505497	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500075
J	Wertli, MM; Schob, M; Brunner, F; Steurer, J				Wertli, Maria M.; Schoeb, Manuela; Brunner, Florian; Steurer, Johann			Incomplete Reporting of Baseline Characteristics in Clinical Trials: An Analysis of Randomized Controlled Trials and Systematic Reviews Involving Patients with Chronic Low Back Pain	PLOS ONE			English	Review							UPDATED METHOD GUIDELINES; METAANALYSES; ACUPUNCTURE; CHALLENGES; PROGNOSIS; QUALITY	Objective: The aim of this study was to evaluate the reporting of relevant prognostic information in a sample of randomized controlled trials (RCTs) that investigated treatments for patients with chronic low back pain (LBP). We also analysed how researchers conducting the meta-analyses and systematic reviews addressed the reporting of relevant prognostic information in RCTs. Methods: We searched the Cochrane Database to identify systematic reviews that investigated non-surgical treatments for patients with chronic LBP. The reported prognostic information was then extracted from the RCTs included in the reviews. We used a purpose-defined score to assess the quantity of information reported in the RCTs. We also determined how the authors of systematic reviews addressed the question of comparability of patient populations between RCTs. Results: Six systematic reviews met our inclusion criteria, and we analysed 84 RCTs. Based on the scores, the reporting of important prognostic variables was incomplete in almost half of the 84 RCTs. Information regarding patients' general health, social support, and work-related conditions was rarely reported. Almost half of the studies included in one of the meta-analyses provided insufficient information that did not allow us to determine whether patients in the primary trials were comparable. Conclusions: Missing prognostic information potentially threatens the external validity (i.e. the generalizability or applicability) not only of primary studies but also of systematic reviews that investigate treatments for LBP. A detailed description of baseline patient characteristics that includes prognostic information is needed in all RCTs to ensure that clinicians can determine the applicability of the study or review results to their patients.	[Wertli, Maria M.; Schoeb, Manuela; Steurer, Johann] Univ Zurich, Dept Internal Med, Horten Ctr Patient Oriented Res & Knowledge Trans, Zurich, Switzerland; [Brunner, Florian] Balgrist Univ Hosp, Dept Phys Med & Rheumatol, Zurich, Switzerland	University of Zurich; University of Zurich	Wertli, MM (corresponding author), Univ Zurich, Dept Internal Med, Horten Ctr Patient Oriented Res & Knowledge Trans, Zurich, Switzerland.	Maria.Wertli@usz.ch	Wertli, Maria/Q-3349-2017	Wertli, Maria/0000-0001-6347-0198				[Anonymous], 2009, CRDS GUIDANCE UNDERT; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; Chou R, 2011, J PAIN, V12, P833, DOI 10.1016/j.jpain.2011.04.012; Dagenais S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004059.pub3; Deeks J J, 2003, Health Technol Assess, V7, piii; Deshpande A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004959.pub3; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Eden J, 2011, FINDING WHAT WORKS IN HEALTH CARE: STANDARDS FOR SYSTEMATIC REVIEWS, P1; Egger M, 2002, INT J EPIDEMIOL, V31, P1, DOI 10.1093/ije/31.1.1; Fourney DR, 2011, SPINE, V36, pS1, DOI 10.1097/BRS.0b013e31822f0a0d; Freeman MD, 2010, SPINE J, V10, P512, DOI 10.1016/j.spinee.2010.04.006; Furlan AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001351.pub2; Furlan AD, 2009, SPINE, V34, P1929, DOI 10.1097/BRS.0b013e3181b1c99f; Hayden JA, 2010, BEST PRACT RES CL RH, V24, P167, DOI 10.1016/j.berh.2009.12.005; Hayden JA, 2009, J CLIN EPIDEMIOL, V62, P781, DOI 10.1016/j.jclinepi.2008.09.004; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Henschke N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002014.pub3; Jane-Wit D, 2010, J CLIN EPIDEMIOL, V63, P56, DOI 10.1016/j.jclinepi.2009.02.010; Khadilkar A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003008.pub3; KIRKHAM JJ, 2010, BMJ-BRIT MED J, V340, pc365, DOI DOI 10.1136/BMJ.C365; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Manchikanti L, 2009, PAIN PHYSICIAN, V12, pE355; Nour K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-12; Ostelo R, 2010, BEST PRACT RES CL RH, V24, P281, DOI 10.1016/j.berh.2009.12.006; Pambrun E, 2010, J CLIN EPIDEMIOL, V63, P342, DOI 10.1016/j.jclinepi.2009.07.021; Pincus T, 2008, ARTHRIT RHEUM-ARTHR, V59, P14, DOI 10.1002/art.23251; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Staal J Bart, 2008, Cochrane Database Syst Rev, pCD001824, DOI 10.1002/14651858.CD001824.pub3; Tricco AC, 2009, J CLIN EPIDEMIOL, V62, P380, DOI 10.1016/j.jclinepi.2008.08.008; Trigkilidas D, 2010, ANN ROY COLL SURG, V92, P595, DOI 10.1308/003588410X12699663904196; Urquhart DM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001703.pub3; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; vanTulder MW, 1997, SPINE, V22, P2323, DOI 10.1097/00007632-199710150-00001; Willis BH, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-163	37	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58512	10.1371/journal.pone.0058512	http://dx.doi.org/10.1371/journal.pone.0058512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505524	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000318334500095
J	Barua, H; Biswas, PK; Olsen, KEP; Shil, SK; Christensen, JP				Barua, Himel; Biswas, Paritosh K.; Olsen, Katharina E. P.; Shil, Subrata K.; Christensen, Jens P.			Molecular Characterization of Motile Serovars of Salmonella enterica from Breeder and Commercial Broiler Poultry Farms in Bangladesh	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL RESISTANCE; INTERNATIONAL SPREAD; KENTUCKY; CIPROFLOXACIN; PREVALENCE; STRAIN; SURVEILLANCE; ENTERITIDIS; CHICKENS	Contaminated poultry and poultry products are a major source of motile Salmonellae for human salmonellosis worldwide. Local circulation of any motile Salmonella serovar in poultry has a wider public health impact beyond its source of origin for being dispersed elsewhere through poultry trades or human travels. To investigate the status of motile Salmonella serovars in breeder farms in Bangladesh, multiple flocks of two breeder farms were observed for a period of six months. In addition, a cross-sectional survey was carried out to determine the prevalence and serovar distribution of motile Salmonella by randomly selecting 100 commercial broiler poultry farms. Five pooled faecal samples representing an entire housed flock of breeders or broilers were screened for presence of motile Salmonella following conventional bacteriological procedures. The Salmonella isolates obtained were subsequently serotyped, and characterized by plasmid profiling and pulsed-field gel electrophoresis (PFGE). The results revealed that both the breeder farms were positive with three Salmonella serovars: S. Virchow, S. Paratyphi B var Java (S. Java) and S. Enteritidis. Eleven of the 100 broiler farms investigated were positive for motile Salmonella, giving a farm-level prevalence of 11% (95% confidence interval 5-17%). S. Virchow and S. Kentucky were the two predominant serovars isolated from the broiler farms. The PFGE genotyping demonstrated that the isolates belonging to the same serovars were closely related due to variation in only 1-4 bands. All the S. Virchow and S. Java isolates, irrespective of breeder or broiler farm origin, were plasmid-free, except for one S. Virchow isolate from a broiler farm that harboured a 9.7 kb-sized plasmid. The S. Kentucky isolates belonged to three plasmid profiles having plasmids of four different sizes, ranging from 2.7 to 109 kb. This is the first report of any motile Salmonella serovars from breeder and commercial broiler poultry farms in Bangladesh.	[Barua, Himel; Christensen, Jens P.] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Barua, Himel; Biswas, Paritosh K.] Chittagong Vet & Anim Sci Univ, Dept Microbiol, Fac Vet Med, Chittagong, Bangladesh; [Olsen, Katharina E. P.] Statens Serum Inst, Natl Reference Lab Enteropathogen Bacteria, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Shil, Subrata K.] Chittagong Vet & Anim Sci Univ, Dept Anat & Histol, Fac Vet Med, Chittagong, Bangladesh	University of Copenhagen; Statens Serum Institut	Barua, H (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark.	hiba@sund.ku.dk		Christensen, Jens Peter/0000-0002-6430-9010; Shil, Dr. Subrata Kumar/0000-0002-8047-6169	University of Copenhagen	University of Copenhagen	The study was supported by the University of Copenhagen, in the form of a PhD grant. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 2007, EMERG INFECT DIS, V13, P726, DOI 10.3201/eid1305.061489; Bangtrakulnonth A, 2004, EMERG INFECT DIS, V10, P131, DOI 10.3201/eid1001.02-0781; Barua H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035914; Brown D J, 2003, Euro Surveill, V8, P35; Byrd JA, 1999, AVIAN DIS, V43, P39, DOI 10.2307/1592760; Centers for Disease Control and Prevention (CDC), 2009, ONE DAY 24 28 H STAN; Collard JM, 2007, J ANTIMICROB CHEMOTH, V60, P190, DOI 10.1093/jac/dkm114; Cox JM, 2010, J APPL MICROBIOL, V108, P745, DOI 10.1111/j.1365-2672.2009.04456.x; Cox NA, 2000, POULTRY SCI, V79, P1571, DOI 10.1093/ps/79.11.1571; Dione MM, 2009, J FOOD PROTECT, V72, P2423, DOI 10.4315/0362-028X-72.11.2423; Dorn C, 2001, BERL MUNCH TIERARZTL, V114, P179; Elgroud R, 2009, ZOONOSES PUBLIC HLTH, V56, P84, DOI 10.1111/j.1863-2378.2008.01164.x; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; FAO, 2008, POULTRY SECTOR COUNT; FAO and OIE in collaboration with WHO, 2005, GLOB STRAT PROGR CON; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Gast R. K., 2003, DIS POULTRY, P583; Grimont P. A. D., 2007, ANTIGENIC FORMULAE S; Gutierrez M, 2009, FOODBORNE PATHOG DIS, V6, P111, DOI 10.1089/fpd.2008.0163; Herikstad H, 2002, EPIDEMIOL INFECT, V129, P1, DOI 10.1017/S0950268802006842; Humphrey T., 2000, Salmonella in domestic animals., P245, DOI 10.1079/9780851992617.0245; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kalender H, 2009, FOODBORNE PATHOG DIS, V6, P265, DOI 10.1089/fpd.2008.9989; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; MACRINA FL, 1978, PLASMID, V1, P417, DOI 10.1016/0147-619X(78)90056-2; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Majtan V, 2006, JPN J INFECT DIS, V59, P358; Nogrady N, 2008, INT J FOOD MICROBIOL, V127, P162, DOI 10.1016/j.ijfoodmicro.2008.07.005; Olsen J. E., 2000, Salmonella in domestic animals., P429, DOI 10.1079/9780851992617.0429; OLSEN JE, 1993, VET QUART, V15, P125, DOI 10.1080/01652176.1993.9694390; Padungtod P, 2006, INT J FOOD MICROBIOL, V108, P346, DOI 10.1016/j.ijfoodmicro.2005.11.020; Papadopoulou C, 2009, VET REC, V165, P681; Poppe C., 2000, Salmonella in domestic animals., P107, DOI 10.1079/9780851992617.0107; ROCHELLE PA, 1986, J GEN MICROBIOL, V132, P53; Snow LC, 2008, VET REC, V163, P649, DOI 10.1136/vr.163.22.649; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; THRELFALL EJ, 1986, J HYG-CAMBRIDGE, V97, P419, DOI 10.1017/S0022172400063609; van Asselt ED, 2009, POULTRY SCI, V88, P2695, DOI 10.3382/ps.2009-00074; Van Immerseel F, 2004, POULTRY SCI, V83, P1911, DOI 10.1093/ps/83.11.1911; van Pelt W, 2003, Euro Surveill, V8, P31; Weill FX, 2006, EMERG INFECT DIS, V12, P1611, DOI 10.3201/eid1210.060589; Wray C., 1999, Poultry meat science., P257	43	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57811	10.1371/journal.pone.0057811	http://dx.doi.org/10.1371/journal.pone.0057811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483931	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100047
J	Demchev, V; Malana, G; Vangala, D; Stoll, J; Desai, A; Kang, HW; Li, YX; Nayeb-Hashemi, H; Niepel, M; Cohen, DE; Ukomadu, C				Demchev, Valeriy; Malana, Geraldine; Vangala, Divya; Stoll, Janis; Desai, Anal; Kang, Hye Won; Li, Yingxia; Nayeb-Hashemi, Hamed; Niepel, Michele; Cohen, David E.; Ukomadu, Chinweike			Targeted Deletion of Fibrinogen Like Protein 1 Reveals a Novel Role in Energy Substrate Utilization	PLOS ONE			English	Article							LIVER-SPECIFIC GENE; MOLECULAR-CLONING; LIPID-METABOLISM; HUMAN HEPASSOCIN; GLUCOSE-UPTAKE; COLD-EXPOSURE; OVEREXPRESSION; INHIBITION; ANGPTL3; MICE	Fibrinogen like protein 1(Fgl1) is a secreted protein with mitogenic activity on primary hepatocytes. Fgl1 is expressed in the liver and its expression is enhanced following acute liver injury. In animals with acute liver failure, administration of recombinant Fgl1 results in decreased mortality supporting the notion that Fgl1 stimulates hepatocyte proliferation and/or protects hepatocytes from injury. However, because Fgl1 is secreted and detected in the plasma, it is possible that the role of Fgl1 extends far beyond its effect on hepatocytes. In this study, we show that Fgl1 is additionally expressed in brown adipose tissue. We find that signals elaborated following liver injury also enhance the expression of Fgl1 in brown adipose tissue suggesting that there is a cross talk between the injured liver and adipose tissues. To identify extra hepatic effects, we generated Fgl1 deficient mice. These mice exhibit a phenotype suggestive of a global metabolic defect: Fgl1 null mice are heavier than wild type mates, have abnormal plasma lipid profiles, fasting hyperglycemia with enhanced gluconeogenesis and exhibit differences in white and brown adipose tissue morphology when compared to wild types. Because Fgl1 shares structural similarity to Angiopoietin like factors 2, 3, 4 and 6 which regulate lipid metabolism and energy utilization, we postulate that Fgl1 is a member of an emerging group of proteins with key roles in metabolism and liver regeneration.	[Demchev, Valeriy; Malana, Geraldine; Vangala, Divya; Stoll, Janis; Desai, Anal; Kang, Hye Won; Li, Yingxia; Nayeb-Hashemi, Hamed; Niepel, Michele; Cohen, David E.; Ukomadu, Chinweike] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ukomadu, C (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02115 USA.	cukomadu@partners.org			Sidney A. Swensrud Foundation; Brigham and Women's Hospital Institutional Research Funds; National Institutes of Health (NIH) [DK080789, DK48873, DK56628]; Digestive Disease Center [5P30 DK034854]; NIH [DK07477, 007533]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007477, P30DK034854, R01DK080789, R01DK048873, R29DK048873, R01DK056626, R37DK048873] Funding Source: NIH RePORTER	Sidney A. Swensrud Foundation; Brigham and Women's Hospital Institutional Research Funds; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Disease Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project was supported by a grant from The Sidney A. Swensrud Foundation, Brigham and Women's Hospital Institutional Research Funds and National Institutes of Health (NIH) DK080789 (to CU) and DK48873, DK56628 (to DEC). Lipid assays were performed by the Core D of Harvard Digestive Disease Center supported by 5P30 DK034854. JS and HN were supported by a NIH T32 grant (DK07477 and 007533 respectively). HWK is a recipient of a Founders Affiliate Postdoctoral Fellowship from the American Heart Association. The authors thank Dr Emily Oken for help with statistical analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021209; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; Chu J, 2012, MOL BIOL CELL; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; German JP, 2011, ENDOCRINOLOGY, V152, P394, DOI 10.1210/en.2010-0890; Hara H, 2001, BBA-GENE STRUCT EXPR, V1520, P45, DOI 10.1016/S0167-4781(01)00249-4; Hara H, 2000, BBA-GENE STRUCT EXPR, V1492, P31, DOI 10.1016/S0167-4781(00)00056-7; Hyogo H, 2002, J BIOL CHEM, V277, P34117, DOI 10.1074/jbc.M203912200; KAM I, 1987, HEPATOLOGY, V7, P362, DOI 10.1002/hep.1840070225; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kersten S, 2005, BIOCHEM SOC T, V33, P1059, DOI 10.1042/BST0331059; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Li CY, 2010, GUT, V59, P817, DOI 10.1136/gut.2008.171124; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Liu ZL, 2008, BIOCHEM BIOPH RES CO, V365, P729, DOI 10.1016/j.bbrc.2007.11.069; Miyoshi H, 2010, J LIPID RES, V51, P975, DOI 10.1194/jlr.M002352; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Rijken DC, 2006, BIOCHEM BIOPH RES CO, V350, P191, DOI 10.1016/j.bbrc.2006.09.018; Ruby MA, 2010, J LIPID RES, V51, P2275, DOI 10.1194/jlr.M005561; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; SHIBATA H, 1989, AM J PHYSIOL, V257, pR96, DOI 10.1152/ajpregu.1989.257.1.R96; Shimamura M, 2003, BIOCHEM BIOPH RES CO, V301, P604, DOI 10.1016/S0006-291X(02)03058-9; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; SIMEK J, 1966, Sbornik Vedeckych Praci Lekarske Fakulty University Karlovy v Hradci Kralove, V9, P579; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Ukomadu C, 2003, J BIOL CHEM, V278, P4840, DOI 10.1074/jbc.M208658200; VALLERAND AL, 1990, AM J PHYSIOL, V259, pR1043, DOI 10.1152/ajpregu.1990.259.5.R1043; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; YAMAMOTO T, 1993, BIOCHEM BIOPH RES CO, V193, P681, DOI 10.1006/bbrc.1993.1678; Yan J, 2002, CELL RES, V12, P353, DOI 10.1038/sj.cr.7290137; Yu HT, 2009, J BIOL CHEM, V284, P13335, DOI 10.1074/jbc.M806393200; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	35	46	50	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58084	10.1371/journal.pone.0058084	http://dx.doi.org/10.1371/journal.pone.0058084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483972	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100073
J	Liu, DW; Tsai, SM; Lin, BF; Jiang, YJ; Wang, WP				Liu, Da-Wei; Tsai, Su-Mei; Lin, Bih-Fen; Jiang, Yun-Jin; Wang, Wen-Pin			Fibroblast Growth Factor Receptor 2c Signaling Is Required for Intestinal Cell Differentiation in Zebrafish	PLOS ONE			English	Article							SELF-RENEWAL; STEM-CELLS; EPITHELIAL-CELLS; PROGENITOR CELLS; PROLIFERATION; GUT; BMP; FIBROBLAST-GROWTH-FACTOR-10; COMMITMENT; INHIBITORS	Background: There are four cell lineages derived from intestinal stem cells that are located at the crypt and villus in the mammalian intestine the non-secretory absorptive enterocytes, and the secretory cells, which include mucous-secreting goblet cells, regulatory peptide-secreting enteroendocrine cells and antimicrobial peptide-secreting Paneth cells. Although fibroblast growth factor (Fgf) signaling is important for cell proliferation and differentiation in various tissues, its role in intestinal differentiation is less well understood. Methodology/Principal Findings: We used a loss of function approach to investigate the importance of Fgf signaling in intestinal cell differentiation in zebrafish; abnormal differentiation of goblet cells was observed when Fgf signaling was inhibited using SU5402 or in the Tg(hsp70ldnfgfr1-EGFP) transgenic line. We identified Fgfr2c as an important receptor for cell differentiation. The number of goblet cells and enteroendocrine cells was reduced in fgfr2c morphants. In addition to secretory cells, enterocyte differentiation was also disrupted in fgfr2c morphants. Furthermore, proliferating cells were increased in the morphants. Interestingly, the loss of fgfr2c expression repressed secretory cell differentiation and increased cell proliferation in the mib (ta52b) mutant that had defective Notch signaling. Conclusions/Significance: In conclusion, we found that Fgfr2c signaling derived from mesenchymal cells is important for regulating the differentiation of zebrafish intestine epithelial cells by promoting cell cycle exit. The results of Fgfr2c knockdown in mib (ta52b) mutants indicated that Fgfr2c signaling is required for intestinal cell differentiation. These findings provide new evidences that Fgf signaling is required for the differentiation of intestinal cells in the zebrafish developing gut.	[Liu, Da-Wei; Tsai, Su-Mei; Wang, Wen-Pin] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Lin, Bih-Fen] Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Jiang, Yun-Jin] Natl Hlth Res Inst, Div Mol & Genom Med, Zhunan Town, Miaoli County, Taiwan; [Wang, Wen-Pin] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan	Tzu Chi University; Tzu Chi University; National Health Research Institutes - Taiwan; Tzu Chi University	Wang, WP (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	wpwang@mail.tcu.edu.tw	Jiang, Yun-Jin/E-3995-2010	Jiang, Yun-Jin/0000-0003-0499-7306	National Science Council [NSC100-2311-B-320-001]; Tzu Chi University [TCMRC-P-99013-01]	National Science Council(Ministry of Science and Technology, Taiwan); Tzu Chi University	This work was supported by grants from the National Science Council (NSC100-2311-B-320-001), and Tzu Chi University (TCMRC-P-99013-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Arnaud-Dabernat S, 2008, J CELL PHYSIOL, V216, P261, DOI 10.1002/jcp.21401; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Burns RC, 2004, DEV BIOL, V265, P61, DOI 10.1016/j.ydbio.2003.09.021; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034408; Chen YH, 2009, DEV DYNAM, V238, P1021, DOI 10.1002/dvdy.21908; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Esain V, 2010, DEVELOPMENT, V137, P33, DOI 10.1242/dev.038026; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Faro A, 2009, ZEBRAFISH, V6, P59, DOI 10.1089/zeb.2009.0580; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Hochmann S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030365; HOUSLEY RM, 1994, J CLIN INVEST, V94, P1764, DOI 10.1172/JCI117524; Kan NG, 2009, FASEB J, V23, P3516, DOI 10.1096/fj.09-131730; Klein C, 2011, DEVELOPMENT, V138, P1935, DOI 10.1242/dev.056861; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Liu DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021793; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; Nakayama Y, 2008, DEV BIOL, V313, P752, DOI 10.1016/j.ydbio.2007.11.013; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Nyeng P, 2007, DEV BIOL, V303, P295, DOI 10.1016/j.ydbio.2006.11.017; Nyeng P, 2011, DEV BIOL, V349, P20, DOI 10.1016/j.ydbio.2010.09.010; Ornitz DM, 2001, GENOME BIOL, V2; Paffett-Lugassy N, 2007, BLOOD, V110, P2718, DOI 10.1182/blood-2006-04-016535; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Rohner N, 2009, CURR BIOL, V19, P1642, DOI 10.1016/j.cub.2009.07.065; Sala FG, 2006, DEV BIOL, V299, P373, DOI 10.1016/j.ydbio.2006.08.001; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shih LJ, 2007, GENE EXPR PATTERNS, V7, P452, DOI 10.1016/j.modgep.2006.11.003; Shin D, 2007, DEVELOPMENT, V134, P2041, DOI 10.1242/dev.000281; Sinha J, 2008, AM J PHYSIOL-GASTR L, V295, pG996, DOI 10.1152/ajpgi.90343.2008; Spencer-Dene B, 2006, GASTROENTEROLOGY, V130, P1233, DOI 10.1053/j.gastro.2006.02.018; Tonou-Fujimori Noriko, 2002, Gene Expression Patterns, V2, P183, DOI 10.1016/S0925-4773(02)00422-7; Tsai SM, 2012, TRANSGENIC RES; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Vidrich A, 2004, DEV DYNAM, V230, P114, DOI 10.1002/dvdy.20018; Vidrich A, 2009, AM J PHYSIOL-GASTR L, V297, pG168, DOI 10.1152/ajpgi.90589.2008; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Yeung TM, 2011, CELL MOL LIFE SCI, V68, P2513, DOI 10.1007/s00018-011-0687-5; Zecchin E, 2007, DEV BIOL, V301, P192, DOI 10.1016/j.ydbio.2006.09.041; Zeng L, 2012, DEV BIOL, V367, P178, DOI 10.1016/j.ydbio.2012.05.009; Zeng L, 2009, P NATL ACAD SCI USA, V106, P17793, DOI 10.1073/pnas.0903693106; Zhang XQ, 2006, DEVELOPMENT, V133, P173, DOI 10.1242/dev.02175	57	5	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58310	10.1371/journal.pone.0058310	http://dx.doi.org/10.1371/journal.pone.0058310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484013	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100103
J	Rossi, L; Queloz, P; Brovelli, A; Margot, J; Barry, DA				Rossi, Luca; Queloz, Pierre; Brovelli, Alessandro; Margot, Jonas; Barry, D. A.			Enhancement of Micropollutant Degradation at the Outlet of Small Wastewater Treatment Plants	PLOS ONE			English	Article							FLOW CONSTRUCTED WETLANDS; PERSONAL CARE PRODUCTS; PHOTOCHEMICAL DEGRADATION; PHARMACEUTICAL COMPOUNDS; EMERGING POLLUTANTS; MEMBRANE BIOREACTOR; UV DISINFECTION; CLOFIBRIC ACID; LAKE GENEVA; WILD FISH	The aim of this work was to evaluate low-cost and easy-to-operate engineering solutions that can be added as a polishing step to small wastewater treatment plants to reduce the micropollutant load to water bodies. The proposed design combines a sand filter/constructed wetland with additional and more advanced treatment technologies (UV degradation, enhanced adsorption to the solid phase, e. g., an engineered substrate) to increase the elimination of recalcitrant compounds. The removal of five micropollutants with different physico-chemical characteristics (three pharmaceuticals: diclofenac, carbamazepine, sulfamethoxazole, one pesticide: mecoprop, and one corrosion inhibitor: benzotriazole) was studied to evaluate the feasibility of the proposed system. Separate batch experiments were conducted to assess the removal efficiency of UV degradation and adsorption. The efficiency of each individual process was substance-specific. No process was effective on all the compounds tested, although elimination rates over 80% using light expanded clay aggregate (an engineered material) were observed. A laboratory-scale flow-through setup was used to evaluate interactions when removal processes were combined. Four of the studied compounds were partially eliminated, with poor removal of the fifth (benzotriazole). The energy requirements for a field-scale installation were estimated to be the same order of magnitude as those of ozonation and powdered activated carbon treatments.	[Rossi, Luca; Queloz, Pierre; Brovelli, Alessandro; Margot, Jonas; Barry, D. A.] Ecole Polytech Fed Lausanne, Inst Ingn Environm, Fac Environm Nat Architectural & Construit, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Rossi, L (corresponding author), Ecole Polytech Fed Lausanne, Inst Ingn Environm, Fac Environm Nat Architectural & Construit, Lausanne, Switzerland.	luca.rossi@epfl.ch	Barry, D. Andrew/C-6077-2008; Queloz, Pierre/G-7373-2015	Barry, D. Andrew/0000-0002-8621-0425; Queloz, Pierre/0000-0003-0756-3351; Margot, Jonas/0000-0003-1673-8993				Adam K, 2006, WATER RES, V40, P1143, DOI 10.1016/j.watres.2006.01.009; Andreozzi R, 2003, CHEMOSPHERE, V50, P1319, DOI 10.1016/S0045-6535(02)00769-5; Andreozzi R, 1998, J CHEM TECHNOL BIOT, V73, P93, DOI 10.1002/(SICI)1097-4660(1998100)73:2&lt;93::AID-JCTB910&gt;3.0.CO;2-7; [Anonymous], [No title captured]; Applebaum J, 2001, PROG PHOTOVOLTAICS, V9, P295, DOI 10.1002/pip.367; Avila C, 2010, CHEMOSPHERE, V81, P1137, DOI 10.1016/j.chemosphere.2010.08.006; Bajpai A.K., 2000, COLLOID SURFACE A, V168, P193, DOI DOI 10.1016/S0927-7757(99)00312-X; Baroudi J. A., 2005, International Electric Machines and Drives Conference (IEEE Cat. No.05EX1023C), P458, DOI 10.1109/IEMDC.2005.195763; Beltran FJ, 2009, J HAZARD MATER, V163, P768, DOI 10.1016/j.jhazmat.2008.07.033; BELTRAN FJ, 1994, IND ENG CHEM RES, V33, P125, DOI 10.1021/ie00025a017; Bernhard M, 2006, WATER RES, V40, P3419, DOI 10.1016/j.watres.2006.07.011; Bonvin F, 2011, ENVIRON SCI TECHNOL, V45, P4702, DOI 10.1021/es2003588; Boule P, 2002, INT J PHOTOENERGY, V4, P69, DOI 10.1155/S1110662X02000119; Brahmi M, 2010, J ENVIRON SCI-CHINA, V22, P1218, DOI 10.1016/S1001-0742(09)60241-2; Brovelli A, 2011, ECOL ENG, V37, P758, DOI 10.1016/j.ecoleng.2010.04.031; Canonica S, 2008, WATER RES, V42, P121, DOI 10.1016/j.watres.2007.07.026; Chevre N, 2007, GAS WASSER ABWASSER, V7, P529; Choubert JM, 2011, WATER SCI TECHNOL, V63, P57, DOI 10.2166/wst.2011.009; Clausen L, 2001, J ENVIRON QUAL, V30, P846, DOI 10.2134/jeq2001.303846x; Close J, 2006, RENEW ENERG, V31, P1657, DOI 10.1016/j.renene.2005.08.034; Cole S, 1998, ENVIRON SCI TECHNOL, V32, p218A, DOI 10.1021/es9834733; Conkle JL, 2008, CHEMOSPHERE, V73, P1741, DOI 10.1016/j.chemosphere.2008.09.020; Dantas RF, 2008, J HAZARD MATER, V150, P790, DOI 10.1016/j.jhazmat.2007.05.034; DETEC, 2009, MEAS WAST TREATM; Diaf S, 2007, ENERG POLICY, V35, P5708, DOI 10.1016/j.enpol.2007.06.020; Dordio A, 2010, BIORESOURCE TECHNOL, V101, P886, DOI 10.1016/j.biortech.2009.09.001; Dordio AV, 2009, ECOL ENG, V35, P290, DOI 10.1016/j.ecoleng.2008.02.014; El-Bestawy E, 2007, INT BIODETER BIODEGR, V59, P193, DOI 10.1016/j.ibiod.2006.12.001; Farias T, 2011, J COLLOID INTERF SCI, V363, P465, DOI 10.1016/j.jcis.2011.07.067; Farre M, 2008, TALANTA, V76, P580, DOI 10.1016/j.talanta.2008.03.055; Gagne F, 2011, COMP BIOCHEM PHYS C, V153, P99, DOI 10.1016/j.cbpc.2010.09.002; Galli R, 2009, CONNAISSANCE ENV, P108; Garcia J, 2005, ECOL ENG, V25, P405, DOI 10.1016/j.ecoleng.2005.06.010; Garcia J, 2010, CRIT REV ENV SCI TEC, V40, P561, DOI 10.1080/10643380802471076; Gonzalez O, 2009, PHOTOCH PHOTOBIO SCI, V8, P1032, DOI 10.1039/b822658j; Harrison I, 2003, CHEMOSPHERE, V53, P539, DOI 10.1016/S0045-6535(03)00456-9; Hassen A, 2000, BIORESOURCE TECHNOL, V74, P141, DOI 10.1016/S0960-8524(99)00179-0; Hem LJ, 2003, J ENVIRON SCI HEAL A, V38, P471, DOI 10.1081/ESE-120016907; Hernandez-Leal L, 2011, WATER RES, V45, P2887, DOI 10.1016/j.watres.2011.03.009; Hijosa-Valsero M, 2011, WATER SCI TECHNOL, V63, P2527, DOI 10.2166/wst.2011.500; Hijosa-Valsero M, 2011, CHEMOSPHERE, V83, P713, DOI 10.1016/j.chemosphere.2011.02.004; Hijosa-Valsero M, 2011, BIORESOURCE TECHNOL, V102, P4981, DOI 10.1016/j.biortech.2011.01.063; Hijosa-Valsero M, 2010, WATER RES, V44, P3669, DOI 10.1016/j.watres.2010.04.022; Hijosa-Valsero M, 2010, WATER RES, V44, P1429, DOI 10.1016/j.watres.2009.10.032; Jose HJ, 2010, OZONE-SCI ENG, V32, P305, DOI 10.1080/01919512.2010.508194; Joss A, 2005, WATER RES, V39, P3139, DOI 10.1016/j.watres.2005.05.031; Kadlec R.H., 2008, TREATMENT WETLANDS, DOI [10.1201/9781420012514, DOI 10.1201/9781420012514]; Kadlec RH, 2000, CONSTRUCTED WETLANDS; Kase R, 2011, WASTE WATER EVALUATI; Katsoyiannis IA, 2011, WATER RES, V45, P3811, DOI 10.1016/j.watres.2011.04.038; Kim I, 2009, ENVIRON INT, V35, P793, DOI 10.1016/j.envint.2009.01.003; Langergraber G, 2009, SCI TOTAL ENVIRON, V407, P3931, DOI 10.1016/j.scitotenv.2008.07.057; Leitner NKV, 2010, WATER RES, V44, P2058, DOI 10.1016/j.watres.2009.12.018; Li E, 2008, CHEM ENG J, V137, P214, DOI 10.1016/j.cej.2007.04.023; Liberti L, 2003, DESALINATION, V152, P315, DOI 10.1016/S0011-9164(02)01079-2; Lienert J, 2007, ENVIRON SCI TECHNOL, V41, P4471, DOI 10.1021/es0627693; Liu YS, 2011, ENVIRON CHEM, V8, P174, DOI 10.1071/EN10141; Llorens E, 2009, SCI TOTAL ENVIRON, V407, P2517, DOI 10.1016/j.scitotenv.2008.12.042; Maltais-Landry G, 2009, ENVIRON POLLUT, V157, P748, DOI 10.1016/j.envpol.2008.11.019; Margot J, 2011, TRAITEMENT MICROPOLL; Margot J, 2011, GWA, V7, P487; Massmann G, 2008, CHEMOSPHERE, V71, P1476, DOI 10.1016/j.chemosphere.2007.12.017; Matallo M, 1998, J ENVIRON SCI HEAL B, V33, P51, DOI 10.1080/03601239809373129; Matamoros V, 2005, ENVIRON SCI TECHNOL, V39, P5449, DOI 10.1021/es050022r; Matamoros V, 2009, WATER RES, V43, P55, DOI 10.1016/j.watres.2008.10.005; Matamoros V, 2008, SCI TOTAL ENVIRON, V394, P171, DOI 10.1016/j.scitotenv.2008.01.029; Matamoros V, 2008, WATER RES, V42, P653, DOI 10.1016/j.watres.2007.08.016; Matamoros V, 2007, ENVIRON SCI TECHNOL, V41, P8171, DOI 10.1021/es071594+; Matamoros V, 2007, CHEMOSPHERE, V69, P1374, DOI 10.1016/j.chemosphere.2007.05.012; Matamoros V, 2006, ENVIRON SCI TECHNOL, V40, P5811, DOI 10.1021/es0607741; Matamoros V, 2010, WATER SCI TECHNOL, V61, P191, DOI 10.2166/wst.2010.797; Matamoros Victor, 2008, V5, P199, DOI 10.1007/698_5_096; Memon GZ, 2008, CHEM ENG J, V138, P616, DOI 10.1016/j.cej.2007.09.027; Morasch B, 2010, ENVIRON TOXICOL CHEM, V29, P1658, DOI 10.1002/etc.222; Nivala J, 2007, SCI TOTAL ENVIRON, V380, P19, DOI 10.1016/j.scitotenv.2006.12.030; Nowotny N, 2007, ENVIRON SCI TECHNOL, V41, P2050, DOI 10.1021/es0618595; Ort C, 2009, ENVIRON SCI TECHNOL, V43, P3214, DOI 10.1021/es802286v; Ouellet-Plamondon C, 2006, ECOL ENG, V27, P258, DOI 10.1016/j.ecoleng.2006.03.006; Palmer H, 2009, J ENVIRON ENG, V135, P972, DOI 10.1061/(ASCE)EE.1943-7870.0000053; Perazzolo C, 2010, ENVIRON TOXICOL CHEM, V29, P1649, DOI 10.1002/etc.221; Petala M, 2008, WATER RES, V42, P4929, DOI 10.1016/j.watres.2008.09.018; Quinn B, 2008, SCI TOTAL ENVIRON, V389, P306, DOI 10.1016/j.scitotenv.2007.08.038; Reemtsma T, 2010, WATER RES, V44, P596, DOI 10.1016/j.watres.2009.07.016; Rodriguez-Cruz MS, 2006, SOIL BIOL BIOCHEM, V38, P2910, DOI 10.1016/j.soilbio.2006.04.051; Sanderson H, 2009, TOXICOL LETT, V187, P84, DOI 10.1016/j.toxlet.2009.02.003; Santos LHMLM, 2010, J HAZARD MATER, V175, P45, DOI 10.1016/j.jhazmat.2009.10.100; Schnell S, 2009, AQUAT TOXICOL, V93, P244, DOI 10.1016/j.aquatox.2009.05.007; Scholz M, 2005, INT J ENVIRON STUD, V62, P421, DOI DOI 10.1080/00207230500119783; Schulze T, 2010, ENVIRON POLLUT, V158, P1461, DOI 10.1016/j.envpol.2009.12.032; Stalter D, 2010, WATER RES, V44, P2610, DOI 10.1016/j.watres.2010.01.023; Steinberger J, 2008, J IND ECOL, V12, P248; Stottmeister U, 2003, BIOTECHNOL ADV, V22, P93, DOI 10.1016/j.biotechadv.2003.08.010; Suhadolnik JC, 2002, J COATING TECHNOL, V74, P55, DOI 10.1007/BF02720140; Suliman F, 2006, ECOL ENG, V27, P124, DOI 10.1016/j.ecoleng.2005.12.007; Tauxe AW, 2005, WASTEWATERS OCCURREN, DOI [10.5075/epfl-thesis-3280, DOI 10.5075/EPFL-THESIS-3280]; Ternes A, 2006, HUMAN PHARM HORMONES; Tetreault GR, 2011, AQUAT TOXICOL, V104, P278, DOI 10.1016/j.aquatox.2011.05.008; Truu M, 2009, SCI TOTAL ENVIRON, V407, P3958, DOI 10.1016/j.scitotenv.2008.11.036; Tyler CR, 2008, BIOSCIENCE, V58, P1051, DOI 10.1641/B581108; Vajda AM, 2008, ENVIRON SCI TECHNOL, V42, P3407, DOI 10.1021/es0720661; Vernouillet G, 2010, CHEMOSPHERE, V80, P1062, DOI 10.1016/j.chemosphere.2010.05.010; Vethaak AD, 2005, CHEMOSPHERE, V59, P511, DOI 10.1016/j.chemosphere.2004.12.053; Vieno NM, 2007, ENVIRON SCI TECHNOL, V41, P5077, DOI 10.1021/es062720x; Vink JPM, 1997, ENVIRON TOXICOL CHEM, V16, P608, DOI [10.1897/1551-5028(1997)016&lt;0608:EOOSOP&gt;2.3.CO;2, 10.1002/etc.5620160402]; Vogna D, 2004, CHEMOSPHERE, V54, P497, DOI 10.1016/S0045-6535(03)00757-4; Vymazal J., 1998, CONSTRUCTED WETLANDS; Vymazal J, 2007, SCI TOTAL ENVIRON, V380, P48, DOI 10.1016/j.scitotenv.2006.09.014; Weiss S, 2006, ENVIRON SCI TECHNOL, V40, P7193, DOI 10.1021/es061434i; White JR, 2006, THESCIENTIFICWORLDJO, V6, P1731, DOI 10.1100/tsw.2006.287; Woodling JD, 2006, COMP BIOCHEM PHYS C, V144, P10, DOI 10.1016/j.cbpc.2006.04.019; Yu L, 2009, WATER RES, V43, P951, DOI 10.1016/j.watres.2008.11.032; Yu ZR, 2008, WATER RES, V42, P2873, DOI 10.1016/j.watres.2008.02.020; Zwiener C, 2003, SCI TOTAL ENVIRON, V309, P201, DOI 10.1016/S0048-9697(03)00002-0	115	12	12	1	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58864	10.1371/journal.pone.0058864	http://dx.doi.org/10.1371/journal.pone.0058864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484055	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100141
J	Santos, SICO; Mathew, M; Olarte, OE; Psilodimitrakopoulos, S; Loza-Alvarez, P				Santos, Susana I. C. O.; Mathew, Manoj; Olarte, Omar E.; Psilodimitrakopoulos, Sotiris; Loza-Alvarez, Pablo			Femtosecond Laser Axotomy in Caenorhabditis elegans and Collateral Damage Assessment Using a Combination of Linear and Nonlinear Imaging Techniques	PLOS ONE			English	Article							C-ELEGANS; ABLATION; NEUROSURGERY; REGENERATION; MECHANISMS; BEHAVIOR; TISSUES; NEURONS; CELLS	In this work highly localized femtosecond laser ablation is used to dissect single axons within a living Caenorhabditis elegans (C. elegans). We present a multimodal imaging methodology for the assessment of the collateral damage induced by the laser. This relies on the observation of the tissues surrounding the targeted region using a combination of different high resolution microscopy modalities. We present the use of Second Harmonic Generation (SHG) and Polarization Sensitive SHG (PSHG) to determine damage in the neighbor muscle cells. All the above is done using a single instrument: multimodal microscopy setup that allows simultaneous imaging in the linear and non-linear regimes and femtosecond-laser ablation.	[Santos, Susana I. C. O.; Mathew, Manoj; Olarte, Omar E.; Psilodimitrakopoulos, Sotiris; Loza-Alvarez, Pablo] ICFO Inst Ciencies Fotoniques, Castelldefels, Barcelona, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO)	Loza-Alvarez, P (corresponding author), ICFO Inst Ciencies Fotoniques, Mediterranean Technol Pk, Castelldefels, Barcelona, Spain.	pablo.loza@icfo.eu	Loza Alvarez, Pablo/M-2564-2014; Olarte, Omar/B-7168-2014; Psilodimitrakopoulos, Sotiris/AAG-8933-2019; Loza-Alvarez, Pablo/AAA-9118-2020	Loza Alvarez, Pablo/0000-0002-3129-1213; Olarte, Omar/0000-0003-1988-6967; Loza-Alvarez, Pablo/0000-0002-3129-1213	Generalitat de Catalunya; Spanish government [TEC2009-09698]; FAST DOT EU project; Fundacio Cellex Barcelona	Generalitat de Catalunya(Generalitat de Catalunya); Spanish government(Spanish GovernmentEuropean Commission); FAST DOT EU project; Fundacio Cellex Barcelona(Foundation CELLEXEuropean Commission)	This work is supported by the Generalitat de Catalunya, the Spanish government grants TEC2009-09698 and the FAST DOT EU project. Authors also acknowledge the Laser Lab Europe (optobio) and the Photonics4Life network. This research has been partially supported by Fundacio Cellex Barcelona and has been conducted at ICFO's "Super-Resolution Light Microscopy and Nanoscopy Facility" (SLN@ICFO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart J, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253382; Bourgeois F, 2007, OPT EXPRESS, V15, P8521, DOI 10.1364/OE.15.008521; BRENNER S, 1974, GENETICS, V77, P71; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Chung SH, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-30; Clark DA, 2007, J NEUROPHYSIOL, V97, P1903, DOI 10.1152/jn.00892.2006; Clark DA, 2006, J NEUROSCI, V26, P7444, DOI 10.1523/JNEUROSCI.1137-06.2006; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Grill S, 1999, J OPT SOC AM A, V16, P2658, DOI 10.1364/JOSAA.16.002658; Kalies S, 2011, BIOMED OPT EXPRESS, V2, P805, DOI 10.1364/BOE.2.000816; Kuetemeyer K, 2011, P SOC PHOTO-OPT INS, V7897; Ku┬nig K., 2006, HDB BIOL CONFOCAL MI, P680, DOI DOI 10.1007/978-0-387-45524-2_38; Mathew M, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3142225; Plotnikov SV, 2006, BIOPHYS J, V90, P693, DOI 10.1529/biophysj.105.071555; Psilodimitrakopoulos S, 2009, OPT EXPRESS, V17, P14418, DOI 10.1364/OE.17.014418; Psilodimitrakopoulos S, 2009, OPT EXPRESS, V17, P10168, DOI 10.1364/OE.17.010168; Psilodimitrakopoulos S, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3059627; Recher G, 2011, J MICROSC-OXFORD, V241, P207, DOI 10.1111/j.1365-2818.2010.03425.x; Recher G, 2011, BIOMED OPT EXPRESS, V2, P374, DOI 10.1364/BOE.2.000374; Santos SICO, 2010, OPT EXPRESS, V18, P364, DOI 10.1364/OE.18.000364; Shaham, 2006, METHODS CELL BIOL; Thayil AKN, 2008, J MICROSC-OXFORD, V232, P362, DOI 10.1111/j.1365-2818.2008.02107.x; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Yanik MF, 2006, IEEE J SEL TOP QUANT, V12, P1283, DOI 10.1109/JSTQE.2006.879579; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a	25	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58600	10.1371/journal.pone.0058600	http://dx.doi.org/10.1371/journal.pone.0058600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484040	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100129
J	Zain, SM; Mohamed, Z; Mahadeva, S; Rampal, S; Basu, RC; Cheah, PL; Salim, A; Mohamed, R				Zain, Shamsul Mohd; Mohamed, Zahurin; Mahadeva, Sanjiv; Rampal, Sanjay; Basu, Roma Choudhury; Cheah, Phaik-Leng; Salim, Agus; Mohamed, Rosmawati			Susceptibility and Gene Interaction Study of the Angiotensin II Type 1 Receptor (AGTR1) Gene Polymorphisms with Non-Alcoholic Fatty Liver Disease in a Multi-Ethnic Population	PLOS ONE			English	Article							METABOLIC SYNDROME; HEPATIC STEATOSIS; KAPPA-B; FIBROSIS; STEATOHEPATITIS; BLOCKER; OBESE; RATS; ASSOCIATION; PREDICTORS	Angiotensin II type 1 receptor (AGTR1) has been reported to play a fibrogenic role in non-alcoholic fatty liver disease (NAFLD). In this study, five variants of the AGTR1 gene (rs3772622, rs3772627, rs3772630, rs3772633, and rs2276736) were examined for their association with susceptibility to NAFLD. Subjects made up of 144 biopsy-proven NAFLD patients and 198 controls were genotyped using TaqMan assays. The liver biopsy specimens were histologically graded and scored according to the method of Brunt. Single locus analysis in pooled subjects revealed no association between each of the five variants with susceptibility to NAFLD. In the Indian ethnic group, the rs2276736, rs3772630 and rs3772627 appear to be protective against NAFLD (p = 0.010, p = 0.016 and p = 0.026, respectively). Haplotype ACGCA is shown to be protective against NAFLD for the Indian ethnic subgroup (p = 0.03). Gene-gene interaction between the AGTR1 gene and the patatinlike phospholipase domain-containing 3 (PNPLA3) gene, which we previously reported as associated with NAFLD in this sample, showed a strong interaction between AGTR1 (rs3772627), AGTRI (rs3772630) and PNPLA3 (rs738409) polymorphisms on NAFLD susceptibility (p = 0.007). Further analysis of the NAFLD patients revealed that the G allele of the AGTR1 rs3772622 is associated with increased fibrosis score (p = 0.003). This is the first study that replicates an association between AGTR1 polymorphism and NAFLD, with further details in histological features of NAFLD. There is lack of evidence to suggest an association between any of the five variants of the AGTR1 gene and NAFLD in the Malays and Chinese. In the Indians, the rs2276736, rs3772630 and rs3772627 appear to protect against NAFLD. We report novel findings of an association between the G allele of the rs3772622 with occurrence of fibrosis and of the gene-gene interaction between AGTR1gene and the much-studied PNPLA3 gene.	[Zain, Shamsul Mohd; Mohamed, Zahurin] Univ Malaya, Fac Med, Dept Pharmacol, Pharmacogen Lab, Kuala Lumpur 50603, Malaysia; [Mahadeva, Sanjiv; Mohamed, Rosmawati] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Rampal, Sanjay] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Basu, Roma Choudhury] Univ Malaya, Med Ctr, Clin Invest Ctr, Kuala Lumpur, Malaysia; [Cheah, Phaik-Leng] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Salim, Agus] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; National University of Singapore	Zain, SM (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Pharmacogen Lab, Kuala Lumpur 50603, Malaysia.	soulz712@gmail.com	Rampal, Sanjay/B-9691-2010; Mohamed, Zahurin/C-1112-2010; Zain, Shamsul Mohd/U-8718-2019; ZAIN, SHAMSUL MOHD/N-6995-2013; Mahadeva, Sanjiv/E-1711-2011; Salim, Agus/P-1407-2014	Rampal, Sanjay/0000-0002-0105-6407; Mohamed, Zahurin/0000-0002-4396-0517; Zain, Shamsul Mohd/0000-0002-3441-6659; ZAIN, SHAMSUL MOHD/0000-0002-3441-6659; Mahadeva, Sanjiv/0000-0001-5824-0590; Salim, Agus/0000-0003-3999-7701	University Malaya Research [RG069/09HTM, RG364/11HTM]; High Impact Research Ministry of Higher Education (HIRMOHE) [E000025-20001]	University Malaya Research(Universiti Malaya); High Impact Research Ministry of Higher Education (HIRMOHE)	This study was supported by University Malaya Research Grant RG069/09HTM and RG364/11HTM, and by the High Impact Research Ministry of Higher Education (HIRMOHE) Grant E000025-20001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GA, 2004, HEPATOLOGY, V40, P475, DOI 10.1002/hep.20323; Adams LA, 2009, AM J GASTROENTEROL, V104, P861, DOI 10.1038/ajg.2009.67; Benjamini Y., 1995, J ROYAL STAT SOC B, V57, P12; Bertrand JB, 2011, ARCH PEDIATRIE, V18, P62, DOI 10.1016/j.arcped.2010.10.010; Brookes MJ, 2007, J HUM HYPERTENS, V21, P264, DOI 10.1038/sj.jhh.1002148; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Chen GB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016981; Corey KE, 2009, LIVER INT, V29, P748, DOI 10.1111/j.1478-3231.2009.01973.x; Day CP, 2010, DIGEST DIS, V28, P255, DOI 10.1159/000282098; Dixon JB, 2001, GASTROENTEROLOGY, V121, P91, DOI 10.1053/gast.2001.25540; Fatani S, 2011, INT J GEN MED, V4, P211, DOI 10.2147/IJGM.S17376; Fujita K, 2007, DIGEST DIS SCI, V52, P3455, DOI 10.1007/s10620-007-9741-4; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Hock SS, 2007, CHINESE MIGRATION PO; Hoekstra M, 2010, J HEPATOL, V52, P244, DOI 10.1016/j.jhep.2009.11.004; Hubscher SG, 2006, HISTOPATHOLOGY, V49, P450, DOI 10.1111/j.1365-2559.2006.02416.x; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Li X, 2007, REGUL PEPTIDES, V138, P15, DOI 10.1016/j.regpep.2006.07.011; Lima MLRP, 2005, OBES SURG, V15, P661; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Merriman RB, 2006, J CLIN GASTROENTEROL, V40, pS30; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; Nabeshima Y, 2009, J HEPATOL, V50, P1226, DOI 10.1016/j.jhep.2009.01.018; Oakley F, 2009, GASTROENTEROLOGY, V136, P2334, DOI 10.1053/j.gastro.2009.02.081; Omoto K, 1997, AM J PHYS ANTHROPOL, V102, P437; Ong JP, 2005, OBES SURG, V15, P310, DOI 10.1381/0960892053576820; Periasamy M, 2007, INDIAN MIGRATION MAL; Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3; Schwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050; Sorrentino P, 2004, J HEPATOL, V41, P751, DOI 10.1016/j.jhep.2004.07.010; Vanni E, 2010, DIGEST LIVER DIS, V42, P320, DOI 10.1016/j.dld.2010.01.016; Yokohama S, 2004, HEPATOLOGY, V40, P1222, DOI 10.1002/hep.20420; Yoneda M, 2009, LIVER INT, V29, P1078, DOI 10.1111/j.1478-3231.2009.01988.x; Yoshiji H, 2001, HEPATOLOGY, V34, P745, DOI 10.1053/jhep.2001.28231; Zain SM, 2012, HUM GENET, V131, P1145, DOI 10.1007/s00439-012-1141-y	40	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58538	10.1371/journal.pone.0058538	http://dx.doi.org/10.1371/journal.pone.0058538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484035	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100123
J	Hu, JZ; He, Y; Yan, M; Zhu, C; Ye, WM; Zhu, HG; Chen, WT; Zhang, CP; Zhang, ZY				Hu, Jingzhou; He, Yue; Yan, Ming; Zhu, Chao; Ye, Weimin; Zhu, Hanguang; Chen, Wantao; Zhang, Chenping; Zhang, Zhiyuan			Dose Dependent Activation of Retinoic Acid-Inducible Gene-I Promotes Both Proliferation and Apoptosis Signals in Human Head and Neck Squamous Cell Carcinoma	PLOS ONE			English	Article							RIG-I; STRANDED-RNA; PROTEIN; PATHWAY; RECOGNITION; KINASE; AKT	The retinoic-acid-inducible gene (RIG)-like receptor (RLR) family proteins are major pathogen reorganization receptors (PRR) responsible for detection of viral RNA, which initiates antiviral response. Here, we evaluated the functional role of one RLR family member, RIG-I, in human head and neck squamous cell carcinoma (HNSCC). RIG-I is abundantly expressed both in poorly-differentiated primary cancer and lymph node metastasis, but not in normal adjacent tissues. Activation of RIG-I by transfection with low dose of 5'-triphosphate RNA (3p-RNA) induces low levels of interferon and proinflammatory cytokines and promotes NF-kappa B- and Akt-dependent cell proliferation, migration and invasion. In contrast, activation of RIG-I by a high dose of 3p-RNA induces robust mitochondria-derived apoptosis accompanied by decreased activation of Akt, which is independent of the interferon and TNF alpha receptor, but can be rescued by over-expression of constitutively active Akt. Furthermore, co-immunoprecipitation experiments indicate that the CARD domain of RIG-I is essential for inducing apoptosis by interacting with caspase-9. Together, our results reveal a dual role of RIG-I in HNSCC through regulating activation of Akt, in which RIG-I activation by low-dose viral dsRNA increases host cell surviral, whereas higher level of RIG-I activation leads to apopotosis. These findings highlight the therapeutic potential of dsRNA mediated RIG-I activation in the treatment of HNSCC.	[Hu, Jingzhou; He, Yue; Yan, Ming; Zhu, Chao; Ye, Weimin; Zhu, Hanguang; Chen, Wantao; Zhang, Chenping; Zhang, Zhiyuan] Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Head & Neck Oncol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Hu, Jingzhou; He, Yue; Yan, Ming; Zhu, Chao; Chen, Wantao; Zhang, Chenping; Zhang, Zhiyuan] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, ZY (corresponding author), Shanghai Jiao Tong Univ, Dept Oral & Maxillofacial Head & Neck Oncol, Shanghai Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	zhzhyomschina@gmail.com	zhang, zhiyuan/GRS-2141-2022		Project of National Natural Science Foundation of China [31140007]; Shanghai Leading Academic Discipline Project [S30206]	Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This study was supported by Project of National Natural Science Foundation of China( Grant No. 31140007) to JH and Shanghai Leading Academic Discipline Project ( Project No. S30206) to ZZ. The URL of National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm). The URL of Shanghai education committee: http://www.shec.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Banerjee P, 2011, J BIOL CHEM, V286, P33580, DOI 10.1074/jbc.M111.248401; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Cao W, 2012, CANCER-AM CANCER SOC, V118, P2858, DOI 10.1002/cncr.26575; Chattopadhyay S, 2011, J VIROL, V85, P3708, DOI 10.1128/JVI.02133-10; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Evan GI, 2006, CANCER CELL, V10, P345, DOI 10.1016/j.ccr.2006.10.013; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jiang YJ, 2011, CANCER RES, V71, P234, DOI 10.1158/0008-5472.CAN-10-1487; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Lichtenstein DL, 2004, INT REV IMMUNOL, V23, P75, DOI 10.1080/08830180490265556; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mori I, 2006, MICROBES INFECT, V8, P1806, DOI 10.1016/j.micinf.2006.02.018; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Rampias T, 2009, JNCI-J NATL CANCER I, V101, P412, DOI 10.1093/jnci/djp017; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Swart R, 2000, J VIROL, V74, P10838, DOI 10.1128/JVI.74.22.10838-10845.2000; Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X; van Domselaar R, 2011, REV MED VIROL	33	77	77	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58273	10.1371/journal.pone.0058273	http://dx.doi.org/10.1371/journal.pone.0058273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484008	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900081
J	Zhou, J; Chen, ZM; Malysa, A; Li, X; Oliveira, P; Zhang, YT; Bepler, G				Zhou, Jun; Chen, Zhengming; Malysa, Agnes; Li, Xin; Oliveira, Paula; Zhang, Yingtao; Bepler, Gerold			A Kinome Screen Identifies Checkpoint Kinase 1 (CHK1) as a Sensitizer for RRM1-Dependent Gemcitabine Efficacy	PLOS ONE			English	Article							CELL LUNG-CANCER; RIBONUCLEOTIDE REDUCTASE; IN-VIVO; PANCREATIC-CANCER; EXPRESSION; RRM1; ABROGATION; RESISTANCE; SUBUNIT; CHEMOTHERAPY	Gemcitabine is among the most efficacious and widely used antimetabolite agents. Its molecular targets are ribonucleotide reductase M1 (RRM1) and elongating DNA. Acquired and de novo resistance as a result of RRM1 overexpression are major obstacles to therapeutic efficacy. We deployed a synthetic lethality screen to investigate if knockdown of 87 selected protein kinases by siRNA could overcome RRM1-dependent gemcitabine resistance in high and low RRM1-expressing model systems. The models included genetically RRM1-modified lung and breast cancer cell lines, cell lines with gemcitabine-induced RRM1 overexpression, and a series of naturally gemcitabine-resistant cell lines. Lead molecular targets were validated by determination of differential gemcitabine activity using cell lines with and without target knock down, and by assessing synergistic activity between gemcitabine and an inhibitor of the lead target. CHK1 was identified has the kinase with the most significant and robust interaction, and it was validated using AZD7762, a small-molecule ATP-competitive inhibitor of CHK1 activation. Synergism between CHK1 inhibition and RRM1-dependent gemcitabine efficacy was observed in cells with high RRM1 levels, while antagonism was observed in cells with low RRM1 levels. In addition, four cell lines with natural gemcitabine resistance demonstrated improved gemcitabine efficacy after CHK1 inhibition. In tumor specimens from 187 patients with non-small-cell lung cancer, total CHK1 and RRM1 in situ protein levels were significantly (p = 0.003) and inversely correlated. We conclude that inhibition of CHK1 may have its greatest clinical utility in malignancies where gemcitabine resistance is a result of elevated RRM1 levels. We also conclude that CHK1 inhibition in tumors with low RRM1 levels may be detrimental to gemcitabine efficacy.	[Bepler, Gerold] Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA; Karmanos Canc Inst, Mol Imaging & Biomarkers Program, Detroit, MI USA	Barbara Ann Karmanos Cancer Institute; Barbara Ann Karmanos Cancer Institute	Bepler, G (corresponding author), Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA.	beplerg@karmanos.org			National Cancer Institute [R01-CA129343]; NATIONAL CANCER INSTITUTE [R01CA129343] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute R01-CA129343. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITCHISON JD, 1995, J CELL BIOL, V131, P1133, DOI 10.1083/jcb.131.5.1133; Akita H, 2009, ONCOGENE, V28, P2903, DOI 10.1038/onc.2009.158; Artin E, 2009, BIOCHEMISTRY-US, V48, P11622, DOI 10.1021/bi901590q; Bepler G, 2004, J CLIN ONCOL, V22, P1878, DOI 10.1200/JCO.2004.12.002; Bepler G, 2010, J NUCL ACID, V2010, P1; Bepler G, 2008, J THORAC ONCOL, V3, P1112, DOI 10.1097/JTO.0b013e3181874936; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Carlomagno F, 2002, CANCER RES, V62, P7284; Chen ZM, 2011, BIOCHEM BIOPH RES CO, V413, P383, DOI 10.1016/j.bbrc.2011.08.111; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Davidson JD, 2004, CANCER RES, V64, P3761, DOI 10.1158/0008-5472.CAN-03-3363; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; Gautam A, 2006, CANCER RES, V66, P6497, DOI 10.1158/0008-5472.CAN-05-4462; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Koniaras K, 2001, ONCOGENE, V20, P7453, DOI 10.1038/sj.onc.1204942; Nakahira S, 2007, INT J CANCER, V120, P1355, DOI 10.1002/ijc.22390; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Pereira S, 2004, J COMPUT CHEM, V25, P1286, DOI 10.1002/jcc.20054; Plunkett W, 1996, SEMIN ONCOL, V23, P3; Reynolds C, 2009, J CLIN ONCOL, V27, P5808, DOI 10.1200/JCO.2009.21.9766; RUSSELL KJ, 1995, CANCER RES, V55, P1639; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Spielmann M, 2001, ONCOLOGY-BASEL, V60, P303, DOI 10.1159/000058524; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Wang QZ, 1996, J NATL CANCER I, V88, P956, DOI 10.1093/jnci/88.14.956; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	34	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58091	10.1371/journal.pone.0058091	http://dx.doi.org/10.1371/journal.pone.0058091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483975	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900068
J	Ferreira, AK; Freitas, VM; Levy, D; Ruiz, JLM; Bydlowski, SP; Rici, REG; Filho, OMR; Chierice, GO; Maria, DA				Ferreira, Adilson Kleber; Freitas, Vanessa Morais; Levy, Debora; Maria Ruiz, Jorge Luiz; Bydlowski, Sergio Paulo; Grassi Rici, Rose Eli; Filho, Otaviano Mendonca R.; Chierice, Gilberto Orivaldo; Maria, Durvanei Augusto			Anti-Angiogenic and Anti-Metastatic Activity of Synthetic Phosphoethanolamine	PLOS ONE			English	Article							CELLS; TUMOR; REORGANIZATION; INHIBITORS; MIGRATION; ACTIN; K-562; VEGF	Background: Renal cell carcinoma (RCC) is the most common type of kidney cancer, and represents the third most common urological malignancy. Despite the advent of targeted therapies for RCC and the improvement of the lifespan of patients, its cost-effectiveness restricted the therapeutic efficacy. In a recent report, we showed that synthetic phosphoethanolamine (Pho-s) has a broad antitumor activity on a variety of tumor cells and showed potent inhibitor effects on tumor progress in vivo. Methodology/Principal Findings: We show that murine renal carcinoma (Renca) is more sensitive to Pho-s when compared to normal immortalized rat proximal tubule cells (IRPTC) and human umbilical vein endothelial cells (HUVEC). In vitro anti-angiogenic activity assays show that Pho-s inhibits endothelial cell proliferation, migration and tube formation. In addition, Pho-s has anti-proliferative effects on HUVEC by inducing a cell cycle arrest at the G2/M phase. It causes a decrease in cyclin D1 mRNA, VEGFR1 gene transcription and VEGFR1 receptor expression. Pho-s also induces nuclear fragmentation and affects the organization of the cytoskeleton through the disruption of actin filaments. Additionally, Pho-s induces apoptosis through the mitochondrial pathway. The putative therapeutic potential of Pho-s was validated in a renal carcinoma model, on which our remarkable in vivo results show that Pho-s potentially inhibits lung metastasis in nude mice, with a superior efficacy when compared to Sunitinib. Conclusions/Significance: Taken together, our findings provide evidence that Pho-s is a compound that potently inhibits lung metastasis, suggesting that it is a promising novel candidate drug for future developments.	[Ferreira, Adilson Kleber; Maria, Durvanei Augusto] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil; [Ferreira, Adilson Kleber; Maria, Durvanei Augusto] Univ Sao Paulo, Fac Med, Sao Paulo, Brazil; [Freitas, Vanessa Morais] Univ Sao Paulo, Dept Cell & Dev Biol, Sao Paulo, Brazil; [Levy, Debora; Maria Ruiz, Jorge Luiz; Bydlowski, Sergio Paulo] Univ Sao Paulo, Fac Med, Lab Genet & Mol Hematol LIM 31, Sao Paulo, Brazil; [Chierice, Gilberto Orivaldo] Univ Sao Paulo, Dept Chem & Polymers Technol, Sao Carlos, SP, Brazil; [Filho, Otaviano Mendonca R.] Univ Uberaba, Uberaba, MG, Brazil; [Grassi Rici, Rose Eli] Univ Sao Paulo, Dept Surg, Fac Vet Med & Zootecny, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Uberaba (Uniube); Universidade de Sao Paulo	Maria, DA (corresponding author), Butantan Inst, Biochem & Biophys Lab, Sao Paulo, Brazil.	durvanei@usp.br	Ruiz, Jorge Luis Maria/U-4468-2019; Bydlowski, Sérgio Paulo/D-5171-2013; Freitas, Vanessa M/D-7897-2012; Ferreira, Adilson/K-1991-2013; Levy, Debora/G-8208-2014; Ruiz, Jorge L.M./D-4093-2013; Ferreira, Adilson/AAS-6996-2021	Bydlowski, Sérgio Paulo/0000-0002-7582-5942; Freitas, Vanessa M/0000-0001-9613-8626; Ferreira, Adilson/0000-0002-2605-1899; Levy, Debora/0000-0001-7492-997X; Ruiz, Jorge L.M./0000-0002-7131-2162; Ferreira, Adilson/0000-0002-6160-9798	Sao Paulo Research Foundation (FAPESP) [2007/50571-3, 2008/56089-1, 2010/50220-9]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by a Sao Paulo Research Foundation (FAPESP) - grant (2007/50571-3; Doctorate and Master Fellowship 2008/56089-1; 2010/50220-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima S, 2011, DEVELOPMENT, V138, P4763, DOI 10.1242/dev.068023; Basappa, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039444; Boren J, 2012, CELL DEATH DIFFER, V19, P1561, DOI 10.1038/cdd.2012.34; Bukowski RM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00013; Carraro-Lacroix LR, 2010, CELL PHYSIOL BIOCHEM, V26, P563, DOI 10.1159/000322324; Das M, 2012, EXPERT OPIN THER TAR, V16, P395, DOI 10.1517/14728222.2012.669752; Rocha FGD, 2011, J GENE MED, V13, P148, DOI 10.1002/jgm.1547; ELLISON DW, 1987, BRAIN RES, V417, P389, DOI 10.1016/0006-8993(87)90471-9; Eyster KM, 2007, ADV PHYSIOL EDUC, V31, P5, DOI 10.1152/advan.00088.2006; Ferreira AK, 2012, ANTICANCER RES, V32, P95; Ferreira AK, 2012, BIOMED PHARMACOTHER, V17, P38; Ferreira AK, 2011, J CANC SCI THER, V3, P053; Fiaschi Tania, 2012, Int J Cell Biol, V2012, P762825, DOI 10.1155/2012/762825; Foehring D, 2012, CELLS TISSUES ORGANS, V196, P195, DOI 10.1159/000334600; Freitas VM, 2008, J CELL PHYSIOL, V216, P583, DOI 10.1002/jcp.21432; Gagne Paul, 2004, Expert Rev Anticancer Ther, V4, P129, DOI 10.1586/14737140.4.1.129; Ganesamoni R, 2012, J UROLOGY, V187, P1172, DOI 10.1016/j.juro.2011.11.105; Garcia-Donas J, 2011, LANCET ONCOL, V12, P1143, DOI 10.1016/S1470-2045(11)70266-2; Graeven U, 1999, J CANCER RES CLIN, V125, P621, DOI 10.1007/s004320050325; Grzanka A, 2006, NEOPLASMA, V53, P56; Grzanka A, 2003, BIOCHEM PHARMACOL, V66, P1611, DOI 10.1016/S0006-2952(03)00532-X; Hyoudou K, 2006, FREE RADICAL BIO MED, V41, P1449, DOI 10.1016/j.freeradbiomed.2006.08.004; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Nacev BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024793; Nishikawa M, 2008, CANCER LETT, V266, P53, DOI 10.1016/j.canlet.2008.02.031; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Ralph SJ, 2010, MOL ASPECTS MED, V31, P145, DOI 10.1016/j.mam.2010.02.008; SEER Star Database, 2003, SEER STAR DAT INC SE; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Sharma A, 2007, BRIT J BIOMED SCI, V64, P23, DOI 10.1080/09674845.2007.11732751; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Siefert SA, 2012, VASCULAR, V20, P210, DOI 10.1258/vasc.2011.201202; Sotgia F, 2011, BMC MED, V23, P9; Vaziri SAJ, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00051; Wacker A, 2011, CURR OPIN CELL BIOL, V23, P676, DOI 10.1016/j.ceb.2011.10.002; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Weinstein S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043343	37	31	32	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57937	10.1371/journal.pone.0057937	http://dx.doi.org/10.1371/journal.pone.0057937			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516420	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400014
J	Han, YF; Pu, R; Han, X; Zhao, J; Zhang, YW; Zhang, Q; Yin, JH; Xie, JX; Shen, QX; Deng, Y; Ding, YB; Li, WP; Li, JH; Zhang, HW; Cao, GW				Han, Yifang; Pu, Rui; Han, Xue; Zhao, Jun; Zhang, Yuwei; Zhang, Qi; Yin, Jianhua; Xie, Jiaxin; Shen, Qiuxia; Deng, Yang; Ding, Yibo; Li, Weiping; Li, Juhong; Zhang, Hongwei; Cao, Guangwen			Associations of pri-miR-34b/c and pre-miR-196a2 Polymorphisms and Their Multiplicative Interactions with Hepatitis B Virus Mutations with Hepatocellular Carcinoma Risk	PLOS ONE			English	Article							FUNCTIONAL POLYMORPHISM; ESTROGEN-RECEPTOR; PROMOTER REGION; DOWN-REGULATION; FRAGILE SITES; CANCER; SUSCEPTIBILITY; MICRORNA-34B/C; EXPRESSION; GENOTYPES	Background: Genetic polymorphisms of pri-miR-34b/c and pre-miR-196a2 have been reported to be associated with the susceptibility to cancers. However, the effect of these polymorphisms and their interactions with hepatitis B virus (HBV) mutations on the development of hepatocellular carcinoma (HCC) remains largely unknown. We hypothesized that these polymorphisms might interact with the HBV mutations and play a role in hepatocarcinogenesis. Methods: Pri-miR-34b/c rs4938723 (T>C) and pre-miR-196a2 rs11614913 (T>C) were genotyped in 3,325 subjects including 1,021 HBV-HCC patients using quantitative PCR. HBV mutations were determined by direct sequencing. Contributions of the polymorphisms and their multiplicative interactions with gender or HCC-related HBV mutations to HCC risk were assessed using multivariate regression analyses. Results: rs4938723 CC genotype was significantly associated with HCC risk compared to HBV natural clearance subjects, adjusted for age and gender (adjusted odds ratio [AOR] = 2.01, 95% confidence interval [CI] = 1.16-3.49). rs4938723 variant genotypes in dominant model significantly increased HCC risk in women, compared to female healthy controls (AOR = 1.85, 95% CI = 1.20-2.84) or female HCC-free subjects (AOR = 1.62, 95% CI = 1.14-2.31). rs4938723 CC genotype and rs11614913 TC genotype were significantly associated with increased frequencies of the HCC-related HBV mutations T1674C/G and G1896A, respectively. rs11614913 was not significantly associated with HCC risk, but its CC genotype significantly enhanced the effect of rs4938723 in women. In multivariate regression analyses, rs4938723 in dominant model increased HCC risk (AOR = 1.62, 95% CI = 1.05-2.49), whereas its multiplicative interaction with C1730G, a HBV mutation inversely associated with HCC risk, reduced HCC risk (AOR = 0.34, 95% CI = 0.15-0.81); rs11614913 strengthened the G1896A effect but attenuated the A3120G/T effect on HCC risk. Conclusions: rs4938723 might be a genetic risk factor of HCC but its effect on HCC is significantly affected by the HBV mutations. rs11614913 might not be a HCC susceptible factor but it might affect the effects of the HBV mutations or rs4938723 on HCC risk.	[Han, Yifang; Pu, Rui; Zhang, Yuwei; Zhang, Qi; Yin, Jianhua; Xie, Jiaxin; Shen, Qiuxia; Deng, Yang; Ding, Yibo; Zhang, Hongwei; Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China; [Han, Xue] Ctr Dis Control & Prevent Yangpu Dist, Div Chron Dis, Shanghai, Peoples R China; [Zhao, Jun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepatobiliary Surg, Shanghai, Peoples R China; [Li, Weiping] Second Mil Med Univ, Dept Ultrasonog, Changhai Hosp, Shanghai, Peoples R China; [Li, Juhong] Second Mil Med Univ, Hlth Examinat Ctr, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University; Shanghai Center for Disease Control & Prevention; Naval Medical University; Naval Medical University; Naval Medical University	Cao, GW (corresponding author), Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China.	gcao@smmu.edu.cn		Cao, Guangwen/0000-0002-8094-1278	National Natural Science Foundation of China [81025015, 91129301, 30901272, 81221061]; National Major S&T Project for Controlling Infection-Related Diseases in China [2012ZX10002-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major S&T Project for Controlling Infection-Related Diseases in China	This study was supported by grants from the National Natural Science Foundation of China (81025015, 91129301, 30901272, and 81221061) and the National Major S&T Project for Controlling Infection-Related Diseases in China (2012ZX10002-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, J VIRAL HEPATITIS, V18, pE399, DOI 10.1111/j.1365-2893.2010.01414.x; Andreu-Vieyra C, 2011, MOL CELL BIOL, V31, P4648, DOI 10.1128/MCB.05934-11; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen JS, 2007, J CLIN VIROL, V38, P238, DOI 10.1016/j.jcv.2006.12.007; Chen XD, 2012, INT J CANCER, V130, P1607, DOI 10.1002/ijc.26171; Chou YC, 2008, GUT, V57, P91, DOI 10.1136/gut.2006.114066; Clifford RJ, 2010, HEPATOLOGY, V52, P2034, DOI 10.1002/hep.23943; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Feitelson MA, 2007, CANCER LETT, V252, P157, DOI 10.1016/j.canlet.2006.11.010; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; He YC, 2009, CARCINOGENESIS, V30, P1916, DOI 10.1093/carcin/bgp226; Hoch RV, 1999, INT J CANCER, V84, P122; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hou WH, 2010, HEPATOLOGY, V51, P1494, DOI 10.1002/hep.23401; Huang YT, 2011, J CLIN ONCOL, V29, P3643, DOI 10.1200/JCO.2011.36.2335; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; Jain AK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002859; Jee SH, 2004, JNCI-J NATL CANCER I, V96, P1851, DOI 10.1093/jnci/djh334; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jian Guo, 2012, International Journal of Mechatronics and Automation, V2, P15, DOI 10.1504/IJMA.2012.046583; Jiang DK, 2013, NAT GENET, V45, P72, DOI 10.1038/ng.2483; Keng VW, 2013, HEPATOLOGY, V57, P120, DOI 10.1002/hep.26004; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047372; Kubo T, 2011, CLIN CANCER RES, V17, P4965, DOI 10.1158/1078-0432.CCR-10-3040; LaVoie HA, 2003, EXP BIOL MED, V228, P1282, DOI 10.1177/153537020322801107; Li SP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002791; Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Liu CJ, 2013, ANN SURG ONCOL, V20, pS406, DOI 10.1245/s10434-012-2618-6; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Luthra R, 2008, ONCOGENE, V27, P6667, DOI 10.1038/onc.2008.256; Mathe E, 2012, INT J CANCER, V131, P760, DOI 10.1002/ijc.26403; Mazar J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024922; Suzuki H, 2010, CARCINOGENESIS, V31, P2066, DOI 10.1093/carcin/bgq203; Wang Z., 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0040039.PUBMED:22768213; Xie J, 2013, HEPATOLOGY IN PRESS; Xu Y, 2011, INT J CANCER, V128, P412, DOI 10.1002/ijc.25342; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Yin JH, 2010, J GASTROENTEROL, V45, P1063, DOI 10.1007/s00535-010-0253-1; Yoon YJ, 2008, CARCINOGENESIS, V29, P1192, DOI 10.1093/carcin/bgn090; Yu MW, 2001, J NATL CANCER I, V93, P1644, DOI 10.1093/jnci/93.21.1644; Zhang HW, 2008, GUT, V57, P1713, DOI 10.1136/gut.2008.157149; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zhang Q, 2012, CANCER LETT, V321, P1, DOI 10.1016/j.canlet.2012.03.011; Zhang Q, 2011, HEPAT MON, V11, P86	49	57	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58564	10.1371/journal.pone.0058564	http://dx.doi.org/10.1371/journal.pone.0058564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516510	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200089
J	Ma, YM; Duan, FB; Chapeau-Blondeau, F; Abbott, D				Ma, Yumei; Duan, Fabing; Chapeau-Blondeau, Francois; Abbott, Derek			Weak-Periodic Stochastic Resonance in a Parallel Array of Static Nonlinearities	PLOS ONE			English	Article							SIGNAL-DETECTION; NOISE; INFORMATION; IMPROVEMENT; BENEFITS	This paper studies the output-input signal-to-noise ratio (SNR) gain of an uncoupled parallel array of static, yet arbitrary, nonlinear elements for transmitting a weak periodic signal in additive white noise. In the small-signal limit, an explicit expression for the SNR gain is derived. It serves to prove that the SNR gain is always a monotonically increasing function of the array size for any given nonlinearity and noisy environment. It also determines the SNR gain maximized by the locally optimal nonlinearity as the upper bound of the SNR gain achieved by an array of static nonlinear elements. With locally optimal nonlinearity, it is demonstrated that stochastic resonance cannot occur, i.e. adding internal noise into the array never improves the SNR gain. However, in an array of suboptimal but easily implemented threshold nonlinearities, we show the feasibility of situations where stochastic resonance occurs, and also the possibility of the SNR gain exceeding unity for a wide range of input noise distributions.	[Ma, Yumei; Duan, Fabing] Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China; [Chapeau-Blondeau, Francois] Univ Angers, Lab Ingn Syst Automatises, Angers, France; [Abbott, Derek] Univ Adelaide, Ctr Biomed Engn, Adelaide, SA, Australia; [Abbott, Derek] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	Qingdao University; Universite d'Angers; University of Adelaide; University of Adelaide	Duan, FB (corresponding author), Qingdao Univ, Coll Automat Engn, Qingdao 266071, Peoples R China.	fabing.duan@gmail.com	Abbott, Derek/E-8352-2011	Abbott, Derek/0000-0002-0945-2674; CHAPEAU-BLONDEAU, Francois/0000-0003-0536-7146	National Science Foundation of Shandong Province, China [ZR2010FM006]	National Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province)	This work is sponsored by the National Science Foundation of Shandong Province, China (No. ZR2010FM006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Benzi R, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/01/P01052; BEZRUKOV SM, 1995, NATURE, V378, P362, DOI 10.1038/378362a0; Chapeau-Blondeau F, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.060101; Chapeau-Blondeau F, 2008, DIGIT SIGNAL PROCESS, V18, P434, DOI 10.1016/j.dsp.2007.04.012; Chapeau-Blondeau F, 2006, CIRC SYST SIGNAL PR, V25, P431, DOI 10.1007/s00034-005-0528-6; Chapeau-Blondeau F, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021124; ChapeauBlondeau F, 1997, PHYS REV E, V55, P1478, DOI 10.1103/PhysRevE.55.1478; Chen H, 2008, IEEE T SIGNAL PROCES, V56, P5031, DOI 10.1109/TSP.2008.928509; Chen H, 2008, IEEE T SIGNAL PROCES, V56, P5074, DOI 10.1109/TSP.2008.928508; Chen HO, 2007, IEEE T SIGNAL PROCES, V55, P3172, DOI 10.1109/TSP.2007.893757; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; Collins JJ, 2003, IEEE ENG MED BIOL, V22, P76, DOI 10.1109/MEMB.2003.1195700; COLLINS JJ, 1995, PHYS REV E, V52, pR3321, DOI 10.1103/PhysRevE.52.R3321; Cover T. M., 1991, ELEMENTS INFORM THEO; Duan F, 2006, ELECTRON LETT, V42, P1008, DOI 10.1049/el:20061670; Duan F, 2008, PHYS LETT A, V372, P2159, DOI 10.1016/j.physleta.2007.10.092; Duan FB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034282; Duan FB, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051107; Dykman MI, 1998, NATURE, V391, P344, DOI 10.1038/34812; Gailey PC, 1997, PHYS REV LETT, V79, P4701, DOI 10.1103/PhysRevLett.79.4701; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gan CB, 2010, CHINESE PHYS B, V19, DOI 10.1088/1674-1056/19/4/040508; Godivier X, 1997, SIGNAL PROCESS, V56, P293, DOI 10.1016/S0165-1684(96)00176-4; Gosak M, 2011, EUR PHYS J B, V80, P519, DOI 10.1140/epjb/e2011-10573-8; Gosak M, 2012, MOL CRYST LIQ CRYST, V553, P13, DOI 10.1080/15421406.2011.609343; Greenwood PE, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051110; Hanggi P, 2000, PHYS REV E, V62, P6155, DOI 10.1103/PhysRevE.62.6155; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Hutt MT, 2012, CHAOS SOLITON FRACT, V45, P611, DOI 10.1016/j.chaos.2011.12.011; Inchiosa ME, 1996, PHYS REV E, V53, pR2021, DOI 10.1103/PhysRevE.53.R2021; JUNG P, 1991, PHYS REV A, V44, P8032, DOI 10.1103/PhysRevA.44.8032; Kassam S. A., 1988, SIGNAL DETECTION NON; Kay S, 2000, IEEE SIGNAL PROC LET, V7, P8, DOI 10.1109/97.809511; Kitajo K, 2006, EUROPHYS LETT, V76, P1029, DOI 10.1209/epl/i2006-10377-0; Li JL, 2006, CHINESE PHYS, V15, P2867, DOI 10.1088/1009-1963/15/12/017; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; LINDNER JF, 1995, PHYS REV LETT, V75, P3, DOI 10.1103/PhysRevLett.75.3; McDonnell M.D., 2008, STOCH RES SUPR, DOI DOI 10.1017/CBO9780511535239; Mori T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.218101; MOSS F, 1995, NATURE, V376, P211, DOI 10.1038/376211a0; Patel A, 2011, IEEE T SIGNAL PROCES, V59, P488, DOI 10.1109/TSP.2010.2091409; Patel A, 2010, IEEE SIGNAL PROC LET, V17, P1005, DOI 10.1109/LSP.2010.2059376; Perc M, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066203; Perc M, 2008, SOFT MATTER, V4, P1861, DOI 10.1039/b804566f; Perc M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036105; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Rousseau D, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021102; Rousseau D, 2005, DIGIT SIGNAL PROCESS, V15, P19, DOI 10.1016/j.dsp.2004.09.006; Rousseau D, 2004, PHYS LETT A, V321, P280, DOI 10.1016/j.physleta.2003.12.042; Rousseau D, 2007, IEEE T INSTRUM MEAS, V56, P2658, DOI 10.1109/TIM.2007.908125; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Stacey WC, 2001, J NEUROPHYSIOL, V86, P1104, DOI 10.1152/jn.2001.86.3.1104; Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; Stocks NG, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041114; Teramae J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00485; Wang QY, 2009, CHAOS, V19, DOI 10.1063/1.3133126; Ward LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014371; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Zozor S, 2003, IEEE T SIGNAL PROCES, V51, P3177, DOI 10.1109/TSP.2003.818905	61	6	7	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58507	10.1371/journal.pone.0058507	http://dx.doi.org/10.1371/journal.pone.0058507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505523	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100057
J	Wang, J; Urbanowicz, RA; Tighe, PJ; Todd, I; Corne, JM; Fairclough, LC				Wang, Jia; Urbanowicz, Richard A.; Tighe, Patrick J.; Todd, Ian; Corne, Jonathan M.; Fairclough, Lucy C.			Differential Activation of Killer Cells in the Circulation and the Lung: A Study of Current Smoking Status and Chronic Obstructive Pulmonary Disease (COPD)	PLOS ONE			English	Article							T-LYMPHOCYTE SUBSETS; INDUCED SPUTUM; BRONCHOALVEOLAR LAVAGE; BRONCHIAL BIOPSIES; EFFECTOR FUNCTION; CYTOTOXIC-CELLS; SYSTEMIC CD4+; NK CELLS; EXPRESSION; RECEPTORS	Background: CD8(+) T-lymphocytes, natural killer T-like cells (NKT-like cells, CD56(+)CD3(+)) and natural killer cells (NK cells, CD56(+)CD3(-)) are the three main classes of human killer cells and they are implicated in the pathogenesis of chronic obstructive pulmonary disease (COPD). Activation of these cells can initiate immune responses by virtue of their production of inflammatory cytokines and chemokines that cause lung tissue damage, mucus hypersecretion and emphysema. The objective of the current study was to investigate the activation levels of human killer cells in healthy non-smokers, healthy smokers, ex-smokers with COPD and current smokers with COPD, in both peripheral blood and induced sputum. Methods/Principal Findings: After informed consent, 124 participants were recruited into the study and peripheral blood or induced sputum was taken. The activation states and receptor expression of killer cells were measured by flow cytometry. In peripheral blood, current smokers, regardless of disease state, have the highest proportion of activated CD8(+) T-lymphocytes, NKT-like cells and NK cells compared with ex-smokers with COPD and healthy non-smokers. Furthermore, CD8+ T-lymphocyte and NK cell activation is positively correlated with the number of cigarettes currently smoked. Conversely, in induced sputum, the proportion of activated killer cells was related to disease state rather than current smoking status, with current and ex-smokers with COPD having significantly higher rates of activation than healthy smokers and healthy non-smokers. Conclusions: A differential effect in systemic and lung activation of killer cells in COPD is evident. Systemic activation appears to be related to current smoking whereas lung activation is related to the presence or absence of COPD, irrespective of current smoking status. These findings suggest that modulating killer cell activation may be a new target for the treatment of COPD.	[Wang, Jia; Urbanowicz, Richard A.; Tighe, Patrick J.; Todd, Ian; Fairclough, Lucy C.] Univ Nottingham, Sch Mol Med Sci, COPD Res Grp, Nottingham NG7 2RD, Notts, England; [Corne, Jonathan M.] Nottingham Univ Hosp NHS Trust, Dept Resp Med, Nottingham NG7 2UH, Notts, England	University of Nottingham; Nottingham University Hospital NHS Trust	Fairclough, LC (corresponding author), Univ Nottingham, Sch Mol Med Sci, COPD Res Grp, Nottingham NG7 2RD, Notts, England.	lucy.fairclough@nottingham.ac.uk	Fairclough, Lucy/Q-8685-2018; Urbanowicz, Richard Antoni/M-3354-2019	Fairclough, Lucy/0000-0003-4581-9741; Urbanowicz, Richard Antoni/0000-0002-2461-4993; Tighe, Patrick/0000-0001-8326-093X	University of Nottingham; Jones' 1986 Charitable Trust; Nottingham Respiratory Biomedical Research Unit	University of Nottingham; Jones' 1986 Charitable Trust; Nottingham Respiratory Biomedical Research Unit	This work was supported by University of Nottingham (JW) and The Jones' 1986 Charitable Trust (RAU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge our research nurse, Lizz Everitt, for recruiting the patients. LF and JC are grateful for the support of the Nottingham Respiratory Biomedical Research Unit. We also appreciate all participants for their willingness to contribute to this study.	Agusti A, 2012, AM J RESP CRIT CARE, V185, P1171, DOI 10.1164/rccm.201203-0505UP; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Crapo RO, 2003, EUR RESPIR J, V21, p19S, DOI 10.1183/09031936.03.00077902; Diefenbach A, 2002, NAT IMMUNOL, V3, P1142, DOI 10.1038/ni858; Ekberg-Jansson A, 2000, RESP MED, V94, P264, DOI 10.1053/rmed.1999.0735; Fairclough L, 2008, CLIN SCI, V114, P533, DOI 10.1042/CS20070356; FERRINI S, 1994, EUR J IMMUNOL, V24, P2294, DOI 10.1002/eji.1830241005; Glader P, 2006, RESP MED, V100, P1088, DOI 10.1016/j.rmed.2005.09.025; Kim WD, 2002, CHEST, V122, P437, DOI 10.1378/chest.122.2.437; Knight DA, 2012, RESPIROLOGY, V17, P563, DOI 10.1111/j.1440-1843.2012.02126.x; Lane N, 2010, CLIN SCI, V119, P75, DOI 10.1042/CS20100033; Leckie MJ, 2003, THORAX, V58, P23, DOI 10.1136/thorax.58.1.23; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Marquez ME, 2010, CELL IMMUNOL, V264, P86, DOI 10.1016/j.cellimm.2010.05.002; McDonald DR, 2010, J ALLERGY CLIN IMMUN, V126, P332, DOI 10.1016/j.jaci.2010.05.013; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; Paats MS, 2012, EUR RESPIR J, V40, P330, DOI 10.1183/09031936.00079611; Parasa VRR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037448; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Patterson S, 2008, J IMMUNOL, V181, P3268, DOI 10.4049/jimmunol.181.5.3268; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pavord ID, 1997, THORAX, V52, P498, DOI 10.1136/thx.52.6.498; PHILLIPS JH, 1995, SCIENCE, V268, P403, DOI 10.1126/science.7716542; Profita M, 2012, IMMUNOBIOLOGY, V217, P345, DOI 10.1016/j.imbio.2011.07.013; Roos-Engstrand E, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-128; Roos-Engstrand E, 2009, COPD, V6, P112, DOI 10.1080/15412550902755358; Rutgers SR, 2000, EUR RESPIR J, V15, P109, DOI 10.1183/09031936.00.15110900; Siena L, 2011, RESP MED, V105, P1491, DOI 10.1016/j.rmed.2011.04.014; Urbanowicz RA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-76; Urbanowicz RA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-53; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Young NT, 2001, J IMMUNOL, V166, P3933, DOI 10.4049/jimmunol.166.6.3933	36	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58556	10.1371/journal.pone.0058556	http://dx.doi.org/10.1371/journal.pone.0058556			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505535	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100063
J	Allerston, CK; von Delft, F; Gileadi, O				Allerston, Charles K.; von Delft, Frank; Gileadi, Opher			Crystal Structures of the Catalytic Domain of Human Soluble Guanylate Cyclase	PLOS ONE			English	Article							MAMMALIAN ADENYLYL-CYCLASE; ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE; FUNCTIONAL-CHARACTERIZATION; ACTIVATION; ANGIOGENESIS; INHIBITION; EXPRESSION; ENZYME; SITE	Soluble guanylate cyclase (sGC) catalyses the synthesis of cyclic GMP in response to nitric oxide. The enzyme is a heterodimer of homologous alpha and beta subunits, each of which is composed of multiple domains. We present here crystal structures of a heterodimer of the catalytic domains of the alpha and beta subunits, as well as an inactive homodimer of beta subunits. This first structure of a metazoan, heteromeric cyclase provides several observations. First, the structures resemble known structures of adenylate cyclases and other guanylate cyclases in overall fold and in the arrangement of conserved active-site residues, which are contributed by both subunits at the interface. Second, the subunit interaction surface is promiscuous, allowing both homodimeric and heteromeric association; the preference of the full-length enzyme for heterodimer formation must derive from the combined contribution of other interaction interfaces. Third, the heterodimeric structure is in an inactive conformation, but can be superposed onto an active conformation of adenylate cyclase by a structural transition involving a 26 degrees rigid-body rotation of the alpha subunit. In the modelled active conformation, most active site residues in the subunit interface are precisely aligned with those of adenylate cyclase. Finally, the modelled active conformation also reveals a cavity related to the active site by pseudo-symmetry. The pseudosymmetric site lacks key active site residues, but may bind allosteric regulators in a manner analogous to the binding of forskolin to adenylate cyclase. This indicates the possibility of developing a new class of small-molecule modulators of guanylate cyclase activity targeting the catalytic domain.	[Allerston, Charles K.; von Delft, Frank; Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Oxford, England	University of Oxford	Gileadi, O (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford, England.	opher.gileadi@sgc.ox.ac.uk	Gileadi, Opher/F-1105-2013	Gileadi, Opher/0000-0001-6886-898X; von Delft, Frank/0000-0003-0378-0017	Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; AbbVie; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust [092809/ /10/Z]; SGC	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); AbbVie(AbbVie); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome TrustEuropean Commission); SGC	The SGC (Structural Genomics Consortium) is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, AbbVie, the Canada Foundation for Innovation, the Ontario Ministry of Economic Development and Innovation, and the Wellcome Trust [092809/ /10/Z]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. This study was funded by The SGC which is a charity funded by a public-private partnership that includes commercial entities (GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, and AbbVie). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amini A, 2012, CURR CANCER DRUG TAR, V12, P23, DOI 10.2174/156800912798888956; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bricogne G., 2011, BUSTER VERSION 2 10; Chang FJ, 2005, J BIOL CHEM, V280, P11513, DOI 10.1074/jbc.M412203200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cook KM, 2010, CA-CANCER J CLIN, V60, P222, DOI 10.3322/caac.20075; Crawford TN, 2009, CURR DIABETES REV, V5, P8, DOI 10.2174/157339909787314149; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-26; Friebe A, 1999, BIOCHEMISTRY-US, V38, P15253, DOI 10.1021/bi9908944; Friebe A, 1997, BIOCHEMISTRY-US, V36, P1194, DOI 10.1021/bi962047w; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; HUMBERT P, 1990, EUR J BIOCHEM, V190, P273, DOI 10.1111/j.1432-1033.1990.tb15572.x; Hurley JH, 1998, CURR OPIN STRUC BIOL, V8, P770, DOI 10.1016/S0959-440X(98)80097-3; IGNARRO LJ, 1991, BLOOD VESSELS, V28, P67; Jeganathan VSE, 2011, CURR PHARM BIOTECHNO, V12, P369; Kajiya K, 2008, FASEB J, V22, P530, DOI 10.1096/fj.07-8873com; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lamothe M, 2004, BIOCHEMISTRY-US, V43, P3039, DOI 10.1021/bi0360051; Linder JU, 2000, J BIOL CHEM, V275, P11235, DOI 10.1074/jbc.275.15.11235; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; Majumder S, 2009, BRIT J PHARMACOL, V158, P1720, DOI 10.1111/j.1476-5381.2009.00446.x; Martin F, 2010, J BIOL CHEM, V285, P22651, DOI 10.1074/jbc.M110.111559; Mergia E, 2003, CELL SIGNAL, V15, P189, DOI 10.1016/S0898-6568(02)00078-5; Mergia Evanthia, 2009, V191, P33, DOI 10.1007/978-3-540-68964-5_3; Mitrovic Veselin, 2011, Curr Heart Fail Rep, V8, P38, DOI 10.1007/s11897-010-0045-1; Morbidelli L, 2010, AM J PHYSIOL-REG I, V298, pR824, DOI 10.1152/ajpregu.00222.2009; Morton DB, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.12; Morton DB, 2003, J EXP BIOL, V206, P937, DOI 10.1242/jeb.00160; Mou TC, 2006, MOL PHARMACOL, V70, P878, DOI 10.1124/mol.106.026427; Mou TC, 2009, BIOCHEMISTRY-US, V48, P3387, DOI 10.1021/bi802122k; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olesen SP, 1998, BRIT J PHARMACOL, V123, P299, DOI 10.1038/sj.bjp.0701603; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; Pyriochou A, 2006, J PHARMACOL EXP THER, V319, P663, DOI 10.1124/jpet.106.108878; Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105; Roy B, 2006, P NATL ACAD SCI USA, V103, P12185, DOI 10.1073/pnas.0602544103; Russwurm M, 2002, MOL CELL BIOCHEM, V230, P159, DOI 10.1023/A:1014252309493; Saino M, 2004, ONCOL REP, V12, P47; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schmidtko A, 2008, J NEUROSCI, V28, P8568, DOI 10.1523/JNEUROSCI.2128-08.2008; Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603; Sinha SC, 2005, EMBO J, V24, P663, DOI 10.1038/sj.emboj.7600573; Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332; Surmeli NB, 2012, CHEMBIOCHEM; Tesmer JJG, 2000, BIOCHEMISTRY-US, V39, P14464, DOI 10.1021/bi0015562; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993; Whisnant RE, 1996, P NATL ACAD SCI USA, V93, P6621, DOI 10.1073/pnas.93.13.6621; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Yan SZ, 1996, J BIOL CHEM, V271, P10941, DOI 10.1074/jbc.271.18.10941; Yazawa S, 2006, J BIOL CHEM, V281, P21763, DOI 10.1074/jbc.M508983200; Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0; Zhu HF, 2011, MOL PHARMACOL, V80, P1076, DOI 10.1124/mol.111.073585	63	73	76	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57644	10.1371/journal.pone.0057644	http://dx.doi.org/10.1371/journal.pone.0057644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505436	gold, Green Submitted, Green Published			2022-12-27	WOS:000318334500028
J	Njuguna, HN; Cosmas, L; Williamson, J; Nyachieo, D; Olack, B; Ochieng, JB; Wamola, N; Oundo, JO; Feikin, DR; Mintz, ED; Breiman, RF				Njuguna, Henry N.; Cosmas, Leonard; Williamson, John; Nyachieo, Dhillon; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Oundo, Joseph O.; Feikin, Daniel R.; Mintz, Eric D.; Breiman, Robert F.			Use of Population-based Surveillance to Define the High Incidence of Shigellosis in an Urban Slum in Nairobi, Kenya	PLOS ONE			English	Article							RURAL WESTERN KENYA; ANTIMICROBIAL RESISTANCE; BACTERIAL DIARRHEA; CHILDREN; EPIDEMIOLOGY; MANAGEMENT; COUNTRIES; DISEASE; SUSCEPTIBILITY; MULTICENTER	Background: Worldwide, Shigella causes an estimated 160 million infections and >1 million deaths annually. However, limited incidence data are available from African urban slums. We investigated the epidemiology of shigellosis and drug susceptibility patterns within a densely populated urban settlement in Nairobi, Kenya through population-based surveillance. Methods: Surveillance participants were interviewed in their homes every 2 weeks by community interviewers. Participants also had free access to a designated study clinic in the surveillance area where stool specimens were collected from patients with diarrhea (>= 3 loose stools within 24 hours) or dysentery (>= 1 stool with visible blood during previous 24 hours). We adjusted crude incidence rates for participants meeting stool collection criteria at household visits who reported visiting another clinic. Results: Shigella species were isolated from 224 (23%) of 976 stool specimens. The overall adjusted incidence rate was 408/100,000 person years of observation (PYO) with highest rates among adults 34-49 years old (1,575/100,000 PYO). Isolates were: Shigella flexneri (64%), S. dysenteriae (11%), S. sonnei (9%), and S. boydii (5%). Over 90% of all Shigella isolates were resistant to trimethoprim-sulfamethoxazole and sulfisoxazole. Additional resistance included nalidixic acid (3%), ciprofloxacin (1%) and ceftriaxone (1%). Conclusion: More than 1 of every 200 persons experience shigellosis each year in this Kenyan urban slum, yielding rates similar to those in some Asian countries. Provision of safe drinking water, improved sanitation, and hygiene in urban slums are needed to reduce disease burden, in addition to development of effective Shigella vaccines.	[Njuguna, Henry N.; Cosmas, Leonard; Williamson, John; Nyachieo, Dhillon; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Oundo, Joseph O.; Feikin, Daniel R.; Breiman, Robert F.] Ctr Dis Control & Prevent Kenya CDC K Collaborat, Kenya Med Res Inst KEMRI, Global Dis Detect Program, Nairobi, Kenya; [Njuguna, Henry N.; Cosmas, Leonard; Williamson, John; Nyachieo, Dhillon; Olack, Beatrice; Ochieng, John B.; Wamola, Newton; Oundo, Joseph O.; Feikin, Daniel R.; Breiman, Robert F.] Ctr Dis Control & Prevent Kenya CDC K Collaborat, Kenya Med Res Inst KEMRI, Global Dis Detect Program, Kisumu, Kenya; [Mintz, Eric D.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA	Kenya Medical Research Institute; Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA	Njuguna, HN (corresponding author), Ctr Dis Control & Prevent Kenya CDC K Collaborat, Kenya Med Res Inst KEMRI, Global Dis Detect Program, Nairobi, Kenya.	hnjuguna@ke.cdc.gov			Centers for Disease Control and Prevention (CDC US)	Centers for Disease Control and Prevention (CDC US)	This work was supported by the Centers for Disease Control and Prevention (CDC US). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed F, 1997, AM J TROP MED HYG, V56, P258, DOI 10.4269/ajtmh.1997.56.258; ALAM N, 1989, INT J EPIDEMIOL, V18, P697, DOI 10.1093/ije/18.3.697; [Anonymous], NOAA KEN WEATH; BAQUI AH, 1991, INT J EPIDEMIOL, V20, P1057, DOI 10.1093/ije/20.4.1057; Basualdo W, 2003, PEDIATR INFECT DIS J, V22, P374; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Beatty M E, 2009, East Afr Med J, V86, P387; BENNISH ML, 1992, CLIN INFECT DIS, V14, P1055, DOI 10.1093/clinids/14.5.1055; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Brooks JT, 2006, CLIN INFECT DIS, V43, P393, DOI 10.1086/505866; CDC, 1986, MMWR-MORBID MORTAL W, P35; CDC, 1986, MMWR-MORBID MORTAL W, P753; *CLSI, 2006, CLIN LAB STAND I QUA; Crump JA, 2003, CLIN INFECT DIS, V37, P75, DOI 10.1086/375602; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; Feikin DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016085; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; FONTAINE O, 1989, REV INFECT DIS, V11, pS1145; Ghaemi Ezzat Ollah, 2007, Saudi J Gastroenterol, V13, P129; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Herwana E, 2010, SE ASIAN J TROP MED, V41, P418; Iwalokun BA, 2001, J HEALTH POPUL NUTR, V19, P183; Kosek M, 2003, B WORLD HEALTH ORGAN, P986; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Krieg NR, 1984, BERGEYS MANUAL SYSTE, V1; LEVINE OS, 1991, REV INFECT DIS, V13, P688; Mandomando I, 2009, ANTIMICROB AGENTS CH, V53, P2450, DOI 10.1128/AAC.01282-08; MUNDY LS, 1991, AM J CLIN PATHOL, V96, P364, DOI 10.1093/ajcp/96.3.364; Murphy MS, 2008, BRIT MED J, V336, P1010, DOI 10.1136/bmj.39542.440417.BE; Niyogi SK, 2005, J MICROBIOL, V43, P133; Patel RB, 2009, NEW ENGL J MED, V361, P741, DOI 10.1056/NEJMp0810878; Ram PK, 2008, EPIDEMIOL INFECT, V136, P577, DOI 10.1017/S0950268807009351; RIES AA, 1994, J INFECT DIS, V169, P1035, DOI 10.1093/infdis/169.5.1035; Sack DA, 2001, ANIMICROBIAL RESISTA; Shapiro RL, 2001, J INFECT DIS, V183, P1701, DOI 10.1086/320710; Sire JM, 2008, JPN J INFECT DIS, V61, P307; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; Udo S M, 2004, Asia Pac J Public Health, V16, P41, DOI 10.1177/101053950401600107; UN-HABITAT, 2010, STAT URB YOUTH 2010; von Seidlein L, 2006, PLOS MED, V3, P1556, DOI 10.1371/journal.pmed.0030353; Zwane AP, 2007, WORLD BANK RES OBSER	44	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58437	10.1371/journal.pone.0058437	http://dx.doi.org/10.1371/journal.pone.0058437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505506	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500083
J	Pfeiffer, V; Gotz, R; Xiang, CM; Camarero, G; Braun, A; Zhang, YN; Blum, R; Heinsen, H; Nieswandt, B; Rapp, UR				Pfeiffer, Verena; Goetz, Rudolf; Xiang, Chaomei; Camarero, Guadelupe; Braun, Attila; Zhang, Yina; Blum, Robert; Heinsen, Helmut; Nieswandt, Bernhard; Rapp, Ulf R.			Ablation of BRaf Impairs Neuronal Differentiation in the Postnatal Hippocampus and Cerebellum	PLOS ONE			English	Article							FACIO-CUTANEOUS SYNDROME; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; B-RAF; ADULT NEUROGENESIS; IN-VIVO; C-RAF; HUMAN CANCER; A-RAF; KINASE	This study focuses on the role of the kinase BRaf in postnatal brain development. Mice expressing truncated, non-functional BRaf in neural stem cell-derived brain tissue demonstrate alterations in the cerebellum, with decreased sizes and fuzzy borders of the glomeruli in the granule cell layer. In addition we observed reduced numbers and misplaced ectopic Purkinje cells that showed an altered structure of their dendritic arborizations in the hippocampus, while the overall cornus ammonis architecture appeared to be unchanged. In male mice lacking BRaf in the hippocampus the size of the granule cell layer was normal at postnatal day 12 (P12) but diminished at P21, as compared to control littermates. This defect was caused by a reduced ability of dentate gyrus progenitor cells to differentiate into NeuN positive granule cell neurons. In vitro cell culture of P0/P1 hippocampal cells revealed that BRaf deficient cells were impaired in their ability to form microtubule-associated protein 2 positive neurons. Together with the alterations in behaviour, such as autoaggression and loss of balance fitness, these observations indicate that in the absence of BRaf all neuronal cellular structures develop, but neuronal circuits in the cerebellum and hippocampus are partially disturbed besides impaired neuronal generation in both structures.	[Pfeiffer, Verena; Goetz, Rudolf; Xiang, Chaomei; Camarero, Guadelupe; Zhang, Yina; Rapp, Ulf R.] Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, D-97070 Wurzburg, Germany; [Goetz, Rudolf; Blum, Robert] Univ Hosp Wurzburg, Inst Clin Neurobiol, Wurzburg, Germany; [Braun, Attila; Nieswandt, Bernhard] Univ Hosp Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, Wurzburg, Germany; [Heinsen, Helmut] Univ Wurzburg, Morphol Brain Res Unit, Dept Psychiat, D-97070 Wurzburg, Germany; [Rapp, Ulf R.] Max Planck Inst Heart & Lung Res, Dept Mol Mech Lung Canc, Bad Nauheim, Germany	University of Wurzburg; University of Wurzburg; German Research Foundation (DFG); University of Wurzburg; University of Wurzburg; Max Planck Society	Rapp, UR (corresponding author), Univ Wurzburg, Inst Med Radiat & Cell Res MSZ, D-97070 Wurzburg, Germany.	Ulf.Rapp@mpi-bn.mpg.de	Blum, Robert/E-8899-2013	Blum, Robert/0000-0002-5270-3854	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 581]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 581) to UR Rapp. Grants of the Deutsche Forschungsgemeinschaft to the Graduate College 1048 University of Wurzburg to C. Xiang and V. Pfeiffer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Allanson JE, 2011, AM J MED GENET C, V157C, P129, DOI 10.1002/ajmg.c.30295; ALTMAN J, 1969, J COMP NEUROL, V136, P269, DOI 10.1002/cne.901360303; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; BAYER SA, 1983, EXP BRAIN RES, V50, P329; BAYER SA, 1980, J COMP NEUROL, V190, P115, DOI 10.1002/cne.901900108; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Camarero G, 2006, MOL CELL BIOL, V26, P7103, DOI 10.1128/MCB.00424-06; Causeret F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019367; Chen AP, 2006, J NEUROSCI RES, V83, P28, DOI 10.1002/jnr.20703; Chong A, 2004, GENOMICS, V84, P762, DOI 10.1016/j.ygeno.2004.05.007; CHUANG E, 1994, MOL CELL BIOL, V14, P5318, DOI 10.1128/MCB.14.8.5318; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Galabova-Kovacs G, 2006, P NATL ACAD SCI USA, V103, P1325, DOI 10.1073/pnas.0507399103; Galabova-Kovacs G, 2008, J CELL BIOL, V180, P947, DOI 10.1083/jcb.200709069; Galabova-Kovacs G, 2006, CELL CYCLE, V5, P1514, DOI 10.4161/cc.5.14.2981; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Gehart H, 2010, EMBO REP, V11, P834, DOI 10.1038/embor.2010.160; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Marais R, 1997, J BIOL CHEM, V272, P4378, DOI 10.1074/jbc.272.7.4378; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Pritchard CA, 2004, MOL CELL BIOL, V24, P5937, DOI 10.1128/MCB.24.13.5937-5952.2004; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; REYNOLDS JF, 1986, AM J MED GENET, V25, P413, DOI 10.1002/ajmg.1320250303; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schultz KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017736; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; THOMAS KL, 1994, NEURON, V13, P737, DOI 10.1016/0896-6273(94)90040-X; Tran NH, 2005, J BIOL CHEM, V280, P16244, DOI 10.1074/jbc.M501185200; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Valluet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015272; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wiese S, 2001, NAT NEUROSCI, V4, P137, DOI 10.1038/83960; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wu X, 2012, MOL CELL BIOL, V32, P3872, DOI 10.1128/MCB.00751-12; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhong J, 2007, NAT NEUROSCI, V10, P598, DOI 10.1038/nn1898	57	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58259	10.1371/journal.pone.0058259	http://dx.doi.org/10.1371/journal.pone.0058259			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505473	gold, Green Submitted, Green Published			2022-12-27	WOS:000318334500060
J	Ramani, RG; Jacob, SG				Ramani, R. Geetha; Jacob, Shomona Gracia			Improved Classification of Lung Cancer Tumors Based on Structural and Physicochemical Properties of Proteins Using Data Mining Models	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; TNM CLASSIFICATION; WEB SERVER; FEATURES; ALGORITHMS; PREDICTION; PEPTIDES; PROFEAT; MARKERS; GENES	Detecting divergence between oncogenic tumors plays a pivotal role in cancer diagnosis and therapy. This research work was focused on designing a computational strategy to predict the class of lung cancer tumors from the structural and physicochemical properties (1497 attributes) of protein sequences obtained from genes defined by microarray analysis. The proposed methodology involved the use of hybrid feature selection techniques (gain ratio and correlation based subset evaluators with Incremental Feature Selection) followed by Bayesian Network prediction to discriminate lung cancer tumors as Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC) and the COMMON classes. Moreover, this methodology eliminated the need for extensive data cleansing strategies on the protein properties and revealed the optimal and minimal set of features that contributed to lung cancer tumor classification with an improved accuracy compared to previous work. We also attempted to predict via supervised clustering the possible clusters in the lung tumor data. Our results revealed that supervised clustering algorithms exhibited poor performance in differentiating the lung tumor classes. Hybrid feature selection identified the distribution of solvent accessibility, polarizability and hydrophobicity as the highest ranked features with Incremental feature selection and Bayesian Network prediction generating the optimal Jack-knife cross validation accuracy of 87.6%. Precise categorization of oncogenic genes causing SCLC and NSCLC based on the structural and physicochemical properties of their protein sequences is expected to unravel the functionality of proteins that are essential in maintaining the genomic integrity of a cell and also act as an informative source for drug design, targeting essential protein properties and their composition that are found to exist in lung cancer tumors.	[Ramani, R. Geetha] Anna Univ, Coll Engn, Dept Informat Sci & Technol, Chennai 600025, Tamil Nadu, India; [Jacob, Shomona Gracia] Anna Univ, Fac Informat & Commun Engn, Chennai 600025, Tamil Nadu, India	Anna University; Anna University Chennai; Anna University; Anna University Chennai	Jacob, SG (corresponding author), Anna Univ, Fac Informat & Commun Engn, Chennai 600025, Tamil Nadu, India.	graciarun@gmail.com	Jacob, Shomona/GZB-1912-2022; r, geetharamani/AHH-4747-2022	r, geetharamani/0000-0003-2283-3428	All India Council for Technical Education (AICTE), India [8023/RID/RPS-56/2010-11, 200-62/FIN/04/05/1624]	All India Council for Technical Education (AICTE), India	This research work is a part of the All India Council for Technical Education (AICTE), India-funded Research Promotion Scheme project titled "Efficient Classifier for clinical life data (Parkinson, Breast Cancer and P53 mutants) through feature relevance analysis and classification'' with Reference numbers 8023/RID/RPS-56/2010-11 and 200-62/FIN/04/05/1624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, EUR J SCI RES, V78, P468; [Anonymous], MACH LEARN TOOL; [Anonymous], 1999, CORRELATION BASED FE; Aragues R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-172; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Barash O, 2012, NANOMED-NANOTECHNOL, V8, P580, DOI 10.1016/j.nano.2011.10.001; Breiman Leo, RANDOM TREES; Chopra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014305; Cios KJ, 1998, DATA MINING METHODS, P1; Crimins F, 2003, CAMDA 03; Dagliyan O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014579; Deng HT, 2011, LECT NOTES COMPUT SC, V6792, P293, DOI 10.1007/978-3-642-21738-8_38; Ebrahimi M, 2010, J RES MED SCI, V15, P299; Eick CF, 2004, PROC INT C TOOLS ART, P774; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Furney SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-3; Gracia J, 2013, RES J BIOTECHNOL, V8, P16; Guan P, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-103; Guyon I, 2009, NIPS WORKSH CLUST TH; Han J, 2006, DATA MINING CONCEPTS; Harris Jr Earl, 2003, INFORM GAIN VERSUS G; Heckerman D., 1995, TECHNICAL REPORT; Hosseinzadeh F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040017, 10.1371/annotation/2b218d50-a9d5-45b2-80d0-0e806e530749]; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Iba W, 1992, P 9 INT C MACH LEARN, P233, DOI DOI 10.1016/B978-1-55860-247-2.50035-8; Jacob SG, 2012, P INT C ADV COMP COM, P997, DOI 10.1145/2345396.2345557; Jacob SG., 2011, INT J COMPUTERS APPL, V32, P46, DOI DOI 10.5120/3920-5521; Jacob Shomona Gracia, 2012, P INT C COMP APPL PO, DOI 10.73445/ISBN_0768; Jacob Shomona Gracia, 2011, P IEEE INT C COMP IN, P661; Jiang X, 2010, J AM MED INFORM ASSN, V17, P462, DOI 10.1136/jamia.2009.000356; Kligerman S, 2010, AM J ROENTGENOL, V194, P562, DOI 10.2214/AJR.09.3354; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kotsiantis SB, 2007, INFORMATICA, P31249; Kraskov A., 2003, QBIO0311039 ARXIV; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037657; Li J, 2010, BAYES NET CLASSIFIER, V39, P144; Li ZR, 2006, NUCLEIC ACIDS RES, V34, pW32, DOI 10.1093/nar/gkl305; Lin Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034457; Lucas Peter, 2004, Curr Opin Crit Care, V10, P399, DOI 10.1097/01.ccx.0000141546.74590.d6; Marchevsky AM, 2004, J MOL DIAGN, V6, P28, DOI 10.1016/S1525-1578(10)60488-6; Markey MK, 2003, PROTEOMICS, V3, P1678, DOI 10.1002/pmic.200300521; Mehan MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035157; Meila M., 2003, LECT NOTES COMPUTER, P462; Mitchell T.M, 2003, MACH LEARN; Nevins Joseph R, 2011, Proc Am Thorac Soc, V8, P180, DOI 10.1513/pats.201006-040MS; Nguyen AN, 2010, J AM MED INFORM ASSN, V17, P440, DOI 10.1136/jamia.2010.003707; Nie Guang-jin, 2009, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V27, P257; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Pourret O., 2008, BAYESIAN NETWORKS PR; Raj V, 2011, CURR PROBL DIAGN RAD, V40, P85, DOI 10.1067/j.cpradiol.2010.02.002; Ramani RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055401; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Schutze H., 2008, INTRO INFORM RETRIEV, V39; Selvakuberan K, 2008, J INFORM COMPUTING S, V3, P083; Travis WD, 2011, SEMIN ROENTGENOL, V46, P178, DOI 10.1053/j.ro.2011.02.003; Uebersax, 2004, GEN COUNS CANC RISK; Watt Emily W, 2008, AMIA Annu Symp Proc, P788; West L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031906; Wrona Anna, 2010, Pneumonol Alergol Pol, V78, P407; Yamagata N, 2003, CLIN CANCER RES, V9, P4695; Yang Yan, 2008, Zhonghua Zhongliu Zazhi, V30, P616; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001	66	25	26	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58772	10.1371/journal.pone.0058772	http://dx.doi.org/10.1371/journal.pone.0058772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505559	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500124
J	Song, JS; Kim, EJ; Choi, J; Gong, G; Sung, CO				Song, Joon Seon; Kim, Eun Ju; Choi, Jene; Gong, Gyungyub; Sung, Chang Ohk			Significance of HPV-58 Infection in Women Who Are HPV-Positive, Cytology-Negative and Living in a Country with a High Prevalence of HPV-58 Infection	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE DISTRIBUTION; AMERICAN-CANCER-SOCIETY; CERVICAL-CANCER; CONSENSUS PRIMERS; KOREAN WOMEN; RISK; METAANALYSIS; PERSISTENCE; NEOPLASIA; TYPE-58	Purpose: Cervical cytology and human papillomavirus (HPV) DNA co-testing is recommended as a screening method for detecting cervical lesions. However, for women who are HPV-positive but cytology-negative, the appropriate management and significance of HPV-58 infection remain unknown. Methods: This study of prevalent HPV detected at baseline with a median follow-up of 3.2 years evaluated the risk factors associated with cervical abnormalities and assessed the significance of HPV-58 infection. A total of 265 women were enrolled. All high-grade squamous intraepithelial lesions (HSIL) that were detected by cytology were confirmed by histology. Histological diagnoses of cervical intraepithelial neoplasia 2/3 were classified as HSIL. Women were classified into four groups according to the HPV genotype that was detected at their first visit: HPV-58 (n = 27), HPV-16 (n = 52; 3 women had HPV-58 co-infection), ten other high risk (HR) types (n = 79), or low/undetermined risk types (n = 107). Results: Of 265 women, 20 (7.5%) had HSIL on their follow-up examinations. There were significant differences in the cumulative incidence of HSIL between the four groups (p<0.001). The 5-year cumulative incidence rates of HSIL were 34.0% (95% CI: 17.3-59.8%) in HPV-58 positive cases, 28.0% (95% CI: 13.8-51.6) in HPV-16 positive cases, 5.5% (95% CI: 2.1-14.0%) in one of the ten other types of HR-HPV positive cases, and 0% in women with low/undetermined risk HPV. When seen in women with HR-HPV (n = 158), persistent HPV infection was a significant factor associated with the development of HSIL (hazard ratio = 15.459, 95% CI: 2.042-117.045). Women with HPV-58 had a higher risk (hazard ratio = 5.260, 95% CI: 1.538-17.987) for the development of HSIL than women with HPV-16 (hazard ratio = 3.822, 95% CI: 1.176-12.424) in comparison with women with other types of HR-HPV. Conclusion: HPV-58 has a high association with the development of HSIL in women who are HPV-positive and cytology-negative.	[Song, Joon Seon; Kim, Eun Ju; Choi, Jene; Gong, Gyungyub; Sung, Chang Ohk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea	University of Ulsan; Asan Medical Center	Sung, CO (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.	co.sung@amc.seoul.kr		Sung, Chang Ohk/0000-0002-8567-456X				Asato T, 2004, J INFECT DIS, V189, P1829, DOI 10.1086/382896; Bao YP, 2008, INT J GYNECOL CANCER, V18, P71, DOI 10.1111/j.1525-1438.2007.00959.x; Chan PKS, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-17; Chan PKS, 2012, INT J CANCER, V131, P692, DOI 10.1002/ijc.26404; Chan PKS, 2009, INT J CANCER, V125, P1671, DOI 10.1002/ijc.24495; Chan PKS, 2006, INT J CANCER, V118, P243, DOI 10.1002/ijc.21299; Chan PKS, 2002, J NATL CANCER I, V94, P1249, DOI 10.1093/jnci/94.16.1249; Cogliano VJ, 2011, JNCI-J NATL CANCER I, V103, P1827, DOI 10.1093/jnci/djr483; Ding DC, 2008, EUR J OBSTET GYN R B, V140, P245, DOI 10.1016/j.ejogrb.2008.03.014; Hong SR, 2009, KOREAN J PATHOL, V43, P342, DOI 10.4132/KoreanJPathol.2009.43.4.342; Huang SX, 1997, INT J CANCER, V70, P408, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;408::AID-IJC6&gt;3.0.CO;2-#; Hwang T, 1999, J KOREAN MED SCI, V14, P593, DOI 10.3346/jkms.1999.14.6.593; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kjaer SK, 2010, JNCI-J NATL CANCER I, V102, P1478, DOI 10.1093/jnci/djq356; Maucort-Boulch D, 2010, INT J CANCER, V126, P684, DOI 10.1002/ijc.24752; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Sherman ME, 1998, CANCER CYTOPATHOL, V84, P273; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Thrall MJ, 2010, AM J CLIN PATHOL, V133, P894, DOI 10.1309/AJCPAZV88VIFZSFD; Wright Thomas C Jr, 2007, J Low Genit Tract Dis, V11, P201, DOI 10.1097/LGT.0b013e3181585870; Wright TC, 2011, AM J CLIN PATHOL, V136, P578, DOI 10.1309/AJCPTUS5EXAS6DKZ; Wu EQ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-202	25	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58678	10.1371/journal.pone.0058678	http://dx.doi.org/10.1371/journal.pone.0058678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505548	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500112
J	Zhang, XZ; Krause, KH; Xenarios, I; Soldati, T; Boeckmann, B				Zhang, Xuezhi; Krause, Karl-Heinz; Xenarios, Ioannis; Soldati, Thierry; Boeckmann, Brigitte			Evolution of the Ferric Reductase Domain (FRD) Superfamily: Modularity, Functional Diversification, and Signature Motifs	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN TOPOLOGY; GENERATING NADPH OXIDASE; HYDROGEN-PEROXIDE; IRON UPTAKE; CHELATE REDUCTASE; DUAL OXIDASE; CELL-DIFFERENTIATION; HEME-BINDING; NOX-FAMILY; ESOPHAGEAL ADENOCARCINOMA	A heme-containing transmembrane ferric reductase domain (FRD) is found in bacterial and eukaryotic protein families, including ferric reductases (FRE), and NADPH oxidases (NOX). The aim of this study was to understand the phylogeny of the FRD superfamily. Bacteria contain FRD proteins consisting only of the ferric reductase domain, such as YedZ and short bFRE proteins. Full length FRE and NOX enzymes are mostly found in eukaryotic cells and all possess a dehydrogenase domain, allowing them to catalyze electron transfer from cytosolic NADPH to extracellular metal ions (FRE) or oxygen (NOX). Metazoa possess YedZ-related STEAP proteins, possibly derived from bacteria through horizontal gene transfer. Phylogenetic analyses suggests that FRE enzymes appeared early in evolution, followed by a transition towards EF-hand containing NOX enzymes (NOX5- and DUOX-like). An ancestral gene of the NOX(1-4) family probably lost the EF-hands and new regulatory mechanisms of increasing complexity evolved in this clade. Two signature motifs were identified: NOX enzymes are distinguished from FRE enzymes through a four amino acid motif spanning from transmembrane domain 3 (TM3) to TM4, and YedZ/STEAP proteins are identified by the replacement of the first canonical heme-spanning histidine by a highly conserved arginine. The FRD superfamily most likely originated in bacteria.	[Zhang, Xuezhi; Soldati, Thierry] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Krause, Karl-Heinz] Univ Geneva, Dept Pathol & Immunol, Cent Med Univ, Geneva, Switzerland; [Xenarios, Ioannis; Boeckmann, Brigitte] Swiss Inst Bioinformat, SwissProt, Geneva, Switzerland; [Xenarios, Ioannis] Swiss Inst Bioinformat, Vital IT, Lausanne, Switzerland; [Xenarios, Ioannis] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, Lausanne, Switzerland	University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Swiss Institute of Bioinformatics; University of Lausanne	Boeckmann, B (corresponding author), Swiss Inst Bioinformat, SwissProt, Geneva, Switzerland.	brigitte.boeckmann@isb-sib.ch	SOLDATI, Thierry/U-6494-2019; Krause, Karl-Heinz/E-8030-2011; Xenarios, Ioannis/ABD-5045-2021; SOLDATI, Thierry/A-2902-2009	SOLDATI, Thierry/0000-0002-2056-7931; Krause, Karl-Heinz/0000-0002-9033-6768; Xenarios, Ioannis/0000-0002-3413-6841; SOLDATI, Thierry/0000-0002-2056-7931	Swiss Federal Government through the Federal Office of Education and Science; Swiss National Science Foundation ProDoc Research Module [PDFMP3_127302]; Swiss Institute of Bioinformatics	Swiss Federal Government through the Federal Office of Education and Science; Swiss National Science Foundation ProDoc Research Module; Swiss Institute of Bioinformatics	This work was supported in part by the Swiss Federal Government through the Federal Office of Education and Science (BB) and by a Swiss National Science Foundation ProDoc Research Module, PDFMP3_127302 (TS and KHK). Funding for open access charge: Swiss Institute of Bioinformatics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Aguirre J, 2010, FREE RADICAL BIO MED, V49, P1342, DOI 10.1016/j.freeradbiomed.2010.07.027; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P524, DOI 10.1016/S0968-0004(01)01924-7; Babior BM, 2000, IUBMB LIFE, V50, P267, DOI 10.1080/15216540051080976; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Banfi B, 2004, J BIOL CHEM, V279, P46065, DOI 10.1074/jbc.M403046200; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bedard K, 2007, BIOCHIMIE, V89, P1107, DOI 10.1016/j.biochi.2007.01.012; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bernal M, 2012, PLANT CELL, V24, P738, DOI 10.1105/tpc.111.090431; Boeckmann B, 2011, BRIEF BIOINFORM, V12, P423, DOI 10.1093/bib/bbr034; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Brokx SJ, 2005, BIOCHEMISTRY-US, V44, P10339, DOI 10.1021/bi050621a; Brown GD, 2011, ANNU REV IMMUNOL, V29, P1, DOI 10.1146/annurev-immunol-030409-101229; Brun S, 2009, MOL MICROBIOL, V74, P480, DOI 10.1111/j.1365-2958.2009.06878.x; Bustamante J, 2011, NAT IMMUNOL, V12, P213, DOI 10.1038/ni.1992; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Cardoso LC, 2001, J CLIN ENDOCR METAB, V86, P4339, DOI 10.1210/jc.86.9.4339; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Crichton RR, 2001, BIOMETALS, V14, P99, DOI 10.1023/A:1016710810701; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; DANCIS A, 1992, P NATL ACAD SCI USA, V89, P3869, DOI 10.1073/pnas.89.9.3869; De Deken X, 2000, J BIOL CHEM, V275, P23227, DOI 10.1074/jbc.M000916200; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dikalova A, 2005, CIRCULATION, V112, P2668, DOI 10.1161/CIRCULATIONAHA.105.538934; Donko A, 2010, FREE RADICAL BIO MED, V49, P2040, DOI 10.1016/j.freeradbiomed.2010.09.027; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Einset J, 2008, PHYSIOL PLANTARUM, V134, P334, DOI 10.1111/j.1399-3054.2008.01141.x; Eisenhaber F, 2003, NUCLEIC ACIDS RES, V31, P3631, DOI 10.1093/nar/gkg537; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fagard M, 2007, MOL PLANT MICROBE IN, V20, P794, DOI 10.1094/MPMI-20-7-0794; Feng HZ, 2006, PLANT PHYSIOL, V140, P1345, DOI 10.1104/pp.105.074138; Finegold AA, 1996, J BIOL CHEM, V271, P31021, DOI 10.1074/jbc.271.49.31021; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Garrido-Urbani S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014665; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Georgatsou E, 1997, J BIOL CHEM, V272, P13786, DOI 10.1074/jbc.272.21.13786; Grasberger H, 2012, MOL ENDOCRINOL, V26, P481, DOI 10.1210/me.2011-1320; Grissa I, 2010, FUNGAL BIOL-UK, V114, P766, DOI 10.1016/j.funbio.2010.07.002; Groeger G, 2009, ANTIOXID REDOX SIGN, V11, P2655, DOI 10.1089/ARS.2009.2728; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; HASSETT R, 1995, J BIOL CHEM, V270, P128, DOI 10.1074/jbc.270.1.128; Herve C, 2006, CURR GENET, V49, P190, DOI 10.1007/s00294-005-0044-z; Holliday GL, 2009, J MOL BIOL, V390, P560, DOI 10.1016/j.jmb.2009.05.015; Hong J, 2010, CANCER RES, V70, P1247, DOI 10.1158/0008-5472.CAN-09-2774; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Iyer LM, 2007, BIOINFORMATICS, V23, P2660, DOI 10.1093/bioinformatics/btm411; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Jendrysik MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028198; Jeong J, 2008, P NATL ACAD SCI USA, V105, P10619, DOI 10.1073/pnas.0708367105; Jeong J, 2009, PLANT SCI, V176, P709, DOI 10.1016/j.plantsci.2009.02.011; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Juarez MT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002424; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Kim KS, 2010, J BIOL CHEM, V285, P40294, DOI 10.1074/jbc.M110.126821; Knutson MD, 2007, NUTR REV, V65, P335, DOI 10.1301/nr.2007.jul.335-340; Kosman DJ, 2010, J BIOL CHEM, V285, P26729, DOI 10.1074/jbc.R110.113217; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Kumatori A, 1998, GENOMICS, V53, P123, DOI 10.1006/geno.1998.5510; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; Lardy B, 2005, BBA-MOL CELL RES, V1744, P199, DOI 10.1016/j.bbamcr.2005.02.004; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Makarova KS, 2005, NUCLEIC ACIDS RES, V33, P4626, DOI 10.1093/nar/gki775; Malagnac F, 2004, FUNGAL GENET BIOL, V41, P982, DOI 10.1016/j.fgb.2004.07.008; Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Mayer BJ, 2001, J CELL SCI, V114, P1253; Meitzler JL, 2010, J BIOL CHEM, V285, P40991, DOI 10.1074/jbc.M110.170902; Moreno Jose C., 2007, V10, P99, DOI 10.1159/000106822; Mukherjee I, 2006, PLANTA, V223, P1178, DOI 10.1007/s00425-005-0165-0; Nguyen TTA, 2011, J BIOL CHEM, V286, P33244, DOI 10.1074/jbc.M111.263178; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohye H, 2010, EXP BIOL MED, V235, P424, DOI 10.1258/ebm.2009.009241; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; OLSON JS, 1988, NATURE, V336, P265, DOI 10.1038/336265a0; Paffenholz R, 2004, GENE DEV, V18, P486, DOI 10.1101/gad.1172504; Paravicini TM, 2004, STROKE, V35, P584, DOI 10.1161/01.STR.0000112974.37028.58; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Rae J, 1998, AM J HUM GENET, V62, P1320, DOI 10.1086/301874; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Rinnerthaler M, 2012, P NATL ACAD SCI USA, V109, P8658, DOI 10.1073/pnas.1201629109; Ritsick DR, 2007, FREE RADICAL BIO MED, V43, P31, DOI 10.1016/j.freeradbiomed.2007.03.006; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; ROMAN DG, 1993, MOL CELL BIOL, V13, P4342, DOI 10.1128/MCB.13.7.4342; Sanchez-Pulido L, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-98; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; Singh A, 2007, J BIOL CHEM, V282, P28619, DOI 10.1074/jbc.M703398200; Song Y, 2007, J CLIN ENDOCR METAB, V92, P3764, DOI 10.1210/jc.2007-0660; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Tirone F, 2007, FEBS LETT, V581, P1202, DOI 10.1016/j.febslet.2007.02.047; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Touyz RM, 2011, MOL INTERV, V11, P27, DOI 10.1124/mi.11.1.5; Tripathi S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2928634; Tsuda M, 1998, HUM GENET, V103, P377, DOI 10.1007/s004390050836; Ueno N, 2005, J BIOL CHEM, V280, P23328, DOI 10.1074/jbc.M414548200; Vasconcelos M, 2006, PLANTA, V224, P1116, DOI 10.1007/s00425-006-0293-1; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; von Rozycki T, 2004, J MOL MICROB BIOTECH, V8, P129, DOI 10.1159/000085786; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014; Wu HL, 2005, PLANT CELL PHYSIOL, V46, P1505, DOI 10.1093/pcp/pci163; Yun CW, 2001, J BIOL CHEM, V276, P10218, DOI 10.1074/jbc.M010065200; Yutin N, 2008, MOL BIOL EVOL, V25, P1619, DOI 10.1093/molbev/msn108; Zhou XX, 2011, J PHARMACOL EXP THER, V339, P218, DOI 10.1124/jpet.111.182352	127	51	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58126	10.1371/journal.pone.0058126	http://dx.doi.org/10.1371/journal.pone.0058126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505460	Green Submitted, gold, Green Published			2022-12-27	WOS:000318334500052
J	Li, QQ; Yang, T; Zhao, EB; Xia, XA; Han, ZG				Li, Qianqian; Yang, Tao; Zhao, Erbo; Xia, Xing'ang; Han, Zhangang			The Impacts of Information-Sharing Mechanisms on Spatial Market Formation Based on Agent-Based Modeling	PLOS ONE			English	Article							ORGANIZATION; COOPERATION; EMERGENCE; TRUST; LAW; US	There has been an increasing interest in the geographic aspects of economic development, exemplified by P. Krugman's logical analysis. We show in this paper that the geographic aspects of economic development can be modeled using multiagent systems that incorporate multiple underlying factors. The extent of information sharing is assumed to be a driving force that leads to economic geographic heterogeneity across locations without geographic advantages or disadvantages. We propose an agent-based market model that considers a spectrum of different information-sharing mechanisms: no information sharing, information sharing among friends and pheromone-like information sharing. Finally, we build a unified model that accommodates all three of these information-sharing mechanisms based on the number of friends who can share information. We find that the no information-sharing model does not yield large economic zones, and more information sharing can give rise to a power-law distribution of market size that corresponds to the stylized fact of city size and firm size distributions. The simulations show that this model is robust. This paper provides an alternative approach to studying economic geographic development, and this model could be used as a test bed to validate the detailed assumptions that regulate real economic agglomeration.	[Li, Qianqian; Yang, Tao; Zhao, Erbo; Xia, Xing'ang; Han, Zhangang] Beijing Normal Univ, Dept Syst Sci, Beijing 100875, Peoples R China	Beijing Normal University	Han, ZG (corresponding author), Beijing Normal Univ, Dept Syst Sci, Beijing 100875, Peoples R China.	zhan@bnu.edu.cn			China National Natural Science Foundation [61074116]; Fundamental Research Funds for the Central Universities of China; China National Science & Technology Pillar Program [2009BAI77B04]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); China National Science & Technology Pillar Program	This research is supported by China National Natural Science Foundation grant 61074116, the Fundamental Research Funds for the Central Universities of China, and China National Science & Technology Pillar Program grant 2009BAI77B04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Anand KS, 1997, MANAGE SCI, V43, P1609, DOI 10.1287/mnsc.43.12.1609; ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Arthur WB, 1999, SCIENCE, V284, P107, DOI 10.1126/science.284.5411.107; Axtell RL, 2001, SCIENCE, V293, P1818, DOI 10.1126/science.1062081; Axtell RL, 2002, P NATL ACAD SCI USA, V99, P7275, DOI 10.1073/pnas.092080799; Balch T, 2000, AUTON ROBOT, V8, P209, DOI 10.1023/A:1008973424594; Bonabeau E., 1997, Proceedings of BCEC97. Biocomputing and Emergent Computation, P36; Challet D, 1997, PHYSICA A, V246, P407, DOI 10.1016/S0378-4371(97)00419-6; Chli M, 2008, IEEE T SYST MAN CY A, V38, P1056, DOI 10.1109/TSMCA.2008.2001079; Dorigo M, 2005, THEOR COMPUT SCI, V344, P243, DOI 10.1016/j.tcs.2005.05.020; Epstein J.M., 1996, GROWING ARTIFICIAL S; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fujita M, 1996, J JPN INT ECON, V10, P339, DOI 10.1006/jjie.1996.0021; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; Gallup J.L., 1998, GEOGRAPHY EC DEV; Gavirneni S, 1999, MANAGE SCI, V45, P16, DOI 10.1287/mnsc.45.1.16; Gorelick R, 2007, INSECT SOC, V54, P105, DOI 10.1007/s00040-007-0923-z; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185, DOI [DOI 10.1785/BSSA0340040185, 10.1785/BSSA0340040185]; Ioannou CC, 2012, SCIENCE, V337, P1212, DOI 10.1126/science.1218919; Kirman A., 2007, LES HOUCHES, V85, P217; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Krugman P, 1999, INT REGIONAL SCI REV, V22, P142, DOI 10.1177/016001799761012307; Lim M, 2007, SCIENCE, V317, P1540, DOI 10.1126/science.1142734; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7214, DOI 10.1073/pnas.082097399; Ottaviano GIP, 1998, WORLD ECON, V21, P707, DOI 10.1111/1467-9701.00160; Sabater J, 2005, ARTIF INTELL REV, V24, P33, DOI 10.1007/s10462-004-0041-5; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Stutzle T, 2004, ANT COLONY OPTIMIZAT; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Zanette DH, 2001, PHYSICA A, V295, P1, DOI 10.1016/S0378-4371(01)00046-2; Zhang YC, 2005, PHYSICA A, V350, P500, DOI 10.1016/j.physa.2004.11.057; Zipf GK, 1929, HARV STUD CLASS PHIL, V40, P1, DOI [DOI 10.2307/310585, 10.2307/408772]	34	2	3	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58270	10.1371/journal.pone.0058270	http://dx.doi.org/10.1371/journal.pone.0058270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23484007	Green Published, gold			2022-12-27	WOS:000316936100098
J	Lloveras, B; Gomez, S; Alameda, F; Bellosillo, B; Mojal, S; Muset, M; Parra, M; Palomares, JC; Serrano, S				Lloveras, Belen; Gomez, Silvia; Alameda, Francesc; Bellosillo, Beatriz; Mojal, Sergi; Muset, Merce; Parra, Manuel; Carlos Palomares, Jose; Serrano, Sergi			HPV Testing by cobas HPV Test in a Population from Catalonia	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; CANCER; CYTOLOGY; WOMEN; RISK; NEOPLASIA	Background: HPV testing in cervical cancer screening has been proposed as an alternative or complementary to cytology in women older than 30 years. However, adequate clinical sensitivity and specificity are crucial for a new test to be implemented. Hybrid Capture 2 (HC2) has proved good clinical performance in selecting women at risk for high-grade intraepithelial lesions with a high sensitivity and specificity. cobas HPV Test has been recently launched and its performance in different clinical settings needs to be determined. Objectives: The aim of this study was to evaluate the cobas HPV Test for the detection of cervical HPV infection in a population of women in Catalonia (Spain) using HC2 as a reference. Materials and Methods: Cervical liquid cytology samples from 958 women have been studied. Sensitivity was analyzed in 60 samples from patients with a high-grade intraepithelial lesion (>= CIN2) on histology and specificity was determined in 898 samples from women with no >= CIN2. All cases had HC2 and cobas HPV Test performed. Statistical analyses of sensitivity, specificity and comparison between HC2 and cobas HPV Test by a non-inferiority test were applied. Results: Sensitivity of HC2 and cobas HPV Test for detecting >= CIN2 proved identical (98.3%) while specificity was 85.3% and 86.2% respectively. The non-inferiority test demonstrated that cobas HPV Test surpassed 90% sensitivity and 98% specificity of HC2. Conclusion: The cobas HPV Test results fulfilled sensitivity and specificity requirements for HPV based cervical cancer screening and for the triage of minor cytological abnormalities, allowing its introduction in clinical settings.	[Lloveras, Belen; Gomez, Silvia; Alameda, Francesc; Bellosillo, Beatriz; Muset, Merce; Serrano, Sergi] Univ Autonoma Barcelona, Hosp Mar, Dept Pathol, E-08193 Barcelona, Spain; [Mojal, Sergi] IMIM, Consulting Serv Methodol Biomed Res, Barcelona, Spain; [Parra, Manuel; Carlos Palomares, Jose] Hosp Valme, Clin Unit Infect Dis & Microbiol, Seville, Spain	Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital Valme	Lloveras, B (corresponding author), Univ Autonoma Barcelona, Hosp Mar, Dept Pathol, E-08193 Barcelona, Spain.	blloveras@parcdesalutmar.cat	IBIS, TUBERCULOSIS/O-9334-2015	Mojal, Sergi/0000-0003-0523-3869	Instituto de Salud Carlos III FEDER 23 [RD09/0076/00036]; Pla 24 Director d'Oncologia de Catalunya (XBTC)	Instituto de Salud Carlos III FEDER 23; Pla 24 Director d'Oncologia de Catalunya (XBTC)	This work was supported by grants from Instituto de Salud Carlos III FEDER 23 (RD09/0076/00036) and the "Xarxa de Bancs de tumors sponsored by Pla 24 Director d'Oncologia de Catalunya (XBTC). Roche Diagnostics has provided reagents for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No current external funding sources for this study.	Arbyn M, 2009, LANCET ONCOL, V10, P935, DOI 10.1016/S1470-2045(09)70296-7; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Heideman DAM, 2011, J CLIN MICROBIOL, V49, P3983, DOI 10.1128/JCM.05552-11; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kinney W, 2010, AM J CLIN PATHOL, V134, P193, DOI 10.1309/AJCPRI8XPQUEAA3K; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; Meijer CJLM, 2011, LANCET ONCOL, V12, P612, DOI 10.1016/S1470-2045(11)70159-0; Meijer CJLM, 2009, INT J CANCER, V124, P516, DOI 10.1002/ijc.24010; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Ronco G, 2006, LANCET ONCOL, V7, P547, DOI 10.1016/S1470-2045(06)70731-8; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P946; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT	20	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58153	10.1371/journal.pone.0058153	http://dx.doi.org/10.1371/journal.pone.0058153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483984	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100080
J	Yeom, J; Shin, JH; Yang, JY; Kim, J; Hwang, GS				Yeom, Jinki; Shin, Ji-Hyun; Yang, Ji-Young; Kim, Jungmin; Hwang, Geum-Sook			H-1 NMR-Based Metabolite Profiling of Planktonic and Biofilm Cells in Acinetobacter baumannii 1656-2	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTERIAL BIOFILMS; ANTIBIOTIC-RESISTANCE; METABOLOMICS; FERMENTATION; SURFACES; GROWTH	Acinetobacter baumannii is an aerobic and gram-negative pathogenic bacterium that is resistant to most antibiotics. Recently, A. baumannii 1656-2 exhibited the ability to form biofilms under clinical conditions. In this study, global metabolite profiling of both planktonic and biofilm forms of A. baumannii 1656-2 was performed using high-resolution nuclear magnetic resonance (NMR) spectroscopy and multivariate statistical analysis to investigate the metabolic patterns leading to biofilm formation. Principal components analysis (PCA) and orthogonal partial least-squares discriminant analysis (OPLS-DA) score plots showed a distinct separation between planktonic and biofilm cells. Metabolites including acetates, pyruvate, succinate, UDP-glucose, AMP, glutamate, and lysine were increasingly involved in the energy metabolism of biofilm formation. In particular, the ratio of N-acetyl-D-glucosamine (GlcNAc) to D-glucosamine (GlcNH(2)) was significantly higher during biofilm formation than under the planktonic condition. This study demonstrates that NMR-based global metabolite profiling of bacterial cells can provide valuable insight into the metabolic changes in multidrug resistant and biofilm-forming bacteria such as A. baumannii 1656-2.	[Yeom, Jinki; Yang, Ji-Young; Hwang, Geum-Sook] Korea Basic Sci Inst, Seoul Ctr, Integrated Metabol Res Grp, Seoul, South Korea; [Shin, Ji-Hyun; Kim, Jungmin] Kyungpook Natl Univ, Dept Microbiol, Sch Med, Taegu, South Korea; [Shin, Ji-Hyun] Dankook Univ, Dept Pharmacol, Coll Med, Cheonan, South Korea; [Yang, Ji-Young; Hwang, Geum-Sook] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Taejon, South Korea	Korea Basic Science Institute (KBSI); Kyungpook National University; Dankook University; Chungnam National University	Kim, J (corresponding author), Kyungpook Natl Univ, Dept Microbiol, Sch Med, Taegu, South Korea.	minkim@knu.ac.kr; gshwang@kbsi.re.kr	Kim, Jungmin/AAX-6484-2021	Kim, Jungmin/0000-0002-1795-1844; Yeom, Jinki/0000-0002-5332-2658	National Research Foundation [2010-0019394, 2010-0007203]; Ministry of Education, Science and Technology; Korea Basic Science Institute [T32409]	National Research Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Basic Science Institute	This study was supported by National Research Foundation Grants, no. 2010-0019394 (to G.S.H) and no.2010-0007203 (to J.K.) funded by the Ministry of Education, Science and Technology and the Korea Basic Science Institute (T32409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereket W, 2012, EUR REV MED PHARMACO, V16, P1039; Booth SC, 2011, J PROTEOME RES, V10, P3190, DOI 10.1021/pr2002353; Cabral MP, 2011, J PROTEOME RES, V10, P3399, DOI 10.1021/pr101299j; Candela T, 2011, J BIOL CHEM, V286, P31250, DOI 10.1074/jbc.M111.249821; Cerqueira GM, 2011, IUBMB LIFE, V63, P1055, DOI 10.1002/iub.533; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; Gjersing EL, 2007, ANAL CHEM, V79, P8037, DOI 10.1021/ac070800t; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005; Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; Jung J, 2011, APPL ENVIRON MICROB, V77, P7418, DOI 10.1128/AEM.05231-11; Jung Y, 2010, J AGR FOOD CHEM, V58, P10458, DOI 10.1021/jf102194t; Kim YH, 2006, PROTEOMICS, V6, P6181, DOI 10.1002/pmic.200600320; Kronthaler J, 2012, OMICS, V16, P90, DOI 10.1089/omi.2011.0048; Larsen FH, 2006, J CHEMOMETR, V20, P198, DOI 10.1002/cem.991; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Li J, 2012, J PROTEOME RES, V11, P4654, DOI 10.1021/pr300469v; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; Park JY, 2011, J BACTERIOL, V193, P6393, DOI 10.1128/JB.06109-11; Poirel L, 2011, IUBMB LIFE, V63, P1061, DOI 10.1002/iub.532; Pruss BM, 2010, ARCH MICROBIOL, V192, P715, DOI 10.1007/s00203-010-0599-z; Pysz MA, 2004, APPL ENVIRON MICROB, V70, P6098, DOI 10.1128/AEM.70.10.6098-6112.2004; Shin JH, 2011, J PROTEOME RES, V10, P2238, DOI 10.1021/pr101054m; Shin JH, 2009, J MICROBIOL, V47, P728, DOI 10.1007/s12275-009-0158-y; Son HS, 2009, ANAL CHEM, V81, P1137, DOI 10.1021/ac802305c; Tatarko M, 2001, CURR MICROBIOL, V43, P26, DOI 10.1007/s002840010255; Thomas VL, 1997, CURR MICROBIOL, V35, P249, DOI 10.1007/s002849900248; Thompson FL, 2011, MICROBES ENVIRON, V26, P61, DOI 10.1264/jsme2.ME10152; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Valle J, 2008, J BACTERIOL, V190, P264, DOI 10.1128/JB.01405-07; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Worthington RJ, 2012, ORG BIOMOL CHEM, V10, P7457, DOI 10.1039/c2ob25835h; Yeom J, 2012, RES MICROBIOL, V163, P258, DOI 10.1016/j.resmic.2012.01.008	34	52	53	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57730	10.1371/journal.pone.0057730	http://dx.doi.org/10.1371/journal.pone.0057730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483923	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100039
J	Sorhouet-Pereira, C; Efron, A; Gagetti, P; Faccone, D; Regueira, M; Corso, A; Gabastou, JM; Ibarz-Pavon, AB				Sorhouet-Pereira, Cecilia; Efron, Adriana; Gagetti, Paula; Faccone, Diego; Regueira, Mabel; Corso, Alejandra; Gabastou, Jean-Marc; Ibarz-Pavon, Ana Belen		Argentinean SIREVA II Working Grp	Phenotypic and Genotypic Characteristics of Neisseria meningitidis Disease-Causing Strains in Argentina, 2010	PLOS ONE			English	Article							MENINGOCOCCAL DISEASE; FLUOROQUINOLONE RESISTANCE; DECREASED SUSCEPTIBILITY; SEROGROUP; CIPROFLOXACIN; VACCINE; EMERGENCE; W135; PREVALENCE; AMERICA	Phenotypic and genotypic characterization of 133 isolates of Neisseria meningitidis obtained from meningococcal disease cases in Argentina during 2010 were performed by the National Reference Laboratory as part of a project coordinated by the PAHO within the SIREVA II network. Serogroup, serotype, serosubtype and MLST characterization were performed. Minimum Inhibitory Concentration to penicillin, ampicillin, ceftriaxone, rifampin, chloramphenicol, tetracycline and ciprofloxacin were determined and interpreted according to CLSI guidelines. Almost 49% of isolates were W135, and two serotype: serosubtype combinations, W135:2a:P1.5,2:ST-11 and W135:2a:P1.2:ST-11 accounted for 78% of all W135 isolates. Serogroup B accounted for 42.1% of isolates, and was both phenotypically and genotypically diverse. Serogroup C isolates represented 5.3% of the dataset, and one isolate belonging to the ST-198 complex was non-groupable. Isolates belonged mainly to the ST-11 complex (48%) and to a lesser extent to the ST-865 (18%), ST-32 (9,8%) and the ST-35 complexes (9%). Intermediate resistance to penicillin and ampicillin was detected in 35.4% and 33.1% of isolates respectively. Two W135: 2a: P1.5,2: ST-11: ST-11 isolates presented resistance to ciprofloxacin associated with a mutation in the QRDR of gyrA gene Thr91-Ile. These data show serogroup W135 was the first cause of disease in Argentina in 2010, and was strongly associated with the W135: 2a: P1.5,2: ST-11 epidemic clone. Serogroup B was the second cause of disease and isolates belonging to this serogroup were phenotypically and genotypically diverse. The presence of isolates with intermediate resistance to penicillin and the presence of fluorquinolone-resistant isolates highlight the necessity and importance of maintaining and strengthening National Surveillance Programs.	[Sorhouet-Pereira, Cecilia; Efron, Adriana; Regueira, Mabel] Minist Hlth, Clin Bacteriol Serv, Dept Bacteriol, Natl Inst Infect Dis ANLIS INEI, Buenos Aires, DF, Argentina; [Gagetti, Paula; Faccone, Diego; Corso, Alejandra] Minist Hlth, Antimicrobial Resistance Serv, Dept Bacteriol, Natl Inst Infect Dis ANLIS INEI, Buenos Aires, DF, Argentina; [Gabastou, Jean-Marc; Ibarz-Pavon, Ana Belen] Pan Amer Hlth Org, Washington, DC USA	Pan American Health Organization	Ibarz-Pavon, AB (corresponding author), Pan Amer Hlth Org, Washington, DC USA.	ibarzpav@paho.org			Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF)	Funding was provided by Sanofi-Pasteur through the Pan-American Health and Education Foundation (PAHEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDILLAHI H, 1987, FEMS MICROBIOL LETT, V48, P367, DOI 10.1016/0378-1097(87)90077-2; Alcala B, 2004, J ANTIMICROB CHEMOTH, V53, P409, DOI 10.1093/jac/dkh075; Barroso DE, 2007, MEM I OSWALDO CRUZ, V102, P773, DOI [10.1590/S0074-02762007005000104, 10.1590/S0074-02762007000600019]; Brehony C, 2009, MICROBIOL-SGM, V155, P4155, DOI 10.1099/mic.0.027995-0; Castaneda Elizabeth, 2009, Pediatr Infect Dis J, V28, pe265, DOI 10.1097/INF.0b013e3181a74b22; Castanheira M, 2012, DIAGN MICR INFEC DIS, V72, P263, DOI 10.1016/j.diagmicrobio.2011.12.001; Chiavetta L., 2007, Rev. argent. microbiol., V39, P21; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; CLSI, 2010, M7A8 CLSI; Corso A, 2005, J ANTIMICROB CHEMOTH, V55, P596, DOI 10.1093/jac/dki048; de Filippis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033016; Efron AM, 2009, J CLIN MICROBIOL, V47, P1979, DOI 10.1128/JCM.02390-08; Enriquez R, 2008, J ANTIMICROB CHEMOTH, V61, P286, DOI 10.1093/jac/dkm452; Findlow H, 2007, J INFECT DIS, V195, P1071, DOI 10.1086/512084; Gabastou JM, 2008, REV PANAM SALUD PUBL, V24, P1, DOI 10.1590/S1020-49892008000700001; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Gorla MCO, 2012, ENFERM INFEC MICR CL, V30, P56, DOI 10.1016/j.eimc.2011.07.022; Hoang LMN, 2005, CLIN INFECT DIS, V40, pE38, DOI 10.1086/427875; Ibarz-Pavon AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044102; Iser BPM, 2012, EPIDEMIOL INFECT, V140, P906, DOI 10.1017/S0950268811001610; Jacobsson S, 2009, VACCINE, V27, P1579, DOI 10.1016/j.vaccine.2008.12.052; Lucidarme J, 2009, J CLIN MICROBIOL, V47, P3577, DOI 10.1128/JCM.00936-09; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; McCaw SE, 2012, INFECT IMMUN; Mehta G, 2007, J ANTIMICROB CHEMOTH, V59, P329, DOI [10.1093/jac/dk1484, 10.1093/jac/dkl484]; Moriel DG, 2008, HUM VACCINES, V4, P184, DOI 10.4161/hv.4.3.6313; OPS, 2012, INF REG SIREVA 2 DAT; OPS, 2011, INF REG SIREVA 2 DAT; Panatto D, 2011, EXPERT REV VACCINES, V10, P1337, DOI [10.1586/ERV.11.103, 10.1586/erv.11.103]; Pereira CS, 2008, J MED MICROBIOL, V57, P338, DOI 10.1099/jmm.0.47631-0; Racloz VN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-175; Rainbow J., 2008, Morbidity and Mortality Weekly Report, V57, P173; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Salisbury D, 2001, J Paediatr Child Health, V37, pS34, DOI 10.1046/j.1440-1754.2001.00738.x; Salisbury D, 2001, J PAEDIATR CHILD H, V37, P37; Singhal S, 2007, EMERG INFECT DIS, V13, P1614, DOI 10.3201/eid1310.060820; Skoczynska A, 2008, EMERG INFECT DIS, V14, P1322, DOI 10.3201/eid1408.080040; Sorhouet Pereira C, 2009, NATL SURVEILLANCE AN; Stephens DS, 2007, FEMS MICROBIOL REV, V31, P3, DOI 10.1111/j.1574-6976.2006.00051.x; Taha MK, 2004, J CLIN MICROBIOL, V42, P4158, DOI 10.1128/JCM.42.9.4158-4163.2004; Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Trotter CL, 2007, FEMS MICROBIOL REV, V31, P27, DOI 10.1111/j.1574-6976.2006.00060.x; Urwin R, 2004, INFECT IMMUN, V72, P5955, DOI 10.1128/IAI.72.10.5955-5962.2004; Vazquez JA, 2003, ANTIMICROB AGENTS CH, V47, P3430, DOI 10.1128/AAC.47.11.3430-3434.2003; Vogel U, 2004, J CLIN MICROBIOL, V42, P2898, DOI 10.1128/JCM.42.7.2898-2901.2004; Weidlich L, 2008, J INFECTION, V57, P324, DOI 10.1016/j.jinf.2008.07.014; Wu HM, 2009, NEW ENGL J MED, V360, P886, DOI 10.1056/NEJMoa0806414	48	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58065	10.1371/journal.pone.0058065	http://dx.doi.org/10.1371/journal.pone.0058065			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483970	gold, Green Published			2022-12-27	WOS:000315634900067
J	Voskarides, K; Demosthenous, P; Papazachariou, L; Arsali, M; Athanasiou, Y; Zavros, M; Stylianou, K; Xydakis, D; Daphnis, E; Gale, DP; Maxwell, PH; Elia, A; Pattaro, C; Pierides, A; Deltas, C				Voskarides, Konstantinos; Demosthenous, Panayiota; Papazachariou, Louiza; Arsali, Maria; Athanasiou, Yiannis; Zavros, Michalis; Stylianou, Kostas; Xydakis, Dimitris; Daphnis, Eugenios; Gale, Daniel P.; Maxwell, Patrick H.; Elia, Avraam; Pattaro, Cristian; Pierides, Alkis; Deltas, Constantinos			Epistatic Role of the MYH9/APOL1 Region on Familial Hematuria Genes	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; BASEMENT-MEMBRANE NEPHROPATHY; CHRONIC KIDNEY-DISEASE; COL4A5 COLLAGEN GENE; ALPORT-SYNDROME; RENAL-FAILURE; EUROPEAN-AMERICANS; AFRICAN-AMERICANS; HEARING-LOSS; MUTATIONS	Familial hematuria (FH) is explained by at least four different genes (see below). About 50% of patients develop late proteinuria and chronic kidney disease (CKD). We hypothesized that MYH9/APOL1, two closely linked genes associated with CKD, may be associated with adverse progression in FH. Our study included 102 thin basement membrane nephropathy (TBMN) patients with three known COL4A3/COL4A4 mutations (cohort A), 83 CFHR5/C3 glomerulopathy patients (cohort B) with a single CFHR5 mutation and 15 Alport syndrome patients (cohort C) with two known COL4A5 mild mutations, who were categorized as "Mild'' (controls) or "Severe'' (cases), based on renal manifestations. E1 and S1 MYH9 haplotypes and variant rs11089788 were analyzed for association with disease phenotype. Evidence for association with "Severe'' progression in CFHR5 nephropathy was found with MYH9 variant rs11089788 and was confirmed in an independent FH cohort, D (cumulative p value = 0.001, odds ratio = 3.06, recessive model). No association was found with APOL1 gene. Quantitative Real time PCR did not reveal any functional significance for the rs11089788 risk allele. Our results derive additional evidence supporting previous reports according to which MYH9 is an important gene per se, predisposing to CKD, suggesting its usefulness as a prognostic marker for young hematuric patients.	[Voskarides, Konstantinos; Demosthenous, Panayiota; Papazachariou, Louiza; Deltas, Constantinos] Univ Cyprus, Mol Med Res Ctr, Nicosia, Cyprus; [Voskarides, Konstantinos; Demosthenous, Panayiota; Papazachariou, Louiza; Deltas, Constantinos] Univ Cyprus, Lab Mol & Med Genet, Dept Biol Sci, Nicosia, Cyprus; [Arsali, Maria; Athanasiou, Yiannis; Zavros, Michalis] Nicosia Gen Hosp, Dept Nephrol, Nicosia, Cyprus; [Stylianou, Kostas; Xydakis, Dimitris; Daphnis, Eugenios] Univ Crete, Dept Nephrol, Iraklion, Greece; [Gale, Daniel P.] UCL, Ctr Nephrol, London, England; [Maxwell, Patrick H.] UCL, Div Med, London, England; [Elia, Avraam] Archbishop Makarios III Hosp, Dept Pediat, Nicosia, Cyprus; [Pattaro, Cristian] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Pattaro, Cristian] Med Univ Lubeck, D-23538 Lubeck, Germany; [Pierides, Alkis] Hippocrateon Hosp, Dept Nephrol, Nicosia, Cyprus	University of Cyprus; University of Cyprus; University of Crete; University of London; University College London; University of London; University College London; European Academy of Bozen-Bolzano; University of Lubeck; Hippocrateon Private Hospital	Deltas, C (corresponding author), Univ Cyprus, Mol Med Res Ctr, Nicosia, Cyprus.	Deltas@ucy.ac.cy	Gale, Daniel/D-5594-2013; Stylianou, Konstantinos/H-2806-2019; Voskarides, Konstantinos/A-4669-2013; Deltas, Constantinos/J-9345-2013; Maxwell, Patrick H/C-5557-2008; Deltas, Constantinos/A-4936-2013; Stylianou, Konstantinos/C-5868-2009	Gale, Daniel/0000-0002-9170-1579; Stylianou, Konstantinos/0000-0003-3678-9421; Voskarides, Konstantinos/0000-0002-3705-3451; Deltas, Constantinos/0000-0001-5549-9169; Maxwell, Patrick H/0000-0002-0338-2679; Deltas, Constantinos/0000-0001-5549-9169; Stylianou, Konstantinos/0000-0003-3678-9421; Pattaro, Cristian/0000-0002-4119-0109	Cyprus Research Promotion Foundation [PiENEK ENISigmaX/0505/02, PENEK/ENISigmaX/0308/08, NEW INFRASTRUCTURE/STRATEGIC/0308/24]; EU; University of Cyprus [3/311, 3/346]; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish; Wellcome Trust [096956/Z/11/Z] Funding Source: researchfish	Cyprus Research Promotion Foundation; EU(European Commission); University of Cyprus; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported from the Cyprus Research Promotion Foundation grants: Pi ENEK ENI Sigma X/0505/02, PENEK/ENI Sigma X/0308/08, NEW INFRASTRUCTURE/STRATEGIC/0308/24 (co-funding by the EU Structural Funds) and from the University of Cyprus articles 3/311 and 3/346, to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KL, 2002, AM J PATHOL, V160, P721, DOI 10.1016/S0002-9440(10)64892-4; Athanasiou Y, 2011, CLIN J AM SOC NEPHRO, V6, P1436, DOI 10.2215/CJN.09541010; Badenas C, 2002, J AM SOC NEPHROL, V13, P1248, DOI 10.1681/ASN.V1351248; Barker DF, 1996, AM J HUM GENET, V58, P1157; BARKER DF, 1990, SCIENCE, V248, P1224, DOI 10.1126/science.2349482; Behar DM, 2010, HUM MOL GENET, V19, P1816, DOI 10.1093/hmg/ddq040; Beirowski B, 2006, J AM SOC NEPHROL, V17, P1986, DOI 10.1681/ASN.2005101044; Buzza M, 2001, KIDNEY INT, V60, P480, DOI 10.1046/j.1523-1755.2001.060002480.x; Chen Y, 2001, Zhonghua Nei Ke Za Zhi, V40, P239; Cheng WR, 2011, NEPHROL DIAL TRANSPL, V26, P2544, DOI 10.1093/ndt/gfq768; Cooke JN, 2012, NEPHROL DIAL TRANSPL, V27, P1505, DOI 10.1093/ndt/gfr522; Deltas C, 2012, PEDIATR NEPHROL, V27, P1221, DOI 10.1007/s00467-011-1935-5; Demosthenous P, 2012, CLIN GENET, V81, P240, DOI 10.1111/j.1399-0004.2011.01647.x; Gale DP, 2010, LANCET, V376, P794, DOI 10.1016/S0140-6736(10)60670-8; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kashtan CE, 2005, PEDIATR NEPHROL, V20, P1027, DOI 10.1007/s00467-005-1859-z; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lemmink HH, 1996, J CLIN INVEST, V98, P1114, DOI 10.1172/JCI118893; Liang SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018409; Martin P, 1998, J AM SOC NEPHROL, V9, P2291; Nelson GW, 2010, HUM MOL GENET, V19, P1805, DOI 10.1093/hmg/ddq039; O'Seaghdha CM, 2011, HUM MOL GENET, V20, P2450, DOI 10.1093/hmg/ddr118; Papagregoriou G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031021; Pattaro C, 2009, KIDNEY INT, V76, P297, DOI 10.1038/ki.2009.135; Pierides A, 2009, NEPHROL DIAL TRANSPL, V24, P2721, DOI 10.1093/ndt/gfp158; Slajpah M, 2007, KIDNEY INT, V71, P1287, DOI 10.1038/sj.ki.5002221; Tonna S, 2008, PEDIATR NEPHROL, V23, P2201, DOI 10.1007/s00467-008-0934-7; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Voskarides K, 2008, CONNECT TISSUE RES, V49, P283, DOI 10.1080/03008200802148280; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; Voskarides K, 2012, PEDIATR NEPHROL, V27, P675, DOI 10.1007/s00467-011-2084-6; Wilson JC, 2007, NEPHROL DIAL TRANSPL, V22, P1338, DOI 10.1093/ndt/gfl793	33	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e57925	10.1371/journal.pone.0057925	http://dx.doi.org/10.1371/journal.pone.0057925			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516419	Green Published, Green Submitted, gold			2022-12-27	WOS:000316407400013
J	Andreo, U; Guo, L; Chirieac, DV; Tuyama, AC; Montenont, E; Brodsky, JL; Fisher, EA				Andreo, Ursula; Guo, Liang; Chirieac, Doru V.; Tuyama, Ana C.; Montenont, Emilie; Brodsky, Jeffrey L.; Fisher, Edward A.			Insulin-Stimulated Degradation of Apolipoprotein B100: Roles of Class II Phosphatidylinositol-3-Kinase and Autophagy	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; APO-B; QUALITY-CONTROL; MESSENGER-RNA; APOPROTEIN-B; FATTY-ACIDS; SECRETION; LIPOPROTEIN; INHIBITION; TRANSPORT	Both in humans and animal models, an acute increase in plasma insulin levels, typically following meals, leads to transient depression of hepatic secretion of very low density lipoproteins (VLDL). One contributing mechanism for the decrease in VLDL secretion is enhanced degradation of apolipoprotein B100 (apoB100), which is required for VLDL formation. Unlike the degradation of nascent apoB100, which occurs in the endoplasmic reticulum (ER), insulin-stimulated apoB100 degradation occurs post-ER and is inhibited by pan-phosphatidylinositol (PI)3-kinase inhibitors. It is unclear, however, which of the three classes of PI3-kinases is required for insulin-stimulated apoB100 degradation, as well as the proteolytic machinery underlying this response. Class III PI3-kinase is not activated by insulin, but the other two classes are. By using a class I-specific inhibitor and siRNA to the major class II isoform in liver, we now show that it is class II PI3-kinase that is required for insulin-stimulated apoB100 degradation in primary mouse hepatocytes. Because the insulin-stimulated process resembles other examples of apoB100 post-ER proteolysis mediated by autophagy, we hypothesized that the effects of insulin in autophagy-deficient mouse primary hepatocytes would be attenuated. Indeed, apoB100 degradation in response to insulin was significantly impaired in two types of autophagy-deficient hepatocytes. Together, our data demonstrate that insulin-stimulated apoB100 degradation in the liver requires both class II PI3-kinase activity and autophagy.	[Andreo, Ursula; Guo, Liang; Chirieac, Doru V.; Tuyama, Ana C.; Montenont, Emilie; Fisher, Edward A.] NYU, Sch Med, Dept Med Cardiol, New York, NY 10003 USA; [Andreo, Ursula; Guo, Liang; Chirieac, Doru V.; Tuyama, Ana C.; Montenont, Emilie; Fisher, Edward A.] NYU, Sch Med, Marc & Ruti Bell Program Vasc Biol, New York, NY USA; [Andreo, Ursula; Guo, Liang; Chirieac, Doru V.; Tuyama, Ana C.; Montenont, Emilie; Fisher, Edward A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Tuyama, Ana C.] Rockefeller Univ, Lab Biochem Genet & Metab, New York, NY 10021 USA; [Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	New York University; New York University; New York University; Rockefeller University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Fisher, EA (corresponding author), NYU, Sch Med, Dept Med Cardiol, New York, NY 10003 USA.	edward.fisher@nyumc.org	Fisher, Edward/ABE-7469-2020	Guo, Liang/0000-0003-1633-1544; Fisher, Edward/0000-0001-9802-143X	NIH grant [HL58541]; American Heart Association post-doctoral fellowship [0825883D]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058541] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association post-doctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH grant HL58541 and American Heart Association post-doctoral fellowship 0825883D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au CS, 2004, METABOLISM, V53, P228, DOI 10.1016/j.metabol.2003.09.011; BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394; BOSTROM K, 1986, J BIOL CHEM, V261, P3800; Brodsky JL, 2008, TRENDS ENDOCRIN MET, V19, P254, DOI 10.1016/j.tem.2008.07.002; Brodsky JL, 2011, CURR OPIN CELL BIOL, V23, P464, DOI 10.1016/j.ceb.2011.05.004; Brown AM, 2001, ARTERIOSCL THROM VAS, V21, P1656, DOI 10.1161/hq1001.096640; Burman C, 2010, FEBS LETT, V584, P1302, DOI 10.1016/j.febslet.2010.01.011; Chan DC, 2004, CLIN SCI, V107, P233, DOI 10.1042/CS20040109; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Chirieac DV, 2006, AM J PHYSIOL-GASTR L, V291, pG382, DOI 10.1152/ajpgi.00472.2005; Chirieac DV, 2000, AM J PHYSIOL-ENDOC M, V279, pE1003, DOI 10.1152/ajpendo.2000.279.5.E1003; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Fisher EA, 2001, J BIOL CHEM, V276, P27855, DOI 10.1074/jbc.M008885200; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hirano K, 1996, J BIOL CHEM, V271, P9887, DOI 10.1074/jbc.271.17.9887; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine DM, 1997, CLIN CHEM, V43, P669; LEWIS GF, 1995, J CLIN INVEST, V95, P158, DOI 10.1172/JCI117633; LEWIS GF, 1993, DIABETES, V42, P833, DOI 10.2337/diabetes.42.6.833; Misawa H, 1998, BIOCHEM BIOPH RES CO, V244, P531, DOI 10.1006/bbrc.1998.8294; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Ono F, 1998, J BIOL CHEM, V273, P7731, DOI 10.1074/jbc.273.13.7731; Pan MH, 2008, P NATL ACAD SCI USA, V105, P5862, DOI 10.1073/pnas.0707460104; Pan MH, 2004, J CLIN INVEST, V113, P1277, DOI 10.1172/JCI200419197; Phung TL, 1997, J BIOL CHEM, V272, P30693, DOI 10.1074/jbc.272.49.30693; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Qiu W, 2011, HEPATOLOGY, V53, P1515, DOI 10.1002/hep.24269; Rozycka M, 1998, GENOMICS, V54, P569, DOI 10.1006/geno.1998.5621; Sparks JD, 1996, BIOCHEM J, V313, P567, DOI 10.1042/bj3130567; SPARKS JD, 1990, J BIOL CHEM, V265, P8854; St-Pierre AC, 2006, AM J CARDIOL, V97, P997, DOI 10.1016/j.amjcard.2005.10.060; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; WANG HX, 1993, J CLIN INVEST, V91, P1380, DOI 10.1172/JCI116340; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zhong SM, 2010, J BIOL CHEM, V285, P6453, DOI 10.1074/jbc.M109.060467	44	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57590	10.1371/journal.pone.0057590	http://dx.doi.org/10.1371/journal.pone.0057590			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516411	Green Accepted, Green Published, gold			2022-12-27	WOS:000316849200013
J	Liu, CH; Jiang, D; Cheng, YJ; Deng, XX; Chen, F; Fang, L; Ma, ZC; Xu, J				Liu, Cuihua; Jiang, Dong; Cheng, Yunjiang; Deng, Xiuxin; Chen, Feng; Fang, Liu; Ma, Zhaocheng; Xu, Juan			Chemotaxonomic Study of Citrus, Poncirus and Fortunella Genotypes Based on Peel Oil Volatile Compounds - Deciphering the Genetic Origin of Mangshanyegan (Citrus nobilis Lauriro)	PLOS ONE			English	Article							DIFFERENTIAL ANALYSIS; DIVERSITY; METABOLOMICS; MANDARINS; MARKERS; NUCLEAR	Volatile profiles yielded from gas chromatography-mass spectrometry (GC-MS) analysis provide abundant information not only for metabolism-related research, but also for chemotaxonomy. To study the chemotaxonomy of Mangshanyegan, its volatile profiles of fruit and leaf and those of 29 other genotypes of Citrus, Poncirus, and Fortunella were subjected to phylogenetic analyses. Results showed that 145 identified (including 64 tentatively identified) and 15 unidentified volatile compounds were detected from their peel oils. The phylogenetic analysis of peel oils based on hierarchical cluster analysis (HCA) demonstrated a good agreement with the Swingle taxonomy system, in which the three genera of Citrus, Poncirus, and Fortunella were almost completely separated. As to Citrus, HCA indicated that Citrophorum, Cephalocitrus, and Sinocitrus fell into three subgroups, respectively. Also, it revealed that Mangshanyegan contain volatile compounds similar to those from pummelo, though it is genetically believed to be a mandarin. These results were further supported by the principal component analysis of the peel oils and the HCA results of volatile profiles of leaves in the study.	[Liu, Cuihua; Cheng, Yunjiang; Deng, Xiuxin; Fang, Liu; Ma, Zhaocheng; Xu, Juan] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Key Lab Hort Plant Biol, Minist Educ,Coll Hort & Forestry, Wuhan, Peoples R China; [Jiang, Dong] Chinese Acad Agr Sci, Citrus Res Inst, Chongqing, Peoples R China; [Chen, Feng] Clemson Univ, Dept Food Nutr & Packaging Sci, Clemson, SC USA	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Clemson University	Xu, J (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Key Lab Hort Plant Biol, Minist Educ,Coll Hort & Forestry, Wuhan, Peoples R China.	xujuan@mail.hzau.edu.cn	cheng, yunjiang/B-1199-2015; cheng, yj/G-4049-2011	cheng, yunjiang/0000-0002-9159-9455; cheng, yj/0000-0002-9159-9455; Xiuxin, Deng/0000-0003-4490-4514	National Basic Research Program of China [2011CB100600]; National Natural Science Foundation of China [31272122]; Fundamental Research Funds for the Central Universities [2012MBDX006]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was financially supported by the National Basic Research Program of China (grant 2011CB100600), the National Natural Science Foundation of China (grant 31272122), and The Fundamental Research Funds for the Central Universities (grant 2012MBDX006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis KA, 2011, METABOLOMICS; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; Barkley NA, 2006, THEOR APPL GENET, V112, P1519, DOI 10.1007/s00122-006-0255-9; Biswas MK, 2012, MOL BIOL REP, V39, P5373, DOI 10.1007/s11033-011-1338-5; Biswas MK, 2011, SCI HORTIC-AMSTERDAM, V129, P798, DOI 10.1016/j.scienta.2011.06.015; Gonzalez-Mas MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022016; Chen ML, 1987, P NAT C FRUIT CROP R; Cheng YJ, 2005, TREE PHYSIOL, V25, P661, DOI 10.1093/treephys/25.6.661; Deng XX, 2000, ACTA HORTIC, P99, DOI 10.17660/ActaHortic.2000.535.10; Fang DQ, 1998, J AM SOC HORTIC SCI, V123, P612, DOI 10.21273/JASHS.123.4.612; Fowler C, 2004, ANNU REV ENV RESOUR, V29, P143, DOI 10.1146/annurev.energy.29.062403.102203; Fraga BM, 2012, PHYTOCHEMISTRY, V76, P7, DOI 10.1016/j.phytochem.2012.01.018; GREEN RM, 1986, THEOR APPL GENET, V72, P170, DOI 10.1007/BF00266989; HANDA T, 1986, JPN J GENET, V61, P15, DOI 10.1266/jjg.61.15; Herrero R, 1996, THEOR APPL GENET, V93, P1327, DOI 10.1007/BF00223466; HIRAI M, 1987, JPN J BREED, V37, P377; Hou YS, 2011, FRONT ENVIRON SCI EN, V5, P84, DOI 10.1007/s11783-010-0283-1; Katajamaa M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-179; KESTERSON J. W., 1964, PROC AMER SOC HORT SCI, V84, P199; Li R.T., 2009, GUANGDONG AGR SCI, V8, P11; Li RC, 2012, PLANT SYST EVOL, V298, P731, DOI 10.1007/s00606-011-0584-2; Li RT, 2000, HUNAN AGR SCI, V5, P30; Li WB, 1993, HUNAN AGR SCI, V3, P3; Li WB, 1992, P INT SOC CITRICULTU, V1, P217; Li YZ, 2006, J HORTIC SCI BIOTECH, V81, P371, DOI 10.1080/14620316.2006.11512075; LIN Z-K, 1992, Acta Botanica Sinica, V34, P133; Liu CH, 2012, FOOD SCI BIOTECHNOL, V21, P531, DOI 10.1007/s10068-012-0068-3; Liu CH, 2012, J AGR FOOD CHEM, V60, P2617, DOI 10.1021/jf2039197; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Luedemann A, 2008, BIOINFORMATICS, V24, P732, DOI 10.1093/bioinformatics/btn023; Luro F, 2012, PHYTOCHEMISTRY, V77, P186, DOI 10.1016/j.phytochem.2011.12.013; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Merle H, 2004, BIOCHEM SYST ECOL, V32, P491, DOI 10.1016/j.bse.2003.09.010; Moore GA, 2001, TRENDS GENET, V17, P536, DOI 10.1016/S0168-9525(01)02442-8; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; Nicolosi E, 2000, THEOR APPL GENET, V100, P1155, DOI 10.1007/s001220051419; Pang Xiao-Ming, 2003, Acta Genetica Sinica, V30, P81; PIERINGER A. P., 1964, PROC AMER SOC HORT SCI, V84, P204; Radulovic N, 2012, CHEM BIODIVERS, V9, P106, DOI 10.1002/cbdv.201100204; Schmidt MR, 2006, RISK ANAL, V26, P455, DOI 10.1111/j.1539-6924.2006.00744.x; SCORA RW, 1975, B TORREY BOT CLUB, V102, P369, DOI 10.2307/2484763; Skogerson K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-321; Swingle WT., 1943, CITRUS IND, P128; Tanaka T., 1977, STUD CITROG, V14, P1; Tanaka T, 1954, REV AURANTIACEARUM, P1; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Wayman KA, 2010, PHYTOCHEMISTRY, V71, P766, DOI 10.1016/j.phytochem.2010.01.017; Yamamoto M, 2003, EUPHYTICA, V129, P267, DOI 10.1023/A:1022284908424	50	25	25	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58411	10.1371/journal.pone.0058411	http://dx.doi.org/10.1371/journal.pone.0058411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516475	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200066
J	Mori, H; Nakayama, T				Mori, Hiroko; Nakayama, Takeo			Academic Impact of Qualitative Studies in Healthcare: Bibliometric Analysis	PLOS ONE			English	Article							PUBLICATION BIAS; CITATION; MEDICINE; TRIALS	Context: Although qualitative studies are becoming more appreciated in healthcare, the number of publications of quality studies remains low. Little is known about the frequency and characteristics of citation in qualitative studies. Objective: To compare the academic impact of qualitative studies to that of two quantitative studies: systematic reviews and randomized controlled trials. Methods: Publications in BMJ between 1997 and 2006 (BMJ's median impact factor was 7.04 during this period) employing qualitative methods were matched to two quantitative studies appearing the same year using PubMed. Using Web of Science, citations within a 24-month publication period were determined. Additionally, three hypotheses were examined: qualitative studies are 1) infrequently cited in original articles or reviews; 2) rarely cited by authors in non-English-speaking countries; and 3) more frequently cited in non-medical disciplines (e. g., psychology or sociology). Results: A total of 121 qualitative studies, 270 systematic reviews, and 515 randomised controlled trials were retrieved. Qualitative studies were cited a total of 1,089 times, with a median of 7.00 times (range, 0-34) for each study. Matched systematic reviews and randomized controlled trials were cited 2,411times and 1,600 times, respectively. With respect to citing documents, original articles and reviews exceeded 60% for each study design. Relative to quantitative studies, qualitative studies were cited more often by authors in English-speaking countries. With respect to subject area, medical disciplines were more frequently cited than non-medical disciplines for all three study designs (>80%). Conclusion: The median number of citations for qualitative studies was almost the same as the median of BMJ's impact factor during the survey period. For a suitable evaluation of qualitative studies in healthcare, it will be necessary to develop a reporting framework and include explicit discussions of clinical implications when reporting findings. Coordination between researchers and editors will be needed to achieve this goal.	[Mori, Hiroko; Nakayama, Takeo] Kyoto Univ, Dept Hlth Informat, Sch Publ Hlth, Kyoto, Japan; [Mori, Hiroko] Tsuda Coll, Dept Int & Cultural Studies, Kodaira, Tokyo, Japan	Kyoto University	Mori, H (corresponding author), Kyoto Univ, Dept Hlth Informat, Sch Publ Hlth, Kyoto, Japan.	hmori-kyt@umin.ac.jp	NAKAYAMA, Takeo/HCH-0537-2022	Nakayama, Takeo/0000-0002-7918-6252	"The 3rd-term Comprehensive 10-year Strategy for Cancer Control-general-042" by the Ministry of Health, Labour and Welfare, Japan	"The 3rd-term Comprehensive 10-year Strategy for Cancer Control-general-042" by the Ministry of Health, Labour and Welfare, Japan	This study was partly supported by "The 2010 3rd-term Comprehensive 10-year Strategy for Cancer Control-general-042" by the Ministry of Health, Labour and Welfare, Japan (http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin-koubo20/09.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aksnes DW, 2009, RES POLICY, V38, P895, DOI 10.1016/j.respol.2009.02.001; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bhandari M, 2007, CAN J SURG, V50, P119; Borreani C., 2004, HEALTH QUAL LIFE OUT, V22, P2; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; CAMPBELL FM, 1990, B MED LIBR ASSOC, V78, P376; Dickersin K, 2002, JAMA-J AM MED ASSOC, V287, P2772, DOI 10.1001/jama.287.21.2772; Dingwall R, 1998, J Health Serv Res Policy, V3, P167; Flick U., 1998, INTRO QUALITATIVE RE; Garfield E, 1996, BRIT MED J, V313, P411, DOI 10.1136/bmj.313.7054.411; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; Kuper A, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a288; MacRoberts MH, 1996, SCIENTOMETRICS, V36, P435, DOI 10.1007/BF02129604; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Moed HF, 2009, ARCH IMMUNOL THER EX, V57, P13, DOI 10.1007/s00005-009-0001-5; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Mori H, 2012, PSYCHO-ONCOLOGY, V21, P666, DOI 10.1002/pon.1964; Nieminen Pentti, 2006, BMC Med Res Methodol, V6, P42, DOI 10.1186/1471-2288-6-42; Owens C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5801; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Patsopoulos NA, 2006, BMJ-BRIT MED J, V332, P1061, DOI 10.1136/bmj.38768.420139.80; Petticrew M, 2008, J EPIDEMIOL COMMUN H, V62, P552, DOI 10.1136/jech.2006.059394; Shuval K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016937; Straus E., 2011, EVIDENCE BACED MED P; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Weightman AL, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1083; Yamazaki H, 2009, BIOSCI TRENDS, V3, P202	28	16	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57371	10.1371/journal.pone.0057371	http://dx.doi.org/10.1371/journal.pone.0057371			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516404	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200010
J	Otero-Millan, J; Schneider, R; Leigh, RJ; Macknik, SL; Martinez-Conde, S				Otero-Millan, Jorge; Schneider, Rosalyn; Leigh, R. John; Macknik, Stephen L.; Martinez-Conde, Susana			Saccades during Attempted Fixation in Parkinsonian Disorders and Recessive Ataxia: From Microsaccades to Square-Wave Jerks	PLOS ONE			English	Article							CAUDAL FASTIGIAL NUCLEUS; SUPERIOR COLLICULUS; OMNIPAUSE NEURONS; EYE-MOVEMENTS; MUSCIMOL INACTIVATION; GAZE SHIFTS; ABNORMALITIES; INTRUSIONS; GENERATION; PALLIDOTOMY	During attempted visual fixation, saccades of a range of sizes occur. These "fixational saccades'' include microsaccades, which are not apparent in regular clinical tests, and "saccadic intrusions'', predominantly horizontal saccades that interrupt accurate fixation. Square-wave jerks (SWJs), the most common type of saccadic intrusion, consist of an initial saccade away from the target followed, after a short delay, by a "return saccade'' that brings the eye back onto target. SWJs are present in most human subjects, but are prominent by their increased frequency and size in certain parkinsonian disorders and in recessive, hereditary spinocerebellar ataxias. Here we asked whether fixational saccades showed distinctive features in various parkinsonian disorders and in recessive ataxia. Although some saccadic properties differed between patient groups, in all conditions larger saccades were more likely to form SWJs, and the intervals between the first and second saccade of SWJs were similar. These findings support the proposal of a common oculomotor mechanism that generates all fixational saccades, including microsaccades and SWJs. The same mechanism also explains how the return saccade in SWJs is triggered by the position error that occurs when the first saccadic component is large, both in the healthy brain and in neurological disease.	[Otero-Millan, Jorge; Macknik, Stephen L.; Martinez-Conde, Susana] Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA; [Otero-Millan, Jorge] Univ Vigo, Dept Signal Theory & Commun, Vigo 36310, Spain; [Schneider, Rosalyn; Leigh, R. John] Case Western Reserve Univ, Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Macknik, Stephen L.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA	Barrow Neurological Institute; Universidade de Vigo; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Barrow Neurological Institute	Martinez-Conde, S (corresponding author), Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ 85013 USA.	smart@neuralcorrelate.com	Macknik, Stephen L./H-7704-2019; Otero-Millan, Jorge/A-4193-2014; Otero-Millan, Jorge/A-9863-2010	Macknik, Stephen L./0000-0002-3143-9230; Otero-Millan, Jorge/0000-0002-9789-8392; 	Barrow Neurological Foundation; Arizona Biomedical Research Commission; National Science Foundation [0643306, 0852636, 1153786]; NIH [EY06717]; Office of Research and Development, Medical Research Service, Department of Veterans Affairs; Evenor Armington Fund; NATIONAL EYE INSTITUTE [R01EY006717] Funding Source: NIH RePORTER	Barrow Neurological Foundation; Arizona Biomedical Research Commission; National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); Evenor Armington Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the following funding agencies: Barrow Neurological Foundation (to SLM and SMC), Arizona Biomedical Research Commission (to SMC), National Science Foundation (awards 0643306, 0852636 and 1153786 to SMC), NIH (grant EY06717 to RJL), the Office of Research and Development, Medical Research Service, Department of Veterans Affairs (to RJL), and the Evenor Armington Fund (to RJL). Jorge Otero-Millan was a Fellow of the Pedro Barrie de la Maza Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadi R, 2004, VISION RES, V44, P2675, DOI 10.1016/j.visres.2004.05.009; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Averbuch-Heller L, 1999, NEUROLOGY, V52, P185, DOI 10.1212/WNL.52.1.185; BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Bergeron A, 2002, J NEUROPHYSIOL, V88, P1726, DOI 10.1152/jn.2002.88.4.1726; Bergeron A, 2001, PROG BRAIN RES, V134, P97; Bhidayasiri R, 2001, NEUROLOGY, V57, P2070, DOI 10.1212/WNL.57.11.2070; Boeve BF, 1999, NEUROLOGY, V53, P795, DOI 10.1212/WNL.53.4.795; Boxer AL, 2012, ARCH NEUROL-CHICAGO, V69, P509, DOI 10.1001/archneurol.2011.1021; Buttner-Ennever JA, 1999, J COMP NEUROL, V413, P55, DOI 10.1002/(SICI)1096-9861(19991011)413:1<55::AID-CNE3>3.0.CO;2-K; Chan F, 2005, NEUROPSYCHOLOGIA, V43, P784, DOI 10.1016/j.neuropsychologia.2004.06.026; Chen Athena L, 2010, Front Neurol, V1, P147, DOI 10.3389/fneur.2010.00147; CORNSWEET TN, 1956, J OPT SOC AM, V46, P987, DOI 10.1364/JOSA.46.000987; Cui J, 2009, VISION RES, V49, P228, DOI 10.1016/j.visres.2008.10.015; Cullen KE, 1997, J NEUROPHYSIOL, V78, P3259, DOI 10.1152/jn.1997.78.6.3259; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Engbert R, 2006, PROG BRAIN RES, V154, P177, DOI 10.1016/S0079-6123(06)54009-9; EVINGER C, 1982, J NEUROPHYSIOL, V47, P827, DOI 10.1152/jn.1982.47.5.827; EVINGER C, 1991, INVEST OPHTH VIS SCI, V32, P387; Fahey MC, 2008, BRAIN, V131, P1035, DOI 10.1093/brain/awm323; Gandhi NJ, 1997, J NEUROPHYSIOL, V78, P2221, DOI 10.1152/jn.1997.78.4.2221; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Goffart L, 2004, J NEUROPHYSIOL, V92, P3351, DOI 10.1152/jn.01199.2003; Goffart L, 1998, J NEUROPHYSIOL, V79, P1942, DOI 10.1152/jn.1998.79.4.1942; Gowen E, 2007, BRAIN RES, V1141, P154, DOI 10.1016/j.brainres.2007.01.047; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; KAPOULA ZA, 1986, EXP BRAIN RES, V61, P386; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; Martinez-Conde S, 2007, SCI AM, V297, P56, DOI 10.1038/scientificamerican0807-56; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; McCamy MB, 2012, J NEUROSCI, V32, P9194, DOI 10.1523/JNEUROSCI.0515-12.2012; McLachlan GJ, 2005, DISCRIMINANT ANAL ST, pi; Moller F, 2002, GRAEF ARCH CLIN EXP, V240, P765, DOI 10.1007/s00417-002-0519-2; Moschovakis AK, 1998, J NEUROSCI, V18, P10219; O'Sullivan JD, 2003, J CLIN NEUROSCI, V10, P181, DOI 10.1016/S0967-5868(02)00125-X; Otero-Millan J, 2011, ANN NY ACAD SCI, V1233, P107, DOI 10.1111/j.1749-6632.2011.06177.x; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Pinkhardt EH, 2011, PARKINSONISM RELAT D, V17, P223, DOI 10.1016/j.parkreldis.2010.08.004; Pinnock RA, 2010, J NEUROL, V257, P533, DOI 10.1007/s00415-009-5356-3; Ramat S, 1999, INVEST OPHTH VIS SCI, V40, P1681; RASCOL O, 1991, J NEUROL NEUROSUR PS, V54, P599, DOI 10.1136/jnnp.54.7.599; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROBINSON FR, 1993, J NEUROPHYSIOL, V70, P1741, DOI 10.1152/jn.1993.70.5.1741; Rolfs M, 2008, J VISION, V8, DOI 10.1167/8.11.5; Serra A, 2008, NEUROLOGY, V70, P810, DOI 10.1212/01.wnl.0000286952.01476.eb; Shinoda Y, 2011, ANN NY ACAD SCI, V1233, P100, DOI 10.1111/j.1749-6632.2011.06171.x; Sparks D, 2000, VISION RES, V40, P2763, DOI 10.1016/S0042-6989(00)00133-4; Swartz BE, 2003, ANN NEUROL, V54, P824, DOI 10.1002/ana.10758; Troncoso XG, 2005, PERCEPTION, V34, P409, DOI 10.1068/p5383; Troncoso XG, 2008, P NATL ACAD SCI USA, V105, P16033, DOI 10.1073/pnas.0709389105; Troncoso XG, 2008, J VISION, V8, DOI 10.1167/8.14.15; Watanabe M, 2011, EUR J NEUROSCI, V33, P2070, DOI 10.1111/j.1460-9568.2011.07691.x; WEBER H, 1989, J HIRNFORSCH, V30, P603	61	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58535	10.1371/journal.pone.0058535	http://dx.doi.org/10.1371/journal.pone.0058535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516502	Green Submitted, Green Published, gold			2022-12-27	WOS:000316849200082
J	Kent, R; Levanoni, O; Banker, E; Pe'er, G; Kark, S				Kent, Rafi; Levanoni, Oded; Banker, Eran; Pe'er, Guy; Kark, Salit			Comparing the Response of Birds and Butterflies to Vegetation-Based Mountain Ecotones Using Boundary Detection Approaches	PLOS ONE			English	Article							ELEVATIONAL GRADIENTS; DIVERSITY; LANDSCAPE; RICHNESS; TURNOVER	Mountains provide an opportunity to examine changes in biodiversity across environmental gradients and areas of transition (ecotones). Mountain ecotones separate vegetation belts. Here, we aimed to examine whether transition areas for birds and butterflies spatially correspond with ecotones between three previously described altitudinal vegetation belts on Mt. Hermon, northern Israel. These include the Mediterranean Maquis, xero-montane open forest and Tragacanthic mountain steppe vegetation belts. We sampled the abundance of bird and butterfly species in 34 sampling locations along an elevational gradient between 500 and 2200 m. We applied wombling, a boundary-detection technique, which detects rapid changes in a continuous variable, in order to locate the transition areas for bird and butterfly communities and compare the location of these areas with the location of vegetation belts as described in earlier studies of Mt. Hermon. We found some correspondence between the areas of transition of both bird and butterfly communities and the ecotones between vegetation belts. For birds and butterflies, important transitions occurred at the lower vegetation ecotone between Mediterranean maquis and the xero-montane open forest vegetation belts, and between the xero-montane open forest and the mountain steppe Tragacanthic belts. While patterns of species turnover with elevation were similar for birds and butterflies, the change in species richness and diversity with elevation differed substantially between the two taxa. Birds and butterflies responded quite similarly to the elevational gradient and to the shift between vegetation belts in terms of species turnover rates. While the mechanisms generating these patterns may differ, the resulting areas of peak turnover in species show correspondence among three different taxa (plants, birds and butterflies).	[Kent, Rafi; Levanoni, Oded; Banker, Eran; Pe'er, Guy; Kark, Salit] Hebrew Univ Jerusalem, Dept Ecol Evolut & Behav, Biodivers Res Grp, Jerusalem, Israel; [Kark, Salit] Univ Queensland, ARC Ctr Excellence Environm Decis, Sch Biol Sci, Brisbane, Qld, Australia	Hebrew University of Jerusalem; University of Queensland	Kent, R (corresponding author), Technion Israel Inst Technol, Dept Civil & Environm Engn, Haifa, Israel.	rkent@technion.ac.il	Kark, Salit/C-6795-2016; Kark, Salit/I-7123-2013	Kark, Salit/0000-0002-7183-3988; Kark, Salit/0000-0002-7183-3988; Levanoni, Oded/0000-0003-0257-8693	Israel Science Foundation [740/04]; Raymond and Jenine Bollag post-doctoral fellowship at the Hebrew University of Jerusalem	Israel Science Foundation(Israel Science Foundation); Raymond and Jenine Bollag post-doctoral fellowship at the Hebrew University of Jerusalem	This research was supported by the Israel Science Foundation (grant no. 740/04 to SK). GP was partly supported by a Raymond and Jenine Bollag post-doctoral fellowship at the Hebrew University of Jerusalem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERBACH M, 1993, J ECOL, V81, P25, DOI 10.2307/2261221; Benyamini D, 2002, FIELD GUIDE BUTTERFL; BioMedware, 2001, BOUNDARYSEER 1 0; Blair RB, 1999, ECOL APPL, V9, P164, DOI 10.1890/1051-0761(1999)009[0164:BABAAU]2.0.CO;2; Blake JG, 2000, AUK, V117, P663, DOI 10.1642/0004-8038(2000)117[0663:DOBAAE]2.0.CO;2; Boggs CL, 1997, GLOBAL ECOL BIOGEOGR, V6, P39, DOI 10.2307/2997525; Cavieres LA, 2000, REV CHIL HIST NAT, V73, P331; CODY ML, 1981, BIOSCIENCE, V31, P107, DOI 10.2307/1308252; Colwell RK, 2006, ESTIMATES ESTIMATION; Debinski DM, 2000, ENVIRON MONIT ASSESS, V64, P213, DOI 10.1023/A:1006432030089; Dennis RLH, 2004, ECOL ENTOMOL, V29, P12, DOI 10.1111/j.1365-2311.2004.00572.x; DOWNEY JC, 1962, SYST ZOOL, V11, P150, DOI 10.2307/2411462; Fitzpatrick MC, 2010, ECOLOGY, V91, P3448, DOI 10.1890/10-0807.1; Fleishman E, 1998, ECOLOGY, V79, P2482, DOI 10.1890/0012-9658(1998)079[2482:AETORS]2.0.CO;2; Fortin MJ, 1997, CAN J FOREST RES, V27, P1851, DOI 10.1139/cjfr-27-11-1851; Fortin MJ, 2000, LANDSCAPE ECOL, V15, P453, DOI 10.1023/A:1008194205292; Gehrig-Fasel J, 2007, J VEG SCI, V18, P571, DOI 10.1111/j.1654-1103.2007.tb02571.x; Grace J, 2002, ANN BOT-LONDON, V90, P537, DOI 10.1093/aob/mcf222; Holtmeier FK, 2005, GLOBAL ECOL BIOGEOGR, V14, P395, DOI 10.1111/j.1466-822x.2005.00168.x; Kark S., 2007, ENCY BIODIVERSITY; Kark S, 2007, GLOBAL ECOLOGY BIOGE, V15; Kark S, 2006, ISR J ECOL EVOL, V52, P29, DOI 10.1560/IJEE.52.1.29; Kent M, 1997, PROG PHYS GEOG, V21, P315, DOI 10.1177/030913339702100301; KITAYAMA K, 1992, VEGETATIO, V102, P149, DOI 10.1007/BF00044731; Krementz D. G., 1995, USDA FOREST SERVICE, DOI [10.2307/3802161, DOI 10.2307/3802161]; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Levanoni O, 2011, ECOGRAPHY, V34, P372, DOI 10.1111/j.1600-0587.2010.06460.x; Levin N, 2007, DIVERS DISTRIB, V13, P692, DOI 10.1111/j.1472-4642.2007.00372.x; Levin SA, 2000, ECOSYSTEMS, V3, P498, DOI 10.1007/s100210000044; Ma HJ, 2007, BAYESIAN ANAL, V2, P281, DOI 10.1214/07-BA211; Mac Nally R, 2004, J BIOGEOGR, V31, P917, DOI 10.1111/j.1365-2699.2004.01089.x; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Mena JL, 2005, GLOBAL ECOL BIOGEOGR, V14, P539, DOI 10.1111/j.1466-822x.2005.00189.x; ODUM E P, 1971, P574; Pe'er G, 2004, ANIM BEHAV, V68, P825, DOI 10.1016/j.anbehav.2004.02.006; RISSER PG, 1995, BIOSCIENCE, V45, P318, DOI 10.2307/1312492; Sanchez-Rodriguez J. F., 1995, Journal of the Lepidopterists' Society, V49, P192; SHIELDS O, 1967, Journal of Research on the Lepidoptera, V6, P69; SHMIDA A, 1977, THESIS HEBREW U JERU; Shmida A, 1980, MT HERMON NATURE LAN; TERBORGH J, 1970, ECOLOGY, V52, P23; van Rensburg BJ, 2009, DIVERS DISTRIB, V15, P379, DOI 10.1111/j.1472-4642.2008.00545.x	44	4	4	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58229	10.1371/journal.pone.0058229	http://dx.doi.org/10.1371/journal.pone.0058229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505472	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100038
J	Amaro, SM; Golub, JE; Nuovo, GJ; Cunha, CB; Levi, JE; Villa, LL; Andrade, CV; Russomano, FB; Tristao, A; Pires, A; Nicol, AF				Amaro-Filho, Sergio M.; Golub, Jonathan E.; Nuovo, Gerard J.; Cunha, Cynthia B.; Levi, Jose E.; Villa, Luisa L.; Andrade, Cecilia V.; Russomano, Fabio B.; Tristao, Aparecida; Pires, Andrea; Nicol, Alcina F.			A Comparative Analysis of Clinical and Molecular Factors with the Stage of Cervical Cancer in a Brazilian Cohort	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; P16(INK4A) EXPRESSION; COMPUTED-TOMOGRAPHY; CYCLE REGULATORS; HPV; P53; MARKER; KI-67	Cell cycle protein expression plays an important role in the pathophysiology of cervical cancer. However, few studies have attempted to correlate the use of these biomarkers with the clinical progression of the tumor. Objectives: 1) To analyze the expression of Ki-67, p53 and p16(INK4a) in cervical cancer, 2) to correlate the relative expression of these proteins as well as clinical parameters with the stage of disease, and 3) to determine the HPV DNA prevalence and subtype distribution. Methods: Tissue Micro-Arrays (TMA) from patients with invasive cervical cancer (ICC) and controls were analyzed. HPV DNA detection was done by PCR and in situ hybridization. Ki-67, p53 and p16(INK4a) were analyzed by immunohistochemistry; clinical data was derived from the chart review. Results: Advanced tumor stage (III and IV) was strongly associated (p<0.005) with advanced age (>55 years old), with more than four pregnancies and with the lack of formal education. HPV DNA was found in 94.3% of cases with the most prevalent types being HPV16 (67.5%), followed by HPV33 (12.0%) and HPV35 (3.6%). High expression of Ki-67 and p16 was more common in the advanced FIGO stages (p = 0.023). Women with HPV16 tended to be younger (50.9 years; SE 1.9) compared to women with other types (59.9 years; SE 2.8). Conclusion: We found that Ki-67 and p16 expression were independently associated with the tumor stage. We also noted that about 1/3 of the cervical cancers in this Brazilian cohort were not associated with HPV types directly targeted by the current HPV vaccines.	[Amaro-Filho, Sergio M.; Nicol, Alcina F.] Fiocruz MS, IOC, Lab Interdisciplinary Med Res LIPMED, BR-21045900 Rio De Janeiro, Brazil; [Golub, Jonathan E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol Infect Dis, Baltimore, MD USA; [Nuovo, Gerard J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Cunha, Cynthia B.] Fiocruz MS, IPEC, Evandro Chagas Clin Res Inst, Dept Infect Dis, BR-21045900 Rio De Janeiro, Brazil; [Levi, Jose E.] Univ Sao Paulo, Virol Lab, Inst Trop Med, BR-09500900 Sao Paulo, Brazil; [Villa, Luisa L.] Hosp Alemao Oswaldo Cruz, Ludwig Inst Canc Res, Sao Paulo, Brazil; [Andrade, Cecilia V.; Russomano, Fabio B.; Tristao, Aparecida] Fiocruz MS, Fernandes Figueira Inst, BR-21045900 Rio De Janeiro, Brazil; [Pires, Andrea] Fonte Med Diagnost Lab, Niteroi, RJ, Brazil; [Pires, Andrea] Univ Fed Fluminense, Niteroi, RJ, Brazil	Fundacao Oswaldo Cruz; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Ludwig Institute for Cancer Research; Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Nicol, AF (corresponding author), Fiocruz MS, IOC, Lab Interdisciplinary Med Res LIPMED, BR-21045900 Rio De Janeiro, Brazil.	nicol@ioc.fiocruz.br	VILLA, LUISA/AAH-4761-2019; Papilomavirus, Inct/I-2406-2013; Andrade, Cecilia V/B-5916-2017; USP, Oncologia/F-9053-2014	VILLA, LUISA/0000-0003-4074-2335; Andrade, Cecilia V/0000-0001-7980-4367; Amaro-Filho, Sergio/0000-0002-7374-4081	Fogarty International Center, National Institutes of Health (NIH) [2 D 43 TW000010-23-AITRP]; LIPMED-IOCFiocruz, RJ, Brazil; Lewis Foundation (from Dr Gerard J Nuovo Laboratory); FOGARTY INTERNATIONAL CENTER [D43TW000010] Funding Source: NIH RePORTER	Fogarty International Center, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); LIPMED-IOCFiocruz, RJ, Brazil; Lewis Foundation (from Dr Gerard J Nuovo Laboratory); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Grant Support: AFN and SAF were scholars in the International AIDS Research and Training Program, supported by the Fogarty International Center, National Institutes of Health (NIH) Research Grant 2 D 43 TW000010-23-AITRP. This work was supported in part by grants from LIPMED-IOCFiocruz, RJ, Brazil, and the Lewis Foundation (from Dr Gerard J Nuovo Laboratory). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta E, 2009, ROM J MORPHOL EMBRYO, V50, P413; Angeletti PC, 2008, ADV PHARMACOL, V56, P509, DOI 10.1016/S1054-3589(07)56016-3; Bahnassy AA, 2007, BMC CLIN PATHOL, V7, DOI 10.1186/1472-6890-7-4; Bidus MA, 2007, CERVICAL VAGINAL CAN; BUCHWALD C, 1995, LARYNGOSCOPE, V105, P66, DOI 10.1288/00005537-199501000-00015; Cheah PL, 2012, ASIAN PAC J CANCER P, V13, P469, DOI 10.7314/APJCP.2012.13.2.469; Conesa-Zamora P, 2009, AM J CLIN PATHOL, V132, P378, DOI 10.1309/AJCPO0WY1VIFCYDC; Pires ARC, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-14; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; DRYJA TP, 1986, AM J HUM GENET, V38, P59; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; FUJITA M, 1992, CANCER RES, V52, P5323; Funk JO, 1997, GENE DEV, V11, P2090, DOI 10.1101/gad.11.16.2090; Galgano MT, 2010, AM J SURG PATHOL, V34, P1077, DOI 10.1097/PAS.0b013e3181e8b2c4; Giarnieri E, 2000, CLIN CANCER RES, V6, P3600; Giarre M, 2001, J VIROL, V75, P4705, DOI 10.1128/JVI.75.10.4705-4712.2001; Goel MM, 2005, DIAGN CYTOPATHOL, V33, P15, DOI 10.1002/dc.20218; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Gupta N, 2010, DIAGN CYTOPATHOL, V38, P618, DOI 10.1002/dc.21270; Hampl M, 2007, J CANCER RES CLIN, V133, P235, DOI 10.1007/s00432-006-0162-0; Harima Y, 2002, INT J RADIAT ONCOL, V52, P1345, DOI 10.1016/S0360-3016(01)02796-1; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kalof AN, 2006, ADV ANAT PATHOL, V13, P190, DOI 10.1097/00125480-200607000-00006; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Ku JL, 1997, INT J CANCER, V72, P313, DOI 10.1002/(SICI)1097-0215(19970717)72:2<313::AID-IJC19>3.0.CO;2-G; Kuo KT, 2006, BRIT J OPHTHALMOL, V90, P894, DOI 10.1136/bjo.2005.086314; Mimica M, 2010, INT J GYNECOL CANCER, V20, P116, DOI 10.1111/IGC.0b013e3181bc8da7; Munger K, 2002, VIRUS RES, V89, P213, DOI 10.1016/S0168-1702(02)00190-9; Nicol AF, 2012, MEM I OSWALDO CRUZ, V107, P571, DOI 10.1590/S0074-02762012000500001; Nicol AF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-289; Oka K, 2000, CANCER, V88, P2766, DOI 10.1002/1097-0142(20000615)88:12<2766::AID-CNCR15>3.0.CO;2-G; OMIM, LI FRAUM SYNDR; Otto TD, 2008, GENET MOL RES, V7, P861, DOI 10.4238/vol7-3X-Meeting04; Queiroz C, 2006, PATHOL RES PRACT, V202, P77, DOI 10.1016/j.prp.2005.08.012; Rajaram S, 2010, J CANCER RES THER, V6, P267, DOI 10.4103/0973-1482.73342; Rajkumar T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-80; Skomedal H, 1999, GYNECOL ONCOL, V73, P223, DOI 10.1006/gyno.1999.5346; SUBAK LL, 1995, OBSTET GYNECOL, V86, P43, DOI 10.1016/0029-7844(95)00109-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan GC, 2008, ASIAN PAC J CANCER P, V9, P781; Tjalma WA, 2001, EUR J OBSTET GYN R B, V97, P223, DOI 10.1016/S0301-2115(00)00541-8; Tsuda H, 2003, GYNECOL ONCOL, V91, P476, DOI 10.1016/j.ygyno.2003.08.019; Volgareva G, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-58	46	11	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57810	10.1371/journal.pone.0057810	http://dx.doi.org/10.1371/journal.pone.0057810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505442	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500034
J	Bartis, D; Csongei, V; Weich, A; Kiss, E; Barko, S; Kovacs, T; Avdicevic, M; D'Souza, VK; Rapp, J; Kvell, K; Jakab, L; Nyitrai, M; Molnar, TF; Thickett, DR; Laszlo, T; Pongracz, JE				Bartis, Domokos; Csongei, Veronika; Weich, Alexander; Kiss, Edit; Barko, Szilvia; Kovacs, Tamas; Avdicevic, Monika; D'Souza, Vijay K.; Rapp, Judit; Kvell, Krisztian; Jakab, Laszlo; Nyitrai, Miklos; Molnar, Tamas F.; Thickett, David R.; Laszlo, Terezia; Pongracz, Judit E.			Down-Regulation of Canonical and Up-Regulation of Non-Canonical Wnt Signalling in the Carcinogenic Process of Squamous Cell Lung Carcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BETA-CATENIN; CANCER; EXPRESSION; PATHWAY; GENE; INHIBITION; ACTIVATION; PROMOTER; ADHESION	The majority of lung cancers (LC) belong to the non-small cell lung carcinoma (NSCLC) type. The two main NSCLC sub-types, namely adenocarcinoma (AC) and squamous cell carcinoma (SCC), respond differently to therapy. Whereas the link between cigarette smoke and lung cancer risk is well established, the relevance of non-canonical Wnt pathway up-regulation detected in SCC remains poorly understood. The present study was undertaken to investigate further the molecular events in canonical and non-canonical Wnt signalling during SCC development. A total of 20 SCC and AC samples with matched non-cancerous controls were obtained after surgery. TaqMan array analysis confirmed up-regulation of non-canonical Wnt5a and Wnt11 and identified down-regulation of canonical Wnt signalling in SCC samples. The molecular changes were tested in primary small airway epithelial cells (SAEC) and various lung cancer cell lines (e. g. A549, H157, etc). Our studies identified Wnt11 and Wnt5a as regulators of cadherin expression and potentiated relocation of beta-catenin to the nucleus as an important step in decreased cellular adhesion. The presented data identifies additional details in the regulation of SCC that can aid identification of therapeutic drug targets in the future.	[Bartis, Domokos; Csongei, Veronika; Weich, Alexander; Kiss, Edit; Kovacs, Tamas; Avdicevic, Monika; Rapp, Judit; Kvell, Krisztian; Pongracz, Judit E.] Univ Pecs, Sch Med, Inst Immunol & Biotechnol, Dept Med Biotechnol, Pecs, Hungary; [Bartis, Domokos; D'Souza, Vijay K.; Nyitrai, Miklos; Thickett, David R.] Univ Birmingham, Sch Med, Dept Med, Birmingham, W Midlands, England; [Barko, Szilvia] Univ Pecs, Sch Med, Dept Biophys, Pecs, Hungary; [Jakab, Laszlo; Molnar, Tamas F.] Univ Pecs, Sch Med, Dept Surg, Pecs, Hungary; [Laszlo, Terezia] Univ Pecs, Sch Med, Dept Pathol, Pecs, Hungary; [Csongei, Veronika; Kiss, Edit; Kovacs, Tamas; Rapp, Judit; Kvell, Krisztian; Nyitrai, Miklos; Pongracz, Judit E.] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Birmingham; University of Pecs; University of Pecs; University of Pecs; University of Pecs	Pongracz, JE (corresponding author), Univ Pecs, Sch Med, Inst Immunol & Biotechnol, Dept Med Biotechnol, Pecs, Hungary.	judit.e.pongracz@aok.pte.hu	Pongracz, Judit E/N-7927-2018; Bartis, Domokos/C-7763-2016; Pongracz, Judit E/J-7517-2019	Pongracz, Judit E/0000-0002-0278-5556; Bartis, Domokos/0000-0003-2301-3704; Pongracz, Judit E/0000-0002-0278-5556; Weich, Alexander/0000-0002-4127-1347; thickett, david/0000-0002-5456-6080; Kvell MD PhD dr. habil., Krisztian/0000-0001-8609-6274; D'Souza, Vijay/0000-0002-9402-7516; Nyitrai, Miklos/0000-0002-6229-4337	Tarsadalmi Megujulas Operativ Program; Tarsadalmi Infrastruktura Operativ Program [TIOP 1.3.1-07/1-2F-2008-0002]; MAG Zrt-NKTH(NFU)-OTKA(Magyar Gazdasagfejlesztesi Kozpont Zrt-Nemzeti Kutatastamogatasi Hivatal (Nemzeti Fejlesztesi Ugynokseg)-Orszagos Tudomanyos Kutatasi Alapprogramok Iroda or Hungarian Scientific Research Fund [K-OTKA_67807_ A_O7 -2-2012-0093328]; K-OTKA [34039/KA-OTKA/11-02];  [TAMOP-4.2.1.B-10/2/KONV-2010-0002]	Tarsadalmi Megujulas Operativ Program; Tarsadalmi Infrastruktura Operativ Program; MAG Zrt-NKTH(NFU)-OTKA(Magyar Gazdasagfejlesztesi Kozpont Zrt-Nemzeti Kutatastamogatasi Hivatal (Nemzeti Fejlesztesi Ugynokseg)-Orszagos Tudomanyos Kutatasi Alapprogramok Iroda or Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); K-OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); 	This work was supported by the TAMOP-4.2.1.B-10/2/KONV-2010-0002; (Tarsadalmi Megujulas Operativ Program); TIOP 1.3.1-07/1-2F-2008-0002 (Tarsadalmi Infrastruktura Operativ Program); K-OTKA_67807_ A_O7 -2-2012-0093328 (MAG Zrt-NKTH(NFU)-OTKA(Magyar Gazdasagfejlesztesi Kozpont Zrt-Nemzeti Kutatastamogatasi Hivatal (Nemzeti Fejlesztesi Ugynokseg)-Orszagos Tudomanyos Kutatasi Alapprogramok Iroda or Hungarian Scientific Research Fund) all to JEP and by the K-OTKA grant 34039/KA-OTKA/11-02 to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiri G, 2009, ONCOGENE, V28, P2163, DOI 10.1038/onc.2009.82; Arnsdorf EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005388; Blanco D, 2004, LAB INVEST, V84, P999, DOI 10.1038/labinvest.3700129; Bovia F, 2003, BLOOD, V101, P1727, DOI 10.1182/blood-2001-12-0249; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Brambilla E, 2001, EUR RESPIR J, V18, P1059, DOI 10.1183/09031936.01.00275301; Brandon C, 2000, BLOOD, V96, P4132, DOI 10.1182/blood.V96.13.4132.h8004132_4132_4141; Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Danielson KG, 1995, J BIOL CHEM, V270, P31225, DOI 10.1074/jbc.270.52.31225; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025807; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Iioka H, 2007, NAT CELL BIOL, V9, P813, DOI 10.1038/ncb1607; Kang Moon-Il, 2012, Genes Cancer, V3, P37, DOI 10.1177/1947601912448820; Kawakami Y, 2000, DEV GROWTH DIFFER, V42, P561; Kawasaki A, 2007, CELL SIGNAL, V19, P2498, DOI 10.1016/j.cellsig.2007.07.023; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Lee AY, 2004, ONCOGENE, V23, P6672, DOI 10.1038/sj.onc.1207881; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nozaki I, 2001, INT J ONCOL, V19, P117; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Pourreyron C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031827; Shu WG, 2002, DEVELOPMENT, V129, P4831; Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9; Taki M, 2003, CANCER SCI, V94, P593, DOI 10.1111/j.1349-7006.2003.tb01488.x; Tichelaar JW, 2010, CANCER PREV RES, V3, P1148, DOI 10.1158/1940-6207.CAPR-10-0023; Ueda M, 2001, BRIT J CANCER, V85, P64, DOI 10.1054/bjoc.2001.1863; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Weidenfeld J, 2002, J BIOL CHEM, V277, P21061, DOI 10.1074/jbc.M111702200; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Yuan G, 2013, ONCOGENE, V32, P375, DOI 10.1038/onc.2012.40	41	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57393	10.1371/journal.pone.0057393	http://dx.doi.org/10.1371/journal.pone.0057393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505429	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500021
J	Caceres, NE; Aerts, M; Marquez, B; Mingeot-Leclercq, MP; Tulkens, PM; Devreese, B; Van Bambeke, F				Caceres, Nancy E.; Aerts, Maarten; Marquez, Beatrice; Mingeot-Leclercq, Marie-Paule; Tulkens, Paul M.; Devreese, Bart; Van Bambeke, Francoise			Analysis of the Membrane Proteome of Ciprofloxacin-Resistant Macrophages by Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC)	PLOS ONE			English	Article							NF-KAPPA-B; PHOSPHOLIPID-BINDING PROTEINS; GROWTH-FACTOR RECEPTOR; PROSTATE-CANCER; ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; MULTIDRUG-RESISTANT; EFFLUX TRANSPORTER; PREVENTS APOPTOSIS; J774 MACROPHAGES	Overexpression of multidrug transporters is a well-established mechanism of resistance to chemotherapy, but other changes may be co-selected upon exposure to drugs that contribute to resistance. Using a model of J774 macrophages made resistant to the fluoroquinolone antibiotic ciprofloxacin and comparing it with the wild-type parent cell line, we performed a quantitative proteomic analysis using the stable isotope labeling with amino acids in cell culture technology coupled with liquid chromatography electrospray ionization Fourier transform tandem mass spectrometry (LC-ESI-FT-MS/MS) on 2 samples enriched in membrane proteins (fractions F1 and F2 collected from discontinuous sucrose gradient). Nine hundred proteins were identified with at least 3 unique peptides in these 2 pooled fractions among which 61 (F1) and 69 (F2) showed a significantly modified abundance among the 2 cell lines. The multidrug resistance associated protein Abcc4, known as the ciprofloxacin efflux transporter in these cells, was the most upregulated, together with Dnajc3, a protein encoded by a gene located downstream of Abcc4. The other modulated proteins are involved in transport functions, cell adhesion and cytoskeleton organization, immune response, signal transduction, and metabolism. This indicates that the antibiotic ciprofloxacin is able to trigger a pleiotropic adaptative response in macrophages that includes the overexpression of its efflux transporter.	[Caceres, Nancy E.; Marquez, Beatrice; Mingeot-Leclercq, Marie-Paule; Tulkens, Paul M.; Van Bambeke, Francoise] Catholic Univ Louvain, Louvain Drug Res Inst, B-1200 Brussels, Belgium; [Aerts, Maarten; Devreese, Bart] Univ Ghent, Lab Eiwitbiochem & Biomol Engn, Ghent, Belgium	Universite Catholique Louvain; Ghent University	Devreese, B (corresponding author), Univ Ghent, Lab Eiwitbiochem & Biomol Engn, Ghent, Belgium.	bart.devreese@ugent.be; francoise.vanbambeke@uclouvain.be	Devreese, Bart/K-2841-2019; Devreese, Bart/B-2011-2009; Van Bambeke, Françoise/H-5934-2019; Aerts, Maarten/O-6194-2014; Tulkens, Paul/B-2087-2015	Devreese, Bart/0000-0002-9764-2581; Devreese, Bart/0000-0002-9764-2581; Van Bambeke, Françoise/0000-0002-0052-7991; Aerts, Maarten/0000-0003-0125-6721; Tulkens, Paul/0000-0002-7121-3623	Belgian Interuniversity Attraction Poles (Interuniversitaire Attractiepolen/Poles d'attraction interuniversitaires) [P6/19]; IWT-Flanders (SBO) [B/06921/01]; Fonds de la Recherche Scientifique Medicale (FRSM) [3.4.597.06, 3.4.583.08]; French Association Mucoviscidose: ABCF	Belgian Interuniversity Attraction Poles (Interuniversitaire Attractiepolen/Poles d'attraction interuniversitaires); IWT-Flanders (SBO); Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); French Association Mucoviscidose: ABCF	NEC and BM were respectively post-doctoral fellows of the Fonds de la Recherche Scientifique (F.R.S-FNRS) and of the Region Wallonne (programme FIRST post-doc). FVB is Maitre de recherches of the F.R.S.-FNRS. This work was supported by the Belgian Interuniversity Attraction Poles (Interuniversitaire Attractiepolen/Poles d'attraction interuniversitaires) Research project P6/19 [research action P6]), IWT-Flanders (SBO project B/06921/01), the Fonds de la Recherche Scientifique Medicale (FRSM; grants no. 3.4.597.06 and 3.4.583.08) and a grant from the French Association Mucoviscidose: ABCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagri A, 2009, CLIN CANCER RES, V15, P1860, DOI 10.1158/1078-0432.CCR-08-0563; Bakos E, 1998, J BIOL CHEM, V273, P32167, DOI 10.1074/jbc.273.48.32167; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; Bernatchez PN, 2009, AM J PHYSIOL-CELL PH, V297, pC484, DOI 10.1152/ajpcell.00498.2008; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Biswas G, 2008, J BIOL CHEM, V283, P12586, DOI 10.1074/jbc.M710481200; Borst P, 2007, CELL CYCLE, V6, P2782, DOI 10.4161/cc.6.22.4936; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Chavez JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019892; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Conacci -Sorrell M, 2005, CANCER RES, V65, P11605, DOI 10.1158/0008-5472.CAN-05-2647; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Cormont M, 2001, P NATL ACAD SCI USA, V98, P1637, DOI 10.1073/pnas.031586998; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Dupressoir A, 1997, ONCOGENE, V14, P2951, DOI 10.1038/sj.onc.1201148; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eriksson E, 2003, J LEUKOCYTE BIOL, V74, P456, DOI 10.1189/jlb.0103048; Garlanda C, 2009, TRENDS IMMUNOL, V30, P439, DOI 10.1016/j.it.2009.06.001; Gavert N, 2008, EXPERT OPIN BIOL TH, V8, P1749, DOI 10.1517/14712598.8.11.1749 ; Girard M, 2005, J BIOL CHEM, V280, P40135, DOI 10.1074/jbc.M505036200; Girard M, 2008, FEBS LETT, V582, P961, DOI 10.1016/j.febslet.2008.02.042; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hinz M, 2001, BLOOD, V97, P2798, DOI 10.1182/blood.V97.9.2798; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Hu SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-30; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutton JJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-82; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Koochekpour S, 2005, GENE CHROMOSOME CANC, V44, P351, DOI 10.1002/gcc.20249; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Lee TJ, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-31; LEPAGE P, 1993, MOL CELL BIOL, V13, P7380, DOI 10.1128/MCB.13.12.7380; Lin HH, 1997, GENOMICS, V41, P301, DOI 10.1006/geno.1997.4674; Lin ST, 2012, J PROTEOMICS; Lin ZP, 2008, MOL PHARMACOL, V73, P243, DOI 10.1124/mol.107.039594; Liu C, 2003, CANCER RES, V63, P2957; Lucki NC, 2012, MOL ENDOCRINOL, V26, P228, DOI 10.1210/me.2011-1150; LUEDERS KK, 1993, MOL CELL BIOL, V13, P7439, DOI 10.1128/MCB.13.12.7439; Mari M, 2001, J BIOL CHEM, V276, P42501, DOI 10.1074/jbc.M104885200; Marquez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028368; Marquez B, 2009, ANTIMICROB AGENTS CH, V53, P2410, DOI 10.1128/AAC.01428-08; Matusan-Ilijas K, 2011, PATHOL RES PRACT, V207, P104, DOI 10.1016/j.prp.2010.11.004; Meyers JM, 2002, J BIOL CHEM, V277, P49003, DOI 10.1074/jbc.M205728200; Michot JM, 2006, ANTIMICROB AGENTS CH, V50, P1689, DOI 10.1128/AAC.50.5.1689-1695.2006; Michot JM, 2004, ANTIMICROB AGENTS CH, V48, P2673, DOI 10.1128/AAC.48.7.2673-2682.2004; Misasi R, 2001, FASEB J, V15, P467, DOI 10.1096/fj.00-0217com; Misasi R, 2004, EXP CELL RES, V298, P38, DOI 10.1016/j.yexcr.2004.04.011; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Naito M, 2008, PATHOL INT, V58, P143, DOI 10.1111/j.1440-1827.2007.02203.x; Nakamura K, 2001, BBA-GENE STRUCT EXPR, V1522, P53, DOI 10.1016/S0167-4781(01)00284-6; Novak N, 2008, DRUG NEWS PERSPECT, V21, P158, DOI 10.1358/dnp.2008.21.3.1203412; O'Connell K, 2012, PROTEOMICS, V12, P2115, DOI 10.1002/pmic.201100489; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Park JH, 2006, BBA-BIOMEMBRANES, V1758, P2133, DOI 10.1016/j.bbamem.2006.08.019; Parker PJ, 2004, BIOCHEM SOC T, V32, P893, DOI 10.1042/BST0320893; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Reid G, 2003, P NATL ACAD SCI USA, V100, P9244, DOI 10.1073/pnas.1033060100; Reidegeld KA, 2008, PROTEOMICS, V8, P1129, DOI 10.1002/pmic.200701073; RENARD C, 1987, ANTIMICROB AGENTS CH, V31, P410, DOI 10.1128/AAC.31.3.410; Riesbeck K, 1998, ANTIMICROB AGENTS CH, V42, P1923, DOI 10.1128/AAC.42.8.1923; Rius M, 2008, J PHARMACOL EXP THER, V324, P86, DOI 10.1124/jpet.107.131342; SANGO K, 1995, GENOMICS, V27, P362, DOI 10.1006/geno.1995.1058; Seo KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042960; Sierra JR, 2008, J EXP MED, V205, P1673, DOI 10.1084/jem.20072602; SPILSBURY K, 1995, BLOOD, V85, P1620, DOI 10.1182/blood.V85.6.1620.bloodjournal8561620; Tomsig JL, 2002, CELL MOL LIFE SCI, V59, P1467, DOI 10.1007/s00018-002-8522-7; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Tsou CL, 1998, J EXP MED, V188, P603, DOI 10.1084/jem.188.3.603; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Vanrobaeys F, 2005, J PROTEOME RES, V4, P2283, DOI 10.1021/pr050205c; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; White JM, 2003, CURR OPIN CELL BIOL, V15, P598, DOI 10.1016/j.ceb.2003.08.001; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; Zhou CH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3144	90	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58285	10.1371/journal.pone.0058285	http://dx.doi.org/10.1371/journal.pone.0058285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505477	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500063
J	Kalliokoski, O; Jacobsen, KR; Darusman, HS; Henriksen, T; Weimann, A; Poulsen, HE; Hau, J; Abelson, KSP				Kalliokoski, Otto; Jacobsen, Kirsten R.; Darusman, Huda S.; Henriksen, Trine; Weimann, Allan; Poulsen, Henrik E.; Hau, Jann; Abelson, Klas S. P.			Mice Do Not Habituate to Metabolism Cage Housing-A Three Week Study of Male BALB/c Mice	PLOS ONE			English	Article							CHRONIC MILD STRESS; CORTICOSTERONE EXCRETION; OXIDATIVE DAMAGE; LABORATORY RATS; FEMALE MICE; IN-VIVO; DEPRESSION; RESPONSES; URINE; BEHAVIOR	The metabolism cage is a barren, non-enriched, environment, combining a number of recognized environmental stressors. We investigated the ability of male BALB/c mice to acclimatize to this form of housing. For three weeks markers of acute and oxidative stress, as well as clinical signs of abnormality were monitored. Forced swim tests were conducted to determine whether the animals experienced behavioral despair and the serotonergic integrity was tested using an 8-OH-DPAT challenge. The metabolism cage housed mice excreted approximately tenfold higher amounts of corticosterone metabolites in feces throughout the study when compared to controls. Urinary biomarkers confirmed that these mice suffered from elevated levels of oxidative stress, and increased creatinine excretions indicated increased muscle catabolism. Changes in the core body temperature (stress-induced hyperthermia) and the fur state of the mice also indicated impaired well-being in the metabolism cage housed mice. However, monitoring body weight and feed intake was found misleading in assessing the wellbeing of mice over a longer time course, and the forced swim test was found poorly suited for studying chronic stress in mice in the present setup. In conclusion, the mice were found not to acclimatize to the metabolism cages whereby concern for animal welfare would dictate that mice should be housed in this way for as short periods as possible. The elevated degree of HPA axis activity, oxidative stress, and increased overall metabolism warrant caution when interpreting data obtained from metabolism cage housed mice, as their condition cannot be considered representative of a normal physiology.	[Kalliokoski, Otto; Jacobsen, Kirsten R.; Darusman, Huda S.; Hau, Jann; Abelson, Klas S. P.] Univ Copenhagen, Dept Expt Med, Copenhagen, Denmark; [Kalliokoski, Otto; Jacobsen, Kirsten R.; Darusman, Huda S.; Hau, Jann; Abelson, Klas S. P.] Univ Copenhagen Hosp, DK-2100 Copenhagen, Denmark; [Darusman, Huda S.] Bogor Agr Univ, Fac Vet Med, Dept Anat Physiol & Pharmacol, Bogor, Indonesia; [Henriksen, Trine; Weimann, Allan; Poulsen, Henrik E.] Rigshosp, Lab Clin Pharmacol, DK-2100 Copenhagen, Denmark; [Henriksen, Trine; Weimann, Allan; Poulsen, Henrik E.] Bispebjerg Hosp, Dept Clin Pharmacol, DK-2400 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Bogor Agricultural University; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Kalliokoski, O (corresponding author), Univ Copenhagen, Dept Expt Med, Copenhagen, Denmark.	otto.kalliokoski@gmail.com	Hau, Jann/C-8692-2012; Kalliokoski, Otto/I-3828-2019	Hau, Jann/0000-0001-8586-5705; Kalliokoski, Otto/0000-0001-6531-3487; Poulsen, Henrik Enghusen/0000-0003-4242-9924; Rosenmay Jacobsen, Kirsten/0000-0002-3211-7890	Danish Council for Strategic Research [09-066115]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	The present investigation was supported by a generous grant from the Danish Council for Strategic Research (http://en.fi.dk/councils-commissions/the-danish-council-for-strategic-research). Grant Journal no.: 09-066115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Baumans V., 2010, COST MANUAL LAB ANIM, P75; Bhatnagar S, 2006, J NEUROENDOCRINOL, V18, P13, DOI 10.1111/j.1365-2826.2005.01375.x; Bhatnagar S, 1998, NEUROSCIENCE, V84, P1025, DOI 10.1016/S0306-4522(97)00577-0; Broedbaek K, 2011, DIABETES CARE; CORNFIELD LJ, 1991, MOL PHARMACOL, V39, P780; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; CUPPLES LA, 1984, ANN INTERN MED, V100, P122, DOI 10.7326/0003-4819-100-1-122; David DJP, 2003, PSYCHOPHARMACOLOGY, V166, P373, DOI 10.1007/s00213-002-1335-4; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Eriksson E, 2004, EXP PHYSIOL, V89, P427, DOI 10.1113/expphysiol.2004.027656; Fawcett A, 2011, GUIDELINES IN PRESS, P22; Gaeggeler HP, 2005, J AM SOC NEPHROL, V16, P878, DOI 10.1681/ASN.2004121110; Gaskill BN, 2011, J THERM BIOL, V36, P193, DOI 10.1016/j.jtherbio.2011.02.004; Gaskill BN, 2009, APPL ANIM BEHAV SCI, V116, P279, DOI 10.1016/j.applanim.2008.10.002; Gil MC, 1999, CELL MOL NEUROBIOL, V19, P625, DOI 10.1023/A:1006984402291; Gilmore AJ, 2008, LAB ANIM-UK, V42, P140, DOI 10.1258/la.2007.06030e; GOMEZSANCHEZ EP, 1991, STEROIDS, V56, P451, DOI 10.1016/0039-128X(91)90035-T; Gordon CJ, 2004, COMPARATIVE MED, V54, P63; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Halliwell B, 2002, FREE RADICAL BIO MED, V32, P968, DOI 10.1016/S0891-5849(02)00808-0; Hau J, 2011, LAB ANIM-UK, V45, P129, DOI 10.1258/la.2010.010125; HENNESSY MB, 1977, PHYSIOL BEHAV, V18, P799, DOI 10.1016/0031-9384(77)90186-X; Henriksen T, 2009, FREE RADICAL BIO MED, V47, P629, DOI 10.1016/j.freeradbiomed.2009.06.002; Hoppe CC, 2009, PHYSIOL RES, V58, P69, DOI 10.33549/physiolres.931390; Ishida H, 2003, BIOL PHARM BULL, V26, P170, DOI 10.1248/bpb.26.170; Joergensen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020795; Kalliokoski O, 2012, IN VIVO, V26, P213; Kalliokoski O, 2010, GEN COMP ENDOCR, V168, P450, DOI 10.1016/j.ygcen.2010.06.003; Kong QM, 2010, CELL MOL LIFE SCI, V67, P1817, DOI 10.1007/s00018-010-0277-y; Kudoh A, 2003, ANESTH ANALG, V97, P275, DOI 10.1213/01.ANE.0000068821.29712.AC; Kurien BT, 2004, LAB ANIM-UK, V38, P333, DOI 10.1258/0023677041958945; Larauche M, 2010, STRESS, V13, P344, DOI 10.3109/10253891003664166; Liu JK, 1999, NEUROCHEM RES, V24, P1479, DOI 10.1023/A:1022597010078; Lunec J, 2002, FREE RADICAL BIO MED, V33, P875, DOI 10.1016/S0891-5849(02)00882-1; MANSER CE, 1995, LAB ANIM, V29, P353, DOI 10.1258/002367795780740023; Manser CE, 1996, LAB ANIM, V30, P1, DOI 10.1258/002367796780744974; Mineur YS, 2006, BEHAV BRAIN RES, V175, P43, DOI 10.1016/j.bbr.2006.07.029; Mineur YS, 2003, BEHAV GENET, V33, P513, DOI 10.1023/A:1025770616068; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; POLLACK GM, 1991, DRUG METAB DISPOS, V19, P130; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Ramos A, 1998, NEUROSCI BIOBEHAV R, V22, P33; REBUFFESCRIVE M, 1992, PHYSIOL BEHAV, V52, P583, DOI 10.1016/0031-9384(92)90351-2; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Sheridan J, 2009, BRIT J CANCER, V100, P381, DOI 10.1038/sj.bjc.6604821; Solich J, 2008, PHARMACOL REP, V60, P1008; Stechman MJ, 2010, LAB ANIM-UK, V44, P218, DOI 10.1258/la.2010.009128; Sun L, 2008, P NATL ACAD SCI USA, V105, P3339, DOI 10.1073/pnas.0800165105; Sundbom R, 2011, IN VIVO, V25, P335; Tabata H, 1998, LAB ANIM-UK, V32, P143, DOI 10.1258/002367798780599983; TULI JS, 1995, LAB ANIM, V29, P132, DOI 10.1258/002367795780740249; Van Reenen CG, 2005, PHYSIOL BEHAV, V85, P557, DOI 10.1016/j.physbeh.2005.06.015; Wang SH, 2009, PSYCHIAT RES, V170, P245, DOI 10.1016/j.psychres.2008.07.006; WEISS JM, 1981, BRAIN RES REV, V3, P167, DOI 10.1016/0165-0173(81)90005-9; Zethof TJJ, 1995, EUR J PHARMACOL, V294, P125, DOI 10.1016/0014-2999(95)00520-X; Zhu SW, 2006, BEHAV BRAIN RES, V169, P10, DOI 10.1016/j.bbr.2005.11.024	59	50	50	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58460	10.1371/journal.pone.0058460	http://dx.doi.org/10.1371/journal.pone.0058460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505511	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500087
J	Tori, K; Ishino, S; Kiyonari, S; Tahara, S; Ishino, Y				Tori, Kazuo; Ishino, Sonoko; Kiyonari, Shinichi; Tahara, Saki; Ishino, Yoshizumi			A Novel Single-Strand Specific 3 '-5 ' Exonuclease Found in the Hyperthermophilic Archaeon, Pyrococcus furiosus	PLOS ONE			English	Article							IONIZING-RADIATION; THERMOCOCCUS-KODAKARAENSIS; HOMOLOGOUS RECOMBINATION; ESCHERICHIA-COLI; DNA-REPLICATION; SULFOLOBUS-ACIDOCALDARIUS; GAMMA-IRRADIATION; MISMATCH REPAIR; MECHANISMS; MUTANT	Nucleases play important roles in all DNA transactions, including replication, repair, and recombination. Many different nucleases from bacterial and eukaryotic organisms have been identified and functionally characterized. However, our knowledge about the nucleases from Archaea, the third domain of life, is still limited. We searched for 3'-5' exonuclease activity in the hyperthermophilic archaeon, Pyrococcus furiosus, and identified a protein with the target activity. The purified protein, encoded by PF2046, is composed of 229 amino acids with a molecular weight of 25,596, and displayed single-strand specific 3'-5' exonuclease activity. The protein, designated as PfuExo I, forms a stable trimeric complex in solution and excises the DNA at every two nucleotides from the 3' to 5' direction. The amino acid sequence of this protein is conserved only in Thermococci, one of the hyperthermophilic classes in the Euryarchaeota subdomain in Archaea. The newly discovered exonuclease lacks similarity to any other proteins with known function, including hitherto reported 3'-5' exonucleases. This novel nuclease may be involved in a DNA repair pathway conserved in the living organisms as a specific member for some hyperthermophilic archaea.	[Ishino, Sonoko] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 812, Japan; Kyushu Univ, Fac Agr, Fukuoka 812, Japan	Kyushu University; Kyushu University	Ishino, S (corresponding author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Dept Biosci & Biotechnol, Fukuoka 812, Japan.	sonoko@agr.kyushu-u.ac.jp; ishino@agr.kyushu-u.ac.jp	Kiyonari, Shinichi/I-7329-2014	Ishino, Sonoko/0000-0002-1833-1735; Ishino, Yoshizumi/0000-0001-9419-0826	Ministry of Education, Culture, Sports, Science and Technology of Japan [21113005, 23310152]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan [grant numbers 21113005 and 23310152 to YI]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Cann IKO, 1999, GENETICS, V152, P1249; Capes MD, 2011, PLASMID, V65, P77, DOI 10.1016/j.plasmid.2010.11.005; Constantinesco F, 2002, EMBO REP, V3, P537, DOI 10.1093/embo-reports/kvf112; Crowley David J, 2006, Saline Syst, V2, P11, DOI 10.1186/1746-1448-2-11; DiRuggiero J, 1997, J BACTERIOL, V179, P4643, DOI 10.1128/jb.179.14.4643-4645.1997; Farkas JZ, 2012, J BIOL DYNAM, V6, P1, DOI 10.1080/17513758.2011.615464; Feschenko VV, 2003, P NATL ACAD SCI USA, V100, P1134, DOI 10.1073/pnas.0233122100; Fujikane R, 2010, GENES GENET SYST, V85, P243, DOI 10.1266/ggs.85.243; Grabowski B, 2003, ANNU REV MICROBIOL, V57, P487, DOI 10.1146/annurev.micro.57.030502.090709; Grogan DW, 2004, CURR ISSUES MOL BIOL, V6, P137; GROGAN DW, 1991, J BACTERIOL, V173, P7725, DOI 10.1128/jb.173.23.7725-7727.1991; HENNER WD, 1983, J BIOL CHEM, V258, P5198; HUTCHINSON F, 1985, PROG NUCLEIC ACID RE, V32, P115, DOI 10.1016/S0079-6603(08)60347-5; Ishino Y, 2006, CHEM REV, V106, P324, DOI 10.1021/cr0404803; Ishino Y, 2012, SCI CHINA, V189, P5652; Ishino Y, 2006, METHOD ENZYMOL, V11, P99; Jacobs KL, 1998, ARCH MICROBIOL, V169, P81; Kelman Z, 2005, CURR OPIN MICROBIOL, V8, P669, DOI 10.1016/j.mib.2005.10.001; Kish A, 2008, J BACTERIOL, V190, P5210, DOI 10.1128/JB.00292-08; Komori K, 2000, PROTEIN ENG, V13, P41, DOI 10.1093/protein/13.1.41; Komori K, 1999, P NATL ACAD SCI USA, V96, P8873, DOI 10.1073/pnas.96.16.8873; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Nishino T, 2006, CURR OPIN STRUC BIOL, V16, P60, DOI 10.1016/j.sbi.2006.01.009; Olsen GJ, 1997, CELL, V89, P991, DOI 10.1016/S0092-8674(00)80284-6; Quaiser A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-25; Rajman LA, 2000, J BACTERIOL, V182, P607, DOI 10.1128/JB.182.3.607-612.2000; Rouillon C, 2011, RES MICROBIOL, V162, P19, DOI 10.1016/j.resmic.2010.09.003; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sato T, 2005, APPL ENVIRON MICROB, V71, P3889, DOI 10.1128/AEM.71.7.3889-3899.2005; Sato T, 2003, J BACTERIOL, V185, P210, DOI 10.1128/JB.185.1.210-220.2003; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Uemori T, 1997, GENES CELLS, V2, P499, DOI 10.1046/j.1365-2443.1997.1380336.x; Viswanathan M, 1998, GENETICS, V149, P7; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Watrin L, 1996, CURR MICROBIOL, V33, P377, DOI 10.1007/s002849900131; Williams E, 2007, EXTREMOPHILES, V11, P19, DOI 10.1007/s00792-006-0002-9; Woods WG, 1997, MOL MICROBIOL, V23, P791, DOI 10.1046/j.1365-2958.1997.2651626.x; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zhang CY, 2010, MICROBIOL-SGM, V156, P3386, DOI 10.1099/mic.0.042523-0	44	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58497	10.1371/journal.pone.0058497	http://dx.doi.org/10.1371/journal.pone.0058497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505520	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500093
J	Valverde, JR; Mellado, RP				Valverde, Jose R.; Mellado, Rafael P.			Analysis of Metagenomic Data Containing High Biodiversity Levels	PLOS ONE			English	Article							RIBOSOMAL-RNA; MICROBIAL DIVERSITY; COMMUNITY; BLAST; GENERATION; BIOSPHERE; SEQUENCES; RESOURCE; SEARCH	In this paper we have addressed the problem of analysing Next Generation Sequencing samples with an expected large biodiversity content. We analysed several well-known 16S rRNA datasets from experimental samples, including both large and short sequences, in numbers of tens of thousands, in addition to carefully crafted synthetic datasets containing more than 7000 OTUs. From this data analysis several patterns were identified and used to develop new guidelines for experimentation in conditions of high biodiversity. We analysed the suitability of different clustering packages for these type of situations, the problem of even sampling, the relative effectiveness of Chao1 and ACE estimators as well as their effect on sampling size for a variety of population distributions. As regards practical analysis procedures, we advocated an approach that retains as much high-quality experimental data as possible. By carefully applying selection rules combining the taxonomic assignment with clustering strategies, we derived a set of recommendations for ultra-sequencing data analysis at high biodiversity levels.	[Valverde, Jose R.] CSIC, Ctr Nacl Biotecnol, Sci Comp Serv, Madrid, Spain; [Mellado, Rafael P.] CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Mellado, RP (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, C Darwin 3, Madrid, Spain.	rpmellado@cnb.csic.es	Mellado, Rafael P/D-2680-2009; Valverde, Jose R/K-8853-2014	Valverde, Jose R/0000-0002-6655-7114	Spanish Ministry of Agriculture, Food and Environment [EGO22008]; Spanish Research Council (CSIC) [200420E397]; CYTED [510RT0391]; EU [BM1006]	Spanish Ministry of Agriculture, Food and Environment; Spanish Research Council (CSIC); CYTED; EU(European Commission)	The authors wish to acknowledge the support provided by grant EGO22008 from the Spanish Ministry of Agriculture, Food and Environment for this research, as well as partial support from the Spanish Research Council (CSIC) PIE number 200420E397, and grants 510RT0391 (FreeBIT) from CYTED and BM1006 (SEQAHEAD) from the EU 7FP COST program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barriuso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035481; Barriuso J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-473; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Eells WC, 1926, J AM STAT ASSOC, V21, P119, DOI 10.2307/2277140; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Heidelberg KB, 2010, MICROB BIOTECHNOL, V3, P531, DOI 10.1111/j.1751-7915.2010.00193.x; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Krueger F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016607; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; R Core Team, 2018, R LANG ENV STAT COMP; Razgour O, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.49; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; TRUDEL L, 1986, CAN J MICROBIOL, V32, P673, DOI 10.1139/m86-124; VandePeer Y, 1996, NUCLEIC ACIDS RES, V24, P3381, DOI 10.1093/nar/24.17.3381; Wooley JC, 2010, J COMPUT SCI TECH-CH, V25, P71, DOI 10.1007/s11390-010-9306-4	41	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58118	10.1371/journal.pone.0058118	http://dx.doi.org/10.1371/journal.pone.0058118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505458	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500050
J	Hotomi, M; Togawa, A; Kono, M; Ikeda, Y; Takei, S; Hollingshead, SK; Briles, DE; Suzuki, K; Yamanaka, N				Hotomi, Muneki; Togawa, Akihisa; Kono, Masamitsu; Ikeda, Yorihiko; Takei, Shin; Hollingshead, Susan K.; Briles, David E.; Suzuki, Kenji; Yamanaka, Noboru			PspA Family Distribution, Antimicrobial Resistance and Serotype of Streptococcus pneumoniae Isolated from Upper Respiratory Tract Infections in Japan	PLOS ONE			English	Article							SURFACE PROTEIN-A; PNEUMOCOCCAL CONJUGATE VACCINE; ACUTE OTITIS-MEDIA; ANTIBIOTIC-RESISTANCE; GENETIC DIVERSITY; UNITED-STATES; ANTIBACTERIAL SUSCEPTIBILITY; NATIONWIDE SURVEILLANCE; ELICIT PROTECTION; HETEROLOGOUS PSPA	Background: The protection against pneumococcal infections provided by currently available pneumococcal polysaccharide conjugate vaccines are restricted to the limited number of the serotypes included in the vaccine. In the present study, we evaluated the distribution of the pneumococcal capsular type and surface protein A (PspA) family of pneumococcal isolates from upper respiratory tract infections in Japan. Methods: A total of 251 S. pneumoniae isolates from patients seeking treatment for upper respiratory tract infections were characterized for PspA family, antibiotic resistance and capsular type. Results: Among the 251 pneumococci studied, the majority (49.4%) was identified as belonging to PspA family 2, while most of the remaining isolates (44.6%) belonged to family 1. There were no significant differences between the distributions of PspA1 versus PspA2 isolates based on the age or gender of the patient, source of the isolates or the isolates' susceptibilities to penicillin G. In contrast, the frequency of the mefA gene presence and of serotypes 15B and 19F were statistically more common among PspA2 strains. Conclusion: The vast majority of pneumococci isolated from the middle ear fluids, nasal discharges/ sinus aspirates or pharyngeal secretions represented PspA families 1 and 2. Capsular serotypes were generally not exclusively associated with certain PspA families, although some capsular types showed a much higher proportion of either PspA1 or PspA2. A PspA-containing vaccine would potentially provide high coverage against pneumococcal infectious diseases because it would be cross-protective versus invasive disease with the majority of pneumococci infecting children and adults.	[Hotomi, Muneki; Togawa, Akihisa; Kono, Masamitsu; Ikeda, Yorihiko; Takei, Shin; Yamanaka, Noboru] Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan; [Hollingshead, Susan K.; Briles, David E.] Univ Birmingham Alabama, Dept Microbiol, Birmingham, AL USA; [Suzuki, Kenji] Fujita Hlth Univ, Sch Med, Hosp 2, Dept Otolaryngol, Toyoake, Aichi 47011, Japan; [Suzuki, Kenji; Yamanaka, Noboru] Japan Soc Infect Dis Otolaryngol, Surveillance Subcomm, Nagoya, Aichi, Japan	Wakayama Medical University; Fujita Health University	Hotomi, M (corresponding author), Wakayama Med Univ, Dept Otolaryngol Head & Neck Surg, Wakayama, Japan.	mhotomi@wakayama-med.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology [22791624]; National Institutes of Health (NIH) [R01-AI021458]; Bill & Melinda Gates Foundation Grant [37863]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation Grant	This work was supported by national grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (no. 22791624). The PspA work of David E. Briles and Susan K Hollingshead is supported by a National Institutes of Health (NIH) grant (Grant No. R01-AI021458) and Bill & Melinda Gates Foundation Grant (Grant No. 37863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELBAUM PC, 1992, CLIN INFECT DIS, V15, P77, DOI 10.1093/clinids/15.1.77; Beall B, 2000, J CLIN MICROBIOL, V38, P3663, DOI 10.1128/JCM.38.10.3663-3669.2000; Brandileone MCC, 2004, VACCINE, V22, P3890, DOI 10.1016/j.vaccine.2004.04.009; BREIMAN RF, 1994, JAMA-J AM MED ASSOC, V271, P1831, DOI 10.1001/jama.271.23.1831; Briles D. E., 2006, Gram-positive pathogens, P289; Briles DE, 2000, INFECT IMMUN, V68, P796, DOI 10.1128/IAI.68.2.796-800.2000; Briles DE, 1998, CLIN MICROBIOL REV, V11, P645, DOI 10.1128/CMR.11.4.645; Briles DE, 2000, VACCINE, V19, pS87, DOI 10.1016/S0264-410X(00)00285-1; Briles DE, 2000, J INFECT DIS, V182, P1694, DOI 10.1086/317602; BRILES DE, 1988, REV INFECT DIS, V10, pS372; Brooks-Walter A, 1995, 35 ICAAC; Chiba N, 2010, EPIDEMIOL INFECT, V138, P61, DOI 10.1017/S0950268809990239; Coral MCV, 2001, EMERG INFECT DIS, V7, P832; Crain MJ, 1996, MICROB PATHOGENESIS, V21, P265, DOI 10.1006/mpat.1996.0060; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Darrieux M, 2007, INFECT IMMUN, V75, P5930, DOI 10.1128/IAI.00940-07; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Ferreira DM, 2010, MICROB PATHOGENESIS, V48, P205, DOI 10.1016/j.micpath.2010.02.009; Franco CM, 2010, PEDIATR INFECT DIS J, V29, P77, DOI 10.1097/INF.0b013e3181af7e90; Fukuyama Y, 2010, J IMMUNOL, V185, P1755, DOI 10.4049/jimmunol.1000831; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Heeg C, 2007, VACCINE, V25, P1030, DOI 10.1016/j.vaccine.2006.09.061; Hollingshead SK, 2000, INFECT IMMUN, V68, P5889, DOI 10.1128/IAI.68.10.5889-5900.2000; Hollingshead SK, 2006, J MED MICROBIOL, V55, P215, DOI 10.1099/jmm.0.46268-0; Hollingshead SK, 2001, CURR OPIN MICROBIOL, V4, P71, DOI 10.1016/S1369-5274(00)00167-3; Hotomi M, 2006, ORL-J OTO-RHIN-LARYN, V68, P139, DOI 10.1159/000091276; Hotomi M, 2008, J CLIN MICROBIOL, V46, P3808, DOI 10.1128/JCM.01782-08; Hsu HE, 2009, NEW ENGL J MED, V360, P244, DOI 10.1056/NEJMoa0800836; Imai S, 2011, CLIN MICROBIOL INFEC, V17, P1409, DOI 10.1111/j.1469-0691.2010.03446.x; Ito Y, 2007, EUR J CLIN MICROBIOL, V26, P739, DOI 10.1007/s10096-007-0364-7; Jedrzejas MJ, 2000, ARCH BIOCHEM BIOPHYS, V373, P116, DOI 10.1006/abbi.1999.1544; Jedrzejas MJ, 2001, J BIOL CHEM, V276, P33121, DOI 10.1074/jbc.M103304200; Klugman KP, 2009, ADV EXP MED BIOL, V634, P121, DOI 10.1007/978-0-387-79838-7_11; KLUGMAN KP, 1990, CLIN MICROBIOL REV, V3, P171, DOI 10.1128/CMR.3.2.171-196.1990; MCDANIEL LS, 1992, MICROB PATHOGENESIS, V13, P261, DOI 10.1016/0882-4010(92)90036-N; Melin MM, 2008, CLIN VACCINE IMMUNOL, V15, P1555, DOI 10.1128/CVI.00177-08; Mollerach M, 2004, EPIDEMIOL INFECT, V132, P177, DOI 10.1017/S0950268803001626; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; MUSHER DM, 2000, STREPTOCOCCUS PNEUMO, P485; Nabors GS, 2000, VACCINE, V18, P1743, DOI 10.1016/S0264-410X(99)00530-7; Niki Y., 2008, Journal of Infection and Chemotherapy, V14, P279, DOI 10.1007/s10156-008-0623-2; Niki Y, 2009, J INFECT CHEMOTHER, V15, P156, DOI 10.1007/s10156-009-0674-z; Ogunniyi AD, 2007, INFECT IMMUN, V75, P1843, DOI 10.1128/IAI.01384-06; Ortqvist A, 1998, LANCET, V351, P399, DOI 10.1016/S0140-6736(97)07358-3; Pimenta FC, 2006, J CLIN MICROBIOL, V44, P2838, DOI 10.1128/JCM.00156-06; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Razzaque R, 2012, INFECT IMMUN UNPUB; Ren B, 2012, CLIN VACCINE IMMUNOL, V19, P1574, DOI 10.1128/CVI.00393-12; Robinson DA, 1999, J INFECT DIS, V179, P414, DOI 10.1086/314589; Roche H, 2003, INFECT IMMUN, V71, P1033, DOI 10.1128/IAI.71.3.1033-1041.2003; Rolo D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-80; Sadowy E, 2006, CLIN VACCINE IMMUNOL, V13, P139, DOI 10.1128/CVI.13.1.139-144.2006; Shouval DS, 2009, PEDIATR INFECT DIS J, V28, P277, DOI 10.1097/INF.0b013e31818e0e2e; Tart RC, 1996, J INFECT DIS, V173, P380, DOI 10.1093/infdis/173.2.380; Weinstein MP, 2009, CLIN INFECT DIS, V48, P1596, DOI 10.1086/598975; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Yamanaka Noboru, 2008, Journal of Infection and Chemotherapy, V14, P180, DOI 10.1007/s10156-007-0599-3	59	16	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58124	10.1371/journal.pone.0058124	http://dx.doi.org/10.1371/journal.pone.0058124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483982	Green Published, Green Submitted, gold			2022-12-27	WOS:000316936100079
J	Larsen, P; Gilbert, J				Larsen, Peter; Gilbert, Jack			Microbial Bebop: Creating Music from Complex Dynamics in Microbial Ecology	PLOS ONE			English	Article								In order for society to make effective policy decisions on complex and far-reaching subjects, such as appropriate responses to global climate change, scientists must effectively communicate complex results to the non-scientifically specialized public. However, there are few ways however to transform highly complicated scientific data into formats that are engaging to the general community. Taking inspiration from patterns observed in nature and from some of the principles of jazz bebop improvisation, we have generated Microbial Bebop, a method by which microbial environmental data are transformed into music. Microbial Bebop uses meter, pitch, duration, and harmony to highlight the relationships between multiple data types in complex biological datasets. We use a comprehensive microbial ecology, time course dataset collected at the L4 marine monitoring station in the Western English Channel as an example of microbial ecological data that can be transformed into music. Four compositions were generated (www.bio.anl.gov/MicrobialBebop.htm.) from L4 Station data using Microbial Bebop. Each composition, though deriving from the same dataset, is created to highlight different relationships between environmental conditions and microbial community structure. The approach presented here can be applied to a wide variety of complex biological datasets.	[Larsen, Peter; Gilbert, Jack] Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA; [Gilbert, Jack] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Larsen, P (corresponding author), Argonne Natl Lab, Biosci Div, 9700 S Cass Ave, Argonne, IL 60439 USA.	plarsen@anl.gov	Gilbert, Jack/AAF-3270-2019		United States Department of Energy [DE-AC02-06CH11357]; U.S. Department of Energy Office of Science laboratory [DE-AC02-06CH11357]	United States Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy Office of Science laboratory(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The submitted manuscript has been created by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne''). Argonne, a U.S. Department of Energy Office of Science laboratory, is operated under Contract No. DE-AC02-06CH11357. The U.S. Government retains for itself, and others acting on its behalf, a paid-up nonexclusive, irrevocable worldwide license in said article to reproduce, prepare derivative works, distribute copies to the public, and perform publicly and display publicly, by or on behalf of the Government.	Engel A, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00083; Gilbert J.A., 2011, ISME J; Keller B, 2011, IMPROVISOR V4 12; Khatib F, 2011, NATURE STRUCTURAL MO; Morris RM, 2005, LIMNOL OCEANOGR, V50, P1687, DOI 10.4319/lo.2005.50.5.1687; National Science Board, 2012, SCI ENG IND 2012; OHNO S, 1986, CHEM SCRIPTA, V26B, P43; Szwed John, 2000, JAZZ 101 COMPLETE GU; Takahashi R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-405; Treusch AH, 2009, ISME J, V3, P1148, DOI 10.1038/ismej.2009.60	10	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58119	10.1371/journal.pone.0058119	http://dx.doi.org/10.1371/journal.pone.0058119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483981	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100078
J	Chipaux, M; Vercueil, L; Kaminska, A; Mahon, S; Charpier, S				Chipaux, Mathilde; Vercueil, Laurent; Kaminska, Anna; Mahon, Severine; Charpier, Stephane			Persistence of Cortical Sensory Processing during Absence Seizures in Human and an Animal Model: Evidence from EEG and Intracellular Recordings	PLOS ONE			English	Article							RHYTHMIC SPIKE DISCHARGE; BARREL CORTEX NEURONS; LONG-EVANS RATS; THALAMIC NEURONS; WAVE DISCHARGES; THALAMOCORTICAL SYSTEM; SOMATOSENSORY CORTEX; GENETIC MODEL; EPILEPSY; RESPONSES	Absence seizures are caused by brief periods of abnormal synchronized oscillations in the thalamocortical loops, resulting in widespread spike-and-wave discharges (SWDs) in the electroencephalogram (EEG). SWDs are concomitant with a complete or partial impairment of consciousness, notably expressed by an interruption of ongoing behaviour together with a lack of conscious perception of external stimuli. It is largely considered that the paroxysmal synchronizations during the epileptic episode transiently render the thalamocortical system incapable of transmitting primary sensory information to the cortex. Here, we examined in young patients and in the Genetic Absence Epilepsy Rats from Strasbourg (GAERS), a well-established genetic model of absence epilepsy, how sensory inputs are processed in the related cortical areas during SWDs. In epileptic patients, visual event-related potentials (ERPs) were still present in the occipital EEG when the stimuli were delivered during seizures, with a significant increase in amplitude compared to interictal periods and a decrease in latency compared to that measured from non-epileptic subjects. Using simultaneous in vivo EEG and intracellular recordings from the primary somatosensory cortex of GAERS and non-epileptic rats, we found that ERPs and firing responses of related pyramidal neurons to whisker deflection were not significantly modified during SWDs. However, the intracellular subthreshold synaptic responses in somatosensory cortical neurons during seizures had larger amplitude compared to quiescent situations. These convergent findings from human patients and a rodent genetic model show the persistence of cortical responses to sensory stimulations during SWDs, indicating that the brain can still process external stimuli during absence seizures. They also demonstrate that the disruption of conscious perception during absences is not due to an obliteration of information transfer in the thalamocortical system. The possible mechanisms rendering the cortical operation ineffective for conscious perception are discussed, but their definite elucidation will require further investigations.	[Chipaux, Mathilde; Mahon, Severine; Charpier, Stephane] Hop La Pitie Salpetriere, Ctr Rech, Inst Cerveau & Moelle Epiniere, UPMC INSERM UMR S 975,CNRS UMR 7225, Paris, France; [Chipaux, Mathilde] Fdn Ophtalmolog, Pediat Neurosurg Unit, Paris, France; [Vercueil, Laurent] Ctr Rech INSERM 836 UJF CEA CHU, Grenoble Inst Neurosci, Equipe 9, Grenoble, France; [Kaminska, Anna] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Clin Neurophysiol Lab, Paris, France; [Charpier, Stephane] Univ Paris 06, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite	Charpier, S (corresponding author), Hop La Pitie Salpetriere, Ctr Rech, Inst Cerveau & Moelle Epiniere, UPMC INSERM UMR S 975,CNRS UMR 7225, Paris, France.	stephane.charpier@upmc.fr	mahon, severine/AAG-9225-2021; Mahon, Severine/E-7195-2017; VERCUEIL, Laurent/AAN-2941-2021	mahon, severine/0000-0001-8339-9034; VERCUEIL, Laurent/0000-0003-3323-0091; Kaminska, Anna/0000-0003-3805-6651	Ligue Francaise Contre l'Epilepsie (LFCE); la Federation Francaise pour la Recherche contre l'Epilepsie (FFRE); Federation pour la Recherche sur le Cerveau (FRC); Fondation de France	Ligue Francaise Contre l'Epilepsie (LFCE); la Federation Francaise pour la Recherche contre l'Epilepsie (FFRE); Federation pour la Recherche sur le Cerveau (FRC); Fondation de France(Fondation de France)	This work was supported by the Ligue Francaise Contre l'Epilepsie (LFCE), la Federation Francaise pour la Recherche contre l'Epilepsie (FFRE), Federation pour la Recherche sur le Cerveau (FRC) and the Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Azouz R, 1999, J NEUROSCI, V19, P2209; Bastuji H, 1999, SLEEP MED REV, V3, P23, DOI 10.1016/S1087-0792(99)90012-6; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; BLUME WT, 1988, ELECTROEN CLIN NEURO, V69, P508, DOI 10.1016/0013-4694(88)90162-9; Blumenfeld H, 2005, PROG BRAIN RES, V150, P271, DOI 10.1016/S0079-6123(05)50020-7; Blumenfeld H, 2003, NEUROSCIENTIST, V9, P301, DOI 10.1177/1073858403255624; Blumenfeld H, 2003, NEUROIMAGE, V19, P1556, DOI 10.1016/S1053-8119(03)00204-0; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; Brecht M, 2002, J PHYSIOL-LONDON, V538, P495, DOI 10.1113/jphysiol.2001.012334; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Cavanna AE, 2009, NAT REV NEUROL, V5, P267, DOI 10.1038/nrneurol.2009.38; Charpier S, 1999, NEUROPHARMACOLOGY, V38, P1699, DOI 10.1016/S0028-3908(99)00139-2; Chipaux M, 2011, NEUROSCIENCE, V192, P642, DOI 10.1016/j.neuroscience.2011.06.037; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Conte B, 1996, J PHARMACOL EXP THER, V276, P212; Danober L, 1998, PROG NEUROBIOL, V55, P27, DOI 10.1016/S0301-0082(97)00091-9; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Depaulis A, 2006, MODELS OF SEIZURES AND EPILEPSY, P233, DOI 10.1016/B978-012088554-1/50020-7; Duncan CC, 1988, ELEMENTS PETIT MAL E, P341; Duncan CC, 2009, INT J PSYCHOPHYSIOL, V73, P118, DOI 10.1016/j.ijpsycho.2009.03.005; Edeline JM, 2003, EXP BRAIN RES, V153, P554, DOI 10.1007/s00221-003-1608-0; FEDIO P, 1969, NEUROPSYCHOLOGIA, V7, P287, DOI 10.1016/0028-3932(69)90054-2; Fox K, 2008, BARREL CORTEX, P1, DOI 10.1017/CBO9780511541636.003; Getova D, 1997, EUR J PHARMACOL, V320, P9, DOI 10.1016/S0014-2999(96)00877-1; Gibbs FA, 1935, ARCH NEURO PSYCHIATR, V34, P1133, DOI 10.1001/archneurpsyc.1935.02250240002001; Gutnick Michael J., 1995, P33; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; HIRSCH E, 2005, SYNDROMES EPILEPTIQU, P315; Holmes MD, 2004, EPILEPSIA, V45, P1568, DOI 10.1111/j.0013-9580.2004.23204.x; Jung R, 1939, NERVENARZT, V12, P169; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kostopoulos GK, 2001, EPILEPSIA, V42, P13, DOI 10.1046/j.1528-1157.2001.042suppl.3013.x; LEMIEUX JF, 1986, BRAIN RES, V373, P275, DOI 10.1016/0006-8993(86)90342-2; LIBET B, 1967, SCIENCE, V158, P1597, DOI 10.1126/science.158.3808.1597; Libet B., 1972, NEUROPHYSIOLOGY STUD, P157; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Mahon S, 2003, J PHYSIOL-PARIS, V97, P557, DOI 10.1016/j.jphysparis.2004.01.013; Mahon S, 2012, J NEUROSCI, V32, P11377, DOI 10.1523/JNEUROSCI.0415-12.2012; Manning JPA, 2004, NEUROSCIENCE, V123, P5, DOI 10.1016/j.neuroscience.2003.09.026; Massimini M, 2003, J NEUROPHYSIOL, V89, P1205, DOI 10.1152/jn.00373.2002; Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; MIRSKY AF, 1965, ELECTROEN CLIN NEURO, V18, P334, DOI 10.1016/0013-4694(65)90053-2; Nicolelis MAL, 2002, NAT NEUROSCI, V5, P517, DOI 10.1038/nn0602-517; Orren M M, 1978, Electroencephalogr Clin Neurophysiol Suppl, P251; Panayiotopoulos CP, 2008, EPILEPSIA, V49, P2131, DOI 10.1111/j.1528-1167.2008.01777.x; Panayiotopoulos CP, 1997, J NEUROL NEUROSUR PS, V63, P622, DOI 10.1136/jnnp.63.5.622; Pastor MA, 2007, CEREB CORTEX, V17, P1899, DOI 10.1093/cercor/bhl098; Paxinos G, 1988, RAT BRAIN STEREOTAXI, V4th; Paz JT, 2009, PAN BRAIN ABNORMAL N, P41; Pidoux M, 2011, J PHYSIOL-LONDON, V589, P263, DOI 10.1113/jphysiol.2010.199646; Pinault D, 1998, J PHYSIOL-LONDON, V509, P449, DOI 10.1111/j.1469-7793.1998.449bn.x; Pinault D, 2003, J PHYSIOL-LONDON, V552, P881, DOI 10.1113/jphysiol.2003.046573; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Polack PO, 2009, CEREB CORTEX, V19, P2078, DOI 10.1093/cercor/bhn237; Polack PO, 2009, EPILEPSIA, V50, P1816, DOI 10.1111/j.1528-1167.2009.02047.x; Polack PO, 2006, J PHYSIOL-LONDON, V571, P461, DOI 10.1113/jphysiol.2005.100925; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; Rees G, 2002, NAT REV NEUROSCI, V3, P261, DOI 10.1038/nrn783; Sadleir LG, 2006, NEUROLOGY, V67, P413, DOI 10.1212/01.wnl.0000228257.60184.82; Schabus Manuel, 2012, Front Neurol, V3, P40, DOI 10.3389/fneur.2012.00040; Schwab, 1939, J NERV MENT DIS, V89, P690; Shaw FZ, 2004, J NEUROPHYSIOL, V91, P63, DOI 10.1152/jn.00487.2003; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; Slaght SJ, 2002, EPILEPTIC DISORD, V4, pS9; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; STERIADE M, 1991, J NEUROSCI, V11, P3200; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Syed ECJ, 2011, EUR J NEUROSCI, V33, P461, DOI 10.1111/j.1460-9568.2010.07549.x; Dang-Vu TT, 2011, P NATL ACAD SCI USA, V108, P15438, DOI 10.1073/pnas.1112503108; Timofeev I, 2004, NEUROSCIENCE, V123, P299, DOI 10.1016/j.neuroscience.2003.08.051; van Luijtelaar G, 2006, NEUROSCI BIOBEHAV R, V30, P983, DOI 10.1016/j.neubiorev.2006.03.002; VERGNES M, 1991, EPILEPSY RES, V9, P97, DOI 10.1016/0920-1211(91)90019-C; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Westmijse I, 2009, EPILEPSIA, V50, P2538, DOI 10.1111/j.1528-1167.2009.02162.x; Wiest MC, 2003, NAT NEUROSCI, V6, P913, DOI 10.1038/nn1107; WILLIAMS D, 1953, BRAIN, V76, P50, DOI 10.1093/brain/76.1.50; Wygnanski-Jaffe T, 2009, DOC OPHTHALMOL, V119, P101, DOI 10.1007/s10633-009-9176-7; Young GB, 1999, ARCH NEUROL-CHICAGO, V56, P153, DOI 10.1001/archneur.56.2.153	81	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58180	10.1371/journal.pone.0058180	http://dx.doi.org/10.1371/journal.pone.0058180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483991	gold, Green Submitted, Green Published			2022-12-27	WOS:000315634900075
J	Kainerstorfer, JM; Yu, Y; Weliwitigoda, G; Anderson, PG; Sassaroli, A; Fantini, S				Kainerstorfer, Jana M.; Yu, Yang; Weliwitigoda, Geethika; Anderson, Pamela G.; Sassaroli, Angelo; Fantini, Sergio			Depth Discrimination in Diffuse Optical Transmission Imaging by Planar Scanning Off-Axis Fibers: INITIAL Applications to Optical Mammography	PLOS ONE			English	Article							BREAST-CANCER; QUANTITATIVE OXIMETRY; TOMOGRAPHY; DOMAIN; HEALTHY; HEMOGLOBIN	We present a method for depth discrimination in parallel-plate, transmission mode, diffuse optical imaging. The method is based on scanning a set of detector pairs, where the two detectors in each pair are separated by a distance delta D-i along direction delta D-i within the x-y scanning plane. A given optical inhomogeneity appears shifted by alpha(i)delta D-i (with 0 <= alpha(i) <= 1) in the images collected with the two detection fibers of the i-th pair. Such a spatial shift can be translated into a measurement of the depth z of the inhomogeneity, and the depth measurements based on each detector pair are combined into a specially designed weighted average. This depth assessment is demonstrated on tissue-like phantoms for simple inhomogeneities such as straight rods in single-rod or multiple-rod configurations, and for more complex curved structures which mimic blood vessels in the female breast. In these phantom tests, the method has recovered the depth of single inhomogeneities in the central position of the phantom to within 4 mm of their actual value, and within 7 mm for more superficial inhomogeneities, where the thickness of the phantom was 65 mm. The application of this method to more complex images, such as optical mammograms, requires a robust approach to identify corresponding structures in the images collected with the two detectors of a given pair. To this aim, we propose an approach based on the inner product of the skeleton images collected with the two detectors of each pair, and we present an application of this approach to optical in vivo images of the female breast. This depth discrimination method can enhance the spatial information content of 2D projection images of the breast by assessing the depth of detected structures, and by allowing for 3D localization of breast tumors.	[Kainerstorfer, Jana M.; Yu, Yang; Weliwitigoda, Geethika; Anderson, Pamela G.; Sassaroli, Angelo; Fantini, Sergio] Tufts Univ, Dept Biomed Engn, Medford, MA USA	Tufts University	Kainerstorfer, JM (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA USA.	jana.kainerstorfer@tufts.edu		Anderson, Pamela/0000-0002-6602-9186	National Institutes of Health [R01 CA154774)]; NATIONAL CANCER INSTITUTE [R01CA154774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Institutes of Health (Grant R01 CA154774)[www.nih.gov]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerussi A, 2007, P NATL ACAD SCI USA, V104, P4014, DOI 10.1073/pnas.0611058104; Chance B, 2005, ACAD RADIOL, V12, P925, DOI 10.1016/j.acra.2005.04.016; Choe R, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3103325; Contini D, 1997, APPL OPTICS, V36, P4587, DOI 10.1364/AO.36.004587; Enfield LC, 2007, APPL OPTICS, V46, P3628, DOI 10.1364/AO.46.003628; Enfield LC, 2009, TARGET ONCOL, V4, P219, DOI 10.1007/s11523-009-0115-z; Fang QQ, 2009, IEEE T MED IMAGING, V28, P30, DOI 10.1109/TMI.2008.925082; Grosenick D, 1999, APPL OPTICS, V38, P2927, DOI 10.1364/AO.38.002927; Grosenick D, 2004, PHYS MED BIOL, V49, P1165, DOI 10.1088/0031-9155/49/7/006; Konovalov AB, 2006, QUANTUM ELECTRON+, V36, P1048, DOI 10.1070/QE2006v036n11ABEH013302; Kukreti S, 2010, RADIOLOGY, V254, P277, DOI 10.1148/radiol.09082134; Leff DR, 2008, BREAST CANCER RES TR, V108, P9, DOI 10.1007/s10549-007-9582-z; Liu N, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2085172; Longatto A, 2010, J ONCOL, V2010, DOI 10.1155/2010/576384; Martin LJ, 2010, CANCER EPIDEM BIOMAR, V19, P456, DOI 10.1158/1055-9965.EPI-09-0881; Milani M, 2008, EUR J CANCER, V44, P2766, DOI 10.1016/j.ejca.2008.09.025; Pera VE, 2003, J BIOMED OPT, V8, P517, DOI 10.1117/1.1578496; Sassaroli A, 1998, APPL OPTICS, V37, P7392, DOI 10.1364/AO.37.007392; Schmitz CH, 2005, APPL OPTICS, V44, P2140, DOI 10.1364/AO.44.002140; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; Soliman H, 2010, CLIN CANCER RES, V16, P2605, DOI 10.1158/1078-0432.CCR-09-1510; Taroni P, 2009, OPT EXPRESS, V17, P15932, DOI 10.1364/OE.17.015932; Wang J, 2010, OPT LETT, V35, P82, DOI 10.1364/OL.35.000082; Wolf M, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804899; Yu Y, 2010, J INNOV OPT HEAL SCI, V3, P267, DOI 10.1142/S179354581000112X; Yu Y, 2009, APPL OPTICS, V48, pD225, DOI 10.1364/AO.48.00D225; Zhu Q, 2008, NEOPLASIA, V10, P1028, DOI 10.1593/neo.08602; Zhu Q, 2010, RADIOLOGY, V256, P367, DOI 10.1148/radiol.10091237	28	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58510	10.1371/journal.pone.0058510	http://dx.doi.org/10.1371/journal.pone.0058510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516494	gold, Green Published			2022-12-27	WOS:000316407400036
J	Crump, MJC; McDonnell, JV; Gureckis, TM				Crump, Matthew J. C.; McDonnell, John V.; Gureckis, Todd M.			Evaluating Amazon's Mechanical Turk as a Tool for Experimental Behavioral Research	PLOS ONE			English	Article							IRRELEVANT LOCATION INFORMATION; REACTION-TIME MEASUREMENT; INTERFERENCE; TASK; INHIBITION; MODEL	Amazon Mechanical Turk (AMT) is an online crowdsourcing service where anonymous online workers complete web-based tasks for small sums of money. The service has attracted attention from experimental psychologists interested in gathering human subject data more efficiently. However, relative to traditional laboratory studies, many aspects of the testing environment are not under the experimenter's control. In this paper, we attempt to empirically evaluate the fidelity of the AMT system for use in cognitive behavioral experiments. These types of experiment differ from simple surveys in that they require multiple trials, sustained attention from participants, comprehension of complex instructions, and millisecond accuracy for response recording and stimulus presentation. We replicate a diverse body of tasks from experimental psychology including the Stroop, Switching, Flanker, Simon, Posner Cuing, attentional blink, subliminal priming, and category learning tasks using participants recruited using AMT. While most of replications were qualitatively successful and validated the approach of collecting data anonymously online using a web-browser, others revealed disparity between laboratory results and online results. A number of important lessons were encountered in the process of conducting these replications that should be of value to other researchers.	[Crump, Matthew J. C.] CUNY Brooklyn Coll, Dept Psychol, Brooklyn, NY 11210 USA; [McDonnell, John V.; Gureckis, Todd M.] NYU, Dept Psychol, New York, NY 10003 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); New York University	Crump, MJC (corresponding author), CUNY Brooklyn Coll, Dept Psychol, Brooklyn, NY 11210 USA.	mcrump@brooklyn.cuny.edu	Crump, Matthew/A-9103-2011	Crump, Matthew/0000-0002-5612-0090; Gureckis, Todd/0000-0002-7139-4778				Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; CRAFT JL, 1970, J EXP PSYCHOL, V83, P415, DOI 10.1037/h0028843; Eimer M, 1998, J EXP PSYCHOL HUMAN, V24, P1737, DOI 10.1037/0096-1523.24.6.1737; Eimer M, 2002, PSYCHON B REV, V9, P514, DOI 10.3758/BF03196307; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Eriksen CW, 1995, VISUAL SELECTIVE ATTENTION, P101; Germine L, 2012, PSYCHON B REV; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Ipeirotis PG, 2010, TECH REP NO CEDER 10; Jasmin K, 2012, PSYCHON B REV, V19, P499, DOI 10.3758/s13423-012-0229-7; Jersild AT, 1927, ARCH PSYCHOL, V14; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; KRUSCHKE JK, 1992, PSYCHOL REV, V99, P22, DOI 10.1037/0033-295X.99.1.22; Kurtz KJ, 2013, J EXP PSYCHOL LEARN, V39, P552, DOI 10.1037/a0029178; Lewandowsky S, 2011, J EXP PSYCHOL LEARN, V37, P720, DOI 10.1037/a0022639; Logan GD, 1998, J EXP PSYCHOL HUMAN, V24, P978, DOI 10.1037/0096-1523.24.3.978; Love BC, 2004, PSYCHOL REV, V111, P309, DOI 10.1037/0033-295X.111.2.309; Love BC, 2002, PSYCHON B REV, V9, P829, DOI 10.3758/BF03196342; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; Lupianez J, 1997, PERCEPT PSYCHOPHYS, V59, P1241, DOI 10.3758/BF03214211; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mason W., 2010, SIGKDD EXPLORATIONS, V11, P100, DOI [DOI 10.1145/1809400.1809422, 10.1145/1600150.1600175]; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Neath I, 2011, BEHAV RES METHODS, V43, P353, DOI 10.3758/s13428-011-0069-9; NOSOFSKY RM, 1994, MEM COGNITION, V22, P352, DOI 10.3758/BF03200862; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pontin J, 2007, NY TIMES; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Proctor RW, 1999, MEM COGNITION, V27, P63, DOI 10.3758/BF03201214; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rehder B, 2005, COGNITIVE PSYCHOL, V51, P1, DOI 10.1016/j.cogpsych.2004.11.001; Reimers S, 2005, DEV PSYCHOL, V41, P661, DOI 10.1037/0012-1649.41.4.661; Reimers S, 2007, BEHAV RES METHODS, V39, P365, DOI 10.3758/BF03193004; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Ross J., 2010, C HUM FACT COMP SYST, P2863, DOI [DOI 10.5888/PCD14.170066, DOI 10.1145/1753846.1753873]; Schnoebelen T, 2010, PSIHOLOGIJA, V43, P441, DOI 10.2298/PSI1004441S; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; SHEPARD RN, 1961, PSYCHOL MONOGR, V75, P1, DOI 10.1037/h0093825; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Spies J, 2012, REPRODUCIBILITY PROJ; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; ULRICH R, 1989, BRIT J MATH STAT PSY, V42, P1, DOI 10.1111/j.2044-8317.1989.tb01111.x; VANSELST M, 1994, Q J EXP PSYCHOL-A, V47, P631, DOI 10.1080/14640749408401131; Wendt M, 2011, PSYCHON B REV, V18, P910, DOI 10.3758/s13423-011-0119-4	49	925	928	8	180	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57410	10.1371/journal.pone.0057410	http://dx.doi.org/10.1371/journal.pone.0057410			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516406	gold, Green Published			2022-12-27	WOS:000316849200012
J	Golle, J; Lisibach, S; Mast, FW; Lobmaier, JS				Golle, Jessika; Lisibach, Stephanie; Mast, Fred W.; Lobmaier, Janek S.			Sweet Puppies and Cute Babies: Perceptual Adaptation to Babyfacedness Transfers across Species	PLOS ONE			English	Article							NEURAL REPRESENTATIONS; INFANT ATTRACTIVENESS; PERCEIVED CUTENESS; FACE ADAPTATION; EXPRESSION; LOOKING; ADULT; LEVEL; SHAPE; ME	Infant faces are very salient stimuli. The Kindchenschema describes specific features that characterize a cute infant face. In this study we used a visual adaptation paradigm to investigate the universality of the perceptual properties of the Kindchenschema. In Experiment 1, twenty-four participants adapted to cute and less cute human infant faces and in Experiment 2, twenty-four new participants adapted to cute and less cute faces of puppy dogs. In both experiments the task was to assess the cuteness of subsequently presented human infant faces. The results revealed cuteness after-effects for human infant faces in both adaptation conditions, suggesting a common mechanism coding cuteness in human and non-human faces. This study provides experimental evidence for the universality of the well-described concept of the Kindchenschema.	[Golle, Jessika; Lisibach, Stephanie; Mast, Fred W.; Lobmaier, Janek S.] Univ Bern, Dept Psychol, Bern, Switzerland; [Golle, Jessika; Mast, Fred W.; Lobmaier, Janek S.] Univ Bern, Ctr Cognit Learning & Memory, Bern, Switzerland	University of Bern; University of Bern	Lobmaier, JS (corresponding author), Univ Bern, Dept Psychol, Bern, Switzerland.	janek.lobmaier@psy.unibe.ch	Golle, Jessika/AAO-3924-2020; Mast, Fred/B-5058-2013	Mast, Fred/0000-0002-0665-4457; Lobmaier, Janek/0000-0001-8025-1616; Golle, Jessika/0000-0002-8507-7079	Pro*Doc program of the Swiss National Science Foundation [PDFMP1_127238]; Swiss National Science Foundation [PZ00P1_121622/1]	Pro*Doc program of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Jessika Golle was supported by a grant from the Pro*Doc program of the Swiss National Science Foundation awarded to Fred W. Mast (PDFMP1_127238). Janek S. Lobmaier was supported by the Swiss National Science Foundation (grant number PZ00P1_121622/1, www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY TR, 1981, DEV PSYCHOL, V17, P650, DOI 10.1037/0012-1649.17.5.650; BERRY DS, 1985, J PERS SOC PSYCHOL, V48, P312, DOI 10.1037/0022-3514.48.2.312; BROOKS V., 1960, PERCEPT AND MOT SKILLS, V11, P205; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; Fox CJ, 2007, BRAIN RES, V1127, P80, DOI 10.1016/j.brainres.2006.09.104; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; HILDEBRANDT KA, 1979, INFANT BEHAV DEV, V2, P329, DOI 10.1016/S0163-6383(79)80043-0; Hrdy SB., 1999, ANIM BEHAV, DOI DOI 10.1006/ANBE.1999.1378; Huckstedt B, 1965, Z EXP ANGEW PSYCHOL, V12, P421; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Jenkins R, 2006, PSYCHOL SCI, V17, P506, DOI 10.1111/j.1467-9280.2006.01736.x; Kloth N, 2008, J VISION, V8, DOI 10.1167/8.11.4; LANGLOIS JH, 1995, DEV PSYCHOL, V31, P464, DOI 10.1037/0012-1649.31.3.464; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; Little AC, 2008, COGNITION, V106, P1537, DOI 10.1016/j.cognition.2007.06.008; Little AC, 2012, ETHOLOGY, V118, P775, DOI 10.1111/j.1439-0310.2012.02068.x; Lorenz K, 1943, Z TIERPSYCHOL, V5, P94; MCKELVIE SJ, 1993, J SOC BEHAV PERS, V8, P297; Nittono H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046362; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Rhodes G, 2003, PSYCHOL SCI, V14, P558, DOI 10.1046/j.0956-7976.2003.psci_1465.x; Rhodes G, 2005, FITTING MIND WORLD A; Sato A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038387; Schweinberger SR, 2004, NEUROREPORT, V15, P1501, DOI 10.1097/01.wnr.0000131675.00319.42; Schweinberger SR, 2007, NEUROREPORT, V18, P693, DOI 10.1097/WNR.0b013e3280c1e2d2; Schweinberger SR, 2010, VISION RES, V50, P2570, DOI 10.1016/j.visres.2010.08.017; Sherman GD, 2009, EMOTION, V9, P282, DOI 10.1037/a0014904; STERNGLANZ SH, 1977, ANIM BEHAV, V25, P108, DOI 10.1016/0003-3472(77)90072-0; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Wade N., 2005, FITTING MIND WORLD A, P83; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	33	33	35	4	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58248	10.1371/journal.pone.0058248	http://dx.doi.org/10.1371/journal.pone.0058248			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516453	Green Published, gold			2022-12-27	WOS:000316849200046
J	Kidane, YH; Lawrence, C; Murali, TM				Kidane, Yared H.; Lawrence, Christopher; Murali, T. M.			The Landscape of Host Transcriptional Response Programs Commonly Perturbed by Bacterial Pathogens: Towards Host-Oriented Broad-Spectrum Drug Targets	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; EHRLICHIA-CHAFFEENSIS; ANAPLASMA-PHAGOCYTOPHILUM; YERSINIA-ENTEROCOLITICA; CHOLESTEROL; INFECTION; PROFILES; THERAPY; CANCER	Background: The emergence of drug-resistant pathogen strains and new infectious agents pose major challenges to public health. A promising approach to combat these problems is to target the host's genes or proteins, especially to discover targets that are effective against multiple pathogens, i.e., host-oriented broad-spectrum (HOBS) drug targets. An important first step in the discovery of such drug targets is the identification of host responses that are commonly perturbed by multiple pathogens. Results: In this paper, we present a methodology to identify common host responses elicited by multiple pathogens. First, we identified host responses perturbed by each pathogen using a gene set enrichment analysis of publicly available genome-wide transcriptional datasets. Then, we used biclustering to identify groups of host pathways and biological processes that were perturbed only by a subset of the analyzed pathogens. Finally, we tested the enrichment of each bicluster in human genes that are known drug targets, on the basis of which we elicited putative HOBS targets for specific groups of bacterial pathogens. We identified 84 up-regulated and three down-regulated statistically significant biclusters. Each bicluster contained a group of pathogens that commonly dysregulated a group of biological processes. We validated our approach by checking whether these biclusters correspond to known hallmarks of bacterial infection. Indeed, these biclusters contained biological process such as inflammation, activation of dendritic cells, pro- and anti- apoptotic responses and other innate immune responses. Next, we identified biclusters containing pathogens that infected the same tissue. After a literature-based analysis of the drug targets contained in these biclusters, we suggested new uses of the drugs Anakinra, Etanercept, and Infliximab for gastrointestinal pathogens Yersinia enterocolitica, Helicobacter pylori kx2 strain, and enterohemorrhagic Escherichia coli and the drug Simvastatin for hematopoietic pathogen Ehrlichia chaffeensis. Conclusions: Using a combination of automated analysis of host-response gene expression data and manual study of the literature, we have been able to suggest host-oriented treatments for specific bacterial infections. The analyses and suggestions made in this study may be utilized to generate concrete hypothesis on which gene sets to probe further in the quest for HOBS drug targets for bacterial infections. All our results are available at the following supplementary website: http://bioinformatics.cs.vt.edu/ murali/supplements/2013-kidane-plos-one	[Kidane, Yared H.] Virginia Tech, Genet Bioinformat & Computat Biol PhD Program, Blacksburg, VA USA; [Lawrence, Christopher] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [Lawrence, Christopher] Virginia Tech, Dept Biol, Blacksburg, VA USA; [Murali, T. M.] Virginia Tech, Dept Comp Sci, Blacksburg, VA 24060 USA; [Murali, T. M.] Virginia Tech, ICTAS Ctr Syst Biol Engn Tissues, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Murali, TM (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24060 USA.	murali@cs.vt.edu			Initiative to Maximize Students Development program at Virginia Polytechnic Institute and State University; Genetics, Bioinformatics and Computational Biology program at Virginia Polytechnic Institute and State University; Southern Regional Education Board dissertation fellowship program	Initiative to Maximize Students Development program at Virginia Polytechnic Institute and State University; Genetics, Bioinformatics and Computational Biology program at Virginia Polytechnic Institute and State University; Southern Regional Education Board dissertation fellowship program	The work presented in this paper was supported by Initiative to Maximize Students Development program, Genetics, Bioinformatics and Computational Biology program at Virginia Polytechnic Institute and State University, and Southern Regional Education Board dissertation fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkow S, 2006, BIOINFORMATICS, V22, P1282, DOI 10.1093/bioinformatics/btl099; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Bauer S, 2010, NUCLEIC ACIDS RES, V38, P3523, DOI 10.1093/nar/gkq045; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERCOVIER H, 1980, CURR MICROBIOL, V4, P201, DOI 10.1007/BF02605857; Berriz GF, 2008, BIOINFORMATICS, V24, P2272, DOI 10.1093/bioinformatics/btn424; Bodey GP, 1983, REV INFECT DIS, V5; Boya P, 2001, EMBO J, V20, P4325, DOI 10.1093/emboj/20.16.4325; CAMPOS LC, 1994, INFECT IMMUN, V62, P3282, DOI 10.1128/IAI.62.8.3282-3288.1994; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061; Dirmeier U, 2005, ONCOGENE, V24, P1711, DOI 10.1038/sj.onc.1208367; Dubin PJ, 2007, AM J PHYSIOL-LUNG C, V292, pL519, DOI 10.1152/ajplung.00312.2006; Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fauci A. S., 2005, International Journal of Risk & Safety in Medicine, V17, P157; Finlay BB, 2004, NAT REV MICROBIOL, V2, P497, DOI 10.1038/nrmicro908; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Giannakis M, 2008, P NATL ACAD SCI USA, V105, P4358, DOI 10.1073/pnas.0800668105; Gionis A, 2007, ACM T KNOWL DISCOV D, V1, p14+; Hamill P, 2008, CURR OPIN BIOTECH, V19, P628, DOI 10.1016/j.copbio.2008.10.006; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kandasamy K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r3; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Lindstedt M, 2002, INT IMMUNOL, V14, P1203, DOI 10.1093/intimm/dxf082; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; McDermott JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014673; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Perusse L, 2005, OBES RES, V13, P381, DOI 10.1038/oby.2005.50; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Pucadyil TJ, 2007, TRENDS PARASITOL, V23, P49, DOI 10.1016/j.pt.2006.12.003; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rawlins MD, 2004, NAT REV DRUG DISCOV, V3, P360, DOI 10.1038/nrd1347; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; Ritchie JM, 2003, INFECT IMMUN, V71, P7129, DOI 10.1128/IAI.71.12.7129-7139.2003; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; SAEBO A, 1994, INT J TISSUE REACT, V16, P51; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; Schwegmann A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.129re8; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Subramanian A., 2005, P NATL ACAD SCI US; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tan SL, 2007, NAT BIOTECHNOL, V25, P1383, DOI 10.1038/nbt1207-1383; Teshima CW, 2009, CAN J GASTROENTEROL, V23, P348, DOI 10.1155/2009/180840; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Uzonyi B, 2006, P NATL ACAD SCI USA, V103, P6326, DOI 10.1073/pnas.0601223103; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; Zhang YX, 2008, CANCER RES, V68, P9519, DOI 10.1158/0008-5472.CAN-08-1549; Zhu YL, 2008, BIOINFORMATICS, V24, P2798, DOI 10.1093/bioinformatics/btn520	65	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58553	10.1371/journal.pone.0058553	http://dx.doi.org/10.1371/journal.pone.0058553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516507	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200086
J	Nivison-Smith, L; Collin, SP; Zhu, Y; Ready, S; Acosta, ML; Hunt, DM; Potter, IC; Kalloniatis, M				Nivison-Smith, Lisa; Collin, Shaun P.; Zhu, Yuan; Ready, Sarah; Acosta, Monica L.; Hunt, David M.; Potter, Ian C.; Kalloniatis, Michael			Retinal Amino Acid Neurochemistry of the Southern Hemisphere Lamprey, Geotria australis	PLOS ONE			English	Article							GABA-LIKE IMMUNOREACTIVITY; LARVAL SEA LAMPREY; TRANSPORTER KNOCKOUT MOUSE; GAMMA-AMINOBUTYRIC-ACID; MACAQUE MONKEY RETINA; GOLDFISH RETINA; BIPOLAR CELLS; GANGLION-CELLS; CAT RETINA; LAMPETRA-FLUVIATILIS	Lampreys are one of the two surviving groups of the agnathan (jawless) stages in vertebrate evolution and are thus ideal candidates for elucidating the evolution of visual systems. This study investigated the retinal amino acid neurochemistry of the southern hemisphere lamprey Geotria australis during the downstream migration of the young, recently-metamorphosed juveniles to the sea and during the upstream migration of the fully-grown and sexually-maturing adults to their spawning areas. Glutamate and taurine were distributed throughout the retina, whilst GABA and glycine were confined to neurons of the inner retina matching patterns seen in most other vertebrates. Glutamine and aspartate immunoreactivity was closely matched to Muller cell morphology. Between the migratory phases, few differences were observed in the distribution of major neurotransmitters i.e. glutamate, GABA and glycine, but changes in amino acids associated with retinal metabolism i.e. glutamine and aspartate, were evident. Taurine immunoreactivity was mostly conserved between migrant stages, consistent with its role in primary cell functions such as osmoregulation. Further investigation of glutamate signalling using the probe agmatine (AGB) to map cation channel permeability revealed entry of AGB into photoreceptors and horizontal cells followed by accumulation in inner retinal neurons. Similarities in AGB profiles between upstream and downstream migrant of G. australis confirmed the conservation of glutamate neurotransmission. Finally, calcium binding proteins, calbindin and calretinin were localized to the inner retina whilst recoverin was localized to photoreceptors. Overall, conservation of major amino acid neurotransmitters and calcium-associated proteins in the lamprey retina confirms these elements as essential features of the vertebrate visual system. On the other hand, metabolic elements of the retina such as neurotransmitter precursor amino acids and Muller cells are more sensitive to environmental changes associated with migration.	[Nivison-Smith, Lisa; Zhu, Yuan; Kalloniatis, Michael] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Collin, Shaun P.; Hunt, David M.] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Collin, Shaun P.; Hunt, David M.] Univ Western Australia, Oceans Inst, Crawley, WA, Australia; [Collin, Shaun P.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Collin, Shaun P.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Ready, Sarah; Acosta, Monica L.; Kalloniatis, Michael] Univ Auckland, Dept Optometry & Vis Sci, Auckland 1, New Zealand; [Potter, Ian C.] Murdoch Univ, Sch Biol Sci & Biotechnol, Murdoch, WA 6150, Australia; [Kalloniatis, Michael] Univ New S Wales, Ctr Eye Hlth, Sydney, NSW, Australia	University of New South Wales Sydney; University of Western Australia; University of Western Australia; University of Queensland; University of Queensland; University of Auckland; Murdoch University; University of New South Wales Sydney	Kalloniatis, M (corresponding author), Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	m.kalloniatis@unsw.edu.au	Hunt, David M/K-6024-2012; Acosta, Monica/H-2700-2019; Collin, Shaun/K-8827-2012	Hunt, David M/0000-0002-9264-3948; Acosta, Monica/0000-0002-5018-339X; Collin, Shaun/0000-0001-6236-0771; Kalloniatis, Michael/0000-0002-5264-4639; Nivison-Smith, Lisa/0000-0001-6677-1949	National Health and Medical Research Council of Australia [1009342]; Australian Research Council; WA State Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); WA State Government	This work was supported in part by research grants from the National Health and Medical Research Council of Australia National Health and Medical Research Council of Australia (number 1009342), the Australian Research Council and The WA State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARDH E, 1987, HISTOCHEMISTRY, V86, P485, DOI 10.1007/BF00500621; CARLISLE DB, 1959, J MAR BIOL ASSOC UK, V38, P97, DOI 10.1017/S0025315400015629; Chen C-KJ, 2003, RECOVERIN RHODOPSIN, P101; Collin Shaun P, 2004, Clin Exp Optom, V87, P217; Collin SP, 2004, VISUAL NEUROSCI, V21, P765, DOI 10.1017/S0952523804215103; Collin SP, 2003, CURR BIOL, V13, pR864, DOI 10.1016/j.cub.2003.10.044; Collin SP, 2003, VISUAL NEUROSCI, V20, P119, DOI 10.1017/S0952523803202030; Collin SP, 1999, BRAIN BEHAV EVOLUT, V54, P96, DOI 10.1159/000006616; COLLIN SP, 1993, CAN J ZOOL, V71, P34, DOI 10.1139/z93-006; Collin SP, 2000, BRAIN BEHAV EVOLUT, V55, P120, DOI 10.1159/000006647; CRESCITELLI F, 1956, J GEN PHYSIOL, V39, P423, DOI 10.1085/jgp.39.3.423; CROOKS J, 1992, J COMP NEUROL, V315, P287, DOI 10.1002/cne.903150305; DALIL N, 1990, CR ACAD SCI III-VIE, V311, P403; Dalil-Thiney N, 1998, NEUROSCI LETT, V247, P163, DOI 10.1016/S0304-3940(98)00301-2; DALILTHINEY N, 1994, J COMP NEUROL, V340, P140, DOI 10.1002/cne.903400110; DalilThiney N, 1996, NEUROSCI LETT, V207, P159, DOI 10.1016/0304-3940(96)12511-8; DAVANGER S, 1991, J COMP NEUROL, V311, P483, DOI 10.1002/cne.903110404; Davies WIL, 2012, MOL ECOL, V21, P3121, DOI 10.1111/j.1365-294X.2012.05617.x; Davies WL, 2007, FASEB J, V21, P2713, DOI 10.1096/fj.06-8057com; Davies WL, 2009, MOL BIOL EVOL, V26, P1803, DOI 10.1093/molbev/msp089; Dickson D.H., 1981, P43; DOWLING JE, 1978, PROC R SOC SER B-BIO, V201, P7, DOI 10.1098/rspb.1978.0030; Duke-Elder SS., 1985, SYSTEM OPHTHALMOLOGY, P453; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; EHINGER B, 1988, P NATL ACAD SCI USA, V85, P8321, DOI 10.1073/pnas.85.21.8321; Einarson L, 1932, AM J PATHOL, V8, P295; Fletcher EL, 1997, J COMP NEUROL, V380, P449, DOI 10.1002/(SICI)1096-9861(19970421)380:4<449::AID-CNE3>3.0.CO;2-1; Fletcher EL, 1996, J COMP NEUROL, V376, P343; FRITZSCH B, 1990, VISUAL NEUROSCI, V4, P533, DOI 10.1017/S0952523800005745; Gill HS, 2003, PHYLOGENY LIVING PAR; GRUNERT U, 1990, J COMP NEUROL, V297, P509, DOI 10.1002/cne.902970405; Gustafsson OSE, 2008, J EXP BIOL, V211, P1559, DOI 10.1242/jeb.016048; Hardisty M. W., 1982, BIOL LAMPREYS B, V4B, P165; HAROSI FI, 1993, VISUAL NEUROSCI, V10, P711, DOI 10.1017/S0952523800005411; Haverkamp S, 2000, NEURON, V27, P85, DOI 10.1016/S0896-6273(00)00011-8; HENDRICKSON AE, 1988, J COMP NEUROL, V273, P473, DOI 10.1002/cne.902730404; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; HOLMBERG K, 1978, VISION RES, V18, P1313, DOI 10.1016/0042-6989(78)90221-3; Jiang Z, 2010, J NEUROPHYSIOL, V103, P924, DOI 10.1152/jn.00876.2009; KALLONIATIS M, 1994, VISUAL NEUROSCI, V11, P793, DOI 10.1017/S0952523800003096; Kalloniatis M, 1999, PROG RETIN EYE RES, V18, P811, DOI 10.1016/S1350-9462(98)00036-6; Kalloniatis M, 1996, J NEUROSCI, V16, P6807; KALLONIATIS M, 1993, J COMP NEUROL, V336, P174, DOI 10.1002/cne.903360203; Kalloniatis M, 2002, VISUAL NEUROSCI, V19, P61, DOI 10.1017/S0952523801191066; KALLONIATIS M, 1990, J COMP NEUROL, V297, P340, DOI 10.1002/cne.902970303; Kalloniatis M, 2013, CLIN EXP OPTOM, V96, P310, DOI 10.1111/cxo.12015; Kalloniatis Michael, 2002, Clin Exp Optom, V85, P27; Kao YH, 2004, J COMP NEUROL, V478, P207, DOI 10.1002/cne.20221; KOLB H, 1977, J NEUROCYTOL, V6, P155, DOI 10.1007/BF01261503; KURIYAMA K, 1990, PROG CLIN BIOL RES, V351, P29; LOMBARDINI JB, 1991, BRAIN RES REV, V16, P151, DOI 10.1016/0165-0173(91)90003-Q; LUGOGARCIA N, 1991, BRAIN RES, V564, P19, DOI 10.1016/0006-8993(91)91346-3; Marc R.E., 1985, P119; MARC RE, 1982, VISION RES, V22, P589, DOI 10.1016/0042-6989(82)90117-1; Marc RE, 1998, INVEST OPHTH VIS SCI, V39, P1694; Marc RE, 1998, INVEST OPHTH VIS SCI, V39, P1685; Marc RE, 2005, VISION RES, V45, P3454, DOI 10.1016/j.visres.2005.07.025; MARC RE, 1990, J NEUROSCI, V10, P4006, DOI 10.1523/JNEUROSCI.10-12-04006.1990; MARC RE, 1981, P NATL ACAD SCI-BIOL, V78, P7185, DOI 10.1073/pnas.78.11.7185; MARC RE, 1992, PROG BRAIN RES, V90, P61; MARC RE, 1985, J COMP NEUROL, V232, P241, DOI 10.1002/cne.902320209; MARC RE, 1995, J NEUROSCI, V15, P5106; MARC RE, 1984, NATURE, V312, P266, DOI 10.1038/312266a0; Marc RE, 1999, J COMP NEUROL, V407, P47, DOI 10.1002/(SICI)1096-9861(19990428)407:1<47::AID-CNE4>3.0.CO;2-0; Marc RE, 1999, J COMP NEUROL, V407, P65; Marc RE, 2002, J NEUROSCI, V22, P413, DOI 10.1523/JNEUROSCI.22-02-00413.2002; MARC RE, 1986, VISION RES, V26, P223, DOI 10.1016/0042-6989(86)90017-9; Marc RE, 1989, PROGR RETINAL RES, P67; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; MARTIN PR, 1992, J COMP NEUROL, V323, P269, DOI 10.1002/cne.903230210; MOSINGER JL, 1986, EXP EYE RES, V42, P631, DOI 10.1016/0014-4835(86)90052-7; Muradov H, 2008, VISION RES, V48, P2302, DOI 10.1016/j.visres.2008.07.006; Muradov H, 2007, BIOCHEMISTRY-US, V46, P9992, DOI 10.1021/bi700535s; OSBORNE NN, 1986, CELL TISSUE RES, V243, P117; PASTEELS B, 1990, VISUAL NEUROSCI, V5, P1, DOI 10.1017/S0952523800000031; PICCO C, 1993, J PHYSIOL-LONDON, V460, P741, DOI 10.1113/jphysiol.1993.sp019497; Pombal MA, 2003, BRAIN RES, V993, P154, DOI 10.1016/j.brainres.2003.09.005; POTTER I C, 1968, Proceedings of the Linnean Society of London, V179, P229; POTTER I C, 1979, Environmental Biology of Fishes, V4, P65, DOI 10.1007/BF00005929; POTTER IC, 1983, J ZOOL, V200, P1; POTTER IC, 1980, CAN J FISH AQUAT SCI, V37, P1595, DOI 10.1139/f80-207; POURCHO RG, 1987, J NEUROSCI, V7, P1189; POURCHO RG, 1985, BRAIN RES, V348, P339, DOI 10.1016/0006-8993(85)90453-6; POURCHO RG, 1989, VISUAL NEUROSCI, V2, P425, DOI 10.1017/S0952523800012323; POURCHO RG, 1985, J COMP NEUROL, V233, P473, DOI 10.1002/cne.902330406; POW DV, 1994, VISUAL NEUROSCI, V11, P1115, DOI 10.1017/S0952523800006933; Renaud CB, 1997, J APPL ICHTHYOL, V13, P143, DOI 10.1111/j.1439-0426.1997.tb00114.x; RUBINSON K, 1989, VISUAL NEUROSCI, V3, P241, DOI 10.1017/S0952523800009998; RUBINSON K, 1990, J NEUROBIOL, V21, P1123, DOI 10.1002/neu.480210715; SHERRY DM, 1992, VISUAL NEUROSCI, V9, P313, DOI 10.1017/S0952523800010725; Sun D, 2006, J COMP NEUROL, V494, P686, DOI 10.1002/cne.20813; Sun D, 2003, J COMP NEUROL, V465, P38, DOI 10.1002/cne.10830; Sun D, 2007, J COMP NEUROL, V505, P92, DOI 10.1002/cne.21478; Trexler EB, 2001, J COMP NEUROL, V437, P408, DOI 10.1002/cne.1292; Vaney DI, 1998, J NEUROSCI, V18, P10594; VERSAUXBOTTERI C, 1991, VISUAL NEUROSCI, V7, P171; Villar-Cervino V, 2006, J COMP NEUROL, V499, P810, DOI 10.1002/cne.21136; Villar-Cheda B, 2006, BRAIN RES, V1068, P118, DOI 10.1016/j.brainres.2005.11.014; VOADEN MJ, 1978, J NEUROCHEM, V31, P1069, DOI 10.1111/j.1471-4159.1978.tb00149.x; WALD G, 1946, BIOL BULL, V91, P239; WALD G, 1957, J GEN PHYSIOL, V40, P901, DOI 10.1085/jgp.40.6.901; Warskulat U, 2007, ARCH BIOCHEM BIOPHYS, V462, P202, DOI 10.1016/j.abb.2007.03.022; Warskulat U, 2007, METHOD ENZYMOL, V428, P439, DOI 10.1016/S0076-6879(07)28025-5; WASOWICZ M, 1993, CR ACAD SCI III-VIE, V316, P455; WASSLE H, 1989, J COMP NEUROL, V279, P43, DOI 10.1002/cne.902790105; Yan XX, 1997, ANAT EMBRYOL, V195, P51; Yang CY, 1998, VISION RES, V38, P2521, DOI 10.1016/S0042-6989(98)00100-X; YANG CY, 1994, VISUAL NEUROSCI, V11, P1193, DOI 10.1017/S0952523800006994; YAQUB A, 1991, J COMP NEUROL, V312, P584, DOI 10.1002/cne.903120409; YAZULLA S, 1990, VISUAL NEUROSCI, V4, P299, DOI 10.1017/S0952523800003424	110	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58406	10.1371/journal.pone.0058406	http://dx.doi.org/10.1371/journal.pone.0058406			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516473	Green Published, gold			2022-12-27	WOS:000316849200064
J	De Souza, CP; Hashmi, SB; Osmani, AH; Andrews, P; Ringelberg, CS; Dunlap, JC; Osmani, SA				De Souza, Colin P.; Hashmi, Shahr B.; Osmani, Aysha H.; Andrews, Peter; Ringelberg, Carol S.; Dunlap, Jay C.; Osmani, Stephen A.			Functional Analysis of the Aspergillus nidulans Kinome	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; SEPTATION INITIATION NETWORK; SPINDLE ASSEMBLY CHECKPOINT; PROTEIN-KINASE FAMILY; POLO-LIKE KINASE; FISSION YEAST; MESSENGER-RNA; CELL MORPHOGENESIS; SEXUAL DEVELOPMENT; NEUROSPORA-CRASSA	The filamentous fungi are an ecologically important group of organisms which also have important industrial applications but devastating effects as pathogens and agents of food spoilage. Protein kinases have been implicated in the regulation of virtually all biological processes but how they regulate filamentous fungal specific processes is not understood. The filamentous fungus Aspergillus nidulans has long been utilized as a powerful molecular genetic system and recent technical advances have made systematic approaches to study large gene sets possible. To enhance A. nidulans functional genomics we have created gene deletion constructs for 9851 genes representing 93.3% of the encoding genome. To illustrate the utility of these constructs, and advance the understanding of fungal kinases, we have systematically generated deletion strains for 128 A. nidulans kinases including expanded groups of 15 histidine kinases, 7 SRPK (serine-arginine protein kinases) kinases and an interesting group of 11 filamentous fungal specific kinases. We defined the terminal phenotype of 23 of the 25 essential kinases by heterokaryon rescue and identified phenotypes for 43 of the 103 non-essential kinases. Uncovered phenotypes ranged from almost no growth for a small number of essential kinases implicated in processes such as ribosomal biosynthesis, to conditional defects in response to cellular stresses. The data provide experimental evidence that previously uncharacterized kinases function in the septation initiation network, the cell wall integrity and the morphogenesis Orb6 kinase signaling pathways, as well as in pathways regulating vesicular trafficking, sexual development and secondary metabolism. Finally, we identify ChkC as a third effector kinase functioning in the cellular response to genotoxic stress. The identification of many previously unknown functions for kinases through the functional analysis of the A. nidulans kinome illustrates the utility of the A. nidulans gene deletion constructs.	[De Souza, Colin P.; Hashmi, Shahr B.; Osmani, Aysha H.; Osmani, Stephen A.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Ringelberg, Carol S.; Dunlap, Jay C.] Geisel Sch Med Dartmouth, Dept Genet, Hanover, NH USA; [Andrews, Peter] Geisel Sch Med Dartmouth, Inst Quantitat Biomed Sci, Hanover, NH USA	University System of Ohio; Ohio State University; Dartmouth College; Dartmouth College	De Souza, CP (corresponding author), Ohio State Univ, Dept Mol Genet, 484 W 12Th Ave, Columbus, OH 43210 USA.	de-souza.1@osu.edu	Dunlap, Jay/L-6232-2013; Osmani, Stephen A./AAS-3904-2021	Dunlap, Jay/0000-0003-1577-0457; 	National Institutes of Health [P01 GM068087-08S1, GM042564, P01 GM068087]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042564, P01GM068087, R01GM083336, R01GM034985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (P01 GM068087-08S1 and GM042564) to SAO and (P01 GM068087) to JCD and SAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaya P, 1998, GENE, V211, P323, DOI 10.1016/S0378-1119(98)00115-2; Apostolaki A, 2012, MOL MICROBIOL, V84, P530, DOI 10.1111/j.1365-2958.2012.08042.x; Arnaud MB, 2010, NUCLEIC ACIDS RES, V38, pD420, DOI 10.1093/nar/gkp751; Bachewich C, 2005, MOL MICROBIOL, V55, P572, DOI 10.1111/j.1365-2958.2004.04404.x; Bayram O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002816; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bayram O, 2009, MOL MICROBIOL, V71, P1278, DOI 10.1111/j.1365-2958.2009.06606.x; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Boyce KJ, 2011, TRENDS MICROBIOL, V19, P400, DOI 10.1016/j.tim.2011.04.006; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Bruno KS, 2001, MOL MICROBIOL, V42, P3, DOI 10.1046/j.1365-2958.2001.02605.x; Calcagno-Pizarelli AM, 2011, J CELL SCI, V124, P4064, DOI 10.1242/jcs.088344; CID VJ, 1995, MICROBIOL REV, V59, P345, DOI 10.1128/MMBR.59.3.345-386.1995; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; De Souza CP, 2011, EMBO J, V30, P2648, DOI 10.1038/emboj.2011.176; De Souza CPC, 2006, GENETICS, V174, P1881, DOI 10.1534/genetics.106.063438; De Souza CPC, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P63; De Souza CPC, 1999, MOL BIOL CELL, V10, P3661, DOI 10.1091/mbc.10.11.3661; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dementhon K, 2003, EUKARYOT CELL, V2, P238, DOI 10.1128/EC.2.2.238-246.2003; Desjardins CA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002345; Doering TL, 2011, PLOS PATHOG, V7; Dominguez-Kelly R, 2011, J CELL BIOL, V194, P567, DOI 10.1083/jcb.201101047; Dou XW, 2003, GENETICS, V165, P1105; Draghetti C, 2009, J BIOL CHEM, V284, P32053, DOI 10.1074/jbc.M109.009324; Dvash E, 2010, EUKARYOT CELL, V9, P502, DOI 10.1128/EC.00230-09; Efimov VP, 1998, GENETICS, V149, P101; Findon H, 2010, FUNGAL GENET BIOL, V47, P647, DOI 10.1016/j.fgb.2010.04.002; Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x; Furukawa K, 2005, MOL MICROBIOL, V56, P1246, DOI 10.1111/j.1365-2958.2005.04605.x; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Giannakouros T, 2011, FEBS J, V278, P570, DOI 10.1111/j.1742-4658.2010.07987.x; Goldman G. H., 2008, ASPERGILLI GENOMICS; Goldman GH, 2004, FUNGAL GENET BIOL, V41, P428, DOI 10.1016/j.fgb.2003.12.001; Goldman GH, 2002, FUNGAL GENET BIOL, V35, P183, DOI 10.1006/fgbi.2002.1344; Gorovits R, 2003, EUKARYOT CELL, V2, P699, DOI 10.1128/EC.2.4.699-707.2003; Gupta S, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-19; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P1003, DOI 10.1271/bbb.60665; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; HARRIS SD, 1994, GENETICS, V136, P517; Hofmann AF, 2000, GENETICS, V154, P1577; Holt CL, 1996, GENETICS, V142, P777; Ichinomiya M, 2007, BIOSCI BIOTECH BIOCH, V71, P2787, DOI 10.1271/bbb.70409; James SW, 1999, J CELL SCI, V112, P1313; Judelson HS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-700; Jun SC, 2011, J MICROBIOL, V49, P418, DOI 10.1007/s12275-011-0193-3; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; KAFER E, 1965, GENETICS, V52, P217; Kim JM, 2006, GENETICS, V173, P685, DOI 10.1534/genetics.105.054304; Kim JM, 2009, MOL BIOL CELL, V20, P2874, DOI 10.1091/mbc.E08-12-1177; LaRonde-LeBlanc N, 2005, BBA-PROTEINS PROTEOM, V1754, P14, DOI 10.1016/j.bbapap.2005.07.037; Lee KM, 2005, MOL BIOL CELL, V16, P2734, DOI 10.1091/mbc.E04-11-0982; Liu HL, 2010, EUKARYOT CELL, V9, P831, DOI 10.1128/EC.00032-10; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Malavazi I, 2008, GENETICS, V178, P675, DOI 10.1534/genetics.107.080879; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Martin Y, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-21; Martinez DA, 2012, MBIO, V3, DOI 10.1128/mBio.00259-12; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Miranda-Saavedra D, 2007, PROTEINS, V68, P893, DOI 10.1002/prot.21444; Mirouse V, 2006, DEVELOPMENT, V133, P4005, DOI 10.1242/dev.02565; Mogilevsky K, 2012, EUKARYOT CELL, V11, P194, DOI 10.1128/EC.05130-11; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Moriya H, 2001, GENE DEV, V15, P1217, DOI 10.1101/gad.884001; MORRIS NR, 1975, GENET RES, V26, P237, DOI 10.1017/S0016672300016049; Mulder HJ, 2009, EUKARYOT CELL, V8, P665, DOI 10.1128/EC.00131-08; Muthuvijayan Vignesh, 2004, In Silico Biology, V4, P605; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Ni M, 2005, EUKARYOT CELL, V4, P1465, DOI 10.1128/EC.4.8.1465-1476.2005; Nielsen ML, 2006, FUNGAL GENET BIOL, V43, P54, DOI 10.1016/j.fgb.2005.09.005; OSMANI AH, 1994, J CELL SCI, V107, P1519; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Park G, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P50; Park JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006179; Pei Y, 2006, MOL CELL BIOL, V26, P777, DOI 10.1128/MCB.26.3.777-788.2006; Perez-Martin J, 2009, DNA REPAIR, V8, P720, DOI 10.1016/j.dnarep.2009.01.023; Plowman GD, 1999, P NATL ACAD SCI USA, V96, P13603, DOI 10.1073/pnas.96.24.13603; Rethinaswamy A, 1998, J BIOL CHEM, V273, P5869, DOI 10.1074/jbc.273.10.5869; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Rubin-Bejerano I, 2004, MOL CELL BIOL, V24, P6967, DOI 10.1128/MCB.24.16.6967-6979.2004; Sawin KE, 2009, NATURE, V459, P782, DOI 10.1038/459782a; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Schaller GE, 2011, CURR BIOL, V21, pR320, DOI 10.1016/j.cub.2011.02.045; Schwelnus W, 2001, EMBO REP, V2, P35, DOI 10.1093/embo-reports/kve009; Seiler S, 2006, MOL BIOL CELL, V17, P4080, DOI 10.1091/mbc.E06-01-0072; Sgarlata C, 2005, J CELL SCI, V118, P3607, DOI 10.1242/jcs.02499; Shi J, 2008, FUNGAL GENET BIOL, V45, P1570, DOI 10.1016/j.fgb.2008.08.011; SNELL V, 1994, EMBO J, V13, P2066, DOI 10.1002/j.1460-2075.1994.tb06481.x; Son S, 2009, EUKARYOT CELL, V8, P573, DOI 10.1128/EC.00346-08; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stracker TH, 2009, DNA REPAIR, V8, P1047, DOI 10.1016/j.dnarep.2009.04.012; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; Suzuki A, 2008, BIOSCI BIOTECH BIOCH, V72, P428, DOI 10.1271/bbb.70543; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JW, 2010, P NATL ACAD SCI USA, V107, P11655, DOI 10.1073/pnas.1006430107; Teepe AG, 2007, FUNGAL GENET BIOL, V44, P554, DOI 10.1016/j.fgb.2006.10.001; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; VERDE F, 1995, J CELL BIOL, V131, P1529, DOI 10.1083/jcb.131.6.1529; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; Wakabayashi M, 2008, DNA REPAIR, V7, P1951, DOI 10.1016/j.dnarep.2008.08.004; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Wei HJ, 2003, MOL MICROBIOL, V47, P1577, DOI 10.1046/j.1365-2958.2003.03405.x; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004; YARDEN O, 1992, EMBO J, V11, P2159, DOI 10.1002/j.1460-2075.1992.tb05275.x; Ye XS, 1998, MOL BIOL CELL, V9, P3019, DOI 10.1091/mbc.9.11.3019; Ye XS, 1997, EMBO J, V16, P182, DOI 10.1093/emboj/16.1.182; Ye XS, 1996, EMBO J, V15, P3599, DOI 10.1002/j.1460-2075.1996.tb00729.x; YOSHIDA S, 1994, MOL GEN GENET, V242, P631, DOI 10.1007/BF00283416; Ziv C, 2009, MOL MICROBIOL, V74, P974, DOI 10.1111/j.1365-2958.2009.06911.x	124	95	97	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58008	10.1371/journal.pone.0058008	http://dx.doi.org/10.1371/journal.pone.0058008			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505451	Green Submitted, gold, Green Published			2022-12-27	WOS:000318334500043
J	Herman, B; Gudrun, A; Potopalsky, AI; Chroboczek, J; Tcherniuk, SO				Herman, Bastien; Gudrun, Aldrian; Potopalsky, Anatoly I.; Chroboczek, Jadwiga; Tcherniuk, Sergey O.			Amitozyn Impairs Chromosome Segregation and Induces Apoptosis via Mitotic Checkpoint Activation	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; BENZOPHENANTHRIDINE ALKALOIDS; RETINOBLASTOMA PROTEIN; TUBULIN POLYMERIZATION; CHELIDONIUM-MAJUS; DRUG-RESISTANCE; MELANOMA-CELLS; DNA-DAMAGE; SANGUINARINE; PHOSPHORYLATION	Amitozyn (Am) is a semi-synthetic drug produced by the alkylation of major celandine (Chelidonium majus L.) alkaloids with the organophosphorous compound N,N'N'-triethylenethiophosphoramide (ThioTEPA). We show here that the treatment of living cells with Am reversibly perturbs the microtubule cytoskeleton, provoking a dose-dependent cell arrest in the M phase. Am changed the dynamics of tubulin polymerization in vitro, promoted the appearance of aberrant mitotic phenotypes in HeLa cells and induced apoptosis by the activation of caspase-9, caspase-3 and PARP, without inducing DNA breaks. Am treatment of HeLa cells induced changes in the phosphorylation of the growth suppressor pRb that coincided with maximum mitotic index. The dose-dependent and reversible anti-proliferative effect of Am was observed in several transformed cell lines. Importantly, the drug was also efficient against multidrug-resistant, paclitaxel-resistant or p53-deficient cells. Our results thus open the way to further pre-clinical evaluation of Am.	[Herman, Bastien; Chroboczek, Jadwiga; Tcherniuk, Sergey O.] CNRS, Inst Biol Struct, Grenoble, France; [Gudrun, Aldrian; Tcherniuk, Sergey O.] CNRS, Ctr Rech Biochim Macromol, Montpellier, France; [Potopalsky, Anatoly I.] Natl Acad Sci Ukraine NAN Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine; [Chroboczek, Jadwiga] Polish Acad Sci PAN, Inst Biochem & Biophys, Warsaw, Poland; [Chroboczek, Jadwiga] Univ Grenoble 1, CNRS, Therapeut Recombinante Expt Tech Ingn Med & Compl, La Tronche, France; [Tcherniuk, Sergey O.] AYSU, Dept Biol Sci, Kiev, Ukraine	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Tcherniuk, SO (corresponding author), CNRS, Inst Biol Struct, Grenoble, France.	sergey.tcherniuk@crbm.cnrs.fr	Chroboczek, Jadwiga/M-6554-2014	Aldrian, Gudrun/0000-0002-7899-0572	CNRS (France); Gefluc Association (France); Academy of Young Scientists of Ukraine [4791/05]	CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); Gefluc Association (France); Academy of Young Scientists of Ukraine	This study was in part supported by CNRS (France), by the Gefluc Association (France) and by the Academy of Young Scientists of Ukraine (Grant 4791/05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMINEV A M, 1963, Am J Proctol, V14, P25; Bai LP, 2006, BIOORGAN MED CHEM, V14, P5439, DOI 10.1016/j.bmc.2006.05.012; Caballero-George C, 2002, PLANTA MED, V68, P770, DOI 10.1055/s-2002-34406; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chadebech P, 1999, BIOCHEM BIOPH RES CO, V262, P823, DOI 10.1006/bbrc.1999.1291; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Colombo ML, 2001, FARMACO, V56, P403, DOI 10.1016/S0014-827X(01)01121-1; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; DOHADWALA M, 1994, P NATL ACAD SCI USA, V91, P6408, DOI 10.1073/pnas.91.14.6408; Drsata J, 1996, J ENZYM INHIB, V10, P231, DOI 10.3109/14756369609036530; FERNANDESALNEMRI T, 1994, J BIOL CHEM, V269, P30761; Galmarini CM, 2003, BRIT J CANCER, V88, P1793, DOI 10.1038/sj.bjc.6600960; Gasco M, 2003, DRUG RESIST UPDATE, V6, P323, DOI 10.1016/j.drup.2003.11.001; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hammerova J, 2011, J DERMATOL SCI, V62, P22, DOI 10.1016/j.jdermsci.2011.01.006; Hari M, 2006, MOL CANCER THER, V5, P270, DOI 10.1158/1535-7163.MCT-05-0190; HARKER WG, 1985, CANCER RES, V45, P4091; Haslam G, 2000, CYTOTECHNOLOGY, V32, P63, DOI 10.1023/A:1008121125755; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Huang HM, 2008, J CELL BIOL, V183, P667, DOI 10.1083/jcb.200805163; Joubert A, 2004, BIOMED RES-TOKYO, V25, P27, DOI 10.2220/biomedres.25.27; Kaminskyy V, 2008, TOXICOL LETT, V177, P168, DOI 10.1016/j.toxlet.2008.01.009; Kaminskyy V, 2008, CELL BIOL INT, V32, P271, DOI 10.1016/j.cellbi.2007.09.004; Kavallaris M, 1997, J CLIN INVEST, V100, P1282, DOI 10.1172/JCI119642; Kemeny-Beke A, 2006, CANCER LETT, V237, P67, DOI 10.1016/j.canlet.2005.05.037; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lee Jun, 2005, Journal of Applied Biological Chemistry, V48, P198; Lee SK, 1998, J BIOL CHEM, V273, P19829, DOI 10.1074/jbc.273.31.19829; Lee SS, 2001, PHYTOTHER RES, V15, P167, DOI 10.1002/ptr.703; LETTRE H., 1942, Naturwissenschaften, V30, P184; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li WQ, 1999, CELL GROWTH DIFFER, V10, P769; Ling YH, 1998, J BIOL CHEM, V273, P18984, DOI 10.1074/jbc.273.30.18984; Lopus M, 2006, FEBS J, V273, P2139, DOI 10.1111/j.1742-4658.2006.05227.x; LUDLOW JW, 1993, MOL CELL BIOL, V13, P367, DOI 10.1128/MCB.13.1.367; MAITI M, 1982, FEBS LETT, V142, P280, DOI 10.1016/0014-5793(82)80152-X; Martello LA, 2003, CANCER RES, V63, P1207; Matkar SS, 2008, CHEM-BIOL INTERACT, V172, P63, DOI 10.1016/j.cbi.2007.12.006; Nakanishi Y, 1999, ONCOLOGY-BASEL, V57, P318, DOI 10.1159/000012068; Nelson DA, 1997, J BIOL CHEM, V272, P4528, DOI 10.1074/jbc.272.7.4528; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; Panzer A, 2001, EUR J CELL BIOL, V80, P111, DOI 10.1078/0171-9335-00135; Park JE, 2011, BIOORG MED CHEM LETT, V21, P6960, DOI 10.1016/j.bmcl.2011.09.128; Paul Avijit, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P1025, DOI 10.3736/jcim20120912; Philchenkov A. A., 2006, Ukrainskii Biokhimicheskii Zhurnal, V78, P81; ROSS W, 1984, CANCER RES, V44, P5857; Sarkozi A, 2006, CHROMATOGRAPHIA, V63, pS81, DOI 10.1365/s10337-006-0728-7; SAVCHAK V I, 1976, Vestnik Dermatologii i Venerologii, V3, P77; Shin HJ, 2003, CANCER CELL, V4, P483, DOI 10.1016/S1535-6108(03)00302-7; Tanabe H, 2006, PHYTOMEDICINE, V13, P334, DOI 10.1016/j.phymed.2005.02.001; TANAKA T, 1993, PLANTA MED, V59, P200, DOI 10.1055/s-2006-959651; Tcherniuk S, 2011, CHEM BIOL, V18, P631, DOI 10.1016/j.chembiol.2011.03.006; Tcherniuk S, 2010, ANGEW CHEM INT EDIT, V49, P8228, DOI 10.1002/anie.201003254; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vasey PA, 1996, MOL PHARMACOL, V50, P1536; Vavreckova C, 1996, PLANTA MED, V62, P397, DOI 10.1055/s-2006-957924; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x; WIDMANN H, 1955, Arch Geschwulstforsch, V9, P6; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376; WOLFF J, 1993, BIOCHEMISTRY-US, V32, P13334, DOI 10.1021/bi00211a047; Wong OK, 2007, J CELL BIOL, V179, P611, DOI 10.1083/jcb.200708044	66	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57461	10.1371/journal.pone.0057461	http://dx.doi.org/10.1371/journal.pone.0057461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505430	gold, Green Published			2022-12-27	WOS:000318334500022
J	Smagghe, BJ; Stewart, AK; Carter, MG; Shelton, LM; Bernier, KJ; Hartman, EJ; Calhoun, AK; Hatziioannou, VM; Lillacci, G; Kirk, BA; DiNardo, BA; Kosik, KS; Bamdad, C				Smagghe, Benoit J.; Stewart, Andrew K.; Carter, Mark G.; Shelton, Laura M.; Bernier, Kyle J.; Hartman, Eric J.; Calhoun, Amy K.; Hatziioannou, Vasilios M.; Lillacci, Gabriele; Kirk, Brian A.; DiNardo, Brian A.; Kosik, Kenneth S.; Bamdad, Cynthia			MUC1*Ligand, NM23-H1, Is a Novel Growth Factor That Maintains Human Stem Cells in a More Naive State	PLOS ONE			English	Article							NUCLEOSIDE DIPHOSPHATE KINASE; OLIGOMERIC STRUCTURE; SELF-RENEWAL; MATRIX; LINES; DIFFERENTIATION; SUPPORTS; PROLIFERATION; PLURIPOTENCY; DERIVATION	We report that a single growth factor, NM23-H1, enables serial passaging of both human ES and iPS cells in the absence of feeder cells, their conditioned media or bFGF in a fully defined xeno-free media on a novel defined, xeno-free surface. Stem cells cultured in this system show a gene expression pattern indicative of a more "naive" state than stem cells grown in bFGF-based media. NM23-H1 and MUC1* growth factor receptor cooperate to control stem cell self-replication. By manipulating the multimerization state of NM23-H1, we override the stem cell's inherent programming that turns off pluripotency and trick the cells into continuously replicating as pluripotent stem cells. Dimeric NM23-H1 binds to and dimerizes the extra cellular domain of the MUC1* transmembrane receptor which stimulates growth and promotes pluripotency. Inhibition of the NM23-H1/MUC1* interaction accelerates differentiation and causes a spike in miR-145 expression which signals a cell's exit from pluripotency.	[Smagghe, Benoit J.; Stewart, Andrew K.; Carter, Mark G.; Shelton, Laura M.; Bernier, Kyle J.; Hartman, Eric J.; Calhoun, Amy K.; Hatziioannou, Vasilios M.; Kirk, Brian A.; DiNardo, Brian A.; Bamdad, Cynthia] Minerva Biotechnol, Waltham, MA USA; [Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Lillacci, Gabriele] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Bamdad, C (corresponding author), Minerva Biotechnol, Waltham, MA USA.	cbamdad@minervabio.com		Lillacci, Gabriele/0000-0002-5162-1750	National Science Foundation [NSF-CDI ECC-0835847]	National Science Foundation(National Science Foundation (NSF))	The work of GL was supported by the National Science Foundation under Grant NSF-CDI ECC-0835847. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; [Anonymous], 2007, HUM CELL CULT; Bamdad C, 1998, BIOPHYS J, V75, P1989, DOI 10.1016/S0006-3495(98)77640-4; Bamdad C, 1999, RAPID SENSITIVE DETE; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; CHANG CL, 1994, NATURE, V370, P335, DOI 10.1038/370335a0; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Derda R, 2010, J AM CHEM SOC, V132, P1289, DOI 10.1021/ja906089g; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hikita ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003312; HOZUMI M, 1985, CRC CR REV ONCOL-HEM, V3, P235, DOI 10.1016/S1040-8428(85)80028-7; Kim YI, 2003, BIOCHEM BIOPH RES CO, V307, P281, DOI 10.1016/S0006-291X(03)01195-1; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532; Klim JR, 2012, ACS CHEM BIOL; Klimanskaya I, 2005, LANCET, V365, P1636, DOI 10.1016/S0140-6736(05)66473-2; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Lascu I, 1997, J BIOL CHEM, V272, P15599, DOI 10.1074/jbc.272.25.15599; Li YJ, 2006, J BIOMED MATER RES A, V79A, P1, DOI 10.1002/jbm.a.30732; LIEDBERG B, 1993, SENSOR ACTUAT B-CHEM, V11, P63, DOI 10.1016/0925-4005(93)85239-7; LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7; Lombardi D, 2000, J CELL PHYSIOL, V182, P144, DOI 10.1002/(SICI)1097-4652(200002)182:2<144::AID-JCP2>3.3.CO;2-Y; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mahanta S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002054; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Meng Y, 2010, FASEB J, V24, P1056, DOI 10.1096/fj.08-126821; Mesnildrey S, 1997, FEBS LETT, V418, P53, DOI 10.1016/S0014-5793(97)01292-1; Mesnildrey S, 1998, J BIOL CHEM, V273, P4436, DOI 10.1074/jbc.273.8.4436; Nelson TJ, 2010, NAT REV CARDIOL, V7, P700, DOI 10.1038/nrcardio.2010.159; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; OKABEKADO J, 1992, BIOCHEM BIOPH RES CO, V182, P987, DOI 10.1016/0006-291X(92)91829-F; OKABEKADO J, 1995, FEBS LETT, V363, P311, DOI 10.1016/0014-5793(95)00338-A; ORKIN RW, 1977, J EXP MED, V145, P204, DOI 10.1084/jem.145.1.204; Pompe T, 2010, NAT PROTOC, V5, P1042, DOI 10.1038/nprot.2010.70; Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726; Saha K, 2011, P NATL ACAD SCI USA, V108, P18714, DOI 10.1073/pnas.1114854108; Song EJ, 2000, BIOCHEMISTRY-US, V39, P10090, DOI 10.1021/bi000267a; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Thompson AB, 2011, ACS APPL MATER INTER, V3, P2979, DOI 10.1021/am200459a; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Unger C, 2008, HUM MOL GENET, V17, pR48, DOI 10.1093/hmg/ddn079; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Vr Wallet, 1990, DICTYOSTELIUM NUCLEO, P1199; Vuoristo S, 2009, J CELL MOL MED, V13, P2622, DOI 10.1111/j.1582-4934.2008.00643.x; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189	55	20	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58601	10.1371/journal.pone.0058601	http://dx.doi.org/10.1371/journal.pone.0058601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505541	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500106
J	Zhou, J; Zhuang, J; Li, J; Ooi, E; Bloom, J; Poon, C; Lax, D; Rosenbaum, DM; Barone, FC				Zhou, Jin; Zhuang, Jian; Li, Jie; Ooi, Evelyn; Bloom, Jonathan; Poon, Carrie; Lax, Daniel; Rosenbaum, Daniel M.; Barone, Frank C.			Long-Term Post-Stroke Changes Include Myelin Loss, Specific Deficits in Sensory and Motor Behaviors and Complex Cognitive Impairment Detected Using Active Place Avoidance	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; WHITE-MATTER INTEGRITY; DELAYED NEURONAL DEATH; BRAIN-INJURY; OCCLUSION; STROKE; ISCHEMIA; RAT; SENSORIMOTOR; MEMORY	Persistent neurobehavioral deficits and brain changes need validation for brain restoration. Two hours middle cerebral artery occlusion (tMCAO) or sham surgery was performed in male Sprague-Dawley rats. Neurobehavioral and cognitive deficits were measured over 10 weeks included: (1) sensory, motor, beam balance, reflex/abnormal responses, hindlimb placement, forepaw foot fault and cylinder placement tests, and (2) complex active place avoidance learning (APA) and simple passive avoidance retention (PA). Electroretinogram (ERG), hemispheric loss (infarction), hippocampus CA1 neuronal loss and myelin (Luxol Fast Blue) staining in several fiber tracts were also measured. In comparison to Sham surgery, tMCAO surgery produced significant deficits in all behavioral tests except reflex/abnormal responses. Acute, short lived deficits following tMCAO were observed for forelimb foot fault and forelimb cylinder placement. Persistent, sustained deficits for the whole 10 weeks were exhibited for motor (p<0.001), sensory (p<0.001), beam balance performance (p<0.01) and hindlimb placement behavior (p<0.01). tMCAO produced much greater and prolonged cognitive deficits in APA learning (maximum on last trial of 604 +/- 83% change, p<0.05) but only a small, comparative effect on PA retention. Hemispheric loss/atrophy was measured 10 weeks after tMCAO and cross-validated by two methods (e. g., almost identical % ischemic hemispheric loss of 33.4 +/- 3.5% for H&E and of 34.2 +/- 3.5% for TTC staining). No visual dysfunction by ERG and no hippocampus neuronal loss were detected after tMCAO. Fiber tract damage measured by Luxol Fast Blue myelin staining intensity was significant (p<0.01) in the external capsule and striatum but not in corpus callosum and anterior commissure. In summary, persistent neurobehavioral deficits were validated as important endpoints for stroke restorative research in the future. Fiber myelin loss appears to contribute to these long term behavioral dysfunctions and can be important for cognitive behavioral control necessary for complex APA learning.	[Zhou, Jin; Zhuang, Jian; Li, Jie; Ooi, Evelyn; Bloom, Jonathan; Poon, Carrie; Lax, Daniel; Rosenbaum, Daniel M.; Barone, Frank C.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Rosenbaum, Daniel M.; Barone, Frank C.] Suny Downstate Med Ctr, Robert F Furchgott Fdn, Brooklyn, NY 11203 USA; [Barone, Frank C.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Zhou, J (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA.	jin.zhou@downstate.edu		Lax, Daniel/0000-0003-1186-3111	States University of New York Downstate Research Foundation; Department of Neurology	States University of New York Downstate Research Foundation; Department of Neurology	This work was supported using basic research funds provided by the States University of New York Downstate Research Foundation and Department of Neurology. Only the persons listed as authors of this manuscript had roles in the study design, the collection and analysis of data, the decision to publish, and/or the preparation of this paper for publication.	Aronowski J, 1996, J CEREBR BLOOD F MET, V16, P705, DOI 10.1097/00004647-199607000-00022; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Barone FC, 2010, NEUROPHARMACOLOGY, V59, P650, DOI 10.1016/j.neuropharm.2010.08.016; Barone FC, 2009, CURR OPIN INVEST DR, V10, P220; Biernaskie J, 2001, J NEUROSCI, V21, P5272, DOI 10.1523/JNEUROSCI.21-14-05272.2001; Bingham D, 2012, J CEREBR BLOOD F MET, V32, P989, DOI 10.1038/jcbfm.2012.16; Blahna K, 2011, BEHAV BRAIN RES, V216, P207, DOI 10.1016/j.bbr.2010.07.038; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cimadevilla JM, 2000, NEUROSCI LETT, V285, P53, DOI 10.1016/S0304-3940(00)01019-3; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; Dahlqvist P, 2004, EUR J NEUROSCI, V19, P2288, DOI 10.1111/j.0953-816X.2004.03248.x; Das A, 2005, PHARMACOL BIOCHEM BE, V81, P89, DOI 10.1016/j.pbb.2005.02.006; David J, 2011, NEUROREPORT, V22, P633, DOI 10.1097/WNR.0b013e32834959c5; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; DeVries AC, 2001, NEUROSCI BIOBEHAV R, V25, P325, DOI 10.1016/S0149-7634(01)00017-3; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Ding Y, 2004, NEUROSCIENCE, V123, P667, DOI 10.1016/j.neuroscience.2003.08.031; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P11493, DOI 10.1073/pnas.95.19.11493; Ferrucci L, 1996, J AM GERIATR SOC, V44, P237; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Fjell AM, 2011, J NEUROSCI, V31, P18060, DOI 10.1523/JNEUROSCI.4735-11.2011; Freret T, 2006, BEHAV NEUROSCI, V120, P1285, DOI 10.1037/0735-7044.120.6.1285; Freret Thomas, 2011, Exp Transl Stroke Med, V3, P6, DOI 10.1186/2040-7378-3-6; Gwag BJ, 2007, J CEREBR BLOOD F MET, V27, P1142, DOI 10.1038/sj.jcbfm.9600418; HIRAKAWA M, 1994, STROKE, V25, P2471, DOI 10.1161/01.STR.25.12.2471; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; Johansson BB, 1996, STROKE, V27, P324, DOI 10.1161/01.STR.27.2.324; Kalesnykas G, 2008, NEUROSCIENCE, V155, P937, DOI 10.1016/j.neuroscience.2008.06.038; KIRINO T, 1984, ACTA NEUROPATHOL, V64, P139, DOI 10.1007/BF00695577; Lee JH, 2011, ANAT CELL BIOL, V44, P25, DOI 10.5115/acb.2011.44.1.25; Lei B, 2004, NEUROSCIENCE, V125, P691, DOI 10.1016/j.neuroscience.2004.02.034; Lenhard SC, 2008, PHARMACOLOGY, V81, P1, DOI 10.1159/000107661; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Lin SY, 2004, BRAIN RES, V1007, P132, DOI 10.1016/j.brainres.2004.01.074; Liu ZW, 2008, STROKE, V39, P2571, DOI 10.1161/STROKEAHA.107.511659; Ma JY, 2006, J NEUROSCI METH, V156, P76, DOI 10.1016/j.jneumeth.2006.02.006; Merino Jose G, 2002, Curr Atheroscler Rep, V4, P285, DOI 10.1007/s11883-002-0007-5; Pendlebury ST, 1999, STROKE, V30, P956, DOI 10.1161/01.STR.30.5.956; Petito CK, 1997, J CEREBR BLOOD F MET, V17, P967, DOI 10.1097/00004647-199709000-00006; Raz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012606; Roof RL, 2001, STROKE, V32, P2648, DOI 10.1161/hs1101.097397; Sachdev PS, 2004, NEUROLOGY, V63, P1618, DOI 10.1212/01.WNL.0000142964.83484.DE; Sakai N, 1996, BEHAV BRAIN RES, V77, P181, DOI 10.1016/0166-4328(95)00232-4; Samanez-Larkin GR, 2012, J NEUROSCI, V32, P5333, DOI 10.1523/JNEUROSCI.5756-11.2012; Savva GM, 2010, STROKE, V41, pE41, DOI 10.1161/STROKEAHA.109.559880; Schaar Krystal L, 2010, Exp Transl Stroke Med, V2, P13, DOI 10.1186/2040-7378-2-13; WAHL F, 1992, STROKE, V23, P267, DOI 10.1161/01.STR.23.2.267; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Willing AE, 2002, INT J NEUROSCI, V112, P503, DOI 10.1080/00207450290025617; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; YAMAGUCHI T, 1995, BRAIN RES, V669, P107, DOI 10.1016/0006-8993(94)01268-M; Zausinger S, 2000, BRAIN RES, V863, P94, DOI 10.1016/S0006-8993(00)02100-4; Zhou J, 2011, J CEREBR BLOOD F MET, V31, P924, DOI 10.1038/jcbfm.2010.171; Zvejniece L, 2012, J NEUROSCI METHODS	57	30	33	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57503	10.1371/journal.pone.0057503	http://dx.doi.org/10.1371/journal.pone.0057503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505432	gold, Green Submitted, Green Published			2022-12-27	WOS:000318334500024
J	Miura, K; Deng, BB; Tullo, G; Diouf, A; Moretz, SE; Locke, E; Morin, M; Fay, MP; Long, CA				Miura, Kazutoyo; Deng, Bingbing; Tullo, Gregory; Diouf, Ababacar; Moretz, Samuel E.; Locke, Emily; Morin, Merribeth; Fay, Michael P.; Long, Carole A.			Qualification of Standard Membrane-Feeding Assay with Plasmodium falciparum Malaria and Potential Improvements for Future Assays	PLOS ONE			English	Article							TRANSMISSION-BLOCKING IMMUNITY; GAMETOCYTE INFECTIVITY; VACCINE; ANTIBODIES; AREA; MOSQUITOS; PFS25; PARASITEMIA; POPULATIONS; VALIDATION	Vaccines that interrupt malaria transmission are of increasing interest and a robust functional assay to measure this activity would promote their development by providing a biologically relevant means of evaluating potential vaccine candidates. Therefore, we aimed to qualify the standard membrane-feeding assay (SMFA). The assay measures the transmission-blocking activity of antibodies by feeding cultured P. falciparum gametocytes to Anopheles mosquitoes in the presence of the test antibodies and measuring subsequent mosquito infection. The International Conference on Harmonisation (ICH) Harmonised Tripartite Guideline Q2(R1) details characteristics considered in assay validation. Of these characteristics, we decided to qualify the SMFA for Precision, Linearity, Range and Specificity. The transmission-blocking 4B7 monoclonal antibody was tested over 6 feeding experiments at several concentrations to determine four suitable concentrations that were tested in triplicate in the qualification experiments (3 additional feeds) to evaluate Precision, Linearity and Range. For Specificity, 4B7 was tested in the presence of normal mouse IgG. We determined intra-and inter-assay variability of % inhibition of mean oocyst intensity at each concentration of 4B7 (lower concentrations showed higher variability). We also showed that % inhibition was dependent on 4B7 concentration and the activity is specific to 4B7. Since obtaining empirical data is time-consuming, we generated a model using data from all 9 feeds and simulated the effects of different parameters on final readouts to improve the assay procedure and analytical methods for future studies. For example, we estimated the effect of number of mosquitoes dissected on variability of % inhibition, and simulated the relationship between % inhibition in oocyst intensity and % inhibition of prevalence of infected mosquitos at different mean oocysts in the control. SMFA is one of the few biological assays used in preclinical and early clinical development of transmission-blocking vaccines, and this study strongly supports its further development and application.	[Miura, Kazutoyo; Deng, Bingbing; Tullo, Gregory; Diouf, Ababacar; Moretz, Samuel E.; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Locke, Emily; Morin, Merribeth] PATH Malaria Vaccine Initiat, Washington, DC USA; [Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Miura, K (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA.	kmiura@niaid.nih.gov	Miura, Kazutoyo/AAY-9751-2020; Fay, Michael P/A-2974-2008	Miura, Kazutoyo/0000-0003-4455-2432; Fay, Michael P/0000-0002-8643-9625	National Institute of Allergy and Infectious Diseases/National Institutes of Health; PATH Malaria Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PATH Malaria Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by the intramural program of the National Institute of Allergy and Infectious Diseases/National Institutes of Health and by the PATH Malaria Vaccine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; BARR PJ, 1991, J EXP MED, V174, P1203, DOI 10.1084/jem.174.5.1203; BILLINGSLEY PF, 1994, AM J TROP MED HYG, V51, P260, DOI 10.4269/ajtmh.1994.51.260; Bousema JT, 2006, AM J TROP MED HYG, V74, P425; Bousema T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042821; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Delves MJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-35; Drakeley CJ, 2004, PARASITE IMMUNOL, V26, P159, DOI 10.1111/j.0141-9838.2004.00696.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fay MP, 2001, BIOMETRICS, V57, P1198, DOI 10.1111/j.0006-341X.2001.01198.x; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; Gozar MMG, 2001, EXP PARASITOL, V97, P61, DOI 10.1006/expr.2000.4580; GRAVES PM, 1988, PARASITOLOGY, V96, P251, DOI 10.1017/S003118200005825X; Hisaeda H, 2000, INFECT IMMUN, V68, P6618, DOI 10.1128/IAI.68.12.6618-6623.2000; ICH(INTERNATIONALCOUNCILFOR HARMONISATION), 2005, VALIDATION ANALYTICA; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; KASLOW DC, 1994, INFECT IMMUN, V62, P5576, DOI 10.1128/IAI.62.12.5576-5580.1994; Lee A.J., 1990, U STAT THEORY PRACTI; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; MEDLEY GF, 1993, PARASITOLOGY, V106, P441, DOI 10.1017/S0031182000076721; Miura K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-107; Mulder B, 1999, EXP PARASITOL, V92, P81, DOI 10.1006/expr.1999.4398; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Ouedraogo AL, 2011, INFECT IMMUN, V79, P4957, DOI 10.1128/IAI.05288-11; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; SATTABONGKOT J, 1991, PARASITOLOGY, V102, P27, DOI 10.1017/S0031182000060303; SKAUG H., 2012, GEN LINEAR MIXED MOD; Stowers AW, 2000, INFECT IMMUN, V68, P5530, DOI 10.1128/IAI.68.10.5530-5538.2000; Toure YT, 1998, AM J TROP MED HYG, V59, P481, DOI 10.4269/ajtmh.1998.59.481; Van Der Kolk M, 2005, PARASITOLOGY, V130, P13, DOI 10.1017/S0031182004006067; van der Kolk M, 2006, INT J PARASITOL, V36, P1091, DOI 10.1016/j.ijpara.2006.05.004; Vossen MG, 2010, AM J TROP MED HYG, V82, P398, DOI 10.4269/ajtmh.2010.09-0417; Wu Yu-Huan, 2008, P3	36	90	92	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57909	10.1371/journal.pone.0057909	http://dx.doi.org/10.1371/journal.pone.0057909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483940	Green Published, gold			2022-12-27	WOS:000316936100053
J	Porcheron, A; Mauger, E; Russell, R				Porcheron, Aurelie; Mauger, Emmanuelle; Russell, Richard			Aspects of Facial Contrast Decrease with Age and Are Cues for Age Perception	PLOS ONE			English	Article							COSMETICS USE; ATTRACTIVENESS; SEX; HEALTH; FACES; IMPACT; YOUNG; SHAPE; OLD	Age is a primary social dimension. We behave differently toward people as a function of how old we perceive them to be. Age perception relies on cues that are correlated with age, such as wrinkles. Here we report that aspects of facial contrast-the contrast between facial features and the surrounding skin-decreased with age in a large sample of adult Caucasian females. These same aspects of facial contrast were also significantly correlated with the perceived age of the faces. Individual faces were perceived as younger when these aspects of facial contrast were artificially increased, but older when these aspects of facial contrast were artificially decreased. These findings show that facial contrast plays a role in age perception, and that faces with greater facial contrast look younger. Because facial contrast is increased by typical cosmetics use, we infer that cosmetics function in part by making the face appear younger.	[Porcheron, Aurelie; Mauger, Emmanuelle] CERIES, Neuilly Sur Seine, France; [Porcheron, Aurelie; Russell, Richard] Gettysburg Coll, Gettysburg, PA 17325 USA	Gettysburg College	Russell, R (corresponding author), Gettysburg Coll, Gettysburg, PA 17325 USA.	rrussell@gettysburg.edu	Russell, Richard/A-1331-2007	Russell, Richard/0000-0002-4007-8596				BERRY DS, 1986, PSYCHOL BULL, V100, P3, DOI 10.1037/0033-2909.100.1.3; Brainard D.H., 2003, SCI COLOR, V2, P191, DOI DOI 10.1016/B978-044451251-2/50006-4; Bruce V., 1998, EYE BEHOLDER SCI FAC; Bulpitt CJ, 2001, POSTGRAD MED J, V77, P578, DOI 10.1136/pmj.77.911.578; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; CASH TF, 1989, J SOC PSYCHOL, V129, P349, DOI 10.1080/00224545.1989.9712051; Christensen K, 2004, EPIDEMIOLOGY, V15, P251, DOI 10.1097/01.ede.0000112211.11416.a6; Christensen K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5262; COX CL, 1986, SEX ROLES, V14, P51, DOI 10.1007/BF00287847; Dakin SC, 2009, J VISION, V9, DOI [10.1167/9.4.2, 10.1167/9.11.28]; Dupuis-Roy N, 2009, J VISION, V9, DOI 10.1167/9.2.10; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Etcoff NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025656; Farage M. A., 2010, TXB AGING SKIN, P983; Farkas LG, 2004, J CRANIOFAC SURG, V15, P288, DOI 10.1097/00001665-200403000-00027; Fink B, 2012, INT J COSMETIC SCI, V34, P307, DOI 10.1111/j.1468-2494.2012.00724.x; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; GEORGE PA, 1995, PERCEPTION, V24, P1059, DOI 10.1068/p241059; George PA, 1998, PERCEPTION, V27, P295, DOI 10.1068/p270295; GRAHAM JA, 1980, INT J COSMETIC SCI, V2, P77, DOI 10.1111/j.1467-2494.1980.tb00237.x; Gunn DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008021; Gupta MA, 2005, DERMATOL CLIN, V23, P643, DOI 10.1016/j.det.2005.05.012; HENLEY NM, 1973, B PSYCHONOMIC SOC, V2, P91, DOI 10.3758/BF03327726; Hillebrand GG., 2007, ETHNIC SKIN HAIR, P105; Hole G, 2011, VIS COGN, V19, P585, DOI 10.1080/13506285.2011.562076; Huguet P, 2004, J APPL SOC PSYCHOL, V34, P1752, DOI 10.1111/j.1559-1816.2004.tb02796.x; Hwang SW, 2011, J GEN INTERN MED, V26, P136, DOI 10.1007/s11606-010-1537-0; KLIGMAN AM, 1989, CUTIS, V43, P498; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Leong Paul L, 2008, Facial Plast Surg Clin North Am, V16, P277, DOI 10.1016/j.fsc.2008.03.007; MARK LS, 1980, PERCEPT PSYCHOPHYS, V27, P117, DOI 10.3758/BF03204298; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; Mayes AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015270; Mulhern R., 2003, International Journal of Cosmetic Science, V25, P199, DOI 10.1046/j.1467-2494.2003.00188.x; Nash R, 2006, J APPL SOC PSYCHOL, V36, P493, DOI 10.1111/j.0021-9029.2006.00016.x; Nestor A, 2008, PSYCHOL SCI, V19, P1242, DOI 10.1111/j.1467-9280.2008.02232.x; Nkengne A, 2008, J EUR ACAD DERMATOL, V22, P982, DOI 10.1111/j.1468-3083.2008.02698.x; Porcheron A, 2011, PIGM CELL MELANOMA R, V24, P840; Rexbye H, 2006, AGE AGEING, V35, P110, DOI 10.1093/ageing/afj031; Russell R, 2003, PERCEPTION, V32, P1093, DOI 10.1068/p5101; Russell R, 2010, SCI SOCIAL VISION; Russell R, 2009, PERCEPTION, V38, P1211, DOI 10.1068/p6331; Samson N, 2010, J COSMET DERMATOL-US, V9, P79, DOI 10.1111/j.1473-2165.2010.00489.x; SEDDON JM, 1990, INVEST OPHTH VIS SCI, V31, P1592; Stephen ID, 2011, EVOL HUM BEHAV, V32, P216, DOI 10.1016/j.evolhumbehav.2010.09.003; Stephen ID, 2010, PERCEPTION, V39, P1104, DOI 10.1068/p6730; Stephen ID, 2010, PLOS ONE; Swanson E, 2011, J PLAST RECONSTR AES, V64, P1124, DOI 10.1016/j.bjps.2011.04.004; Tschachler E, 2005, SKIN AGING, P23; Verbeke G, 1997, LINEAR MIXED MODELS; Zebrowitz L. A., 1997, READING FACES WINDOW	51	72	73	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57985	10.1371/journal.pone.0057985	http://dx.doi.org/10.1371/journal.pone.0057985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483959	gold, Green Published			2022-12-27	WOS:000316936100064
J	Saxena, N; Muthukumaraswamy, SD; Diukova, A; Singh, K; Hall, J; Wise, R				Saxena, Neeraj; Muthukumaraswamy, Suresh D.; Diukova, Ana; Singh, Krish; Hall, Judith; Wise, Richard			Enhanced Stimulus-Induced Gamma Activity in Humans during Propofol-Induced Sedation	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; GENERAL ANESTHETIC PROPOFOL; HIPPOCAMPUS IN-VITRO; INDUCED ALPHA-RHYTHM; FAST-SPIKING CELLS; NEURAL OSCILLATIONS; GABA(A) RECEPTORS; FREQUENCY; EEG; MEG	Stimulus-induced gamma oscillations in the 30-80 Hz range have been implicated in a wide number of functions including visual processing, memory and attention. While occipital gamma-band oscillations can be pharmacologically modified in animal preparations, pharmacological modulation of stimulus-induced visual gamma oscillations has yet to be demonstrated in non-invasive human recordings. Here, in fifteen healthy humans volunteers, we probed the effects of the GABA(A) agonist and sedative propofol on stimulus-related gamma activity recorded with magnetoencephalography, using a simple visual grating stimulus designed to elicit gamma oscillations in the primary visual cortex. During propofol sedation as compared to the normal awake state, a significant 60% increase in stimulus-induced gamma amplitude was seen together with a 94% enhancement of stimulus-induced alpha suppression and a simultaneous reduction in the amplitude of the pattern-onset evoked response. These data demonstrate, that propofol-induced sedation is accompanied by increased stimulus-induced gamma activity providing a potential window into mechanisms of gamma-oscillation generation in humans.	[Saxena, Neeraj; Hall, Judith] Cardiff Univ, Sch Med, Dept Anaesthet Intens Care & Pain Med, Cardiff CF10 3AX, S Glam, Wales; [Saxena, Neeraj] Royal Glamorgan Hosp, Dept Anaesthet, Cwm Taf Local Hlth Board, Llantrisant, Wales; [Muthukumaraswamy, Suresh D.; Diukova, Ana; Singh, Krish; Wise, Richard] Cardiff Univ, CUBRIC, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Wise, R (corresponding author), Cardiff Univ, CUBRIC, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales.	wiserg@cardiff.ac.uk		Muthukumaraswamy, Suresh/0000-0001-7042-3920; Saxena, Neeraj/0000-0003-0913-9351; Singh, Krishna/0000-0002-3094-2475				Adjamian P, 2004, EUR J NEUROSCI, V20, P587, DOI 10.1111/j.1460-9568.2004.03495.x; Bai DL, 2001, MOL PHARMACOL, V59, P814, DOI 10.1124/mol.59.4.814; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bauer M, 2012, CURR BIOL, V22, P397, DOI 10.1016/j.cub.2012.01.022; Brookes MJ, 2005, NEUROIMAGE, V26, P302, DOI 10.1016/j.neuroimage.2005.01.050; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chambers JD, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00053; Ching SN, 2010, P NATL ACAD SCI USA, V107, P22665, DOI 10.1073/pnas.1017069108; Clapp WC, 2006, NEUROSCI LETT, V398, P220, DOI 10.1016/j.neulet.2005.12.081; COLLINS GGS, 1988, BRIT J PHARMACOL, V95, P939, DOI 10.1111/j.1476-5381.1988.tb11724.x; CONCAS A, 1991, BRAIN RES, V542, P225, DOI 10.1016/0006-8993(91)91571-H; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Feng HJ, 2004, MOL PHARMACOL, V66, P1517, DOI 10.1124/mol.104.003426; Feshchenko VA, 2004, NEUROPSYCHOBIOLOGY, V50, P257, DOI 10.1159/000079981; Fries P, 2008, NEURON, V58, P303, DOI 10.1016/j.neuron.2008.04.020; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; GRAY CM, 1990, EUR J NEUROSCI, V2, P607, DOI 10.1111/j.1460-9568.1990.tb00450.x; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Gugino LA, 2001, BRIT J ANAESTH, V87, P421, DOI 10.1093/bja/87.3.421; Hadjipapas A, 2007, NEUROIMAGE, V35, P518, DOI 10.1016/j.neuroimage.2007.01.002; Hall SD, 2005, CLIN NEUROPHYSIOL, V116, P1716, DOI 10.1016/j.clinph.2005.02.027; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hindriks R, 2012, NEUROIMAGE, V60, P2323, DOI 10.1016/j.neuroimage.2012.02.042; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Houston CM, 2012, J NEUROSCI, V32, P3887, DOI 10.1523/JNEUROSCI.5406-11.2012; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Jeong JA, 2011, NEUROSCI LETT, V494, P119, DOI 10.1016/j.neulet.2011.02.072; Kahlbrock N, 2012, NEUROIMAGE, V59, P673, DOI 10.1016/j.neuroimage.2011.07.017; KRAUT MA, 1985, ELECTROEN CLIN NEURO, V62, P300, DOI 10.1016/0168-5597(85)90007-3; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Lee U, 2009, CONSCIOUS COGN, V18, P56, DOI 10.1016/j.concog.2008.10.005; Mann EO, 2011, NAT NEUROSCI, V13, P205; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MARSH B, 1991, BRIT J ANAESTH, V67, P41, DOI 10.1093/bja/67.1.41; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Muthukumaraswamy SD, 2010, J NEUROPHYSIOL, V104, P2873, DOI 10.1152/jn.00607.2010; Muthukumaraswamy SD, 2010, NEUROIMAGE, V49, P3349, DOI 10.1016/j.neuroimage.2009.11.045; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Oke OO, 2010, EUR J NEUROSCI, V31, P1435, DOI 10.1111/j.1460-9568.2010.07171.x; ORSER BA, 1994, J NEUROSCI, V14, P7747; Perry G, 2011, EUR J NEUROSCI, V34, P652, DOI 10.1111/j.1460-9568.2011.07777.x; Pinotsis DA, 2013, NEUROIMAGE, V66, P563, DOI 10.1016/j.neuroimage.2012.10.078; Privman E, 2011, CEREB CORTEX, V21, P616, DOI 10.1093/cercor/bhq128; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; Robinson S.E., 1999, RECENT ADV BIOMAGNET, P302; Robinson SE, 2004, LOCALIZATION EVENT R; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; SANNA E, 1995, J PHARMACOL EXP THER, V274, P353; Schwarzkopf DS, 2012, J NEUROSCI, V32, P1507, DOI 10.1523/JNEUROSCI.4771-11.2012; Singer W, 2001, ANN NY ACAD SCI, V929, P123; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Swettenham JB, 2009, J NEUROPHYSIOL, V102, P1241, DOI 10.1152/jn.91044.2008; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Thomson AJ, 2009, ANAESTHESIA, V64, P32, DOI 10.1111/j.1365-2044.2008.05683.x; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Wang XJ, 1996, J NEUROSCI, V16, P6402; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027; Whitham EM, 2008, CLIN NEUROPHYSIOL, V119, P1166, DOI 10.1016/j.clinph.2008.01.024; Whittington MA, 1996, BRIT J PHARMACOL, V118, P1977, DOI 10.1111/j.1476-5381.1996.tb15633.x; Xing DJ, 2012, P NATL ACAD SCI USA, V109, P13871, DOI 10.1073/pnas.1201478109; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027	67	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57685	10.1371/journal.pone.0057685	http://dx.doi.org/10.1371/journal.pone.0057685			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483920	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000316936100036
J	Huai, C; Song, JP; Ma, ZY; Qin, XF; Li, PL; Chen, HY; Zhao, F; Lu, DR; Song, DL; Mao, Y; Song, X; Zhao, Y				Huai, Cong; Song, Jianping; Ma, Zengyi; Qin, Xuanfeng; Li, Peiliang; Chen, Hongyan; Zhao, Fan; Lu, Daru; Song, Donglei; Mao, Ying; Song, Xiao; Zhao, Yao			Allelic Variation of the MMP3 Promoter Affects Transcription Activity through the Transcription Factor C-MYB in Human Brain Arteriovenous Malformations	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; INTRACRANIAL HEMORRHAGE; GROWTH-FACTOR; EXPRESSION; POLYMORPHISMS; ONCOGENE; GENE	MMPs comprise a family of proteolytic enzymes that degrade pericellular substances, which may result in the destabilization of vessels and related to the development of brain arteriovenous malformations (BAVM). MMP3 is a key member of this family, overexpressed in BAVM tissues, and a single nucleotide polymorphism within MMP3, -709A>G (rs522616), is significantly associated with the risk of BAVM. In this study, we aimed to investigate the mechanism through which the polymorphism rs522616 regulates the expression of MMP3. Our results showed that -709A led to a over 2-fold higher transcriptional activity compared with the G allele (P<0.05) and this transcriptional activity can be depressed by co-ransfecting cells with competitive DNA fragments containing -709A but not -709G. Bioinformatics analyses suggested that the transcription factor C-MYB might bind to the area around rs522616. Overexpressed C-MYB significantly increased the transcriptional activity of -709A compared with -709G or controls that did not overexpress c-myb (P<0.01) in HEK293 and HUVEC cells. ChIP assays indicated that C-MYB bound to the SNP region in the two cell lines and three BAVM tissue samples. Together, these data indicated that C-MYB can bind to the -709A allele of the MMP3 promoter, activate its transcription and lead to a higher expression of this gene. This novel hypothesis, supported by molecular evidence, explains how this SNP affects MMP3 promoter function and results in a risk of BAVM development.	[Huai, Cong; Chen, Hongyan; Lu, Daru; Song, Xiao] Fudan Univ, State Key Lab Genet Engn, Fudan VARI Genet Epidemiol Ctr, Shanghai 200433, Peoples R China; [Huai, Cong; Chen, Hongyan; Lu, Daru; Song, Xiao] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Huai, Cong; Chen, Hongyan; Lu, Daru; Song, Xiao] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Song, Jianping; Ma, Zengyi; Qin, Xuanfeng; Li, Peiliang; Zhao, Fan; Song, Donglei; Mao, Ying; Zhao, Yao] Fudan Univ, Dept Neurosurg, Huashan Hosp, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Song, X (corresponding author), Fudan Univ, State Key Lab Genet Engn, Fudan VARI Genet Epidemiol Ctr, Shanghai 200433, Peoples R China.	dylansong0207@gmail.com; yao.zhao.hs@gmail.com		Mao, Ying/0000-0001-8055-115X; Song, Jianping/0000-0003-3411-1457	National Natural Science Foundation of China [30500524, 30973103, 81070936]; Key Subjects Innovative Talents Training Program of Fudan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Subjects Innovative Talents Training Program of Fudan University	This work was supported by the National Natural Science Foundation of China (30500524, 30973103, 81070936), the web site url of this foundation is http://www.nsfc.gov.cn/Portal0/default152.htm and the Key Subjects Innovative Talents Training Program of Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALITALO K, 1984, P NATL ACAD SCI-BIOL, V81, P4534, DOI 10.1073/pnas.81.14.4534; Berman MF, 2000, NEUROSURGERY, V47, P389, DOI 10.1097/00006123-200008000-00023; Biondi ML, 2000, CLIN CHEM, V46, P2023; Brown RD, 2008, LANCET NEUROL, V7, P195, DOI 10.1016/S1474-4422(08)70027-9; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Dey S, 2012, MOL CARCINOGEN, V51, pE42, DOI 10.1002/mc.21837; Du R, 2007, J NEUROSURG, V106, P470, DOI 10.3171/jns.2007.106.3.470; Fan WW, 2012, MOL CARCINOGEN, V51, pE1, DOI 10.1002/mc.20842; Gang Ouyang, 2011, WORLD CHINESE J DIGE, V19, P3130; Hacein-Bey L, 1999, Interv Neuroradiol, V5 Suppl 1, P177; Halim AX, 2004, STROKE, V35, P1697, DOI 10.1161/01.STR.0000130988.44824.29; Hashimoto T, 2004, NEUROSURGERY, V54, P410, DOI 10.1227/01.NEU.0000103421.35266.71; Hashimoto T, 2003, STROKE, V34, P925, DOI 10.1161/01.STR.0000061888.71524.DF; Jeffree RL, 2009, PEDIATR NEUROSURG, V45, P296, DOI 10.1159/000235604; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Kim H, 2008, ACTA NEUROCHIR SUPPL, V105, P199; Kim H, 2009, STROKE, V40, pS95, DOI 10.1161/STROKEAHA.108.533216; Leblanc GG, 2009, STROKE, V40, pE694, DOI 10.1161/STROKEAHA.109.563692; Letra A, 2012, J CLIN PERIODONTOL, V39, P707, DOI 10.1111/j.1600-051X.2012.01902.x; Luo J, 2005, CEREBELLUM, V4, P239, DOI 10.1080/14734220500247646; O'Brien P, 2008, BBA-PROTEINS PROTEOM, V1784, P1130, DOI 10.1016/j.bbapap.2008.01.006; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Pawlikowska L, 2005, STROKE, V36, P2278, DOI 10.1161/01.STR.0000182253.91167.fa; Quick CM, 2001, NEUROL RES, V23, P641, DOI 10.1179/016164101101198938; Sage EH, 2003, J BIOL CHEM, V278, P37849, DOI 10.1074/jbc.M302946200; Sterneck E, 2006, ONCOGENE, V25, P1272, DOI 10.1038/sj.onc.1209144; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; Zhao Y, 2010, J CLIN NEUROSCI, V17, P1568, DOI 10.1016/j.jocn.2010.04.023; Zhu YQ, 2006, NEUROSURGERY, V59, P687, DOI 10.1227/01.NEU.0000228962.68204.CF	30	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57958	10.1371/journal.pone.0057958	http://dx.doi.org/10.1371/journal.pone.0057958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483952	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900059
J	Figley, SA; Chen, YH; Maeda, A; Conroy, L; McMullen, JD; Silver, JI; Stapleton, S; Vitkin, A; Lindsay, P; Burrell, K; Zadeh, G; Fehlings, MG; DaCosta, RS				Figley, Sarah A.; Chen, Yonghong; Maeda, Azusa; Conroy, Leigh; McMullen, Jesse D.; Silver, Jason I.; Stapleton, Shawn; Vitkin, Alex; Lindsay, Patricia; Burrell, Kelly; Zadeh, Gelareh; Fehlings, Michael G.; DaCosta, Ralph S.			A Spinal Cord Window Chamber Model for In Vivo Longitudinal Multimodal Optical and Acoustic Imaging in a Murine Model	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; NERVOUS-SYSTEM; INJURY; TOMOGRAPHY; MICROSCOPY; REGENERATION; INFLAMMATION; PATHOLOGY; PROTEIN; BRAIN	In vivo and direct imaging of the murine spinal cord and its vasculature using multimodal (optical and acoustic) imaging techniques could significantly advance preclinical studies of the spinal cord. Such intrinsically high resolution and complementary imaging technologies could provide a powerful means of quantitatively monitoring changes in anatomy, structure, physiology and function of the living cord over time after traumatic injury, onset of disease, or therapeutic intervention. However, longitudinal in vivo imaging of the intact spinal cord in rodent models has been challenging, requiring repeated surgeries to expose the cord for imaging or sacrifice of animals at various time points for ex vivo tissue analysis. To address these limitations, we have developed an implantable spinal cord window chamber (SCWC) device and procedures in mice for repeated multimodal intravital microscopic imaging of the cord and its vasculature in situ. We present methodology for using our SCWC to achieve spatially co-registered optical-acoustic imaging performed serially for up to four weeks, without damaging the cord or induction of locomotor deficits in implanted animals. To demonstrate the feasibility, we used the SCWC model to study the response of the normal spinal cord vasculature to ionizing radiation over time using white light and fluorescence microscopy combined with optical coherence tomography (OCT) in vivo. In vivo power Doppler ultrasound and photoacoustics were used to directly visualize the cord and vascular structures and to measure hemoglobin oxygen saturation through the complete spinal cord, respectively. The model was also used for intravital imaging of spinal micrometastases resulting from primary brain tumor using fluorescence and bioluminescence imaging. Our SCWC model overcomes previous in vivo imaging challenges, and our data provide evidence of the broader utility of hybridized optical-acoustic imaging methods for obtaining multiparametric and rich imaging data sets, including over extended periods, for preclinical in vivo spinal cord research.	[Figley, Sarah A.; Fehlings, Michael G.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Figley, Sarah A.; Burrell, Kelly; Zadeh, Gelareh; Fehlings, Michael G.] Univ Hlth Network, Toronto Western Res Inst, Krembil Neurosci Program, Toronto, ON, Canada; [Chen, Yonghong; McMullen, Jesse D.; Silver, Jason I.; Vitkin, Alex; DaCosta, Ralph S.] Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada; [Maeda, Azusa; Conroy, Leigh; Stapleton, Shawn; Vitkin, Alex; DaCosta, Ralph S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Vitkin, Alex; Lindsay, Patricia; DaCosta, Ralph S.] Princess Margaret Hosp, Dept Radiat Oncol, Univ Hlth Network, Toronto, ON M4X 1K9, Canada	University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	DaCosta, RS (corresponding author), Princess Margaret Hosp, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada.	rdacosta@uhnres.utoronto.ca	Vitkin, Alex/C-8123-2016; Vitkin, Alex/I-8166-2012	Vitkin, Alex/0000-0001-5495-8888; Conroy, Leigh/0000-0003-0055-3660; Fehlings, Michael/0000-0002-5722-6364	Cancer Care Ontario; Canadian Institutes of Health Research [93578]; Ontario Ministry of Health and Long Term care	Cancer Care Ontario; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term care(Ministry of Health and Long-Term Care, Ontario)	This research was funded in part by Cancer Care Ontario (DaCosta holds a CCO Research Chair in Cancer Imaging; https://www.cancercare.on.ca/), the Canadian Institutes of Health Research (awarded to Dr. DaCosta, reference number 93578; http://www.cihr-irsc.gc.ca/e/193.html) and the Ontario Ministry of Health and Long Term Care (http://www.health.gov.on.ca/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P115; Bhavna Y, 2009, CURR BIOL, V19, P930; Bilgen M., 2006, NEUROANATOMY, V5, P12; BRAUN IF, 1983, RADIOLOGY, V147, P459, DOI 10.1148/radiology.147.2.6340159; Byrnes KR, 2010, J MAGN RESON IMAGING, V32, P836, DOI 10.1002/jmri.22323; Cadotte DW, 2012, BIOMED OPT EXPRESS, V3, P911, DOI 10.1364/BOE.3.000911; Clarkson R, 2011, MED PHYS, V38, P845, DOI 10.1118/1.3533947; Davalos D, 2008, J NEUROSCI METH, V169, P1, DOI 10.1016/j.jneumeth.2007.11.011; Dibaj P, 2010, GLIA, V58, P1133, DOI 10.1002/glia.20993; DOMMISSE GF, 1974, J BONE JOINT SURG BR, VB 56, P225, DOI 10.1302/0301-620X.56B2.225; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Dray C, 2009, P NATL ACAD SCI USA, V106, P9459, DOI 10.1073/pnas.0900222106; Farrar MJ, 2012, NATURE METHODS ADV; Fehlings MG, 2011, NEUROTHERAPEUTICS, V8, P704, DOI 10.1007/s13311-011-0076-7; Fenrich KK, 2012, J PHYSIOL-LONDON, V590, P3665, DOI 10.1113/jphysiol.2012.230532; HORNSEY S, 1990, INT J RADIAT ONCOL, V18, P1437, DOI 10.1016/0360-3016(90)90319-F; Hsu W, 2012, NEUROSURGERY, DOI [10.1227/NEU.1220-b1013e3182532e3182571, DOI 10.1227/NEU.1220-B1013E3182532E3182571]; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Johannssen HC, 2010, J PHYSIOL-LONDON, V588, P3397, DOI 10.1113/jphysiol.2010.191833; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kim JV, 2010, J IMMUNOL METHODS, V352, P89, DOI 10.1016/j.jim.2009.09.007; Kirkpatrick JP, 2010, INT J RADIAT ONCOL, V76, pS42, DOI 10.1016/j.ijrobp.2009.04.095; Lassmann H, 2005, BRAIN PATHOL, V15, P217; Liu TW, 2011, BIOCONJUGATE CHEM, V22, P1021, DOI 10.1021/bc200169x; Madi S, 2001, AM J NEURORADIOL, V22, P1768; MARCUS ML, 1977, CIRC RES, V41, P128, DOI 10.1161/01.RES.41.1.128; MCAFEE PC, 1986, SPINE, V11, P295, DOI 10.1097/00007632-198605000-00001; Misgeld T, 2006, NAT REV NEUROSCI, V7, P449, DOI 10.1038/nrn1905; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; NIX W, 1976, STROKE, V7, P560, DOI 10.1161/01.STR.7.6.560; Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; POWERS BE, 1992, INT J RADIAT ONCOL, V23, P539, DOI 10.1016/0360-3016(92)90009-7; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sahgal A, 2011, J NEUROSURG-SPINE, V14, P151, DOI 10.3171/2010.9.SPINE091005; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; SIEGAL T, 1995, INT J RADIAT ONCOL, V31, P57, DOI 10.1016/0360-3016(94)E0305-4; Sinescu Crina, 2010, J Med Life, V3, P254; Stroman PW, 2005, CLIN MED RES, V3, P146, DOI 10.3121/cmr.3.3.146; Tench CR, 2005, J NEUROIMAGING, V15, p94S, DOI 10.1177/1051228405283292; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; VANDERKOGEL AJ, 1993, RADIOTHER ONCOL, V29, P105, DOI 10.1016/0167-8140(93)90234-Y; Wang XD, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2192804; Xu MH, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2195024; Yu WR, 2011, ACTA NEUROPATHOL, V122, P747, DOI 10.1007/s00401-011-0882-3	46	28	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58081	10.1371/journal.pone.0058081	http://dx.doi.org/10.1371/journal.pone.0058081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516432	gold, Green Published, Green Submitted			2022-12-27	WOS:000316407400015
J	Hammami, I; Nuel, G; Garcia, A				Hammami, Imen; Nuel, Gregory; Garcia, Andre			Statistical Properties of Parasite Density Estimators in Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; THICK BLOOD FILMS; RELIABILITY; DIAGNOSIS; CHILDREN; TRANSMISSION; MICROSCOPY; INFECTION; QBC(R); TESTS	Malaria is a global health problem responsible for nearly one million deaths every year around 85% of which concern children younger than five years old in Sub-Saharan Africa. In addition, around 300 million clinical cases are declared every year. The level of infection, expressed as parasite density, is classically defined as the number of asexual parasites relative to a microliter of blood. Microscopy of Giemsa-stained thick blood films is the gold standard for parasite enumeration. Parasite density estimation methods usually involve threshold values; either the number of white blood cells counted or the number of high power fields read. However, the statistical properties of parasite density estimators generated by these methods have largely been overlooked. Here, we studied the statistical properties (mean error, coefficient of variation, false negative rates) of parasite density estimators of commonly used threshold-based counting techniques depending on variable threshold values. We also assessed the influence of the thresholds on the cost-effectiveness of parasite density estimation methods. In addition, we gave more insights on the behavior of measurement errors according to varying threshold values, and on what should be the optimal threshold values that minimize this variability.	[Hammami, Imen; Nuel, Gregory] Paris Descartes Univ, Dept Appl Math MAPS, UMR CNRS 8145, Paris, France; [Garcia, Andre] Inst Rech Dev, Dept Mother & Child Relat Trop Infect, UMR 216, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Hammami, I (corresponding author), Paris Descartes Univ, Dept Appl Math MAPS, UMR CNRS 8145, Paris, France.	imen.hammami@parisdescartes.fr	Garcia, Andre/ABA-1820-2020; Garcia, Andre/S-2959-2016	Garcia, Andre/0000-0002-1808-472X; Garcia, Andre/0000-0002-1808-472X	Centre National de la Recherche Scientifique (National Center for Scientific Research) (CNRS)	Centre National de la Recherche Scientifique (National Center for Scientific Research) (CNRS)	The authors are funded by Centre National de la Recherche Scientifique (National Center for Scientific Research) (CNRS) PhD Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander N, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-4; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Bates I, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-38; Bejon P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-104; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRAUNMUNZINGER RA, 1992, TROP MED PARASITOL, V43, P149; Chippaux JP, 1991, ETUDES THESES, P55; Christophers R, 1951, BRIT MED J, V1, P75; CLENDENNEN TE, 1995, T ROY SOC TROP MED H, V89, P183, DOI 10.1016/0035-9203(95)90486-7; Colbourne M J, 1971, Trop Doct, V1, P161; COLLIER JAB, 1983, ANN TROP MED PARASIT, V77, P113, DOI 10.1080/00034983.1983.11811683; DOWLING MAC, 1966, B WORLD HEALTH ORGAN, V34, P249; DRAPER CC, 1971, BRIT MED J, V2, P93, DOI 10.1136/bmj.2.5753.93; Dubey ML, 1999, INDIAN J MED RES, V109, P20; Earle WC, 1931, J LAB CLIN MED, V17, P1124; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; Garcia A, 2004, MICROBES INFECT, V6, P68, DOI 10.1016/j.micinf.2003.09.021; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Kilian AHD, 2000, TROP MED INT HEALTH, V5, P3, DOI 10.1046/j.1365-3156.2000.00509.x; KIRKWOOD BR, 2001, ESSENTIALS MED STAT; KREMSNER PG, 1988, J INFECT DIS, V158, P1368, DOI 10.1093/infdis/158.6.1368; Le Port A, 2011, AM J TROP MED HYG, V84, P270, DOI 10.4269/ajtmh.2011.10-0319; Milet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011616; Molineaux L, 1980, THE GARKI PROJECT; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Mulder B, 1998, T ROY SOC TROP MED H, V92, P395, DOI 10.1016/S0035-9203(98)91061-6; O'Meara WP, 2006, PARASITOL RES, V99, P500, DOI 10.1007/s00436-006-0135-x; O'Meara WP, 2005, AM J TROP MED HYG, V73, P593, DOI 10.4269/ajtmh.2005.73.593; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; Petersen E, 1996, AM J TROP MED HYG, V55, P485, DOI 10.4269/ajtmh.1996.55.485; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; ROGIER C, 1993, T ROY SOC TROP MED H, V87, P245, DOI 10.1016/0035-9203(93)90110-C; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Sakuntabhai A, 2008, MICROBES INFECT, V3, P2000; SCHELLENBERG JRMA, 1994, PARASITOL TODAY, V10, P439, DOI 10.1016/0169-4758(94)90179-1; Scott WA, 1955, PUBLIC OPIN QUART, V19, P321, DOI 10.1086/266577; Small DS, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1201; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; TRAPE JF, 1985, T ROY SOC TROP MED H, V79, P181, DOI 10.1016/0035-9203(85)90329-3; Warhurst DC, 1996, J CLIN PATHOL, V49, P533, DOI 10.1136/jcp.49.7.533; WHO, 2000, B WHO; WHO, 1961, WHORA126261; World Health Organization, 2010, BAS MAL MICR 1; ZUROVAC D, 2006, TROP MED INT HEALTH, V11, P1	47	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e51987	10.1371/journal.pone.0051987	http://dx.doi.org/10.1371/journal.pone.0051987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516389	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400002
J	Adem, A; Al Haj, M; Benedict, S; Yasin, J; Nagelkerke, N; Nyberg, F; Yandle, TG; Frampton, CM; Lewis, LK; Nicholls, MG; Kazzam, E				Adem, Abdu; Al Haj, Mahmoud; Benedict, Sheela; Yasin, Javed; Nagelkerke, Nicolas; Nyberg, Fred; Yandle, Tim G.; Frampton, Chris M.; Lewis, Lynley K.; Nicholls, M. Gary; Kazzam, Elsadig			ANP and BNP Responses to Dehydration in the One-Humped Camel and Effects of Blocking the Renin-Angiotensin System	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; PLASMA; WATER; HEART	The objectives of this study were to investigate and compare the responses of atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) in the circulation of hydrated, dehydrated, and dehydrated losartan - treated camels; and to document the cardiac storage form of B-type natriuretic peptide in the camel heart. Eighteen male camels were used in the study: control or hydrated camels (n = 6), dehydrated camels (n = 6) and dehydrated losartan-treated camels (n = 6) which were dehydrated and received the angiotensin II (Ang II) AT-1 receptor blocker, losartan, at a dose of 5 mg/kg body weight intravenously for 20 days. Control animals were supplied with feed and water ad-libitum while both dehydrated and dehydrated-losartan treated groups were supplied with feed ad-libitum but no water for 20 days. Compared with time-matched controls, dehydrated camels exhibited a significant decrease in plasma levels of both ANP and BNP. Losartan-treated camels also exhibited a significant decline in ANP and BNP levels across 20 days of dehydration but the changes were not different from those seen with dehydration alone. Size exclusion high performance liquid chromatography of extracts of camel heart indicated that proB-type natriuretic peptide is the storage form of the peptide. We conclude first, that dehydration in the camel induces vigorous decrements in circulating levels of ANP and BNP; second, blockade of the renin-angiotensin system has little or no modulatory effect on the ANP and BNP responses to dehydration; third, proB-type natriuretic peptide is the storage form of this hormone in the heart of the one-humped camel.	[Adem, Abdu; Al Haj, Mahmoud] UAE Univ, Fac Med & Hlth Sci, Dept Pharmacol, Al Ain, U Arab Emirates; [Benedict, Sheela; Yasin, Javed; Nagelkerke, Nicolas; Kazzam, Elsadig] UAE Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Al Haj, Mahmoud; Nyberg, Fred] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Yandle, Tim G.; Frampton, Chris M.; Lewis, Lynley K.; Nicholls, M. Gary] Univ Otago, Dept Med, Christchurch Hosp, Christchurch, New Zealand	United Arab Emirates University; United Arab Emirates University; Uppsala University; Christchurch Hospital New Zealand; University of Otago	Kazzam, E (corresponding author), UAE Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.	kazzam@uaeu.ac.ae	Adem, Abdu/AAN-8271-2021; PATHAN, JAVED YASIN/GOE-4396-2022	Adem, Abdu/0000-0002-9289-5301; PATHAN, JAVED YASIN/0000-0002-5867-2833	Sheikh Hamdan Bin Rashid Al Maktoum Award; Faculty of Medicine and Health Sciences; United Arab University	Sheikh Hamdan Bin Rashid Al Maktoum Award; Faculty of Medicine and Health Sciences; United Arab University	This study was supported by a grant from Sheikh Hamdan Bin Rashid Al Maktoum Award for Medical Sciences and grants from the Faculty of Medicine and Health Sciences and the United Arab University. The authors are grateful to Merck (United States of America) for the gift of losartan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037299; BENGOUMI M, 1993, GEN COMP ENDOCR, V89, P378, DOI 10.1006/gcen.1993.1045; DAVIS CL, 1987, AM J PHYSIOL, V252, pF146, DOI 10.1152/ajprenal.1987.252.1.F146; FLORKOWSKI CM, 1994, AM J PHYSIOL, V266, pR1244, DOI 10.1152/ajpregu.1994.266.4.R1244; HUNT PJ, 1995, BIOCHEM BIOPH RES CO, V214, P1175, DOI 10.1006/bbrc.1995.2410; MACFARLANE WV, 1963, NATURE, V197, P270, DOI 10.1038/197270a0; Omland Torbjorn, 2009, Heart Fail Clin, V5, P471, DOI 10.1016/j.hfc.2009.04.005; Osman AHK, 2004, COMP BIOCHEM PHYS A, V139, P417, DOI 10.1016/j.cbpb.2004.05.009; Pemberton CJ, 1997, J ENDOCRINOL, V155, P541, DOI 10.1677/joe.0.1550541; Richards AM, 1996, CLIN SCI, V91, P3, DOI 10.1042/cs0910003; Rosenstrom U, 2004, J MED CHEM, V47, P859, DOI 10.1021/jm030921v; Ruskoaho H, 1997, J MOL MED, V75, P876, DOI 10.1007/s001090050179; SOSA RE, 1986, AM J PHYSIOL, V250, pF520, DOI 10.1152/ajprenal.1986.250.3.F520	13	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57806	10.1371/journal.pone.0057806	http://dx.doi.org/10.1371/journal.pone.0057806			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516417	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200019
J	Nyffeler, M; Knornschild, M				Nyffeler, Martin; Knoernschild, Mirjam			Bat Predation by Spiders	PLOS ONE			English	Article							ORB-WEAVING SPIDERS; SEXUAL SIZE DIMORPHISM; DARWINS BARK SPIDER; GOLDEN-TIPPED BAT; PIPISTRELLUS-ABRAMUS; MYOTIS-EMARGINATUS; INSECTIVOROUS BATS; FORAGING BEHAVIOR; KERIVOULA-PAPUENSIS; POMONA CHIROPTERA	In this paper more than 50 incidences of bats being captured by spiders are reviewed. Bat-catching spiders have been reported from virtually every continent with the exception of Antarctica (similar to 90% of the incidences occurring in the warmer areas of the globe between latitude 30 degrees N and 30 degrees S). Most reports refer to the Neotropics (42% of observed incidences), Asia (28.8%), and Australia-Papua New Guinea (13.5%). Bat-catching spiders belong to the mygalomorph family Theraphosidae and the araneomorph families Nephilidae, Araneidae, and Sparassidae. In addition to this, an attack attempt by a large araneomorph hunting spider of the family Pisauridae on an immature bat was witnessed. Eighty-eight percent of the reported incidences of bat catches were attributable to web-building spiders and 12% to hunting spiders. Large tropical orb-weavers of the genera Nephila and Eriophora in particular have been observed catching bats in their huge, strong orb-webs (of up to 1.5 m diameter). The majority of identifiable captured bats were small aerial insectivorous bats, belonging to the families Vespertilionidae (64%) and Emballonuridae (22%) and usually being among the most common bat species in their respective geographic area. While in some instances bats entangled in spider webs may have died of exhaustion, starvation, dehydration, and/or hyperthermia (i.e., non-predation death), there were numerous other instances where spiders were seen actively attacking, killing, and eating the captured bats (i.e., predation). This evidence suggests that spider predation on flying vertebrates is more widespread than previously assumed.	[Nyffeler, Martin] Univ Basel, Dept Environm Sci, Sect Conservat Biol NLU, Basel, Switzerland; [Knoernschild, Mirjam] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany	University of Basel; Ulm University	Nyffeler, M (corresponding author), Univ Basel, Dept Environm Sci, Sect Conservat Biol NLU, Basel, Switzerland.	martin.nyffeler@unibas.ch	Knörnschild, Mirjam/C-9401-2011	Knornschild, Mirjam/0000-0003-0448-9600				Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Aguiar LMS, 2008, REV BRAS ZOOL, V25, P28, DOI 10.1590/S0101-81752008000100005; Allen GM., 2004, BATS BIOL BEHAV FOLK; Altringham JD, 1996, BATS BIOL BEHAV; [Anonymous], AUK; Baerg W. J., 1963, Journal of the New York Entomological Society, V71, P233; Banfield EJ, 1918, TROPIC DAYS; Barlow KE, 1997, J ZOOL, V243, P597, DOI 10.1111/j.1469-7998.1997.tb02804.x; BAUEROVA Z, 1986, FOLIA ZOOL, V35, P305; Begon M., 2005, ECOLOGY INDIVIDUALS, V4th ed.; BHAT HR, 1980, MAMMALIA, V44, P343, DOI 10.1515/mamm.1980.44.3.343; BHATTACHARYA G. C., 1941, CURRENT SCI, V10, P183; Blackledge TA, 2011, ADV INSECT PHYSIOL, V41, P175, DOI 10.1016/B978-0-12-415919-8.00004-5; Blackledge TA, 2011, J ARACHNOL, V39, P205, DOI 10.1636/Chi10-52.1; Brown Rafe M., 1996, Herpetological Natural History, V4, P1; Burles DW, 2008, CAN J ZOOL, V86, P1367, DOI 10.1139/Z08-125; Cantor T., 1842, J NAT HIST, V9, P481, DOI 10.1080/03745484209445368; Ceballos L, 2005, J ARACHNOL, V33, P509, DOI 10.1636/04-74.1; Churchill S, 2008, AUSTR BATS, V2nd; Conniff R, 1996, NATL GEOGR, V190, P99; Cox James A., 2007, Florida Field Naturalist, V35, P46; CRAIG CL, 1987, BIOL J LINN SOC, V30, P135, DOI 10.1111/j.1095-8312.1987.tb00294.x; Das Karumampoyil Sakthidas Anoop, 2012, Tropical Natural History, V12, P257; Deans A, 2011, SPIDER CAPTURES BIRD; Diniz Suzana, 2011, Herpetology Notes, V4, P357; Douangboubpha B, 2010, ACTA CHIROPTEROL, V12, P415, DOI 10.3161/150811010X537990; Duca C, 2007, REV BRAS ORNITOL, V15, P615; Ebenstein DM, 2006, J MATER RES, V21, P2035, DOI 10.1557/JMR.2006.0246; Edwards GB, 2009, EENY160 U FLOR I FOO, V160; EISNER T, 1964, SCIENCE, V146, P1058, DOI 10.1126/science.146.3647.1058; EISNER T, 1976, P NATL ACAD SCI USA, V73, P1365, DOI 10.1073/pnas.73.4.1365; EISNER T, 1983, SCIENCE, V219, P185, DOI 10.1126/science.219.4581.185; FENTON MB, 1981, J MAMMAL, V62, P233, DOI 10.2307/1380701; Fitzinger LJFJ, 1870, SITZUNGSBERICHTE MN, V61, P123; FORMANOWICZ DR, 1981, HERPETOLOGICA, V37, P125; FULLARD JH, 1991, AUST J ZOOL, V39, P427, DOI 10.1071/ZO9910427; Funakoshi Kimitake, 1998, Mammal Study, V23, P49, DOI 10.3106/mammalstudy.23.49; Funakoshi K, 2010, MAMM STUDY, V35, P65, DOI 10.3106/041.035.0105; Garcia Rivera L., 2009, B SOC ENTOMOLOGICA A, V45, P505; Gertsch W.J., 1979, AM SPIDERS; Gillette DD, 1970, BATS, P262; Goiti U, 2011, FOLIA ZOOL, V60, P17; GOULD EDWIN, 1955, JOUR MAMMAL, V36, P399, DOI 10.2307/1375682; Graham DL, 1997, J FIELD ORNITHOL, V68, P98; Gregoric M, 2011, J ARACHNOL, V39, P287, DOI 10.1636/CB10-95.1; Gregoric M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026847; Griffin DR, 1958, LISTENING DARK; Grundwald J-E, 2004, THESIS LMU MUNICH GE; GUPPY A, 1988, J COMP PHYSIOL A, V162, P653, DOI 10.1007/BF01342641; Hamidy Amir, 2010, Herpetological Review, V41, P66; HAPPOLD DCD, 1987, MAMMALIA, V51, P337, DOI 10.1515/mamm.1987.51.3.337; Harries DB, 2008, J CAVE KARST STUD, V70, P163; Harvey MS, 2007, INVERTEBR SYST, V21, P407, DOI 10.1071/IS05016; Hermanson JW, 2008, CELLS TISSUES ORGANS, V187, P24, DOI 10.1159/000109961; HERMANSON JW, 1986, J MAMMAL, V67, P751, DOI 10.2307/1381140; Higgins L, 2002, OIKOS, V99, P377, DOI 10.1034/j.1600-0706.2002.990220.x; HIGGINS LE, 1987, J ARACHNOL, V15, P401; Higgins L, 2011, J ARACHNOL, V39, P399, DOI 10.1636/B11-18.1; Higgins L, 2011, EVOL ECOL, V25, P1289, DOI 10.1007/s10682-011-9475-9; Hill DS, 1982, INSECTS HONG KONG; Hill J., 1984, BATS NATURAL HIST; Hiryu S, 2007, J ACOUST SOC AM, V121, P1749, DOI 10.1121/1.2431337; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; Huang CY, 2000, THESIS NATL SUN YAT; Jaeger Peter, 2001, Zoosystema, V23, P461; Jager P, 2005, REV SUISSE ZOOL, V112, P87; James D., 2007, CHRISTMAS ISLAND BIO; JONES G, 1993, P ROY SOC B-BIOL SCI, V251, P119, DOI 10.1098/rspb.1993.0017; Jung K, 2007, J ZOOL, V272, P125, DOI 10.1111/j.1469-7998.2006.00250.x; KASTON BJ, 1965, AM MIDL NAT, V73, P336, DOI 10.2307/2423458; Kershaw JCW, 1905, T ROY ENT SOC LONDON, V53, P5; Kilgore CH, 2008, THESIS AUBURN U AUBU; KOH JKH, 2000, GUIDE COMMON SINGAPO; KRULL D, 1991, BEHAV ECOL SOCIOBIOL, V28, P247; Kuntner M, 2007, SYST ENTOMOL, V32, P95, DOI 10.1111/j.1365-3113.2006.00348.x; Kuntner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-119; Kuntner M, 2010, J ARACHNOL, V38, P346, DOI 10.1636/B09-113.1; Kuntner M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007516; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Laduc Travis J., 1993, Bat Research News, V34, P58; Lausen Cori L., 2005, Mammalian Species, P1; LAVAL RK, 1977, J MAMMAL, V58, P403, DOI 10.2307/1379339; Le Souef D., 1915, Emu Melbourne, V14; Lee YF, 2005, ZOOL STUD, V44, P95; Leen N, 1969, WORLD BATS; LEVI H W, 1980, Bulletin of the Museum of Comparative Zoology, V149, P1; Levi Herbert W., 2004, Bulletin of the Museum of Comparative Zoology, V158, P47, DOI 10.3099/0027-4100(2004)158[47:CANRFT]2.0.CO;2; Levi HW, 1970, PSYCHE, V77, P280; Liat L. B., 1964, Malayan Nature Journal, V18, P20; Lin AQ, 2011, ZOOLOGY, V114, P69, DOI 10.1016/j.zool.2010.11.006; Ma J, 2010, ACTA THERIOL, V55, P315, DOI 10.4098/j.at.0001-7051.064.2009; MANCHI S., 2009, INDIAN BIRDS, V5, P118; Manville R. H., 1963, Mammalia, V27, P361, DOI 10.1515/mamm.1963.27.3.361; Marshall SD, 2001, TARANTULAS OTHER ARA; MASTERS WM, 1990, J INSECT BEHAV, V3, P143, DOI 10.1007/BF01417908; McKeown KC, 1952, AUSTR SPIDERS; MEDWAY, 1972, ZOOL J LINN SOC-LOND, V51, P33; Menkhorst, 2001, FIELD GUIDE MAMMALS, V110; Molinari J, 2005, CARIBB J SCI, V41, P340; Moya-Larano J, 2009, J EVOLUTION BIOL, V22, P954, DOI 10.1111/j.1420-9101.2009.01707.x; Neet C.R., 1990, Bulletin of the British Arachnological Society, V8, P161; Nicholas AC, 2011, J ARACHNOL, V39, P22, DOI 10.1636/Hi09-17.1; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; NYFFELER M, 1987, ENTOMOPHAGA, V32, P367, DOI 10.1007/BF02372445; Ochoa G. Jose, 1994, Trianea, V5, P411; Parker DI, 1996, CAN FIELD NAT, V110, P611; Parker DI, 1997, ARCTIC, V50, P256; Pavey CR, 2000, WILDLIFE RES, V27, P283, DOI 10.1071/WR99054; Peloso PL, 2007, REV BRAS ORNITOL, V15, P461; Platnick N.I., 2013, WORLD SPIDER CATALOG, DOI [10.5531/db.iz.0001, DOI 10.5531/DB.IZ.0001]; RICE DALE W., 1957, JOUR MAMMAL, V38, P15, DOI 10.2307/1376471; Robinson M. H, 1971, Revista Peruana de Entomologia Agricola, V14, P304; Robinson M.H., 1973, Smithsonian Contributions to Zoology, VNo. 149, P1; ROBINSON M H, 1971, Psyche (Cambridge), V78, P123, DOI 10.1155/1971/57182; ROBINSON M H, 1970, Zoological Journal of the Linnean Society, V49, P345, DOI 10.1111/j.1096-3642.1970.tb00746.x; Rosevear D., 1965, BATS W AFRICA; RYPSTRA AL, 1985, J ARACHNOL, V13, P71; Sakai WH, 2007, ORNITOL NEOTROP, V18, P117; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; Schoeman MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003715; Schuck-Paim C, 2000, BEHAVIOUR, V137, P1331, DOI 10.1163/156853900501953; Schulz M, 1997, J ZOOL, V243, P653, DOI 10.1111/j.1469-7998.1997.tb01967.x; Schulz M, 2000, J MAMMAL, V81, P948, DOI 10.1644/1545-1542(2000)081<0948:DAFBOT>2.0.CO;2; Selden PA, 2011, BIOL LETTERS, V7, P775, DOI 10.1098/rsbl.2011.0228; SHERRIFFS W. RAE, 1934, HONG KONG NATURALIST, V5, P85; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Siemers BM, 2006, BEHAV ECOL SOCIOBIOL, V59, P373, DOI 10.1007/s00265-005-0060-5; Siemers BM, 2001, BEHAV ECOL SOCIOBIOL, V50, P317, DOI 10.1007/s002650100379; Simmons Nancy B., 1998, American Museum Novitates, V3239, P1; Sirinivasulu C., 2006, Zoos Print Journal, V21, P2241; SPEAKMAN JR, 1991, MAMMAL REV, V21, P123, DOI 10.1111/j.1365-2907.1991.tb00114.x; Steck CE, 2006, ACTA CHIROPTEROL, V8, P445, DOI 10.3161/1733-5329(2006)8[445:TTNOTG]2.0.CO;2; STEWART MM, 1985, J HERPETOL, V19, P391, DOI 10.2307/1564267; STOWE M K, 1986, P101; Sumer S, 2009, J COMP PHYSIOL A, V195, P463, DOI 10.1007/s00359-009-0424-9; Suter RB, 2000, J ARACHNOL, V28, P300, DOI 10.1636/0161-8202(2000)028[0300:SSALOT]2.0.CO;2; Swift SM, 2002, BEHAV ECOL SOCIOBIOL, V52, P408, DOI 10.1007/s00265-002-0531-x; Teixeira Dante Martins, 1991, Ararajuba, V2, P69; Threlfall C, 2011, THESIS U NEW S WALES; Timm RM, 2007, CARIBB J SCI, V43, P282; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105; Weems HV, 2011, GOLDEN SILK SPIDER N; WHITAKER J.O., 1998, MAMMALS E US; WHITAKER JO, 1992, J MAMMAL, V73, P646, DOI 10.2307/1382037; Whitaker JO, 2009, ACTA CHIROPTEROL, V11, P393, DOI 10.3161/150811009X485611; Wilhide J.D., 1998, Journal of the Arkansas Academy of Science, V52, P113; Wilson D. E., 2005, MAMMAL SPECIES WORLD; WILSON DE, 1971, J ZOOL, V163, P1; Woodman N, 2003, CARIBB J SCI, V39, P399; World Association of Zoos and Aquariums (WAZA), 2011, BRAZ SALM PINK LAS P; Zhang L, 2007, J ZOOL, V271, P344, DOI 10.1111/j.1469-7998.2006.00210.x; Zhao HH, 2003, J ZOOL, V259, P189, DOI 10.1017/S0952836902003199; ZUBAID A, 1988, MAMMALIA, V52, P134; [No title captured]	154	57	65	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58120	10.1371/journal.pone.0058120	http://dx.doi.org/10.1371/journal.pone.0058120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516436	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200033
J	Yuan, XW; Zhang, SZ; Liu, SY; Yu, ML; Su, HY; Shu, HR; Li, XZ				Yuan, Xiaowei; Zhang, Shizhong; Liu, Shiyang; Yu, Mingli; Su, Hongyan; Shu, Huairui; Li, Xinzheng			Global Analysis of Ankyrin Repeat Domain C3HC4-Type RING Finger Gene Family in Plants	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CELL-CYCLE CONTROL; E3 LIGASE; ABSCISIC-ACID; REGULATORY NETWORKS; FUNCTIONAL-ANALYSIS; STRESS RESPONSES; PROTEIN; DROUGHT; XBAT32	Ankyrin repeat (ANK) C3HC4-type RING finger (RF) genes comprise a large family in plants and play important roles in various physiological processes of plant life. In this study, we identified 187 ANK C3HC4-type RF proteins from 29 species with complete genomes and named the ANK C3HC4-type RF proteins the XB3-like proteins because they are structurally related to the rice (Oryza sativa) XB3. A phylogenetic relationship analysis suggested that the XB3-like genes originated from ferns, and the encoded proteins fell into 3 major groups. Among these groups, we found that the spacing between the metal ligand position 6 and 7, and the conserved residues, which was in addition to the metal ligand amino acids, in the C3HC4-type RF were different. Using a wide range of protein structural analyses, protein models were established, and all XB3-like proteins were found to contain two to seven ANKs and a C3HC4-type RF. The microarray data for the XB3-like genes of Arabidopsis, Oryza sative, Zea mays and Glycine max revealed that the expression of XB3-like genes was in different tissues and during different life stages. The preferential expression of XB3-like genes in specified tissues and the response to phytohormone and abiotic stress treatments of Arabidopsis and Zea mays not only confirmed the microarray analysis data but also demonstrated that the XB3-like proteins play roles in plant growth and development as well as in stress responses. Our data provide a very useful reference for the identification and functional analysis of members of this gene family and also provide a new method for the genome-wide analysis of gene families.	[Yuan, Xiaowei; Zhang, Shizhong; Liu, Shiyang; Yu, Mingli; Shu, Huairui; Li, Xinzheng] Shandong Agr Univ, Natl Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Zhang, Shizhong; Shu, Huairui] Shandong Agr Univ, Natl Res Ctr Apple Engn & Technol, Tai An, Shandong, Peoples R China; [Su, Hongyan] Ludong Univ, Yantai, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Ludong University	Li, XZ (corresponding author), Shandong Agr Univ, Natl Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	lxz@sdau.edu.cn			Natural Science Foundation of China [31110103917, 31170233]; National Basic Research Program of China [2011CB100706]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by Natural Science Foundation of China (31110103917), Natural Science Foundation of China (31170233) and National Basic Research Program of China (2011CB100706). The funders had roles in study design, data collection and analysis and decision to publish.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Berrocal-Lobo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014426; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Callis J, 2000, CURR OPIN PLANT BIOL, V3, P381, DOI 10.1016/S1369-5266(00)00100-X; Carvalho SD, 2012, MOL PLANT, V5, P1295, DOI 10.1093/mp/sss048; Cerana M, 2006, PLANT BIOLOGY, V8, P572, DOI 10.1055/s-2006-924111; CHAO S, 1984, NUCLEIC ACIDS RES, V12, P6629, DOI 10.1093/nar/12.16.6629; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ding Y, 2011, PLANT J, V66, P735, DOI 10.1111/j.1365-313X.2011.04534.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elenbaas B, 1996, MOL MED, V2, P439, DOI 10.1007/BF03401903; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gechev TS, 2012, CELLULAR MOL LIFE SC, P1; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Grennan AK, 2006, PLANT PHYSIOL, V141, P1164, DOI 10.1104/pp.104.900198; Guo JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002982; Hatfield PM, 1997, PLANT J, V11, P213, DOI 10.1046/j.1365-313X.1997.11020213.x; Huang JY, 2009, PLANT MOL BIOL, V71, P207, DOI 10.1007/s11103-009-9518-6; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KAULEN H, 1991, MOL CELL BIOL, V11, P412, DOI 10.1128/MCB.11.1.412; Kempa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003935; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035682; LUX SE, 1990, NATURE, V344, P36, DOI 10.1038/344036a0; Lyzenga WJ, 2012, PLANT J, V71, P23, DOI 10.1111/j.1365-313X.2012.04965.x; Ma K, 2009, GENE, V444, P33, DOI 10.1016/j.gene.2009.05.018; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mistry Jaina, 2007, V396, P43; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nodzon LA, 2004, PLANT J, V40, P996, DOI 10.1111/j.1365-313X.2004.02266.x; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Prasad ME, 2010, PLANT SIGNAL BEHAV, V5, P1425, DOI [10.4161/psb.5.11.13294, 10.1104/pp.110.156976]; Prasad ME, 2010, PLANT PHYSIOL, V153, P1587, DOI 10.1104/pp.110.156976; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Seiler C, 2011, J EXP BOT, V62, P2615, DOI 10.1093/jxb/erq446; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Todaka D, 2012, RICE, V5, DOI 10.1186/1939-8433-5-6; Unver T, 2012, PLANT MOL BIOL REP, P1; Urano K, 2010, CURR OPIN PLANT BIOL, V13, P132, DOI 10.1016/j.pbi.2009.12.006; Vanstraelen M, 2012, ANN REV CELL DEV BIO, P28; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Wu Xiaoming, 2002, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V19, P455; Xu XJ, 2007, J EXP BOT, V58, P3623, DOI 10.1093/jxb/erm212; Yang XH, 2008, J BIOSCIENCES, V33, P103, DOI 10.1007/s12038-008-0026-7; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042946; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	62	17	20	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58003	10.1371/journal.pone.0058003	http://dx.doi.org/10.1371/journal.pone.0058003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516424	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200024
J	Crepey, P; Pivette, M; Bar-Hen, A				Crepey, Pascal; Pivette, Mathilde; Bar-Hen, Avner			Quantitative Assessment of Preventive Behaviors in France during the Fukushima Nuclear Crisis	PLOS ONE			English	Article								Background: The Fukushima nuclear disaster has generated worldwide concern on the risk of exposure to nuclear radiations. In Europe, health authorities had to issue statements about the lack of usefulness of iodine based preventive treatments within their borders. However a lack of confidence in official messages has developed in various European countries due to recent perceived failures in managing public health crises. The lay population preventive behaviors in this context are largely unknown. Consequently, to examine the effects of public health crisis on lay behaviors leading to pharmaceuticals purchases, we studied the sales of iodine-based products in France before, during and after the crisis. Methods: We focused our study on 58 iodine-based drugs available with and without a physician prescription. Our data came from a stratified sample of 3004 pharmacies in metropolitan France. Our study period was from January 2010 to April 2012, with a focus on March-April 2011. We differentiated sales of drugs prescribed by physicians from sales of drugs obtained without a prescription. We used a CUSUM method to detect abnormal increases in sales activity and cross-correlations to assess shifts in sales timing. Results: Sales of iodine-based nutritional complements, and later sales of iodine-based homeopathic remedies, substantially increased (up to 3-fold) during a period of 20 days. Their temporal patterns were correlated to specific events during the crisis. Prescriptions for iodine-based homeopathy increased (up to 35% of all sales). Iodine pills, strictly regulated by health authorities, have also been sold but on a very small scale. Conclusion: These results indicate uncontrolled preventive behaviors resulting in the potentially unjustifiable consumption of available drugs. They have implications in public policy, and demonstrate the usefulness of drug sales surveillance for instantaneous evaluation of population behavior during a global crisis.	[Crepey, Pascal; Pivette, Mathilde] EHESP Rennes, Sorbonne Paris Cite, Paris, France; [Crepey, Pascal] Aix Marseille Univ, UMR EPV Emergence Pathol Virales 190, Marseille, France; [Pivette, Mathilde; Bar-Hen, Avner] Univ Paris 05, MAP5, Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite	Crepey, P (corresponding author), EHESP Rennes, Sorbonne Paris Cite, Paris, France.	Pascal.Crepey@ehesp.fr	Crépey, Pascal/G-5422-2011	Crépey, Pascal/0000-0003-1852-0752				Astagneau P., 2011, SURVEILLANCE EPIDEMI; Carle B, 2004, J HAZARD MATER, V111, P21, DOI 10.1016/j.jhazmat.2004.02.004; Kish JL, 1965, SURVEY SAMPLING; Nuclear and Industrial Safety Agency, 2011, INES INT NUCL RAD EV; Nuclear Emergency Response Headquarters, 2011, JAP GOV IAEA MIN C N; Raude Jocelyn, 2010, PLoS Curr, V2, pRRN1188, DOI 10.1371/currents.RRN1188; Setbon M, 2011, PREV MED, V52, P178, DOI 10.1016/j.ypmed.2010.11.010; Spallek L, 2011, RADIAT PROT DOSIM, P1; Vaux S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-30; Watkins RE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-37; Yablokov AV, 2009, POWER, V30, P4	11	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58385	10.1371/journal.pone.0058385	http://dx.doi.org/10.1371/journal.pone.0058385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505499	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500077
J	Durigutto, P; Macor, P; Ziller, F; De Maso, L; Fischetti, F; Marzari, R; Sblattero, D; Tedesco, F				Durigutto, Paolo; Macor, Paolo; Ziller, Federica; De Maso, Luca; Fischetti, Fabio; Marzari, Roberto; Sblattero, Daniele; Tedesco, Francesco			Prevention of Arthritis by Locally Synthesized Recombinant Antibody Neutralizing Complement Component C5	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; RHEUMATOID-ARTHRITIS; IMMUNE-SYSTEM; MICE; THERAPY; INFLAMMATION; ETANERCEPT; ACTIVATION; INJECTION; PROTEINS	Treatment of patients suffering from chronic diseases such as rheumatoid arthritis with recombinant antibodies is time consuming and fairly expensive and can be associated with side effects due to generalized depletion of the target molecule. We have addressed these issues by developing an alternative approach consisting of the intraarticular injection of a DNA vector encoding for the anti-C5 neutralizing recombinant miniantibody MB12/22. This method allows local production of the antibody in sufficient amount to be effective in preventing joint inflammation in a rat model of antigen-induced arthritis. Injection of the DNA vector in a right knee of normal rats resulted in the production of the minibody detected in the synovial washes by western blot with a strong signal peaking at 3 days after administration. DNA encoding for the minibody was shown for 14 days in the synovial tissue and was undetectable in the controlateral knee and in other organs. The preventive effect of this approach was evaluated in rats receiving a single injection of the vector 3 days before the induction of antigen-induced arthritis and analyzed 3 days later. The treated rats exhibited a lower increase in swelling, associated with a lower number of PMN in the articular washes and reduced deposition of C9 in synovial tissue compared to control rats. These results suggest that treating the inflamed joints with a vector that induces a local production of a neutralizing anti-C5 antibody may represent a useful strategy to inhibit in situ complement activation and to treat patients with monoarthritis. Moreover, this approach may be adopted as a novel therapeutic strategy to prevent monoarthritis as an alternative to local treatment with antibodies commonly used in this form of arthritis, with the advantages of the lower cost and the longer persistence of antibody production.	[Durigutto, Paolo; Macor, Paolo; Ziller, Federica; De Maso, Luca; Marzari, Roberto; Tedesco, Francesco] Univ Trieste, Dept Life Sci, Trieste, Italy; [Fischetti, Fabio] Univ Trieste, Dipartimento Univ Clin Sci Med Chirurg & Salute, Trieste, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, Dept Med Sci, Novara, Italy; [Sblattero, Daniele] Univ Piemonte Orientale, IRCAD, Novara, Italy	University of Trieste; University of Trieste; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro	Macor, P (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	pmacor@units.it	Tedesco, Francesco/F-1929-2011	Macor, Paolo/0000-0003-3079-4019; Sblattero, Daniele/0000-0003-4309-242X; Durigutto, Paolo/0000-0003-3862-4970	Italian Ministry of University and Research [MFXE7L_004]; Fondazione SanPaolo; Fondazione Cariplo Bando ricerca biomedica; Fondazione Casali - Trieste	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione SanPaolo(Compagnia di San Paolo); Fondazione Cariplo Bando ricerca biomedica; Fondazione Casali - Trieste	This study has been made possible by research grants from the Italian Ministry of University and Research (PRIN MFXE7L_004); Fondazione SanPaolo, Fondazione Cariplo Bando ricerca biomedica 2009, and Fondazione Casali - Trieste. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banda NK, 2012, J IMMUNOL, V188, P1469, DOI 10.4049/jimmunol.1102310; Banda NK, 2010, J IMMUNOL, V185, P5598, DOI 10.4049/jimmunol.1001564; Bliddal H, 2006, SCAND J RHEUMATOL, V35, P341, DOI 10.1080/03009740600844530; Boscolo S, 2012, NEW BIOTECHNOL, V29, P477, DOI 10.1016/j.nbt.2011.12.005; Cesco-Gaspere M, 2008, SCAND J IMMUNOL, V68, P58, DOI 10.1111/j.1365-3083.2008.02119.x; Copland DA, 2010, CLIN EXP IMMUNOL, V159, P303, DOI 10.1111/j.1365-2249.2009.04070.x; CORVETTA A, 1992, CLIN EXP RHEUMATOL, V10, P433; Di Niro R, 2008, MOL IMMUNOL, V45, P1782, DOI 10.1016/j.molimm.2007.09.025; Dimitrova P, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3926; Fischetti F, 2005, BLOOD, V106, P2340, DOI 10.1182/blood-2005-03-1319; Fischetti F, 2007, ARTHRITIS RHEUM-US, V56, P1187, DOI 10.1002/art.22492; Gao X, 2007, AAPS J, V9, pE92, DOI 10.1208/aapsj0901009; Garmory HS, 2005, ADV DRUG DELIVER REV, V57, P1343, DOI 10.1016/j.addr.2005.01.013; Goodfellow RM, 1997, CLIN EXP IMMUNOL, V110, P45; Hackett NR, 2000, CURR OPIN MOL THER, V2, P376; HANKE T, 1992, J GEN VIROL, V73, P653, DOI 10.1099/0022-1317-73-3-653; Hietala MA, 2004, EUR J IMMUNOL, V34, P1208, DOI 10.1002/eji.200424895; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Linton SM, 1999, MOL IMMUNOL, V36, P905, DOI 10.1016/S0161-5890(99)00113-3; Macor P, 2007, CANCER RES, V67, P10556, DOI 10.1158/0008-5472.CAN-07-1811; Macor P, 2012, ARTHRITIS RHEUM-US, V64, P2559, DOI 10.1002/art.34430; Marzari R, 2002, EUR J IMMUNOL, V32, P2773, DOI 10.1002/1521-4141(2002010)32:10<2773::AID-IMMU2773>3.0.CO;2-G; Morgan B P, 2000, Methods Mol Biol, V150, P1; Neumann E, 2002, ARTHRITIS RHEUM, V46, P934, DOI 10.1002/art.10183; Nilsson KE, 2009, FASEB J, V23, P2450, DOI 10.1096/fj.08-125849; Ochiya T, 1999, BIOCHEM BIOPH RES CO, V258, P358, DOI 10.1006/bbrc.1999.0590; Roux CH, 2011, J RHEUMATOL, V38, P1009, DOI 10.3899/jrheum.100828; Senolt L, 2009, AUTOIMMUN REV, V9, P102, DOI 10.1016/j.autrev.2009.03.010; Skaricic D, 2008, VIROLOGY, V378, P79, DOI 10.1016/j.virol.2008.04.016; Smolen JS, 2010, ANN RHEUM DIS, V69, P1058, DOI 10.1136/ard.2009.114652; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Thrall JH, 2005, RADIOLOGY, V235, P9, DOI 10.1148/radiol.2351041768; Valenta R, 2011, J ALLERGY CLIN IMMUN, V127, P860, DOI 10.1016/j.jaci.2011.02.016; van Vollenhoven RF, 2009, NAT REV RHEUMATOL, V5, P531, DOI 10.1038/nrrheum.2009.182; Wang Y, 2000, J IMMUNOL, V164, P4340, DOI 10.4049/jimmunol.164.8.4340; Weyand CM, 2009, NAT REV RHEUMATOL, V5, P583, DOI 10.1038/nrrheum.2009.180; Ziller F, 2005, EUR J IMMUNOL, V35, P2175, DOI 10.1002/eji.200425920	37	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58696	10.1371/journal.pone.0058696	http://dx.doi.org/10.1371/journal.pone.0058696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505550	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500115
J	Etherton-Beer, C; Venturato, L; Horner, B				Etherton-Beer, Christopher; Venturato, Lorraine; Horner, Barbara			Organisational Culture in Residential Aged Care Facilities: A Cross-Sectional Observational Study	PLOS ONE			English	Article							NURSING-HOMES; COMMUNICATION; DEMENTIA	Background: Organisational culture is increasingly recognised as important for provision of high-quality long-term care. We undertook this study to measure organisational culture in residential aged care facilities in two Australian states. Methodology/Principal Findings: Cross-sectional observational study in 21 residential aged care facilities in Western Australia (n = 14) and Queensland (n = 7), Australia. Staff and next-of-kin of residents participated. Measurement comprised surveys of facility staff and residents' next-of-kin, and structured observation of indicators of care quality. Staff tended to rate organisational culture positively. Some qualitative feedback from staff emphasised negative perceptions of communication, leadership and teamwork. Staffing levels were perceived as a dominant challenge, threatening care quality. Direct observation revealed variability within and between facilities but suggested that most facilities (n = 12) were in the typical range, or were quality facilities (n = 8). Conclusion: There was scope to strengthen organisational culture in participating aged care facilities.	[Etherton-Beer, Christopher] Univ Western Australia, Western Australian Ctr Hlth & Ageing, Crawley, WA, Australia; [Venturato, Lorraine] Griffith Univ, Sch Nursing & Midwifery, Brisbane, Qld 4111, Australia; [Venturato, Lorraine] RSL Care, Res Team, Brisbane, Qld, Australia; [Horner, Barbara] Curtin Univ, Ctr Res Ageing, Perth, WA, Australia	University of Western Australia; Griffith University; Curtin University	Etherton-Beer, C (corresponding author), Univ Western Australia, Western Australian Ctr Hlth & Ageing, Crawley, WA, Australia.	christopher.etherton-beer@uwa.edu.au	Etherton-Beer, Christopher/B-2714-2014	Etherton-Beer, Christopher/0000-0001-5148-0188	National Health and Medical Research Council Dementia Research Grant Program Strategic Award [458797]	National Health and Medical Research Council Dementia Research Grant Program Strategic Award	This study was funded as part of a National Health and Medical Research Council Dementia Research Grant Program Strategic Award (number 458797). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2003, NURS RES, V52, P12, DOI 10.1097/00006199-200301000-00003; Australian Institute of Health and Welfare, 2007, DEM AUSTR NAT DAT AN; Beer C, 2010, INT PSYCHOGERIATR, P1; Beer C., 2009, BMC GERIATR, V9, P36, DOI DOI 10.1186/1471-2318-9-36; Beer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028155; Beer CD, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-63; Cummings GG, 2009, INT J NURS STUD; Hill C. W. L., 2001, STRATEGIC MANAGEMENT; Rahman AN, 2008, GERONTOLOGIST, V48, P142, DOI 10.1093/geront/48.2.142; Rantz MJ, 2006, J NURS MEAS, V14, P129, DOI 10.1891/jnm-v14i2a005; Reid R. C., 2007, DEMENTIA, V6, P89, DOI DOI 10.1177/1471301207075640; Robinson SB, 2006, J GERONTOL NURS, V32, P19, DOI 10.3928/00989134-20061001-04; Robison J, 2007, GERONTOLOGIST, V47, P504, DOI 10.1093/geront/47.4.504; Ronch J.L., 2004, J GERONTOLOGICAL SOC, V43, P61, DOI DOI 10.1300/J083V43N01_06; Scott J, 2005, J NURS CARE QUAL, V20, P36, DOI 10.1097/00001786-200501000-00007; Scott-Cawiezell J, 2004, J NURS CARE QUAL, V19, P242, DOI 10.1097/00001786-200407000-00011; Stafrace S, 2008, AUST HEALTH REV, V32, P577, DOI 10.1071/AH080577; Upenieks VV, 2009, J ADV NURS	18	28	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58002	10.1371/journal.pone.0058002	http://dx.doi.org/10.1371/journal.pone.0058002			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23505450	Green Published, gold			2022-12-27	WOS:000318334500042
J	Li, M; Wen, YL; Lu, Q; Fu, WJJ				Li, Ming; Wen, Yalu; Lu, Qing; Fu, Wenjiang J.			An Imputation Approach for Oligonucleotide Microarrays	PLOS ONE			English	Article							DNA MICROARRAY; ARRAY DATA; MODEL; SNPS; NORMALIZATION; ALGORITHM	Oligonucleotide microarrays are commonly adopted for detecting and qualifying the abundance of molecules in biological samples. Analysis of microarray data starts with recording and interpreting hybridization signals from CEL images. However, many CEL images may be blemished by noises from various sources, observed as "bright spots", "dark clouds", and "shadowy circles", etc. It is crucial that these image defects are correctly identified and properly processed. Existing approaches mainly focus on detecting defect areas and removing affected intensities. In this article, we propose to use a mixed effect model for imputing the affected intensities. The proposed imputation procedure is a single-array-based approach which does not require any biological replicate or between-array normalization. We further examine its performance by using Affymetrix high-density SNP arrays. The results show that this imputation procedure significantly reduces genotyping error rates. We also discuss the necessary adjustments for its potential extension to other oligonucleotide microarrays, such as gene expression profiling. The R source code for the implementation of approach is freely available upon request.	[Li, Ming] Univ Arkansas Med Sci, Dept Pediat, Div Biostat, Little Rock, AR 72205 USA; [Wen, Yalu; Lu, Qing; Fu, Wenjiang J.] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA	University of Arkansas System; University of Arkansas Medical Sciences; Michigan State University	Fu, WJJ (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	fuw@msu.edu	Wen, Yalu/AAM-4043-2020	Wen, Yalu/0000-0002-0071-5917	Summer Oncology Scholarship from Michigan State University; University of Arkansas for Medical Sciences	Summer Oncology Scholarship from Michigan State University; University of Arkansas for Medical Sciences	This work was partly supported by the Summer Oncology Scholarship from Michigan State University and the startup funds from University of Arkansas for Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2006, CISC VIS NETW IND GL, V1, P18; Affymetrix Inc, 2004, GEN CHIP EXPR AN DAT; Arteaga-Salas JM, 2008, BRIEF BIOINFORM, V9, P25, DOI 10.1093/bib/bbm055; Arteaga-Salas JM, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1383; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brown CS, 2001, P NATL ACAD SCI USA, V98, P8944, DOI 10.1073/pnas.161242998; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; Naef F., 2001, TECH REPORT, V1, P1; PARMIGIANI G, 2003, STAT BIOL HLTH, P455; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Reimers M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-166; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Song JS, 2007, BIOINFORMATICS, V23, P966, DOI 10.1093/bioinformatics/btm043; Suarez-Farinas M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-294; Upton GJG, 2005, BIOINFORMATICS, V21, P4162, DOI 10.1093/bioinformatics/bti668; Vainrub A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.041905; Wan L, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp559; Wu ZJ, 2009, STAT METHODS MED RES, V18, P533, DOI 10.1177/0962280209351924; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xiao YY, 2007, BIOINFORMATICS, V23, P1459, DOI 10.1093/bioinformatics/btm131; Zhang L, 2003, NAT BIOTECHNOL, V21, P818, DOI 10.1038/nbt836; Zhang L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1064	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58677	10.1371/journal.pone.0058677	http://dx.doi.org/10.1371/journal.pone.0058677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505547	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500111
J	Lv, M; Ye, HG; Zhao, XS; Zhao, XY; Chang, YJ; Liu, DH; Xu, LP; Huang, XJ				Lv, Meng; Ye, Hai-ge; Zhao, Xiao-su; Zhao, Xiang-yu; Chang, Ying-jun; Liu, Dai-hong; Xu, Lan-ping; Huang, Xiao-jun			Ceruloplasmin Is a Potential Biomarker for aGvHD following Allogeneic Hematopoietic Stem Cell Transplantation	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; ACUTE-PHASE PROTEINS; MARROW; BLOOD; GVHD; OXIDASE; TRIALS; SERUM	Acute graft-versus-host-disease (aGvHD) is the major cause of non-relapse mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Recently, diagnostic biomarkers for aGvHD have been shown to play important roles in evaluating disease status and mortality risk after allo-HSCT. To identify plasma biomarkers for aGvHD with high sensitivity and specificity, a quantitative proteomic approach using 8-plex isobaric tags for relative and absolute quantitation (8-plex iTRAQ) was employed to screen differentially expressed proteins in peripheral blood before and after the onset of aGvHD. Four target proteins, ceruloplasmin (CP), myeloperoxidase (MPO), complement factor H (CFH), and alpha-1-acid glycoprotein (AGP), were chosen for preliminary validation with enzyme linked immunosorbent assay (ELISA) in 20 paired samples at both the time of diagnosis of aGvHD and the time of complete response. The most promising candidate, ceruloplasmin, was further validated at fixed time points after allo-HSCT and during aGvHD. The plasma ceruloplasmin levels were significantly increased during the period of aGvHD onset and were markedly decreased as aGvHD resolved. The plasma ceruloplasmin levels at different time points post-transplant in the aGvHD (+) group were significantly higher than those in the aGvHD (2) group (p<0.001). The elevation of ceruloplasmin level in patients with active aGvHD was independent of infection status. Patients whose ceruloplasmin levels were elevated above 670 mu g/ml at 7, 14 and 21 days after allo-HSCT had a remarkably increased probability of subsequently developing aGvHD. In conclusion, our results suggest that plasma ceruloplasmin is a potential plasma biomarker of aGvHD, and it also has prognostic value for risk-adapted prophylaxis during the consecutive time points monitored in the first month after allo-HSCT.	[Lv, Meng; Ye, Hai-ge; Zhao, Xiao-su; Zhao, Xiang-yu; Chang, Ying-jun; Liu, Dai-hong; Xu, Lan-ping; Huang, Xiao-jun] Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China; [Ye, Hai-ge] Wenzhou Med Coll, Affiliated Hosp 1, Dept Hematol, Wenzhou, Zhejiang, Peoples R China	Peking University; Wenzhou Medical University	Huang, XJ (corresponding author), Peking Univ Peoples Hosp, Peking Univ Inst Hematol, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Beijing, Peoples R China.	huangxiaojun@bjmu.edu.cn	Huang, Xiao-Jun/HIK-3759-2022; Chang, Ying-Jun/AAA-1182-2020; Lv, Meng/I-5203-2014	Huang, Xiao-Jun/0000-0002-2145-6643; Chang, Ying-Jun/0000-0002-6124-6050; Lv, Meng/0000-0001-6625-9523	Key Program of National Natural Science Foundation of China [81230013]; Major State Basic Research Development Program of China (973 Program) [2013CB733700]; Beijing Municipal Science and Technology Program [Z111107067311070]; Natural Science Foundation of Beijing [7122193]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Beijing Municipal Science and Technology Program; Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This research was supported by the Key Program of National Natural Science Foundation of China (grant no. 81230013), the Major State Basic Research Development Program of China (973 Program No. 2013CB733700), the Beijing Municipal Science and Technology Program (grant no. Z111107067311070), Natural Science Foundation of Beijing (grant no. 7122193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer J, 2007, ANN HEMATOL, V86, P753, DOI 10.1007/s00277-007-0321-7; Chang YJ, 2012, CURR OPIN HEMATOL, V19, P454, DOI 10.1097/MOH.0b013e3283582322; Chen YB, 2012, BONE MARROW TRANSPLA; Chiarla C, 2008, J SURG RES, V144, P107, DOI 10.1016/j.jss.2007.03.024; Choi SW, 2008, BLOOD, V112, P1539, DOI 10.1182/blood-2008-02-138867; Ferrara JLM, 2011, BLOOD, V118, P6702, DOI 10.1182/blood-2011-08-375006; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Giurgea N, 2005, MED SCI MONITOR, V11, pRA48; Healy J, 2007, J NEURAL TRANSM, V114, P777, DOI 10.1007/s00702-007-0687-7; Hrycek A, 2007, AUTOIMMUNITY, V40, P217, DOI 10.1080/08916930701306817; Huang XJ, 2012, BLOOD, V119, P5584, DOI 10.1182/blood-2011-11-389809; Huang XJ, 2009, CLIN CANCER RES, V15, P4777, DOI 10.1158/1078-0432.CCR-09-0691; Huang XJ, 2001, LEUKEMIA, V15, P1089, DOI 10.1038/sj.leu.2402151; Koc M, 2003, BIOL PHARM BULL, V26, P1494, DOI 10.1248/bpb.26.1494; Levine JE, 2012, BLOOD, V119, P3854, DOI 10.1182/blood-2012-01-403063; Li TW, 2010, CHINESE MED J-PEKING, V123, P537, DOI 10.3760/cma.j.issn.0366-6999.2010.05.006; MacMillan ML, 2010, BLOOD, V115, P5412, DOI 10.1182/blood-2009-12-258442; Martin PJ, 2008, BEST PRACT RES CL HA, V21, P357, DOI 10.1016/j.beha.2008.03.001; NATESHA RK, 1992, J NATL MED ASSOC, V84, P781; Paczesny S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000406; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; Paradis M, 2010, FREE RADICAL BIO MED, V49, P2019, DOI 10.1016/j.freeradbiomed.2010.09.030; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Sidhu A, 2011, BIOCHEM BIOPH RES CO, V404, P963, DOI 10.1016/j.bbrc.2010.12.089; Weiss Karl Heinz, 2012, Curr Gastroenterol Rep, V14, P1, DOI 10.1007/s11894-011-0227-3; Ye HG, 2012, INT J HEMATOL, V95, P680, DOI 10.1007/s12185-012-1076-z; Ye HG, 2010, MOL CELL BIOCHEM, V343, P91, DOI 10.1007/s11010-010-0502-x	28	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58735	10.1371/journal.pone.0058735	http://dx.doi.org/10.1371/journal.pone.0058735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505556	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500121
J	Solinski, HJ; Petermann, F; Rothe, K; Boekhoff, I; Gudermann, T; Breit, A				Solinski, Hans Juergen; Petermann, Franziska; Rothe, Kathrin; Boekhoff, Ingrid; Gudermann, Thomas; Breit, Andreas			Human Mas-Related G Protein-Coupled Receptors-X1 Induce Chemokine Receptor 2 Expression in Rat Dorsal Root Ganglia Neurons and Release of Chemokine Ligand 2 from the Human LAD-2 Mast Cell Line	PLOS ONE			English	Article							SENSORY NEURON; DEPENDENT TRANSCRIPTION; CONSTITUTIVE ACTIVITY; SPECIES-DIFFERENCES; OPIOID RECEPTORS; NUCLEAR FACTOR; SPINAL-CORD; C-FOS; ACTIVATION; BRADYKININ	Primate-specific Mas-related G protein-coupled receptors-X1 (MRGPR-X1) are highly enriched in dorsal root ganglia (DRG) neurons and induce acute pain. Herein, we analyzed effects of MRGPR-X1 on serum response factors (SRF) or nuclear factors of activated T cells (NFAT), which control expression of various markers of chronic pain. Using HEK293, DRG neuron-derived F11 cells and cultured rat DRG neurons recombinantly expressing human MRGPR-X1, we found activation of a SRF reporter gene construct and induction of the early growth response protein-1 via extracellular signal-regulated kinases-1/2 known to play a significant role in the development of inflammatory pain. Furthermore, we observed MRGPR-X1-induced upregulation of the chemokine receptor 2 (CCR2) via NFAT, which is considered as a key event in the onset of neuropathic pain and, so far, has not yet been described for any endogenous neuropeptide. Up-regulation of CCR2 is often associated with increased release of its endogenous agonist chemokine ligand 2 (CCL2). We also found MRGPR-X1-promoted release of CCL2 in a human connective tissue mast cell line endogenously expressing MRGPR-X1. Thus, we provide first evidence to suggest that MRGPR-X1 induce expression of chronic pain markers in DRG neurons and propose a so far unidentified signaling circuit that enhances chemokine signaling by acting on two distinct yet functionally co-operating cell types. Given the important role of chemokine signaling in pain chronification, we propose that interruption of this signaling circuit might be a promising new strategy to alleviate chemokine-promoted pain.	[Solinski, Hans Juergen; Rothe, Kathrin; Boekhoff, Ingrid; Gudermann, Thomas; Breit, Andreas] Univ Munich, Walther Straub Inst Pharmakol & Toxikol, D-80539 Munich, Germany; [Petermann, Franziska] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-80290 Munich, Germany	University of Munich; Technical University of Munich	Breit, A (corresponding author), Univ Munich, Walther Straub Inst Pharmakol & Toxikol, Nussbaumstr 26, D-80539 Munich, Germany.	andreas.breit@lrz.uni-muenchen.de			Deutsche Forschungsgemeinschaft [BR 3346/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the "Deutsche Forschungsgemeinschaft" [grant BR 3346/3-1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; Andrisani OM, 1999, CRIT REV EUKAR GENE, V9, P19, DOI 10.1615/CritRevEukaryotGeneExpr.v9.i1.20; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Bhangoo S, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-38; Bhangoo SK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-48; BOLAND LM, 1991, J NEUROSCI, V11, P1140; Breit A, 2006, MOL PHARMACOL, V70, P686, DOI 10.1124/mol.106.022897; Brinkmann M, 2002, CYTOTECHNOLOGY, V38, P119, DOI 10.1023/A:1021118501866; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; BULLITT E, 1989, BRAIN RES, V493, P391, DOI 10.1016/0006-8993(89)91177-3; Burstein ES, 2006, BRIT J PHARMACOL, V147, P73, DOI 10.1038/sj.bjp.0706448; Chen HM, 2004, J NEUROSCI, V24, P5044, DOI 10.1523/JNEUROSCI.0990-04.2004; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; Dolan S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-91; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Eijkelkamp N, 2010, J NEUROSCI, V30, P2138, DOI 10.1523/JNEUROSCI.5752-09.2010; FAN SF, 1992, BRAIN RES, V590, P329, DOI 10.1016/0006-8993(92)91116-V; Fatakia SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027813; Fioravanti B, 2008, J NEUROSCI, V28, P11593, DOI 10.1523/JNEUROSCI.3322-08.2008; FRANCEL PC, 1987, J NEUROCHEM, V48, P1624, DOI 10.1111/j.1471-4159.1987.tb05711.x; Gaudioso C, 2012, PAIN, V153, P473, DOI 10.1016/j.pain.2011.11.014; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Grazzini E, 2004, P NATL ACAD SCI USA, V101, P7175, DOI 10.1073/pnas.0307185101; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Groth RD, 2003, J NEUROSCI, V23, P8125; Hao L, 2012, BMC EVOL BIOL, V10, P316; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Jackson JG, 2007, MOL PHARMACOL, V72, P303, DOI 10.1124/mol.107.035048; JAMIESON GA, 1989, J CELL PHYSIOL, V139, P262, DOI 10.1002/jcp.1041390207; Jenkins L, 2012, BIOCHEM J, V432, P451; Jow F, 2006, ASSAY DRUG DEV TECHN, V4, P49, DOI 10.1089/adt.2006.4.49; Jung HT, 2008, MOL CELL NEUROSCI, V37, P170, DOI 10.1016/j.mcn.2007.09.004; Jung HS, 2009, J NEUROSCI, V29, P8051, DOI 10.1523/JNEUROSCI.0485-09.2009; KATAYAMA N, 1993, J NEUROCHEM, V60, P902, DOI 10.1111/j.1471-4159.1993.tb03235.x; KENDALL G, 1994, MOL BRAIN RES, V25, P73, DOI 10.1016/0169-328X(94)90280-1; Kerr N, 2010, MOL CELL NEUROSCI, V44, P165, DOI 10.1016/j.mcn.2010.03.005; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Ko SW, 2005, J PAIN, V6, P12, DOI 10.1016/j.jpain.2004.10.001; Kunapuli P, 2006, ANAL BIOCHEM, V351, P50, DOI 10.1016/j.ab.2006.01.014; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Li J, 2002, MOL PHARMACOL, V61, P73, DOI 10.1124/mol.61.1.73; Li YZ, 2004, J NEUROSCI, V24, P9623, DOI 10.1523/JNEUROSCI.2392-04.2004; Maldonado R, 1996, SCIENCE, V273, P657, DOI 10.1126/science.273.5275.657; McIlvain HB, 2006, BRAIN RES, V1077, P16, DOI 10.1016/j.brainres.2005.12.130; MOORE JJ, 1982, PLACENTA, V3, P257, DOI 10.1016/S0143-4004(82)80003-9; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Puttfarcken PS, 1997, J NEUROCHEM, V69, P930; Romero A, 2012, N-S ARCH PHARMACOL, V385, P397, DOI 10.1007/s00210-011-0721-z; Rothe K, 2012, J PHARMACOL EXP THER, V342, P41, DOI 10.1124/jpet.112.192757; Serrano A, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-90; Seybold VS, 2006, J NEUROCHEM, V97, P397, DOI 10.1111/j.1471-4159.2006.03744.x; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sikand P, 2011, J NEUROSCI, V31, P7563, DOI 10.1523/JNEUROSCI.1192-11.2011; Skaper SD, 2012, FASEB J; Solinski HJ, 2010, MOL PHARMACOL, V78, P249, DOI 10.1124/mol.110.063867; Solinski HJ, 2012, J BIOL CHEM; Strasser A, 2013, TRENDS PHARMACOL SCI, V34, P13, DOI 10.1016/j.tips.2012.10.004; Subramanian H, 2011, MOL PHARMACOL, V79, P1005, DOI 10.1124/mol.111.071472; Sun JH, 2006, J NEUROPHYSIOL, V96, P2189, DOI 10.1152/jn.00222.2006; Tatemoto K, 2006, BIOCHEM BIOPH RES CO, V349, P1322, DOI 10.1016/j.bbrc.2006.08.177; Taylor DA, 2001, J PHARMACOL EXP THER, V297, P11; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Wainscott DB, 2007, J PHARMACOL EXP THER, V320, P475, DOI 10.1124/jpet.106.112532; Wang CH, 2010, NEUROSCI LETT, V475, P48, DOI 10.1016/j.neulet.2010.03.044; White FA, 2005, NAT REV DRUG DISCOV, V4, P834, DOI 10.1038/nrd1852; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Zimmerman B, 2011, CELL SIGNAL, V23, P648, DOI 10.1016/j.cellsig.2010.11.016	69	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58756	10.1371/journal.pone.0058756	http://dx.doi.org/10.1371/journal.pone.0058756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505557	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500122
J	Janek, T; Krasowska, A; Radwanska, A; Lukaszewicz, M				Janek, Tomasz; Krasowska, Anna; Radwanska, Agata; Lukaszewicz, Marcin			Lipopeptide Biosurfactant Pseudofactin II Induced Apoptosis of Melanoma A 375 Cells by Specific Interaction with the Plasma Membrane	PLOS ONE			English	Article							LEUKEMIA K562 CELLS; INDUCTION; MITOCHONDRIA; ARREST	In the case of melanoma, advances in therapies are slow, which raises the need to evaluate new therapeutic strategies and natural products with potential cancer cell inhibiting effect. Pseudofactin II (PFII), a novel cyclic lipopeptide biosurfactant has been isolated from the Arctic strain of Pseudomonas fluorescens BD5. The aim of this study was to investigate the effect of PFII on A375 melanoma cells compared with the effect of PFII on Normal Human Dermis Fibroblast (NHDF) cells and elucidate the underlying mechanism of PFII cytotoxic activity. Melanoma A375 cells and NHDF cells were exposed to PFII or staurosporine and apoptotic death was assessed by monitoring caspase 3-like activity and DNA fragmentation. From time-dependent monitoring of lactate dehydrogenase (LDH) release, Ca2+ influx, and a correlation between Critical Micelle Concentration (CMC) we concluded that cell death is the consequence of plasma membrane permeabilisation by micelles. This finding suggests that pro-apoptotic mechanism of PFII is different from previously described cyclic lipopeptides. The mechanism of PFII specificity towards malignant cells remains to be discovered. The results of this study show that PFII could be a new promising anti-melanoma agent.	[Janek, Tomasz; Krasowska, Anna; Lukaszewicz, Marcin] Univ Wroclaw, Fac Biotechnol, Dept Biotransformat, PL-50138 Wroclaw, Poland; [Radwanska, Agata] Univ Wroclaw, Fac Biotechnol, Dept Cell Pathol, PL-50138 Wroclaw, Poland; [Lukaszewicz, Marcin] Univ Wroclaw, Div Chem & Technol Fuels, PL-50138 Wroclaw, Poland	University of Wroclaw; University of Wroclaw; University of Wroclaw	Lukaszewicz, M (corresponding author), Univ Wroclaw, Fac Biotechnol, Dept Biotransformat, PL-50138 Wroclaw, Poland.	marcin.lukaszewicz@uni.wroc.pl	Janek, Tomasz/AAQ-8641-2020; Janek, Tomasz/AAQ-8642-2020; Łukaszewicz, Marcin/K-8441-2013; Janek, Tomasz/E-2059-2017; Krasowska, Anna/I-5054-2019	Janek, Tomasz/0000-0003-1939-5500; Łukaszewicz, Marcin/0000-0002-1453-8376; Janek, Tomasz/0000-0003-1939-5500; Krasowska, Anna/0000-0002-1925-193X; Radwanska, Agata/0000-0002-8424-4648	Polish National Centre for Science [NN302 640940]; Polish National Centre for Research and Development [KB/48/13639/IT1-B/U/08]; EU [POIG.01.01.02-00-016/2008]	Polish National Centre for Science; Polish National Centre for Research and Development; EU(European Commission)	This work was financially supported by a grant from the Polish National Centre for Science NN302 640940, Polish National Centre for Research and Development KB/48/13639/IT1-B/U/08 and EU POIG.01.01.02-00-016/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Eggermont AMM, 2010, ANN ONCOL, V21, P339, DOI 10.1093/annonc/mdq364; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hersey P, 2003, J CELL PHYSIOL, V196, P9, DOI 10.1002/jcp.10256; Hersey P, 2002, EXPERT OPIN INV DRUG, V11, P75, DOI 10.1517/13543784.11.1.75; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; HUH C, 1975, COLLOID POLYM SCI, V253, P566, DOI 10.1007/BF01753960; Igor NS, 2005, J STEROID BIOCHEM, V97, P145; Janek T, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-24; Janek T, 2010, BIORESOURCE TECHNOL, V101, P6118, DOI 10.1016/j.biortech.2010.02.109; Kim SY, 2007, FEBS LETT, V581, P865, DOI 10.1016/j.febslet.2007.01.059; Krasowska A, 2011, ACTA SCI POL BIOTECH, V10, P3; Landman D, 2008, CLIN MICROBIOL REV, V21, P449, DOI 10.1128/CMR.00006-08; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; Mitchell D, 2012, PIGMENT CELL MELANOM; Nielsen TH, 2003, APPL ENVIRON MICROB, V69, P861, DOI 10.1128/AEM.69.2.861-868.2003; Oakes SA, 2003, BIOCHEM PHARMACOL, V66, P1335, DOI 10.1016/S0006-2952(03)00482-9; Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010; Sudo T, 2000, CYTOTECHNOLOGY, V33, P259, DOI 10.1023/A:1008137817944; Tim M., 1983, J IMMUNOL METHODS, V65, P55, DOI DOI 10.1016/0022-1759(83)90303-4.PMID:6606682; Wang CL, 2007, PEPTIDES, V28, P1344, DOI 10.1016/j.peptides.2007.06.014; Wang CL, 2009, CANCER LETT, V276, P221, DOI 10.1016/j.canlet.2008.11.007; Zaragoza A, 2010, LANGMUIR, V26, P8567, DOI 10.1021/la904637k; Zaragoza A, 2009, LANGMUIR, V25, P7892, DOI 10.1021/la900480q; Zhao XX, 2000, CYTOTECHNOLOGY, V33, P123, DOI 10.1023/A:1008129616127	25	45	50	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57991	10.1371/journal.pone.0057991	http://dx.doi.org/10.1371/journal.pone.0057991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483962	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100067
J	Wang, P; Song, P; Jin, MM; Zhu, GP				Wang, Peng; Song, Ping; Jin, Mingming; Zhu, Guoping			Isocitrate Dehydrogenase from Streptococcus mutans: Biochemical Properties and Evaluation of a Putative Phosphorylation Site at Ser102	PLOS ONE			English	Article							INDUCED OXIDATIVE DAMAGE; CELLULAR DEFENSE; MOLECULAR CHARACTERIZATION; COFACTOR SPECIFICITY; CRYSTAL-STRUCTURE; ENZYME; MECHANISM; INSIGHTS; REVEALS; STATE	Isocitrate deyhdrogenase (IDH) is a reversible enzyme in the tricarboxylic acid cycle that catalyzes the NAD(P)(+)-dependent oxidative decarboxylation of isocitrate to alpha-ketoglutarate (alpha KG) and the NAD(P)H/CO2-dependent reductive carboxylation of alpha KG to isocitrate. The IDH gene from Streptococcus mutans was fused with the icd gene promoter from Escherichia coli to initiate its expression in the glutamate auxotrophic strain E. coli Delta icd::kan(r) of which the icd gene has been replaced by kanamycin resistance gene. The expression of S. mutans IDH (SmIDH) may restore the wild-type phenotype of the icd-defective strain on minimal medium without glutamate. The molecular weight of SmIDH was estimated to be 70 kDa by gel filtration chromatography, suggesting a homodimeric structure. SmIDH was divalent cation-dependent and Mn2+ was found to be the most effective cation. The optimal pH of SmIDH was 7.8 and the maximum activity was around 45 degrees C. SmIDH was completely NAD(+) dependent and its apparent K-m for NAD(+) was 137 mu M. In order to evaluate the role of the putative phosphorylation site at Ser102 in catalysis, two "stably phosphorylated" mutants were constructed by converting Ser102 into Glu102 or Asp102 in SmIDH to mimick a constitutively phosphorylated state. Meanwhile, the functional roles of another four amino acids (threonine, glycine, alanine and tyrosine) containing variant size of side chains were investigated. The replacement of Asp102 or Glu102 totally inactivated the enzyme, while the S102T, S102G, S102A and S102Y mutants decreased the affinity to isocitrate and only retained 16.0%, 2.8%, 3.3% and 1.1% of the original activity, respectively. These results reveal that Ser102 plays important role in substrate binding and is required for the enzyme function. Also, Ser102 in SmIDH is a potential phosphorylation site, indicating that the ancient NAD-dependent IDHs might be the underlying origin of "phosphorylation mechanism" used by their bacterial NADP-dependent homologs.	[Zhu, Guoping] Anhui Normal Univ, Key Lab Mol Evolut & Biodivers, Coll Life Sci, Wuhu, Anhui, Peoples R China; Anhui Normal Univ, Inst Mol Biol & Biotechnol, Coll Life Sci, Wuhu, Anhui, Peoples R China	Anhui Normal University; Anhui Normal University	Zhu, GP (corresponding author), Anhui Normal Univ, Key Lab Mol Evolut & Biodivers, Coll Life Sci, Wuhu, Anhui, Peoples R China.	gpz1996@yahoo.com	Wang, Peng/I-8770-2018; Wang, Peng/AAW-9052-2020	Wang, Peng/0000-0002-5598-0996; Wang, Peng/0000-0002-5598-0996	National High Technology Research and Development Program ("863" Program) [2012AA02A708]; National Natural Science Foundation of China [31170005, 30870062]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20113424110004]; State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (CAS) [GREKF11-07]	National High Technology Research and Development Program ("863" Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (CAS)	This research was supported by the National High Technology Research and Development Program ("863" Program: 2012AA02A708), the National Natural Science Foundation of China (31170005; 30870062), Specialized Research Fund for the Doctoral Program of Higher Education of China (20113424110004), and the Fund of State Key Laboratory of Genetics Resources and Evolution from Kunming Institute of Zoology (CAS) (GREKF11-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshima M, 2004, MOL MICROBIOL, V51, P791, DOI 10.1046/j.1365-2958.2003.03863.x; Aoshima M, 2008, J BACTERIOL, V190, P2050, DOI 10.1128/JB.01799-07; BORTHWICK AC, 1984, BIOCHEM J, V222, P797, DOI 10.1042/bj2220797; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chen RD, 1996, PROTEIN SCI, V5, P287; Cvitkovitch DG, 1997, J BACTERIOL, V179, P650, DOI 10.1128/jb.179.3.650-655.1997; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DEAN AM, 1990, SCIENCE, V249, P1044, DOI 10.1126/science.2204110; DEAN AM, 1989, J BIOL CHEM, V264, P20482; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grodsky NB, 2000, BIOCHEMISTRY-US, V39, P2193, DOI 10.1021/bi9919753; Gross S, 2010, J EXP MED, V207, P339, DOI 10.1084/jem.20092506; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; Hurley JH, 1996, BIOCHEMISTRY-US, V35, P5670, DOI 10.1021/bi953001q; HURLEY JH, 1991, BIOCHEMISTRY-US, V30, P8671, DOI 10.1021/bi00099a026; HURLEY JH, 1990, SCIENCE, V249, P1012, DOI 10.1126/science.2204109; Imada K, 2008, PROTEINS, V70, P63, DOI 10.1002/prot.21486; Inoue H, 2002, FEMS MICROBIOL LETT, V214, P127, DOI 10.1111/j.1574-6968.2002.tb11335.x; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kim HJ, 2005, FREE RADICAL RES, V39, P441, DOI 10.1080/10715760500066265; Kim SY, 2003, FREE RADICAL RES, V37, P309, DOI 10.1080/1071576021000050429; Krell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019868; LAPORTE DC, 1984, J BIOL CHEM, V259, P4068; LAPORTE DC, 1993, J CELL BIOCHEM, V51, P14, DOI 10.1002/jcb.240510104; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Matsuno K, 1999, J BACTERIOL, V181, P3382, DOI 10.1128/JB.181.11.3382-3391.1999; MCKEE JS, 1989, BIOCHEM J, V261, P301, DOI 10.1042/bj2610301; MEIXNERMONORI B, 1986, BIOCHEM J, V236, P549, DOI 10.1042/bj2360549; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Peng YJ, 2008, PROTEIN SCI, V17, P1542, DOI 10.1110/ps.035675.108; Singh SK, 2002, J BIOL CHEM, V277, P7567, DOI 10.1074/jbc.M107908200; Singh SK, 2001, J BIOL CHEM, V276, P26154, DOI 10.1074/jbc.M101191200; Steen IH, 2001, J BIOL CHEM, V276, P43924, DOI 10.1074/jbc.M105999200; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9310, DOI 10.1021/bi00087a008; Stokke R, 2007, ARCH MICROBIOL, V187, P361, DOI 10.1007/s00203-006-0200-y; Taylor AB, 2008, J BIOL CHEM, V283, P10872, DOI 10.1074/jbc.M708719200; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; WALSH K, 1985, J BIOL CHEM, V260, P8430; Wang P, 2012, FEMS MICROBIOL LETT, V327, P134, DOI 10.1111/j.1574-6968.2011.02467.x; Wang P, 2011, BIOCHIMIE, V93, P1470, DOI 10.1016/j.biochi.2011.04.021; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yoon JJ, 2003, BIOSCI BIOTECH BIOCH, V67, P114, DOI 10.1271/bbb.67.114; Zaremba-Czogalla M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032649; Zhang BB, 2009, BIOCHIMIE, V91, P1405, DOI 10.1016/j.biochi.2009.07.011; Zhu GP, 2005, SCIENCE, V307, P1279, DOI 10.1126/science.1106974	49	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58918	10.1371/journal.pone.0058918	http://dx.doi.org/10.1371/journal.pone.0058918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484056	Green Submitted, gold, Green Published			2022-12-27	WOS:000316936100142
J	Garrett, TA; Schmeitzel, JL; Klein, JA; Hwang, JJ; Schwarz, JA				Garrett, Teresa A.; Schmeitzel, John L.; Klein, Joshua A.; Hwang, Janice J.; Schwarz, Jodi A.			Comparative Lipid Profiling of the Cnidarian Aiptasia pallida and Its Dinoflagellate Symbiont	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; ELECTROSPRAY-IONIZATION; STRUCTURAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; ANEMONE AIPTASIA; CELL BIOLOGY; MODEL; FRAGMENTATION; MECHANISMS; MEMBRANE	Corals and other cnidarians house photosynthetic dinoflagellate symbionts within membrane-bound compartments inside gastrodermal cells. Nutritional interchanges between the partners produce carbohydrates and lipids for metabolism, growth, energy stores, and cellular structures. Although lipids play a central role in the both the energetics and the structural/morphological features of the symbiosis, previous research has primarily focused on the fatty acid and neutral lipid composition of the host and symbiont. In this study we conducted a mass spectrometry-based survey of the lipidomic changes associated with symbiosis in the sea anemone Aiptasia pallida, an important model system for coral symbiosis. Lipid extracts from A. pallida in and out of symbiosis with its symbiont Symbiodinium were prepared and analyzed using negative-ion electrospray ionization quadrupole time-of-flight mass spectrometry. Through this analysis we have identified, by exact mass and collision-induced dissociation mass spectrometry (MS/MS), several classes of glycerophospholipids in A. pallida. Several molecular species of di-acyl phosphatidylinositol and phosphatidylserine as well as 1-alkyl, 2-acyl phosphatidylethanolamine (PE) and phosphatidycholine were identified. The 1-alkyl, 2-acyl PEs are acid sensitive suggestive that they are plasmalogen PEs possessing a double bond at the 1-position of the alkyl linked chain. In addition, we identified several molecular species of phosphonosphingolipids called ceramide aminoethylphosphonates in anemone lipid extracts by the release of a characteristic negative product ion at m/z 124.014 during MS/MS analysis. Sulfoquinovosyldiacylglycerol (SQDG), an anionic lipid often found in photosynthetic organisms, was identified as a prominent component of Symbiodinium lipid extracts. A comparison of anemone lipid profiles revealed a subset of lipids that show dramatic differences in abundance when anemones are in the symbiotic state as compared to the non-symbiotic state. The data generated in this analysis will serve as a resource to further investigate the role of lipids in symbiosis between Symbiodinium and A. pallida.	[Garrett, Teresa A.; Schmeitzel, John L.; Hwang, Janice J.] Vassar Coll, Dept Chem, Poughkeepsie, NY 12601 USA; [Schwarz, Jodi A.] Vassar Coll, Dept Biol, Poughkeepsie, NY 12601 USA; [Klein, Joshua A.] Vassar Coll, Dept Comp Sci, Poughkeepsie, NY 12601 USA	Vassar College; Vassar College; Vassar College	Garrett, TA (corresponding author), Vassar Coll, Dept Chem, Poughkeepsie, NY 12601 USA.	tegarrett@vassar.edu			LIPID MAPS Large Scale Collaborative Grant [GM-069338]; Multi-Investigator Cottrell College Science Award from the Research Corporation for Science Advancement; National Science Foundation Major Research Instrumentation award [1039659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	LIPID MAPS Large Scale Collaborative Grant; Multi-Investigator Cottrell College Science Award from the Research Corporation for Science Advancement; National Science Foundation Major Research Instrumentation award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by LIPID MAPS Large Scale Collaborative Grant GM-069338 to Christian R. H. Raetz, a Multi-Investigator Cottrell College Science Award from the Research Corporation for Science Advancement to J. A. S. and the National Science Foundation Major Research Instrumentation award #1039659 to T. A. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awai K., 2012, P 12 INT COR REEF S, DOI [10.4172/2161-1009.1000205, DOI 10.4172/2161-1009.1000205]; Belda-Baillie CA, 2002, BIOL BULL, V202, P74, DOI 10.2307/1543224; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bulat E, 2011, J BIOL CHEM, V286, P33819, DOI 10.1074/jbc.M111.269779; Burgos A, 2011, PLANT J, V66, P656, DOI 10.1111/j.1365-313X.2011.04531.x; CEDERGREN RA, 1994, J LIPID RES, V35, P1452; Chen MC, 2005, BIOCHEM BIOPH RES CO, V338, P1607, DOI 10.1016/j.bbrc.2005.10.133; Chintalapati M, 2009, J AGR FOOD CHEM, V57, P5201, DOI 10.1021/jf803818y; Davy SK, 2012, MICROBIOL MOL BIOL R, V76, P229, DOI 10.1128/MMBR.05014-11; de Souza LM, 2007, CHEM PHYS LIPIDS, V145, P85, DOI 10.1016/j.chemphyslip.2006.11.001; de Souza LM, 2012, MAR DRUGS, V10, P918, DOI 10.3390/md10040918; Diaz-Almeyda E, 2011, CORAL REEFS, V30, P217, DOI 10.1007/s00338-010-0691-5; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; FITT WK, 1983, J CELL SCI, V64, P195; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hsu FF, 2005, J AM SOC MASS SPECTR, V16, P1510, DOI 10.1016/j.jasms.2005.04.018; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Hsu FF, 2009, J CHROMATOGR B, V877, P2673, DOI 10.1016/j.jchromb.2009.02.033; Imbs AB, 2007, COMP BIOCHEM PHYS B, V148, P314, DOI 10.1016/j.cbpb.2007.06.009; Jones MR, 2007, PROG LIPID RES, V46, P56, DOI 10.1016/j.plipres.2006.06.001; Kononova SV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P184, DOI 10.1023/A:1014409929875; LANGWORTHY TA, 1976, BIOCHIM BIOPHYS ACTA, V431, P550, DOI 10.1016/0005-2760(76)90220-4; LEECH RM, 1973, PLANT PHYSIOL, V52, P240, DOI 10.1104/pp.52.3.240; Lehnert EM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-271; Lin C, 2012, PLOS ONE, V7; Luo YJ, 2009, CORAL REEFS, V28, P289, DOI 10.1007/s00338-008-0462-8; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Meyer E, 2012, BIOL BULL-US, V223, P44, DOI 10.1086/BBLv223n1p44; Mukhamedova KS, 2000, CHEM NAT COMPD+, V36, P329, DOI 10.1023/A:1002804409503; MUSCATINE L, 1983, ENDOCYTOBIOLOGY 2, V0002, P00649; Peng SE, 2011, PROTEOMICS, V11, P3540, DOI 10.1002/pmic.201000552; Peng SE, 2010, PROTEOMICS, V10, P1002, DOI 10.1002/pmic.200900595; Pernice M, 2012, ISME J, V6, P1314, DOI 10.1038/ismej.2011.196; Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061; Ren SL, 2006, J LIPID RES, V47, P1081, DOI 10.1194/jlr.M600019-JLR200; ROUSER G, 1968, LIPIDS, V3, P287, DOI 10.1007/BF02531203; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Schwarz JA, 1999, BIOL BULL-US, V196, P70, DOI 10.2307/1543169; SHIBUYA I, 1965, PLANT CELL PHYSIOL, V6, P267, DOI 10.1093/oxfordjournals.pcp.a079099; Shimojima M, 2011, PROG LIPID RES, V50, P234, DOI 10.1016/j.plipres.2011.02.003; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Sprott GD, 2003, BBA-MOL CELL BIOL L, V1633, P179, DOI 10.1016/j.bbalip.2003.08.001; Sunagawa S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-258; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Tautenhahn R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-504; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Wakefield TS, 2001, BIOL BULL-US, V200, P127, DOI 10.2307/1543306; Wang JT, 1998, J EXP BIOL, V201, P2445; Wang Z, 2012, BIOCHEM SOC T, V40, P457, DOI 10.1042/BST20110752; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; YAMADA S, 1995, J BIOCHEM-TOKYO, V117, P794, DOI 10.1093/oxfordjournals.jbchem.a124778; Yamashiro H, 1999, COMP BIOCHEM PHYS B, V122, P397, DOI 10.1016/S0305-0491(99)00014-0; Zhang X, 2012, INT J MASS SPECTROM, V316, P100, DOI 10.1016/j.ijms.2012.01.011; Zhukova NV, 2003, PHYTOCHEMISTRY, V62, P191, DOI 10.1016/S0031-9422(02)00371-0	58	31	32	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57975	10.1371/journal.pone.0057975	http://dx.doi.org/10.1371/journal.pone.0057975			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483956	Green Submitted, Green Published, gold			2022-12-27	WOS:000315634900061
J	Navis, AC; Bourgonje, A; Wesseling, P; Wright, A; Hendriks, W; Verrijp, K; van der Laak, JAWM; Heerschap, A; Leenders, WPJ				Navis, Anna C.; Bourgonje, Annika; Wesseling, Pieter; Wright, Alan; Hendriks, Wiljan; Verrijp, Kiek; van der Laak, Jeroen A. W. M.; Heerschap, Arend; Leenders, William P. J.			Effects of Dual Targeting of Tumor Cells and Stroma in Human Glioblastoma Xenografts with a Tyrosine Kinase Inhibitor against c-MET and VEGFR2	PLOS ONE			English	Article							ANTIANGIOGENIC THERAPY; BRAIN-TUMORS; HUMAN GLIOMA; ANGIOGENESIS; INVASION; GROWTH; METASTASIS; BEVACIZUMAB; PROGRESSION; EXPRESSION	Anti-angiogenic treatment of glioblastoma with Vascular Endothelial Growth Factor (VEGF)- or VEGF Receptor 2 (VEGFR2) inhibitors normalizes tumor vessels, resulting in a profound radiologic response and improved quality of life. This approach however does not halt tumor progression by diffuse infiltration, as this phenotype is less angiogenesis dependent. Combined inhibition of angiogenesis and diffuse infiltrative growth would therefore be a more effective treatment approach in these tumors. The HGF/c-MET axis is important in both angiogenesis and cell migration in several tumor types including glioma. We therefore analyzed the effects of the c-MET- and VEGFR2 tyrosine kinase inhibitor cabozantinib (XL184, Exelixis) on c-MET positive orthotopic E98 glioblastoma xenografts, which routinely present with angiogenesis-dependent areas of tumor growth, as well as diffuse infiltrative growth. In in vitro cultures of E98 cells, cabozantinib effectively inhibited c-MET phosphorylation, concomitant with inhibitory effects on AKT and ERK1/2 phosphorylation, and cell proliferation and migration. VEGFR2 activation in endothelial cells was also effectively inhibited in vitro. Treatment of BALB/c nu/nu mice carrying orthotopic E98 xenografts resulted in a significant increase in overall survival. Cabozantinib effectively inhibited angiogenesis, resulting in increased hypoxia in angiogenesis-dependent tumor areas, and induced vessel normalization. Yet, tumors ultimately escaped cabozantinib therapy by diffuse infiltrative outgrowth via vessel co-option. Of importance, in contrast to the results from in vitro experiments, in vivo blockade of c-MET activation was incomplete, possibly due to multiple factors including restoration of the blood-brain barrier resulting from cabozantinib-induced VEGFR2 inhibition. In conclusion, cabozantinib is a promising therapy for c-MET positive glioma, but improving delivery of the drug to the tumor and/or the surrounding tissue may be needed for full activity.	[Navis, Anna C.; Wesseling, Pieter; Verrijp, Kiek; van der Laak, Jeroen A. W. M.; Leenders, William P. J.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands; [Bourgonje, Annika; Hendriks, Wiljan] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, NL-6525 ED Nijmegen, Netherlands; [Wesseling, Pieter] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Wright, Alan; Heerschap, Arend] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Vrije Universiteit Amsterdam; Radboud University Nijmegen	Leenders, WPJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6525 ED Nijmegen, Netherlands.	w.leenders@pathol.umcn.nl	Wesseling, P./H-8114-2014; Leenders, William P/O-9843-2014; Bourgonje, Annika/E-1580-2016; Leenders, William/O-2541-2019; verrijp, kiek/F-4783-2018; Heerschap, Arend/G-5228-2010; Hendriks, Wiljan J.A.J./A-5214-2013; Hendriks, Wiljan/Q-4325-2019; van der Laak, Jeroen AWM/D-3057-2015	Wesseling, P./0000-0001-5453-5201; Leenders, William P/0000-0003-0066-220X; Bourgonje, Annika/0000-0002-7839-2476; Leenders, William/0000-0003-0066-220X; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; Hendriks, Wiljan/0000-0001-9481-8281; van der Laak, Jeroen AWM/0000-0001-7982-0754; Navis, Anna/0000-0002-5267-4678	NWO middelgroot [40-00506-90-0602]; NWO BIG (VISTA); Radboud University Nijmegen Medical Centre; Dutch Brain Foundation [KS2010(1)-01]; Maurits; Anna de Cock foundation	NWO middelgroot; NWO BIG (VISTA); Radboud University Nijmegen Medical Centre; Dutch Brain Foundation; Maurits; Anna de Cock foundation	The MR research in this study was made possible by investment grants NWO middelgroot 40-00506-90-0602 and NWO BIG (VISTA). ACN is supported by a grant from the Radboud University Nijmegen Medical Centre, WPJL is supported by the Dutch Brain Foundation (grant KS2010(1)-01). Computed image analysis was supported by a grant from the Maurits and Anna de Cock foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockmann MA, 2003, NEUROSURGERY, V52, P1391, DOI 10.1227/01.NEU.0000064806.87785.AB; Caretti V, 2011, BRAIN PATHOL, V21, P441, DOI 10.1111/j.1750-3639.2010.00468.x; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Claes A, 2008, CANCER BIOL THER, V7, P7; Claes A, 2008, BRAIN PATHOL, V18, P423, DOI 10.1111/j.1750-3639.2008.00141.x; Claes A, 2008, INT J CANCER, V122, P1981, DOI 10.1002/ijc.23306; Claes A, 2008, MOL CANCER THER, V7, P71, DOI 10.1158/1535-7163.MCT-07-0552; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hof D, 2005, AUTOIMMUN REV, V4, P380, DOI 10.1016/j.autrev.2005.02.003; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Koochekpour S, 1997, CANCER RES, V57, P5391; Kunkel P, 2001, CANCER RES, V61, P6624; Lamszus K, 2003, ACT NEUR S, V88, P169; Lamszus K, 1998, INT J CANCER, V75, P19, DOI 10.1002/(SICI)1097-0215(19980105)75:1<19::AID-IJC4>3.0.CO;2-4; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Leenders WPJ, 2002, ENDOTHELIUM-J ENDOTH, V9, P83, DOI 10.1080/10623320212006; Li YQ, 2011, P NATL ACAD SCI USA, V108, P9951, DOI 10.1073/pnas.1016912108; Liu W, 2011, J CLIN NEUROSCI, V18, P119, DOI 10.1016/j.jocn.2010.05.010; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Narayana A, 2009, J NEUROSURG, V110, P173, DOI 10.3171/2008.4.17492; Navis AC, 2011, J PATHOL, V223, P626, DOI 10.1002/path.2836; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Sennino B, 2012, CANCER DISCOV, V2, P270, DOI 10.1158/2159-8290.CD-11-0240; Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Verhoeff JJC, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-444; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Weidner KM, 1996, NATURE, V384, P173, DOI 10.1038/384173a0; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wesseling P, 1997, J NEURO-ONCOL, V32, P253, DOI 10.1023/A:1005746320099; Yakes FM, 2011, MOL CANCER THER, V10, P2298, DOI 10.1158/1535-7163.MCT-11-0264; You WK, 2011, CANCER RES, V71, P4758, DOI 10.1158/0008-5472.CAN-10-2527	38	59	63	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58262	10.1371/journal.pone.0058262	http://dx.doi.org/10.1371/journal.pone.0058262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23484006	gold, Green Published, Green Submitted			2022-12-27	WOS:000315634900079
J	Li, XK; Yuan, CF; Wang, JL; Zhang, YQ; Zhang, ZY; Guo, Z				Li, Xiao-Kang; Yuan, Chao-Fan; Wang, Jun-Lin; Zhang, Yong-Quan; Zhang, Zhi-Yong; Guo, Zheng			The Treatment Effect of Porous Titanium Alloy Rod on the Early Stage Talar Osteonecrosis of Sheep	PLOS ONE			English	Article							FEMORAL-HEAD; AVASCULAR NECROSIS; ANIMAL-MODEL; ATRAUMATIC OSTEONECROSIS; FOLLOW-UP; IMPLANTS; TALUS; BONE; BISPHOSPHONATE; PATHOGENESIS	Osteonecrosis of the talus (ONT) may severely affect the function of the ankle joint. Most orthopedists believe that ONT should be treated at an early stage, but a concise and effective surgical treatment is lacking. In this study, porous titanium alloy rods were prepared and implanted into the tali of sheep with early-stage ONT (IM group). The curative effect of the rods was compared to treatment by core decompression (DC group). No significant differences in bone reconstruction were observed between the two groups at 1 month after intervention. After 3 months, the macroscopic view of gross specimens of the IM group showed ordinary contours, but the specimens of the DC group showed obvious partial bone defects and cartilage degeneration. Quantitative analysis of the reconstructed trabeculae by micro-CT and histological study suggested that the curative effect of the IM group was superior to that of the DC group at 3 months after intervention. These favorable short-term results of the implantation of porous titanium alloy rods into the tali of sheep with early-stage ONT may provide insight into an innovative surgical treatment for ONT.	[Li, Xiao-Kang; Yuan, Chao-Fan; Zhang, Yong-Quan; Guo, Zheng] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China; [Wang, Jun-Lin] Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China; [Zhang, Zhi-Yong] Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Sch Med, Shanghai 200030, Peoples R China; [Zhang, Zhi-Yong] Natl Tissue Engn Ctr China, Shanghai, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Shanghai Jiao Tong University	Zhang, ZY (corresponding author), Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Shanghai Peoples Hosp 9, Shanghai Key Lab Tissue Engn,Sch Med, Shanghai 200030, Peoples R China.	mr.zhiyong@gmail.com; guozheng@fmmu.edu.cn	zhang, zhiyong/G-3227-2010	zhang, zhiyong/0000-0001-7903-1544	National Natural Science Foundation of China [81171773, SJZT10Z09, 81101353]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No: 81171773) to Guo Zheng and Xijing Zhutui Project (SJZT10Z09) and National Natural Science Foundation of China (81101353) to Zhang Zhi-Yong. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Assouline-Dayan Y, 2002, SEMIN ARTHRITIS RHEU, V32, P94, DOI 10.1053/sarh.2002.33724; Bagaria V, 2011, EUR J RADIOL, V80, P814, DOI 10.1016/j.ejrad.2010.10.007; Bekler Halil, 2007, Acta Orthop Traumatol Turc, V41, P58; Bertollo N, 2012, J ARTHROPLASTY; Comesana R, 2011, ACTA BIOMATER, V7, P3476, DOI 10.1016/j.actbio.2011.05.023; Delanois RE, 1998, J BONE JOINT SURG AM, V80A, P529, DOI 10.2106/00004623-199804000-00009; Floerkemeier T, 2011, INT ORTHOP, V35, P489, DOI 10.1007/s00264-009-0940-9; Grice John, 2011, Foot Ankle Surg, V17, P317, DOI 10.1016/j.fas.2009.10.005; Guest M., 1999, FOOT, V9, P44; Hasegawa Y, 1997, ARCH ORTHOP TRAUM SU, V116, P251; Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013; Jureus J, 2012, ACTA ORTHOP, V83, P511, DOI 10.3109/17453674.2012.729184; Kim SY, 2005, J BONE JOINT SURG AM, V87A, P2012, DOI 10.2106/JBJS.D.02593; Kitaoka HB, 1998, J BONE JOINT SURG AM, V80A, P370, DOI 10.2106/00004623-199803000-00010; Li YL, 2009, INT ORTHOP, V33, P573, DOI 10.1007/s00264-008-0672-2; Manggold J, 2002, LAB ANIM-UK, V36, P173, DOI 10.1258/0023677021912460; Marulanda GA, 2010, J FOOT ANKLE SURG, V49, P20, DOI 10.1053/j.jfas.2009.07.004; Mont MA, 1996, J BONE JOINT SURG BR, V78B, P827, DOI 10.1302/0301-620X.78B5.0780827; Murr LE, 2011, J MECH BEHAV BIOMED, V4, P1396, DOI 10.1016/j.jmbbm.2011.05.010; Nadeau Melissa, 2007, Mcgill J Med, V10, P4; Norimatsu H, 1997, OSTEOPOROSIS INT, V7, P57, DOI 10.1007/BF03194344; Palmquist A., 2011, J BIOMATER APPL; Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006; Pearce DH, 2005, RADIOGRAPHICS, V25, P399, DOI 10.1148/rg.252045709; Petcu EB, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-78; Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032; Rieger UM, 2009, MICROSURG, V29, P667, DOI 10.1002/micr.20676; Saini A, 2004, CLIN RADIOL, V59, P1079, DOI 10.1016/j.crad.2004.04.014; Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007; Tanzer M, 2008, J BONE JOINT SURG AM, V90A, P1282, DOI 10.2106/JBJS.F.00847; Veillette CJH, 2006, J BONE JOINT SURG AM, V88A, P48, DOI 10.2106/JBJS.F.00538; Velez R, 2011, ARCH ORTHOP TRAUM SU, V131, P5, DOI 10.1007/s00402-010-1084-5; Wan L, 2006, OSTEOARTHR CARTILAGE, V14, P1294, DOI 10.1016/j.joca.2006.05.012; Yu Xiao-guang, 2010, Zhonghua Yi Xue Za Zhi, V90, P1035; Yuan CF, 2012, INT J MED SCI, V9, P816, DOI 10.7150/ijms.4882; Zhang P, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-15	36	13	14	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58459	10.1371/journal.pone.0058459	http://dx.doi.org/10.1371/journal.pone.0058459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516485	Green Submitted, Green Published, gold			2022-12-27	WOS:000316407400031
J	Yoneda, M; Georges-Courbot, MC; Ikeda, F; Ishii, M; Nagata, N; Jacquot, F; Raoul, H; Sato, H; Kai, C				Yoneda, Misako; Georges-Courbot, Marie-Claude; Ikeda, Fusako; Ishii, Miho; Nagata, Noriyo; Jacquot, Frederic; Raoul, Herve; Sato, Hiroki; Kai, Chieko			Recombinant Measles Virus Vaccine Expressing the Nipah Virus Glycoprotein Protects against Lethal Nipah Virus Challenge	PLOS ONE			English	Article							ENCEPHALITIS OUTBREAK; PIG-FARMERS; INFECTION; PATHOGENESIS; PATHOLOGY; RESCUE; MODEL	Nipah virus (NiV) is a member of the genus Henipavirus, which emerged in Malaysia in 1998. In pigs, infection resulted in a predominantly non-lethal respiratory disease; however, infection in humans resulted in over 100 deaths. Nipah virus has continued to re-emerge in Bangladesh and India, and person-to-person transmission appeared in the outbreak. Although a number of NiV vaccine studies have been reported, there are currently no vaccines or treatments licensed for human use. In this study, we have developed a recombinant measles virus (rMV) vaccine expressing NiV envelope glycoproteins (rMV-HL-G and rMV-Ed-G). Vaccinated hamsters were completely protected against NiV challenge, while the mortality of unvaccinated control hamsters was 90%. We trialed our vaccine in a non-human primate model, African green monkeys. Upon intraperitoneal infection with NiV, monkeys showed several clinical signs of disease including severe depression, reduced ability to move and decreased food ingestion and died at 7 days post infection (dpi). Intranasal and oral inoculation induced similar clinical illness in monkeys, evident around 9 dpi, and resulted in a moribund stage around 14 dpi. Two monkeys immunized subcutaneously with rMV-Ed-G showed no clinical illness prior to euthanasia after challenge with NiV. Viral RNA was not detected in any organ samples collected from vaccinated monkeys, and no pathological changes were found upon histopathological examination. From our findings, we propose that rMV-NiV-G is an appropriate NiV vaccine candidate for use in humans.	[Yoneda, Misako; Ikeda, Fusako; Ishii, Miho; Sato, Hiroki; Kai, Chieko] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Minato Ku, Tokyo 108, Japan; [Kai, Chieko] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Minato Ku, Tokyo, Japan; [Georges-Courbot, Marie-Claude; Jacquot, Frederic; Raoul, Herve] INSERM, Lab INSERM Jean Merieux P4, F-69008 Lyon, France; [Nagata, Noriyo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan	University of Tokyo; University of Tokyo; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institute of Infectious Diseases (NIID)	Yoneda, M (corresponding author), Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Minato Ku, Tokyo 108, Japan.	yone@ims.u-tokyo.ac.jp; ckai@ims.u-tokyo.ac.jp	raoul, herve/G-3403-2013		Ministry of Education, Science, Culture and Sports of Japan	Ministry of Education, Science, Culture and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants in aid from the Ministry of Education, Science, Culture and Sports of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, FIELDS VIROLOGY; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chattopadhyay A, 2011, J VIROL, V85, P2004, DOI 10.1128/JVI.01852-10; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2001, J INFECTION, V42, P40, DOI 10.1053/jinf.2000.0782; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824; Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; Guerbois M, 2009, VIROLOGY, V388, P191, DOI 10.1016/j.virol.2009.02.047; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Hilleman MR, 2001, VACCINE, V20, P651, DOI 10.1016/S0264-410X(01)00384-X; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Kai C, 2011, J DISASTER IN PRESS; Lam SK, 2003, ANTIVIR RES, V57, P113, DOI 10.1016/S0166-3542(02)00204-8; Lo MK, 2008, J CLIN VIROL, V43, P396, DOI 10.1016/j.jcv.2008.08.007; Lorin C, 2004, J VIROL, V78, P146, DOI 10.1128/JVI.78.1.146-157.2004; Luby SP, 2009, EMERG INFECT DIS, V15, P1229, DOI 10.3201/eid1508.081237; McEachern JA, 2008, VACCINE, V26, P3842, DOI 10.1016/j.vaccine.2008.05.016; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; Ovsyannikova IG, 2003, CLIN DIAGN LAB IMMUN, V10, P411, DOI 10.1128/CDLI.10.3.411-416.2003; Paton NI, 1999, LANCET, V354, P1253, DOI 10.1016/S0140-6736(99)04379-2; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Tan CT, 2003, ANN ACAD MED SINGAP, V32, P112; Terao-Muto Y, 2008, ANTIVIR RES, V80, P370, DOI 10.1016/j.antiviral.2008.08.006; Walpita P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018437; Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06; Wong KT, 2003, AM J PATHOL, V163, P2127, DOI 10.1016/S0002-9440(10)63569-9; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; Yoneda M, 2006, P NATL ACAD SCI USA, V103, P16508, DOI 10.1073/pnas.0606972103; 2004, HLTH SCI B, V2, P5	32	49	52	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58414	10.1371/journal.pone.0058414	http://dx.doi.org/10.1371/journal.pone.0058414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516477	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400026
J	Chen, L; Liu, HO; Liu, J; Zhu, Y; Xu, L; He, HY; Zhang, H; Wang, SS; Wu, Q; Liu, WS; Liu, YD; Pan, D; Ren, SF; Xu, JJ; Gu, JX				Chen, Lin; Liu, Haiou; Liu, Jing; Zhu, Yu; Xu, Le; He, Hongyong; Zhang, Heng; Wang, Shanshan; Wu, Qian; Liu, Weisi; Liu, Yidong; Pan, Deng; Ren, Shifang; Xu, Jiejie; Gu, Jianxin			Klotho Endows Hepatoma Cells with Resistance to Anoikis via VEGFR2/PAK1 Activation in Hepatocellular Carcinoma	PLOS ONE			English	Article							OXIDATIVE STRESS; GROWTH; EXPRESSION; CANCER; MOUSE; P21-ACTIVATED-KINASE-1; ASSOCIATION; SUPPRESSOR; RECEPTOR; CA2+	Klotho was originally characterized as an aging suppressor gene that predisposed Klotho-deficient mice to premature aging-like syndrome. Although Klotho was recently reported to exhibit tumor suppressive properties during various malignant transformations, the functional role and molecular mechanism of Klotho in hepatocarcinogenesis remains poorly understood. In our present study, immunohistochemical Klotho staining levels in a clinical follow-up of 52 hepatoma patients were significantly associated with liver cirrhosis, tumor multiplicity and venous invasion. The overall survival rate of hepatoma patients with high Klotho expression was significantly lower than those patients with low Klotho expression. Moreover, Klotho overexpression increased cellular migration, anchorage-independent growth, and anoikis resistance in hepatoma cells. Klotho overexpression elevated p21-activated kinase 1 (PAK1) expression and shRNA-mediated PAK1 knockdown and kinase activity inhibition with kinase dead mutant PAK1 K299R coexpression or allosteric inhibitor IPA3 treatment reversed anoikis resistance in Klotho-overexpressed hepatoma cells. More importantly, the pivotal significance of upregulated VEGFR2 protein levels mediated by Klotho expression was confirmed by VEGFR2 inhibitor Axitinib and blocking antibody treatment in hepatoma cells. Axitinib treatment sensitized anoikis was reversed by constitutive active mutant PAK1 T423E coexpression in Klotho-overexpressed hepatoma cells. Conversely, knockdown of Klotho reduced VEGFR2/PAK1 dependent anoikis resistance, which could be reversed by PAK1 T423E. These results revealed a novel oncogenic function of Klotho in promoting anoikis resistance via activating VEGFR2/PAK1 signaling, thus facilitating tumor migration and invasion during hepatoma progression, which could provide a putative molecular mechanism for tumor metastasis.	[Chen, Lin; Liu, Haiou; Wang, Shanshan; Wu, Qian; Liu, Weisi; Liu, Yidong; Pan, Deng; Ren, Shifang; Xu, Jiejie; Gu, Jianxin] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China; [Zhu, Yu; Xu, Le] Fudan Univ, Shanghai Med Coll, Dept Urol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [He, Hongyong; Zhang, Heng] Fudan Univ, Shanghai Med Coll, Dept Gen Surg, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Liu, Jing] Nantong Univ, Sch Med, Nantong, Peoples R China	Fudan University; Fudan University; Fudan University; Nantong University	Xu, JJ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China.	jjxufdu@fudan.edu.cn	Liu, Haiou/AFS-2886-2022; Xu, Le/HDN-9623-2022	Liu, Haiou/0000-0003-0200-8981; liu, weisi/0000-0002-4730-5448	National Basic Research Program of China 973 Program [2012CB822104, 2010CB912104]; State Key Project Specialized for Infectious Diseases of China [2012ZX10002-008, 2012ZX10002-012]; National High-Tech RD 863 Program [2012AA020203]; National Natural Science Fund [30930025, 31010103906, 31170766, 31100629, 31270863]	National Basic Research Program of China 973 Program(National Basic Research Program of China); State Key Project Specialized for Infectious Diseases of China; National High-Tech RD 863 Program(National High Technology Research and Development Program of China); National Natural Science Fund(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Basic Research Program of China 973 Program (2012CB822104, 2010CB912104) and State Key Project Specialized for Infectious Diseases of China (2012ZX10002-008, 2012ZX10002-012), National High-Tech R&D 863 Program (2012AA020203), and National Natural Science Fund (30930025, 31010103906, 31170766, 31100629, 31270863). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-99; Chen S, 2003, J BIOL CHEM, V278, P20029, DOI 10.1074/jbc.M300818200; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fukino K, 2002, BIOCHEM BIOPH RES CO, V293, P332, DOI 10.1016/S0006-291X(02)00216-4; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; He H, 2012, CANC SCI; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kusaba T, 2010, P NATL ACAD SCI USA, V107, P19308, DOI 10.1073/pnas.1008544107; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; Liu H, 2012, CANC SCI; Liu HO, 2011, CANCER RES, V71, P7547, DOI 10.1158/0008-5472.CAN-11-2260; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Lu L, 2008, CANCER INVEST, V26, P185, DOI 10.1080/07357900701638343; Mitobe M, 2005, NEPHRON EXP NEPHROL, V101, pE67, DOI 10.1159/000086500; Nagai R, 2000, CELL MOL LIFE SCI, V57, P738, DOI 10.1007/s000180050038; Nagai T, 2002, FASEB J, V16, P50, DOI 10.1096/fj.02-0448fje; Nagaprashantha LD, 2011, INT J CANCER, V128, P743, DOI 10.1002/ijc.25725; Nussbaum T, 2008, HEPATOLOGY, V48, P146, DOI 10.1002/hep.22297; Saito Y, 1998, BIOCHEM BIOPH RES CO, V248, P324, DOI 10.1006/bbrc.1998.8943; Thomas MB, 2010, J CLIN ONCOL, V28, P3994, DOI 10.1200/JCO.2010.28.7805; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Woolfolk EA, 2005, AM J PHYSIOL-CELL PH, V289, pC1286, DOI 10.1152/ajpcell.00448.2004; Xu JJ, 2012, GASTROENTEROLOGY, V143, P199, DOI 10.1053/j.gastro.2012.03.053; Xu JJ, 2010, HEPATOLOGY, V52, P142, DOI 10.1002/hep.23613; Xu L, 2012, CANC SCI; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Zhang WJ, 2011, J IMMUNOL, V187, P1764, DOI 10.4049/jimmunol.1002315; Zhang WJ, 2010, J IMMUNOL, V184, P6465, DOI 10.4049/jimmunol.0904016	39	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58413	10.1371/journal.pone.0058413	http://dx.doi.org/10.1371/journal.pone.0058413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516476	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200067
J	de Bock, M; Derraik, JGB; Brennan, CM; Biggs, JB; Morgan, PE; Hodgkinson, SC; Hofman, PL; Cutfield, WS				de Bock, Martin; Derraik, Jose G. B.; Brennan, Christine M.; Biggs, Janene B.; Morgan, Philip E.; Hodgkinson, Steven C.; Hofman, Paul L.; Cutfield, Wayne S.			Olive (Olea europaea L.) Leaf Polyphenols Improve Insulin Sensitivity in Middle-Aged Overweight Men: A Randomized, Placebo-Controlled, Crossover Trial	PLOS ONE			English	Article							BETA-CELL FUNCTION; CARDIOVASCULAR RISK-FACTORS; GLUCOSE-TOLERANCE; BLOOD-PRESSURE; INTERLEUKIN-6; SECRETION; EXTRACT; COMPLEMENTARY; QUESTIONNAIRE; RESISTANCE	Background: Olive plant leaves (Olea europaea L.) have been used for centuries in folk medicine to treat diabetes, but there are very limited data examining the effects of olive polyphenols on glucose homeostasis in humans. Objective: To assess the effects of supplementation with olive leaf polyphenols (51.1 mg oleuropein, 9.7 mg hydroxytyrosol per day) on insulin action and cardiovascular risk factors in middle-aged overweight men. Design: Randomized, double-blinded, placebo-controlled, crossover trial in New Zealand. 46 participants (aged 46.4 +/- 5.5 years and BMI 28.0 +/- 2.0 kg/m(2)) were randomized to receive capsules with olive leaf extract (OLE) or placebo for 12 weeks, crossing over to other treatment after a 6-week washout. Primary outcome was insulin sensitivity (Matsuda method). Secondary outcomes included glucose and insulin profiles, cytokines, lipid profile, body composition, 24-hour ambulatory blood pressure, and carotid intima-media thickness. Results: Treatment evaluations were based on the intention-to-treat principle. All participants took >96% of prescribed capsules. OLE supplementation was associated with a 15% improvement in insulin sensitivity (p = 0.024) compared to placebo. There was also a 28% improvement in pancreatic beta-cell responsiveness (p = 0.013). OLE supplementation also led to increased fasting interleukin-6 (p = 0.014), IGFBP-1 (p = 0.024), and IGFBP-2 (p = 0.015) concentrations. There were however, no effects on interleukin-8, TNF-alpha, ultra-sensitive CRP, lipid profile, ambulatory blood pressure, body composition, carotid intima-media thickness, or liver function. Conclusions: Supplementation with olive leaf polyphenols for 12 weeks significantly improved insulin sensitivity and pancreatic beta-cell secretory capacity in overweight middle-aged men at risk of developing the metabolic syndrome.	[de Bock, Martin; Derraik, Jose G. B.; Brennan, Christine M.; Biggs, Janene B.; Hodgkinson, Steven C.; Hofman, Paul L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Morgan, Philip E.] Univ Sydney, Heart Res Inst, Sydney, NSW 2006, Australia; [Hofman, Paul L.; Cutfield, Wayne S.] Gravida Natl Ctr Growth & Dev, Auckland, New Zealand	University of Auckland; University of Sydney; Heart Research Institute	Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Morgan, Philip/0000-0002-6120-1936	TECHNZ grant (University of Auckland - UniS) through the New Zealand Ministry of Science and Innovation (MSI) [30475.001]; MSI; Comvita; Joan Mary Reynolds Trust	TECHNZ grant (University of Auckland - UniS) through the New Zealand Ministry of Science and Innovation (MSI); MSI; Comvita; Joan Mary Reynolds Trust	This study was supported by a TECHNZ grant (University of Auckland - UniS 30475.001) through the New Zealand Ministry of Science and Innovation (MSI). TECHNZ grants are funded 50% by the MSI, and 50% by a commercial partner following an extensive independent science review process. In this project, the commercial partner was the olive leaf extract manufacturer (Comvita). MdB was funded by the Joan Mary Reynolds Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TECHNZ grants are funded 50% by the MSI, and 50% by a commercial partner following an extensive independent science review process. In this project, the commercial partner was the olive leaf extract manufacturer (Comvita), who supplied the olive leaf extract (OLE) and placebo for this study. The authors have no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Agostoni C, 2011, EFSA J, V9; Agostoni C, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2604; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; de Bock M, 2012, J ACAD NUTR DIET, V112, P808, DOI 10.1016/j.jand.2012.01.018; Degn KB, 2004, DIABETES, V53, P1187, DOI 10.2337/diabetes.53.5.1187; Derosa G, 2012, DIABETIC MED, V29, P1515, DOI 10.1111/j.1464-5491.2012.03699.x; El SN, 2009, NUTR REV, V67, P632, DOI 10.1111/j.1753-4887.2009.00248.x; Ferrannini E, 1998, ENDOCR REV, V19, P477, DOI 10.1210/edrv.19.4.0336; FISHER P, 1994, BRIT MED J, V309, P107, DOI 10.1136/bmj.309.6947.107; Fonolla J, 2010, ATHEROSCLEROSIS SUPP, V11, P182, DOI 10.1016/S1567-5688(10)70859-X; Gerich JE, 1998, ENDOCR REV, V19, P491, DOI 10.1210/er.19.4.491; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Heald AH, 2001, DIABETOLOGIA, V44, P333, DOI 10.1007/s001250051623; KAHN SE, 1993, DIABETES, V42, P1663, DOI 10.2337/diabetes.42.11.1663; KEYS A, 1995, AM J CLIN NUTR, V61, p1321S, DOI 10.1093/ajcn/61.6.1321S; Kim JH, 2009, VITAM HORM, V80, P613, DOI 10.1016/S0083-6729(08)00621-3; Komaki E, 2003, FOOD SCI TECHNOL RES, V9, P35, DOI 10.3136/fstr.9.35; Lorenzo C, 2010, J CLIN ENDOCR METAB, V95, P5082, DOI 10.1210/jc.2010-1144; Maki KC, 2010, DIABETES TECHNOL THE, V12, P895, DOI 10.1089/dia.2010.0083; Maki KC, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-22; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Miyazaki Y, 2002, DIABETES CARE, V25, P517, DOI 10.2337/diacare.25.3.517; Novotny R, 2007, OBESITY, V15, P1565, DOI 10.1038/oby.2007.185; Ou HY, 2006, HORM METAB RES, V38, P106, DOI 10.1055/s-2006-925128; Perrinjaquet-Moccetti T, 2008, PHYTOTHER RES, V22, P1239, DOI 10.1002/ptr.2455; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Schmidt K, 2002, COMPLEMENT THER MED, V10, P141, DOI 10.1016/S0965229902000560; Susalit E, 2011, PHYTOMEDICINE, V18, P251, DOI 10.1016/j.phymed.2010.08.016; Tardif JC, 2011, CIRC-CARDIOVASC IMAG, V4, P319, DOI 10.1161/CIRCIMAGING.110.962001; Wainstein J, 2012, J MED FOOD, V15, P605, DOI 10.1089/jmf.2011.0243; Weigert C, 2006, J BIOL CHEM, V281, P7060, DOI 10.1074/jbc.M509782200; Wheatcroft SB, 2007, DIABETES, V56, P285, DOI 10.2337/db06-0436; Wuhl E, 2002, J HYPERTENS, V20, P1995, DOI 10.1097/00004872-200210000-00019; Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277	35	165	167	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e57622	10.1371/journal.pone.0057622	http://dx.doi.org/10.1371/journal.pone.0057622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516412	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200014
J	Deuba, K; Ekstrom, AM; Shrestha, R; Ionita, G; Bhatta, L; Karki, DK				Deuba, Keshab; Ekstrom, Anna Mia; Shrestha, Rachana; Ionita, George; Bhatta, Laxmi; Karki, Deepak Kumar			Psychosocial Health Problems Associated with Increased HIV Risk Behavior among Men Who Have Sex with Men in Nepal: A Cross-Sectional Survey	PLOS ONE			English	Article							SOCIAL SUPPORT; BISEXUAL ADULTS; SUBSTANCE USE; URBAN MEN; GAY; DISCRIMINATION; DISORDERS; INFECTION; VIOLENCE; CHENNAI	Background: Men who have sex with men (MSM) are marginalized, hidden, underserved and at high risk for HIV in Nepal. We examined the association between MSM sub-populations, psychosocial health problems and support, access to prevention and non-use of condoms. Methods: Between September-November of 2010, a cross-sectional survey on HIV-related risk behavior was performed across Nepal through snowball sampling facilitated by non-governmental organizations, recruiting 339 MSM, age 15 or older. The primary outcomes were: (a) non-use of condoms at least once in last three anal sex encounters with men and (b) non-use of condoms with women in the last encounter. The secondary outcome was participation in HIV prevention interventions in the past year. Results: Among the 339 MSM interviewed, 78% did not use condoms at their last anal sex with another man, 35% did not use condoms in their last sex with a woman, 70% had experienced violence in the last 12 months, 61% were experiencing depression and 47% had thought of committing suicide. After adjustment for age, religion, marital status, and MSM subpopulations (bisexual, ta, meti, gay), non-use of condoms at last anal sex with a man was significantly associated with non-participation in HIV interventions, experience of physical and sexual violence, depression, repeated suicidal thoughts, small social support network and being dissatisfied with social support. Depression was marginally associated with non-use of condoms with women. The findings suggest that among MSM who reported non-use of condoms at last anal sex, the ta subgroup and those lacking family acceptance were the least likely to have participated in any preventive interventions. Conclusions: MSM in Nepal have a prevalence of psychosocial health problems in turn associated with high risk behavior for HIV. Future HIV prevention efforts targeting MSM in Nepal should cover all MSM subpopulations and prioritize psychosocial health interventions.	[Deuba, Keshab] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Ekstrom, Anna Mia] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth IHCAR, Stockholm, Sweden; [Ekstrom, Anna Mia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Shrestha, Rachana; Bhatta, Laxmi] Pokhara Univ, Nobel Coll, Kathmandu, Nepal; [Ionita, George] UNDP, Kathmandu, Nepal; [Karki, Deepak Kumar] Natl Ctr AIDS & STD Control, Kathmandu, Nepal	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Deuba, K (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	deuba4k@gmail.com	Ekström, Anna Mia/H-6901-2013	Deuba, Keshab/0000-0002-9933-2210; Karki, Deepak Kumar/0000-0002-0392-6592; Bhatta, Laxmi/0000-0002-8166-1470	Netherlands Development Organization (SNV) through the Social Inclusion Research Fund (SIRF), Nepal	Netherlands Development Organization (SNV) through the Social Inclusion Research Fund (SIRF), Nepal	The Netherlands Development Organization (SNV) provided financial support through the Social Inclusion Research Fund (SIRF), Nepal for this work. The SNV had no role in study design or protocol development, data collection or analysis, report writing or the decision to publish this research data in a peer-reviewed article.	ALTMAN DG, 1994, BRIT MED J, V309, P996, DOI 10.1136/bmj.309.6960.996; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-36; BARTHOLOW BN, 1994, CHILD ABUSE NEGLECT, V18, P747; Chu Sandra Ka Hon, 2008, HIV AIDS Policy Law Rev, V13, P62; Collins S, 2006, LANCET, V368, P907, DOI 10.1016/S0140-6736(06)69353-7; Dandona L, 2005, AIDS, V19, P611, DOI 10.1097/01.aids.0000163938.01188.e4; Darbes LA, 2005, HEALTH PSYCHOL, V24, P617, DOI 10.1037/0278-6133.24.6.617; Darbes LA, 2012, AIDS BEHAV, V16, P159, DOI 10.1007/s10461-010-9868-8; Deuba K, 2014, ASIA-PAC J PUBLIC HE, V26, P126, DOI 10.1177/1010539512441491; Devkota B, 2009, ASIA-PAC J PUBLIC HE, V21, P377, DOI 10.1177/1010539509342434; Dilley JW, 1998, AIDS EDUC PREV, V10, P317; FOLKMAN S, 1992, HEALTH PSYCHOL, V11, P218, DOI 10.1037/0278-6133.11.4.218; Heintz AJ, 2006, J INTERPERS VIOLENCE, V21, P193, DOI 10.1177/0886260505282104; Herbst JH, 2005, JAIDS-J ACQ IMM DEF, V39, P228; HIV/AIDS and STD Control Board, 2007, NEP NAT AIDS SPEND A; IV/AIDS and STD Control Board, 2010, UNGASS COUNTR PROGR; Johnson WD, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001230.pub2; King M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-70; Lu L, 1997, J SOC PSYCHOL, V137, P618, DOI 10.1080/00224549709595483; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; McCabe SE, 2010, AM J PUBLIC HEALTH, V100, P1946, DOI 10.2105/AJPH.2009.163147; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; National Institute on Alcohol Abuse and Alcoholism, 2006, ALC US ALC US DIS US; NCASC, 2012, NAT EST HIV INF NEP; NCASC FHI New ERA, 2009, INT BIOB SURV IBBS M; NCASC FHI New ERA, 2007, INT BIOB SURV IBBS M; New ERA/SACTS, 2006, INT BIOB SURV FEM SE; OBRIEN K, 1993, SOC SCI MED, V36, P1161, DOI 10.1016/0277-9536(93)90236-W; Pant Sunil, 2006, HIV AIDS Policy Law Rev, V11, P87; RADLOFF LS, 1977, J APPL PSYCHOL MEASU, V1, P385, DOI DOI 10.1177/014662167700100306; Relf MV, 2004, J ASSOC NURSE AIDS C, V15, P14, DOI 10.1177/1055329003261965; Remafedi G, 1998, AM J PUBLIC HEALTH, V88, P57, DOI 10.2105/AJPH.88.1.57; RET Asia amfAR, 2006, MSM HIV AIDS RISK AS; Ruan WJ, 2008, DRUG ALCOHOL DEPEN, V92, P27, DOI 10.1016/j.drugalcdep.2007.06.001; Saavedra Jorge, 2008, J Int AIDS Soc, V11, P9, DOI 10.1186/1758-2652-11-9; Safren SA, 2010, JAIDS-J ACQ IMM DEF, V55, pS74, DOI 10.1097/QAI.0b013e3181fbc939; Safren SA, 2009, PSYCHOL HEALTH MED, V14, P705, DOI 10.1080/13548500903334754; Samet Sharon, 2007, Addict Sci Clin Pract, V4, P19; SARASON IG, 1987, J SOC PERS RELAT, V4, P497, DOI 10.1177/0265407587044007; Simoni JM, 2006, AM J PUBLIC HEALTH, V96, P2240, DOI 10.2105/AJPH.2004.054056; Singer MC, 2006, SOC SCI MED, V63, P2010, DOI 10.1016/j.socscimed.2006.05.012; Sivasubramanian M, 2011, PSYCHOL HEALTH MED, V16, P450, DOI 10.1080/13548506.2011.554645; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; Strathdee SA, 1998, J ACQ IMMUN DEF SYND, V19, P61, DOI 10.1097/00042560-199809010-00010; Thomas B, 2009, AIDS PATIENT CARE ST, V23, P981, DOI 10.1089/apc.2009.0092; Thomas B, 2009, AIDS EDUC PREV, V21, P372, DOI 10.1521/aeap.2009.21.4.372; Wilson E, 2011, CULT HEALTH SEX, V13, P253, DOI 10.1080/13691058.2010.524247	49	42	45	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58099	10.1371/journal.pone.0058099	http://dx.doi.org/10.1371/journal.pone.0058099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516434	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200032
J	Huang, JF; Lv, CJ; Hu, MY; Zhong, GH				Huang, Jingfei; Lv, Chaojun; Hu, Meiying; Zhong, Guohua			The Mitochondria-Mediate Apoptosis of Lepidopteran Cells Induced by Azadirachtin	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; NEEM LIMONOIDS AZADIRACHTIN; CASPASE ACTIVATION; CYCLOSPORINE-A; CAMPTOTHECIN; SF9; RESPONSES; DEATH; PROLIFERATION	Mitochondria have been shown to play an important role in apoptosis using mammalian cell lines. However, this seems not to be the case in Drosophila, an insect model organism; thus more in-depth studies of insect cell apoptosis are necessary. In the present study, mitochondrial involvement during azadirachtin- and camptothecin-induced apoptosis in Spodoptera frugiperda Sf9 cells (isolated from Spodoptera frugiperda pupal ovarian tissue) was investigated. The results showed that both azadirachtin and camptothecin could induce apoptosis in Sf9 cells. Reactive oxygen species (ROS) generation, activation of mitochondrial permeability transition pores (MPTPs) and loss of mitochondrial membrane potential (MMP) were observed very early during apoptosis and were followed subsequently by the release of cytochrome-c from the mitochondria. Furthermore, the results also revealed that the opening of MPTPs and the loss of MMP induced by azadirachtin could be significantly inhibited by the permeability transition pore (PTP) inhibitor cyclosporin A (CsA), which was used to identify the key role of mitochondria in the apoptosis of Sf9 cells. However, in camptothecin-treated Sf9 cells, CsA could not suppress the opening of MPTPs and the loss of MMP when apoptosis was induced. The data from caspase-3 and caspase-9 activity assays and detection of apoptosis by morphological observation and flow cytometry also uncovered the different effect of CsA on the two botanical apoptosis inducers. Although different mechanisms of apoptosis induction exist, our study revealed that mitochondria play a crucial role in insect cell line apoptosis.	[Huang, Jingfei; Lv, Chaojun; Hu, Meiying; Zhong, Guohua] South China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China; [Lv, Chaojun] Chinese Acad Trop Agr Sci, Inst Coconut, Wenchang, Hainan Province, Peoples R China	South China Agricultural University; Chinese Academy of Tropical Agricultural Sciences	Zhong, GH (corresponding author), South China Agr Univ, Minist Educ, Key Lab Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China.	guohuazhong@scau.edu.cn			China National Nature Science Foundation [30971944]	China National Nature Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by grants from China National Nature Science Foundation (No. 30971944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahid E, 2011, BIOCHIM BIOPHYS ACTA, V181, P3597; Abdelwahid E, 2007, DEV CELL, V12, P793, DOI 10.1016/j.devcel.2007.04.004; Adrain C, 2001, TRENDS BIOCHEM SCI, V26, P390, DOI 10.1016/S0968-0004(01)01844-8; Anuradha A, 2007, INSECT BIOCHEM MOLEC, V37, P627, DOI 10.1016/j.ibmb.2007.03.009; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; BENNETT WM, 1986, ANNU REV MED, V37, P215; Bredholt T, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-101; Challa M, 2007, EMBO J, V26, P3144, DOI 10.1038/sj.emboj.7601745; Chandna S, 2004, INT J RADIAT BIOL, V80, P301, DOI [10.1080/09553000440001679794, 10.1080/09553000410001679794]; Chapman A, 2009, NUMBERS LIVING SPECI; Colombini M, 2007, METHOD CELL BIOL, V80, P241, DOI 10.1016/S0091-679X(06)80012-9; Cotran R. S., 1999, ROBBINS PATHOLOGIC B, V6th; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dorstyn L, 2002, J CELL BIOL, V156, P1089, DOI 10.1083/jcb.200111107; Dorstyn L, 2004, J CELL BIOL, V167, P405, DOI 10.1083/jcb.200408054; Dorstyn L, 2006, CELL DEATH DIFFER, V13, P1049, DOI 10.1038/sj.cdd.4401918; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Huang JF, 2011, PESTIC BIOCHEM PHYS, V100, P256, DOI 10.1016/j.pestbp.2011.04.010; Huang JF, 2011, PESTIC BIOCHEM PHYS, V99, P16, DOI 10.1016/j.pestbp.2010.08.002; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z; Kumar GH, 2010, INVEST NEW DRUG, V28, P392, DOI 10.1007/s10637-009-9263-3; Kumar RP, 2007, INSECT BIOCHEM MOLEC, V37, P635, DOI 10.1016/j.ibmb.2007.03.010; Kumarswamy R, 2009, INT J BIOCHEM CELL B, V41, P1430, DOI 10.1016/j.biocel.2008.12.009; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee An-Chin, 1997, Methods in Cell Science, V19, P71, DOI 10.1023/A:1009761922055; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Liu KY, 2012, INSECT SCI, V19, P30, DOI 10.1111/j.1744-7917.2011.01431.x; Liu LJ, 2007, CELL BIOL INT, V31, P996, DOI 10.1016/j.cellbi.2007.03.011; Liu TX, 2006, PEST MANAG SCI, V62, P38, DOI 10.1002/ps.1123; LOWERY DT, 1994, ENTOMOL EXP APPL, V72, P77, DOI 10.1007/BF02382417; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Means J, 2006, CELL DEATH DIFFER, V13, P1222, DOI 10.1038/sj.cdd.4401821; Mendes CS, 2006, EMBO REP, V7, P933, DOI 10.1038/sj.embor.7400773; Mitchell MJ, 1997, ARCH INSECT BIOCHEM, V35, P199, DOI 10.1002/(SICI)1520-6327(1997)35:1/2<199::AID-ARCH18>3.3.CO;2-7; Mohan M, 2003, CELL BIOL INT, V27, P483, DOI 10.1016/S1065-6995(03)00071-4; MORDUE AJ, 1993, J INSECT PHYSIOL, V39, P903, DOI 10.1016/0022-1910(93)90001-8; MOREIRA MF, 1994, ARCH INSECT BIOCHEM, V27, P287, DOI 10.1002/arch.940270405; Nathan SS, 2006, CHEMOSPHERE, V64, P1650, DOI 10.1016/j.chemosphere.2006.01.037; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Ott M, 2007, CELL DEATH DIFFER, V14, P1243, DOI 10.1038/sj.cdd.4402135; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Palmeira CM, 1996, J PHARMACOL TOX MET, V35, P35, DOI 10.1016/1056-8719(95)00131-X; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Pfau W, 2009, TOXICOL LETT, V189, P214; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Priyadarsini RV, 2010, FREE RADICAL RES, V44, P624, DOI 10.3109/10715761003692503; Priyadarsini RV, 2009, FREE RADICAL RES, V43, P492, DOI 10.1080/10715760902870637; REMBOLD H, 1993, Z NATURFORSCH C, V48, P495; Rhee WJ, 2002, BIOCHEM BIOPH RES CO, V295, P779, DOI 10.1016/S0006-291X(02)00746-5; Robertson SL, 2007, ARCH INSECT BIOCHEM, V64, P200, DOI 10.1002/arch.20171; Ruiz-Meana M, 2006, CARDIOVASC RES, V71, P715, DOI 10.1016/j.cardiores.2006.06.019; RYAN AJ, 1991, NUCLEIC ACIDS RES, V19, P3295, DOI 10.1093/nar/19.12.3295; Salehzadeh A, 2003, INSECT BIOCHEM MOLEC, V33, P681, DOI 10.1016/S0965-1748(03)00057-2; Sanchez-Alcazar JA, 2000, CELL DEATH DIFFER, V7, P1090, DOI 10.1038/sj.cdd.4400740; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Sharov VG, 2007, J MOL CELL CARDIOL, V42, P150, DOI 10.1016/j.yjmcc.2006.09.013; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thoh M, 2010, J BIOL CHEM, V285, P5888, DOI 10.1074/jbc.M109.065847; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Ulukan H, 2002, DRUGS, V62, P2039, DOI 10.2165/00003495-200262140-00004; Vande VC, 2000, MOL CELL BIOL, V20; WALL ME, 1966, J AM CHEM SOC, V88, P3888, DOI 10.1021/ja00968a057; WALSH CT, 1992, J BIOL CHEM, V267, P13115; Wang XD, 2001, GENE DEV, V15, P2922; Xiu MH, 2005, CHINESE SCI BULL, V50, P1191, DOI 10.1360/04WC0275; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682; Zimmermann KC, 2002, J CELL BIOL, V156, P1077, DOI 10.1083/jcb.20112068; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	74	48	52	5	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58499	10.1371/journal.pone.0058499	http://dx.doi.org/10.1371/journal.pone.0058499			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516491	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200073
J	Korup, S; Rietscher, J; Calvignac-Spencer, S; Trusch, F; Hofmann, J; Moens, U; Sauer, I; Voigt, S; Schmuck, R; Ehlers, B				Korup, Sarah; Rietscher, Janita; Calvignac-Spencer, Sebastien; Trusch, Franziska; Hofmann, Joerg; Moens, Ugo; Sauer, Igor; Voigt, Sebastian; Schmuck, Rosa; Ehlers, Bernhard			Identification of a Novel Human Polyomavirus in Organs of the Gastrointestinal Tract	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; JC VIRUS; CROSS-REACTIVITY; WU POLYOMAVIRUS; BK VIRUS; STOOL; SEROEPIDEMIOLOGY; SEROPREVALENCE; INFECTION; SEQUENCES	Polyomaviruses are small, non-enveloped viruses with a circular double-stranded DNA genome. Using a generic polyomavirus PCR targeting the VP1 major structural protein gene, a novel polyomavirus was initially identified in resected human liver tissue and provisionally named Human Polyomavirus 12 (HPyV12). Its 5033 bp genome is predicted to encode large and small T antigens and the 3 structural proteins VP1, VP2 and VP3. Phylogenetic analyses did not reveal a close relationship to any known human or animal polyomavirus. Investigation of organs, body fluids and excretions of diseased individuals and healthy subjects with both HPyV12-specific nested PCR and quantitative real-time PCR revealed additional virus-positive samples of resected liver, cecum and rectum tissues and a positive fecal sample. A capsomer-based IgG ELISA was established using the major capsid protein VP1 of HPyV12. Seroprevalences of 23% and 17%, respectively, were determined in sera from healthy adults and adolescents and a pediatric group of children. These data indicate that the virus naturally infects humans and that primary infection may already occur in childhood.	[Korup, Sarah; Rietscher, Janita; Trusch, Franziska; Voigt, Sebastian; Ehlers, Bernhard] Robert Koch Inst, Div Viral Infect, Berlin, Germany; [Calvignac-Spencer, Sebastien] Robert Koch Inst, Res Grp Emerging Zoonoses, Berlin, Germany; [Hofmann, Joerg] Charite, Inst Virol, D-13353 Berlin, Germany; [Moens, Ugo] Univ Tromso, Dept Med Biol, Tromso, Norway; [Sauer, Igor; Schmuck, Rosa] Charite, Charite Campus Virchow, D-13353 Berlin, Germany	Robert Koch Institute; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; UiT The Arctic University of Tromso; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ehlers, B (corresponding author), Robert Koch Inst, Div Viral Infect, Berlin, Germany.	EhlersB@rki.de	Sauer, Igor/AAM-4217-2021; Calvignac-Spencer, Sebastien/D-2313-2010; Voigt, Sebastian/W-8594-2019	Calvignac-Spencer, Sebastien/0000-0003-4834-0509; Voigt, Sebastian/0000-0003-1544-9903; Sauer, Igor/0000-0001-9355-937X; Hofmann, Joerg/0000-0003-3966-515X				Abend JR, 2009, SEMIN CANCER BIOL, V19, P252, DOI 10.1016/j.semcancer.2009.02.004; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Babakir-Mina M, 2009, J MED VIROL, V81, P1668, DOI 10.1002/jmv.21559; Bergallo M, 2009, J VIROL METHODS, V162, P69, DOI 10.1016/j.jviromet.2009.07.016; Bialasiewicz S, 2009, J CLIN VIROL, V45, P249, DOI 10.1016/j.jcv.2009.05.002; Bofill-Mas S, 2001, J VIROL, V75, P10290, DOI 10.1128/JVI.75.21.10290-10299.2001; Buck CB, 2012, J VIROL, V86, P10887, DOI 10.1128/JVI.01690-12; Chen TT, 2011, J INFECT DIS, V204, P1523, DOI 10.1093/infdis/jir614; Donepudi S, 2012, SEMIN ONCOL, V39, P163, DOI 10.1053/j.seminoncol.2012.01.003; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; GARDNER SD, 1971, LANCET, V1, P1253; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gerits N, 2012, VIROLOGY, V432, P316, DOI 10.1016/j.virol.2012.05.024; Imperiale M.J., 2007, FIELDS VIROLOGY, V2, P2263; Imperiale MJ, 2000, VIROLOGY, V267, P1, DOI 10.1006/viro.1999.0092; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; Leendertz FH, 2011, J VIROL, V85, P916, DOI 10.1128/JVI.01585-10; Lim ES, 2012, VIROLOGY; Loyo M, 2010, INT J CANCER, V126, P2991, DOI 10.1002/ijc.24737; Maginnis MS, 2009, SEMIN CANCER BIOL, V19, P261, DOI 10.1016/j.semcancer.2009.02.013; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Moens U, 2011, PATHOLOG RES INT, V2011; Moens U, 2008, J DTSCH DERMATOL GES, V6, P704, DOI 10.1111/j.1610-0387.2008.06810.x; Neske F, 2009, J CLIN VIROL, V44, P115, DOI 10.1016/j.jcv.2008.12.004; Ren LL, 2009, EMERG INFECT DIS, V15, P134, DOI 10.3201/eid1501.080693; Ricciardiello L, 2000, GASTROENTEROLOGY, V119, P1228, DOI 10.1053/gast.2000.19269; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Siebrasse EA, 2012, J VIROL, V86, P10321, DOI 10.1128/JVI.01210-12; Stolt A, 2003, J GEN VIROL, V84, P1499, DOI 10.1099/vir.0.18842-0; Tan CS, 2010, J VIROL, V84, P9200, DOI 10.1128/JVI.00609-10; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Toracchio S, 2010, EMERG INFECT DIS, V16, P1702, DOI 10.3201/eid1611.100628; Touze A, 2010, J CLIN MICROBIOL, V48, P1767, DOI 10.1128/JCM.01691-09; Trusch F, 2012, J GEN VIROL, V93, P698, DOI 10.1099/vir.0.039156-0; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Van Ghelue M, 2012, REV MED VIROL, V22, P354, DOI 10.1002/rmv.1711; Vanchiere JA, 2005, J INFECT DIS, V192, P658, DOI 10.1086/432076; Viscidi RP, 2011, CLIN VACCINE IMMUNOL, V18, P1737, DOI 10.1128/CVI.05175-11; Viscidi RP, 2006, ADV EXP MED BIOL, V577, P73; Yu GX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049449	48	119	120	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58021	10.1371/journal.pone.0058021	http://dx.doi.org/10.1371/journal.pone.0058021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516426	Green Published, gold			2022-12-27	WOS:000316849200026
J	Moorjani, P; Patterson, N; Loh, PR; Lipson, M; Kisfali, P; Melegh, BI; Bonin, M; Kadasi, L; Riess, O; Berger, B; Reich, D; Melegh, B				Moorjani, Priya; Patterson, Nick; Loh, Po-Ru; Lipson, Mark; Kisfali, Peter; Melegh, Bela I.; Bonin, Michael; Kadasi, L'udevit; Riess, Olaf; Berger, Bonnie; Reich, David; Melegh, Bela			Reconstructing Roma History from Genome-Wide Data	PLOS ONE			English	Article							POPULATION; PERSPECTIVE; GYPSIES	The Roma people, living throughout Europe and West Asia, are a diverse population linked by the Romani language and culture. Previous linguistic and genetic studies have suggested that the Roma migrated into Europe from South Asia about 1,000-1,500 years ago. Genetic inferences about Roma history have mostly focused on the Y chromosome and mitochondrial DNA. To explore what additional information can be learned from genome-wide data, we analyzed data from six Roma groups that we genotyped at hundreds of thousands of single nucleotide polymorphisms (SNPs). We estimate that the Roma harbor about 80% West Eurasian ancestry-derived from a combination of European and South Asian sources-and that the date of admixture of South Asian and European ancestry was about 850 years before present. We provide evidence for Eastern Europe being a major source of European ancestry, and North-west India being a major source of the South Asian ancestry in the Roma. By computing allele sharing as a measure of linkage disequilibrium, we estimate that the migration of Roma out of the Indian subcontinent was accompanied by a severe founder event, which appears to have been followed by a major demographic expansion after the arrival in Europe.	[Moorjani, Priya; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA; [Moorjani, Priya; Patterson, Nick; Reich, David] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Loh, Po-Ru; Lipson, Mark; Berger, Bonnie] MIT, Dept Math & Comp Sci, Cambridge, MA 02139 USA; [Loh, Po-Ru; Lipson, Mark; Berger, Bonnie] MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Kisfali, Peter; Melegh, Bela I.; Melegh, Bela] Univ Pecs, Dept Med Genet, Pecs, Hungary; [Kisfali, Peter; Melegh, Bela I.; Melegh, Bela] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Bonin, Michael; Riess, Olaf] Univ Tubingen, Dept Med Genet, Tubingen, Germany; [Kadasi, L'udevit] Slovak Acad Sci, Inst Mol Physiol & Genet, Bratislava 83334, Slovakia	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Pecs; University of Pecs; Eberhard Karls University of Tubingen; Slovak Academy of Sciences	Moorjani, P (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA.	moorjani@fas.harvard.edu; bela.melegh@aok.pte.hu	Kadasi, Ludevit/A-4677-2013		OTKA [73430, K 103983]; Medical Faculty of the University of Tubingen; U.S. National Science Foundation HOMINID grant [1032255]; National Institutes of Heath grant [GM100233]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100233] Funding Source: NIH RePORTER	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Medical Faculty of the University of Tubingen; U.S. National Science Foundation HOMINID grant(National Science Foundation (NSF)); National Institutes of Heath grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the OTKA 73430 and K 103983 and the microarray facility was supported by a core facility grant of the Medical Faculty of the University of Tubingen. PM, NP and DR were funded by U.S. National Science Foundation HOMINID grant 1032255, and by National Institutes of Heath grant GM100233. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Atzmon G, 2010, AM J HUMAN GENETICS; Boerger BH, 1984, THESIS; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fraser, 1995, GYPSIES; Gresham D, 2001, AM J HUM GENET, V69, P1314, DOI 10.1086/324681; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Gusmao A, 2008, ANN HUM GENET, V72, P215, DOI 10.1111/j.1469-1809.2007.00421.x; Gusmao A, 2010, AM J PHYS ANTHROPOL, V141, P507, DOI 10.1002/ajpa.21166; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Iovita RP, 2004, AM ANTHROPOL, V106, P267, DOI 10.1525/aa.2004.106.2.267; Kaaydjieva L, 2005, BIOESSAYS, V27, P1084, DOI 10.1002/bies.20287; Kalaydjieva L, 2001, BMC Med Genet, V2, P5, DOI 10.1186/1471-2350-2-5; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liegeois Jean-Pierre, 1994, ROMA GYPSIES TRAVELL; Mendizabal I, 2012, CURRENT BIOL; Mendizabal I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015988; Moorjani P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001373; Morar B, 2004, AM J HUM GENET, V75, P596, DOI 10.1086/424759; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Pamjav H, 2011, AM J PHYS ANTHROPOL, V145, P21, DOI 10.1002/ajpa.21454; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson NJ, 2012, GENETICS; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rai N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048477; Regueiro M, 2012, GENE, V504, P296, DOI 10.1016/j.gene.2012.04.093; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Trail RL, 1970, GRAMAR LAMANI; Turner R.L, 1927, GYPSY LORE SOC MONOG	35	37	37	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58633	10.1371/journal.pone.0058633	http://dx.doi.org/10.1371/journal.pone.0058633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516520	gold, Green Published, Green Submitted			2022-12-27	WOS:000316849200096
J	Zhang, YG; Wu, SP; Xia, YL; Sun, J				Zhang, Yong-guo; Wu, Shaoping; Xia, Yinglin; Sun, Jun			Salmonella Infection Upregulates the Leaky Protein Claudin-2 in Intestinal Epithelial Cells	PLOS ONE			English	Article							TIGHT JUNCTIONS; BARRIER DYSFUNCTION; CANCER-CELLS; EXPRESSION; RECEPTOR; TUMORIGENICITY; INFLAMMATION; ACTIVATION; DISEASE	Background: Tight junctions seal the space between adjacent epithelial cells. Mounting evidence suggests that tight junction proteins play a key role in the pathogenesis of human disease. Claudin is a member of the tight junction protein family, which has 24 members in humans. To regulate cellular function, claudins interact structurally and functionally with membrane and scaffolding proteins via their cytoplasmic domain. In particular, claudin-2 is known to be a leaky protein that contributes to inflammatory bowel disease and colon cancer. However, the involvement of claudin-2 in bacterial infection in the intestine remains unknown. Methods/Principal Findings: We hypothesized that Salmonella elevates the leaky protein claudin-2 for its own benefit to facilitate bacterial invasion in the colon. Using a Salmonella-colitis mouse model and cultured colonic epithelial cells, we found that pathogenic Salmonella colonization significantly increases the levels of claudin-2 protein and mRNA in the intestine, but not that of claudin-3 or claudin-7 in the colon, in a time-dependent manner. Immunostaining studies showed that the claudin-2 expression along the crypt-villous axis postinfection. In vitro, Salmonella stimulated claudin-2 expression in the human intestinal epithelial cell lines SKCO15 and HT29C19A. Further analysis by siRNA knockdown revealed that claudin-2 is associated with the Salmonella-induced elevation of cell permeability. Epithelial cells with claudin-2 knockdown had significantly less internalized Salmonella than control cells with normal claudin-2 expression. Inhibitor assays demonstrated that this regulation is mediated through activation of the EGFR pathway and the downstream protein JNK. Conclusion/Significance: We have shown that Salmonella targets the tight junction protein claudin-2 to facilitate bacterial invasion. We speculate that this disruption of barrier function contributes to a new mechanism by which bacteria interact with their host cells and suggests the possibility of blocking claudin-2 as a potential therapeutic strategy to prevent bacterial invasion.	[Zhang, Yong-guo; Wu, Shaoping; Sun, Jun] Rush Univ, Dept Biochem, Chicago, IL 60612 USA; [Xia, Yinglin] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA; [Sun, Jun] Univ Rochester, Dept Med, Div Gastroenterol & Hepatol, Rochester, NY USA	Rush University; University of Rochester; University of Rochester	Sun, J (corresponding author), Rush Univ, Dept Biochem, Chicago, IL 60612 USA.	jun_sun@rush.edu	Sun, Jun/S-7440-2019	Sun, Jun/0000-0001-7465-3133	National Institute of Diabetes and Digestive and Kidney Diseases [KO1 DK075386, 1R03DK089010-01]; American Cancer Society [RSG-09-075-01-MBC]; Swim Across America Cancer Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075386, R03DK089010] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society(American Cancer Society); Swim Across America Cancer Research Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (KO1 DK075386 and 1R03DK089010-01), the American Cancer Society (RSG-09-075-01-MBC), and Swim Across America Cancer Research Award to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott IDR, 2000, SCAND J GASTROENTERO, V35, P1163; Berkes J, 2003, GUT, V52, P439, DOI 10.1136/gut.52.3.439; Buchert M, 2010, P NATL ACAD SCI USA, V107, P2628, DOI 10.1073/pnas.0903747107; Capaldo CT, 2011, MOL BIOL CELL, V22, P1677, DOI 10.1091/mbc.E10-08-0677; Caplan MS, 1999, GASTROENTEROLOGY, V117, P577, DOI 10.1016/S0016-5085(99)70450-6; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Christakos S, 2010, J STEROID BIOCHEM, V121, P183, DOI 10.1016/j.jsbmb.2010.03.005; Clark JA, 2009, AM J PHYSIOL-GASTR L, V297, pG471, DOI 10.1152/ajpgi.00012.2009; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; HOLLANDER D, 1988, GUT, V29, P1621, DOI 10.1136/gut.29.12.1621; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Ivanov AI, 2004, NOVART FDN SYMP, V263, P124; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x; Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P1, DOI 10.1111/j.1749-6632.2009.04925.x; Severson EA, 2010, BIOCHEM BIOPH RES CO, V397, P592, DOI 10.1016/j.bbrc.2010.05.164; Shiou SR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.154625; Smith AJ, 2010, JAIDS-J ACQ IMM DEF, V55, P306, DOI 10.1097/QAI.0b013e3181ecfeca; Sun J, 2004, AM J PHYSIOL-GASTR L, V287, pG220, DOI 10.1152/ajpgi.00498.2003; Takeuchi K, 2010, FEBS J, V277, P316, DOI 10.1111/j.1742-4658.2009.07450.x; Takeuchi K, 2009, FEBS J, V276, P1255, DOI 10.1111/j.1742-4658.2008.06861.x; Turner JR, 1997, AM J PHYSIOL-CELL PH, V273, pC1378, DOI 10.1152/ajpcell.1997.273.4.C1378; Turner JR, 2000, AM J PHYSIOL-CELL PH, V279, pC1918, DOI 10.1152/ajpcell.2000.279.6.C1918; Van Itallie CM, 2009, ANN NY ACAD SCI, V1165, P82, DOI 10.1111/j.1749-6632.2009.04052.x; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	32	53	53	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58606	10.1371/journal.pone.0058606	http://dx.doi.org/10.1371/journal.pone.0058606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505542	gold, Green Published, Green Submitted			2022-12-27	WOS:000316251100070
J	Deng, C; Sun, ZC; Tong, G; Yi, W; Ma, L; Zhao, BJ; Cheng, L; Zhang, JZ; Cao, F; Yi, DH				Deng, Chao; Sun, Zhongchan; Tong, Guang; Yi, Wei; Ma, Li; Zhao, Bijun; Cheng, Liang; Zhang, Jinzhou; Cao, Feng; Yi, Dinghua			alpha-Lipoic Acid Reduces Infarct Size and Preserves Cardiac Function in Rat Myocardial Ischemia/Reperfusion Injury through Activation of PI3K/Akt/Nrf2 Pathway	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ERYTHROID 2-RELATED FACTOR-2; HEME OXYGENASE-1 EXPRESSION; PROTEIN-KINASE; OXIDATIVE STRESS; CELLS; NRF2; ANTIOXIDANT; PHOSPHORYLATION; TRANSCRIPTION	Background: The present study investigates the effects and mechanisms of alpha-Lipoic acid (LA) on myocardial infarct size, cardiac function and cardiomyocyte apoptosis in rat hearts subjected to in vivo myocardial ischemia/reperfusion (MI/R) injury. Methodology/Principal Findings: Male adult rats underwent 30 minutes of ischemia followed by 3, 24, or 72 h of reperfusion. Animals were pretreated with LA or vehicle before coronary artery ligation. The level of MI/R-induced LDH and CK release, infarct size, cardiomyocyte apoptosis and cardiac functional impairment were examined and compared. Western blot analysis was performed to elucidate the mechanism of LA pretreatment. The level of inflammatory cytokine TNF-alpha released to serum and accumulated in injured myocardium as well as neutrophil accumulation in injured myocardium were also examined after MI/R injury. Our results reveal that LA administration significantly reduced LDH and CK release, attenuated myocardial infarct size, decreased cardiomyocytes apoptosis, and partially preserved heart function. Western blot analysis showed that LA pretreatment up-regulated Akt phosphorylation and Nrf2 nuclear translocation while producing no impact on p38MAPK activation or nitric oxide (NO) production. LA pretreatment also increased expression of HO-1, a major target of Nrf2. LA treatment inhibited neutrophil accumulation and release of TNF-alpha. Moreover, PI3K inhibition abolished the beneficial effects of LA. Conclusions/Significance: This study indicates that LA attenuates cardiac dysfunction by reducing cardiomyoctyes necrosis, apoptosis and inflammation after MI/R. LA exerts its action by activating the PI3K/Akt pathway as well as subsequent Nrf2 nuclear translocation and induction of cytoprotective genes such as HO-1.	[Deng, Chao; Tong, Guang; Yi, Wei; Zhao, Bijun; Cheng, Liang; Zhang, Jinzhou; Yi, Dinghua] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China; [Sun, Zhongchan; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Ma, Li] Navy Gen Hosp, Dept Anesthesia, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Sixth Medical Center of Chinese PLA General Hospital	Cao, F (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China.	wind8828@gmail.com; dinghuayi210@126.com		Yi, Wei/0000-0002-4349-910X	National Natural Science Foundation, People's Republic of China [81102687]	National Natural Science Foundation, People's Republic of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants (No. 81102687) from National Natural Science Foundation, People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; Bitar MS, 2010, LIFE SCI, V86, P844, DOI 10.1016/j.lfs.2010.03.019; Black SC, 1996, J PHARMACOL TOX MET, V35, P179, DOI 10.1016/1056-8719(96)00051-2; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Cheng PY, 2006, FREE RADICAL BIO MED, V40, P1313, DOI 10.1016/j.freeradbiomed.2005.11.024; Coleman MD, 2001, ENVIRON TOXICOL PHAR, V10, P167, DOI 10.1016/S1382-6689(01)00080-1; DeMarco VG, 2004, FREE RADICAL RES, V38, P675, DOI 10.1080/10715760410001702503; Dudek M, 2008, EUR J PHARMACOL, V591, P203, DOI 10.1016/j.ejphar.2008.06.073; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Ghibu S, 2009, J CARDIOVASC PHARM, V54, P391, DOI 10.1097/FJC.0b013e3181be7554; Goraca A, 2011, PHARMACOL REP, V63, P849; GRACE PA, 1994, BRIT J SURG, V81, P637, DOI 10.1002/bjs.1800810504; Hausenloy DJ, 2004, CARDIOVASC RES, V61, P448, DOI 10.1016/j.cardiores.2003.09.024; He L, 2012, EUR J PHARMACOL, V678, P32, DOI 10.1016/j.ejphar.2011.12.042; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Konrad D, 2001, DIABETES, V50, P1464, DOI 10.2337/diabetes.50.6.1464; Melo LG, 2002, CIRCULATION, V105, P602, DOI 10.1161/hc0502.103363; Muller C, 2003, AM J PHYSIOL-GASTR L, V285, pG769, DOI 10.1152/ajpgi.00009.2003; Na HK, 2008, ARCH BIOCHEM BIOPHYS, V476, P171, DOI 10.1016/j.abb.2008.04.003; Ogborne RM, 2005, ARTERIOSCL THROM VAS, V25, P2100, DOI 10.1161/01.ATV.0000183745.37161.6e; Oh Seok Kyu, 2009, Korean Circ J, V39, P359, DOI 10.4070/kcj.2009.39.9.359; Packer L, 1998, DRUG METAB REV, V30, P245, DOI 10.3109/03602539808996311; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; Piper HM, 1998, CARDIOVASC RES, V38, P291, DOI 10.1016/S0008-6363(98)00033-9; Pugazhenthi S, 2007, AM J PHYSIOL-ENDOC M, V293, pE645, DOI 10.1152/ajpendo.00111.2007; Richard MJP, 2011, NEUROSCI RES, V69, P299, DOI 10.1016/j.neures.2010.12.011; Rojo AI, 2008, J NEUROCHEM, V105, P192, DOI 10.1111/j.1471-4159.2007.05124.x; Shaafi S, 2011, MED PRIN PRACT, V20, P19, DOI 10.1159/000319772; Shay KP, 2012, BBA-MOL CELL RES, V1823, P1102, DOI 10.1016/j.bbamcr.2012.04.002; Steffens S, 2009, THROMB HAEMOSTASIS, V102, P240, DOI 10.1160/TH08-12-0837; Sun ZC, 2011, HISTOCHEM CELL BIOL, V135, P27, DOI 10.1007/s00418-010-0776-9; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Tong GA, 2011, LIFE SCI, V88, P31, DOI 10.1016/j.lfs.2010.10.018; Visioli F, 2002, REDOX REP, V7, P223, DOI 10.1179/135100002125000604; Wildhirt SM, 1999, CARDIOVASC RES, V43, P698, DOI 10.1016/S0008-6363(99)00080-2; Wu CC, 2006, LIFE SCI, V78, P2889, DOI 10.1016/j.lfs.2005.11.013; Yamada M, 2012, DIGEST DIS SCI, V57, P943, DOI 10.1007/s10620-011-2012-4; Yan Guang-tao, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P345	43	122	128	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58371	10.1371/journal.pone.0058371	http://dx.doi.org/10.1371/journal.pone.0058371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505496	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500074
J	Lei, M; Li, Z; Yan, SH; Yao, BL; Dan, D; Qi, YJ; Qian, J; Yang, YL; Gao, P; Ye, T				Lei, Ming; Li, Ze; Yan, Shaohui; Yao, Baoli; Dan, Dan; Qi, Yujiao; Qian, Jia; Yang, Yanlong; Gao, Peng; Ye, Tong			Long-Distance Axial Trapping with Focused Annular Laser Beams	PLOS ONE			English	Article							METALLIC RAYLEIGH PARTICLES; OPTICAL TWEEZERS; FORCES; MICROMANIPULATION; EFFICIENCY; STIFFNESS; DEPTH	Focusing an annular laser beam can improve the axial trapping efficiency due to the reduction of the scattering force, which enables the use of a lower numerical aperture (NA) objective lens with a long working distance to trap particles in deeper aqueous medium. In this paper, we present an axicon-to-axicon scheme for producing parallel annular beams with the advantages of higher efficiency compared with the obstructed beam approach. The validity of the scheme is verified by the observation of a stable trapping of silica microspheres with relatively low NA microscope objective lenses (NA = 0.6 and 0.45), and the axial trapping depth of 5 mm is demonstrated in experiment.	[Lei, Ming; Li, Ze; Yan, Shaohui; Yao, Baoli; Dan, Dan; Qi, Yujiao; Qian, Jia; Yang, Yanlong; Gao, Peng; Ye, Tong] Chinese Acad Sci, Xian Inst Opt & Precis Mech, State Key Lab Transient Opt & Photon, Xian, Peoples R China	Chinese Academy of Sciences; Xi'an Institute of Optics & Precision Mechanics, CAS; State Key Laboratory of Transient Optics & Photonics	Yao, BL (corresponding author), Chinese Acad Sci, Xian Inst Opt & Precis Mech, State Key Lab Transient Opt & Photon, Xian, Peoples R China.	yaobl@opt.ac.cn	Yao, Baoli/AAB-4606-2021; Ye, Tong/A-8251-2010; Ye, Tong/ABG-8560-2021	Ye, Tong/0000-0003-1017-6969; Ye, Tong/0000-0003-1017-6969	National Basic Research Program (973 Program) of China [2012CB921900]; Natural Science Foundation of China (NSFC) [61275193, 61205123]	National Basic Research Program (973 Program) of China(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research is supported by the National Basic Research Program (973 Program) of China under Grant No. 2012CB921900, and the Natural Science Foundation of China (NSFC) under Grant Nos. 61275193, 61205123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHKIN A, 1992, BIOPHYS J, V61, P569, DOI 10.1016/S0006-3495(92)81860-X; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Bowman R, 2011, OPT EXPRESS, V19, P9908, DOI 10.1364/OE.19.009908; Carmon G, 2011, OPT LETT, V36, P40, DOI 10.1364/OL.36.000040; Dasgupta R, 2011, APPL OPTICS, V50, P1469, DOI 10.1364/AO.50.001469; Donato MG, 2012, OPT LETT, V37, P3381, DOI 10.1364/OL.37.003381; Ganic D, 2005, OPT EXPRESS, V13, P1260, DOI 10.1364/OPEX.13.001260; Ganic D, 2004, OPT EXPRESS, V12, P2670, DOI 10.1364/OPEX.12.002670; GOLUB I, 1990, J OPT SOC AM B, V7, P1264, DOI 10.1364/JOSAB.7.001264; Gu M, 2000, APPL PHYS LETT, V77, P34, DOI 10.1063/1.126868; Gu M, 2002, J APPL PHYS, V91, P1606, DOI 10.1063/1.1428801; Gutsche C, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/18/184114; Higuchi T, 2011, APPL OPTICS, V50, pH183, DOI 10.1364/AO.50.00H183; Iglesias I, 2012, OPT EXPRESS, V20, P2832, DOI 10.1364/OE.20.002832; Kitamura K, 2010, OPT EXPRESS, V18, P4518, DOI 10.1364/OE.18.004518; Lei M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2960019; Michihata M, 2009, APPL OPTICS, V48, P6143, DOI 10.1364/AO.48.006143; O'Neil AT, 2001, OPT COMMUN, V193, P45, DOI 10.1016/S0030-4018(01)01198-1; Otto O, 2010, OPT EXPRESS, V18, P22722, DOI 10.1364/OE.18.022722; Reihani SNS, 2006, OPT LETT, V31, P766, DOI 10.1364/OL.31.000766; Rodrigo PJ, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866646; Rodrigo PJ, 2004, OPT LETT, V29, P2270, DOI 10.1364/OL.29.002270; Shao B, 2006, OPT LETT, V31, P3375, DOI 10.1364/OL.31.003375; Simpson NB, 1998, J MOD OPTIC, V45, P1943, DOI 10.1080/09500349808231712; Thalhammer G, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/4/044024; Vermeulen KC, 2006, APPL OPTICS, V45, P1812, DOI 10.1364/AO.45.001812; Yan SH, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.053836; Yan SH, 2007, J OPT SOC AM B, V24, P1596, DOI 10.1364/JOSAB.24.001596; Yao BL, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/10/108701; Zhan QW, 2004, OPT EXPRESS, V12, P3377, DOI 10.1364/OPEX.12.003377	32	19	19	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e57984	10.1371/journal.pone.0057984	http://dx.doi.org/10.1371/journal.pone.0057984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505449	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500041
J	Melton, AC; Melrose, J; Alajoki, L; Privat, S; Cho, H; Brown, N; Plavec, AM; Nguyen, D; Johnston, ED; Yang, J; Polokoff, MA; Plavec, I; Berg, EL; O'Mahony, A				Melton, Andrew C.; Melrose, Jennifer; Alajoki, Liisa; Privat, Sylvie; Cho, Hannah; Brown, Naomi; Plavec, Ana Marija; Dat Nguyen; Johnston, Elijah D.; Yang, Jian; Polokoff, Mark A.; Plavec, Ivan; Berg, Ellen L.; O'Mahony, Alison			Regulation of IL-17A Production Is Distinct from IL-17F in a Primary Human Cell Co-culture Model of T Cell-Mediated B Cell Activation	PLOS ONE			English	Article							IL-17-DEFICIENT MICE; CD40 LIGAND; EXPRESSION; DIFFERENTIATION; TH17; RESPONSES; RECEPTOR; INTERLEUKIN-17; IDENTIFICATION; INFLAMMATION	Improper regulation of B cell responses leads to excessive production of antibodies and contributes to the development of autoimmune disease. T helper 17 (Th17) cells also drive the development of autoimmune disease, but the role of B cells in shaping Th17 cell-mediated immune responses, as well as the reciprocal regulation of B cell responses by IL-17 family cytokines, remains unclear. The aim of this study was to characterize the regulation of IL-17A and IL-17F in a model of T cell-dependent B cell activation. Stimulation of primary human B cell and peripheral blood mononuclear cell (BT) co-cultures with alpha-IgM and a non-mitogenic concentration of superantigens for three days promoted a Th17 cell response as evidenced by increased expression of Th17-related gene transcripts, including Il17f, Il21, Il22, and Il23r, in CD4 T cells, as well as the secretion of IL-17A and IL-17F protein. We tested the ability of 144 pharmacologic modulators representing 91 different targets or pathways to regulate IL-17A and IL-17F production in these stimulated BT co-cultures. IL-17A production was found to be preferentially sensitive to inhibition of the PI3K/mTOR pathway, while prostaglandin EP receptor agonists, including PGE2, increased IL-17A concentrations. In contrast, the production of IL-17F was inhibited by PGE2, but selectively increased by TLR2 and TLR5 agonists. These results indicate that IL-17A regulation is distinct from IL-17F in stimulated BT co-cultures and that this co-culture approach can be used to identify pathway mechanisms and novel agents that selectively inhibit production of IL-17A or IL-17F.	[Melton, Andrew C.; Melrose, Jennifer; Alajoki, Liisa; Privat, Sylvie; Cho, Hannah; Brown, Naomi; Plavec, Ana Marija; Dat Nguyen; Johnston, Elijah D.; Yang, Jian; Polokoff, Mark A.; Plavec, Ivan; Berg, Ellen L.; O'Mahony, Alison] BioSeek, San Francisco, CA USA		O'Mahony, A (corresponding author), BioSeek, San Francisco, CA USA.	aomahony@bioseekinc.com	Berg, Ellen/D-9076-2014; Berg, Ellen/T-8827-2019	Berg, Ellen/0000-0001-5149-6665; 	BioSeek, a division of DiscoveRx, Corp.	BioSeek, a division of DiscoveRx, Corp.	The authors have the following interests. BioSeek, a division of DiscoveRx, Corp., provided the financial support for this research and is the employer of all authors. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Aoki Y, 1999, ANTIMICROB AGENTS CH, V43, P2678, DOI 10.1128/AAC.43.11.2678; Bar-Or A, 2010, ANN NEUROL, V67, P452, DOI 10.1002/ana.21939; Barbosa RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022848; Berg EL, 2010, J PHARMACOL TOX MET, V61, P3, DOI 10.1016/j.vascn.2009.10.001; Bueno L, 2008, EUR J CANCER, V44, P142, DOI 10.1016/j.ejca.2007.10.008; Chen Z, 2007, SEMIN IMMUNOL, V19, P400, DOI 10.1016/j.smim.2007.10.015; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; Galimberti D, 2008, MULT SCLER, V14, P547, DOI 10.1177/1352458507084268; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Hebel K, 2011, J IMMUNOL, V187, P5627, DOI 10.4049/jimmunol.1003998; Hedrich CM, 2012, J BIOL CHEM, V287, P4715, DOI 10.1074/jbc.M111.323261; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Johnson-Leger C, 1998, INT IMMUNOL, V10, P1083, DOI 10.1093/intimm/10.8.1083; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Kumar N, 2012, ACS CHEM BIOL, V7, P672, DOI 10.1021/cb200496y; Kunkel EJ, 2004, FASEB J, V18, P1279, DOI 10.1096/fj.04-1538fje; LEDERMAN S, 1992, J EXP MED, V175, P1091, DOI 10.1084/jem.175.4.1091; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Melton AC, 2010, J CLIN INVEST, V120, P4436, DOI 10.1172/JCI43786; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Plavec I, 2004, P NATL ACAD SCI USA, V101, P1223, DOI 10.1073/pnas.0308221100; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; ROY M, 1993, J IMMUNOL, V151, P2497; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; STOHL W, 1994, J IMMUNOL, V153, P117; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; van de Veerdonk FL, 2011, ARTHRITIS RHEUM-US, V63, P1507, DOI 10.1002/art.30314; Vazquez-Tello A, 2012, INT ARCH ALLERGY IMM, V157, P406, DOI 10.1159/000329527; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xu DG, 2012, J PHARMACOL EXP THER, V341, P90, DOI 10.1124/jpet.111.187740; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; YOO ZB, 1995, J IMMUNOL, V155, P5483; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	43	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58966	10.1371/journal.pone.0058966	http://dx.doi.org/10.1371/journal.pone.0058966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505568	gold, Green Submitted, Green Published			2022-12-27	WOS:000318334500133
J	Whitty, JA; Stewart, S; Carrington, MJ; Calderone, A; Marwick, T; Horowitz, JD; Krum, H; Davidson, PM; Macdonald, PS; Reid, C; Scuffham, PA				Whitty, Jennifer A.; Stewart, Simon; Carrington, Melinda J.; Calderone, Alicia; Marwick, Thomas; Horowitz, John D.; Krum, Henry; Davidson, Patricia M.; Macdonald, Peter S.; Reid, Christopher; Scuffham, Paul A.			Patient Preferences and Willingness-To-Pay for a Home or Clinic Based Program of Chronic Heart Failure Management: Findings from the Which? Trial	PLOS ONE			English	Article							DISCRETE-CHOICE EXPERIMENTS; BURDEN; CARE; HETEROGENEITY; POPULATION; ATTRIBUTES; DESIGN; IMPACT	Background: Beyond examining their overall cost-effectiveness and mechanisms of effect, it is important to understand patient preferences for the delivery of different modes of chronic heart failure management programs (CHF-MPs). We elicited patient preferences around the characteristics and willingness-to-pay (WTP) for a clinic or home-based CHF-MP. Methodology/Principal Findings: A Discrete Choice Experiment was completed by a sub-set of patients (n = 91) enrolled in the WHICH? trial comparing home versus clinic-based CHF-MP. Participants provided 5 choices between hypothetical clinic and home-based programs varying by frequency of nurse consultations, nurse continuity, patient costs, and availability of telephone or education support. Participants (aged 71 +/- 13 yrs, 72.5% male, 25.3% NYHA class III/IV) displayed two distinct preference classes. A latent class model of the choice data indicated 56% of participants preferred clinic delivery, access to group CHF education classes, and lower cost programs (p<0.05). The remainder preferred home-based CHF-MPs, monthly rather than weekly visits, and access to a phone advice service (p<0.05). Continuity of nurse contact was consistently important. No significant association was observed between program preference and participant allocation in the parent trial. WTP was estimated from the model and a dichotomous bidding technique. For those preferring clinic, estimated WTP was approximate to AU$9-20 per visit; however for those preferring home-based programs, WTP varied widely (AU$ 15-105). Conclusions/Significance: Patient preferences for CHF-MPs were dichotomised between a home-based model which is more likely to suit older patients, those who live alone, and those with a lower household income; and a clinic-based model which is more likely to suit those who are more socially active and wealthier. To optimise the delivery of CHF-MPs, health care services should consider their patients' preferences when designing CHF-MPs.	[Whitty, Jennifer A.; Scuffham, Paul A.] Griffith Univ, Ctr Appl Hlth Econ, Sch Med, Griffith Hlth Inst, Meadowbrook, Qld 4131, Australia; [Stewart, Simon; Carrington, Melinda J.; Calderone, Alicia] Baker IDI Heart & Diabet Inst, NHMRC Ctr Res Excellence Reduce Inequal Heart Dis, Melbourne, Vic, Australia; [Marwick, Thomas] Cleveland Clin, Cleveland, OH 44106 USA; [Horowitz, John D.] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Horowitz, John D.] Univ Adelaide, Adelaide, SA, Australia; [Krum, Henry; Reid, Christopher] Monash Univ, Sch Publ Hlth & Preventat Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Davidson, Patricia M.] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Davidson, Patricia M.; Macdonald, Peter S.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Macdonald, Peter S.] Victor Chang Cardiac Res Inst, Sydney, NSW, Australia; [Macdonald, Peter S.] Univ New S Wales, Sydney, NSW, Australia	Griffith University; Menzies Health Institute Queensland; Baker Heart and Diabetes Institute; Cleveland Clinic Foundation; University of Adelaide; Monash University; University of Technology Sydney; St Vincents Hospital Sydney; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Whitty, JA (corresponding author), Griffith Univ, Ctr Appl Hlth Econ, Sch Med, Griffith Hlth Inst, Meadowbrook, Qld 4131, Australia.	j.whitty@griffith.edu.au	Whitty, Jennifer A/N-6434-2013; Stewart, Simon/M-3316-2016; Scuffham, Paul/B-3066-2014; Macdonald, Peter/Q-3188-2019; Reid, Christopher M/AAP-8135-2021; Marwick, Thomas/AAK-3869-2021; Scuffham, Paul/AAS-8084-2021	Whitty, Jennifer A/0000-0002-5886-1933; Stewart, Simon/0000-0001-9032-8998; Scuffham, Paul/0000-0001-5931-642X; Marwick, Thomas/0000-0001-9065-0899; Scuffham, Paul/0000-0001-5931-642X; Horowitz, John/0000-0001-6883-0703; Reid, Christopher/0000-0001-9173-3944; Carrington, Melinda J/0000-0003-3865-1645; Davidson, Patricia M./0000-0003-2050-1534	Health Services Research grant from National Health and Medical Research Council of Australia [418967]; Program grant from the National Health and Medical Research Council of Australia [519823]; Queensland Government Department of Employment, Economic Development and Innovation, Queensland Health; Griffith University; National Health and Medical Research Council of Australia; Victorian Government's Operational Infrastructure Support Program	Health Services Research grant from National Health and Medical Research Council of Australia; Program grant from the National Health and Medical Research Council of Australia; Queensland Government Department of Employment, Economic Development and Innovation, Queensland Health; Griffith University(Griffith University); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program	This work was supported by a Health Services Research grant [grant #418967] and a Program grant [grant #519823], both from the National Health and Medical Research Council of Australia. JW is supported by a research fellowship from the Queensland Government Department of Employment, Economic Development and Innovation, Queensland Health and Griffith University. MC & SS are supported by the National Health and Medical Research Council of Australia. The WHICH? trial was supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2004, NAT HLTH SURV; Bauman AE, 2003, MED J AUSTRALIA, V179, P253, DOI 10.5694/j.1326-5377.2003.tb05532.x; Bech M, 2005, HEALTH ECON, V14, P1079, DOI 10.1002/hec.984; Campbell D, 2011, J ENVIRON PLANN MAN, V54, P1061, DOI 10.1080/09640568.2010.549367; Cheraghi-Sohi S, 2008, ANN FAM MED, V6, P107, DOI 10.1370/afm.816; Davidson P, 2010, MULTIDISCIPLINARY CA; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Driscoll Andrea, 2006, Eur J Cardiovasc Nurs, V5, P75, DOI 10.1016/j.ejcnurse.2005.08.001; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; Hole AR, 2008, J HEALTH ECON, V27, P1078, DOI 10.1016/j.jhealeco.2007.11.006; Kim Edward, 2010, J Med Econ, V13, P185, DOI 10.3111/13696991003723023; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lancsar E, 2004, HEALTH ECON, V13, P901, DOI 10.1002/hec.870; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McFadden D., 1981, STRUCTURAL ANAL DISC; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mentzakis E, 2011, HEALTH ECON, V20, P930, DOI 10.1002/hec.1656; Mitchell R.C., 1989, USING SURVEYS VALUE; Stewart S, 2003, HEART, V89, P49, DOI 10.1136/heart.89.1.49; Stewart S, 2002, EUR J HEART FAIL, V4, P361, DOI 10.1016/S1388-9842(01)00198-2; Stewart S, 2012, J AM COLL CARDIOL, V60, P1239, DOI 10.1016/j.jacc.2012.06.025; Stewart S, 2011, EUR J HEART FAIL, V13, P909, DOI 10.1093/eurjhf/hfr048; Stewart S, 2010, CIRC-CARDIOVASC QUAL, V3, P573, DOI 10.1161/CIRCOUTCOMES.110.957571; Thurstone LL, 1927, PSYCHOL REV, V34, P273, DOI 10.1037/h0070288; Vijan S, 2005, J GEN INTERN MED, V20, P479, DOI 10.1111/j.1525-1497.2005.0117.x; Whitty JA, 2012, J CARDIOVASC NURS, V27, P201, DOI 10.1097/JCN.0b013e31821abf22	27	28	29	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58347	10.1371/journal.pone.0058347	http://dx.doi.org/10.1371/journal.pone.0058347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23505491	Green Published, Green Accepted, gold			2022-12-27	WOS:000318334500071
J	Bianco, A; Quaresima, B; Pileggi, C; Faniello, MC; De Lorenzo, C; Costanzo, F; Pavia, M				Bianco, Aida; Quaresima, Barbara; Pileggi, Claudia; Faniello, Maria Concetta; De Lorenzo, Carlo; Costanzo, Francesco; Pavia, Maria			Polymorphic Repeat Length in the AIB1 Gene and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							OVARIAN-CANCER; POLYGLUTAMINE REPEAT; IN-VITRO; GERMLINE MUTATIONS; SYSTEMATIC REVIEWS; SUSCEPTIBILITY; QUALITY; BIAS; EPIDEMIOLOGY; PUBLICATION	Objectives: We carried out a meta-analysis focusing on the relationship between length of AIB1 gene poly-Q repeat domain as a modifier of breast cancer (BC) susceptibility in patients with BRCA1 and BRCA2 mutation carriers. Data sources: We searched MEDLINE and EMBASE for all medical literature published until February, 2012. Study Eligibility criteria: Studies were included in the meta-analysis if they met all the predetermined criteria, such as: (a) case-control or cohort studies; (b) the primary outcome was clearly defined as BC; (c) the exposure of interest measured was AIB1 polyglutamine repeat length genotype; (d) provided relative risk (RR) or odds ratio (OR) estimates and their 95% confidence intervals (CIs). Synthesis methods: Two of the authors independently evaluated the quality of the studies included and extracted the data. Meta-analyses were performed for case-control and cohort studies separately. Heterogeneity was examined and the publication bias was assessed with a funnel plot for asymmetry. Result: 7 studies met our predetermined inclusion criteria and were included in the meta-analysis. Overall quality ratings of the studies varied from 0.36 to 0.77, with a median of 0.5. The overall RR estimates of 29/29 poly-Q repeats on risk of BC in BRCA1/2, BRCA1, and BRCA2, were always greater than 1.00; however, this effect was not statistically significant. In the meta-analysis of studies reporting the effect of 28/28 poly-Q repeats on risk of BC in BRCA1/2, BRCA1, and BRCA2, the overall RR decreased below 1.00; however, this effect was not statistically significant. Similar estimates were shown for at least 1 allele of <= 26 repeats. Conclusions: Genotypes of AIB1 polyglutamine polymorphism analyzed do not appear to be associated to a modified risk of BC development in BRCA1 and BRCA2 mutation carriers. Future research on length of poly-Q repeat domain and BC susceptibility should be discouraged and more promising potential sources of penetrance variation among BRCA1 and BRCA2 mutation carriers should be investigated.	[Bianco, Aida; Pileggi, Claudia; Pavia, Maria] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy; [Quaresima, Barbara; Faniello, Maria Concetta; De Lorenzo, Carlo; Costanzo, Francesco] Univ Catanzaro Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Pavia, M (corresponding author), Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy.	pavia@unicz.it	Costanzo, Francesco Saverio/K-3168-2018; PILEGGI, Claudia/AGU-6397-2022; Bianco, Aida/R-6612-2016; DE LORENZO, Carlo/R-4050-2016	Costanzo, Francesco Saverio/0000-0002-3096-9416; PILEGGI, Claudia/0000-0002-6288-5540; FANIELLO, Concetta Maria/0000-0001-6938-2754; De Lorenzo, Carlo/0000-0002-2579-683X; QUARESIMA, Barbara/0000-0003-3462-624X; PAVIA, Maria/0000-0003-3879-1322; BIANCO, Aida/0000-0003-4674-0306				[Anonymous], 2009, STAT REL 11 STAT SOF; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bautista S, 1998, CLIN CANCER RES, V4, P2925; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Colilla S, 2006, CARCINOGENESIS, V27, P599, DOI 10.1093/carcin/bgi246; Crugliano T, 2007, INT J BIOCHEM CELL B, V39, P220, DOI 10.1016/j.biocel.2006.08.005; De Vito C, 2007, VACCINE, V25, P8794, DOI 10.1016/j.vaccine.2007.10.034; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FitzGerald MG, 1996, NEW ENGL J MED, V334, P143, DOI 10.1056/NEJM199601183340302; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; GREGOIRE G, 1995, J CLIN EPIDEMIOL, V48, P159, DOI 10.1016/0895-4356(94)00098-B; Haiman CA, 2000, BREAST CANCER RES, V2, P378, DOI 10.1186/bcr82; Hughes DJ, 2005, INT J CANCER, V117, P230, DOI 10.1002/ijc.21176; Jakubowska A, 2010, BREAST CANCER RES TR, V119, P201, DOI 10.1007/s10549-009-0390-5; Kadouri L, 2004, INT J CANCER, V108, P399, DOI 10.1002/ijc.11531; Kleibl Z, 2011, J CANCER RES CLIN, V137, P331, DOI 10.1007/s00432-010-0889-5; Laird N M, 1990, Int J Technol Assess Health Care, V6, P5; Manzoli L, 2012, DRUG SAFETY, V35, P191, DOI 10.2165/11598050-000000000-00000; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milne RL, 2008, CLIN CANCER RES, V14, P2861, DOI 10.1158/1078-0432.CCR-07-4436; Moher D, 1996, LANCET, V347, P363, DOI 10.1016/S0140-6736(96)90538-3; Montgomery KG, 2005, BREAST CANCER RES, V7, pR353, DOI 10.1186/bcr1009; Osorio A, 2011, BRIT J CANCER, V104, P1356, DOI 10.1038/bjc.2011.91; Pavia M, 2008, B WORLD HEALTH ORGAN, V81, P732; Pavia M, 2006, AM J CLIN NUTR, V83, P1126, DOI 10.1093/ajcn/83.5.1126; Quaresima B, 2008, CLIN CANCER RES, V14, P6797, DOI 10.1158/1078-0432.CCR-07-5208; Quaresima B, 2006, HUM MUTAT, V27, P715, DOI 10.1002/humu.9427; Quaresima B, 2006, ONCOL REP, V16, P811; Rebbeck TR, 2001, CANCER RES, V61, P5420; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Shirazi SK, 1998, CLIN GENET, V54, P102; Sinilnikova OM, 2009, BRIT J CANCER, V101, P1456, DOI 10.1038/sj.bjc.6605279; Spurdle AB, 2005, BREAST CANCER RES, V7, pR176, DOI 10.1186/bcr971; Spurdle AB, 2006, CANCER EPIDEM BIOMAR, V15, P76, DOI 10.1158/1055-9965.EPI-05-0709; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wells G., 2005, NEWCASTLE OTTAWA SCA; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yang QF, 2001, CANCER-AM CANCER SOC, V92, P54, DOI 10.1002/1097-0142(20010701)92:1<54::AID-CNCR1291>3.0.CO;2-8; Zhang Y, 2012, MOL BIOL REP, V39, P6881, DOI 10.1007/s11033-012-1514-2	47	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57781	10.1371/journal.pone.0057781	http://dx.doi.org/10.1371/journal.pone.0057781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483928	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100044
J	Hsiao, HM; Sapinoro, RE; Thatcher, TH; Croasdell, A; Levy, EP; Fulton, RA; Olsen, KC; Pollock, SJ; Serhan, CN; Phipps, RP; Sime, PJ				Hsiao, Hsi-Min; Sapinoro, Ramil E.; Thatcher, Thomas H.; Croasdell, Amanda; Levy, Elizabeth P.; Fulton, Robert A.; Olsen, Keith C.; Pollock, Stephen J.; Serhan, Charles N.; Phipps, Richard P.; Sime, Patricia J.			A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung Inflammation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ARYL-HYDROCARBON RECEPTOR; AIRWAY INFLAMMATION; DOCOSAHEXAENOIC ACID; PROMOTE RESOLUTION; CYTOKINE RELEASE; BRONCHIAL-ASTHMA; APOPTOTIC CELLS; KAPPA-B; MACROPHAGES	Introduction: Cigarette smoke is a profound pro-inflammatory stimulus that contributes to acute lung injuries and to chronic lung disease including COPD (emphysema and chronic bronchitis). Until recently, it was assumed that resolution of inflammation was a passive process that occurred once the inflammatory stimulus was removed. It is now recognized that resolution of inflammation is a bioactive process, mediated by specialized lipid mediators, and that normal homeostasis is maintained by a balance between pro-inflammatory and pro-resolving pathways. These novel small lipid mediators, including the resolvins, protectins and maresins, are bioactive products mainly derived from dietary omega-3 and omega-6 polyunsaturated fatty acids (PUFA). We hypothesize that resolvin D1 (RvD1) has potent anti-inflammatory and pro-resolving effects in a model of cigarette smoke-induced lung inflammation. Methods: Primary human lung fibroblasts, small airway epithelial cells and blood monocytes were treated with IL-1 beta or cigarette smoke extract in combination with RvD1 in vitro, production of pro-inflammatory mediators was measured. Mice were exposed to dilute mainstream cigarette smoke and treated with RvD1 either concurrently with smoke or after smoking cessation. The effects on lung inflammation and lung macrophage populations were assessed. Results: RvD1 suppressed production of pro-inflammatory mediators by primary human cells in a dose-dependent manner. Treatment of mice with RvD1 concurrently with cigarette smoke exposure significantly reduced neutrophilic lung inflammation and production of pro-inflammatory cytokines, while upregulating the anti-inflammatory cytokine IL-10. RvD1 promoted differentiation of alternatively activated (M2) macrophages and neutrophil efferocytosis. RvD1 also accelerated the resolution of lung inflammation when given after the final smoke exposure. Conclusions: RvD1 has potent anti-inflammatory and pro-resolving effects in cells and mice exposed to cigarette smoke. Resolvins have strong potential as a novel therapeutic approach to resolve lung injury caused by smoke and pulmonary toxicants.	[Hsiao, Hsi-Min] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY USA; [Sapinoro, Ramil E.; Thatcher, Thomas H.; Croasdell, Amanda; Levy, Elizabeth P.; Fulton, Robert A.; Olsen, Keith C.; Pollock, Stephen J.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Lung Biol & Dis Program, Rochester, NY 14627 USA; [Sapinoro, Ramil E.; Thatcher, Thomas H.; Levy, Elizabeth P.; Fulton, Robert A.; Sime, Patricia J.] Univ Rochester, Div Pulm & Crit Care Med, Rochester, NY USA; [Croasdell, Amanda; Pollock, Stephen J.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Dept Environm Med, Rochester, NY USA; [Olsen, Keith C.; Phipps, Richard P.; Sime, Patricia J.] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA; [Serhan, Charles N.] Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Sime, PJ (corresponding author), Univ Rochester, Lung Biol & Dis Program, Rochester, NY 14627 USA.	Patricia_Sime@urmc.rochester.edu		Hsiao, Hsi-Min Jim/0000-0003-1918-7381; Pollock, Stephen/0000-0002-2091-1675; Thatcher, Thomas/0000-0001-7177-3041; , Ramil/0000-0003-4907-6340	National Institutes of Health [R01 HL088325, HL088325-02S1, HL66988, ES07026, 8UL1TR000042, ES01247]; The PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066988, R01HL088325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007026, P30ES001247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants R01 HL088325, HL088325-02S1, HL66988, ES07026, 8UL1TR000042 and ES01247. AC is supported by a pre-doctoral fellowship from The PhRMA Foundation. The funders had no role in study design, data collection; and analysis, decision to publish, or preparation of the manuscript.	Abboud RT, 2008, INT J TUBERC LUNG D, V12, P361; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; ARM JP, 1989, AM REV RESPIR DIS, V139, P1395, DOI 10.1164/ajrccm/139.6.1395; Baines KJ, 2011, PLOS ONE, V6, P18426; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Botelho FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028457; Burgess JL, 2002, INHAL TOXICOL, V14, P133, DOI 10.1080/089583701753403953; Caito S, 2008, ANTIOXID REDOX SIGN, V10, P253, DOI 10.1089/ars.2007.1889; Chen Ya-feng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P1039; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; Eickmeier O, 2012, MUCOSAL IMMUNOL; El Kebir D, 2012, P NATL ACAD SCI US; FRIES KM, 1995, CLIN IMMUNOL IMMUNOP, V77, P42, DOI 10.1016/0090-1229(95)90135-3; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Invernizzi G, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-48; Joo MJ, 2010, RESP MED, V104, P246, DOI 10.1016/j.rmed.2009.10.002; Kent LM, 2010, INT IMMUNOPHARMACOL, V10, P57, DOI 10.1016/j.intimp.2009.09.021; Koumas L, 2002, EUR J IMMUNOL, V32, P477, DOI 10.1002/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Levy BD, 2007, J IMMUNOL, V178, P496, DOI 10.4049/jimmunol.178.1.496; Martey CA, 2005, AM J PHYSIOL-LUNG C, V289, pL391, DOI 10.1152/ajplung.00062.2005; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; Minematsu N, 2011, AM J RESP CELL MOL, V44, P474, DOI 10.1165/rcmb.2009-0463OC; Ogawa Y, 2008, CURR MOL MED, V8, P437, DOI 10.2174/156652408785160907; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Profita M, 2010, AM J PHYSIOL-LUNG C, V298, pL261, DOI 10.1152/ajplung.90593.2008; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Seki H, 2010, J IMMUNOL, V184, P836, DOI 10.4049/jimmunol.0901809; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; SHAHAR E, 1994, NEW ENGL J MED, V331, P228, DOI 10.1056/NEJM199407283310403; Shapiro SD, 2004, AM J RESP CELL MOL, V31, P481, DOI 10.1165/rcmb.F285; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Takanashi S, 1999, EUR RESPIR J, V14, P309, DOI 10.1034/j.1399-3003.1999.14b12.x; Tanaka T, 2010, BIOCHEM BIOPH RES CO, V399, P677, DOI 10.1016/j.bbrc.2010.07.141; Thatcher TH, 2005, AM J PHYSIOL-LUNG C, V289, pL322, DOI 10.1152/ajplung.00039.2005; Thatcher TH, 2008, AM J PHYSIOL-LUNG C, V295, pL412, DOI 10.1152/ajplung.00392.2007; Thatcher TH, 2007, AM J PATHOL, V170, P855, DOI 10.2353/ajpath.2007.060391; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Uddin M, 2011, PROG LIPID RES, V50, P75, DOI 10.1016/j.plipres.2010.09.002; Vachier I, 2002, BIOCHEM BIOPH RES CO, V290, P219, DOI 10.1006/bbrc.2001.6155; Xu J, 2008, AM J PHYSIOL-LUNG C, V295, pL162, DOI 10.1152/ajplung.00282.2007; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yokohori N, 2004, CHEST, V125, P626, DOI 10.1378/chest.125.2.626	54	134	137	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58258	10.1371/journal.pone.0058258	http://dx.doi.org/10.1371/journal.pone.0058258			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484005	Green Published, gold			2022-12-27	WOS:000316936100097
J	Ma-Kellams, C; Blascovich, J				Ma-Kellams, Christine; Blascovich, Jim			Does "Science" Make You Moral? The Effects of Priming Science on Moral Judgments and Behavior	PLOS ONE			English	Article							GOD	Background: Previous work has noted that science stands as an ideological force insofar as the answers it offers to a variety of fundamental questions and concerns; as such, those who pursue scientific inquiry have been shown to be concerned with the moral and social ramifications of their scientific endeavors. No studies to date have directly investigated the links between exposure to science and moral or prosocial behaviors. Methodology/Principal Findings: Across four studies, both naturalistic measures of science exposure and experimental primes of science led to increased adherence to moral norms and more morally normative behaviors across domains. Study 1 (n = 36) tested the natural correlation between exposure to science and likelihood of enforcing moral norms. Studies 2 (n = 49), 3 (n = 52), and 4 (n = 43) manipulated thoughts about science and examined the causal impact of such thoughts on imagined and actual moral behavior. Across studies, thinking about science had a moralizing effect on a broad array of domains, including interpersonal violations (Studies 1, 2), prosocial intentions (Study 3), and economic exploitation (Study 4). Conclusions/Significance: These studies demonstrated the morally normative effects of lay notions of science. Thinking about science leads individuals to endorse more stringent moral norms and exhibit more morally normative behavior. These studies are the first of their kind to systematically and empirically test the relationship between science and morality. The present findings speak to this question and elucidate the value-laden outcomes of the notion of science.	[Ma-Kellams, Christine; Blascovich, Jim] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Ma-Kellams, C (corresponding author), Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA.	christinema@fas.harvard.edu		Ma-Kellams, Christine/0000-0002-5468-5514				Becker L, 1968, J SCI RELIG, V3, P335; Bhaskar Roy, 1975, REALIST THEORY SCI; Bronowski J., 1956, HIGHER ED Q, V11, P26; Emmers-Sommer TM, 2002, LEA COMMUN SER, P315; Fiske D. W., 1986, METATHEORY SOCIAL SC; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; HOWARD GS, 1985, AM PSYCHOL, V40, P255, DOI 10.1037/0003-066X.40.3.255; Jordan J, 2011, PERS SOC PSYCHOL B, V37, P701, DOI 10.1177/0146167211400208; KURTINES WM, 1990, PSYCHOL BULL, V107, P283, DOI 10.1037/0033-2909.107.3.283; McCauley Robert N., 2011, WHY RELIG IS NATURAL; Merton R.K., 1979, SOCIOLOGY SCI; Preston J, 2009, J EXP SOC PSYCHOL, V45, P238, DOI 10.1016/j.jesp.2008.07.013; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Taylor Charles, 2004, MODERN SOCIAL IMAGER; Thorndike E.L., 1940, HUMAN NATURE SOCIAL; Toulmin Stephen E., 1953, PHILOS SCI INTRO; Vohs KD, 2008, PSYCHOL SCI, V19, P49, DOI 10.1111/j.1467-9280.2008.02045.x	17	17	17	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57989	10.1371/journal.pone.0057989	http://dx.doi.org/10.1371/journal.pone.0057989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	117EP	23483960	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100065
J	Tredennick, AT; Bentley, LP; Hanan, NP				Tredennick, Andrew T.; Bentley, Lisa Patrick; Hanan, Niall P.			Allometric Convergence in Savanna Trees and Implications for the Use of Plant Scaling Models in Variable Ecosystems	PLOS ONE			English	Article							SPECIES-LEVEL MODEL; METABOLIC THEORY; MATHEMATICALLY CORRECT; BIOLOGICALLY RELEVANT; BRANCHING PATTERNS; MECHANICAL DESIGN; GENERAL-MODEL; GROWTH; FIRE; FOREST	Theoretical models of allometric scaling provide frameworks for understanding and predicting how and why the morphology and function of organisms vary with scale. It remains unclear, however, if the predictions of 'universal' scaling models for vascular plants hold across diverse species in variable environments. Phenomena such as competition and disturbance may drive allometric scaling relationships away from theoretical predictions based on an optimized tree. Here, we use a hierarchical Bayesian approach to calculate tree-specific, species-specific, and 'global' (i.e. interspecific) scaling exponents for several allometric relationships using tree- and branch-level data harvested from three savanna sites across a rainfall gradient in Mali, West Africa. We use these exponents to provide a rigorous test of three plant scaling models (Metabolic Scaling Theory (MST), Geometric Similarity, and Stress Similarity) in savanna systems. For the allometric relationships we evaluated (diameter vs. length, aboveground mass, stem mass, and leaf mass) the empirically calculated exponents broadly overlapped among species from diverse environments, except for the scaling exponents for length, which increased with tree cover and density. When we compare empirical scaling exponents to the theoretical predictions from the three models we find MST predictions are most consistent with our observed allometries. In those situations where observations are inconsistent with MST we find that departure from theory corresponds with expected tradeoffs related to disturbance and competitive interactions. We hypothesize savanna trees have greater length-scaling exponents than predicted by MST due to an evolutionary tradeoff between fire escape and optimization of mechanical stability and internal resource transport. Future research on the drivers of systematic allometric variation could reconcile the differences between observed scaling relationships in variable ecosystems and those predicted by ideal models such as MST.	[Tredennick, Andrew T.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Tredennick, Andrew T.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Bentley, Lisa Patrick] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Hanan, Niall P.] S Dakota State Univ, Geog Informat Sci Ctr Excellence, Brookings, SD 57007 USA	Colorado State University; Colorado State University; University of Arizona; South Dakota State University	Tredennick, AT (corresponding author), Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA.	Andrew.Tredennick@colostate.edu		Tredennick, Andrew/0000-0003-1254-3339; Hanan, Niall/0000-0002-9130-5306	National Science Foundation [DEB-1139096]; NASA Headquarters under the Earth and Space Science Fellowship Program [NNX11AL43H]; NSF Postdoctoral Fellowship in Bioinformatics [DBI-0905868]; Direct For Biological Sciences [1139096] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NASA Headquarters under the Earth and Space Science Fellowship Program(National Aeronautics & Space Administration (NASA)); NSF Postdoctoral Fellowship in Bioinformatics; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	A National Science Foundation (http://www.nsf.gov/) award (DEB-1139096) to NPH provided funding for this work. ATT was supported by NASA Headquarters (http://science.nasa.gov/) under the Earth and Space Science Fellowship Program (NNX11AL43H). LPB was supported by a NSF Postdoctoral Fellowship in Bioinformatics (DBI-0905868). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyamba A, 2005, J ARID ENVIRON, V63, P596, DOI 10.1016/j.jaridenv.2005.03.007; Archibald S, 2003, OIKOS, V102, P3, DOI 10.1034/j.1600-0706.2003.12181.x; BARKER SB, 1973, J THEOR BIOL, V40, P33, DOI 10.1016/0022-5193(73)90163-X; Bertram JEA, 1989, TREES-STRUCT FUNCT, V3, P241, DOI 10.1007/BF00225358; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Brown JH, 2005, FUNCT ECOL, V19, P735, DOI 10.1111/j.1365-2435.2005.01022.x; Chesson P, 2004, OECOLOGIA, V141, P236, DOI 10.1007/s00442-004-1551-1; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Coomes DA, 2009, J ECOL, V97, P1369, DOI 10.1111/j.1365-2745.2009.01571.x; Costes E, 2012, TREES-STRUCT FUNCT, V26, P865, DOI 10.1007/s00468-011-0661-8; Dahle GA, 2010, TREES-STRUCT FUNCT, V24, P321, DOI 10.1007/s00468-009-0401-5; Day JS, 1997, ANN BOT-LONDON, V79, P607, DOI 10.1006/anbo.1996.0368; DELLAPORTAS P, 1995, BIOMETRICS, V51, P1085, DOI 10.2307/2533007; Dietze MC, 2008, FOREST ECOL MANAG, V256, P1939, DOI 10.1016/j.foreco.2008.07.034; Dodonov P, 2011, BRAZ J BIOL, V71, P527, DOI 10.1590/S1519-69842011000300025; ELLIS JE, 1988, J RANGE MANAGE, V41, P450, DOI 10.2307/3899515; Enquist B.J., 2012, METAB ECOL SCALING A, P164, DOI [10.1002/, DOI 10.1002/9781119968535.CH14]; Enquist BJ, 2002, TREE PHYSIOL, V22, P1045, DOI 10.1093/treephys/22.15-16.1045; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A, 2009, DATA ANAL USING REGR; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gignoux J, 1997, OECOLOGIA, V110, P576, DOI 10.1007/s004420050198; Hanan NP, 2008, AM NAT, V171, P851, DOI 10.1086/587527; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Held IM, 2005, P NATL ACAD SCI USA, V102, P17891, DOI 10.1073/pnas.0509057102; Hobbs NT, 2012, ECOL APPL, V22, P1640, DOI 10.1890/11-1309.1; Hoffmann WA, 2003, FUNCT ECOL, V17, P720, DOI 10.1111/j.1365-2435.2003.00796.x; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Hoffmann WA, 2009, ECOLOGY, V90, P1326, DOI 10.1890/08-0741.1; Horn HS, 2000, SCALING BIOL; Kerkhoff AJ, 2009, J THEOR BIOL, V257, P519, DOI 10.1016/j.jtbi.2008.12.026; Kozlowski J, 2004, FUNCT ECOL, V18, P283, DOI 10.1111/j.0269-8463.2004.00830.x; Lawes MJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00204.1; LEOPOLD LB, 1971, J THEOR BIOL, V31, P339, DOI 10.1016/0022-5193(71)90192-5; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; MCMAHON TA, 1976, J THEOR BIOL, V59, P443, DOI 10.1016/0022-5193(76)90182-X; Moncrieff GR, 2011, ECOLOGY, V92, P2310, DOI 10.1890/11-0230.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Myneni RB, 2007, P NATL ACAD SCI USA, V104, P4820, DOI 10.1073/pnas.0611338104; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2004, P NATL ACAD SCI USA, V101, P15661, DOI 10.1073/pnas.0405857101; Osada N, 2001, J ECOL, V89, P774, DOI 10.1046/j.0022-0477.2001.00590.x; Plummer M., 2003, P 3 INT WORKSH DISTR; Plummer M., 2015, PACKAGE CODA; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Price CA, 2007, P NATL ACAD SCI USA, V104, P13204, DOI 10.1073/pnas.0702242104; Price CA, 2012, ECOL LETT, V15, P1465, DOI 10.1111/j.1461-0248.2012.01860.x; Price CA, 2012, NEW PHYTOL, V193, P882, DOI 10.1111/j.1469-8137.2011.04022.x; Price CA, 2010, NEW PHYTOL, V188, P696, DOI 10.1111/j.1469-8137.2010.03442.x; Price CA, 2009, ECOL LETT, V12, P641, DOI 10.1111/j.1461-0248.2009.01316.x; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Renton M, 2006, J EXP BOT, V57, P3131, DOI 10.1093/jxb/erl075; Rinnan R, 2009, J ECOL, V97, P788, DOI 10.1111/j.1365-2745.2009.01506.x; Ruger N, 2012, FUNCT ECOL, V26, P759, DOI 10.1111/j.1365-2435.2012.01981.x; Russo SE, 2007, ECOL LETT, V10, P889, DOI 10.1111/j.1461-0248.2007.01079.x; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Shinozaki K, 1964, JPN J ECOL, V14, P97, DOI DOI 10.18960/SEITAI.14.3_97; Sone K, 2005, TREE PHYSIOL, V25, P39, DOI 10.1093/treephys/25.1.39; Sperry JS, 2012, FUNCT ECOL, V26, P1054, DOI 10.1111/j.1365-2435.2012.02022.x; Staver AC, 2012, ECOL LETT, V15, P673, DOI 10.1111/j.1461-0248.2012.01784.x; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Team RDC, 2012, R LANG ENV STAT COMP; Tilman D, 2004, ECOLOGY, V85, P1797, DOI 10.1890/03-0725; von Allmen EI, 2012, FUNCT ECOL, V26, P1066, DOI 10.1111/j.1365-2435.2012.02021.x; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1	73	16	16	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58241	10.1371/journal.pone.0058241	http://dx.doi.org/10.1371/journal.pone.0058241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484003	Green Submitted, Green Published, gold			2022-12-27	WOS:000316936100094
J	Cooper, CA; Klobas, LCG; Maga, EA; Murray, JD				Cooper, Caitlin A.; Klobas, Lydia C. Garas; Maga, Elizabeth A.; Murray, James D.			Consuming Transgenic Goats' Milk Containing the Antimicrobial Protein Lysozyme Helps Resolve Diarrhea in Young Pigs	PLOS ONE			English	Article							ENTEROPATHOGENIC ESCHERICHIA-COLI; EXPRESSING HUMAN LYSOZYME; MAMMARY-GLAND; BROILER-CHICKENS; BARRIER FUNCTION; DAIRY GOATS; GROWTH; MODULATION; CONSUMPTION; LACTOFERRIN	Childhood diarrhea is a significant problem in many developing countries and E. coli is a main causative agent of diarrhea in young children. Lysozyme is an antimicrobial protein highly expressed in human milk, but not ruminant milk, and is thought to help protect breastfeeding children against diarrheal diseases. We hypothesized that consumption of milk from transgenic goats which produce human lysozyme (hLZ-milk) in their milk would accelerate recovery from bacterial-induced diarrhea. Young pigs were used as a model for children and infected with enterotoxigenic E. coli. Once clinical signs of diarrhea developed, pigs were fed hLZ-milk or non-transgenic control goat milk three times a day for two days. Clinical observations and complete blood counts (CBC) were performed. Animals were euthanized and samples collected to assess differences in histology, cytokine expression and bacterial translocation into the mesenteric lymph node. Pigs consuming hLZ-milk recovered from clinical signs of infection faster than pigs consuming control milk, with significantly improved fecal consistency (p = 0.0190) and activity level (p = 0.0350). The CBC analysis showed circulating monocytes (p = 0.0413), neutrophils (p = 0.0219), and lymphocytes (p = 0.0222) returned faster to pre-infection proportions in hLZ-milk fed pigs, while control-fed pigs had significantly higher hematocrit (p = 0.027), indicating continuing dehydration. In the ileum, pigs fed hLZ-milk had significantly lower expression of pro-inflammatory cytokine IL-8 (p = 0.0271), longer intestinal villi (p<0.0001), deeper crypts (p = 0.0053), and a thinner lamina propria (p = 0.0004). These data demonstrate that consumption of hLZ-milk helped pigs recover from infection faster, making hLZ-milk an effective treatment of E. coli-induced diarrhea.	[Cooper, Caitlin A.; Klobas, Lydia C. Garas; Maga, Elizabeth A.; Murray, James D.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Murray, James D.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Murray, JD (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.	Jdmurray@ucdavis.edu			Jastro-Shields grant from the University of California, Davis [CAC-1112]	Jastro-Shields grant from the University of California, Davis	This work was supported by a Jastro-Shields grant (CAC-1112) from the University of California, Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actor JK, 2009, CURR PHARM DESIGN, V15, P1956, DOI 10.2174/138161209788453202; Awad WA, 2009, POULTRY SCI, V88, P49, DOI 10.3382/ps.2008-00244; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brundige DR, 2008, J NUTR, V138, P921, DOI 10.1093/jn/138.5.921; Brundige DR, 2010, TRANSGENIC RES, V19, P563, DOI 10.1007/s11248-009-9334-4; Cooper CA, 2011, TRANSGENIC RES, V20, P1235, DOI 10.1007/s11248-011-9489-7; Dwinell MB, 2003, SURGERY, V133, P601, DOI 10.1067/msy.2003.143; GORDON LI, 1979, J CLIN INVEST, V64, P226, DOI 10.1172/JCI109443; Hettinga K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019433; Jackson KA, 2010, TRANSGENIC RES, V19, P977, DOI 10.1007/s11248-010-9371-z; Jensen GM, 2006, VET MICROBIOL, V115, P243, DOI 10.1016/j.vetmic.2006.01.002; JIMENEZFLORES R, 1988, J DAIRY SCI, V71, P2640, DOI 10.3168/jds.S0022-0302(88)79857-4; Koppelmann T, 2012, BR J NUTR, V28, P1; Lessard M, 2009, J ANIM SCI, V87, P922, DOI 10.2527/jas.2008-0919; Liao YL, 2012, BIOCHEM CELL BIOL, V90, P476, DOI [10.1139/o11-075, 10.1139/O11-075]; Liu D, 2010, AVIAN PATHOL, V39, P17, DOI 10.1080/03079450903447404; Liu P, 2010, J ANIM SCI, V88, P3871, DOI 10.2527/jas.2009-2771; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2; MAGA EA, 1995, BIO-TECHNOL, V13, P1452, DOI 10.1038/nbt1295-1452; Maga EA, 2003, TRANSGENIC RES, V12, P485, DOI 10.1023/A:1024257906647; Maga EA, 2006, FOODBORNE PATHOG DIS, V3, P384, DOI 10.1089/fpd.2006.3.384; Maga EA, 2006, TRANSGENIC RES, V15, P515, DOI 10.1007/s11248-006-0014-3; Maga EA, 2012, APPL ENVIRON MICROB, V78, P6153, DOI 10.1128/AEM.00956-12; Matkowskyj KA, 2000, NAT MED, V6, P1048, DOI 10.1038/79563; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Nyachoti CM, 2012, J ANIM SCI, V90, P252, DOI 10.2527/jas.2010-3596; Ogundele MO, 1998, MEDIAT INFLAMM, V7, P363, DOI 10.1080/09629359890893; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PROCTOR VA, 1988, CRC CR REV FOOD SCI, V26, P359, DOI 10.1080/10408398809527473; Rockova S, 2011, ANAEROBE, V17, P223, DOI 10.1016/j.anaerobe.2011.07.009; Savkovic SD, 1996, INFECT IMMUN, V64, P4480, DOI 10.1128/IAI.64.11.4480-4487.1996; SCHULZE F, 1980, ARCH EXP VET MED, V34, P317; Sharma R, 2010, PEDIATR SURG INT, V26, P11, DOI 10.1007/s00383-009-2536-2; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Yang B, 2011, PLOS ONE, V16; Yuhan R, 1997, GASTROENTEROLOGY, V113, P1873, DOI 10.1016/S0016-5085(97)70006-4	37	70	75	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58409	10.1371/journal.pone.0058409	http://dx.doi.org/10.1371/journal.pone.0058409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516474	Green Published, gold			2022-12-27	WOS:000316849200065
J	Nguyen, CQ; Ogunniyi, AO; Karabiyik, A; Love, JC				Nguyen, Cuong Q.; Ogunniyi, Adebola O.; Karabiyik, Afife; Love, J. Christopher			Single-Cell Analysis Reveals Isotype-Specific Autoreactive B Cell Repertoires in Sjogren's Syndrome	PLOS ONE			English	Article							THYROID-STIMULATING IMMUNOGLOBULINS; CLASSIFICATION CRITERIA; ANTINUCLEAR ANTIBODIES; GRAVES-DISEASE; AUTOANTIBODIES; PATHOGENESIS; PREVALENCE; SELECTION; MOUSE	Microengraving is a novel technology that uses an array of microfabricated subnanoliter wells to isolate and characterize secreted proteins from larger number of single cells. This printing technique permits the capture and characterization of secreted antibodies on glass slides. Here, we profiled the antigenic repertoires of B cells reacting against salivary gland tissues in Sjogren's syndrome (SjS), an autoimmune disease targeting the exocrine glands. Single-cell suspensions of spleen and cervical lymph node cells prepared from normal C57BL/6 and SjS-susceptible (SjS(s)) C57BL/6.NOD-AecAec2 mice were dispersed into subnanoliter wells (nanowells). Capture slides preincubated with mouse immunoglobulins were used for printing. Detection antibodies included fluorescence conjugated anti-IgG1, salivary gland lysates of C57BL/6 and SjS(s) mice. Results indicate an increase in the frequency of IgG1-secreting cells in the spleen of SjS(s) mice compared to C57BL/6 mice. Cells from the lymph node of SjS(s) mice yield higher instances of IgG1 reactive against salivary gland antigens than cells from the lymph nodes of C57BL/6 mice. These data demonstrate the isotype-specific reactivity of antibodies during the autoimmune process, and further reveals significant differences in the non-autoimmune and autoimmune antibody repertoires. These results support the generation of self-reactive B cell repertoires during the autoimmune process, at the same time, verifying that microengraving of single cells might allow for identification of novel biomarkers in SjS.	[Nguyen, Cuong Q.; Karabiyik, Afife] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32605 USA; [Nguyen, Cuong Q.] Univ Florida, Coll Dent, Ctr Orphan Autoimmune Disorders, Gainesville, FL USA; [Ogunniyi, Adebola O.; Love, J. Christopher] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Love, J. Christopher] Koch Inst Integrat Canc Res, Cambridge, MA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Massachusetts Institute of Technology (MIT)	Nguyen, CQ (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32605 USA.	nguyenc@ufl.edu			Sjogren's Syndrome Foundation; PHS Grant from the NIDCR [R00 DE018958]; NIH/NIAID [RC1AI086152]; UNCF/Merck Graduate Research Dissertation Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI086152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE018958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK097681] Funding Source: NIH RePORTER	Sjogren's Syndrome Foundation; PHS Grant from the NIDCR; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UNCF/Merck Graduate Research Dissertation Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by the Sjogren's Syndrome Foundation (CQN) and PHS Grant R00 DE018958 grant (CQN) from the NIDCR. This research was also supported in part by the NIH/NIAID (RC1AI086152). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy And Infectious Diseases or the National Institutes of Health. A.O.O. was supported by UNCF/Merck Graduate Research Dissertation Fellowship. J.C.L. is a Camille Dreyfus Teacher-Scholar and Latham Family Career Development Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Cha S, 2002, ARTHRITIS RHEUM-US, V46, P1390, DOI 10.1002/art.10258; Cha SH, 2006, J RHEUMATOL, V33, P296; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; DWYER DS, 1983, NATURE, V301, P611, DOI 10.1038/301611a0; FOX RI, 1992, RHEUM DIS CLIN N AM, V18, P517; Gao JH, 2006, J AUTOIMMUN, V26, P90, DOI 10.1016/j.jaut.2005.11.004; Gao JH, 2004, ARTHRITIS RHEUM-US, V50, P2615, DOI 10.1002/art.20371; Gauld SB, 2002, SCIENCE, V296, P1641, DOI 10.1126/science.1071546; Gordon TP, 2001, AUTOIMMUNITY, V34, P123, DOI 10.3109/08916930109001960; HARDIN JA, 1985, CLIN RHEUM DIS, V11, P485; HARLEY JB, 1986, ARTHRITIS RHEUM, V29, P196, DOI 10.1002/art.1780290207; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hayashi N, 2008, MOD RHEUMATOL, V18, P153, DOI 10.1007/s10165-008-0028-1; Jonsson R, 2000, SCAND J RHEUMATOL, V29, P341; Lavoie TN, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/549107; Lernmark A, 2001, J CLIN INVEST, V108, P1091, DOI 10.1172/JCI200114234; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Nguyen CQ, 2007, J IMMUNOL, V179, P382, DOI 10.4049/jimmunol.179.1.382; Nguyen CQ, 2009, OCUL SURF, V7, P11, DOI 10.1016/S1542-0124(12)70289-6; Nguyen CQ, 2007, FRONT BIOSCI-LANDMRK, V12, P1767, DOI 10.2741/2187; Novljan MP, 2006, SCAND J RHEUMATOL, V35, P463, DOI 10.1080/03009740600759860; Ogunniyi AO, 2009, NAT PROTOC, V4, P767, DOI 10.1038/nprot.2009.40; Ronan JL, 2009, J IMMUNOL METHODS, V340, P164, DOI 10.1016/j.jim.2008.10.018; Routsias JG, 2007, CLIN REV ALLERG IMMU, V32, P238, DOI 10.1007/s12016-007-8003-8; Satoh M, 2012, ARTHRITIS RHEUM-US, V64, P2319, DOI 10.1002/art.34380; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; SMITH BR, 1974, LANCET, V2, P427; Story CM, 2008, P NATL ACAD SCI USA, V105, P17902, DOI 10.1073/pnas.0805470105; Sugai Susumu, 2004, Autoimmun Rev, V3 Suppl 1, pS67; TENG CS, 1977, CLIN ENDOCRINOL, V6, P207, DOI 10.1111/j.1365-2265.1977.tb03316.x; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	33	18	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58127	10.1371/journal.pone.0058127	http://dx.doi.org/10.1371/journal.pone.0058127			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516437	Green Submitted, gold, Green Published			2022-12-27	WOS:000316849200034
J	Matsen, FA; Evans, SN				Matsen, Frederick A.; Evans, Steven N.			Edge Principal Components and Squash Clustering: Using the Special Structure of Phylogenetic Placement Data for Sample Comparison	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; SPACE	Principal components analysis (PCA) and hierarchical clustering are two of the most heavily used techniques for analyzing the differences between nucleic acid sequence samples taken from a given environment. They have led to many insights regarding the structure of microbial communities. We have developed two new complementary methods that leverage how this microbial community data sits on a phylogenetic tree. Edge principal components analysis enables the detection of important differences between samples that contain closely related taxa. Each principal component axis is a collection of signed weights on the edges of the phylogenetic tree, and these weights are easily visualized by a suitable thickening and coloring of the edges. Squash clustering outputs a (rooted) clustering tree in which each internal node corresponds to an appropriate "average" of the original samples at the leaves below the node. Moreover, the length of an edge is a suitably defined distance between the averaged samples associated with the two incident nodes, rather than the less interpretable average of distances produced by UPGMA, the most widely used hierarchical clustering method in this context. We present these methods and illustrate their use with data from the human microbiome.	[Matsen, Frederick A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Evans, Steven N.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Fred Hutchinson Cancer Center; University of California System; University of California Berkeley	Matsen, FA (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	matsen@fhcrc.org			National Institutes of Health [HG005966-01]; National Science Foundation [DMS-09-07630]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The first author was supported in part by National Institutes of Health grant HG005966-01, and the second author was supported in part by National Science Foundation grant DMS-09-07630. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Evans SN, 2012, J R STAT SOC B, V74, P569, DOI 10.1111/j.1467-9868.2011.01018.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Matsen FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031009; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; Mitra S, 2009, BIOINFORMATICS, V25, P1849, DOI 10.1093/bioinformatics/btp341; Morgan JL, 2010, PLOS ONE, V5; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Nye TMW, 2011, ANN STAT, V39, P2716, DOI 10.1214/11-AOS915; Purdom E., 2008, UC BERKELEY STAT TEC, V766, P1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wang H, 2007, ANN STAT, V35, P1849, DOI 10.1214/009053607000000217; White JR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-152; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zozaya-Hinchliffe M, 2008, APPL ENVIRON MICROB, V74, P1656, DOI 10.1128/AEM.02127-07	32	50	50	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e56859	10.1371/journal.pone.0056859	http://dx.doi.org/10.1371/journal.pone.0056859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505415	Green Submitted, Green Published, gold			2022-12-27	WOS:000316251100004
J	Neely, KA; Planetta, PJ; Prodoehl, J; Corcos, DM; Comella, CL; Goetz, CG; Shannon, KL; Vaillancourt, DE				Neely, Kristina A.; Planetta, Peggy J.; Prodoehl, Janey; Corcos, Daniel M.; Comella, Cynthia L.; Goetz, Christopher G.; Shannon, Kathleen L.; Vaillancourt, David E.			Force Control Deficits in Individuals with Parkinson's Disease, Multiple Systems Atrophy, and Progressive Supranuclear Palsy	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; VOXEL-WISE ANALYSIS; ISOMETRIC FORCE; APPLAUSE SIGN; PRECISION GRIP; FOLLOW-UP; DEGENERATION; VARIABILITY; MILESTONES; GENERATION	Objective: This study examined grip force and cognition in Parkinson's disease (PD), Parkinsonian variant of multiple system atrophy (MSAp), progressive supranuclear palsy (PSP), and healthy controls. PD is characterized by a slower rate of force increase and decrease and the production of abnormally large grip forces. Early-stage PD has difficulty with the rapid contraction and relaxation of hand muscles required for precision gripping. The first goal was to determine which features of grip force are abnormal in MSAp and PSP. The second goal was to determine whether a single variable or a combination of motor and cognitive measures would distinguish patient groups. Since PSP is more cognitively impaired relative to PD and MSAp, we expected that combining motor and cognitive measures would further distinguish PSP from PD and MSAp. Methods: We studied 44 participants: 12 PD, 12 MSAp, 8 PSP, and 12 controls. Patients were diagnosed by a movement disorders neurologist and were tested off anti-Parkinsonian medication. Participants completed a visually guided grip force task wherein force pulses were produced for 2 s, followed by 1 s of rest. We also conducted four cognitive tests. Results: PD, MSAp, and PSP were slower at contracting and relaxing force and produced longer pulse durations compared to controls. PSP produced additional force pulses during the task and were more cognitively impaired relative to other groups. A receiver operator characteristic analysis revealed that the combination of number of pulses and Brief Test of Attention (BTA) discriminated PSP from PD, MSAp, and controls with a high degree of sensitivity and specificity. Conclusions: Slowness in contracting and relaxing force represent general features of PD, MSAp, and PSP, whereas producing additional force pulses was specific to PSP. Combining motor and cognitive measures provides a robust method for characterizing behavioral features of PSP compared to MSAp and PD.	[Neely, Kristina A.; Planetta, Peggy J.; Vaillancourt, David E.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA; [Prodoehl, Janey] Midwestern Univ, Phys Therapy Program, Downers Grove, IL 60515 USA; [Corcos, Daniel M.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL USA; [Corcos, Daniel M.] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Corcos, Daniel M.] Univ Illinois, Dept Phys Therapy, Chicago, IL USA; [Corcos, Daniel M.] Univ Illinois, Dept Neurol Sci, Chicago, IL USA; [Comella, Cynthia L.; Goetz, Christopher G.; Shannon, Kathleen L.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Vaillancourt, David E.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Vaillancourt, David E.] Univ Florida, Dept Biomed Engn, Gainesville, FL USA	State University System of Florida; University of Florida; Midwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Vaillancourt, DE (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA.	vcourt@ufl.edu	Corcos, Daniel/AAX-9971-2021; Neely, Kristina A./GQH-9601-2022; Prodoehl, Janey/AAS-4875-2021; Neely, Kristina A./H-7117-2019	Neely, Kristina A./0000-0002-3008-8707	National Institutes of Health (NIH) [R01 NS52318, R01 NS58487, R01 NS75012, R01 NS028127]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058487, R01NS028127, R01NS075012, R01NS052318] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant numbers: R01 NS52318, R01 NS58487, R01 NS75012, and R01 NS028127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini A, 2010, LANCET NEUROL, V9, P130, DOI 10.1016/S1474-4422(09)70360-6; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Berendse HW, 2009, PARKINSONISM RELAT D, V15, pS26, DOI 10.1016/S1353-8020(09)70774-6; Brooks DJ, 2008, NAT CLIN PRACT NEURO, V4, P267, DOI 10.1038/ncpneuro0773; Corcos DM, 1996, ANN NEUROL, V39, P79, DOI 10.1002/ana.410390112; Dodel RC, 2003, MOVEMENT DISORD, V18, pS52, DOI 10.1002/mds.10580; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Dubois B, 2005, NEUROLOGY, V64, P2132, DOI 10.1212/01.WNL.0000165977.38272.15; DUTTA C, 1995, J GERONTOL A-BIOL, V50, P1, DOI 10.1093/gerona/50A.Special_Issue.1; Fellows SJ, 2006, PARKINSONISM RELAT D, V12, P149, DOI 10.1016/j.parkreldis.2005.12.001; Fellows SJ, 2004, MOVEMENT DISORD, V19, P560, DOI 10.1002/mds.10710; Fellows SJ, 1998, BRAIN, V121, P1771, DOI 10.1093/brain/121.9.1771; FREUND HJ, 1978, EXP BRAIN RES, V31, P1; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; GORDON J, 1987, EXP BRAIN RES, V67, P241, DOI 10.1007/BF00248546; Hallett M, 2011, MOVEMENT DISORD, V26, P958, DOI 10.1002/mds.23572; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Hughes AJ, 2001, NEUROLOGY, V57, pS34; Hughes VA, 2001, J GERONTOL A-BIOL, V56, pB209, DOI 10.1093/gerona/56.5.B209; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; JORDAN N, 1992, J NEUROL NEUROSUR PS, V55, P572, DOI 10.1136/jnnp.55.7.572; Ling H, 2012, BRAIN, V135, P1141, DOI 10.1093/brain/aws038; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Luzzi S, 2011, J NEUROL NEUROSUR PS, V82, P830, DOI 10.1136/jnnp.2010.224394; Luzzi S, 2013, J NEUROL, V260, P172, DOI 10.1007/s00415-012-6608-1; Marras C, 2005, NEUROLOGY, V64, P87, DOI 10.1212/01.WNL.0000148603.44618.19; Menke RA, 2009, NEUROIMAGE, V47, P435, DOI 10.1016/j.neuroimage.2009.05.017; Muratori LM, 2003, NEUROPSYCHOLOGIA, V41, P1498, DOI 10.1016/S0028-3932(03)00092-7; Nowak DA, 2005, EXP NEUROL, V193, P427, DOI 10.1016/j.expneurol.2005.01.003; Park JH, 2007, NEUROSCI LETT, V412, P173, DOI 10.1016/j.neulet.2006.11.009; PILLON B, 1995, NEUROLOGY, V45, P1477, DOI 10.1212/WNL.45.8.1477; Prodoehl J, 2010, MOVEMENT DISORD, V25, P2035, DOI 10.1002/mds.23360; Robichaud JA, 2005, MOVEMENT DISORD, V20, P441, DOI 10.1002/mds.20350; Scherfler C, 2006, BRAIN, V129, P538, DOI 10.1093/brain/awh674; Scherfler C, 2005, BRAIN, V128, P1605, DOI 10.1093/brain/awh485; Slifkin A, 1999, J EXP PSYCHOL HUMAN, V25, P837, DOI 10.1037/0096-1523.25.3.837; Slifkin AB, 2000, J MOTOR BEHAV, V32, P141, DOI 10.1080/00222890009601366; Soliveri P, 2000, J NEUROL NEUROSUR PS, V69, P313, DOI 10.1136/jnnp.69.3.313; Sosnov JJ, 2006, EXP BRAIN RES, V174, P86, DOI 10.1007/s00221-006-0422-x; Spraker MB, 2009, CEREB CORTEX, V19, P2640, DOI 10.1093/cercor/bhp015; STELMACH GE, 1988, NEUROPSYCHOLOGIA, V26, P93, DOI 10.1016/0028-3932(88)90033-4; Tang CC, 2010, LANCET NEUROL, V9, P149, DOI 10.1016/S1474-4422(10)70002-8; Tracy BL, 2005, MUSCLE NERVE, V32, P533, DOI 10.1002/mus.20392; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; Vaillancourt DE, 2004, BRAIN, V127, P491, DOI 10.1093/brain/awh057; Vaillancourt DE, 2003, J NEUROPHYSIOL, V90, P3330, DOI 10.1152/jn.00394.2003; Wang Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002566; WENNING GK, 1995, ACTA NEUROL SCAND, V91, P247, DOI 10.1111/j.1600-0404.1995.tb06998.x; Wenning GK, 2011, MOVEMENT DISORD, V26, P1083, DOI 10.1002/mds.23713; Wichmann T, 2011, NEUROSCIENCE, V198, P232, DOI 10.1016/j.neuroscience.2011.06.048; Wichmann T, 2011, MOVEMENT DISORD, V26, P1032, DOI 10.1002/mds.23695; Wu LJC, 2008, MOVEMENT DISORD, V23, P2307, DOI 10.1002/mds.22090	53	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58403	10.1371/journal.pone.0058403	http://dx.doi.org/10.1371/journal.pone.0058403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505500	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100049
J	Wu, F; Chen, Y; Parvez, F; Segers, S; Argos, M; Islam, T; Ahmed, A; Rakibuz-Zaman, M; Hasan, R; Sarwar, G; Ahsan, H				Wu, Fen; Chen, Yu; Parvez, Faruque; Segers, Stephanie; Argos, Maria; Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam; Ahsan, Habibul			A Prospective Study of Tobacco Smoking and Mortality in Bangladesh	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; CIGARETTE-SMOKING; PROSPECTIVE COHORT; ARSENIC EXPOSURE; PASSIVE SMOKING; DRINKING-WATER; VERBAL AUTOPSY; BLOOD-PRESSURE	Background: Limited data are available on smoking-related mortality in low-income countries, where both chronic disease burden and prevalence of smoking are increasing. Methods: Using data on 20, 033 individuals in the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh, we prospectively evaluated the association between tobacco smoking and all-cause, cancer, and cardiovascular disease mortality during similar to 7.6 years of follow-up. Cox proportional hazards models were used to estimate hazard ratios (HRs) and their 95% confidence intervals (CIs) for deaths from all-cause, cancer, CVD, ischemic heart disease (IHD), and stroke, in relation to status, duration, and intensity of cigarette/bidi and hookah smoking. Results: Among men, cigarette/bidi smoking was positively associated with all-cause (HR 1.40, 95% CI 1.06 1.86) and cancer mortality (HR 2.91, 1.24 6.80), and there was a dose-response relationship between increasing intensity of cigarette/bidi consumption and increasing mortality. An elevated risk of death from ischemic heart disease (HR 1.87, 1.08 3.24) was associated with current cigarette/bidi smoking. Among women, the corresponding HRs were 1.65 (95% CI 1.16 2.36) for all-cause mortality and 2.69 (95% CI 1.20 6.01) for ischemic heart disease mortality. Similar associations were observed for hookah smoking. There was a trend towards reduced risk for the mortality outcomes with older age at onset of cigarette/bidi smoking and increasing years since quitting cigarette/bibi smoking among men. We estimated that cigarette/bidi smoking accounted for about 25.0% of deaths in men and 7.6% in women. Conclusions: Tobacco smoking was responsible for substantial proportion of premature deaths in the Bangladeshi population, especially among men. Stringent measures of tobacco control and cessation are needed to reduce tobacco-related deaths in Bangladesh.	[Wu, Fen; Chen, Yu; Segers, Stephanie] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Parvez, Faruque] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Argos, Maria; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam] U Chicago Res Bangladesh Ltd, Dhaka, Bangladesh	New York University; Columbia University; University of Chicago	Chen, Y (corresponding author), Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA.	yu.chen@nyumc.org; habib@uchicago.edu	Wu, Fen/G-1569-2010	Chen, Yu/0000-0002-1519-4894	National Institutes of Health [R01 ES017541, P42 ES010349, P30 ES000260]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017541, P42ES010349, P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (R01 ES017541, P42 ES010349, and P30 ES000260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Akl EA, 2010, INT J EPIDEMIOL, V39, P834, DOI 10.1093/ije/dyq002; Aljarrah Khaled, 2009, Tob Induc Dis, V5, P16, DOI 10.1186/1617-9625-5-16; [Anonymous], 1999, WORLD HLTH REPORT 19; [Anonymous], 2007, MAN INT CLASS DIS IN; Archibald C. P., 1996, Annals Academy of Medicine Singapore, V25, P123; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Baqui AH, 1998, B WORLD HEALTH ORGAN, V76, P161; BOLINDER G, 1994, AM J PUBLIC HEALTH, V84, P399, DOI 10.2105/AJPH.84.3.399; Cao Y, 2011, ARCH INTERN MED, V171, P1956, DOI 10.1001/archinternmed.2011.539; Chen Y, 2006, AM J CLIN NUTR, V84, P1224, DOI 10.1093/ajcn/84.5.1224; Chen Y, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2431; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Enstrom JE, 2003, BMJ-BRIT MED J, V326, P1057, DOI 10.1136/bmj.326.7398.1057; Ezzati M, 2003, TOB CONTROL, V12, P79, DOI 10.1136/tc.12.1.79; Feigin V, 2005, STROKE, V36, P1360, DOI 10.1161/01.STR.0000170710.95689.41; Fenelon A, 2012, DEMOGRAPHY, V49, P797, DOI 10.1007/s13524-012-0108-x; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Godtfredsen NS, 2002, AM J EPIDEMIOL, V156, P994, DOI 10.1093/aje/kwf150; Gu DF, 2009, NEW ENGL J MED, V360, P150, DOI 10.1056/NEJMsa0802902; Gupta PC, 2000, B WORLD HEALTH ORGAN, V78, P877; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Hata J, 2011, CEREBROVASC DIS, V31, P477, DOI 10.1159/000324392; Hill SE, 2004, BMJ-BRIT MED J, V328, P988, DOI 10.1136/bmj.38070.503009.EE; International Agency for Research on Cancer, 2007, IARC HDB CANC PREV, V11; International Centre for Research on Women, 2003, ICRW POL ADV CHILD M; Iso H, 2005, AM J EPIDEMIOL, V161, P170, DOI 10.1093/aje/kwi027; Jee SH, 1999, JAMA-J AM MED ASSOC, V282, P2149, DOI 10.1001/jama.282.22.2149; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; KIYOHARA Y, 1990, J HYPERTENS, V8, pS9; Kondo T, 2011, CIRC J, V75, P2885, DOI 10.1253/circj.CJ-11-0416; KONO S, 1985, J CANCER RES CLIN, V110, P161, DOI 10.1007/BF00402732; Lim SH, 2011, TOB CONTROL; Lopez MJ, 2007, TOB CONTROL, V16, P373, DOI 10.1136/tc.2006.019679; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McGhee SM, 2005, BMJ-BRIT MED J, V330, P287, DOI 10.1136/bmj.38342.706748.47; National Cancer Institute, 1997, SMOK TOB CONTR MON; Pednekar MS, 2011, CANCER CAUSE CONTROL, V22, P859, DOI 10.1007/s10552-011-9756-1; Peto R, 2008, MORTALITY SMOKING DE; Pierce BL, 2010, INT J EPIDEMIOL, V39, P1037, DOI 10.1093/ije/dyp364; Ramadas K, 2010, CANCER EPIDEMIOL, V34, P405, DOI 10.1016/j.canep.2010.04.006; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Ronsmans C, 1998, INT J EPIDEMIOL, V27, P660, DOI 10.1093/ije/27.4.660; Shankar A, 2008, EUR J CANCER, V44, P100, DOI 10.1016/j.ejca.2007.10.015; Shihadeh A, 2005, FOOD CHEM TOXICOL, V43, P655, DOI 10.1016/j.fct.2004.12.013; Shihadeh A, 2003, FOOD CHEM TOXICOL, V41, P143, DOI 10.1016/S0278-6915(02)00220-X; SHINTON R, 1989, BMJ-BRIT MED J, V298, P789, DOI 10.1136/bmj.298.6676.789; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; UICC-Tata Memorial Centre, 1989, TOB HLTH THE IND SCE; US Department of Health and Human Services [Internet], 1990, HLTH BEN SMOK CESS R; Wang YH, 2007, ATHEROSCLEROSIS, V192, P305, DOI 10.1016/j.atherosclerosis.2006.07.029; Wen CP, 2005, TOB CONTROL, V14, pI56, DOI 10.1136/tc.2004.007997; Wen WQ, 2006, BMJ-BRIT MED J, V333, P376, DOI 10.1136/bmj.38834.522894.2F; World Health Organization, 2005, WAT PIP TOB SMOK HLT; World Health Organization, 2008, WHO REP GLOB TOB EP; World Health Organization, 2009, GLOB AD TOB SURV BAN; WYNDER EL, 1992, JPN J CANCER RES, V83, P418, DOI 10.1111/j.1349-7006.1992.tb01944.x; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646	61	42	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58516	10.1371/journal.pone.0058516	http://dx.doi.org/10.1371/journal.pone.0058516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505526	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100058
J	Lamash, NE; Dolmatov, IY				Lamash, Nina E.; Dolmatov, Igor Yu			Proteases from the Regenerating Gut of the Holothurian Eupentacta fraudatrix	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; SEA-URCHIN; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; INTESTINE REGENERATION; HATCHING ENZYME; EXPRESSION; CUCUMBER; INHIBITION; PROTEIN	Four proteases with molecular masses of 132, 58, 53, and 47 kDa were detected in the digestive system of the holothurian Eupentacta fraudatrix. These proteases displayed the gelatinase activity and characteristics of zinc metalloproteinases. The 58 kDa protease had similar protease inhibitor sensitivity to that of mammalian matrix metalloproteinases. Zymographic assay revealed different lytic activities of all four proteases during intestine regeneration in the holothurian. The 132 kDa protease showed the highest activity at the first stage. During morphogenesis (stages 2-4 of regeneration), the highest activity was measured for the 53 and 58 kDa proteases. Inhibition of protease activity exerts a marked effect on regeneration, which was dependent on the time when 1,10-phenanthroline injections commenced. When metalloproteinases were inhibited at the second stage of regeneration, the restoration rates were decreased. However, such an effect proved to be reversible, and when inhibition ceased, the previous rate of regeneration was recovered. When protease activity is inhibited at the first stage, regeneration is completely abolished, and the animals die, suggesting that early activation of the proteases is crucial for triggering the regenerative process in holothurians. The role of the detected proteases in the regeneration processes of holothurians is discussed.	[Lamash, Nina E.; Dolmatov, Igor Yu] Russian Acad Sci, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia; [Lamash, Nina E.; Dolmatov, Igor Yu] Far Eastern Fed Univ, Sch Nat Sci, Vladivostok, Russia	Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Far Eastern Federal University	Dolmatov, IY (corresponding author), Russian Acad Sci, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690022, Russia.	idolmatov@mail.ru	Dolmatov, Igor Yu/A-7704-2014; Lamash, Nina E/Q-1040-2015	Dolmatov, Igor Yu/0000-0003-3923-8131; Lamash, Nina E/0000-0003-4923-4580	Russian Foundation for Basic Research [11-04-00408]; Far Eastern Branch of the Russian Academy of Sciences [12-I-P6-06]; Government of the Russian Federation [11.G34.31.0010]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Far Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences); Government of the Russian Federation	This work was supported by the Russian Foundation for Basic Research (grant number 11-04-00408) and the Far Eastern Branch of the Russian Academy of Sciences (grant number 12-I-P6-06) to ID and the Government of the Russian Federation (grant number 11.G34.31.0010) to NL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JC, 1993, DEVELOPMENT, V117, P1183; Angerer L, 2006, DEV BIOL, V300, P267, DOI 10.1016/j.ydbio.2006.07.046; Atzori L, 2009, AM J RESP CELL MOL, V41, P680, DOI 10.1165/rcmb.2007-0386OC; BYRNE M, 1986, J MORPHOL, V188, P179, DOI 10.1002/jmor.1051880205; Cheung PY, 2000, CIRCULATION, V101, P1833, DOI 10.1161/01.CIR.101.15.1833; Cooley LS, 2010, J CELL SCI, V123, P3808, DOI 10.1242/jcs.064279; Coraux C, 2005, AM J RESP CELL MOL, V32, P87, DOI 10.1165/rcmb.2004-0079RC; Dawbin W. H., 1949, Transactions and Proceedings of the Royal Society of New Zealand, V77, P497; Dolmatov I. Y., 2007, REGENERATSIYA GOLOTU; Dolmatov I.Yu., 1992, Monographs in Developmental Biology, V23, P40; Dolmatov I. Yu, 1996, Ontogenez, V27, P256; Dolmatov IY, 2009, ZH OBSHCH BIOL, V70, P316; Dolmatov IY, 2001, MICROSC RES TECHNIQ, V55, P452, DOI 10.1002/jemt.1190.abs; Dolmatov IY, 1995, BIOL BULL, V4, P490; Dragutinovic VV, 2006, WORLD J GASTROENTERO, V12, P105, DOI 10.3748/wjg.v12.i1.105; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; ELISEIKINA MG, 2002, RUSSIAN J MARINE BIO, V28, P197, DOI DOI 10.1023/A:1016801521216; Flood J, 2000, BIOCHEM CELL BIOL, V78, P455, DOI 10.1139/bcb-78-4-455; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Garcia-Arraras JE, 1998, J EXP ZOOL, V281, P288, DOI 10.1002/(SICI)1097-010X(19980701)281:4<288::AID-JEZ5>3.0.CO;2-K; Garcia-Arraras JE, 2010, CURR PHARM DESIGN, V16, P942, DOI 10.2174/138161210790883426; Garcia-Arraras JE, 2006, DEV DYNAM, V235, P3259, DOI 10.1002/dvdy.20983; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; GROSS J, 1962, P NATL ACAD SCI USA, V48, P1014, DOI 10.1073/pnas.48.6.1014; Humason G., 1962, ANIMAL TISSUE TECHNI; Hyman LH, 1955, INVERTEBRATED ECHINO; Ingersoll EP, 1998, DEV BIOL, V196, P95, DOI 10.1006/dbio.1998.8857; Jourdan-LeSaux C, 2010, LIFE SCI, V87, P391, DOI 10.1016/j.lfs.2010.07.010; Kato T, 2003, DEV DYNAM, V226, P366, DOI 10.1002/dvdy.10247; Kille FR, 1935, BIOL BULL-US, V69, P82, DOI 10.2307/1537360; Lee H, 2011, TOXICON, V58, P277, DOI 10.1016/j.toxicon.2011.06.007; LEIBSON NL, 1992, MG DEVEL B, V23, P51; LEIBSON NL, 1989, ZOOL ZH, V68, P67; Makanae A, 2012, ANAT REC, V295, P1566, DOI 10.1002/ar.22529; Mannello F, 2003, CLIN CHEM, V49, P1546, DOI 10.1373/49.9.1546; Mashanov VS, 2011, BIOL BULL-US, V221, P93, DOI 10.1086/BBLv221n1p93; Mashanov VS, 2005, BIOL BULL-US, V209, P184, DOI 10.2307/3593108; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Mayne J, 2002, J CELL BIOCHEM, V84, P567; Mayne J, 2002, DEV GROWTH DIFFER, V44, P345; Mayne J, 1998, J CELL BIOCHEM, V71, P546, DOI 10.1002/(SICI)1097-4644(19981215)71:4<546::AID-JCB9>3.0.CO;2-Y; Mitten EK, 2012, INSECT BIOC IN PRESS; Miyazaki K, 1996, P NATL ACAD SCI USA, V93, P6819, DOI 10.1073/pnas.93.13.6819; MOSHER CAROL, 1956, ZOOLOGICA [NEW YORK], V41, P17; Mukhi S, 2011, DEV BIOL, V351, P311, DOI 10.1016/j.ydbio.2010.12.020; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nakajima M, 1991, Semin Cancer Biol, V2, P115; NOMURA K, 1993, FEBS LETT, V321, P84, DOI 10.1016/0014-5793(93)80626-6; NOMURA K, 1991, BIOCHEMISTRY-US, V30, P6115, DOI 10.1021/bi00239a005; Ozbek S, 2010, MOL BIOL CELL, V21, P4300, DOI 10.1091/mbc.E10-03-0251; Ortiz-Pineda PA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-262; Page-McCaw A, 2008, SEMIN CELL DEV BIOL, V19, P14, DOI 10.1016/j.semcdb.2007.06.004; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Pilcher BK, 1999, ANN NY ACAD SCI, V878, P12, DOI 10.1111/j.1749-6632.1999.tb07671.x; Qin L, 2010, AM J PATHOL, V177, P1915, DOI 10.2353/ajpath.2010.100011; QUIGLEY JP, 1993, DIFFERENTIATION, V54, P19, DOI 10.1111/j.1432-0436.1993.tb00655.x; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Ranganathan L, 2004, J CELL BIOCHEM, V93, P1075, DOI 10.1002/jcb.20268; Robinson JJ, 2006, J CELL BIOCHEM, V99, P816, DOI 10.1002/jcb.20975; Santosh N, 2011, DEV DYNAM, V240, P1127, DOI 10.1002/dvdy.22503; Satoh A, 2011, DEV BIOL, V355, P263, DOI 10.1016/j.ydbio.2011.04.017; SEKAR V, 1979, BIOCHEM BIOPH RES CO, V89, P474, DOI 10.1016/0006-291X(79)90653-3; Shamshurina EV, 2010, RUSS J MAR BIOL+, V36, P293, DOI 10.1134/S1063074010040073; Sharpe C, 2001, BIOCHEM CELL BIOL, V79, P461; Smiley Scott, 1994, P401; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Steffensen B, 2011, MATRIX BIOL, V30, P34, DOI 10.1016/j.matbio.2010.09.004; Stevens LJ, 2012, MOL BIOL CELL, V23, P1068, DOI 10.1091/mbc.E11-09-0745; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Sun L, 2011, COMP BIOCHEM PHYS D, V6, P195, DOI 10.1016/j.cbd.2011.03.002; Turner NA, 2012, IUBMB LIFE, V64, P143, DOI 10.1002/iub.594; Vafa O, 1996, DIFFERENTIATION, V60, P129, DOI 10.1007/s002580050143; Vanderheyden PML, 2006, FUND CLIN PHARMACOL, V20, P613, DOI 10.1111/j.1472-8206.2006.00444.x; Vinarsky V, 2005, DEV BIOL, V279, P86, DOI 10.1016/j.ydbio.2004.12.003; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Wojcik-Stanaszek L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022465	78	16	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58433	10.1371/journal.pone.0058433	http://dx.doi.org/10.1371/journal.pone.0058433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505505	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500082
J	Lemkau, LR; Comellas, G; Lee, SW; Rikardsen, LK; Woods, WS; George, JM; Rienstra, CM				Lemkau, Luisel R.; Comellas, Gemma; Lee, Shin W.; Rikardsen, Lars K.; Woods, Wendy S.; George, Julia M.; Rienstra, Chad M.			Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K	PLOS ONE			English	Article							SOLID-STATE NMR; PROTEIN SECONDARY STRUCTURE; ANGLE-SPINNING NMR; CHEMICAL-SHIFT; WILD-TYPE; AMYLOID FIBRILS; PHOSPHOLIPID-BINDING; CROSS-POLARIZATION; SPECTROSCOPY; RESOLUTION	Parkinson's disease (PD) is pathologically characterized by the presence of Lewy bodies (LBs) in dopaminergic neurons of the substantia nigra. These intracellular inclusions are largely composed of misfolded alpha-synuclein (AS), a neuronal protein that is abundant in the vertebrate brain. Point mutations in AS are associated with rare, early-onset forms of PD, although aggregation of the wild-type (WT) protein is observed in the more common sporadic forms of the disease. Here, we employed multidimensional solid-state NMR experiments to assess A53T and E46K mutant fibrils, in comparison to our recent description of WT AS fibrils. We made de novo chemical shift assignments for the mutants, and used these chemical shifts to empirically determine secondary structures. We observe significant perturbations in secondary structure throughout the fibril core for the E46K fibril, while the A53T fibril exhibits more localized perturbations near the mutation site. Overall, these results demonstrate that the secondary structure of A53T has some small differences from the WT and the secondary structure of E46K has significant differences, which may alter the overall structural arrangement of the fibrils.	[Lemkau, Luisel R.; Lee, Shin W.; Rikardsen, Lars K.; Rienstra, Chad M.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Comellas, Gemma; Rienstra, Chad M.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Woods, Wendy S.; George, Julia M.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA; [Rienstra, Chad M.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rienstra, CM (corresponding author), Univ Illinois, Dept Chem, 1209 W Calif St, Urbana, IL 61801 USA.	rienstra@illinois.edu	George, Julia M/B-2169-2008	George, Julia M/0000-0001-6194-6914	National Institutes of Health [R01-GM073770, S10RR025037-01]; Novartis Predoctoral Fellowship; Caja Madrid Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073770] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Predoctoral Fellowship; Caja Madrid Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health R01-GM073770; National Institutes of Health S10RR025037-01; Novartis Predoctoral Fellowship to LRL; Caja Madrid Fellowship to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Celej MS, 2009, BIOCHEMISTRY-US, V48, P7465, DOI 10.1021/bi9003843; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Comellas G, 2011, J MAGN RESON, V209, P131, DOI 10.1016/j.jmr.2010.12.011; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ferguson N, 2006, P NATL ACAD SCI USA, V103, P16248, DOI 10.1073/pnas.0607815103; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; HEDIGER S, 1994, CHEM PHYS LETT, V223, P283, DOI 10.1016/0009-2614(94)00470-6; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Heise H, 2008, J MOL BIOL, V380, P444, DOI 10.1016/j.jmb.2008.05.026; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Iwata K, 2006, P NATL ACAD SCI USA, V103, P18119, DOI 10.1073/pnas.0607180103; Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101; Johnson B, 2007, NMRVIEWJ; Kloepper KD, 2006, PROTEIN EXPRES PURIF, V48, P112, DOI 10.1016/j.pep.2006.02.009; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lemkau LR, 2012, J BIOL CHEM, V287, P11526, DOI 10.1074/jbc.M111.306902; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Loquet A, 2010, J AM CHEM SOC, V132, P15164, DOI 10.1021/ja107460j; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Oldfield E, 2002, ANNU REV PHYS CHEM, V53, P349, DOI 10.1146/annurev.physchem.53.082201.124235; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; van Raaij ME, 2006, BIOPHYS J, V91, pL96, DOI 10.1529/biophysj.106.090449; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	44	42	42	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e49750	10.1371/journal.pone.0049750	http://dx.doi.org/10.1371/journal.pone.0049750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505409	Green Published, gold, Green Submitted			2022-12-27	WOS:000318334500001
J	Matic, AI; Robinson, AM; Young, HK; Badofsky, B; Rajguru, SM; Stock, S; Richter, CP				Matic, Agnella Izzo; Robinson, Alan M.; Young, Hunter K.; Badofsky, Ben; Rajguru, Suhrud M.; Stock, Stuart; Richter, Claus-Peter			Behavioral and Electrophysiological Responses Evoked by Chronic Infrared Neural Stimulation of the Cochlea	PLOS ONE			English	Article							OPTICAL STIMULATION; AUDITORY NEURONS; LASER STIMULATION; SPEECH-PERCEPTION; PULSE DURATION; NERVE; RECOGNITION; PROSTHESIS; DEPENDENCE; MONOPOLAR	Infrared neural stimulation (INS) has been proposed as a novel method for neural stimulation. In order for INS to translate to clinical use, which would involve the use of implanted devices over years or decades, the efficacy and safety of chronic INS needs to be determined. We examined a population of cats that were chronically implanted with an optical fiber to stimulate the cochlea with infrared radiation, the first known chronic application of INS. Through behavioral responses, the cats demonstrate that stimulation occurs and a perceptual event results. Long-term stimulation did not result in a change in the electrophysiological responses, either optically-evoked or acoustically-evoked. Spiral ganglion neuron counts and post implantation tissue growth, which was localized at the optical fiber, were similar in chronically stimulated and sham implanted cochleae. Results from chronic INS experiments in the cat cochlea support future work toward INS-based neuroprostheses for humans.	[Matic, Agnella Izzo; Robinson, Alan M.; Young, Hunter K.; Badofsky, Ben; Richter, Claus-Peter] Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol, Chicago, IL 60611 USA; [Rajguru, Suhrud M.] Univ Miami, Dept Biomed Engn, Miami, FL USA; [Rajguru, Suhrud M.] Univ Miami, Dept Otolaryngol, Miami, FL USA; [Stock, Stuart] Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60611 USA; [Richter, Claus-Peter] Northwestern Univ, Dept Commun Sci & Disorders, Hugh Knowles Ctr, Evanston, IL 60611 USA	Northwestern University; Feinberg School of Medicine; University of Miami; University of Miami; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Matic, AI (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Otolaryngol, Chicago, IL 60611 USA.	agnella.matic@gmail.com		Stock, Stuart R./0000-0002-8886-4035	US Army Medical Research and Materiel Command [W81XWH-10-C-0208]	US Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This project has been funded by the US Army Medical Research and Materiel Command under Contract No. W81XWH-10-C-0208 to Lockheed Martin Aculight. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ES, 2012, J NEUROPHYSIOL, V107, P3227, DOI 10.1152/jn.00424.2011; Berenstein CK, 2008, EAR HEARING, V29, P250, DOI 10.1097/AUD.0b013e3181645336; Bierer JA, 2002, J NEUROPHYSIOL, V87, P478, DOI 10.1152/jn.00212.2001; Bohne BA, 2000, AM J OTOL, V21, P505; BOWMAN BR, 1985, ANN BIOMED ENG, V13, P75, DOI 10.1007/BF02371251; Carvalho GJ, 1999, AM J OTOL, V20, P87; DORMAN M, 1989, EAR HEARING, V10, P288, DOI 10.1097/00003446-198910000-00003; Dorman MF, 1998, J ACOUST SOC AM, V104, P3583, DOI 10.1121/1.423940; DOWELL RC, 1987, ACTA OTO-LARYNGOL, V104, P439, DOI 10.3109/00016488709128272; FALK M, 1966, CAN J CHEMISTRY, V44, P1699, DOI 10.1139/v66-255; Goyal V, 2012, ANAT REC, V295, P1987, DOI 10.1002/ar.22583; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; IGARASHI M, 1968, J SPEECH HEAR RES, V11, P229, DOI 10.1044/jshr.1102.229; Izzo AD, 2008, BIOPHYS J, V94, P3159, DOI 10.1529/biophysj.107.117150; Izzo AD, 2007, IEEE T BIO-MED ENG, V54, P1108, DOI 10.1109/TBME.2007.892925; Izzo AD, 2006, LASER SURG MED, V38, P745, DOI 10.1002/lsm.20358; Izzo AD, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714296; JACQUES SL, 1992, SURG CLIN N AM, V72, P531; JANSEN ED, 1994, LASER SURG MED, V14, P258, DOI 10.1002/lsm.1900140308; Jenkins MW, 2010, NAT PHOTONICS, V4, P623, DOI 10.1038/NPHOTON.2010.166; JERGER JF, 1957, J ACOUST SOC AM, V29, P357, DOI 10.1121/1.1908889; KAHANA L, 1950, AM J PHYSIOL, V163, P213, DOI 10.1152/ajplegacy.1950.163.2.213; Klinke R, 1999, SCIENCE, V285, P1729, DOI 10.1126/science.285.5434.1729; LEFURGE T, 1991, ANN BIOMED ENG, V19, P197, DOI 10.1007/BF02368469; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Matic AI, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3655590; McIntire CL, 1968, ARCH OTOLARYNGOL, V88, P56; Mens LHM, 2005, OTOL NEUROTOL, V26, P957, DOI 10.1097/01.mao.0000185060.74339.9d; Middlebrooks JC, 2007, JARO-J ASSOC RES OTO, V8, P258, DOI 10.1007/s10162-007-0070-2; Moreno LE, 2011, HEARING RES, V282, P289, DOI 10.1016/j.heares.2011.06.006; OHLEMILLER KK, 1994, HEARING RES, V80, P174, DOI 10.1016/0378-5955(94)90109-0; Rajguru SM, 2011, J PHYSIOL-LONDON, V589, P1283, DOI 10.1113/jphysiol.2010.198333; Rajguru SM, 2010, HEARING RES, V269, P102, DOI 10.1016/j.heares.2010.06.021; Richter CP, 2011, HEARING RES, V278, P43, DOI 10.1016/j.heares.2011.02.003; Richter CP, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056006; Richter CP, 2008, HEARING RES, V242, P42, DOI 10.1016/j.heares.2008.01.011; Richter CP, 2011, LASER PHOTONICS REV, V5, P68, DOI 10.1002/lpor.200900044; Shapiro MG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1742; Snyder RL, 2004, JARO-J ASSOC RES OTO, V5, P305, DOI 10.1007/s10162-004-4026-5; SPOENDLIN H, 1971, ACTA OTO-LARYNGOL, V71, P166, DOI 10.3109/00016487109125346; Teudt IU, 2007, LARYNGOSCOPE, V117, P1641, DOI 10.1097/MLG.0b013e318074ec00; Teudt IU, 2011, IEEE T BIO-MED ENG, V58, P1648, DOI 10.1109/TBME.2011.2108297; THOMPSON G, 1974, J SPEECH HEAR DISORD, V39, P140, DOI 10.1044/jshd.3902.140; THOMSEN S, 1991, PHOTOCHEM PHOTOBIOL, V53, P825, DOI 10.1111/j.1751-1097.1991.tb09897.x; WALSH JT, 1994, LASER SURG MED, V15, P295, DOI 10.1002/lsm.1900150310; Wells J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2121772; Wells J, 2007, BIOPHYS J, V93, P2567, DOI 10.1529/biophysj.107.104786; Wells J, 2007, J NEUROSCI METH, V163, P326, DOI 10.1016/j.jneumeth.2007.03.016; Wells JD, 2011, OPTICAL THERMAL RESPONSE OF LASER-IRRADIATED TISSUE, SECOND EDITION, P915, DOI 10.1007/978-90-481-8831-4_24; Whitlon DS, 2006, NEUROSCIENCE, V138, P653, DOI 10.1016/j.neuroscience.2005.11.030	50	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58189	10.1371/journal.pone.0058189	http://dx.doi.org/10.1371/journal.pone.0058189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505466	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500057
J	Mordel, J; Karnas, D; Pevet, P; Isope, P; Challet, E; Meissl, H				Mordel, Jerome; Karnas, Diana; Pevet, Paul; Isope, Philippe; Challet, Etienne; Meissl, Hilmar			The Output Signal of Purkinje Cells of the Cerebellum and Circadian Rhythmicity	PLOS ONE			English	Article							MOUSE SUPRACHIASMATIC NUCLEUS; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; FOOD-ANTICIPATORY ACTIVITY; SLICE CULTURES; NEURONAL-ACTIVITY; PHASE-SHIFTS; RAT-BRAIN; CORTEX; TIME; INTEGRATION	Measurement of clock gene expression has recently provided evidence that the cerebellum, like the master clock in the SCN, contains a circadian oscillator. The cerebellar oscillator is involved in anticipation of mealtime and possibly resides in Purkinje cells. However, the rhythmic gene expression is likely transduced into a circadian cerebellar output signal to exert an effective control of neuronal brain circuits that are responsible for feeding behavior. Using electrophysiological recordings from acute and organotypic cerebellar slices, we tested the hypothesis whether Purkinje cells transmit a circadian modulated signal to their targets in the brain. Extracellular recordings from brain slices revealed the typical discharge pattern previously described in vivo in single cell recordings showing basically a tonic or a trimodal-like firing pattern. However, in acute sagittal cerebellar slices the average spike rate of randomly selected Purkinje cells did not exhibit significant circadian variations, irrespective of their specific firing pattern. Also, frequency and amplitude of spontaneous inhibitory postsynaptic currents and the amplitude of GABA- and glutamate-evoked currents did not vary with circadian time. Long-term recordings using multielectrode arrays (MEA) allowed to monitor neuronal activity at multiple sites in organotypic cerebellar slices for several days to weeks. With this recording technique we observed oscillations of the firing rate of cerebellar neurons, presumably of Purkinje cells, with a period of about 24 hours which were stable for periods up to three days. The daily renewal of culture medium could induce circadian oscillations of the firing rate of Purkinje cells, a feature that is compatible with the behavior of slave oscillators. However, from the present results it appears that the circadian expression of cerebellar clock genes exerts only a weak influence on the electrical output of cerebellar neurons.	[Mordel, Jerome; Karnas, Diana; Meissl, Hilmar] Max Planck Inst Brain Res, Neuroanat Dept, Frankfurt, Germany; [Mordel, Jerome; Karnas, Diana; Pevet, Paul; Isope, Philippe; Challet, Etienne] CNRS, Inst Cellular & Integrat Neurosci, UPR3212, Strasbourg, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Meissl, H (corresponding author), Max Planck Inst Brain Res, Neuroanat Dept, Frankfurt, Germany.	hilmar.meissl@brain.mpg.de	Challet, Etienne/ABF-7553-2020	Challet, Etienne/0000-0001-9416-9496; Isope, Philippe/0000-0002-0630-5935	Max Planck Society, Munchen; CNRS, Paris; University of Strasbourg; Centre National pour la Recherche Scientifique, Universite de Strasbourg, Agence Nationale pour la Recherche [ANR-09-MNPS-038, ANR-2010-JCJC-1403-1]	Max Planck Society, Munchen(Max Planck Society); CNRS, Paris(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; Centre National pour la Recherche Scientifique, Universite de Strasbourg, Agence Nationale pour la Recherche(French National Research Agency (ANR))	Research carried out within the scope of the Associated European Laboratory "European Laboratory for Circadian Research", LEA CNRS-ULP-MPG (LEA No 367), Strasbourg and Frankfurt/M supported by the Max Planck Society, Munchen, the CNRS, Paris and the University of Strasbourg. The work was also supported by the Centre National pour la Recherche Scientifique, Universite de Strasbourg, Agence Nationale pour la Recherche, Grants ANR-09-MNPS-038 and ANR-2010-JCJC-1403-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Akiyama M, 2001, J NEUROCHEM, V78, P499, DOI 10.1046/j.1471-4159.2001.00452.x; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Buijs RM, 2001, NAT REV NEUROSCI, V2, P521, DOI 10.1038/35081582; Challet E, 2003, BIOL CHEM, V384, P711, DOI 10.1515/BC.2003.079; Challet E, 1996, NEUROSCI LETT, V211, P1, DOI 10.1016/0304-3940(96)12715-4; Choeiri C, 2002, NEUROSCIENCE, V111, P19, DOI 10.1016/S0306-4522(01)00619-4; Davidson AJ, 2000, AM J PHYSIOL-REG I, V278, pR1296, DOI 10.1152/ajpregu.2000.278.5.R1296; de Solages C, 2008, NEURON, V58, P775, DOI 10.1016/j.neuron.2008.05.008; De Vasconcelos AP, 2006, NEUROSCIENCE, V139, P741, DOI 10.1016/j.neuroscience.2005.12.045; Diaz-Munoz M, 2000, AM J PHYSIOL-REG I, V279, pR2048, DOI 10.1152/ajpregu.2000.279.6.R2048; DIETRICHS E, 1994, HISTOL HISTOPATHOL, V9, P603; Dugue GP, 2005, J NEUROSCI, V25, P6490, DOI 10.1523/JNEUROSCI.1500-05.2005; Dupont JL, 2006, CEREBELLUM, V5, P243, DOI 10.1080/14734220600905317; Ebner TJ, 2012, CEREBELLUM, V11, P418, DOI 10.1007/s12311-011-0347-1; Egert U, 2002, EXP BRAIN RES, V142, P268, DOI 10.1007/s00221-001-0932-5; FAUTECK JD, 1994, NEUROSCI LETT, V179, P60, DOI 10.1016/0304-3940(94)90935-0; GAHWILER BH, 1984, EXPERIENTIA, V40, P235, DOI 10.1007/BF01947561; GILLETTE MU, 1986, BRAIN RES, V379, P176, DOI 10.1016/0006-8993(86)90273-8; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; GREEN DJ, 1982, BRAIN RES, V245, P198, DOI 10.1016/0006-8993(82)90361-4; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Hawkes R, 1995, J MOL NEUROSCI, V6, P147, DOI 10.1007/BF02736761; HAWKES R, 1989, BRAIN RES, V476, P279, DOI 10.1016/0006-8993(89)91248-1; Herzog ED, 1997, BRAIN RES, V757, P285, DOI 10.1016/S0006-8993(97)00337-5; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Honma S, 2004, NEUROSCI LETT, V358, P173, DOI 10.1016/j.neulet.2004.01.022; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Ito M, 1984, CEREBELLUM NEURAL CO; Itri J, 2004, J NEUROPHYSIOL, V92, P311, DOI 10.1152/jn.01078.2003; Kessler M, 2008, BRAIN RES, V1218, P54, DOI 10.1016/j.brainres.2008.04.063; Klisch C, 2009, EUR J NEUROSCI, V30, P65, DOI 10.1111/j.1460-9568.2009.06794.x; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Mendoza J, 2010, J NEUROSCI, V30, P1894, DOI 10.1523/JNEUROSCI.5855-09.2010; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Mordel J, 2011, J PHYSIOL-LONDON, V589, P2287, DOI 10.1113/jphysiol.2010.204693; Pekary AE, 2006, BRAIN RES, V1125, P67, DOI 10.1016/j.brainres.2006.10.003; Persengiev SP, 2001, J STEROID BIOCHEM, V77, P151, DOI 10.1016/S0960-0760(01)00037-1; Rath MF, 2012, CHRONOBIOL INT, V29, P1289, DOI 10.3109/07420528.2012.728660; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Carneiro BTS, 2009, CHRONOBIOL INT, V26, P1273, DOI 10.3109/07420520903404480; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Shieh KR, 2003, NEUROSCIENCE, V118, P831, DOI 10.1016/S0306-4522(03)00004-6; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Tousson E, 2004, J NEUROSCI, V24, P2983, DOI 10.1523/JNEUROSCI.5044-03.2004; van Welie I, 2011, CURR OPIN NEUROBIOL, V21, P245, DOI 10.1016/j.conb.2011.01.009; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Zhu JN, 2006, BRAIN RES REV, V52, P93, DOI 10.1016/j.brainresrev.2006.01.003	57	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58457	10.1371/journal.pone.0058457	http://dx.doi.org/10.1371/journal.pone.0058457			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505510	Green Published, gold			2022-12-27	WOS:000318334500086
J	Brox, D; Kiel, A; Worner, SJ; Pernpointner, M; Comba, P; Martin, B; Herten, DP				Brox, Dominik; Kiel, Alexander; Woerner, Svenja Johanna; Pernpointner, Markus; Comba, Peter; Martin, Bodo; Herten, Dirk-Peter			Ensemble and Single-Molecule Studies on Fluorescence Quenching in Transition Metal Bipyridine-Complexes	PLOS ONE			English	Article							SENSORS	Beyond their use in analytical chemistry fluorescent probes continuously gain importance because of recent applications of single-molecule fluorescence spectroscopy to monitor elementary reaction steps. In this context, we characterized quenching of a fluorescent probe by different metal ions with fluorescence spectroscopy in the bulk and at the single-molecule level. We apply a quantitative model to explain deviations from existing standard models for fluorescence quenching. The model is based on a reversible transition from a bright to a dim state upon binding of the metal ion. We use the model to estimate the stability constants of complexes with different metal ions and the change of the relative quantum yield of different reporter dye labels. We found ensemble data to agree widely with results from single-molecule experiments. Our data indicates a mechanism involving close molecular contact of dye and quenching moiety which we also found in molecular dynamics simulations. We close the manuscript with a discussion of possible mechanisms based on Forster distances and electrochemical potentials which renders photo-induced electron transfer to be more likely than Forster resonance energy transfer.	[Brox, Dominik; Kiel, Alexander; Herten, Dirk-Peter] Heidelberg Univ, Heidelberg, Germany; [Brox, Dominik; Kiel, Alexander; Woerner, Svenja Johanna; Pernpointner, Markus; Herten, Dirk-Peter] Heidelberg Univ, Inst Phys Chem, Heidelberg, Germany; [Comba, Peter; Martin, Bodo] Heidelberg Univ, Inst Inorgan Chem, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Herten, DP (corresponding author), Heidelberg Univ, Heidelberg, Germany.	dirk-peter.herten@urz.uni-hd.de	Herten, Dirk-Peter/P-4836-2016; Sauer, Markus/C-4378-2017; Herten, Dirk-Peter/AAT-1458-2020; Comba, Peter/A-2855-2008; Martin, Bodo/C-3507-2014	Herten, Dirk-Peter/0000-0002-3884-0262; Sauer, Markus/0000-0002-1692-3219; Herten, Dirk-Peter/0000-0002-3884-0262; Comba, Peter/0000-0001-7796-3532; 	Deutsche Forschungsgemeinschaft [EXC81, SFB623]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was given by the Deutsche Forschungsgemeinschaft (www.dfg.de) under the grant numbers EXC81 and SFB623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, WEB KNOWLEDGE V 5 3; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; BOAZ H, 1950, J AM CHEM SOC, V72, P3435, DOI 10.1021/ja01164a032; Callan JF, 2005, TETRAHEDRON, V61, P8551, DOI 10.1016/j.tet.2005.05.043; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; HO CN, 1986, TRAC-TREND ANAL CHEM, V5, P37; Jager M, 2009, CHEMPHYSCHEM, V10, P2486, DOI 10.1002/cphc.200900331; Kiel A, 2007, ANGEW CHEM INT EDIT, V46, P3363, DOI 10.1002/anie.200604965; Kovacs J, 2007, SPIE P; PATONAY G, 1986, J PHYS CHEM-US, V90, P1963, DOI 10.1021/j100400a045; Prodi L, 2000, COORDIN CHEM REV, V205, P59, DOI 10.1016/S0010-8545(00)00242-3; RYAN DK, 1982, ANAL CHEM, V54, P986, DOI 10.1021/ac00243a033; Schwering M, 2011, ANGEW CHEM INT EDIT, V50, P2940, DOI 10.1002/anie.201006013; Thomas SW, 2007, CHEM REV, V107, P1339, DOI 10.1021/cr0501339; Valeur B, 2000, COORDIN CHEM REV, V205, P3, DOI 10.1016/S0010-8545(00)00246-0	15	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e58049	10.1371/journal.pone.0058049	http://dx.doi.org/10.1371/journal.pone.0058049			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483966	Green Published, gold, Green Submitted			2022-12-27	WOS:000315634900064
J	Korn, L; Gonen, E; Shaked, Y; Golan, M				Korn, Liat; Gonen, Ester; Shaked, Yael; Golan, Moria			Health Perceptions, Self and Body Image, Physical Activity and Nutrition among Undergraduate Students in Israel	PLOS ONE			English	Article							FRESHMAN WEIGHT-GAIN; COLLEGE-STUDENTS; UNITED-STATES; UNIVERSITY-STUDENTS; GENDER-DIFFERENCES; BEHAVIORS; OBESITY; OVERWEIGHT; EXERCISE; STRESS	Purpose: This study examines health perceptions, self and body image, physical exercise and nutrition among undergraduate students. Methods: A structured, self-reported questionnaire was administered to more than 1500 students at a large academic institute in Israel. The study population was heterogenic in both gender and fields of academic study. Results: High correlations between health perceptions, appropriate nutrition, and positive self and body image were found. The relationships between these variables differed between the subpopulation in the sample and the different genders. Engagement in physical exercise contributed to positive body image and positive health perceptions more than engagement in healthy nutrition. Nutrition students reported higher frequencies of positive health perceptions, positive self and body image and higher engagement in physical exercise in comparison to all other students in the sample. Conclusions: This study suggests, as have many before, that successful health promotion policy should reflect a collectivist rather than an individualist ethos by providing health prerequisites through a public policy of health-promotion, where the academic settings support a healthy lifestyle policy, by increasing availability of a healthy, nutritious and varied menu in the cafeterias, and offering students various activities that enhance healthy eating and exercise. Implications and contribution: This study examined health perceptions, self-image, physical exercise and nutrition among undergraduate students and found high correlations between these topics. Nutrition students reported higher frequencies of positive health perceptions, and positive self and body image and engaged more in physical exercise when compared with all other students in the sample.	[Korn, Liat; Shaked, Yael] Ariel Univ Ctr Samaria, Sch Hlth Sci, Dept Hlth Management, Ariel, Israel; [Gonen, Ester] Ariel Univ Ctr Samaria, Sch Hlth Sci, Dept Nutr, Ariel, Israel; [Gonen, Ester; Golan, Moria] Tel Hai Acad Coll, Dept Nutr, Upper Galilee, Israel	Ariel University; Ariel University; Tel Hai Academy College	Korn, L (corresponding author), Ariel Univ Ctr Samaria, Sch Hlth Sci, Dept Hlth Management, Ariel, Israel.	kornli@zahav.net.il	Korn, Liat/L-1907-2019	Korn, Liat/0000-0001-5688-8983	AUC (Ariel University Center); Tel Hai Academic College, Upper Galilee	AUC (Ariel University Center); Tel Hai Academic College, Upper Galilee	This study was funded by the AUC (Ariel University Center) and Tel Hai Academic College, Upper Galilee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aruguete MS, 2009, EAT BEHAV, V10, P143, DOI 10.1016/j.eatbeh.2009.03.004; Austin SB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-313; Berg KC, 2009, EAT BEHAV, V10, P137, DOI 10.1016/j.eatbeh.2009.03.003; Biro FM, 2006, J ADOLESCENT HEALTH, V39, P501, DOI 10.1016/j.jadohealth.2006.03.010; Center for Disease Control and Prevention- CDC, 2010, VIT SIGNS STAT SPEC; Clarke PJ, 2009, AM J PUBLIC HEALTH, V99, P1893, DOI 10.2105/AJPH.2008.141317; Cluskey M, 2009, J AM DIET ASSOC, V109, P325, DOI 10.1016/j.jada.2008.10.045; COMPAS BE, 1986, AM J COMMUN PSYCHOL, V14, P241, DOI 10.1007/BF00911173; Dahlqvist V, 2008, NURS EDUC TODAY, V28, P476, DOI 10.1016/j.nedt.2007.07.010; DREWNOWSKI A, 1987, PSYCHOSOM MED, V49, P626, DOI 10.1097/00006842-198711000-00008; Greaney ML, 2009, J NUTR EDUC BEHAV, V41, P281, DOI 10.1016/j.jneb.2008.04.354; Grogen S, 1999, BODY IMAGE UNDERSTAN; Jessor R., 2003, SURVEY PERSONAL SOCI; Jessor R, 2010, J RES ADOLESCENCE, V20, P707, DOI 10.1111/j.1532-7795.2010.00656.x; Kicklighter JR, 2010, J AM COLL HEALTH, V59, P98, DOI 10.1080/07448481.2010.483709; Lee RLT, 2005, PUBLIC HEALTH NURS, V22, P209, DOI 10.1111/j.0737-1209.2005.220304.x; Leiker M, 2010, DISS ABSTR INT A, V71, P1239; Levitsky DA, 2004, INT J OBESITY, V28, P1435, DOI 10.1038/sj.ijo.0802776; Liu CH, 2007, PHYSIOL BEHAV, V92, P748, DOI 10.1016/j.physbeh.2007.05.068; Maglione JL, 2009, RES NURS HEALTH, V32, P634, DOI 10.1002/nur.20353; Mareno N., 2010, DISS ABSTR INT B, V70, P4089; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nigg CR, 2010, J OCCUP ENVIRON MED, V52, pS4, DOI 10.1097/JOM.0b013e3181c78a3a; O'Dea JA, 2001, J NUTR EDUC, V33, P332, DOI 10.1016/S1499-4046(06)60355-2; Omigbodun OO, 2006, SOC PSYCH PSYCH EPID, V41, P415, DOI 10.1007/s00127-006-0037-3; Ozier AD, 2008, J AM DIET ASSOC, V108, P49, DOI 10.1016/j.jada.2007.10.011; Pliner P, 2008, PHYSIOL BEHAV, V93, P76, DOI 10.1016/j.physbeh.2007.07.017; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; RYAN RM, 1995, J PERS, V63, P397, DOI 10.1111/j.1467-6494.1995.tb00501.x; Schmalz DL, 2007, J ADOLESCENT HEALTH, V41, P559, DOI 10.1016/j.jadohealth.2007.07.001; Smith BL, 1998, PERCEPT MOTOR SKILL, V86, P723, DOI 10.2466/pms.1998.86.2.723; SONSTROEM RJ, 1989, MED SCI SPORT EXER, V21, P329; Stock C, 2001, HEALTH PROMOT INT, V16, P145, DOI 10.1093/heapro/16.2.145; STRIEGELMOORE RH, 1986, AM PSYCHOL, V41, P246, DOI 10.1037/0003-066X.41.3.246; TIGGEMANN M, 1988, SEX ROLES, V18, P75, DOI 10.1007/BF00288018; Vohs KD, 2001, INT J EAT DISORDER, V29, P280, DOI 10.1002/eat.1019; von Bothmer Margareta I K, 2005, Nurs Health Sci, V7, P107, DOI 10.1111/j.1442-2018.2005.00227.x; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; World Health Organization, 2000, WHO TECHN REP SER, V894	39	43	43	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58543	10.1371/journal.pone.0058543	http://dx.doi.org/10.1371/journal.pone.0058543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	109YM	23516503	Green Published, gold, Green Submitted			2022-12-27	WOS:000316407400038
J	Liu, XH; Yue, LF; Wang, DW; Li, N; Cong, L				Liu, Xiao Hui; Yue, Ling Fen; Wang, Da Wei; Li, Ning; Cong, Lin			Inbreeding Avoidance Drives Consistent Variation of Fine-Scale Genetic Structure Caused by Dispersal in the Seasonal Mating System of Brandt's Voles	PLOS ONE			English	Article							MATE CHOICE; POLYANDRY; EVOLUTION; FEMALES; SUCCESS; RELATEDNESS; PHILOPATRY; PATERNITY; PARENTAGE; SOFTWARE	Inbreeding depression is a major evolutionary and ecological force influencing population dynamics and the evolution of inbreeding-avoidance traits such as mating systems and dispersal. Mating systems and dispersal are fundamental determinants of population genetic structure. Resolving the relationships among genetic structure, seasonal breeding-related mating systems and dispersal will facilitate our understanding of the evolution of inbreeding avoidance. The goals of this study were as follows: (i) to determine whether females actively avoided mating with relatives in a group-living rodent species, Brandt's voles (Lasiopodomys brandtii), by combined analysis of their mating system, dispersal and genetic structure; and (ii) to analyze the relationships among the variation in fine-genetic structure, inbreeding avoidance, season-dependent mating strategies and individual dispersal. Using both individual-and population-level analyses, we found that the majority of Brandt's vole groups consisted of close relatives. However, both group-specific FISs, an inbreeding coefficient that expresses the expected percentage rate of homozygosity arising from a given breeding system, and relatedness of mates showed no sign of inbreeding. Using group pedigrees and paternity analysis, we show that the mating system of Brandt's voles consists of a type of polygyny for males and extra-group polyandry for females, which may decrease inbreeding by increasing the frequency of mating among distantly-related individuals. The consistent variation in within-group relatedness, among-group relatedness and fine-scale genetic structures was mostly due to dispersal, which primarily occurred during the breeding season. Biologically relevant variation in the fine-scale genetic structure suggests that dispersal during the mating season may be a strategy to avoid inbreeding and drive the polygynous and extra-group polyandrous mating system of this species.	[Liu, Xiao Hui; Yue, Ling Fen; Wang, Da Wei; Li, Ning] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Liu, Xiao Hui; Wang, Da Wei; Li, Ning] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Weed & Rodent Biol & Management, Beijing 100193, Peoples R China; [Cong, Lin] Heilongjiang Acad Agr Sci, Inst Plant Protect, Harbin, Heilongjiang Pr, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Heilongjiang Academy of Agricultural Sciences	Liu, XH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	lxiaohui2000@163.com		Liu, Xiao-Hui/0000-0002-8674-1787	National Basic Research Program of China [2007CB109104]	National Basic Research Program of China(National Basic Research Program of China)	This research was funded by the National Basic Research Program of China (project no. 2007CB109104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie EA, 2007, MOL ECOL, V16, P4138, DOI 10.1111/j.1365-294X.2007.03483.x; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Bretman A, 2011, MOL ECOL, V20, P3045, DOI 10.1111/j.1365-294X.2011.05140.x; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Charlesworth B, 1999, GENET RES, V74, P329, DOI 10.1017/S0016672399004152; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chen Guokang, 2003, Acta Theriologica Sinica, V23, P220; Cheptou PO, 2011, NEW PHYTOL, V189, P395, DOI 10.1111/j.1469-8137.2010.03541.x; Cornell SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2873, DOI 10.1098/rspb.2007.0926; Double MC, 2005, EVOLUTION, V59, P625, DOI 10.1111/j.0014-3820.2005.tb01021.x; Duffie CV, 2009, MOL ECOL, V18, P2103, DOI 10.1111/j.1365-294X.2009.04179.x; Evans JP, 2005, EVOLUTION, V59, P106; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faulkes CG, 2001, TRENDS ECOL EVOL, V16, P184, DOI 10.1016/S0169-5347(01)02116-4; Firman RC, 2008, EVOLUTION, V62, P603, DOI 10.1111/j.1558-5646.2007.00307.x; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Honer OP, 2007, NATURE, V448, P798, DOI 10.1038/nature06040; Huo YJ, 2010, BEHAV PROCESS, V84, P745, DOI 10.1016/j.beproc.2010.05.002; Ivy TM, 2005, EVOLUTION, V59, P152, DOI 10.1111/j.0014-3820.2005.tb00902.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Lebigre C, 2010, MOL ECOL, V19, P1929, DOI 10.1111/j.1365-294X.2010.04614.x; Lee JW, 2009, MOL ECOL, V18, P2728, DOI 10.1111/j.1365-294X.2009.04228.x; Lehmann L, 2003, AM NAT, V162, P638, DOI 10.1086/378823; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Moore J, 2007, MOL ECOL, V16, P4421, DOI 10.1111/j.1365-294X.2007.03560.x; Newcomer SD, 1999, P NATL ACAD SCI USA, V96, P10236, DOI 10.1073/pnas.96.18.10236; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Russell DW, 2001, MOL CLONING LAB MANU; Schweizer M, 2007, MOL ECOL, V16, P2463, DOI 10.1111/j.1365-294X.2007.03284.x; SCRIBNER KT, 1993, J MAMMAL, V74, P1026, DOI 10.2307/1382442; Shi D, 1998, ACTA AGRESTIA SINICA, V6, P53; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; Thuman KA, 2005, ANIM BEHAV, V69, P765, DOI 10.1016/j.anbehav.2004.10.003; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Van de Casteele T, 2006, MOL ECOL, V15, P2557, DOI 10.1111/j.1365-294X.2006.02946.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wan Xin-rong, 2007, Shengtaixue Zazhi, V26, P359; Wan Xinrong, 2002, Acta Theriologica Sinica, V22, P116; Wan Xinrong, 2001, Acta Theriologica Sinica, V21, P67; Wan Xinrong, 2006, Acta Theriologica Sinica, V26, P226; [王大伟 Wang Dawei], 2010, [生态学报, Acta Ecologica Sinica], V21, P3562; Wang D, 2007, MOL ECOL NOTES, V7, P671, DOI 10.1111/j.1471-8286.2006.01673.x; Wang D, 2011, CONSERV GENET, V12, P659, DOI 10.1007/s10592-010-0172-y; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wright S, 1931, GENETICS, V16, P0097; Wright S, 1921, GENETICS, V6, P111; Xie Xiao-Ming, 1994, Acta Zoologica Sinica, V40, P262; Yin Feng, 1998, Acta Theriologica Sinica, V18, P277; Yin Feng, 1998, Acta Zoologica Sinica, V44, P162; Yu XD, 2004, J ETHOL, V22, P17, DOI 10.1007/s10164-003-0097-8; Yue LF, 2009, MOL ECOL RESOUR, V9, P1194, DOI 10.1111/j.1755-0998.2009.02601.x; Zeh JA, 1997, P ROY SOC B-BIOL SCI, V264, P69, DOI 10.1098/rspb.1997.0010; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250; Zeh JA, 2008, GENETICA, V134, P45, DOI 10.1007/s10709-007-9192-z; ZHANG J, 1979, Acta Zoologica Sinica, V25, P250; Zhang Jian-Jun, 2006, Acta Zoologica Sinica, V52, P224; Zhang Jian-Jun, 2005, Chinese Journal of Zoology, V40, P19; Zhang Jian-jun, 2007, Shengtaixue Zazhi, V26, P219; Zhong W, 2007, J ARID ENVIRON, V68, P398, DOI 10.1016/j.jaridenv.2006.06.008	67	11	12	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 14	2013	8	3							e58101	10.1371/journal.pone.0058101	http://dx.doi.org/10.1371/journal.pone.0058101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	109YM	23516435	Green Submitted, gold, Green Published			2022-12-27	WOS:000316407400017
J	Millar, K; Lloyd, SM; McLean, JS; Batty, GD; Burns, H; Cavanagh, J; Deans, KA; Ford, I; McConnachie, A; McGinty, A; Mottus, R; Packard, CJ; Sattar, N; Shiels, PG; Velupillai, YN; Tannahill, C				Millar, Keith; Lloyd, Suzanne M.; McLean, Jennifer S.; Batty, G. David; Burns, Harry; Cavanagh, Jonathan; Deans, Kevin A.; Ford, Ian; McConnachie, Alex; McGinty, Agnes; Mottus, Rene; Packard, Chris J.; Sattar, Naveed; Shiels, Paul G.; Velupillai, Yoga N.; Tannahill, Carol			Personality, Socio-Economic Status and Inflammation: Cross-Sectional, Population-Based Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; COGNITIVE-ABILITY; 5-FACTOR MODEL; LIFE-COURSE; HEALTH; MORTALITY; SMOKING; MARKERS; INTELLIGENCE	Background: Associations between socio-economic status (SES), personality and inflammation were examined to determine whether low SES subjects scoring high on neuroticism or hostility might suffer relatively higher levels of inflammation than affluent subjects. Methods: In a cross-sectional design, 666 subjects were recruited from areas of high (most deprived - "MD") and low (least deprived - "LD") deprivation. IL-6, ICAM-1, CRP and fibrinogen were measured along with demographic and health-behaviour variables, and personality traits of neuroticism, extraversion and psychoticism (hostility). Regression models assessed the prediction of inflammation as a function of personality, deprivation and their interaction. Results: Levels of CRP and IL-6 were an increasing function of neuroticism and extraversion only in LD subjects opposite trends were seen in MD subjects. The result was ascribed parsimoniously to an inflammatory ceiling effect or, more speculatively, to SES-related health-behaviour differences. Psychoticism was strongly associated with ICAM-1 in both MD and LD subjects. Conclusions: The association between neuroticism, CRP and IL-6 may be reduced in MD subjects confirming speculation that the association differs across population sub-groups. The association between psychoticism and ICAM-1 supports evidence that hostility has adverse effects upon the endothelium, with consequences for cardiovascular health. Health interventions may be more effective by accounting for personality- related effects upon biological processes.	[Millar, Keith; Cavanagh, Jonathan] Univ Glasgow, Inst Mental Hlth & Wellbeing, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Lloyd, Suzanne M.; Ford, Ian; McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [McLean, Jennifer S.; Tannahill, Carol] Glasgow Ctr Populat Hlth, Glasgow, Lanark, Scotland; [Batty, G. David] MRC Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Batty, G. David] UCL, Dept Epidemiol & Publ Hlth, London, England; [Burns, Harry] Scottish Govt, Edinburgh, Midlothian, Scotland; [Deans, Kevin A.] Glasgow Royal Infirm, Dept Vasc Biochem, NHS Greater Glasgow & Clyde, Glasgow G4 0SF, Lanark, Scotland; [Deans, Kevin A.] Aberdeen Royal Infirm, Dept Clin Biochem, NHS Grampian, Aberdeen, Scotland; [McGinty, Agnes; Packard, Chris J.] Univ Glasgow, Western Infirm, Glasgow Clin Res Facil, Glasgow G11 6NT, Lanark, Scotland; [Mottus, Rene] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Sattar, Naveed] Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Shiels, Paul G.] Univ Glasgow, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Velupillai, Yoga N.] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland	University of Glasgow; University of Glasgow; University of London; University College London; University of Glasgow; University of Aberdeen; University of Glasgow; University of Edinburgh; University of Glasgow; University of Glasgow; University of Limerick	McLean, JS (corresponding author), Glasgow Ctr Populat Hlth, Glasgow, Lanark, Scotland.	Jennifer.mclean@drs.glasgow.gov.uk	Ford, Ian/ABE-6145-2020; Lloyd, Suzanne/H-7424-2013; Batty, GD/Y-4401-2018	Batty, GD/0000-0003-1822-5753; Shiels, Paul/0000-0002-7577-9843	Glasgow Centre for Population Health; Scottish Government; Medical Research Council [MR/K026992/1] Funding Source: researchfish	Glasgow Centre for Population Health; Scottish Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Glasgow Centre for Population Health which is a partnership between National Health Service (NHS) Greater Glasgow and Clyde, Glasgow City Council and the University of Glasgow, supported by the Scottish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 1997, ADDICTION, V92, P1023, DOI 10.1111/j.1360-0443.1997.tb02982.x; Batty GD, 2010, EUR J CARDIOV PREV R, V17, P24, DOI 10.1097/HJR.0b013e328321311b; Batty GD, 2009, EPIDEMIOLOGY, V20, P100, DOI 10.1097/EDE.0b013e31818ba076; Berlin I, 2003, ADDICTION, V98, P1575, DOI 10.1046/j.1360-0443.2003.00523.x; Bosma H, 1999, BRIT MED J, V318, P18; Bright P, 2002, J INT NEUROPSYCH SOC, V8, P847, DOI 10.1017/S1355617702860131; Chapman BP, 2011, BRAIN BEHAV IMMUN, V25, P667, DOI 10.1016/j.bbi.2011.01.003; Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323; Chapman BP, 2009, BRAIN BEHAV IMMUN, V23, P636, DOI 10.1016/j.bbi.2008.12.009; Costa PT, 2007, REVISED NEO PERSONAL; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; De Moor MHM, 2006, PREV MED, V42, P273, DOI 10.1016/j.ypmed.2005.12.002; Deans KA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4170; Eysenck HJ., 1993, MANUAL EYSENCK PERSO, DOI 10.1037/t05461-000; Goldberg D, 1978, MANUAL GEN HLTH QUES; Goodman A, 2008, EUR J EPIDEMIOL, V23, P379, DOI 10.1007/s10654-008-9248-0; Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x; Harper S, 2002, INT J EPIDEMIOL, V31, P395, DOI 10.1093/ije/31.2.395; Hart CL, 2004, SOC SCI MED, V59, P2131, DOI 10.1016/j.socscimed.2004.03.016; Henningsson S, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-16; Janicki-Deverts D, 2010, BRAIN BEHAV IMMUN, V24, P58, DOI 10.1016/j.bbi.2009.07.009; Jonassaint CR, 2011, INT J BEHAV MED, V18, P13, DOI 10.1007/s12529-009-9069-x; Jousilahti P, 2003, J EPIDEMIOL COMMUN H, V57, P730, DOI 10.1136/jech.57.9.730; Kop WJ, 2003, BRAIN BEHAV IMMUN, V17, P233, DOI 10.1016/S0889-1591(03)00051-5; Korten AE, 1999, J EPIDEMIOL COMMUN H, V53, P83, DOI 10.1136/jech.53.2.83; Kubzansky LD, 1999, ANN BEHAV MED, V21, P330, DOI 10.1007/BF02895966; Lubbock LA, 2005, AM J CARDIOL, V96, P1506, DOI 10.1016/j.amjcard.2005.07.059; Marsland AL, 2008, BRAIN BEHAV IMMUN, V22, P753, DOI 10.1016/j.bbi.2007.11.008; Miller GE, 2003, J BEHAV MED, V26, P501, DOI 10.1023/A:1026273817984; Mottus R, 2013, PSYCHOSOM MED, V75, P11, DOI 10.1097/PSY.0b013e31827576cc; Mroczek DK, 2007, PSYCHOL SCI, V18, P371, DOI 10.1111/j.1467-9280.2007.01907.x; Nabi H, 2008, INT J EPIDEMIOL, V37, P386, DOI 10.1093/ije/dyn013; Nazmi A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-212; Nelson H., 1991, NATL ADULT READING T; Packard CJ, 2012, J PUBLIC HEALTH-UK, V34, P615, DOI 10.1093/pubmed/fds030; PARKES KR, 1984, PSYCHOL MED, V14, P825, DOI 10.1017/S0033291700019796; Pollitt RA, 2008, J EPIDEMIOL COMMUN H, V62, P484, DOI 10.1136/jech.2006.054106; Raynor DA, 2009, J AM COLL HEALTH, V58, P73, DOI 10.3200/JACH.58.1.73-82; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Roberts BW, 2009, PSYCHOL SCI, V20, P553, DOI 10.1111/j.1467-9280.2009.02339.x; Scottish Government, 2004, SCOTT IND MULT DEPR; Shipley BA, 2007, PSYCHOSOM MED, V69, P923, DOI 10.1097/PSY.0b013e31815abf83; Singh-Manoux A, 2005, AM J EPIDEMIOL, V161, P831, DOI 10.1093/aje/kwi109; Sutin AR, 2010, PSYCHOL MED, V40, P1485, DOI 10.1017/S0033291709992029; Terracciano A, 2004, ADDICTION, V99, P472, DOI 10.1111/j.1360-0443.2004.00687.x; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; Velupillai YN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-126; Weiss A, 2005, PSYCHOSOM MED, V67, P724, DOI 10.1097/01.psy.0000181272.58103.18; Yeung RR, 1997, PERS INDIV DIFFER, V22, P47, DOI 10.1016/S0191-8869(96)00158-4	49	28	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58256	10.1371/journal.pone.0058256	http://dx.doi.org/10.1371/journal.pone.0058256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516457	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000316849200051
J	Oei, AC; Patterson, MD				Oei, Adam C.; Patterson, Michael D.			Enhancing Cognition with Video Games: A Multiple Game Training Study	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; NEURAL BASIS; VISUAL-SEARCH; TASK; PERFORMANCE; EXPERIENCE; ATTENTION; INHIBITION; EFFICIENCY; PLAYERS	Background: Previous evidence points to a causal link between playing action video games and enhanced cognition and perception. However, benefits of playing other video games are under-investigated. We examined whether playing non-action games also improves cognition. Hence, we compared transfer effects of an action and other non-action types that required different cognitive demands. Methodology/Principal Findings: We instructed 5 groups of non-gamer participants to play one game each on a mobile device (iPhone/iPod Touch) for one hour a day/five days a week over four weeks (20 hours). Games included action, spatial memory, match-3, hidden- object, and an agent-based life simulation. Participants performed four behavioral tasks before and after video game training to assess for transfer effects. Tasks included an attentional blink task, a spatial memory and visual search dual task, a visual filter memory task to assess for multiple object tracking and cognitive control, as well as a complex verbal span task. Action game playing eliminated attentional blink and improved cognitive control and multiple-object tracking. Match-3, spatial memory and hidden object games improved visual search performance while the latter two also improved spatial working memory. Complex verbal span improved after match-3 and action game training. Conclusion/Significance: Cognitive improvements were not limited to action game training alone and different games enhanced different aspects of cognition. We conclude that training specific cognitive abilities frequently in a video game improves performance in tasks that share common underlying demands. Overall, these results suggest that many video game-related cognitive improvements may not be due to training of general broad cognitive systems such as executive attentional control, but instead due to frequent utilization of specific cognitive processes during game play. Thus, many video game training related improvements to cognition may be attributed to near-transfer effects.	[Oei, Adam C.; Patterson, Michael D.] Nanyang Technol Univ, Div Psychol, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Oei, AC (corresponding author), Nanyang Technol Univ, Div Psychol, Singapore 639798, Singapore.	cmoei1@e.ntu.edu.sg	Patterson, Michael/C-1560-2010	Patterson, Michael/0000-0001-9901-8822; Oei, Adam/0000-0003-0922-605X	DSO National Laboratories	DSO National Laboratories	This research was supported by a DSO National Laboratories (http://www.dso.org.sg) grant to Michael D. Patterson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Anderson CA, 2000, J PERS SOC PSYCHOL, V78, P772, DOI 10.1037//0022-3514.78.4.772; Awh E, 1998, J EXP PSYCHOL HUMAN, V24, P780, DOI 10.1037/0096-1523.24.3.780; Baluchg F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009127; Barrouillet P, 2004, J EXP PSYCHOL GEN, V133, P83, DOI 10.1037/0096-3445.133.1.83; Basak C, 2008, PSYCHOL AGING, V23, P765, DOI 10.1037/a0013494; Bavelier D, 2012, VISION RES, V61, P132, DOI 10.1016/j.visres.2011.08.007; Blumen HM, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00145; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; Cain MS, 2012, ATTEN PERCEPT PSYCHO, V74, P641, DOI 10.3758/s13414-012-0284-1; Castel AD, 2005, ACTA PSYCHOL, V119, P217, DOI 10.1016/j.actpsy.2005.02.004; Chisholm JD, 2010, ATTEN PERCEPT PSYCHO, V72, P667; Chisholm JD, 2012, ATTEN PERCEPT PSYCHO, V74, P257, DOI 10.3758/s13414-011-0253-0; Colzato LS, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00008; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Dye MWG, 2009, NEUROPSYCHOLOGIA, V47, P1780, DOI 10.1016/j.neuropsychologia.2009.02.002; Enns J. T., 2001, LIMITS ATTENTION TEM, P65, DOI DOI 10.1093/ACPROF:OSO/9780198505150.003.0004; Fahle M, 1996, CURR BIOL, V6, P292, DOI 10.1016/S0960-9822(02)00479-7; Faraco CC, 2011, NEUROIMAGE, V55, P773, DOI 10.1016/j.neuroimage.2010.12.033; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; Green CS, 2007, PSYCHOL SCI, V18, P88, DOI 10.1111/j.1467-9280.2007.01853.x; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green CS, 2012, CURR BIOL, V22, pR197, DOI 10.1016/j.cub.2012.02.012; Green CS, 2006, J EXP PSYCHOL HUMAN, V32, P1465, DOI 10.1037/0096-1523.32.6.1465; Green CS, 2012, COMPUT HUM BEHAV, V28, P984, DOI 10.1016/j.chb.2011.12.020; Green CS, 2010, TOP COGN SCI, V2, P202, DOI 10.1111/j.1756-8765.2009.01054.x; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Kawahara JI, 2003, PERCEPT PSYCHOPHYS, V65, P339, DOI 10.3758/BF03194565; KLEIN R, 1988, NATURE, V334, P430, DOI 10.1038/334430a0; Kristjansson A, 2000, PSYCHOL SCI, V11, P328, DOI 10.1111/1467-9280.00265; Li RJ, 2010, J VISION, V10, DOI 10.1167/10.14.33; Li RJ, 2009, NAT NEUROSCI, V12, P549, DOI 10.1038/nn.2296; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Mishra J, 2011, J NEUROSCI, V31, P992, DOI 10.1523/JNEUROSCI.4834-10.2011; Oh SH, 2004, PSYCHON B REV, V11, P275, DOI 10.3758/BF03196570; Okagaki Lynn, 1994, J APPL DEV PSYCHOL, V15, P33, DOI DOI 10.1016/0193-3973(94)90005-1; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; Przybylski AK, 2009, PERS SOC PSYCHOL B, V35, P243, DOI 10.1177/0146167208327216; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Smith EE, 2001, P NATL ACAD SCI USA, V98, P2095, DOI 10.1073/pnas.98.4.2095; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; TANNER WP, 1954, PSYCHOL REV, V61, P401, DOI 10.1037/h0058700; Thorndike EL, 1901, PSYCHOL REV, V8, P247, DOI 10.1037/h0071363; TURNER ML, 1989, J MEM LANG, V28, P127, DOI 10.1016/0749-596X(89)90040-5; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Wang XW, 2006, ARCH PEDIAT ADOL MED, V160, P411, DOI 10.1001/archpedi.160.4.411; Woodman GF, 2004, PSYCHON B REV, V11, P269, DOI 10.3758/BF03196569	49	181	189	10	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58546	10.1371/journal.pone.0058546	http://dx.doi.org/10.1371/journal.pone.0058546			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23516504	Green Published, gold			2022-12-27	WOS:000316849200083
J	Tian, L; Zhang, Y; Chen, Y; Cai, M; Dong, HL; Xiong, LZ				Tian, Li; Zhang, Yang; Chen, Yu; Cai, Min; Dong, Hailong; Xiong, Lize			EMMPRIN Is an Independent Negative Prognostic Factor for Patients with Astrocytic Glioma	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; INCREASES CHEMOSENSITIVITY; CD147 OVEREXPRESSION; TUMOR PROGRESSION; POOR-PROGNOSIS; EXPRESSION; CANCER; INDUCER; CLASSIFICATION; INVASION	Extracellular matrix metalloproteinase inducer (EMMPRIN), also known as CD147, is a member of the immunoglobulin superfamily that is present on the surface of tumor cells and stimulates adjacent fibroblasts to produce matrix metalloproteinases (MMPs). It has been proved to be associated with tumor invasion and metastasis in various human malignancies. In our study, the protein expression level of EMMPRIN in 306 cases of astrocytic glioma is investigated by immunohistochemistry assay. Statistical analysis was utilized to evaluate the association of EMMPRIN with clinicopathological characteristics and prognosis of patients. It was proved that EMMPRIN protein expression was increased in glioma compared with that in normal brain tissue. Moreover, EMMPRIN immunohistochemical staining was correlated with WHO grade and Karnofsky performance score for strong positive EMMPRIN staining is more frequently detected in glioma of advanced grade or low KPS score. It is also demonstrated that EMMPRIN could be an independent negative prognostic factor in glioma for patients with glioma of strong EMMPRIN staining tend to have high risk of death. These results proved that EMMPRIN is associated with prognosis of glioma, which may also suggest the potential role of EMMPRIN in glioma management.	[Tian, Li; Chen, Yu; Cai, Min; Dong, Hailong; Xiong, Lize] Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China; [Zhang, Yang] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped Surg, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Dong, HL (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Anesthesiol, Xian 710032, Shaanxi, Peoples R China.	donghl@fmmu.edu.cn; mzkxlz@126.com		Dong, Hailong/0000-0001-8984-9067				Afonso J, 2011, EJSO-EUR J SURG ONC, V37, P811, DOI 10.1016/j.ejso.2011.06.006; Chu TW, 2011, PATHOL ONCOL RES, V17, P705, DOI 10.1007/s12253-011-9373-z; Curran S, 2000, EUR J CANCER, V36, P1621, DOI 10.1016/S0959-8049(00)00156-8; Ducray F, 2011, EXPERT REV ANTICANC, V11, P781, DOI [10.1586/era.10.202, 10.1586/ERA.10.202]; Fan YQ, 2011, INT J MOL MED, V27, P607, DOI 10.3892/ijmm.2011.621; Fuller GN, 2007, BRAIN PATHOL, V17, P304, DOI 10.1111/j.1750-3639.2007.00084.x; Gabison EE, 2005, AM J PATHOL, V166, P209, DOI 10.1016/S0002-9440(10)62245-6; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Gu J, 2009, EUR J PEDIATR, V168, P705, DOI 10.1007/s00431-008-0828-5; Gupta K, 2012, J CANCER RES CLIN, V138, P1971, DOI 10.1007/s00432-012-1323-y; Huet E, 2008, CONNECT TISSUE RES, V49, P175, DOI 10.1080/03008200802151722; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia L, 2009, ANN HEMATOL, V88, P753, DOI 10.1007/s00277-008-0678-2; Kanekura T, 2010, J DERMATOL SCI, V57, P149, DOI 10.1016/j.jdermsci.2009.12.008; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kuang YH, 2009, CANCER LETT, V276, P189, DOI 10.1016/j.canlet.2008.11.010; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Liu FF, 2010, BREAST CANCER RES TR, V124, P677, DOI 10.1007/s10549-010-0790-6; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Pan YQ, 2012, ONCOL REP, V27, P2003, DOI 10.3892/or.2012.1729; Pertega-Gomes N, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-312; Piao SL, 2012, J CANCER RES CLIN, V138, P627, DOI 10.1007/s00432-011-1142-6; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Sameshima T, 2000, INT J CANCER, V88, P21, DOI 10.1002/1097-0215(20001001)88:1<21::AID-IJC4>3.0.CO;2-S; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stenzinger A, 2012, HUM PATHOL, V43, P1471, DOI 10.1016/j.humpath.2011.10.023; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tang Y, 2005, CANCER RES, V65, P3193, DOI 10.1158/0008-5472.CAN-04-3605; Tang Y, 2004, MOL CANCER RES, V2, P73; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P157; Yu XL, 2008, J BIOL CHEM, V283, P18056, DOI 10.1074/jbc.M802694200; Zhong X, 2012, ANN SURG ONCOL	34	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58069	10.1371/journal.pone.0058069	http://dx.doi.org/10.1371/journal.pone.0058069			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	23516431	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200031
J	Soderstjerna, E; Johansson, F; Klefbohm, B; Johansson, UE				Soderstjerna, Erika; Johansson, Fredrik; Klefbohm, Birgitta; Johansson, Ulrica Englund			Gold- and Silver Nanoparticles Affect the Growth Characteristics of Human Embryonic Neural Precursor Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; STEM-CELLS; IN-VITRO; PROGENITOR CELLS; COLLOIDAL GOLD; DRUG-DELIVERY; TOXICITY; PROTEIN; BRAIN; SIZE	Rapid development of nanotechnologies and their applications in clinical research have raised concerns about the adverse effects of nanoparticles (NPs) on human health and environment. NPs can be directly taken up by organs exposed, but also translocated to secondary organs, such as the central nervous system (CNS) after systemic-or subcutaneous administration, or via the olfactory system. The CNS is particularly vulnerable during development and recent reports describe transport of NPs across the placenta and even into brain tissue using in vitro and in vivo experimental systems. Here, we investigated whether well-characterized commercial 20 and 80 nm Au- and AgNPs have an effect on human embryonic neural precursor cell (HNPC) growth. After two weeks of NP exposure, uptake of NPs, morphological features and the amount of viable and dead cells, proliferative cells (Ki67 immunostaining) and apoptotic cells (TUNEL assay), respectively, were studied. We demonstrate uptake of both 20 and 80 nm Au- and AgNPs respectively, by HNPCs during proliferation. A significant effect on the sphere size-and morphology was found for all cultures exposed to Au- and AgNPs. AgNPs of both sizes caused a significant increase in numbers of proliferating and apoptotic HNPCs. In contrast, only the highest dose of 20 nm AuNPs significantly affected proliferation, whereas no effect was seen on apoptotic cell death. Our data demonstrates that both Au- and AgNPs interfere with the growth profile of HNPCs, indicating the need of further detailed studies on the adverse effects of NPs on the developing CNS.	[Soderstjerna, Erika; Klefbohm, Birgitta; Johansson, Ulrica Englund] Lund Univ, Dept Ophthalmol, Inst Clin Sci, Lund, Sweden; [Johansson, Fredrik] Lund Univ, Sect Funct Zool, Dept Biol, Lund, Sweden	Lund University; Lund University	Johansson, UE (corresponding author), Lund Univ, Dept Ophthalmol, Inst Clin Sci, Lund, Sweden.	ulrica.englund_johansson@med.lu.se	Johansson, Fredrik/M-4554-2014	Johansson, Fredrik/0000-0002-7813-8822	Faculties of Medicine and Science, Lund University; Crafoord Foundation; Per Westling Foundation; Crown Princess Margaretas Foundation	Faculties of Medicine and Science, Lund University; Crafoord Foundation; Per Westling Foundation; Crown Princess Margaretas Foundation	This work was supported by the Faculties of Medicine and Science, Lund University and the Crafoord-, Per Westling- Crown Princess Margaretas Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Alvarez-Buylla A, 2000, Prog Brain Res, V127, P1; Arora S, 2008, TOXICOL LETT, V179, P93, DOI 10.1016/j.toxlet.2008.04.009; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Blum JL, 2012, TOXICOL SCI, V126, P478, DOI 10.1093/toxsci/kfs008; Caldwell MA, 2001, NAT BIOTECHNOL, V19, P475, DOI 10.1038/88158; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032254; Chen DF, 2007, BIOMED MATER, V2, pS126, DOI 10.1088/1748-6041/2/3/S08; Chen JM, 2006, TOXICOLOGY, V222, P195, DOI 10.1016/j.tox.2006.02.016; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cortese-Krott MM, 2009, FREE RADICAL BIO MED, V47, P1570, DOI 10.1016/j.freeradbiomed.2009.08.023; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Dziendzikowska K, 2012, J APPL TOXICOL, V32, P920, DOI 10.1002/jat.2758; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; Ema M, 2010, REPROD TOXICOL, V30, P343, DOI 10.1016/j.reprotox.2010.06.002; Englund U, 2002, EXP NEUROL, V173, P1, DOI 10.1006/exnr.2001.7750; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; FITZGERALD WF, 1991, ENVIRON HEALTH PERSP, V96, P159, DOI 10.2307/3431225; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gramowski A, 2010, ENVIRON HEALTH PERSP, V118, P1363, DOI 10.1289/ehp.0901661; Greulich C, 2009, LANGENBECK ARCH SURG, V394, P495, DOI 10.1007/s00423-009-0472-1; Haase A, 2012, TOXICOL SCI, V126, P457, DOI 10.1093/toxsci/kfs003; Hackenberg S, 2011, TOXICOL LETT, V201, P27, DOI 10.1016/j.toxlet.2010.12.001; HORISBERGER M, 1977, J HISTOCHEM CYTOCHEM, V25, P295, DOI 10.1177/25.4.323352; Hussain SM, 2006, TOXICOL SCI, V92, P456, DOI 10.1093/toxsci/kfl020; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Jain KK, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-83; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Ji JH, 2007, INHAL TOXICOL, V19, P857, DOI 10.1080/08958370701432108; Khlebtsov N, 2011, CHEM SOC REV, V40, P1647, DOI 10.1039/c0cs00018c; Kim JH, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/50/505101; Kreyling WG, 2006, J AEROSOL MED, V19, P74, DOI 10.1089/jam.2006.19.74; Kreyling Wolfgang G, 2009, Inhal Toxicol, V21 Suppl 1, P55, DOI 10.1080/08958370902942517; Lima FB, 2010, MOL PSYCHIATR, V15, P657, DOI 10.1038/mp.2009.97; Liu ZW, 2011, ENVIRON TOXICOL, V26, P552, DOI 10.1002/tox.20586; Liu ZW, 2009, TOXICOLOGY, V264, P179, DOI 10.1016/j.tox.2009.08.005; Liu ZP, 2001, J HISTOCHEM CYTOCHEM, V49, P957, DOI 10.1177/002215540104900804; Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P6893, DOI 10.1021/es300839e; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Menezes V, 2011, CURR PHARM BIOTECHNO, V12, P731, DOI 10.2174/138920111795471010; Moors M, 2009, ENVIRON HEALTH PERSP, V117, P1131, DOI 10.1289/ehp.0800207; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; Oberdorster G, 2009, J NANOSCI NANOTECHNO, V9, P4996, DOI 10.1166/jnn.2009.GR02; Park MVDZ, 2009, TOXICOL APPL PHARM, V240, P108, DOI 10.1016/j.taap.2009.07.019; Patra HK, 2007, NANOMED-NANOTECHNOL, V3, P111, DOI 10.1016/j.nano.2007.03.005; Pernodet N, 2006, SMALL, V2, P766, DOI 10.1002/smll.200500492; Prediger RDS, 2012, NEUROTOX RES, V21, P90, DOI 10.1007/s12640-011-9281-8; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rahman MF, 2009, TOXICOL LETT, V187, P15, DOI 10.1016/j.toxlet.2009.01.020; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ricles LM, 2011, INT J NANOMED, V6, P407, DOI 10.2147/IJN.S16354; Rivas-Arancibia S, 2010, TOXICOL SCI, V113, P187, DOI 10.1093/toxsci/kfp252; Sadauskas Evaldas, 2007, Part Fibre Toxicol, V4, P10, DOI 10.1186/1743-8977-4-10; Saunders M, 2009, WIRES NANOMED NANOBI, V1, P671, DOI 10.1002/wnan.53; Schleh C, 2012, NANOTOXICOLOGY, V6, P36, DOI 10.3109/17435390.2011.552811; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Sen E, 2011, ASN NEURO, V3, DOI 10.1042/AN20100029; Sintubin L, 2012, BIOTECHNOL BIOENG, V109, P2422, DOI 10.1002/bit.24570; Skogh C, 2001, MOL CELL NEUROSCI, V17, P811, DOI 10.1006/mcne.2001.0973; Soenen SJ, 2012, ACS NANO, V6, P5767, DOI 10.1021/nn301714n; Sonavane G, 2008, COLLOID SURFACE B, V66, P274, DOI 10.1016/j.colsurfb.2008.07.004; Tang JL, 2009, J NANOSCI NANOTECHNO, V9, P4924, DOI 10.1166/jnn.2009.1269; Tarantola M, 2011, NANOTOXICOLOGY, V5, P254, DOI 10.3109/17435390.2010.528847; Teow Y, 2011, CHEM COMMUN, V47, P7025, DOI 10.1039/c0cc05271j; Wang JY, 2009, NEUROTOXICOLOGY, V30, P926, DOI 10.1016/j.neuro.2009.09.005; Wick P, 2010, ENVIRON HEALTH PERSP, V118, P432, DOI 10.1289/ehp.0901200; Yamada KM, 2002, NAT CELL BIOL, V4, pE75, DOI 10.1038/ncb0402-e75; Yamashita K, 2011, NAT NANOTECHNOL, V6, P321, DOI [10.1038/nnano.2011.41, 10.1038/NNANO.2011.41]; Zhang XD, 2010, INT J NANOMED, V5, P771, DOI 10.2147/IJN.S8428; Zhu AJ, 1999, P NATL ACAD SCI USA, V96, P6728, DOI 10.1073/pnas.96.12.6728	80	62	63	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 11	2013	8	3							e58211	10.1371/journal.pone.0058211	http://dx.doi.org/10.1371/journal.pone.0058211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WI	23505470	Green Published, Green Submitted, gold			2022-12-27	WOS:000316251100035
J	Castillo, V; Chiti, F; Ventura, S				Castillo, Virginia; Chiti, Fabrizio; Ventura, Salvador			The N-terminal Helix Controls the Transition between the Soluble and Amyloid States of an FF Domain	PLOS ONE			English	Article							ON-PATHWAY INTERMEDIATE; PROTEIN AGGREGATION; RELAXATION DISPERSION; FOLDING INTERMEDIATE; SEQUENCE DETERMINANTS; ATOMIC-RESOLUTION; C-PEPTIDE; PREDICTION; FIBRILS; PROPENSITY	Background: Protein aggregation is linked to the onset of an increasing number of human nonneuropathic (either localized or systemic) and neurodegenerative disorders. In particular, misfolding of native alpha-helical structures and their self-assembly into nonnative intermolecular beta-sheets has been proposed to trigger amyloid fibril formation in Alzheimer's and Parkinson's diseases. Methods: Here, we use a battery of biophysical techniques to elucidate the conformational conversion of native alpha-helices into amyloid fibrils using an all-alpha FF domain as a model system. Results: We show that under mild denaturing conditions at low pH this FF domain self-assembles into amyloid fibrils. Theoretical and experimental dissection of the secondary structure elements in this domain indicates that the helix 1 at the N-terminus has both the highest alpha-helical and amyloid propensities, controlling the transition between soluble and aggregated states of the protein. Conclusions: The data illustrates the overlap between the propensity to form native alpha-helices and amyloid structures in protein segments. Significance: The results presented contribute to explain why proteins cannot avoid the presence of aggregation-prone regions and indeed use stable alpha-helices as a strategy to neutralize such potentially deleterious stretches.	[Castillo, Virginia; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol Biomed, Bellaterra, Spain; [Castillo, Virginia; Ventura, Salvador] Univ Autonoma Barcelona, Fac Biociencies, Dept Bioquim Biol Mol, Bellaterra, Spain; [Chiti, Fabrizio] Univ Florence, Dipartimento Sci Biochim, Florence, Italy	Autonomous University of Barcelona; Autonomous University of Barcelona; University of Florence	Ventura, S (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol Biomed, Bellaterra, Spain.	salvador.ventura@uab.es	Ventura, Salvador/C-7021-2008; Ventura, Salvador/AAY-3170-2021	Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351	Ministerio de Ciencia e Innovacion (MCISpain) [BFU2010-14901]; AGAUR (Generalitat de Catalunya) [2009-SGR 760]; Ministerio de Educacion-Spain [FPU AP 2007-02849]; ICREA ACADEMIA award	Ministerio de Ciencia e Innovacion (MCISpain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AGAUR (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Ministerio de Educacion-Spain; ICREA ACADEMIA award(ICREA)	This work was supported by BFU2010-14901 from Ministerio de Ciencia e Innovacion (MCISpain) and 2009-SGR 760 from AGAUR (Generalitat de Catalunya). V.C. is beneficiary of predoctoral FPU AP 2007-02849 fellowship from the Ministerio de Educacion-Spain. S.V. has been granted an ICREA ACADEMIA award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JS, 1995, BIOCHEMISTRY-US, V34, P984, DOI 10.1021/bi00003a033; Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; Apostolidou M, 2008, J BIOL CHEM, V283, P17205, DOI 10.1074/jbc.M801383200; Baldwin RL, 2012, CURR OPIN STRUCT BIO; Barette J, 2012, J PHYS CHEM B, V116, P6637, DOI 10.1021/jp209974f; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bedford MT, 1999, TRENDS BIOCHEM SCI, V24, P264, DOI 10.1016/S0968-0004(99)01417-6; Belli M, 2011, EMBO REP, V12, P657, DOI 10.1038/embor.2011.116; BIERZYNSKI A, 1982, P NATL ACAD SCI-BIOL, V79, P2470, DOI 10.1073/pnas.79.8.2470; Bonet R, 2008, PROTEINS, V73, P1001, DOI 10.1002/prot.22127; Bryan AW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000333; Canet D, 2002, NAT STRUCT BIOL, V9, P308, DOI 10.1038/nsb768; Castillo V, 2011, BIOTECHNOL J, V6, P674, DOI 10.1002/biot.201000331; Castillo V, 2010, PROTEOMICS, V10, P4172, DOI 10.1002/pmic.201000260; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Daggett V, 2009, CURR OPIN STRUC BIOL, V19, P1, DOI 10.1016/j.sbi.2009.01.006; de Groot NS, 2009, TRENDS BIOCHEM SCI, V34, P408, DOI 10.1016/j.tibs.2009.03.009; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Frousios KK, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-44; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Gasch A, 2006, J BIOL CHEM, V281, P356, DOI 10.1074/jbc.M508047200; HAMADA D, 1995, J MOL BIOL, V254, P737, DOI 10.1006/jmbi.1995.0651; Jahn TR, 2005, FEBS J, V272, P5962, DOI 10.1111/j.1742-4658.2005.05021.x; JASANOFF A, 1994, BIOCHEMISTRY-US, V33, P2129, DOI 10.1021/bi00174a020; Jemth P, 2005, J MOL BIOL, V350, P363, DOI 10.1016/j.jmb.2005.04.067; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; Jemth P, 2008, PROTEIN ENG DES SEL, V21, P207, DOI 10.1093/protein/gzm091; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Khurana R, 2001, BIOCHEMISTRY-US, V40, P3525, DOI 10.1021/bi001782b; Korzhnev DM, 2012, P NATL ACAD SCI US; Korzhnev DM, 2007, J MOL BIOL, V372, P497, DOI 10.1016/j.jmb.2007.06.012; Korzhnev DM, 2011, J AM CHEM SOC, V133, P10974, DOI 10.1021/ja203686t; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; MERZ PA, 1983, ACTA NEUROPATHOL, V60, P113, DOI 10.1007/BF00685355; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Nerelius C, 2009, P NATL ACAD SCI USA, V106, P9191, DOI 10.1073/pnas.0810364106; Niraula TN, 2002, J MOL BIOL, V320, P333, DOI 10.1016/S0022-2836(02)00425-4; SEGAWA S, 1991, BIOPOLYMERS, V31, P497, DOI 10.1002/bip.360310505; SHOEMAKER KR, 1985, P NATL ACAD SCI USA, V82, P2349, DOI 10.1073/pnas.82.8.2349; Sirangelo I, 2002, J BIOL CHEM, V277, P45887, DOI 10.1074/jbc.M207659200; Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004; Taddei N, 2001, J BIOL CHEM, V276, P37149, DOI 10.1074/jbc.M105720200; Tartaglia GG, 2008, CHEM SOC REV, V37, P1395, DOI 10.1039/b706784b; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Tzotzos S, 2010, PROTEIN SCI, V19, P327, DOI 10.1002/pro.314; Ventura S, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-11; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Wei J, 2005, MOL CELL, V17, P23, DOI 10.1016/j.molcel.2004.11.024; Zurdo J, 2001, J MOL BIOL, V311, P325, DOI 10.1006/jmbi.2001.4858	55	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58297	10.1371/journal.pone.0058297	http://dx.doi.org/10.1371/journal.pone.0058297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505482	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500066
J	Griffiths, JR; Schindler, DE; Seeb, LW				Griffiths, Jennifer R.; Schindler, Daniel E.; Seeb, Lisa W.			How Stock of Origin Affects Performance of Individuals across a Meta-Ecosystem: An Example from Sockeye Salmon	PLOS ONE			English	Article							POPULATION DIVERSITY; JUVENILE MIGRATION; ECOLOGY; HABITAT; MOVEMENT; PRODUCTIVITY; TEMPERATURE; EVOLUTION; PATTERNS; GENETICS	Connectivity among diverse habitats can buffer populations from adverse environmental conditions, influence the functioning of meta-ecosystems, and ultimately affect the reliability of ecosystem services. This stabilizing effect on populations is proposed to derive from complementarity in growth and survival conditions experienced by individuals in the different habitats that comprise meta-ecosystems. Here we use the fine scale differentiation of salmon populations between diverse lake habitats to assess how rearing habitat and stock of origin affect the body condition of juvenile sockeye salmon. We use genetic markers (single nucleotide polymorphisms) to assign individuals of unknown origin to stock group and in turn characterize ecologically relevant attributes across habitats and stocks. Our analyses show that the body condition of juvenile salmon is related to the productivity of alternative habitats across the watershed, irrespective of their stock of origin. Emigrants and residents with genetic origins in the high productivity lake were also differentiated by their body condition, poor and high respectively. These emigrants represented a substantial proportion of juvenile sockeye salmon rearing in the lower productivity lake habitat. Despite emigrants originating from the more productive lake, they did not differ in body condition from the individuals spawned in the lower productivity, recipient habitat. Genetic tools allowed us to assess the performance of different stocks groups across the diverse habitats comprising their meta-ecosystem. The ability to characterize the ecological consequences of meta-ecosystem connectivity can help develop strategies to protect and restore ecosystems and the services they provide to humans.	[Griffiths, Jennifer R.; Schindler, Daniel E.; Seeb, Lisa W.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Griffiths, JR (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	jeng@uw.edu	Seeb, Lisa W/GSN-3076-2022		US Army Corps of Engineers [WC1JIW01419268]; National Science Foundation; Gordon and Betty Moore Foundation; Chignik Regional Aquaculture Association	US Army Corps of Engineers(United States Department of DefenseUnited States Army); National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Chignik Regional Aquaculture Association	Funding was provided by the US Army Corps of Engineers (contract no. WC1JIW01419268; http://www.usace.army.mil/), National Science Foundation (www.nsf.gov/), Gordon and Betty Moore Foundation (http://www.moore.org/), and the Chignik Regional Aquaculture Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JB, DIEL HORIZO IN PRESS; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Biro PA, 2005, P ROY SOC B-BIOL SCI, V272, P1443, DOI 10.1098/rspb.2005.3096; BRETT JR, 1971, AM ZOOL, V11, P99; Brodersen J, 2011, OIKOS, V120, P1838, DOI 10.1111/j.1600-0706.2011.19433.x; Burgner R.L., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P129; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CARVALHO GR, 1994, REV FISH BIOL FISHER, V4, P326, DOI 10.1007/BF00042908; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK CW, 1988, AM NAT, V131, P271, DOI 10.1086/284789; CONE RS, 1989, T AM FISH SOC, V118, P510, DOI 10.1577/1548-8659(1989)118<0511:TNTRTU>2.3.CO;2; Creelman EK, 2011, T AM FISH SOC, V140, P749, DOI 10.1080/00028487.2011.584494; Crooks K. R., 2006, CONNECTIVITY CONSERV; Dann TH, 2012, SOCKEYE SALMON BASEL; Dingle Hugh, 1996, P1; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Griffiths JR, 2012, ECOL FRESHW FISH, V21, P349, DOI 10.1111/j.1600-0633.2012.00555.x; Griffiths JR, 2011, LIMNOL OCEANOGR, V56, P193, DOI 10.4319/lo.2011.56.1.0193; Habicht C, 2010, T AM FISH SOC, V139, P1171, DOI 10.1577/T09-149.1; Hamann EJ, 2012, ECOLOGY, V93, P733, DOI 10.1890/11-1009.1; Hayes SA, 2011, CAN J FISH AQUAT SCI, V68, P1341, DOI 10.1139/F2011-062; Hendry Andrew P., 2004, P52; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Kahler TH, 2001, CAN J FISH AQUAT SCI, V58, P1947, DOI 10.1139/cjfas-58-10-1947; Koski KV, 2009, ECOL SOC, V14; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; Mazerolle M. J., 2010, AICCMODAVG MODEL SEL; McGlauflin MT, 2011, T AM FISH SOC, V140, P763, DOI 10.1080/00028487.2011.584495; Narum SR, 2008, MOL ECOL, V17, P3464, DOI 10.1111/j.1365-294X.2008.03851.x; Narver DW, 1966, PELAGIAL ECOLOGY CAR; NASLUND I, 1993, OIKOS, V66, P538, DOI 10.2307/3544950; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; Pella J, 2001, FISH B-NOAA, V99, P151; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Quinn TP, 2006, ANIM BEHAV, V72, P941, DOI 10.1016/j.anbehav.2006.03.003; Raftery AE, 1996, MARKOV CHAIN MONTE C; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Ringsby TH, 2002, ECOLOGY, V83, P561, DOI 10.1890/0012-9658(2002)083[0561:ASDOAH]2.0.CO;2; Rogers LA, 2008, OIKOS, V117, P1578, DOI 10.1111/j.0030-1299.2008.16758.x; RUGGERONE G T, 1992, North American Journal of Fisheries Management, V12, P87, DOI 10.1577/1548-8675(1992)012<0087:POSSFB>2.3.CO;2; Ruggerone G. T., 2003, RAPID NATURAL HABITA; Ruggerone GT, 1994, INVESTIGATIONS SALMO; Scheuerell MD, 2003, ECOLOGY, V84, P1713, DOI 10.1890/0012-9658(2003)084[1713:DVMBJS]2.0.CO;2; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; SCHLOSSER IJ, 1991, BIOSCIENCE, V41, P704, DOI 10.2307/1311765; Seeb JE, 2011, MOL ECOL RESOUR, V11, P1, DOI 10.1111/j.1755-0998.2010.02979.x; Seeb JE, 2009, METHODS MOL BIOL, V578, P277, DOI 10.1007/978-1-60327-411-1_18; Seeb LW, 2011, T AM FISH SOC, V140, P734, DOI 10.1080/00028487.2011.584493; Simmons RK, 2012, CANADIAN J FISHERIES; Smith MJ, 2011, MOL ECOL RESOUR, V11, P268, DOI 10.1111/j.1755-0998.2010.02965.x; Stanford JA, 2005, INT VER THEOR ANGEW, V29, P123; STENSETH NC, 1980, OIKOS, V35, P165, DOI 10.2307/3544425; Team RDC, 2010, R LANG ENV STAT COMP; UTTER F, 1993, FISHERIES, V18, P11, DOI 10.1577/1548-8446(1993)018&lt;0011:GMAMSF&gt;2.0.CO;2; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Westley PAH, 2008, ECOL FRESHW FISH, V17, P443, DOI 10.1111/j.1600-0633.2008.00296.x; Westley PA, 2007, BIOCOMPLEXITY RAPID; Westley PAH, 2010, OECOLOGIA, V163, P471, DOI 10.1007/s00442-009-1534-3; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zar J.H., 2010, BIOSTAT ANAL	64	10	12	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58584	10.1371/journal.pone.0058584	http://dx.doi.org/10.1371/journal.pone.0058584			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505539	gold, Green Published, Green Submitted			2022-12-27	WOS:000318334500104
J	Liu, SP; Lin, CC; Lin, HC; Chen, YH; Yu, HJ				Liu, Shih-Ping; Lin, Ching-Chun; Lin, Herng-Ching; Chen, Yi-Hua; Yu, Hong-Jeng			Association between Schizophrenia and Urinary Calculi: A Population-Based Case-Control Study	PLOS ONE			English	Article							KIDNEY-STONES; MEDICAL COMORBIDITY; NEPHROLITHIASIS; RISK; EPIDEMIOLOGY; MORTALITY; PREVALENCE; DISEASE; TIME	Background: People with schizophrenia have been demonstrated to have higher overall morbidity and all-cause mortality rates from general medical conditions. However, little attention has been given to the urinary system of people with schizophrenia. As no direct evidence has been reported demonstrating a link between schizophrenia and urinary calculi, this study utilized a population-based case-control study design to investigate the possibility of an association between schizophrenia and the occurrence of urinary calculi. Method: This study used data from the Taiwan Longitudinal Health Insurance Database. Cases consisted of 53,965 urinary calculi patients newly diagnosed between 2002 and 2008. In total, 269,825 controls were randomly selected and matched with the cases in terms of age and sex. Each person was traced to discern whether he had previously received a diagnosis of schizophrenia. Conditional logistic regression models were performed for the analysis. Results: A total of 3,119 (1.0%) subjects had been diagnosed with schizophrenia prior to the index date. This included 0.7% of the patients with urinary calculi, and 1.0% of the controls. A prior diagnosis of schizophrenia was independently associated with a 30% decrease (95% CI = 0.62-0.76) in the occurrence of urinary calculi. The reduction was even more remarkable in males (38%, 95% CI = 0.55-0.71) and in elder individuals independent of gender (48% in those aged >69,95% CI = 0.36-0.77). Conclusion: Our findings suggest that there is an inverse association between schizophrenia and urinary calculi. Future studies are needed to elucidate the mechanisms by which schizophrenia negatively associates with urinary calculi.	[Liu, Shih-Ping; Yu, Hong-Jeng] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Lin, Ching-Chun] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Hlth Care Adm, Taipei, Taiwan; [Chen, Yi-Hua] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Yu, Hong-Jeng] Far Eastern Mem Hosital, Dept Surg, Div Urol, New Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Far Eastern Memorial Hospital	Yu, HJ (corresponding author), Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan.	yhj5251@ntu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695; YU, HONG-JENG/0000-0003-3287-5736				Amato M, 2004, UROL INT, V72, P1, DOI 10.1159/000076582; Barak Y, 2005, CANCER-AM CANCER SOC, V104, P2817, DOI 10.1002/cncr.21574; Bonney WW, 1997, SCHIZOPHR RES, V25, P243, DOI 10.1016/S0920-9964(97)00021-2; Borghi L, 2002, NEW ENGL J MED, V346, P77, DOI 10.1056/NEJMoa010369; Brown S, 2000, BRIT J PSYCHIAT, V177, P212, DOI 10.1192/bjp.177.3.212; Carney CP, 2006, J GEN INTERN MED, V21, P1133, DOI 10.1111/j.1525-1497.2006.00563.x; Carra G, 2012, EUR ARCH PSY CLIN N, V262, P607, DOI 10.1007/s00406-012-0305-z; Curhan GC, 2007, UROL CLIN N AM, V34, P287, DOI 10.1016/j.ucl.2007.04.003; Curhan GC, 1996, AM J EPIDEMIOL, V143, P240, DOI 10.1093/oxfordjournals.aje.a008734; Curhan GC, 1997, J AM SOC NEPHROL, V8, P1568; DAngelo A, 1997, MINER ELECTROL METAB, V23, P269; DELEON J, 1994, BIOL PSYCHIAT, V35, P408, DOI 10.1016/0006-3223(94)90008-6; Dundas Brian, 2007, Curr Psychiatry Rep, V9, P236, DOI 10.1007/s11920-007-0025-7; EATON WW, 1992, SCHIZOPHR RES, V6, P181, DOI 10.1016/0920-9964(92)90001-L; Ettinger B, 1997, J UROLOGY, V158, P2069, DOI 10.1016/S0022-5347(01)68155-2; Green AI, 2003, PSYCHIAT CLIN N AM, V26, P115, DOI 10.1016/S0193-953X(02)00014-X; HARRIS AE, 1988, SCHIZOPHRENIA BULL, V14, P85, DOI 10.1093/schbul/14.1.85; Jeste DV, 1996, SCHIZOPHRENIA BULL, V22, P413, DOI 10.1093/schbul/22.3.413; JOHNSON CM, 1979, KIDNEY INT, V16, P624, DOI 10.1038/ki.1979.173; Kato Y, 2005, UROL RES, V33, P476, DOI 10.1007/s00240-005-0511-5; KOHRI K, 1990, BONE MINER, V8, P59, DOI 10.1016/0169-6009(91)90141-L; Leucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Shiloh R, 2001, EUR PSYCHIAT, V16, P497, DOI 10.1016/S0924-9338(01)00612-5; Stamatelou KK, 2003, KIDNEY INT, V63, P1817, DOI 10.1046/j.1523-1755.2003.00917.x; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x; Terao T, 1999, AUST NZ J PSYCHIAT, V33, P769; Walker D, 1971, J UROLOGY, V1054, P868; Weber NS, 2009, PSYCHIAT SERV, V60, P1059, DOI 10.1176/appi.ps.60.8.1059; YODER V, 1984, AM J PSYCHIAT, V141, P617, DOI 10.1176/ajp.141.4.617	32	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e56942	10.1371/journal.pone.0056942	http://dx.doi.org/10.1371/journal.pone.0056942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	136BN	23505416	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500008
J	Wilson, N; Nghiem, N; Foster, RH				Wilson, Nick; Nghiem, Nhung; Foster, Rachel H.			The Feasibility of Achieving Low-Sodium Intake in Diets That Are Also Nutritious, Low-Cost, and Have Familiar Meal Components	PLOS ONE			English	Article							SALT INTAKE; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; COLORECTAL-CANCER; METAANALYSIS; HEALTH; REDUCTION; PATTERNS; RISK; CONSUMPTION	Objective: Given the importance of high sodium diets as a risk factor for disease burden (ranked 11th in importance in the Global Burden of Disease Study 2010), we aimed to determine the feasibility of low-sodium diets that were also low-cost, nutritious and (for some scenarios) included familiar meals. Methods: The mathematical technique of "linear programming" was used to model eight optimized daily diets (some with uncertainty), including some diets that contained "familiar meals" for New Zealanders or were Mediterranean-, Asian- and Pacific-style diets. Data inputs included nutrients in foods, food prices and food wastage. Findings: Using nutrient recommendations for men and a cost constraint of <NZ$9/d (US$6.84), the sodium intake levels in the eight optimized daily diets were all well below the 2300 mg/d (5.8 g salt/d) recommended maximum. The only diet to not consistently fall below the recommended "target" upper limit of 1600 mg/d included an evening meal with sausages (median = 1640 mg/d, 95% simulation interval: 1551-1735 mg/d). Many additional nutritional aspects of these optimized low-sodium diets suggest that they would reduce cardiovascular disease risk in other ways (e.g., improved polyunsaturated to saturated fat ratio) and also reduce risk of cancer and other chronic diseases (e.g., via higher intakes of vegetables, fruits and dietary fiber). Even healthier diets (e.g., with higher intakes of fruit) occurred when the cost constraint was relaxed to $NZ15/d (US$11.40). Similar results were obtained when the modeling considered diets for women. Conclusions: These results provide some reassurance for the feasibility of substantially reducing population sodium intake given currently available low-cost foods and while maintaining some level of familiar meals. Policy makers could consider ways to promote such optimized diets and foods, including regulations on maximum salt levels in processed foods, and taxes on alternative foods that are high in salt, sugar and saturated fat.	[Wilson, Nick; Nghiem, Nhung; Foster, Rachel H.] Univ Otago, Dept Publ Hlth, Wellington, New Zealand	University of Otago	Wilson, N (corresponding author), Univ Otago, Dept Publ Hlth, Wellington, New Zealand.	nick.wilson@otago.ac.nz		Nghiem, Nhung/0000-0003-0078-4549	Health Research Council of New Zealand [10/248]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This project was part of the BODE3 Program, which receives funding support from the Health Research Council of New Zealand (Project number 10/248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, 2009 NZ TOT DIET STU; Appel LJ, 2012, ANN EPIDEMIOL, V22, P417, DOI 10.1016/j.annepidem.2012.04.003; Arcand J, 2012, AM J HYPERTENS, V25, P19, DOI 10.1038/ajh.2011.187; Aune D, 2012, BREAST CANCER RES TR, V134, P479, DOI 10.1007/s10549-012-2118-1; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Briend A, 2003, J PEDIATR GASTR NUTR, V36, P12, DOI 10.1097/00005176-200301000-00006; Carter P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4229; Faber J, 2012, BEHAV CLIMATE CHANGE; Fahimi S, 2012, AM J HYPERTENS, V25, P17, DOI 10.1038/ajh.2011.183; Graudal NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub3; Hawkes C, 2009, NUTR REV, V67, P333, DOI 10.1111/j.1753-4887.2009.00206.x; He FJ, 2012, ANN MED, V44, pS127, DOI 10.3109/07853890.2012.660495; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Holt E, 2011, LANCET, V378, P755, DOI 10.1016/S0140-6736(11)61359-7; Human Nutrition University of Otago, FOOD COST SURV; Institute of Medicine (US) Committee on Strategies to Reduce Sodium Intake, 2010, STRAT RED COD INT US; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Maillot M, 2012, AM J PREV MED, V42, P174, DOI 10.1016/j.amepre.2011.10.009; Maillot M, 2010, PUBLIC HEALTH NUTR, V13, P1178, DOI 10.1017/S1368980009993028; McLean R, 2011, JOINT ANN SCI M AUST; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; NHMRC (National Health and Medical Research Council), 2006, NUTR REF VAL AUSTR N; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Sherzai A, 2012, NUTR REV, V70, P423, DOI 10.1111/j.1753-4887.2012.00490.x; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Statistics New Zealand, 2011, FOOD PRIC IND 2011; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Taylor RS, 2011, AM J HYPERTENS, V24, P843, DOI 10.1038/ajh.2011.115; Thomson BM, 2009, BRIT J NUTR, V102, P757, DOI 10.1017/S000711450928901X; Trichopoulou A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2337; University of Otago, 2011, FOC NUTR KEY FIND 20; Villanueva T, 2011, CAN MED ASSOC J, V183, pE1229, DOI 10.1503/cmaj.109-4031; WHO, 2012, GUID SOD INT AD CHIL; Wilson Nick, 2007, N Z Med J, V120, pU2665; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; WRAP (The Waste and Resources Action Programme), 2009, HOUS FOOD DRINK WAST; Yusof AS, 2012, ASIAN PAC J CANCER P, V13, P4713, DOI 10.7314/APJCP.2012.13.9.4713	43	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58539	10.1371/journal.pone.0058539	http://dx.doi.org/10.1371/journal.pone.0058539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	23505532	Green Submitted, Green Published, gold			2022-12-27	WOS:000318334500099
J	Chen, GJ; Yang, MS				Chen, Gui Jv; Yang, Mao Sheng			The Effects of Calcium Channel Blockers in the Prevention of Stroke in Adults with Hypertension: A Meta-Analysis of Data from 273,543 Participants in 31 Randomized Controlled Trials	PLOS ONE			English	Article							ISOLATED SYSTOLIC HYPERTENSION; LONG-ACTING NIFEDIPINE; CARDIOVASCULAR EVENTS; DOUBLE-BLIND; ELDERLY-PATIENTS; OLDER PATIENTS; STABLE ANGINA; MORBIDITY; MORTALITY; ATHEROSCLEROSIS	Background: Hypertension is a major risk factor for the development of stroke. It is well known that lowering blood pressure decreases the risk of stroke in people with moderate to severe hypertension. However, the specific effects of calcium channel blockers (CCBs) against stroke in patients with hypertension as compared to no treatment and other antihypertensive drug classes are not known. Methods and Findings: This systematic review and meta-analysis of randomized controlled trials (RCTs) evaluated CCBs effect on stroke in patients with hypertension in studies of CCBs versus placebo, angiotensin-converting-enzyme inhibitors (ACEIs), beta-adrenergic blockers, and diuretics. The PUBMED, MEDLINE, EMBASE, OVID, CNKI, MEDCH, and WANFANG databases were searched for trials published in English or Chinese during the period January 1, 1996 to July 31, 2012. A total of 177 reports were collected, among them 31 RCTs with 273,543 participants (including 130,466 experimental subjects and 143,077 controls) met the inclusion criteria. In these trials a total of 9,550 stroke events (4,145 in experimental group and 5,405 in control group) were reported. CCBs significantly decreased the incidence of stroke compared with placebo (OR = 0.68, 95% CI 0.61-0.75, p<1x10(-5)), beta-adrenergic blockers combined with diuretics (OR = 0.89, 95% CI 0.83-0.95, p = 7x10(-5)) and beta-adrenergic blockers (OR = 0.79, 95% CI 0.72-0.87, p<1x10(-5)), statistically significant difference was not found between CCBs and ACEIs (OR = 0.92, 95% CI 0.8-1.02, p = 0.12) or diuretics (OR = 0.95, 95% CI 0.84-1.07, p = 0.39). Conclusion: In a pooled analysis of data of 31 RCTs measuring the effect of CCBs on stroke, CCBs reduced stroke more than placebo and beta-adrenergic blockers, but were not different than ACEIs and diuretics. More head to head RCTs are warranted.	[Yang, Mao Sheng] Chongqing Med Univ, Lab Disorder Genes, Coll Pharm, Chongqing, Peoples R China; Chongqing Med Univ, Dept Pharmacol, Coll Pharm, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Yang, MS (corresponding author), Chongqing Med Univ, Lab Disorder Genes, Coll Pharm, Chongqing, Peoples R China.	yangmaosheng@hotmail.com	Yang(秧), Maosheng(茂盛)/J-9581-2012	Yang(秧), Maosheng(茂盛)/0000-0002-0566-6093	Chongqing Medical University [XBZD200701]; Program for Excellent Talents of University in Chongqing Municipality	Chongqing Medical University; Program for Excellent Talents of University in Chongqing Municipality	This work was supported by grants from Chongqing Medical University (XBZD200701) and The Program for Excellent Talents of University in Chongqing Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berl T, 2003, ANN INTERN MED, V138, P542, DOI 10.7326/0003-4819-138-7-200304010-00010; Black HR, 2003, JAMA-J AM MED ASSOC, V289, P2073, DOI 10.1001/jama.289.16.2073; Borhani NO, 1996, JAMA-J AM MED ASSOC, V276, P785, DOI 10.1001/jama.276.10.785; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; COLDITZ GA, 1995, AM J EPIDEMIOL, V142, P371, DOI 10.1093/oxfordjournals.aje.a117644; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Deeks JJ, 2001, BRIT MED J, V323, P157, DOI 10.1136/bmj.323.7305.157; Dens JA, 2001, AM J CARDIOL, V87, P28, DOI 10.1016/S0002-9149(00)01267-4; Donovan AL, 2012, CURR OPIN ANESTHESIO, V25, P516, DOI 10.1097/ACO.0b013e32835721a5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekbom T, 2004, BLOOD PRESSURE, V13, P137, DOI 10.1080/08037050410014944; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Fukui T, 2003, HYPERTENS RES, V26, P979, DOI 10.1291/hypres.26.979; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Gong LS, 1996, J HYPERTENS, V14, P1237, DOI 10.1097/00004872-199610000-00013; HAMILTON M, 1964, LANCET, V1, P235; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HILL AB, 1966, ANN RHEUM DIS, V25, P107, DOI 10.1136/ard.25.2.107; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Kuramoto K, 1999, HYPERTENSION, V34, P1129; Leenen FHH, 2006, HYPERTENSION, V48, P374, DOI 10.1161/01.HYP.0000231662.77359.de; Liu GT, 2011, ZHONGGUO SHE QU YI S, V13, P10; Liu LS, 2005, J HYPERTENS, V23, P2157, DOI 10.1097/01.hjh.0000194120.42722.ac; Liu LS, 1998, J HYPERTENS, V16, P1823, DOI 10.1097/00004872-199816120-00016; Lubsen J, 2005, J HYPERTENS, V23, P641, DOI 10.1097/01.hjh.0000160223.94220.29; Malacco E, 2003, BLOOD PRESSURE, V12, P160, DOI 10.1080/08037050310009545; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Poole-Wilson PA, 2004, LANCET, V364, P849, DOI 10.1016/S0140-6736(04)16980-8; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Song YY, 2011, ZHONGGUO LAO NIAN XU, V31, P4039; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; Tuomilehto J, 1999, NEW ENGL J MED, V340, P677, DOI 10.1056/NEJM199903043400902; Turnbull F, 2003, LANCET, V362, P1527; Wang YZ, 1998, ZHONGGUO MAN XING BI, V6, P235; Zanchetti A, 1998, J HYPERTENS, V16, P1667, DOI 10.1097/00004872-199816110-00014; Zanchetti A, 2002, CIRCULATION, V106, P2422, DOI 10.1161/01.CIR.0000039288.86470.DD	40	29	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57854	10.1371/journal.pone.0057854	http://dx.doi.org/10.1371/journal.pone.0057854			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483932	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100048
J	Ibrahim, AI; El Hassan, AM; Fahal, A; van de Sande, WW				Ibrahim, Anahid Izzat; El Hassan, Ahmed Mohammed; Fahal, Ahmed; van de Sande, Wendy W.			A Histopathological Exploration of the Madurella mycetomatis Grain	PLOS ONE			English	Article							FUNGAL MELANINS; PATHOGENIC FUNGI; ATOMIC-ABSORPTION; METAL-IONS; SPECTROPHOTOMETRY; BIOSYNTHESIS	Although the Madurella mycetomatis grains seem to interfere with the host defense mechanisms and impede the antifungal drugs penetration, yet their histological features are not fully known and hence this study was set out to determine that. The study included 80 patients with confirmed M. mycetomatis eumycetoma. After informed written consent, surgical biopsies were obtained from the excised tissues during the patients' surgical treatment. All sections were stained with haematoxylin and eosin, Grocott's hexamine silver, Periodic Acid-Schiff's, Masson-Fontana, Perl's Prussian Blue, Von-kossa's, Formalin Inducing Fluorescence and Schmorl's stains. Modified bleaching technique was used. The concentrations of Zinc, Copper, Calcium, Iron, Lead, Cobalt and Nickel were determined by Atomic Absorption Spectrophotometer. The M. Mycetomatis grains appeared to consist of lipid, protein and melanin. The melanin was located on the hyphal wall as thick layers. The Zinc, Copper and Calcium concentrations in the grains were four, six, and sixteen folds higher than in normal tissue respectively, the other metals were found in the same concentrations as in normal tissue. In the grains, calcium was located in the melanin vicinity. From this study, it can be concluded that, the grains contain melanin, heavy metals, proteins, lipids and they contribute in the formation of the grain cement matrix. These elements seem to contribute in the organism pathogenicity and might impede the penetration of various anti-fungal agents.	[Ibrahim, Anahid Izzat] Univ Khartoum, Fac Med Lab Sci, Khartoum, Sudan; [El Hassan, Ahmed Mohammed; Fahal, Ahmed] Univ Khartoum, Mycetoma Res Ctr, Khartoum, Sudan; [van de Sande, Wendy W.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	University of Khartoum; University of Khartoum; Erasmus University Rotterdam; Erasmus MC	Fahal, A (corresponding author), Univ Khartoum, Mycetoma Res Ctr, Khartoum, Sudan.	ahfahal@hotmail.com	Fahal, Ahmed H/H-9573-2012; van de Sande, Wendy/AAS-4545-2021	Fahal, Ahmed H/0000-0003-4922-7321; van de Sande, Wendy/0000-0002-8652-8783; Mohamed Elhassan, Ahmed/0000-0003-0740-0499				Ahmed AOA, 2004, LANCET INFECT DIS, V4, P566, DOI 10.1016/S1473-3099(04)01131-4; Behnsen J, 2008, INFECT IMMUN, V76, P820, DOI 10.1128/IAI.01037-07; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; CAESARTONTHAT TC, 1995, APPL ENVIRON MICROB, V61, P1968, DOI 10.1128/AEM.61.5.1968-1975.1995; EL Hassan AM, 1994, SUDAN MED J, V32, P23; ELINOV NP, 1984, ZBL BAKT-INT J MED M, V257, P246, DOI 10.1016/S0174-3031(84)80079-7; Erb-Downward JR, 2006, FUTURE MICROBIOL, V1, P219, DOI 10.2217/17460913.1.2.219; Fahal AH, 2004, T ROY SOC TROP MED H, V98, P3, DOI 10.1016/S0035-9203(03)00009-9; Fahal AH, 2011, KHARTOUM MED J, Vthird, P565; FINDLAY GH, 1980, MYCOPATHOLOGIA, V70, P61, DOI 10.1007/BF00704324; FINDLAY GH, 1977, BRIT J DERMATOL, V97, P497, DOI 10.1111/j.1365-2133.1977.tb14125.x; Fogarty RV, 1996, ENZYME MICROB TECH, V19, P311, DOI 10.1016/0141-0229(96)00002-6; Hamilton AJ, 2000, J MED MICROBIOL, V51, P89; Heung LJ, 2006, INFECT IMMUN, V74, P28, DOI 10.1128/IAI.74.1.28-39.2006; Hong L, 2004, PHOTOCHEM PHOTOBIOL, V80, P477, DOI 10.1562/0031-8655(2004)080<0477:BOMITM>2.0.CO;2; Jacobson ES, 2000, CLIN MICROBIOL REV, V13, P708, DOI 10.1128/CMR.13.4.708-717.2000; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; Roderick NM, 1992, MICROBIAL INFECT MUI, P333; Ropek D, 2002, J INVERTEBR PATHOL, V79, P123, DOI 10.1016/S0022-2011(02)00013-7; Shea JM, 2006, CURR OPIN MICROBIOL, V9, P352, DOI 10.1016/j.mib.2006.06.003; Steven A, 1996, THEORY PRACTICE HIST, P250; Turan S, 2001, J TROP PEDIATRICS, V47, P81, DOI 10.1093/tropej/47.2.81; van de Sande WWJ, 2007, MICROBES INFECT, V9, P1114, DOI 10.1016/j.micinf.2007.05.015; WETHERED DB, 1987, J MED VET MYCOL, V25, P39	24	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57774	10.1371/journal.pone.0057774	http://dx.doi.org/10.1371/journal.pone.0057774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483927	Green Published, gold			2022-12-27	WOS:000316936100043
J	Sartori, A; Mano, CM; Mantovani, MC; Dyszy, FH; Massari, J; Tokikawa, R; Nascimento, OR; Nantes, IL; Bechara, EJH				Sartori, Adriano; Mano, Camila M.; Mantovani, Mariana C.; Dyszy, Fabio H.; Massari, Julio; Tokikawa, Rita; Nascimento, Otaciro R.; Nantes, Iseli L.; Bechara, Etelvino J. H.			Ferricytochrome c Directly Oxidizes Aminoacetone to Methylglyoxal, a Catabolite Accumulated in Carbonyl Stress	PLOS ONE			English	Article							HYDROXYL-RADICAL GENERATION; ADVANCED GLYCATION ENDPRODUCTS; SENSITIVE AMINE OXIDASE; RAT-LIVER MITOCHONDRIA; CYTOCHROME-C; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; DIABETES-MELLITUS; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM	Age-related diseases are associated with increased production of reactive oxygen and carbonyl species such as methylglyoxal. Aminoacetone, a putative threonine catabolite, is reportedly known to undergo metal-catalyzed oxidation to methylglyoxal, NH4+ ion, and H2O2 coupled with (i) permeabilization of rat liver mitochondria, and (ii) apoptosis of insulin-producing cells. Oxidation of aminoacetone to methylglyoxal is now shown to be accelerated by ferricytochrome c, a reaction initiated by one-electron reduction of ferricytochrome c by aminoacetone without amino acid modifications. The participation of O-2(center dot-) and HO center dot radical intermediates is demonstrated by the inhibitory effect of added superoxide dismutase and Electron Paramagnetic Resonance spin-trapping experiments with 5,5'-dimethyl-1-pyrroline-N-oxide. We hypothesize that two consecutive one-electron transfers from aminoacetone (E-0 values = -0.51 and -1.0 V) to ferricytochrome c (E-0 = 0.26 V) may lead to aminoacetone enoyl radical and, subsequently, imine aminoacetone, whose hydrolysis yields methylglyoxal and NH4+ ion. In the presence of oxygen, aminoacetone enoyl and O-2(center dot-) radicals propagate aminoacetone oxidation to methylglyoxal and H2O2. These data endorse the hypothesis that aminoacetone, putatively accumulated in diabetes, may directly reduce ferricyt c yielding methylglyoxal and free radicals, thereby triggering redox imbalance and adverse mitochondrial responses.	[Sartori, Adriano; Mano, Camila M.; Massari, Julio; Tokikawa, Rita; Bechara, Etelvino J. H.] Univ Sao Paulo, Dept Bioquim, Sao Paulo, Brazil; [Sartori, Adriano] Univ Fed Sao Paulo, Dept Bioquim & Biol Mol, Sao Paulo, Brazil; [Mantovani, Mariana C.; Bechara, Etelvino J. H.] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Sao Paulo, Brazil; [Dyszy, Fabio H.; Nascimento, Otaciro R.] Univ Sao Paulo, Dept Fis & Informat, Sao Paulo, Brazil; [Nantes, Iseli L.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Bechara, EJH (corresponding author), Univ Sao Paulo, Dept Bioquim, Sao Paulo, Brazil.	ejhbechara@gmail.com	Nantes, Iseli Lourenço/B-9517-2012; Bechara, Etelvino JH/AAN-1136-2021; Bechara, Etelvino JH/M-6251-2013	Nantes, Iseli Lourenço/0000-0003-1434-3154; Bechara, Etelvino JH/0000-0001-9526-2529; Bechara, Etelvino JH/0000-0001-9526-2529	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); INCT Processos Redox em Biomedicina (Brazil)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT Processos Redox em Biomedicina (Brazil)	This work was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and the INCT Processos Redox em Biomedicina (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2007, DIABETES OBES METAB, V9, P233, DOI 10.1111/j.1463-1326.2006.00595.x; Ahmed N, 2002, BIOCHEM J, V364, P1; BAADER WJ, 1985, J BIOL CHEM, V260, P217; Banach MS, 2009, CHEM-BIOL INTERACT, V178, P324, DOI 10.1016/j.cbi.2008.10.003; Bechara EJH, 2007, COMP BIOCHEM PHYS C, V146, P88, DOI 10.1016/j.cbpc.2006.07.004; Bertini I, 2006, CHEM REV, V106, P90, DOI 10.1021/cr050241v; Best L, 1999, J MEMBRANE BIOL, V167, P65, DOI 10.1007/s002329900472; BIRD MI, 1984, BIOCHIM BIOPHYS ACTA, V802, P229, DOI 10.1016/0304-4165(84)90166-1; Brewer GJ, 2010, CHEM RES TOXICOL, V23, P319, DOI 10.1021/tx900338d; BRITIGAN BE, 1991, BIOCHIM BIOPHYS ACTA, V1075, P213, DOI 10.1016/0304-4165(91)90269-M; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; BURKITT MJ, 1991, P NATL ACAD SCI USA, V88, P8440, DOI 10.1073/pnas.88.19.8440; CASTRO CE, 1986, J AM CHEM SOC, V108, P4179, DOI 10.1021/ja00274a055; Chan WH, 2008, J CELL BIOCHEM, V103, P1144, DOI 10.1002/jcb.21489; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; CILENTO G, 1995, FREE RADICAL BIO MED, V19, P103, DOI 10.1016/0891-5849(95)00002-F; DAVISON AJ, 1984, ARCH BIOCHEM BIOPHYS, V233, P761, DOI 10.1016/0003-9861(84)90504-6; Deng YL, 1999, ANAL BIOCHEM, V270, P97, DOI 10.1006/abio.1999.4058; Duran-Jimenez B, 2009, DIABETES, V58, P2893, DOI 10.2337/db09-0320; Dutra F, 2005, CHEM RES TOXICOL, V18, P755, DOI 10.1021/tx049655u; Dutra F, 2004, ARCH BIOCHEM BIOPHYS, V430, P284, DOI 10.1016/j.abb.2004.06.029; Dutra F, 2003, FREE RADICAL RES, V37, P1113, DOI 10.1080/10715760310001604116; Dutra F, 2001, CHEM RES TOXICOL, V14, P1323, DOI 10.1021/tx015526r; Ellis EM, 2007, PHARMACOL THERAPEUT, V115, P13, DOI 10.1016/j.pharmthera.2007.03.015; Estevam ML, 2004, J BIOL CHEM, V279, P39214, DOI 10.1074/jbc.M402093200; Fleming T, 2012, DIABETOLOGIA, V55, P1151, DOI 10.1007/s00125-012-2452-1; Garcia-Roves Pablo M., 2011, Archives of Physiology and Biochemistry, V117, P177, DOI 10.3109/13813455.2011.584538; GIULIVI C, 1995, ARCH BIOCHEM BIOPHYS, V316, P909, DOI 10.1006/abbi.1995.1122; Gokturk C, 2003, BBA-PROTEINS PROTEOM, V1647, P88, DOI 10.1016/S1570-9639(03)00064-5; Guerranti R, 2001, BBA-GEN SUBJECTS, V1568, P45, DOI 10.1016/S0304-4165(01)00197-0; HANNA PM, 1992, CHEM RES TOXICOL, V5, P109, DOI 10.1021/tx00025a019; Hepworth JD, 1976, ORG SYNTH, V45, P1; Hiraku Y, 1999, FREE RADICAL RES, V31, P389, DOI 10.1080/10715769900300961; House JD, 2001, AM J PHYSIOL-ENDOC M, V281, pE1300, DOI 10.1152/ajpendo.2001.281.6.E1300; Kalapos Miklos Peter, 2008, Drug Metabolism and Drug Interactions, V23, P69; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; KALAPOS MP, 1991, BIOCHIM BIOPHYS ACTA, V1092, P284, DOI 10.1016/S0167-4889(97)90002-1; KALAPOS MP, 1992, BIOCHEM EDUC, V20, P27, DOI 10.1016/0307-4412(92)90012-B; Kalapos MP, 2012, DIABETES RES CLIN PR, DOI S0168-8227(12)00426-3.10.1016; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Krautwald M, 2010, EXP GERONTOL, V45, P744, DOI 10.1016/j.exger.2010.03.001; Lee C, 1998, J BIOL CHEM, V273, P25272, DOI 10.1074/jbc.273.39.25272; LEONCINI G, 1980, FEBS LETT, V117, P17, DOI 10.1016/0014-5793(80)80903-3; LIOTTI FS, 1989, INT J CANCER, V43, P1145, DOI 10.1002/ijc.2910430630; LoPachin RM, 2009, CHEM RES TOXICOL, V22, P1499, DOI 10.1021/tx900147g; MASHINO T, 1987, ARCH BIOCHEM BIOPHYS, V254, P547, DOI 10.1016/0003-9861(87)90136-6; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MONTEIRO HP, 1989, ARCH BIOCHEM BIOPHYS, V271, P206, DOI 10.1016/0003-9861(89)90271-3; Mugnol KCU, 2008, BIOPHYS J, V94, P4066, DOI 10.1529/biophysj.107.116483; Murphy MP, 2011, CELL METAB, V13, P361, DOI 10.1016/j.cmet.2011.03.010; Nakayama K, 2008, AM J NEPHROL, V28, P871, DOI 10.1159/000139653; Nantes IL, 2000, FREE RADICAL BIO MED, V28, P786, DOI 10.1016/S0891-5849(00)00170-2; Nohara Y, 2002, CHEM PHARM BULL, V50, P179, DOI 10.1248/cpb.50.179; O'Sullivan J, 2004, NEUROTOXICOLOGY, V25, P303, DOI 10.1016/S0161-813X(03)00117-7; Park YS, 2003, FREE RADICAL RES, V37, P205, DOI 10.1080/1071576021000041005; Rebelato E, 2010, METABOLISM, V59, P409, DOI 10.1016/j.metabol.2009.08.010; Rinaldi TA, 2004, FREE RADICAL BIO MED, V36, P802, DOI 10.1016/j.freeradbiomed.2003.12.002; Rocha MEM, 2000, FREE RADICAL BIO MED, V29, P1272, DOI 10.1016/S0891-5849(00)00437-8; Rodrigues T, 2007, J BIOL CHEM, V282, P25577, DOI 10.1074/jbc.M700009200; Sartori A, 2008, CHEM RES TOXICOL, V21, P1841, DOI 10.1021/tx8001753; Shang Y, 2012, ENVIRON SCI TECHNOL, V46, P2935, DOI 10.1021/es203032v; Sheader EA, 2001, BIOCHEM PHARMACOL, V61, P1381, DOI 10.1016/S0006-2952(01)00603-7; Singh M, 2010, J ALZHEIMERS DIS, V21, P229, DOI 10.3233/JAD-2010-091729; Soares CO, 2012, ARCH BIOCHEM BIOPHYS, V528, P103, DOI 10.1016/j.abb.2012.09.005; Soares CO, 2011, FREE RADICAL BIO MED, V50, P1760, DOI 10.1016/j.freeradbiomed.2011.03.033; Stoll S, 2007, BIOL MAGN RESON, V27, P299; Toledo JC, 2012, CHEM RES TOXICOL, V25, P975, DOI 10.1021/tx300042g; VanderJagt DL, 1997, BIOCHEM PHARMACOL, V53, P1133, DOI 10.1016/S0006-2952(97)00090-7; Wallace JW, 1982, J BIOL CHEM, V257, P4966; WOOD PM, 1988, BIOCHEM J, V253, P287, DOI 10.1042/bj2530287; Yamazaki I, 1993, QUIM NOVA, V16, P365; YIM HS, 1995, J BIOL CHEM, V270, P28228	73	11	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e57790	10.1371/journal.pone.0057790	http://dx.doi.org/10.1371/journal.pone.0057790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483930	Green Submitted, gold, Green Published			2022-12-27	WOS:000316936100046
J	Stoll, SJ; Bartsch, S; Kroll, J				Stoll, Sandra J.; Bartsch, Susanne; Kroll, Jens			HOXC9 Regulates Formation of Parachordal Lymphangioplasts and the Thoracic Duct in Zebrafish via Stabilin 2	PLOS ONE			English	Article							ENDOTHELIAL-CELL QUIESCENCE; VASCULAR MORPHOGENESIS; LYMPHATIC DEVELOPMENT; TRANSCRIPTION FACTOR; ANGIOGENESIS; RECEPTOR; GENES; LYMPHANGIOGENESIS; IDENTIFICATION; INHIBITION	HOXC9 belongs to the family of homeobox transcription factors, which are regulators of body patterning and development. HOXC9 acts as a negative regulator on blood endothelial cells but its function on lymphatic vessel development has not been studied. The hyaluronan receptor homologs stabilin 1 and stabilin 2 are expressed in endothelial cells but their role in vascular development is poorly understood. This study was aimed at investigating the function of HOXC9, stabilin 2 and stabilin 1 in lymphatic vessel development in zebrafish and in endothelial cells. Morpholino-based expression silencing of HOXC9 repressed parachordal lymphangioblast assembly and thoracic duct formation in zebrafish. HOXC9 positively regulated stabilin 2 expression in zebrafish and in HUVECs and expression silencing of stabilin 2 phenocopied the HOXC9 morphant vascular phenotype. This effect could be compensated by HOXC9 mRNA injection in stabilin 2 morphant zebrafish embryos. Stabilin 1 also regulated parachordal lymphangioblast and thoracic duct formation in zebrafish but acts independently of HOXC9. On a cellular level stabilin 1 and stabilin 2 regulated endothelial cell migration and in-gel sprouting angiogenesis in endothelial cells. HOXC9 was identified as novel transcriptional regulator of parachordal lymphangioblast assembly and thoracic duct formation in zebrafish that acts via stabilin 2. Stabilin 1, which acts independently of HOXC9, has a similar function in zebrafish and both receptors control important cellular processes in endothelial cells.	[Stoll, Sandra J.; Bartsch, Susanne; Kroll, Jens] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Dept Vasc Biol & Tumor Angiogenesis, Mannheim, Germany; [Kroll, Jens] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Vasc Oncol & Metastasis, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Kroll, J (corresponding author), Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim CBTM, Dept Vasc Biol & Tumor Angiogenesis, Mannheim, Germany.	jens.kroll@medma.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [SFB/TR23, KR1887/5-1]; German Cardiac Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cardiac Society	This work was supported by grants from the Deutsche Forschungsgemeinschaft (www.dfg.de) (SFB/TR23, project Z5, to J.K.) and by the German Cardiac Society (http://dgk.org/)( to S.J.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.KR1887/5-1	Adachi H, 2002, J BIOL CHEM, V277, P34264, DOI 10.1074/jbc.M204277200; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Bussmann J, 2010, DEVELOPMENT, V137, P2653, DOI 10.1242/dev.048207; Butler MG, 2009, BIRTH DEFECTS RES C, V87, P222, DOI 10.1002/bdrc.20155; Cantile M, 2008, NUTR METAB CARDIOVAS, V18, P651, DOI 10.1016/j.numecd.2008.08.001; Choi I, 2012, ANGIOGENESIS; ELGJO RF, 1975, CELL TISSUE RES, V162, P49; Epting D, 2010, CIRC RES, V107, P45, DOI 10.1161/CIRCRESAHA.109.213983; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Hirose Y, 2012, P NATL ACAD SCI USA, V109, P4263, DOI 10.1073/pnas.1117560109; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Jorgens K, 2011, DEUT MED WOCHENSCHR, V136, P1865, DOI 10.1055/s-0031-1286357; Jung MY, 2007, J LEUKOCYTE BIOL, V82, P1156, DOI 10.1189/jlb.0107052; Karikoski M, 2009, EUR J IMMUNOL, V39, P3477, DOI 10.1002/eji.200939896; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kzhyshkowska J, 2010, THESCIENTIFICWORLDJO, V10, P2039, DOI 10.1100/tsw.2010.189; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee GY, 2011, J CONTROL RELEASE, V155, P211, DOI 10.1016/j.jconrel.2011.07.010; Nacak TG, 2007, CIRC RES, V100, P1155, DOI 10.1161/01.RES.0000265844.56493.ac; Park SY, 2009, FEBS LETT, V583, P1375, DOI 10.1016/j.febslet.2009.03.046; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Pruett ND, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-93; Salmi M, 2004, BLOOD, V104, P3849, DOI 10.1182/blood-2004-01-0222; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Schulte-Merker S, 2011, J CELL BIOL, V193, P607, DOI 10.1083/jcb.201012094; Shah N, 2010, NAT REV CANCER, V10, P361, DOI 10.1038/nrc2826; Stoll SJ, 2011, CIRC RES, V108, P1367, DOI 10.1161/CIRCRESAHA.111.244095; Stoll SJ, 2012, TRENDS CARDIOVAS MED, V22, P7, DOI 10.1016/j.tcm.2012.06.002; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wong KS, 2009, DEV DYNAM, V238, P1836, DOI 10.1002/dvdy.21990; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58311	10.1371/journal.pone.0058311	http://dx.doi.org/10.1371/journal.pone.0058311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23484014	gold, Green Published, Green Submitted			2022-12-27	WOS:000316936100104
J	Weber, M; Lupp, C; Stein, P; Kreft, A; Bopp, T; Wehler, TC; Schmitt, E; Schild, H; Radsak, MP				Weber, Michael; Lupp, Corinna; Stein, Pamela; Kreft, Andreas; Bopp, Tobias; Wehler, Thomas C.; Schmitt, Edgar; Schild, Hansjoerg; Radsak, Markus P.			Mechanisms of Cyclic Nucleotide Phosphodiesterases in Modulating T Cell Responses in Murine Graft-versus-Host Disease	PLOS ONE			English	Article							DENDRITIC CELLS; ADENOSINE-MONOPHOSPHATE; REGULATORY CELLS; SUPPRESSION; TOLERANCE; INHIBITION; EXPRESSION; RECIPIENTS; INDUCTION; DELETION	Graft-versus-host disease (GvHD) is a key contributor to the morbidity and mortality after allogeneic hematopoetic stem cell transplantation (HSCT). Regulatory Foxp3(+)CD4(+) T cells (T-reg) suppress conventional T cell activation and can control GvHD. In our previous work, we demonstrate that a basic mechanism of T-reg mediated suppression occurs by the transfer of cyclic adenosine monophosphate (cAMP) to responder cells. Whether this mechanism is relevant for T-reg mediated suppression of GvHD is currently unknown. To address this question, bone marrow and T cells from C57BL/6 mice were transferred into lethally irradiated BALB/c recipients, and the course of GvHD and survival were monitored. Transplanted recipients developed severe GvHD that was strongly ameliorated by the transfer of donor T-reg cells. Towards the underlying mechanisms, in vitro studies revealed that T-reg communicated with DCs via gap junctions, resulting in functional inactivation of DC by a metabolic pathway involving cAMP that is modulated by the phosphodiesterase (PDE) 4 inhibitor rolipram. PDE2 or PDE3 inhibitors as well as rolipram suppressed allogeneic T cell activation, indirectly by enhancing T-reg mediated suppression of DC activation and directly by inhibiting responder T cell proliferation. In line with this, we observed a cooperative suppression of GvHD upon T-reg transfer and additional rolipram treatment. In conclusion, we propose that an important pathway of T-reg mediated control of GvHD is based on a cAMP dependent mechanism. These data provide the basis for future concepts to manipulate allogeneic T cell responses to prevent GvHD.	[Weber, Michael; Lupp, Corinna; Stein, Pamela; Bopp, Tobias; Schmitt, Edgar; Schild, Hansjoerg] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Immunol, D-55122 Mainz, Germany; [Kreft, Andreas; Wehler, Thomas C.] Johannes Gutenberg Univ Mainz, Med Ctr, Inst Pathol, D-55122 Mainz, Germany; [Radsak, Markus P.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 3, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Radsak, MP (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 3, D-55122 Mainz, Germany.	radsak@uni-mainz.de	Wehler, Thomas Christian/AAY-6362-2020; Bopp, Tobias/A-4328-2018; Radsak, Markus P/L-3651-2013	Bopp, Tobias/0000-0002-3232-8065; Radsak, Markus P/0000-0002-3991-5721	Deutsche Forschungsgemeinschaft [Ra988/4-2]; International Graduate School of Immunotherapy [GRK 1043]; "Forschungszentrum Immunologie (FZI)'' of the University medical center;  [SFB TR52 TPA1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School of Immunotherapy; "Forschungszentrum Immunologie (FZI)'' of the University medical center; 	This work was supported by grants from the Deutsche Forschungsgemeinschaft to M. P. R. and H. S. (Ra988/4-2), SFB TR52 TPA1 (T. B. and E. S.), the GRK 1043 International Graduate School of Immunotherapy (E. S. and T. B.), "Forschungszentrum Immunologie (FZI)'' of the University medical center (H. S., E. S. and T. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluestone JA, 2003, NAT REV IMMUNOL, V3, P253, DOI 10.1038/nri1032; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Bopp T, 2009, J IMMUNOL, V182, P4017, DOI 10.4049/jimmunol.0803310; Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Evans WH, 2001, BIOCHEM SOC T, V29, P606, DOI 10.1042/BST0290606; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Fassbender M, 2010, CELL IMMUNOL, V265, P91, DOI 10.1016/j.cellimm.2010.07.007; Fehr T, 2005, EUR J IMMUNOL, V35, P2679, DOI 10.1002/eji.200526190; Feng G, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002099; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Kearley J, 2005, J EXP MED, V202, P1539, DOI 10.1084/jem.20051166; Klein M, 2012, J IMMUNOL, V188, P1091, DOI 10.4049/jimmunol.1102045; KOLB HJ, 1995, BLOOD, V86, P2041, DOI 10.1182/blood.V86.5.2041.bloodjournal8652041; Kurtz J, 2004, BLOOD, V103, P4336, DOI 10.1182/blood-2003-08-2642; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Neijssen J, 2005, NATURE, V434, P83, DOI 10.1038/nature03290; O'Shaughnessy MJ, 2007, BIOL BLOOD MARROW TR, V13, P530, DOI 10.1016/j.bbmt.2007.01.071; Onizuka S, 1999, CANCER RES, V59, P3128; Ring S, 2010, J ALLERGY CLIN IMMUN, V125, P237, DOI 10.1016/j.jaci.2009.10.025; Rowe V, 2006, BLOOD, V108, P2485, DOI 10.1182/blood-2006-04-016063; Ruedl C, 1996, EUR J IMMUNOL, V26, P1801, DOI 10.1002/eji.1830260821; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sela U, 2011, J EXP MED, V208, P2489, DOI 10.1084/jem.20110466; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Tawara I, 2010, J IMMUNOL, V185, P3866, DOI 10.4049/jimmunol.1001625; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Vaeth M, 2012, P NATL ACAD SCI USA, V109, P16258, DOI 10.1073/pnas.1203870109; Vela-Ojeda J, 2010, STEM CELLS DEV, V19, P333, DOI 10.1089/scd.2009.0216; Warger T, 2006, BLOOD, V108, P544, DOI 10.1182/blood-2005-10-4015; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yi TS, 2011, J IMMUNOL, V186, P2739, DOI 10.4049/jimmunol.1002939; Zeiser R, 2006, BLOOD, V108, P390, DOI 10.1182/blood-2006-01-0329; Zhai YA, 2006, J IMMUNOL, V176, P5988, DOI 10.4049/jimmunol.176.10.5988	41	13	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58110	10.1371/journal.pone.0058110	http://dx.doi.org/10.1371/journal.pone.0058110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23483980	Green Published, gold, Green Submitted			2022-12-27	WOS:000316936100077
J	Besser, MJ; Shoham, T; Harari-Steinberg, O; Zabari, N; Ortenberg, R; Yakirevitch, A; Nagler, A; Loewenthal, R; Schachter, J; Markel, G				Besser, Michal J.; Shoham, Tsipi; Harari-Steinberg, Orit; Zabari, Naama; Ortenberg, Rona; Yakirevitch, Arkadi; Nagler, Arnon; Loewenthal, Ron; Schachter, Jacob; Markel, Gal			Development of Allogeneic NK Cell Adoptive Transfer Therapy in Metastatic Melanoma Patients: In Vitro Preclinical Optimization Studies	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; RECEPTOR; LYSIS; CYTOTOXICITY; NKG2D; HEMAGGLUTININS; ALLOREACTIVITY; POLYMORPHISMS; RECOGNITION; ACTIVATION	Natural killer (NK) cells have long been considered as potential agents for adoptive cell therapy for solid cancer patients. Until today most studies utilized autologous NK cells and yielded disappointing results. Here we analyze various modular strategies to employ allogeneic NK cells for adoptive cell transfer, including donor-recipient HLA-C mismatching, selective activation and induction of melanoma-recognizing lysis receptors, and co-administration of antibodies to elicit antibody-dependent cell cytotoxicity (ADCC). We show that NK cell activation and induction of the relevant lysis receptors, as well as co-administration of antibodies yield substantial anti-cancer effects, which are functionally superior to HLA-C mismatching. Combination of the various strategies yielded improved effects. In addition, we developed various clinically-compatible ex vivo expansion protocols that were optimized according to fold expansion, purity and expression of lysis receptors. The main advantages of employing allogeneic NK cells are accessibility, the ability to use a single donor for many patients, combination with various strategies associated with the mechanism of action, e. g. antibodies and specific activation, as well as donor selection according to HLA or CD16 genotypes. This study rationalizes a clinical trial that combines adoptive transfer of highly potent allogeneic NK cells and antibody therapy.	[Besser, Michal J.; Harari-Steinberg, Orit; Zabari, Naama; Ortenberg, Rona; Schachter, Jacob; Markel, Gal] Chaim Sheba Med Ctr, Ella Inst Melanoma, IL-52621 Tel Hashomer, Israel; [Besser, Michal J.; Zabari, Naama; Ortenberg, Rona; Markel, Gal] Tel Aviv Univ, Dept Clin Microbiol & Immunol, Sackler Fac Med, GreenOnyx, Tel Aviv, Israel; [Shoham, Tsipi] GreenOnyx, Tel Aviv, Israel; [Harari-Steinberg, Orit] Chaim Sheba Med Ctr, Pediat Stem Cell Res Inst, IL-52621 Tel Hashomer, Israel; [Yakirevitch, Arkadi] Chaim Sheba Med Ctr, Dept Otolaryngol & Head & Neck Surg, IL-52621 Tel Hashomer, Israel; [Nagler, Arnon] Chaim Sheba Med Ctr, Div Hematol, IL-52621 Tel Hashomer, Israel; [Loewenthal, Ron] Chaim Sheba Med Ctr, Tissue Typing Lab, IL-52621 Tel Hashomer, Israel; [Markel, Gal] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Markel, G (corresponding author), Chaim Sheba Med Ctr, Ella Inst Melanoma, IL-52621 Tel Hashomer, Israel.	markel@post.tau.ac.il		Yakirevitch, Arkadi/0000-0002-2540-3549				Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Bachanova V, 2010, CANCER IMMUNOL IMMUN, V59, P1739, DOI 10.1007/s00262-010-0896-z; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Bibeau F, 2009, J CLIN ONCOL, V27, P1122, DOI 10.1200/JCO.2008.18.0463; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2011, NAT REV DRUG DISCOV, V10, P811, DOI 10.1038/nrd3579; Frohn C, 2000, J IMMUNOTHER, V23, P499, DOI 10.1097/00002371-200007000-00014; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001; Hatjiharissi E, 2007, BLOOD, V110, P2561, DOI 10.1182/blood-2007-01-070656; Hodi MS, 2012, J CLIN ONCOL S, V30; Igarashi T, 2004, BLOOD, V104, P170, DOI 10.1182/blood-2003-12-4438; Kono K, 2002, CANCER RES, V62, P5813; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Ledford H, 2011, NATURE, V471, P561, DOI 10.1038/471561a; Leibson PJ, 1997, IMMUNITY, V6, P655, DOI 10.1016/S1074-7613(00)80441-0; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Mandelboim O, 1999, P NATL ACAD SCI USA, V96, P5640, DOI 10.1073/pnas.96.10.5640; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Levy EM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/676198; Markel G, 2002, J IMMUNOL, V168, P2803, DOI 10.4049/jimmunol.168.6.2803; Markel G, 2010, CANCER IMMUNOL IMMUN, V59, P215, DOI 10.1007/s00262-009-0740-5; Markel G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005597; Markel G, 2009, IMMUNOLOGY, V126, P186, DOI 10.1111/j.1365-2567.2008.02888.x; McKenna David H, 2012, Methods Mol Biol, V882, P491, DOI 10.1007/978-1-61779-842-9_28; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Moretta A, 2008, IMMUNOL REV, V224, P58, DOI 10.1111/j.1600-065X.2008.00651.x; Moretta L, 2004, CURR OPIN IMMUNOL, V16, P626, DOI 10.1016/j.coi.2004.07.010; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Murphy WJ, 2012, BIOL BLOOD MARROW TR, V18, pS2, DOI 10.1016/j.bbmt.2011.10.033; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Parham P, 2006, IMMUNOL REV, V214, P155, DOI 10.1111/j.1600-065X.2006.00462.x; Parkhurst MR, 2011, CLIN CANCER RES, V17, P6287, DOI 10.1158/1078-0432.CCR-11-1347; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Roda-Navarro P, 2006, P NATL ACAD SCI USA, V103, P11258, DOI 10.1073/pnas.0600721103; Rosenberg SA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003634; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Scott Andrew M, 2005, Cancer Immun, V5, P3; VANDEGRIEND RJ, 1987, J IMMUNOL, V138, P3137; Weisdorf D, 2012, BIOL BLOOD MARROW TR, V18, P937, DOI 10.1016/j.bbmt.2011.11.024; Welte S, 2006, NAT IMMUNOL, V7, P1334, DOI 10.1038/ni1402	52	22	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2013	8	3							e57922	10.1371/journal.pone.0057922	http://dx.doi.org/10.1371/journal.pone.0057922			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	099PY	23483943	Green Submitted, gold, Green Published			2022-12-27	WOS:000315634900055
J	Ahmed, I; Greenwood, R; Costello, BD; Ratcliffe, NM; Probert, CS				Ahmed, Iftikhar; Greenwood, Rosemary; Costello, Ben de lacy; Ratcliffe, Norman M.; Probert, Chris S.			An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome	PLOS ONE			English	Article							ULCERATIVE-COLITIS; METHANE PRODUCTION; CALPROTECTIN; MARKERS; DISEASE; EPIDEMIOLOGY; INFLAMMATION; PERFORMANCE; BIOMARKERS; DIAGNOSIS	Diagnosing irritable bowel syndrome (IBS) can be a challenge; many clinicians resort to invasive investigations in order to rule out other diseases and reassure their patients. Volatile organic metabolites (VOMs) are emitted from feces; understanding changes in the patterns of these VOMs could aid our understanding of the etiology of the disease and the development of biomarkers, which can assist in the diagnosis of IBS. We report the first comprehensive study of the fecal VOMs patterns in patients with diarrhea-predominant IBS (IBS-D), active Crohn's disease (CD), ulcerative colitis (UC) and healthy controls. 30 patients with IBS-D, 62 with CD, 48 with UC and 109 healthy controls were studied. Diagnosis of IBS-D was made using the Manning criteria and all patients with CD and UC met endoscopic, histologic and/or radiologic criteria. Fecal VOMs were extracted by solid phase microextraction (SPME) and analyzed by gas chromatography-mass spectrometry (GC-MS). 240 VOMs were identified. Univariate analysis showed that esters of short chain fatty acids, cyclohexanecarboxylic acid and its ester derivatives were associated with IBS-D (p<0.05), while aldehydes were more abundant in IBD (p<0.05). A predictive model, developed by multivariate analysis, separated IBS-D from active CD, UC and healthy controls with a sensitivity of 94%, 96% and 90%; and a specificity of 82%, 80% and 80% respectively (p<0.05). The understanding of the derivation of these VOMs may cast light on the etiology of IBS-D and IBD. These data show that fecal VOMs analyses could contribute to the diagnosis of IBS-D, for which there is no laboratory test, as well as IBD.	[Ahmed, Iftikhar] Univ Bristol, Bristol Royal Infirm, Dept Gastroenterol, Bristol, Avon, England; [Greenwood, Rosemary] Bristol Royal Infirm & Gen Hosp, Dept Res & Dev, Bristol, Avon, England; [Costello, Ben de lacy; Ratcliffe, Norman M.] Univ W England, Dept Appl Sci, Bristol BS16 1QY, Avon, England; [Probert, Chris S.] Univ Liverpool, Dept Gastroenterol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	Bristol Royal Infirmary; University of Bristol; Bristol Royal Infirmary; University of West England; University of Liverpool	Ratcliffe, NM (corresponding author), Univ W England, Dept Appl Sci, Bristol BS16 1QY, Avon, England.	norman.ratcliffe@uwe.ac.uk	De Lacy Costello, Ben/I-8259-2019; de Lacy Costello, Ben/ABG-2043-2021	de Lacy Costello, Ben/0000-0003-2999-6801; Probert, Christopher/0000-0003-4550-0239; Wu, Feibo/0000-0001-8797-3398	University of Bristol	University of Bristol	Iftikhar Ahmed received research fellowship from University of Bristol. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BP, 2012, GASTROENTEROL CLIN N, V41, P483, DOI 10.1016/j.gtc.2012.01.007; Ahmed I, 2011, THESIS U BRISTOL; Ali F, 2007, GUT, V56, P1, DOI 10.1136/gut.2006.117598; Azpiroz F, 2007, NEUROGASTROENT MOTIL, V19, P62, DOI 10.1111/j.1365-2982.2006.00875.x; Chang L, 2004, ALIMENT PHARM THER, V20, P31, DOI 10.1111/j.1365-2036.2004.02183.x; Codling C, 2010, DIGEST DIS SCI, V55, P392, DOI 10.1007/s10620-009-0934-x; Costa F, 2005, GUT, V54, P364, DOI 10.1136/gut.2004.043406; Costello BDL, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037023; D'Inca R, 2008, AM J GASTROENTEROL, V103, P2007, DOI 10.1111/j.1572-0241.2008.01870.x; De Preter V, 2011, MOL NUTR FOOD RES, V55, P714, DOI 10.1002/mnfr.201000442; Sanchez MDG, 2006, MED CLIN-BARCELONA, V127, P41; Dixon E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018471; Drossman DA, 2005, GASTROENTEROLOGY, V128, P580, DOI 10.1053/j.gastro.2004.12.006; Drossman Douglas A, 2006, Chin J Dig Dis, V7, P181, DOI 10.1111/j.1443-9573.2006.00265.x; Durant JA, 1997, ANAEROBE, V3, P391, DOI 10.1006/anae.1997.0129; Elia M, 2008, ALIMENT PHARM THER, V27, P120, DOI 10.1111/j.1365-2036.2007.03544.x; Furnari M, 2012, J GASTROINTEST LIVER, V21, P157; Garcia-Sanchez V, 2010, J CROHNS COLITIS, V4, P144, DOI 10.1016/j.crohns.2009.09.008; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Garner CE, 2009, J PEDIATR GASTR NUTR, V49, P559, DOI 10.1097/MPG.0b013e3181a3bfbc; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; Gonlachanvit S, 2004, GUT, V53, P1577, DOI 10.1136/gut.2004.041632; Grundy D, 2006, GASTROENTEROLOGY, V130, P1391, DOI 10.1053/j.gastro.2005.11.060; HARVEY RF, 1980, LANCET, V1, P514; HEGAZI F Z, 1980, Zentralblatt fuer Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene Zweite Naturwissenschaftliche Abteilung Mikrobiologie der Landwirtschaft der Technologie und des Umweltschutzes, V135, P212; Jones J, 2000, GUT, V47, pII1, DOI 10.1136/gut.47.suppl_2.ii1; Kajander K, 2009, WORLD J GASTROENTERO, V15, P6068, DOI 10.3748/wjg.15.6068; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; Maxion-Bergemann S, 2006, PHARMACOECONOMICS, V24, P21, DOI 10.2165/00019053-200624010-00002; Mulak A, 2004, MED SCI MONITOR, V10, pRA55; Ong DK, J GASTROENTEROL HEPA, V25, P1366; Oresic M, 2006, EXPERT REV MOL DIAGN, V6, P575, DOI 10.1586/14737159.6.4.575; Otten CMT, 2008, CLIN CHEM LAB MED, V46, P1275, DOI 10.1515/CCLM.2008.246; Pelli MA, 1999, DIS COLON RECTUM, V42, P71, DOI 10.1007/BF02235186; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; Phillips Michael, 2003, Breast J, V9, P184, DOI 10.1046/j.1524-4741.2003.09309.x; Pimentel M, 2003, DIGEST DIS SCI, V48, P86, DOI 10.1023/A:1021738515885; Probert CSJ, 2009, J GASTROINTEST LIVER, V18, P337; Probert CSJ, 2004, GUT, V53, P58, DOI 10.1136/gut.53.1.58; Quigley EMM, 2006, DIGEST LIVER DIS, V38, P717, DOI 10.1016/j.dld.2006.05.009; Quigley Eamonn M M, 2005, Chin J Dig Dis, V6, P122, DOI 10.1111/j.1443-9573.2005.00202.x; Reddymasu SC, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-23; SANDLER RS, 1990, GASTROENTEROLOGY, V99, P409, DOI 10.1016/0016-5085(90)91023-Y; Schlotterbeck G, 2006, PHARMACOGENOMICS, V7, P1055, DOI 10.2217/14622416.7.7.1055; Schoepfer AM, 2008, INFLAMM BOWEL DIS, V14, P32, DOI 10.1002/ibd.20275; SEO M, 1995, AM J GASTROENTEROL, V90, P1759; Shen Q, 2011, EUROPEAN J NUTR, P1; Silberer H, 2005, CLIN LAB, V51, P117; Staudacher HM, 2011, J HUM NUTR DIET, V24, P487, DOI 10.1111/j.1365-277X.2011.01162.x; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x; Tibble JA, 2002, GASTROENTEROLOGY, V123, P450, DOI 10.1053/gast.2002.34755; Whitehead WE, 2010, AM J GASTROENTEROL, V105, P814, DOI 10.1038/ajg.2010.56; Xue RY, 2008, RAPID COMMUN MASS SP, V22, P1181, DOI 10.1002/rcm.3466; Zumarraga L, 1997, ALIMENT PHARM THERAP, V11, P1067, DOI 10.1046/j.1365-2036.1997.00250.x	57	188	193	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58204	10.1371/journal.pone.0058204	http://dx.doi.org/10.1371/journal.pone.0058204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	115YY	24205003	Green Published, Green Submitted, gold			2022-12-27	WOS:000316849200042
J	Yu, JH; Peng, Y; Wu, LC; Xie, ZL; Deng, YC; Hughes, T; He, S; Mo, XK; Chiu, M; Wang, QE; He, XM; Liu, SJ; Grever, MR; Chan, KK; Liu, ZF				Yu, Jianhua; Peng, Yong; Wu, Lai-Chu; Xie, Zhiliang; Deng, Youcai; Hughes, Tiffany; He, Shun; Mo, XiaoKui; Chiu, Ming; Wang, Qi-En; He, Xiaoming; Liu, Shujun; Grever, Michael R.; Chan, Kenneth K.; Liu, Zhongfa			Curcumin Down-Regulates DNA Methyltransferase 1 and Plays an Anti-Leukemic Role in Acute Myeloid Leukemia	PLOS ONE			English	Article							CANCER-THERAPY; METHYLATION; TRANSCRIPTION; INHIBITORS; ACETYLTRANSFERASE; HYPOMETHYLATION; DECITABINE; DELIVERY; TARGET; GENES	Bioactive components from dietary supplements such as curcumin may represent attractive agents for cancer prevention or treatment. DNA methylation plays a critical role in acute myeloid leukemia (AML) development, and presents an excellent target for treatment of this disease. However, it remains largely unknown how curcumin, a component of the popular Indian spice turmeric, plays a role in DNA hypomethylation to reactivate silenced tumor suppressor genes and to present a potential treatment option for AML. Here we show that curcumin down-regulates DNMT1 expression in AML cell lines, both in vitro and in vivo, and in primary AML cells ex vivo. Mechanistically, curcumin reduced the expression of positive regulators of DNMT1, p65 and Sp1, which correlated with a reduction in binding of these transcription factors to the DNMT1 promoter in AML cell lines. This curcumin-mediated down-regulation of DNMT1 expression was concomitant with p15(INK4B) tumor suppressor gene reactivation, hypomethylation of the p15(INK4B) promoter, G1 cell cycle arrest, and induction of tumor cell apoptosis in vitro. In mice implanted with the human AML MV4-11 cell line, administration of curcumin resulted in remarkable suppression of AML tumor growth. Collectively, our data indicate that curcumin shows promise as a potential treatment for AML, and our findings provide a basis for future studies to test the clinical efficacy of curcumin - whether used as a single agent or as an adjuvant - for AML treatment.	[Yu, Jianhua; Grever, Michael R.] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Yu, Jianhua; Peng, Yong; Wu, Lai-Chu; Deng, Youcai; Hughes, Tiffany; He, Shun; Wang, Qi-En; He, Xiaoming; Grever, Michael R.; Chan, Kenneth K.; Liu, Zhongfa] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Wu, Lai-Chu] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Xie, Zhiliang; Chiu, Ming; Chan, Kenneth K.; Liu, Zhongfa] Ohio State Univ, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA; [Deng, Youcai] Third Mil Med Univ, Coll Pharm, Chongqing, Peoples R China; [Mo, XiaoKui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [He, Xiaoming] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Liu, Shujun] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Army Medical University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Minnesota System	Yu, JH (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA.	Jianhua.yu@osumc.edu; liu.550@osu.edu	Wu, Lai-Chu/E-4328-2011; Liu, Zhongfa/G-8549-2013; He, Xiaoming/C-5499-2008; Deng, Youcai/GZK-9548-2022; He, Shun/K-7448-2014	Wu, Lai-Chu/0000-0002-1348-269X; He, Xiaoming/0000-0003-0125-6086; Deng, Youcai/0000-0001-5488-8576; Ye, Xiaojian/0000-0003-2402-5782; He, Dannong/0000-0003-4921-1063; Li, Kai/0000-0001-5436-4836; Wang, Meiyan/0000-0002-2118-6647	U.S. National Institutes of Health (NIH) [CA155521, CA135478]; Experimental Therapeutic Program seed grant; Biomedical Mass Spectrometric Laboratory at The Ohio State University; American Cancer Society [IRG-67-003-47]; National Blood Foundation Scientific Research Grant; NATIONAL CANCER INSTITUTE [R01CA151248, R01CA155521, P30CA016058, R21CA135478] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000090] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Experimental Therapeutic Program seed grant; Biomedical Mass Spectrometric Laboratory at The Ohio State University; American Cancer Society(American Cancer Society); National Blood Foundation Scientific Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the U.S. National Institutes of Health (NIH) grants CA155521 (to JY) and CA135478 (to ZL), the Experimental Therapeutic Program seed grant (to ZL), and the Biomedical Mass Spectrometric Laboratory (KKC and ZL) at The Ohio State University. It was also supported in part by Grant # IRG-67-003-47 from the American Cancer Society and by a National Blood Foundation Scientific Research Grant (both to JY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Blum William, 2005, Clin Adv Hematol Oncol, V3, P855; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chim CS, 2006, LEUKEMIA LYMPHOMA, V47, P815, DOI 10.1080/10428190500513827; Christiansen DH, 2003, LEUKEMIA, V17, P1813, DOI 10.1038/sj.leu.2403054; de Vos D, 2005, ANN HEMATOL, V84, P3, DOI 10.1007/s00277-005-0008-x; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Fu SQ, 2010, CANCER-AM CANCER SOC, V116, P4670, DOI 10.1002/cncr.25414; Grovdal M, 2007, CLIN CANCER RES, V13, P7107, DOI 10.1158/1078-0432.CCR-07-1193; Issa JPJ, 2007, CLIN CANCER RES, V13, P1634, DOI 10.1158/1078-0432.CCR-06-2076; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Li Xin-gang, 2005, Zhonghua Xue Ye Xue Za Zhi, V26, P551; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Liu Z, 2009, ANAL BIOCH; Liu ZF, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1156; Liu ZF, 2012, CANCER CHEMOTH PHARM, V69, P679, DOI 10.1007/s00280-011-1749-y; Liu ZF, 2009, BIOORG MED CHEM LETT, V19, P706, DOI 10.1016/j.bmcl.2008.12.041; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Melisi D, 2007, EXPERT OPIN THER TAR, V11, P133, DOI 10.1517/14728222.11.2.133; Menon VP, 2007, ADV EXP MED BIOL, V595, P105; Moiseeva EP, 2007, MOL CANCER THER, V6, P3071, DOI 10.1158/1535-7163.MCT-07-0117; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Plass C, 2008, SEMIN ONCOL, V35, P378, DOI 10.1053/j.seminoncol.2008.04.008; Pouton CW, 2000, EUR J PHARM SCI, V11, pS93, DOI 10.1016/S0928-0987(00)00167-6; Reuter S, 2011, GENES NUTR, V6, P93, DOI 10.1007/s12263-011-0222-1; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; Shishodia S, 2007, ADV EXP MED BIOL, V595, P127; Siedlecki P, 2006, J MED CHEM, V49, P678, DOI 10.1021/jm050844z; Singh Sarvjeet, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P259, DOI 10.2174/187152006776930918; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; vanIersel MLPS, 1996, CHEM-BIOL INTERACT, V102, P117, DOI 10.1016/S0009-2797(96)03739-8; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yoo CB, 2007, CANCER RES, V67, P6400, DOI 10.1158/0008-5472.CAN-07-0251	36	104	111	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2013	8	2							e55934	10.1371/journal.pone.0055934	http://dx.doi.org/10.1371/journal.pone.0055934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	104DM	23483914	Green Submitted, gold, Green Published			2022-12-27	WOS:000315970300068
J	Zhang, LF; Thomas, JC; Miragaia, M; Bouchami, O; Chaves, F; d'Azevedo, PA; Aanensen, DM; de Lencastre, H; Gray, BM; Robinson, DA				Zhang, Liangfen; Thomas, Jonathan C.; Miragaia, Maria; Bouchami, Ons; Chaves, Fernando; d'Azevedo, Pedro A.; Aanensen, David M.; de Lencastre, Herminia; Gray, Barry M.; Robinson, D. Ashley			Multilocus Sequence Typing and Further Genetic Characterization of the Enigmatic Pathogen, Staphylococcus hominis	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; METHICILLIN-RESISTANT; LEVEL RESISTANCE; BLOOD CULTURES; IDENTIFICATION; NOVOBIOCIN; EMERGENCE; SKIN; INFECTIONS	Staphylococcus hominis is a commensal resident of human skin and an opportunistic pathogen. The species is subdivided into two subspecies, S. hominis subsp. hominis and S. hominis subsp. novobiosepticus, which are difficult to distinguish. To investigate the evolution and epidemiology of S. hominis, a total of 108 isolates collected from 10 countries over 40 years were characterized by classical phenotypic methods and genetic methods. One nonsynonymous mutation in gyrB, scored with a novel SNP typing assay, had a perfect association with the novobiocin-resistant phenotype. A multilocus sequence typing (MLST) scheme was developed from six housekeeping gene fragments, and revealed relatively high levels of genetic diversity and a significant impact of recombination on S. hominis population structure. Among the 40 sequence types (STs) identified by MLST, three STs (ST2, ST16 and ST23) were S. hominis subsp. novobiosepticus, and they distinguished between isolates from different outbreaks, whereas 37 other STs were S. hominis subsp. hominis, one of which was widely disseminated (ST1). A modified PCR assay was developed to detect the presence of ccrAB4 from the SCCmec genetic element. S. hominis subsp. novobiosepticus isolates were oxacillin-resistant and carriers of specific components of SCCmec (mecA class A, ccrAB3, ccrAB4, ccrC), whereas S. hominis subsp. hominis included both oxacillin-sensitive and -resistant isolates and a more diverse array of SCCmec components. Surprisingly, phylogenetic analyses indicated that S. hominis subsp. novobiosepticus may be a polyphyletic and, hence, artificial taxon. In summary, these results revealed the genetic diversity of S. hominis, the identities of outbreak-causing clones, and the evolutionary relationships between subspecies and clones. The pathogenic lifestyle attributed to S. hominis subsp. novobiosepticus may have originated on more than one occasion.	[Zhang, Liangfen; Thomas, Jonathan C.; Robinson, D. Ashley] Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA; [Miragaia, Maria; Bouchami, Ons; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Chaves, Fernando] Hosp Univ 12 Octubre, Microbiol Serv, Madrid, Spain; [d'Azevedo, Pedro A.] Univ Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, Brazil; [Aanensen, David M.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Gray, Barry M.] Univ Illinois, Dept Pediat, Peoria, IL USA	University of Mississippi; University of Mississippi Medical Center; Universidade Nova de Lisboa; Hospital Universitario 12 de Octubre; Universidade Federal de Ciencias da Saude de Porto Alegre; Imperial College London; Rockefeller University; University of Illinois System; University of Illinois Peoria	Robinson, DA (corresponding author), Univ Mississippi, Med Ctr, Dept Microbiol, Jackson, MS 39216 USA.	darobinson@umc.edu	Miragaia, Maria/J-2704-2015; Chaves, Fernando/C-6176-2016	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Bouchami, Ons/0000-0002-9425-3513; Thomas, Jonathan/0000-0002-1599-9123	National Institutes of Health [GM080602]; Spanish Network for Research in Infectious Diseases [RD06/0008]; Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/BIA-EVF/117507/2010, Pest-OE/EQB/LAO004/2011]; NIGMS NIH HHS [R01 GM080602, GM080602] Funding Source: Medline	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Network for Research in Infectious Diseases; Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grant GM080602 from the National Institutes of Health (to DAR) and grant RD06/0008 from the Spanish Network for Research in Infectious Diseases (to FC). The work performed in Portugal was supported by grants PTDC/BIA-EVF/117507/2010 (to MM) and grant #Pest-OE/EQB/LAO004/2011 (to ITQB) from Fundacao para a Ciencia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannoehr J, 2007, J BACTERIOL, V189, P8685, DOI 10.1128/JB.01150-07; Bouchami O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021940; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavanagh JP, 2012, J MICROBIOL METH, V89, P159, DOI 10.1016/j.mimet.2012.03.014; Chassain B, 2012, J CLIN MICROBIOL, V50, P3003, DOI 10.1128/JCM.00988-12; Chen LA, 2010, ANTIMICROB AGENTS CH, V54, P3347, DOI 10.1128/AAC.00001-10; CLSI, 2007, M100S17 CLSI; Cunha BA, 2007, HEART LUNG, V36, P380, DOI 10.1016/j.hrtlng.2006.11.002; d'Azevedo PA, 2008, J MED MICROBIOL, V57, P256, DOI 10.1099/jmm.0.47345-0; Santos OCDS, 2009, DIAGN MICR INFEC DIS, V64, P1, DOI 10.1016/j.diagmicrobio.2008.12.017; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELLENDER RD, 1995, J FOOD PROTECT, V58, P853, DOI 10.4315/0362-028X-58.8.853; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; FAGHRI MA, 1984, APPL ENVIRON MICROB, V47, P1054, DOI 10.1128/AEM.47.5.1054-1061.1984; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fitzgibbon JE, 2001, RES MICROBIOL, V152, P805, DOI 10.1016/S0923-2508(01)01264-5; Fournier B, 1998, ANTIMICROB AGENTS CH, V42, P121, DOI 10.1128/AAC.42.1.121; Fujimoto-Nakamura M, 2005, ANTIMICROB AGENTS CH, V49, P3810, DOI 10.1128/AAC.49.9.3810-3815.2005; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Garza-Gonzalez E, 2011, SCAND J INFECT DIS, V43, P930, DOI 10.3109/00365548.2011.598873; Gilad J, 2007, J CLIN MICROBIOL, V45, P685, DOI 10.1128/JCM.02228-06; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; GUNN BA, 1983, INT J SYST BACTERIOL, V33, P751, DOI 10.1099/00207713-33-4-751; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Heikens E, 2005, J CLIN MICROBIOL, V43, P2286, DOI 10.1128/JCM.43.5.2286-2290.2005; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Iyer MN, 2005, AM J OPHTHALMOL, V139, P930, DOI 10.1016/j.ajo.2004.10.060; Katayama Y, 2003, J BACTERIOL, V185, P2711, DOI 10.1128/JB.185.9.2711-2722.2003; Kim SD, 2000, INFECT CONT HOSP EP, V21, P213, DOI 10.1086/501747; KLOOS WE, 1975, J CLIN MICROBIOL, V1, P82, DOI 10.1128/JCM.1.1.82-88.1975; Kloos WE, 1998, INT J SYST BACTERIOL, V48, P799, DOI 10.1099/00207713-48-3-799; KLOOS WE, 1975, INT J SYST BACTERIOL, V25, P62, DOI 10.1099/00207713-25-1-62; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117, DOI 10.1128/CMR.7.1.117-140.1994; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Larson EL, 1998, AM J INFECT CONTROL, V26, P513, DOI 10.1016/S0196-6553(98)70025-2; Lebeaux D, 2012, ANTIMICROB AGENTS CH, V56, P315, DOI 10.1128/AAC.00547-11; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Oliveira DC, 2006, ANTIMICROB AGENTS CH, V50, P3457, DOI 10.1128/AAC.00629-06; Petinaki E, 2005, J ANTIMICROB CHEMOTH, V55, P811, DOI 10.1093/jac/dki072; Robinson DA, 2003, ANTIMICROB AGENTS CH, V47, P3926, DOI 10.1128/AAC.47.12.3926-3934.2003; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; Ruhe J, 2004, EUR J CLIN MICROBIOL, V23, P495, DOI 10.1007/s10096-004-1134-4; de Gopegui ER, 2011, ENFERM INFEC MICR CL, V29, P339, DOI 10.1016/j.eimc.2011.02.001; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; SMITH JM, 1994, J EVOLUTION BIOL, V7, P525, DOI 10.1046/j.1420-9101.1994.7050525.x; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Thomas JC, 2007, J CLIN MICROBIOL, V45, P616, DOI 10.1128/JCM.01934-06; Palazzo ICV, 2008, J ANTIMICROB CHEMOTH, V62, P1222, DOI 10.1093/jac/dkn375; Vickers AA, 2007, ANTIMICROB AGENTS CH, V51, P4484, DOI 10.1128/AAC.00708-07; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weinstein MP, 1998, J CLIN MICROBIOL, V36, P2089, DOI 10.1128/JCM.36.7.2089-2092.1998; Wohoush A, 2011, CLIN MICROBIOL INFEC, V17, P569, DOI 10.1111/j.1469-0691.2010.03372.x; Zhang LF, 2012, J MOL EVOL, V75, P43, DOI 10.1007/s00239-012-9520-5	63	59	65	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2013	8	6							e66496	10.1371/journal.pone.0066496	http://dx.doi.org/10.1371/journal.pone.0066496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	169CU	23776678	Green Published, Green Submitted, gold			2022-12-27	WOS:000320755400148
J	Goblirsch, M; Huang, ZY; Spivak, M				Goblirsch, Mike; Huang, Zachary Y.; Spivak, Marla			Physiological and Behavioral Changes in Honey Bees (Apis mellifera) Induced by Nosema ceranae Infection	PLOS ONE			English	Article							DIVISION-OF-LABOR; JUVENILE-HORMONE; HYPOPHARYNGEAL GLANDS; WORKER HONEYBEES; EUSOCIAL INSECT; LIFE-SPAN; COLONIES; MICROSPORIDIA; VITELLOGENIN; PHEROMONE	Persistent exposure to mite pests, poor nutrition, pesticides, and pathogens threaten honey bee survival. In healthy colonies, the interaction of the yolk precursor protein, vitellogenin (Vg), and endocrine factor, juvenile hormone (JH), functions as a pacemaker driving the sequence of behaviors that workers perform throughout their lives. Young bees perform nursing duties within the hive and have high Vg and low JH; as older bees transition to foraging, this trend reverses. Pathogens and parasites can alter this regulatory network. For example, infection with the microsporidian, Nosema apis, has been shown to advance behavioral maturation in workers. We investigated the effects of infection with a recent honey bee pathogen on physiological factors underlying the division of labor in workers. Bees infected with N. ceranae were nearly twice as likely to engage in precocious foraging and lived 9 days less, on average, compared to controls. We also show that Vg transcript was low, while JH titer spiked, in infected nurse-aged bees in cages. This pattern of expression is atypical and the reverse of what would be expected for healthy, non-infected bees. Disruption of the basic underpinnings of temporal polyethism due to infection may be a contributing factor to recent high colony mortality, as workers may lose flexibility in their response to colony demands.	[Goblirsch, Mike; Spivak, Marla] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	University of Minnesota System; University of Minnesota Twin Cities; Michigan State University	Goblirsch, M (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	goblirmj@umn.edu	Spivak, Marla/AAI-5088-2020; Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)-Coordinated Agricultural Project (CAP); North Central Region Sustainable Agriculture Research and Education (NCR-SARE); Eastern Apicultural Society	United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)-Coordinated Agricultural Project (CAP); North Central Region Sustainable Agriculture Research and Education (NCR-SARE); Eastern Apicultural Society	This research was supported by a United States Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA)-Coordinated Agricultural Project (CAP) grant awarded to MS and ZH and research grants from North Central Region Sustainable Agriculture Research and Education (NCR-SARE) and the Eastern Apicultural Society awarded to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Amdam GV, 2003, J THEOR BIOL, V223, P451, DOI 10.1016/S0022-5193(03)00121-8; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Amdam GV, 2011, NEUROBIOLOGY BEHAV H, P17; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Ares AM, 2012, J CHROMATOGR B, V899, P146, DOI 10.1016/j.jchromb.2012.05.016; Aronstein KA, 2011, J APICULT RES, V50, P145, DOI 10.3896/IBRA.1.50.2.06; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Blaser M, 2005, J INVERTEBR PATHOL, V89, P251, DOI 10.1016/j.jip.2005.04.004; Botias C, 2012, J INVERTEBR PATHOL, V110, P108, DOI 10.1016/j.jip.2012.02.014; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Chaimanee V, 2012, J INSECT PHYSIOL, V58, P1090, DOI 10.1016/j.jinsphys.2012.04.016; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Forsgren E, 2010, VET PARASITOL, V170, P212, DOI 10.1016/j.vetpar.2010.02.010; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; HASSANEIN MH, 1953, ANN APPL BIOL, V40, P418, DOI 10.1111/j.1744-7348.1953.tb01093.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Hurd H, 2001, P ROY SOC B-BIOL SCI, V268, P1749, DOI 10.1098/rspb.2001.1729; KAATZ HH, 1992, J COMP PHYSIOL B, V162, P588, DOI 10.1007/BF00296638; Medici SK, 2012, PARASITOL RES, V110, P859, DOI 10.1007/s00436-011-2566-2; LIU TP, 1990, TISSUE CELL, V22, P533, DOI 10.1016/0040-8166(90)90081-J; Mayack C, 2010, J INSECT PHYSIOL, V56, P1572, DOI 10.1016/j.jinsphys.2010.05.016; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; PAGE RE, 1992, BEHAV ECOL, V3, P173, DOI 10.1093/beheco/3.2.173; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sakagami SF, 1968, RES POPUL ECOL, V10; Schulz DJ, 1998, BEHAV ECOL SOCIOBIOL, V42, P295, DOI 10.1007/s002650050442; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; SEELEY TD, 1983, BEHAV ECOL SOCIOBIOL, V12, P253, DOI 10.1007/BF00290778; Smedal B, 2009, J EXP BIOL, V212, P3795, DOI 10.1242/jeb.035063; SOLTER LF, 1990, J INVERTEBR PATHOL, V55, P337, DOI 10.1016/0022-2011(90)90076-I; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Traver BE, 2012, J INVERTEBR PATHOL, V109, P187, DOI 10.1016/j.jip.2011.11.001; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; WANG DI, 1970, J ECON ENTOMOL, V63, P1539, DOI 10.1093/jee/63.5.1539; WANG DI, 1969, J INVERTEBR PATHOL, V14, P135, DOI 10.1016/0022-2011(69)90098-6; WINSTON ML, 1987, BIOL HONEY BEE, P89; Woyciechowski M, 2009, INSECT SOC, V56, P193, DOI 10.1007/s00040-009-0012-6	53	195	202	4	166	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 6	2013	8	3							e58165	10.1371/journal.pone.0058165	http://dx.doi.org/10.1371/journal.pone.0058165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	117EP	23894551	gold, Green Published			2022-12-27	WOS:000316936100082
J	Zhang, L; Zhang, DD; Yu, BW; Wang, SB; Liu, YL; Wang, J; Li, X; Shang, XY; Li, HY				Zhang, Ling; Zhang, Dandan; Yu, Baowen; Wang, Shangbo; Liu, Yanlin; Wang, Jian; Li, Xin; Shang, Xiaoyun; Li, Hongyuan			Prevalence of HIV Infection and Associated Risk Factors among Men Who Have Sex with Men (MSM) in Harbin, P. R. China	PLOS ONE			English	Article							EPIDEMIC; BEHAVIOR; HIV/AIDS; SHANGHAI; SYPHILIS	Objective: To assess the prevalence of HIV infection and characteristically risk of factors which associated with HIV infection among MSM in Harbin, China. Methods: A face-to-face questionnaire interview was conducted among 463 Men Who Have Sex with Men (MSM) who were recruited by the snowball sampling in Harbin from April, 2011 to July, 2011. The questionnaire mainly included demographics, AIDS knowledge, homosexual behavior and the status of intervention in MSM. Blood specimens were obtained and tested for the diagnoses of HIV, syphilis and hepatitis C virus (HCV). Associations between above exposed factors and HIV infection were analyzed using a univariate analysis and forward stepwise logistic regression. Results: The prevalence of HIV and syphilis was 9.5 and 14.3%. The awareness rate of AIDS was 86.8%. The rate of unprotected sexual behavior was 57.6% of MSM during the past 6 months. The univariate analysis identified that the age (age >= 35 years old), cohabitation, more than 10 years of homosexual behavior and more than 10 homosexual partners were risk factors which associated with the HIV infection, and that protected sex during the past 6 months was a protective factor for the HIV infection. The multivariate analysis identified that the duration of homosexual behavior and commercial sexual behavior were independent risk factors which associated with the HIV infection, and the protected sex during the past 6 months was a protective factor for the HIV infection. Conclusion: The prevalence of HIV among MSM in Harbin has been rapidly increasing in the past few years. Targeted, tailored, and comprehensive interventions are urgently needed to prevent the HIV infection from MSM.	[Zhang, Ling; Li, Xin; Shang, Xiaoyun; Li, Hongyuan] Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Peoples R China; [Zhang, Dandan] AntiTB Stn, Harbin, Peoples R China; [Yu, Baowen] Sanitat Supervis Stn, Harbin, Peoples R China; [Zhang, Ling; Wang, Shangbo; Liu, Yanlin; Wang, Jian] Ctr Dis Control & Prevent, Harbin, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention	Li, HY (corresponding author), Harbin Med Univ, Coll Publ Hlth, Dept Epidemiol, Harbin, Peoples R China.	lihongyuan00@126.com	Miragaia, Maria/J-2704-2015; Chaves, Fernando/C-6176-2016	Miragaia, Maria/0000-0002-1323-7184; /0000-0001-6816-8932; Bouchami, Ons/0000-0002-9425-3513; Thomas, Jonathan/0000-0002-1599-9123	NIGMS NIH HHS [R01 GM080602, GM080602] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adimora AA, 2006, SEX TRANSM DIS, V33, P596, DOI 10.1097/01.olq.0000233666.67788.fc; Center of control and prevention of STD and AIDS of Chinese Center for Disease Control and Prevention, 2007, CTR CONTR PREV STD A; China Ministry of Health, 2011, CHIN EST REP EN; China's Ministry of Health/ WHO / UNAIDS, 2005 UPD HIV AIDS EP; De Cock KM, 2012, AIDS, V26, P1205, DOI 10.1097/QAD.0b013e328354622a; Feng TJ, 2008, SEX TRANSM DIS, V35, P1022, DOI 10.1097/OLQ.0b013e31818600f4; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; He N, 2007, AIDS CARE, V19, P109, DOI 10.1080/09540120600888394; He Q, 2008, AIDS BEHAV, V12, pS93, DOI 10.1007/s10461-008-9388-y; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2008, SEX TRANSM DIS, V35, P406, DOI 10.1097/OLQ.0b013e318164467f; Li HM, 2011, PLOS ONE, V6; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Mi GD, 2007, AIDS, V21, pS67, DOI 10.1097/01.aids.0000304699.85379.32; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Office for AIDS prevention and control committee of the State Council, 2004, JOINT EV REP AIDS PR, P7; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Qian ZH, 2005, SEX TRANSM INFECT, V81, P442, DOI 10.1136/sti.2004.014258; Qiu RZ, 1997, AIDS SEXUAL ETHICS, P121; *STAT COUNC AIDS W, 2004, JOINT ASS HIV AIDS P; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Guevara WJU, 2012, J SEX MED, V9, P1634, DOI 10.1111/j.1743-6109.2012.02713.x; USAID, 2007, HLTH POL INT VAL INV; USAID, 2006, VAL INV MSM PROGR AS; WANG J, 2008, CHIN J AIDS STD, V14, P75; Wang Lan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P20; Wong FY, 2008, AIDS CARE, V20, P170, DOI 10.1080/09540120701534707; Xu Juan, 2010, Zhonghua Yu Fang Yi Xue Za Zhi, V44, P975; Zhang BC, 2012, CHIN J AIDS STD PREV, V8, P197; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015; Zhang XX, 2007, AIDS, V21, pS53, DOI 10.1097/01.aids.0000304697.39637.4c	33	59	65	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2013	8	3							e58440	10.1371/journal.pone.0058440	http://dx.doi.org/10.1371/journal.pone.0058440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	115YY	23776678	Green Published, gold, Green Submitted			2022-12-27	WOS:000316849200068
J	Kang, HS; Liao, G; DeGraff, LM; Gerrish, K; Bortner, CD; Garantziotis, S; Jetten, AM				Kang, Hong Soon; Liao, Grace; DeGraff, Laura M.; Gerrish, Kevin; Bortner, Carl D.; Garantziotis, Stavros; Jetten, Anton M.			CD44 Plays a Critical Role in Regulating Diet-Induced Adipose Inflammation, Hepatic Steatosis, and Insulin Resistance	PLOS ONE			English	Article							GENE-EXPRESSION; MACROPHAGE ACCUMULATION; PROFILING REVEALS; LIVER STEATOSIS; ROR-ALPHA; OBESITY; OSTEOPONTIN; TISSUE; RECRUITMENT; HYALURONAN	CD44 is a multifunctional membrane receptor implicated in the regulation of several biological processes, including inflammation. CD44 expression is elevated in liver and white adipose tissue (WAT) during obesity suggesting a possible regulatory role for CD44 in metabolic syndrome. To study this hypothesis, we examined the effect of the loss of CD44 expression on the development of various features of metabolic syndrome using CD44 null mice. Our study demonstrates that CD44-deficient mice (CD44KO) exhibit a significantly reduced susceptibility to the development of high fat-diet (HFD)-induced hepatic steatosis, WAT-associated inflammation, and insulin resistance. The decreased expression of genes involved in fatty acid synthesis and transport (Fasn and Cd36), de novo triglyceride synthesis (Mogat1), and triglyceride accumulation (Cidea, Cidec) appears in part responsible for the reduced hepatic lipid accumulation in CD44KO(HFD) mice. In addition, the expression of various inflammatory and cell matrix genes, including several chemokines and its receptors, osteopontin, and several matrix metalloproteinases and collagen genes was greatly diminished in CD44KO(HFD) liver consistent with reduced inflammation and fibrogenesis. In contrast, lipid accumulation was significantly increased in CD44KO(HFD) WAT, whereas inflammation as indicated by the reduced infiltration of macrophages and expression of macrophage marker genes, was significantly diminished in WAT of CD44KO(HFD) mice compared to WT(HFD) mice. CD44KO(HFD) mice remained considerably more insulin sensitive and glucose tolerant than WT(HFD) mice and exhibited lower blood insulin levels. Our study indicates that CD44 plays a critical role in regulating several aspects of metabolic syndrome and may provide a new therapeutic target in the management of insulin resistance.	[Kang, Hong Soon; Liao, Grace; DeGraff, Laura M.; Jetten, Anton M.] NIH, Cell Biol Sect, Res Triangle Pk, NC USA; [Gerrish, Kevin] NIH, Microarray Grp, Res Triangle Pk, NC USA; [Bortner, Carl D.] NIEHS, Lab Signal Transduct, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Garantziotis, Stavros] NIH, Matrix Biol Sect, LRB, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA	Jetten, AM (corresponding author), NIH, Cell Biol Sect, Res Triangle Pk, NC USA.	jetten@niehs.nih.gov	yu, qing/HGC-4611-2022; Jetten, Anton/C-3736-2019; Yu, Qinghua/T-3261-2019; Garantziotis, Stavros/A-6903-2009	Jetten, Anton/0000-0003-0954-4445; Garantziotis, Stavros/0000-0003-4007-375X	Intramural Research Program of the NIEHS, NIH [Z01-ES-101586]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586, ZICES102445, ZIAES102605, ZICES102486, Z01ES101586] Funding Source: NIH RePORTER	Intramural Research Program of the NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the NIEHS, NIH (Z01-ES-101586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; Consolo M, 2009, INT J MOL MED, V24, P143, DOI 10.3892/ijmm_00000217; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fujii H, 2012, J GASTROENTEROL, V47, P215, DOI 10.1007/s00535-012-0527-x; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guillen N, 2009, PHYSIOL GENOMICS, V37, P187, DOI 10.1152/physiolgenomics.90339.2008; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hollingsworth JW, 2007, AM J RESP CELL MOL, V37, P248, DOI 10.1165/rcmb.2006-0363OC; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hursting SD, 2012, ARTERIOSCL THROM VAS, V32, P1766, DOI 10.1161/ATVBAHA.111.241927; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Kang HS, 2007, PHYSIOL GENOMICS, V31, P281, DOI 10.1152/physiolgenomics.00098.2007; Kang HS, 2011, PHYSIOL GENOMICS, V43, P818, DOI 10.1152/physiolgenomics.00206.2010; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Kitade H, 2012, DIABETES; Kodama K, 2012, P NATL ACAD SCI US; Li L, 2012, VITAM HORM, V90, P375, DOI 10.1016/B978-0-12-398313-8.00014-2; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mandrekar P, 2011, HEPATOLOGY, V54, P2185, DOI 10.1002/hep.24599; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Miletti-Gonzalez KE, 2012, J BIOL CHEM, V287, P18995, DOI 10.1074/jbc.M111.318774; Morimoto J, 2010, CURR DRUG TARGETS, V11, P494, DOI 10.2174/138945010790980321; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nakamachi T, 2007, DIABETES, V56, P1662, DOI 10.2337/db06-1177; Nicholls HT, 2011, DIABETES, V60, P1100, DOI 10.2337/db10-1353; Nio Y, 2012, DIABETOLOGIA; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Nystrom T, 2007, EXP CELL RES, V313, P1149, DOI 10.1016/j.yexcr.2006.12.026; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pivetta E, 2011, J CELL PHYSIOL, V226, P769, DOI 10.1002/jcp.22398; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schmits R, 1997, BLOOD, V90, P2217, DOI 10.1182/blood.V90.6.2217.2217_2217_2233; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Solis MA, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/346972; Toole BP, 2009, CLIN CANCER RES, V15, P7462, DOI 10.1158/1078-0432.CCR-09-0479; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Wan ZX, 2012, OBESITY, V20, P453, DOI 10.1038/oby.2011.252; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Zeyda M, 2011, ENDOCRINOLOGY, V152, P2219, DOI 10.1210/en.2010-1328; Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709; Zhou LK, 2012, HEPATOLOGY, V56, P95, DOI 10.1002/hep.25611; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zhu BQ, 2004, J CELL PHYSIOL, V198, P155, DOI 10.1002/jcp.10394; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	61	75	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 7	2013	8	3							e58417	10.1371/journal.pone.0058417	http://dx.doi.org/10.1371/journal.pone.0058417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	136BN	24391892	Green Published, Green Submitted, gold			2022-12-27	WOS:000318334500081
J	Caraiani, P; Haven, E				Caraiani, Petre; Haven, Emmanuel			The Role of Recurrence Plots in Characterizing the Output-Unemployment Relationship: An Analysis	PLOS ONE			English	Article							INFLATION; BUSINESS; EXPECTATIONS; DYNAMICS; CYCLES; STATES; RATES	We analyse the output-unemployment relationship using an approach based on cross-recurrence plots and quantitative recurrence analysis. We use post-war period quarterly U. S. data. The results obtained show the emergence of a complex and interesting relationship.	[Caraiani, Petre] Romanian Acad, Inst Econ Forecasting, Bucharest, Romania; [Haven, Emmanuel] Univ Leicester, Sch Management, Leicester, Leics, England; [Haven, Emmanuel] Univ Leicester, Inst Finance, Leicester, Leics, England	Romanian Academy of Sciences; University of Leicester; University of Leicester	Haven, E (corresponding author), Univ Leicester, Sch Management, Leicester, Leics, England.	eh76@le.ac.uk	Caraiani, Petre/A-2963-2009; Haven, E./AAC-2273-2022; Caraiani, Petre/E-9082-2018	Caraiani, Petre/0000-0002-7526-580X; Caraiani, Petre/0000-0002-7526-580X	Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund; Romanian Government [SOP HRD/89/1.5/S/62988]	Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund(European Social Fund (ESF)); Romanian Government(Romanian Government)	This paper is supported by the Sectorial Operational Programme Human Resources Development (SOP HRD), financed from the European Social Fund and by the Romanian Government under the contract number SOP HRD/89/1.5/S/62988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belaire-Franch J, 2002, PHYSICA D, V171, P249, DOI 10.1016/S0167-2789(02)00625-5; BLANCHARD OJ, 1989, AM ECON REV, V79, P655; Casdagli MC, 1997, PHYSICA D, V108, P12, DOI 10.1016/S0167-2789(97)82003-9; Chen WS, 2011, PHYSICA A, V390, P1332, DOI 10.1016/j.physa.2010.12.020; Clarida R, 1999, J ECON LIT, V37, P1661, DOI 10.1257/jel.37.4.1661; Crowley PM, 2008, EUR PHYS J-SPEC TOP, V164, P67, DOI 10.1140/epjst/e2008-00835-3; CROWLEY P.M., 2007, ANAL VISUALIZATION S; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; EVANS GW, 1989, J APPL ECONOMET, V4, P213, DOI 10.1002/jae.3950040302; FRIEDMAN BM, 1974, REV ECON STAT, V56, P167, DOI 10.2307/1924436; FRIEDMAN M, 1968, AM ECON REV, V58, P1; GORDON RJ, 1984, BROOKINGS PAP ECO AC, P537; Karagianni S, 2011, STUD NONLINEAR DYN E, V15; Lo Cascio I, 2013, MANCH SCH, V81, P226, DOI 10.1111/j.1467-9957.2011.02273.x; Marwan N, 2002, PHYS LETT A, V302, P299, DOI 10.1016/S0375-9601(02)01170-2; MARWAN N, 2003, THESIS U POTSDAM; Marwan N, 2011, INT J BIFURCAT CHAOS, V21, P1003, DOI 10.1142/S0218127411029008; Nalewaik JJ, 2010, BROOKINGS PAP ECO AC, P71; Okun A. M., 1962, P BUS EC STAT SECT A, P98, DOI DOI 10.1016/0167-2231(79)90009-5; Palley TI., 1993, INT REV APPL ECON, V7, P144, DOI DOI 10.1080/758530144; PHELPS ES, 1967, ECONOMICA, V34, P254, DOI 10.2307/2552025; Roberts JM, 1995, J MONEY CREDIT BANK, V27, P975, DOI 10.2307/2077783; Romer CD, 1999, J ECON PERSPECT, V13, P23, DOI 10.1257/jep.13.2.23; ROSE H, 1967, REV ECON STUD, V34, P153, DOI 10.2307/2296806; Rothman PA, 2008, STUD NONLINEAR DYN E, V12; Silvapulle P, 2004, CAN J ECON, V37, P353, DOI 10.1111/j.0008-4085.2004.00006.x; Stock JH, 2003, NBER MACROEC ANN-SER, V17, P159; Swamy PAVB, 2007, ECON THEOR, V31, P293, DOI 10.1007/s00199-006-0100-z; TAKANAMI T, 1991, ANN I STAT MATH, V43, P407, DOI 10.1007/BF00053364; Viren M, 2001, ECON LETT, V70, P253, DOI 10.1016/S0165-1765(00)00370-0; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; WEBER CE, 1995, J APPL ECONOMET, V10, P433, DOI 10.1002/jae.3950100407; Zbilut JP, 2005, NEW ECON WINDOWS, P91, DOI 10.1007/88-470-0344-X_5; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M; Zbilut JP, 1998, PHYS LETT A, V246, P122, DOI 10.1016/S0375-9601(98)00457-5	37	16	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e56767	10.1371/journal.pone.0056767	http://dx.doi.org/10.1371/journal.pone.0056767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098BN	23483979	Green Published, gold, Green Submitted			2022-12-27	WOS:000315519000037
J	Kang, HH; Yan, MF; Yu, QH; Yang, Q				Kang, Haihong; Yan, Mengfei; Yu, Qinghua; Yang, Qian			Characteristics of Nasal-Associated Lymphoid Tissue (NALT) and Nasal Absorption Capacity in Chicken	PLOS ONE			English	Article							OVIDUCTAL EPITHELIAL-CELLS; IMMUNE-SYSTEM; MUCOSAL IMMUNITY; INFLUENZA-VIRUS; FALLOPIAN-TUBE; PARTICLES; ANTIGENS; ORGAN; SITE	As the main mucosal immune inductive site of nasal cavity, nasal-associated lymphoid tissue (NALT) plays an important role in both antigen recognition and immune activation after intranasal immunization. However, the efficiency of intranasal vaccines is commonly restricted by the insufficient intake of antigen by the nasal mucosa, resulting from the nasal mucosal barrier and the nasal mucociliary clearance. The distribution of NALT and the characteristic of nasal cavity have already been described in humans and many laboratory rodents, while data about poultry are scarce. For this purpose, histological sections of the chicken nasal cavities were used to examine the anatomical structure and histological characteristics of nasal cavity. Besides, the absorptive capacity of chicken nasal mucosa was also studied using the materials with different particle size. Results showed that the NALT of chicken was located on the bottom of nasal septum and both sides of choanal cleft, which mainly consisted of second lymphoid follicle. A large number of lymphocytes were distributed under the mucosal epithelium of inferior nasal meatus. In addition, there were also diffuse lymphoid tissues located under the epithelium of the concha nasalis media and the walls of nasal cavity. The results of absorption experiment showed that the chicken nasal mucosa was capable to absorb trypan blue, OVA, and fluorescent latex particles. Inactivated avian influenza virus (IAIV) could be taken up by chicken nasal mucosa except for the stratified squamous epithelium sites located on the forepart of nasal cavity. The intake of IAIV by NALT was greater than that of the nasal mucosa covering on non-lymphoid tissue, which could be further enhanced after intranasal inoculation combined with sodium cholate or CpG DNA. The study on NALT and nasal absorptive capacity will be benefit for further understanding of immune mechanisms after nasal vaccination and development of nasal vaccines for poultry.	[Kang, Haihong; Yan, Mengfei; Yu, Qinghua; Yang, Qian] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China.	zxbyq@njau.edu.cn	yu, qing/HGC-4611-2022; Jetten, Anton/C-3736-2019; Yu, Qinghua/T-3261-2019; Garantziotis, Stavros/A-6903-2009	Jetten, Anton/0000-0003-0954-4445; Garantziotis, Stavros/0000-0003-4007-375X	National Science Grant of China [31172302]; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101586, ZICES102445, ZIAES102605, ZICES102486, Z01ES101586] Funding Source: NIH RePORTER	National Science Grant of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Science Grant of China (31172302, http://www.nsfc.gov.cn/), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://www.ec.js.edu.cn/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI N, 1988, JPN J VET SCI, V50, P183; BANG BG, 1968, AM J PATHOL, V53, P735; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Brayden DJ, 2001, EUR J PHARM SCI, V14, P183, DOI 10.1016/S0928-0987(01)00175-0; Casteleyn C, 2010, VET IMMUNOL IMMUNOP, V133, P212, DOI 10.1016/j.vetimm.2009.08.011; FAGERLAND JA, 1993, AVIAN DIS, V37, P10, DOI 10.2307/1591451; FAGERLAND JA, 1990, AM J ANAT, V189, P24, DOI 10.1002/aja.1001890104; Fagerland Jane A., 1993, Regional Immunology, V5, P28; Fujimura Y, 2000, VIRCHOWS ARCH, V436, P560, DOI 10.1007/s004289900177; Golias J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037156; HAMELEERS DMH, 1989, CELL TISSUE RES, V256, P431, DOI 10.1007/BF00218901; Harkema JR, 2006, TOXICOL PATHOL, V34, P252, DOI 10.1080/01926230600713475; Harmsen A, 2002, J IMMUNOL, V168, P986, DOI 10.4049/jimmunol.168.3.986; Heritage PL, 1997, AM J RESP CRIT CARE, V156, P1256, DOI 10.1164/ajrccm.156.4.97-03017; Hiller AS, 1998, SCAND J IMMUNOL, V47, P159; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Itoh H, 2006, AM J REPROD IMMUNOL, V56, P91, DOI 10.1111/j.1600-0897.2006.00389.x; Kanaya T, 2012, NAT IMMUNOL, V13, P729, DOI 10.1038/ni.2352; KUPER CF, 1992, IMMUNOL TODAY, V13, P219; Lathers DMR, 1998, INVEST OPHTH VIS SCI, V39, P1005; Lee HJ, 2005, EXP MOL MED, V37, P297, DOI 10.1038/emm.2005.40; Liu GY, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-36; Liu HS, 2005, INVEST OPHTH VIS SCI, V46, P4217, DOI 10.1167/iovs.05-0280; LOO SK, 1974, J ANAT, V117, P249; Louis KS, 2011, METHODS MOL BIOL, V740, P7, DOI 10.1007/978-1-61779-108-6_2; Mabbott NA, 2013, MUCOSAL IMMUNOL, V6, P666, DOI 10.1038/mi.2013.30; MAIR TS, 1987, J COMP PATHOL, V97, P575, DOI 10.1016/0021-9975(87)90008-9; MAIR TS, 1988, J COMP PATHOL, V99, P159, DOI 10.1016/0021-9975(88)90069-2; Maldonado-Contreras AL, 2011, CELL TISSUE RES, V343, P5, DOI 10.1007/s00441-010-1082-5; Nasu K, 2007, HUM REPROD, V22, P356, DOI 10.1093/humrep/del385; Ohshima K, 2000, HISTOL HISTOPATHOL, V15, P713, DOI 10.14670/HH-15.713; PAPPO J, 1989, CLIN EXP IMMUNOL, V76, P144; Pawar D, 2010, AAPS J, V12, P130, DOI 10.1208/s12248-009-9169-1; Qian L, 2002, ACTA BIOCH BIOPH SIN, V34, P719; Quinteiro P, 2005, ANATOMIA HISTOLOGIA, V34, P41; Reese S, 2006, VET RES, V37, P311, DOI 10.1051/vetres:2006003; Sato S, 2012, CURR OPIN VIROL, V2, P225, DOI 10.1016/j.coviro.2012.03.009; Smialek M, 2011, POL J VET SCI, V14, P291, DOI 10.2478/v10181-011-0047-2; SPIT BJ, 1989, CELL TISSUE RES, V255, P193; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Tamura S, 1998, J GEN VIROL, V79, P291, DOI 10.1099/0022-1317-79-2-291; TlaskalovaHogenova H, 1995, FOLIA MICROBIOL, V40, P385, DOI 10.1007/BF02814746; Yuanji G, 1997, INFLUENZA VIRUS EXPT; Zhang XW, 2009, VACCINE, V27, P5628, DOI 10.1016/j.vaccine.2009.07.023; Zhao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053314; Zuercher AW, 2002, J IMMUNOL, V168, P1796, DOI 10.4049/jimmunol.168.4.1796	46	75	77	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 31	2013	8	12							e84097	10.1371/journal.pone.0084097	http://dx.doi.org/10.1371/journal.pone.0084097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	284MV	24391892	Green Submitted, Green Published, gold			2022-12-27	WOS:000329323900035
J	Liu, XQ; Zhou, CL; Li, YJ; Ji, Y; Xu, GP; Wang, XT; Yan, JL				Liu, Xiaoqi; Zhou, Changlong; Li, Yanjing; Ji, Ye; Xu, Gongping; Wang, Xintao; Yan, Jinglong			SDF-1 Promotes Endochondral Bone Repair during Fracture Healing at the Traumatic Brain Injury Condition	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEAD-INJURY; ENHANCED OSTEOGENESIS; IN-VITRO; MYOCARDIAL-INFARCTION; MARROW; GROWTH; MIGRATION; MODEL; RATS	Purposes: The objective of this study was to investigate the role of stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, on bone healing and whether SDF-1 contributes to accelerating bone repair in traumatic brain injury (TBI)/fracture model. Materials and Methods: Real-time polymerase chain reaction and immunohistochemical analysis were used to detect the expression of SDF-1 during the repair of femoral bone in TBI/fracture model. The TBI/fracture model was treated with anti-SDF-1 neutralizing antibody or AMD3100, an antagonist for CXCR4, and evaluated by histomorphometry. In vitro and in vivo migration assays were used to evaluate the functional effect of SDF-1 on primary mesenchymal stem cells. Results: The expression of SDF1 and CXCR4 messenger RNA was increased during the bone healing in TBI/fracture model but was less increased in fracture only model. High expression of SDF-1 protein was observed in the surrounding tissue of the damaged bone. Treated with anti-SDF-1 antibody or AMD3100 could inhibit new bone formation. SDF-1 increased mesenchymal stem cell chemotaxis in vitro in a dose-dependent manner. The in vivo migration study demonstrated that mesenchymal stem cells recruited by SDF-1 participate in endochondral bone repair. Conclusion: The SDF-1/CXCR4 axis plays a crucial role in the accelerating fracture healing under the condition of TBI and contributes to endochondral bone repair.	[Liu, Xiaoqi; Zhou, Changlong; Li, Yanjing; Ji, Ye; Xu, Gongping; Wang, Xintao; Yan, Jinglong] Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Peoples R China	Harbin Medical University	Yan, JL (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Harbin, Peoples R China.	yanjlhyd@hotmail.com		John, Ciny/0000-0003-3688-0751; Liu, Geoffrey/0000-0002-2603-7296	National Natural Science Foundation of China [100334]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (100334) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Castano-Izquierdo H, 2007, J BIOMED MATER RES A, V82A, P129, DOI 10.1002/jbm.a.31082; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Guo ZK, 2006, STEM CELLS, V24, P992, DOI 10.1634/stemcells.2005-0224; HaraIrie F, 1996, BONE, V18, P29, DOI 10.1016/8756-3282(95)00425-4; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Khare G N, 1995, Indian J Med Sci, V49, P281; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kucia M, 2004, BLOOD CELL MOL DIS, V32, P52, DOI 10.1016/j.bcmd.2003.09.025; Liu XQ, 2012, BIOTECHNOL LETT, V34, P387, DOI 10.1007/s10529-011-0757-7; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mori T, 2004, MOL CANCER THER, V3, P29; Otfinowski Janusz, 1993, Patologia Polska, V44, P133; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; SPENCER RF, 1990, S AFR J SURG, V28, P51; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Sun YX, 2005, J BONE MINER RES, V20, P318, DOI 10.1359/JBMR.041109; Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144; Tiyapatanaputi P, 2004, J ORTHOP RES, V22, P1254, DOI 10.1016/j.orthres.2004.03.017; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; Wieczorek G, 2003, CELL TISSUE RES, V311, P227, DOI 10.1007/s00441-002-0671-3; WILDBURGER R, 1995, EUR J CLIN CHEM CLIN, V33, P693; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4; WILDBURGER R, 1994, RES EXP MED, V194, P247, DOI 10.1007/BF02576386; Wildburger R, 1998, J ENDOCRINOL INVEST, V21, P78, DOI 10.1007/BF03350319; Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013	35	100	110	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e54077	10.1371/journal.pone.0054077	http://dx.doi.org/10.1371/journal.pone.0054077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	24130878	Green Published, gold, Green Submitted			2022-12-27	WOS:000314019100041
